PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Saitoh, S; Okano, S; Nohara, H; Nakano, H; Shirasawa, N; Naito, A; Yamamoto, M; Kelly, VP; Takahashi, K; Tanaka, T; Nakajima, M; Nakajima, O				Saitoh, Shinichi; Okano, Satoshi; Nohara, Hidekazu; Nakano, Hiroshi; Shirasawa, Nobuyuki; Naito, Akira; Yamamoto, Masayuki; Kelly, Vincent P.; Takahashi, Kiwamu; Tanaka, Tohru; Nakajima, Motowo; Nakajima, Osamu			5-aminolevulinic acid (ALA) deficiency causes impaired glucose tolerance and insulin resistance coincident with an attenuation of mitochondrial function in aged mice	PLOS ONE			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; REV-ERB-ALPHA; SKELETAL-MUSCLE; HEME DEFICIENCY; NONSPECIFIC FORM; RAT-LIVER; DYSFUNCTION; EXPRESSION; INHIBITION; METABOLISM	In vertebrates, the initial step in heme biosynthesis is the production of 5-aminolevulinic acid (ALA) by ALA synthase (ALAS). ALA formation is believed to be the rate-limiting step for cellular heme production. Recently, several cohort studies have demonstrated the potential of ALA as a treatment for individuals with prediabetes and type-2 diabetes mellitus. These studies imply that a mechanism exists by which ALA or heme can control glucose metabolism. The ALAS1 gene encodes a ubiquitously expressed isozyme. Mice heterozygous null for ALAS1 (A1(+/-)s) experience impaired glucose tolerance (IGT) and insulin resistance (IR) beyond 20-weeks of age (aged A1(+/-)s). IGT and IR were remedied in aged A1(+/-)s by the oral administration of ALA for 1 week. However, the positive effect of ALA proved to be reversible and was lost upon termination of ALA administration. In the skeletal muscle of aged A1(+/-)s an attenuation of mitochondrial function is observed, coinciding with IGT and IR. Oral administration of ALA for 1-week brought about only a partial improvement in mitochondrial activity however, a 6-week period of ALA treatment was sufficient to remedy mitochondrial function. Studies on differentiated C2C12 myocytes indicate that the impairment of glucose metabolism is a cell autonomous effect and that ALA deficiency ultimately leads to heme depletion. This sequela is evidenced by a reduction of glucose uptake in C2C12 cells following the knockdown of ALAS1 or the inhibition of heme biosynthesis by succinylacetone. Our data provide in vivo proof that ALA deficiency attenuates mitochondrial function, and causes IGT and IR in an age-dependent manner. The data reveals an unexpected metabolic link between heme and glucose that is relevant to the pathogenesis of IGT/IR.	[Saitoh, Shinichi; Okano, Satoshi; Nohara, Hidekazu; Nakano, Hiroshi; Nakajima, Osamu] Yamagata Univ, Fac Med, Res Ctr Mol Genet, Inst Promot Med Sci Res, Yamagata, Yamagata, Japan; [Shirasawa, Nobuyuki; Naito, Akira] Yamagata Univ, Fac Med, Dept Anat & Struct Sci, Yamagata, Yamagata, Japan; [Yamamoto, Masayuki] Tohoku Univ, Sch Med, Dept Med Biochem, Sendai, Miyagi, Japan; [Kelly, Vincent P.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Takahashi, Kiwamu; Tanaka, Tohru; Nakajima, Motowo] SBI Pharmaceut Co Ltd, Tokyo, Japan	Yamagata University; Yamagata University; Tohoku University; Trinity College Dublin; SBI Pharmaceuticals	Nakajima, O (corresponding author), Yamagata Univ, Fac Med, Res Ctr Mol Genet, Inst Promot Med Sci Res, Yamagata, Yamagata, Japan.	nakajima@med.id.yamagata-u.ac.jp	Kelly, Vincent P/I-2151-2017; Yamamoto, Masayuki/A-4873-2010	Kelly, Vincent P/0000-0001-7067-5407; Yamamoto, Masayuki/0000-0002-9073-9436; Saitoh, Shinichi/0000-0001-7523-8177	JSPS KAKENHI [25670158]; SBI Pharmaceuticals Co.,Ltd. (Tokyo, Japan); SBI Pharmaceuticals Co., Ltd., Tokyo, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SBI Pharmaceuticals Co.,Ltd. (Tokyo, Japan); SBI Pharmaceuticals Co., Ltd., Tokyo, Japan	This study was supported by JSPS KAKENHI (Grant-in-Aid for Challenging Exploratory Research) Grant Number 25670158 and was a cooperative research effort with SBI Pharmaceuticals Co.,Ltd. (Tokyo, Japan), who provided financial support for the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A part of the study was financially supported by SBI Pharmaceuticals Co., Ltd., Tokyo, Japan. The authors who are employees of SBI Pharmaceuticals Co., Ltd. have committed to study design, supply of materials, result analysis, discussion and manuscript preparation but not to data collection by executing the experiments. In particular, they performed a critical role in the design of the study.	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; ABRAHAM NG, 1985, EXP GERONTOL, V20, P277, DOI 10.1016/0531-5565(85)90053-1; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799; Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200; Bakhtiyari S, 2010, LIPIDS, V45, P237, DOI 10.1007/s11745-010-3394-3; BISHOP DF, 1990, NUCLEIC ACIDS RES, V18, P7187, DOI 10.1093/nar/18.23.7187; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fujii C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03917-0; Fuse Y, 2015, GENES CELLS, V20, P590, DOI 10.1111/gtc.12249; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Higashikawa F, 2013, NUTRITION, V29, P1030, DOI 10.1016/j.nut.2013.02.008; Hoeks J, 2012, TRENDS ENDOCRIN MET, V23, P444, DOI 10.1016/j.tem.2012.05.007; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; KIKUCHI G, 1981, MOL CELL BIOCHEM, V37, P27, DOI 10.1007/BF02355885; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; MAY BK, 1986, CURR TOP CELL REGUL, V28, P233; MORITA Y, 1994, IND HEALTH, V32, P85, DOI 10.2486/indhealth.32.85; Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282; Nakajima O, 2006, GENES CELLS, V11, P685, DOI 10.1111/j.1365-2443.2006.00973.x; Oishi H, 1996, J ANAL TOXICOL, V20, P106, DOI 10.1093/jat/20.2.106; Okano S, 2010, GENES CELLS, V15, P77, DOI 10.1111/j.1365-2443.2009.01366.x; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Rodriguez BL, 2012, CTS-CLIN TRANSL SCI, V5, P314, DOI 10.1111/j.1752-8062.2012.00421.x; Sassa S, 1982, Trans Assoc Am Physicians, V95, P42; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Taketani S, 2005, TOHOKU J EXP MED, V205, P297, DOI 10.1620/tjem.205.297; Wang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033426; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809; Yamada M, 1988, JPN J LAB AUTO, V13, P659; Yamamoto M, 2000, INT J HEMATOL, V72, P157; YAMAMOTO M, 1985, P NATL ACAD SCI USA, V82, P3702, DOI 10.1073/pnas.82.11.3702; YAMAMOTO M, 1982, BIOCHEM BIOPH RES CO, V105, P985, DOI 10.1016/0006-291X(82)91067-1; YAMAMOTO M, 1983, BIOCHEM BIOPH RES CO, V115, P225, DOI 10.1016/0006-291X(83)90993-2; YAMAMOTO M, 1988, J BIOL CHEM, V263, P15973; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; YOMOGIDA K, 1993, J BIOCHEM-TOKYO, V113, P364, DOI 10.1093/oxfordjournals.jbchem.a124052	48	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0189593	10.1371/journal.pone.0189593	http://dx.doi.org/10.1371/journal.pone.0189593			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364890	Green Published, gold, Green Submitted			2022-12-27	WOS:000423412500005
J	Carrillo, JB; Gomez-Casati, DF; Martin, M; Busi, MV				Carrillo, Julieta B.; Gomez-Casati, Diego F.; Martin, Mariana; Busi, Maria V.			Identification and analysis of OsttaDSP, a phosphoglucan phosphatase from &ITOstreococcus tauri&IT	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GLUCAN PHOSPHATASES; SEX FOUR2; STARCH DEPHOSPHORYLATION; 3-DIMENSIONAL STRUCTURES; ARABIDOPSIS-THALIANA; LAFORA DISEASE; GREEN-ALGAE; R1 PROTEIN; METABOLISM	Ostreococcus tauri, the smallest free-living (non-symbiotic) eukaryote yet described, is a unicellular green alga of the Prasinophyceae family. It has a very simple cellular organization and presents a unique starch granule and chloroplast. However, its starch metabolism exhibits a complexity comparable to higher plants, with multiple enzyme forms for each metabolic reaction. Glucan phosphatases, a family of enzymes functionally conserved in animals and plants, are essential for normal starch or glycogen degradation in plants and mammals, respectively. Despite the importance of O. tauri microalgae in evolution, there is no information available concerning the enzymes involved in reversible phosphorylation of starch. Here, we report the molecular cloning and heterologous expression of the gene coding for a dual specific phosphatase from O. tauri (OsttaDSP), homologous to Arabidopsis thaliana LSF2. The recombinant enzyme was purified to electrophoretic homogeneity to characterize its oligomeric and kinetic properties accurately. OsttaDSP is a homodimer of 54.5 kDa that binds and dephosphorylates amylopectin. Also, we also determined that residue C162 is involved in catalysis and possibly also in structural stability of the enzyme. Our results could contribute to better understand the role of glucan phosphatases in the metabolism of starch in green algae.	[Carrillo, Julieta B.; Gomez-Casati, Diego F.; Martin, Mariana; Busi, Maria V.] Univ Nacl Rosario, CONICET, Ctr Estudios Fotosintet & Bioquim CEFOBI, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Martin, M; Busi, MV (corresponding author), Univ Nacl Rosario, CONICET, Ctr Estudios Fotosintet & Bioquim CEFOBI, Rosario, Santa Fe, Argentina.	martin@cefobi-conicet.gov.ar; busi@cefobi-conicet.gov.ar		Busi, Maria Victoria/0000-0003-3638-7043	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP00134-2012, PIP0476-2015]; Agencia Nacional de Investigaciones Cienntificas y Tecnologicas [PICT 2011-0982, PICT 2013-2438]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Investigaciones Cienntificas y Tecnologicas	This work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas PIP00134-2012; PIP0476-2015. (www.conicet.gov.ar) and Agencia Nacional de Investigaciones Cienntificas y Tecnologicas PICT 2011-0982; PICT 2013-2438 (www.agencia.mincyt.gob.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ball S, 2015, TRANSITION GLYCOGEN, P93; Barchiesi Julieta, 2015, BMC Research Notes, V8, P613, DOI 10.1186/s13104-015-1598-6; Blennow A, 2000, INT J BIOL MACROMOL, V27, P211, DOI 10.1016/S0141-8130(00)00121-5; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Busi MV, 2014, STARCH-STARKE, V66, P28, DOI 10.1002/star.201200211; Carciofi M, 2011, J CEREAL SCI, V54, P339, DOI 10.1016/j.jcs.2011.06.013; Carrillo JB, 2017, ANAL BIOCHEM, V517, P36, DOI 10.1016/j.ab.2016.11.005; CASPAR T, 1991, PLANT PHYSIOL, V95, P1181, DOI 10.1104/pp.95.4.1181; Dukhande VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024040; Emanuelle S, 2016, CELL MOL LIFE SCI, V73, P2765, DOI 10.1007/s00018-016-2249-3; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2016, CURR OPIN STRUC BIOL, V40, P62, DOI 10.1016/j.sbi.2016.07.015; Gentry MS, 2013, FEBS J, V280, P525, DOI 10.1111/j.1742-4658.2012.08549.x; Gentry MS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-138; Hofmann NR, 2013, PLANT CELL, V25, P1915, DOI 10.1105/tpc.113.250614; Kerk D, 2006, PLANT J, V46, P400, DOI 10.1111/j.1365-313X.2006.02704.x; Kooi CWV, 2010, P NATL ACAD SCI USA, V107, P15379, DOI 10.1073/pnas.1009386107; Lorberth R, 1998, NAT BIOTECHNOL, V16, P473, DOI 10.1038/nbt0598-473; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maliandi MV, 2007, PROTEIN EXPRES PURIF, V51, P157, DOI 10.1016/j.pep.2006.06.007; Meekins DA, 2015, J BIOL CHEM, V290, P23361, DOI 10.1074/jbc.M115.658203; Meekins DA, 2014, P NATL ACAD SCI USA, V111, P7272, DOI 10.1073/pnas.1400757111; Meekins DA, 2013, PLANT CELL, V25, P2302, DOI 10.1105/tpc.113.112706; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Niittyla T, 2006, J BIOL CHEM, V281, P11815, DOI 10.1074/jbc.M600519200; PLAXTON WC, 1989, EUR J BIOCHEM, V181, P443, DOI 10.1111/j.1432-1033.1989.tb14745.x; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Roach PJ, 2015, MOL ASPECTS MED, V46, P78, DOI 10.1016/j.mam.2015.08.003; Santelia D, 2011, PLANT CELL, V23, P4096, DOI 10.1105/tpc.111.092155; Serratosa J M, 1999, Neurologia, V14, P325; Sherwood AR, 2013, CLIN BIOCHEM, V46, P1869, DOI 10.1016/j.clinbiochem.2013.08.016; Sherwood AR, 2013, ANAL BIOCHEM, V435, P54, DOI 10.1016/j.ab.2012.10.044; Silver DM, 2014, TRENDS PLANT SCI, V19, P471, DOI 10.1016/j.tplants.2014.01.008; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sokolov LN, 2006, P NATL ACAD SCI USA, V103, P9732, DOI 10.1073/pnas.0603329103; Tardif M, 2012, MOL BIOL EVOL, V29, P3625, DOI 10.1093/molbev/mss178; Tester RF, 2004, WORLD POULTRY SCI J, V60, P186, DOI [10.1079/WPS200312, 10.1079/WPS200412, 10.1079/WPS20040014]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Turowski VR, 2012, MOL PLANT, V5, P1001, DOI 10.1093/mp/sss037; Westcott KR, 1997, Q REV BIOL, V72, P200; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilkens C, 2016, FEBS LETT, V590, P118, DOI 10.1002/1873-3468.12027; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012	48	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191621	10.1371/journal.pone.0191621	http://dx.doi.org/10.1371/journal.pone.0191621			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360855	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800042
J	Shayegani, R; Song, KW; Amuan, ME; Jaramillo, CA; Eapen, BC; Pugh, MJ				Shayegani, Ramona; Song, Kangwon; Amuan, Megan E.; Jaramillo, Carlos A.; Eapen, Blessen C.; Pugh, Mary Jo			Patterns of zolpidem use among Iraq and Afghanistan veterans: A retrospective cohort analysis	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; NIGHTLY ZOLPIDEM; BEHAVIORAL TREATMENT; DRUG OVERDOSE; INSOMNIA; RISK; HYPNOTICS; DEATHS; PRESCRIPTIONS; MORTALITY	Background & para;& para;Although concern exists regarding the adverse effects and rate of zolpidem use, especially long-term use, limited information is available concerning patterns of zolpidem use.& para;& para; Objective & para;& para;To examine the prevalence and correlates of zolpidem exposure in Iraq and Afghanistan Veterans (IAVs).& para;& para;Methods & para;& para;A retrospective cohort study of zolpidem prescriptions was performed with National Veterans Health Administration (VHA) data. We gathered national VA inpatient, outpatient, and pharmacy data files for IAV's who received VA care between fiscal years (FY) 2013 and 2014. The VA pharmacy database was used to identify the prevalence of long term (>30 days), high-dose zolpidem exposure (>10mg immediate-release; >12.5mg extended-release) and other medications received in FY14. Baseline characteristics (demographics, diagnoses) were identified in FY13. Bivariate and multivariable analyses were used to examine the demographic, clinical, and medication correlates of zolpidem use.& para;& para;Results & para;& para;Of 493,683 IAVs who received VHA care in FY 2013 and 2014, 7.6% (n = 37,422) were prescribed zolpidem in FY 2014. Women had lower odds of high-dose zolpidem exposure than men. The majority (77.3%) of IAVs who received zolpidem prescriptions had long-term use with an average days' supply of 189.3 days and a minority (0.9%) had high-dose exposure. In multivariable analyses, factors associated with long-term zolpidem exposure included age greater than 29 years old, PTSD, insomnia, Selim Index, physical 2-3 conditions, opioids, antidepressants, benzodiazepines, atypical antipsychotics, and stimulants. High dose exposure was associated with PTSD, depression, substance use disorder, insomnia, benzodiazepines, atypical antipsychotics, and stimulant prescriptions.& para;& para;Conclusion & para;& para;The current practices of insomnia pharmacotherapy in IAVs fall short of the clinical guidelines and may reflect high-risk zolpidem prescribing practices that put Iraq and Afghanistan Veterans at risk for adverse effects of zolpidem and poor health outcomes.	[Shayegani, Ramona] VA Southern Nevada Healthcare Syst, North Las Vegas, NV USA; [Song, Kangwon; Jaramillo, Carlos A.; Eapen, Blessen C.; Pugh, Mary Jo] South Texas Vet Hlth Care Syst, San Antonio, TX 78228 USA; [Song, Kangwon; Jaramillo, Carlos A.; Eapen, Blessen C.; Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Amuan, Megan E.] Edith Nourse Rogers Mem Vet Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84148 USA; [Pugh, Mary Jo] Univ Utah Hlth, Div Epidemiol, Salt Lake City, UT 84112 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah	Pugh, MJ (corresponding author), South Texas Vet Hlth Care Syst, San Antonio, TX 78228 USA.; Pugh, MJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.; Pugh, MJ (corresponding author), VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84148 USA.; Pugh, MJ (corresponding author), Univ Utah Hlth, Div Epidemiol, Salt Lake City, UT 84112 USA.	pughm@uthscsa.edu	Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763; Song, Kangwon/0000-0001-6642-8753	VA, Office of Research and Development; VA Health Services Research and Development Services [1I01HX001304-01, 1I01HX000717-01]; Department of Veterans Affairs (VA) Health Services Research and Development Services [DHI 09-237]; Chronic Effects of Neurotrauma Consortium award [W81XWH-12-04 PHTBI-CENC]; VA Introduction Rehabilitation Research and Development Service [I21 RX002060-01]	VA, Office of Research and Development; VA Health Services Research and Development Services; Department of Veterans Affairs (VA) Health Services Research and Development Services(US Department of Veterans Affairs); Chronic Effects of Neurotrauma Consortium award; VA Introduction Rehabilitation Research and Development Service	This study was funded by the Department of Veterans Affairs (VA) Health Services Research and Development Services (DHI 09-237) [Pugh]. Dr. Pugh receives additional funding from the VA, Office of Research and Development, VA Health Services Research and Development Services (1I01HX001304-01, 1I01HX000717-01), VA Introduction Rehabilitation Research and Development Service (I21 RX002060-01) and the Chronic Effects of Neurotrauma Consortium award (W81XWH-12-04 PHTBI-CENC).	Anderson BJ, 2014, PEDIATR ANESTH, V24, P549, DOI 10.1111/pan.12421; Bernardy NC, 2012, J CLIN PSYCHIAT, V73, P297, DOI 10.4088/JCP.11m07311; Blom K, 2016, SLEEP, V39, P1267, DOI 10.5665/sleep.5850; Bohnert ASB, 2013, INJURY PREV, V19, P326, DOI 10.1136/injuryprev-2012-040631; Bohnert ASB, 2011, MED CARE, V49, P393, DOI 10.1097/MLR.0b013e318202aa27; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Buysse DJ, 2013, JAMA-J AM MED ASSOC, V309, P706, DOI 10.1001/jama.2013.193; Collett GA., 2016, DRUGS-REAL WOR OUTC, V3, P45; Copeland LA, 2016, MED CARE, V55, P1078, DOI 10.1097/MLR.0000000000000588; Drug Abuse Warning Network, 2011, NAT EST DRUG REL EM; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Finley EP, 2010, MIL MED, V175, P953, DOI 10.7205/MILMED-D-10-00040; Hajak G, 2003, ADDICTION, V98, P1371, DOI 10.1046/j.1360-0443.2003.00491.x; Hampton LM, 2014, JAMA PSYCHIAT, V71, P1006, DOI 10.1001/jamapsychiatry.2014.436; Ho FYY, 2015, SLEEP MED REV, V19, P17, DOI 10.1016/j.smrv.2014.06.010; Jaramillo CA, 2015, BRAIN IMAGING BEHAV, V9, P445, DOI 10.1007/s11682-015-9402-8; Jones CM, 2015, AM J PREV MED, V49, P493, DOI 10.1016/j.amepre.2015.03.040; Kaufmann CN, 2016, PHARMACOEPIDEM DR S, V25, P637, DOI 10.1002/pds.3951; Knapik JJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-231; Kolla BP, 2013, J HOSP MED, V8, P1, DOI 10.1002/jhm.1985; Kripke DF, 2016, DRUG SAFETY, V39, P93, DOI 10.1007/s40264-015-0362-0; Lai MM, 2014, MAYO CLIN PROC, V89, P589, DOI 10.1016/j.mayocp.2014.01.021; Licata SC, 2008, PHARMACOL BIOCHEM BE, V90, P74, DOI 10.1016/j.pbb.2008.01.001; Lund BC, 2012, J CLIN PSYCHIAT, V73, P292, DOI 10.4088/JCP.10m06775; MALCOLM R, 1993, J PSYCHOACTIVE DRUGS, V25, P315, DOI 10.1080/02791072.1993.10472289; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Management of Concussion-mild Traumatic Brain Injury (mTBI), 2016, VA DOD CLIN PRACT GU; Management of Post-Traumatic Stress Working Group, 2010, VA DOD CLIN PRACT GU; Management of Post-Traumatic Stress Working Group, 2010, VA DOD CLIN PRACT GU, P1; Morgenthaler T, 2006, SLEEP, V29, P1415; Morgenthaler TI, 2014, MAYO CLIN PROC, V89, P579, DOI 10.1016/j.mayocp.2014.03.006; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Park TW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2698; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Randall S, 2012, SLEEP, V35, P1551, DOI 10.5665/sleep.2208; Rochon PA, 1997, BMJ-BRIT MED J, V315, P1096, DOI 10.1136/bmj.315.7115.1096; Roehrs TA, 2012, J PSYCHOPHARMACOL, V26, P1088, DOI 10.1177/0269881111424455; Roehrs TA, 2011, SLEEP, V34, P207, DOI 10.1093/sleep/34.2.207; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; Seyffert M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149139; Sun EC, 2017, BMJ; Tjagvad C, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0881-y; Turner BJ, 2015, J GEN INTERN MED, V30, P1081, DOI 10.1007/s11606-015-3199-4; Verster JC, 2002, J CLIN PSYCHOPHARM, V22, P576, DOI 10.1097/00004714-200212000-00007; Victorri-Vigneau C, 2013, EUR J CLIN PHARMACOL, V69, P1965, DOI 10.1007/s00228-013-1557-x; Vincent N, 2013, J CLIN SLEEP MED, V9, P227, DOI 10.5664/jcsm.2484; Wang PS, 2001, J AM GERIATR SOC, V49, P1685, DOI 10.1111/j.1532-5415.2001.49280.x; Weaver Michael F., 2015, Yale Journal of Biology and Medicine, V88, P247; Yang Z, 2015, J PAIN, V16, P445, DOI 10.1016/j.jpain.2015.01.475; Ye YY, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010707; Yoon JR, 2010, J INT MED RES, V38, P1795, DOI 10.1177/147323001003800526; Zedler B, 2014, PAIN MED, V15, P1911, DOI 10.1111/pme.12480; Zosel A, 2011, AM J THER, V18, P305, DOI 10.1097/MJT.0b013e3181d169ed	55	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190022	10.1371/journal.pone.0190022	http://dx.doi.org/10.1371/journal.pone.0190022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360821	gold, Green Published, Green Submitted			2022-12-27	WOS:000423161800006
J	Mujibi, FD; Okoth, E; Cheruiyot, EK; Onzere, C; Bishop, RP; Fevre, EM; Thomas, L; Masembe, C; Plastow, G; Rothschild, M				Mujibi, Fidalis Denis; Okoth, Edward; Cheruiyot, Evans K.; Onzere, Cynthia; Bishop, Richard P.; Fevre, Eric M.; Thomas, Lian; Masembe, Charles; Plastow, Graham; Rothschild, Max			Genetic diversity, breed composition and admixture of Kenyan domestic pigs	PLOS ONE			English	Article							AFRICAN-SWINE-FEVER; GENOME; ASSOCIATION; SELECTION; ANCESTRY; VIRUS	The genetic diversity of African pigs, whether domestic or wild has not been widely studied and there is very limited published information available. Available data suggests that African domestic pigs originate from different domestication centers as opposed to international commercial breeds. We evaluated two domestic pig populations in Western Kenya, in order to characterize the genetic diversity, breed composition and admixture of the pigs in an area known to be endemic for African swine fever (ASF). One of the reasons for characterizing these specific populations is the fact that a proportion of indigenous pigs have tested ASF virus (ASFv) positive but do not present with clinical symptoms of disease indicating some form of tolerance to infection. Pigs were genotyped using either the porcine SNP60 or SNP80 chip. Village pigs were sourced from Busia and Homabay counties in Kenya. Because bush pigs (Potamochoerus larvatus) and warthogs (Phacochoerus spp.) are known to be tolerant to ASFv infection (exhibiting no clinical symptoms despite infection), they were included in the study to assess whether domestic pigs have similar genomic signatures. Additionally, samples representing European wild boar and international commercial breeds were included as references, given their potential contribution to the genetic make-up of the target domestic populations. The data indicate that village pigs in Busia are a non-homogenous admixed population with significant introgression of genes from international commercial breeds. Pigs from Homabay by contrast, represent a homogenous population with a "local indigenous' composition that is distinct from the international breeds, and clusters more closely with the European wild boar than African wild pigs. Interestingly, village pigs from Busia that tested negative by PCR for ASFv genotype IX, had significantly higher local ancestry (> 54%) compared to those testing positive, which contained more commercial breed gene introgression. This may have implication for breed selection and utilization in ASF endemic areas. A genome wide scan detected several regions under preferential selection with signatures for pigs from Busia and Homabay being very distinct. Additionally, there was no similarity in specific genes under selection between the wild pigs and domestic pigs despite having some broad areas under similar selection signatures. These results provide a basis to explore possible genetic determinants underlying tolerance to infection by ASFv genotypes and suggests multiple pathways for genetically mediated ASFv tolerance given the diversity of selection signatures observed among the populations studied.	[Mujibi, Fidalis Denis] Nelson Mandela Africa Inst Sci & Technol, Arusha, Tanzania; [Mujibi, Fidalis Denis; Cheruiyot, Evans K.] USOMI Ltd, Nairobi, Kenya; [Okoth, Edward; Fevre, Eric M.] Int Livestock Res Inst, Nairobi, Kenya; [Onzere, Cynthia; Bishop, Richard P.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Fevre, Eric M.] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool, Cheshire, England; [Thomas, Lian] Univ Edinburgh, Ctr Infect Immun & Evolut, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Masembe, Charles] Makerere Univ, Coll Nat Sci, Kampala, Uganda; [Plastow, Graham] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Rothschild, Max] Iowa State Univ, Dept Anim Sci, Ames, IA USA	Nelson Mandela African Institution of Science & Technology; CGIAR; International Livestock Research Institute (ILRI); Washington State University; University of Liverpool; University of Edinburgh; Makerere University; University of Alberta; Iowa State University	Mujibi, FD (corresponding author), Nelson Mandela Africa Inst Sci & Technol, Arusha, Tanzania.; Mujibi, FD (corresponding author), USOMI Ltd, Nairobi, Kenya.	fmujibi@gmail.com	Thomas, Lian/H-2818-2019; Mujibi, Denis Fidalis/AAJ-2740-2020	Thomas, Lian/0000-0001-8447-1210; Mujibi, Denis Fidalis/0000-0002-1478-9001; Fevre, Eric/0000-0001-8931-4986; Masembe, Charles/0000-0002-9581-0414	AusAID; Wellcome trust [085308, 105684/Z/14/Z]; University of Edinburgh Innovation Initiative Grant fund; USDA/FAS [58-3148-1-252]; Swedish Research Links Programme (Swedish research council); Ensminger Endowment; US Pig Genome Coordination Program; State of Iowa; Hatch funding; USOMI Limited; Biotechnology and Biological Sciences Research Council [BB/L019019/1] Funding Source: researchfish; BBSRC [BB/L019019/1] Funding Source: UKRI	AusAID(Australian Aid (AusAID)); Wellcome trust(Wellcome TrustEuropean Commission); University of Edinburgh Innovation Initiative Grant fund; USDA/FAS(United States Department of Agriculture (USDA)); Swedish Research Links Programme (Swedish research council); Ensminger Endowment; US Pig Genome Coordination Program; State of Iowa; Hatch funding; USOMI Limited; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Porcine sample collection was funded by AusAID, the Wellcome trust (grant #085308) and The University of Edinburgh Innovation Initiative Grant fund. Bush pig sample collection in Uganda was made possible with financial support obtained through the USDA/FAS cooperative agreement 58-3148-1-252 and the Swedish Research Links Programme (Swedish research council) and the Wellcome Trust [105684/Z/14/Z]. Genotyping was made possible thanks to funds provided by the Ensminger Endowment and the US Pig Genome Coordination Program, State of Iowa and Hatch funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [Peter Bishop, Edward Okoth, Charles Masembe, Cynthia Onzere] and reagents, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. USOMI Limited provided support in the form of salaries for authors [FM, EC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguero M, 2003, J CLIN MICROBIOL, V41, P4431, DOI 10.1128/JCM.41.9.4431-4434.2003; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amills M, 2010, ENCY LIFE SCI; [Anonymous], 2010, VET REC, V166, P546, DOI [10.1136/vr.c2373, 10.1136/yr.c2373]; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Blench RM, ORIGINS DEV AFRICAN; Briggs H.M., 1969, MODERN BREEDS LIVEST; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Gallardo C, 2009, VIRUS GENES, V38, P85, DOI 10.1007/s11262-008-0293-2; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Gongora J, 2011, ZOOL SCR, V40, P327, DOI 10.1111/j.1463-6409.2011.00480.x; Holness D. H., 1974, RHOD J AGR RES, V73, P59; Jia X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14605; Herrero-Medrano JM, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-106; Noce A, 2015, ANIM GENET, V46, P433, DOI 10.1111/age.12305; Oliver WL., 1993, PIGS PECCARIES HIPPO; Oura CAL, 1998, J GEN VIROL, V79, P1439, DOI 10.1099/0022-1317-79-6-1439; Penrith M.L., 2004, INFECT DIS LIVESTOCK, P1087; Porter V., 1993, PIGS HDB BREEDS WORL; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Thomas LF, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0830-5; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072	24	26	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0190080	10.1371/journal.pone.0190080	http://dx.doi.org/10.1371/journal.pone.0190080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357367	gold, Green Published, Green Submitted			2022-12-27	WOS:000422919500003
J	Garcia-Ruiz, E; Loureiro, I; Farinos, GP; Gomez, P; Gutierrez, E; Sanchez, FJ; Escorial, MC; Ortego, F; Chueca, MC; Castanera, P				Garcia-Ruiz, Esteban; Loureiro, Inigo; Farinos, Gema P.; Gomez, Pablo; Gutierrez, Elena; Javier Sanchez, Francisco; Concepcion Escorial, Maria; Ortego, Felix; Cristina Chueca, Maria; Castanera, Pedro			Weeds and ground-dwelling predators' response to two different weed management systems in glyphosate-tolerant cotton: A farm-scale study	PLOS ONE			English	Article							MODIFIED HERBICIDE-TOLERANT; INVERTEBRATE RESPONSES; PLANT DIVERSITY; SUGAR-BEET; CROPS; POPULATIONS; ABUNDANCE; IMPACTS; MAIZE; FIELD	The use of glyphosate, as a post-emergence broad-spectrum herbicide in genetically modified glyphosate-tolerant (GT) cotton, supposes a big change in weed management programs with respect to a conventional regime. Thus, alterations in arable flora and arthropod fauna must be considered when evaluating their potential impacts. A 3-year farm-scale study was conducted in a 2-ha GT cotton crop, in southern Spain, to compare the effects of conventional and glyphosate herbicide regimes on weed abundance and diversity and their consequences for ground-dwelling predators. Surveys reveal that weed density was relatively low within all treatments with a few dominant species, with significantly higher weed densities and modifications of the floristic composition in glyphosate-treated plots that led to an increase in the abundance of Portulaca oleracea and to a reduction in plant diversity. The activity-density of the main predatory arthropod taxa (spiders, ground beetles, rove beetles and earwigs) varied among years, but no significant differences were obtained between conventional and glyphosate herbicide regimes. However, significant differences between treatments were obtained for ground beetles species richness and diversity, being higher under the glyphosate herbicide regime, and a positive correlation with weed density could be established for both parameters. The implications of these findings to weed control in GT cotton are discussed.	[Garcia-Ruiz, Esteban; Loureiro, Inigo; Gomez, Pablo; Gutierrez, Elena; Javier Sanchez, Francisco; Concepcion Escorial, Maria; Cristina Chueca, Maria] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Protecc Vegetal, Lab Malherbol, Madrid, Spain; [Farinos, Gema P.; Ortego, Felix; Castanera, Pedro] CSIC, Ctr Invest Biol, Dept Biol Medioambiental, Lab Interacc Planta Insecto, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Loureiro, I (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Protecc Vegetal, Lab Malherbol, Madrid, Spain.	loureiro@inia.es	Loureiro, Iñigo/F-2451-2010; Escorial, María Concepción/ABG-2982-2020; Ortego, Félix/F-9402-2011; FARINÓS, GEMA P./D-9849-2015	Loureiro, Iñigo/0000-0003-3022-2002; Ortego, Félix/0000-0002-7778-8508; FARINÓS, GEMA P./0000-0002-4952-5372; Escorial Bonet, Maria Concepcion/0000-0001-5507-5956	Spanish Ministry for Environment, Marine and Rural Affairs [AEG 06-038]	Spanish Ministry for Environment, Marine and Rural Affairs	This work was supported by the Spanish Ministry for Environment, Marine and Rural Affairs (grant AEG 06-038) to MCC.	Albajes R., 2014, Journal of Agricultural Science (Toronto), V6, P67; Albajes R, 2009, ENVIRON ENTOMOL, V38, P944, DOI 10.1603/022.038.0349; [Anonymous], 2001, PLANT STRATEGIES VEG; Bell JR, 2001, J ZOOL, V255, P377, DOI 10.1017/S0952836901001479; Bonny S, 2016, ENVIRON MANAGE, V57, P31, DOI 10.1007/s00267-015-0589-7; Brooks DR, 2003, PHILOS T R SOC B, V358, P1847, DOI 10.1098/rstb.2003.1407; BRUST GE, 1990, PESTIC SCI, V30, P309, DOI 10.1002/ps.2780300308; Buckelew LD, 2000, J ECON ENTOMOL, V93, P1437, DOI 10.1603/0022-0493-93.5.1437; Cao MX, 2011, J AGR FOOD CHEM, V59, P5830, DOI 10.1021/jf104233h; Carpenter Janet E, 2011, GM Crops, V2, P7, DOI 10.4161/gmcr.2.1.15086; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; Cerdeira AL, 2006, J ENVIRON QUAL, V35, P1633, DOI 10.2134/jeq2005.0378; Coble HD, 1992, WEEDS COTTON CHARACT, P73; Culpepper AS, 2006, WEED TECHNOL, V20, P277, DOI 10.1614/WT-04-155R.1; DEFRA, 2005, FARM SCAL EV MAN GM; Dewar AM, 2009, PEST MANAG SCI, V65, P1047, DOI 10.1002/ps.1806; Dewar AM, 2003, P ROY SOC B-BIOL SCI, V270, P335, DOI 10.1098/rspb.2002.2248; Dotray, 2008, TEXAS J AGR NAT RESO, V21, P1; European Commission, 2007, STUD COTT SECT EUR U; Evans SC, 2010, ECOTOXICOLOGY, V19, P1249, DOI 10.1007/s10646-010-0509-9; Gaupp-Berghausen M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12886; Griesinger LM, 2011, CHEMOSPHERE, V84, P1461, DOI 10.1016/j.chemosphere.2011.04.044; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Hagler JR, 2016, FOOD WEBS, V4, P8; Haughton AJ, 2003, PHILOS T ROY SOC B, V358, P1863, DOI 10.1098/rstb.2003.1408; Haughton AJ, 2001, PEST MANAG SCI, V57, P1037, DOI 10.1002/ps.389; Hawes C, 2003, PHILOS T ROY SOC B, V358, P1899, DOI 10.1098/rstb.2003.1406; Heard MS, 2003, PHILOS T ROY SOC B, V358, P1819, DOI 10.1098/rstb.2003.1402; Henle K, 2008, AGR ECOSYST ENVIRON, V124, P60, DOI 10.1016/j.agee.2007.09.005; Hilgenfeld KL, 2004, WEED TECHNOL, V18, P284, DOI 10.1614/WT-03-045R1; Hodge MA, 1999, J ARACHNOL, V27, P351; Holland J.M., 2000, Integrated Pest Management Reviews, V5, P109, DOI 10.1023/A:1009619309424; Huang ZY, 2004, J ECON ENTOMOL, V97, P1517, DOI 10.1603/0022-0493-97.5.1517; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Johnson WG, 2009, EUR J AGRON, V31, P162, DOI 10.1016/j.eja.2009.03.008; Junta de Andalucia, 2017, NETW AGR STAT JUND D; Kudsk P., 1998, DJF Rapport, Markbrug, P125; Kulkarni SS, 2015, WEED SCI, V63, P355, DOI 10.1614/WS-D-14-00067.1; Marshall EJP, 2003, WEED RES, V43, P77, DOI 10.1046/j.1365-3180.2003.00326.x; Moreno F, 2001, AGR WATER MANAGE, V48, P133, DOI 10.1016/S0378-3774(00)00120-7; Morjan WE, 2002, J ECON ENTOMOL, V95, P1275, DOI 10.1603/0022-0493-95.6.1275; Norris RF, 2005, ANNU REV ENTOMOL, V50, P479, DOI 10.1146/annurev.ento.49.061802.123218; Owen MDK, 2008, PEST MANAG SCI, V64, P377, DOI 10.1002/ps.1539; Palinkas Z, 2016, CROP PROT, V80, P87, DOI 10.1016/j.cropro.2015.11.001; Petit S, 2011, AGRON SUSTAIN DEV, V31, P309, DOI 10.1051/agro/2010020; Puricelli E, 2005, CROP PROT, V24, P533, DOI 10.1016/j.cropro.2004.10.005; Radosevich SR, 1997, IMPLICATIONS MANAGEM; Saska P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27801; Scursoni JA, 2007, CROP PROT, V26, P212, DOI 10.1016/j.cropro.2006.04.028; Showler AT, 2003, ENVIRON ENTOMOL, V32, P39, DOI 10.1603/0046-225X-32.1.39; Snyder WE, 1999, BIOL CONTROL, V15, P283, DOI 10.1006/bcon.1999.0723; Strandberg B, 2005, AGR ECOSYST ENVIRON, V105, P243, DOI 10.1016/j.agee.2004.03.005; Svobodova Z, 2018, AGR ECOSYST ENVIRON, V251, P171, DOI 10.1016/j.agee.2017.09.018; Tuesca D, 2007, CROP PROT, V26, P1765, DOI 10.1016/j.cropro.2007.03.008; Umeda K, 2002, TIMING GLYPHOSATE AP; USDA, 2016, AD GEN ENG CROPS US; Waltz E, 2010, NAT BIOTECHNOL, V28, P537, DOI 10.1038/nbt0610-537; Webster TM, 2010, WEED SCI, V58, P73, DOI 10.1614/WS-09-058.1; Werth J, 2013, CROP PASTURE SCI, V64, P791, DOI 10.1071/CP13167; Wilson RG, 2007, WEED TECHNOL, V21, P900, DOI 10.1614/WT-06-199.1; Wrinn KM, 2012, CHEMOSPHERE, V87, P390, DOI 10.1016/j.chemosphere.2011.12.030; Zimdahl L.R., 2007, FUNDAMENTALS WEED SC, V3rd	62	11	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191408	10.1371/journal.pone.0191408	http://dx.doi.org/10.1371/journal.pone.0191408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351549	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300085
J	Li, J; Tian, YX; Guo, SM; Gu, HF; Yuan, QT; Xie, X				Li, Jing; Tian, Yanxin; Guo, Shimeng; Gu, Haifeng; Yuan, Qianting; Xie, Xin			Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms	PLOS ONE			English	Article							THERAPEUTIC AGENTS; OUTLET OBSTRUCTION; BLADDER; ANTAGONISTS; HORMONE; GROWTH; PATHOPHYSIOLOGY; MICTURITION; PREVALENCE; PRESSURE	Benign prostatic hyperplasia (BPH) is an age-related disease, affecting a majority of elderly men worldwide. Medical management of BPH is an alternative to surgical treatment of this disease. Currently, alpha(1)-adrenergic receptor (alpha(1)-AR) antagonists are among the first line drugs to treat BPH by reducing the tension of urinary track and thus the obstructive symptoms in voiding. In drug development, old male dogs with spontaneous BPH are considered the golden standard of the animal models. However, old dogs (>6 years) are expensive and not all old dogs develop BPH. So it is necessary to develop more accessible animal models for drug efficacy evaluation. Here we describe the development of testosterone-induced BPH models in both rats and young adult dogs and their applications in the in vivo evaluation of alpha 1-AR antagonist. The BPH rats and dogs induced by chronic testosterone treatment have significantly increased micturition frequency and reduced mean voided volume, very similar to the clinical symptoms of BPH patients. Silodosin, an alpha 1-AR antagonist, significantly reduces the urinary frequency and increases the voided volume in BPH model animals in a dose-dependent manner. The results demonstrate that testosterone-induced BPH rat and dog models might provide a more efficient way to evaluate micturition behavior in anti-BPH drug studies.	[Li, Jing; Tian, Yanxin; Guo, Shimeng; Gu, Haifeng; Yuan, Qianting; Xie, Xin] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Natl Ctr Drug Screening, Shanghai, Peoples R China; [Xie, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, J; Xie, X (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Natl Ctr Drug Screening, Shanghai, Peoples R China.; Xie, X (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	lijing@simm.ac.cn; xxie@simm.ac.cn			National Natural Sciences Foundation of China [81425024, 81573442]; Personalized Medicines Molecular Signature-based Drug Discovery and Development; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12040212]; Shanghai Commission of Science and Technology [16431901500]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" [2017ZX09101004-012-008]; Institutes for Drug Discovery and Development, Chinese Academy of Sciences [CASIM M0120151007]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Personalized Medicines Molecular Signature-based Drug Discovery and Development; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program"; Institutes for Drug Discovery and Development, Chinese Academy of Sciences	Project was supported by grants from the National Natural Sciences Foundation of China (81425024, 81573442), "Personalized Medicines Molecular Signature-based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences, Grant (XDA12040212), Shanghai Commission of Science and Technology (16431901500), the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" (2017ZX09101004-012-008), and Institutes for Drug Discovery and Development, Chinese Academy of Sciences (CASIM M0120151007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Project was supported by grants from the National Natural Sciences Foundation of China (81425024, 81573442), the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" (2017ZX09101004-012-008), "Personalized Medicines-Molecular Signature-based Drug Discovery and Development", Strategic Priority Research Program of the Chinese Academy of Sciences, Grant (XDA12040212), Shanghai Commission of Science and Technology (16431901500), and Institutes for Drug Discovery and Development, Chinese Academy of Sciences (CASIMM0120151007).	BERRY SJ, 1986, PROSTATE, V9, P363, DOI 10.1002/pros.2990090406; BRADING AF, 1994, BRIT J UROL, V73, P3, DOI 10.1111/j.1464-410X.1994.tb07447.x; BRENDLER CB, 1983, J CLIN INVEST, V71, P1114, DOI 10.1172/JCI110861; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; CLAUS S, 1993, UROL RES, V21, P305, DOI 10.1007/BF00296825; Constantinou CE, 1996, PROSTATE, V29, P30; DEBIECRYCHTER M, 1994, IN VIVO, V8, P449; DEKLERK DP, 1979, J CLIN INVEST, V64, P842, DOI 10.1172/JCI109532; Drake M., 2006, Autonomic & Autacoid Pharmacology, V26, P261, DOI 10.1111/j.1474-8673.2006.00363.x; Fullhase C, 2013, EUR UROL, V64, P228, DOI 10.1016/j.eururo.2013.01.018; GUESS HA, 1990, PROSTATE, V17, P241, DOI 10.1002/pros.2990170308; Irwin DE, 2009, EUR UROL, V56, P14, DOI 10.1016/j.eururo.2009.02.026; Lee JZ, 1998, NEUROUROL URODYNAM, V17, P55, DOI 10.1002/(SICI)1520-6777(1998)17:1<55::AID-NAU8>3.0.CO;2-C; MAGGI CA, 1989, GEN PHARMACOL-VASC S, V20, P345, DOI 10.1016/0306-3623(89)90271-1; Mahapokai W, 2000, PROSTATE CANCER P D, V3, P28, DOI 10.1038/sj.pcan.4500391; MCNEAL JE, 1978, INVEST UROL, V15, P340; Michel MC, 2010, J PHARMACOL SCI, V112, P151, DOI 10.1254/jphs.09R15FM; Milani S, 2005, BJU INT, V95, P29, DOI 10.1111/j.1464-410X.2005.05485.x; NEVALAINEN MT, 1991, ENDOCRINOLOGY, V129, P612, DOI 10.1210/endo-129-2-612; Ohtake A, 2006, EUR J PHARMACOL, V545, P185, DOI 10.1016/j.ejphar.2006.06.054; Okutsu H, 2010, UROLOGY, V75, P235, DOI 10.1016/j.urology.2009.05.045; OTTO U, 1992, UROL INT, V48, P167, DOI 10.1159/000282323; Pagano E, 2014, PHYTOTHER RES, V28, P949, DOI 10.1002/ptr.5084; Pampinella F, 1997, J UROLOGY, V157, P677, DOI 10.1016/S0022-5347(01)65249-2; Pulito VL, 2000, J PHARMACOL EXP THER, V294, P224; Rosini M, 2007, CURR TOP MED CHEM, V7, P147, DOI 10.2174/156802607779318244; Ruan WF, 1999, ENDOCRINOLOGY, V140, P1984, DOI 10.1210/en.140.5.1984; Schauer IG, 2011, DIFFERENTIATION, V82, P200, DOI 10.1016/j.diff.2011.05.007; Schwinn DA, 2001, BJU INT, V88, P27, DOI 10.1046/j.1464-410X.2001.00116.x; Schwinn DA, 2008, INT J UROL, V15, P193, DOI 10.1111/j.1442-2042.2007.01956.x; Steiner MS, 1999, J UROLOGY, V162, P1454, DOI 10.1016/S0022-5347(05)68340-1; Suzuki Y, 1999, EUR J PHARMACOL, V374, P495, DOI 10.1016/S0014-2999(99)00344-1; Thorpe A, 2003, LANCET, V361, P1359, DOI 10.1016/S0140-6736(03)13073-5; Tiwari A, 2005, EXPERT OPIN INV DRUG, V14, P1359, DOI 10.1517/13543784.14.11.1359; Turner WH, 1997, PHARMACOL THERAPEUT, V75, P77, DOI 10.1016/S0163-7258(97)00038-7; Yazaki J, 2011, NEUROUROL URODYNAM, V30, P461, DOI 10.1002/nau.20984	36	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191469	10.1371/journal.pone.0191469	http://dx.doi.org/10.1371/journal.pone.0191469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351556	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300094
J	Oyinlola, MA; Reygondeau, G; Wabnitz, CCC; Troell, M; Cheung, WWL				Oyinlola, Muhammed A.; Reygondeau, Gabriel; Wabnitz, Colette C. C.; Troell, Max; Cheung, William W. L.			Global estimation of areas with suitable environmental conditions for mariculture species	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; DISTRIBUTION MODELS; SITE SELECTION; SHELLFISH AQUACULTURE; CARRYING-CAPACITY; GROWTH-RATE; FISH-MEAL; FOOD; ECOSYSTEM; IMPACTS	Aquaculture has grown rapidly over the last three decades expanding at an average annual growth rate of 5.8% (2005-2014), down from 8.8% achieved between 1980 and 2010. The sector now produces 44% of total food fish production. Increasing demand and consumption from a growing global population are driving further expansion of both inland and marine aquaculture (i.e., mariculture, including marine species farmed on land). However, the growth of mariculture is dependent on the availability of suitable farming areas for new facilities, particularly for open farming practices that rely on the natural oceanic environmental parameters such as temperature, oxygen, chlorophyll etc. In this study, we estimated the marine areas within the exclusive economic zones of all countries that were suitable for potential open ocean mariculture activities. To this end, we quantify the environmental niche and inferred the global habitat suitability index (HSI) of the 102 most farmed marine species using four species distribution models. The average weighted HSI across the four models suggests that 72,000,000 km(2) of ocean are to be environmentally suitable to farm one or more species. About 92% of the predicted area (66,000,000 km(2)) is environmentally suitable for farming finfish, 43% (31,000,000 km(2)) for molluscs and 54% (39,000,000 km(2)) for crustaceans. These predictions do not consider technological feasibility that can limit crustaceans farming in open waters. Suitable mariculture areas along the Atlantic coast of South America and West Africa appear to be most under-utilized for farming. Our results suggest that factors other than environmental considerations such as the lack of socio-economic and technological capacity, as well as aqua feed supply are currently limiting the potential for mariculture expansion in many areas.	[Oyinlola, Muhammed A.; Reygondeau, Gabriel; Wabnitz, Colette C. C.; Cheung, William W. L.] Univ British Columbia, Inst Oceans & Fisheries, Nippon Fdn Nereus Program & Changing Ocean Res Un, Vancouver, BC, Canada; [Troell, Max] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Troell, Max] Swedish Royal Acad Sci, Beijer Inst, Stockholm, Sweden	University of British Columbia; Stockholm University; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics	Oyinlola, MA (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Nippon Fdn Nereus Program & Changing Ocean Res Un, Vancouver, BC, Canada.	m.oyinlola@oceans.ubc.ca	Troell, Max/I-1724-2019; Oyinlola, Muhammed Alolade/B-4363-2019	Troell, Max/0000-0002-7509-8140; Oyinlola, Muhammed Alolade/0000-0001-5177-854X; Wabnitz, Colette C.C./0000-0002-5076-9163	Nippon Foundation-Nereus Program, an interdisciplinary ocean research program; Natural Sciences and Engineering Research Council of Canada; Nippon Foundation- the University of British Columbia Nereus Program, an interdisciplinary ocean research program	Nippon Foundation-Nereus Program, an interdisciplinary ocean research program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Nippon Foundation- the University of British Columbia Nereus Program, an interdisciplinary ocean research program	This study is a contribution by the Nippon Foundation-Nereus Program (http://www. nereusprogram.org/), an interdisciplinary ocean research program to WC. W. Cheung also acknowledges funding support from the Natural Sciences and Engineering Research Council of Canada.; This study is a contribution by the Nippon Foundation- the University of British Columbia Nereus Program, an interdisciplinary ocean research program.	Akinrotimi OA, 2007, AGR J, V2, P600; [Anonymous], WORLD EC SOC SURV SU; Basille M, 2008, ECOL MODEL, V211, P233, DOI 10.1016/j.ecolmodel.2007.09.006; Beaugrand G, 2011, MAR ECOL PROG SER, V424, P175, DOI 10.3354/meps08939; Belton B, 2014, GLOB FOOD SECUR-AGR, V3, P59, DOI 10.1016/j.gfs.2013.10.001; Benetti DD, 2010, MAR TECHNOL SOC J, V44, P22, DOI 10.4031/MTSJ.44.3.11; Besson M, 2016, AQUACULTURE, V462, P47, DOI 10.1016/j.aquaculture.2016.04.030; Beveridge MCM, 2013, J FISH BIOL, V83, P1067, DOI 10.1111/jfb.12187; Borja A, 2009, AQUACULTURE, V293, P231, DOI 10.1016/j.aquaculture.2009.04.037; Broitman BR, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00015; Brown N, 2010, REV FISH SCI, V10, P403; Burbridge P, 2001, J APPL ICHTHYOL, V17, P194, DOI 10.1046/j.1439-0426.2001.00316.x; Busby J., 1991, PLANT PROTECTION Q A; Buschmann AH, 2009, OCEAN COAST MANAGE, V52, P243, DOI 10.1016/j.ocecoaman.2009.03.002; Byron C, 2011, ECOL MODEL, V222, P1743, DOI 10.1016/j.ecolmodel.2011.03.010; Callaway R, 2012, AQUAT CONSERV, V22, P389, DOI 10.1002/aqc.2247; Campbell B, 2013, MAR POLICY, V39, P94, DOI 10.1016/j.marpol.2012.10.009; Cao L, 2015, SCIENCE, V347, P133, DOI 10.1126/science.1260149; Cashion T, 2017, FISH FISHERIES; CHATAIN B, 1994, AQUACULTURE, V119, P371, DOI 10.1016/0044-8486(94)90301-8; Cheung WWL, 2015, PROG OCEANOGR, V130, P19, DOI 10.1016/j.pocean.2014.09.003; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Christophersen G, 2003, AQUACULTURE, V215, P79, DOI 10.1016/S0044-8486(02)00094-7; Clements JC, 2016, REV AQUACULTURE; Cochrane K., 2009, FAO FISHERIES AQUACU; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Crawley MJ, 2005, STAT INTRO USING R; Delgado CL, 2003, FISH 2020 SUPPLY DEM, P62; Discovering statistics using R, 2012, CHOICE REV ONLINE, V50, DOI [10.5860/choice.50-2114, DOI 10.5860/CHOICE.50-2114]; Easterling W., 2007, FOOD FIBRE FOREST PR; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Evans W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130384; FAO, 2011, STAT WORLD FISH AQ O; FAO, 2016, CONTR FOOD SEC NUTR, P200; Ferreira JG, 2008, AQUACULTURE, V275, P138, DOI 10.1016/j.aquaculture.2007.12.018; Ferreira JG, 2007, AQUACULTURE, V264, P160, DOI 10.1016/j.aquaculture.2006.12.017; Foucher E, 2016, EUROPEAN SCALLOP FIS, V40, P781; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gentry RR, 2017, NAT ECOL EVOL, V1, P1317, DOI 10.1038/s41559-017-0257-9; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Gomez-Requeni P, 2004, AQUACULTURE, V232, P493, DOI 10.1016/S0044-8486(03)00532-5; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Halwart M., 2007, CAGE AQUACULTURE REG, V498, P42; Hermansen O., 2008, CAPTURE BASED AQUACU; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hishamunda N, 2003, 427 FAO, V427; Hishamunda N, 2001, PROMOTION SUSTAINABL, P401; Hofherr J, 2015, OCEAN COAST MANAGE, V116, P27, DOI 10.1016/j.ocecoaman.2015.06.010; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Imsland AK, 1996, J FISH BIOL, V49, P926; Islam MS, 2005, MAR POLLUT BULL, V50, P48, DOI 10.1016/j.marpolbul.2004.08.008; Jones MC, 2015, ICES J MAR SCI, V72, P741, DOI 10.1093/icesjms/fsu172; Jones MC, 2013, AQUAT CONSERV, V23, P710, DOI 10.1002/aqc.2364; Kapetsky J.M., 2013, GLOBAL ASSESSMENT OF; Kapetsky JM, 2013, GLOBAL ASSESSMENT PO; Karthik M, 2005, AQUACULT ENG, V32, P285, DOI 10.1016/j.aquaeng.2004.05.009; Kristensen V, 2000, CAHIERS OPTIONS MEDI; Legendre P., 1998, NUMERICAL ECOLOGY, V2nd, P24; Longdill PC, 2008, OCEAN COAST MANAGE, V51, P612, DOI 10.1016/j.ocecoaman.2008.06.010; Mallya Y.J., 2007, EFFECTS DISSOLVED OX, P30; Martins CIM, 2010, AQUACULT ENG, V43, P83, DOI 10.1016/j.aquaeng.2010.09.002; Merino GE, 2007, AQUACULTURE, V265, P176, DOI 10.1016/j.aquaculture.2007.01.028; Merino G, 2012, GLOBAL ENVIRON CHANG, V22, P795, DOI 10.1016/j.gloenvcha.2012.03.003; Moe H, 2007, AQUAC RES, V38, P91, DOI 10.1111/j.1365-2109.2006.01638.x; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Newell RIE, 2004, J SHELLFISH RES, V23, P51; NMFS NOAA Commerce UDo, IMPL PLAN COD COND R; Ottolenghi F., 2004, FATTENING EELS GROUP; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pickering T. D., 2011, VULNERABILITY TROPIC, P647; Pilditch CA, 2001, CAN J FISH AQUAT SCI, V58, P241, DOI 10.1139/cjfas-58-2-241; Pillay T.V.R., 2008, AQUACULTURE ENV, DOI DOI 10.1002/9780470995730; Reygondeau G, 2013, GLOBAL BIOGEOCHEM CY, V27, P1046, DOI 10.1002/gbc.20089; Roos N, 2007, J NUTR, V137, P1106, DOI 10.1093/jn/137.4.1106; ROSS LG, 1993, AQUACULTURE, V112, P165, DOI 10.1016/0044-8486(93)90442-2; Sing T, 2007, TECHNICAL REPORT; Tacon AGJ, 2013, REV FISH SCI, V21, P22, DOI 10.1080/10641262.2012.753405; Tacon AGJ, 2009, REV FISH SCI, V17, P305, DOI 10.1080/10641260802677074; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tal Y, 2009, AQUACULTURE, V286, P28, DOI 10.1016/j.aquaculture.2008.08.043; Tandler A, 1995, AQUACULTURE, V135, P343, DOI 10.1016/0044-8486(95)01029-7; Theodorou JA, 2010, REV FISH SCI, V10, P529; Tidwell JH, 2001, EMBO REP, V2, P958, DOI 10.1093/embo-reports/kve236; Toufique KA, 2014, WORLD DEV, V64, P609, DOI 10.1016/j.worlddev.2014.06.035; Troell M, 2017, NAT ECOL EVOL, V1, P1224, DOI 10.1038/s41559-017-0304-6; Troell M, 2014, P NATL ACAD SCI USA, V111, P13257, DOI 10.1073/pnas.1404067111; Troell M, 2009, AQUACULTURE, V297, P1, DOI 10.1016/j.aquaculture.2009.09.010; Trujillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030546; Turchini G. M., 2010, FISH OIL REPLACEMENT; van Rijn J, 2013, AQUACULT ENG, V53, P49, DOI 10.1016/j.aquaeng.2012.11.010; VanHoutte A, 2000, TECHN P C AQ 3 MILL, P20; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891; Watson RA, 2017, FISH FISH, V18, P105, DOI 10.1111/faf.12128	102	45	47	6	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191086	10.1371/journal.pone.0191086	http://dx.doi.org/10.1371/journal.pone.0191086			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29357374	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300047
J	Ponsi, G; Panasiti, MS; Aglioti, SM; Liuzza, MT				Ponsi, Giorgia; Panasiti, Maria Serena; Aglioti, Salvatore Maria; Liuzza, Marco Tullio			Right-wing authoritarianism and stereotype-driven expectations interact in shaping intergroup trust in one-shot vs multiple-round social interactions (vol 12, e0190142, 2017)	PLOS ONE			English	Correction													Ponsi, Giorgia/K-3960-2018; Liuzza, Marco Tullio/A-9967-2012	Ponsi, Giorgia/0000-0002-7188-8102; Liuzza, Marco Tullio/0000-0001-6708-1253	PRIN grant (Progetti di Ricerca di Rilevante Interesse Nazionale) [20159CZFJK]; Swedish Research Council [2016-02018]; Lars Hierta Memorial Foundation [FO20160386];  [H2020-SESAR- 2015-1];  [699379]	PRIN grant (Progetti di Ricerca di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lars Hierta Memorial Foundation; ; 	This study was supported by the PRIN grant (Progetti di Ricerca di Rilevante Interesse Nazionale, Edit. 2015, Prot. 20159CZFJK), by the H2020-SESAR- 2015-1 (MOTO: The embodied reMOte TOwer, Project Number 699379), by a research grant to Marco Tullio Liuzza from the Swedish Research Council (2016-02018), and from the Lars Hierta Memorial Foundation (FO20160386).	Ponsi G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190142	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191811	10.1371/journal.pone.0191811	http://dx.doi.org/10.1371/journal.pone.0191811			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352296	Green Submitted, gold, Green Published			2022-12-27	WOS:000422911300134
J	Vreemann, S; Gubern-Merida, A; Borelli, C; Bult, P; Karssemeijer, N; Mann, RM				Vreemann, Suzan; Gubern-Merida, Albert; Borelli, Cristina; Bult, Peter; Karssemeijer, Nico; Mann, Ritse M.			The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; ESTROGEN PLUS PROGESTIN; CARCINOMA IN-SITU; COST-EFFECTIVENESS; MENSTRUAL-CYCLE; FOLLOW-UP; RISK; WOMEN; MAMMOGRAPHY; RECEPTOR	Purpose Higher background parenchymal enhancement (BPE) could be used for stratification of MRI screening programs since it might be related to a higher breast cancer risk. Therefore, the purpose of this study is to correlate BPE to patient and tumor characteristics in women with unilateral MRI-screen detected breast cancer who participated in an intermediate and high risk screening program. As BPE in the affected breast may be difficult to discern from enhancing cancer, we assumed that BPE in the contralateral breast is a representative measure for BPE in women with unilateral breast cancer. Materials and methods This retrospective study was approved by our local institutional board and a waiver for consent was granted. MR-examinations of women with unilateral breast cancers screen-detected on breast MRI were evaluated by two readers. BPE in the contralateral breast was rated according to BI-RADS. Univariate analyses were performed to study associations. Observer variability was computed. Results Analysis included 77 breast cancers in 76 patients (age: 48 +/- 9.8 years), including 62 invasive and 15 pure ductal carcinoma in-situ cases. A negative association between BPE and tumor grade (p <= 0.016) and a positive association with progesterone status (p <= 0.021) was found. The correlation was stronger when only considering invasive disease. Inter-reader agreement was substantial. Conclusion Lower BPE in the contralateral breast in women with unilateral breast cancer might be associated to higher tumor grade and progesterone receptor negativity. Great care should be taken using BPE for stratification of patients to tailored screening programs.	[Vreemann, Suzan; Gubern-Merida, Albert; Karssemeijer, Nico; Mann, Ritse M.] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Geert Grootepl 10, Nijmegen, Netherlands; [Borelli, Cristina] Casa Sollievo Sofferenza, Dept Radiol, San Giovanni Rotondo Fog, Italy; [Bult, Peter] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; IRCCS Casa Sollievo Della Sofferenza; Radboud University Nijmegen	Mann, RM (corresponding author), Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Geert Grootepl 10, Nijmegen, Netherlands.	Ritse.Mann@radboudumc.nl	Bult, Peter/L-4236-2015; Karssemeijer, N./H-8058-2014; Mann, R.M./L-4502-2015	Bult, Peter/0000-0001-6427-9889; Mann, R.M./0000-0001-8111-1930	European Union's Seventh Framework Program for research, technological development and demonstration [601040]	European Union's Seventh Framework Program for research, technological development and demonstration	This work received funding from the European Union's Seventh Framework Program for research, technological development and demonstration (grant agreement no 601040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, BREAST CANC GUID; Baek JE, 2014, EUR J RADIOL, V83, P1356, DOI 10.1016/j.ejrad.2014.05.007; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Bulut N, 2015, INT J CLIN EXP MED, V8, P21454; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Colditz GA, 1998, JNCI-J NATL CANCER I, V90, P814, DOI 10.1093/jnci/90.11.814; Delille JP, 2005, BREAST J, V11, P236, DOI 10.1111/j.1075-122X.2005.21499.x; DeMartini WB, 2012, AM J ROENTGENOL, V198, pW373, DOI 10.2214/AJR.10.6272; Dmitriev I, 2015, RADIOLOGY; Edwards SD, 2013, MAGN RESON IMAGING C, V21, P483, DOI 10.1016/j.mric.2013.02.005; Ellis RL, 2009, AM J ROENTGENOL, V193, P1738, DOI 10.2214/AJR.09.2657; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Erbas B, 2004, CANCER EPIDEM BIOMAR, V13, P1569; Feig S, 2010, RADIOL CLIN N AM, V48, P879, DOI 10.1016/j.rcl.2010.06.002; Giess CS, 2014, RADIOGRAPHICS, V34, P234, DOI 10.1148/rg.341135034; Gubern-Merida A, 2015, MED IMAGE ANAL, V20, P265, DOI 10.1016/j.media.2014.12.001; Hambly NM, 2011, AM J ROENTGENOL, V196, P218, DOI 10.2214/AJR.10.4550; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hu YF, 2009, INT J BIOL SCI, V5, P20; Kim MY, 2015, CLIN RADIOL, V70, P706, DOI 10.1016/j.crad.2015.02.017; King V, 2011, RADIOLOGY, V260, P50, DOI 10.1148/radiol.11102156; Kuhl C, 2007, RADIOLOGY, V244, P356, DOI 10.1148/radiol.2442051620; Magnusson C, 1999, INT J CANCER, V81, P339, DOI 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.3.CO;2-Y; Millet I, 2012, BRIT J RADIOL, V85, P197, DOI 10.1259/bjr/47213729; Moelans CB, 2011, CELL ONCOL, V34, P475, DOI 10.1007/s13402-011-0043-7; Mohsin SK, 2004, MODERN PATHOL, V17, P1545, DOI 10.1038/modpathol.3800229; Morris Elizabeth A, 2010, Magn Reson Imaging Clin N Am, V18, P57, DOI 10.1016/j.mric.2009.09.005; Park SY, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140638; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Saadatmand S, 2013, JNCI-J NATL CANCER I, V105, P1314, DOI 10.1093/jnci/djt203; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Tabar L, 1996, INT J CANCER, V66, P413, DOI 10.1002/(SICI)1097-0215(19960516)66:4<413::AID-IJC1>3.0.CO;2-Z; Telegrafo M, 2016, DIAGN INTERV IMAG, V97, P313, DOI 10.1016/j.diii.2015.12.006; Telegrafo M, 2016, MAGN RESON IMAGING, V34, P173, DOI 10.1016/j.mri.2015.10.014; Uematsu T, 2012, BREAST CANCER-TOKYO, V19, P259, DOI 10.1007/s12282-011-0279-0; Uematsu T, 2012, AM J ROENTGENOL, V198, pW611, DOI 10.2214/AJR.11.7463; van Zelst JCM, 2017, ULTRASOUND MED BIOL, V43, P1820, DOI 10.1016/j.ultrasmedbio.2017.03.019; Vinnicombe S, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0078-0	40	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191399	10.1371/journal.pone.0191399	http://dx.doi.org/10.1371/journal.pone.0191399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351560	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300083
J	Xue, YF; Chen, BJ; Win, AN; Fu, C; Lian, JP; Liu, X; Wang, R; Zhang, XC; Chai, YR				Xue, Yufei; Chen, Baojun; Win, Aung Naing; Fu, Chun; Lian, Jianping; Liu, Xue; Wang, Rui; Zhang, Xingcui; Chai, Yourong			Omega-3 fatty acid desaturase gene family from two omega-3 sources, Salvia hispanica and Perilla frutescens: Cloning, characterization and expression	PLOS ONE			English	Article							ANTISENSE-MEDIATED DEPLETION; ENHANCES THERMAL TOLERANCE; FATTY-ACID DESATURATION; LINOLENIC ACID; ARABIDOPSIS-THALIANA; SACCHAROMYCES-CEREVISIAE; BRASSICA-NAPUS; FUNCTIONAL-CHARACTERIZATION; CONSENSUS PREDICTION; TRANSGENIC TOBACCO	Omega-3 fatty acid desaturase (omega-3 FAD, D15D) is a key enzyme for alpha-linolenic acid (ALA) biosynthesis. Both chia (Salvia hispanica) and perilla (Perilla frutescens) contain high levels of ALA in seeds. In this study, the omega-3 FAD gene family was systematically and comparatively cloned from chia and perilla. Perilla FAD3, FAD7, FAD8 and chia FAD7 are encoded by single-copy (but heterozygous) genes, while chia FAD3 is encoded by 2 distinct genes. Only 1 chia FAD8 sequence was isolated. In these genes, there are 1 to 6 transcription start sites, 1 to 8 poly(A) tailing sites, and 7 introns. The 5' UTRs of PfFAD8a/b contain 1 to 2 purine-stretches and 2 pyrimidine-stretches. An alternative splice variant of ShFAD7a/ b comprises a 5' UTR intron. Their encoded proteins harbor an FA_desaturase conserved domain together with 4 trans-membrane helices and 3 histidine boxes. Phylogenetic analysis validated their identity of dicot microsomal or plastidial omega-3 FAD proteins, and revealed some important evolutionary features of plant omega-3 FAD genes such as convergent evolution across different phylums, single-copy status in algae, and duplication events in certain taxa. The qRT-PCR assay showed that the omega-3 FAD genes of two species were expressed at different levels in various organs, and they also responded to multiple stress treatments. The functionality of the ShFAD3 and PfFAD3 enzymes was confirmed by yeast expression. The systemic molecular and functional features of the omega-3 FAD gene family from chia and perilla revealed in this study will facilitate their use in future studies on genetic improvement of ALA traits in oilseed crops.	[Xue, Yufei; Chen, Baojun; Win, Aung Naing; Fu, Chun; Lian, Jianping; Liu, Xue; Wang, Rui; Zhang, Xingcui; Chai, Yourong] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China; [Xue, Yufei; Chen, Baojun; Win, Aung Naing; Fu, Chun; Lian, Jianping; Liu, Xue; Wang, Rui; Chai, Yourong] Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China; [Xue, Yufei; Chen, Baojun; Win, Aung Naing; Fu, Chun; Lian, Jianping; Liu, Xue; Wang, Rui; Chai, Yourong] Southwest Univ, Chongqing Engn Res Ctr Rapeseed, Chongqing, Peoples R China; [Xue, Yufei; Chen, Baojun; Win, Aung Naing; Fu, Chun; Lian, Jianping; Liu, Xue; Wang, Rui; Zhang, Xingcui; Chai, Yourong] Southwest Univ, Chongqing Key Lab Crop Qual Improvement, Chongqing, Peoples R China; [Xue, Yufei; Chen, Baojun; Win, Aung Naing; Fu, Chun; Lian, Jianping; Liu, Xue; Wang, Rui; Zhang, Xingcui; Chai, Yourong] Southwest Univ, Engn Res Ctr South Upland Agr, Minist Educ, Chongqing, Peoples R China	Southwest University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Southwest University - China; Southwest University - China; Southwest University - China; Southwest University - China	Chai, YR (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China.; Chai, YR (corresponding author), Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China.; Chai, YR (corresponding author), Southwest Univ, Chongqing Engn Res Ctr Rapeseed, Chongqing, Peoples R China.; Chai, YR (corresponding author), Southwest Univ, Chongqing Key Lab Crop Qual Improvement, Chongqing, Peoples R China.; Chai, YR (corresponding author), Southwest Univ, Engn Res Ctr South Upland Agr, Minist Educ, Chongqing, Peoples R China.	chaiyourong2@163.com		Xue, Yufei/0000-0001-7041-5517; Lian, Jianping/0000-0003-2453-2266; Chai, Yourong/0000-0001-6611-624X	Chongqing Research Program of Basic Research and Frontier Technology [cstc2015jcyjBX0143]; National Key R&D Program of China [2016YFD0100506]; Fundamental Research Funds for the Central Universities [XDJK2014D009]; National Basic Research Program of China (973 Program) [2015CB150201]	Chongqing Research Program of Basic Research and Frontier Technology; National Key R&D Program of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by Chongqing Research Program of Basic Research and Frontier Technology (cstc2015jcyjBX0143), National Key R&D Program of China (2016YFD0100506), Fundamental Research Funds for the Central Universities (XDJK2014D009), and National Basic Research Program of China (973 Program, 2015CB150201).	Abdel-Reheem M, 2013, TURK J BIOL, V37, P591, DOI 10.3906/biy-1301-32; Andreu V, 2010, J EXP BOT, V61, P3371, DOI 10.1093/jxb/erq158; [Anonymous], 2012, EUR J LIPID SCI TECH, V114, P794; ARONDEL V, 1992, SCIENCE, V258, P1353, DOI 10.1126/science.1455229; Avila CA, 2012, PLANT PHYSIOL, V158, P2028, DOI 10.1104/pp.111.191262; Baker EJ, 2016, PROG LIPID RES, V64, P30, DOI 10.1016/j.plipres.2016.07.002; Banik M, 2011, GENOME, V54, P471, DOI [10.1139/g11-013, 10.1139/G11-013]; Banno N, 2004, BIOSCI BIOTECH BIOCH, V68, P85, DOI 10.1271/bbb.68.85; Berberich T, 1998, PLANT MOL BIOL, V36, P297, DOI 10.1023/A:1005993408270; Bilyeu KD, 2003, CROP SCI, V43, P1833, DOI 10.2135/cropsci2003.1833; Chung CH, 1999, PLANT CELL PHYSIOL, V40, P114, DOI 10.1093/oxfordjournals.pcp.a029468; Collados R, 2006, FEBS LETT, V580, P4934, DOI 10.1016/j.febslet.2006.07.087; Dominguez T, 2010, PLANT PHYSIOL, V153, P655, DOI 10.1104/pp.110.154815; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; ESTILAI A, 1990, HORTSCIENCE, V25, P1646, DOI 10.21273/HORTSCI.25.12.1646; Farmer EE, 1998, PLANTA, V206, P167, DOI 10.1007/s004250050388; FARMER EE, 1992, PLANT CELL, V4, P129, DOI 10.1105/tpc.4.2.129; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guan LL, 2014, GENET MOL RES, V13, P6623, DOI [10.4238/2014.August.28.7, 10.4238/2014]; Guo HH, 2014, J SCI FOOD AGR, V94, P482, DOI 10.1002/jsfa.6273; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; Hernandez ML, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv159; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; IBA K, 1993, J BIOL CHEM, V268, P24099; Ito M, 2008, J NAT MED, V62, P387, DOI 10.1007/s11418-008-0262-z; Ixtaina VY, 2008, IND CROP PROD, V28, P286, DOI 10.1016/j.indcrop.2008.03.009; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim HU, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2805-0; Kim MJ, 2006, MOL GENET GENOMICS, V276, P351, DOI 10.1007/s00438-006-0148-2; Kirsch C, 1997, P NATL ACAD SCI USA, V94, P2079, DOI 10.1073/pnas.94.5.2079; KODAMA H, 1994, PLANT PHYSIOL, V105, P601, DOI 10.1104/pp.105.2.601; Kwon JH, 2000, MOL CELLS, V10, P493, DOI 10.1007/s10059-000-0493-7; Lee KR, 2016, PLANT CELL REP, V35, P2523, DOI 10.1007/s00299-016-2053-4; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Lewandowska-Gnatowska E, 2011, PHYTOCHEMISTRY, V72, P1285, DOI 10.1016/j.phytochem.2011.01.030; Liu HL, 2012, J EXP BOT, V63, P3279, DOI 10.1093/jxb/ers051; Liu XY, 2006, J INTEGR PLANT BIOL, V48, P1096, DOI 10.1111/j.1744-7909.2006.00335.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Lu H, 2009, MOL BIOL REP, V36, P2291, DOI 10.1007/s11033-009-9447-0; Luke GA, 2012, INNOVATIONS BIOTECHN, P67; Ma QP, 2014, ACTA PHYSIOL PLANT, V36, P2345, DOI 10.1007/s11738-014-1607-8; Martz F, 2006, J EXP BOT, V57, P897, DOI 10.1093/jxb/erj075; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; Murphy DJ, 1999, CURR OPIN BIOTECH, V10, P175, DOI 10.1016/S0958-1669(99)80031-7; Nguyen HM, 2013, PLANT PHYSIOL, V163, P914, DOI 10.1104/pp.113.223941; Nishiuchi T, 1995, PLANT MOL BIOL, V29, P599, DOI 10.1007/BF00020987; Nishiuchi T, 1998, J PLANT RES, V111, P481, DOI 10.1007/BF02507782; Nishiuchi T, 1997, PLANT CELL, V9, P1701, DOI 10.1105/tpc.9.10.1701; NISHIUCHI T, 1994, PLANT PHYSIOL, V105, P767, DOI 10.1104/pp.105.2.767; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Radovanovic N, 2014, MOL BIOTECHNOL, V56, P609, DOI 10.1007/s12033-014-9737-1; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Reed DW, 2000, PLANT PHYSIOL, V122, P715, DOI 10.1104/pp.122.3.715; Roman A, 2015, MOL PLANT, V8, P1599, DOI 10.1016/j.molp.2015.06.004; Roman A, 2012, J EXP BOT, V63, P4973, DOI 10.1093/jxb/ers174; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 1997, P NATL ACAD SCI USA, V94, P2981, DOI 10.1073/pnas.94.7.2981; SHIN HS, 1994, J AM OIL CHEM SOC, V71, P619, DOI 10.1007/BF02540589; Singh AK, 2011, MOL PLANT MICROBE IN, V24, P506, DOI 10.1094/MPMI-09-10-0201; Sreedhar RV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123580; Tang SY, 2007, BIOTECHNOL LETT, V29, P1417, DOI 10.1007/s10529-007-9391-9; Teixeira MC, 2010, J AGR FOOD CHEM, V58, P1870, DOI 10.1021/jf902684v; Torres-Franklin ML, 2009, ENVIRON EXP BOT, V65, P162, DOI 10.1016/j.envexpbot.2008.12.010; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Venegas-Caleron M, 2006, PLANT PHYSIOL BIOCH, V44, P517, DOI 10.1016/j.plaphy.2006.09.005; Venegas-Caleron M, 2010, PHYTOCHEMISTRY, V71, P1050, DOI 10.1016/j.phytochem.2010.04.017; Vrinten P, 2005, PLANT PHYSIOL, V139, P79, DOI 10.1104/pp.105.064451; Wang HS, 2014, PLANT CELL REP, V33, P131, DOI 10.1007/s00299-013-1517-z; Wang HS, 2010, J INTEGR PLANT BIOL, V52, P568, DOI 10.1111/j.1744-7909.2010.00957.x; Wang WJ, 2014, J EXP BOT, V65, P2147, DOI 10.1093/jxb/eru084; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Xiao G, 2014, GENE, V545, P45, DOI 10.1016/j.gene.2014.05.008; Xue YF, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2390-0; Xue YF, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2377-x; Yaeno T, 2004, PLANT J, V40, P931, DOI 10.1111/j.1365-313X.2004.02260.x; Yang QY, 2012, THEOR APPL GENET, V125, P715, DOI 10.1007/s00122-012-1863-1; Yurchenko OP, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0312-5; Zhang M, 2005, PLANT J, V44, P361, DOI 10.1111/j.1365-313X.2005.02536.x; Zhang YM, 2011, BIOTECHNOL LETT, V33, P395, DOI 10.1007/s10529-010-0432-4; ZOU JT, 1995, PLANT PHYSIOL, V108, P563, DOI 10.1104/pp.108.2.563	88	33	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191432	10.1371/journal.pone.0191432	http://dx.doi.org/10.1371/journal.pone.0191432			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351555	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300090
J	Frouin, J; Languillaume, A; Mas, J; Mieulet, D; Boisnard, A; Labeyrie, A; Bettembourg, M; Bureau, C; Lorenzini, E; Portefaix, M; Turquay, P; Vernet, A; Perin, C; Ahmadi, N; Courtois, B				Frouin, Julien; Languillaume, Antoine; Mas, Justine; Mieulet, Delphine; Boisnard, Arnaud; Labeyrie, Axel; Bettembourg, Mathilde; Bureau, Charlotte; Lorenzini, Eve; Portefaix, Muriel; Turquay, Patricia; Vernet, Aurore; Perin, Christophe; Ahmadi, Nourollah; Courtois, Brigitte			Tolerance to mild salinity stress in japonica rice: A genome-wide association mapping study highlights calcium signaling and metabolism genes	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; SALT-TOLERANCE; SOIL-SALINITY; NACL STRESS; GENOTYPES; ARCHITECTURE; HOMEOSTASIS; RESISTANCE; POPULATION; VARIETIES	Salinity tolerance is an important quality for European rice grown in river deltas. We evaluated the salinity tolerance of a panel of 235 temperate japonica rice accessions genotyped with 30,000 SNP markers. The panel was exposed to mild salt stress (50 mM NaCI; conductivity of 6 dS m(-1)) at the seedling stage. Eight different root and shoot growth parameters were measured for both the control and stressed treatments. The Na+ and K+ mass fractions of the stressed plants were measured using atomic absorption spectroscopy. The salt treatment affected plant growth, particularly the shoot parameters. The panel showed a wide range of Na+/K+ ratio and the temperate accessions were distributed over an increasing axis, from the most resistant to the most susceptible checks. We conducted a genome-wide association study on indices of stress response and ion mass fractions in the leaves using a classical mixed model controlling structure and kinship. A total of 27 QTLs validated by sub sampling were identified. For indices of stress responses, we also used another model that focused on marker x treatment interactions and detected 50 QTLs, three of which were also identified using the classical method. We compared the positions of the significant QTLs to those of approximately 300 genes that play a role in rice salt tolerance. The positions of several QTLs were close to those of genes involved in calcium signaling and metabolism, while other QTLs were close to those of kinases. These results reveal the salinity tolerance of accessions with a temperate japonica background. Although the detected QTLs must be confirmed by other approaches, the number of associations linked to candidate genes involved in calcium-mediated ion homeostasis highlights pathways to explore in priority to understand the salinity tolerance of temperate rice.	[Frouin, Julien; Languillaume, Antoine; Mas, Justine; Mieulet, Delphine; Labeyrie, Axel; Bettembourg, Mathilde; Bureau, Charlotte; Lorenzini, Eve; Turquay, Patricia; Vernet, Aurore; Perin, Christophe; Ahmadi, Nourollah; Courtois, Brigitte] Ctr Cooperat Int Rech Agron Dev, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France; [Boisnard, Arnaud] Ctr Francais Riz, Arles, France; [Portefaix, Muriel] INRA, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France	CIRAD; INRAE	Courtois, B (corresponding author), Ctr Cooperat Int Rech Agron Dev, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France.	brigitte.courtois@cirad.fr	; COURTOIS, Brigitte/A-4004-2009	MIEULET, Delphine/0000-0001-6220-0372; COURTOIS, Brigitte/0000-0003-2118-7102; AHMADI, Nourollah/0000-0003-0072-6285	French Agence Nationale de la Recherche [ANR-14-JFAC-0005-01]	French Agence Nationale de la Recherche(French National Research Agency (ANR))	This research was conducted in the framework of the FACCE-JPI project GreenRice (Sustainable and environmental friendly rice cultivation systems in Europe) and was funded by French Agence Nationale de la Recherche (ANR-14-JFAC-0005-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Z, 2001, J AGRON CROP SCI, V187, P25, DOI 10.1046/j.1439-037X.2001.00500.x; Addinsoft, 2011, XLSTAT VERSION 2011; Ahmadi N, 2011, THEOR APPL GENET, V123, P881, DOI 10.1007/s00122-011-1634-4; Al-Tamimi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13342; Almeida DM, 2017, GENET MOL BIOL, V40, P326, DOI [10.1590/1678-4685-gmb-2016-0106, 10.1590/1678-4685-GMB-2016-0106]; [Anonymous], 2014, R LANG ENV STAT COMP; Bettembourg M, 2017, RICE, V10, DOI 10.1186/s12284-017-0184-z; Bian Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1068; Bimpong IK, 2016, PLANT SCI, V242, P288, DOI 10.1016/j.plantsci.2015.09.020; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burnham KP., 2004, MODEL SELECTION MULT, V2, DOI 10.1007/b97636; Butler D., 2007, ANAL MIXED MODELS S; Campbell MT, 2015, PLANT PHYSIOL, V168, P1476, DOI 10.1104/pp.15.00450; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Courtois B, 2012, CROP SCI, V52, P1663, DOI 10.2135/cropsci2011.11.0588; Daliakopoulos IN, 2016, SCI TOTAL ENVIRON, V573, P727, DOI 10.1016/j.scitotenv.2016.08.177; Platten JD, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-32; De Leon TB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00374; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fukuda A, 2011, PLANTA, V233, P175, DOI 10.1007/s00425-010-1289-4; Garcia A, 1997, PLANT CELL ENVIRON, V20, P1167, DOI 10.1046/j.1365-3040.1997.d01-146.x; Garcia AB, 1997, PLANT PHYSIOL, V115, P159, DOI 10.1104/pp.115.1.159; Gimhani DR, 2016, MOL GENET GENOMICS, V291, P2081, DOI 10.1007/s00438-016-1241-9; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Grattan S. R., 2002, California Agriculture, V56, P189, DOI 10.3733/ca.v056n06p189; Gregorio G. B., 2013, SABRAO Journal of Breeding and Genetics, V45, P31; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Horie T, 2012, RICE, V5, DOI 10.1186/1939-8433-5-11; Ismail AM, 2007, PLANT MOL BIOL, V65, P547, DOI 10.1007/s11103-007-9215-2; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kim SG, 2010, GENOMICS, V95, P56, DOI 10.1016/j.ygeno.2009.09.003; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Kumar K, 2013, RICE, V6, DOI 10.1186/1939-8433-6-27; Kumar V, 2015, DNA RES, V22, P133, DOI 10.1093/dnares/dsu046; Lafarge T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171254; Lampayan RM, 2015, FIELD CROP RES, V170, P95, DOI 10.1016/j.fcr.2014.10.013; Lekakis E, 2015, AGRONOMY-BASEL, V5, P35, DOI 10.3390/agronomy5010035; Linquist BA, 2015, GLOBAL CHANGE BIOL, V21, P407, DOI 10.1111/gcb.12701; Liu YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004037; Maas E. V., 1977, Journal of the Irrigation and Drainage Division, American Society of Civil Engineers, V103, P115; Meijon M, 2014, NAT GENET, V46, P77, DOI 10.1038/ng.2824; Moradi F., 2003, IND J PLANT PHYSL, V8, P105; Negrao S, 2017, ANN BOT-LONDON, V119, P1, DOI 10.1093/aob/mcw191; Negrao S, 2011, CRIT REV PLANT SCI, V30, P329, DOI 10.1080/07352689.2011.587725; Negrao S, 2013, PLANT BIOTECHNOL J, V11, P87, DOI 10.1111/pbi.12010; Phung NTP, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0747-y; Norton GJ, 2008, GENOMICS, V92, P344, DOI 10.1016/j.ygeno.2008.07.002; Nutan KK, 2017, FUNCT INTEGR GENOMIC, V17, P69, DOI 10.1007/s10142-016-0529-5; Obata T, 2007, PLANT PHYSIOL, V144, P1978, DOI 10.1104/pp.107.101154; Olesen JE, 2011, EUR J AGRON, V34, P96, DOI 10.1016/j.eja.2010.11.003; Panagea IS, 2016, SOLID EARTH, V7, P177, DOI 10.5194/se-7-177-2016; Pires IS, 2015, PHYSIOL PLANTARUM, V155, P43, DOI 10.1111/ppl.12356; Pittman JK, 2016, RICE, V9, DOI 10.1186/s12284-016-0075-8; Platten JD, 2006, TRENDS PLANT SCI, V11, P372, DOI 10.1016/j.tplants.2006.06.001; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Price AH, 2013, FOOD ENERGY SECUR, V2, P120, DOI 10.1002/fes3.29; Punyawaew K, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0574-8; Ranathunge K, 2003, PLANTA, V217, P193, DOI 10.1007/s00425-003-0984-9; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomson MJ, 2010, RICE, V3, P148, DOI 10.1007/s12284-010-9053-8; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yamada N, 2014, PROTOPLASMA, V251, P1067, DOI 10.1007/s00709-014-0615-2; Yano K, 2016, NAT GENET, V48, P927, DOI 10.1038/ng.3596; YEO AR, 1986, AUST J PLANT PHYSIOL, V13, P161, DOI 10.1071/PP9860161; Yoshida S., 1976, LAB MANUAL PHYSL STU; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zeng LH, 2003, EUPHYTICA, V129, P281, DOI 10.1023/A:1022248522536; Zheng HL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0342-1; Zheng HL, 2015, EUPHYTICA, V201, P109, DOI 10.1007/s10681-014-1192-3	77	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190964	10.1371/journal.pone.0190964	http://dx.doi.org/10.1371/journal.pone.0190964			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342194	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800039
J	Vialet, A; Modesto-Mata, M; Martinon-Torres, M; de Pinillos, MM; de Castro, JM				Vialet, Amellie; Modesto-Mata, Mario; Martinon-Torres, Maria; Martinez de Pinillos, Marina; Bermudez de Castro, Jose-Maria			A reassessment of the Montmaurin-La Niche mandible (Haute Garonne, France) in the context of European Pleistocene human evolution	PLOS ONE			English	Article							HOMO-ERECTUS; TAXONOMIC AFFINITIES; EAST RUDOLF; GENUS HOMO; ATAPUERCA; NEANDERTHAL; HOMINID; CAVE; SIMA; SPAIN	We here present a comparative study of the Montmaurin-LN Middle Pleistocene mandible (Haute-Garonne, France). This mandible, of which its right and left molar series are preserved in situ, was found in La Niche cave (Montmaurin's karst system) in 1949, and was first attributed to the `Mindel-Riss' interglacial (= MIS 9 to 11) based on its geological context. Later studies based on geological and faunal evidence have attributed the Montmaurin-LN mandible to MIS 7. Following a detailed morphological and metric comparative study of the mandible in the 1970s, it was interpreted in the light of a still limited fossil record and the prevailing paradigm back then. Waiting for geochronological studies in the forthcoming years, here we review the main morphological and metrical features of this mandible and its molars, which have been reassessed in the framework of a remarkably enlarged Pleistocene fossil record since the mandible was first described, and our current, more in-depth understanding of human evolution in Europe. Using a selection of mandibular features with potential taxonomic signal we have found that the Montmaurin-LN mandible shares only a few derived traits with Neandertals. Our analyses reveal that this mandible is more closely related to the ancient specimens from the African and Eurasian Early and Middle Pleistocene, particularly due to the presence of primitive features of the Homo clade. In contrast, the external morphology of the molars is clearly similar to that of Neandertals. The results are assessed in the light of the present competing hypotheses used to explain the European hominin fossil record.	[Vialet, Amellie] UPVD, Museum Natl Hist Nat, UMR7194, Ctr Europeen Rech Prehist Tautavel, Paris, France; [Modesto-Mata, Mario; Martinon-Torres, Maria; Martinez de Pinillos, Marina; Bermudez de Castro, Jose-Maria] Ctr Nacl Invest Evoluc Humana CENIEH, Paseo Sierra Atapuerca 3, Burgos, Spain; [Modesto-Mata, Mario] Equipo Primeros Pobladores Extremadura EPPEX, Casa Cultura Rodriguez Monino, Caceres, Spain; [Martinon-Torres, Maria; Martinez de Pinillos, Marina; Bermudez de Castro, Jose-Maria] UCL, Dept Anthropol, London, England; [Martinon-Torres, Maria] Univ Burgos, LEH, Dept Ciencias Hist & Geog, Hosp Rey S-N, Burgos, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of London; University College London; Universidad de Burgos	de Castro, JM (corresponding author), Ctr Nacl Invest Evoluc Humana CENIEH, Paseo Sierra Atapuerca 3, Burgos, Spain.; de Castro, JM (corresponding author), UCL, Dept Anthropol, London, England.	josemaria.bermudezdecastro@cenieh.es	Martínez de Pinillos, Marina/D-9631-2018; de Pinillos, Marina Martínez/N-7595-2019	Martínez de Pinillos, Marina/0000-0002-8035-337X; de Pinillos, Marina Martínez/0000-0002-8035-337X; Bermudez de Castro, Jose Maria/0000-0003-1314-3273	Ministerio de Economia y Competitividad (MINECO) [CGL2015-65387-C3-1, CGL2015-65387-C3-P]; Leakey Foundation; Junta de Castilla y Leon [BOCYL-D-02102014-10, BOCYL-D-20052013-14]; European Social Funds	Ministerio de Economia y Competitividad (MINECO); Leakey Foundation; Junta de Castilla y Leon(Junta de Castilla y Leon); European Social Funds(European Social Fund (ESF))	This study was part of the Ministerio de Economia y Competitividad (MINECO), project CGL2015-65387-C3-1, 3-P to Jose Maria Bermudez de Castro, and the Leakey Foundation through the personal support of Gordon Getty and Dub Crook to one of the authors (MMT). MMM and MMP have a predoctoral contract of the Junta de Castilla y Leon, (BOCYL-D-02102014-10 and BOCYL-D-20052013-14, respectively, co-financed by the European Social Funds.	AGUIRRE E, 1977, J HUM EVOL, V6, P681, DOI 10.1016/S0047-2484(77)80094-8; Aguirre E., 1976, ZEPHYRUS, V26, P489; Agusti J, 2009, J HUM EVOL, V57, P815, DOI 10.1016/j.jhevol.2009.06.005; Alcazar de Velasco Almudena, 2011, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Geologica, V105, P99; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Arsuaga JL, 1997, J HUM EVOL, V33, P219, DOI 10.1006/jhev.1997.0133; Ascenzi A, 1996, J HUM EVOL, V31, P409, DOI 10.1006/jhev.1996.0069; Bailey SE, 2011, AM J PHYS ANTHROPOL, V145, P505, DOI 10.1002/ajpa.21468; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; de Castro JMB, 2016, QUATERNARY SCI REV, V153, P51, DOI 10.1016/j.quascirev.2016.10.010; de Castro JMB, 2015, AM J PHYS ANTHROPOL, V156, P102, DOI 10.1002/ajpa.22631; BILLY G, 1977, ANTHROPOLOGIE, V81, P411; BILLY G, 1977, ANTHROPOLOGIE, V81, P273; Blain HA, 2009, J HUM EVOL, V56, P55, DOI 10.1016/j.jhevol.2008.08.020; Boule M, 1902, ANTHROPOLOGIE, V13, P305; Brothwell D.R., 1963, DENT ANTHR; CAMMAS R, 1986, CR ACAD SCI II, V302, P609; Carbonell E, 2005, P NATL ACAD SCI USA, V102, P5674, DOI 10.1073/pnas.0501841102; CARBONELL E, 1995, SCIENCE, V269, P826, DOI 10.1126/science.7638598; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carrion JS, 2011, QUATERNARY SCI REV, V30, P1281, DOI 10.1016/j.quascirev.2011.04.003; Chang CH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7037; Compton T, 2015, J QUATERNARY SCI, V30, P713, DOI 10.1002/jqs.2811; Condemi S., 1991, CIRCEO 1 NEANDERTHAL, P339; Condemi Silvana, 1991, Rivista di Antropologia, V69, P27; Cook J., 1982, YEARB PHYS ANTHROPOL, V25, P19, DOI DOI 10.1002/AJPA.1330250504; Cregut-Bonnoure E, 2010, PREHISTOIRES MEDITER, V1, P3; Cuenca-Bescos G, 2011, J HUM EVOL, V60, P481, DOI 10.1016/j.jhevol.2010.04.002; Daura J, 2017, P NATL ACAD SCI USA, V114, P3397, DOI 10.1073/pnas.1619040114; DAY MH, 1973, AM J PHYS ANTHROPOL, V39, P341, DOI 10.1002/ajpa.1330390303; de Castro JMB, 2003, J ARCHAEOL SCI, V30, P1421, DOI 10.1016/S0305-4403(03)00036-0; de Lumley MA, 2015, ANTHROPOLOGIE, V119, P303, DOI 10.1016/j.anthro.2015.06.001; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; deCastro JMB, 1997, SCIENCE, V276, P1392; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; FRANCISCUS RG, 1995, J HUM EVOL, V28, P577, DOI 10.1006/jhev.1995.1043; Gabounia L, 2002, CR PALEVOL, V1, P243, DOI 10.1016/S1631-0683(02)00032-5; GABUNIA L, 1995, NATURE, V373, P509, DOI 10.1038/373509a0; Gaillard C., 1982, GALLIA PREHIST, V25, P79; HEIM JL, 1976, ARCH I PALEONTOLOGIE, V35; Herisson D, 2016, QUATERN INT, V411, P233, DOI 10.1016/j.quaint.2016.02.049; HERSHKOVITZ I, 1995, AM J PHYS ANTHROPOL, V96, P215, DOI 10.1002/ajpa.1330960302; HOWELL FC, 1960, CURR ANTHROPOL, V1, P195, DOI 10.1086/200100; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Hublin JJ, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P295; Hughes JK, 2007, J HUM EVOL, V53, P465, DOI 10.1016/j.jhevol.2006.12.011; Irish J.D., 1993, THESIS; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P709, DOI 10.1002/ajpa.10425; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P497, DOI 10.1002/ajpa.10427; Leakey LBS, 1969, P PREHIST SOC, V25, P48; Leakey R.E., 1978, KOOBI FORA RES PROJE, P86; LEAKEY REF, 1973, AM J PHYS ANTHROPOL, V39, P355, DOI 10.1002/ajpa.1330390304; Lefevre J, 1973, B MEM SOC ANTHRO PAR, V10, P301, DOI [10.3406/bmsap.1973.2076, DOI 10.3406/BMSAP.1973.2076]; Leroy SAG, 2011, QUATERNARY SCI REV, V30, P1448, DOI 10.1016/j.quascirev.2010.01.017; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Lumley M.-A. de, 2015, ANTHROPOLOGIE, V119, P303, DOI DOI 10.1016/PANTHR0.2015.06.001; MacDonald K, 2012, QUATERN INT, V271, P84, DOI 10.1016/j.quaint.2011.10.009; Manzi G, 2004, EVOL ANTHROPOL, V13, P11, DOI 10.1002/evan.10127; Manzi G, 2001, P NATL ACAD SCI USA, V98, P10011, DOI 10.1073/pnas.151259998; Manzi G, 2010, J HUM EVOL, V59, P580, DOI 10.1016/j.jhevol.2010.06.010; de Castro JMB, 2013, QUATERN INT, V295, P102, DOI 10.1016/j.quaint.2012.02.036; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Meroc L, 1948, GALLIA, V6, P409; Meroc L, 1963, B SOC GEOL FRANCE, V5, P508; Meroc L, 1947, GALLIA, VV, P193; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Nicholson E, 2006, AM J PHYS ANTHROPOL, V131, P368, DOI 10.1002/ajpa.20425; Rak Y, 2002, AM J PHYS ANTHROPOL, V119, P199, DOI 10.1002/ajpa.10131; RAK Y, 1986, J HUM EVOL, V15, P151, DOI 10.1016/S0047-2484(86)80042-2; RAK Y, 1994, J HUM EVOL, V26, P313, DOI 10.1006/jhev.1994.1019; Renault-Miskovsky J, 1988, QUATERNAIRE, V9, P185; Rightmire G.P., 1990, EVOLUTION HOMOERECTU; Roksandic M, 2011, J HUM EVOL, V61, P186, DOI 10.1016/j.jhevol.2011.03.003; Rosas A, 1998, AM J PHYS ANTHROPOL, V107, P145, DOI 10.1002/(SICI)1096-8644(199810)107:2<145::AID-AJPA2>3.3.CO;2-8; Rosas A, 1997, J HUM EVOL, V33, P319, DOI 10.1006/jhev.1997.0138; Rosas A, 2007, VERTEBR PALEOBIOL PA, P37; ROSAS A, 1987, J HUM EVOL, V16, P417, DOI 10.1016/0047-2484(87)90070-4; Rosas A, 1999, J HUM EVOL, V37, P567, DOI 10.1006/jhev.1999.0340; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; Rosas A, 1998, GEOBIOS-LYON, V31, P687, DOI 10.1016/S0016-6995(98)80055-7; ROSAS A, 1995, J HUM EVOL, V28, P533, DOI 10.1006/jhev.1995.1041; Rosas A, 1991, ANTHROPOLOGIE, V4, P89; Saint-Perier R, 1922, ANTHROPOLOGIE, V32, P193; SAUSSE F, 1975, ANTHROPOLOGIE, V79, P81; SCHRENK F, 1993, NATURE, V365, P833, DOI 10.1038/365833a0; Schwartz JH, 2000, J HUM EVOL, V38, P367, DOI 10.1006/jhev.1999.0339; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; Serra-Joulin D, 2002, PREHISTOIRES MEDITER, V10-11, P5; Shea JJ, 2008, QUATERNARY SCI REV, V27, P2253, DOI 10.1016/j.quascirev.2008.08.015; SNEATH PHA, 1995, SYST BIOL, V44, P281, DOI 10.2307/2413593; Stringer C.B., 1984, P51; Stringer CB, 1999, J HUM EVOL, V37, P873, DOI 10.1006/jhev.1999.0367; Suwa G, 2007, ANTHROPOL SCI, V115, P133, DOI 10.1537/ase.061203; Tavoso A., 1982, 1ER C PAL HUM NIC, P96; Tobias P.V, 1991, O GORGE, V4; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; TRINKAUS E, 1987, J HUM EVOL, V16, P429, DOI 10.1016/0047-2484(87)90071-6; TRINKAUS E, 1993, RIV ANTROPOL, V71, P259; Trinkaus E., 1983, SHANIDAR NEANDERTHAL; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Turner II C. G., 1991, ADV DENT ANTHR, P13; VALLOIS H, 1956, AM J PHYS ANTHROPOL, V14, P319, DOI 10.1002/ajpa.1330140224; VALLOIS H, 1955, CR HEBD ACAD SCI, V240, P1577; Wagner GA, 2010, P NATL ACAD SCI USA, V107, P19726, DOI 10.1073/pnas.1012722107; Walker Alan, 1993, P63; Weaver TD, 2009, P NATL ACAD SCI USA, V106, P16028, DOI 10.1073/pnas.0903864106; Weidenreich F., 1936, Palaeontologia Sinica, VD7, P1; WHITE TD, 1981, S AFR J SCI, V77, P445; Wolpoff MH, 2005, AM J PHYS ANTHROPOL, V128, P245, DOI 10.1002/ajpa.10432; WOLPOFF MH, 1979, AM J PHYS ANTHROPOL, V50, P67, DOI 10.1002/ajpa.1330500110; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD BA, 1986, AM J PHYS ANTHROPOL, V69, P117, DOI 10.1002/ajpa.1330690113; Wu L, 2017, AM J PHYS ANTHR; Wu XJ, 2014, CR PALEVOL, V13, P333, DOI 10.1016/j.crpv.2013.10.002	117	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0189714	10.1371/journal.pone.0189714	http://dx.doi.org/10.1371/journal.pone.0189714			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29337994	Green Submitted, Green Published, gold			2022-12-27	WOS:000422652700003
J	Waugh, DA; Suydam, RS; Ortiz, JD; Thewissen, JGM				Waugh, David A.; Suydam, Robert S.; Ortiz, Joseph D.; Thewissen, J. G. M.			Validation of Growth Layer Group (GLG) depositional rate using daily incremental growth lines in the dentin of beluga (Delphinapterus leucas (Pallas, 1776)) teeth	PLOS ONE			English	Article							AGE; WHALES; ORGANIZATION; PATTERNS; STENELLA; DOLPHINS; INCISOR; ENAMEL; ISLAND; MARKS	Counts of Growth Layer Groups (GLGs) in the dentin of marine mammal teeth are widely used as indicators of age. In most marine mammals, observations document that GLGs are deposited yearly, but in beluga whales, some studies have supported the view that two GLGs are deposited each year. Our understanding of beluga life-history differs substantially depending on assumptions regarding the timing of GLG deposition; therefore, resolving this issue has important considerations for population assessments. In this study, we used incremental lines that represent daily pulses of dentin mineralization to test the hypothesis that GLGs in beluga dentin are deposited on a yearly basis. Our estimate of the number of daily growth lines within one GLG is remarkably close to 365 days within error, supporting the hypothesis that GLGs are deposited annually in beluga. We show that measurement of daily growth increments can be used to validate the time represented by GLGs in beluga. Furthermore, we believe this methodology may have broader applications to age estimation in other taxa.	[Waugh, David A.; Thewissen, J. G. M.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH 44272 USA; [Suydam, Robert S.] North Slope Borough, Dept Wildlife Management, Barrow, AK USA; [Ortiz, Joseph D.] Kent State Univ, Dept Geol, Kent, OH 44242 USA	Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Waugh, DA (corresponding author), Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH 44272 USA.	dwaugh@neomed.edu	; Ortiz, Joseph/E-1144-2011	Waugh, David/0000-0002-6725-1272; Ortiz, Joseph/0000-0002-6583-3850	North Slope Borough Department of Wildlife Management	North Slope Borough Department of Wildlife Management	This work was funded by the North Slope Borough Department of Wildlife Management. The funder had no role in study design, data collectionand analysis, decision to publish, or preparation ofthe manuscript.	Aguet F, 2008, IEEE T IMAGE PROCESS, V17, P1144, DOI 10.1109/TIP.2008.924393; BEST PB, 1976, S AFR J SCI, V72, P216; BEYNON AD, 1991, AM J PHYS ANTHROPOL, V86, P189, DOI 10.1002/ajpa.1330860208; Beynon AD, 1998, J HUM EVOL, V35, P163, DOI 10.1006/jhev.1998.0230; Boyde A., 1980, International Whaling Commission Report of the Commission, P65; BOYDE A, 1968, J DENT RES, V47, P1007; BOYDE A, 1983, ANAT EMBRYOL, V168, P211, DOI 10.1007/BF00315817; Braham H. W, 1984, REPORTS INT WHALING, V6, P81; Brodie P., 2013, Journal of Cetacean Research and Management, V13, P1; Brodie P.F., 1982, International Whaling Commission Report of the Commission, V32, P445; Brodie P.F., 1990, Canadian Bulletin of Fisheries and Aquatic Sciences, V224, P141; BRODIE PF, 1969, NATURE, V221, P956, DOI 10.1038/221956a0; BROMAGE TG, 1991, AM J PHYS ANTHROPOL, V86, P205, DOI 10.1002/ajpa.1330860209; Carvalho RM, 1996, ARCH ORAL BIOL, V41, P369, DOI 10.1016/0003-9969(95)00115-8; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; Cornell, 1980, REP INT WHALES COMM, V3, P165; Dean MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054534; Dean MC, 2012, J HUM EVOL, V62, P174, DOI 10.1016/j.jhevol.2011.10.003; Dean MC, 2004, ANN ANAT, V186, P405; Dean MC, 1996, ARCH ORAL BIOL, V41, P233, DOI 10.1016/0003-9969(95)00137-9; Dean MC, 1998, ARCH ORAL BIOL, V43, P1009, DOI 10.1016/S0003-9969(98)00069-7; Dean MC, 1993, INT J OSTEOARCHAEOL, V3, P199, DOI DOI 10.1002/0A.1390030306; Dean MC, 2016, COMPTES RENDUS PALEV; Dean MC., 1995, STRUCTURE FUNCTION E, P239; Dellabianca NA, 2012, GLOBAL CHANGE BIOL, V18, P2477, DOI 10.1111/j.1365-2486.2012.02707.x; EBERHARDT LL, 1985, J WILDLIFE MANAGE, V49, P997, DOI 10.2307/3801386; Erickson GM, 1996, J MORPHOL, V228, P189, DOI 10.1002/(SICI)1097-4687(199605)228:2<189::AID-JMOR7>3.0.CO;2-0; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Erickson GM, 2017, P NATL ACAD SCI USA, V114, P540, DOI 10.1073/pnas.1613716114; Evans K, 2011, AG DET MAR MAMM US T; Fraker MA, 1978, BEAUFORT SEA PROJ TE, V4, P1; GOREN AD, 1987, MAR MAMMAL SCI, V3, P14, DOI 10.1111/j.1748-7692.1987.tb00148.x; Hamilton V, 2013, J EXP MAR BIOL ECOL, V446, P236, DOI 10.1016/j.jembe.2013.05.031; Hauser DDW, 2017, GLOBAL CHANGE BIOL, V23, P2206, DOI 10.1111/gcb.13564; Hauser DDW, 2014, POLAR BIOL, V37, P1171, DOI 10.1007/s00300-014-1510-1; Heide-Jorgensen MP, 1994, MEDDELELSER GRONL BI, V39, P185; HOHN A A, 1980, Scientific Reports of the Whales Research Institute Tokyo, P39; Hohn AA, 2008, ENCY MARINE MAMMALS, P11; Hohn AA, 1999, GROWTH LAYER P UNPUB, P1; Hohn AA, 2016, NAMMCO SCI PUBLICATI, V10, P68; IWC (International Whaling Commission), 1980, REPORT INT WHALING C, P1; Jones S. J., 1984, DENTIN DENTINOGENESI, P81; Katagir M, 1968, ODONTOLOGY, V56, P9; KAWASAKI K, 1979, ARCH ORAL BIOL, V24, P939, DOI 10.1016/0003-9969(79)90221-8; Kear BP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172759; Keil A, 1969, CAN TRANSL FISH AQUA; Khuzin R, 1961, B PINRO, V1, P58; Klevezal G., 1996, RECORDING STRUCTURES; KLEVEZAL GA, 1984, J MAMMAL, V65, P103, DOI 10.2307/1381206; KLEVEZAL GA, 1987, ZOOL ZH, V66, P1886; KLEVEZAL GA, 1990, ACTA THERIOL, V35, P331, DOI 10.4098/AT.arch.90-38; Klevezal GA, 1971, T ATL SCI RES I FISH, V39; Kodaka T, 1995, JPN J ORAL BIOL, V37, P80; KRISTENSEN HK, 1948, STAIN TECHNOL, V23, P151, DOI 10.3109/10520294809106242; Lockyer C., 2016, NAMMCO SCI PUBL, V10, DOI [10.7557/3.3731, DOI 10.7557/3.3731]; Lockyer Christina, 1993, V14, P137; Lockyer Christina, 2007, Aquatic Mammals, V33, P293, DOI 10.1578/AM.33.3.2007.293; Luque PL, 2013, J ZOOL, V291, P194, DOI 10.1111/jzo.12062; Luque PL, 2009, J MAR BIOL ASSOC UK, V89, P893, DOI 10.1017/S0025315409001866; Luque Sebastian P., 2007, Aquatic Mammals, V33, P241, DOI 10.1578/AM.33.2.2007.241; MANZANILLA SR, 1989, CAN J ZOOL, V67, P2120, DOI 10.1139/z89-301; Marcoux M, 2015, MAR MAMMAL SCI, V31, P944, DOI 10.1111/mms.12212; Matthews CJD, 2014, NAMMCO SCI PUBL, V10, P1; MAYER P, 1903, Z WISSENSCHAFTLICHE, V20, P409; MIRRA SS, 1993, ARCH PATHOL LAB MED, V117, P132; Myrick A.C., 1991, P251; Myrick A.C. Jr, 1980, International Whaling Commission Report of the Commission, P105; Myrick A.C. Jr, 1990, P587; MYRICK A C JR, 1988, Rit Fiskideildar, V11, P285; MYRICK AC, 1984, FISH B-NOAA, V82, P207; Myrick ACJ, 1983, SWFC30 NOAA NMFS; O'Corry-Crowe G, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0404; OCorryCrowe GM, 1997, MOL ECOL, V6, P955, DOI 10.1046/j.1365-294X.1997.00267.x; Ohtsuka-Isoya M, 2001, AM J PHYSIOL-REG I, V280, pR1364, DOI 10.1152/ajpregu.2001.280.5.R1364; Pleskach K, 2016, MAR MAMMAL SCI, V32, P1370, DOI 10.1111/mms.12347; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; ROSENBERG GD, 1980, CALCIFIED TISSUE INT, V32, P29, DOI 10.1007/BF02408519; Scheffer VB, 1978, GROWTH ODONTOCETES S; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHOUR I., 1939, JOUR DENTAL RES, V18, P91, DOI 10.1177/00220345390180010701; Schour I., 1939, J DENT RES, V18, P161, DOI [DOI 10.1177/00220345390180020601, 10.1177/00220345390180020601]; SERGEANT DE, 1973, J FISH RES BOARD CAN, V30, P1065, DOI 10.1139/f73-178; SHELLIS RP, 1983, ARCH ORAL BIOL, V28, P85, DOI 10.1016/0003-9969(83)90030-4; Smith TM, 2008, J HUM EVOL, V54, P205, DOI 10.1016/j.jhevol.2007.09.020; Stewart BE, 2012, CAN TECH REPORTS FIS, V3020, pxi; Stewart REA, 2006, CAN J ZOOL, V84, P1840, DOI 10.1139/Z06-182; Suydam R.S., 2009, AGE GROWTH REPROD MO; TITFORD M, 1984, Journal of Histotechnology, V7, P171; Wallington, 1980, CARLETONS HISTOLOGIC; Weiner S, 1999, J STRUCT BIOL, V126, P27, DOI 10.1006/jsbi.1999.4096; WHITTAKER DK, 1979, BRIT DENT J, V146, P43, DOI 10.1038/sj.bdj.4804196; YILMAZ S, 1977, ARCH ORAL BIOL, V22, P511, DOI 10.1016/0003-9969(77)90046-2	92	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190498	10.1371/journal.pone.0190498	http://dx.doi.org/10.1371/journal.pone.0190498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338011	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700011
J	Henry, R; Galbraith, P; Coutts, S; Prosser, T; Boyce, J; McCarthy, DT				Henry, Rebekah; Galbraith, Penelope; Coutts, Scott; Prosser, Toby; Boyce, John; McCarthy, David T.			What's the risk? Identifying potential human pathogens within grey-headed flying foxes faeces	PLOS ONE			English	Article							BACTERIAL COMMUNITY; RESERVOIR HOSTS; FRUIT BATS; SALMONELLA; DIVERSITY; SURVIVAL; IDENTIFICATION; CONTAMINATION; TYPHIMURIUM; MICROBIOTA	Pteropus poliocephalus (grey-headed flying foxes) are recognised vectors for a range of potentially fatal human pathogens. However, to date research has primarily focused on viral disease carriage, overlooking bacterial pathogens, which also represent a significant human disease risk. The current study applied 16S rRNA amplicon sequencing, community analysis and a multi-tiered database OTU picking approach to identify faecal-derived zoo-notic bacteria within two colonies of P. poliocephalus from Victoria, Australia. Our data show that sequences associated with Enterobacteriaceae (62.8% +/- 24.7%), Pasteurellaceae (19.9% +/- 25.7%) and Moraxellaceae (9.4% +/- 11.8%) dominate flying fox faeces. Further colony specific differences in bacterial faecal colonisation patterns were also identified. In total, 34 potential pathogens, representing 15 genera, were identified. However, species level definition was only possible for Clostridium perfringens, which likely represents a low infectious risk due to the low proportion observed within the faeces and high infectious dose required for transmission. In contrast, sequences associated with other pathogenic species clusters such as Haemophilus haemolyticus-H. influenzae and Salmonella bongori-S. enterica, were present at high proportions in the faeces, and due to their relatively low infectious doses and modes of transmissions, represent a greater potential human disease risk. These analyses of the microbial community composition of Pteropus poliocephalus have significantly advanced our understanding of the potential bacterial disease risk associated with flying foxes and should direct future epidemiological and quantitative microbial risk assessments to further define the health risks presented by these animals.	[Henry, Rebekah; Galbraith, Penelope; McCarthy, David T.] Monash Univ, Dept Civil Engn, EPHM Lab, Clayton, Vic, Australia; [Coutts, Scott] Monash Univ, Dept Microbiol, Micromon, Clayton, Vic, Australia; [Prosser, Toby] Melbourne Water, Docklands, Vic, Australia; [Boyce, John] Monash Univ, Dept Microbiol, Clayton, Vic, Australia	Monash University; Monash University; Monash University	McCarthy, DT (corresponding author), Monash Univ, Dept Civil Engn, EPHM Lab, Clayton, Vic, Australia.	david.mccarthy@monash.edu	Boyce, John D/F-5058-2012	Boyce, John D/0000-0002-8614-3074; Galbraith, Penelope/0000-0003-3595-8190; McCarthy, David/0000-0001-8845-6501; Henry, Rebekah/0000-0001-6530-8557	Australian Research Council [LP160100408, LP120100718]; Environmental Protection Authority; Melbourne Water	Australian Research Council(Australian Research Council); Environmental Protection Authority; Melbourne Water	DTM wished to acknowledge funding received from Melbourne Water, Environmental Protection Authority and the Australian Research Council (LP160100408 and LP120100718).& para;& para;We would like to acknowledge support from the Australian Research Council through the Linkage Program (LP120100718 and LP160100408). The authors would also like to gratefully acknowledge the data contribution from Melbourne Water, in particular Rhys Coleman, and the Environmental Protection Authority. We would also like to thank Ms Christelle Schang, Mr. Peter Kolotelo and Mr Richard Williamson for their technical support during this study.	Abia ALK, 2016, MICROB ECOL, V72, P881, DOI 10.1007/s00248-016-0784-y; Adesiyun AA, 2009, J WILDLIFE DIS, V45, P952, DOI 10.7589/0090-3558-45.4.952; Alfano N, 2015, SCI REP-UK, V5, DOI 10.1038/srep10189; Allard G, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0747-1; Australia S, 2016, 12892112005R2016 AS; Banskar S, 2016, MICROBIOL RES, V182, P99, DOI 10.1016/j.micres.2015.10.006; Bengis RH, 2004, REV SCI TECH OIE, V23, P497; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRYGOO ER, 1971, CR SOC BIOL, V165, P1203; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caroline J, 2003, PAK J BIOL SCI, V6, P1564, DOI DOI 10.3923/PJBS.2003.1564.1573; Christensen H, 2008, PASTEURELLACEAE BIOL; Chung WSF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-015-0224-3; Cole JR, 2014, RNA BIOL, V11, P239, DOI 10.4161/rna.28306; Cox TE, 2005, J WILDLIFE DIS, V41, P753, DOI 10.7589/0090-3558-41.4.753; Daniel DS, 2013, MICROBIOL RES, V168, P485, DOI 10.1016/j.micres.2013.04.001; De Mandal S, 2015, GENOM DATA, V4, P99, DOI 10.1016/j.gdata.2015.04.001; De Souza Luiz Carlos, 2002, Veterinaria e Zootecnia, V11, P123; Decuypere S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004470; Dietrich M, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnw284; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Mejri S, 2012, J FOOD SAFETY, V32, P270, DOI 10.1111/j.1745-4565.2012.00377.x; Flygare S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0969-1; Flynn JM, 2015, ECOL EVOL, V5, P2252, DOI 10.1002/ece3.1497; Fujita M., 1991, FLYING FOX CHIROPTE; Garcia-Mazcorro JF, 2017, MICROB ECOL, V73, P224, DOI 10.1007/s00248-016-0840-7; Gonzalez A, 2011, EMBO REP, V12, P775, DOI 10.1038/embor.2011.137; Gutman N, 2016, LETT APPL MICROBIOL, V62, P237, DOI 10.1111/lam.12545; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Heard DJ, 1997, J ZOO WILDLIFE MED, V28, P471; Henry R, 2016, WATER RES, V93, P242, DOI 10.1016/j.watres.2016.02.029; Ionescu D., 2016, MANUAL ENV MICROBIOL; Jacobsen CS, 2012, FOOD RES INT, V45, P557, DOI 10.1016/j.foodres.2011.07.026; Grilli DJ, 2016, ANAEROBE, V42, P17, DOI 10.1016/j.anaerobe.2016.07.002; Johnson EA, 2007, CLOSTRIDIUM; Kooser A, 2015, BIORXIV; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Mackenzie JS, 2003, J APPL MICROBIOL, V94, p59S; Menke S, 2015, METHODS ECOL EVOL, V6, P1080, DOI 10.1111/2041-210X.12394; Moriarty EM, 2011, APPL ENVIRON MICROB, V77, P1797, DOI 10.1128/AEM.01329-10; Musher DM., 1996, HAEMOPHILUS SPECIES; Myer PR, 2016, J MICROBIOL METH, V127, P132, DOI 10.1016/j.mimet.2016.06.004; Neuweiler G., 2000, BIOL BATS; Norskov-Lauritsen N, 2011, MICROBIOL-SGM, V157, P1050, DOI 10.1099/mic.0.047233-0; Oladeinde A, 2014, APPL ENVIRON MICROB, V80, P110, DOI 10.1128/AEM.02203-13; Quinn EK, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-144; Russo D, 2015, MAMM BIOL, V80, P205, DOI 10.1016/j.mambio.2014.10.003; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sanchez CA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004411; Schang C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155848; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Seeliger H, 1974, ANN MICROBIOLOGI; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SLEMONS RD, 1978, AVIAN DIS, V22, P367, DOI 10.2307/1589291; Smith CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109522; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; van der Ree Rodney, 2004, P195; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Voidarou C, 2011, ANAEROBE, V17, P320, DOI 10.1016/j.anaerobe.2011.05.004; Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475; Wang HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080430; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yilmaz P., 2013, NUCL ACIDS RES; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	71	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191301	10.1371/journal.pone.0191301	http://dx.doi.org/10.1371/journal.pone.0191301			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360880	gold, Green Published, Green Submitted			2022-12-27	WOS:000423161800022
J	Kitanishi, S; Onikura, N; Mukai, T				Kitanishi, Shigeru; Onikura, Norio; Mukai, Takahiko			A simple SNP genotyping method reveals extreme invasions of non-native haplotypes in pale chub &ITOpsariichthys platypus&IT, a common cyprinid fish in Japan	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; TROUT SALMO-TRUTTA; DNA; INTROGRESSION; HYBRIDIZATION; POPULATIONS; BIOLOGY	Biological invasion by non-native subspecies or populations is one of the most serious threats to ecosystems, because these species might be easily established in the introduced area and can negatively affect native populations through competition and hybridization. Pale chub Opsariichthys platypus, one of the most common fish in East Asia, exhibits clear genetic differentiation among regional populations; however, introgression and subsequent loss of genetic integrity have been occurring throughout Japan due to the artificial introduction of non-native conspecifics. In this study, we developed a simple SNP genotyping method to discriminate between native and non-native mitochondrial DNA (mtDNA) haplotypes in pale chub using real-time PCR assay. We then investigated the distribution patterns of non-native pale chub in Tokai region, located in the center of Honshu Island, Japan and developed a predictive model of the occurrence of non-natives to reveal the factors influencing their invasion. The specificity and accuracy of the genotyping method were confirmed by using samples whose haplotypes were determined previously. Extensive occurrence of non-native haplotypes in Tokai region was detected by this method. In addition, our models suggested that the presence of non-natives varied greatly depending on the river system, and was positively influenced by the impounded water areas. Our method could accurately distinguish between native and non-native haplotypes of pale chub in Japan and suggested key environmental factors associated with the presence of non-natives. This approach can greatly reduce experimental costs be a great contribution for quantitative investigation.	[Kitanishi, Shigeru; Mukai, Takahiko] Gifu Univ, Fac Reg Studies, Gifu, Japan; [Onikura, Norio] Kyushu Univ, Fishery Res Lab, Fukuoka, Japan; [Kitanishi, Shigeru; Mukai, Takahiko] Oita Univ, Fac Sci & Technol, Oita, Japan	Gifu University; Kyushu University; Oita University	Kitanishi, S (corresponding author), Gifu Univ, Fac Reg Studies, Gifu, Japan.; Kitanishi, S (corresponding author), Oita Univ, Fac Sci & Technol, Oita, Japan.	kitanishi@oita-u.ac.jp			JSPS KAKENHI [26250044]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (https://www.jsps.go.jp/j-grantsinaid/) Grant Number 26250044 to Takahiko Mukai. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Araguas RM, 2004, J FISH BIOL, V65, P28, DOI 10.1111/j.0022-1112.2004.00544.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Blanchet S, 2012, FISHERIES MANAG ECOL, V19, P120, DOI 10.1111/j.1365-2400.2011.00832.x; Ciancio JE, 2015, BIOL INVASIONS, V17, P2989, DOI 10.1007/s10530-015-0928-x; De La Vega FA, 2005, MUTAT RES-FUND MOL M, V573, P111, DOI 10.1016/j.mrfmmm.2005.01.008; Eldridge WH, 2007, MOL ECOL, V16, P2407, DOI 10.1111/j.1365-294X.2007.03271.x; Endo K, 2005, LUNG CANCER, V50, P375, DOI 10.1016/j.lungcan.2005.08.009; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Hosoya K., 2013, FISHES JAPAN PICTORI, P1813; Kawamura K, 2001, ZOOL SCI, V18, P1027, DOI 10.2108/zsj.18.1027; Kitanishi S, 2016, ICHTHYOL RES, V63, P506, DOI 10.1007/s10228-016-0522-y; Komiya T, 2014, ENVIRON BIOL FISH, V97, P741, DOI 10.1007/s10641-013-0176-9; Konishi M, 2003, J FISH BIOL, V63, P213, DOI 10.1046/j.1095-8649.2003.00146.x; Kushida K, 2015, J VET MED SCI, V77, P743, DOI 10.1292/jvms.14-0600; Lockwood JL., 2013, INVASION ECOLOGY; Ma GC, 2006, ICHTHYOL RES, V53, P323, DOI 10.1007/s10228-006-0353-3; Mabuchi K, 2008, MOL ECOL, V17, P796, DOI 10.1111/j.1365-294X.2007.03626.x; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Miura O, 2007, ECOL RES, V22, P876, DOI 10.1007/s11284-007-0389-5; Mizuguchi K, 1990, REP TOKYO U FISH, V25, P149; Morin PA, 1999, BIOTECHNIQUES, V27, P538, DOI 10.2144/99273rr02; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Office for the Promotion of Fisheries GP, 2017, FISH GIF PRIF GIF PR; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Quantum GIS Development Team, 2013, QGIS GEOGR INF SYST; Ryan ME, 2009, P NATL ACAD SCI USA, V106, P11166, DOI 10.1073/pnas.0902252106; RYMAN N, 1995, REV FISH BIOL FISHER, V5, P417, DOI 10.1007/BF01103814; Schulte U, 2012, MOL ECOL, V21, P4313, DOI 10.1111/j.1365-294X.2012.05693.x; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Shi MM, 1999, J CLIN PATHOL-MOL PA, V52, P295, DOI 10.1136/mp.52.5.295; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Takami T, 2002, NIPPON SUISAN GAKK, V68, P24; Takamura K, 2015, LIMNOLOGY; Thompson Paul D., 1998, North American Journal of Fisheries Management, V18, P206, DOI 10.1577/1548-8675(1998)018<0206:EOABIS>2.0.CO;2; UEDA K, 1989, Acta Phytotaxonomica et Geobotanica, V40, P190; Utter F, 2000, REV FISH BIOL FISHER, V10, P265, DOI 10.1023/A:1016686415022; Van Houdt JKJ, 2005, CONSERV GENET, V6, P175, DOI 10.1007/s10592-004-7822-x; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Watanabe K, 1998, ICHTHYOL RES, V45, P259, DOI 10.1007/BF02673924; Watanabe K, 2012, ENVIRON BIOL FISH, V94, P533, DOI 10.1007/s10641-010-9601-5	44	1	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191731	10.1371/journal.pone.0191731	http://dx.doi.org/10.1371/journal.pone.0191731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360868	Green Submitted, Green Published, gold			2022-12-27	WOS:000423161800056
J	Berejikian, BA; Van Doornik, DM				Berejikian, Barry A.; Van Doornik, Donald M.			Increased natural reproduction and genetic diversity one generation after cessation of a steelhead trout (Oncorhynchus mykiss) conservation hatchery program	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; COMPUTER-PROGRAM; CHINOOK SALMON; COHO SALMON; WILD; CALIFORNIA; WASHINGTON; PACIFIC; SUCCESS; DEPRESSION	Spatial and temporal fluctuations in productivity and abundance confound assessments of captive propagation programs aimed at recovery of Threatened and Endangered populations. We conducted a 17 year before-after-control-impact experiment to determine the effects of a captive rearing program for anadromous steelhead trout (Oncorhynchus mykiss) on a key indicator of natural spawner abundance (naturally produced nests or 'redds'). The supplemented population exhibited a significant (2.6-fold) increase in redd abundance in the generation following supplementation. Four non-supplemented (control) populations monitored over the same 17 year period exhibited stable or decreasing trends in redd abundance. Expected heterozygosity in the supplemented population increased significantly. Allelic richness increased, but to a lesser (non-significant) degree. Estimates of the effective number of breeders increased from a harmonic mean of 24.4 in the generation before supplementation to 38.9 after supplementation. Several non-conventional aspects of the captive rearing program may have contributed to the positive response in the natural population.	[Berejikian, Barry A.] NOAA, Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Environm & Fisheries Sci Div, Port Orchard, WA 98366 USA; [Van Doornik, Donald M.] NOAA, Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Conservat Biol Div, Port Orchard, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Berejikian, BA (corresponding author), NOAA, Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Environm & Fisheries Sci Div, Port Orchard, WA 98366 USA.	barry.berejikian@noaa.gov		Berejikian, Barry/0000-0003-2933-7806	Washington State Interagency Committee [01-042]; NOAA Fisheries, Northwest Fisheries Science Center	Washington State Interagency Committee; NOAA Fisheries, Northwest Fisheries Science Center(National Oceanic Atmospheric Admin (NOAA) - USA)	Initial funding was provided by the Washington State Interagency Committee for Outdoor Recreation Grant #01-042 (original URL no longer available; current web address for this organization is http://www.rco.wa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Subsequent funding was provided by NOAA Fisheries, Northwest Fisheries Science Center.	Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Berejikian B, 2005, T AM FISH SOC, V134, P1236, DOI 10.1577/T04-192.1; Berejikian BA, 2008, CAN J FISH AQUAT SCI, V65, P754, DOI 10.1139/F08-014; Berejikian BA, 2013, CAN J FISH AQUAT SCI, V70, P756, DOI 10.1139/cjfas-2012-0491; Berejikian BA, 2011, T AM FISH SOC, V140, P549, DOI 10.1080/00028487.2011.583540; Bingham DM, 2014, N AM J FISH MANAGE, V34, P609, DOI 10.1080/02755947.2014.901257; Brannon EL, 2004, REV FISH SCI, V12, P99, DOI 10.1080/10641260490280313; Buhle ER, 2009, BIOL CONSERV, V142, P2449, DOI 10.1016/j.biocon.2009.05.013; Chaput G, 2012, ICES J MAR SCI, V69, P1538, DOI 10.1093/icesjms/fss013; Christie MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10676; Christie MR, 2014, EVOL APPL, V7, P883, DOI 10.1111/eva.12183; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Ford MJ, 2011, NMFSNWFSC113; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; Gallagher SP, 2005, N AM J FISH MANAGE, V25, P284, DOI 10.1577/M04-016.1; Hedrick PW, 2016, TRENDS ECOL EVOL, V31, P940, DOI 10.1016/j.tree.2016.09.005; Hess MA, 2012, MOL ECOL, V21, P5236, DOI 10.1111/mec.12046; Horne JS, 2016, BIOL CONSERV, V196, P133, DOI 10.1016/j.biocon.2016.02.005; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kanghae H, 2016, ZOO BIOL, V35, P454, DOI 10.1002/zoo.21318; Katz J, 2013, ENVIRON BIOL FISH, V96, P1169, DOI 10.1007/s10641-012-9974-8; Kinsel C., 2009, 0912 FPA WASH DEP FI; Kline PA, 2014, FISHERIES, V39, P488, DOI 10.1080/03632415.2014.966087; Kuligowski DR, 2005, T AM FISH SOC, V134, P1202, DOI 10.1577/T04-187.1; Lagios EL, 2015, ORYX, V49, P321, DOI 10.1017/S0030605313000690; McClure MM, 2008, EVOL APPL, V1, P356, DOI 10.1111/j.1752-4571.2008.00034.x; Meretsky V, 2001, CONSERV BIOL, V15, P1449, DOI 10.1046/j.1523-1739.2001.01004.x; Moore M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073427; Moore M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049645; Moore ME, 2015, MAR ECOL PROG SER, V537, P217, DOI 10.3354/meps11460; Naish KA, ADV MAR BIOL, P61; Neff BD, 2011, CAN J FISH AQUAT SCI, V68, P1139, DOI [10.1139/F2011-029, 10.1139/f2011-029]; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Ortego J, 2007, BIOL LETTERS, V3, P585, DOI 10.1098/rsbl.2007.0268; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PSSTRT (Puget Sound Steelhead Technical Recovery Team), 2013, ID HIST POP STEELH P; Rand PS, 2012, ENVIRON BIOL FISH, V94, P343, DOI 10.1007/s10641-012-9988-2; Rollinson N, 2014, CONSERV BIOL, V28, P529, DOI 10.1111/cobi.12188; RYMAN N, 1991, CONSERV BIOL, V5, P325, DOI 10.1111/j.1523-1739.1991.tb00144.x; Santymire RM, 2014, ADV EXP MED BIOL, V753, P119, DOI 10.1007/978-1-4939-0820-2_7; Scheuerell MD, 2015, ECOL EVOL, V5, P2115, DOI 10.1002/ece3.1509; Small MP, 2009, CAN J FISH AQUAT SCI, V66, P1216, DOI 10.1139/F09-068; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Van Doornik DM, 2015, ENVIRON BIOL FISH, V98, P637, DOI 10.1007/s10641-014-0301-4; Van Doornik DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079931; Van Doornik DM, 2010, CAN J FISH AQUAT SCI, V67, P1449, DOI 10.1139/F10-073; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 1999, FISHERIES, V24, P12, DOI 10.1577/1548-8446(1999)024<0012:DSMAH>2.0.CO;2; Warton DI, 2016, METHODS ECOL EVOL, V7, P882, DOI 10.1111/2041-210X.12552; Williams SE, 2009, BIOL CONSERV, V142, P2388, DOI 10.1016/j.biocon.2009.05.034; Wootton JT, 2014, ECOL APPL, V24, P1251, DOI 10.1890/13-1323.1; Zimmerman MS, 2015, MAR COAST FISH, V7, P116, DOI 10.1080/19425120.2015.1012246	55	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190799	10.1371/journal.pone.0190799	http://dx.doi.org/10.1371/journal.pone.0190799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351326	Green Submitted, gold, Green Published			2022-12-27	WOS:000422911300026
J	Faigle, R; Carrese, JA; Cooper, LA; Urrutia, VC; Gottesman, RF				Faigle, Roland; Carrese, Joseph A.; Cooper, Lisa A.; Urrutia, Victor C.; Gottesman, Rebecca F.			Minority race and male sex as risk factors for non-beneficial gastrostomy tube placements after stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; HEALTH-CARE PROFESSIONALS; RESUSCITATE ORDERS; GUIDELINES; DIAGNOSIS; GENDER; ASSOCIATION; DISPARITIES; WITHDRAWAL	Background Percutaneous endoscopic gastrostomy (PEG) tubes are widely used for enteral feeding after stroke; however, PEG tubes placed in patients in whom death is imminent are considered non-beneficial. Aim We sought to determine whether placement of non-beneficial PEG tubes differs by race and sex. Design and setting/participants In this retrospective cohort study, inpatient admissions for stroke patients who underwent palliative/withdrawal of care, were discharged to hospice, or died during the hospitalization, were identified from the Nationwide Inpatient Sample between 2007 and 2011. Logistic regression was used to evaluate the association between race and sex with PEG placement. Results Of 36,109 stroke admissions who underwent palliative/withdrawal of care, were discharge to hospice, or experienced in-hospital death, a PEG was placed in 2,258 (6.3%). Among PEG recipients 41.1% were of a race other than white, while only 22.0% of patients without PEG were of a minority race (p< 0.001). The proportion of men was higher among those with compared to without a PEG tube (50.0% vs. 39.2%, p < 0.001). Minority race was associated with PEG placement compared to whites (OR 1.75, 95% CI 1.57 +/- 1.96), and men had 1.27 times higher odds of PEG compared to women (95% CI 1.16 +/- 1.40). Racial differences were most pronounced among women: ethnic/racial minority women had over 2-fold higher odds of a PEG compared to their white counterparts (OR 2.09, 95% CI 1.81 +/- 2.41), while male ethnic/racial minority patients had 1.44 increased odds of a PEG when compared to white men (95% CI 1.24 +/- 1.67, p-value for interaction < 0.001). Conclusion Minority race and male sex are risk factors for non-beneficial PEG tube placements after stroke.	[Faigle, Roland; Urrutia, Victor C.; Gottesman, Rebecca F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Carrese, Joseph A.; Cooper, Lisa A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Carrese, Joseph A.] Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Faigle, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	rfaigle1@jhmi.edu	Urrutia, Victor/AAH-6683-2021; Faigle, Roland/ABB-9082-2020; Gottesman, Rebecca/ABA-8468-2020	Urrutia, Victor/0000-0002-4995-6949; Faigle, Roland/0000-0002-9074-1915; 	NINDS Career Development Award [K23 NS101124]; National Heart, Lung, and Blood Institute [K24HL083113]; National Institute on Aging [K24AG052573]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS101124] Funding Source: NIH RePORTER	NINDS Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Faigle is supported by an NINDS Career Development Award (K23 NS101124). Dr. Cooper is supported by a grant from the National Heart, Lung, and Blood Institute (K24HL083113). Dr Gottesman is supported by a grant from the National Institute on Aging (K24AG052573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar B, 2011, STROKE, V42, P2944, DOI 10.1161/STROKEAHA.111.617639; Bookwala J, 2001, DEATH STUD, V25, P127, DOI 10.1080/074811801461919; Brown F, 2011, ICD 9 CM CODING HDB; Corrigan ML, 2011, NUTR CLIN PRACT, V26, P242, DOI 10.1177/0884533611405795; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; EDWARDS N, 1994, HEALTH CARE FINANC R, V16, P45; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; FRANKL D, 1989, AM J MED, V86, P645, DOI 10.1016/0002-9343(89)90436-1; George BP, 2017, STROKE, V48, P420, DOI 10.1161/STROKEAHA.116.015119; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; James A, 1998, AGE AGEING, V27, P671, DOI 10.1093/ageing/27.6.671; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Johnston SD, 2008, GASTROINTEST ENDOSC, V68, P223, DOI 10.1016/j.gie.2007.10.019; Kent JA, 2012, MT SINAI J MED, V79, P555, DOI 10.1002/msj.21336; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Loser C, 2005, CLIN NUTR, V24, P848, DOI 10.1016/j.clnu.2005.06.013; Mack JW, 2010, ARCH INTERN MED, V170, P1533, DOI 10.1001/archinternmed.2010.322; Mann G, 1999, STROKE, V30, P744, DOI 10.1161/01.STR.30.4.744; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Perkins HS, 2002, J GEN INTERN MED, V17, P48, DOI 10.1046/j.1525-1497.2002.01032.x; Qureshi AI, 2013, MED CARE, V51, P1094, DOI 10.1097/MLR.0b013e3182a95db4; Reeves M, 2009, STROKE, V40, P1743, DOI 10.1161/STROKEAHA.108.543181; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Shepardson LB, 1999, J GEN INTERN MED, V14, P15, DOI 10.1046/j.1525-1497.1999.00275.x; Smithard DG, 1997, DYSPHAGIA, V12, P188, DOI 10.1007/PL00009535; Steiner Claudia, 2002, Eff Clin Pract, V5, P143; Stroud M, 2003, GUT, V52, P1; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Towfighi A, 2013, J STROKE CEREBROVASC, V22, pE347, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.018; WENGER NS, 1995, ARCH INTERN MED, V155, P2056, DOI 10.1001/archinte.155.19.2056; Wijdicks EFM, 2004, CRIT CARE MED, V32, P2332, DOI 10.1097/01.CCM.0000145949.34618.E1; Wilmskoetter J, 2016, J STROKE CEREBROVASC, V25, P2694, DOI 10.1016/j.jstrokecerebrovasdis.2016.07.017; Xian Y, 2012, STROKE, V43, P1687, DOI 10.1161/STROKEAHA.111.648600; Zaide GB, 2013, PALLIAT SUPPORT CARE, V11, P5, DOI 10.1017/S1478951512000417	37	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191293	10.1371/journal.pone.0191293	http://dx.doi.org/10.1371/journal.pone.0191293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351343	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300068
J	Merrick, BA; Chang, JS; Phadke, DP; Bostrom, MA; Shah, RR; Wang, XG; Gordon, O; Wright, GM				Merrick, B. Alex; Chang, Justin S.; Phadke, Dhiral P.; Bostrom, Meredith A.; Shah, Ruchir R.; Wang, Xinguo; Gordon, Oksana; Wright, Garron M.			HAfTs are novel lncRNA transcripts from aflatoxin exposure	PLOS ONE			English	Article							LONG NONCODING RNAS; HEPATOCELLULAR-CARCINOMA; SPLICE VARIANTS; HEPATIC TRANSCRIPTOME; HUMAN HEPATOCYTES; GENE-EXPRESSION; B-1; CANCER; PATHOGENESIS; EVOLUTION	The transcriptome can reveal insights into precancer biology. We recently conducted RNA-Seq analysis on liver RNA from male rats exposed to the carcinogen, aflatoxin B1 (AFB1), for 90 days prior to liver tumor onset. Among > 1,000 differentially expressed transcripts, several novel, unannotated Cufflinks-assembled transcripts, or HAfTs (Hepatic Aflatoxin Transcripts) were found. We hypothesized PCR-cloning and RACE (rapid amplification of cDNA ends) could further HAfT identification. Sanger data was obtained for 6 transcripts by PCR and 16 transcripts by 5'- and 3'-RACE. BLAST alignments showed, with two exceptions, HAfT transcripts were lncRNAs, >200nt without apparent long open reading frames. Six rat HAfT transcripts were classified as 'novel' without RefSeq annotation. Sequence alignment and genomic synteny showed each rat lncRNA had a homologous locus in the mouse genome and over half had homologous loci in the human genome, including at least two loci (and possibly three others) that were previously unannotated. While HAfT functions are not yet clear, coregulatory roles may be possible from their adjacent orientation to known coding genes with altered expression that include 8 HAfT-gene pairs. For example, a unique rat HAfT, homologous to Pvt1, was adjacent to known genes controlling cell proliferation. Additionally, PCR and RACE Sanger sequencing showed many alternative splice variants and refinements of exon sequences compared to Cufflinks assembled transcripts and gene prediction algorithms. Presence of multiple splice variants and short tandem repeats found in some HAfTs may be consequential for secondary structure, transcriptional regulation, and function. In summary, we report novel, differentially expressed lncRNAs after exposure to the genotoxicant, AFB1, prior to neoplastic lesions. Complete cloning and sequencing of such transcripts could pave the way for a new set of sensitive and early prediction markers for chemical hepatocarcinogens.	[Merrick, B. Alex; Chang, Justin S.] NIEHS, Biomol Screening Branch, Div Natl Toxicol Program, Res Triangle Pk, NC 27709 USA; [Phadke, Dhiral P.; Shah, Ruchir R.] Sciome LLC, Res Triangle Pk, NC USA; [Bostrom, Meredith A.; Wang, Xinguo; Gordon, Oksana; Wright, Garron M.] David H Murdock Res Inst, Genom Lab, Kannapolis, NC USA; [Chang, Justin S.] Columbia Univ, Columbia Coll, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Columbia University	Merrick, BA (corresponding author), NIEHS, Biomol Screening Branch, Div Natl Toxicol Program, Res Triangle Pk, NC 27709 USA.	merrick@niehs.nih.gov			Division of the National Toxicology Program at the National Institute of Environmental Health Sciences of the NIH; Division of the Intramural Research at the National Institute of Environmental Health Sciences of the NIH; NIEHS;  [HHSN273201100016C];  [HHSN273201700001C]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103318] Funding Source: NIH RePORTER	Division of the National Toxicology Program at the National Institute of Environmental Health Sciences of the NIH; Division of the Intramural Research at the National Institute of Environmental Health Sciences of the NIH; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Divisions of the National Toxicology Program and Intramural Research at the National Institute of Environmental Health Sciences of the NIH. A portion of work was performed under Contract HHSN273201100016C and HHSN273201700001C. The funder [NIEHS] provided support in the form of salaries for authors [MAB, DPP, RRS, XW, OG, GMW], but they did not have any additional role in the study design, decision to publish, or preparation of the manuscript. MAB, XW, OG and GMW provided a portion of data and analysis. DP and RRS provided a portion of data analysis. The specific roles of these authors are articulated in the 'author contributions' section.	Auerbach SS, 2015, J APPL TOXICOL, V35, P766, DOI 10.1002/jat.3068; Auerbach SS, 2010, TOXICOL APPL PHARM, V243, P300, DOI 10.1016/j.taap.2009.11.021; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bussotti G, 2013, INT J MOL SCI, V14, P15423, DOI 10.3390/ijms140815423; BUTLER WH, 1981, J PATHOL, V134, P157, DOI 10.1002/path.1711340206; Calviello L, 2016, NAT METHODS, V13, P165, DOI [10.1038/NMETH.3688, 10.1038/nmeth.3688]; Chawanthayatham S, 2015, INT J CANCER, V136, P1254, DOI 10.1002/ijc.29102; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Colombo T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/304208; Cui M, 2016, BIOCHEM BIOPH RES CO, V471, P10, DOI 10.1016/j.bbrc.2015.12.101; Dayalu P, 2015, NEUROL CLIN, V33, P101, DOI 10.1016/j.ncl.2014.09.003; De Ruyck K, 2015, MUTAT RES-REV MUTAT, V766, P32, DOI 10.1016/j.mrrev.2015.07.003; DEGEN GH, 1981, CARCINOGENESIS, V2, P299, DOI 10.1093/carcin/2.4.299; Dempsey JL, 2017, TOXICOL SCI, V155, P3, DOI 10.1093/toxsci/kfw203; Deng N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068352; Diederichs S, 2014, TRENDS GENET, V30, P121, DOI 10.1016/j.tig.2014.01.004; Dutto I, 2015, ARCH TOXICOL, V89, P155, DOI 10.1007/s00204-014-1430-4; Ellinger-Ziegelbauer H, 2004, TOXICOL SCI, V77, P19, DOI 10.1093/toxsci/kfh016; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gong BS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.21; Gross-Steinmeyer K, 2012, TOXICOLOGY, V299, P69, DOI 10.1016/j.tox.2012.05.016; Gross-Steinmeyer K, 2010, TOXICOL SCI, V116, P422, DOI 10.1093/toxsci/kfq135; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hacisuleyman E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11021; Hagerman PJ, 2015, ANN NY ACAD SCI, V1338, P58, DOI 10.1111/nyas.12693; Hamid AS, 2013, ONCOL LETT, V5, P1087, DOI 10.3892/ol.2013.1169; Harris AJ, 2004, MUTAT RES-FUND MOL M, V549, P79, DOI 10.1016/j.mrfmmm.2003.11.014; Howald C, 2012, GENOME RES, V22, P1698, DOI 10.1101/gr.134478.111; Huang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067043; Hubley R., 2013, REPEATMASKER OPEN 40; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Hutchins AP, 2012, GENOMICS, V100, P303, DOI 10.1016/j.ygeno.2012.07.014; INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V56, P245; Johnson NM, 2014, CANCER PREV RES, V7, P658, DOI 10.1158/1940-6207.CAPR-13-0430; Kaya M, 2016, ANIM BIOTECHNOL, V27, P238, DOI 10.1080/10495398.2016.1178139; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Kim HP, 2014, ONCOGENE, V33, P5434, DOI 10.1038/onc.2013.490; Kumar RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2872; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liu AY, 2012, CELL TISSUE RES, V348, P589, DOI 10.1007/s00441-012-1383-y; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Liu SP, 2011, INT J CANCER, V128, P511, DOI 10.1002/ijc.25386; Liu S, 2016, MOL CANCER THER, V15, P2977, DOI 10.1158/1535-7163.MCT-16-0320; Lu XY, 2013, FOOD CHEM TOXICOL, V55, P444, DOI 10.1016/j.fct.2013.01.020; Mehravar M, 2017, GENE, V603, P27, DOI 10.1016/j.gene.2016.12.008; Merrick BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061768; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Monson MS, 2016, TOXINS, V8, DOI 10.3390/toxins8010016; Monson M, 2015, IMMUNOGENETICS, V67, P163, DOI 10.1007/s00251-014-0825-y; Monson MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100930; National Toxicology Program, 2011, Rep Carcinog, V12, P32; Nault JC, 2014, BEST PRACT RES CL GA, V28, P937, DOI 10.1016/j.bpg.2014.08.006; Pacheco-Marin R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23373; Pacholewska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122011; Parasramka MA, 2016, PHARMACOL THERAPEUT, V161, P67, DOI 10.1016/j.pharmthera.2016.03.004; Peng JY, 2015, FEBS J, V282, P2089, DOI 10.1111/febs.13251; Plaza S, 2017, ANNU REV CELL DEV BI, V33, P391, DOI 10.1146/annurev-cellbio-100616-060516; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ratajewski M, 2011, TOXICOL LETT, V205, P146, DOI 10.1016/j.toxlet.2011.05.1034; Ray MK, 2016, J BIOL CHEM, V291, P19558, DOI 10.1074/jbc.M116.730853; Rothe B, 2015, MOL CELL BIOL, V35, P3339, DOI 10.1128/MCB.00341-15; Rustemeyer SM, 2011, J ANIM SCI, V89, P916, DOI 10.2527/jas.2010-3473; Shahryari A, 2014, STEM CELLS, V32, P126, DOI 10.1002/stem.1542; Shi JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31898; Smith MA, 2013, NUCLEIC ACIDS RES, V41, P8220, DOI 10.1093/nar/gkt596; Souvorov A., 2010, GNOMON NCBI EUKARYOT; Surget S, 2014, ONCOTARGETS THER, V7, P57, DOI 10.2147/OTT.S53876; Takai A, 2014, INT J MOL SCI, V15, P11142, DOI 10.3390/ijms150611142; Teoh WW, 2015, DIS MODEL MECH, V8, P743, DOI 10.1242/dmm.017624; Tsai FD, 2015, P NATL ACAD SCI USA, V112, P779, DOI 10.1073/pnas.1412811112; Tsuiji H, 2011, GENES CELLS, V16, P479, DOI 10.1111/j.1365-2443.2011.01502.x; Wang XQD, 2017, NUCLEIC ACIDS RES, V45, P1091, DOI 10.1093/nar/gkw966; Ward Melanie, 2015, J Hum Transcr, V1, P2; WOGAN GN, 1974, FOOD COSMET TOXICOL, V12, P681, DOI 10.1016/0015-6264(74)90239-9; Xiong X, 2011, ONCOGENE, V30, P1798, DOI 10.1038/onc.2010.569; Yang WQ, 2014, TOXICOL LETT, V226, P140, DOI 10.1016/j.toxlet.2014.01.021; Yarru LP, 2009, POULTRY SCI, V88, P360, DOI 10.3382/ps.2008-00258; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang NY, 2016, TOXICON, V111, P69, DOI 10.1016/j.toxicon.2015.12.022; Zhao YH, 2014, ACTA BIOCH BIOPH SIN, V46, P180, DOI 10.1093/abbs/gmt147; Zhou CC, 2016, HEPATOLOGY, V63, P850, DOI 10.1002/hep.28393; Zhou W, 2014, EXP MOL PATHOL, V97, P550, DOI 10.1016/j.yexmp.2014.11.005	84	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190992	10.1371/journal.pone.0190992	http://dx.doi.org/10.1371/journal.pone.0190992			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351317	Green Submitted, gold, Green Published			2022-12-27	WOS:000422911300036
J	Passera, A; Marcolungo, L; Casati, P; Brasca, M; Quaglino, F; Cantaloni, C; Delledonne, M				Passera, Alessandro; Marcolungo, Luca; Casati, Paola; Brasca, Milena; Quaglino, Fabio; Cantaloni, Chiara; Delledonne, Massimo			Hybrid genome assembly and annotation of Paenibacillus pasadenensis strain R16 reveals insights on endophytic life style and antifungal activity	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; PLANT-DISEASE; GROWTH; CHITINASE; BACTERIA; FARNESOL	Bacteria of the Paenibacillus genus are becoming important in many fields of science, including agriculture, for their positive effects on the health of plants. However, there are little information available on this genus compared to other bacteria (such as Bacillus or Pseudomonas), especially when considering genomic information. Sequencing the genomes of plant-beneficial bacteria is a crucial step to identify the genetic elements underlying the adaptation to life inside a plant host and, in particular, which of these features determine the differences between a helpful microorganism and a pathogenic one. In this study, we have characterized the genome of Paenibacillus pasadenensis, strain R16, recently investigated for its antifungal activities and plant-associated features. An hybrid assembly approach was used integrating the very precise reads obtained by Illumina technology and long fragments acquired with Oxford Nanopore Technology (ONT) sequencing. De novo genome assembly based solely on Illumina reads generated a relatively fragmented assembly of 5.72 Mbp in 99 ungapped sequences with an N50 length of 544 Kbp; hybrid assembly, integrating Illumina and ONT reads, improved the assembly quality, generating a genome of 5.75 Mbp, organized in 6 contigs with an N50 length of 3.4 Mbp. Annotation of the latter genome identified 4987 coding sequences, of which 1610 are hypothetical proteins. Enrichment analysis identified pathways of particular interest for the endophyte biology, including the chitin-utilization pathway and the incomplete siderophore pathway which hints at siderophore parasitism. In addition the analysis led to the identification of genes for the production of terpenes, as for example farnesol, that was hypothesized as the main antifungal molecule produced by the strain. The functional analysis on the genome confirmed several plant-associated, plant-growth promotion, and biocontrol traits of strain R16, thus adding insights in the genetic bases of these complex features, and of the Paenibacillus genus in general.	[Passera, Alessandro; Casati, Paola; Quaglino, Fabio] Univ Milan, Dept Agr & Environm Sci Prod Landscape Agroenerg, Milan, Italy; [Marcolungo, Luca; Cantaloni, Chiara; Delledonne, Massimo] Univ Verona, Dept Biotechnol, Verona, Italy; [Brasca, Milena] Inst Sci Food Prod, Italian Natl Res Council, Milan, Italy	University of Milan; University of Verona; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR)	Casati, P (corresponding author), Univ Milan, Dept Agr & Environm Sci Prod Landscape Agroenerg, Milan, Italy.	paola.casati@unimi.it	Brasca, Milena/AAE-7819-2021; Delledonne, Massimo/O-8685-2017; Brasca, Milena/AAY-5763-2020; QUAGLINO, FABIO/A-6519-2009	Brasca, Milena/0000-0002-8821-0787; Marcolungo, Luca/0000-0002-2366-5684; QUAGLINO, FABIO/0000-0001-8866-0633; Casati, Paola/0000-0001-6152-8712; Delledonne, Massimo/0000-0002-7100-4581				Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; ASH C, 1993, ANTON LEEUW INT J G, V64, P253; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bulgari D, 2011, APPL ENVIRON MICROB, V77, P5018, DOI 10.1128/AEM.00051-11; Burse A, 2004, MOL PLANT MICROBE IN, V17, P43, DOI 10.1094/MPMI.2004.17.1.43; Busby JN, 2012, J MOL BIOL, V415, P359, DOI 10.1016/j.jmb.2011.11.018; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chakdar H, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0457-z; Chandler JC, 2011, J BACTERIOL, V193, P3265, DOI 10.1128/JB.00093-11; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Simionato AVC, 2007, J MASS SPECTROM, V42, P490, DOI 10.1002/jms.1181; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Cotoras M, 2013, MYCOLOGIA, V105, P28, DOI 10.3852/12-012; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P1195, DOI 10.1128/AEM.66.3.1195-1201.2000; Dahiya N, 2006, APPL MICROBIOL BIOT, V71, P773, DOI 10.1007/s00253-005-0183-7; Emmert EAB, 1999, FEMS MICROBIOL LETT, V171, P1, DOI 10.1111/j.1574-6968.1999.tb13405.x; Faramarzi M. A., 2009, Biotechnology, V8, P93; Feng XX, 2014, CHEM BIOL, V21, P1557, DOI 10.1016/j.chembiol.2014.08.018; Gonzalez JF, 2013, TRENDS PLANT SCI, V18, P167, DOI 10.1016/j.tplants.2012.09.007; Grady EN, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0603-7; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kokalis-Burelle N, 2006, APPL SOIL ECOL, V31, P91, DOI 10.1016/j.apsoil.2005.03.007; Krom BP, 2016, ISR J CHEM, V56, P295, DOI 10.1002/ijch.201500025; Langford ML, 2010, ANTIMICROB AGENTS CH, V54, P940, DOI 10.1128/AAC.01214-09; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Loni PP, 2014, J BASIC MICROB, V54, P1080, DOI 10.1002/jobm.201300533; Lorek J, 2008, J BASIC MICROB, V48, P99, DOI 10.1002/jobm.200700292; Mitter B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00120; Monnet V, 2016, CRIT REV MICROBIOL, V42, P339, DOI 10.3109/1040841X.2014.948804; Montes MJ, 2004, INT J SYST EVOL MICR, V54, P1521, DOI 10.1099/ijs.0.63078-0; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Parray JA, 2016, J PLANT GROWTH REGUL, V35, P877, DOI 10.1007/s00344-016-9583-4; Passera A, 2017, MICROBIOL RES, V198, P16, DOI 10.1016/j.micres.2017.02.001; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Rybakova D, 2016, PLANT SOIL, V405, P125, DOI 10.1007/s11104-015-2526-1; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Sarethy IP, 2011, J IND MICROBIOL BIOT, V38, P769, DOI 10.1007/s10295-011-0968-x; Semighini CP, 2008, FEMS MICROBIOL LETT, V279, P259, DOI 10.1111/j.1574-6968.2007.01042.x; Shaheen M, 2011, CHEM BIOL, V18, P1640, DOI 10.1016/j.chembiol.2011.09.017; Sheibani-Tezerji R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00440; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Venturi V, 2013, ANNU REV PHYTOPATHOL, V51, P17, DOI 10.1146/annurev-phyto-082712-102239; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Weber T, 2015, NUC AC RES; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x	50	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0189993	10.1371/journal.pone.0189993	http://dx.doi.org/10.1371/journal.pone.0189993			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351296	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300013
J	Ullah, A; Malik, SA; Alimgeer, KS				Ullah, Azmat; Malik, Suheel Abdullah; Alimgeer, Khurram Saleem			Evolutionary algorithm based heuristic scheme for nonlinear heat transfer equations	PLOS ONE			English	Article							HOMOTOPY-PERTURBATION; NUMERICAL-SOLUTION	In this paper, a hybrid heuristic scheme based on two different basis functions i.e. Log Sigmoid and Bernstein Polynomial with unknown parameters is used for solving the nonlinear heat transfer equations efficiently. The proposed technique transforms the given nonlinear ordinary differential equation into an equivalent global error minimization problem. Trial solution for the given nonlinear differential equation is formulated using a fitness function with unknown parameters. The proposed hybrid scheme of Genetic Algorithm (GA) with Interior Point Algorithm (IPA) is opted to solve the minimization problem and to achieve the optimal values of unknown parameters. The effectiveness of the proposed scheme is validated by solving nonlinear heat transfer equations. The results obtained by the proposed scheme are compared and found in sharp agreement with both the exact solution and solution obtained by Haar Wavelet-Quasilinearization technique which witnesses the effectiveness and viability of the suggested scheme. Moreover, the statistical analysis is also conducted for investigating the stability and reliability of the presented scheme.	[Ullah, Azmat] OGDCL, Instrumentat, Islamabad, Pakistan; [Malik, Suheel Abdullah] Int Islamic Univ, Fac Engn & Technol, Dept Elect Engn, Islamabad, Pakistan; [Alimgeer, Khurram Saleem] COMSATS Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan	International Islamic University, Pakistan; COMSATS University Islamabad (CUI)	Ullah, A (corresponding author), OGDCL, Instrumentat, Islamabad, Pakistan.	ad80kw@gmail.com	Alimgeer, Khurram S/AGW-9805-2022; Alimgeer, Khurram S/F-4911-2011; Saleem, Khurram/N-9547-2019	Alimgeer, Khurram S/0000-0001-5732-2463; Ullah, Azmat/0000-0002-4519-5222				Abo-Hammour Z, 2014, DISCRETE DYN NAT SOC, V2014, DOI 10.1155/2014/401696; Abu Arqub O, 2012, ABSTR APPL ANAL, DOI 10.1155/2012/205391; Abu-Arqub O, 2014, APPL MATH INFORM SCI, V8, P235; Ahmad H., 2018, NONLINEAR SCI LETT A, V9, P27; Atangana A, 2014, NEURAL COMPUT APPL, V25, P1021, DOI 10.1007/s00521-014-1586-0; Danish M, 2011, ENG LETT, V19; Dehghan M, 2015, RENEW ENERG, V74, P448, DOI 10.1016/j.renene.2014.08.044; Ganji DD, 2007, J COMPUT APPL MATH, V207, P24, DOI 10.1016/j.cam.2006.07.030; Juan-Cheng Y, 2015, CHINESE PHYS B, V24; Kadri MB, 2014, SCI WORLD J, DOI 10.1155/2014/451274; Khan JA, 2009, PROCEEDINGS OF THE SECOND INTERNATIONAL CONFERENCE ON ENVIRONMENTAL AND COMPUTER SCIENCE, P141, DOI 10.1109/ICECS.2009.85; Khan RA, 2009, APPL MATH COMPUT, V212, P287, DOI 10.1016/j.amc.2009.02.028; Malik S., 2013, RES J RECENT SCI, V2, P47; Malik SA., 2014, ADV STUD BIOL, V6, P99, DOI 10.12988/asb.2014.4520; Malik SA, 2015, MAGNT RES REPORT, V3, P21; Malik SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121728; Owolabi KM, 2016, EUR PHYS J PLUS, V131, DOI 10.1140/epjp/i2016-16335-8; Rafiq M, 2017, NONLINEAR SCI LETT A, V8, P389; Raja MAZ, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/675075; Saeed U, 2014, APPL COMPUT INTELL S, V2014, DOI 10.1155/2014/454231	20	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191103	10.1371/journal.pone.0191103	http://dx.doi.org/10.1371/journal.pone.0191103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351304	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300049
J	Iimori, S; Naito, S; Noda, Y; Sato, H; Nomura, N; Sohara, E; Okado, T; Sasaki, S; Uchida, S; Rai, T				Iimori, Soichiro; Naito, Shotaro; Noda, Yumi; Sato, Hidehiko; Nomura, Naohiro; Sohara, Eisei; Okado, Tomokazu; Sasaki, Sei; Uchida, Shinichi; Rai, Tatemitsu			Prognosis of chronic kidney disease with normal-range proteinuria: The CKD-ROUTE study	PLOS ONE			English	Article							RISK; OUTCOMES; PROGRESSION; MICROALBUMINURIA; ALBUMINURIA; MORTALITY; MODERATE	Background Although lower estimated glomerular filtration rate (eGFR) and higher proteinuria are high risks for mortality and kidney outcomes, the prognosis of chronic kidney disease (CKD) in patients with normal-range proteinuria remains unclear. Methods In this prospective cohort study, 1138 newly visiting stage G2-G5 CKD patients were stratified into normal-range and abnormal-range proteinuria groups. Study endpoints were CKD progression (>50% eGFR loss or initiation of dialysis), cardiovascular events, and all-cause death. Results In total, 927 patients who were followed for >6 months were included in the analysis. The mean age was 67 years, and 70.2% were male. During a median follow-up of 35 months, CKD progression, cardiovascular events, and mortality were observed in 223, 110, and 55 patients, respectively. Patients with normal-range proteinuria had a significantly lower risk for CKD progression (hazard ratio, 0.20; 95% confidence interval, 0.10-0.38) than those with abnormal-proteinuria by multivariate Cox proportional hazard analysis. We also analyzed patients with normal-range proteinuria (n = 351). Nephrosclerosis was the most frequent cause of CKD among all patients with normal-range proteinuria (59.7%). During a median follow-up of 36 months, CKD progression, cardiovascular events, and mortality were observed in 10, 28, and 18 patients, respectively. The Kaplan +/- Meyer analysis demonstrated that the risks of CKD progression and cardiovascular events were not significantly different among CKD stages, whereas the risk of death was significantly higher in patients with advanced-stage CKD. Multivariate Cox proportional hazard analysis showed that the risk of three endpoints did not significantly differ among CKD stages. Conclusion Newly visiting CKD patients with normal-range proteinuria, who tend to be overlooked during health checkups did not exhibit a decrease in kidney function even in advanced CKD stages under specialized nephrology care.	[Iimori, Soichiro; Naito, Shotaro; Noda, Yumi; Sato, Hidehiko; Nomura, Naohiro; Sohara, Eisei; Okado, Tomokazu; Sasaki, Sei; Uchida, Shinichi; Rai, Tatemitsu] Tokyo Med & Dent Univ, Dept Nephrol, Bunkyo Ku, Tokyo, Japan; [Noda, Yumi; Sato, Hidehiko] Nitobe Mem Nakano Gen Hosp, Dept Nephrol, Nakano Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Rai, T (corresponding author), Tokyo Med & Dent Univ, Dept Nephrol, Bunkyo Ku, Tokyo, Japan.	trai.kid@tmd.ac.jp	Rai, Tatemitsu/K-7165-2019					Atkins RC, 2005, AM J KIDNEY DIS, V45, P281, DOI 10.1053/j.ajkd.2004.10.019; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; Cravedi P, 2012, NAT REV NEPHROL, V8, P301, DOI 10.1038/nrneph.2012.42; De Nicola L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172241; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Iimori S, 2015, NEPHROLOGY, V20, P601, DOI 10.1111/nep.12493; Iimori S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-152; Imai E, 2010, CLIN EXP NEPHROL, V14, P558, DOI 10.1007/s10157-010-0328-6; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Japanese Soc Nephrology, 2014, CLIN EXP NEPHROL, V18, P346, DOI 10.1007/s10157-014-0949-2; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Levin A, 2008, AM J KIDNEY DIS, V52, P661, DOI 10.1053/j.ajkd.2008.06.023; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mottl AK, 2013, J DIABETES COMPLICAT, V27, P123, DOI 10.1016/j.jdiacomp.2012.09.010; Obi Y, 2010, CLIN J AM SOC NEPHRO, V5, P1558, DOI 10.2215/CJN.08061109; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Roscioni SS, 2014, KIDNEY INT, V86, P40, DOI 10.1038/ki.2013.490; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Titze S, 2015, NEPHROL DIAL TRANSPL, V30, P441, DOI 10.1093/ndt/gfu294	25	12	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190493	10.1371/journal.pone.0190493	http://dx.doi.org/10.1371/journal.pone.0190493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342207	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800023
J	Chen, WT; Lin, GB; Lin, SH; Lu, CH; Hsieh, CH; Ma, BL; Chao, CY				Chen, Wei-Ting; Lin, Guan-Bo; Lin, Shu-Hui; Lu, Chueh-Hsuan; Hsieh, Chih-Hsiung; Ma, Bo-Lun; Chao, Chih-Yu			Static magnetic field enhances the anticancer efficacy of capsaicin on HepG2 cells via capsaicin receptor TRPV1	PLOS ONE			English	Article							BCL-2 FAMILY PROTEINS; ION-CHANNEL; VANILLOID RECEPTOR; INDUCED APOPTOSIS; EXPOSURE; CANCER; ANTAGONIST; ACTIVATION; TUMORIGENESIS; INVOLVEMENT	Static magnetic field (SMF) has shown some possibilities for cancer therapies. In particular, the combinational effect between SMF and anti-cancer drugs has drawn scientists' attentions in recent years. However, the underlying mechanism for the drug-specific synergistic effect is far from being understood. Besides, the drugs used are all conventional chemotherapy drugs, which may cause unpleasant side effects. In this study, our results demonstrate for the first time that SMF could enhance the anti-cancer effect of natural compound, capsaicin, on HepG2 cancer cells through the mitochondria-dependent apoptosis pathway. We found that the synergistic effect could be due to that SMF increased the binding efficiency of capsaicin for the TRPV1 channel. These findings may provide a support to develop an application of SMF for cancer therapy. The present study offers the first trial in combining SMF with natural compound on anti-cancer treatment, which provides additional insight into the interaction between SMF and anti-cancer drugs and opens the door for the development of new strategies in fighting cancer with minimum cytotoxicity and side effects.	[Chen, Wei-Ting; Lin, Guan-Bo; Lu, Chueh-Hsuan; Hsieh, Chih-Hsiung; Chao, Chih-Yu] Natl Taiwan Univ, Dept Phys, Lab Med Phys & Biomed Engn, Taipei, Taiwan; [Chen, Wei-Ting; Lin, Guan-Bo; Lin, Shu-Hui; Lu, Chueh-Hsuan; Hsieh, Chih-Hsiung; Ma, Bo-Lun; Chao, Chih-Yu] Natl Taiwan Univ, Biomed & Mol Imaging Ctr, Coll Med, Taipei, Taiwan; [Ma, Bo-Lun; Chao, Chih-Yu] Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chao, CY (corresponding author), Natl Taiwan Univ, Dept Phys, Lab Med Phys & Biomed Engn, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Biomed & Mol Imaging Ctr, Coll Med, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan.	cychao@phys.ntu.edu.tw	Hsieh, Chih-Hsiung/GMX-1452-2022; Hsieh, Chih-Hsiung/AFI-4085-2022		Ministry of Science and Technology of the Republic of China [MOST 105-2112-M-002-006-MY3]; Ministry of Education of the Republic of China [NTU-ICRP-103R7560-2]; National Taiwan University	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education of the Republic of China(Ministry of Education, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by grants from Ministry of Science and Technology (MOST 105-2112-M-002-006-MY3; C.Y. Chao) and Ministry of Education (NTU-ICRP-103R7560-2; C.Y. Chao) of the Republic of China. One of authors (CYC) acknowledges the National Taiwan University for financial supports on this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Technology Commons in College of Life Science, National Taiwan University for use of flow cytometry system. One of authors (CYC) acknowledges the National Taiwan University for financial supports on this work.	Amantini C, 2007, J NEUROCHEM, V102, P977, DOI 10.1111/j.1471-4159.2007.04582.x; Brito R, 2014, CELLS-BASEL, V3, P517, DOI 10.3390/cells3020517; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHARD PS, 1995, NEUROSCIENCE, V65, P1099, DOI 10.1016/0306-4522(94)00548-J; Chionna A, 2005, BIOELECTROMAGNETICS, V26, P275, DOI 10.1002/bem.20081; Clark R, 2016, ANTICANCER RES, V36, P837; Darre L, 2015, MOL PHARMACEUT, V12, P4454, DOI 10.1021/acs.molpharmaceut.5b00641; Dejean LM, 2006, BBA-MOL BASIS DIS, V1762, P191, DOI 10.1016/j.bbadis.2005.07.002; Del Seppia C, 2003, BEHAV BRAIN RES, V144, P1, DOI 10.1016/S0166-4328(03)00042-1; Ding YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166303; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Fang EF, 2012, APOPTOSIS, V17, P377, DOI 10.1007/s10495-011-0684-z; Gellrich D, 2014, CANCER LETT, V343, P107, DOI 10.1016/j.canlet.2013.09.021; Gunthorpe MJ, 2007, J PHARMACOL EXP THER, V321, P1183, DOI 10.1124/jpet.106.116657; Holland C, 2014, BRIT J CLIN PHARMACO, V77, P777, DOI 10.1111/bcp.12219; Hong ZF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121538; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Huang SP, 2009, ANTICANCER RES, V29, P165; Jing D, 2010, BIOELECTROMAGNETICS, V31, P640, DOI 10.1002/bem.20592; Kanai S, 2012, ADV BIOSCI BIOTECHNO, V3, P511; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Knudson CM, 2001, CANCER RES, V61, P659; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu Y, 2011, TUMORI, V97, P386, DOI 10.1700/912.10039; Lundbaek JA, 2005, MOL PHARMACOL, V68, P680, DOI 10.1124/mol.105.013573; Luo Y, 2016, BIOELECTROCHEMISTRY, V109, P31, DOI 10.1016/j.bioelechem.2016.01.001; Manson MM, 2003, TRENDS MOL MED, V9, P11, DOI 10.1016/S1471-4914(02)00002-3; Markov MS, 2007, ELECTROMAGN BIOL MED, V26, P1, DOI 10.1080/15368370600925342; Meng J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02655; Okano H, 2005, BIOELECTROMAGNETICS, V26, P469, DOI 10.1002/bem.20115; Perlman H, 1999, CELL DEATH DIFFER, V6, P48, DOI 10.1038/sj.cdd.4400453; Pinter M, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000042; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Ramos-Torres A, 2016, ONCOTARGET, V7, P1569, DOI 10.18632/oncotarget.6415; Rosen AD, 2003, CELL BIOCHEM BIOPHYS, V39, P163, DOI 10.1385/CBB:39:2:163; Salakou S, 2007, IN VIVO, V21, P123; Sandor K, 2007, LIFE SCI, V81, P97, DOI 10.1016/j.lfs.2007.04.029; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Sisken Betty F., 2007, Environmentalist, V27, P477, DOI 10.1007/s10669-007-9117-5; Strelczyk D, 2009, CANCER BIOL THER, V8, P1756, DOI 10.4161/cbt.8.18.9294; SZALLASI A, 1990, LIFE SCI, V47, P1399, DOI 10.1016/0024-3205(90)90518-V; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tofani S, 2002, BIOELECTROMAGNETICS, V23, P230, DOI 10.1002/bem.10010; Vergallo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113530; Vergallo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072374; Zhang K, 2014, BIOELECTROMAGNETICS, V35, P437, DOI 10.1002/bem.21863; Zheng L, 2016, MOL MED REP, V13, P881, DOI 10.3892/mmr.2015.4623	47	17	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191078	10.1371/journal.pone.0191078	http://dx.doi.org/10.1371/journal.pone.0191078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338036	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700030
J	Badano, I; Sanabria, DJ; Totem, ME; Rubinstein, S; Gili, JA; Liotta, DJ; Picconi, MA; Campos, RH; Schurr, TG				Badano, Ines; Sanabria, Daiana J.; Totem, Maria E.; Rubinstein, Samara; Gili, Juan A.; Liotta, Domingo J.; Picconi, Maria A.; Campos, Rodolfo H.; Schurr, Theodore G.			Mitochondrial DNAancestry, HPV infection and the risk of cervical cancer in a multiethnic population of northeastern Argentina	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; RACIAL DISPARITIES; EMBEDDED TISSUES; GENETIC ANCESTRY; BREAST-CANCER; DNA VARIATION; BUENOS-AIRES; CLASSIFICATION; EXTRACTION; ADMIXTURE	Background Misiones Province in northeastern Argentina is considered to be a region with a high prevalence of HPV infection and a high mortality rate due to cervical cancer. The reasons for this epidemiological trend are not completely understood. To gain insight into this problem, we explored the relationship between mitochondrial DNA (mtDNA) ancestry, HPV infection, and development of cervical lesions/cancer in women from the city of Posadas in Misiones Province. Methods Two hundred and sixty-one women, including 92 cases of patients diagnosed with cervical lesions and 169 controls, were analyzed. mtDNA ancestry was assessed through HVS1 sequencing, while the detection and typing of HPV infection was conducted through nested multiplex PCR analysis. Multivariate logistic regression was conducted with the resulting data to estimate the odds ratios (ORs) adjusted by socio-demographic variables. Results The study participants showed 68.6% Amerindian, 26.1 % European and 5.3% African mtDNA ancestry, respectively. Multiple regression analysis showed that women with African mtDNAs were three times more likely to develop a cervical lesion than those with Native American or European mtDNAs [OR of 3.8 (1.2-11.5) for ancestry and OR of 3.5 (1.0-12.0) for L haplogroups], although the associated p values were not significant when tested under more complex multivariate models. HPV infection and the development of cervical lesions/cancer were significant for all tested models, with the highest OR values for HPV16 [OR of 24.2 (9.3-62.7)] and HPV-58 [OR of 19.0 (2.4-147.7)]. Conclusion HPV infection remains a central risk factor for cervical cancer in the Posadas population. The potential role of African mtDNA ancestry opens a new avenue for future medical association studies in multiethnic populations, and will require further confirmation in large-scale studies.	[Badano, Ines; Sanabria, Daiana J.; Totem, Maria E.; Liotta, Domingo J.] Univ Nacl Misiones, Fac Ciencias Exactas Quim & Nat, Lab Biol Mol Aplicada, Misiones, Argentina; [Badano, Ines; Sanabria, Daiana J.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Rubinstein, Samara; Schurr, Theodore G.] Univ Penn, Dept Anthropol, Lab Mol Anthropol, Philadelphia, PA 19104 USA; [Gili, Juan A.] Consejo Nacl Invest Cient & Tecn, Direcc Invest CEMIC, Lab Epidemiol Genet, Buenos Aires, DF, Argentina; [Picconi, Maria A.] INEI ANLIS Dr Carlos G Malbran, Serv Virus Oncogen, Dept Virol, Buenos Aires, DF, Argentina; [Campos, Rodolfo H.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Pennsylvania; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Badano, I (corresponding author), Univ Nacl Misiones, Fac Ciencias Exactas Quim & Nat, Lab Biol Mol Aplicada, Misiones, Argentina.; Badano, I (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	inesbadano@gmail.com	Gili, Juan Antonio/P-2970-2016	Gili, Juan Antonio/0000-0001-7924-0776; Sanabria, Daiana/0000-0002-6908-9387	Agenda Nacional de Promotion Cientffica y Tecnologica, Argentina [PICT- 2012 - 0761]; Comite Ejecutivo de Desarrollo e Innovation Tecnologica, Gobiernode Misiones, Argentina [31/12]; Ministerio de Salud de la Nation (MSAL) Argentina-Comision National Salud Investiga-Becas "Carrillo-Onativia" [699/13]; CONICET Argentina [4838/13, 3993/12]; Codon-Code Aligner License Grant-USA	Agenda Nacional de Promotion Cientffica y Tecnologica, Argentina; Comite Ejecutivo de Desarrollo e Innovation Tecnologica, Gobiernode Misiones, Argentina; Ministerio de Salud de la Nation (MSAL) Argentina-Comision National Salud Investiga-Becas "Carrillo-Onativia"; CONICET Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Codon-Code Aligner License Grant-USA	This work was supported by the Agenda Nacional de Promotion Cientffica y Tecnologica, Argentina (Grant number PICT- 2012 - 0761); the Comite Ejecutivo de Desarrollo e Innovation Tecnologica, Gobiernode Misiones, Argentina (Becas CEDIT - Res. 31/12 to DJS); the Ministerio de Salud de la Nacion (MSAL) Argentina-Comision National Salud Investiga - Becas "Carrillo - Onativia" (Res. 699/13 to DJS); and CONICET Argentina (Res. 4838/13 to DJS and Res. Resolucion D No 3993/12 to IB) and Codon-Code Aligner License Grant-USA (2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Altuna ME, 2006, HUM BIOL, V78, P635, DOI 10.1353/hub.2007.0000; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Arrossi S, 2008, PROYECTO MEJORAMIENT; Avena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034695; Badano I, 2013, INT J IMMUNOGENET, V40, P216, DOI 10.1111/iji.12002; Badano I, 2011, REV ARGENT MICROBIOL, V43, P263, DOI 10.1590/S0325-75412011000400005; Badano I, 2012, J CLIN VIROL, V53, P54, DOI 10.1016/j.jcv.2011.09.030; Bartolome L., 2007, COLONOS APOSTOLES ES; BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/infdis/170.5.1077; Bonilla C, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0171-8; Bruni L., 2016, SUMMARY REPORT; Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005; Catelli ML, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-77; Chan PKS, 2001, J CLIN PATHOL, V54, P401, DOI 10.1136/jcp.54.5.401; Conley AB, 2017, G3-GENES GENOM GENET, V7, P3435, DOI 10.1534/g3.117.1118; Corach D, 2010, ANN HUM GENET, V74, P65, DOI 10.1111/j.1469-1809.2009.00556.x; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P290, DOI 10.3322/caac.21340; Fang H, BMC CANC, V10, P421; Fejerman L, 2005, AM J PHYS ANTHROPOL, V128, P164, DOI 10.1002/ajpa.20083; Guardado-Estrada M, 2012, J HUM GENET, V57, P269, DOI 10.1038/jhg.2012.17; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; Instituto Nacional de Estadisticas y Censos, 2010, CENS NAC REP ARG; Instituto Provincial de Estadistica y Censos, 2015, GRAN ATL MIS; Kabekkodu SP, 2014, MITOCHONDRION, V16, P73, DOI 10.1016/j.mito.2013.07.001; Klemba A, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-73; Lagheden C, 2016, J CLIN VIROL, V80, P36, DOI 10.1016/j.jcv.2016.04.016; Lamborghini E, 2017, ESTUDIOS AFROLATINOA; Li YY, 2016, J OBSTET GYNAECOL RE, V42, P325, DOI 10.1111/jog.12879; Lopera EA, 2014, INFECT GENET EVOL, V28, P339, DOI 10.1016/j.meegid.2014.10.014; Madeleine MM, 2008, CANCER RES, V68, P3532, DOI 10.1158/0008-5472.CAN-07-6471; Marignac VLM, 2004, HUM BIOL, V76, P543, DOI 10.1353/hub.2004.0058; Movva S, 2008, CANCER-AM CANCER SOC, V112, P1264, DOI 10.1002/cncr.23310; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Rauh-Hain JA, 2013, CANCER-AM CANCER SOC, V119, P3644, DOI 10.1002/cncr.28261; Rosa A, 2011, J ANTHROPOL SCI, V89, P25, DOI 10.4436/jass.89006; Ruiz JM, 2013, AM J PUBLIC HEALTH, V103, pE52, DOI 10.2105/AJPH.2012.301103; Sala A, 2010, HUM BIOL, V82, P433, DOI 10.3378/027.082.0406; Salas A, 2008, J HUM GENET, V53, P662, DOI 10.1007/s10038-008-0297-8; Salas A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-659; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008347; Sans M, 2000, HUM BIOL, V72, P155; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; Sheppard CS, 2016, INT J CANCER, V138, P2622, DOI 10.1002/ijc.29996; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van Oven M, 2015, FORENS SCI INT-GEN S, V5, pE392, DOI 10.1016/j.fsigss.2015.09.155; Viens LJ, 2016, MMWR-MORBID MORTAL W, V65, P661, DOI 10.15585/mmwr.mm6526a1; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297	58	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190966	10.1371/journal.pone.0190966	http://dx.doi.org/10.1371/journal.pone.0190966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BY	29329337	Green Published, Green Submitted, gold			2022-12-27	WOS:000419954100030
J	Chuang, MC; Yang, YH; Tsai, YH; Hsieh, MJ; Lin, YC; Lin, CK; Chen, PC; Yang, TM				Chuang, Min-Chun; Yang, Yao-Hsu; Tsai, Ying-Huang; Hsieh, Meng-Jer; Lin, Yu-Ching; Lin, Chin-Kuo; Chen, Pau-Chung; Yang, Tsung-Ming			Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study	PLOS ONE			English	Article							MORTALITY; NSCLC; RISK; COMBINATION; APOPTOSIS; IMPACT; GROWTH	Objective To evaluate the effects of metformin use on the survival of inoperable non-small cell lung cancer (NSCLC) patients with diabetes using the Taiwanese National Health Insurance Research Database. Research design and methods In total, 7,620 patients were eligible in this study, among them, 3,578 patients were metformin users and 4,042 were non-users. Propensity score matching was used to reduce possible confounding factors. In total, 4,182 patients (2,091 matched pairs) were included in the matched cohort. Cox proportional hazard model with time-dependent covariate were also applied to evaluate the association between metformin use and overall survival (OS). Results A total of 3,578 patients were metformin users at the time of diagnosis of NSCLC. Cox proportional hazard model with time-dependent covariate revealed that metformin use was associated with a significantly longer OS (HR: 0.85, 95.0% Cl: 0.80-0.90). The survival benefit of metformin use was maintained after propensity score matching at a ratio of 1:1 (HR: 0.90, 95.0% Cl: 0.84-0.97). Conclusions Metformin use is associated with longer OS in inoperable NSCLC patients with diabetes, suggesting a potential anti-tumorigenic effect for metformin. Further research is needed to investigate the actual role of metformin in the treatment of NSCLC patients with diabetes.	[Chuang, Min-Chun; Hsieh, Meng-Jer; Lin, Yu-Ching; Lin, Chin-Kuo; Yang, Tsung-Ming] Chiayi Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Chiayi, Taiwan; [Chuang, Min-Chun] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Yang, Yao-Hsu] Chiayi Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Tsai, Ying-Huang] Chang Gung Mem Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Kaohsiung Med Ctr, Kaohsiung, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Yang, TM (corresponding author), Chiayi Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Chiayi, Taiwan.	n120633@cgmh.org.tw	楊, 曜旭/A-3450-2019; Chen, Pau-Chung/H-5686-2011	楊, 曜旭/0000-0002-8080-0504; Chen, Pau-Chung/0000-0002-6242-5974; Chuang, Min-Chun/0000-0002-2817-2790; Hsieh, Meng-Jer/0000-0002-2077-0470; Lin, Chin-Kuo/0000-0002-5940-3715	Chiayi Chang Gung Memorial Hospital, Taiwan [CORPG6D0162, CLRPG6G0041]	Chiayi Chang Gung Memorial Hospital, Taiwan	This study was supported by a grant from Chiayi Chang Gung Memorial Hospital, Taiwan (CORPG6D0162) and (CLRPG6G0041) to YHY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2015, J THORAC DIS, V7, P346, DOI 10.3978/j.issn.2072-1439.2014.12.32; Algire C, 2008, ENDOCR-RELAT CANCER, V15, P833, DOI 10.1677/ERC-08-0038; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Ashinuma H, 2012, ONCOL REP, V28, P8, DOI 10.3892/or.2012.1763; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Brule S.Y., 2015, ONCOL EXCH, V14, P12; Chen HY, 2015, CANCER LETT, V369, P97, DOI 10.1016/j.canlet.2015.08.024; Chen HL, 2014, J DIABETES COMPLICAT, V28, P612, DOI 10.1016/j.jdiacomp.2014.05.011; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gaga M, 2013, EUR RESPIR J, V42, P1183, DOI 10.1183/09031936.00145813; He XX, 2011, ANN ONCOL, V22, P2640, DOI 10.1093/annonc/mdr020; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Lin JJ, 2015, AM J RESP CRIT CARE, V191, P448, DOI 10.1164/rccm.201407-1395OC; Luo JH, 2016, BRIT J CANCER, V115, P76, DOI 10.1038/bjc.2016.141; Mazzone PJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-410; Mc Menamin UC, 2016, LUNG CANCER, V94, P35, DOI 10.1016/j.lungcan.2016.01.012; Morgillo F, 2013, CLIN CANCER RES, V19, P3508, DOI 10.1158/1078-0432.CCR-12-2777; National Comprehensive Cancer Network, 2015, THE NCCN CLINICAL PR; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Pollak M, 2014, NAT MED, V20, P591, DOI 10.1038/nm.3596; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Saxena A, 2015, ONCOLOGIST, V20, P934, DOI 10.1634/theoncologist.2015-0064; Sayed Rana, 2015, Asian Pac J Cancer Prev, V16, P6621; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Skinner HD, 2013, CANCER MED-US, V2, P99, DOI 10.1002/cam4.54; Stevens RJ, 2012, DIABETOLOGIA, V55, P2593, DOI 10.1007/s00125-012-2653-7; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Tan BX, 2011, CANCER-AM CANCER SOC, V117, P5103, DOI 10.1002/cncr.26151; Teixeira SF, 2013, J BRAS PNEUMOL, V39, P644, DOI 10.1590/S1806-37132013000600002; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Tsilidis KK, 2014, DIABETES CARE, V37, P2522, DOI 10.2337/dc14-0584; Wink KCJ, 2016, RADIOTHER ONCOL, V118, P453, DOI 10.1016/j.radonc.2016.01.012; Wu N, 2011, NEOPLASMA, V58, P482, DOI 10.4149/neo_2011_06_482; Xu H, 2015, ONCOLOGIST, V20, P1236, DOI 10.1634/theoncologist.2015-0096; Xu H, 2015, J AM MED INFORM ASSN, V22, P179, DOI 10.1136/amiajnl-2014-002649; Zhang PP, 2013, CANCER EPIDEMIOL, V37, P207, DOI 10.1016/j.canep.2012.12.009	39	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191129	10.1371/journal.pone.0191129	http://dx.doi.org/10.1371/journal.pone.0191129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329345	Green Published, Green Submitted, gold			2022-12-27	WOS:000419954100040
J	Mohri, S; Takahashi, H; Sakai, M; Takahashi, S; Waki, N; Aizawa, K; Suganuma, H; Ara, T; Matsumura, Y; Shibata, D; Goto, T; Kawada, T				Mohri, Shinsuke; Takahashi, Haruya; Sakai, Maiko; Takahashi, Shingo; Waki, Naoko; Aizawa, Koichi; Suganuma, Hiroyuki; Ara, Takeshi; Matsumura, Yasuki; Shibata, Daisuke; Goto, Tsuyoshi; Kawada, Teruo			Wide-range screening of anti-inflammatory compounds in tomato using LC-MS and elucidating the mechanism of their functions	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; INFLAMMATORY CHANGES; METABOLIC SYNDROME; LIPID-METABOLISM; FATTY-ACID; PPAR-ALPHA; OBESITY; MACROPHAGES	Obesity-induced chronic inflammation is a key factor in type 2 diabetes. A vicious cycle involving pro-inflammatory mediators between adipocytes and macrophages is a common cause of chronic inflammation in the adipose tissue. Tomato is one of the most popular vegetables and is associated with a reduced risk of diabetes. However, the molecular mechanism underlying the effect of tomato on diabetes is unclear. In this study, we focused on anti-inflammatory compounds in tomato. We found that the extract of tomato reduced plasma glucose and inflammatory markers in mice. We screened anti-inflammatory fractions in tomato using lipopolysaccharide-stimulated RAW264.7 macrophages, and active compounds were estimated by liquid chromatography-mass spectrometry over a wide range. Surprisingly, a large number of compounds including oxylipin and coumarin derivatives were estimated as anti-inflammatory compounds. Especially, 9-oxo-octadecadienoic acid and daphnetin suppressed pro-inflammatory cytokines in RAW264.7 macrophages inhibiting mitogen-activated protein kinase phosphorylation and inhibitor of kappa B a protein degradation. These findings suggest that tomato containing diverse anti-inflammatory compounds ameliorates chronic inflammation in obese adipose tissue.	[Mohri, Shinsuke; Takahashi, Haruya; Sakai, Maiko; Goto, Tsuyoshi; Kawada, Teruo] Kyoto Univ, Grad Sch Agr, Lab Mol Funct Food, Uji, Kyoto, Japan; [Takahashi, Haruya; Waki, Naoko; Ara, Takeshi; Shibata, Daisuke] Kyoto Univ, Grad Sch Agr, KAGOME Tomato Discoveries Lab, Kyoto, Japan; [Takahashi, Shingo; Waki, Naoko; Aizawa, Koichi; Suganuma, Hiroyuki] KAGOME Co Ltd, Innovat Div, Nasushiobara, Tochigi, Japan; [Matsumura, Yasuki] Kyoto Univ, Grad Sch Agr, Lab Qual Anal & Assessment, Uji, Kyoto, Japan; [Shibata, Daisuke] Kazusa DNA Res Inst, Kisarazu, Chiba, Japan; [Goto, Tsuyoshi; Kawada, Teruo] Kyoto Univ, Res Unit Physiol Chem, Kyoto, Japan	Kyoto University; Kyoto University; Kagome Co., Ltd.; Kyoto University; Kazusa DNA Research Institute; Kyoto University	Kawada, T (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Mol Funct Food, Uji, Kyoto, Japan.; Kawada, T (corresponding author), Kyoto Univ, Res Unit Physiol Chem, Kyoto, Japan.	fat@kais.kyoto-u.ac.jp	Goto, Tsuyoshi/AAY-2344-2020	Goto, Tsuyoshi/0000-0003-1283-147X; Ara, Takeshi/0000-0003-1754-2837; Takahashi, Shingo/0000-0002-0182-2589; Suganuma, Hiroyuki/0000-0001-6596-9881	KAGOME CO., LTD	KAGOME CO., LTD	This study was funded by KAGOME CO., LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Benzler J, 2015, DIABETES, V64, P2015, DOI 10.2337/db14-0093; Blum Arnon, 2005, Eur J Intern Med, V16, P402, DOI 10.1016/j.ejim.2005.02.017; Bogna GG, 2014, NUTR J, V13, P17, DOI DOI 10.1186/1475-2891-13-17; Canene-Adams K, 2005, J NUTR, V135, P1226, DOI 10.1093/jn/135.5.1226; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Engeli S, 2007, J CLIN ENDOCR METAB, V92, P2706, DOI 10.1210/jc.2007-0234; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Fenni S, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601083; Ghavipour M, 2013, BRIT J NUTR, V109, P2031, DOI 10.1017/S0007114512004278; Gouranton E, 2011, J NUTR BIOCHEM, V22, P642, DOI 10.1016/j.jnutbio.2010.04.016; Granger DL, 1996, METHOD ENZYMOL, V268, P142; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Iijima Y, 2008, PLANT J, V54, P949, DOI 10.1111/j.1365-313X.2008.03434.x; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang MS, 2008, BIOCHEM BIOPH RES CO, V369, P333, DOI 10.1016/j.bbrc.2008.02.002; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kim YI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031317; Kim YI, 2011, MOL NUTR FOOD RES, V55, P585, DOI 10.1002/mnfr.201000264; Kim Y, 2014, FOOD FUNCT, V5, P2371, DOI 10.1039/c4fo00351a; Kuo JM, 2006, J AGR FOOD CHEM, V54, P3151, DOI 10.1021/jf060022q; Lazarus SA, 2004, JAMA-J AM MED ASSOC, V292, P805, DOI 10.1001/jama.292.7.805; Li Y, 2016, OBESITY, V24, P2351, DOI 10.1002/oby.21611; Li YF, 2015, NUTRITION, V31, P691, DOI 10.1016/j.nut.2014.11.008; Lin CH, 2016, DRUG DES DEV THER, V10, P3591, DOI 10.2147/DDDT.S114879; Mariutto M, 2014, PLANT MOL BIOL, V84, P455, DOI 10.1007/s11103-013-0144-y; Luvizotto RDM, 2013, BRIT J NUTR, V110, P1803, DOI 10.1017/S0007114513001256; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Palozza P, 2010, CURR MED CHEM, V17, P2547, DOI 10.2174/092986710791556041; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pulvera ZM, 2006, BIOSCI BIOTECH BIOCH, V70, P2598, DOI 10.1271/bbb.60121; Ravi R, 1998, CANCER RES, V58, P4531; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Roepstorff C, 2005, AM J PHYSIOL-ENDOC M, V288, pE133, DOI 10.1152/ajpendo.00379.2004; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Takahashi H, 2015, LIPIDS, V50, P1083, DOI 10.1007/s11745-015-4071-3; Takahashi H, 2015, J LIPID RES, V56, P254, DOI 10.1194/jlr.M052464; Takahashi H, 2014, BIOSCI BIOTECH BIOCH, V78, P1761, DOI 10.1080/09168451.2014.930330; Tsuchiya K, 2007, ENDOCRINOLOGY, V148, P4548, DOI 10.1210/en.2006-1371; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wensveen FM, 2015, EUR J IMMUNOL, V45, P2446, DOI 10.1002/eji.201545502; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang EB, 1999, BIOCHEM BIOPH RES CO, V260, P682, DOI 10.1006/bbrc.1999.0958; Yu WW, 2014, INT IMMUNOPHARMACOL, V21, P1, DOI 10.1016/j.intimp.2014.04.005	53	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191203	10.1371/journal.pone.0191203	http://dx.doi.org/10.1371/journal.pone.0191203			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329333	Green Published, gold, Green Submitted			2022-12-27	WOS:000419954100048
J	Liu, ZX; Zhu, JF; Yang, XY; Wu, HW; Wei, Q; Wei, HR; Zhang, HX				Liu, Zhengxiang; Zhu, Jianfeng; Yang, Xiuyan; Wu, Haiwen; Wei, Qi; Wei, Hairong; Zhang, Huaxin			Growth performance, organ-level ionic relations and organic osmoregulation of &ITElaeagnus angustifolia&IT in response to salt stress	PLOS ONE			English	Article							PHOTOSYNTHETIC CHARACTERISTICS; SALINITY TOLERANCE; WATER RELATIONS; MECHANISMS; ACCUMULATION; ARABIDOPSIS; TRANSPORT; MARITIMA; NACL	Elaeagnus angustifolia is one of the most extensively afforested tree species in environment-harsh regions of northern China. Despite its exceptional tolerance to saline soil, the intrinsic adaptive physiology has not been revealed. In this study, we investigated the growth, organ-level ionic relations and organic osmoregulation of the seedlings hydroponically treated with 0, 100 and 200 mM NaCl for 30 days. We found that the growth characteristics and the whole-plant dry weight were not obviously stunted, but instead, were even slightly stimulated by the treatment of 100 mM NaCl. In contrast, these traits were significantly inhibited by 200 mM NaCl treatment. Interestingly, as compared with the control (0 mM NaCl), both 100 and 200 mM NaCl treatments had a promotional effect on root growth as evidenced by 26.3% and 2.4% increases in root dry weight, respectively. Roots had the highest Na+ and Cl- concentrations and obviously served as the sink for the net increased Na+ and while, stems might maintain the capacity of effective Na+ constraint, resulting in reduced Na+ transport to the leaves. K+, Ca2+ and Mg2+ concentrations in three plant organs of NaCl-treated seedlings presented a substantial decline, eventually leading to an enormously drop of K+/Na+ ratio. As the salt concentration increased, proline and soluble protein contents continuously exhibited a prominent and a relatively tardy accumulation, respectively, whereas soluble sugar firstly fell to a significant level and then regained to a level that is close to that of the control. Taken together, our results provided quantitative measures that revealed some robust adaptive physiological mechanisms underpinning E. angustifolia's moderately high salt tolerance, and those mechanisms comprise scalable capacity for root Na+ and Cl- storage, effectively constrained transportation of Na+ from stems to leaves, root compensatory growth, as well as an immediate and prominent leaf proline accumulation.	[Liu, Zhengxiang; Zhu, Jianfeng; Yang, Xiuyan; Wu, Haiwen; Zhang, Huaxin] Chinese Acad Forestry, Res Ctr Saline & Alkali Land State Forestry Adm, Beijing, Peoples R China; [Wei, Qi] Gen Forestry Stn Beijing Municipal, Beijing, Peoples R China; [Wei, Hairong] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Chinese Academy of Forestry; Research Center of Saline & Alkali Land of State Forestry Administration, CAF; Michigan Technological University	Liu, ZX; Zhang, HX (corresponding author), Chinese Acad Forestry, Res Ctr Saline & Alkali Land State Forestry Adm, Beijing, Peoples R China.	xiangzilz@163.com; zhanghx1998@126.com	wei, hairong/GNM-7061-2022	wei, hairong/0000-0002-3551-4998	Fundamental Research Funds for the Central Non-profit Research Institution of CAF [CAFYBB2014QB052]; National Natural Science Foundation of China [31400571]	Fundamental Research Funds for the Central Non-profit Research Institution of CAF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was sponsored by grants from the National Natural Science Foundation of China (31400571), the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (CAFYBB2014QB052). The funders had no role in experimental design and conduct, data collection and analysis, decision to publish, or preparation of the manuscript.	Abideen Z, 2014, ENVIRON EXP BOT, V105, P70, DOI 10.1016/j.envexpbot.2014.04.009; Ahmed MZ, 2013, FUNCT PLANT BIOL, V40, P860, DOI 10.1071/FP12346; Ailijiang Maimaiti, 2008, Xinjiang Agricultural Sciences, V45, P1069; Al Hassan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160236; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Britto DT, 2006, TRENDS PLANT SCI, V11, P529, DOI 10.1016/j.tplants.2006.09.011; Chartzoulakis KS, 2005, AGR WATER MANAGE, V78, P108, DOI 10.1016/j.agwat.2005.04.025; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen S, 2010, PLANT BIOLOGY, V12, P317, DOI 10.1111/j.1438-8677.2009.00301.x; Cramer GR, 2002, FUNCT PLANT BIOL, V29, P561, DOI 10.1071/PP01132; Cristiano G, 2016, FORESTS, V7, DOI 10.3390/f7080156; Cuartero J, 2006, J EXP BOT, V57, P1045, DOI 10.1093/jxb/erj102; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Gadallah MAA, 1999, BIOL PLANTARUM, V42, P249, DOI 10.1023/A:1002164719609; Gong Q, 2008, J XINJIANG AGR U, V31, P46; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Henderson SW, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0273-8; Jaarsma R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060183; James JJ, 2006, J EXP BOT, V57, P139, DOI 10.1093/jxb/erj016; Li JG, 2014, J GEOGR SCI, V24, P943, DOI 10.1007/s11442-014-1130-2; Li L, 2013, PHYSIOL PLANTARUM, V147, P477, DOI 10.1111/j.1399-3054.2012.01676.x; Liu BaoYu, 2007, Bulletin of Botanical Research, V27, P721; Liu Zheng-xiang, 2014, Forest Research, V27, P186; Liu ZhengXiang, 2014, Scientia Silvae Sinicae, V50, P32; Liu ZX, 2013, COMMUN SOIL SCI PLAN, V44, P3187, DOI 10.1080/00103624.2013.832289; Lv SL, 2012, PLANT PHYSIOL BIOCH, V51, P47, DOI 10.1016/j.plaphy.2011.10.015; M'rah S, 2006, J PLANT PHYSIOL, V163, P1022, DOI 10.1016/j.jplph.2005.07.015; Mullet JE, 1996, PLANT GROWTH REGUL, V20, P119, DOI 10.1007/BF00024008; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Naidoo G, 2012, AFR J AQUAT SCI, V37, P81, DOI 10.2989/16085914.2012.666377; PARRONDO RT, 1978, BOT GAZ, V139, P102, DOI 10.1086/336975; [邱念伟 Qiu Nianwei], 2014, [生态学报, Acta Ecologica Sinica], V34, P6147; Song J, 2011, PHYSIOL PLANTARUM, V141, P343, DOI 10.1111/j.1399-3054.2011.01445.x; Tattini M, 2006, NEW PHYTOL, V170, P779, DOI 10.1111/j.1469-8137.2006.01723.x; Teakle NL, 2010, PLANT CELL ENVIRON, V33, P566, DOI 10.1111/j.1365-3040.2009.02060.x; Turkan I, 2009, ENVIRON EXP BOT, V67, P2, DOI 10.1016/j.envexpbot.2009.05.008; Volkov V, 2004, PLANT CELL ENVIRON, V27, P1, DOI 10.1046/j.0016-8025.2003.01116.x; [王树凤 Wang Shufeng], 2010, [生态学报, Acta Ecologica Sinica], V30, P4609; Wei QJ, 2015, BIOL PLANTARUM, V59, P645, DOI 10.1007/s10535-015-0532-z; Wu B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171451; Xu H., 2004, HALOPHYTE ECOLOGICAL; [杨升 Yang Sheng], 2013, [林业科学, Scientia Silvae Sinicae], V49, P91; YEO AR, 1980, J EXP BOT, V31, P1171, DOI 10.1093/jxb/31.4.1171; [张华新 ZHANG Hua-Xin], 2009, [生态学报, Acta Ecologica Sinica], V29, P2263; Zhang WW, 2015, PLANT PHYSIOL BIOCH, V89, P85, DOI 10.1016/j.plaphy.2015.02.012; Zhang Yi, 2010, Forest Research, V23, P920; Zhao KF, 2011, PLANT SOIL, V342, P495, DOI 10.1007/s11104-010-0470-7	51	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191552	10.1371/journal.pone.0191552	http://dx.doi.org/10.1371/journal.pone.0191552			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360848	Green Published, gold			2022-12-27	WOS:000423161800036
J	Bibault, JE; Zapletal, E; Rance, B; Giraud, P; Burgun, A				Bibault, Jean-Emmanuel; Zapletal, Eric; Rance, Bastien; Giraud, Philippe; Burgun, Anita			Labeling for Big Data in radiation oncology: The Radiation Oncology Structures ontology	PLOS ONE			English	Article							CLINICAL-DATA WAREHOUSE; RADIOTHERAPY; DELINEATION; CANCER; SUPPORT	Purpose Leveraging Electronic Health Records (EHR) and Oncology Information Systems (OIS) has great potential to generate hypotheses for cancer treatment, since they directly provide medical data on a large scale. In order to gather a significant amount of patients with a high level of clinical details, multicenter studies are necessary. A challenge in creating high quality Big Data studies involving several treatment centers is the lack of semantic interoperability between data sources. We present the ontology we developed to address this issue. Methods Radiation Oncology anatomical and target volumes were categorized in anatomical and treatment planning classes. International delineation guidelines specific to radiation oncology were used for lymph nodes areas and target volumes. Hierarchical classes were created to generate The Radiation Oncology Structures (ROS) Ontology. The ROS was then applied to the data from our institution. Results Four hundred and seventeen classes were created with a maximum of 14 children classes (average = 5). The ontology was then converted into a Web Ontology Language (.owl) format and made available online on Bioportal and GitHub under an Apache 2.0 License. We extracted all structures delineated in our department since the opening in 2001. 20,758 structures were exported from our "record-and-verify" system, demonstrating a significant heterogeneity within a single center. All structures were matched to the ROS ontology before integration into our clinical data warehouse (CDW). Conclusion In this study we describe a new ontology, specific to radiation oncology, that reports all anatomical and treatment planning structures that can be delineated. This ontology will be used to integrate dosimetric data in the Assistance Publique-Hopitaux de Paris CDW that stores data from 6.5 million patients (as of February 2017).	[Bibault, Jean-Emmanuel; Giraud, Philippe] Paris Descartes Univ, Georges Pompidou European Hosp, AP HP, Sorbonne Paris Cite,Radiat Oncol Dept, Paris, France; [Bibault, Jean-Emmanuel; Rance, Bastien; Burgun, Anita] Paris Descartes Univ, Paris Sorbonne Cite, INSERM, UMR 1138,Team Informat Sci Support Personalized M, Paris, France; [Zapletal, Eric; Rance, Bastien; Burgun, Anita] Paris Descartes Univ, Georges Pompidou European Hosp, AP HP, Biomed Informat & Publ Hlth Dept,Paris Sorbonne C, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Bibault, JE (corresponding author), Paris Descartes Univ, Georges Pompidou European Hosp, AP HP, Sorbonne Paris Cite,Radiat Oncol Dept, Paris, France.; Bibault, JE (corresponding author), Paris Descartes Univ, Paris Sorbonne Cite, INSERM, UMR 1138,Team Informat Sci Support Personalized M, Paris, France.	jean-emmanuel.bibault@aphp.fr		Rance, Bastien/0000-0003-4417-1197; Bibault, Jean-Emmanuel/0000-0002-1728-6776				[Anonymous], RADIATION ONCOLOGY O; [Anonymous], FDN MOD AN SUMM; [Anonymous], SNOMED CT SUMM; Baumann M, 2016, NAT REV CANCER, V16, P234, DOI 10.1038/nrc.2016.18; Bibault J.-E., RAD ONCOLOGY STRUCTU; Bibault JE, 2016, CANCER LETT, V382, P110, DOI 10.1016/j.canlet.2016.05.033; Bibault JE, 2013, CANCER METAST REV, V32, P479, DOI 10.1007/s10555-013-9419-7; Chen CS, 2015, CANCER METAST REV, V34, P313, DOI 10.1007/s10555-015-9555-3; Gregoire V, 2014, RADIOTHER ONCOL, V110, P172, DOI 10.1016/j.radonc.2013.10.010; Harris VA, 2015, INT J RADIAT ONCOL, V92, P874, DOI 10.1016/j.ijrobp.2015.03.021; Hwang KH, 2017, J DIGIT IMAGING, V30, P4, DOI 10.1007/s10278-016-9916-7; Jannot A, INT J MED I IN PRESS; Lengele B, 2007, RADIOTHER ONCOL, V84, P335, DOI 10.1016/j.radonc.2007.07.016; Lengele B, 2009, RADIOTHER ONCOL, V92, P22, DOI 10.1016/j.radonc.2008.11.007; McNutt TR, 2015, INT J RAD ONCOL; Meldolesi E, 2014, RADIOTHER ONCOL, V112, P59, DOI 10.1016/j.radonc.2014.04.008; Musen Mark A, 2015, AI Matters, V1, P4; Musen Mark A, PROTEGE; Noy NF, PUSHING THE ENVELOPE; Potters L, 2015, INT J RAD ONCOL; Rance B, 2016, APPL CLIN INFORM, V7, P260, DOI 10.4338/ACI-2015-09-RA-0125; Roelofs E, 2014, RADIOTHER ONCOL, V110, P370, DOI 10.1016/j.radonc.2013.11.001; Roelofs E, 2013, RADIOTHER ONCOL, V108, P174, DOI 10.1016/j.radonc.2012.09.019; Rubin DL, 2008, J DIGIT IMAGING, V21, P355, DOI 10.1007/s10278-007-9073-0; Rusch VW, 2009, J THORAC ONCOL, V4, P568, DOI 10.1097/JTO.0b013e3181a0d82e; Rutzner S, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00016; Santanam L, 2012, INT J RADIAT ONCOL, V83, P1344, DOI 10.1016/j.ijrobp.2011.09.054; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Zapletal E, 2010, STUD HEALTH TECHNOL, V160, P193, DOI 10.3233/978-1-60750-588-4-193	29	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191263	10.1371/journal.pone.0191263	http://dx.doi.org/10.1371/journal.pone.0191263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351341	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300064
J	Bzhalava, Z; Hultin, E; Dillner, J				Bzhalava, Zurab; Hultin, Emilie; Dillner, Joakim			Extension of the viral ecology in humans using viral profile hidden Markov models	PLOS ONE			English	Article							SKIN-CANCER; TRANSPLANT RECIPIENTS; HUMAN PAPILLOMAVIRUSES; CYSTIC-FIBROSIS; HUMAN VIROME; DNA VIRUSES; GENOME; INDIVIDUALS; GENERATION; DIVERSITY	When human samples are sequenced, many assembled contigs are "unknown", as conventional alignments find no similarity to known sequences. Hidden Markov models (HMM) exploit the positions of specific nucleotides in protein-encoding codons in various microbes. The algorithm HMMER3 implements HMM using a reference set of sequences encoding viral proteins, "vFam". We used HMMER3 analysis of "unknown" human sample-derived sequences and identified 510 contigs distantly related to viruses (Anelloviridae (n = 1), Baculoviridae (n = 34), Circoviridae (n = 35), Caulimoviridae (n = 3), Closteroviridae (n = 5), Geminiviridae (n = 21), Herpesviridae (n = 10), Iridoviridae (n = 12), Marseillevirus (n = 26), Mimiviridae (n = 80), Phycodnaviridae (n = 165), Poxviridae (n = 23), Retroviridae (n = 6) and 89 contigs related to described viruses not yet assigned to any taxonomic family). In summary, we find that analysis using the HMMER3 algorithm and the "vFam" database greatly extended the detection of viruses in biospecimens from humans.	[Bzhalava, Zurab; Hultin, Emilie; Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet	Dillner, J (corresponding author), Karolinska Inst, Dept Lab Med, Stockholm, Sweden.	joakim.dillner@ki.se			Swedish Research Council [K2015-57X-21044-07-3]; NordForsk [62721]	Swedish Research Council(Swedish Research CouncilEuropean Commission); NordForsk	This work was supported by the Swedish Research Council, www.vr.se, Grant number: K2015-57X-21044-07-3 and the NordForsk, www.nordforsk.org, Grant number: 62721 to JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; Besprozvannaya M, 2013, J BIOL CHEM, V288, P28962, DOI 10.1074/jbc.M113.484055; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Bzhalava D DJ, 2013, J DATA MINING GENOMI, V4; Bzhalava D, 2016, INT J CANCER, V138, P2212, DOI 10.1002/ijc.29666; Bzhalava D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05807; Bzhalava D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065953; Cantalupo PG, 2011, MBIO, V2, DOI 10.1128/mBio.00180-11; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Delaroque N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-110; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Frick DN, 2006, CURR PHARM DESIGN, V12, P1315, DOI 10.2174/138161206776361147; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grazziotin AL, 2017, NUCLEIC ACIDS RES, V45, pD491, DOI 10.1093/nar/gkw975; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; HARTEVELT MM, 1990, TRANSPLANTATION, V49, P506, DOI 10.1097/00007890-199003000-00006; Johansson H., 2013, VIROLOGY; Johansson H, 2013, VIROLOGY, V440, P1, DOI 10.1016/j.virol.2013.01.023; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; La Rosa G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052391; Labonte JM, 2013, ISME J, V7, P2169, DOI 10.1038/ismej.2013.110; Lecuit M, 2013, TRENDS MICROBIOL, V21, P510, DOI 10.1016/j.tim.2013.07.001; Lehtinen M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015867; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Manso CF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02239-5; Meiring TL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-164; Mercalli A, 2012, DIABETOLOGIA, V55, P2479, DOI 10.1007/s00125-012-2591-4; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Miyashita H, 2014, PROTEIN PEPTIDE LETT, V21, P292, DOI 10.2174/09298665113206660112; Moloney FJ, 2006, BRIT J DERMATOL, V154, P498, DOI 10.1111/j.1365-2133.2005.07021.x; Muhr LSA, 2015, INT J CANCER, V136, P2546, DOI 10.1002/ijc.29325; Muhr LSA, 2015, VIROLOGY, V485, P283, DOI 10.1016/j.virol.2015.07.023; Omland T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099114; Paez-Espino D, 2017, NAT PROTOC, V12, P1673, DOI 10.1038/nprot.2017.063; Pappalardo M, 2016, CONSERVED DIFFERENCE, V6, P23743; Roux S, 2015, VIRSORTER MINING VIR; Schulz TF, 2009, INT J CANCER, V125, P1755, DOI 10.1002/ijc.24741; Schwarz E. M., 2013, REFERENCE FREE ALGOR; Sherif F, 2011, CLASSIFICATION HUMAN; Skewes-Cox P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105067; Smelov V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25235; Sundstrom P, 2004, ALTERED IMMUNE RESPO, P2277; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Willner D, 2012, AM J RESP CELL MOL, V46, P127, DOI 10.1165/rcmb.2011-0253OC; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wylie KM, 2012, TRANSL RES, V160, P283, DOI 10.1016/j.trsl.2012.03.006; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735; Zhang YP, 1998, VIROLOGY, V240, P366, DOI 10.1006/viro.1997.8936	56	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190938	10.1371/journal.pone.0190938	http://dx.doi.org/10.1371/journal.pone.0190938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351302	Green Submitted, gold, Green Published			2022-12-27	WOS:000422911300033
J	Hammami, P; Lancelot, R; Domenech, J; Lesnoff, M				Hammami, Pachka; Lancelot, Renaud; Domenech, Joseph; Lesnoff, Matthieu			Ex-ante assessment of different vaccination-based control schedules against the peste des petits ruminants virus in sub-Saharan Africa	PLOS ONE			English	Article							ANTIBODY DYNAMICS; SHEEP; IMMUNITY; GOATS; POPULATION; OUTBREAK; DISTRICT; VACCINES; SENEGAL	Background Peste des petits ruminants (PPR) is a highly contagious and widespread viral infection of small ruminants (goats and sheep), causing heavy economic losses in many developing countries. Therefore, its progressive control and global eradication by 2030 was defined as a priority by international organizations addressing animal health. The control phase of the global strategy is based on mass vaccination of small ruminant populations in endemic regions or countries. It is estimated that a 70% post-vaccination immunity rate (PVIR) is needed in a given epidemiological unit to prevent PPR virus spread. However, implementing mass vaccination is difficult and costly in smallholder farming systems with scattered livestock and limited facilities. Regarding this, controlling PPR is a special challenge in subSaharan Africa. In this study, we focused on this region to assess the effect of several variables of PVIR in two contrasted smallholder farming systems. Methods Using a seasonal matrix population model of PVIR, we estimated its decay in goats reared in sub-humid areas, and sheep reared in semi-arid areas, over a 4-year vaccination program. Assuming immunologically naive and PPR-free epidemiological unit, we assessed the ability of different vaccination scenarios to reach the 70% PVIR throughout the program. The tested scenarios differed in i) their overall schedule, ii) their delivery month and iii) their vaccination coverage. Results In sheep reared in semi-arid areas, the vaccination month did affect the PVIR decay though it did not in goats in humid regions. In both cases, our study highlighted i) the importance of targeting the whole eligible population at least during the two first years of the vaccination program and ii) the importance of reaching a vaccination coverage as high as 80% of this population. This study confirmed the relevance of the vaccination schedules recommended by international organizations.	[Hammami, Pachka; Lancelot, Renaud] Ctr Cooperat Int Rech Agronom Dev CIRAD, Animals Hlth Terr Risks & Ecosyst ASTRE, UMR 117, Campus Int Baillarguet, F-34398 Montpellier, France; [Hammami, Pachka; Lancelot, Renaud] INRA, ASTRE, UMR 117, F-34398 Montpellier, France; [Lesnoff, Matthieu] CIRAD, UMR Syst Elevage Mediterraneens & Trop SELMET, Campus Int Baillarguet, F-34398 Montpellier, France; [Lesnoff, Matthieu] INRA, UMR SELMET, Campus Int Baillarguet, F-34398 Montpellier, France; [Lesnoff, Matthieu] Montpellier SUPAGRO, UMR SELMET, Campus Int Baillarguet, F-34398 Montpellier, France	CIRAD; Universite de Montpellier; INRAE; CIRAD; INRAE; Institut Agro; Montpellier SupAgro	Hammami, P (corresponding author), Ctr Cooperat Int Rech Agronom Dev CIRAD, Animals Hlth Terr Risks & Ecosyst ASTRE, UMR 117, Campus Int Baillarguet, F-34398 Montpellier, France.; Hammami, P (corresponding author), INRA, ASTRE, UMR 117, F-34398 Montpellier, France.	pachka.hammami@cirad.fr	Lancelot, Renaud/HGE-1086-2022	Lancelot, Renaud/0000-0002-5826-5242; Hammami, Pachka/0000-0002-7490-6257	Bill and Melinda Gates Foundation; OIE World Animal Health and Welfare Fund; Cirad; Institut Senegalais de Recherches Agricoles (Isra, Dakar, Senegal); Directorate of Veterinary Services (DSV, Dakar, Senegal)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); OIE World Animal Health and Welfare Fund; Cirad; Institut Senegalais de Recherches Agricoles (Isra, Dakar, Senegal); Directorate of Veterinary Services (DSV, Dakar, Senegal)	This study was conducted in the frame of the project "Vaccine Standard and Pilot Approach for the Progressive Control and Eradication of PPR in Africa" (VSPA), funded by the Bill and Melinda Gates Foundation, the OIE World Animal Health and Welfare Fund, and Cirad. Small ruminant demographic data were collected during the joint research programme "Pathologie et Productivite des Petits Ruminants" co-funded by the Institut Senegalais de Recherches Agricoles (Isra, Dakar, Senegal), the Directorate of Veterinary Services (DSV, Dakar, Senegal), and Cirad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar Muhammad, 2015, Journal of Animal Science and Technology, V57, P2, DOI 10.1186/s40781-014-0036-y; Abubakar M, 2012, VIRUS RES, V167, P43, DOI 10.1016/j.virusres.2012.03.018; Alary V, 2011, WORLD DEV, V39, P1638, DOI 10.1016/j.worlddev.2011.02.008; Albina E, 2013, VET MICROBIOL, V165, P38, DOI 10.1016/j.vetmic.2012.12.013; ALSABBAGH TA, 1995, J ANIM SCI, V73, P2860; [Anonymous], 2006, CARBON LAND WATER GL; Anyamba A, 2014, REMOTE SENS-BASEL, V6, P3101, DOI 10.3390/rs6043101; ATA FA, 1989, VET REC, V124, P590, DOI 10.1136/vr.124.22.590; Awa DN, 2002, PREV VET MED, V55, P265, DOI 10.1016/S0167-5877(02)00013-2; Balamurugan Vinayagamurthy, 2012, Virologica Sinica, V27, P228, DOI 10.1007/s12250-012-3249-6; Baron MD, 2016, ADV VIRUS RES, V95; Bidjeh Kebkiba, 1999, Cahiers Agricultures, V8, P219; Bodjo SC, 2006, BIOKEMISTRI, V18; Buczkowski H, 2014, VACCINE, V32, P3155, DOI 10.1016/j.vaccine.2014.03.053; Caswell, 2000, MATRIX POPULATION MO; Cetre-Sossah C, 2014, TRANSBOUND EMERG DIS; Clement V., 1997, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V50, P235; Cosseddu GM, 2016, TRANSBOUND EMERG DIS, V63, pE447, DOI 10.1111/tbed.12314; Couacy-Hymann E, 2007, VET J, V173, P178, DOI 10.1016/j.tvjl.2005.08.020; Diallo A., 2006, Journal of Veterinary Medicine. Series B, V53, P11, DOI 10.1111/j.1439-0450.2006.01012.x; Diallo A, 2007, VACCINE, V25, P5591, DOI 10.1016/j.vaccine.2007.02.013; El Arbi AS, 2014, EMERG INFECT DIS, V20, P334, DOI 10.3201/eid2002.131345; El-Yuguda A-D., 2014, WORLD J VACCINES, V04, P1, DOI [10.4236/wjv.2014.41001, DOI 10.4236/WJV.2014.41001]; Ettair M., 2012, REMESA ATELIER CONJO, P1; FAO OIE, 2015, GLOB STRAT PROGR CON; Faugere O., 1990, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V43, P249; Faugere O, 1990, REV ELEV MED VET PAY, V43; Geiger R, 1999, P RES COORD M FAO IA; Goossens B, 1997, INT J PARASITOL, V27, P1579, DOI 10.1016/S0020-7519(97)00094-5; Hammami P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161769; Hashemi M, 2008, SMALL RUMINANT RES, V75, P204, DOI 10.1016/j.smallrumres.2007.11.002; Heesterbeek JAP, 2007, MATH BIOSCI, V206, P3, DOI 10.1016/j.mbs.2004.10.013; Kairu-Wanyoike SW, 2014, PREV VET MED, V115, P130, DOI 10.1016/j.prevetmed.2014.03.028; Kivaria FM, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.593; Lancelot R., 1998, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V51, P135; Lancelot R, 2014, VACCINE STANDARDS PI; Lancelot R, 2017, P NATL ACAD SCI USA, V114, P938, DOI 10.1073/pnas.1607948114; Lefevre PC, 2010, INFECT PARASITIC DIS; Lesnoff M, 1999, AGR SYST, V61, P207, DOI 10.1016/S0308-521X(99)00053-0; Lesnoff M, 2009, EPIDEMIOL INFECT, V137, P1405, DOI 10.1017/S0950268809002453; Lesnoff M, 2014, CALCULATION DEMOGRAP; Liu FX, 2014, VET RES COMMUN, V38, P307, DOI 10.1007/s11259-014-9618-x; Liu W, 2013, TRANSBOUND EMERG DIS, V60, P63, DOI 10.1111/tbed.12136; Ly C, 1998, REV SCI TECH OIE, V17, P767, DOI 10.20506/rst.17.3.1133; Mariner JC, 2012, SCIENCE, V337, P1309, DOI 10.1126/science.1223805; MCCuLLAGH P., 1989, GEN LINEAR MODELS, V37; Moulin CH, 1993, ANIMAL PERFORMANCE B, P2864; Niewiesk S., 2014, FRONT IMMUNOL, P5; Perry B, 2007, SCIENCE, V315, P333, DOI 10.1126/science.1138614; Provost A, 1982, Rev Sci Tech, V1, P589, DOI 10.20506/rst.1.3.88; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Roeder P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0139; Sarr J, 1994, RES COORD M FAO AEA, P195; STEM C, 1993, PREV VET MED, V16, P141, DOI 10.1016/0167-5877(93)90084-7; Texeira M, 2008, ECOL MODEL, V217, P197, DOI 10.1016/j.ecolmodel.2008.06.027; Trabucco A, 2009, CGIAR CONSORT SPATIA; Wemike K, 2014, VET MICROBIOL, V172, P140, DOI 10.1016/j.vetmic.2014.05.010; Yoccoz N.G., 1991, B ECOL SOC AM, V72, P106; Zahur AB, 2009, PAK VET J, V29, P174; Zahur A.B., 2014, J BIOSCI MED, V2, P27, DOI DOI 10.4236/JBM.2014.26005	60	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190296	10.1371/journal.pone.0190296	http://dx.doi.org/10.1371/journal.pone.0190296			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351277	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300016
J	He, HJ; Zhang, CY; Zhao, XH; Fousseni, F; Wang, JS; Dai, HJ; Yang, S; Zuo, Q				He, Huaijiang; Zhang, Chunyu; Zhao, Xiuhai; Fousseni, Folega; Wang, Jinsong; Dai, Haijun; Yang, Song; Zuo, Qiang			Allometric biomass equations for 12 tree species in coniferous and broadleaved mixed forests, Northeastern China	PLOS ONE			English	Article							BELOW-GROUND BIOMASS; NET PRIMARY PRODUCTION; ABOVEGROUND BIOMASS; ALLOCATION; PINE; ROOT; PATTERNS; STORAGE; HEIGHT; MODELS	Understanding forest carbon budget and dynamics for sustainable resource management and ecosystem functions requires quantification of above- and below-ground biomass at individual tree species and stand levels. In this study, a total of 122 trees (9 +/- 12 per species) were destructively sampled to determine above-and below-ground biomass of 12 tree species (Acer mandshuricum, Acer mono, Betula platyphylla, Carpinus cordata, Fraxinus mandshurica, Juglans mandshurica, Maackia amurensis, P. koraiensis, Populus ussuriensis, Quercus mongolica, Tilia amurensis and Ulmus japonica) in coniferous and broadleaved mixed forests of Northeastern China, an area of the largest natural forest in the country. Biomass allocation was examined and biomass models were developed using diameter as independent variable for individual tree species and all species combined. The results showed that the largest biomass allocation of all species combined was on stems (57.1%), followed by coarse root (21.3%), branch (18.7%), and foliage (2.9%). The log-transformed model was statistically significant for all biomass components, although predicting power was higher for species-specific models than for all species combined, general biomass models, and higher for stems, roots, above-ground biomass, and total tree biomass than for branch and foliage biomass. These findings supplement the previous studies on this forest type by additional sample trees, species and locations, and support biomass research on forest carbon budget and dynamics by management activities such as thinning and harvesting in the northeastern part of China.	[He, Huaijiang; Zhang, Chunyu; Zhao, Xiuhai; Fousseni, Folega; Wang, Jinsong; Dai, Haijun; Yang, Song; Zuo, Qiang] Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc, Beijing, Peoples R China; [Fousseni, Folega] Univ Lome, Lab Bot & Ecol Vegetale, Lome, Togo; [Wang, Jinsong] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zhang, CY (corresponding author), Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc, Beijing, Peoples R China.	zcy_0520@163.com	Zhang, Chun-yu/HDP-5776-2022; Wang, Jinsong/AAO-3115-2021; Zhang, Chunyu/GYA-2925-2022	Wang, Jinsong/0000-0002-3425-7387; Zhang, Chunyu/0000-0003-3091-5060	Fundamental Research Funds for the State Key Program of National Natural Science Foundation of China [41330530]; National Basic Research Program of China (973 Program) [2011CB403203]	Fundamental Research Funds for the State Key Program of National Natural Science Foundation of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research is supported by the Fundamental Research Funds for the State Key Program of National Natural Science Foundation of China (41330530) and the National Basic Research Program of China (973 Program: 2011CB403203).	Avsar M. D., 2004, Journal of Biological Sciences, V4, P437; Bond-Lamberty B, 2002, CAN J FOREST RES, V32, P1441, DOI [10.1139/x02-063, 10.1139/X02-063]; Bond-Lamberty B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050441; Cai S, 2013, ANN FOR RES, V56, P105; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Conti G, 2013, ANN FOREST SCI, V70, P515, DOI 10.1007/s13595-013-0285-9; Cushman KC, 2014, METHODS ECOL EVOL, V5, P573, DOI 10.1111/2041-210X.12187; Fatemi FR, 2011, CAN J FOREST RES, V41, P881, DOI [10.1139/X10-248, 10.1139/x10-248]; Gahagan A, 2015, FOREST ECOL MANAG, V337, P88, DOI 10.1016/j.foreco.2014.10.037; Gower ST, 1999, REMOTE SENS ENVIRON, V70, P29, DOI 10.1016/S0034-4257(99)00056-5; Grote R, 2002, SILVA FENNICA, V36; HAASE R, 1995, FOREST ECOL MANAG, V73, P29, DOI 10.1016/0378-1127(94)03509-U; Henry M, 2010, FOREST ECOL MANAG, V260, P1375, DOI 10.1016/j.foreco.2010.07.040; Hosoda K, 2010, J FOREST RES-JPN, V15, P299, DOI 10.1007/s10310-010-0192-y; Hunter MO, 2013, BIOGEOSCIENCES, V10, P8385, DOI 10.5194/bg-10-8385-2013; Jenkins JC, 2003, FOREST SCI, V49, P12; Karlik JF, 2014, BIOMASS BIOENERG, V62, P228, DOI 10.1016/j.biombioe.2013.11.018; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; Kralicek K, 2017, FOREST ECOL MANAG, V390, P147, DOI 10.1016/j.foreco.2017.01.030; Kuyah S, 2013, BIOMASS BIOENERG, V55, P276, DOI 10.1016/j.biombioe.2013.02.011; Li CP, 2007, J ARID ENVIRON, V70, P195, DOI 10.1016/j.jaridenv.2006.12.017; Litton CM, 2003, CAN J FOREST RES, V33, P351, DOI 10.1139/X02-181; Litton CM, 2008, BIOTROPICA, V40, P313, DOI 10.1111/j.1744-7429.2007.00383.x; Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087600; Martin JG, 1998, CAN J FOREST RES, V28, P1648, DOI 10.1139/cjfr-28-11-1648; Mate R, 2014, FORESTS, V5, P535, DOI 10.3390/f5030535; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Mosseler A, 2014, FOREST ECOL MANAG, V320, P190, DOI 10.1016/j.foreco.2014.02.027; Packard GC, 2011, BIOL REV, V86, P549, DOI 10.1111/j.1469-185X.2010.00160.x; PASTOR J, 1984, FOREST ECOL MANAG, V7, P265, DOI 10.1016/0378-1127(84)90003-3; Paul KI, 2013, FOREST ECOL MANAG, V310, P483, DOI 10.1016/j.foreco.2013.08.054; Peichl M, 2007, FOREST ECOL MANAG, V253, P68, DOI 10.1016/j.foreco.2007.07.003; Shaiek O, 2011, ANN FOREST SCI, V68, P443, DOI 10.1007/s13595-011-0044-8; TerMikaelian MT, 1997, FOREST ECOL MANAG, V97, P1, DOI 10.1016/S0378-1127(97)00019-4; Tumwebaze SB, 2013, AGROFOREST SYST, V87, P781, DOI 10.1007/s10457-013-9596-y; Wang CK, 2006, FOREST ECOL MANAG, V222, P9, DOI 10.1016/j.foreco.2005.10.074; Wang JS, 2013, EUR J FOREST RES, V132, P313, DOI 10.1007/s10342-012-0676-8; Wang JS, 2011, SILVA FENN, V45, P211, DOI 10.14214/sf.113; Wang XP, 2008, FOREST ECOL MANAG, V255, P4007, DOI 10.1016/j.foreco.2008.03.055; Wang XP, 2006, FOREST ECOL MANAG, V234, P264, DOI 10.1016/j.foreco.2006.07.007; Wang XP, 2013, FOREST ECOL MANAG, V293, P149, DOI 10.1016/j.foreco.2013.01.001; Xiao CW, 2003, TREE PHYSIOL, V23, P505, DOI 10.1093/treephys/23.8.505; Xu JD, 2014, J FOREST ECON, V36, P6; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Zhang CY, 2012, EUR J FOREST RES, V131, P1287, DOI 10.1007/s10342-012-0598-5; Zhang H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15997; Zhu BA, 2010, J PLANT RES, V123, P439, DOI 10.1007/s10265-009-0301-1; Zianis D, 2003, ANN FOREST SCI, V60, P439, DOI 10.1051/forest:2003036	49	32	39	8	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0186226	10.1371/journal.pone.0186226	http://dx.doi.org/10.1371/journal.pone.0186226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351291	Green Submitted, gold, Green Published			2022-12-27	WOS:000422911300004
J	Samoilys, M; Roche, R; Koldewey, H; Turner, J				Samoilys, Melita; Roche, Ronan; Koldewey, Heather; Turner, John			Patterns in reef fish assemblages: Insights from the Chagos Archipelago	PLOS ONE			English	Article							CORAL-REEFS; COMMUNITY STRUCTURE; INDIAN-OCEAN; HERBIVOROUS FISHES; PHASE-SHIFTS; MARINE; RESILIENCE; HABITAT; SHELF; PARROTFISHES	Understanding the drivers of variability in the composition of fish assemblages across the Indo-Pacific region is crucial to support coral reef ecosystem resilience. Whilst numerous relationships and feedback mechanisms between the functional roles of coral reef fishes and reef benthic composition have been investigated, certain key groups, such as the herbivores, are widely suggested to maintain reefs in a coral-dominated state. Examining links between fishes and reef benthos is complicated by the interactions between natural processes, disturbance events and anthropogenic impacts, particularly fishing pressure. This study examined fish assemblages and associated benthic variables across five atolls within the Chagos Archipelago, where fishing pressure is largely absent, to better understand these relationships. We found high variability in fish assemblages among atolls and sites across the archipelago, especially for key groups such as a suite of grazer-detritivore surgeonfish, and the parrotfishes which varied in density over 40-fold between sites. Differences in fish assemblages were significantly associated with variable levels of both live and recently dead coral cover and rugosity. We suggest these results reflect differing coral recovery trajectories following coral bleaching events and a strong influence of 'bottom-up' control mechanisms on fish assemblages. Species level analyses revealed that Scarus niger, Acanthurus nigrofuscus and Chlorurus strongylocephalos were key species driving differences in fish assemblage structure. Clarifying the trophic roles of herbivorous and detritivorous reef fishes will require species-level studies, which also examine feeding behaviour, to fully understand their contribution in maintaining reef resilience to climate change and fishing impacts.	[Samoilys, Melita] CORDIO East Africa, Mombasa, Kenya; [Samoilys, Melita] Univ Oxford, Dept Zool, Oxford, England; [Roche, Ronan; Turner, John] Bangor Univ, Sch Ocean Sci, Bangor, Gwynedd, Wales; [Koldewey, Heather] Zool Soc London, Conservat Programmes, London, England; [Koldewey, Heather] Univ Exeter, Ctr Ecol & Conservat, Cornwall Campus, Penryn, Cornwall, England	University of Oxford; Bangor University; Zoological Society of London; University of Exeter	Samoilys, M (corresponding author), CORDIO East Africa, Mombasa, Kenya.; Samoilys, M (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	melita.samoilys@gmail.com	Roche, Ronan/AAX-1395-2020	Roche, Ronan/0000-0002-6342-9571; Samoilys, Melita/0000-0003-1933-357X	Coastal Oceans Research and Development Indian Ocean (CORDIO); Perivoli Trust fellowship at the University of Oxford; DEFRA Darwin Initiative grant [19-027]; University of Warwick; Zoological Society of London; Bertarelli Foundation	Coastal Oceans Research and Development Indian Ocean (CORDIO); Perivoli Trust fellowship at the University of Oxford; DEFRA Darwin Initiative grant; University of Warwick; Zoological Society of London; Bertarelli Foundation	MS was supported by Coastal Oceans Research and Development Indian Ocean (CORDIO) and a Perivoli Trust fellowship at the University of Oxford; http://cordioea.net. The project was funded by DEFRA Darwin Initiative grant 19-027 to Bangor University, University of Warwick and the Zoological Society of London; https://www.gov.uk/government/groups/the-darwin-initiative. HK was supported by the Bertarelli Foundation; https://www.fondation-bertarelli.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2011, CORAL REEFS, V30, P1051, DOI 10.1007/s00338-011-0795-6; Andrefouet S., 2009, ATLAS W INDIAN OCEAN; [Anonymous], 2014, R LANG ENV STAT COMP; Anthony KRN, 2015, GLOBAL CHANGE BIOL, V21, P48, DOI 10.1111/gcb.12700; Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Bellwood DR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3046; Bellwood DR, 2017, BIOL REV, V92, P878, DOI 10.1111/brv.12259; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bonaldo RM, 2014, OCEANOGR MAR BIOL, V52, P81; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; Chabanet P, 2015, ACTA OECOL, P1; Cheal A, 2012, MAR BIOL, V159, P1143, DOI 10.1007/s00227-012-1893-x; Choat JH, 1998, ANNU REV ECOL SYST, V29, P375, DOI 10.1146/annurev.ecolsys.29.1.375; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Clements KD, 2017, BIOL J LINN SOC, V120, P729, DOI 10.1111/bij.12914; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Crochelet E, 2016, REG STUD MAR SCI, V7, P159, DOI 10.1016/j.rsma.2016.06.007; Doherty Peter J., 2002, P327, DOI 10.1016/B978-012615185-5/50019-0; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duff H, 2015, OTC2015WPEB1148 MAR; Dumbraveanu D., 1999, ECOLOGY CHAGOS ARCHI, V2, P351; Edwards CB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1835; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Friedman ST, 2016, J EVOLUTION BIOL, V29, P965, DOI 10.1111/jeb.12837; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Graham Nicholas A.J., 2013, P253; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Green A.L., 2009, MONITORING FUNCTIONA; HARMELINVIVIEN ML, 1985, REV ECOL-TERRE VIE, V40, P466; Heenan A, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1716; Hobson E.S., 1991, P69; Hoey AS, 2008, CORAL REEFS, V27, P37, DOI 10.1007/s00338-007-0287-x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2014, STATUS AND TRENDS OF; Jeffries TC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15383; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Jouffray JB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0268; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kulbicki M, 2005, CYBIUM, V29, P235; Letourneur Y, 1998, LENGTH WEIGHT RELATI, P37; Lieske E, 1996, CORAL REEF FISHES; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; McClanahan TR, 2016, PLOS ONE, V11, P1; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Nash KL, 2012, MAR ECOL PROG SER, V457, P113, DOI 10.3354/meps09742; Obura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045013; Oksanen J, 2005, THE VEGAN PACKAGE R, P1; Osuka K, 2016, J MAR BIOL ASSOC UK, P1; Pinca S, 2012, FISH FISH, V13, P361, DOI 10.1111/j.1467-2979.2011.00425.x; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Reese ES., 1993, P C GLOB ASP COR REE, P59; RUSS G, 1984, MAR ECOL PROG SER, V20, P35, DOI 10.3354/meps020035; Russ GR, 2015, MAR BIOL, V162, P2029, DOI 10.1007/s00227-015-2728-3; Samoilys MA, 2000, ENV BIOL FISHES, V57; Samoilys Melita, 2011, RAP Bulletin of Biological Assessment, V61, P29; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard CRC, 2012, AQUAT CONSERV, V22, P232, DOI 10.1002/aqc.1248; SMITH MPL, 1989, ENVIRON BIOL FISH, V26, P29, DOI 10.1007/BF00002473; Spalding M.D., 1999, Linnean Society Occasional Publication, V2, P119; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Taylor BM, 2015, ECOGRAPHY, V38, P520, DOI 10.1111/ecog.01093; Turner J, 2005, PHILOS T R SOC A, V363, P229, DOI 10.1098/rsta.2004.1489; Whitaker D, 2010, CLUSTSIG SIMILARITY; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279; Winterbottom R., 1999, Linnean Society Occasional Publication, V2, P101	75	20	20	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191448	10.1371/journal.pone.0191448	http://dx.doi.org/10.1371/journal.pone.0191448			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351566	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300091
J	Sigauque, B; Kobayashi, M; Vubil, D; Nhacolo, A; Chauque, A; Moaine, B; Massora, S; Mandomando, I; Nhampossa, T; Bassat, Q; Pimenta, F; Menendez, C; Carvalho, MD; Macete, E; Schrag, SJ				Sigauque, Betuel; Kobayashi, Miwako; Vubil, Delfino; Nhacolo, Ariel; Chauque, Alberto; Moaine, Benild; Massora, Sergio; Mandomando, Inacio; Nhampossa, Tacilta; Bassat, Quique; Pimenta, Fabiana; Menendez, Clara; Carvalho, Maria da Gloria; Macete, Eusebio; Schrag, Stephanie J.			Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015	PLOS ONE			English	Article							NEWBORN BABIES; PREVENTION; SEPSIS; EPIDEMIOLOGY; INFECTIONS; STILLBIRTH; MANHICA; HIV	Background Maternal group B streptococcal (GBS) vaccines under development hold promise to prevent GBS disease in young infants. Sub-Saharan Africa has the highest estimated disease burden, although data on incidence and circulating strains are limited. We described invasive bacterial disease (IBD) trends among infants <90 days in rural Mozambique during 2001-2015, with a focus on GBS epidemiology and strain characteristics. Methods Community-level birth and mortality data were obtained from Manhica's demographic surveillance system. IBD cases were captured through ongoing surveillance at Manhica district hospital. Stored GBS isolates from cases underwent serotyping by multiplex PCR, antimicrobial susceptibility testing, and whole genome sequencing. Results There were 437 IBD cases, including 57 GBS cases. Significant declines in overall IBD, neonatal mortality, and stillbirth rates were observed (P<0.0001), but not for GBS (P = 0.17). In 2015, GBS was the leading cause of young infant IBD (2.7 per 1,000 live births). Among 35 GBS isolates available for testing, 31 (88.6%) were highly related serotype III isolates within multilocus sequence types (STs) 17 (68.6%) or 109 (20.0%). All seven ST109 isolates (21.9%) had elevated minimum inhibitory concentration (MIC) to penicillin (>= 0.12 mu g/mL) associated with penicillin-binding protein (PBP) 2x substitution G398A. Epidemiologic and molecular data suggest this is a well-established clone. Conclusion A notable young infant GBS disease burden persisted despite improvements in overall maternal and neonatal health. We report an established strain with pbp2x point mutation, a first-step mutation associated with reduced penicillin susceptibility within a well-known virulent lineage in rural Mozambique. Our findings further underscores the need for non-antibiotic GBS prevention strategies.	[Sigauque, Betuel; Vubil, Delfino; Nhacolo, Ariel; Chauque, Alberto; Moaine, Benild; Massora, Sergio; Mandomando, Inacio; Nhampossa, Tacilta; Bassat, Quique; Menendez, Clara; Macete, Eusebio] Ctr Invest Sau Manh, Maputo, Mozambique; [Sigauque, Betuel] John Snow Inc, USAID Grantee, MCSP, Maputo, Mozambique; [Kobayashi, Miwako; Pimenta, Fabiana; Macete, Eusebio; Schrag, Stephanie J.] Natl Ctr Immunizat & Resp Dis, Cr Dis Control & Prevent, Div Bacterial Dis, Atlanta, GA USA; [Bassat, Quique; Menendez, Clara] ISGlobal, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Bassat, Quique; Menendez, Clara] Univ Barcelona, Hosp Clin, Barcelona, Spain; [Menendez, Clara] Consorcio Investd Red Epidemiol & Salud Publ, Barcelona, Spain	Centro de Investigacao em Saude de Manhica; United States Agency for International Development (USAID); Centers for Disease Control & Prevention - USA; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Sigauque, B (corresponding author), Ctr Invest Sau Manh, Maputo, Mozambique.; Sigauque, B (corresponding author), John Snow Inc, USAID Grantee, MCSP, Maputo, Mozambique.	betuel.sigauque@manhica.net	Mandomando, Inacio/ABD-8007-2020; Bassat, Quique/P-2341-2016; Menéndez, Clara/Q-3446-2016	Mandomando, Inacio/0000-0002-1078-2187; Bassat, Quique/0000-0003-0875-7596; Menéndez, Clara/0000-0002-2641-6907	Spanish Agency for International Cooperation (AECI-Ministry of Foreign Affairs, Spain); PATH [GAT.770-790-01350-LPS]; Bill & Melinda Gates Foundation through Center for Vaccine Development, University of Maryland School of Medicine [S00957]; United States Agency for International Development mission in Mozambique [AID-656-F-12-00001, RFA-656-12-000003]; Johns Snow, Inc.	Spanish Agency for International Cooperation (AECI-Ministry of Foreign Affairs, Spain); PATH; Bill & Melinda Gates Foundation through Center for Vaccine Development, University of Maryland School of Medicine; United States Agency for International Development mission in Mozambique(United States Agency for International Development (USAID)); Johns Snow, Inc.	This study was funded by CISM core funding provided by the Spanish Agency for International Cooperation (AECI-Ministry of Foreign Affairs, Spain). This study was also partly supported by funds from PATH through to the pneumonia and pneumococcus surveillance study (GAT.770-790-01350-LPS), Bill & Melinda Gates Foundation through Center for Vaccine Development, University of Maryland School of Medicine (Grant: S00957) and the United States Agency for International Development mission in Mozambique through to Fixed Obligation Grant No. AID-656-F-12-00001, under RFA-656-12-000003. Johns Snow, Inc. currently provides support in the form of salary for author B.S. None of the funders have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda C, 2005, J MED ENTOMOL, V42, P180, DOI 10.1603/0022-2585(2005)042[0180:ECOMTI]2.0.CO;2; BAKER CJ, 1978, J PEDIATR-US, V93, P124, DOI 10.1016/S0022-3476(78)80623-4; Bekker V, 2014, LANCET INFECT DIS, V14, P1083, DOI 10.1016/S1473-3099(14)70919-3; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; BOYER KM, 1986, NEW ENGL J MED, V314, P1665, DOI 10.1056/NEJM198606263142603; CLSI, 2021, PERFORMANCE STANDARD, VM100, 31st ed; Cutland CL, 2015, EMERG INFECT DIS, V21, P638, DOI 10.3201/eid2104.141562; Cutland CL, 2009, LANCET, V374, P1909, DOI 10.1016/S0140-6736(09)61339-8; Dahesh S, 2008, ANTIMICROB AGENTS CH, V52, P2915, DOI 10.1128/AAC.00461-08; Donders GGG, 2016, OBSTET GYNECOL, V127, P213, DOI 10.1097/AOG.0000000000001190; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Epalza C, 2010, PEDIATRICS, V126, pE631, DOI 10.1542/peds.2010-0183; Gardner SN, 2015, BIOINFORMATICS, V31, P2877, DOI 10.1093/bioinformatics/btv271; Heyderman RS, 2016, LANCET INFECT DIS; International Vaccine Access Center (IVAC), JHBSOPH VIEW HUB; Kimura K, 2008, ANTIMICROB AGENTS CH, V52, P2890, DOI 10.1128/AAC.00185-08; Kobayashi M., 2016, VACCINE; Kobayashi Miwako, 2016, F1000Res, V5, P2355; Lamagni TL, 2013, CLIN INFECT DIS, V57, P682, DOI 10.1093/cid/cit337; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Longtin J, 2011, ANTIMICROB AGENTS CH, V55, P2983, DOI 10.1128/AAC.01243-10; Madhi SA, 2016, LANCET INFECT DIS, V16, P923, DOI 10.1016/S1473-3099(16)00152-3; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Melin P, 2013, VACCINE, V31, pD31, DOI 10.1016/j.vaccine.2013.05.012; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Metcalf BJ, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.02.021; Metcalf BJ, 2016, CLIN MICROBIOL INFEC, V22, P60; Nagano N, 2008, ANTIMICROB AGENTS CH, V52, P4258, DOI 10.1128/AAC.00596-08; Nan C, 2015, BJOG-INT J OBSTET GY, V122, P1437, DOI 10.1111/1471-0528.13527; Roca A, 2006, TROP MED INT HEALTH, V11, P1422, DOI 10.1111/j.1365-3156.2006.01697.x; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Schrag SJ, 2013, VACCINE, V31, pD20, DOI 10.1016/j.vaccine.2012.11.056; Seale AC, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.67, 10.1038/NMICROBIOL.2016.67]; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Sinha AK, 2016, PEDIATR INFECT DIS J, V35, P401, DOI 10.1097/INF.0000000000001019; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Thigpen MC, 2007, NEW ENGL J MED, V364, P2016, DOI DOI 10.1056/NEJMoa1005384; TUPPURAINEN N, 1989, OBSTET GYNECOL, V73, P583; UNICEF, 2010, MOZ EL MAT NEON TET; Valkenburg-van den Berg AW, 2009, ACTA OBSTET GYN SCAN, V88, P958, DOI 10.1080/00016340903176800; World Health Organization Regional Office for Africa, MAK PREGN SAF MOZ	43	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191193	10.1371/journal.pone.0191193	http://dx.doi.org/10.1371/journal.pone.0191193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351318	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300055
J	van Nes, EH; Staal, A; Hantson, S; Holmgren, M; Pueyo, S; Bernardi, RE; Flores, BM; Xu, C; Scheffer, M				van Nes, Egbert H.; Staal, Arie; Hantson, Stijn; Holmgren, Milena; Pueyo, Salvador; Bernardi, Rafael E.; Flores, Bernardo M.; Xu, Chi; Scheffer, Marten			Fire forbids fifty-fifty forest	PLOS ONE			English	Article							TROPICAL FOREST; STABLE STATES; TREE COVER; PERCOLATION THRESHOLDS; EXPERIMENTAL DROUGHT; POSITIVE FEEDBACKS; GLOBAL SAVANNAS; EASTERN AMAZON; LINKING THEORY; LAND-USE	Recent studies have interpreted patterns of remotely sensed tree cover as evidence that forest with intermediate tree cover might be unstable in the tropics, as it will tip into either a closed forest or a more open savanna state. Here we show that across all continents the frequency of wildfires rises sharply as tree cover falls below similar to 40%. Using a simple empirical model, we hypothesize that the steepness of this pattern causes intermediate tree cover (30 +/- 60%) to be unstable for a broad range of assumptions on tree growth and fire-driven mortality. We show that across all continents, observed frequency distributions of tropical tree cover are consistent with this hypothesis. We argue that percolation of fire through an open landscape may explain the remarkably universal rise of fire frequency around a critical tree cover, but we show that simple percolation models cannot predict the actual threshold quantitatively. The fire-driven instability of intermediate states implies that tree cover will not change smoothly with climate or other stressors and shifts between closed forest and a state of low tree cover will likely tend to be relatively sharp and difficult to reverse.	[van Nes, Egbert H.; Staal, Arie; Bernardi, Rafael E.; Flores, Bernardo M.; Scheffer, Marten] Wageningen Univ, Environm Sci Dept, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands; [Hantson, Stijn] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, Atmospher Environm Res, Garmisch Partenkirchen, Germany; [Holmgren, Milena; Bernardi, Rafael E.; Flores, Bernardo M.] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Pueyo, Salvador] Univ Barcelona, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Catalonia, Spain; [Bernardi, Rafael E.] Univ Republ, CURE, Maldonado, Uruguay; [Flores, Bernardo M.] Univ Fed Rio Grande do Norte, Ctr Biosci, Ecol Dept, Natal, RN, Brazil; [Xu, Chi] Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China	Wageningen University & Research; Helmholtz Association; Karlsruhe Institute of Technology; Wageningen University & Research; University of Barcelona; Universidad de la Republica, Uruguay; Universidade Federal do Rio Grande do Norte; Nanjing University	van Nes, EH (corresponding author), Wageningen Univ, Environm Sci Dept, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands.	egbert.vannes@wur.nl	van Nes, Egbert H/F-2681-2011; Flores, Bernardo Monteiro/O-8570-2018; Hantson, Stijn/H-4785-2019	Flores, Bernardo Monteiro/0000-0003-4555-5598; Hantson, Stijn/0000-0003-4607-9204; van Nes, Egbert/0000-0002-6345-104X; Staal, Arie/0000-0001-5409-1436; Xu, Chi/0000-0002-1841-9032	European Union [643073]; SENSE Research School; EU FP7 project BACCHUS [603445]; EU FP7 project LUC4C [603542]	European Union(European Commission); SENSE Research School; EU FP7 project BACCHUS; EU FP7 project LUC4C	This work was carried out under the programme of the Netherlands Earth System Science Centre (NESSC) to EHN and received funding from the European Union's Horizon 2020 research and innovation Programme under the Marie Sklodowska-Curie grant agreement No 643073 to MS. A.S. was supported by SENSE Research School. S.H. acknowledges support by the EU FP7 projects BACCHUS (grant agreement no. 603445) and LUC4C (grant ag. No. 603542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abades SR, 2014, J ECOL, V102, P1386, DOI 10.1111/1365-2745.12321; Accatino F, 2010, J THEOR BIOL, V267, P235, DOI 10.1016/j.jtbi.2010.08.012; Andela N, 2017, SCIENCE, V356, P1356, DOI 10.1126/science.aal4108; [Anonymous], 2004, HDB STOCHASTIC METHO; Archibald S, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0309; Archibald S, 2012, P NATL ACAD SCI USA, V109, P847, DOI 10.1073/pnas.1118648109; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Bernardi RE, 2016, FOREST ECOL MANAG, V363, P212, DOI 10.1016/j.foreco.2015.12.032; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowman DMJS, 2015, TRENDS ECOL EVOL, V30, P255, DOI 10.1016/j.tree.2015.03.005; Brando PM, 2012, GLOBAL CHANGE BIOL, V18, P630, DOI 10.1111/j.1365-2486.2011.02533.x; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Dantas VD, 2016, ECOL LETT, V19, P12, DOI 10.1111/ele.12537; Dantas VD, 2013, ECOLOGY, V94, P2454, DOI 10.1890/12-1629.1; DeAngelis DL., 1986, POSITIVE FEEDBACK NA, DOI 10.1007/978-3-642-82625-2; DiMiceli C. M., 2017, ANN GLOBAL AUTOMATED; Furley PA, 2008, PROG PHYS GEOG, V32, P611, DOI 10.1177/0309133308101383; Giglio L, 2013, J GEOPHYS RES-BIOGEO, V118, P317, DOI 10.1002/jgrg.20042; GILBERT EN, 1961, J SOC IND APPL MATH, V9, P533, DOI 10.1137/0109045; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Grasman J, 2010, ASYMPTOTIC METHODS F, DOI [10.1073/pnas.1118648109, DOI 10.1073/PNAS.1118648109]; Hanan NP, 2015, GLOBAL ECOL BIOGEOGR, V24, P988, DOI 10.1111/geb.12321; Hanan NP, 2014, GLOBAL ECOL BIOGEOGR, V23, P259, DOI 10.1111/geb.12122; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Hoffmann WA, 2003, FUNCT ECOL, V17, P720, DOI 10.1111/j.1365-2435.2003.00796.x; Hoffmann WA, 2003, J ECOL, V91, P475, DOI 10.1046/j.1365-2745.2003.00777.x; Hoffmann WA, 2012, AUSTRAL ECOL, V37, P634, DOI 10.1111/j.1442-9993.2011.02324.x; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; Hoffmann WA, 2009, ECOLOGY, V90, P1326, DOI 10.1890/08-0741.1; Holmgren M, 2013, NAT CLIM CHANGE, V3, P755, DOI [10.1038/nclimate1906, 10.1038/NCLIMATE1906]; Lasslop G, 2016, GEOPHYS RES LETT, V43, P6324, DOI 10.1002/2016GL069365; Lehmann CER, 2014, SCIENCE, V343, P548, DOI 10.1126/science.1247355; da Costa ACL, 2010, NEW PHYTOL, V187, P579, DOI 10.1111/j.1469-8137.2010.03309.x; MACKAY G, 1984, J PHYS A-MATH GEN, V17, pL757, DOI 10.1088/0305-4470/17/14/006; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; MARKHAM CG, 1970, ANN ASSOC AM GEOGR, V60, P593, DOI 10.1111/j.1467-8306.1970.tb00743.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Murphy BP, 2012, ECOL LETT, V15, P748, DOI 10.1111/j.1461-0248.2012.01771.x; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Pausas JG, 2013, GLOBAL ECOL BIOGEOGR, V22, P728, DOI 10.1111/geb.12043; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Roy DP, 2008, REMOTE SENS ENVIRON, V112, P3690, DOI 10.1016/j.rse.2008.05.013; Scanlon TM, 2007, NATURE, V449, P209, DOI 10.1038/nature06060; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheiter S, 2007, AM NAT, V170, P587, DOI 10.1086/521317; Schertzer E, 2015, J MATH BIOL, V70, P329, DOI 10.1007/s00285-014-0757-z; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Spracklen DV, 2012, NATURE, V489, P282, DOI 10.1038/nature11390; Staal A, 2015, ECOL COMPLEX, V22, P65, DOI 10.1016/j.ecocom.2015.01.003; Staver AC, 2012, AM NAT, V180, P211, DOI 10.1086/666648; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Suding PN, 1999, PHYS REV E, V60, P275, DOI 10.1103/PhysRevE.60.275; van der Werf GR, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003122; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2; van Nes EH, 2016, TRENDS ECOL EVOL, V31, P902, DOI 10.1016/j.tree.2016.09.011; van Nes EH, 2014, GLOBAL CHANGE BIOL, V20, P1016, DOI 10.1111/gcb.12398; WARING RH, 1981, FORESTRY, V54, P126, DOI 10.1093/forestry/54.2.129; Wuyts B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15519; Xu C, 2016, ECOLOGY, V97, P2518, DOI 10.1002/ecy.1470; Zemp DC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14681	68	31	33	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191027	10.1371/journal.pone.0191027	http://dx.doi.org/10.1371/journal.pone.0191027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351323	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300039
J	Jones, G; Brennan, V; Jacques, R; Wood, H; Dixon, S; Radley, S				Jones, Georgina; Brennan, Victoria; Jacques, Richard; Wood, Hilary; Dixon, Simon; Radley, Stephen			Evaluating the impact of a 'virtual clinic' on patient experience, personal and provider costs of care in urinary incontinence: A randomised controlled trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; ASSESSMENT QUESTIONNAIRE; HEALTH-CARE; FOLLOW-UP; EPAQ-PF; UROGYNAECOLOGY; TECHNOLOGY; VALIDITY; UTILITY; TESTS	Objective To evaluate the impact of using a 'virtual clinic' on patient experience and cost in the care of women with urinary incontinence. Materials and methods Women, aged > 18 years referred to a urogynaecology unit were randomised to either (1) A Standard Clinic or (2) A Virtual Clinic. Both groups completed a validated, web-based interactive, patient-reported outome measure (ePAQ-Pelvic Floor), in advance of their appointment followed by either a telephone consultation (Virtual Clinic) or face-to-face consultation (Standard Care). The primary outcome was the mean 'short-term outcome scale' score on the Patient Experience Questionnaire (PEQ). Secondary Outcome Measures included the other domains of the PEQ (Communications, Emotions and Barriers), Client Satisfaction Questionnaire (CSQ), Short-Form 12 (SF-12), personal, societal and NHS costs. Results 195 women were randomised: 98 received the intervention and 97 received standard care. The primary outcome showed a non-significant difference between the two study arms. No significant differences were also observed on the CSQ and SF-12. However, the intervention group showed significantly higher PEQ domain scores for Communications, Emotions and Barriers (including following adjustment for age and parity). Whilst standard care was overall more cost-effective, this was minimal (38.04) pound. The virtual clinic also significantly reduced consultation time (10.94 minutes, compared with a mean duration of 25.9 minutes respectively) and consultation costs compared to usual care (31.75 pound versus 72.17 pound respectively), thus presenting potential cost-savings in out-patient management. Conclusions The virtual clinical had no impact on the short-term dimension of the PEQ and overall was not as cost-effective as standard care, due to greater clinic re-attendances in this group. In the virtual clinic group, consultation times were briefer, communication experience was enhanced and personal costs lower. For medical conditions of a sensitive or intimate nature, a virtual clinic has potential to support patients to communicate with health professionals about their condition.	[Jones, Georgina] Leeds Beckett Univ, Sch Social Sci, Dept Psychol, Leeds, W Yorkshire, England; [Brennan, Victoria; Wood, Hilary; Dixon, Simon] Univ Sheffield, Sch Hlth & Related Res, Hlth Econ & Decis Sci, Sheffield, S Yorkshire, England; [Jacques, Richard] Univ Sheffield, Sch Hlth & Related Res, Design Trials & Stat, Sheffield, S Yorkshire, England; [Radley, Stephen] Sheffield Teaching Hosp NHS Trust, Jessop Wing, Urogynaecol Unit, Sheffield, S Yorkshire, England	Leeds Beckett University; University of Sheffield; University of Sheffield; University of Sheffield	Jones, G (corresponding author), Leeds Beckett Univ, Sch Social Sci, Dept Psychol, Leeds, W Yorkshire, England.	g.l.jones@leedsbeckett.ac.uk	Jacques, Richard/A-2410-2010	Jacques, Richard/0000-0001-6710-5403; radley, stephen/0000-0002-3980-7712; Dixon, Simon/0000-0001-7394-7009; Jones, Georgina/0000-0002-5267-1776	Sheffield Hospitals Charity [7863]	Sheffield Hospitals Charity	This study was supported by a grant from the Sheffield Hospitals Charity (No 7863, Principal Investigator Mr Stephen Radley). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altman DG, 2012, STAT MED, V31, P2985, DOI 10.1002/sim.5402; Balas EA, 1997, JAMA-J AM MED ASSOC, V278, P152, DOI 10.1001/jama.278.2.152; Beaver K, 2009, BRIT J SURG, V96, P1406, DOI 10.1002/bjs.6753; Bhattacharyya R, 2017, INJURY, V48, P720, DOI 10.1016/j.injury.2017.01.041; Brazier J, 2016, MEASURING VALUING HL; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Brennan VK, 2013, PHARMACOECONOMICS, V31, P677, DOI 10.1007/s40273-013-0066-1; Buxton J, 1998, QUAL LIFE RES, V7, P513, DOI 10.1023/A:1008826408328; Campbell MJ, 2007, MED STAT TXB HLTH SC, P4; Connor A, 2011, CLIN MED, V11, P242, DOI 10.7861/clinmedicine.11-3-242; Currell R., 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002098; Curtis L, 2011, PERSONAL SOCIAL SERV; Department of Health, NAT SCHED REF COSTS; Dorsey ER, 2013, JAMA NEUROL, V70, P565, DOI 10.1001/jamaneurol.2013.123; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Dua A, 2013, INT UROGYNECOL J, V24, P1969, DOI 10.1007/s00192-013-2132-9; Fitzpatrick R, 1998, HLTH SERVICES RES ME, P13; Hunter J, 2012, POSTGRAD MED J, V88, P487, DOI 10.1136/postgradmedj-2012-100123rep; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; Jones GL, 2008, INT UROGYNECOL J, V19, P1337, DOI 10.1007/s00192-008-0655-2; Jones GL, 2009, INT UROGYNECOL J, V20, P557, DOI 10.1007/s00192-008-0790-9; Kleinman L, 2001, MED CARE, V39, P181, DOI 10.1097/00005650-200102000-00008; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; Levy Sharon, 2014, Inform Prim Care, V21, P113, DOI 10.14236/jhi.v21i3.58; Lofland JH, 2000, PHARMACOTHERAPY, V20, P1390, DOI 10.1592/phco.20.17.1390.34887; Mark DA, 2011, INT J CLIN PRACT, V65, P1100, DOI 10.1111/j.1742-1241.2011.02750.x; Moores KL, 2012, INT J QUAL HEALTH C, V24, P517, DOI 10.1093/intqhc/mzs051; National Institute for Health and Clinical Excellence, 2008, GUID METH TECHN APPR; Pinnock H, 2007, BRIT J GEN PRACT, V57, P714; Radley SC, 2006, BJOG-INT J OBSTET GY, V113, P231, DOI 10.1111/j.1471-0528.2005.00820.x; Radley SC, 2004, BJOG-INT J OBSTET GY, V111, P33, DOI 10.1111/j.1471-0528.2004.00463.x; Ramsey SD, 2001, ANNU REV PUBL HEALTH, V22, P129, DOI 10.1146/annurev.publhealth.22.1.129; Rose SMSF, 2015, J WOMENS HEALTH, V24, P940, DOI 10.1089/jwh.2015.5230; Schussler-Fiorenza SM, 2015, J WOMENS HLTH, V24; Steine S, 2001, FAM PRACT, V18, P410, DOI 10.1093/fampra/18.4.410; Tabak M, 2014, INT J CHRONIC OBSTR, V9, P935, DOI 10.2147/COPD.S60179; Velikova G, 1999, J CLIN ONCOL, V17, P998, DOI 10.1200/JCO.1999.17.3.998; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	38	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0189174	10.1371/journal.pone.0189174	http://dx.doi.org/10.1371/journal.pone.0189174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9PC	29346378	gold, Green Published, Green Accepted			2022-12-27	WOS:000422749500004
J	Benetti, E; Mastrocola, R; Chiazza, F; Nigro, D; D'Antona, G; Bordano, V; Fantozzi, R; Aragno, M; Collino, M; Minetto, MA				Benetti, Elisa; Mastrocola, Raffaella; Chiazza, Fausto; Nigro, Debora; D'Antona, Giuseppe; Bordano, Valentina; Fantozzi, Roberto; Aragno, Manuela; Collino, Massimo; Minetto, Marco Alessandro			Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; SERUM 25-HYDROXYVITAMIN D; SKELETAL-MUSCLE; D SUPPLEMENTATION; TNF-ALPHA; GLUCOSE-HOMEOSTASIS; HEPATIC STEATOSIS; HYPOVITAMINOSIS-D; ACTIVATION	Epidemiological studies pointed out to a strong association between vitamin D deficiency and type 2 diabetes prevalence. However, the role of vitamin D supplementation in the skeletal muscle, a tissue that play a crucial role in the maintenance of glucose homeostasis, has been scarcely investigated so far. On this basis, this study aimed to evaluate the effect of vitamin D supplementation in a murine model of diet-induced insulin resistance with particular attention to the effects evoked on the skeletal muscle. Male C57BU6J mice (n = 40) were fed with a control or a High Fat-High Sugar (HFHS) diet for 4 months. Subsets of animals were treated for 2 months with vitamin D (7 mu g.kg-1, i.p. three times/week). HFHS diet induced body weight increase, hyperglycemia and impaired glucose tolerance. HFHS animals showed an impaired insulin signaling and a marked fat accumulation in the skeletal muscle. Vitamin D reduced body weight and improved systemic glucose tolerance. In addition, vitamin D restored the impaired muscle insulin signaling and reverted myosteatosis evoked by the diet. These effects were associated to decreased activation of NF-kappa B and lower levels of TNF-alpha. Consistently, a significantly decreased activation of the SCAP/SREBP lipogenic pathway and lower levels of CML protein adducts and RAGE expression were observed in skeletal muscle of animals treated with vitamin D. Collectively, these data indicate that vitamin D-induced selective inhibition of signaling pathways (including NF-kappa B, SCAP/SREBP and CMURAGE cascades) within the skeletal muscle significantly contributed to the beneficial effects of vitamin D supplementation against diet-induced metabolic derangements.	[Benetti, Elisa; Chiazza, Fausto; Bordano, Valentina; Fantozzi, Roberto; Collino, Massimo] Univ Turin, Dipartimento Sci & Tecnol Farmaco, Turin, Italy; [Mastrocola, Raffaella; Nigro, Debora; Aragno, Manuela] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [D'Antona, Giuseppe] Univ Pavia, Dept Publ Hlth Mol & Forens Med, Pavia, Italy; [D'Antona, Giuseppe] Univ Pavia, Sport Med Ctr Voghera, Pavia, Italy; [Minetto, Marco Alessandro] Univ Turin, Dept Med Sci, Div Endocrinol Diabetol & Metab, Turin, Italy; [Minetto, Marco Alessandro] Univ Turin, Dept Surg Sci, Div Phys Med & Rehabil, Turin, Italy	University of Turin; University of Turin; University of Pavia; University of Pavia; University of Turin; University of Turin	Benetti, E (corresponding author), Univ Turin, Dipartimento Sci & Tecnol Farmaco, Turin, Italy.	elisa.benetti@unito.it	Chiazza, Fausto/I-5559-2015; Collino, Massimo/AAK-8532-2020	Collino, Massimo/0000-0001-8782-3496; ARAGNO, Manuela/0000-0002-0453-5235; Chiazza, Fausto/0000-0001-7273-0051	University of Turin	University of Turin	This work was supported and funded by the University of Turin (Ricerca Locale 2015) to Elisa Benetti.	Alemzadeh R, 2008, METABOLISM, V57, P183, DOI 10.1016/j.metabol.2007.08.023; Alkharfy KM, 2013, METAB SYNDR RELAT D, V11, P283, DOI 10.1089/met.2012.0068; Alkharfy KM, 2013, BASIC CLIN PHARMACOL, V112, P42, DOI 10.1111/j.1742-7843.2012.00936.x; Benetti E, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/509502; Benetti E, 2016, J PHARMACOL EXP THER, V359, P45, DOI 10.1124/jpet.116.235069; Chen SC, 2016, J BONE MINER RES, V31, P585, DOI 10.1002/jbmr.2729; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Collino M, 2014, BRIT J PHARMACOL, V171, P5802, DOI 10.1111/bph.12888; Collino M, 2013, BIOCHEM PHARMACOL, V85, P257, DOI 10.1016/j.bcp.2012.10.014; Crescenzo R, 2013, EUR J NUTR, V52, P537, DOI 10.1007/s00394-012-0356-y; De Stefanis D, 2017, EUR J NUTR, V56, P363, DOI 10.1007/s00394-015-1086-8; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Earthman CP, 2012, INT J OBESITY, V36, P387, DOI 10.1038/ijo.2011.119; Endo M, 2007, EXP BIOL MED, V232, P614; Gagnon C, 2011, DIABETES CARE, V34, P1133, DOI 10.2337/dc10-2167; Girgis CM, 2014, ENDOCRINOLOGY, V155, P3227, DOI 10.1210/en.2014-1016; Girgis CM, 2013, ENDOCR REV, V34, P33, DOI 10.1210/er.2012-1012; Grubler MR, 2016, DIABETES OBES METAB, V18, P1006, DOI 10.1111/dom.12709; Hamrick MW, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00069; Harant H, 1998, FEBS LETT, V436, P329, DOI 10.1016/S0014-5793(98)01153-3; Haroon NN, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0130-9; Hassan-Smith ZK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170665; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jorde R, 2010, EUR J NUTR, V49, P401, DOI 10.1007/s00394-010-0098-7; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kaur P, 2015, CLIN ENDOCRINOL, V83, P327, DOI 10.1111/cen.12836; Leung PS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030147; Li JF, 1997, J BIOL CHEM, V272, P16498, DOI 10.1074/jbc.272.26.16498; Liu LN, 2016, EXP THER MED, V11, P2284, DOI 10.3892/etm.2016.3242; Manna P, 2012, J BIOL CHEM, V287, P42324, DOI 10.1074/jbc.M112.407833; Mastrocola R, 2016, FREE RADICAL BIO MED, V91, P224, DOI 10.1016/j.freeradbiomed.2015.12.022; Mastrocola R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119587; Mastrocola R, 2013, AM J PHYSIOL-GASTR L, V305, pG398, DOI 10.1152/ajpgi.00450.2012; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meerza D, 2012, J DIABETES COMPLICAT, V26, P363, DOI 10.1016/j.jdiacomp.2012.05.013; Miljkovic I, 2010, CURR OPIN CLIN NUTR, V13, P260, DOI 10.1097/MCO.0b013e328337d826; Mishima Y, 2001, DIABETES RES CLIN PR, V52, P119, DOI 10.1016/S0168-8227(00)00247-3; Mostafa DK, 2016, EUR J PHARMACOL, V792, P38, DOI 10.1016/j.ejphar.2016.10.031; Muscogiuri G, 2017, ARCH TOXICOL, V91, P97, DOI 10.1007/s00204-016-1804-x; Muscogiuri G, 2014, EUR J ENDOCRINOL, V171, pR101, DOI 10.1530/EJE-14-0158; Nameni G, 2017, J MOL NEUROSCI, V61, P247, DOI 10.1007/s12031-016-0864-y; Osati S, 2016, DIABETES METAB SYND, V10, pS7, DOI 10.1016/j.dsx.2016.01.007; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Sisley SR, 2016, DIABETES, V65, P2732, DOI 10.2337/db16-0309; Song BJ, 2013, LIVER INT, V33, P653, DOI 10.1111/liv.12147; Song YQ, 2013, DIABETES CARE, V36, P1422, DOI 10.2337/dc12-0962; Stio M, 2007, J STEROID BIOCHEM, V103, P51, DOI 10.1016/j.jsbmb.2006.07.008; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Trinko JR, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0122-15.2016; Tukaj S, 2012, ACTA BIOCHIM POL, V59, P395; Tzotzas T, 2010, J CLIN ENDOCR METAB, V95, P4251, DOI 10.1210/jc.2010-0757; Yin Y, 2012, EUR J CLIN INVEST, V42, P1189, DOI 10.1111/j.1365-2362.2012.02706.x; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Zhou QG, 2008, DIABETES-METAB RES, V24, P459, DOI 10.1002/dmrr.873	61	46	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189707	10.1371/journal.pone.0189707	http://dx.doi.org/10.1371/journal.pone.0189707			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342166	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800010
J	Depue, SM; Neilson, MM; Lusk, JL; Mafi, G; Norwood, FB; Ramanathan, R; VanOverbeke, D				Depue, Sandra Molly; Neilson, Morgan Marie; Lusk, Jayson L.; Mafi, Gretchen; Norwood, F. Bailey; Ramanathan, Ranjith; VanOverbeke, Deborah			Preference evaluation of ground beef by untrained subjects with three levels of finely textured beef	PLOS ONE			English	Article							CONSUMER SENSORY ACCEPTANCE; CHOICE EXPERIMENTS; QUALITY; PALATABILITY; TENDERNESS; ATTRIBUTES; RATINGS; STEAKS; SHEAR; PANEL	After receiving bad publicity in 2012 and being removed from many ground beef products, finely textured beef (referred to as 'pink slime' by some) is making a comeback. Some of its proponents argue that consumers prefer ground beef containing finely textured beef, but no objective scientific party has tested this claim that is the purpose of the present study. Over 200 untrained subjects participated in a sensory analysis in which they tasted one ground beef sample with no finely textured beef, another with 15% finely textured beef (by weight), and another with more than 15%. Beef with 15% finely textured beef has an improved juiciness (p < 0.01) and tenderness (p < 0.01) quality. However, subjects rate the flavor-liking and overall likeability the same regardless of the finely textured beef content. Moreover, when the three beef types are consumed as part of a slider (small hamburger), subjects are indifferent to the level of finely textured beef.	[Depue, Sandra Molly; Lusk, Jayson L.; Norwood, F. Bailey] Oklahoma State Univ, Dept Agr Econ, Stillwater, OK 74078 USA; [Neilson, Morgan Marie; Mafi, Gretchen; Ramanathan, Ranjith; VanOverbeke, Deborah] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Norwood, FB (corresponding author), Oklahoma State Univ, Dept Agr Econ, Stillwater, OK 74078 USA.	bailey.norwood@okstate.edu	Ramanathan, Ranjith/AAW-3071-2021	VanOverbeke, Deborah/0000-0001-8791-382X	USDA National Institute of Food and Agriculture, Hatch grant [OKLO 2851]; Oklahoma Agricultural Experiment Station	USDA National Institute of Food and Agriculture, Hatch grant; Oklahoma Agricultural Experiment Station	Funding was provided by the USDA National Institute of Food and Agriculture, Hatch grant number OKLO 2851, and by the Oklahoma Agricultural Experiment Station. Support does not constitute an endorsement of the views expressed in the paper by the USDA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2014, BUS SOC REV, V119, P221, DOI 10.1111/basr.12031; Anderson EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160424; Barrena R, 2009, FOOD QUAL PREFER, V20, P144, DOI 10.1016/j.foodqual.2008.08.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonny SP, 2017, ANIMAL, V11, P8; Brewer S, 2007, J SENSORY FOOD QUALI, V73, P2008; Calhoun CM, 1999, J FOOD SCI, V64, P76, DOI 10.1111/j.1365-2621.1999.tb09864.x; Cargill, 2016, WHAT IS FIN TEXT BEE; Dominguez-Torreiro M, 2014, FOOD QUAL PREFER, V35, P15, DOI 10.1016/j.foodqual.2014.01.006; Greene JL., 2012, LEAN FINELY TEXTURED, P7; Hamling AE, 2008, J ANIM SCI, V86, P967, DOI 10.2527/jas.2007-0346; Hamling AE, 2007, MP9091 U NEBR; HAMM REINER, 1960, ADVANCES IN FOOD RES, V10, P355; Johansson L, 1999, FOOD QUAL PREFER, V10, P289, DOI 10.1016/S0950-3293(99)00022-1; Kerth CR, 2015, MEAT SCI, V104, P30, DOI 10.1016/j.meatsci.2015.01.014; Killinger KM, 2004, J ANIM SCI, V82, P3302; KRINSKY I, 1986, REV ECON STAT, V68, P715, DOI 10.2307/1924536; Lagerkvist CJ, 2014, FOOD QUAL PREFER, V34, P50, DOI 10.1016/j.foodqual.2013.12.009; Lazarus D, 2014, LOS ANGELES TIMES; Legako JF, 2016, MEAT SCI, V112, P77, DOI 10.1016/j.meatsci.2015.10.018; Lusk JL, 2004, AM J AGR ECON, V86, P467, DOI 10.1111/j.0092-5853.2004.00592.x; Marsh JM, 2003, TECHNOLOGICAL CHANGE; Moon CT, 2012, INCORPORATION LEAN F; Morales R, 2013, FOOD QUAL PREFER, V29, P166, DOI 10.1016/j.foodqual.2013.02.006; Napolitano F, 2010, FOOD QUAL PREFER, V21, P207, DOI 10.1016/j.foodqual.2009.08.007; Parsons AN, 2011, J FOOD SCI, V76, pS84, DOI 10.1111/j.1750-3841.2010.01903.x; Platter WJ, 2003, J ANIM SCI, V81, P2741; Pruitt JR, 2012, ASSESSING IMPACT LFT; Sitz BM, 2005, J ANIM SCI, V83, P2863; Thomas H.A., 2012, SENSORY EVALUATION P; Van Laack R. L. J. M., 1997, J MUSCLE FOODS, V8, P287; Voges KL, 2007, MEAT SCI, V77, P357, DOI 10.1016/j.meatsci.2007.03.024; Watson R, 2008, AUST J EXP AGR, V48, P1360, DOI 10.1071/EA07176; Wheeler TL, 1999, J ANIM SCI, V77, P3219; Yadavalli A, 2014, FOOD POLICY, V49, P219, DOI 10.1016/j.foodpol.2014.08.002; Yan KS, 2015, J EXP PSYCHOL HUMAN, V41, P590, DOI 10.1037/xhp0000044; Zimoch J, 1997, FOOD QUAL PREFER, V8, P203, DOI 10.1016/S0950-3293(96)00049-3	37	2	2	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190680	10.1371/journal.pone.0190680	http://dx.doi.org/10.1371/journal.pone.0190680			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8II	29342174	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800031
J	Neska-Matuszewska, M; Bladowska, J; Sasiadek, M; Zimny, A				Neska-Matuszewska, Malgorzata; Bladowska, Joanna; Sasiadek, Marek; Zimny, Anna			Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; BRAIN-TUMORS; SOLITARY METASTASES; LESIONS; COEFFICIENT; PERCENTAGE; VALUES; EDEMA	Introduction In conventional MR examinations glioblastomas multiforme (GBMs), metastases and primary CNS lymphomas (PCNSLs) may show very similar appearance. The aim of the study was to evaluate usefulness of multiparametric T2*DSC perfusion and diffusion MR imaging in the preoperative differentiation of these tumors. Material and methods Seventy four solitary enhancing tumors (27 GBMs, 30 metastases, 17 PCNSLs) were enrolled in the study. Parameters of cerebral blood volume (rCBV), peak height (rPH), percentage of signal recovery (rPSR) and apparent diffusion coefficient (ADC) were assessed from the tumor core and the peritumoral non-enhancing T2-hyperintense zone. Results Within the tumor core there were no differences in perfusion and diffusion parameters between GBMs and metastases. Compared to GBMs and metastases, PCNSLs showed significantly lower rCBV and rPH, ADC as well as higher rPSR values. Max rCBV with a cutoff value of 2.18 demonstrated the highest accuracy of 0.98 in differentiating PCNSLs from other tumors. To distinguish GBMs from metastases analysis of the peritumoral zone was performed showing significantly higher rCBV, rPH and lower ADC values in GBMs with the highest accuracy of 0.94 found for max rCBV at a cut-off value of 0.98. Conclusions Max rCBV seems to be the most important parameter to differentiate GBMs, metastases and PCNSLs. Analysis of max rCBV within the tumor core enables to distinguish hypoperfused PCNSLs from hyperperfused GBMs and metastases while evaluation of max rCBV within the peritumoral zone is helpful to distinguish GBMs showing peritumoral infiltration from metastases surrounded by pure edema.	[Neska-Matuszewska, Malgorzata; Bladowska, Joanna; Sasiadek, Marek; Zimny, Anna] Wroclaw Med Univ, Dept Gen & Intervent Radiol & Neuroradiol, Wroclaw, Poland	Wroclaw Medical University	Neska-Matuszewska, M (corresponding author), Wroclaw Med Univ, Dept Gen & Intervent Radiol & Neuroradiol, Wroclaw, Poland.	neskamatuszewska@gmail.com		Sasiadek, Marek/0000-0003-3627-118X	Wroclaw Medical University grant [ST-868]	Wroclaw Medical University grant	Source of financial support: Wroclaw Medical University grant No ST-868, responsible author: Anna Zimny. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Blasel S, 2010, ACTA NEUROCHIR, V152, P1893, DOI 10.1007/s00701-010-0774-7; Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032; Cha S, 2007, AM J NEURORADIOL, V28, P1078, DOI 10.3174/ajnr.A0484; Cha S, 2006, AM J NEURORADIOL, V27, P475; Chiang IC, 2004, NEURORADIOLOGY, V46, P619, DOI 10.1007/s00234-004-1246-7; Cho SK, 2002, KOREAN J RADIOL, V3, P171, DOI 10.3348/kjr.2002.3.3.171; Essig M, 2013, AM J ROENTGENOL, V201, pW495, DOI 10.2214/AJR.12.9544; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Hartmann M, 2003, NEUROSCI LETT, V338, P119, DOI 10.1016/S0304-3940(02)01367-8; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Krabbe K, 1997, NEURORADIOLOGY, V39, P483, DOI 10.1007/s002340050450; Kremer S, 2002, J NEURORADIOLOGY, V29, P105; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; Lee EJ, 2011, AM J ROENTGENOL, V196, P71, DOI 10.2214/AJR.10.4752; Lemercier P, 2014, AM J ROENTGENOL, V203, P163, DOI 10.2214/AJR.13.11186; Liao WH, 2009, ACTA RADIOL, V50, P217, DOI 10.1080/02841850802616752; Lupo JM, 2005, AM J NEURORADIOL, V26, P1446; Mangla R, 2011, AM J NEURORADIOL, V32, P1004, DOI 10.3174/ajnr.A2441; Neska-Matuszewska M, 2015, POL J RADIOL, V80, P31, DOI 10.12659/PJR.892106; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Pasricha S, 2011, INDIAN J CANCER, V48, P199, DOI 10.4103/0019-509X.82890; Pavlisa G, 2009, CLIN IMAG, V33, P96, DOI 10.1016/j.clinimag.2008.06.035; Rizzo L, 2009, RADIOL MED, V114, P645, DOI 10.1007/s11547-009-0401-y; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Sperduto PW, 2010, INT J RADIAT ONCOL, V77, P655, DOI 10.1016/j.ijrobp.2009.08.025; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Svolos P, 2013, MAGN RESON IMAGING, V31, P1567, DOI 10.1016/j.mri.2013.06.010; Toh CH, 2013, AM J NEURORADIOL, V34, P1145, DOI 10.3174/ajnr.A3383; Tsougos I, 2012, CANCER IMAGING, V12, P423, DOI 10.1102/1470-7330.2012.0038; Wetzel SG, 2002, RADIOLOGY, V224, P797, DOI 10.1148/radiol.2243011014; Zhao JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123694	33	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191341	10.1371/journal.pone.0191341	http://dx.doi.org/10.1371/journal.pone.0191341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342201	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800064
J	Xu, SX; Leontyev, D; Kaul, R; Gray-Owen, SD				Xu, Stacey X.; Leontyev, Danila; Kaul, Rupert; Gray-Owen, Scott D.			&ITNeisseria gonorrhoeae&IT co-infection exacerbates vaginal HIV shedding without affecting systemic viral loads in human CD34(+) engrafted mice	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; GENITAL-TRACT; ANTIRETROVIRAL THERAPY; TRANSMISSION; INFECTION; URETHRITIS; CELLS; SEX; MEN; EXPRESSION	HIV synergy with sexually transmitted co-infections is well-documented in the clinic. Co-infection with Neisseria gonorrhoeae in particular, increases genital HIV shedding and mucosal transmission. However, no animal model of co-infection currently exists to directly explore this relationship or to bridge the gap in understanding between clinical and in vitro studies of this interaction. This study aims to test the feasibility of using a humanized mouse model to overcome this barrier. Combining recent in vivo modelling advancements in both HIV and gonococcal research, we developed a co infection model by engrafting immunodeficient NSG mice with human CD34(+) hematopoietic stem cells to generate humanized mice that permit both systemic HIV infection and genital N. gonorrhoeae infection. Systemic plasma and vaginal lavage titres of HIV were measured in order to assess the impact of gonococcal challenge on viral plasma titres and genital shedding. Engrafted mice showed human CD45(+) leukocyte repopulation in blood and mucosal tissues. Systemic HIV challenge resulted in 10(4)-10(5) copies/mL of viral RNA in blood by week 4 post-infection, as well as vaginal shedding of virus. Subsequent gonococcal challenge resulted in unchanged as vaginal shedding of virus. Subsequent gonococcal challenge resulted in unchanged plasma HIV levels but higher viral shedding in the genital tract, which reflects published clinical observations. Thus, human CD34(+) stem cell-transplanted NSG mice represent an experimentally tractable animal model in which to study HIV shedding during gonococcal co-infection, allowing dissection of molecular and immunological interactions between these pathogens, and providing a platform to assess future therapeutics aimed at reducing HIV transmission.	[Xu, Stacey X.; Gray-Owen, Scott D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Leontyev, Danila; Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kaul, Rupert] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gray-Owen, SD (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	scott.gray.owen@utoronto.ca	Gray-Owen, Scott/AFL-7380-2022; Gray-Owen, Scott/AAG-7337-2022	Gray-Owen, Scott D./0000-0002-1477-3616	Department of Medicine Challenge Fund; Canadian Institutes of Health Research (CIHR) [HOP-137697]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125421] Funding Source: NIH RePORTER	Department of Medicine Challenge Fund; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this project was provided by the Department of Medicine Challenge Fund and the Canadian Institutes of Health Research (CIHR) operating grants HOP-137697, http://www.cihr-irsc.gc.ca/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berges BK, 2008, VIROLOGY, V373, P342, DOI 10.1016/j.virol.2007.11.020; Champredon D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0961-5; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Cone RA, 2014, J INFECT DIS, V210, pS616, DOI 10.1093/infdis/jiu459; Denton PW, 2011, AIDS REV, V13, P135; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Ding J, 2010, J IMMUNOL, V184, P2814, DOI 10.4049/jimmunol.0902125; Dobson-Belaire WN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018133; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gaudet RG, 2015, SCIENCE; Islam EA, 2016, MUCOSAL IMMUNOL, V9, P1051, DOI 10.1038/mi.2015.122; Jaspan HB, 2011, J INFECT DIS, V204, P1550, DOI 10.1093/infdis/jir591; Jerse AE, 1999, INFECT IMMUN, V67, P5699, DOI 10.1128/IAI.67.11.5699-5708.1999; Jerse AE, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00107; Kaul R, 2002, J INFECT DIS, V185, P1525, DOI 10.1086/340214; Liu XY, 2006, J INFECT DIS, V194, P751, DOI 10.1086/506360; Malott RJ, 2013, P NATL ACAD SCI USA, V110, P10234, DOI 10.1073/pnas.1303738110; Mayer KH, 2011, AM J REPROD IMMUNOL, V65, P308, DOI 10.1111/j.1600-0897.2010.00942.x; McClelland RS, 2001, AIDS, V15, P105, DOI 10.1097/00002030-200101050-00015; Meditz AL, 2012, JAIDS-J ACQ IMM DEF, V59, P221, DOI 10.1097/QAI.0b013e31823fd215; MOSS GB, 1995, J INFECT DIS, V172, P1469, DOI 10.1093/infdis/172.6.1469; Politch JA, 2012, AIDS, V26, P1535, DOI 10.1097/QAD.0b013e328353b11b; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Sadiq ST, 2005, SEX TRANSM INFECT, V81, P120, DOI 10.1136/sti.2004.010249; Sheung A, 2008, AIDS, V22, P1729, DOI 10.1097/QAD.0b013e32830baf5e; Singh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038491; Song W, 2008, VACCINE; Veazey RS, 2003, J INFECT DIS, V187, P769, DOI 10.1086/368386; Wira CR, 2014, AM J REPROD IMMUNOL, V72, P171, DOI 10.1111/aji.12235; Yu QG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056705; Zhang JZ, 2005, J IMMUNOL, V174, P7995, DOI 10.4049/jimmunol.174.12.7995	32	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191672	10.1371/journal.pone.0191672	http://dx.doi.org/10.1371/journal.pone.0191672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360873	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800049
J	Aoun, M; Karam, R; Sleilaty, G; Antoun, L; Ammar, W				Aoun, Mabel; Karam, Rita; Sleilaty, Ghassan; Antoun, Leony; Ammar, Walid			Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern?	PLOS ONE			English	Article							ANEMIA; MANAGEMENT; DIAGNOSIS; DIALYSIS; CKD; RECOMMENDATIONS; PREVALENCE; BURDEN	In non-dialysis chronic kidney disease patients, looking for iron deficiency is highly variable in practice and there is a great variability regarding the cutoffs used to treat iron deficiency. The aim of this study is to investigate the degree of iron deficiency in non-dialysis chronic kidney disease patients on erythropoiesis-stimulating agents. We included all non-dialysis chronic kidney disease patients that applied to the Lebanese Ministry of Public Health for erythropoiesis-stimulating agents' coverage during a 5-month period. Iron requirement was assessed based on two guidelines' target-to-treat cutoffs: 1-ferritin < 100 ng/ml and/or TSAT < 20% (KDOQI 2006), 2-ferritin <= 500 ng/ml and TSAT <= 30% (KDIGO 2012). A total of 238 CKD patients were included over 5 months. All patients had a ferritin level in their record and 64% had an available TSAT. Median age was 71.0 (59.8 +/- 79.3) years and 61.8% were female. All had an eGFR< 60 ml/min. The proportion of patients found to require iron therapy ranged between 48 and 78% with a trend towards higher values when using KDIGO-based criteria. Using ANCOVA test, inverse normal transformations of ferritin and TSAT showed a reverse pattern between men and women with women being more iron deficient in the early stage. Iron deficiency is highly prevalent in non-dialysis chronic kidney disease patients on erythropoiesis-stimulating agents' therapy. These findings reflect a lack in effective iron supplementation when managing anemia in pre-dialysis patients, especially in men at advanced stages. Renal societies should spread awareness about iron deficiency screening in those patients.	[Aoun, Mabel] St Joseph Univ, Dept Nephrol, Beirut, Lebanon; [Aoun, Mabel; Karam, Rita; Ammar, Walid] Minist Publ Hlth, Beirut, Lebanon; [Karam, Rita; Ammar, Walid] Lebanese Univ, Fac Sci & Med Sci, Beirut, Lebanon; [Sleilaty, Ghassan] St Joseph Univ, Dept Epidemiol & Biostat, Sch Med, Beirut, Lebanon; [Antoun, Leony] Holy Spirit Univ, Dept Internal Med, Kaslik, Lebanon	Lebanese University	Aoun, M (corresponding author), St Joseph Univ, Dept Nephrol, Beirut, Lebanon.; Aoun, M (corresponding author), Minist Publ Hlth, Beirut, Lebanon.	aounmabel@yahoo.fr	Aoun, Mabel/ADU-1246-2022; Barretti, Pasqual/K-4156-2012	Barretti, Pasqual/0000-0003-4979-4836; Sleilaty, Ghassan/0000-0001-8490-6958				Babitt JL, 2012, J AM SOC NEPHROL, V23, P1631, DOI 10.1681/ASN.2011111078; Bahrainwala J, 2016, SEMIN NEPHROL, V36, P94, DOI 10.1016/j.semnephrol.2016.02.002; Besarab A., 2007, DIS KIDNEY URINARY T, V8th ed., P2406; Cases-Amenos A, 2014, NEFROLOGIA, V34, P189, DOI 10.3265/Nefrologia.pre2013.Dec.12261; Cohen-Solal A, 2014, HEART, V100, P1414, DOI 10.1136/heartjnl-2014-305669; Fishbane S, 2009, CLIN J AM SOC NEPHRO, V4, P57, DOI 10.2215/CJN.01670408; Gotloib L, 2006, J NEPHROL, V19, P161; Gowanlock Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157279; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; JACOBSON LO, 1957, NATURE, V179, P633, DOI 10.1038/179633a0; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Klip IT, 2014, EUR J HEART FAIL, V16, P655, DOI 10.1002/ejhf.84; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Macdougall IC, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0444-6; Macdougall IC, 2016, KIDNEY INT, V89, P28, DOI 10.1016/j.kint.2015.10.002; McClellan W, 2004, CURR MED RES OPIN, V20, P1501, DOI 10.1185/030079904X2763; Mercadal L, 2012, CLIN J AM SOC NEPHRO, V7, P35, DOI 10.2215/CJN.04690511; Minutolo R, 2013, NEPHROL DIAL TRANSPL, V28, P3035, DOI 10.1093/ndt/gft338; Peyrin-Biroulet L, 2015, AM J CLIN NUTR, V102, P1585, DOI 10.3945/ajcn.114.103366; Ratcliffe LEK, 2016, AM J KIDNEY DIS, V67, P548, DOI 10.1053/j.ajkd.2015.11.012; Rottembourg J, 2015, NEPHROL THER, V11, P531, DOI 10.1016/j.nephro.2015.04.009; Toblli JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125528	25	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191541	10.1371/journal.pone.0191541	http://dx.doi.org/10.1371/journal.pone.0191541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357391	Green Submitted, Green Published, gold			2022-12-27	WOS:000422919500016
J	Alhazmi, A; Vargas, E; Palomo, JM; Hans, M; Latimer, B; Simpson, S				Alhazmi, Anwar; Vargas, Eduardo; Palomo, J. Martin; Hans, Mark; Latimer, Bruce; Simpson, Scott			Timing and rate of spheno-occipital synchondrosis closure and its relationship to puberty (vol 12, e0183305, 2017)	PLOS ONE			English	Correction													Simpson, Scott/GRS-0081-2022					Alhazmi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183305	1	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191703	10.1371/journal.pone.0191703	http://dx.doi.org/10.1371/journal.pone.0191703			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352313	Green Published, gold			2022-12-27	WOS:000422911300125
J	Chang, W; Lajko, M; Fawzi, AA				Chang, William; Lajko, Michelle; Fawzi, Amani A.			Endothelin-1 is associated with fibrosis in proliferative diabetic retinopathy membranes	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; EPIRETINAL MEMBRANES; FIBROVASCULAR MEMBRANES; CELL-PROLIFERATION; ETB-RECEPTOR; EXPRESSION; FIBROCYTES; RETINA; BETA	Purpose To characterize the relationship between endothelin-1 and fibrosis in epiretinal membranes in proliferative diabetic retinopathy and explore the role of endothelial-mesenchymal transition in these membranes. Methods Membranes were obtained from eyes undergoing pars plana vitrectomy for complicated proliferative diabetic retinopathy or idiopathic epiretinal membrane. Through standard immunohistochemical techniques, we labeled membranes to explore the distribution of endothelin-1 and endothelin receptor B, comparing proliferative diabetic retinopathy and idiopathic epiretinal membranes. In addition, membranes were also labeled with markers for fibroblasts, endothelial, and glial cells and studied with confocal laser scanning microscopy. The intensity of endothelin-1 labeling was quantified using standard image analysis software. Results Fourteen membranes were included in the analysis, nine from eyes with proliferative diabetic retinopathy and five idiopathic membranes. Flatmount diabetic membranes showed co-localization of endothelin-1 with S100A4 and CD31. Immunohistochemistry and quantitative analysis of cross-sectional membranes showed significantly higher endothelin-1 labeling in proliferative diabetic retinopathy membranes compared to idiopathic membranes (p<0.05). Diabetic membranes showed more elements staining positive for S100A4 compared to idiopathic membranes. Conclusion Epiretinal membrane formation in proliferative diabetic retinopathy involves higher tissue levels of endothelin-1 and fibroblastic activity. Furthermore, endothelin-1, endothelial and fibroblastic staining appear to be correlated, suggestive of endothelial-to-mesenchymal transition in proliferative diabetic retinopathy.	[Chang, William; Lajko, Michelle; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	afawzimd@gmail.com	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558	Research to Prevent Blindness, Inc; Illinois Society for the Prevention of Blindness; NCI [CCSG P30 CA060553]	Research to Prevent Blindness, Inc(Research to Prevent Blindness (RPB)); Illinois Society for the Prevention of Blindness; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by unrestricted funds from Research to Prevent Blindness, Inc (to the Department of Ophthalmology, Northwestern University Feinberg School of Medicine), and from the Illinois Society for the Prevention of Blindness (WC). Confocal Microscopy was performed at the Northwestern University Center for Advanced Microscopy, supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2015, EXP EYE RES, V132, P179, DOI 10.1016/j.exer.2015.01.023; Adamiec-Mroczek J, 2010, CYTOKINE, V49, P269, DOI 10.1016/j.cyto.2009.11.004; Bu SC, 2014, RETINA-J RET VIT DIS, V34, P897, DOI 10.1097/IAE.0000000000000013; Cao YA, 2014, INVEST OPHTH VIS SCI, V55, P7321, DOI 10.1167/iovs.14-15167; Chakrabarti S, 1998, CURR EYE RES, V17, P301, DOI 10.1076/ceyr.17.3.301.5216; Chou JC, 2014, INVEST OPHTH VIS SCI, V55, P2516, DOI 10.1167/iovs.13-13676; Cipriani P, 2015, J RHEUMATOL, V42, P1808, DOI 10.3899/jrheum.150088; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Cooley B. C, 2014, SCI TRANSL MED, V6; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Guidry C, 2005, PROG RETIN EYE RES, V24, P75, DOI 10.1016/j.preteyeres.2004.07.001; Hiscott P, 2002, EYE, V16, P393, DOI 10.1038/sj.eye.6700196; Iribarne M, 2008, AM J PATHOL, V172, P1030, DOI 10.2353/ajpath.2008.070605; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Kelland NF, 2010, CAN J PHYSIOL PHARM, V88, P644, DOI 10.1139/Y10-041; Kertes PJ, 2007, EVIDENCE BASED EYE C, pxiv; Kim LA, 2015, MOL VIS, V21, P673; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lim JI, 2010, RETINA-J RET VIT DIS, V30, P1472, DOI 10.1097/IAE.0b013e3181d6df09; Mazzuca MQ, 2012, BIOCHEM PHARMACOL, V84, P147, DOI 10.1016/j.bcp.2012.03.020; Mititelu M, 2013, JAMA OPHTHALMOL, V131, P1187, DOI 10.1001/jamaophthalmol.2013.4244; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Oberstein SYL, 2011, MOL VIS, V17, P1794; Park JY, 2000, DIABETES, V49, P1239, DOI 10.2337/diabetes.49.7.1239; Piera-Velazquez S, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040045; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Roldan-Pallares M, 2007, RETINA-J RET VIT DIS, V27, P222, DOI 10.1097/01.iae.0000231376.76601.40; Ross B, 2010, AM J RESP CELL MOL, V42, P16, DOI 10.1165/rcmb.2009-0175TR; Sanchez-Duffhues G, 2016, J PATHOL, V238, P378, DOI 10.1002/path.4653; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Swigris JJ, 2010, BIODRUGS, V24, P49, DOI 10.2165/11319550-000000000-00000; Tamaki K, 2016, INVEST OPHTH VIS SCI, V57, P4999, DOI 10.1167/iovs.16-19798; TONNESSEN T, 1995, CIRC RES, V76, P767; Vereb Z, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/492376; Wang XW, 2015, J MOL CELL CARDIOL, V80, P101, DOI 10.1016/j.yjmcc.2015.01.001; Wang ZL, 2010, EXP EYE RES, V91, P670, DOI 10.1016/j.exer.2010.08.008; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Yoshida S, 2011, INVEST OPHTH VIS SCI, V52, P5670, DOI 10.1167/iovs.10-6625; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zhao F, 2013, RETINA-J RET VIT DIS, V33, P77, DOI 10.1097/IAE.0b013e3182602087; Zhou JZ, 2012, CURR EYE RES, V37, P416, DOI 10.3109/02713683.2012.661114	45	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191285	10.1371/journal.pone.0191285	http://dx.doi.org/10.1371/journal.pone.0191285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351334	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300066
J	Hooper, A; Fuller, PM; Maguire, J				Hooper, Andrew; Fuller, Patrick M.; Maguire, Jamie			Hippocampal corticotropin-releasing hormone neurons support recognition memory and modulate hippocampal excitability	PLOS ONE			English	Article							TRANSGENIC MICE; ACUTE STRESS; INTERNEURONS; EXPRESSION; RECEPTOR; DIVERSITY; DYNAMICS; LINES; CRH	Corticotropin-releasing hormone (CRH) signaling in the hippocampus has been established to be important for mediating the effects of stress on learning and memory. Given our laboratory's recent characterization of a subset of hippocampal CRH neurons as a novel class of GABAergic interneurons, we hypothesized that these local GABAergic hippocampal CRH neurons may influence hippocampal function. Here we applied an array of molecular tools to selectively label and manipulate hippocampal CRH neurons in mice, in order to assess this interneuron population's impact on hippocampus-dependent behaviors and hippocampal network excitability. Genetically-targeted ablation of hippocampal CRH neurons in vivo impaired object recognition memory and substantially enhanced the severity of kainic acid-induced seizures. Conversely, selective activation of CRH neurons in vitro suppressed the excitability of the mossy fiber-CA3 pathway. Additional experiments are needed to reconcile the functions of GABA and CRH signaling of hippocampal CRH neurons on hippocampal function. However, our results indicate that this interneuron population plays an important role in maintaining adaptive network excitability, and provide a specific circuit-level mechanism for this role.	[Hooper, Andrew; Maguire, Jamie] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Fuller, Patrick M.] Harvard Med Sch, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA USA	Tufts University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Maguire, J (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Jamie.Maguire@tufts.edu	Core, Vector/CAF-4832-2022	Maguire, Jamie/0000-0002-4085-8605	Epilepsy Foundation; Tufts University School of Medicine; SAGE Therapeutics;  [NS073574];  [NS102937];  [NS092652]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061764] Funding Source: NIH RePORTER	Epilepsy Foundation; Tufts University School of Medicine; SAGE Therapeutics; ; ; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	J.M. was supported by NS073574 (J.M.) and NS102937 (J.M.). Development of AAV-DTA was supported by NS092652 (P.M.F.). A.H. was supported by a predoctoral fellowship from the Epilepsy Foundation and the Dean's Award from Tufts University School of Medicine. SAGE Therapeutics provided support in the form of salaries for authors (JM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Bergstrom HC, 2016, NEUROSCI BIOBEHAV R, V71, P409, DOI 10.1016/j.neubiorev.2016.09.028; Blank T, 2002, J NEUROSCI, V22, P3788; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Castro OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046044; Chen Y, 2013, MOL PSYCHIATR, V18, P485, DOI 10.1038/mp.2012.17; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Chen YC, 2015, ENDOCRINOLOGY, V156, P4769, DOI 10.1210/en.2015-1673; Chen Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00013; Chen YC, 2010, P NATL ACAD SCI USA, V107, P13123, DOI 10.1073/pnas.1003825107; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Eichenbaum H, 2013, J COGNITIVE NEUROSCI, V25, P14, DOI 10.1162/jocn_a_00285; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gomez JL, 2017, SCIENCE, V357, P503, DOI 10.1126/science.aan2475; Gonzalez MI, 2011, NEUROSCI LETT, V497, P218, DOI 10.1016/j.neulet.2011.02.052; Grigoryan G, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2540462; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Holter Sabine M, 2015, Curr Protoc Mouse Biol, V5, P331, DOI 10.1002/9780470942390.mo150068; Holter Sabine M, 2015, Curr Protoc Mouse Biol, V5, P291, DOI 10.1002/9780470942390.mo150010; Hooper A, 2016, HIPPOCAMPUS, V26, P41, DOI 10.1002/hipo.22487; Howard MW, 2015, BRAIN RES, V1621, P345, DOI 10.1016/j.brainres.2014.10.069; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Jiruska P, 2017, EPILEPSIA; Kittelberger KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029940; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kono J, 2016, BRAIN STRUCT FUNCT; LeDoux J E, 1992, Curr Opin Neurobiol, V2, P191, DOI 10.1016/0959-4388(92)90011-9; Lee V, 2014, PSYCHONEUROENDOCRINO, V41, P75, DOI 10.1016/j.psyneuen.2013.12.011; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Loup F, 2000, J NEUROSCI, V20, P5401, DOI 10.1523/JNEUROSCI.20-14-05401.2000; Marx M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00167; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; Melon L, 2017, PSYCHONEUROENDOCRINO; Muller-Chretien E, 2014, METHODS MOL BIOL, V1183, P195, DOI 10.1007/978-1-4939-1096-0_12; National Research Council, 2011, GUIDE CARE USE LAB A; O'Toole KK, 2014, EPILEPSY RES, V108, P29, DOI 10.1016/j.eplepsyres.2013.10.013; Pinol RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112138; Sarkar J, 2011, J NEUROSCI, V31, P18198, DOI 10.1523/JNEUROSCI.2560-11.2011; Sivakumaran S, 2016, EPILEPSIA, V57, P222, DOI 10.1111/epi.13270; Stark E, 2014, NEURON, V83, P467, DOI 10.1016/j.neuron.2014.06.023; SUDHOF T, 2011, COLD SPRING HARB PER, V3; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Weninger SC, 1999, P NATL ACAD SCI USA, V96, P8283, DOI 10.1073/pnas.96.14.8283; Yan HC, 2010, NEUROSCI BULL, V26, P327, DOI 10.1007/s12264-010-0323-7	49	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191363	10.1371/journal.pone.0191363	http://dx.doi.org/10.1371/journal.pone.0191363			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346425	Green Submitted, Green Published, gold			2022-12-27	WOS:000422749500043
J	Takai, Y; Nakatani, M; Aoki, T; Komori, D; Oyamada, K; Murata, K; Fujita, E; Akamine, T; Urita, Y; Yamamoto, M; Kanehisa, H				Takai, Yohei; Nakatani, Miyuki; Aoki, Toru; Komori, Daisuke; Oyamada, Kazuyuki; Murata, Kensuke; Fujita, Eiji; Akamine, Takuya; Urita, Yoshihisa; Yamamoto, Masayoshi; Kanehisa, Hiroaki			Body shape indices are predictors for estimating fat-free mass in male athletes	PLOS ONE			English	Article							CROSS-SECTIONAL AREAS; SKELETAL-MUSCLE MASS	It is unknown whether body size and body shape parameters can be predictors for estimating whole body fat-free mass (FFM) in male athletes. This study aimed to investigate whether body size and shape variables can be predictors for FFM in male athletes. Using a whole-body dual-energy X-ray absorptiometry scanner, whole body fat mass (FM) and FFM were determined in 132 male athletes and 14 sedentary males. The sample was divided into two groups: validation (N = 98) and cross-validation (N = 48) groups. Body height (BH), body mass (BM), and waist circumference at immediately above the iliac crest (W) were measured. BM-to-W and W-to-BH ratios were calculated as indices of body shapes. Stepwise multiple regression analysis revealed that BM/W and W/BH were selected as explainable variables for predicting FFM. The equation developed in the validation group was FFM (kg) = 0.883 x BM/W (kg/m) + 43.674 x W/BH (cm/cm) - 41.480 [R-2 = 0.900, SEE (% SEE) = 2.3 kg (3.8%)], which was validated in the cross-validation group. Thus, the current results demonstrate that an equation using BM/W and W/BH as independent variables is applicable for predicting FFM in male athletes.	[Takai, Yohei; Nakatani, Miyuki; Aoki, Toru; Komori, Daisuke; Oyamada, Kazuyuki; Murata, Kensuke; Fujita, Eiji; Akamine, Takuya; Urita, Yoshihisa; Yamamoto, Masayoshi; Kanehisa, Hiroaki] Natl Inst Fitness & Sports Kanoya, Kanoya, Japan	National Institute Fitness & Sports Kanoya	Takai, Y (corresponding author), Natl Inst Fitness & Sports Kanoya, Kanoya, Japan.	y-takai@nifs-k.ac.jp		Takai, Yohei/0000-0002-0142-0993	NIFS project for assessment of physical fitness for athletes	NIFS project for assessment of physical fitness for athletes	This study was supported by a NIFS project for assessment of physical fitness for athletes to MY.	Abe T, 2003, BRIT J SPORT MED, V37, P436, DOI 10.1136/bjsm.37.5.436; Bilsborough JC, 2014, J SPORT SCI, V32, P1821, DOI 10.1080/02640414.2014.926380; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bosch TA, 2014, J STRENGTH COND RES, V28, P3313, DOI 10.1519/JSC.0000000000000650; Bosy-Westphal A, 2006, BRIT J NUTR, V95, P1212, DOI 10.1079/BJN20061763; Brechue WF, 2002, EUR J APPL PHYSIOL, V86, P327, DOI 10.1007/s00421-001-0543-7; Grundy SM, 2013, J OBES, V2013, DOI 10.1155/2013/454285; HATTORI K, 1991, J ANTHROPOL SOC NIP, V99, P141; Heymsfield SB, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-24; Hopkins WG, 2010, SPORT SCI, V14, P49; Hoshikawa Y, 2010, J PHYSIOL ANTHROPOL, V29, P13, DOI 10.2114/jpa2.29.13; Kanehisa H, 1998, INT J SPORTS MED, V19, P265, DOI 10.1055/s-2007-971916; Kanehisa H, 1998, SCAND J MED SCI SPOR, V8, P271, DOI 10.1111/j.1600-0838.1998.tb00482.x; Malina R M, 1971, Med Sci Sports, V3, P32; Nevill A, 2009, J SPORT SCI, V27, P419, DOI 10.1080/02640410802668676; Ohta M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177155; Oshima S, 2011, J NUTR SCI VITAMINOL, V57, P394, DOI 10.3177/jnsv.57.394; Poortmans JR, 2005, MED SCI SPORT EXER, V37, P316, DOI 10.1249/01.MSS.0000152804.93039.CE; Quiterio AL, 2009, MED SCI SPORT EXER, V41, P828, DOI 10.1249/MSS.0b013e31818ffe4b; Swainson MG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177175; Takai Y., 2017, FOOTBALL SCI, V14, P8; Wang J, 2003, AM J CLIN NUTR, V77, P379, DOI 10.1093/ajcn/77.2.379; Willems A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00356	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0189836	10.1371/journal.pone.0189836	http://dx.doi.org/10.1371/journal.pone.0189836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346452	Green Submitted, gold, Green Published			2022-12-27	WOS:000422749500007
J	van Mastrigt, E; Zweekhorst, S; Bol, B; Tibboel, J; van Rosmalen, J; Samsom, JN; Kroon, AA; de Jongste, JC; Reiss, IKM; Post, M; Pijnenburg, MW				van Mastrigt, Esther; Zweekhorst, Salome; Bol, Bas; Tibboel, Jeroen; van Rosmalen, Joost; Samsom, Janneke N.; Kroon, Andre A.; de Jongste, Johan C.; Reiss, Irwin K. M.; Post, Martin; Pijnenburg, Marielle W.			Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia	PLOS ONE			English	Article							INDUCED APOPTOSIS; CIGARETTE-SMOKE; LUNG; SPHINGOLIPIDS; INFLAMMATION; STRESS; SPHINGOSINE-1-PHOSPHATE; HYPEROXIA	Background In an experimental mouse model we showed that ceramides play a role in the pathogenesis of bronchopulmonary dysplasia (BPD) and are a potential target for therapeutic intervention. We investigated whether ceramides are detectable in tracheal aspirates (TAs) of preterm infants and differ between infants with or without BPD. Methods Infants born <= 32 weeks of gestational age in need of mechanical ventilation in the first week of life were included. TAs were obtained directly after intubation and at day 1, 3, 5, 7, and 14. Ceramide concentrations were measured by tandem mass spectrometry. At 36 weeks postmenstrual age BPD was defined as having had >= 28 days supplemental oxygen. Results 122 infants were included, of which 14 died and 41 developed BPD. All infants showed an increase in ceramides after the first day of intubation. The ceramide profile differed significantly between preterm infants who did and did not develop BPD. However, the ceramide profile had no additional predictive value for BPD development over GA at birth, birth weight and total days of mechanical ventilation. Conclusions Ceramides are measurable in TAs of preterm born infants and may be an early marker for BPD development.	[van Mastrigt, Esther; Zweekhorst, Salome; de Jongste, Johan C.; Pijnenburg, Marielle W.] Erasmus MC, Sophia Childrens Hosp, Div Pediat Pulmonol, Rotterdam, Netherlands; [van Mastrigt, Esther; Bol, Bas; Kroon, Andre A.; Reiss, Irwin K. M.] Erasmus MC, Sophia Childrens Hosp, Div Neonatol, Rotterdam, Netherlands; [Tibboel, Jeroen; Post, Martin] Hosp Sick Children, Program Physiol & Expt Med, Toronto, ON, Canada; [van Rosmalen, Joost] Erasmus MC, Dept Biostat, Rotterdam, Netherlands; [Samsom, Janneke N.] Erasmus MC, Lab Pediat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Pijnenburg, MW (corresponding author), Erasmus MC, Sophia Childrens Hosp, Div Pediat Pulmonol, Rotterdam, Netherlands.	m.pijnenburg@erasmusmc.nl			Stichting Sophia Wetenschappelijk Onderzoek [S13-24]	Stichting Sophia Wetenschappelijk Onderzoek	Funding from the Stichting Sophia Wetenschappelijk Onderzoek, abbreviated as SSWO, number S13-24. However, we declare that the funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Becker KA, 2010, BIOCHEM BIOPH RES CO, V403, P368, DOI 10.1016/j.bbrc.2010.11.038; Becker KA, 2010, AM J RESP CELL MOL, V42, P716, DOI 10.1165/rcmb.2009-0174OC; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Boucherat O, 2007, PLOS MED, V4, P1205, DOI 10.1371/journal.pmed.0040237; D'Angio CT, 2002, BIOL NEONATE, V82, P145, DOI 10.1159/000063608; De Brauwer EIGB, 2000, ANAL QUANT CYTOL, V22, P416; De Brauwer EIGB, 2002, ANAL QUANT CYTOL, V24, P337; Dechecchi MC, 2011, AM J RESP CELL MOL, V45, P825, DOI 10.1165/rcmb.2010-0457OC; Dieperink HI, 2006, PEDIATR RES, V59, P185, DOI 10.1203/01.pdr.0000196371.85945.3a; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; Gough A, 2012, CHEST, V141, P1554, DOI 10.1378/chest.11-1306; Hammad SM, 2012, J LIPIDS, V2012, DOI 10.1155/2012/180705; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hartmann D, 2012, INT J BIOCHEM CELL B, V44, P620, DOI 10.1016/j.biocel.2011.12.019; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kroon AA, 2013, AM J PHYSIOL-LUNG C, V305, pL795, DOI 10.1152/ajplung.00048.2013; Kunzmann S, 2011, AM J RESP CELL MOL, V45, P969, DOI 10.1165/rcmb.2010-0519OC; Levy BD, 2013, NEW ENGL J MED, V369, P976, DOI 10.1056/NEJMcibr1306864; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Mathew B, 2011, FASEB J, V25, P3388, DOI 10.1096/fj.11-183970; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; May M, 2004, EUR RESPIR J, V23, P113, DOI 10.1183/09031936.03.00038403; Onland W, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-207; Ono Jennie G, 2015, Mol Cell Pediatr, V2, P13, DOI 10.1186/s40348-015-0025-3; Payne SG, 2002, FEBS LETT, V531, P54, DOI 10.1016/S0014-5793(02)03480-4; Rook D, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-65; Sawicka E, 2003, J IMMUNOL, V171, P6206, DOI 10.4049/jimmunol.171.11.6206; Schweitzer KS, 2011, AM J PHYSIOL-LUNG C, V301, pL836, DOI 10.1152/ajplung.00385.2010; Snoek KG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155136; Tibboel J, 2014, CHEST, V145, P120, DOI 10.1378/chest.13-0967; Tibboel J, 2013, EUR RESPIR J, V42, P776, DOI 10.1183/09031936.00092212; Verbeke G, 2000, LINEAR MIXED MODELS; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; Yang Yang, 2011, Ther Adv Respir Dis, V5, P325, DOI 10.1177/1753465811406772	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0185969	10.1371/journal.pone.0185969	http://dx.doi.org/10.1371/journal.pone.0185969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346372	gold, Green Published, Green Submitted			2022-12-27	WOS:000422749500001
J	Straatmann, VS; Almquist, YB; Oliveira, AJ; Rostila, M; Lopes, CS				Straatmann, Viviane S.; Almquist, Ylva B.; Oliveira, Aldair J.; Rostila, Mikael; Lopes, Claudia S.			Cross-lagged structural equation models for the relationship between health-related state and behaviours and body bullying in adolescence: findings from longitudinal study ELANA	PLOS ONE			English	Article							PHYSICAL-ACTIVITY CHANGE; PSYCHOSOCIAL ADJUSTMENT; SOCIAL DETERMINANTS; SEDENTARY BEHAVIOR; WEIGHT; PREVALENCE; CHILDREN; TELEVISION; PREDICTORS; TRENDS	We investigated the stability and the directionality of being body bullied and a set of four variables 1) Body Mass Index (BMI), 2) moderate and vigorous physical activity (MVPA), 3) television time (TV) and 4) video game/computer time (VG)-, termed in the present study as `health-related state and behaviours (HRSB)' across adolescence. The Adolescent Nutritional Assessment Longitudinal Study (ELANA) is a cohort study conducted among middle school students from two public and four private schools in Rio de Janeiro-Brazil. We analysed data from 2010 (T1) and 2012 (T2) among 810 adolescents (aged 9-15 at T1). Gender-specific structural equation models (SEM) were estimated, including autoregressive paths for the HRSB and being body bullied over time, correlations at T1 and T2, respectively, and cross-lagged effects. The results presented significant stability coefficients for almost all variables over time in both genders (except for MVPA in boys and girls and TV time among girls). There were positive correlations between BMI and being body bullied, as well as between TV and VG for boys (0.32, p<0.001 and 0.24, p<0.001, respectively) and girls (0.30, p<0.001 and 0.30, p<0.001, respectively) at T1. It remained significant at T2 (boys: 0.18, p<0.05 and 0.16, p<0.01; girls: 0.21, p<0.01 and 0.22, p<0.01, respectively). Examining the cross-lagged paths between being body bullied and HRSB, we observed that the reciprocal model provided the best fit for boys, indicating that BMI at T1 had a significant effect in being body bullied at T2 (0.12, p<0.05) and being body bullied at T1 had an effect on VG at T2 (0.14, p<0.01). Among girls the forward causation model showed the best fit, demonstrating a significant effect of being body bullied at T1 on VG at T2 (0.16, p<0.01). Apart from MVPA, both being body bullying and HRSB were largely stable across adolescence. For boys and girls alike, exposure to being body bullied seemed to increase their time spent on VG, while for boys BMI also predicted being body bullied. This study highlighted the complex interplay between being body bullied and HRSB and the importance of acknowledging gender differences in this context.	[Straatmann, Viviane S.] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Straatmann, Viviane S.; Lopes, Claudia S.] State Univ Rio Janeiro UERJ, Dept Epidemiol, Rio De Janeiro, Brazil; [Almquist, Ylva B.; Rostila, Mikael] Ctr Hlth & Equ Studies CHESS, Stockholm, Sweden; [Oliveira, Aldair J.] UFRRJ, Lab Social Dimens Appl Phys Act & Sport LABSAFE, Seropedica, Brazil	University of Liverpool; Universidade do Estado do Rio de Janeiro; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Straatmann, VS (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England.; Straatmann, VS (corresponding author), State Univ Rio Janeiro UERJ, Dept Epidemiol, Rio De Janeiro, Brazil.	v.schultz-straatmann@liverpool.ac.uk	J Oliveira, Aldair/AAE-7422-2022; de Souza Lopes, Claudia/H-9150-2013	J Oliveira, Aldair/0000-0002-2714-0615; Straatmann, Viviane/0000-0003-2355-1174; de Souza Lopes, Claudia/0000-0002-0401-689X	National Council for Scientific and Technological Development [47667/2011-9]; Research Support Foundation of the State of Rio de Janeiro [E26/110.847/2009, E26/110.626/2011, E-26/110.774/2013]; Coordination for the Improvement of Higher Education Personnel [23038.007702/2011-5]	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Support Foundation of the State of Rio de Janeiro; Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The ELANA was funded by the National Council for Scientific and Technological Development (grant 47667/2011-9), the Research Support Foundation of the State of Rio de Janeiro (grants E26/110.847/2009, E26/110.626/2011 and E-26/110.774/2013) and Coordination for the Improvement of Higher Education Personnel (grant 23038.007702/2011-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2012, J PHYS ACT HEALTH, V9, pS76, DOI 10.1123/jpah.9.s1.s76; Al Junaibi A, 2013, INT J OBESITY, V37, P68, DOI 10.1038/ijo.2012.131; Barbosa Kiriaque Barra Ferreira, 2006, Rev. Bras. Saude Mater. Infant., V6, P375, DOI 10.1590/S1519-38292006000400003; Brazil. Ministry of Health. Department of Health Care. Department of Primary Care, 2011, STEP STEP PSE SCH HL; Bucksch J, 2016, J ADOLESC HLTH; Costigan SA, 2013, J ADOLESCENT HEALTH, V52, P382, DOI 10.1016/j.jadohealth.2012.07.018; Currie C, 2008, HLTH POLICY CHILDREN, V5, P206; de Farias JC, 2010, CAD SAUDE PUBLICA, V26, P1669, DOI 10.1590/S0102-311X2010000900002; DeSmet A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-224; Diaz EB, 1996, REV CHIL PEDIATR, V67, P153; Dodge KA, 2003, DEV PSYCHOL, V39, P349, DOI 10.1037/0012-1649.39.2.349; Dumith SC, 2012, PUBLIC HEALTH NUTR, V15, P2237, DOI 10.1017/S1368980012000948; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Eisenberg ME, 2006, J ADOLESCENT HEALTH, V38, P675, DOI 10.1016/j.jadohealth.2005.07.002; Elgar FJ, 2015, J ADOLESCENT HEALTH, P1; Eschenbeck H., 2007, J INDIVID DIFFER, V28, P18, DOI [10.1027/1614-0001.28.1.18, DOI 10.1027/1614-0001.28.1.18]; Faith MS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e23; Fallon Elizabeth A, 2005, Body Image, V2, P62; Gordon CC, 1988, ANTHR STAND REF MANU, P3; Greitemeyer T, 2014, PERS SOC PSYCHOL B; Guedes Dartagnan Pinto, 2005, Rev Bras Med Esporte, V11, P151, DOI 10.1590/S1517-86922005000200011; Haines J, 2008, OBESITY, V16, pS18, DOI 10.1038/oby.2008.447; Hargreaves Duane A, 2004, Body Image, V1, P351, DOI 10.1016/j.bodyim.2004.10.002; Hazler R., 1996, BREAKING CYCLE VIOLE; Hellstrom L, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/2049-3258-73-4; Horowitz J. A., 2004, J AM PSYCHIAT NURSES, V10, P165, DOI DOI 10.1177/1078390304267862; Iannotti RJ, 2013, PEDIATRICS, V132, P606, DOI 10.1542/peds.2013-1488; Junior GC, 2015, REV BRAS CIENC ESPOR; Kuntsche E, 2006, J ADOLESCENT HEALTH, V39, P908, DOI 10.1016/j.jadohealth.2006.06.007; Lampard AM, 2013, J YOUTH ADOLESCENCE; Lopes AS, 2014, J PUBLIC HEALTH-UK, V36, P608, DOI 10.1093/pubmed/fdt133; Losekam S, 2010, OBESITY FACTS, V3, P239, DOI 10.1159/000319433; Malta Deborah Carvalho, 2014, Rev. bras. epidemiol., V17, P46, DOI 10.1590/1809-4503201400050005; Medeiros P, 2014, CINERGIS, V15, P158; Nansel TR, 2001, JAMA-J AM MED ASSOC, V285, P2094, DOI 10.1001/jama.285.16.2094; Nesello Francine, 2014, Rev. Bras. Saude Mater. Infant., V14, P119, DOI 10.1590/S1519-38292014000200002; Neumark-Sztainer D, 2001, INT J OBESITY, V1, P123; Olson CK, 2010, REV GEN PSYCHOL, V14, P180, DOI 10.1037/a0018984; Parkes A, 2013, ARCH DIS CHILD, V98, P341, DOI 10.1136/archdischild-2011-301508; Patterson E., 2005, GUIDELINES DATA PROC; Pronk NP, 2004, AM J PREV MED, V27, P25, DOI 10.1016/j.amepre.2004.04.022; Puhl RM, 2013, BEST PRACT RES CL EN, V27, P117, DOI 10.1016/j.beem.2012.12.002; Ravens-Sieberer U, 2006, KIDSCREEN QUESTIONNA; Ravens-Sieberer U, 2014, QUAL LIFE RES, V23, P791, DOI 10.1007/s11136-013-0428-3; Rech RR, 2013, J PEDIAT-BRAZIL, V89, P164, DOI 10.1016/j.jped.2013.03.006; Rossen LM, 2014, ANN EPIDEMIOL, V24, P705, DOI 10.1016/j.annepidem.2014.07.010; Selig JP, 2012, HDB DEV RES METHODS; Sibold J, 2015, J AM ACAD CHILD ADOL; Slater A, 2011, J ADOLESCENCE, V34, P455, DOI 10.1016/j.adolescence.2010.06.007; Szwarcwald Célia Landmann, 2005, Rev. Bras. Saude Mater. Infant., V5, ps11, DOI 10.1590/S1519-38292005000500002; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Wang J, 2009, J ADOLESCENT HEALTH, V45, P368, DOI 10.1016/j.jadohealth.2009.03.021	53	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1								10.1371/journal.pone.0191253	http://dx.doi.org/10.1371/journal.pone.0191253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8II	29342218	gold, Green Submitted, Green Published			2022-12-27	WOS:000422653800055
J	Bhende, M; Raman, R; Jain, M; Shah, PK; Sharma, T; Gopal, L; Bhende, PS; Srinivasan, S; Jambulingam, M				Bhende, Muna; Raman, Rajiv; Jain, Mukesh; Shah, Pratik K.; Sharma, Tarun; Gopal, Lingam; Bhende, Pramod S.; Srinivasan, Sangeetha; Jambulingam, Malathi		Sankara Nethralaya Vitreoretinal S	Incidence, microbiology, and outcomes of endophthalmitis after 111,876 pars plana vitrectomies at a single, tertiary eye care hospital	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; 25-GAUGE; 20-GAUGE; MANAGEMENT; NATIONWIDE; ORGANISMS; DIAGNOSIS; 23-GAUGE	Purpose To describe the incidence, risk factors, clinical presentation, causative organisms, and outcomes in patients with endophthalmitis following pars plana vitrectomy (20G and minimally invasive vitrectomy surgery (MIVS). Methods Of 111,876 vitrectomies (70,585 20-G 41,291 MIVS) performed, 45 cases developed acute onset, postoperative endophthalmitis. Results The rate of culture positive and culture negative endophthalmitis was 0.021% (2.1/10,000 surgeries) and 0.019% (1.9/10,000 surgeries) overall, 0.031% (3.1/10,000 surgeries) and 0.025% (2.5/10,000 surgeries) in 20G, and 0.005% (0.5/10,000 surgeries) and 0.007% (0.7/10,000 surgeries) in the MIVS group respectively. Potential predisposing factors were as follows: diabetes, 46.7%; vitrectomy for vascular retinopathies, 44.4%; and vitrectomy combined with anterior segment surgeries, 35.5%. The culture proven rates were 53.3% overall, 55.0% for 20G and 40.0% for MIVS. The most common organism was Pseudomonas aeruginosa for 20G. Klebsiella and Staphylococcus aureus were isolated in the two culture positive cases in MIVS group. The follow-up period for the patients with endophthalmitis was 586.14 +/- 825.15 days. Seven were lost to follow up beyond one week. Of the remaining 38, 13 (34.2%) cases had a favorable visual outcome (i.e., best-corrected visual acuity [BCVA] > 5/200) and 24 (63.2%) had unfavorable visual outcome (BCVA < 5/200). Group with culture test results negative had significantly better outcomes (P < 0.05) as compared to those with positive. Conclusions MIVS does not increase the risk of endophthalmitis. Outcomes are poor despite appropriate treatment, particularly in cases with culture results positive.	[Bhende, Muna; Raman, Rajiv; Jain, Mukesh; Shah, Pratik K.; Sharma, Tarun; Gopal, Lingam; Bhende, Pramod S.; Srinivasan, Sangeetha] Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India; [Jambulingam, Malathi] Sankara Nethralaya, Vis Res Fdn, L&T Microbiol Res Ctr, Madras, Tamil Nadu, India		Bhende, M (corresponding author), Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India.	drmuna@snmail.org	Ratra, Dhanashree/AAE-2517-2020; Raman, Rajiv/A-7234-2009	Ratra, Dhanashree/0000-0001-5687-6384; Raman, Rajiv/0000-0001-5842-0233; Khetan, Vikas/0000-0003-4396-9877; Bhende, Muna/0000-0002-9251-170X				Anand A R, 2000, Indian J Ophthalmol, V48, P123; Anand AR, 2001, OPHTHALMOLOGY, V108, P326, DOI 10.1016/S0161-6420(00)00517-0; [Anonymous], 1995, Arch Ophthalmol, V113, P1479; Chen JK, 2009, EYE, V23, P780, DOI 10.1038/eye.2008.160; Chiang A, 2011, RETINA-J RET VIT DIS, V31, P1513, DOI 10.1097/IAE.0b013e3182209290; Chiquet C, 2007, J CATARACT REFR SURG, V33, P635, DOI 10.1016/j.jcrs.2006.12.017; COHEN SM, 1995, OPHTHALMOLOGY, V102, P705, DOI 10.1016/S0161-6420(95)30965-7; Czajka MP, 2016, ACTA OPHTHALMOL, V94, P829, DOI 10.1111/aos.13121; Dave VP, 2016, ASIA-PAC J OPHTHALMO, V5, P192, DOI 10.1097/APO.0000000000000192; Eifrig CWG, 2004, AM J OPHTHALMOL, V138, P799, DOI 10.1016/j.ajo.2004.06.035; Fujii GY, 2002, OPHTHALMOLOGY, V109, P1807, DOI 10.1016/S0161-6420(02)01179-X; Gupta Amit, 2003, Indian Journal of Ophthalmology, V51, P139; Gupta OP, 2008, AM J OPHTHALMOL, V146, P193, DOI 10.1016/j.ajo.2008.04.010; Gupta OP, 2007, OPHTHAL SURG LAS IM, V38, P270, DOI 10.3928/15428877-20070701-01; Jambulingam M, 2010, INDIAN J OPHTHALMOL, V58, P297, DOI 10.4103/0301-4738.64132; Joondeph BC, 2005, RETINA-J RET VIT DIS, V25, P587, DOI 10.1097/00006982-200507000-00008; Kunimoto DY, 2007, OPHTHALMOLOGY, V114, P2133, DOI 10.1016/j.ophtha.2007.08.009; Lisboa T, 2010, CRIT CARE MED, V38, pS656, DOI 10.1097/CCM.0b013e3181f2453a; Oshima Y, 2010, AM J OPHTHALMOL, V150, P716, DOI 10.1016/j.ajo.2010.06.002; Park JC, 2014, BRIT J OPHTHALMOL, V98, P1080, DOI 10.1136/bjophthalmol-2013-304486; Park JC, 2014, BRIT J OPHTHALMOL, V98, P529, DOI 10.1136/bjophthalmol-2013-304485; Scott IU, 2008, RETINA-J RET VIT DIS, V28, P138, DOI 10.1097/IAE.0b013e31815e9313; Scott IU, 2011, GRAEF ARCH CLIN EXP, V249, P377, DOI 10.1007/s00417-010-1505-8; Sharma S, 2014, INDIAN J MED RES, V139, P91; Shimada H, 2008, OPHTHALMOLOGY, V115, P2215, DOI 10.1016/j.ophtha.2008.07.015; Therese KL, 1998, BRIT J OPHTHALMOL, V82, P1078, DOI 10.1136/bjo.82.9.1078; Turhan V, 2013, J INFECT DEV COUNTR, V7, P707, DOI 10.3855/jidc.2967; Wu L, 2011, RETINA-J RET VIT DIS, V31, P673, DOI 10.1097/IAE.0b013e318203c183	28	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191173	10.1371/journal.pone.0191173	http://dx.doi.org/10.1371/journal.pone.0191173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338030	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700037
J	Jacobs, C; Michelo, C; Chola, M; Oliphant, N; Halwiindi, H; Maswenyeho, S; Baboo, KS; Moshabela, M				Jacobs, Choolwe; Michelo, Charles; Chola, Mumbi; Oliphant, Nicholas; Halwiindi, Hikabasa; Maswenyeho, Sitali; Baboo, Kumar Sridutt; Moshabela, Mosa			Evaluation of a community-based intervention to improve maternal and neonatal health service coverage in the most rural and remote districts of Zambia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CARE; WORKERS; COUNTRIES; BEHAVIOR; NEWBORN	Background A community-based intervention comprising both men and women, known as Safe Motherhood Action Groups (SMAGs), was implemented in four of Zambia's poorest and most remote districts to improve coverage of selected maternal and neonatal health interventions. This paper reports on outcomes in the coverage of maternal and neonatal care interventions, including antenatal care (ANC), skilled birth attendance (SBA) and postnatal care (PNC) in the study areas. Methodology Three serial cross-sectional surveys were conducted between 2012 and 2015 among 1,652 mothers of children 0-5 months of age using a 'before-and-after evaluation design with multi-stage sampling, combining probability proportional to size and simple random sampling. Logistic regression and chi-square test for trend were used to assess effect size and changes in measures of coverage for ANC, SBA and PNC during the intervention. Results Mothers' mean age and educational status were non-differentially comparable at all the three-time points. The odds of attending ANC at least four times (aOR 1.63; 95% CI 1.381.99) and SBA (aOR 1.72; 95% CI 1.38-1.99) were at least 60% higher at endline than baseline surveillance. A two-fold and four-fold increase in the odds of mothers receiving PNC from an appropriate skilled provider (aOR 2.13; 95% CI 1.62-2.79) and a SMAG (aOR 4.87; 95% CI 3.14-7.54), respectively, were observed at endline. Receiving birth preparedness messages from a SMAG during pregnancy (aOR 1.76; 95% CI, 1.20-2.19) and receiving ANC from a skilled provider (aOR 4.01; 95% CI, 2.88-5.75) were significant predictors for SBA at delivery and PNC. Conclusions Strengthening community-based action groups in poor and remote districts through the support of mothers by SMAGs was associated with increased coverage of maternal and newborn health interventions, measured through ANC, SBA and PNC. In remote and marginalised settings, where the need is greatest, context-specific and innovative task-sharing strategies using community health volunteers can be effective in improving coverage of maternal and neonatal services and hold promise for better maternal and child survival in poorly-resourced parts of sub-Saharan Africa.	[Jacobs, Choolwe; Moshabela, Mosa] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa; [Jacobs, Choolwe; Michelo, Charles] Univ Zambia, Sch Publ Hlth, Strateg Ctr Hlth Syst Metr & Evaluat SCHEME, Lusaka, Zambia; [Jacobs, Choolwe; Michelo, Charles; Chola, Mumbi] Univ Zambia, Sch Publ Hlth, Dept Epidemiol & Biostat, Lusaka, Zambia; [Oliphant, Nicholas; Maswenyeho, Sitali] UNICEF, Lusaka, Zambia; [Halwiindi, Hikabasa; Baboo, Kumar Sridutt] Univ Zambia, Sch Publ Hlth, Dept Global Hlth, Lusaka, Zambia; [Moshabela, Mosa] Africa Hlth Res Inst, Durban, South Africa	University of Kwazulu Natal; University of Zambia; University of Zambia; University of Zambia; Africa Health Research Institute	Jacobs, C (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa.; Jacobs, C (corresponding author), Univ Zambia, Sch Publ Hlth, Strateg Ctr Hlth Syst Metr & Evaluat SCHEME, Lusaka, Zambia.; Jacobs, C (corresponding author), Univ Zambia, Sch Publ Hlth, Dept Epidemiol & Biostat, Lusaka, Zambia.	choolwe2003@yahoo.com	Moshabela, Mosa/AAK-4418-2021	Moshabela, Mosa/0000-0002-9438-7095; Chola, Mumbi/0000-0002-6488-113X	UNICEF through the Health for the poorest Population [43207625]; African Union	UNICEF through the Health for the poorest Population; African Union	Part of this research was supported by UNICEF through the Health for the poorest Population (Grant # 43207625). Additional support includes the African Union Scholarship for Female Students (to CJ) (http://www.scholarshipsbar.com/african-union-scholarship-for-female-students.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2005, NATURE, V437, P310; Adam MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104027; [Anonymous], 2010, ZAMB 2010 CENS POP H; Bryce J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001423; Chama-Chiliba CM, 2015, HEALTH POLICY PLANN, V30, P78, DOI 10.1093/heapol/czt099; Dhakal Sulochana, 2007, BMC Pregnancy Childbirth, V7, P19, DOI 10.1186/1471-2393-7-19; Ensor T, 2014, B WORLD HEALTH ORGAN, V92, P51, DOI 10.2471/BLT.13.122721; Gage AL, 2006, POP STUD-J DEMOG, V60, P271, DOI 10.1080/00324720600895934; Greenland K, 2011, TROP MED INT HEALTH, V16, P863, DOI 10.1111/j.1365-3156.2011.02770.x; Hamukwala P., 2011, FACTORS AFFECTING PO; Herlihy JM, 2017, J ACQ IMMUN DEF SYND, P22; Hosseinpoor AR, 2011, B WORLD HEALTH ORGAN, V89, P881, DOI 10.2471/BLT.11.087536; Jacobs C, 2017, FRONTIERS PUBLIC HLT, P5; Kirkwood BR, 2013, LANCET, V381, P2184, DOI 10.1016/S0140-6736(13)60095-1; Kumar V, 2010, SEMIN PERINATOL, V34, P446, DOI 10.1053/j.semperi.2010.09.006; LANATA C F, 1991, World Health Statistics Quarterly, V44, P133; Lehmann U, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-19; Lewin S., 2010, LAY HLTH WORKERS PRI; Lowe M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163653; Lundborg CS, 2014, UPSALA J MED SCI, V119, P125, DOI 10.3109/03009734.2014.905664; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Mekonnen Y, 2002, UTILIZATION MATERNHA; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; Mwewa CMD., 2010, MED J ZAMBIA, V37, P234; Neal S, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0184-9; Osubor KM, 2006, MATERN CHILD HLTH J, V10, P159, DOI 10.1007/s10995-005-0037-z; Phiri SN, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-219; Prata N, 2012, SOC SCI MED, V74, P1288, DOI 10.1016/j.socscimed.2011.11.035; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Robertson Susan E., 1997, World Health Statistics Quarterly, V50, P199; Rockers PC, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000104; Sharma S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155144; Sialubanje C, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0342-1; Sialubanje C, 2014, HEALTH EDUC RES, V29, P521, DOI 10.1093/her/cyu011; Singh P, 2013, LANCET, V382, P363, DOI 10.1016/S0140-6736(12)62002-9; Sprague DA, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0049-8; StataCrop, 2013, STATA STAT SOFTW REL; UNDP, 2005, ZAMB MILL DEV GOALS; VALADEZ JJ, 1995, AM J PUBLIC HEALTH, V85, P1165, DOI 10.2105/AJPH.85.8_Pt_1.1165-a; Valadez JJ, 2007, ASSESSING COMMUNITY; Valadez JJ, 2015, TROP MED INT HEALTH, V20, P1711, DOI 10.1111/tmi.12613; Van Damme W, 2008, SOC SCI MED, V66, P2108, DOI 10.1016/j.socscimed.2008.01.043; Viswanathan K, 2012, J EPIDEMIOL COMMUN H, V66, P894, DOI 10.1136/jech-2011-200275; WHO, 1996, WHOVRDTRAM9601; Wilunda C, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0213-1; Zambia Central Statistical Office Zambia Ministry of Health ICF International., 2014, ZAMB DEM HLTH SURV 2	46	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190145	10.1371/journal.pone.0190145	http://dx.doi.org/10.1371/journal.pone.0190145			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29337995	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700006
J	Muraduzzaman, AKM; Khan, MH; Parveen, R; Sultana, S; Alam, AN; Akram, A; Rahman, M; Shirin, T				Muraduzzaman, A. K. M.; Khan, Manjur Hossain; Parveen, Rezina; Sultana, Sharmin; Alam, Ahmed Nawsher; Akram, Arifa; Rahman, Mahmudur; Shirin, Tahmina			Event based surveillance of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Bangladesh among pilgrims and travelers from the Middle East: An update for the period 2013-2016	PLOS ONE			English	Article							INFECTION	Introduction Every year around 150,000 pilgrims from Bangladesh perform Umrah and Hajj. Emergence and continuous reporting of MERS-CoV infection in Saudi Arabia emphasize the need for surveillance of MERS-CoV in returning pilgrims or travelers from the Middle East and capacity building of health care providers for disease containment. The Institute of Epidemiology, Disease Control & Research (IEDCR) under the Bangladesh Ministry of Health and Family welfare (MoHFW), is responsible for MERS-CoV screening of pilgrims/travelers returning from the Middle East with respiratory illness as part of its outbreak investigation and surveillance activities. Methods Bangladeshi travelers/pilgrims who returned from the Middle East and presented with fever and respiratory symptoms were studied over the period from October 2013 to June 2016. Patients with respiratory symptoms that fulfilled the WHO MERS-CoV case algorithm were tested for MERS-CoV and other respiratory tract viruses. Beside surveillance, case recognition training was conducted at multiple levels of health care facilities across the country in support of early detection and containment of the disease. Results Eighty one suspected cases tested by real time PCR resulted in zero detection of MERSCoV infection. Viral etiology detected in 29.6% of the cases was predominantly influenza A (H 1N 1 and H3N2), and influenza B infection (22%). Peak testing occurred mostly following the annual Hajj season. Conclusions Respiratory tract infections in travelers/pilgrims returning to Bangladesh from the Middle East are mainly due to influenza A and influenza B. Though MERS-CoV was not detected in the 81 patients tested, continuous screening and surveillance are essential for early detection of MERS-CoV infection and other respiratory pathogens to prevent transmissions in hospital settings and within communities. Awareness building among healthcare providers will help identify suspected cases.	[Muraduzzaman, A. K. M.; Khan, Manjur Hossain; Sultana, Sharmin; Alam, Ahmed Nawsher; Akram, Arifa; Shirin, Tahmina] IEDCR, Dept Virol, Dhaka, Bangladesh; [Parveen, Rezina] Dhaka Dent Coll, Dept Pathol & Microbiol, Dhaka, Bangladesh; [Rahman, Mahmudur] IEDCR, Dhaka, Bangladesh		Shirin, T (corresponding author), IEDCR, Dept Virol, Dhaka, Bangladesh.	tahmina.shirin14@gmail.com	Akram, Arifa/ADI-4706-2022; sultana, sharmin/HHZ-7068-2022	Akram, Arifa/0000-0001-8829-9817; Shirin, Tahmina/0000-0002-5061-3783				Al-Hajjar S, 1998, ANN TROP PAEDIATR, V18, P87, DOI 10.1080/02724936.1998.11747933; Al-Tawfiq JA, 2013, SAUDI MED J, V34, P991; Alzeer AH, 2009, ANN THORAC MED, V4, P50, DOI 10.4103/1817-1737.49412; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P435; Arabi Y, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1490-9; Assiri A, N ENGL J MED, V369, P407; Atabani SF, 2016, INT J INFECT DIS; CDC, 2014, CDC LAB TEST MIDDL E; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gautret P, 2016, INT J INFECT DIS; Gautret P, 2014, EMERG INFECT DIS, V20, P728, DOI 10.3201/eid2004.131708; Gautret P, 2013, TRAVEL MED INFECT DI, V11, P95, DOI 10.1016/j.tmaid.2013.03.003; Hashem AM, 2016, ANN THORAC MED, V11, P161, DOI 10.4103/1817-1737.180022; Korea Centers for Disease Control and Prevention, 2016, Osong Public Health Res Perspect, V7, P138, DOI 10.1016/j.phrp.2016.03.002; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Lu XY, 2014, J CLIN MICROBIOL, V52, P67, DOI 10.1128/JCM.02533-13; Mackay IM, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0439-5; [MaMWR MMWR], 2014, 1 CONF CAS MIDDL E R; Memish ZA, 2014, J INFECT DIS; Memish ZA, N ENGL J MED, V368, P2487; Memish ZA, B WHO, V91, P899; Pavli A, 2014, TRAVEL MED INFECT DI, V12, P602, DOI 10.1016/j.tmaid.2014.10.006; Puzelli S., 2013, EURO SURVEILL, V18; Sridhar S, 2015, TRAVEL MED INFECT DI, V13, P106, DOI 10.1016/j.tmaid.2014.11.006; The WHO MERS-CoV Research Group, 2013, PLOS CURR, V5; Van Boheemen S, MBIO, V3; WHO (World Health Organization), 2012, GUID REG TRANSP INF; World Health Organization, 2016, WHO MERS COV GLOB SU; World Health Organization, 2016, WHOMERSRA161; World Health Organization (WHO), 2019, MIDDLE E RESP SYNDRO; Zaki A.M., N ENGL J MED, V367, P1814	31	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0189914	10.1371/journal.pone.0189914	http://dx.doi.org/10.1371/journal.pone.0189914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29337997	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700005
J	Dolka, I; Czopowicz, M; Gruk-Jurka, A; Wojtkowska, A; Sapierzynski, R; Jurka, P				Dolka, Izabella; Czopowicz, Michal; Gruk-Jurka, Anna; Wojtkowska, Agata; Sapierzynski, Rafal; Jurka, Piotr			Diagnostic efficacy of smear cytology and Robinson's cytological grading of canine mammary tumors with respect to histopathology, cytomorphometry, metastases and overall survival	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; INVASIVE BREAST-CARCINOMA; GLAND TUMORS; NUCLEAR MORPHOMETRY; PROGNOSTIC VALUE; CANCER; BIOPSY; DIFFERENTIATION; PREDICTOR; ACCURACY	Cytology is a simple, rapid, and inexpensive method used for pre-operative diagnosis of canine mammary tumors (CMTs) in veterinary practice. Studies related to human breast cancer showed the Robinson's grading system-established for invasive ductal carcinoma, not otherwise specified (IDC, NOS) and used on cytological material-to not only closely correspond to the histopathological grading but also be helpful in assessing prognosis and selecting most suitable treatments before surgery. The objectives of this study were: to evaluate the accuracy of cytological diagnosis and cytological Robinson's grading system compared to the histopathological examination of CMTs; to compare of cytological features and cytomorphometric parameters with tumor behavior, as well as cytological and histological grading; and to determine an association of the Robinson's grading system and cytological background details with metastases, and patients' survival. We report substantial diagnostic accuracy in detecting simple types and high grade tumors. Cytological diagnosis of tumor behavior showed relatively low sensitivity and specificity compared to human studies, and this might be caused by the heterogeneous morphology of CMTs. The presence of mucosecretory material and extracellular matrix was not significantly associated with tumor behavior. We report a positive correlation between both grading systems and cytological features (included in Robinson's grading), the presence of necrotic debris, inflammation, and red blood cells. A negative correlation was determined only for the presence of extracellular matrix. The univariate and multivariate analyses confirmed a significantly higher risk of developing metastasis and shorter overall survival for dogs with tumors of grade 2 or 3 on cytology. In addition, these tumors were the most common cause of CMT-related deaths in dogs. Taken together, our findings suggest that the Robinson's method of cytological grading applied for malignant CMTs evaluated in cytological smears regardless of tumor type can be adapted to veterinary cytology. Additionally, some background features seem to aid malignancy assessment.	[Dolka, Izabella; Sapierzynski, Rafal] Warsaw Univ Life Sci SGGW, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland; [Czopowicz, Michal] Warsaw Univ Life Sci SGGW, Fac Vet Med, Lab Vet Epidemiol & Econ, Warsaw, Poland; [Gruk-Jurka, Anna; Wojtkowska, Agata; Jurka, Piotr] Warsaw Univ Life Sci SGGW, Fac Vet Med, Dept Small Anim Dis Clin, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Warsaw University of Life Sciences	Dolka, I (corresponding author), Warsaw Univ Life Sci SGGW, Fac Vet Med, Dept Pathol & Vet Diagnost, Warsaw, Poland.	izabella_dolka@sggw.pl	Czopowicz, Michał/U-5452-2018	Czopowicz, Michał/0000-0002-4238-8360; Jurka, Piotr/0000-0002-3321-4844; /0000-0002-6904-0700	KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food" [05-1/KNOW2/2015]; Department of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Warsaw, Poland [505-10-023700-L00182-99]	KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food"; Department of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Warsaw, Poland	Research was supported by grant no 505-10-023700-L00182-99 received by Izabella Dolka from Department of Pathology and Veterinary Diagnostics, Faculty of Veterinary Medicine, Warsaw University of Life Sciences (SGGW), Warsaw, Poland. The costs of manuscript publication were funded by KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food", decision of Ministry of Science and Higher Education No. 05-1/KNOW2/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abati A, 1997, DIAGN CYTOPATHOL, V16, P295; ALLEN SW, 1986, VET PATHOL, V23, P649, DOI 10.1177/030098588602300601; Allison RW, 2007, DIAGNOSTIC CYTOLOGY, P112; Altman E. I., 2000, PREDICTING FINANCIAL, P15; Barra ADA, 2008, DIAGN CYTOPATHOL, V36, P26, DOI 10.1002/dc.20748; Cassali GD, 2007, CYTOPATHOLOGY, V18, P191, DOI 10.1111/j.1365-2303.2007.00412.x; Cassali GD, 2015, VET CLIN PATH, V44, P448, DOI 10.1111/vcp.12269; Colodel M. M., 2012, Veterinaria e Zootecnia, V19, P557; Das AK, 2003, INDIAN J MED RES, V118, P247; de las Mulas JM, 2005, VET PATHOL, V42, P200, DOI 10.1354/vp.42-2-200; De Vico G, 2007, VET RES COMMUN, V31, P1005, DOI 10.1007/s11259-006-0108-7; Dennis MM, 2011, VET PATHOL, V48, P73, DOI 10.1177/0300985810388820; Dias MLD, 2016, PESQUI VET BRASIL, V36, P181, DOI 10.1590/S0100-736X2016000300006; Dutra AP, 2008, ARQ BRAS MED VET ZOO, V60, P1403, DOI 10.1590/S0102-09352008000600015; Einstien D, 2014, ISRN ONCOLOGY, P1; GILCHRIST KW, 1993, J CLIN ONCOL, V11, P1929, DOI 10.1200/JCO.1993.11.10.1929; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Gore CR, 2013, INT J PHARM BIOL SCI, V3, P564; Haziroglu R, 2010, REV MED VET-TOULOUSE, V161, P212; HELLMEN E, 1989, J COMP PATHOL, V101, P443, DOI 10.1016/0021-9975(89)90027-3; Jayaram G, 2005, ACTA CYTOL, V49, P605, DOI 10.1159/000326247; Kalhan S, 2010, J CYTOL, V27, P16, DOI 10.4103/0970-9371.66694; Karayannopoulou M, 2005, J COMP PATHOL, V133, P246, DOI 10.1016/j.jcpa.2005.05.003; Karim BO, 2008, VET CLIN PATH, V37, P229, DOI 10.1111/j.1939-165X.2008.00030.x; Khan MZ, 2003, DIAGN CYTOPATHOL, V29, P185, DOI 10.1002/dc.10285; Khan N, 2009, J CYTOL, V26, P65, DOI 10.4103/0970-9371.55224; Kocaay Akin Firat, 2016, Niger Med J, V57, P77, DOI 10.4103/0300-1652.182078; Krishnakanth GVRN, 2016, ANN PATHOL LAB MED, V3, P190; Lale S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-7; Lana S.E, 2007, SMALL ANIMAL CLIN ON, P619; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Maiorano E, 2010, BREAST CANCER RES TR, V121, P211, DOI 10.1007/s10549-009-0360-y; Meinkoth JH, 2007, DIAGNOSTIC CYTOLOGY, P37; Miskovic J, 2016, ACTA CLIN CROAT, V55, P625, DOI 10.20471/acc.2016.55.04.13; Moe L, 2001, J REP FER S, P439; Pal S, 2016, J CYTOL, V33, P182, DOI 10.4103/0970-9371.190449; Park S., 2010, BASIC APPL PATHOL, V3, P1, DOI DOI 10.1186/1754-6834-3-10; Pena L, 2013, VET PATHOL, V50, P94, DOI 10.1177/0300985812447830; Phukan JP, 2015, SOUTH ASIAN J CANCER, V4, P32, DOI 10.4103/2278-330X.149948; Pierini A, 2017, J VET DIAGN INVEST, V29, P869, DOI 10.1177/1040638717718886; Queiroga FL, 2011, IN VIVO, V25, P455; ROBINSON IA, 1994, LANCET, V343, P947, DOI 10.1016/S0140-6736(94)90066-3; ROBINSON IA, 1995, DIAGN CYTOPATHOL, V13, P260, DOI 10.1002/dc.2840130315; Saha K, 2013, J CYTOL, V30, P87, DOI 10.4103/0970-9371.112647; Salas Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127381; Sapierzynski R, 2017, J SMALL ANIM PRACT, V58, P73, DOI 10.1111/jsap.12598; Schiller AB, 2001, AM J CLIN PATHOL, V115, P219; Shivani Bhalla, 2011, Brazilian Journal of Veterinary Pathology, V4, P13; Simeonov R., 2006, Bulgarian Journal of Veterinary Medicine, V9, P211; Simeonov R, 2006, VET CLIN PATH, V35, P88, DOI 10.1111/j.1939-165X.2006.tb00093.x; Simon D, 2009, VET CLIN PATH, V38, P521, DOI 10.1111/j.1939-165X.2009.00150.x; Skrbinc B, 2001, CYTOPATHOLOGY, V12, P15, DOI 10.1046/j.1365-2303.2001.00297.x; Solano-Gallego L, 2009, CANINE FELINE CYTOLO, P274; Sontas BH, 2012, REPROD DOMEST ANIM, V47, P125, DOI 10.1111/j.1439-0531.2011.01810.x; Sood Neelam, 2013, Patholog Res Int, V2013, P146542, DOI 10.1155/2013/146542; Taniguchi E, 2000, ACTA CYTOL, V44, P587, DOI 10.1159/000328533; Vascellari M, 2016, PREV VET MED, V126, P183, DOI 10.1016/j.prevetmed.2016.02.008; Wurm Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-5; Yildirim F, 2012, REV MED VET-TOULOUSE, V163, P116; Yu GH, 1998, AM J CLIN PATHOL, V109, P315, DOI 10.1093/ajcp/109.3.315; Zuccari D. A. P. de C., 2001, Brazilian Journal of Veterinary Research and Animal Science, V38, P38, DOI 10.1590/S1413-95962001000100007	61	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191595	10.1371/journal.pone.0191595	http://dx.doi.org/10.1371/journal.pone.0191595			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360854	Green Submitted, Green Published, gold			2022-12-27	WOS:000423161800039
J	Yuan, XC; Si, YT; Lin, WS; Yang, JQ; Wang, Z; Zhang, QF; Qian, W; Chen, YM; Yang, YS				Yuan, Xiaochun; Si, Youtao; Lin, Weisheng; Yang, Jingqing; Wang, Zheng; Zhang, Qiufang; Qian, Wei; Chen, Yuehmin; Yang, Yusheng			Effects of short-term warming and nitrogen addition on the quantity and quality of dissolved organic matter in a subtropical &ITCunninghamia&IT &ITlanceolate &ITplantation	PLOS ONE			English	Article							SOIL CARBON; ELEVATION GRADIENT; MICROBIAL BIOMASS; FLUORESCENCE; DEPOSITION; TEMPERATE; CO2; CLIMATE; FOREST; UV	Increasing temperature and nitrogen (N) deposition are two large-scale changes projected to occur over the coming decades. The effects of these changes on dissolved organic matter (DOM) are largely unknown. This study aimed to assess the effects of warming and N addition on the quantity and quality of DOM from a subtropical Cunninghamia lanceolata plantation. Between 2014 and 2016, soil solutions were collected from 0-15, 15-30, and 30-60 cm depths by using a negative pressure sampling method. The quantity and quality of DOM were measured under six different treatments. The spectra showed that the DOM of the forest soil solution mainly consisted of aromatic protein-like components, microbial degradation products, and negligible amounts of humic-like substances. Warming, N addition, and warming + N addition significantly inhibited the concentration of dissolved organic carbon (DOC) in the surface (0-15 cm) soil solution. Our results suggested that warming reduced the amount of DOM originating from microbes. The decrease in protein and carboxylic acid contents was mostly attributed to the reduction of DOC following N addition. The warming + N addition treatment showed an interactive effect rather than an additive effect. Thus, short-term warming and warming + N addition decreased the quantity of DOM and facilitated the migration of nutrients to deeper soils. Further, N addition increased the complexity of the DOM structure. Hence, the loss of soil nutrients and the rational application of N need to be considered in order to prevent the accumulation of N compounds in soil.	[Yuan, Xiaochun; Si, Youtao; Lin, Weisheng; Yang, Jingqing; Wang, Zheng; Zhang, Qiufang; Qian, Wei; Chen, Yuehmin; Yang, Yusheng] Fujian Normal Univ, Sch Geograph Sci, Key Lab Subtrop Mt Ecol, Fuzhou, Fujian, Peoples R China; [Si, Youtao; Lin, Weisheng; Qian, Wei; Chen, Yuehmin; Yang, Yusheng] Fujian Normal Univ, Inst Geog Sci, Fuzhou, Fujian, Peoples R China	Fujian Normal University; Fujian Normal University	Chen, YM; Yang, YS (corresponding author), Fujian Normal Univ, Sch Geograph Sci, Key Lab Subtrop Mt Ecol, Fuzhou, Fujian, Peoples R China.; Chen, YM; Yang, YS (corresponding author), Fujian Normal Univ, Inst Geog Sci, Fuzhou, Fujian, Peoples R China.	ymchen@fjnu.edu.cn; geoyys@fjnu.edu.cn	Zhang, qiufang/AFP-9827-2022; Qian, Wei/B-8231-2013		National Natural Science Foundation of China [U1505233, 31670620, 31570606, 41401555]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (Nos. U1505233, 31670620, 31570606, and 41401555).	Abouelwafa R, 2008, BIORESOURCE TECHNOL, V99, P8571, DOI 10.1016/j.biortech.2008.04.007; Artz RRE, 2008, SOIL BIOL BIOCHEM, V40, P515, DOI 10.1016/j.soilbio.2007.09.019; Birdwell JE, 2010, ORG GEOCHEM, V41, P270, DOI 10.1016/j.orggeochem.2009.11.002; BRICAUD A, 1981, LIMNOL OCEANOGR, V26, P43; Bro R, 1997, CHEMOMETR INTELL LAB, V38, P149, DOI 10.1016/S0169-7439(97)00032-4; Bu XL, 2010, GEODERMA, V159, P139, DOI 10.1016/j.geoderma.2010.07.005; Camino-Serrano M, 2014, GLOBAL BIOGEOCHEM CY, V28, P497, DOI 10.1002/2013GB004726; Chang Chen-hui, 2016, Yingyong Shengtai Xuebao, V27, P663, DOI 10.13287/j.1001-9332.201603.019; Chen H, 2015, ENVIRON POLLUT, V206, P352, DOI 10.1016/j.envpol.2015.07.033; Chen W, 2003, ENVIRON SCI TECHNOL, V37, P5701, DOI 10.1021/es034354c; Cook S, 2017, WATER RES, V115, P229, DOI 10.1016/j.watres.2017.02.059; Dilling J, 2002, WATER RES, V36, P5037, DOI 10.1016/S0043-1354(02)00365-2; Fellman JB, 2010, LIMNOL OCEANOGR, V55, P2452, DOI 10.4319/lo.2010.55.6.2452; Fenner N, 2007, ENVIRON SCI TECHNOL, V41, P3146, DOI 10.1021/es061765v; Freppaz M, 2012, APPL SOIL ECOL, V62, P131, DOI 10.1016/j.apsoil.2012.06.006; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Frey SD, 2014, BIOGEOCHEMISTRY, V121, P305, DOI 10.1007/s10533-014-0004-0; Froberg M, 2013, GEODERMA, V200, P172, DOI 10.1016/j.geoderma.2013.02.002; [傅平青 Fu Pingqing], 2004, [第四纪研究, Quaternary Sciences], V24, P695; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gao JK, 2017, CHEMOSPHERE, V176, P108, DOI 10.1016/j.chemosphere.2017.02.104; Graham SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091204; Guo XJ, 2012, ENVIRON SCI POLLUT R, V19, P2079, DOI 10.1007/s11356-011-0704-0; Hu LG, 2009, FIXED POINT THEORY A, DOI 10.1155/2009/491583; Hutchison JS, 2010, ECOSYSTEMS, V13, P661, DOI 10.1007/s10021-010-9344-3; Hyvonen R, 2007, NEW PHYTOL, V173, P463, DOI 10.1111/j.1469-8137.2007.01967.x; Ishii SKL, 2012, ENVIRON SCI TECHNOL, V46, P2006, DOI 10.1021/es2043504; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kane ES, 2016, HUMIC ACID, V119, P161; Komada T, 2002, MAR CHEM, V79, P81, DOI 10.1016/S0304-4203(02)00056-7; Lawaetz AJ, 2009, APPL SPECTROSC, V63, P936, DOI 10.1366/000370209788964548; Li PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130852; Li Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060441; Li Q, 2017, FRONT EARTH SCI-PRC, V11, P76, DOI 10.1007/s11707-016-0568-1; Li ZP, 2010, GEODERMA, V157, P206, DOI 10.1016/j.geoderma.2010.04.015; Liu XF, 2017, AGR FOREST METEOROL, V246, P78, DOI 10.1016/j.agrformet.2017.06.010; Lv FL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172382; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Nie ZY, 2016, ENVIRON SCI POLLUT R, V23, P8756, DOI 10.1007/s11356-016-6110-x; Nimptsch J, 2014, LIMNOLOGICA, V48, P57, DOI 10.1016/j.limno.2014.06.003; Nottingham AT, 2015, BIOSCIENCE, V65, P906, DOI 10.1093/biosci/biv109; Ohno T, 2002, ENVIRON SCI TECHNOL, V36, P742, DOI 10.1021/es0155276; Peuravuori J, 2005, TALANTA, V65, P408, DOI 10.1016/j.talanta.2004.06.042; Pisani O, 2015, BIOGEOCHEMISTRY, V123, P391, DOI 10.1007/s10533-015-0073-8; Rappegeorge MO, 2012, BIOGEOSCIENCES DISCU, V9, P1365; Reid JP, 2012, ECOSYSTEMS, V15, P580, DOI 10.1007/s10021-012-9532-4; Richter A, 2005, NATURE, V437, P129, DOI 10.1038/nature04092; Spring GM, 1996, FUNCT ECOL, V10, P541, DOI 10.2307/2389948; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572, DOI 10.4319/lom.2008.6.572; Torn MS, 2015, SOIL-GERMANY, V1, P575, DOI 10.5194/soil-1-575-2015; VANBREEMEN N, 1984, NATURE, V307, P599, DOI 10.1038/307599a0; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Verstraeten A, 2016, SCI TOTAL ENVIRON, V553, P107, DOI 10.1016/j.scitotenv.2016.02.060; Vourlitis GL, 2007, SOIL SCI SOC AM J, V71, P836, DOI 10.2136/sssaj2006.0339; Vourlitis GL, 2015, J ARID ENVIRON, V122, P37, DOI 10.1016/j.jaridenv.2015.06.007; Wang XG, 2016, J MT SCI-ENGL, V13, P95, DOI 10.1007/s11629-015-3556-0; Wang Y, 2014, CHEMOSPHERE, V95, P353, DOI 10.1016/j.chemosphere.2013.09.044; Webb EE, 2016, J GEOPHYS RES-BIOGEO, V121, P249, DOI 10.1002/2014JG002795; Williams CJ, 2010, LIMNOL OCEANOGR, V55, P1159, DOI 10.4319/lo.2010.55.3.1159; Xu X, 2010, IEEE INFOCOM SER; Xu XK, 2009, GEODERMA, V151, P370, DOI 10.1016/j.geoderma.2009.05.008; Yang YS, 2009, PLANT SOIL, V323, P153, DOI 10.1007/s11104-009-9921-4; Yin HJ, 2012, SOIL BIOL BIOCHEM, V50, P77, DOI 10.1016/j.soilbio.2012.03.004; Zhang QF, 2017, PLANT SOIL, V411, P395, DOI 10.1007/s11104-016-3037-4; Zhang YL, 2009, WATER RES, V43, P4685, DOI 10.1016/j.watres.2009.07.024; Ziegler SE, 2013, SOIL BIOL BIOCHEM, V60, P23, DOI 10.1016/j.soilbio.2013.01.001	67	12	16	10	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191403	10.1371/journal.pone.0191403	http://dx.doi.org/10.1371/journal.pone.0191403			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360853	Green Submitted, gold, Green Published			2022-12-27	WOS:000423161800028
J	Akbilgic, O; Langham, MR; Walter, AI; Jones, TL; Huang, EY; Davis, RL				Akbilgic, Oguz; Langham, Max R., Jr.; Walter, Arianne I.; Jones, Tamekia L.; Huang, Eunice Y.; Davis, Robert L.			A novel risk classification system for 30-day mortality in children undergoing surgery	PLOS ONE			English	Article							PHYSICAL STATUS; PERIOPERATIVE RISK; ASA CLASSIFICATION; SURGICAL CARE; SOCIETY; SAFETY; MORBIDITY; VARIABLES; INFANTS; QUALITY	A simple, objective and accurate way of grouping children undergoing surgery into clinically relevant risk groups is needed. The purpose of this study, is to develop and validate a preoperative risk classification system for postsurgical 30-day mortality for children undergoing a wide variety of operations. The National Surgical Quality Improvement Project-Pediatric participant use file data for calendar years 2012-2014 was analyzed to determine preoperative variables most associated with death within 30 days of operation (D30). Risk groups were created using classification tree analysis based on these preoperative variables. The resulting risk groups were validated using 2015 data, and applied to neonates and higher risk CPT codes to determine validity in high-risk subpopulations. A five-level risk classification was found to be most accurate. The preoperative need for ventilation, oxygen support, inotropic support, sepsis, the need for emergent surgery and a do not resuscitate order defined non-overlapping groups with observed rates of D30 that vary from 0.075% (Very Low Risk) to 38.6% (Very High Risk). When CPT codes where death was never observed are eliminated or when the system is applied to neonates, the groupings remained predictive of death in an ordinal manner.	[Akbilgic, Oguz; Davis, Robert L.] Univ Tennessee, Hlth Sci Ctr, Ctr Biomed Informat, Oak Ridge Natl Lab, Memphis, TN 38163 USA; [Akbilgic, Oguz; Huang, Eunice Y.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN 38163 USA; [Langham, Max R., Jr.; Walter, Arianne I.; Huang, Eunice Y.] Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38163 USA; [Huang, Eunice Y.] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38163 USA; [Huang, Eunice Y.] La Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Langham, MR (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN 38163 USA.	mlangham@uthsc.edu	akbilgic, oguz/F-9407-2013; Langham, Max/U-4060-2019	akbilgic, oguz/0000-0003-0313-9254; Langham, Max/0000-0002-3195-4857; Huang, Eunice/0000-0003-1413-7860	Children's Foundation Research Institute at LeBonheur Children's Hospital	Children's Foundation Research Institute at LeBonheur Children's Hospital	We would like to thank, Kim Giles, Robert Beck and other Surgical Case Reviewers, and our colleagues who have served on the data definitions and modeling committees of NSQIP-Pediatric. Their dedicated work has resulted in the information that made this work possible. We also gratefully acknowledge the support of the Children's Foundation Research Institute at LeBonheur Children's Hospital.	American College of Surgeons, 2015, OPT RES CHILDR SURG OPT RES CHILDR SURG; American College of Surgeons National Surgical Quality Improvement Program Pediatric, 2014, US GUID 2013 ACS NSQ; Aplin S, 2017, PEDIAT ANESTHESIA, V17, P216; Bezner SK, 2014, J PEDIATR SURG, V49, P1475, DOI 10.1016/j.jpedsurg.2014.03.002; Boyd O, 2005, CRIT CARE, V9, P390, DOI 10.1186/cc3057; Breiman L., 1984, CLASSIFICATION REGRE; Bucher TB, 2016, J PEDIAT SURG; Carson-Stevens A, 2015, LANCET, V385, P1593, DOI 10.1016/S0140-6736(14)61739-6; Catré Dora, 2013, Rev. bras. epidemiol., V16, P943, DOI 10.1590/S1415-790X2013000400014; Cohen ME, 2009, ANN SURG, V249, P682, DOI 10.1097/SLA.0b013e31819eda21; Cooper JN, 2015, COMPUT BIOL MED, V57, P54, DOI 10.1016/j.compbiomed.2014.11.009; Davenport DL, 2006, ANN SURG, V243, P636, DOI 10.1097/01.sla.0000216508.95556.cc; Demir E, 2014, DECISION SCI, V45, P849, DOI 10.1111/deci.12094; Dillon P, 2008, SEMIN PEDIATR SURG, V17, P131, DOI 10.1053/j.sempedsurg.2008.02.009; Fitz-Henry J, 2011, ANN ROY COLL SURG, V93, P185, DOI 10.1308/rcsann.2011.93.3.185a; Freilich DA, 2010, UROLOGY, V76, P3, DOI 10.1016/j.urology.2009.08.079; Fritsch G, 2012, ACTA ANAESTH SCAND, V56, P339, DOI 10.1111/j.1399-6576.2011.02593.x; Glotzbecker MP, 2016, J PEDIATR ORTHOPED, V36, P549, DOI 10.1097/BPO.0000000000000506; Grosfeld JG, 2012, PEDIAT SURG, V1, P3; Hankinson TC, 2016, J NEUROSURG-PEDIATR, V17, P289, DOI 10.3171/2015.7.PEDS15224; Hawkins DM, 1982, TOPICS APPL MULTIVAR, P269; Jacobs JP, 2014, ANN THORAC SURG, V98, P1653, DOI 10.1016/j.athoracsur.2014.07.029; Kazaure H, 2011, ARCH SURG-CHICAGO, V146, P922, DOI 10.1001/archsurg.2011.69; Kraemer K, 2016, J AM COLL SURGEONS, V223, P685, DOI 10.1016/j.jamcollsurg.2016.08.542; Langham MR, 2015, SURGERY, V158, P1482, DOI 10.1016/j.surg.2015.04.026; Lewis RJ, 2000 ANN M SOC AC EM; McArdle JJ, 2013, QUANTITATIVE METHODO; Morriss FH, 2014, JAMA PEDIATR, V168, P746, DOI 10.1001/jamapediatrics.2014.307; Rappaport B, 2011, NEW ENGL J MED, V364, P1387, DOI 10.1056/NEJMp1102155; Sankar A, 2014, BRIT J ANAESTH, V113, P424, DOI 10.1093/bja/aeu100; Scott JP, 2015, ADV ANESTH; Semel ME, 2012, SURGERY, V151, P171, DOI 10.1016/j.surg.2011.07.021; Shah N, 2013, CRIT CARE, V17, DOI 10.1186/cc11904; Skarsgard ED, 2016, CAN J SURG, V59, P161, DOI 10.1503/cjs.016715; Steinberg D, 2009, CH CRC DATA MIN KNOW, P179, DOI 10.1201/9781420089653.ch10; Udupa AN, 2015, PEDIATR ANESTH, V25, P309, DOI 10.1111/pan.12588; Williams RK, 2006, ANESTH ANALG, V102, P67, DOI 10.1213/01.ANE.0000159162.86033.21; Wolters U, 1996, BRIT J ANAESTH, V77, P217, DOI 10.1093/bja/77.2.217	38	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191176	10.1371/journal.pone.0191176	http://dx.doi.org/10.1371/journal.pone.0191176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351327	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300054
J	Zhou, XJ; Desai, R; Zhang, YH; Stec, WJ; Miller, KW; Jounaidi, Y				Zhou, Xiaojuan; Desai, Rooma; Zhang, Yinghui; Stec, Wojciech J.; Miller, Keith W.; Jounaidi, Youssef			High-level production and purification in a functional state of an extrasynaptic gammaaminobutyric acid type A receptor containing alpha 4 beta 3 delta subunits	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; GABA(A) RECEPTORS; DELTA-SUBUNIT; PHARMACOLOGICAL CHARACTERIZATION; EXPRESSION; RECOMBINANT; ALPHA-1-BETA-3-DELTA; STOICHIOMETRY; ARRANGEMENT; ACTIVATION	The inhibitory.-aminobutyric acid type A receptors are implicated in numerous physiological processes, including cognition and inhibition of neurotransmission, rendering them important molecular targets for many classes of drugs. Functionally, the entire GABA(A)R family of receptors can be subdivided into phasic, fast acting synaptic receptors, composed of alpha-, beta- and gamma-subunits, and tonic extrasynaptic receptors, many of which contain the delta-subunit in addition to a-and beta-subunits. Whereas the subunit arrangement of the former group is agreed upon, that of the alpha beta delta GABA(A)Rs remains unresolved by electrophysiological and pharmacological research. To resolve such issues will require biophysical techniques that demand quantities of receptor that have been previously unavailable. Therefore, we have engineered a stable cell line with tetracycline inducible expression of human alpha 4-, beta 3- and Nterminally Flag-tagged delta-subunits. This cell line achieved a specific activity between 15 and 20 pmol[H-3] muscimol sites/mg of membrane protein, making it possible to obtain 1 nmole of purified alpha 4 beta 3 delta GABAAR from sixty 15 +/- cm culture dishes. When induced, these cells exhibited agonist +/- induced currents with characteristics comparable to those previously reported for this receptor and a pharmacology that included strong modulation by etomidate and the d-subunit-specific ligand, DS2. Immunoaffinity purification and reconstitution in CHAPS/asolectin micelles resulted in the retention of equilibrium allosteric interactions between the separate agonist, anesthetic and DS2 sites. Moreover, all three subunits retained glycosylation. The establishment of this well +/- characterized cell line will allow molecular level studies of tonic receptors to be undertaken.	[Zhou, Xiaojuan; Desai, Rooma; Zhang, Yinghui; Stec, Wojciech J.; Miller, Keith W.; Jounaidi, Youssef] Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Miller, KW (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA.	kwmiller@mgh.harvard.edu			National Institute of General Medical Sciences [GM 58448]; Department of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital; National Institutes of Health Grant [GM-58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the National Institute of General Medical Sciences GM 58448 (to KWM) and by the Department of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital (to YJ, RD and KWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health Grant GM-58448 and by the Department of Anesthesia, Critical Care & Pain Medicine, Massachusetts General Hospital. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adkins CE, 2001, J BIOL CHEM, V276, P38934, DOI 10.1074/jbc.M104318200; Akk G, 2004, J PHYSIOL-LONDON, V556, P387, DOI 10.1113/jphysiol.2003.058230; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Botzolakis EJ, 2016, J BIOL CHEM, V291, P20440, DOI 10.1074/jbc.M115.698860; Brickley SG, 2012, NEURON, V73, P23, DOI 10.1016/j.neuron.2011.12.012; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Chiara DC, 2016, J BIOL CHEM, V291, P26529, DOI 10.1074/jbc.M116.753335; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; Dostalova Z, 2014, PROTEIN SCI, V23, P157, DOI 10.1002/pro.2401; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; Eaton MM, 2014, MOL PHARMACOL, V86, P647, DOI 10.1124/mol.114.094813; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng HJ, 2004, MOL PHARMACOL, V66, P988, DOI 10.1124/mol.104.002543; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Forman SA, 1999, BIOCHEMISTRY-US, V38, P14559, DOI 10.1021/bi9914457; Forman SA, 2016, ANESTH ANALG, V123, P1263, DOI 10.1213/ANE.0000000000001368; Hartiadi LY, 2016, BIOCHEM PHARMACOL, V103, P98, DOI 10.1016/j.bcp.2015.12.021; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Jensen ML, 2013, BRIT J PHARMACOL, V168, P1118, DOI 10.1111/bph.12001; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; Lee HJ, 2016, BRAIN RES, V1644, P222, DOI 10.1016/j.brainres.2016.05.019; Liu K, 2015, NEUROSCIENCE, V300, P307, DOI 10.1016/j.neuroscience.2015.05.051; Meera P, 2010, MOL PHARMACOL, V78, P918, DOI 10.1124/mol.109.062687; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; QUIRK K, 1995, EUR J PHARM-MOLEC PH, V290, P175, DOI 10.1016/0922-4106(95)00061-5; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Sieghart W, 2015, ADV PHARMACOL, V72, P53, DOI 10.1016/bs.apha.2014.10.002; Tang X, 2010, J NEUROPHYSIOL, V103, P1007, DOI 10.1152/jn.00801.2009; Wagoner KR, 2010, J BIOL CHEM, V285, P14187, DOI 10.1074/jbc.M110.104257; Wongsamitkul N, 2016, J BIOL CHEM, V291, P18474, DOI 10.1074/jbc.M116.738906; Zhang YH, 2014, BIOPHYS J, V106, p547A, DOI 10.1016/j.bpj.2013.11.3044	34	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191583	10.1371/journal.pone.0191583	http://dx.doi.org/10.1371/journal.pone.0191583			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352320	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300117
J	Agah, E; Zardoui, A; Saghazadeh, A; Ahmadi, M; Tafakhori, A; Rezaei, N				Agah, Elmira; Zardoui, Arshia; Saghazadeh, Amene; Ahmadi, Mona; Tafakhori, Abbas; Rezaei, Nima			Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis	PLOS ONE			English	Review							BODY-FLUID BIOMARKERS; CEREBROSPINAL-FLUID; DISEASE-ACTIVITY; DENDRITIC CELLS; DIAGNOSIS; CORRELATE; NATALIZUMAB; SURVIVAL; INFLAMMATION; PROGRESSION	Identifying a reliable biomarker may accelerate diagnosis of multiple sclerosis (MS) and lead to early management of the disease. Accumulating evidence suggest that cerebrospinal fluid (CSF) and peripheral blood concentration of osteopontin (OPN) may have diagnostic and prognostic value in MS. We conducted a systematic review and meta-analysis of studies that measured peripheral blood and CSF levels of OPN in MS patients and controls to evaluate the diagnostic potential of this biomarker better. We searched PubMed, Web of Science and Scopus databases to find articles that measured OPN concentration in peripheral blood and CSF samples from MS patients up to October 19, 2016. Q statistic tests and the I2 index were applied for heterogeneity assessment. If the I2 index was less than 40%, the fixed-effects model was used for meta-analysis. Random-effects meta-analysis was chosen if the I2 value was greater than 40%. After removal of duplicates, 918 articles were identified, and 27 of them fulfilled the inclusion criteria. We included 22 eligible studies in the final meta-analysis. MS patients, in general, had considerably higher levels of OPN in their CSF and blood when compared to all types of controls (p<0.05). When the comparisons were made between different subtypes of MS patients and controls, the results pointed to significantly higher levels of OPN in CSF of MS subgroups (p<0.05). All subtypes of MS patients, except CIS patients, had increased blood levels of OPN compared to controls (p<0.05). In the second set of meta-analyses, we compared the peripheral blood and CSF concentrations of OPN between MS patient subtypes. CIS patients had significantly lower levels of OPN both in their peripheral blood and CSF compared to patients with progressive subtypes of MS (p<0.05). CSF concentration of OPN was significantly higher among RRMS patients compared to the CIS patients and SPMS patients (P<0.05). Finally, patients with active MS had significantly higher OPN levels in their CSF compared to patients with stable disease (P = 0.007). The result of this study confirms that increased levels of OPN exist in CSF and peripheral blood of MS patients and strengthens the evidence regarding the clinical utility of OPN as a promising and validated biomarker for MS.	[Agah, Elmira; Zardoui, Arshia] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran; [Agah, Elmira; Zardoui, Arshia; Tafakhori, Abbas] USERN, NeuroImmunol Res Assoc NIRA, Tehran, Iran; [Saghazadeh, Amene; Rezaei, Nima] Univ Tehran Med Sci, Childrens Med Ctr, Res Ctr Immunodeficiencies RCID, Tehran, Iran; [Saghazadeh, Amene] USERN, Systemat Review & Meta Anal Expert Grp SRMEG, Boston, MA USA; [Tafakhori, Abbas] Univ Tehran Med Sci, ICNR, Tehran, Iran; [Rezaei, Nima] USERN, NIIMA, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Tafakhori, A (corresponding author), USERN, NeuroImmunol Res Assoc NIRA, Tehran, Iran.; Rezaei, N (corresponding author), Univ Tehran Med Sci, Childrens Med Ctr, Res Ctr Immunodeficiencies RCID, Tehran, Iran.; Tafakhori, A (corresponding author), Univ Tehran Med Sci, ICNR, Tehran, Iran.; Rezaei, N (corresponding author), USERN, NIIMA, Tehran, Iran.	a_tafakhori@sina.tums.ac.ir; rezaei_nima@tums.ac.ir	Rezaei, Nima/B-4245-2008	Rezaei, Nima/0000-0002-3836-1827; Agah, Elmira/0000-0001-8541-8075; Saghazadeh, Amene/0000-0002-0945-8443				Altintas A, 2009, J NEUROL SCI, V276, P41, DOI 10.1016/j.jns.2008.08.031; [Anonymous], 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119681; Assadi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024240; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bandopadhyay M, 2014, EXPERT OPIN THER TAR, V18, P883, DOI 10.1517/14728222.2014.925447; Bornsen L, 2011, MULT SCLER J, V17, P32, DOI 10.1177/1352458510382247; Braitch M, 2008, ARCH NEUROL-CHICAGO, V65, P633, DOI 10.1001/archneur.65.5.633; Carecchio M, 2011, J ALZHEIMERS DIS, V25, P179, DOI 10.3233/JAD-2011-102151; Carvalho AF, 2016, PSYCHOTHER PSYCHOSOM, V85, P81, DOI 10.1159/000441457; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chabas DE, 2001, FASEB J, V15, pA354; Chiocchetti A, 2005, J NEUROIMMUNOL, V163, P172, DOI 10.1016/j.jneuroim.2005.02.020; Chowdhury SA, 2008, ARCH NEUROL-CHICAGO, V65, P232, DOI 10.1001/archneurol.2007.33; Christensen JR, 2014, NEUROLOGY, V82, P1499, DOI 10.1212/WNL.0000000000000361; Christensen JR, 2013, MULT SCLER J, V19, P877, DOI 10.1177/1352458512466929; Chung SE, 2012, EPIDEMIOL HEALTH, V34, DOI 10.4178/epih/e2012008; Comabella M, 2005, J NEUROIMMUNOL, V158, P231, DOI 10.1016/j.jneuroim.2004.09.004; Comabella M, 2014, LANCET NEUROL, V13, P113, DOI 10.1016/S1474-4422(13)70233-3; Comi C, 2007, MULT SCLER, V13, pS194; Comi C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/212893; Comi C, 2010, J ALZHEIMERS DIS, V19, P1143, DOI 10.3233/JAD-2010-1309; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Diao HY, 2012, CYTOKINE, V60, P129, DOI 10.1016/j.cyto.2012.06.287; Edwards LJ, 2013, AM J CLIN EXP IMMUNO, V2, P234; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferret-Sena V, 2016, NATALIZUMAB TREATMEN, V2016; Filippi M, 2016, LANCET NEUROL, V15, P292, DOI 10.1016/S1474-4422(15)00393-2; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Giesser BS, 2011, NEUROL CLIN, V29, P381, DOI 10.1016/j.ncl.2010.12.001; Harris VK, 2014, MOL DIAGN THER, V18, P605, DOI 10.1007/s40291-014-0117-0; Hemmer B, 2015, LANCET NEUROL, V14, P406, DOI 10.1016/S1474-4422(14)70305-9; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Housley WJ, 2015, CLIN IMMUNOL, V161, P51, DOI 10.1016/j.clim.2015.06.015; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Iaffaldano P, 2014, BRAIN BEHAV IMMUN, V35, P176, DOI 10.1016/j.bbi.2013.08.009; Jones AP, 2017, CLIN EXP IMMUNOL, V187, P193, DOI 10.1111/cei.12878; Kanekar S, 2014, RADIOL CLIN N AM, V52, P241, DOI 10.1016/j.rcl.2013.11.010; Kariya Y, 2015, BBA CLIN, V3, P126, DOI 10.1016/j.bbacli.2015.01.003; Kawamura K, 2005, CLIN DIAGN LAB IMMUN, V12, P206, DOI 10.1128/CDLI.12.1.206-212.2005; Khademi M, 2009, EUR J NEUROL, V16, P528, DOI 10.1111/j.1468-1331.2009.02532.x; Khademi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063172; Kivisakk P, 2014, MULT SCLER J, V20, P438, DOI 10.1177/1352458513503052; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Ma N, 2014, MOL IMMUNOL, V57, P129, DOI 10.1016/j.molimm.2013.08.014; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Ratzer R, 2015, MULTIPLE SCLEROSIS; Rittling SR, 2015, J DENT RES, V94, P1638, DOI 10.1177/0022034515605270; Shimizu Y, 2013, J NEUROIMMUNOL, V263, P148, DOI 10.1016/j.jneuroim.2013.07.005; Strehlow F, 2016, J NEURO-ONCOL, V129, P165, DOI 10.1007/s11060-016-2162-5; SUN Y, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/615745; Szalardy L, 2013, J NEUROL SCI, V331, P38, DOI 10.1016/j.jns.2013.04.024; Teunissen CE, 2015, NAT REV NEUROL, V11, P585, DOI 10.1038/nrneurol.2015.173; Tullman MJ, 2013, AM J MANAG CARE, V19, pS15; Tumani H, 2011, EUR NEUROL, V65, P164, DOI 10.1159/000324035; Vogt MHJ, 2010, MULT SCLER J, V16, P443, DOI 10.1177/1352458509359723; Vogt MHJ, 2004, J NEUROIMMUNOL, V155, P155, DOI 10.1016/j.jneuroim.2004.06.007; Vogt MHJ, 2003, ANN NEUROL, V53, P819, DOI 10.1002/ana.10606; Weiner HL, 2004, ARCH NEUROL-CHICAGO, V61, P1613, DOI 10.1001/archneur.61.10.1613; Wells G, 2000, NEWCASTLE OTTAWA SCA; Wen SR, 2012, J NEUROIMMUNOL, V244, P94, DOI 10.1016/j.jneuroim.2011.12.004; Yu ZY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015843, 10.1371/journal.pone.0017951]	66	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190252	10.1371/journal.pone.0190252	http://dx.doi.org/10.1371/journal.pone.0190252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346446	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500012
J	Chiarelli, N; Carini, G; Zoppi, N; Ritelli, M; Colombi, M				Chiarelli, Nicola; Carini, Giulia; Zoppi, Nicoletta; Ritelli, Marco; Colombi, Marina			Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SYNDROME TYPE-IV; UNFOLDED PROTEIN RESPONSE; EXTRACELLULAR-MATRIX; ENDOPLASMIC-RETICULUM; CONNECTIVE TISSUES; COLLAGEN; HAPLOINSUFFICIENCY; SPECIFICITY; FIBRONECTIN	Vascular Ehlers-Danlos syndrome (vEDS) is a dominantly inherited connective tissue disorder caused by mutations in the COL3A1 gene that encodes type III collagen (COLLIII), which is the major expressed collagen in blood vessels and hollow organs. The majority of disease-causing variants in COL3A1 are glycine substitutions and in-frame splice mutations in the triple helix domain that through a dominant negative effect are associated with the severe clinical spectrum potentially lethal of vEDS, characterized by fragility of soft connective tissues with arterial and organ ruptures. To shed lights into molecular mechanisms underlying vEDS, we performed gene expression profiling in cultured skin fibroblasts from three patients with different structural COL3A1 mutations. Transcriptome analysis revealed significant changes in the expression levels of several genes involved in maintenance of cell redox and endoplasmic reticulum (ER) homeostasis, COLLs folding and extracellular matrix (ECM) organization, formation of the proteasome complex, and cell cycle regulation. Protein analyses showed that aberrant COLLIII expression is associated with the disassembly of many structural ECM constituents, such as fibrillins, EMILINs, and elastin, as well as with the reduction of the proteoglycans perlecan, decorin, and versican, all playing an important role in the vascular system. Furthermore, the altered distribution of the ER marker protein disulfide isomerase PDI and the strong reduction of the COLLs-modifying enzyme FKBP22 are consistent with the disturbance of ER-related homeostasis and COLLs biosynthesis and post-translational modifications, indicated by microarray analysis. Our findings add new insights into the pathophysiology of this severe vascular disorder, since they provide a picture of the gene expression changes in vEDS skin fibroblasts and highlight that dominant negative mutations in COL3A1 also affect post-translational modifications and deposition into the ECM of several structural proteins crucial to the integrity of soft connective tissues.	[Chiarelli, Nicola; Carini, Giulia; Zoppi, Nicoletta; Ritelli, Marco; Colombi, Marina] Univ Brescia, Dept Mol & Translat Med, Div Biol & Genet, Brescia, Italy	University of Brescia	Colombi, M (corresponding author), Univ Brescia, Dept Mol & Translat Med, Div Biol & Genet, Brescia, Italy.	marina.colombi@unibs.it	Carini, Giulia/AAA-8800-2022; Chiarelli, Nicola/T-4923-2019	Carini, Giulia/0000-0001-8096-9417; RITELLI, Marco/0000-0002-7025-2495; Chiarelli, Nicola/0000-0002-1760-5079; Colombi, Marina/0000-0002-3105-5990; ZOPPI, Nicoletta/0000-0003-0197-8927				Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Aziz J, 2016, SKIN PHARMACOL PHYS, V29, P190, DOI 10.1159/000447017; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Baumann M, 2012, AM J HUM GENET, V90, P201, DOI 10.1016/j.ajhg.2011.12.004; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Boot-Handford RP, 2010, CELL TISSUE RES, V339, P197, DOI 10.1007/s00441-009-0877-8; Busch A, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0491-2; Byers PH, 2017, AM J MED GENET C, V175, P40, DOI 10.1002/ajmg.c.31553; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; Cooper TK, 2010, VET PATHOL, V47, P1028, DOI 10.1177/0300985810374842; Davenport AP, 2016, PHARMACOL REV, V68, P357, DOI 10.1124/pr.115.011833; Davis MR, 2012, MOL GENET METAB, V107, P635, DOI 10.1016/j.ymgme.2012.07.023; De Palma S, 2014, J PROTEOME RES, V13, P5022, DOI 10.1021/pr500675e; DEPAEPE A, 1987, BRIT J DERMATOL, V117, P89; Dietz HC, 2010, J CLIN INVEST, V120, P403, DOI 10.1172/JCI42014; Dordoni C, 2016, AM J MED GENET A, V170, P2031, DOI 10.1002/ajmg.a.37728; Drera B, 2011, J DERMATOL SCI, V64, P237, DOI 10.1016/j.jdermsci.2011.09.002; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Forlino A, 2007, PROTEOMICS, V7, P1877, DOI 10.1002/pmic.200600919; Frank M, 2015, EUR J HUM GENET, V23, P1657, DOI 10.1038/ejhg.2015.32; Giunta C, 2017, GENET MED; Gjaltema RAF, 2017, CRIT REV BIOCHEM MOL, V52, P74, DOI 10.1080/10409238.2016.1269716; Halper J, 2014, ADV EXP MED BIOL, V802, P31, DOI 10.1007/978-94-007-7893-1_3; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; HOLBROOK KA, 1981, LAB INVEST, V44, P342; Hughes A, 2017, INT J MOL SCI, V18; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Ishikawa Y, 2014, J BIOL CHEM, V289, P18189, DOI 10.1074/jbc.M114.561944; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kvist AJ, 2006, J BIOL CHEM, V281, P33127, DOI 10.1074/jbc.M607892200; Leistritz DF, 2011, GENET MED, V13, P717, DOI 10.1097/GIM.0b013e3182180c89; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Lord MS, 2014, MATRIX BIOL, V35, P112, DOI 10.1016/j.matbio.2014.01.016; Lu J, 2014, ANTIOXID REDOX SIGN, V21, P457, DOI 10.1089/ars.2014.5849; Lu M, 2016, ONCOL RES, V23, P267, DOI 10.3727/096504016X14549667333963; Malfait F, 2017, AM J MED GENET C, V175, P8, DOI 10.1002/ajmg.c.31552; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Marthandan S, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0095-2; Masuno M, 2012, CONGENIT ANOM, V52, P207, DOI 10.1111/j.1741-4520.2011.00353.x; Meirelles T, 2016, INT J BIOCHEM CELL B, V71, P81, DOI 10.1016/j.biocel.2015.12.009; Melnyk Armin, 2015, Subcell Biochem, V78, P179, DOI 10.1007/978-3-319-11731-7_9; Morissette R, 2014, CIRC-CARDIOVASC GENE, V7, P80, DOI 10.1161/CIRCGENETICS.113.000280; Murray ML, 2014, AM J MED GENET A, V164, P1750, DOI 10.1002/ajmg.a.36492; Ong KT, 2010, LANCET, V376, P1476, DOI 10.1016/S0140-6736(10)60960-9; Parkin J. D, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0175582; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Pepin MG, 2014, GENET MED, V16, P881, DOI 10.1038/gim.2014.72; Pieri M, 2014, J AM SOC NEPHROL, V25, P260, DOI 10.1681/ASN.2012121217; Randell A, 2017, J AM SOC HYPERTENS, V11, P437, DOI 10.1016/j.jash.2017.04.010; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Ritelli M, 2015, MOLEC GENET METAB RE, V2, P1, DOI 10.1016/j.ymgmr.2014.11.005; Rodriguez-Vita J, 2005, CIRC RES, V97, P125, DOI 10.1161/01.RES.0000174614.74469.83; Schoenhoff FS, 2009, CIRCULATION, V120, pS1048; Schwartz MA, 2001, J CELL SCI, V114, P2553; Schwarze U, 2001, AM J HUM GENET, V69, P989, DOI 10.1086/324123; Smith LB, 2011, CARDIOVASC RES, V90, P182, DOI 10.1093/cvr/cvq356; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; Moretti AIS, 2017, ARCH BIOCHEM BIOPHYS, V617, P106, DOI 10.1016/j.abb.2016.11.007; Stepanov GA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/206849; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Ullman E, 2008, CELL DEATH DIFFER, V15, P422, DOI 10.1038/sj.cdd.4402234; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Villani GRD, 2012, J INHERIT METAB DIS, V35, P479, DOI 10.1007/s10545-011-9403-8; Wan GH, 2014, ANTIOXID REDOX SIGN, V20, P655, DOI 10.1089/ars.2013.5514; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zilberberg L, 2012, J CELL PHYSIOL, V227, P3828, DOI 10.1002/jcp.24094; Zoppi N, 2004, J BIOL CHEM, V279, P18157, DOI 10.1074/jbc.M312609200; Zoppi N, 2008, BBA-MOL CELL RES, V1783, P1177, DOI 10.1016/j.bbamcr.2008.03.003; Zoppi N, 2015, HUM MOL GENET, V24, P6769, DOI 10.1093/hmg/ddv382; Zoppi N, 2012, BBA-GEN SUBJECTS, V1820, P1576, DOI 10.1016/j.bbagen.2012.06.004	72	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191220	10.1371/journal.pone.0191220	http://dx.doi.org/10.1371/journal.pone.0191220			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346445	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500037
J	Gal, B; Rubio, M; Iglesias, E; Gonzalez, P				Gal, Beatriz; Rubio, Margarita; Iglesias, Eva; Gonzalez, Purificacion			Evaluation of participatory teaching methods in undergraduate medical students' learning along the first academic courses	PLOS ONE			English	Article								The European Higher Education Area (EHEA)is an opportunity to redesign medical education. Academic training is now focused on acquiring not only knowledge, but also those competencies critical to face complex professional scenarios. Together with re-evaluating traditional teaching methods, EHEA has forced a technological shift in the way we teach. By critically assessing the impact of novel teaching methodologies, we can better define biomedical education demands. Here, we address this question on a sample of medical students instructed in basic subjects along the first two academic courses. Two hundred and one medical students participated in the study (n = 128 first year, n = 73 second year). Quantitative (conventional survey statistics) and qualitative (open coding) approaches were combined to analyze data from surveys, confidential questionnaires, semi-structured interviews and open discussion. First year medical students rated more positively the use of participatory methodologies than second year students. A major drawback is detected in the perceived workload. Active teaching methodologies show a strong reliance on their time of implementation for medical students, a key aspect to be considered in the design of integrative participatory curricula along the first academic courses.	[Gal, Beatriz; Iglesias, Eva] Univ Europea Madrid, Fac Ciencias Basicas & Salud, Dept Ciencias Biomed Basicas, Madrid, Spain; [Rubio, Margarita] Univ Europea Madrid, Fac Ciencias Basicas & Salud, Dept Farm & Biotecnol, Madrid, Spain; [Gonzalez, Purificacion] Univ Alcala, Fac Enfermeria, Dept Enfermeria & Fisioterapia, Madrid, Spain	European University of Madrid; European University of Madrid; Universidad de Alcala	Gal, B (corresponding author), Univ Europea Madrid, Fac Ciencias Basicas & Salud, Dept Ciencias Biomed Basicas, Madrid, Spain.	beatriz.gal@universidadeuropea.es	Iglesias, Eva/K-6614-2017; Gal, Beatriz/J-3530-2018; Rubio, Margarita/Q-8825-2018	Iglesias, Eva/0000-0002-7086-7553; Gal, Beatriz/0000-0001-5189-1147; Rubio, Margarita/0000-0003-2484-1042	UEM [OTRI 2015/UEM18]	UEM	This work was supported by UEM, grant# OTRI 2015/UEM18 (to BG) (www.uem.es). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ESPANA PROCESO BOLON; [Anonymous], 1999, BOLOGNA PROCESS SETT; Bloom B.S., 1956, HANDBOOK; Breaux A, 2016, ED LEADERSHIP, V73; Collins G, 2003, GREENWOOD DICT ED; Gal B, 2013, ED MED FEM, V16, P225; Gal Beatriz, 2011, BMC Res Notes, V4, P360, DOI 10.1186/1756-0500-4-360; Guerrero S. M., 2005, Journal of Educational Computing Research, V33, P249, DOI 10.2190/BLQ7-AT6T-2X81-D3J9; Hounsell D, 2009, HDB TEACHING LEARNIN; Khan Khalid S, 2006, BMC Med Educ, V6, P59, DOI 10.1186/1472-6920-6-59; Morales P, 2004, THEORIA; Nicol DJ, 2006, STUD HIGH EDUC, V31, P199, DOI 10.1080/03075070600572090; Pales JL, 2006, ED MED, V9, P59; Prat-Corominas Joan, 2011, Educ. méd., V14, P141; Prince M, 2004, J ENG EDUC, V93, P223, DOI 10.1002/j.2168-9830.2004.tb00809.x; Ruiz Olabuenaga J.I., 2003, METODOLOGIA INVESTIG; Somacarrera ML, 2009, MED ORAL PATHOLOGIA, V14, P583; Strauss A, 2002, TECNICAS PROCEDIMIEN; Wochter, 2004, EUR J EDUC, V39, P265, DOI [10.1111/j.1465-3435.2004.00182.x, DOI 10.1111/J.1465-3435.2004.00182.X]; Yaniz C, 2006, RETO SOC CONOCIMIENT	20	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190173	10.1371/journal.pone.0190173	http://dx.doi.org/10.1371/journal.pone.0190173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9PC	29346395	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500009
J	Gautam, M; Bhattacharya, I; Rai, U; Majumdar, SS				Gautam, Mukesh; Bhattacharya, Indrashis; Rai, Umesh; Majumdar, Subeer S.			Hormone induced differential transcriptome analysis of Sertoli cells during postnatal maturation of rat testes	PLOS ONE			English	Article							GERM-CELL; GENE-EXPRESSION; ANDROGEN RECEPTOR; MOUSE TESTIS; JUNCTION DYNAMICS; MONONUCLEAR-CELLS; MESSENGER-RNA; FSH; IDENTIFICATION; CYTOKINES	Sertoli cells (Sc) are unique somatic cells of testis that are the target of both FSH and testosterone (T) and regulate spermatogenesis. Although Sc of neonatal rat testes are exposed to high levels of FSH and T, robust differentiation of spermatogonial cells becomes conspicuous only after 11-days of postnatal age. We have demonstrated earlier that a developmental switch in terms of hormonal responsiveness occurs in rat Sc at around 12 days of postnatal age during the rapid transition of spermatogonia A to B. Therefore, such "functional maturation" of Sc, during pubertal development becomes prerequisite for the onset of spermatogenesis. However, a conspicuous difference in robust hormone (both T and FSH) induced gene expression during the different phases of Sc maturation restricts our understanding about molecular events necessary for the spermatogenic onset and maintenance. Here, using microarray technology, we for the first time have compared the differential transcriptional profile of Sc isolated and cultured from immature (5 days old), maturing (12 days old) and mature (60 days old) rat testes. Our data revealed that immature Sc express genes involved in cellular growth, metabolism, chemokines, cell division, MAPK and Wnt pathways, while mature Sc are more specialized expressing genes involved in glucose metabolism, phagocytosis, insulin signaling and cytoskeleton structuring. Taken together, this differential transcriptome data provide an important resource to reveal the molecular network of Sc maturation which is necessary to govern male germ cell differentiation, hence, will improve our current understanding of the etiology of some forms of idiopathic male infertility.	[Gautam, Mukesh; Rai, Umesh] Univ Delhi, Dept Zool, Delhi, India; [Bhattacharya, Indrashis; Majumdar, Subeer S.] Natl Inst Immunol, Cellular Endocrinol Lab, New Delhi, India; [Majumdar, Subeer S.] Natl Inst Anim Biotechnol, Hyderabad, Andhra Pradesh, India; [Gautam, Mukesh] Northwestern Univ, Ken & Ruth Davee Dept Neurol, Chicago, IL 60611 USA; [Bhattacharya, Indrashis] Hemvati Nandan Bahuguna Garhwal Univ, Dept Zool, Garhwal, Uttarakhand, India	University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; National Institute of Animal Biotechnology (NIAB); Northwestern University; Hemwati Nandan Bahuguna Garhwal University	Majumdar, SS (corresponding author), Natl Inst Immunol, Cellular Endocrinol Lab, New Delhi, India.; Majumdar, SS (corresponding author), Natl Inst Anim Biotechnol, Hyderabad, Andhra Pradesh, India.	subeer@nii.ac.in	Gautam, Mukesh/AAB-9208-2020	Gautam, Mukesh/0000-0002-6595-3051; Majumdar, Subeer/0000-0003-1724-7483	Indian Council of Medical Research [5/10/FR/8/2010-RHN]; Tata Innovation Award [BT/HRD/35/01/01/2010]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Tata Innovation Award	Funded by Indian Council of Medical Research. Grant number: 5/10/FR/8/2010-RHN. Tata Innovation Award.Grant number: BT/HRD/35/01/01/2010. SSM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2009, J MOL ENDOCRINOL, V42, P291, DOI 10.1677/JME-08-0107; Anderson R, 1999, DEVELOPMENT, V126, P1655; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bhattacharya I, 2017, CELL TISSUE RES, V368, P389, DOI 10.1007/s00441-016-2410-1; Bhattacharya I, 2012, AM J PHYSIOL-ENDOC M, V303, pE886, DOI 10.1152/ajpendo.00293.2012; Boyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029764; Chalmel F, 2015, REPRODUCTION, V150, pR149, DOI 10.1530/REP-15-0073; Com E, 2014, J PROTEOMICS, V107, P128, DOI 10.1016/j.jprot.2014.04.013; Crepieux P, 2001, ONCOGENE, V20, P4696, DOI 10.1038/sj.onc.1204632; DeFalco T, 2009, ANNU REV CELL DEV BI, V25, P457, DOI 10.1146/annurev.cellbio.042308.13350; Denolet E, 2006, MOL ENDOCRINOL, V20, P321, DOI 10.1210/me.2005-0113; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Eacker SM, 2007, MOL ENDOCRINOL, V21, P895, DOI 10.1210/me.2006-0113; Ewen K, 2010, BIOL REPROD, V83, P1005, DOI 10.1095/biolreprod.110.086801; Fujimoto T, 1998, J ELECTRON MICROSC, V47, P451, DOI 10.1093/oxfordjournals.jmicro.a023616; GALDIERI M, 1983, EXP CELL RES, V145, P191, DOI 10.1016/S0014-4827(83)80020-2; Gassei K, 2017, BIOL REPROD, V96, P707, DOI 10.1095/biolreprod.116.142828; Gautam M, 2016, ANDROLOGY-US, V4, P509, DOI 10.1111/andr.12161; Gautam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058276; Gilbert DC, 2009, J PATHOL, V217, P94, DOI 10.1002/path.2436; Gondos B, 1993, SERTOLI CELL, P115; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Guraya SS., 1998, CELLULAR MOL BIOL GO, V346, P1998; Hedger MP, 2003, J REPROD IMMUNOL, V58, P1, DOI 10.1016/S0165-0378(02)00060-8; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; Hoeben E, 1996, ENDOCRINOLOGY, V137, P514, DOI 10.1210/en.137.2.514; Hoeben E, 1997, MOL CELL ENDOCRINOL, V132, P149, DOI 10.1016/S0303-7207(97)00132-9; Iida H, 2005, MOL REPROD DEV, V71, P178, DOI 10.1002/mrd.20294; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Jeays-Ward K, 2004, DEV BIOL, V276, P431, DOI 10.1016/j.ydbio.2004.08.049; JEGOU B, 1983, INT J ANDROL, V6, P249, DOI 10.1111/j.1365-2605.1983.tb00539.x; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; Jiang X, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/489095; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; LINGWOOD CA, 1994, MOL REPROD DEV, V37, P462, DOI 10.1002/mrd.1080370414; Lui WY, 2003, BIOL REPROD, V68, P2189, DOI 10.1095/biolreprod.102.011379; Lui WY, 2003, BIOL REPROD, V68, P1087, DOI 10.1095/biolreprod.102.010371; Majumdar SS, 2013, PROG BIOPHYS MOL BIO, V113, P409, DOI 10.1016/j.pbiomolbio.2013.01.002; Majumdar SS, 2012, HUM REPROD, V27, P2515, DOI 10.1093/humrep/des184; Malkov M, 1998, BIOL REPROD, V59, P84, DOI 10.1095/biolreprod59.1.84; Mandal K, 2017, DNA RES, V24, P143, DOI 10.1093/dnares/dsw057; Masters JR, 2007, NAT PROTOC, V2, P2276, DOI 10.1038/nprot.2007.319; Mastroianni L., 1994, P 4 ORG ROUND TABL C, Vviii; MATSUMOTO AM, 1990, AM J OBSTET GYNECOL, V163, P1743, DOI 10.1016/0002-9378(90)91439-J; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; Miller TL, 2002, IMMUNOLOGY, V105, P101, DOI 10.1046/j.0019-2805.2001.01352.x; Mithraprabhu S, 2010, BIOL REPROD, V82, P980, DOI 10.1095/biolreprod.109.079855; Mruk DD, 2015, ENDOCR REV, V36, P681, DOI [10.1210/er.2015-1127, 10.1210/er.2014-1101]; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; O'Shaughnessy PJ, 2007, ENDOCRINOLOGY, V148, P2914, DOI 10.1210/en.2006-1412; O'Shaughnessy PJ, 2014, SEMIN CELL DEV BIOL, V29, P55, DOI 10.1016/j.semcdb.2014.02.010; O'Shaughnessy PJ, 2003, BIOL REPROD, V69, P797, DOI 10.1095/biolreprod.103.016899; Oatley MJ, 2011, BIOL REPROD, V84, P639, DOI 10.1095/biolreprod.110.087320; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Petersen C, 2002, MOL CELL ENDOCRINOL, V186, P37, DOI 10.1016/S0303-7207(01)00680-3; Plant TM, 2016, J ENDOCRINOL, V226, pT41; Primig M, 2012, BBA-MOL BASIS DIS, V1822, P1880, DOI 10.1016/j.bbadis.2012.05.018; Rato L, 2012, NAT REV UROL, V9, P330, DOI 10.1038/nrurol.2012.77; Rato L, 2010, J MEMBRANE BIOL, V236, P215, DOI 10.1007/s00232-010-9294-x; Robinson LLL, 2003, J CLIN ENDOCR METAB, V88, P3943, DOI 10.1210/jc.2003-030196; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P2805, DOI 10.1210/me.2003-0203; Sarkar H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151150; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Setchell B P, 1975, Curr Top Mol Endocrinol, V2, P223; Sharpe Richard M., 1994, P1363; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tassi E, 1991, JBIOLCHEM, V274, P33287; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thompson IR, 2014, MOL CELL ENDOCRINOL, V385, P28, DOI 10.1016/j.mce.2013.09.012; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Wang SW, 1997, BIOCHEM BIOPH RES CO, V236, P502, DOI 10.1006/bbrc.1997.6995; Warr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019572; WEISS L, 1963, EXP CELL RES, V30, P509, DOI 10.1016/0014-4827(63)90327-6; Willems A, 2010, INT J ANDROL, V33, P507, DOI 10.1111/j.1365-2605.2009.00964.x; Wong EWP, 2013, FASEB J, V27, P464, DOI 10.1096/fj.12-212514; Yang S, 2004, GENOME RES, V14, P517, DOI 10.1101/gr.1984404; Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Zhang JD, 2011, DEVELOPMENT, V138, P3159, DOI 10.1242/dev.062380; Zhao SY, 2004, GENOME RES, V14, P1851, DOI 10.1101/gr.2663304; Zhou Q, 2005, BIOL REPROD, V72, P1010, DOI 10.1095/biolreprod.104.035915; Zimmermann C, 2015, MOL ENDOCRINOL, V29, P627, DOI 10.1210/me.2014-1356	91	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191201	10.1371/journal.pone.0191201	http://dx.doi.org/10.1371/journal.pone.0191201			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342173	Green Submitted, Green Published, gold			2022-12-27	WOS:000422653800051
J	Hultman, I; Haeggblom, L; Rognmo, I; Edqvist, JJ; Blomberg, E; Ali, R; Phillips, L; Sandstedt, B; Kogner, P; Fard, SS; Ahrlund-Richter, L				Hultman, Isabell; Haeggblom, Linnea; Rognmo, Ingvild; Edqvist, Josefin Jansson; Blomberg, Evelina; Ali, Rouknuddin; Phillips, Lottie; Sandstedt, Bengt; Kogner, Per; Fard, Shahrzad Shirazi; Ahrlund-Richter, Lars			Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastoma	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CANCER-CELLS; TUMOR MICROENVIRONMENT; EXPERIMENTAL TERATOMA; DRUG-RESISTANCE; DNA-DAMAGE; IN-VITRO; GROWTH; MYCN; HETEROGENEITY	In this study chemotherapy response in neuroblastoma (NB) was assessed for the first time in a transplantation model comprising non-malignant human embryonic microenvironment of pluripotent stem cell teratoma (PSCT) derived from diploid bona fide hESC. Two NB cell lines with known high-risk phenotypes; the multi-resistant BE(2)-C and the drug sensitive IMR-32, were transplanted to the PSCT model and the tumour growth was exposed to single or repeated treatments with doxorubicin, and thereafter evaluated for cell death, apoptosis, and proliferation. Dose dependent cytotoxic effects were observed, this way corroborating the experimental platform for this type of analysis. Notably, analysis of doxorubicin-resilient BE(2)-C growth in the PSCT model revealed an unexpected 1,5 fold increase in Ki67-index (p<0.05), indicating that non-cycling (GO) cells entered the cell cycle following the doxorubicin exposure. Support for this notion was obtained also in vitro. A pharmacologically relevant dose (1 mu M) resulted in a marked accumulation of Ki67 positive BE(2)-C cells (p<0.0001), as well as a >3-fold increase in active cell cycle (i.e. cells positive staining for PH3 together with incorporation of EdU) (p<0.01). Considering the clinical challenge for treating high-risk NB, the discovery of a therapy-provoked growth stimulating effect in the multi-resistant and p53-mutated BE(2)-C cell line, but not in the drug-sensitive p53wt IMR-32 cell line, warrants further studies concerning generality and clinical significance of this new observation.	[Hultman, Isabell; Rognmo, Ingvild; Edqvist, Josefin Jansson; Blomberg, Evelina; Ali, Rouknuddin; Phillips, Lottie; Sandstedt, Bengt; Kogner, Per; Fard, Shahrzad Shirazi; Ahrlund-Richter, Lars] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Haeggblom, Linnea] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Fard, SS (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	shahrzad.shirazifard@ki.se	Phillips, Lottie/AAV-7902-2021	Kogner, Per/0000-0002-2202-9694	Cancer Research Foundations of Radiumhemmet [121262, 141393]; Swedish Childhood Cancer Foundation [2015-0168]; Robert Lundbergs minnesstiftelse; Stiftelsen Anna Brita och Bo Castegrens Minne	Cancer Research Foundations of Radiumhemmet; Swedish Childhood Cancer Foundation(European Commission); Robert Lundbergs minnesstiftelse; Stiftelsen Anna Brita och Bo Castegrens Minne	This work was supported by the Cancer Research Foundations of Radiumhemmet (Dnr 121262 and 141393) to LAR, The Swedish Childhood Cancer Foundation (Dnr 2015-0168) to LAR, Robert Lundbergs minnesstiftelse to IH, and Stiftelsen Anna Brita och Bo Castegrens Minne to SSF and LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083651; [Anonymous], 2011, CHAR HUM PLUR STEM C; BECKWITH JB, 1963, AM J PATHOL, V43, P1089; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Braekeveldt N, 2015, INT J CANCER, V136, pE252, DOI 10.1002/ijc.29217; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burgos-Ojeda D, 2013, CANCER RES, V73, P3555, DOI 10.1158/0008-5472.CAN-12-2845; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Castedo M, 2006, ANN NY ACAD SCI, V1090, P35, DOI 10.1196/annals.1378.004; Choi SY, 2012, INT J ONCOL, V40, P277, DOI 10.3892/ijo.2011.1184; Das Thakur M, 2014, J PATHOL, V232, P103, DOI 10.1002/path.4285; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Eckerle I, 2009, CANCER LETT, V285, P99, DOI 10.1016/j.canlet.2009.05.007; ELBADRY OM, 1991, J CLIN INVEST, V87, P648, DOI 10.1172/JCI115042; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; GERDES J, 1984, J IMMUNOL, V133, P1710; Gertow K, 2004, STEM CELLS DEV, V13, P421, DOI 10.1089/scd.2004.13.421; Gertow K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027741; Hopkins-Donaldson S, 2002, ONCOGENE, V21, P6132, DOI 10.1038/sj.onc.1205879; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Hultman I, 2014, SEMIN CANCER BIOL, V29, P75, DOI 10.1016/j.semcancer.2014.08.005; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Jamil S, 2013, INT J ONCOL, V43, P831, DOI 10.3892/ijo.2013.2014; Jamil S, 2014, INT J CANCER, V134, P1630, DOI 10.1002/ijc.28498; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Katz E, 2009, CLIN CANCER RES, V15, P70, DOI 10.1158/1078-0432.CCR-08-1233; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Morton CL, 2009, CANC DRUG DISCOVERY, P195; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Normand G, 2005, J BIOL CHEM, V280, P7118, DOI 10.1074/jbc.M412330200; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Pession A, 2005, CURR CANCER DRUG TAR, V5, P273, DOI 10.2174/1568009054064606; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Scotting PJ, 2005, NAT REV CANCER, V5, P481, DOI 10.1038/nrc1633; Shen H, 2008, CANCER RES, V68, P8260, DOI 10.1158/0008-5472.CAN-08-1901; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; TEICHER BA, 1989, CANCER RES, V49, P5994; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Tzukerman M, 2006, CANCER RES, V66, P3792, DOI 10.1158/0008-5472.CAN-05-3467; Tzukerman M, 2003, P NATL ACAD SCI USA, V100, P13507, DOI 10.1073/pnas.2235551100; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Wickstrom M, 2007, MOL CANCER THER, V6, P2409, DOI 10.1158/1535-7163.MCT-07-0156; Zheng X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.264	51	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190970	10.1371/journal.pone.0190970	http://dx.doi.org/10.1371/journal.pone.0190970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342186	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800040
J	Piotrowska, A; Syguda, A; Wyrwas, B; Chrzanowski, L; Luckenbach, T; Heipieper, HJ				Piotrowska, Aleksandra; Syguda, Anna; Wyrwas, Bogdan; Chrzanowski, Lukasz; Luckenbach, Till; Heipieper, Hermann J.			Effects of ammonium-based ionic liquids and 2,4-dichlorophenol on the phospholipid fatty acid composition of zebrafish embryos	PLOS ONE			English	Article							TOXICITY; MODEL; FISH; MECHANISMS; 2,4-D	Ionic liquids consisting of a combination of herbicidal anions with a quaternary ammonium cation act as efficient herbicides, which are under consideration to be used in the agriculture. In the present study, we used embryos of the zebrafish (Danio rerio) as a model to assess the toxic potential of ammonium-based ionic liquids for aquatic organisms. As we assumed interference of the partially hydrophobic ionic liquid cation with lipids, we investigated the adaptation response in the lipid composition of the zebrafish embryos, triggered by the ionic compound. Therefore, the impact of ammonium-based ionic liquids with different lengths of the alkyl chain ([C-6,C-6,C-1,C1N][Br], [C-8,C-8,C-1,C1N][Br]) on the phospholipid fatty acid (PLFA) profile of zebrafish embryos up to 72 hours post fertilization (hpf) was examined. Furthermore, the changes in the unsaturation index (UI) of PLFAs, as the sum parameter of membrane fluidity in eukaryotic cells, were presented. The PLFA's UI in the zebrafish embryos upon exposure to quaternary ammonium salts was compared to the UI of the embryos upon exposure to nonionic 2,4-dichlorophenol, which has a similar hydrophobicity but is structurally different to [C-8,C-8,C-1,C-1 Nl][Br]. It was shown that for ammonium-based ionic liquid precursors non-specific mode of action occurs and the toxic effect on lipid composition of zebrafish embryos can be well predicted based on chemical properties, like hydrophobicity. Furthermore, the changes in PLFAs, expressed by the UI, can be useful to study toxic effects of organic contamination. However, for zebrafish embryos, after ionic liquids and 2,4-DCP exposure, the changes were observed at high lethal concentrations, which caused the incidence of lethality of 30 and 50% of a group of test animals.	[Piotrowska, Aleksandra; Heipieper, Hermann J.] UFZ Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany; [Piotrowska, Aleksandra; Syguda, Anna; Wyrwas, Bogdan; Chrzanowski, Lukasz] Poznan Univ Tech, Fac Chem Technol, Poznan, Poland; [Luckenbach, Till] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Poznan University of Technology; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Heipieper, HJ (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany.	hermann.heipieper@ufz.de	Chrzanowski, Lukasz/M-3439-2014; Luckenbach, Till/G-6482-2015; Heipieper, Hermann/D-1864-2010; Wyrwas, Bogdan/B-3116-2016	Luckenbach, Till/0000-0001-6204-1033; Heipieper, Hermann/0000-0002-3723-9600; Wyrwas, Bogdan/0000-0002-4791-5318; Syguda, Anna/0000-0003-0145-7478; Chrzanowski, Lukasz/0000-0002-2171-4913	National Science Centre in Poland [DEC-2011/03/B/NZ9/00731]; "Chemicals in the Environment" (CITE) within the research program of the UFZ-Helmholtz Centre for Environmental Research [POF II-U45]	National Science Centre in Poland(National Science Centre, Poland); "Chemicals in the Environment" (CITE) within the research program of the UFZ-Helmholtz Centre for Environmental Research	This work was funded by the National Science Centre in Poland conferred on the basis of the decision DEC-2011/03/B/NZ9/00731.; This work is part of the research topic "Chemicals in the Environment" (CITE) within the research program of the UFZ-Helmholtz Centre for Environmental Research (POF II-U45). This work was performed within the doctoral thesis of Aleksandra Piotrowska at the University of Technology in Poznan, Poland. This work was funded by the National Science Centre in Poland conferred on the basis of the decision DEC-2011/03/B/NZ9/00731.	Armitage JM, 2017, ENVIRON TOXICOL CHEM, V36, P882, DOI 10.1002/etc.3680; Belanger SE, 2013, ENVIRON TOXICOL CHEM, V32, P1768, DOI 10.1002/etc.2244; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cojocaru OA, 2013, GREEN CHEM, V15, P2110, DOI 10.1039/c3gc37143c; COUTURE P, 1995, J MEMBRANE BIOL, V148, P27; Goldsmith P, 2004, CURR OPIN PHARMACOL, V4, P504, DOI 10.1016/j.coph.2004.04.005; Hachicho N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134755; HAZEL JR, 1984, AM J PHYSIOL, V246, pR460, DOI 10.1152/ajpregu.1984.246.4.R460; Kaszycki P, 2013, APPL MICROBIOL BIOT, V97, P5555, DOI 10.1007/s00253-013-4796-y; Kluver N, 2016, CHEMOSPHERE, V164, P164, DOI 10.1016/j.chemosphere.2016.08.079; KROES J, 1972, BIOCHIM BIOPHYS ACTA, V274, P71, DOI 10.1016/0005-2736(72)90281-7; Lam PKS, 2003, MAR POLLUT BULL, V46, P182, DOI 10.1016/S0025-326X(02)00449-6; Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006; MORRISON WR, 1964, J LIPID RES, V5, P600; Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38; OECD, 2013, OECD TEST NO 236 FIS; Padmini E, 2010, REV ENVIRON CONTAM T, V206, P1, DOI 10.1007/978-1-4419-6260-7_1; Pelster Bernd, 2008, P91; Pernak J, 2012, TETRAHEDRON, V68, P4267, DOI 10.1016/j.tet.2012.03.065; Pernak J, 2011, TETRAHEDRON, V67, P4838, DOI 10.1016/j.tet.2011.05.016; Piotrowska A, 2017, CHEMOSPHERE, V167, P114, DOI 10.1016/j.chemosphere.2016.09.140; Pirro V, 2016, MOL BIOSYST, V12, P2069, DOI 10.1039/c6mb00168h; Praczyk T, 2012, WEED SCI, V60, P189, DOI 10.1614/WS-D-11-00171.1; Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121; VAN WEZEL A, 1995, CRIT REV TOXICOL, V25, P255, DOI 10.3109/10408449509089890; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	30	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190779	10.1371/journal.pone.0190779	http://dx.doi.org/10.1371/journal.pone.0190779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342167	Green Submitted, Green Published, gold			2022-12-27	WOS:000422653800033
J	Takematsu, E; Noguchi, K; Kuroda, K; Ikoma, T; Niinomi, M; Matsushita, N				Takematsu, Eri; Noguchi, Kimihiro; Kuroda, Kensuke; Ikoma, Toshiyuki; Niinomi, Mitsuo; Matsushita, Nobuhiro			In vivo osteoconductivity of surface modified Ti-29Nb-13Ta-4.6Zr alloy with low dissolution of toxic trace elements	PLOS ONE			English	Article							TITANIUM; VITRO; BIOACTIVITY	Simulated Body Fluid (SBF) has served as a useful standard to check the bioactivity of implant materials for years. However, it is not perfectly able to imitate human serum; sometimes disparities between the SBF test and animal test were confirmed. Therefore, to ensure the reliability of the results of the SBF test obtained from our previous study, an animal study was performed to check osteoconductivity of surface modified implant materials. Three types of solution processes, hydrothermal (H), electrochemical (E), and hydrothermal-electrochemical (HE), were performed on the Ti-29Nb-13Ta-4.6Zr alloy (TNTZ) to improve its bioactivity, and their bioactivities were measured in vivo using bone-implant contacts (BICs). BICs of the HE-and H-treated samples were significantly higher than that of the control. Metal ion diffusion towards the bone was also evaluated to examine the adverse effect of metal ions. No metal ion diffusion was observed, indicating the safety of our solution processed implant materials.	[Takematsu, Eri] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Noguchi, Kimihiro] Western Washington Univ, Dept Math, Bellingham, WA 98225 USA; [Kuroda, Kensuke; Niinomi, Mitsuo] Nagoya Univ, Inst Mat & Syst Sustainabil, Nagoya, Aichi, Japan; [Ikoma, Toshiyuki; Matsushita, Nobuhiro] Tokyo Inst Technol, Sch Mat & Chem Technol, Dept Mat Sci & Engn, Meguro Ku, Tokyo, Japan; [Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi, Japan; [Niinomi, Mitsuo] Osaka Univ, Grad Sch Engn, Dept Mat & Mfg Sci, Suita, Osaka, Japan	University of Texas System; University of Texas Austin; Western Washington University; Nagoya University; Tokyo Institute of Technology; Tohoku University; Osaka University	Matsushita, N (corresponding author), Tokyo Inst Technol, Sch Mat & Chem Technol, Dept Mat Sci & Engn, Meguro Ku, Tokyo, Japan.	matsushita.n.ab@m.titech.ac.jp	Niinomi, Mitsuo/HGE-6839-2022; Ikoma, Toshiyuki/E-4288-2012; Kuroda, Kensuke/P-4037-2019; Kuroda, Kensuke/I-6069-2014	Ikoma, Toshiyuki/0000-0003-3154-1777; Kuroda, Kensuke/0000-0002-9848-7528; Kuroda, Kensuke/0000-0002-9848-7528	Collaboration Research Project of Advanced Materials Development and Integration of Novel Structured Metallic and Inorganic Materials - MEXT as well as the collaborative research of the Institute for Materials Research at Tohoku University	Collaboration Research Project of Advanced Materials Development and Integration of Novel Structured Metallic and Inorganic Materials - MEXT as well as the collaborative research of the Institute for Materials Research at Tohoku University	This research was funded by a grant from the Collaboration Research Project of Advanced Materials Development and Integration of Novel Structured Metallic and Inorganic Materials supported by MEXT as well as the collaborative research of the Institute for Materials Research at Tohoku University (http://www.msl.titech.ac.jp/english/member/six_institutes.html; http://www.imr.tohoku.ac.jp/en/).	Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008; DAVIES L, 1993, J AM STAT ASSOC, V88, P782, DOI 10.2307/2290763; Fukuda A, 2011, ACTA BIOMATER, V7, P1379, DOI 10.1016/j.actbio.2010.09.026; GABRIEL KR, 1969, ANN MATH STAT, V40, P224, DOI 10.1214/aoms/1177697819; Sanchez AG, 2013, J MATER SCI-MATER M, V24, P161, DOI 10.1007/s10856-012-4770-8; Hamadouche M, 2000, J BIOMED MATER RES, V52, P422, DOI 10.1002/1097-4636(200011)52:2<422::AID-JBM24>3.3.CO;2-G; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Konietschke F, 2015, J STAT SOFTW, V64; Konietschke F, 2012, ELECTRON J STAT, V6, P738, DOI 10.1214/12-EJS691; Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9; Mine Y, 2010, J PROSTHODONT RES, V54, P1, DOI 10.1016/j.jpor.2009.07.003; Mizutani M., 2005, DIGITAL REPOSITORY I; Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970; Ozcan M, 2012, MATERIALS, V5, P1528, DOI 10.3390/ma5091528; Park SK, 2009, CRYST GROWTH DES, V9, P3615, DOI 10.1021/cg9003593; Strehle MA, 2004, PHYS CHEM CHEM PHYS, V6, P5232, DOI 10.1039/b406524g; Taira M, 2006, DENT MATER J, V25, P726, DOI 10.4012/dmj.25.726; Takematsu E, 2016, J MECH BEHAV BIOMED, V61, P174, DOI 10.1016/j.jmbbm.2015.12.046; Takematsu E, 2016, MAT SCI ENG C-MATER, V62, P662, DOI 10.1016/j.msec.2016.01.041; TONDEVOLD E, 1982, ACTA ORTHOP SCAND, V53, P7, DOI 10.3109/17453678208992171; Xin RL, 2005, BIOMATERIALS, V26, P6477, DOI 10.1016/j.biomaterials.2005.04.028; Yamamoto D., 2013, J BIOMATER NANOBIOTE, V04, P45, DOI DOI 10.4236/JBNB.2013.41007; Zadpoor AA, 2014, MAT SCI ENG C-MATER, V35, P134, DOI 10.1016/j.msec.2013.10.026	25	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189967	10.1371/journal.pone.0189967	http://dx.doi.org/10.1371/journal.pone.0189967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342150	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800013
J	Alpert, NM; Guehl, N; Ptaszek, L; Pelletier-Galarneau, M; Ruskin, J; Mansour, MC; Wooten, D; Ma, C; Takahashi, K; Zhou, Y; Shoup, TM; Normandin, MD; El Fakhri, G				Alpert, Nathaniel M.; Guehl, Nicolas; Ptaszek, Leon; Pelletier-Galarneau, Matthieu; Ruskin, Jeremy; Mansour, Moussa C.; Wooten, Dustin; Ma, Chao; Takahashi, Kazue; Zhou, Yun; Shoup, Timothy M.; Normandin, Marc D.; El Fakhri, Georges			Quantitative in vivo mapping of myocardial mitochondrial membrane potential	PLOS ONE			English	Article							GRAPHICAL ANALYSIS; LIPOPHILIC CATION; VOLTAGE SENSOR; ION CHANNELS; PET TRACER; BINDING; CELLS; TETRAPHENYLPHOSPHONIUM; PHOSPHORYLATION; QUANTIFICATION	Background Mitochondrial membrane potential (Delta psi(m)) arises from normal function of the electron transport chain. Maintenance of Delta psi(m) within a narrow range is essential for mitochondrial function. Methods for in vivo measurement of Delta psi(m) do not exist. We use F-18-labeled tetraphenylphosphonium (F-18-TPP+) to measure and map the total membrane potential, Delta psi(T), as the sum of Delta psi(m) and cellular (Delta psi(c)) electrical potentials. Methods Eight pigs, five controls and three with a scar-like injury, were studied. Pigs were studied with a dynamic PET scanning protocol to measure F-18-TPP+ volume of distribution, V-T. Fractional extracellular space (f(Ecs)) was measured in 3 pigs. We derived equations expressing Delta psi(T) as a function of V-T and the volume-fractions of mitochondria and fEcs. Seventeen segment polar maps and parametric images of Delta psi(T) were calculated in millivolts (mV). Results In controls, mean segmental Delta psi(T) = -129.4 +/- 1.4 mV (SEM). In pigs with segmental tissue injury, Delta psi(T) was clearly separated from control segments but variable, in the range -100 to 0 mV. The quality of Delta psi(T) maps was excellent, with low noise and good resolution. Measurements of Delta psi(T) in the left ventricle of pigs agree with previous in in-vitro measurements. Conclusions We have analyzed the factors affecting the uptake of voltage sensing tracers and developed a minimally invasive method for mapping Delta psi(T) in left ventricular myocardium of pigs. Delta psi(T) is computed in absolute units, allowing for visual and statistical comparison of individual values with normative data. These studies demonstrate the first in vivo application of quantitative mapping of total tissue membrane potential, Delta psi(T).	[Alpert, Nathaniel M.; Guehl, Nicolas; Pelletier-Galarneau, Matthieu; Wooten, Dustin; Ma, Chao; Takahashi, Kazue; Shoup, Timothy M.; Normandin, Marc D.; El Fakhri, Georges] Harvard Med Sch, Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Boston, MA 02114 USA; [Ptaszek, Leon; Ruskin, Jeremy; Mansour, Moussa C.] Harvard Med Sch, Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; [Zhou, Yun] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University	Alpert, NM (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Boston, MA 02114 USA.	alpert@pet.mgh.harvard.edu	Normandin, Marc D/C-6728-2015; Pelletier-Galarneau, Matthieu/L-7818-2019	Normandin, Marc D/0000-0003-1645-523X; 	United States National Institutes of Health [R01HL110241, R01HL137230]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB022544] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by two grants from the United States National Institutes of Health: R01HL110241 (GEF) and R01HL137230 (GEF), https://www.nhibi.nih.gov. These grants were awarded as part of the standard peer review process for new grants. The study design and analysis are solely the work of the study authors, meaning that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIUCHI T, 1989, CHEM PHARM BULL, V37, P3333; Alberts B., 2008, MOL BIOL CEL, V5th ed.; Bandula S, 2013, RADIOLOGY, V269, P395, DOI 10.1148/radiol.13130130; BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; Bockris JOM, 2012, MODERN ELECTROCHEMIS; Brown DA, 2010, CARDIOVASC RES, V88, P241, DOI 10.1093/cvr/cvq231; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954; DEMURA M, 1987, BIOCHIM BIOPHYS ACTA, V894, P355, DOI 10.1016/0005-2728(87)90113-7; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; Gurm GS, 2012, JACC-CARDIOVASC IMAG, V5, P285, DOI 10.1016/j.jcmg.2011.11.017; Ho CY, 2012, CIRCULATION CARDIOVA, V6, P415; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; KAUPPINEN R, 1983, BIOCHIM BIOPHYS ACTA, V725, P131, DOI 10.1016/0005-2728(83)90232-3; KAUPPINEN RA, 1984, AM J PHYSIOL, V247, pH508, DOI 10.1152/ajpheart.1984.247.4.H508; Kawamoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117091; Kim DY, 2015, J NUCL MED, V56, P1581, DOI 10.2967/jnumed.115.156794; Kim DY, 2012, J NUCL MED, V53, DOI 10.2967/jnumed.111.102657; Labajova A, 2006, ANAL BIOCHEM, V353, P37, DOI 10.1016/j.ab.2006.03.032; LANOUE KF, 1986, J BIOL CHEM, V261, P298; LICHTSTEIN D, 1979, P NATL ACAD SCI USA, V76, P650, DOI 10.1073/pnas.76.2.650; Liu SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138716; Logan A, 2016, CELL METAB, V23, P379, DOI 10.1016/j.cmet.2015.11.014; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; lwai S, 2013, ELECTROPHYSIOLOGY CA, P261; Madar I, 2007, EUR J NUCL MED MOL I, V34, P2057, DOI 10.1007/s00259-007-0500-8; Madar I, 2009, J NUCL MED, V50, P774, DOI 10.2967/jnumed.108.061283; Min JJ, 2004, J NUCL MED, V45, P636; Moreno AnJ, 2015, CURRENT PROTOCOLS TO, V25; Nernst W, 1889, Z PHYS CHEM, V4, P129, DOI 10.1515/zpch- 1889-0412.; Nernst W, 1907, EXPT THEORETICAL APP; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; O'Rourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005; O'Rourke B, 2016, NAT REV CARDIOL, V13, P386, DOI 10.1038/nrcardio.2016.95; Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389; Pohanka M, 2014, CURR MED CHEM, V21, P356; Rich P, 2003, NATURE, V421, P583, DOI 10.1038/421583a; RITCHIE RJ, 1984, PROG BIOPHYS MOL BIO, V43, P1, DOI 10.1016/0079-6107(84)90002-6; ROTTENBERG H, 1984, J MEMBRANE BIOL, V81, P127, DOI 10.1007/BF01868977; Rutledge C, 2013, EXPERT REV CARDIOVAS, V11, P799, DOI 10.1586/14779072.2013.811969; Sado DM, 2012, HEART; Schelbert EB, J CARDIOVASCULAR MAG, V13, P16; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Shoup TM, 2011, MOL IMAGING BIOL, V13, P511, DOI 10.1007/s11307-010-0349-2; Slifstein M, 2000, J NUCL MED, V41, P2083; SUMMERHAYES IC, 1982, P NATL ACAD SCI-BIOL, V79, P5292, DOI 10.1073/pnas.79.17.5292; Varga J, 2002, J CEREBR BLOOD F MET, V22, P240, DOI 10.1097/00004647-200202000-00012; WAN B, 1993, AM J PHYSIOL, V265, pH453, DOI 10.1152/ajpheart.1993.265.2.H453; WHALLEY DW, 1995, PACE, V18, P1556, DOI 10.1111/j.1540-8159.1995.tb06742.x; Wong TC, 2012, EUROPEAN HEART J; Zhou Y, 2009, NEUROIMAGE, V44, P661, DOI 10.1016/j.neuroimage.2008.09.021	53	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190968	10.1371/journal.pone.0190968	http://dx.doi.org/10.1371/journal.pone.0190968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338024	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700025
J	Solazzo, A; Testa, F; Giovanella, S; Busutti, M; Furci, L; Carrera, P; Ferrari, M; Ligabue, G; Mori, G; Leonelli, M; Cappelli, G; Magistroni, R				Solazzo, Andrea; Testa, Francesca; Giovanella, Silvia; Busutti, Marco; Furci, Luciana; Carrera, Paola; Ferrari, Maurizio; Ligabue, Giulia; Mori, Giacomo; Leonelli, Marco; Cappelli, Gianni; Magistroni, Riccardo			The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition	PLOS ONE			English	Article							EPIDEMIOLOGY; DIAGNOSIS; HYPERTENSION; ASSOCIATION; PROGNOSIS; FREQUENCY; MUTATION; IMPACT	Background and objectives ADPKD is erroneously perceived as a not rare condition, which is mainly due to the repeated citation of a mistaken interpretation of old epidemiological data, as reported in the Dalgaard's work (1957). Even if ADPKD is not a common condition, the correct prevalence of ADPKD in the general population is uncertain, with a wide range of estimations reported by different authors. In this work, we have performed a meta-analysis of available epidemiological data in the European literature. Furthermore we collected the diagnosis and clinical data of ADPKD in a province in the north of Italy (Modena). We describe the point and predicted prevalence of ADPKD, as well as the main clinical characteristics of ADPKD in this region. Methods We looked at the epidemiological data according to specific parameters and criteria in the Pubmed, CINAHL, Scopus and Web of Science databases. Data were summarized using linear regression analysis. We collected patients' diagnoses in the Province of Modena according to accepted clinical criteria and/or molecular analysis. Predicted prevalence has been calculated through a logistic regression prediction applied to the at-risk population. Results The average prevalence of ADPKD, as obtained from 8 epidemiological studies of sufficient quality, is 2.7: 10,000 (C195 = 0.73-4.67). The point prevalence of ADPKD in the province of Modena is 3.63: 10,000 (C195 = 3.010-3.758). On the basis of the collected pedigrees and identification of the at-risk subjects, the predicted prevalence in the Province of Modena is 4.76: 10,000 (CI 95% = 4.109-4.918). Conclusion As identified in our study, point prevalence is comparable with the majority of the studies of literature, while predicted prevalence (4.76: 10,000) generally appears higher than in the previous estimates of the literature, with a few exceptions. Thus, this could suggest that undiagnosed ADPKD subjects, as predicted by our approach, could be relevant and will most likely require more clinical attention. Nevertheless, our estimation, in addition to the averaged ones derived from literature, not exceeding the limit of 5:10,000 inhabitants, are compatible with the definition of rare disease adopted by the European Medicines Agency and Food and Drug Administration.	[Solazzo, Andrea; Testa, Francesca; Giovanella, Silvia; Ligabue, Giulia; Cappelli, Gianni; Magistroni, Riccardo] Univ Modena & Reggio Emilia, Dipartimento Chirurg Med Odontoiatr & Sci Interes, Oncol & Med Rigenerat, Modena, Italy; [Busutti, Marco] Alma Mater Studiorum Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, UO Nefrol Dialisi & Trapianto, Osped St Orsola Malpighi, Modena, Italy; [Furci, Luciana; Mori, Giacomo; Leonelli, Marco; Cappelli, Gianni; Magistroni, Riccardo] Univ Modena, Azienda Osped, Div Nefrol Dialisi & Trapianto Renale, Dipartimento Interaziendale Attivita Integrata Ma, Modena, Italy; [Carrera, Paola; Ferrari, Maurizio] Ist Sci San Raffaele, Div Genet & Cell Biol, Unit Genom Human Dis Diag, Milan, Italy; [Carrera, Paola; Ferrari, Maurizio] Ist Sci San Raffaele, Lab Clin Mol Genet, Milan, Italy; [Ferrari, Maurizio] Univ Vita & Salute San Raffaele, Milan, Italy	Universita di Modena e Reggio Emilia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Universita di Modena e Reggio Emilia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Magistroni, R (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Chirurg Med Odontoiatr & Sci Interes, Oncol & Med Rigenerat, Modena, Italy.; Magistroni, R (corresponding author), Univ Modena, Azienda Osped, Div Nefrol Dialisi & Trapianto Renale, Dipartimento Interaziendale Attivita Integrata Ma, Modena, Italy.	magistroni.riccardo@unimore.it	Giovanella, Silvia/AAS-8253-2021; Magistroni, Riccardo/AAL-8753-2020; Giovanella, Silvia/AAZ-8377-2021; Cappelli, Gianni/N-8812-2019; Cappelli, Gianni/F-8277-2012	Giovanella, Silvia/0000-0003-1298-5508; Magistroni, Riccardo/0000-0002-3319-0248; Cappelli, Gianni/0000-0003-2304-5001; Cappelli, Gianni/0000-0003-2304-5001; Busutti, Marco/0000-0002-3150-6704; Ligabue, Giulia/0000-0002-0043-2300; Carrera, Paola/0000-0001-7376-2119	Italian Ministry of Health [RF-2013-02356802]	Italian Ministry of Health(Ministry of Health, Italy)	This study was partially funded by a grant provided by the Italian Ministry of Health (Ricerca Finalizzata Protocol RF-2013-02356802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining funding of this work was covered by the Institute's internal resources of the last author. There was no additional external funding received for this study.	Barua M, 2009, J AM SOC NEPHROL, V20, P1833, DOI 10.1681/ASN.2009020162; Carrera P, 2016, SCI REP-UK, V6, DOI 10.1038/srep30850; Cornec-Le Gall E, 2015, J AM SOC NEPHROL; Cornec-Le Gall E, 2013, J AM SOC NEPHROL, V24, P1006, DOI 10.1681/ASN.2012070650; Corradi Valentina, 2010, G Ital Nefrol, V27, P655; DALGAARD O. Z., 1957, ACTA MED SCAND SUPPL, V158, P1; DAVIES F, 1991, Q J MED, V79, P477; de Almeida E, 2001, KIDNEY INT, V59, P2374, DOI 10.1046/j.1523-1755.2001.00758.x; Ecder T, 2013, CURR HYPERTENS REV, V9, P2, DOI 10.2174/1573402111309010002; EIJAN J, 1993, NEFROLOGIA, V13, P122; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gansevoort RT, 2016, NEPHROL DIAL TRANSPL, V31, P337, DOI 10.1093/ndt/gfv456; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Heidland A, 2009, J NEPHROL, V22, P249; Higashihara E, 1998, NEPHRON, V80, P421, DOI 10.1159/000045214; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hwang YH, 2015, J AM SOC NEPHROL; IGLESIAS CG, 1983, AM J KIDNEY DIS, V2, P630; Iliuta IA, 2017, J AM SOC NEPHROL, V28, P2768, DOI 10.1681/ASN.2016090938; Irazabal MV, 2014, J AM SOC NEPHROL; McGovern AP, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-182; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Neumann HPH, 2013, NEPHROL DIAL TRANSPL, V28, P1472, DOI 10.1093/ndt/gfs551; Patch C, 2011, AM J KIDNEY DIS, V57, P856, DOI 10.1053/j.ajkd.2011.01.023; Pei Y, 2015, J AM SOC NEPHROL, V26, P746, DOI 10.1681/ASN.2014030297; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Pippias M, 2017, CLIN KIDNEY J, V10, P154, DOI 10.1093/ckj/sfw135; Porath B, 2016, AM J HUM GENET, V98, P1193, DOI 10.1016/j.ajhg.2016.05.004; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rossetti MA Sandro, 2007, J AM SOC NEPHROL, V18, p365A; Cabezas OR, 2017, J AM SOC NEPHROL, V28, P2529, DOI 10.1681/ASN.2016121312; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Schrier RW, 2011, AM J KIDNEY DIS, V57, P811, DOI 10.1053/j.ajkd.2011.02.379; Schrier RW, 2003, KIDNEY INT, V64, P1792, DOI 10.1046/j.1523-1755.2003.00264.x; Simon P, 1996, NEPHROLOGIE, V17, P123; Spithoven EM, 2014, KIDNEY INT, V86, P1244, DOI 10.1038/ki.2014.120; Sweeney WE, 2014, PEDIATR RES, V75, P148, DOI 10.1038/pr.2013.191; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2014, NEW ENGL J MED, V371, P2267, DOI 10.1056/NEJMoa1402686; Willey CJ, 2017, NEPHROL DIAL TRANSPL, V32, P1356, DOI 10.1093/ndt/gfw240; World MJ, 2012, J ROY ARMY MED CORPS, V158, P300, DOI 10.1136/jramc-158-04-04; Yersin C, 1997, NEPHROL DIAL TRANSPL, V12, P2069, DOI 10.1093/ndt/12.10.2069	44	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190430	10.1371/journal.pone.0190430	http://dx.doi.org/10.1371/journal.pone.0190430			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338003	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700008
J	Sunde, RA				Sunde, Roger A.			Selenium regulation of selenoprotein enzyme activity and transcripts in a pilot study with Founder strains from the Collaborative Cross	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; GLUTATHIONE-PEROXIDASE-ACTIVITY; THIOREDOXIN REDUCTASE-ACTIVITY; DIETARY SELENIUM; RAT-LIVER; SELENOCYSTEINE INCORPORATION; DEPENDENT PARAMETERS; POPULATION; DEFICIENCY; TISSUES	Rodents and humans have 24-25 selenoproteins, and these proteins contain the 21st amino acid, selenocysteine, incorporated co-translationally into the peptide backbone in a series of reactions dependent on at least 6 unique gene products. In selenium (Se) deficiency, there is differential regulation of selenoprotein expression, whereby levels of some selenoproteins and their transcripts decrease dramatically in Se deficiency, but other selenoprotein transcripts are spared this decrease; the underlying mechanism, however, is not fully understood. To begin explore the genetic basis for this variation in regulation by Se status in a pilot study, we fed Se-deficient or Se-adequate diets (0.005 or 0.2 mu g Se/g, respectively) for eight weeks to the eight Founder strains of the Collaborative Cross. We found rather uniform expression of selenoenzyme activity for glutathione peroxidase (Gpx) 3 in plasma, Gpx1 in red blood cells, and Gpx1, Gpx4, and thioredoxin reductase in liver. In Founder mice, Se deficiency decreased each of these activities to a similar extent. Regulation of selenoprotein transcript expression by Se status was also globally retained intact, with dramatic down-regulation of Gpxl, Selenow, and Selenoh transcripts in all 8 strains of Founder mice. These results indicate that differential regulation of selenoprotein expression by Se status is an essential aspect of Se metabolism and selenoprotein function. A few lone differences in Se regulation were observed for individual selenoproteins in this pilot study, but these differences did not single-out one strain or one selenoprotein that consistently had unique Se regulation of selenoprotein expression. These differences should be affirmed in larger studies; use of the Diversity Outbred and Collaborative Cross strains may help to better define the functions of these selenoproteins.	[Sunde, Roger A.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sunde, RA (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	sunde@nutrisci.wisc.edu			Wisconsin Alumni Foundation Selenium Nutrition Research Fund [12046295]	Wisconsin Alumni Foundation Selenium Nutrition Research Fund	This Research was supported by the Wisconsin Alumni Foundation (http://www.uwalumni.com) Selenium Nutrition Research Fund (No. 12046295). There was no additional external funding received for this study.	Attie AD, 2017, CURR OPIN ENDOCRINOL, V24, P83, DOI 10.1097/MED.0000000000000321; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; BEHNE D, 1990, BIOCHIM BIOPHYS ACTA, V1033, P219, DOI 10.1016/0304-4165(90)90124-F; BERMANO G, 1995, BIOCHEM J, V311, P425, DOI 10.1042/bj3110425; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Carlson BA, 2007, J BIOL CHEM, V282, P32591, DOI 10.1074/jbc.M707036200; Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270; Church RJ, 2015, FOOD CHEM TOXICOL, V76, P19, DOI 10.1016/j.fct.2014.11.008; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Fradejas-Villar N, 2017, NUCLEIC ACIDS RES, V45, P4094, DOI 10.1093/nar/gkw1255; Gladyshev VN, 2016, J BIOL CHEM, V291, P24036, DOI 10.1074/jbc.M116.756155; Hadley KB, 2001, J NUTR BIOCHEM, V12, P693, DOI 10.1016/S0955-2863(01)00189-9; HAFEMAN DG, 1974, J NUTR, V104, P580, DOI 10.1093/jn/104.5.580; Hatfield D.L., 2016, SELENIUM ITS MOL BIO, Vfourth; HILL KE, 1992, BIOCHEM BIOPH RES CO, V185, P260, DOI 10.1016/S0006-291X(05)80984-2; Hill KE, 1997, ANAL BIOCHEM, V253, P123, DOI 10.1006/abio.1997.2373; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Kohrle J, 1996, ACTA MED AUST, V23, P17; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; LAWRENCE RA, 1974, EXP EYE RES, V18, P563, DOI 10.1016/0014-4835(74)90062-1; LEI XG, 1995, J NUTR, V125, P1438; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maurer S, 1998, Z ERNAHRUNGSWISS, V37, P110; Munger SC, 2014, GENETICS, V198, P59, DOI 10.1534/genetics.114.165886; National Research Council, 1995, NUTR REQ LAB AN; Odet F, 2015, G3-GENES GENOM GENET, V5, P2671, DOI 10.1534/g3.115.020172; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raines AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-26; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; SAEDI MS, 1988, BIOCHEM BIOPH RES CO, V153, P855, DOI 10.1016/S0006-291X(88)81174-4; Srivastava A, 2017, GENETICS, V206, P537, DOI 10.1534/genetics.116.198838; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; Sun XL, 2001, MOL BIOL CELL, V12, P1009, DOI 10.1091/mbc.12.4.1009; SUNDE RA, 1987, J BIOL CHEM, V262, P933; Sunde RA, 2005, J NUTR, V135, P2144, DOI 10.1093/jn/135.9.2144; Sunde RA, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P137, DOI 10.1007/978-1-4614-1025-6_11; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Thompson KM, 1998, J NUTR, V128, P1289, DOI 10.1093/jn/128.8.1289; THOMPSON KM, 1995, J NUTR, V125, P864; Weiss SL, 1996, J NUTR, V126, P2260, DOI 10.1093/jn/126.9.2260; Weiss SL, 1997, J NUTR BIOCHEM, V8, P85, DOI 10.1016/S0955-2863(96)00178-7; Wen W, 1998, J BIOL CHEM, V273, P28533, DOI 10.1074/jbc.273.43.28533	47	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191449	10.1371/journal.pone.0191449	http://dx.doi.org/10.1371/journal.pone.0191449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338053	Green Submitted, Green Published, gold			2022-12-27	WOS:000422652700053
J	Capdevila, P; Linares, C; Aspillaga, E; Riera, JL; Hereu, B				Capdevila, Pol; Linares, Cristina; Aspillaga, Eneko; Lluis Riera, Joan; Hereu, Bernet			Effective dispersal and density-dependence in mesophotic macroalgal forests: Insights from the Mediterranean species Cystoseira zosteroides	PLOS ONE			English	Article							LONG-TERM DECLINE; SPORE DISPERSAL; SEED DISPERSAL; PROPAGULE DISPERSAL; ASCOPHYLLUM-NODOSUM; PHAEOPHYCEAE POPULATIONS; SETTLEMENT DENSITY; PLANT DISPERSAL; LIFE-HISTORIES; RECRUITMENT	Dispersal and recruitment are fundamental processes for population recovery following disturbances in sessile species. While both processes are well understood for many terrestrial species, they still remain poorly resolved for some macroalgal species. Here we experimentally investigated the effective dispersal and recruit survival of a mesophotic Mediterranean fucoid, Cystoseira zosteroides. In three isolated populations, four sets of settlement collectors were placed at increasing distances (from 0 to 10 m) and different orientations (North, South, East and West). We observed that effective dispersal was restricted to populations' vicinity, with an average of 6.43 m and not further than 13.33 m, following a Weibull distribution. During their first year of life, survival was up to 50%, but it was lower underneath the adult canopy, suggesting a negative density-dependence. To put our results in a broader context we compared the effective dispersal of other fucoid and kelp species reported in the literature, which confirmed the low dispersal ability of brown algae, in particular for fucoids, with an effective dispersal of few meters. Given the importance of recruitment for the persistence and recovery of populations after disturbances, these results underline the vulnerability of C. zosteroides and other fucoid species to escalating threats.	[Capdevila, Pol; Linares, Cristina; Aspillaga, Eneko; Lluis Riera, Joan; Hereu, Bernet] Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Spain	University of Barcelona	Capdevila, P (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Spain.	pcapdevila.pc@gmail.com	Hereu, Bernat/K-9150-2015; Linares, Cristina/A-5244-2018; Aspillaga, Eneko/AAH-8613-2019; Capdevila, Pol/J-7730-2016	Hereu, Bernat/0000-0001-6247-7638; Linares, Cristina/0000-0003-3855-2743; Aspillaga, Eneko/0000-0002-8888-8731; Capdevila, Pol/0000-0002-2842-4302; Riera Rey, Joan Lluis/0000-0002-2810-2581	Spanish MINECO [CGL2012-32194]; European Union's Horizon research and innovation program [689518]; FI-DRG grant from the Secretaria d'Universitats i Recercafrom the Economy and Knowledge Department of the Generalitat de Catalunya to Pol Capdevila; Ramon y Cajal research contract [RyC-2011-08134]; Generalitat de Catalunya [2014SGR1297]	Spanish MINECO(Spanish Government); European Union's Horizon research and innovation program; FI-DRG grant from the Secretaria d'Universitats i Recercafrom the Economy and Knowledge Department of the Generalitat de Catalunya to Pol Capdevila; Ramon y Cajal research contract(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	Funding was provided by the Spanish MINECO (CGL2012-32194) and the European Union's Horizon 2020 research and innovation program under grant agreement No 689518 (MERCES). Support for this work was provided by an FI-DRG grant from the Secretaria d'Universitats i Recercafrom the Economy and Knowledge Department of the Generalitat de Catalunya to Pol Capdevila and by a Ramon y Cajal research contract (RyC-2011-08134) to Cristina Linares. The authors are part of the Marine Biodiversity Conservation research group (2014SGR1297,www.medrecover.org) from Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BALLESTEROS E, 1990, Scientia Marina, V54, P217; Ballesteros E, 2009, ESTUAR COAST SHELF S, V82, P477, DOI 10.1016/j.ecss.2009.02.013; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bolker B, 2016, DEV CORE TEAM BBMLE, P1; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Bullock JM, 2017, J ECOL, V105, P6, DOI 10.1111/1365-2745.12666; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Buonomo R, 2016, MOL ECOL; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Campbell AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084106; Capdevila P, 2015, MAR BIOL, V162, P1165, DOI 10.1007/s00227-015-2658-0; Capdevila P, 2016, J ECOL, V104, P1799, DOI 10.1111/1365-2745.12625; Carr MH, 2003, ECOL APPL, V13, pS90; Cervin G, 2005, MAR ECOL PROG SER, V305, P31, DOI 10.3354/meps305031; CHAPMAN ARO, 1995, PHYCOLOGIA, V34, P1, DOI 10.2216/i0031-8884-34-1-1.1; Cheminee A, 2013, J EXP MAR BIOL ECOL, V442, P70, DOI 10.1016/j.jembe.2013.02.003; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; Coulson SJ, 2001, J APPL ECOL, V38, P204, DOI 10.1046/j.1365-2664.2001.00585.x; Dayton PK, 1973, POSTELSIA PALMAEFORM, V54, P433; DEYSHER L, 1981, J EXP MAR BIOL ECOL, V56, P179, DOI 10.1016/0022-0981(81)90188-X; Doropoulos C, 2016, ECOL MONOGR, V86, P20, DOI 10.1890/15-0668.1; Dudgeon S, 2005, OIKOS, V109, P405, DOI 10.1111/j.0030-1299.2005.13782.x; Dudgeon S, 2001, FUNCT ECOL, V15, P595, DOI 10.1046/j.0269-8463.2001.00559.x; Durrant HMS, 2014, CONSERV BIOL, V28, P438, DOI 10.1111/cobi.12203; Engelen AH, 2001, MAR BIOL, V139, P267; Forbis TA, 2004, AM J BOT, V91, P1147, DOI 10.3732/ajb.91.7.1147; FREDRIKSEN S, 1995, SARSIA, V80, P47, DOI 10.1080/00364827.1995.10413579; Gaylord B, 2002, ECOLOGY, V83, P1239, DOI 10.1890/0012-9658(2002)083[1239:APBMOM]2.0.CO;2; Gaylord B, 2006, ECOL MONOGR, V76, P481, DOI 10.1890/0012-9615(2006)076[0481:MSDICE]2.0.CO;2; Giaccone G, 1973, CISTOSEIRE VEGETAZIO; Giaccone G, 1973, RAPPORTS COMMUNICATI, V22, P49; Gianni Fabrizio, 2014, Advances in Oceanography and Limnology, V4, P83, DOI 10.1080/19475721.2013.845604; Hereu B, 2008, EUR J PHYCOL, V43, P263, DOI 10.1080/09670260801930330; Hernandez-Carmona G, 2000, BOT MAR, V43, P273, DOI 10.1515/BOT.2000.029; Hirsch BT, 2012, METHODS ECOL EVOL, V3, P595, DOI 10.1111/j.2041-210X.2011.00183.x; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Irving AD, 2009, MAR BIOL, V156, P1223, DOI 10.1007/s00227-009-1164-7; Jenkins SR, 2004, J MAR BIOL ASSOC UK, V84, P327, DOI 10.1017/S0025315404009221h; Kang YH, 2016, J APPL PHYCOL, V28, P1859, DOI 10.1007/s10811-015-0689-z; KENDRICK GA, 1994, MAR ECOL PROG SER, V103, P129, DOI 10.3354/meps103129; KENDRICK GA, 1995, J EXP MAR BIOL ECOL, V192, P273, DOI 10.1016/0022-0981(95)00076-4; KENDRICK GA, 1991, MAR ECOL PROG SER, V79, P133, DOI 10.3354/meps079133; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; Mangialajo L, 2012, J EXP MAR BIOL ECOL, V412, P72, DOI 10.1016/j.jembe.2011.10.031; Mineur F, 2015, J SEA RES, V98, P91, DOI 10.1016/j.seares.2014.11.004; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Navarro L, 2011, ESTUAR COAST SHELF S, V95, P52, DOI 10.1016/j.ecss.2011.08.002; NORTON TA, 1992, BRIT PHYCOL J, V27, P293, DOI 10.1080/00071619200650271; Paine RT, 2017, ECOLOGY, V98, P1560, DOI 10.1002/ecy.1798; Parada GM, 2016, BOT MAR, V59, P283, DOI 10.1515/bot-2016-0034; Pearson GA, 1996, MAR ECOL PROG SER, V143, P211, DOI 10.3354/meps143211; R Development Core Team, 2009, R LANG ENV STAT COMP; REED DC, 1988, ECOL MONOGR, V58, P321, DOI 10.2307/1942543; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Schiel DR, 2012, J EXP MAR BIOL ECOL, V434, P25, DOI 10.1016/j.jembe.2012.07.023; Shanks AL, 2003, ECOL APPL, V13, pS159; Skarpaas O, 2004, J ECOL, V92, P747, DOI 10.1111/j.0022-0477.2004.00915.x; Steen H, 2004, MAR BIOL, V144, P61, DOI 10.1007/s00227-003-1175-8; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stevens CL, 2008, J MARINE SYST, V74, P96, DOI 10.1016/j.jmarsys.2007.11.006; Susini ML, 2007, PHYCOLOGIA, V46, P605, DOI 10.2216/06-100.1; Taylor D, 2010, LIMNOL OCEANOGR, V55, P66, DOI 10.4319/lo.2010.55.1.0066; Tegner MJ, 1997, MAR ECOL PROG SER, V146, P117, DOI 10.3354/meps146117; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Thibaut T, 2015, MEDITERR MAR SCI, V16, P206, DOI 10.12681/mms.1032; Tufto J, 1997, THEOR POPUL BIOL, V52, P16, DOI 10.1006/tpbi.1997.1306; Underwood AJ, 1999, J EXP MAR BIOL ECOL, V232, P125, DOI 10.1016/S0022-0981(98)00105-1; VADAS RL, 1992, BRIT PHYCOL J, V27, P331, DOI 10.1080/00071619200650291; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; Wright JT, 2001, ECOLOGY, V82, P2200, DOI 10.1890/0012-9658(2001)082[2200:EOVRAP]2.0.CO;2	81	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191346	10.1371/journal.pone.0191346	http://dx.doi.org/10.1371/journal.pone.0191346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329336	Green Published, Green Submitted, gold			2022-12-27	WOS:000419954100060
J	Beggs, CB; Giaquinta, A; Veroux, M; De Marco, E; Mociskyte, D; Veroux, P				Beggs, Clive B.; Giaquinta, Alessia; Veroux, Massimiliano; De Marco, Ester; Mociskyte, Dovile; Veroux, Pierfrancesco			Mid-term sustained relief from headaches after balloon angioplasty of the internal jugular veins in patients with multiple sclerosis	PLOS ONE			English	Article							CEREBROSPINAL VENOUS INSUFFICIENCY; ASSESSMENT MIDAS QUESTIONNAIRE; NORMAL-PRESSURE HYDROCEPHALUS; ENDOVASCULAR TREATMENT; HEMODYNAMIC IMPAIRMENT; CEREBRAL HYPOPERFUSION; MIGRAINE DISABILITY; FLUID DYNAMICS; OUTFLOW; FLOW	Objectives & para;& para;Multiple sclerosis (MS) patients frequently suffer from headaches and fatigue, and many reports have linked headaches with intracranial and/or extracranial venous obstruction. We therefore designed a study involving MS patients diagnosed with obstructive disease of internal jugular veins (IJVs), with the aim of evaluating the impact of percutaneous transluminal angioplasty (PTA) on headache and fatigue indicators.& para;& para;Methods & para;& para;286 MS patients (175 relapsing remitting (RR), 75 secondary progressive (SP), and 36 primary progressive (PP)), diagnosed with obstructive disease of IJVs, underwent PTA of IJVs during the period 2011-2015. This included 113 headache positive patients (82 RR, 22 SP, and 9 PP) and 277 fatigue positive patients (167 RR, 74 SP, and 36 PP). Migraine Disability Assessment (MIDAS), and the Fatigue Severity Scale (FSS) were evaluated: before PTA; 3-months after PTA; and at final follow-up in 2017. Patients were evaluated with Doppler sonography of the IJVs at 1, 6 and 12 months after PTA and yearly thereafter. Non-parametric statistical analysis was performed using a combination of the Friedman test and Spearman correlation analysis.& para;& para;Results & para;& para;With the exception of the PP patients there were significant reductions (all p < 0.001) in the MIDAS and FSS scores in the 3-month following PTA. The improvement in MIDAS score following PTA was maintained throughout the follow-up period in both the RR (p < 0.001; mean of 3.55 years) and SP (p = 0.002; mean of 3.52 years) MS cohorts. With FSS, significant improvement was only observed at 2017 follow-up in the RR patients (p < 0.001; mean of 3.37 years). In the headache-positive patients, post-PTA MIDAS score was significantly negatively correlated with the change in the blood flow score in the left (r = -0.238, p = 0.031) and right (r = -0.250, p = 0.023) IJVs in the RR patients and left IJV (r = -0.727, p = 0.026) in the PP patients. In the fatigue-positive cohort, post-PTA FSS score was also significantly negatively correlated with the change in blood flow in the right IJV in the PP patients (r = -0.423, p = 0.010). In addition, the pre and post-PTA FSS scores were significantly positively correlated in the fatigue-positive RR (r = 0.249, p = 0.001) and SP patients (r = 0.272, p =0.01 9).& para;& para;Conclusions & para;& para;The intervention of PTA was associated with a large and sustained (>3 years) reduction in MIDAS score in both RR and SP MS patients. While a similar initial post-PTA reduction in FSS score was also observed, this was not maintained in the SP and PP patients, although it remained significant at follow-up (>3 years) in the RR MS patients. This suggests that venoplasty might be a useful intervention for treating patients with persistent headaches and selected concomitant obstructive disease of the IJVs.	[Beggs, Clive B.] Leeds Beckett Univ, Sch Sport, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England; [Giaquinta, Alessia; Veroux, Massimiliano; De Marco, Ester; Mociskyte, Dovile; Veroux, Pierfrancesco] Azienda Osped Univ Policlin, Vasc Surg & Organ Transplant Unit, Catania, Italy	Leeds Beckett University; University of Catania	Beggs, CB (corresponding author), Leeds Beckett Univ, Sch Sport, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England.	c.beggs@leedsbeckett.ac.uk	veroux, pierfrancesco/K-5195-2018; Veroux, Massimiliano/K-4821-2018	Veroux, Massimiliano/0000-0002-2780-6421				Adhya S, 2006, NEUROIMAGE, V33, P1029, DOI 10.1016/j.neuroimage.2006.08.008; Alberti Andrea, 2008, Front Neurol Neurosci, V23, P89; Bateman GA, 2008, AM J NEURORADIOL, V29, P198, DOI 10.3174/ajnr.A0739; Bateman GA, 2000, AM J NEURORADIOL, V21, P1574; Bateman GA, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0066-1; Bateman GA, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0041-2; Bavera PM, 2015, VEINS LYMPHATICS, V4, P5400; Beggs C, 2014, PHLEBOLOGY, V29, P191, DOI 10.1258/phleb.2012.012039; Beggs CB, 2014, J MAGN RESON IMAGING, V40, P1215, DOI 10.1002/jmri.24468; Beggs CB, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-142; Burch RC, 2015, HEADACHE, V55, P21, DOI 10.1111/head.12482; Chou CH, 2004, CEPHALALGIA, V24, P973, DOI 10.1111/j.1468-2982.2004.00781.x; Chung CP, 2010, ULTRASOUND MED BIOL, V36, P11, DOI 10.1016/j.ultrasmedbio.2009.08.007; D'Amico D, 2001, CEPHALALGIA, V21, P947, DOI 10.1046/j.0333-1024.2001.00277.x; D'Amico D, 2013, NEUROL SCI, V34, pS1, DOI 10.1007/s10072-013-1378-9; Day MA, 2014, COMPLEMENT THER MED, V22, P278, DOI 10.1016/j.ctim.2013.12.018; Denuelle M, 2008, CEPHALALGIA, V28, P856, DOI 10.1111/j.1468-2982.2008.01623.x; Doepp F, 2003, HEADACHE, V43, P96, DOI 10.1046/j.1526-4610.2003.03024.x; Gadda G, 2015, AM J PHYSIOL-HEART C, V308, pH217, DOI 10.1152/ajpheart.00469.2014; Ge YL, 2005, AM J NEURORADIOL, V26, P1539; Giaquinta A, 2017, J VASCULAR SURG VENO; Gorucu Y, 2011, FUNCT NEUROL, V26, P215; Haacke EM, 2012, J VASC INTERV RADIOL, V23, P60, DOI 10.1016/j.jvir.2011.09.027; Hatt A, 2015, AM J NEURORADIOL, V36, P1971, DOI 10.3174/ajnr.A4361; Holland CM, 2012, J NEUROIMAGING, V22, P129, DOI 10.1111/j.1552-6569.2011.00585.x; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Ittyachen Abraham M, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-209888; Kiritsi O, 2011, FOLIA MORPHOL, V70, P305; Kister I, 2010, J HEADACHE PAIN, V11, P417, DOI 10.1007/s10194-010-0237-9; KITANO M, 1964, J NUCL MED, V5, P613; Kostecki J, 2016, BRAIN DISORDERS THEA, V5, P3; Kostecki J, 2011, NEUROENDOCRINOL LETT, V32, P557; Lagana MM, 2017, BIOMED SIGNAL PROCES, V36, P84, DOI 10.1016/j.bspc.2017.03.019; Lange G, 2001, Appl Neuropsychol, V8, P23, DOI 10.1207/S15324826AN0801_4; Lupattelli T, 2013, J VASC SURG, V58, P1609, DOI 10.1016/j.jvs.2013.05.108; Malagoni AM, 2010, INT ANGIOL, V29, P176; Mayer CA, 2012, EUR J VASC ENDOVASC, V43, P124, DOI 10.1016/j.ejvs.2011.09.014; Mayer CA, 2011, J NEUROL NEUROSUR PS, V82, P436, DOI 10.1136/jnnp.2010.231613; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; Pereira L, 2016, CEPHALALGIA, V36, P1370, DOI 10.1177/0333102416629241; Petrov I, 2011, J ENDOVASC THER, V18, P314, DOI 10.1583/11-3440.1; Radak D, 2014, PHLEBOLOGY, V29, P367, DOI 10.1177/0268355513481766; Sander C, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00155; Silberstein SD, 2015, J NEUROL NEUROSUR PS, V86, P996, DOI 10.1136/jnnp-2013-307149; Simka M, 2010, INT ANGIOL, V29, P109; Sparaco M, 2015, HEADACHE, V55, P806, DOI 10.1111/head.12599; Stewart WF, 2001, NEUROLOGY, V56, pS20, DOI 10.1212/WNL.56.suppl_1.S20; Tessari M, 2017, VEINS LYMPHATICS, V6, P2; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; Veroux P, 2013, J VASC INTERV RADIOL, V24, P1790, DOI 10.1016/j.jvir.2013.08.024; VIJAYAN N, 1995, NEW ENGL J MED, V332, P1516; Wasay M, 2010, J HEADACHE PAIN, V11, P137, DOI 10.1007/s10194-010-0186-3; WATKINS SM, 1969, J NEUROL NEUROSUR PS, V32, P35, DOI 10.1136/jnnp.32.1.35; Zamboni P, 2012, EUR J VASC ENDOVASC, V43, P116, DOI 10.1016/j.ejvs.2011.03.035; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2016, J VASC SURG-VENOUS L, V4, P434, DOI 10.1016/j.jvsv.2016.06.006; Zamboni P, 2012, J VASC SURG, V56, P677, DOI 10.1016/j.jvs.2012.01.074; Zamboni P, 2009, FUNCT NEUROL, V24, P133; Zamboni P, 2009, J VASC SURG, V50, P1348, DOI 10.1016/j.jvs.2009.07.096; Zaniewski M, 2013, PHLEBOLOGY, V28, P24, DOI 10.1258/phleb.2011.011070; Zivadinov R, 2013, J VASC INTERV RADIOL, V24, P829, DOI 10.1016/j.jvir.2013.01.490	61	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191534	10.1371/journal.pone.0191534	http://dx.doi.org/10.1371/journal.pone.0191534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360844	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000423161800035
J	Mucke, D; Hermes, A; Roettger, TB; Becker, J; Niemann, H; Dembek, TA; Timmermann, L; Visser-Vandewalle, V; Fink, GR; Grice, M; Barbe, MT				Muecke, Doris; Hermes, Anne; Roettger, Timo B.; Becker, Johannes; Niemann, Henrik; Dembek, Till A.; Timmermann, Lars; Visser-Vandewalle, Veerle; Fink, Gereon R.; Grice, Martine; Barbe, Michael T.			The effects of Thalamic Deep Brain Stimulation on speech dynamics in patients with Essential Tremor: An articulographic study	PLOS ONE			English	Article							VOICE ONSET TIME; PARKINSONS-DISEASE; ORAL DIADOCHOKINESIS; SUBTHALAMIC NUCLEUS; MOTOR CONTROL; COARTICULATION; GAIT; ARTICULATION; PERCEPTION; DYSARTHRIA	Acoustic studies have revealed that patients with Essential Tremor treated with thalamic Deep Brain Stimulation (DBS) may suffer from speech deterioration in terms of imprecise oral articulation and reduced voicing control. Based on the acoustic signal one cannot infer, however, whether this deterioration is due to a general slowing down of the speech motor system (e.g., a target undershoot of a desired articulatory goal resulting from being too slow) or disturbed coordination (e.g., a target undershoot caused by problems with the relative phasing of articulatory movements). To elucidate this issue further, we here investigated both acoustics and articulatory patterns of the labial and lingual system using Electromagnetic Articulography (EMA) in twelve Essential Tremor patients treated with thalamic DBS and twelve age- and sex-matched controls. By comparing patients with activated (DBS-ON) and inactivated stimulation (DBS-OFF) with control speakers, we show that critical changes in speech dynamics occur on two levels: With inactivated stimulation (DBS-OFF), patients showed coordination problems of the labial and lingual system in terms of articulatory imprecision and slowness. These effects of articulatory discoordination worsened under activated stimulation, accompanied by an additional overall slowing down of the speech motor system. This leads to a poor performance of syllables on the acoustic surface, reflecting an aggravation either of pre-existing cerebellar deficits and/or the affection of the upper motor fibers of the internal capsule.	[Muecke, Doris; Hermes, Anne; Roettger, Timo B.; Niemann, Henrik; Grice, Martine] Univ Cologne, IfL Phonet, Cologne, Germany; [Becker, Johannes; Dembek, Till A.; Visser-Vandewalle, Veerle; Fink, Gereon R.; Barbe, Michael T.] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Timmermann, Lars] Univ Hosp Marburg, Dept Neurol, Marburg, Germany; [Fink, Gereon R.] Univ Hosp Cologne, Dept Stereotaxy & Funct Neurosurg, Cologne, Germany	University of Cologne; University of Cologne; University Hospital of Giessen & Marburg; University of Cologne	Mucke, D (corresponding author), Univ Cologne, IfL Phonet, Cologne, Germany.	doris.muecke@uni-koeln.de	Dembek, Till Anselm/J-4160-2019; Fink, Gereon R./AFW-9377-2022; Fink, Gereon R./E-1616-2012; Hermes, Anne/A-3260-2015; Roettger, Timo/L-9503-2019	Dembek, Till Anselm/0000-0001-7023-146X; Fink, Gereon R./0000-0002-8230-1856; Fink, Gereon R./0000-0002-8230-1856; Hermes, Anne/0000-0003-1111-0005; Roettger, Timo/0000-0003-1400-2739; Timmermann, Lars/0000-0002-5301-3580; Barbe, Michael T./0000-0003-1149-8054; Grice, Martine/0000-0003-4973-4059	German Research Foundation (DFG) [SFB 1252]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) as part of the SFB 1252 "Prominence in Language" in the project A04 "Dynamic modelling of prosodic prominence" at the University of Cologne.	ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15, DOI 10.1159/000266338; ACKERMANN H, 1991, J NEUROL NEUROSUR PS, V54, P1093, DOI 10.1136/jnnp.54.12.1093; Arkadir D, 2013, THER ADV NEUROL DISO, V6, P229, DOI 10.1177/1756285612471415; Baese-Berk M, 2009, LANG COGNITIVE PROC, V24, P527, DOI 10.1080/01690960802299378; Barbe MT, 2011, J NEUROL, V258, P434, DOI 10.1007/s00415-010-5773-3; Becker J, 2017, NEUROMODULATION, V20, P223, DOI 10.1111/ner.12546; Beckman M, GESTURE SEGMENT PROS, P68; Boersma P., 2010, PRAAT DOING PHONETIC; Browman C., 1989, PHONOLOGY, V6, P201, DOI [10.1017/S0952675700001019, DOI 10.1017/S0952675700001019]; BROWMAN CP, 1992, PHONETICA, V49, P155, DOI 10.1159/000261913; Cassidy S, 2001, SPEECH COMMUN, V33, P61, DOI 10.1016/S0167-6393(00)00069-8; Chenausky K., 2011, PARKINSONS DIS, V2011, P13; Cho T., 2006, LAB PHONOLOGY, V8, P519; Darley FL, 1975, MOTOR SPEECH DISORDE, P171; DEJONG KJ, 1995, J ACOUST SOC AM, V97, P491, DOI 10.1121/1.412275; Deuschl G, 2009, MOVEMENT DISORD, V24, P2033, DOI 10.1002/mds.22755; Dromey C, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/796205; Farnetari E, 1997, HDB PHONETIC SCI, P316; Fasano A, 2010, BRAIN, V133, P3635, DOI 10.1093/brain/awq267; Flora ED, 2010, MOVEMENT DISORD, V25, P1550, DOI 10.1002/mds.23195; Fougeron C, 1997, J ACOUST SOC AM, V101, P3728, DOI 10.1121/1.418332; Frost E, 2010, INT J SPEECH-LANG PA, V12, P399, DOI 10.3109/17549507.2010.497560; Groppa S, 2014, BRAIN, V137, P109, DOI 10.1093/brain/awt304; Hall KC, MESSAGE SHA IN PRESS; Harrington J., 2000, PAPERS LAB PHONOLOGY, P40; Hartinger M, 2010, EFFECTS MED SUBTHALA, V25, P210; Hawkins S., 1992, PAPERS LAB PHONOLOGY, P9, DOI DOI 10.1017/CBO9780511519918.002; Helmchen C, 2003, BRAIN, V126, P1319, DOI 10.1093/brain/awg132; Iskarous K, 2010, J PHONETICS, V38, P625, DOI 10.1016/j.wocn.2010.09.004; Jacobson BH, 1997, AM J SPEECH LANGUAGE, V6, P66, DOI DOI 10.1044/1058-0360.0603.66; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Karlsson F, 2012, J MED SPEECH-LANG PA, V20, P65; Karlsson F, 2014, J SPEECH LANG HEAR R, V57, P1178, DOI 10.1044/2014_JSLHR-S-13-0010; Kent RD, 1999, J COMMUN DISORD, V32, P141, DOI 10.1016/S0021-9924(99)00004-0; Klebe S, 2005, NEUROLOGY, V65, P96, DOI 10.1212/01.wnl.0000167550.97413.1f; Klein JC, 2011, HUM BRAIN MAPP, V32, P896, DOI 10.1002/hbm.21077; Krack P, 2002, MOVEMENT DISORD, V17, pS2, DOI 10.1002/mds.10136; Kronenbuerger M, 2007, BRAIN, V130, P1538, DOI 10.1093/brain/awm081; Kronenbuerger M, 2009, CEREBELLUM, V8, P389, DOI 10.1007/s12311-009-0111-y; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; LINDBLOM B, 1990, NATO ADV SCI I D-BEH, V55, P403; LOGEMANN JA, 1981, J SPEECH HEAR DISORD, V46, P348, DOI 10.1044/jshd.4604.348; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Mai J.K., 2015, ATLAS HUMAN BRAIN, Vfourth; Montgomery EB., 2010, PROGRAMMING PRINCIPL; Mucke D, 2014, J SPEECH LANG HEAR R, V57, P1206, DOI 10.1044/2014_JSLHR-S-13-0155; Mucke D, 2014, J PHONETICS, V44, P1, DOI 10.1016/j.wocn.2014.03.001; MUNHALL KG, 1985, J EXP PSYCHOL HUMAN, V11, P457, DOI 10.1037/0096-1523.11.4.457; Nelson NR, 2017, J PHONETICS, V64, P51, DOI 10.1016/j.wocn.2017.01.008; Pahwa R, 2006, J NEUROSURG, V104, P506, DOI 10.3171/jns.2006.104.4.506; PARDO B, 1993, MOVEMENT DISORD, V8, P278, DOI 10.1002/mds.870080305; Patri JF, 2015, BIOL CYBERN, V109, P611, DOI 10.1007/s00422-015-0664-4; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Putzer M, 2007, J VOICE, V21, P741, DOI 10.1016/j.jvoice.2006.05.007; Roon K., 2007, P 16 INT C PHON SCI, P409; SALTZMAN E, 1987, PSYCHOL REV, V94, P84, DOI 10.1037/0033-295X.94.1.84; Saltzman E, 1975, STATUS REPORT SPEECH, P1; Scarborough R, 2013, J PHONETICS, V41, P491, DOI 10.1016/j.wocn.2013.09.004; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Singer C, 2004, MOVEMENT DISORD, V9, P193; Staiger A, 2017, J MOTOR BEHAV, V49, P482, DOI 10.1080/00222895.2016.1241747; Team RC., 2013, R LANG ENV STAT COMP; Temperli P, 2003, NEUROLOGY, V60, P78, DOI 10.1212/WNL.60.1.78; Weismer G., 1992, INTELLIGIBILITY SPEE, P67; Weismer Gary., 1984, SEMIN SPEECH LANG, V5, P293, DOI [10.1055/s-2008-1064291, DOI 10.1055/S-2008-1064291]; ZIEGLER W, 1986, BRAIN LANG, V29, P34, DOI 10.1016/0093-934X(86)90032-5; Ziegler W, 1996, NEUROLOGY, V47, P208, DOI 10.1212/WNL.47.1.208; Ziegler W, 2002, BRAIN LANG, V80, P556, DOI 10.1006/brln.2001.2614	69	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191359	10.1371/journal.pone.0191359	http://dx.doi.org/10.1371/journal.pone.0191359			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360867	Green Published, gold, Green Submitted			2022-12-27	WOS:000423161800026
J	Wang, XX; Wang, CG; Ye, MH; Lin, J; Jin, J; Hu, QT; Zhu, CC; Chen, BF				Wang, Xinxin; Wang, Chunguo; Ye, Minhua; Lin, Jiang; Jin, Jiang; Hu, Quanteng; Zhu, Chengchu; Chen, Baofu			Left atrial concomitant surgical ablation for treatment of atrial fibrillation in cardiac surgery: A meta-analysis of randomized controlled trials	PLOS ONE			English	Article							MITRAL-VALVE DISEASE; PACEMAKER IMPLANTATION; PULMONARY VEINS; STROKE	Introduction & para;& para;Surgical ablation is a generally established treatment for patients with atrial fibrillation undergoing concomitant cardiac surgery. Left atrial (LA) lesion set for ablation is a simplified procedure suggested to reduce the surgery time and morbidity after procedure. The present meta-analysis aims to explore the outcomes of left atrial lesion set versus no ablative treatment in patients with AF undergoing cardiac surgery.& para;& para;Methods & para;& para;A literature research was performed in six database from their inception to July 2017, identifying all relevant randomized controlled trials (RCTs) comparing left atrial lesion set versus no ablative treatment in AF patient undergoing cardiac surgery. Data were extracted and analyzed according to predefined clinical endpoints.& para;& para;Results & para;& para;Eleven relevant RCTs were included for analysis in the present study. The prevalence of sinus rhythm in ablation group was significantly higher at discharge, 6-month and 1-year follow-up period. The morbidity including 30 day mortality, late all-cause mortality, reoperation for bleeding, permanent pacemaker implantation and neurological events were of no significant difference between two groups.& para;& para;Conclusions & para;& para;The result of our meta-analysis demonstrates that left atrial lesion set is an effective and safe surgical ablation strategy for AF patients undergoing concomitant cardiac surgery.	[Wang, Xinxin; Wang, Chunguo; Ye, Minhua; Lin, Jiang; Jin, Jiang; Hu, Quanteng; Zhu, Chengchu; Chen, Baofu] Wenzhou Med Univ, Affiliated Taizhou Hosp, Dept Thorac & Cardiovasc Surg, Taizhou, Peoples R China	Wenzhou Medical University	Chen, BF (corresponding author), Wenzhou Med Univ, Affiliated Taizhou Hosp, Dept Thorac & Cardiovasc Surg, Taizhou, Peoples R China.	986725634@qq.com	wang, xinxin/HIR-2598-2022		Taizhou Science and Technology Bureau [2016A33739]	Taizhou Science and Technology Bureau	This study was supported by the Taizhou Science and Technology Bureau (grant no. 2016A33739) to BC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.& para;& para;The present study was supported by grants from Taizhou science and technology bureau (2016A33739).	Ad N, 2013, CURR OPIN CARDIOL, V28, P170, DOI 10.1097/HCO.0b013e32835ced9c; Ad N, 2010, INNOVATIONS, V5, P74, DOI 10.1097/IMI.0b013e3181d72939; Albrecht A, 2009, J THORAC CARDIOV SUR, V138, P454, DOI 10.1016/j.jtcvs.2009.04.023; Blomstrom Lundqvist C, 2007, EUR HEART J, V28, P2902, DOI 10.1093/eurheartj/ehm378; Cheng DCH, 2010, INNOVATIONS, V5, P84, DOI 10.1097/imi.0b013e3181d9199b; Cherniavsky A, 2014, INTERACT CARDIOV TH, V18, P727, DOI 10.1093/icvts/ivu016; Chevalier P, 2009, ARCH CARDIOVASC DIS, V102, P769, DOI 10.1016/j.acvd.2009.08.010; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Cox J L, 2000, Semin Thorac Cardiovasc Surg, V12, P2; COX JL, 1991, J THORAC CARDIOV SUR, V101, P569, DOI 10.1016/s0022-5223(19)36684-x; de Lima GG, 2004, ANN THORAC SURG, V77, P2089, DOI 10.1016/j.athoracsur.2003.11.018; Doukas G, 2005, C G MEX MICC; El-Chami MF, 2015, AM J CARDIOL, V116, P88, DOI 10.1016/j.amjcard.2015.03.046; Gammie JS, 2008, ANN THORAC SURG, V85, P909, DOI 10.1016/j.athoracsur.2007.10.097; Gillinov AM, 2007, SEMIN THORAC CARDIOV, V19, P25, DOI 10.1053/j.semtcvs.2007.01.002; Glotzer TV, 2003, CIRCULATION, V107, P1614, DOI 10.1161/01.CIR.0000057981.70380.45; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Khargi K, 2001, ANN THORAC SURG, V72, pS1090, DOI 10.1016/S0003-4975(01)02940-X; Knaut M, 2010, ACP-APPL CARDIOPUL P, V14, P249; Lee R, 2012, J THORAC CARDIOV SUR, V143, P1341, DOI 10.1016/j.jtcvs.2012.02.006; McCarthy P M, 2000, Semin Thorac Cardiovasc Surg, V12, P25; Melo J, 2008, J THORAC CARDIOV SUR, V135, P863, DOI 10.1016/j.jtcvs.2007.08.069; Pecha S, 2014, J THORAC CARDIOV SUR, V147, P984, DOI 10.1016/j.jtcvs.2013.03.012; Phan K, 2015, HEART LUNG CIRCULATI, V24, pe47; Phan K, 2014, ANN CARDIOTHORAC SUR, V3, P3, DOI 10.3978/j.issn.2225-319X.2014.01.04; Phan K, 2014, HEART, V100, P722, DOI 10.1136/heartjnl-2013-305351; Prasad SM, J THORACIC CARDIOVAS, V126, P1822; Schaff H V, 2000, Semin Thorac Cardiovasc Surg, V12, P30; Schuetz A, 2003, EUR J CARDIO-THORAC, V24, P475, DOI 10.1016/S1010-7940(03)00377-4; Srivastava V, HEART LUNG CIRCULATI, V17, P232; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Vasconcelos JT, 2004, ARQ BRAS CARDIOL, V83, P211; Wang X, 2014, INT J CARDIOL, V174, P497, DOI 10.1016/j.ijcard.2014.03.153; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229	34	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191354	10.1371/journal.pone.0191354	http://dx.doi.org/10.1371/journal.pone.0191354			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360851	Green Published, gold, Green Submitted			2022-12-27	WOS:000423161800024
J	Hoang, TT; Goldmuntz, E; Roberts, AE; Chung, WK; Kline, JK; Deanfield, JE; Giardini, A; Aleman, A; Gelb, BD; Mac Neal, M; Porter, GA; Kim, R; Brueckner, M; Lifton, RP; Edman, S; Woyciechowski, S; Mitchell, LE; Agopian, AJ				Hoang, Thanh T.; Goldmuntz, Elizabeth; Roberts, Amy E.; Chung, Wendy K.; Kline, Jennie K.; Deanfield, John E.; Giardini, Alessandro; Aleman, Adolfo; Gelb, Bruce D.; Mac Neal, Meghan; Porter, George A., Jr.; Kim, Richard; Brueckner, Martina; Lifton, Richard P.; Edman, Sharon; Woyciechowski, Stacy; Mitchell, Laura E.; Agopian, A. J.			The Congenital Heart Disease Genetic Network Study: Cohort description	PLOS ONE			English	Article							DE-NOVO MUTATIONS; BIRTH-DEFECTS; UNITED-STATES; METROPOLITAN ATLANTA; MATERNAL SMOKING; PREVALENCE; OUTCOMES; CHILDREN; INFANT; SEX	The Pediatric Cardiac Genomics Consortium (PCGC) designed the Congenital Heart Disease Genetic Network Study to provide phenotype and genotype data for a large congenital heart defects (CHDs)cohort. This article describes the PCGC cohort, overall and by major types of CHDs (e.g., conotruncaldefects) and subtypes of conotrucal heart defects (e.g., tetralogy of Fallot) and left ventricular outflow tract obstructions (e.g., hypoplastic left heart syndrome). Cases with CHDs were recruited through ten sites, 2010 +/- 2014. Information on cases (N = 9,727) and their parents was collected through interviews and medical record abstraction. Four case characteristics, eleven parental characteristics, and thirteen parentreported neurodevelopment outcomes were summarized using counts and frequencies and compared across CHD types and subtypes. Eleven percent of cases had a genetic diagnosis. Among cases without a genetic diagnosis, the majority had conotruncal heart defects (40%) or left ventricular outflow tract obstruction (21%). Across CHD types, there were significant differences (p<0.05) in the distribution of all four case characteristics (e.g., sex), four parental characteristics (e.g., maternal pregestational diabetes), and five neurodevelopmental outcomes (e.g., learning disabilities). Several characteristics (e.g., sex) were also significantly different across CHD subtypes. The PCGC cohort is one of the largest CHD cohorts available for the study of genetic determinants of risk and outcomes. The majority of cases do not have a genetic diagnosis. This description of the PCGC cohort, including differences across CHD types and subtypes, provides a reference work for investigators who are interested in collaborating with or using publically available resources from the PCGC.	[Hoang, Thanh T.; Mitchell, Laura E.; Agopian, A. J.] UTHealth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Goldmuntz, Elizabeth; Edman, Sharon; Woyciechowski, Stacy] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Roberts, Amy E.] Childrens Hosp Boston, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY USA; [Kline, Jennie K.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Deanfield, John E.; Giardini, Alessandro] Great Ormond St Hosp Sick Children, Cardiothorac Unit, London, England; [Deanfield, John E.] UCL, Inst Cardiovasc Sci, London, England; [Aleman, Adolfo; Gelb, Bruce D.; Mac Neal, Meghan] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Porter, George A., Jr.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Kim, Richard] Univ Southern Calif, Keck Sch Med, Sect Cardiothorac Surg, Los Angeles, CA 90033 USA; [Brueckner, Martina; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Yale Ctr Mendelian Gen, New Haven, CT USA; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital; Columbia University; Columbia University; Columbia University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Rochester; University of Southern California; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Agopian, AJ (corresponding author), UTHealth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.	a.j.agopian@uth.tmc.edu	Aleman, Adolfo/GPG-1788-2022; Porter, George/E-7315-2013	Porter, George/0000-0003-0726-9988; Deanfield, John/0000-0001-8806-6052; Gelb, Bruce/0000-0001-8527-5027	National Institutes of Health (NIH); National Heart, Lung, and Blood Institute; Pediatric Cardiac Genomics Consortium [U01-HL098123, U01-HL098147, U01-HL098153, U01-HL098162, U01-HL098163, U01-HL098188, P50-HL74731, R21HL-098844, R01HL-076773, R01-HL74094]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD070454]; National Center for Advancing Translational Sciences [UL1TR000003]; National Institute of Environmental Health Sciences [R21-E5024895]; Cardiovascular Development Consortium [U01-HL098166]; National Human Genome Research Institute [U54HG006504]; Columbia University's CTSA grant [UL1-RR024156]; American Heart Association Award [16GRNT29660001]; Howard Hughes Medical Institute; Children's Hospital of Philadelphia; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL098147, UM1HL098123, U01HL131003] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018521] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pediatric Cardiac Genomics Consortium; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cardiovascular Development Consortium; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Columbia University's CTSA grant; American Heart Association Award(American Heart Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Children's Hospital of Philadelphia; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (NIH) and National Heart, Lung, and Blood Institute, including the Pediatric Cardiac Genomics Consortium [U01-HL098123, U01-HL098147, U01-HL098153, U01-HL098162, U01-HL098163, U01-HL098188, P50-HL74731, R21HL-098844, R01HL-076773, R01-HL74094]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD070454]; the National Center for Research Resources [UL1RR024134, M01-RR-000240] (now the National Center for Advancing Translational Sciences [UL1TR000003]); National Institute of Environmental Health Sciences [R21-E5024895]; the Cardiovascular Development Consortium [U01-HL098166]; the National Human Genome Research Institute [U54HG006504]; Columbia University's CTSA grant [UL1-RR024156]; American Heart Association Award [16GRNT29660001]; and the Howard Hughes Medical Institute. GWAS genotyping was funded by an Institutional Development Fund to The Center for Applied Genomics from The Children's Hospital of Philadelphia. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson CJ, 2011, PEDIATRICS, V127, pE647, DOI 10.1542/peds.2010-1399; Bjornard K, 2013, BIRTH DEFECTS RES A, V97, P87, DOI 10.1002/bdra.23111; Canfield MA, 2006, BIRTH DEFECTS RES A, V76, P747, DOI 10.1002/bdra.20294; Conners C.K., 1997, CONNERS RATING SCALE; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Dykes JC, 2016, HEART, V102, P634, DOI 10.1136/heartjnl-2015-308650; FERENCZ C, 1997, GENETIC ENV RISK FAC; Gaynor JW, 2015, PEDIATRICS, V135, P816, DOI 10.1542/peds.2014-3825; Gelb B, 2013, CIRC RES, V112, P698, DOI 10.1161/CIRCRESAHA.111.300297; Gilboa SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.005; Glessner JT, 2014, CIRC RES, V115, P884, DOI 10.1161/CIRCRESAHA.115.304458; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Khodr ZG, 2014, BIRTH DEFECTS RES A, V100, P472, DOI 10.1002/bdra.23238; Lary JM, 2001, TERATOLOGY, V64, P237, DOI 10.1002/tera.1070; Leirgul E, 2014, AM HEART J, V168, P956, DOI 10.1016/j.ahj.2014.07.030; Malik S, 2008, PEDIATRICS, V121, pE810, DOI 10.1542/peds.2007-1519; Masho SW, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1002-0; Razzaghi H, 2015, J PEDIATR-US, V166, P119, DOI 10.1016/j.jpeds.2014.09.006; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; STORCH TG, 1992, TERATOLOGY, V46, P271, DOI 10.1002/tera.1420460311; Tinker SC, 2012, BIRTH DEFECTS RES A, V103, P517, DOI DOI 10.1002/BDRA.23378; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wang Y, 2015, J PEDIATR-US, V166, P819, DOI 10.1016/j.jpeds.2014.12.025; Warnes CA, 2005, J AM COLL CARDIOL, V46, P1, DOI 10.1016/j.jacc.2005.02.083; Yang QH, 2006, BIRTH DEFECTS RES A, V76, P706, DOI 10.1002/bdra.20308; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	26	47	48	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191319	10.1371/journal.pone.0191319	http://dx.doi.org/10.1371/journal.pone.0191319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351346	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300072
J	Khan, MA; Arif, Z; Khan, MA; Moinuddin; Alam, K				Khan, Mohd Adnan; Arif, Zarina; Khan, Mohd Asad; Moinuddin; Alam, Khursheed			Methylglyoxal produces more changes in biochemical and biophysical properties of human IgG under high glucose compared to normal glucose level	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; IMMUNOGLOBULIN-G; NONENZYMATIC GLYCOSYLATION; RHEUMATOID-ARTHRITIS; FLUORESCENCE ASSAY; OXIDATIVE STRESS; CONGO RED; HYPERGLYCEMIA; DISEASE; SPECTROSCOPY	Hyperglycaemia triggers increased production of methylglyoxal which can cause gross modification in proteins' structure vis-a-vis function though advanced glycation end products (AGEs). The AGEs may initiate vascular and nonvascular pathologies. In this study, we have examined the biochemical and biophysical changes in human IgG under normal and high glucose after introducing methylglyoxal into the assay mixture. This non-enzymatic reaction mainly engaged lysine residues as indicated by TNBS results. The UV results showed hyperchromicity in modified-IgG samples while fluorescence data supported AGEs formation during the course of reaction. Shift in amide I and amide II band position indicated perturbations in secondary structure. Increase carbonyl content and decrease in sulfhydryl suggests that the modification is accompanied by oxidative stress. All modified-IgG samples showed more thermostability than native IgG; the highest Tm was shown by IgG-high glucose-MGO variant. Results of ANS, Congo red and Thioflavin T dyes clearly suggest increase in hydrophobic patches and aggregation, respectively. SEM and TEM images support aggregates generation in modified-IgG samples.	[Khan, Mohd Adnan; Arif, Zarina; Moinuddin; Alam, Khursheed] Aligarh Muslim Univ, Fac Med, JN Med Coll, Dept Biochem, Aligarh, Uttar Pradesh, India; [Khan, Mohd Asad] Jamia Millia Islamia, Dept Biosci, New Delhi, India	Aligarh Muslim University; Jamia Millia Islamia	Alam, K (corresponding author), Aligarh Muslim Univ, Fac Med, JN Med Coll, Dept Biochem, Aligarh, Uttar Pradesh, India.	kalam786@rediffmail.com	Arif, Zarina/AAI-4441-2020	Arif, Zarina/0000-0002-8895-353X; Alam, Khursheed/0000-0001-9729-9966	CSIR, New Delhi [09/112 (0506)/2013-EMR-I]; Indian Council of Medical Research, New Delhi [61/01/2011-BMS]	CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	MAK is thankful to the CSIR, New Delhi for NET-Junior/Senior Research Fellowship awarded vide letter no. 09/112 (0506)/2013-EMR-I.The major part of the work was supported by an Indian Council of Medical Research, New Delhi research grant no. 61/01/2011-BMS to KA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed U, 2014, BIOCHEM SOC T, V42, P538, DOI 10.1042/BST20140024; Alizadeh-Pasdar N, 2000, J AGR FOOD CHEM, V48, P328, DOI 10.1021/jf990393p; Allaman I, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00023; Ardigo Diego, 2004, Current Drug Targets - Inflammation and Allergy, V3, P455, DOI 10.2174/1568010042634488; Arfat MY, 2014, INT J BIOL MACROMOL, V69, P408, DOI 10.1016/j.ijbiomac.2014.05.069; Arif B, 2012, ARCH BIOCHEM BIOPHYS, V522, P17, DOI 10.1016/j.abb.2012.04.005; Ashraf JM, 2015, PLOS ONE, V10, P1; BAKER JR, 1993, CLIN CHEM, V39, P2460; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bose PP, 2010, ACS CHEM NEUROSCI, V1, P315, DOI 10.1021/cn900041x; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Davidson JA, 2009, DIABETES CARE, V32, pS331, DOI 10.2337/dc09-S333; DOLHOFERBLIESENER R, 1990, SCAND J CLIN LAB INV, V50, P739, DOI 10.3109/00365519009091067; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Elosta A, 2017, SCI REP-UK, V7, DOI 10.1038/srep39613; Ercan A, 2010, ARTHRITIS RHEUM-US, V62, P2239, DOI 10.1002/art.27533; Faisal M, 2017, PROTEIN PEPTIDE LETT, V24, P241, DOI 10.2174/0929866524666170117142723; Fokkens BT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173379; Frid P, 2007, BRAIN RES REV, V53, P135, DOI 10.1016/j.brainresrev.2006.08.001; GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4; Hashimoto C, 2013, ANAL CHEM, V85, P4289, DOI 10.1021/ac400294q; Hegab Z, 2012, WORLD J CARDIOL, V4, P90, DOI 10.4330/wjc.v4.i4.90; Heilmann M, 2014, J BIOL CHEM, V289, P7919, DOI 10.1074/jbc.M113.523621; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Iram A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072075; Jensen TM, 2016, DIABETIC MED, V33, P1625, DOI 10.1111/dme.13201; KANESHIGE H, 1987, DIABETES, V36, P822, DOI 10.2337/diabetes.36.7.822; Kim IJ, 2012, ASIAN ONCOL NURS, V12, P44, DOI 10.5388/aon.2012.12.1.44; Kumosinski TF, 1996, TALANTA, V43, P199, DOI 10.1016/0039-9140(95)01726-7; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; MANKARIOUS S, 1988, J LAB CLIN MED, V112, P634; MANNIK M, 1993, RHEUMATOL INT, V13, P121, DOI 10.1007/BF00290300; Manning MC, 2005, EXPERT REV PROTEOMIC, V2, P731, DOI 10.1586/14789450.2.5.731; Matafome P, 2013, ENDOCRINE, V43, P472, DOI 10.1007/s12020-012-9795-8; Miyata T, 1998, BIOCHEM BIOPH RES CO, V244, P45, DOI 10.1006/bbrc.1998.8203; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Mustafa MF, 2016, J FLUORESC, V26, P1743, DOI 10.1007/s10895-016-1866-4; NEY KA, 1981, ANAL BIOCHEM, V118, P294, DOI 10.1016/0003-2697(81)90585-6; Obayashi H, 1996, BIOCHEM BIOPH RES CO, V226, P37, DOI 10.1006/bbrc.1996.1308; Olar LE, 2015, B UASVM VET MED, V72, P100; Pampati PK, 2011, ANAL BIOCHEM, V408, P59, DOI 10.1016/j.ab.2010.08.038; PAMPLONA R, 1995, LIFE SCI, V57, P873, DOI 10.1016/0024-3205(95)02020-J; Paolino Alison S, 2005, J Neurosci Nurs, V37, P130; Pistrosch F, 2011, DIABETES CARE, V34, pS128, DOI 10.2337/dc11-s207; Pradeep AR, 2013, CONTEMP CLIN DENT, V4, P27, DOI 10.4103/0976-237X.111589; Price CL, 2009, TRENDS ENDOCRIN MET, V20, P312, DOI 10.1016/j.tem.2009.03.010; SASHIDHAR RB, 1994, J IMMUNOL METHODS, V167, P121, DOI 10.1016/0022-1759(94)90081-7; Schrijvers BF, 2004, ENDOCR REV, V25, P971, DOI 10.1210/er.2003-0018; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; Sokolove J, 2014, ARTHRITIS RHEUMATOL, V66, P813, DOI 10.1002/art.38307; Silva MS, 2013, BIOCHEM J, V453, P1, DOI 10.1042/BJ20121743; Spallone V, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2882; Sun Q, 2001, MEAT SCI, V57, P55, DOI 10.1016/S0309-1740(00)00076-0; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Traverso N, 1997, BBA-GEN SUBJECTS, V1336, P409, DOI 10.1016/S0304-4165(97)00052-4; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Wang ZQ, 2012, ATHEROSCLEROSIS, V221, P387, DOI 10.1016/j.atherosclerosis.2012.01.019; Wiemer NGM, 2008, GRAEF ARCH CLIN EXP, V246, P703, DOI 10.1007/s00417-007-0729-8; Yanagisawa K, 1998, METABOLISM, V47, P1348, DOI 10.1016/S0026-0495(98)90303-1; Yilmaz Z, 2017, ARCH PHYSIOL BIOCHEM, V123, P192, DOI 10.1080/13813455.2017.1296468	61	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191014	10.1371/journal.pone.0191014	http://dx.doi.org/10.1371/journal.pone.0191014			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351321	gold, Green Submitted, Green Published			2022-12-27	WOS:000422911300038
J	Liao, CD; Tsauo, JY; Hsiao, DJ; Liou, TH; Huang, SW; Lin, LF				Liao, Chun-De; Tsauo, Jau-Yih; Hsiao, Dun-Jen; Liou, Tsan-Hon; Huang, Shih-Wei; Lin, Li-Fong			Association of physical capacity with heart rate variability based on a short-duration measurement of resting pulse rate in older adults with obesity (vol 12, e0189150, 2017)	PLOS ONE			English	Correction									[Liao, Chun-De; Tsauo, Jau-Yih] Natl Taiwan Univ, Sch & Grad Inst Phys Therapy, Coll Med, Taipei, Taiwan; [Liao, Chun-De; Liou, Tsan-Hon; Huang, Shih-Wei; Lin, Li-Fong] Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, New Taipei, Taiwan; [Hsiao, Dun-Jen] Taipei Med Univ, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Liou, Tsan-Hon] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Liou, Tsan-Hon; Huang, Shih-Wei] Taipei Med Univ, Sch Med, Dept Phys Med & Rehabil, Coll Med, Taipei, Taiwan; [Huang, Shih-Wei] Natl Taiwan Sport Univ, Grad Inst Sports Sci, Taoyuan, Taiwan; [Lin, Li-Fong] Taipei Med Univ, Coll Nursing, Sch Gerontol Hlth Management, Taipei, Taiwan	National Taiwan University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University	Liao, CD (corresponding author), Natl Taiwan Univ, Sch & Grad Inst Phys Therapy, Coll Med, Taipei, Taiwan.; Liao, CD (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, New Taipei, Taiwan.		Lin, Li-Fong/AAU-4368-2021; Liou, Tsan-Hon/I-8808-2019; Liao, Chun-De/AAW-5990-2020	Liao, Chun-De/0000-0002-1930-4915	 [105-SHH-HCP-06];  [106TMU-SHH-05]	; 	The correct grant numbers are 105-SHH-HCP-06 and 106TMU-SHH-05.	Liao CD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189150	1	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191842	10.1371/journal.pone.0191842	http://dx.doi.org/10.1371/journal.pone.0191842			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352290	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300135
J	Anuja, P; Venugopalan, V; Darakhshan, N; Awadh, P; Wilson, V; Manoj, G; Manish, M; Vivek, L				Anuja, Patil; Venugopalan, Vishnu; Darakhshan, Naheed; Awadh, Pandit; Wilson, Vinny; Manoj, Goyal; Manish, Modi; Vivek, Lal			Rapidly progressive dementia: An eight year (2008-2016) retrospective study	PLOS ONE			English	Article							SUBACUTE SCLEROSING-PANENCEPHALITIS; CREUTZFELDT-JAKOB-DISEASE; YOUNG-ONSET DEMENTIA; DIAGNOSTIC-CRITERIA; INTERNATIONAL WORKSHOP; GUIDELINES	Background and purpose Rapidly progressive dementia (RPD) is an emergency in cognitive neurology, defined as cognitive impairment affecting the daily living activities developed over less than 1 year. This study investigated the profile of patients with rapidly progressive dementia at first presentation. Methods Retrospective case analysis was done in 187 patients with rapidly progressive dementia who presented to the Postgraduate Institute of Medical Education and Research, Chandigarh, India from January 2008 to August 2016. Patients were divided into three groups: (1) Reversible (treatable) secondary dementia group, (2) Prion dementia group (sporadic Creutzfeldt-Jakob disease), (3) Non-prion Neurodegenerative and vascular dementias (primary neurodegenerative and vascular dementia). Cases presenting with delirium secondary to metabolic, drug induced or septic causes and those with signs of meningitis were excluded. Results Secondary reversible causes formed the most common cause for RPD with immune mediated encephalitides, neoplastic and infectious disorders as the leading causes. The patients in this series had an younger onset of RPD. Infections presenting with RPD accounted for the most common cause in our series (39%) with SSPE (41%) as the leading cause followed by neurosyphilis (17.9%) and progressive multifocal leukoencephalopathy (15.3%). Immune mediated dementias formed the second most common (18.1%) etiologic cause for RPD. The neurodegenerative dementias were third common cause for RPD in our series. Neoplastic disorders and immune mediated presented early (< 6 months) while neurodegenerative disorders presented later (> 6 months). Conclusions Rapidly progressive dementia is an emergency in cognitive neurology with potentially treatable or reversible causes that should be sought for diligently.	[Anuja, Patil; Darakhshan, Naheed; Wilson, Vinny; Manoj, Goyal; Manish, Modi; Vivek, Lal] Postgrad Inst Med Educ & Res, Dept Neurol, Sect 12, Chandigarh, India; [Venugopalan, Vishnu; Awadh, Pandit] All India Inst Med Sci, Dept Neurol, New Delhi, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; All India Institute of Medical Sciences (AIIMS) New Delhi	Venugopalan, V (corresponding author), All India Inst Med Sci, Dept Neurol, New Delhi, India.	vishnuvy16@yahoo.com	Vishnu, Venugopalan Y/Q-1382-2019	Vishnu, Venugopalan Y/0000-0002-3654-8137; Modi, Manish/0000-0002-5494-3704				CALABRESE LH, 1988, MEDICINE, V67, P20, DOI 10.1097/00005792-198801000-00002; Chakor RT, 2013, J PAK MED ASSOC, V63, P921; Chitravas N, 2011, ANN NEUROL, V70, P437, DOI 10.1002/ana.22454; Degnan AJ, 2014, AM J NEURORADIOL, V35, P418, DOI 10.3174/ajnr.A3454; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; DYKEN PR, 1985, NEUROL CLIN, V3, P179, DOI 10.1016/S0733-8619(18)31062-4; Geschwind Michael D, 2016, Continuum (Minneap Minn), V22, P510, DOI 10.1212/CON.0000000000000319; Geschwind Michael D, 2010, Continuum (Minneap Minn), V16, P31, DOI 10.1212/01.CON.0000368211.79211.4c; GILBERSTADT SJ, 1980, ARCH INTERN MED, V140, P519, DOI 10.1001/archinte.140.4.519; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Grau-Rivera O, 2015, NEURODEGENER DIS, V15, P350, DOI 10.1159/000439251; Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9; Kelley BJ, 2008, ARCH NEUROL-CHICAGO, V65, P1502, DOI 10.1001/archneur.65.11.1502; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; McKeon Andrew, 2010, Continuum (Minneap Minn), V16, P80, DOI 10.1212/01.CON.0000368213.63964.34; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Neto AS, 2017, ALZ DIS ASSOC DIS, V31, P239, DOI 10.1097/WAD.0000000000000170; Papageorgiou SG, 2009, ALZ DIS ASSOC DIS, V23, P337, DOI 10.1097/WAD.0b013e31819e099b; Paterson Ross W, 2012, Neurol Clin Pract, V2, P187; Poser S, 1999, BRAIN, V122, P2345, DOI 10.1093/brain/122.12.2345; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Sala I, 2012, ALZ DIS ASSOC DIS, V26, P267, DOI 10.1097/WAD.0b013e3182368ed4; Singer C, 1997, MOVEMENT DISORD, V12, P342, DOI 10.1002/mds.870120313; Tagliapietra M, 2013, J ALZHEIMERS DIS, V34, P231, DOI 10.3233/JAD-121873; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191	26	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0189832	10.1371/journal.pone.0189832	http://dx.doi.org/10.1371/journal.pone.0189832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346380	Green Submitted, gold, Green Published			2022-12-27	WOS:000422749500006
J	Harada, S; Hirayama, A; Chan, Q; Kurihara, A; Fukai, K; Iida, M; Kato, S; Sugiyama, D; Kuwabara, K; Takeuchi, A; Akiyama, M; Okamura, T; Ebbels, TMD; Elliott, P; Tomita, M; Sato, A; Suzuki, C; Sugimoto, M; Soga, T; Takebayashi, T				Harada, Sei; Hirayama, Akiyoshi; Chan, Queenie; Kurihara, Ayako; Fukai, Kota; Iida, Miho; Kato, Suzuka; Sugiyama, Daisuke; Kuwabara, Kazuyo; Takeuchi, Ayano; Akiyama, Miki; Okamura, Tomonori; Ebbels, Timothy M. D.; Elliott, Paul; Tomita, Masaru; Sato, Asako; Suzuki, Chizuru; Sugimoto, Masahiro; Soga, Tomoyoshi; Takebayashi, Toru			Reliability of plasma polar metabolite concentrations in a large-scale cohort study using capillary electrophoresis-mass spectrometry	PLOS ONE			English	Article							HUMAN BLOOD METABOLITES; PROFILING REVEALS; WIDE ASSOCIATION; SERUM METABOLOME; BIOMARKERS; CANCER; RISK; URINE; IDENTIFICATION; MULTICENTER	Background Cohort studies with metabolomics data are becoming more widespread, however, large-scale studies involving 10,000s of participants are still limited, especially in Asian populations. Therefore, we started the Tsuruoka Metabolomics Cohort Study enrolling 11,002 community-dwelling adults in Japan, and using capillary electrophoresis-mass spectrometry (CE-MS) and liquid chromatography-mass spectrometry. The CE-MS method is highly amenable to absolute quantification of polar metabolites, however, its reliability for large-scale measurement is unclear. The aim of this study is to examine reproducibility and validity of large-scale CE-MS measurements. In addition, the study presents absolute concentrations of polar metabolites in human plasma, which can be used in future as reference ranges in a Japanese population. Methods Metabolomic profiling of 8,413 fasting plasma samples were completed using CE-MS, and 94 polar metabolites were structurally identified and quantified. Quality control (QC) samples were injected every ten samples and assessed throughout the analysis. Inter-and intra-batch coefficients of variation of QC and participant samples, and technical intraclass correlation coefficients were estimated. Passing-Bablok regression of plasma concentrations by CE-MS on serum concentrations by standard clinical chemistry assays was conducted for creatinine and uric acid. Results and conclusions In QC samples, coefficient of variation was less than 20% for 64 metabolites, and less than 30% for 80 metabolites out of the 94 metabolites. Inter-batch coefficient of variation was less than 20% for 81 metabolites. Estimated technical intraclass correlation coefficient was above 0.75 for 67 metabolites. The slope of Passing-Bablok regression was estimated as 0.97 (95% confidence interval: 0.95, 0.98) for creatinine and 0.95 (0.92, 0.96) for uric acid. Compared to published data from other large cohort measurement platforms, reproducibility of metabolites common to the platforms was similar to or better than in the other studies. These results show that our CE-MS platform is suitable for conducting large-scale epidemiological studies.	[Harada, Sei; Kurihara, Ayako; Fukai, Kota; Iida, Miho; Kato, Suzuka; Sugiyama, Daisuke; Kuwabara, Kazuyo; Takeuchi, Ayano; Okamura, Tomonori; Takebayashi, Toru] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Harada, Sei; Hirayama, Akiyoshi; Kurihara, Ayako; Akiyama, Miki; Tomita, Masaru; Sato, Asako; Suzuki, Chizuru; Sugimoto, Masahiro; Soga, Tomoyoshi; Takebayashi, Toru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Harada, Sei; Chan, Queenie; Elliott, Paul] Imperial Coll London, Fac Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Chan, Queenie; Ebbels, Timothy M. D.; Elliott, Paul] Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England; [Iida, Miho] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Akiyama, Miki; Tomita, Masaru; Soga, Tomoyoshi] Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa, Japan; [Ebbels, Timothy M. D.] Imperial Coll London, Dept Surg & Canc, Computat & Syst Med, London, England	Keio University; Keio University; Imperial College London; Imperial College London; Keio University; Keio University; Imperial College London	Harada, S (corresponding author), Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan.; Harada, S (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.; Harada, S (corresponding author), Imperial Coll London, Fac Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	seiharada@keio.jp	Takeuchi, Ayano/C-3130-2019; Fukai, Kota/P-9046-2017; Takebayashi, Toru/AAB-9356-2019; Takebayashi, Toru/K-7526-2013; Ebbels, Tim/ABB-2627-2021; Okamura, Tomonori/L-1693-2013; Chan, Queenie/C-5017-2011; Harada, Sei/ABA-5975-2020	Takeuchi, Ayano/0000-0002-0908-1850; Fukai, Kota/0000-0002-8319-8467; Takebayashi, Toru/0000-0002-8268-8026; Takebayashi, Toru/0000-0002-8268-8026; Ebbels, Tim/0000-0002-3372-8423; Okamura, Tomonori/0000-0003-0488-0351; Chan, Queenie/0000-0001-9278-230X; Harada, Sei/0000-0003-2666-4932; Sugimoto, Masahiro/0000-0003-3316-2543; Elliott, Paul/0000-0002-7511-5684	Yamagata Prefectural Government; city of Tsuruoka; Public Health England [MR/L01341X/1]; Medical Research Council; NIHR Health Protection Research Unit in Health Impact of Environmental Hazards [HPRU-2012-10141]; Japan Society for the Promotion of Science [JP24390168, JP15H04778, 25670303, JP15K19231]; MRC [MR/L01341X/1] Funding Source: UKRI; Medical Research Council [MR/L01341X/1, HDR-2002] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136] Funding Source: researchfish; Grants-in-Aid for Scientific Research [15K21364] Funding Source: KAKEN	Yamagata Prefectural Government; city of Tsuruoka; Public Health England; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Health Protection Research Unit in Health Impact of Environmental Hazards; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by research funds from the Yamagata Prefectural Government (http://www.pref.yamagata.jp/) and the city of Tsuruoka (https://www.city.tsuruoka.lg.jp/), Medical Research Council and Public Health England (https://www.mrc.ac.uk/, grant number MR/L01341X/1) and NIHR Health Protection Research Unit in Health Impact of Environmental Hazards (http://hieh.hpru.nihr.ac.uk/, grant number HPRU-2012-10141), and by the Grant-in-Aid for Scientific Research (B) (grant numbers JP24390168, JP15H04778), Grant-in-Aid for Challenging Exploratory Research (grant number 25670303), and Grant-in-Aid for Young Scientists (B) (grant number JP15K19231) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage EG, 2014, J PHARMACEUT BIOMED, V87, P1, DOI 10.1016/j.jpba.2013.08.041; Athersuch TJ, 2015, MUTAGENESIS, V30, P755, DOI 10.1093/mutage/gev060; Boizard F, 2016, SCI REP-UK, V6, DOI 10.1038/srep34453; Brunius C, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1124-4; Chan Q, 2017, HYPERTENS RES, V40, P336, DOI 10.1038/hr.2016.164; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; DiBattista A, 2017, ANAL CHEM, V89, P8112, DOI 10.1021/acs.analchem.7b01727; Dunn WB, 2015, METABOLOMICS, V11, P9, DOI 10.1007/s11306-014-0707-1; Dunn WB, 2012, BIOANALYSIS, V4, P2249, DOI [10.4155/BIO.12.204, 10.4155/bio.12.204]; Elliott P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5680; Fischer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001606; FOSSATI P, 1980, CLIN CHEM, V26, P227; Frantzi M, 2016, CLIN CANCER RES, V22, P4077, DOI 10.1158/1078-0432.CCR-15-2715; Fukai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164877; Guertin KA, 2014, AM J CLIN NUTR, V100, P208, DOI 10.3945/ajcn.113.078758; Harada S, 2016, ENVIRON HEALTH PREV, V21, P18, DOI 10.1007/s12199-015-0494-y; Hirayama A, 2015, ELECTROPHORESIS, V36, P2148, DOI 10.1002/elps.201400600; Hirayama A, 2012, ANAL BIOANAL CHEM, V404, P3101, DOI 10.1007/s00216-012-6412-x; Hirayama A, 2012, ANALYST, V137, P5026, DOI 10.1039/c2an35492f; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Hornung R.W., 1990, APPL OCCUP ENV HYG, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Iida M, 2016, MENOPAUSE, V23, P749, DOI 10.1097/GME.0000000000000630; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Karaman I, 2016, J PROTEOME RES, V15, P4188, DOI 10.1021/acs.jproteome.6b00125; Kuligowski J, 2014, TALANTA, V130, P442, DOI 10.1016/j.talanta.2014.07.031; Long T, 2017, NAT GENET, V49, P568, DOI 10.1038/ng.3809; Macedo AN, 2017, ACS CENTRAL SCI, V3, P904, DOI 10.1021/acscentsci.7b00299; Mondul AM, 2015, INT J CANCER, V137, P2124, DOI 10.1002/ijc.29576; Peake Michael, 2006, Clin Biochem Rev, V27, P173; Ramautar R, 2017, ELECTROPHORESIS, V38, P190, DOI 10.1002/elps.201600370; Ramautar R, 2009, ELECTROPHORESIS, V30, P276, DOI 10.1002/elps.200800512; Rhee EP, 2013, CELL METAB, V18, P130, DOI 10.1016/j.cmet.2013.06.013; Sampson JN, 2013, CANCER EPIDEM BIOMAR, V22, P631, DOI 10.1158/1055-9965.EPI-12-1109; Sekula P, 2016, J AM SOC NEPHROL, V27, P1175, DOI 10.1681/ASN.2014111099; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Sugimoto M, 2010, ELECTROPHORESIS, V31, P2311, DOI 10.1002/elps.200900584; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; TANGANELLI E, 1982, CLIN CHEM, V28, P1461; Townsend MK, 2013, CLIN CHEM, V59, P1657, DOI 10.1373/clinchem.2012.199133; US FDA, 2011, GUID IND BIOAN METH; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wehrens R, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1015-8; White Emily, 2011, IARC Sci Publ, P143; Xu T, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-60; Yamamoto Y, 2013, CLIN CHEM LAB MED, V51, P1663, DOI 10.1515/cclm-2012-0413; Yu B, 2016, AM J EPIDEMIOL, V183, P650, DOI 10.1093/aje/kwv213; Yu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021230	51	36	36	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191230	10.1371/journal.pone.0191230	http://dx.doi.org/10.1371/journal.pone.0191230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346414	Green Published, gold			2022-12-27	WOS:000422749500038
J	Boddaert, J; Bielen, K; Jongers, B; Manocha, E; Yperzeele, L; Cras, P; Pirici, D; Kumar-Singh, S				Boddaert, Jan; Bielen, Kenny; Jongers, Bart's; Manocha, Ekta; Yperzeele, Laetitia; Cras, Patrick; Pirici, Daniel; Kumar-Singh, Samir			CD8 signaling in microglia/macrophage polarization in a rat model of cerebral ischemia	PLOS ONE			English	Article							NF-KAPPA-B; FOCAL ISCHEMIA; MACROPHAGE ACTIVATION; STROKE; INJURY; MICROGLIA; BRAIN; INFLAMMATION; MICE; MTOR	Classical or M1 activity of microglia/macrophages has been described in several neurode-generative and brain inflammatory conditions and has also been linked to expansion of ischemic injury in post-stroke brain. While different pathways of M1 polarization have been suggested to occur in the post-stroke brain, the precise underlying mechanisms remain undefined. Using a transient middle cerebral artery occlusion (MCAO) rat model, we showed a progressive M2 to M1 polarization in the perilesional brain region with M1 cells becoming one of the dominant subsets by day 4 post-stroke. Comparing key receptors involved in M1 polarization (CD8, IFNyR, Clec4, FcyR, TLR3 and TLR4) and their signal transducers (Syk, Stat1, Irf3, and Traf6) at the day 4 time point, we showed a strong upregulation of CD8 along with SYK transducer in dissected perilesional brain tissue. We further showed that CD8 expression in the post-stroke brain was associated with activated (CD68+) macrophages and that progressive accumulation of CD8+CD68+ cells in the post-stroke brain coincided with increased iNOS (M1 marker) and reduced Arg1 (M2 marker) expression on these cells. In vitro ligand-based stimulation of the CD8 receptor caused increased iNOS expression and an enhanced capacity to phagocytose E. coll particles; and interestingly, CD8 stimulation was also able to repolarize IL4-treated M2 cells to an M1 phenotype. Our data suggest that increased CD8 signaling in the post-stroke brain is primarily associated with microglia/macrophages and can independently drive M1 polarization, and that modulation of CD8 signaling could be a potential target to limit secondary post-stroke brain damage.	[Boddaert, Jan; Bielen, Kenny; Jongers, Bart's; Manocha, Ekta; Kumar-Singh, Samir] Fac Med & Hlth Sci, Mol Pathol Grp, Cell Biol & Histol, Antwerp, Belgium; [Yperzeele, Laetitia; Cras, Patrick] Univ Ziekenhuis Antwerpen, Dept Neurol, Edegem, Belgium; [Cras, Patrick; Kumar-Singh, Samir] Fac Med & Hlth Sci, Translat Neurosci, Antwerp, Belgium; [Pirici, Daniel] Univ Med & Pharm Craiova, Dept Res Methodol, Craiova, Romania	University of Antwerp; University of Medicine & Pharmacy of Craiova	Kumar-Singh, S (corresponding author), Fac Med & Hlth Sci, Mol Pathol Grp, Cell Biol & Histol, Antwerp, Belgium.; Kumar-Singh, S (corresponding author), Fac Med & Hlth Sci, Translat Neurosci, Antwerp, Belgium.	samir.kumarsingh@uantwerpen.be	Yperzeele, Laetitia/AAQ-7742-2020; Kumar-Singh, Samir/G-6280-2012	Yperzeele, Laetitia/0000-0002-5503-5724; Kumar-Singh, Samir/0000-0001-9466-6732	BOF grant from the University of Antwerp [BOF/NOI/LP/DOCPR025813, BOF/NOI-FFP130265, GOA-s30729]; Romanian National Authority for Scientific Research and Innovation - CNCS - UEFISCDI [PN-II-RU-TE-2014-4-0582]; Flemish Fund for Scientific Research/Flemish Institute for Science and technology [IWT-SB111664, FWO- SB151525]	BOF grant from the University of Antwerp; Romanian National Authority for Scientific Research and Innovation - CNCS - UEFISCDI; Flemish Fund for Scientific Research/Flemish Institute for Science and technology	This work was supported by a BOF grant from the University of Antwerp (BOF/NOI/LP/DOCPR025813; BOF/NOI-FFP130265; GOA-s30729) and a project granted by the Romanian National Authority for Scientific Research and Innovation - CNCS - UEFISCDI (project number PN-II-RU-TE-2014-4-0582). KB (IWT-SB111664) and BsJ (FWO- SB151525) are doctoral fellows of the Flemish Fund for Scientific Research/Flemish Institute for Science and technology.; The authors would like to thank Tom K Raju for his assistance in experimental procedures and the Biomedical Microscopic Imaging core facility of the University of Antwerp for equipment and technical support. This work was supported by a BOF grant from the University of Antwerp (B0F/NOI/LP/DOCPRO25813; BOF/NOI-FFP130265; GOA-s30729) and a project granted by the Romanian National Authority for Scientific Research and Innovation-CNCS-UEFISCDI (project number PN-II-RU-TE-2014-4-0582). KB (IWT-SB111664) and BsJ (FWO-SB151525) are doctoral fellows of the Flemish Fund for Scientific Research/Flemish Institute for Science and technology. All authors read, edited, and approved the final draft.	Araki E, 2001, STROKE, V32, P2370, DOI 10.1161/hs1001.096057; Baba T, 2006, BLOOD, V107, P2004, DOI 10.1182/blood-2005-06-2345; Bielen K, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00274; Bielen K, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.72; Carnevale J, 2013, LEUKEMIA, V27, P2118, DOI 10.1038/leu.2013.89; CHAO CC, 1992, J IMMUNOL, V149, P2736; Chernykh ER, 2015, CELL TRANSPLANTATION; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Desestret V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067063; Frieler RA, 2011, STROKE, V42, P179, DOI 10.1161/STROKEAHA.110.598441; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gibbings DJ, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-12; Gliem M, 2016, BBA-MOL BASIS DIS, V1862, P329, DOI 10.1016/j.bbadis.2015.11.004; Han ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105711; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Hill JK, 1999, BRAIN RES, V820, P45, DOI 10.1016/S0006-8993(98)01140-8; Hirji N, 1997, J IMMUNOL, V158, P1833; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jander S, 1998, EUR J NEUROSCI, V10, P680, DOI 10.1046/j.1460-9568.1998.00078.x; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Lan X, 2016, BRAIN BEHAV IMMUNITY; Li T, 2013, BRAIN, V136, P3578, DOI 10.1093/brain/awt287; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mosser David M, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1402s83; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Pirici D, 2009, J HISTOCHEM CYTOCHEM, V57, P567, DOI 10.1369/jhc.2009.953240; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Ritzel RM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0329-1; Schmidt A, 2017, STROKE, V48, P1061, DOI 10.1161/STROKEAHA.116.015577; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroeter M, 2001, ACTA NEUROPATHOL, V101, P440; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sladojevic N, 2014, NEUROBIOL DIS, V67, P57, DOI 10.1016/j.nbd.2014.03.010; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Wang-Fischer Y., 2008, MANUAL STROKE MODELS; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; Xie LK, 2014, J IMMUNOL, V192, P6009, DOI 10.4049/jimmunol.1303492; Xu Y, 2012, NEUROSCIENCE, V218, P35, DOI 10.1016/j.neuroscience.2012.05.036; Yang JJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00061; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Zheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063967	50	31	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0186937	10.1371/journal.pone.0186937	http://dx.doi.org/10.1371/journal.pone.0186937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342151	Green Submitted, Green Published, gold			2022-12-27	WOS:000422653800003
J	Chung, H; Oh, J; Yoon, SH; Yu, KS; Cho, JY; Chung, JY				Chung, Hyewon; Oh, Jaeseong; Yoon, Seo Hyun; Yu, Kyung-Sang; Cho, Joo-Youn; Chung, Jae-Yong			A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; GENETIC-VARIANTS; SLC47A1 GENE; ASSOCIATION; THERAPY; CURVE; RATS; AREA	Background The aim of this study was to explore the pharmacokinetic-pharmacodynamic (PK-PD) relationship of metformin on glucose levels after the administration of 250 mg and 1000 mg of metformin in healthy volunteers. Methods A total of 20 healthy male volunteers were randomized to receive two doses of either a low dose (375 mg followed by 250 mg) or a high dose (1000 mg followed by 1000 mg) of metformin at 12-h intervals. The pharmacodynamics of metformin was assessed using oral glucose tolerance tests before and after metformin administration. The PK parameters after the second dose were evaluated through noncompartmental analyses. Four single nucleotide polymorphisms in MATE1, MATE2-K, and OCT2 were genotyped, and their effects on PK characteristics were additionally evaluated. Results The plasma exposure of metformin increased as the metformin dose increased. The mean values for the area under the concentration-time curve from dosing to 12 hours post-dose (AUC(0-12h)) were 3160.4 and 8808.2 h-mu g/L for the low- and high-dose groups, respectively. Non-linear relationships were found between the glucose-lowering effect and PK parameters with a significant inverse trend at high metformin exposure. The PK parameters were comparable among subjects with the genetic polymorphisms. Conclusions This study showed a non-linear PK-PD relationship on plasma glucose levels after the administration of metformin. The inverse relationship between systemic exposure and the glucose-lowering effect at a high exposure indicates a possible role for the intestines as an action site for metformin.	[Chung, Hyewon; Oh, Jaeseong; Yoon, Seo Hyun; Yu, Kyung-Sang; Cho, Joo-Youn; Chung, Jae-Yong] Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med, Seoul, South Korea; [Chung, Hyewon] Korea Univ, Dept Clin Pharmacol & Toxicol, Guro Hosp, Seoul, South Korea; [Oh, Jaeseong; Yoon, Seo Hyun; Yu, Kyung-Sang; Cho, Joo-Youn] Seoul Natl Univ Hosp, Dept Clin Pharmacol & Therapeut, Seoul, South Korea; [Chung, Jae-Yong] Seoul Natl Univ, Bundang Hosp, Clin Trials Ctr, Seongnam, South Korea	Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Chung, JY (corresponding author), Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med, Seoul, South Korea.; Chung, JY (corresponding author), Seoul Natl Univ, Bundang Hosp, Clin Trials Ctr, Seongnam, South Korea.	jychung@snubh.org	Cho, Joo-Youn/ABC-2044-2021; Cho, Joo-Youn/J-5672-2012	Cho, Joo-Youn/0000-0001-9270-8273; Cho, Joo-Youn/0000-0001-9270-8273; Chung, Jae Yong/0000-0003-4188-2786	Seoul National University and Bundang Hospital Research Fund [06-2013-101]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - funded by the Ministry of Health & Welfare, Republic of Korea [HI14C2770]	Seoul National University and Bundang Hospital Research Fund; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - funded by the Ministry of Health & Welfare, Republic of Korea	This research was funded by the Seoul National University and Bundang Hospital Research Fund [grant 06-2013-101], and supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2770). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS52, DOI 10.2337/dc16-S010; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Buse JB, 2016, DIABETES CARE, V39, P198, DOI 10.2337/dc15-0488; CHIOU WL, 1978, J PHARMACOKINET BIOP, V6, P539, DOI 10.1007/BF01062108; Cho SK, 2014, BRIT J CLIN PHARMACO, V78, P1426, DOI 10.1111/bcp.12476; Christensen MMH, 2015, EUR J CLIN PHARMACOL, V71, P691, DOI 10.1007/s00228-015-1853-8; Chung JY, 2013, PHARMACOGENET GENOM, V23, P365, DOI 10.1097/FPC.0b013e3283622037; Cook MN, 2007, DIABETIC MED, V24, P350, DOI 10.1111/j.1464-5491.2007.02078.x; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; El Messaoudi S, 2016, EUR J CLIN PHARMACOL, V72, P725, DOI 10.1007/s00228-016-2039-8; Garber AJ, 1997, AM J MED, V103, P491, DOI 10.1016/S0002-9343(97)00254-4; Goswami S, 2014, CLIN PHARMACOL THER, V96, P370, DOI 10.1038/clpt.2014.109; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; Grant PJ, 1996, DIABETES CARE, V19, P64, DOI 10.2337/diacare.19.1.64; He R, 2015, DIABETES RES CLIN PR, V109, P57, DOI 10.1016/j.diabres.2015.05.003; Hong Y, 2008, J CLIN PHARMACOL, V48, P696, DOI 10.1177/0091270008316884; Lalonde RL, 2006, APPL PHARMACOKINETIC, P62; Lee SH, 2004, ARCH PHARM RES, V27, P806, DOI 10.1007/BF02980152; LEFLOCH JP, 1990, DIABETES CARE, V13, P172, DOI 10.2337/diacare.13.2.172; Marathe PH, 2000, BRIT J CLIN PHARMACO, V50, P325; MCINTYRE HD, 1991, AUST NZ J MED, V21, P714; Nakamaru Y, 2015, CLIN THER, V37, P2007, DOI 10.1016/j.clinthera.2015.06.012; Rao N, 2005, CLIN THER, V27, P1596, DOI 10.1016/j.clinthera.2005.10.006; Stepensky D, 2002, DRUG METAB DISPOS, V30, P861, DOI 10.1124/dmd.30.8.861; Tkac I, 2013, DIABETES OBES METAB, V15, P189, DOI 10.1111/j.1463-1326.2012.01691.x; Tkac I, 2015, EUR J CLIN PHARMACOL, V71, P59, DOI 10.1007/s00228-014-1774-y; Yoon H, 2013, AAPS J, V15, P571, DOI 10.1208/s12248-013-9460-z; Zhou Y, 2015, INT J CLIN EXP PATHO, V8, P9533	28	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191258	10.1371/Journal.pone.0191258	http://dx.doi.org/10.1371/Journal.pone.0191258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342199	gold, Green Published, Green Submitted			2022-12-27	WOS:000422653800057
J	Li, Z; Coffey, L; Garfin, J; Miller, ND; White, MR; Spalding, EP; de Leon, N; Kaeppler, SM; Schnable, PS; Springer, NM; Hirsch, CN				Li, Zhi; Coffey, Lisa; Garfin, Jacob; Miller, Nathan D.; White, Michael R.; Spalding, Edgar P.; de Leon, Natalia; Kaeppler, Shawn M.; Schnable, Patrick S.; Springer, Nathan M.; Hirsch, Candice N.			Genotype-by-environment interactions affecting heterosis in maize	PLOS ONE			English	Article							SINGLE-CROSS PERFORMANCE; GENE-EXPRESSION; YIELD STABILITY; HYBRID VIGOR; ARABIDOPSIS; PREDICTION; MANIFESTATION; GENOME; NETWORKS; INBREDS	The environment can influence heterosis, the phenomena in which the offspring of two inbred parents exhibits phenotypic performance beyond the inbred parents for specific traits. In this study we measured 25 traits in a set of 47 maize hybrids and their inbred parents grown in 16 different environments with varying levels of average productivity. By quantifying 25 vegetative and reproductive traits across the life cycle we were able to analyze interactions between the environment and multiple distinct instances of heterosis. The magnitude and rank among hybrids for better -parent heterosis (BPH) varied for the different traits and environments. Across the traits, a higher within plot variance was observed for inbred lines compared to hybrids. However, for most traits, variance across environments was not significantly different for inbred lines compared to hybrids. Further, for many traits the correlations of BPH to hybrid performance and BPH to better parent performance were of comparable magnitude. These results indicate that inbred lines and hybrids show similar trends in environmental response and both are contributing to observed genotype -by -environment interactions for heterosis. This study highlights the degree of heterosis is not an inherent trait of a specific hybrid, but varies depending on the trait measured and the environment where that trait is measured. Studies that attempt to correlate molecular processes with heterosis are hindered by the fact that heterosis is not a consistent attribute of a specific hybrid.	[Li, Zhi; Garfin, Jacob; Hirsch, Candice N.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Coffey, Lisa; Schnable, Patrick S.] Iowa State Univ, Dept Agron, Ames, IA USA; [Miller, Nathan D.; Spalding, Edgar P.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [White, Michael R.; de Leon, Natalia; Kaeppler, Shawn M.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Springer, Nathan M.] Univ Minnesota, Dept Plant & Microbial Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities	Hirsch, CN (corresponding author), Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA.	cnhirsch@umn.edu	Spalding, Edgar P/GWC-1811-2022; Spalding, Edgar P/A-9034-2008; Spalding, Edgar P/ABF-3253-2021	Spalding, Edgar P/0000-0002-6890-4765; Spalding, Edgar P/0000-0002-6890-4765; Li, Zhi/0000-0002-6572-7935; Schnable, Patrick/0000-0001-9169-5204; Garfin, Jacob/0000-0002-4120-2376	Minnesota Corn Research and Promotion Council [4108-16SP]; Minnesota Agricultural Experiment Station [13-014]; Iowa Corn Growers; Iowa State University's Plant Sciences Institute	Minnesota Corn Research and Promotion Council; Minnesota Agricultural Experiment Station; Iowa Corn Growers; Iowa State University's Plant Sciences Institute	This work was supported in part by the Minnesota Corn Research and Promotion Council (Project Number 4108-16SP) to CNH, the Minnesota Agricultural Experiment Station (Project 13-014) to CNH, the Iowa Corn Growers to PSS, and Iowa State University's Plant Sciences Institute to PSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD R. W., 1964, CROP SCI, V4, P503; Bernardo R, 1996, CROP SCI, V36, P50, DOI [10.2135/cropsci1996.0011183X003600040009x, 10.2135/cropsci1996.0011183X003600040007x]; BERNARDO R, 1994, CROP SCI, V34, P20, DOI 10.2135/cropsci1994.0011183X003400010003x; Chairi F, 2016, AGR WATER MANAGE, V164, P100, DOI 10.1016/j.agwat.2015.08.005; Cole CB, 2009, CROP SCI, V49, P1577, DOI 10.2135/cropsci2008.08.0450; Crow JF, 1998, GENETICS, V148, P923; Dahal D, 2012, PLANT J, V72, P70, DOI 10.1111/j.1365-313X.2012.05056.x; de Abreu ELF, 2017, PLANT J; Duvick DN, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P19; EAST E.M., 1908, CONN AGR EXP STN REP, P419; Falconer DS, 1996, INTRO QUANTITATIVE G; Fasoula DA, 2005, MAYDICA, V50, P49; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; Frisch M, 2010, THEOR APPL GENET, V120, P441, DOI 10.1007/s00122-009-1204-1; GRIFFING B, 1971, GENETICS, V68, P443; Groszmann M, 2015, P NATL ACAD SCI USA, V112, pE6397, DOI 10.1073/pnas.1519926112; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Hoecker N, 2006, THEOR APPL GENET, V112, P421, DOI 10.1007/s00122-005-0139-4; Janick J, 1998, CSSA SPEC PUBL, P45; Kaeppler S, 2012, ISRN BOT, DOI [10.5402/2012/682824, DOI 10.5402/2012/682824]; Melchinger AE, 1998, CSSA SPEC PUBL, P29; Meyer RC, 2004, PLANT PHYSIOL, V134, P1813, DOI 10.1104/pp.103.033001; Meyer RC, 2012, PLANT J, V71, P669, DOI 10.1111/j.1365-313X.2012.05021.x; Meyer RC, 2010, THEOR APPL GENET, V120, P227, DOI 10.1007/s00122-009-1074-6; Meyer S, 2007, PLANT MOL BIOL, V63, P381, DOI 10.1007/s11103-006-9095-x; Miller M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8453; Miller ND, 2017, PLANT J, V89, P169, DOI 10.1111/tpj.13320; Munaro EM, 2011, FIELD CROP RES, V124, P441, DOI 10.1016/j.fcr.2011.08.001; Munaro EM, 2011, HETEROTIC RESPONSE G, V51; Paschold A, 2010, THEOR APPL GENET, V120, P383, DOI 10.1007/s00122-009-1082-6; Pordes R, 2007, J PHYS CONF SER, V78, DOI 10.1088/1742-6596/78/1/012057; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; SAS Institute, 2002, SAS SYST WIND VERS 9; Schnable PS, 2013, ANNU REV PLANT BIOL, V64, P71, DOI 10.1146/annurev-arplant-042110-103827; SCHNELL FW, 1986, PLANT BREEDING, V97, P30, DOI 10.1111/j.1439-0523.1986.tb01298.x; Scholten S., 2013, DIAGNOSTICS PLANT BR, P265; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shull G., 1909, AM BREEDERS ASS REPO, V5, P51, DOI 10.1093/jhered/os-5.1.51; SHULL G.H., 1908, J HERED, V4, P296; Thain D, 2005, CONCURR COMP-PRACT E, V17, P323, DOI 10.1002/cpe.938; Thiemann A, 2009, CHINESE SCI BULL, V54, P2363, DOI 10.1007/s11434-009-0326-9; Troyer AF, 2009, CROP SCI, V49, P1969, DOI 10.2135/cropsci2009.04.0170; Troyer AF, 2006, CROP SCI, V46, P528, DOI 10.2135/cropsci2005.0065; Zhang L, 2014, J EXP BOT, V65, P5989, DOI 10.1093/jxb/eru337	49	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191321	10.1371/journal.pone.0191321	http://dx.doi.org/10.1371/journal.pone.0191321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342221	Green Submitted, Green Published, gold			2022-12-27	WOS:000422653800061
J	Reeves, LE; Krysko, KL; Avery, ML; Gillett-Kaufman, JL; Kawahara, AY; Connelly, CR; Kaufman, PE				Reeves, Lawrence E.; Krysko, Kenneth L.; Avery, Michael L.; Gillett-Kaufman, Jennifer L.; Kawahara, Akito Y.; Connelly, C. Roxanne; Kaufman, Phillip E.			Interactions between the invasive Burmese python, Python bivittatus Kuhl, and the local mosquito community in Florida, USA	PLOS ONE			English	Article							HOST-FEEDING PATTERNS; EQUINE ENCEPHALITIS-VIRUS; ERRATICUS DIPTERA-CULICIDAE; EVERGLADES NATIONAL-PARK; MOLURUS-BIVITTATUS; BLOOD MEALS; HEPATOZOON APICOMPLEXA; PLASMODIUM-FLORIDENSE; CULEX; INFECTION	The Burmese python, Python bivittatus Kuhl, is a well-established invasive species in the greater Everglades ecosystem of southern Florida, USA. Most research on its ecological impacts focuses on its role as a predator and its trophic interactions with native vertebrate species, particularly mammals. Beyond predation, there is little known about the ecological interactions between P. bivittatus and native faunal communities. It is likely that established populations of P. bivittatus in southern Florida serve as hosts for native mosquito communities. To test this concept, we used mitochondrial cytochrome c oxidase subunit I DNA bar-coding to determine the hosts of blood fed mosquitoes collected at a research facility in northern Florida where captive P. bivittatus and Argentine black and white tegu, Salvator merianae (Dume A ril and Bibron), are maintained in outdoor enclosures, accessible to local mosquitoes. We recovered python DNA from the blood meals of three species of Culex mosquitoes: Culex erraticus (Dyar and Knab), Culex quinquefasciatus Say, and Culex pilosus (Dyar and Knab). Culex erraticus conclusively (P = 0.001; Fisher's Exact Test) took more blood meals from P. bivittatus than from any other available host. While the majority of mosquito blood meals in our sample were derived from P. bivittatus, only one was derived from S. merianae. These results demonstrate that local mosquitoes will feed on invasive P. bivittatus, a recently introduced host. If these interactions also occur in southern Florida, P. bivittatus may be involved in the transmission networks of mosquito-vectored pathogens. Our results also illustrate the potential of detecting the presence of P. bivittatus in the field through screening mosquito blood meals for their DNA.	[Reeves, Lawrence E.; Gillett-Kaufman, Jennifer L.; Kaufman, Phillip E.] Univ Florida, Inst Food & Agr Sci, Entomol & Nematol Dept, Gainesville, FL 32611 USA; [Krysko, Kenneth L.] Univ Florida, Florida Museum Nat Hist, Div Herpetol, Gainesville, FL 32611 USA; [Avery, Michael L.] Natl Wildlife Res Ctr, USDA, Gainesville, FL USA; [Kawahara, Akito Y.] Univ Florida, Florida Museum Nat Hist, McGuire Ctr Lepidoptera & Biodivers, Gainesville, FL 32611 USA; [Connelly, C. Roxanne] Univ Florida, Inst Food & Agr Sci, Florida Med Entomol Lab, Vero Beach, FL 32962 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Reeves, LE (corresponding author), Univ Florida, Inst Food & Agr Sci, Entomol & Nematol Dept, Gainesville, FL 32611 USA.	lereeves@ufl.edu		Gillett-Kaufman, Jennifer/0000-0001-8116-0249; Reeves, Lawrence/0000-0003-3968-8124; Kaufman, Phillip/0000-0001-6159-8358	National Science Foundation [00107251]; United States Department of Agriculture, National Wildlife Research Center; University of Florida Open Access Publishing Fund	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture, National Wildlife Research Center; University of Florida Open Access Publishing Fund	This material is based upon work supported by the National Science Foundation (http://www.nsf.gov) Graduate Research Fellowship under Grant No. 00107251 to LER. Additional support for this study was provided by the United States Department of Agriculture, National Wildlife Research Center (http://www.usda.gov). Publication of this article was funded in part by the University of Florida Open Access Publishing Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffenberg K, 2010, ZOOTAXA, P1; Bataille A, 2012, INFECT GENET EVOL, V12, P1831, DOI 10.1016/j.meegid.2012.07.019; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bingham AM, 2016, J MED ENTOMOL, V53, P473, DOI 10.1093/jme/tjv195; Bingham AM, 2014, AM J TROP MED HYG, V91, P685, DOI 10.4269/ajtmh.14-0081; Bingham AM, 2012, AM J TROP MED HYG, V87, P1140, DOI 10.4269/ajtmh.2012.12-0257; Blosser EM, 2016, ACTA TROP, V164, P352, DOI 10.1016/j.actatropica.2016.10.001; Boback SM, 2016, BIOINVASIONS REC, V5, P197, DOI 10.3391/bir.2016.5.4.02; Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101; Burkett-Cadena ND, 2008, AM J TROP MED HYG, V79, P809, DOI 10.4269/ajtmh.2008.79.809; Burkett-Cadena ND, 2011, J AM MOSQUITO CONTR, V27, P153, DOI 10.2987/10-6076.1; Coffey LL, 2006, EMERG INFECT DIS, V12, P1873; Coffey LL, 2004, EMERG INFECT DIS, V10, P2182, DOI 10.3201/eid1012.040442; COLEMAN PH, 1969, AM J EPIDEMIOL, V89, P217, DOI 10.1093/oxfordjournals.aje.a120931; Cronk QCB, 1995, PLANT INVADERS THREA; Cupp EW, 2004, AM J TROP MED HYG, V71, P272, DOI 10.4269/ajtmh.2004.71.272; Dahlin CR, 2016, ONE HEALTH, V2, P136, DOI 10.1016/j.onehlt.2016.09.003; Darsie RF, 2000, KEYS ADULT FEMALES F; Detinova TS, 1962, B WORLD HEALTH ORGAN, V47, P48; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096; Dorcas ME, 2012, P NATL ACAD SCI USA, V109, P2418, DOI 10.1073/pnas.1115226109; Dove CJ, 2011, WILSON J ORNITHOL, V123, P126, DOI 10.1676/10-092.1; EDMAN JD, 1974, J MED ENTOMOL, V11, P95, DOI 10.1093/jmedent/11.1.95; EDMAN JD, 1972, J MED ENTOMOL, V9, P429, DOI 10.1093/jmedent/9.5.429; EDMAN JD, 1979, J MED ENTOMOL, V15, P521, DOI 10.1093/jmedent/15.5-6.521; Engeman R, 2011, CURR ZOOL, V57, P599, DOI 10.1093/czoolo/57.5.599; Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993; FIELDS BN, 1969, AM J EPIDEMIOL, V89, P222, DOI 10.1093/oxfordjournals.aje.a120932; Fonseca DM, 2000, MOL ECOL, V9, P1803, DOI 10.1046/j.1365-294x.2000.01070.x; GEBHARDT LP, 1964, NEW ENGL J MED, V271, P172, DOI 10.1056/NEJM196407232710402; Graham SP, 2012, AM J TROP MED HYG, V86, P540, DOI 10.4269/ajtmh.2012.11-0283; Greene Daniel U., 2007, Herpetological Review, V38, P355; Guedes DRD, 2016, 073197 BIORXIVORG; Hardin Scott, 2007, P43; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HENDERSON BE, 1969, AM J EPIDEMIOL, V89, P227, DOI 10.1093/oxfordjournals.aje.a120933; Holbrook Joshua, 2011, Florida Scientist, V74, P17; Hoyer IJ, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0353; Hunter ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121655; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; KLEIN TA, 1987, J AM MOSQUITO CONTR, V3, P165; Krysko Kenneth L., 2016, IRCF Reptiles & Amphibians, V23, P110; Martinez-de la Puente J, 2015, PARASITOL RES, V114, P1607, DOI 10.1007/s00436-015-4343-0; McCleery RA, 2015, P ROY SOC LOND B BIO, V282, P2015, DOI DOI 10.1098/RSPB.2015.0120); McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Mendenhall IH, 2012, J MED ENTOMOL, V49, P1092, DOI 10.1603/ME11260; Meshaka Walter E. Jr., 2000, Florida Scientist, V63, P84; Molaei G, 2007, AM J TROP MED HYG, V77, P73; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Paperna I, 2004, PARASITE, V11, P175, DOI 10.1051/parasite/2004112175; Perkins SL, 2007, J HERPETOL, V41, P750, DOI 10.1670/07-052.1; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Reeves LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1791-z; Rodrigues SCG, 2006, J AM MOSQUITO CONTR, V22, P557, DOI 10.2987/8756-971X(2006)22[557:BMIFMC]2.0.CO;2; Savage HM, 2008, J MED ENTOMOL, V45, P276, DOI 10.1603/0022-2585(2008)45[276:HHHAPA]2.0.CO;2; Savage HM, 2007, VECTOR-BORNE ZOONOT, V7, P365, DOI 10.1089/vbz.2006.0602; Simberloff Daniel, 1997, P3; Smith TG, 1996, J PARASITOL, V82, P565, DOI 10.2307/3283781; Snow Ray W., 2007, Herpetological Bulletin, P5; Snow RW, BIOL BOAS PYTHONS; Steinman A, 2006, VECTOR-BORNE ZOONOT, V6, P361, DOI 10.1089/vbz.2006.6.361; Telford SR, 2001, J PARASITOL, V87, P890, DOI 10.2307/3285149; TEMPELIS CH, 1975, J MED ENTOMOL, V11, P635, DOI 10.1093/jmedent/11.6.635; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Unlu I, 2010, J MED ENTOMOL, V47, P625, DOI 10.1603/ME09087; Viana LA, 2010, J MED ENTOMOL, V47, P670, DOI 10.1603/ME09260; Walters TM, 2016, J HERPETOL, V50, P50, DOI 10.1670/14-098; White G, 2011, AM J TROP MED HYG, V85, P421, DOI 10.4269/ajtmh.2011.11-0006; Willson JD, 2017, J APPL ECOL, V54, P1251, DOI 10.1111/1365-2664.12844; Willson JD, 2011, BIOL INVASIONS, V13, P1493, DOI 10.1007/s10530-010-9908-3; WORK TH, 1964, SCIENCE, V145, P270, DOI 10.1126/science.145.3629.270	79	9	9	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190633	10.1371/journal.pone.0190633	http://dx.doi.org/10.1371/journal.pone.0190633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342169	gold, Green Published			2022-12-27	WOS:000422653800028
J	Resnik, LJ; Borgia, ML; Acluche, F; Cancio, JM; Latlief, G; Sasson, N				Resnik, Linda J.; Borgia, Matthew L.; Acluche, Frantzy; Cancio, Jill M.; Latlief, Gail; Sasson, Nicole			How do the outcomes of the DEKA Arm compare to conventional prostheses?	PLOS ONE			English	Article							QUALITY-OF-LIFE; TRINITY AMPUTATION; EXPERIENCE SCALES; COMMUNITY REINTEGRATION; VETERANS AFFAIRS; OPTIMIZE; RELIABILITY; ORTHOTICS; PEOPLE; ADULTS	Objectives Objectives were to 1) compare self-reported function, dexterity, activity performance, quality of life and community integration of the DEKA Arm to conventional prostheses; and 2) examine differences in outcomes by conventional prosthesis type, terminal device type and by DEKA Arm configuration level. Methods This was a two-part study; Part A consisted of in-laboratory training. Part B consisted of home use. Study participants were 23 prosthesis users (mean age = 45 16; 87% male) who completed Part A, and 15 (mean age = 45 18; 87% male) who completed Parts A and B. Outcomes including self-report and performance measures, were collected at Baseline using participants' personal prostheses and at the End of Parts A and B. Scores were compared using paired t-tests. Wilcoxon signed-rank tests were used to compare outcomes for the full sample, and for the sample stratified by device and terminal device type. Analysis of outcomes by configuration level was performed graphically. Results At the End of Part A activity performance using the DEKA Arm and conventional prosthesis was equivalent, but slower with the DEKA Arm. After Part B, performance using the DEKA Arm surpassed conventional prosthesis scores, and speed of activity completion was equivalent. Participants reported using the DEKA Arm to perform more activities, had less perceived disability, and less difficulty in activities at the End of A and B as compared to Baseline. No differences were observed in dexterity, prosthetic skill, spontaneity, pain, community integration or quality of life. Comparisons stratified by device type revealed similar patterns. Graphic comparisons revealed variations by configuration level. Conclusion Participants using the DEKA Arm had less perceived disability and more engagement of the prosthesis in everyday tasks, although activity performance was slower. After home use experience, activity performance was improved and activity speed equivalent to using conventional prostheses.	[Resnik, Linda J.; Borgia, Matthew L.; Acluche, Frantzy] Providence VA Med Ctr, Res Dept, Providence, RI 02908 USA; [Resnik, Linda J.] Brown Univ, Hlth Serv, Policy & Practice, Providence, RI 02912 USA; [Cancio, Jill M.] Brooke Army Med Ctr, JBSA, Ctr Intrepid, Ft Sam Houston, TX 78234 USA; [Cancio, Jill M.] Extremtiy Trauma & Amputat Ctr Excellence, Ft Sam Houston, TX USA; [Latlief, Gail] James A Haley Vet Hosp, Dept PM&R, Tampa, FL USA; [Sasson, Nicole] NYU, Sch Med, New York, NY USA; [Sasson, Nicole] VA NY Hlth Harbor Syst, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; San Antonio Military Medical Center; United States Department of Defense; United States Army; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; New York University	Resnik, LJ (corresponding author), Providence VA Med Ctr, Res Dept, Providence, RI 02908 USA.; Resnik, LJ (corresponding author), Brown Univ, Hlth Serv, Policy & Practice, Providence, RI 02912 USA.	Linda.Resnik@va.gov			United States Department of Veterans Affairs Rehabilitation Research & Development Service (RRD), VA RRD [A9226-R]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009264] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000771] Funding Source: NIH RePORTER	United States Department of Veterans Affairs Rehabilitation Research & Development Service (RRD), VA RRD; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This research was supported by United States Department of Veterans Affairs Rehabilitation Research & Development Service (RR&D), VA RR&D A9226-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LUK ARM; Beaton DE, 2005, J BONE JOINT SURG AM, V87A, P1038, DOI 10.2106/JBJS.D.02060; Burckhardt Carol S, 2003, Health Qual Life Outcomes, V1, P60, DOI 10.1186/1477-7525-1-60; BURCKHARDT CS, 1989, RES NURS HEALTH, V12, P347, DOI 10.1002/nur.4770120604; Burger H, 2008, J REHABIL MED, V40, P393, DOI 10.2340/16501977-0183; Chatman AB, 1997, PHYS THER, V77, P820, DOI 10.1093/ptj/77.8.820; Desmond DM, 2005, AM J PHYS MED REHAB, V84, P506, DOI 10.1097/01.phm.0000166885.16180.63; Gallagher P, 2004, ARCH PHYS MED REHAB, V85, P730, DOI 10.1016/j.apmr.2003.07.009; Gallagher P, 2000, REHABIL PSYCHOL, V45, P130, DOI 10.1037/0090-5550.45.2.130; Heinemann AW, 2003, PROSTHET ORTHOT INT, V27, P191, DOI 10.1080/03093640308726682; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Phillips SL, 2013, J POSTHET OTHOT, V25, P8; Resnik L., 2013, DISABIL REHABIL ASSI; Resnik L., 2017, FUNCTION QU IN PRESS; Resnik L., 2012, J PROSTHET ORTHOT, V24, P192, DOI [10.1097/JPO.0b013e31826ff91c, DOI 10.1097/JPO.0B013E31826FF91C]; Resnik L., 2010, CRIS MEASURE COMMUNI; Resnik L, 2017, ARCH PHYS MED REHABI; Resnik L, 2017, PROSTHET ORTHOT INT; Resnik L., 2012, ARCH PHYS MED REHABI; Resnik L, 2015, ARCH PHYS MED REHABI; Resnik L., 2011, MYOEL S; Resnik L., 2017, DOES DEKA S IN PRESS; Resnik L., 2017, J HAND THER; Resnik L, 2014, PROSTHET ORTHOT INT; Resnik L, 2016, PROSTHET ORTHOT INT, V40, P96, DOI 10.1177/0309364614554032; Resnik L, 2014, PROSTHET ORTHOT INT, V38, P492, DOI 10.1177/0309364613506913; Resnik L, 2014, PROSTHET ORTHOT INT, V38, P456, DOI 10.1177/0309364613506914; Resnik L, 2014, J REHABIL RES DEV, V51, P351, DOI 10.1682/JRRD.2013.08.0180; Resnik L, 2014, J REHABIL RES DEV, V51, P15, DOI 10.1682/JRRD.2013.02.0056; Resnik L, 2013, J HAND THER, V26, P353, DOI 10.1016/j.jht.2013.06.004; Resnik L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-145; Resnik L, 2012, J REHABIL RES DEV, V49, P557, DOI 10.1682/JRRD.2011.04.0081; Resnik L, 2011, PHYS THER, V91, P555, DOI 10.2522/ptj.20100287; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Resnik R L, PROSTHETICS IN PRESS; Rider B., 1988, J HAND THER, V1, P121; Rossier P, 2001, J REHABIL MED, V33, P61; Scott RN, 1985, UNB TEST PROSTHETICS; Stratford P, 1995, PHYSIOTHER CAN, V47, P258, DOI [10.3138/ptc.47.4.258, DOI 10.3138/PTC.47.4.258]; Stuppy DJ, 1998, APPL NURS RES, V11, P84, DOI 10.1016/S0897-1897(98)80229-2; Wong DL, 2001, PAIN, V89, P295, DOI 10.1016/S0304-3959(00)00375-4	41	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191326	10.1371/journal.pone.0191326	http://dx.doi.org/10.1371/journal.pone.0191326			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8II	29342217	gold, Green Published, Green Submitted			2022-12-27	WOS:000422653800062
J	Zurauskaite, G; Meier, M; Voegeli, A; Koch, D; Haubitz, S; Kutz, A; Bernasconi, L; Huber, A; Bargetzi, M; Mueller, B; Schuetz, P				Zurauskaite, Giedre; Meier, Marc; Voegeli, Alaadin; Koch, Daniel; Haubitz, Sebastian; Kutz, Alexander; Bernasconi, Luca; Huber, Andreas; Bargetzi, Mario; Mueller, Beat; Schuetz, Philipp			Biological pathways underlying the association of red cell distribution width and adverse clinical outcome: Results of a prospective cohort study	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT ADMISSION; INFLAMMATION; BIOMARKERS; MORTALITY; DEATH; RISK; AGE	Background Red cell distribution width (RDW) predicts disease outcome in several patient populations, but its prognostic value in addition to other disease parameters in unselected medical inpatients remains unclear. Our aim was to investigate the association of admission RDW levels and mortality adjusted for several disease pathways in unselected medical patients from a previous multicenter study. Methods We included consecutive adult, medical patients at the time point of hospital admission through the emergency department into this observational, cohort study. The primary endpoint was mortality at 30-day. To study association of admission RDW and outcomes, we calculated regression analysis with step-wise inclusion of clinical and laboratory parameters from different biological pathways. Results The 30-day mortality of the 4273 included patients was 5.6% and increased from 1.4% to 14.3% from the lowest to the highest RDW quartile. There was a strong association of RDW and mortality in unadjusted analysis (OR 1.32; 95%Cl 1.27-1.39, p<0.001). RDW was strongly correlated with different pathways including inflammation (coefficient of determination (R-2) 0.30; p<0.001), nutrition (R-2 0.20; p<0.001) and blood diseases (R2 0.30; p<0.001 The association was eliminated after including different biological pathways into the models with the fully adjusted regression model showing an OR of 1.02 (95%Cl 0.93-1.12; p = 0.664) for the association of RDW and mortality. Similar effects were found for other outcomes including intensive care unit admission and hospital readmission. Conclusion Our data suggests that RDW is a strong surrogate marker of mortality in unselected medical inpatients with most of the prognostic information being explained by other disease factors. The strong correlation of RDW and different biological pathways such as chronic inflammation, malnutrition and blood disease suggest that RDW may be viewed as an unspecific and general "chronic disease prognostic marker".	[Zurauskaite, Giedre; Meier, Marc; Voegeli, Alaadin; Koch, Daniel; Haubitz, Sebastian; Kutz, Alexander; Mueller, Beat; Schuetz, Philipp] Kantonsspital Aarau, Med Univ Dept, Aarau, Switzerland; [Bernasconi, Luca; Huber, Andreas] Kantonsspital Aarau, Inst Lab Med, Aarau, Switzerland; [Bargetzi, Mario] Kantonsspital Aarau, Div Hematol Oncol & Transfus Med, Aarau, Switzerland	Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA)	Schuetz, P (corresponding author), Kantonsspital Aarau, Med Univ Dept, Aarau, Switzerland.	schuetzph@gmail.com	schuetz, philipp/C-8475-2013; Mueller, Beat/G-2662-2012	schuetz, philipp/0000-0001-6400-4949; Koch, Daniel/0000-0002-4660-5924				Alfthan G, 2000, BIOL TRACE ELEM RES, V73, P113, DOI 10.1385/BTER:73:2:113; Bion JF, 2000, INTENS CARE MED, V26, pS57, DOI 10.1007/s001340051120; Chen CK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003692; Danese E, 2015, J THORAC DIS, V7, pE402, DOI 10.3978/j.issn.2072-1439.2015.10.04; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Goffaux J, 2005, SOUTH MED J, V98, P985, DOI 10.1097/01.smj.0000182178.22607.47; Gorelik O, 2016, LUNG; Gyawali P, 2015, BLOOD CELL MOL DIS, V54, P360, DOI 10.1016/j.bcmd.2015.01.005; Hu LH, 2017, ONCOTARGET, V8, P16027, DOI 10.18632/oncotarget.13784; Huang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104861; Hunziker S, 2012, CRIT CARE, V16, DOI 10.1186/cc11351; Hunziker S, 2012, AM J MED, V125, P283, DOI 10.1016/j.amjmed.2011.08.021; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kozlitina J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051046; Lippi G, 2016, AM J CARDIOL, V117, P670, DOI 10.1016/j.amjcard.2015.11.024; Lippi G, 2013, EUR J INTERN MED, V24, pE15, DOI 10.1016/j.ejim.2012.09.005; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; Luo RB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167000; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Rodgers GP, BETHESDA HDB CLIN HE; Semba RD, 2010, CLIN NUTR, V29, P600, DOI 10.1016/j.clnu.2010.03.001; Stevens RD, TXB POSTICU MED LEGA, Vxxiv; TAKAHASHI K, 1986, J CLIN INVEST, V77, P1402, DOI 10.1172/JCI112449; Turcato G, 2016, INT J CARDIOL, V222, P999, DOI 10.1016/j.ijcard.2016.08.093; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809	26	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191280	10.1371/journal.pone.0191280	http://dx.doi.org/10.1371/journal.pone.0191280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342203	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800059
J	Dreyer-Andersen, N; Almeida, AS; Jensen, P; Kamand, M; Okarmus, J; Rosenberg, T; Friis, SD; Serrano, AM; Blaabjerg, M; Kristensen, BW; Skrydstrup, T; Gramsbergen, JB; Vieira, HLA; Meyer, M				Dreyer-Andersen, Nanna; Almeida, Ana Sofia; Jensen, Pia; Kamand, Morad; Okarmus, Justyna; Rosenberg, Tine; Friis, Stig During; Serrano, Alberto Martinez; Blaabjerg, Morten; Kristensen, Bjarne Winther; Skrydstrup, Troels; Gramsbergen, Jan Bert; Vieira, Helena L. A.; Meyer, Morten			Intermittent, low dose carbon monoxide exposure enhances survival and dopaminergic differentiation of human neural stem cells	PLOS ONE			English	Article							HEME OXYGENASE 1; FETAL NIGRAL TRANSPLANTATION; ENDOTHELIAL GROWTH-FACTOR; PARKINSONS-DISEASE; NEURONAL DIFFERENTIATION; INFLAMMATORY RESPONSE; MOLECULE-2 CORM-2; PROLIFERATION; ACTIVATION; PROTECTION	Exploratory studies using human fetal tissue have suggested that intrastriatal transplantation of dopaminergic neurons may become a future treatment for patients with Parkinson's disease. However, the use of human fetal tissue is compromised by ethical, regulatory and practical concerns. Human stem cells constitute an alternative source of cells for transplantation in Parkinson's disease, but efficient protocols for controlled dopaminergic differentiation need to be developed. Short-term, low-level carbon monoxide (CO) exposure has been shown to affect signaling in several tissues, resulting in both protection and generation of reactive oxygen species. The present study investigated the effect of CO produced by a novel CO-releasing molecule on dopaminergic differentiation of human neural stem cells. Short-term exposure to 25 ppm CO at days 0 and 4 significantly increased the relative content of beta-tubulin III-immunoreactive immature neurons and tyrosine hydroxylase expressing catecholaminergic neurons, as assessed 6 days after differentiation. Also the number of microtubule associated protein 2-positive mature neurons had increased significantly. Moreover, the content of apoptotic cells (Caspase3) was reduced, whereas the expression of a cell proliferation marker (Ki67) was left unchanged. Increased expression of hypoxia inducible factor-l alpha and production of reactive oxygen species (ROS) in cultures exposed to CO may suggest a mechanism involving mitochondrial alterations and generation of ROS. In conclusion, the present procedure using controlled, short-term CO exposure allows efficient dopaminergic differentiation of human neural stem cells at low cost and may as such be useful for derivation of cells for experimental studies and future development of donor cells for transplantation in Parkinson's disease.	[Dreyer-Andersen, Nanna; Jensen, Pia; Kamand, Morad; Okarmus, Justyna; Gramsbergen, Jan Bert; Meyer, Morten] Univ Southern Denmark, Inst Mol Med, Dept Neurobiol Res, Odense, Denmark; [Almeida, Ana Sofia; Vieira, Helena L. A.] IBET, Oeiras, Portugal; [Almeida, Ana Sofia] Inst Tecnol Quim & Biol, Oeiras, Portugal; [Almeida, Ana Sofia; Vieira, Helena L. A.] Univ Nova Lisboa, Fac Ciencia Med, NOVA Med Sch, CEDOC, Lisbon, Portugal; [Rosenberg, Tine; Kristensen, Bjarne Winther] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Rosenberg, Tine; Kristensen, Bjarne Winther] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Friis, Stig During; Skrydstrup, Troels] Aarhus Univ, Dept Chem, Ctr Insoluble Prot Struct InSPIN, Aarhus, Denmark; [Serrano, Alberto Martinez] Univ Autonoma Madrid, Dept Mol Biol, CSIC, Campus Cantoblanco, Madrid, Spain; [Serrano, Alberto Martinez] Univ Autonoma Madrid, Ctr Mol Biol Severo Ochoa, CSIC, Campus Cantoblanco, Madrid, Spain; [Blaabjerg, Morten; Meyer, Morten] Zealand Univ Hosp, Dept Neurol, Roskilde, Denmark	University of Southern Denmark; Universidade Nova de Lisboa; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Aarhus University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Meyer, M (corresponding author), Univ Southern Denmark, Inst Mol Med, Dept Neurobiol Res, Odense, Denmark.; Meyer, M (corresponding author), Zealand Univ Hosp, Dept Neurol, Roskilde, Denmark.	mmeyer@health.sdu.dk	Kristensen, Bjarne Winther/AAX-5491-2020; Kristensen, Bjarne Winther/A-6690-2012; Vieira, Helena/AAZ-9562-2021	Kristensen, Bjarne Winther/0000-0002-6352-0826; Kristensen, Bjarne Winther/0000-0002-6352-0826; Blaabjerg, Morten/0000-0001-6007-1861; Friis, Stig/0000-0003-4330-5173; Vieira, Helena/0000-0001-9415-3742; Rosenberg, Tine/0000-0002-7874-5526	Lundbeck Foundation; Danish Parkinson Association; Danish National Research Foundation [DNRF118]	Lundbeck Foundation(Lundbeckfonden); Danish Parkinson Association; Danish National Research Foundation(Danmarks Grundforskningsfond)	This research was supported by the Lundbeck Foundation (MM, NDA), the Danish Parkinson Association (MM), I MK Almene Fond (MM), and the Danish National Research Foundation (TS, SF; grant no. DNRF118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154781; Almeida AS, 2012, J BIOL CHEM, V287, P10761, DOI 10.1074/jbc.M111.306738; Bani-Hani MG, 2006, J PHARMACOL EXP THER, V318, P1315, DOI 10.1124/jpet.106.104729; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Brookes PS, 2002, FREE RADICAL BIO MED, V33, P755, DOI 10.1016/S0891-5849(02)00901-2; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Brundin P, 2000, BRAIN, V123, P1380, DOI 10.1093/brain/123.7.1380; Butterfield DA, 2012, INT J NEUROPSYCHOPH, V15, P981, DOI 10.1017/S1461145711001118; Caumartin Y, 2011, KIDNEY INT, V79, P1080, DOI 10.1038/ki.2010.542; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Choi YK, 2010, J BIOL CHEM, V285, P32116, DOI 10.1074/jbc.M110.131284; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Cochen V, 2003, MOVEMENT DISORD, V18, P928, DOI 10.1002/mds.10463; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Eells JB, 2001, J NEUROSCI RES, V64, P322, DOI 10.1002/jnr.1082; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Fagone P, 2011, CLIN EXP IMMUNOL, V163, P368, DOI 10.1111/j.1365-2249.2010.04303.x; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freed CR, 1990, NEW ENGL J MED, V344, P710; Friis SD, 2011, J AM CHEM SOC, V133, P18114, DOI 10.1021/ja208652n; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Garcia-Gallego S, 2014, ANGEW CHEM INT EDIT, V53, P9712, DOI 10.1002/anie.201311225; Gomez-Nicola D, 2008, GLIA, V56, P494, DOI 10.1002/glia.20628; Gomez-Nicola D, 2011, MOL BIOL CELL, V22, P1960, DOI 10.1091/mbc.E11-01-0053; Gramsbergen JB, 2002, BRAIN RES, V935, P47, DOI 10.1016/S0006-8993(02)02451-4; Hagell P, 1999, BRAIN, V122, P1121, DOI 10.1093/brain/122.6.1121; Hashemi SB, 2008, EUR J APPL PHYSIOL, V104, P95, DOI 10.1007/s00421-008-0776-9; Hauser RA, 1999, ARCH NEUROL-CHICAGO, V56, P179, DOI 10.1001/archneur.56.2.179; Hervera A, 2013, PSYCHOPHARMACOLOGY, V228, P463, DOI 10.1007/s00213-013-3053-5; Hoffrogge R, 2006, PROTEOMICS, V6, P1833, DOI 10.1002/pmic.200500556; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Huang YS, 2009, BRAIN RES, V1304, P38, DOI 10.1016/j.brainres.2009.09.009; Hung SY, 2008, MOL PHARMACOL, V74, P1564, DOI 10.1124/mol.108.048611; Jensen P, 2007, J NEUROSCI RES, V85, P1884, DOI 10.1002/jnr.21327; Jiang XH, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-132; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Kim JY, 2003, J NEUROCHEM, V85, P1443, DOI 10.1046/j.1471-4159.2003.01780.x; Kim SJ, 2010, J ENDODONT, V36, P1326, DOI 10.1016/j.joen.2010.04.011; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Krabbe C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096465; Krabbe C, 2009, J NEUROCHEM, V110, P1908, DOI 10.1111/j.1471-4159.2009.06281.x; Larsen TR, 2008, EUR J NEUROSCI, V28, P569, DOI 10.1111/j.1460-9568.2008.06354.x; Leffler CW, 2011, AM J PHYSIOL-HEART C, V301, pH1, DOI 10.1152/ajpheart.00230.2011; Lin HH, 2011, J BIOL CHEM, V286, P3829, DOI 10.1074/jbc.M110.168831; Lindvall O, 2011, NEUROTHERAPEUTICS, V8, P539, DOI 10.1007/s13311-011-0069-6; Liste I, 2007, CELL DEATH DIFFER, V14, P1880, DOI 10.1038/sj.cdd.4402205; Masini E, 2008, FASEB J, V22, P3380, DOI 10.1096/fj.08-107110; Mendez I, 2000, J NEUROSURG, V92, P863, DOI 10.3171/jns.2000.92.5.0863; Meyer AK, 2010, J NEUROL SCI, V289, P93, DOI 10.1016/j.jns.2009.08.024; Morita T, 1997, J BIOL CHEM, V272, P32804, DOI 10.1074/jbc.272.52.32804; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2004, FASEB J; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Opii W, 2008, NEUROBIOL AGING, V29, P51, DOI 10.1016/j.neurobiolaging.2006.09.012; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Parfenova H, 2003, J CEREBR BLOOD F MET, V23, P190, DOI 10.1097/01.WCB.000004823561824.C4; Parfenova H, 2012, J CEREBR BLOOD F MET, V32, P1024, DOI 10.1038/jcbfm.2012.13; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Petrache I, 2000, AM J PHYSIOL-LUNG C, V278, pL312, DOI 10.1152/ajplung.2000.278.2.L312; Queiroga CSF, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/749845; Queiroga CSF, 2015, BRIT J PHARMACOL, V172, P1533, DOI 10.1111/bph.12729; Queiroga CSF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042632; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Ryan MJ, 2006, PHARMACOL RES, V54, P24, DOI 10.1016/j.phrs.2006.01.012; Ryter SW, 2013, KOREAN J INTERN MED, V28, P123, DOI 10.3904/kjim.2013.28.2.123; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Schallner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060672; Song RP, 2004, J IMMUNOL, V172, P1220, DOI 10.4049/jimmunol.172.2.1220; Soni H, 2011, TOXICOL APPL PHARM, V253, P70, DOI 10.1016/j.taap.2011.03.013; Soni H, 2010, VASC PHARMACOL, V53, P68, DOI 10.1016/j.vph.2010.04.002; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Studer L, 2000, J NEUROSCI, V20, P7377; Sutherland BA, 2009, NEUROSCI RES, V65, P326, DOI 10.1016/j.neures.2009.08.007; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Vieira HLA, 2011, PROG NEUROBIOL, V93, P444, DOI 10.1016/j.pneurobio.2011.01.007; Villa A, 2009, EXP CELL RES, V315, P1860, DOI 10.1016/j.yexcr.2009.03.011; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; Wang N, 2007, J CELL BIOCHEM, V100, P1548, DOI 10.1002/jcb.21139; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Yabluchanskiy A, 2012, CRIT CARE MED, V40, P544, DOI 10.1097/CCM.0b013e31822f0d64; Yu S, 2006, NEUROSCIENCE, V141, P817, DOI 10.1016/j.neuroscience.2006.02.080; Zeynalov E, 2009, NEUROBIOL DIS, V35, P264, DOI 10.1016/j.nbd.2009.05.010; Zimmermann A, 2007, AM J PHYSIOL-HEART C, V293, pH2501, DOI 10.1152/ajpheart.00354.2007	97	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191207	10.1371/journal.pone.0191207	http://dx.doi.org/10.1371/journal.pone.0191207			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338033	gold, Green Published, Green Submitted			2022-12-27	WOS:000422652700040
J	Laufenberg, JS; Clark, JD; Chandler, RB				Laufenberg, Jared S.; Clark, Joseph D.; Chandler, Richard B.			Estimating population extinction thresholds with categorical classification trees for Louisiana black bears	PLOS ONE			English	Article							REGRESSION TREES; URSUS-AMERICANUS; LIFE-HISTORY; RECAPTURE; SURVIVAL; DEMOGRAPHY; SCIENCE	Monitoring vulnerable species is critical for their conservation. Thresholds or tipping points are commonly used to indicate when populations become vulnerable to extinction and to trigger changes in conservation actions. However, quantitative methods to determine such thresholds have not been well explored. The Louisiana black bear (Ursus americanus luteolus) was removed from the list of threatened and endangered species under the U.S. Endangered Species Act in 2016 and our objectives were to determine the most appropriate parameters and thresholds for monitoring and management action. Capture mark recapture (CMR) data from 2006 to 2012 were used to estimate population parameters and variances. We used stochastic population simulations and conditional classification trees to identify demographic rates for monitoring that would be most indicative of heighted extinction risk. We then identified thresholds that would be reliable predictors of population viability. Conditional classification trees indicated that annual apparent survival rates for adult females averaged over 5 years ((phi)over-bar(5)) was the best predictor of population persistence. Specifically, population persistence was estimated to be >= 95% over 100 years when ((phi)over-bar(5) >= 0.90, suggesting that this statistic can be used as threshold to trigger management intervention. Our evaluation produced monitoring protocols that reliably predicted population persistence and was cost-effective. We conclude that population projections and conditional classification trees can be valuable tools for identifying extinction thresholds used in monitoring programs.	[Laufenberg, Jared S.] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN USA; [Clark, Joseph D.] Univ Tennessee, US Geol Survey, Southern Appalachian Res Branch, Northern Rocky Mt Sci Ctr, Knoxville, TN 37996 USA; [Chandler, Richard B.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; United States Department of the Interior; United States Geological Survey; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Georgia; University of Georgia	Clark, JD (corresponding author), Univ Tennessee, US Geol Survey, Southern Appalachian Res Branch, Northern Rocky Mt Sci Ctr, Knoxville, TN 37996 USA.	jclark1@utk.edu		Chandler, Richard/0000-0003-4930-2790; Clark, Joseph/0000-0002-8547-8112	Louisiana Department of Wildlife and Fisheries [R2219-631]	Louisiana Department of Wildlife and Fisheries	This study was funded by the Louisiana Department of Wildlife and Fisheries (R2219-631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beston JA, 2011, J WILDLIFE MANAGE, V75, P1588, DOI 10.1002/jwmg.195; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BROWNIE C, 1983, BIOMETRICS, V39, P437, DOI 10.2307/2531015; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Doak DF, 2015, BIOSCIENCE, V65, P189, DOI 10.1093/biosci/biu215; Freedman AH, 2003, ECOL MODEL, V167, P47, DOI 10.1016/S0304-3800(03)00171-6; Gitzen R.A., 2012, DESIGN ANAL LONG TER; Hebblewhite M, 2003, BIOL CONSERV, V112, P415, DOI 10.1016/S0006-3207(02)00341-5; Hines JE, 2002, J APPL STAT, V29, P573, DOI 10.1080/02664760120108872; Hochachka WM, 2007, J WILDLIFE MANAGE, V71, P2427, DOI 10.2193/2006-503; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; Kendall W.L., 2012, DESIGN ANAL LONG TER, P74, DOI DOI 10.1017/CBO9781139022422.007; Laufenberg JS, 2016, WILDL MONOG, V194; Lebreton JD, 2013, J WILDLIFE MANAGE, V77, P12, DOI 10.1002/jwmg.425; Lin Y, 2006, J AM STAT ASSOC, V101, P578, DOI 10.1198/016214505000001230; Lindenmayer DB, 2013, FRONT ECOL ENVIRON, V11, P549, DOI 10.1890/120220; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P745, DOI 10.1111/j.1442-9993.2011.02351.x; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lindenmayer DB, 2010, EFFECTIVE ECOLOGICAL MONITORING, P1; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P298; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; McDonald-Madden E, 2010, TRENDS ECOL EVOL, V25, P547, DOI 10.1016/j.tree.2010.07.002; Mills L. S., 2007, CONSERVATION WILDLIF; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; O'Grady JJ, 2004, BIOL CONSERV, V118, P513, DOI 10.1016/j.biocon.2003.10.002; Otis DL, 1978, WILDL MONOG, V62; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Possingham HP, 2012, DESIGN ANAL LONG TER, P498; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; Reynolds JH, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5397-x; Royle J. A., 2008, HIERARCHICAL MODELIN; Shaffer M., 1987, P69, DOI 10.1017/CBO9780511623400.006; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2009, R J, V1, P14; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; U.S. Fish and Wildlife Service, 2016, FED REGISTER, V81, P13124; U.S. Fish and Wildlife Service, 1995, LOUIS BLACK BEAR REC; U. S. Fish and Wildlife Service, 2016, POSTD MON PLAN LOUIS; [USFWS] US Fish and Wildlife Service, 1992, FED REGISTER, V57, P588; Williams B.K., 2012, ADAPTIVE MANAGEMENT; Williams BK, 2015, ECOL EVOL, V5, P466, DOI 10.1002/ece3.1363; Woods JG, 1999, WILDLIFE SOC B, V27, P616; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	46	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191435	10.1371/journal.pone.0191435	http://dx.doi.org/10.1371/journal.pone.0191435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360863	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800032
J	Petkeviciute, R; Stunzenas, V; Staneviciute, G				Petkeviciute, Romualda; Stunzenas, Virmantas; Staneviciute, Grazina			Comments on species divergence in the genus &ITSphaerium&IT (Bivalvia) and phylogenetic affinities of &ITSphaerium&IT &ITnucleus&IT and &ITS&IT. &ITcorneum&IT var. &ITmamillanum&IT based on karyotypes and sequences of 16S and ITS1 rDNA	PLOS ONE			English	Article							FAMILY SPHAERIIDAE MOLLUSCA; NORTH-AMERICAN; B-CHROMOSOMES; POPULATIONS; DIVERSITY; VENEROIDA; PATTERNS; CLAMS	Chromosome, 16S and ITS1 rDNA sequence analyses were used to obtain reliable diagnostic characters and to clarify phylogenetic relationships of sphaeriid bivalves of the genus Sphaerium. The species studied were found to be diploid, with modal number 2n = 28 in S. nucleus and 2n = 30 in S. corneum var. mamillanum. Small, biarmed, C- negative B chromosomes were found in all studied populations of both species. Karyological and molecular markers revealed no differences between S. corneum s. str. and S. corneum var. mamillanum. No intraspecific differences were found in the basic karyotype of S. nucleus. Molecular analyses, however, uncovered three genetically distinct ITS1 lineages: one comprised of samples from Lithuania, Slovakia, and Russia, another from Czech, and a third from Ukraine. Additionally to known 16S haplotype from Ukraine, three new 16S haplotypes of S. nucleus were detected: one in the samples from Lithuania and Russia, one in Slovakian and one in Czech population. In the ITS1 phylogenetic tree, all branches of S. nucleus clustered in one clade. In the 16S phylogenetic tree, however, the haplotype of Czech S. nucleus formed a separate branch, distant from three other haplotypes of S. nucleus. Molecular results indicate that in the context of the Evolutionary Species Concept the S. nucleus morphospecies may represent a complex of separate taxa, however referring on the Biological Species Concept the genetic lineages could represent the intraspecific variability.	[Petkeviciute, Romualda; Stunzenas, Virmantas; Staneviciute, Grazina] Nat Res Ctr, PB Sivickis Lab Parasitol, Vilnius, Lithuania	Nature Research Center - Lithuania	Petkeviciute, R (corresponding author), Nat Res Ctr, PB Sivickis Lab Parasitol, Vilnius, Lithuania.	romualda@ekoi.it		Staneviciute, Grazina/0000-0002-1641-6516; Stunzenas, Virmantas/0000-0003-4299-6451	SYNTHESYS; Research Council of Lithuania [MIP-43/2015]; European Commission [DE-TAF-3965]	SYNTHESYS; Research Council of Lithuania(Research Council of Lithuania (LMTLT)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by the Research Council of Lithuania grant No MIP-43/2015 (http://lmt.lt/download/6113/mip%20gtm_vi%20kv%20%20finansuojamu%20projektu%20sarasas_galutinis.pdf) awarded to V.S. and by SYNTHESYS (http://www.synthesys.info/network-activities/synthesys2-na2/), European Commission grant No DE-TAF-3965 awarded to R.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev NI, 2011, INLAND WATER BIOL, V4, P264, DOI 10.1134/S1995082911020039; BAILEY RC, 1983, CAN J ZOOL, V61, P2781, DOI 10.1139/z83-365; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Birky CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052544; Birky CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010609; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Burch J. B, 1998, MICHIGAN ACAD, V30, P351; BURCH J.B., 1975, FRESHWATER SPHAERIAC; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Cooley LR, 2000, INVERTEBR BIOL, V119, P299; Cross I, 2005, AQUACULTURE, V247, P135, DOI 10.1016/j.aquaculture.2005.02.039; Dyduch-Falniowska A., 1988, Folia Malacologica Bulletin, V2, P83; Falkner Gerhard, 2000, Heldia, V3, P11; Foighil DO, 1999, ZOOL J LINN SOC-LOND, V127, P477, DOI 10.1111/j.1096-3642.1999.tb01382.x; Fredga K, 1964, HEREDITAS, V52, P101; GLOER P., 1998, SUSSWASSERMOLLUSKEN; Graf DL, 2013, AM MALACOL BULL, V31, P135, DOI 10.4003/006.031.0106; Guralnick R, 2004, J MOLLUS STUD, V70, P341, DOI 10.1093/mollus/70.4.341; HEARD WH, 1977, MALACOLOGIA, V16, P421; INSUA A, 1992, Aquatic Living Resources, V5, P1, DOI 10.1051/alr:1992001; INSUA A, 1991, AQUACULTURE, V97, P317, DOI 10.1016/0044-8486(91)90324-Z; Insua A, 1998, GENES GENET SYST, V73, P193, DOI 10.1266/ggs.73.193; Jenkinson JJ, 2014, MALACOLOGIA, V57, P377, DOI 10.4002/040.057.0210; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Jones RN, 1982, B CHROMOSOMES; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; KEYL HG, 1956, CHROMOSOMA, V8, P12, DOI 10.1007/BF01259490; Killeen I, 2011, SPHAERIUM NUCL IUCN; Killeen I., 2004, OCCASIONAL PUBLICATI, V82; Killeen I., 2012, SPHAERIUM CORNEUM IU; Korinkova T, 2006, ACTA SOC ZOOLOGICAE, V69, P293; Korinkova T, 2011, GENETICA, V139, P155, DOI 10.1007/s10709-010-9533-1; Korinkova T, 2010, CENT EUR J BIOL, V5, P777, DOI 10.2478/s11535-010-0066-5; Korinkova Tereza, 2008, Malacologica Bohemoslovaca, V7, P26; Korniushin A. V., 1998, MALACOL REV S; Korniushin Alexei V., 1996, Annales Zoologici (Warsaw), V46, P111; Korniushin Alexei V., 2001, Archiv fuer Molluskenkunde, V129, P77; Korniushin AV, 2002, ZOOL SCR, V31, P415, DOI 10.1046/j.1463-6409.2002.00083.x; Korniushin AV, 1996, BIVALVE MOLLUSKS SUP; Kosel V, 2006, BIOLOGIA, V61, P524, DOI 10.2478/s11756-006-0104-y; Lee T, 2003, ZOOL J LINN SOC-LOND, V137, P245, DOI 10.1046/j.1096-3642.2003.00047.x; Lee T, 2002, MOL PHYLOGENET EVOL, V25, P112, DOI 10.1016/S1055-7903(02)00249-X; Lee Taehwan, 1999, Cytologia (Tokyo), V64, P247; Leitao A, 2002, J SHELLFISH RES, V21, P685; Leitao A, 2008, ESTUAR COAST SHELF S, V79, P152, DOI 10.1016/j.ecss.2008.03.015; Li XX, 1997, MAR BIOL, V127, P443, DOI 10.1007/s002270050031; Libertini Angelo, 1996, Kromosomo (Tokyo), V82, P2819; MARTINEZLAGE A, 1994, HEREDITY, V72, P242, DOI 10.1038/hdy.1994.34; MARTINEZLAGE A, 1995, HEREDITY, V74, P369, DOI 10.1038/hdy.1995.55; NAKAMURA H K, 1985, Venus the Japanese Journal of Malacology, V44, P193; Odhner NH., 1922, P MALACOLOGICAL SOC, V15, P155; OFOIGHIL D, 1991, BIOL BULL-US, V181, P222, DOI 10.2307/1542093; Palumbi Stephen R., 1996, P205; Park Gab-Man, 1996, Malacological Review, V28, P43; Petkeviciute R, 2007, J MOLLUS STUD, V73, P315, DOI 10.1093/mollus/eym025; Petkeviciute R, 2006, BIOL J LINN SOC, V89, P53, DOI 10.1111/j.1095-8312.2006.00657.x; PIECHOCKI A, 1989, Annales Zoologici (Warsaw), V42, P249; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rannala B, 2015, CURR ZOOL, V61, P846, DOI 10.1093/czoolo/61.5.846; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; Sivickis P, 1960, MOLLUSKS LITHUANIA T; Stunzenas V, 2011, CENT EUR J BIOL, V6, P105, DOI 10.2478/s11535-010-0101-6; Sumner A. T, 1990, CHROMOSOME BANDING; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiriot-Quievreux C, 2002, CAH BIOL MAR, V43, P17; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vujosevic M, 2004, CYTOGENET GENOME RES, V106, P247, DOI 10.1159/000079295; White LR, 1996, MALACOLOGIA, V38, P181; Williams Christopher, 2010, Irish Naturalists' Journal, V31, P64	71	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191427	10.1371/journal.pone.0191427	http://dx.doi.org/10.1371/journal.pone.0191427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360839	Green Published, gold, Green Submitted			2022-12-27	WOS:000423161800031
J	Rodrigues, TC; Oliveira, MLS; Soares-Schanoski, A; Chavez-Rico, SL; Figueiredo, DB; Goncalves, VM; Ferreira, DM; Kunda, NK; Saleem, IY; Miyaji, EN				Rodrigues, Tasson C.; Oliveira, Maria Leonor S.; Soares-Schanoski, Alessandra; Chavez-Rico, Stefanni L.; Figueiredo, Douglas B.; Goncalves, Viviane M.; Ferreira, Daniela M.; Kunda, Nitesh K.; Saleem, Imran Y.; Miyaji, Eliane N.			Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; INHALATIVE VACCINATION; COMPLEMENT DEPOSITION; PULMONARY INFECTION; CONJUGATE VACCINE; MICE; POLYSACCHARIDE; TUBERCULOSIS; RESPONSES; DELIVERY	Burden of pneumonia caused by Streptococcus pneumoniae remains high despite the availability of conjugate vaccines. Mucosal immunization targeting the lungs is an attractive alternative for the induction of local immune responses to improve protection against pneumonia. Our group had previously described the development of poly(glycerol adipate-co-omega-pentadecalactone) (PGA-co-PDL) polymeric nanoparticles (NPs) adsorbed with Pneumococcal surface protein A from clade 4 (PspA4Pro) within L-leucine microcarriers (nanocomposite microparticles-NCMPs) for mucosal delivery targeting the lungs (NP/NCMP PspA4Pro). NP/NCMP PspA4Pro was now used for immunization of mice. Inoculation of this formulation induced anti-PspA4Pro IgG antibodies in serum and lungs. Analysis of binding of serum IgG to intact bacteria showed efficient binding to bacteria expressing PspA from clades 3, 4 and 5 (family 2), but no binding to bacteria expressing PspA from clades 1 and 2 (family 1) was observed. Both mucosal immunization with NP/NCMP PspA4Pro and subcutaneous injection of the protein elicited partial protection against intranasal lethal pneumococcal challenge with a serotype 3 strain expressing PspA from clade 5 (PspA5). Although similar survival levels were observed for mucosal immunization with NP/NCMP PspA4Pro and subcutaneous immunization with purified protein, NP/NCMP PspA4Pro induced earlier control of the infection. Conversely, neither immunization with NP/NCMP PspA4Pro nor subcutaneous immunization with purified protein reduced bacterial burden in the lungs after challenge with a serotype 19F strain expressing PspA from clade 1 (PspA1). Mucosal immunization with NP/NCMP PspA4Pro targeting the lungs is thus able to induce local and systemic antibodies, conferring protection only against a strain expressing PspA from the homologous family 2.	[Rodrigues, Tasson C.; Oliveira, Maria Leonor S.; Soares-Schanoski, Alessandra; Chavez-Rico, Stefanni L.; Miyaji, Eliane N.] Inst Butantan, Lab Bacteriol, Sao Paulo, SP, Brazil; [Figueiredo, Douglas B.; Goncalves, Viviane M.] Inst Butantan, Lab Especial Desenvolvimento Vacinas, Sao Paulo, SP, Brazil; [Ferreira, Daniela M.] Univ Liverpool Liverpool Sch Trop Med, Resp Infect Grp, Liverpool, Merseyside, England; [Kunda, Nitesh K.; Saleem, Imran Y.] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Formulat & Drug Delivery Res, Liverpool, Merseyside, England; [Kunda, Nitesh K.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	Instituto Butantan; Instituto Butantan; Liverpool School of Tropical Medicine; Liverpool John Moores University; University of New Mexico	Miyaji, EN (corresponding author), Inst Butantan, Lab Bacteriol, Sao Paulo, SP, Brazil.	eliane.miyaji@butantan.gov.br	Kunda, Nitesh/AAS-8713-2021; Ferreira, Daniela M/AAE-9881-2022; Schanoski, Alessandra/H-8144-2014; Miyaji, Eliane N/D-7642-2012; Saleem, Imran/M-5423-2019; Oliveira, Maria Leonor S/F-4988-2012; Ferreira, Daniela M/AFF-4763-2022; Gonçalves, Viviane/B-9674-2012; da Costa Rodrigues, Tasson/F-7229-2019	Kunda, Nitesh/0000-0002-3063-0375; Schanoski, Alessandra/0000-0002-6514-8458; Miyaji, Eliane N/0000-0003-1689-5366; Saleem, Imran/0000-0003-2382-6668; Ferreira, Daniela M/0000-0002-0594-0902; Gonçalves, Viviane/0000-0002-0980-8116; da Costa Rodrigues, Tasson/0000-0002-1481-0691; Oliveira, Maria Leonor/0000-0003-4849-3062	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303198/2014-1, 140573/2015-1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2015/06255-6, 2014/25436-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; MRC [MR/K01188X/1, MR/M011569/1] Funding Source: UKRI; Medical Research Council [MR/M011569/1, MR/K01188X/1] Funding Source: researchfish	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br) (VMG grant 2015/06255-6) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) (ENM grant 303198/2014-1). TCR received an undergraduate studentship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2014/25436-9) and a MSc studentship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br). SLC received a studentship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. DBF received a PhD studentship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (140573/2015-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorij JP, 2010, LANCET INFECT DIS, V10, P699, DOI 10.1016/S1473-3099(10)70157-2; Anish C, 2014, INT J PHARMACEUT, V466, P198, DOI 10.1016/j.ijpharm.2014.03.025; Ballester M, 2011, VACCINE, V29, P6959, DOI 10.1016/j.vaccine.2011.07.039; Beverley PCL, 2014, MUCOSAL IMMUNOL, V7, P20, DOI 10.1038/mi.2013.99; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Briles DE, 1996, VACCINE, V14, P858, DOI 10.1016/0264-410X(96)82948-3; Briles DE, 2003, J INFECT DIS, V188, P339, DOI 10.1086/376571; Dallaire F, 2001, J INFECT DIS, V184, P292, DOI 10.1086/322021; Figueiredo DB, 2017, APPL MICROBIOL BIOT, V101, P2305, DOI 10.1007/s00253-016-7983-9; Fukuyama Y, 2015, MUCOSAL IMMUNOL, V8, P1144, DOI 10.1038/mi.2015.5; Gordon SB, 2008, VACCINE, V26, P5400, DOI 10.1016/j.vaccine.2008.07.082; group Avftw, 2015, VACCINE, V33, p[3038, 3038]; Haughney SL, 2013, ACTA BIOMATER, V9, P8262, DOI 10.1016/j.actbio.2013.06.006; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Kong IG, 2013, INFECT IMMUN, V81, P1625, DOI 10.1128/IAI.00240-13; Kunda NK, 2015, INT J PHARMACEUT, V495, P903, DOI 10.1016/j.ijpharm.2015.09.034; Kunda NK, 2013, PHARM RES-DORDR, V30, P325, DOI 10.1007/s11095-012-0891-5; Lima FA, 2012, CLIN VACCINE IMMUNOL, V19, P1382, DOI 10.1128/CVI.00171-12; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS140, DOI 10.1097/INF.0000000000000082; Low N, 2015, NEW ENGL J MED, V372, P1519, DOI 10.1056/NEJMoa1407417; Menzel M, 2005, VACCINE, V23, P5113, DOI 10.1016/j.vaccine.2005.05.040; Meyer P, 2006, VACCINE, V24, P5832, DOI 10.1016/j.vaccine.2006.05.002; Moreno AT, 2010, CLIN VACCINE IMMUNOL, V17, P439, DOI 10.1128/CVI.00430-09; Ogunniyi AD, 2000, INFECT IMMUN, V68, P3028, DOI 10.1128/IAI.68.5.3028-3033.2000; Oliveira MLS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010863; Ren B, 2003, INFECT IMMUN, V71, P75, DOI 10.1128/IAI.71.1.75-85.2003; Smith NM, 2017, MUCOSAL IMMUNOLOGY; Tyne AS, 2013, VACCINE, V31, P4322, DOI 10.1016/j.vaccine.2013.07.022; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wang Y, 2017, MUCOSAL IMMUNOL, V10, P250, DOI 10.1038/mi.2016.41; Wu HY, 1997, J INFECT DIS, V175, P839, DOI 10.1086/513980; Yamamoto M, 1998, J IMMUNOL, V161, P4115	32	27	28	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191692	10.1371/journal.pone.0191692	http://dx.doi.org/10.1371/journal.pone.0191692			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360883	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000423161800053
J	Sathe, A; Chalaud, G; Oppolzer, I; Wong, KY; von Busch, M; Schmid, SC; Tong, ZC; Retz, M; Gschwend, JE; Schulz, WA; Nawroth, R				Sathe, Anuja; Chalaud, Geraldine; Oppolzer, Immanuel; Wong, Kit Yeng; von Busch, Margarita; Schmid, Sebastian C.; Tong, Zhichao; Retz, Margitta; Gschwend, Juergen E.; Schulz, Wolfgang A.; Nawroth, Roman			Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy	PLOS ONE			English	Article							PHASE-II; BLADDER-CANCER; EVEROLIMUS; TARGET; PHOSPHORYLATION; IDENTIFICATION; NVP-BEZ235; LESSONS	Targeting the PI3K pathway has achieved limited success in cancer therapy. One reason for the disappointing activity of drugs that interfere with molecules that are important player in this pathway is the induction of multiple feedback loops that have been only partially understood. To understand these limitations and develop improved treatment strategies, we comprehensively characterized molecular mechanisms of PI3K pathway signaling in bladder cancer cell lines upon using small molecule inhibitors and RNAi technologies against all key molecules and protein complexes within the pathway and analyzed functional and molecular consequences. When targeting either mTORC1, mTOR, AKT or PI3K, only S6K1 phosphorylation was affected in most cell lines examined. Dephosphorylation of 4E-BP1 required combined inhibition of PI3K and mTORC1, independent from AKT, and resulted in a robust reduction in cell viability. Long-term inhibition of PI3K however resulted in a PDK1-dependent, PIP3 and mTORC2 independent rephosphorylation of AKT. AKT rephosphorylation could also be induced by mTOR or PDK1 inhibition. Combining PI3K/mTOR inhibitors with AKT or PDK1 inhibitors suppressed this rephosphorylation, induced apoptosis, decreased colony formation, cell viability and growth of tumor xenografts. Our findings reveal novel molecular mechanisms that explain the requirement for simultaneous targeting of PI3K, AKT and mTORC1 to achieve effective tumor growth inhibition.	[Sathe, Anuja; Chalaud, Geraldine; Oppolzer, Immanuel; Wong, Kit Yeng; von Busch, Margarita; Schmid, Sebastian C.; Tong, Zhichao; Retz, Margitta; Gschwend, Juergen E.; Nawroth, Roman] Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Munich, Germany; [Schulz, Wolfgang A.] Heinrich Heine Univ Duesseldorf, Dept Urol, Med Fac, Dusseldorf, Germany	Technical University of Munich; Heinrich Heine University Dusseldorf	Nawroth, R (corresponding author), Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Munich, Germany.	roman.nawroth@tum.de		Schulz, Wolfgang/0000-0002-2196-463X	Fritz Thyssen Foundation	Fritz Thyssen Foundation	This work was supported by the Fritz Thyssen Foundation, Postdoctoral Fellowship for Anuja Sathe.; AS is supported by a post-doctoral stipend from the Fritz Thyssen Stiftung.	Alfred Witjes J, 2016, EUR UROL; Aylett CHS, 2016, SCIENCE, V351, P48, DOI 10.1126/science.aaa3870; Bai XC, 2010, CELL MOL LIFE SCI, V67, P239, DOI 10.1007/s00018-009-0163-7; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Brana I, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-161; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Castel P, 2016, CANCER CELL, V30, P229, DOI 10.1016/j.ccell.2016.06.004; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Costa C, 2015, CANCER CELL, V27, P97, DOI 10.1016/j.ccell.2014.11.007; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Garcia-Echeverria C, 2010, BIOORG MED CHEM LETT, V20, P4308, DOI 10.1016/j.bmcl.2010.05.099; Gerullis H, 2011, ANTI-CANCER DRUG, V22, P940, DOI 10.1097/CAD.0b013e328347a86a; Gingras AC, 2001, GENE DEV, V15, P2852; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Milowsky MI, 2013, BJU INT, V112, P462, DOI 10.1111/j.1464-410X.2012.11720.x; Mukherjee B, 2012, NEOPLASIA, V14, P34, DOI 10.1593/neo.111512; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Nawroth R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027509; Niegisch G, 2015, ONCOLOGY-BASEL, V89, P70, DOI 10.1159/000376551; Park J, 2009, J BIOL CHEM, V284, P6169, DOI 10.1074/jbc.C800210200; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Ratner M, 2016, NAT BIOTECHNOL, V34, P789, DOI 10.1038/nbt0816-789; Ribatti D, 2014, EXP CELL RES, V328, P314, DOI 10.1016/j.yexcr.2014.06.010; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Ross RL, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2570-0; Rozengurt E, 2014, MOL CANCER THER, V13, P2477, DOI 10.1158/1535-7163.MCT-14-0330; Sathe A, 2014, BRIT J CANCER, V111, P2103, DOI 10.1038/bjc.2014.534; Sathe A, 2016, J UROLOGY, V195, P771, DOI 10.1016/j.juro.2015.08.082; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Seront E, 2012, ANN ONCOL, V23, P2663, DOI 10.1093/annonc/mds057; Seront E, 2016, BJU INT, V118, P408, DOI 10.1111/bju.13415; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yap TA, 2015, CURR OPIN PHARMACOL, V23, P98, DOI 10.1016/j.coph.2015.05.016; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017	48	33	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0190854	10.1371/journal.pone.0190854	http://dx.doi.org/10.1371/journal.pone.0190854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357370	Green Published, Green Submitted, gold			2022-12-27	WOS:000422919500007
J	Islam, KMM; Asadullah, MN				Islam, Kazi Md. Mukitul; Asadullah, M. Niaz			Gender stereotypes and education: A comparative content analysis of Malaysian, Indonesian, Pakistani and Bangladeshi school textbooks	PLOS ONE			English	Article							IMPACT	Using government secondary school English language textbooks from Malaysia, Indonesia, Pakistan and Bangladesh, we conducted a quantitative content analysis in order to identify gender stereotypes in school education. In total, 21 categories of exclusion and quality of representation were used to study gender stereotypes. Our analysis confirms a pro-male bias in textbooks: the aggregate female share is 40.4% in textual and pictorial indicators combined. Female occupations are mostly traditional and less prestigious while the characters are predominantly introverted and passive in terms of personality traits. Women are also shown to be mostly involved in domestic and in-door activities while men have a higher presence in professional roles. Systematic underrepresentation of females is evident regardless of whether we look at the text or pictures. A cross-country analysis shows that the female share in picture content is only 35.2% in Malaysia and Bangladesh. Overall, the proportion of female to male characters (text and pictures combined) is balanced in Malaysia and Indonesia (44.4% and 44.1% respectively) while this share is only 24.4% and 37.3% in Pakistani and Bangladeshi textbooks respectively. The finding of underrepresentation of women in Pakistani textbooks, in terms of quality and quantity, is robust to the selection of province-, grade- and subject-specific textbooks, as well as the range and type of categories used.	[Islam, Kazi Md. Mukitul; Asadullah, M. Niaz] Univ Malaya, Fac Econ & Adm, Kuala Lumpur, Malaysia; [Islam, Kazi Md. Mukitul] German Embassy, Polit & Press Sect, Dhaka, Bangladesh; [Asadullah, M. Niaz] Univ Reading, Dept Econ, Reading, Berks, England; [Asadullah, M. Niaz] Univ Oxford, Ctr Skills Knowledge & Organisat Performance SKOP, Dept Educ, Oxford, England; [Asadullah, M. Niaz] Univ Manchester, Sch Educ Environm & Dev, Manchester, Lancs, England; [Asadullah, M. Niaz] IZA Inst Labor Econ, Bonn, Germany	Universiti Malaya; University of Reading; University of Oxford; University of Manchester; IZA Institute Labor Economics	Asadullah, MN (corresponding author), Univ Malaya, Fac Econ & Adm, Kuala Lumpur, Malaysia.; Asadullah, MN (corresponding author), Univ Reading, Dept Econ, Reading, Berks, England.; Asadullah, MN (corresponding author), Univ Oxford, Ctr Skills Knowledge & Organisat Performance SKOP, Dept Educ, Oxford, England.; Asadullah, MN (corresponding author), Univ Manchester, Sch Educ Environm & Dev, Manchester, Lancs, England.; Asadullah, MN (corresponding author), IZA Inst Labor Econ, Bonn, Germany.	m.niaz@um.edu.my	Islam, Kazi Md Mukitul/AAC-3488-2020; Asadullah, M Niaz/H-6768-2013	Asadullah, M Niaz/0000-0001-8047-5548	Population Studies Unit (PSU) grant of the University of Malaya, Malaysia [IF2014-002]	Population Studies Unit (PSU) grant of the University of Malaya, Malaysia	This study is part of a research project supported by the Population Studies Unit (PSU) grant number IF2014-002 of the University of Malaya, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadian S, 1996, WORLD DEV, V24, P1793, DOI 10.1016/S0305-750X(96)00075-7; Aikman S, 2012, THEORY RES EDUC, V10, P211, DOI 10.1177/1477878512459391; Alayan S., 2010, J ED MEDIA MEMORY SO, V2, P78, DOI [https://doi.org/10.3167/jemms.2010.020105, DOI 10.3167/JEMMS.2010.020105]; ALRABAA S, 1985, INT REV EDUC, V31, P335, DOI 10.1007/BF02262586; Amin S., 2017, ROUND TABLE, V106, P221, DOI DOI 10.1080/00358533.2017.1299461; Amin SA, 2017, EC POLITICAL WEEKLY, V52; Amini M., 2012, ENGLISH LANGUAGE TEA, V5, pP134, DOI [10.5539/elt.v5n2p134, DOI 10.5539/ELT.V5N2P134]; [Anonymous], 2001, EFF ED TIM MARR 1 BI; [Anonymous], 2014, WOMEN POLITICS; [Anonymous], 2016, ED PERCENTAGE FEMALE; [Anonymous], 2013, UN CHRONICLE; [Anonymous], 2015, HUM DEV REP 2015; [Anonymous], 2000, DEV FREEDOM; Asadullah MN, 2014, CONVERSATION; Asadullah MN, J DEV STUDIES FORTHC; Asadullah MN, 2009, EDUC ECON, V17, P377, DOI 10.1080/09645290903142593; Asadullah MN, 2006, EDUC ECON, V14, P453, DOI 10.1080/09645290600854144; Asadullah MN, 2010, WORLD DEV, V38, P205, DOI 10.1016/j.worlddev.2009.10.014; Bahman M, 2010, PROCD SOC BEHV, V9, DOI 10.1016/j.sbspro.2010.12.149; Bailey S, 1992, AAUW REPORT; Balatchandirane G, 2007, INT STUDIES, V40, P349, DOI DOI 10.1177/002088170304000403; Baldwin P., 1992, CANADIAN SOCIAL STUD, V26, P110; Banda V., 2014, THESIS; Bank W, 2014, VOICE AGENCY EMPOWER; Baruah B, 2005, CAN J DEV STUD, V26, P677, DOI 10.1080/02255189.2005.9669106; Blankenship CL, 2011, THESIS; Blumberg R., 2007, GENDER BIAS TXB HIDD; Blumberg RL, 2004, SOCIOL THEOR, V22, P278, DOI 10.1111/j.0735-2751.2004.00218.x; Blumberg RL., MAKING CASE GENDER V; Blumberg RL, 2014, ELIMINATING GENDER B; BRITTON GE, 1977, READ TEACH, V31, P40; Bussey K, 1999, PSYCHOL REV, V106, P676, DOI 10.1037/0033-295X.106.4.676; CANDRAWATI P, 2014, J PENDIDIKAN BAHASA, V2; Chisamya G, 2012, INT J EDUC DEV, V32, P743, DOI 10.1016/j.ijedudev.2011.10.004; Chou P-I, 2016, ASIA PACIFIC ED REV, P1; Chowdhury FD., 2010, INT J LAW POLICY FAM, V24, P198, DOI DOI 10.1093/LAWFAM/EBQ003; Cohen L., 2007, APPROACHES QUALITATI; Cooke-Sawyer S, 2000, THESIS; Costa P.T., 1992, PERS INDIVID DIF, V13, P653, DOI [10.1016/0191-8869(92)90236-I, DOI 10.1016/0191-8869(92)90236-I]; Davies B., 1995, GENDER BIAS SCH TXB; DMKaT K. T, 2015, IOSR J HUMANITIES SO, V20, P16; Do Thi Bich Loan NTMH Kieu Thi Bich Thuy Nguyen Tri Trinh Thi Ahn Hoa, 2010, GUID TXB REV AN GEND; Dollar D., 1999, GENDER INEQUALITY IN; Douglas E., 2002, QUALITATIVE ANAL PRA; Dreze J., 2013, UNCERTAIN GLORY INDI, DOI 10.2307/j.ctt32bcbm; Ena O. T., 2013, THESIS; ETIM JS, 1988, J READING, V31, P452; Ferree MM, 1990, GENDER SOC, V4, P500, DOI 10.1177/089124390004004005; Gakidou E, 2010, LANCET, P376; Gouvias D, 2016, GENDER ED, P1; Hadi ST, 2011, GENDER STEREOTYPES C; Hall M., 2014, J LANGUAGE TEACHING, V5, P253, DOI DOI 10.4304/JLTR.5.2.253-261; Hameed A, 2014, LANGUAGE, V5; he Kaya, 2003, STEREOTYPED GENDER R; Heijnen-Maathuis E., 2008, PARITY EQUALITY GIRL; Hellinger M., 1980, WOMENS STUDIES INT Q, V3, P267, DOI DOI 10.1016/S0148-0685(80)92323-4; HHR, 2014, IND VIRG TEST FEM PO; Hirschman C., 2016, GENDER STATUS WOMEN; International Labour Organization, 2016, WOM WORK TRENDS 2016; Jabeen S, 2012, PAKISTAN J WOMENS ST, V19, P75; Jabeen S., 2014, B ED RES, V36, P55; Jaber, 2014, BREAKING GLASS DOORS; JAHAN R., 2001, SCIENCES, V1, P372, DOI DOI 10.3923/JMS.2001.372.376; JAIN AK, 1981, DEMOGRAPHY, V18, P577, DOI 10.2307/2060948; Jalaluddin A, 2008, GEMA ONLINE J LANGUA, V8; Jasmani MFIB, 2011, 3L-LANG LINGUIST LIT, V17, P61; Jimenez E, WORLD BANK POLICY RE, V2008; Jin N.Y., 2013, INT J HUMANITIES SOC, V3, P115; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; John O. P., 1990, HDB PERSONALITY THEO; Jones MA., 1997, GENDER EDUCA TION, V9, P469, DOI [10.1080/09540259721204, DOI 10.1080/09540259721204]; Kabeer Naila., 2005, GENDER DEV, V13, P13, DOI [10.1080/13552070512331332273, DOI 10.1080/13552070512331332273]; Kelly GP, 1982, CULTURAL EC REPROD E; Kent J, 2006, BBC NEWS; Khan J, 2011, IMPACT ED TOTAL FERT; Klasen S, 2009, FEM ECON, V15, P91, DOI 10.1080/13545700902893106; Klein H, 2009, HOWARD J COMMUN, V20, P55, DOI 10.1080/10646170802665208; KOLBE R, 1981, SOC PSYCHOL QUART, V44, P369, DOI 10.2307/3033906; Kotiswaran Prabha, 2014, ROUTLEDGE HDB GENDER; Lee JFK, 2008, SEX ROLES, V59, P127, DOI 10.1007/s11199-008-9414-6; Lee JFK, 2010, J GENDER STUD, V19, P121, DOI 10.1080/09589231003695856; Lee P.T, 2011, ENGLISH FORM 4 KURUK; Londergan B, 2013, HUFFINGTON POST; Maitra P, 2004, J HEALTH POPUL NUTR, V22, P84; Majumder G., 2012, ENGLISH TODAY CLASS; Malik RZ, 2011, TXB ENGLISH 9 G; Mccabe J, 2011, GENDER SOC, V25, P197, DOI 10.1177/0891243211398358; Milne M. J., 1999, ACCOUNTING AUDITING, V12, P237, DOI DOI 10.1108/09513579910270138; Mineshima Michio, 2008, B NIIGATA I TECHNOLO, V13, P121; Mirza M., 2004, GENDER ANAL SCH CURR; Murphy-Graham E., 2014, OPENING BLACK BOX WO; Nonaka D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036629; Page E, 2009, EXPLORING BIAS GENDE; Peng Tey Nai, 2007, ASIAN POPULATION STU, V3, P243, DOI DOI 10.1080/17441730701746391; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; Ramachandran DP, 2010, STORIES SCH BAG STUD; Roohani A., 2013, INDONESIAN J APPL LI, V3, P115, DOI [10.17509/ijal.v3i1.194, DOI 10.17509/IJAL.V3I1.194]; Rosser YC, 2003, CURRICULUM DESTINY F; Sadker David, 2007, HDB ACHIEVING GENDER, P131; Smith Philip, 1985, LANGUAGE SEXES SOC; Srivastava G., 2006, SOCIAL CHANGE, V36, P83; Srivastava G, 2005, GENDER CONCERN SOCIA, P217; Stromquist N., 1998, WOMEN 3 WORLD ENCY C, P397; Sumalatha K, 2004, AM J APPL SCI, V1, P62, DOI DOI 10.3844/AJASSP.2004.62.63; Twintoh F., 2012, THESIS KDI SCH; Ullah H, 2013, EDUC STUD-UK, V39, P183, DOI 10.1080/03055698.2012.702892; UN Women. UTUN, 2015, FACTS FIG END VIOL W; UNESCO, 2006, ED ALL GLOB MON REP; UNESCO, 2015, EFA GLOB MON REP ACH; UNESCO, 2016, CONFERENCE; UNESCO, 2015, ED ALL GLOB MON REP; United Nations Girls' Education Initiative (UNGEI), 2010, UNGEI 10 JOURN GEND; Wang W, 1998, ASIAN J WOMEN STUD, V4, P39; Wardiman A, 2008, ENGLISH FOCUS PUSAT; Weber R. P., 1990, BASIC CONTENT ANAL, V2nd; Winthrop R., 2015, WHAT WORKS GIRLS ED; Women) UtUN, 2016, CONST DAT UN WOM; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Bank, 2020, WORLD DEV IND 2020; World Economic Forum, 2015, GLOBAL GENDER GAP RE; WRIGHT RA, 1995, TEACH SOCIOL, V23, P111, DOI 10.2307/1319341; Zeenatunissa M., 1989, ISS WORKING PAPER SE, V62, P1	122	41	42	9	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190807	10.1371/journal.pone.0190807	http://dx.doi.org/10.1371/journal.pone.0190807			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351305	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300027
J	Li, JZ; Liu, PC; Yu, WH; Cheng, XQ				Li, Jingzhong; Liu, Pengcheng; Yu, Wenhao; Cheng, Xiaoqiang			The morphing of geographical features by Fourier transformation	PLOS ONE			English	Article							SHAPE; DESCRIPTORS	This paper presents a morphing model of vector geographical data based on Fourier transformation. This model involves three main steps. They are conversion from vector data to Fourier series, generation of intermediate function by combination of the two Fourier series concerning a large scale and a small scale, and reverse conversion from combination function to vector data. By mirror processing, the model can also be used for morphing of linear features. Experimental results show that this method is sensitive to scale variations and it can be used for vector map features' continuous scale transformation. The efficiency of this model is linearly related to the point number of shape boundary and the interceptive value n of Fourier expansion. The effect of morphing by Fourier transformation is plausible and the efficiency of the algorithm is acceptable.	[Li, Jingzhong] Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Hubei, Peoples R China; [Liu, Pengcheng] Cent China Normal Univ, Coll Urban & Environm Sci, Wuhan, Hubei, Peoples R China; [Yu, Wenhao] China Univ Geosci, Fac Informat Engn, Wuhan, Hubei, Peoples R China; [Cheng, Xiaoqiang] Hubei Univ, Fac Resources & Environm Sci, Wuhan, Hubei, Peoples R China	Wuhan University; Central China Normal University; China University of Geosciences; Hubei University	Li, JZ (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Hubei, Peoples R China.	00009232@whu.edu.cn		li, jingzhong/0000-0001-9868-5404	National Key Research and Development Program of China [2017YFB0503601]; National Natural Science Foundation of China [41671448]; China Scholarship Council (CSC) [201706275018]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the National Key Research and Development Program of China under Grant 2017YFB0503601 to JL; the National Natural Science Foundation of China under Grant 41671448 to JL; and China Scholarship Council (CSC) under Grant 201706275018 to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Key Research and Development Program of China under Grant 2017YFB0503601; the National Natural Science Foundation of China under Grant 41671448; and China Scholarship Council (CSC) under Grant 201706275018.	Ai TH, 2013, COMPUT ENVIRON URBAN, V41, P219, DOI 10.1016/j.compenvurbsys.2013.07.002; Alexa M, 2000, COMP GRAPH, P157, DOI 10.1145/344779.344859; Boutoura C, 1989, CARTOGRAPHICA, V26, P33, DOI [DOI 10.3138/G237-67W4-15N4-1R59, 10.3138/G237-67W4-15N4-1R59]; Cecconi A, 2002, COMPUT GRAPH FORUM, V21, P787, DOI 10.1111/1467-8659.00636; Clarke KC, 1993, P AUT 11 11 INT S CO, P72; Danciger J, 2009, GEOINFORMATICA, V13, P203, DOI 10.1007/s10707-008-0049-0; Deng M, 2015, T GIS, V19, P653, DOI 10.1111/tgis.12111; Efrat A, 2001, SIAM PROC S, P680; Fritsch E, 1995, LECT NOTES COMPUT SC, V988, P157; Gomes J., 1999, WARPING MORPHING GRA; HUGHES JF, 1992, COMP GRAPH, V26, P43, DOI 10.1145/142920.134004; KAUPPINEN H, 1995, IEEE T PATTERN ANAL, V17, P201, DOI 10.1109/34.368168; Lawford GJ, 2006, INT J GEOGR INF SCI, V20, P31, DOI 10.1080/13658810512331319109; Li J, 2017, INT J E-NAVIG MARIT, V6, P1, DOI 10.1016/j.enavi.2017.05.001; Li JZ, 2017, ISPRS INT GEO-INF, V6, DOI 10.3390/ijgi6060173; Liu PC, 2015, CARTOGRAPHY GEOGRAPH; Nollenburg M, 2008, COMPUT ENVIRON URBAN, V32, P248, DOI 10.1016/j.compenvurbsys.2008.06.004; PERSOON E, 1977, IEEE T SYST MAN CYB, V7, P170, DOI 10.1109/TSMC.1977.4309681; Sederberg T. W., 1993, Computer Graphics Proceedings, P15, DOI 10.1145/166117.166118; SEDERBERG TW, 1992, COMP GRAPH, V26, P25, DOI 10.1145/142920.134001; Surazhsky V., 2003, International Journal of Shape Modeling, V9, P191, DOI 10.1142/S0218654303000115; Taosong He, 1994, Proceedings. Visualization '94 (Cat. No.94CH35707), P85, DOI 10.1109/VISUAL.1994.346333; van Oostrum R, 2004, COMP GEOM-THEOR APPL, V28, P75, DOI 10.1016/j.comgeo.2004.03.006; Whited B., 2009, P ACM SIAM JOINT C G, P187; Yang WW, 2009, COMPUT GRAPH-UK, V33, P414, DOI 10.1016/j.cag.2009.03.007; ZAHN CT, 1972, IEEE T COMPUT, VC 21, P269, DOI 10.1109/TC.1972.5008949	26	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191136	10.1371/journal.pone.0191136	http://dx.doi.org/10.1371/journal.pone.0191136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351344	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300050
J	Maatouk, I; Muller, A; Angerer, P; Schmook, R; Nikendei, C; Herbst, K; Gantner, M; Herzog, W; Gundel, H				Maatouk, Imad; Mueller, Andreas; Angerer, Peter; Schmook, Renate; Nikendei, Christoph; Herbst, Kirsten; Gantner, Melanie; Herzog, Wolfgang; Guendel, Harald			Healthy ageing at work-Efficacy of group interventions on the mental health of nurses aged 45 and older: Results of a randomised, controlled trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; OCCUPATIONAL-HEALTH; PARTICIPATIVE INTERVENTION; MEASURING DEPRESSION; SELF-REPORT; ABILITY; COMPENSATION; OPTIMIZATION; PREVENTION; IRRITATION	Objective This multicentre, randomised controlled trial (RCT) aimed to evaluate the efficacy of a smallgroup intervention promoting successful ageing at work in older nurses (aged >= 45). Method A sample of 115 nurses aged >= 45 from 4 trial sites in Germany were randomly assigned to either the intervention group (IG), that received a small-group intervention of seven weekly sessions of 120 min with a booster session after six weeks or to a wait-list control condition (WL). Outcomes were measured via validated self-report questionnaires at baseline (T1) and at post-treatment (T2). Primary outcomes were mental health-related well-being and mental health-related quality of life (QOL). The secondary outcomes included mental health-related and work-related measures. Results The intention to treat (ITT) analysis showed significant positive effects of the intervention on mental health. A significant small effect (d = 0.3) in favour of the IG was found for psychological health-related quality of life. Positive small effects (d = 0.24 to d = 0.31) were also found for work related mental strain. Conclusions Our small-group intervention based on a theory of successful ageing for nurses aged >= 45 was found to be effective with regard to improvements of psychological health related quality of life and other mental health-related outcomes. Thus, our study shows that the ageing workforce can be reached through specifically designed preventive interventions. The components of our intervention could be easily adapted to the belongings of other professions. Our results suggest that these components should be evaluated in various settings outside the healthcare sector.	[Maatouk, Imad; Nikendei, Christoph; Herbst, Kirsten; Herzog, Wolfgang] Heidelberg Univ, Dept Gen Internal & Psychosomat Med, Heidelberg, Germany; [Mueller, Andreas; Angerer, Peter; Schmook, Renate] Univ Dusseldorf, Med Fac, Inst Occupat Med & Social Med, Dusseldorf, Germany; [Gantner, Melanie; Guendel, Harald] Univ Ulm, Dept Psychosomat Med & Psychotherapy, Ulm, Germany	Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; Ulm University	Maatouk, I (corresponding author), Heidelberg Univ, Dept Gen Internal & Psychosomat Med, Heidelberg, Germany.	imad.maatouk@med.uni-heidelberg.de	Gündel, Harald/AAZ-2905-2020	Maatouk, Imad/0000-0002-8030-1182	Deutsche Forschungsgemeinschaft; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	We acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding programme Open Access Publishing, by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes B. B., 2001, APPL DEV SCI, V5, P51, DOI DOI 10.1207/S1532480XADS0501_5; Baltes P. B., 1990, SUCCESSFUL AGING PER, P1, DOI [10.1017/CBO9780511665684.003, DOI 10.1017/CBO9780511665684.003]; Blanc PD, 2004, OCCUP ENVIRON MED, V61, P571, DOI 10.1136/oem.2004.013888; Bourbonnais R, 2006, OCCUP ENVIRON MED, V63, P326, DOI 10.1136/oem.2004.018069; Bourbonnais R, 2006, OCCUP ENVIRON MED, V63, P335, DOI 10.1136/oem.2004.018077; Bourbonnais R, 2011, OCCUP ENVIRON MED, V68, P479, DOI 10.1136/oem.2010.055202; Braher E, 2007, DIAGNOSTICA, V53, P83, DOI 10.1026/0012-1924.53.2.83; Bussing A, 2001, DIAGNOSTICA, V47, P77, DOI 10.1026//0012-1924.47.2.77; Bussing A, 2002, TATIGKEITS ARBEITSAN; Camerino D, 2006, J ADV NURS, V56, P542, DOI 10.1111/j.1365-2648.2006.04046.x; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Cloostermans L, 2015, INT ARCH OCC ENV HEA, V88, P521, DOI 10.1007/s00420-014-0969-y; Cuijpers P, 2003, AM J PSYCHIAT, V160, P1385, DOI 10.1176/appi.ajp.160.8.1385; Dominick KL, 2002, AGING CLIN EXP RES, V14, P499, DOI 10.1007/BF03327351; Dormann C, 2002, J OCCUP ORGAN PSYCH, V75, P33, DOI 10.1348/096317902167630; Estryn-Behar M, 2007, MED CARE, V45, P939, DOI 10.1097/MLR.0b013e31806728d8; Freund AM, 2002, J PERS SOC PSYCHOL, V82, P642, DOI 10.1037//0022-3514.82.4.642; Freund AM, 2000, CONTROL OF HUMAN BEHAVIOR, MENTAL PROCESSES, AND CONSCIOUSNESS, P35; Friis K, 2007, SCAND J PUBLIC HEALT, V35, P23, DOI 10.1080/14034940600777278; Grafe K, 2004, DIAGNOSTICA, V50, P171, DOI 10.1026/0012-1924.50.4.171; Gunusen NP, 2010, INT NURS REV, V57, P485, DOI 10.1111/j.1466-7657.2010.00808.x; Ilmarinen J, 2006, OCCUP MED-OXFORD, V56, P362, DOI 10.1093/occmed/kql046; Ilmarinen J, 2004, PROCEEDINGS OF THE 1; Ilmarinen JE, 2001, OCCUP ENVIRON MED, V58, P546, DOI 10.1136/oem.58.8.546; Ilmarinen J, 2009, SCAND J WORK ENV HEA, V35, P1; Jolivet A, 2010, SOC SCI MED, V71, P534, DOI 10.1016/j.socscimed.2010.04.003; Jones MC, 2000, PSYCHOL HEALTH, V15, P689, DOI 10.1080/08870440008405480; Kaluza G, 2012, GELASSEN UND SICHER; Krieger T, 2014, J AFFECT DISORDERS, V156, P240, DOI 10.1016/j.jad.2013.12.015; Lazarus R., 1987, STRESS APPRAISAL COP, V1, P141, DOI https://doi.org/10.1002/per.2410010304; Locke EA, 2006, CURR DIR PSYCHOL SCI, V15, P265, DOI 10.1111/j.1467-8721.2006.00449.x; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Maatouk I., 2016, MENTAL HLTH PREVENTI, V4, P42, DOI [10.1016/j.mhp.2016.01.002, DOI 10.1016/J.MHP.2016.01.002]; Maatouk I, 2016, GESUNDHEITSWESEN; McAlister AL, 2008, HEALTH BEHAVIOR, V169; Moghimi D, 2016, JOURNAL OF ORGANIZAT; Mohr G, 2005, Z ARB ORGAN, V49, P44, DOI 10.1026/0932-4089.49.1.44; Mohr G, 2006, EUR J PSYCHOL ASSESS, V22, P198, DOI 10.1027/1015-5759.22.3.198; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Muller A, 2016, J OCCUP HEALTH PSYCH, V21, P169, DOI 10.1037/a0039676; Muller A, 2013, J VOCAT BEHAV, V83, P68, DOI 10.1016/j.jvb.2013.03.002; Muller A, 2013, J ADV NURS, V69, P1630, DOI 10.1111/jan.12026; Muller A, 2015, ENCYCLOPEDIA OF GERO; Ng R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117086; Ng TWH, 2012, PERS PSYCHOL, V65, P821, DOI 10.1111/peps.12003; Peterson U, 2008, J ADV NURS, V63, P506, DOI 10.1111/j.1365-2648.2008.04743.x; Potzsch O, 2015, BEVOLKERUNG DEUTSCHL, V13; Rauschenbach C, 2013, J MANAGE PSYCHOL, V28, P781, DOI 10.1108/JMP-07-2013-0251; Ruotsalainen JH, 2015, COCHRANE DATABASE SY, V4; Kurebayashi LFS, 2012, REV ESC ENFERM USP, V46, P89, DOI 10.1590/S0080-62342012000100012; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Tavel P, 2008, HUM AFF, V18, P183, DOI 10.2478/v10023-008-0018-0; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Tuomi K, 2001, OCCUP MED-OXFORD, V51, P318, DOI 10.1093/occmed/51.5.318; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; Zacher H, 2015, WORK AGING RETIRE, V1, P4, DOI 10.1093/workar/wau006	57	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191000	10.1371/journal.pone.0191000	http://dx.doi.org/10.1371/journal.pone.0191000			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351310	Green Published, gold			2022-12-27	WOS:000422911300037
J	Teame, H; Addissie, A; Ayele, W; Hirpa, S; Gebremariam, A; Gebreheat, G; Jemal, A				Teame, Hirut; Addissie, Adamu; Ayele, Wondimu; Hirpa, Selamawit; Gebremariam, Alem; Gebreheat, Gdiom; Jemal, Ahmedin			Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: A case control study	PLOS ONE			English	Article							PREVALENCE; JIMMA	Background Cervical cancer is the second most prevalent cancer among women in the developing countries including Ethiopia. Precancerous lesions can be developed and risk to the development of cervical cancer over time. Early identification of the precancerous lesion and its risk factor is paramount in preventing cervical cancer. However, the determinants of cervical precancerous lesions are not well documented in Ethiopia. Therefore, this study is conducted to determine factors associated with cervical precancerous lesion among women screened for cervical cancer. Methods A hospital-based unmatched case-control study was conducted in selected health facilities in Addis Ababa from March to April 2016. Data were collected from 114 cases and 229 controls using an interviewer-administered questionnaire, entered to Epi Info version 7, and exported to SPSS version 20 for analysis. Odds ratios with its 95% confidence intervals and two-tailed P-value were calculated. Variables with P-value <= 0.2 in the bivariate analysis were included in the multivariate logistic regression model. Results Women aged 40 +/- 49 years had 2.4-fold higher odds of precancerous lesions compared to those aged 30 +/- 39 (Adjusted Odds Ratio = 2.4, 95% Confidence Interval: 1.27 +/- 4.54). Women having history of sexually transmitted infections were significantly associated with cervical precancerous lesion compared to their counterparts (Adjusted Odds Ratio = 3.20, 95% Confidence Interval: 1.26 +/- 8.10). Similarly, those women who had two or more lifetime sexual partners (Adjusted Odds Ratio = 2.17 95% Confidence Interval: 1.01 +/- 4.67), and women whose husbands had two or more lifetime sexual partners (Adjusted Odds Ratio = 3.03, 95% Confidence Interval: 1.25, 7.33) had higher odds of cervical precancerous lesions. Conclusions Older age, history of multiple sexual partners and sexual transmitted infections were associated with increased risk of precancerous lesion. Therefore, women with higher risk of precancerous lesions should be encouraged to be screened more frequently for cervical cancer.	[Teame, Hirut; Gebremariam, Alem] Adigrat Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Adigrat, Ethiopia; [Addissie, Adamu; Ayele, Wondimu; Hirpa, Selamawit] Addis Ababa Univ, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Gebreheat, Gdiom] Adigrat Univ, Dept Nursing, Coll Med & Hlth Sci, Adigrat, Ethiopia; [Jemal, Ahmedin] Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30329 USA	Addis Ababa University; American Cancer Society	Gebremariam, A (corresponding author), Adigrat Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Adigrat, Ethiopia.	alemg25@gmail.com	Abady, Gdiom/AAD-4290-2020	Abady, Gdiom/0000-0003-1775-8216; Gebremariam, Alem/0000-0003-2173-6685; Teame, Hirut/0000-0002-7519-8133; Ayele, Wondimu/0000-0001-5899-347X	Intramural Research Department of the American Cancer Society; Addis Ababa Health Office	Intramural Research Department of the American Cancer Society; Addis Ababa Health Office	This work was supported by the Intramural Research Department of the American Cancer Society. This study was supported by Intramural Research Department of the American Cancer Society.; We would like to thank all data collectors, supervisors, and the study participants who took part in the study and who showed great effort in acquiring and giving appropriate information. We are also grateful to Addis Ababa Health Office for their support to conduct this research. We would also like to thank Mr. John M. Daniel for editing the manuscript.	Abate SM, 2015, CERVICAL CANC OPEN A, V1; Addissie A, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0127-z; [Anonymous], 2014, ETH HUM PAP REL CANC; Bayu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149908; Belete Netsanet, 2015, Gynecol Oncol Res Pract, V2, P6, DOI 10.1186/s40661-015-0012-3; Bezabih M, 2015, ETHIOP J HEALTH SCI, V25, P345, DOI 10.4314/ejhs.v25i4.8; Botelho MC, 2017, LETT DRUG DES DISCOV, V14, P135, DOI 10.2174/1570180813666160720165057; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Dam J, 2017, EUR J MED CHEM, V126, P353, DOI 10.1016/j.ejmech.2016.10.041; Deksissa Zewdie Mulissa, 2015, BMC Res Notes, V8, P618, DOI 10.1186/s13104-015-1594-x; Dulla D, 2017, INT J WOMENS HEALTH, V9, P365, DOI 10.2147/IJWH.S132202; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR; Federal Democratic Republic of Ethiopia Ministry of Health, 2015, GUID CERV CANC UNPUB; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Gessesse Zekariase, 2015, Ethiop Med J, VSuppl 2, P17; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; Getinet M, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0016-2; Jean D., 2015, PAN AFRICAN MED J, V22; Leyh-Bannurah SR, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-33; Michael V., 2013, RISK FACTORS CERVICA; Mitiku I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163136; Nesrin R., 2011, INT J HEMATOLOGY ONC, V21; Pathfinder international, 2012, SINGL VIS APPR CERV; Sankaranarayanan R, 2003, PRACTICAL MANUAL VIS; Shiferaw N, 2016, GLOB HEALTH-SCI PRAC, V4, P87, DOI 10.9745/GHSP-D-15-00325; Tefera F, 2016, J CANC ED OFFIC 0413; Tekola F, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-13; Trufelli DC, 2015, REV ASSOC MED BRAS, V61, P411, DOI 10.1590/1806-9282.61.05.411; WHO, 2013, WHO GUID SCREEN TREA; Williamson AL, 2015, J CLIN MED, V4, P579, DOI 10.3390/jcm4040579; Wondimu Yehualashet Tadesse, 2015, Ethiop Med J, V53, P65	32	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191506	10.1371/journal.pone.0191506	http://dx.doi.org/10.1371/journal.pone.0191506			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352278	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300103
J	Wang, Z; Koonen, D; Hofker, M; Bao, ZJ				Wang, Zheng; Koonen, Debby; Hofker, Marten; Bao, Zhijun			RETRACTED: 5-aminosalicylic acid improves lipid profile in mice fed a high-fat cholesterol diet through its dual effects on intestinal PPAR gamma and PPAR alpha (Retracted article. See vol. 13, art no. e0200947. 2018)	PLOS ONE			English	Article; Retracted Publication							ACTIVATED RECEPTOR-ALPHA; NF-KAPPA-B; ULCERATIVE-COLITIS; METABOLIC SYNDROME; INFLAMMATION; TRIGLYCERIDE; 5-ASA; ABSORPTION; MESALAZINE; TRANSPORT	Obesity is associated with a series of metabolic complications, including dyslipidemia and insulin resistance (IR) that lack effective therapies. In recent years, intestinal inflammation has been suggested to contribute to obesity related metabolic syndrome and targeting gut inflammation with 5-ASA improves diet induced IR, however, its role in dyslipidemia is unknown and has never been explored. In the present study, we reported for the first time that administration of 5-ASA for 12 weeks significantly improved lipid profile by repressing plasma triglycerides and free cholesterol levels in mice fed high-fat cholesterol diet (HFC). In addition, liver lipids were significantly reduced by 5-ASA treatment in HFC-fed mice. Mechanistically, anti-inflammatory genes peroxisome proliferator-activated receptor-gamma (Ppar gamma) and M2 marker, such as Mrc1 and Ym1, were remarkably upregulated, while pro-inflammation gene monocyte chemoattractant protein-1 (Mcp-1) were downregulated in small intestine of mice treated by 5-ASA. Further, 5-ASA improved gastrointestinal barrier by increasing the expression of the tight junction marker ZO-1. 5-ASA also enhanced cholesterol translocation by elevating genes expression of Npc1l1 and Abcg5/8. Moreover, mice fed HFC 5-ASA expressed increased Ppar alpha in small intestinal and its target genes function in lipid oxidation and hydrolysis were remarkable elevated. Taken together, we reported a novel role of 5-ASA which may serve as a therapy target intestinal inflammation induced dyslipidemia.	[Wang, Zheng; Bao, Zhijun] Fudan Univ, Shanghai Key Lab Clin Geriatr Med, Huadong Hosp, Dept Geriatr & Gastroenterol,Shanghai Med Coll, Shanghai, Peoples R China; [Wang, Zheng; Koonen, Debby; Hofker, Marten] Univ Groningen, Univ Med Ctr Groningen, Mol Genet Sect, Dept Pediat, Groningen, Netherlands	Fudan University; University of Groningen	Bao, ZJ (corresponding author), Fudan Univ, Shanghai Key Lab Clin Geriatr Med, Huadong Hosp, Dept Geriatr & Gastroenterol,Shanghai Med Coll, Shanghai, Peoples R China.	xinyi8681@sina.com			Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines Program [2015ZB0501]; CardioVasculair Onderzoek Nederland [CVON2012-03]	Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines Program; CardioVasculair Onderzoek Nederland	Wang Z and Bao ZJ are supported by grants from Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines Program (No: 2015ZB0501). M.H. and D.K. are supported by a grant from CardioVasculair Onderzoek Nederland (CVON2012-03).; ZW and ZJB are supported by grant from Shanghai Key Developing Disciplines Program (No: 2015ZB0501). DK and MH are supported by grant from CardioVasculair Onderzoek Nederland (CVON2012-03). We thank Niels Kloosterhuis and Albert Gerding for technical instructions, and thank Bart van de Sluis and Eelke Brandsma for comments for preparing the manuscript.	Agrawal NK, 2014, WORLD J DIABETES, V5, P697, DOI 10.4239/wjd.v5.i5.697; Auwerx J, 1996, J Atheroscler Thromb, V3, P81; Bantel H, 2000, AM J GASTROENTEROL, V95, P3452; Bernstein LE, 2006, ARCH INTERN MED, V166, P902, DOI 10.1001/archinte.166.8.902; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROGDEN RN, 1989, DRUGS, V38, P500, DOI 10.2165/00003495-198938040-00003; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; CHRISTENSEN LA, 1990, ALIMENT PHARM THERAP, V4, P523; D'Aquila T, 2016, BBA-MOL CELL BIOL L, V1861, P730, DOI 10.1016/j.bbalip.2016.04.012; DAS KM, 1973, GUT, V14, P631, DOI 10.1136/gut.14.8.631; Debril MB, 2001, J MOL MED, V79, P30, DOI 10.1007/s001090000145; Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Dubuquoy L, 2002, LANCET, V360, P1410, DOI 10.1016/S0140-6736(02)11395-X; Egan LJ, 1999, J BIOL CHEM, V274, P26448, DOI 10.1074/jbc.274.37.26448; Esser N, 2015, EXPERT OPIN INV DRUG, V24, P283, DOI 10.1517/13543784.2015.974804; Feagan BG, 2013, INFLAMM BOWEL DIS, V19, P2031, DOI 10.1097/MIB.0b013e3182920108; Frazier-Wood AC, 2013, PHARMACOGENOMICS J, V13, P312, DOI 10.1038/tpj.2012.9; Giannini EG, 2005, DIGEST LIVER DIS, V37, P723, DOI 10.1016/j.dld.2005.02.012; GREENFIELD SM, 1993, ALIMENT PHARM THER, V7, P369; Hennuyer N, 2016, ATHEROSCLEROSIS, V249, P200, DOI 10.1016/j.atherosclerosis.2016.03.003; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Jia L, 2011, ANNU REV PHYSIOL, V73, P239, DOI 10.1146/annurev-physiol-012110-142233; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Luck H, 2015, CELL METAB, V21, P527, DOI 10.1016/j.cmet.2015.03.001; Madrigal-Perez VM, 2015, INT J CLIN EXP MED, V8, P22477; Megna BW, 2016, WORLD J GASTRO SURG, V8, P115, DOI 10.4240/wjgs.v8.i2.115; Merlo G, 2017, EFFECTS TNF ALPHA IN; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Murakami K, 1998, DIABETES, V47, P1841, DOI 10.2337/diabetes.47.12.1841; MYERS B, 1987, GUT, V28, P196, DOI 10.1136/gut.28.2.196; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; Sharma VK, 1990, CANADIAN J GASTROENT, V4; Shimada T, 2004, FEBS LETT, V558, P33, DOI 10.1016/S0014-5793(03)01527-8; Staels B, 1997, BIOCHIMIE, V79, P95, DOI 10.1016/S0300-9084(97)81497-6; Sutherland LR, 1997, INFLAMM BOWEL DIS, V3, P65, DOI 10.1002/ibd.3780030202; van Asseldonk EJP, 2011, J CLIN ENDOCR METAB, V96, P2119, DOI 10.1210/jc.2010-2992; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Wang J, 2015, J LIPID RES, V56, P319, DOI 10.1194/jlr.M054544; Watts GF, 1999, CURR OPIN LIPIDOL, V10, P561, DOI 10.1097/00041433-199912000-00011; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhou SY, 1999, DRUG METAB DISPOS, V27, P479	47	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191485	10.1371/journal.pone.0191485	http://dx.doi.org/10.1371/journal.pone.0191485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352300	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300096
J	Yoon, Y; Jung, H; Lee, H				Yoon, Young; Jung, Hyunwoo; Lee, Hana			Abnormal network flow detection based on application execution patterns from Web of Things (WoT) platforms	PLOS ONE			English	Article								In this paper, we present a research work on a novel methodology of identifying abnormal behaviors at the underlying network monitor layer during runtime based on the execution patterns of Web of Things (WoT) applications. An execution pattern of a WoT application is a sequence of profiled time delays between the invocations of involved Web services, and it can be obtained from WoT platforms. We convert the execution pattern to a time sequence of network flows that are generated when the WoT applications are executed. We consider such time sequences as a whitelist. This whitelist reflects the valid application execution patterns. At the network monitor layer, our applied RETE algorithm examines whether any given runtime sequence of network flow instances does not conform to the whitelist. Through this approach, it is possible to interpret a sequence of network flows with regard to application logic. Given such contextual information, we believe that the administrators can detect and reason about any abnormal behaviors more effectively. Our empirical evaluation shows that our RETE-based algorithm outperforms the baseline algorithm in terms of memory usage.	[Yoon, Young; Jung, Hyunwoo; Lee, Hana] Hongik Univ, Dept Comp Engn, Seoul, South Korea	Hongik University	Yoon, Y (corresponding author), Hongik Univ, Dept Comp Engn, Seoul, South Korea.	young.yoon@hongik.ac.kr			Hongik University new faculty research support fund	Hongik University new faculty research support fund	This research was supported by Hongik University new faculty research support fund to YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Hongik University new faculty research support fund.	Bali M., 2009, DROOLS JBOSS RULES 5; Barford P, 2002, IMW 2002: PROCEEDINGS OF THE SECOND INTERNET MEASUREMENT WORKSHOP, P71, DOI 10.1145/637201.637210; Barham P., 2003, HOTOS, V9, P15, DOI 10.5555/1251054.1251069; Butun I, 2015, COMM WORKSH ICCW 201; Choi B, 2016, 13TH USENIX SYMPOSIUM ON NETWORKED SYSTEMS DESIGN AND IMPLEMENTATION (NSDI '16), P551; Dubrawsky I, 2003, SECURITY FOCUS, P29; Estan C, 2004, ACM SIGCOMM COMP COM, V34, P245, DOI 10.1145/1030194.1015495; Feldmann A, 2000, IEEE NETWORK, V14, P11, DOI 10.1109/65.826367; Finch M., 2014, CODE4LIB J; FORGY CL, 1982, ARTIF INTELL, V19, P17, DOI 10.1016/0004-3702(82)90020-0; Friedman-Hill Ernest, 2003, JESS IN ACTION, V46; Jacobsen  H.-A., 2013, P 7 ACM INT C DISTR, P295; John III CA, 2003, FLOW BASED DETECTION; Kasinathan P, 2013, IEEE CONF WIREL MOB, P600, DOI 10.1109/WiMOB.2013.6673419; Kim MS, 2004, NOMS 2004: IEEE/IFIP NETWORK OPERATIONS AND MANAGMENT SYMPOSIUM, P599, DOI 10.1109/NOMS.2004.1317747; Kreps J., 2011, P 6 INT WORKSHOP NET, VVolume 11, P1, DOI DOI 10.1007/BF00640482; Lakkaraju Kiran, 2004, P ACM WORKSHOP VISUA, P65, DOI DOI 10.1145/1029208.1029219; Lee GM, 2005, P 5 ACM SIGCOMM C IN, P24; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Mitchell R, 2014, COMPUT COMMUN, V42, P1, DOI 10.1016/j.comcom.2014.01.012; Ovadia S., 2014, BEHAV SOC SCI LIBR, V33, P208, DOI [DOI 10.1080/01639269.2014.964593, 10.1080/01639269.2014.964593]; Sommer R, 2010, P IEEE S SECUR PRIV, P305, DOI 10.1109/SP.2010.25; Sperotto A, 2010, IEEE COMMUN SURV TUT, V12, P343, DOI 10.1109/SURV.2010.032210.00054; Thottan M, 2003, IEEE T SIGNAL PROCES, V51, P2191, DOI 10.1109/TSP.2003.814797; Yoon Y, 2017, PLOS ONE, V12, P1	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191083	10.1371/journal.pone.0191083	http://dx.doi.org/10.1371/journal.pone.0191083			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351324	gold, Green Submitted, Green Published			2022-12-27	WOS:000422911300046
J	Jensen, PN; Bao, TQ; Huong, TTT; Heckbert, SR; Fitzpatrick, AL; LoGerfo, JP; Ngoc, TLV; Mokdad, AH				Jensen, Paul N.; Tran Quoc Bao; Tran Thi Thanh Huong; Heckbert, Susan R.; Fitzpatrick, Annette L.; LoGerfo, James P.; Truong Le Van Ngoc; Mokdad, Ali H.			The association of estimated salt intake with blood pressure in a Viet Nam national survey	PLOS ONE			English	Article							24-H URINARY SODIUM; POTASSIUM EXCRETION; SENSITIVITY; HEALTH; ADULTS; URBAN; INTERVENTIONS; HYPERTENSION; MIGRATION; COSTS	Objective To evaluate the association of salt consumption with blood pressure in Viet Nam, a developing country with a high level of salt consumption. Design and setting Analysis of a nationally representative sample of Vietnamese adults 25 +/- 65 years of age who were surveyed using the World Health Organization STEPwise approach to Surveillance protocol. Participants who reported acute illness, pregnancy, or current use of antihypertensive medications were excluded. Daily salt consumption was estimated from fasting mid-morning spot urine samples. Associations of salt consumption with systolic blood pressure and prevalent hypertension were assessed using adjusted linear and generalized linear models. Interaction terms were tested to assess differences by age, smoking, alcohol consumption, and rural/urban status. Results The analysis included 2,333 participants (mean age: 37 years, 46% male, 33% urban). The average estimated salt consumption was 10g/day. No associations of salt consumption with blood pressure or prevalent hypertension were observed at a national scale in men or women. The associations did not differ in subgroups defined by age, smoking, or alcohol consumption; however, associations differed between urban and rural participants (p-value for interaction of urban/rural status with salt consumption, p = 0.02), suggesting that higher salt consumption may be associated with higher systolic blood pressure in urban residents but lower systolic blood pressure in rural residents. Conclusions Although there was no evidence of an association at a national level, associations of salt consumption with blood pressure differed between urban and rural residents in Viet Nam. The reasons for this differential association are not clear, and given the large rate of rural to urban migration experienced in Viet Nam, this topic warrants further investigation.	[Jensen, Paul N.; Heckbert, Susan R.; Fitzpatrick, Annette L.; Mokdad, Ali H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Tran Quoc Bao; Truong Le Van Ngoc] Viet Nam Minist Hlth, Dept Prevent Med, Hanoi, Vietnam; [Tran Thi Thanh Huong] Hanoi Med Univ, Dept Eth & Social Med, Hanoi, Vietnam; [Fitzpatrick, Annette L.; LoGerfo, James P.; Mokdad, Ali H.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [LoGerfo, James P.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Hanoi Medical University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jensen, PN (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	pnjensen@uw.edu	Mokdad, Ali H./AAD-1232-2022	Mokdad, Ali H./0000-0002-4994-3339	Atlantic Philanthropies Inc.	Atlantic Philanthropies Inc.	Funding to support data collection (TQB, TTTH, TLVN) was provided by The Atlantic Philanthropies Inc.; the sponsor had no role in the study design, data analysis, writing or preparation of the article, or decision to have it submitted for publication. Study authors had no association with the funding organization. http://www.atlanticphilanthropies.org/	[Anonymous], 1988, BMJ, V297, P319; [Anonymous], 2005, ASEAN EC B, DOI DOI 10.1355/AE22-1G; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; CARVALHO JJM, 1989, HYPERTENSION, V14, P238, DOI 10.1161/01.HYP.14.3.238; Cogswell ME, 2013, AM J CLIN NUTR, V98, P1502, DOI 10.3945/ajcn.113.059436; Cuong TQ, 2007, EUR J CLIN NUTR, V61, P673, DOI 10.1038/sj.ejcn.1602563; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Do HTP, 2014, THESIS; Elliott P, 2013, AM J EPIDEMIOL, V177, P1196, DOI 10.1093/aje/kwt065; Do HTP, 2016, J CLIN HYPERTENS, V18, P1135, DOI 10.1111/jch.12884; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; He F. J., 2013, BMJ, V346; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; HE J, 1991, AM J EPIDEMIOL, V134, P1085, DOI 10.1093/oxfordjournals.aje.a116012; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Huang LP, 2016, INT J EPIDEMIOL, V45, P239, DOI 10.1093/ije/dyv313; Huyen DNTN, VIETNAMS EC DEV OPPO; Ji C, 2012, REV PANAM SALUD PUBL, V32, P307, DOI 10.1590/S1020-49892012001000010; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Kotchen TA, 1998, CIRCULATION, V98, P613, DOI 10.1161/01.CIR.98.6.613; LIU K, 1984, ANN CLIN RES, V16, P49; LUFT FC, 1979, CIRCULATION, V60, P697, DOI 10.1161/01.CIR.60.3.697; Lumley T, 2006, UW BIOSTATISTICS WOR; Mann SJ, 2010, J CLIN HYPERTENS, V12, P174, DOI 10.1111/j.1751-7176.2009.00241.x; Mattson DL, 2008, AM J PHYSIOL-RENAL, V295, pF837, DOI 10.1152/ajprenal.90341.2008; MENEELY GR, 1976, AM J CARDIOL, V38, P768, DOI 10.1016/0002-9149(76)90356-8; Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122; Mill José Geraldo, 2015, Rev. bras. epidemiol., V18, P224, DOI 10.1590/1980-5497201500060020; MILLER JZ, 1987, AM J EPIDEMIOL, V126, P822, DOI 10.1093/oxfordjournals.aje.a114719; Mohani S, 2013, PROMOTING POPULATION; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; NADIM A, 1978, INT J EPIDEMIOL, V7, P131, DOI 10.1093/ije/7.2.131; Nguyen QN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042825; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Oh J, 2014, J KOREAN MED SCI, V29, pS109, DOI 10.3346/jkms.2014.29.S2.S109; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; POULTER N, 1984, J EPIDEMIOL COMMUN H, V38, P181, DOI 10.1136/jech.38.3.181; Rubinstein Adolfo, 2009, Cost Eff Resour Alloc, V7, P10, DOI 10.1186/1478-7547-7-10; Sanada H, 2011, CURR HYPERTENS REP, V13, P55, DOI 10.1007/s11906-010-0167-6; Sanders PW, 2009, HYPERTENSION, V53, P442, DOI 10.1161/HYPERTENSIONAHA.108.120303; Steffen PR, 2006, PSYCHOSOM MED, V68, P386, DOI 10.1097/01.psy.0000221255.48190.32; Svetkey LP, 1996, HYPERTENSION, V28, P854, DOI 10.1161/01.HYP.28.5.854; Bui TV, 2015, NICOTINE TOB RES, V17, P831, DOI 10.1093/ntr/ntu202; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Trang Nguyen Hoang Hanh Doan, 2012, BMJ Open, V2, pe000362, DOI 10.1136/bmjopen-2011-000362; Trinh OTH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-204; United Nations Population Fund, 2011, VIETN POP HOUS CENS; Wang GJ, 2011, J HYPERTENS, V29, P1693, DOI 10.1097/HJH.0b013e328349ba18; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481; White E, 2008, PRINCIPLES EXPOSURE, Vxi; World Health Organization, 2012, STEPWISE APPR SURV S; World Health Organization, 2016, SALT RED D FACT SHEE	54	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191437	10.1371/journal.pone.0191437	http://dx.doi.org/10.1371/journal.pone.0191437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9PC	29346423	Green Submitted, Green Published, gold			2022-12-27	WOS:000422749500051
J	Martinez-Andrade, JM; Avalos-Borja, M; Vilchis-Nestor, AR; Sanchez-Vargas, LO; Castro-Longoria, E				Martinez-Andrade, Juan M.; Avalos-Borja, Miguel; Vilchis-Nestor, Alfredo R.; Sanchez-Vargas, Luis O.; Castro-Longoria, Ernestina			Dual function of EDTA with silver nanoparticles for root canal treatment-A novel modification	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS BIOFILMS; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; BACTERICIDAL ACTIVITY; AMPHOTERICIN-B; IN-VITRO; ANTIBACTERIAL; ACID; DENTIN; IRRIGATION	The chelating and antimicrobial capacity of a novel modification of 17% EDTA with silver nanoparticles (AgNPs) (EDTA-AgNPs) was evaluated in-vitro for root canal treatment (RCT). The EDTA-AgNPs solution was characterized by UV-Vis spectroscopy,zeta-potential and high-resolution transmission electron microscopy (HRTEM). Antimicrobial capacity was evaluated against Candida albicans and Staphylococcus aureus in planktonic and biofilm cells by broth macrodilution (24 h) and XTT assays, (1, 10 and 30 min) respectively. The chelating capacity of EDTA-AgNPs was assessed indirectly (smear layer removal) and directly (demineralizing effect) in bovine dentin at two silver concentrations, 16 and 512 mu g/ml at 1 and 10 minutes of exposure time. Smear layer removal was evaluated by atomic force microscopy (AFM) and scanning electron microscopy (SEM). The demineralizing effect was determined by atomic absorption spectroscopy (AAS), microhardness test (MH) and X-ray diffractometer (XRD). Synthesized AgNPs were quasi-spherical in shape with an average size of 13.09 +/- 8.05 nm. 17% EDTA-AgNPs was effective to inhibit C. albicans and S. aureus in planktonic and biofilm cultures. The smear layer removal and demineralizing effect were similar between 17% EDTA-AgNPs and 17% EDTA treatments. The 17% EDTA-AgNPs solution proved to be an effective antimicrobial agent, and has a similar chelating capacity to 17% EDTA alone. These in-vitro studies strongly suggest that EDTA-AgNPs could be used for effective smear layer removal, having an antimicrobial effect at the same time during RCT.	[Martinez-Andrade, Juan M.; Castro-Longoria, Ernestina] CICESE, Dept Microbiol, Ensenada, Baja California, Mexico; [Avalos-Borja, Miguel] Inst Potosino Invest Cient & Tecnol IPICyT, San Luis Potosi, San Luis Potosi, Mexico; [Vilchis-Nestor, Alfredo R.] Univ Autonoma Estado Mexico, Ctr Conjunto Invest Quim Sustentable, Toluca, Estado De Mexic, Mexico; [Vilchis-Nestor, Alfredo R.] UNAM, UAEM, Toluca, Estado De Mexic, Mexico; [Sanchez-Vargas, Luis O.] UASLP, Fac Estomatol, San Luis Potosi, San Luis Potosi, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad Autonoma del Estado de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma de San Luis Potosi	Castro-Longoria, E (corresponding author), CICESE, Dept Microbiol, Ensenada, Baja California, Mexico.	ecastro@cicese.mx	VILCHIS-NESTOR, ALFREDO R/B-6776-2016; Castro-Longoria, Ernestina/GYV-4776-2022	VILCHIS-NESTOR, ALFREDO R/0000-0001-8490-0900; Martinez-Andrade, Juan Manuel/0000-0002-2166-6659	SEP-CONACyT [CB2011/169154, LN-0271911]; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was partially funded by a SEP-CONACyT grant CB2011/169154 to EC-L and LN-0271911 to MA-B (www.conacyt.mx). We also thank Consejo Nacional de Ciencia y Tecnologia (CONACyT) for a scholarship to JMM-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bakri AG, 2009, J APPL MICROBIOL, V107, P280, DOI 10.1111/j.1365-2672.2009.04205.x; Arias-Moliz MT, 2008, ORAL SURG ORAL MED O, V106, pE84, DOI 10.1016/j.tripleo.2008.04.002; Baumgartner JC, 2007, J ENDODONT, V33, P48, DOI 10.1016/j.joen.2006.08.007; Bian SW, 2011, LANGMUIR, V27, P6059, DOI 10.1021/la200570n; Branen JK, 2004, INT J FOOD MICROBIOL, V90, P63, DOI 10.1016/S0168-1605(03)00172-7; Calt S, J ENDOD, V28, P17; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; CLSI, 2008, M27A3 CLSI; Teruel JD, 2015, ARCH ORAL BIOL, V60, P768, DOI 10.1016/j.archoralbio.2015.01.014; Dunavant TR, 2006, J ENDODONT, V32, P527, DOI 10.1016/j.joen.2005.09.001; Dutner J, J ENDOD, V38, P37; El Din SN, 2016, INT J NANOMED, V11, P1749, DOI 10.2147/IJN.S102398; El-Sharif AA, 2011, CURR MICROBIOL, V62, P739, DOI 10.1007/s00284-010-9777-0; Gill AO, 2003, INT J FOOD MICROBIOL, V80, P251, DOI 10.1016/S0168-1605(02)00171-X; Gomes JE, 2010, J ENDODONT, V36, P1698, DOI 10.1016/j.joen.2010.07.007; GRAY GW, 1965, J APPL BACTERIOL, V28, P153, DOI 10.1111/j.1365-2672.1965.tb04547.x; Haapasalo M, 2014, BRIT DENT J, V216, P299, DOI 10.1038/sj.bdj.2014.204; Hansen LT, 2001, INT J FOOD MICROBIOL, V66, P149, DOI 10.1016/S0168-1605(01)00428-7; Hulsmann M, 2003, INT ENDOD J, V36, P810, DOI 10.1111/j.1365-2591.2003.00754.x; Le Ouay B, 2015, NANO TODAY, V10, P339, DOI 10.1016/j.nantod.2015.04.002; Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z; McComb D, 1975, J Endod, V1, P238, DOI 10.1016/S0099-2399(75)80226-3; Morgental RD, 2013, J ENDODONT, V39, P406, DOI 10.1016/j.joen.2012.10.028; Narayanan L Lakshmi, 2010, J Conserv Dent, V13, P233, DOI 10.4103/0972-0707.73386; Niu W, 2002, INT ENDOD J, V35, P934, DOI 10.1046/j.1365-2591.2002.00594.x; Novais JS, RSC ADV; Ordinola-Zapata R, 2012, INT ENDOD J, V45, P162, DOI 10.1111/j.1365-2591.2011.01959.x; Pan HC, 2007, TALANTA, V71, P276, DOI 10.1016/j.talanta.2006.03.057; Panacek A, 2016, COLLOID SURFACE B, V142, P392, DOI 10.1016/j.colsurfb.2016.03.007; PFALLER MA, 1995, J CLIN MICROBIOL, V33, P1104, DOI 10.1128/JCM.33.5.1104-1107.1995; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; PUGH D, 1980, SABOURAUDIA, V18, P157; Raad II, 2008, INT J ANTIMICROB AG, V32, P515, DOI 10.1016/j.ijantimicag.2008.06.020; Serper A, 2002, J ENDODONT, V28, P501, DOI 10.1097/00004770-200207000-00002; Siqueira JF, 2004, ORAL SURG ORAL MED O, V97, P632, DOI 10.1016/j.tripleo.2003.12.022; Slistan-Grijalva A, 2005, PHYSICA E, V27, P104, DOI 10.1016/j.physe.2004.10.014; Sreeprasad TS, 2011, LANGMUIR, V27, P3381, DOI 10.1021/la104828e; Stuart CH, 2006, J ENDODONT, V32, P93, DOI 10.1016/j.joen.2005.10.049; Arias-Moliz MT, 2009, J ENDODONT, V35, P711, DOI 10.1016/j.joen.2009.01.018; Torabinejad M, 2003, J ENDODONT, V29, P400, DOI 10.1097/00004770-200306000-00005; Touzel RE, 2016, J HOSP INFECT, V92, P154, DOI 10.1016/j.jhin.2015.09.013; Wang CC, 2009, TALANTA, V77, P1238, DOI 10.1016/j.talanta.2008.08.035; Wang ZJ, 2013, J ENDODONT, V39, P1395, DOI 10.1016/j.joen.2013.05.007; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Xia YN, 2005, MRS BULL, V30, P338, DOI 10.1557/mrs2005.96; Xiu ZM, 2011, ENVIRON SCI TECHNOL, V45, P9003, DOI 10.1021/es201918f; Zhang HZ, 2010, J PHYS CHEM C, V114, P14876, DOI 10.1021/jp1060842	47	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190866	10.1371/journal.pone.0190866	http://dx.doi.org/10.1371/journal.pone.0190866			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346398	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500019
J	Pollack, TM; Duong, HT; Truong, PT; Pham, TT; Do, CD; Colby, D				Pollack, Todd M.; Duong, Hao T.; Truong, Phuong T.; Pham, Thuy T.; Do, Cuong D.; Colby, Donn			Sensitivity and specificity of two dried blood spot methods for HIV-1 viral load monitoring among patients in Hanoi, Vietnam	PLOS ONE			English	Article							SCALE-UP; SETTINGS; THERAPY	The use of dried blood spot (DBS) specimens for HIV viral load (VL) monitoring is recommended to support the roll-out of routine VL monitoring in low and middle income countries (LMICs). To better understand the use of DBS for VL monitoring, we evaluated two DBS testing methods, Roche TaqMan (R) Free Virus Evolution protocol (DBS-FVE) and Roche TaqMan (R) SPEX protocol (DBS-SPEX)) in patients receiving ART at an HIV clinic in Hanoi, Vietnam. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for each DBS testing method at the thresholds of 1000 and 5000 copies/ml compared to plasma VL. At a threshold of 1000 copies/ml, sensitivity, specificity, PPV and NPV of the DBS-SPEX method were 98.8% (95% CI: 93.3%-100%), 74.3% (95% CI: 70.8%-77.5%), 31.5% (95% CI: 25.8%-37.6%), and 99.8% (95% CI: 98.9%-100%), respectively. Increasing the VL threshold value to 5000 copies/ml improved specificity (97.9% CI: 96.6%-98.9%) and PPV (83.9% CI: 74.5%-90.9%). Using the DBS-FVE method, at the threshold of 1000 copies/ml and with a correction factor of + 0.3 log copies/ml, sensitivity was 95.1% (87.8%-98.6%) and specificity was 98.8% (97.7%-99.5%). Sensitivity decreased at the threshold of 5000 copies/ml (65.8%, 95% CI: 54.3%-76.1%). With a correction factor of + 0.7 log copies/ml, the sensitivity was 96.3% (89.6%-99.2%) and specificity was 98.2% (96.9%-99.1%) at the threshold of 1000 copies/ml. We found that the Roche DBS-FVE method, with a + 0.7 log copies/ml correction factor, performed well with sensitivity and specificity greater than 96% at a VL threshold of 1000 copies/m. These findings add to the growing body of evidence supporting the use of DBS VL testing for ART monitoring. Future research should evaluate the association between VL results by DBS and clinical outcome measures such as HIV drug resistance, morbidity, and mortality.	[Pollack, Todd M.; Duong, Hao T.; Pham, Thuy T.] Beth Israel Deaconess Med Ctr, Partnership Hlth Adv Vietnam, Hanoi, Vietnam; [Pollack, Todd M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Truong, Phuong T.] Bach Mai Hosp, Dept Microbiol, Hanoi, Vietnam; [Pham, Thuy T.; Do, Cuong D.] Bach Mai Hosp, Dept Infect Dis, Hanoi, Vietnam; [Colby, Donn] Ctr Appl Res Men & Community Hlth, Ho Chi Minh City, Vietnam; [Colby, Donn] Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand	Harvard University; Beth Israel Deaconess Medical Center; Thai Red Cross Society	Pollack, TM (corresponding author), Beth Israel Deaconess Med Ctr, Partnership Hlth Adv Vietnam, Hanoi, Vietnam.; Pollack, TM (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	todd@haivn.org		Pollack, Todd/0000-0002-0011-5233; colby, donn j./0000-0003-3931-5926	Roche Molecular Systems, Inc. [974, L-18559]	Roche Molecular Systems, Inc.	This study was funded by Roche Molecular Systems, Inc. (https://molecular.roche.com) under Contract No. 974 and Contract No L-18559. Funding was received by TMP. The study sponsor participated in the study design but otherwise had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention, 2016, FREQ ASK QUEST US DR; EPP Technical Working Group M of H, 2013, VIET NAM 2013; Ferreyra C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049834; Harrigan R., 1995, JAIDS-J ACQ IMM DEF, V10, pS1 ; Inzaule S, 2016, STRINGENT HIV VIRAL, V71, P30; Johannessen A, 2009, J ANTIMICROB CHEMOTH, V64, P1126, DOI 10.1093/jac/dkp353; KROUWER J, 2002, METHOD COMP BIAS EST, V22; Lecher S, 2015, MMWR-MORBID MORTAL W, V64, P1287, DOI 10.15585/mmwr.mm6446a3; Mavedzenge SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126878; MOH, 2015, GUID HIV AIDS DIAGN; MOH, 2011, GUID HIV AIDS DIAGN; Pollack TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173534; Rangarajan S, 2016, J VIRUS ERAD, V2, P94; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Rottinghaus E, 2013, J CLIN MICROBIOL, V51, P55, DOI 10.1128/JCM.02002-12; Rutstein SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124748; Smit PW, 2014, PLOS ONE, V9; Taieb F, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw142; The U. S. President's Emergency Plan for AIDS Relief (PEPFAR), 2016, VIETN COUNTR REG OP; UNAIDS, 2016, 90 90 90 RIGHT TRACK; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2014, TECHN OP CONS IMPL H; Wu XN, 2015, J CLIN VIROL, V65, P38, DOI 10.1016/j.jcv.2015.01.022	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191411	10.1371/journal.pone.0191411	http://dx.doi.org/10.1371/journal.pone.0191411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346431	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500048
J	Sanscrainte, ND; Arimoto, H; Waits, CM; Li, LY; Johnson, D; Geden, C; Becnel, JJ; Estep, AS				Sanscrainte, Neil D.; Arimoto, Hanayo; Waits, Christy M.; Li, Lucy Y.; Johnson, Dana; Geden, Chris; Becnel, James J.; Estep, Alden S.			Reduction in Musca domestica fecundity by dsRNA-mediated gene knockdown	PLOS ONE			English	Article							IN-HOUSE FLIES; RNA INTERFERENCE; RESISTANCE; FLY; INSECTICIDES; EXPRESSION; DELIVERY; MUSCIDAE; INSECTS; DIPTERA	House flies (Musca domestica) are worldwide agricultural pests with estimated control costs at $375 million annually in the U.S. Non-target effects and widespread resistance challenge the efficacy of traditional chemical control. Double stranded RNA (dsRNA) has been suggested as a biopesticide for M. domestica but a phenotypic response due to the induction of the RNAi pathway has not been demonstrated in adults. In this study female house flies were injected with dsRNA targeting actin-5C or ribosomal protein (RP) transcripts RPL26 and RPS6. Ovaries showed highly reduced provisioning and clutch reductions of 94-99% in RP dsRNA treated flies but not in actin-5C or GFP treated flies. Gene expression levels were significantly and specifically reduced in dsRNA injected groups but remained unchanged in the control dsGFP treated group. Furthermore, injections with an Aedes aegypti conspecific dsRNA designed against RPS6 did not impact fecundity, demonstrating species specificity of the RNAi response. Analysis of M. domestica tissues following RPS6 dsRNA injection showed significant reduction of transcript levels in the head, thorax, and abdomen but increased expression in ovarian tissues. This study demonstrates that exogenous dsRNA is specifically effective and has potential efficacy as a highly specific biocontrol intervention in adult house flies. Further work is required to develop effective methods for delivery of dsRNA to adult flies.	[Sanscrainte, Neil D.; Li, Lucy Y.; Johnson, Dana; Geden, Chris; Becnel, James J.; Estep, Alden S.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Arimoto, Hanayo] Naval Med Res Unit 3, Cairo, Egypt; [Waits, Christy M.; Estep, Alden S.] US Navy Entomol Ctr Excellence, CMAVE Detachment, Gainesville, FL USA; [Waits, Christy M.] Lovelace Resp Res Inst, Albuquerque, NM USA	United States Department of Agriculture (USDA); Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); Lovelace Respiratory Research Institute	Sanscrainte, ND (corresponding author), USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.	neil.sanscrainte@ars.usda.gov	Geden, Christopher J/J-5413-2016	Sanscrainte, Neil/0000-0002-0891-5278; Estep, Alden/0000-0002-8281-3229	USDA; WII-141C project of the Navy and Marine Corps Public Health Center; Deployed War Fighters Protection Program	USDA(United States Department of Agriculture (USDA)); WII-141C project of the Navy and Marine Corps Public Health Center; Deployed War Fighters Protection Program	Funding was provided by the USDA, the WII-141C project of the Navy and Marine Corps Public Health Center, and the Deployed War Fighters Protection Program. The funders had no role in design or direction of the study or development of the manuscript.; The authors thank Drs. Pia Olafson and James Baum for critical review of the manuscript as well as Jessica Louton and Roxie White (USDA) for technical support. Funding was provided by the USDA, the WII-141C project of the Navy and Marine Corps Public Health Center, and the Deployed War Fighters Protection Program. The funders had no role in design or direction of the study or development of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baum JA, 2014, ADV INSECT PHYSIOL, V47, P249, DOI 10.1016/B978-0-12-800197-4.00005-1; Bobbin ML, 2016, ANNU REV PHARMACOL, V56, P103, DOI 10.1146/annurev-pharmtox-010715-103633; Burghardt G, 2005, DEV GENES EVOL, V215, P165, DOI 10.1007/s00427-004-0464-7; CHAMBERLAIN R, 1961, ANNU REV ENTOMOL, V6, P371, DOI 10.1146/annurev.en.06.010161.002103; Coy MR, 2012, J APPL ENTOMOL, V136, P741, DOI 10.1111/j.1439-0418.2012.01713.x; Estep AS, 2016, J INSECT PHYSIOL, V90, P17, DOI 10.1016/j.jinsphys.2016.05.001; Gao YF, 2015, MOL IMMUNOL, V67, P465, DOI 10.1016/j.molimm.2015.08.007; Geden C. J., 2001, P WORKSHOP LINCOLN; Ghosh A, 2015, J FOOD PROTECT, V78, P567, DOI 10.4315/0362-028X.JFP-14-429; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Graczyk TK, 2001, MICROBES INFECT, V3, P231, DOI 10.1016/S1286-4579(01)01371-5; HAGEDORN HH, 1972, J EXP ZOOL, V182, P367, DOI 10.1002/jez.1401820308; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; Horn T, 2010, NUCLEIC ACIDS RES; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Kaufman PE, 2001, PEST MANAG SCI, V57, P514, DOI 10.1002/ps.319; Khan HAA, 2013, PARASITOL RES, V112, P2049, DOI 10.1007/s00436-013-3365-8; Kim M, 2010, INSECT MOL BIOL, V19, P27, DOI 10.1111/j.1365-2583.2009.00926.x; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Machtinger ET, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew032; Machtinger ET, 2017, ECOLOGY CONTROL VECT, V5; Malik A, 2007, J ENVIRON SCI HEAL B, V42, P453, DOI 10.1080/03601230701316481; Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470; Palli SR, 2014, CURR OPIN INSECT SCI, V6, P1, DOI 10.1016/j.cois.2014.09.011; Puglise JM, 2016, J MED ENTOMOL, V53, P304, DOI 10.1093/jme/tjv191; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott JG, 2017, PEST MANAG SCI, V73, P716, DOI 10.1002/ps.4328; Scott JG, 2013, PESTIC BIOCHEM PHYS, V107, P377, DOI 10.1016/j.pestbp.2013.10.006; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Tang T, 2012, J INSECT PHYSIOL, V58, P1226, DOI 10.1016/j.jinsphys.2012.06.007; Tang T, 2012, GENE, V505, P211, DOI 10.1016/j.gene.2012.06.025; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; TYNDALEBISCOE M, 1969, B ENTOMOL RES, V59, P129, DOI 10.1017/S0007485300003126; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Wu K, 2014, EXP APPL ACAROL, V63, P171, DOI 10.1007/s10493-014-9772-4; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048; Zurek L, 2014, APPL ENVIRON MICROB, V80, P3562, DOI 10.1128/AEM.00600-14	43	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0187353	10.1371/journal.pone.0187353	http://dx.doi.org/10.1371/journal.pone.0187353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342168	gold, Green Published, Green Submitted			2022-12-27	WOS:000422653800004
J	Zhao, H; Zhao, J; Sun, XL; Chen, FJ; Han, GQ				Zhao, Hui; Zhao, Jian; Sun, Xingli; Chen, Fajin; Han, Guoqi			A strong summer phytoplankton bloom southeast of Vietnam in 2007, a transitional year from El Nino to La Nina	PLOS ONE			English	Article							LUZON STRAIT; CHINA SEA; CHLOROPHYLL; VARIABILITY; WATERS; COAST	Summer upwelling occurs frequently off the southeast Vietnam coast in the western South China Sea (SCS), where summer phytoplankton blooms generally appear during June-August. In this study, we investigate inter-annual variation of Ekman pumping and offshore transport, and its modulation on summer blooms southeast of Vietnam. The results indicate that there are low intensities of summer blooms in El Nino years, under higher sea surface temperatures (SST) and weaker winds. However, a different pattern of monthly chlorophyll a (Chl-a) blooms occurred in summer of 2007, a transitional stage from El Nino to La Nina, with weak (strong) wind and high (low) SST before (after) early July. There is a weak phytoplankton bloom before July 2007 and a strong phytoplankton bloom after July 2007. The abrupt change in the wind intensity may enhance the upwelling associated with Ekman pumping and offshore Ekman transport, bringing more high-nutrient water into the upper layer from the subsurface, and thus leading to an evident Chl-a bloom in the region.	[Zhao, Hui; Zhao, Jian; Sun, Xingli; Chen, Fajin] Guangdong Ocean Univ, Zhanjiang, Peoples R China; [Han, Guoqi] Fisheries & Oceans Canada, Northwest Atlantic Fisheries Ctr, St John, NF, Canada	Guangdong Ocean University; Fisheries & Oceans Canada	Chen, FJ (corresponding author), Guangdong Ocean Univ, Zhanjiang, Peoples R China.	fjchen04@163.com; guoqi.han@dfo-mpo.gc.ca	Han, Guoqi/T-7365-2019		National Natural Science Foundation of China [41376125, 41476066, 41006070]; International Scientific & Technological Cooperation Project of Education of Department Guangdong Province [2015KGJHZ017]; Foundation for Distinguished Young Teacher in Higher Education of Guangdong [Yq2014004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Scientific & Technological Cooperation Project of Education of Department Guangdong Province; Foundation for Distinguished Young Teacher in Higher Education of Guangdong	The present research is supported by the National Natural Science Foundation of China (grants 41376125, 41476066 and 41006070), International Scientific & Technological Cooperation Project of Education of Department Guangdong Province (2015KGJHZ017), and The Foundation for Distinguished Young Teacher in Higher Education of Guangdong (Yq2014004).	Antico PL, 2009, INT J CLIMATOL, V29, P719, DOI 10.1002/joc.1734; Babin SM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001938; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; [陈湘雅 CHEN Xiang-ya], 2009, [南京气象学院学报, Journal of Nanjing Institute of Meteorology], V32, P71; Chen YLL, 2004, CONT SHELF RES, V24, P527, DOI 10.1016/j.csr.2003.12.006; Chen Z, 2016, J GEOPHYS RES OCEANS, V121; DICKSON ML, 1995, LIMNOL OCEANOGR, V40, P533, DOI 10.4319/lo.1995.40.3.0533; [高姗 Gao Shan], 2010, [海洋学报, Acta Oceanologica Sinica], V32, P168; Gong X, 2015, BIOGEOSCIENCES, V12, P905, DOI 10.5194/bg-12-905-2015; Halpern D, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014097; Hein H, 2013, GLOBAL PLANET CHANGE, V110, P170, DOI 10.1016/j.gloplacha.2013.09.009; Iles AC, 2012, GLOBAL CHANGE BIOL, V18, P783, DOI 10.1111/j.1365-2486.2011.02567.x; Isoguchi O, 2006, GEOPHYS RES LETT, V331, P597; Jin X, 2009, J PHYS OCEANOGR, V39, P2957, DOI 10.1175/2009JPO4205.1; Kowalewski M, 2014, PALAIOS, P277; Kuo NJ, 2004, REMOTE SENS ENVIRON, V89, P106, DOI 10.1016/j.rse.2003.10.009; Li LA, 1990, J OCEANOGRAPHY TAIWA; Lin LR, 2012, J MARINE SCI; Maritorena S, 2005, REMOTE SENS ENVIRON, V94, P429, DOI 10.1016/j.rse.2004.08.014; Ogashawara I, 2014, REMOTE SENS-BASEL, V6, P1634, DOI 10.3390/rs6021634; Picado A, 2016, INT J CLIMATOL, V36, P3280, DOI 10.1002/joc.4555; Renault L, 2012, J GEOPHYS RES-ATMOS, V117, P41; Renault L, 2016, CLIM DYNAM, V46, P273, DOI 10.1007/s00382-015-2583-4; Roy C, 2001, PROG OCEANOGR, V49, P245, DOI 10.1016/S0079-6611(01)00025-8; Santos F, 2012, CONT SHELF RES, V34, P79, DOI 10.1016/j.csr.2011.12.004; Shu Y., 2006, J GEOPHYS RES-OCEANS, V121, P1145; Signorini SR, 1999, J GEOPHYS RES-OCEANS, V104, P18367, DOI 10.1029/1999JC900134; SMITH R L, 1968, Oceanography and Marine Biology an Annual Review, V6, P11; Tang D, 2014, PUBLIC HLTH REPORTS, P1899; Tang DL, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002045; Tang DL, 2003, HARMFUL ALGAE, V2, P89, DOI 10.1016/S1568-9883(03)00021-0; Tang DL, 1999, MAR ECOL PROG SER, V191, P43, DOI 10.3354/meps191043; Voss M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025569; Wang CZ, 2013, J CLIMATE, V26, P1322, DOI 10.1175/JCLI-D-12-00107.1; Wang DX, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007465; Wang Q, 2015, J GEOPHYS RES-OCEANS, V120, P517, DOI 10.1002/2014JC009814; Ware DM, 2011, CANADIAN J FISHERIES, V48, P2296; Xie SP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001867; Zhao H., 2005, ACTA OCEANOGR, V27, P45, DOI [10.3321/j.issn:0253, DOI 10.3321/J.ISSN:0253, 10.3321/j.issn:0253-4193.2005.04.006, DOI 10.3321/J.ISSN:0253-4193.2005.04.006]; Zhao H, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003536; Zhao H, 2013, J GEOPHYS RES-BIOGEO, V118, P412, DOI 10.1002/jgrg.20041; [赵辉 ZHAO Hui], 2005, [热带海洋学报, Journal of tropical oceanography], V24, P31; Zhou W, 2010, INT J CLIMATOLOGY, V27, P157	43	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189926	10.1371/journal.pone.0189926	http://dx.doi.org/10.1371/journal.pone.0189926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342148	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800012
J	Vanzyl, EJ; Rick, KRC; Blackmore, AB; MacFarlane, EM; McKay, BC				Vanzyl, Erin J.; Rick, Kayleigh R. C.; Blackmore, Alex B.; MacFarlane, Erin M.; McKay, Bruce C.			Flow cytometric analysis identifies changes in S and M phases as novel cell cycle alterations induced by the splicing inhibitor isoginkgetin	PLOS ONE			English	Article							GENETIC-CONTROL; DIVISION CYCLE; IN-VITRO; P53; PROGRESSION; YEAST; PHOSPHORYLATION; REPLICATION; SPLICEOSOME; SUBSTANCES	The spliceosome is a large ribonucleoprotein complex that catalyzes the removal of introns from RNA polymerase II-transcribed RNAs. Spliceosome assembly occurs in a stepwise manner through specific intermediates referred to as pre-spliceosome complexes E, A, B, B* and C. It has been reported that small molecule inhibitors of the spliceosome that target the SF3B1 protein component of complex A lead to the accumulation of cells in the G(1) and G(2)/M phases of the cell cycle. Here we performed a comprehensive flow cytometry analysis of the effects of isoginkgetin (IGG), a natural compound that interferes with spliceosome assembly at a later step, complex B formation. We found that IGG slowed cell cycle progression in multiple phases of the cell cycle (G(1), S and G(2)) but not M phase. This pattern was somewhat similar to but distinguishable from changes associated with an SF3B1 inhibitor, pladienolide B (PB). Both drugs led to a significant decrease in nascent DNA synthesis in S phase, indicative of an S phase arrest. However, IGG led to a much more prominent S phase arrest than PB while PB exhibited a more pronounced G(1) arrest that decreased the proportion of cells in S phase as well. We also found that both drugs led to a comparable decrease in the proportion of cells in M phase. This work indicates that spliceosome inhibitors affect multiple phases of the cell cycle and that some of these effects vary in an agent specific manner despite the fact that they target splicing at similar stages of spliceosome assembly.	[Vanzyl, Erin J.; Rick, Kayleigh R. C.; Blackmore, Alex B.; MacFarlane, Erin M.; McKay, Bruce C.] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [McKay, Bruce C.] Carleton Univ, Inst Biochem, Ottawa, ON, Canada	Carleton University; Carleton University	McKay, BC (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.; McKay, BC (corresponding author), Carleton Univ, Inst Biochem, Ottawa, ON, Canada.	bruce_mckay@carleton.ca	McKay, Bruce C/I-4081-2013	McKay, Bruce C/0000-0002-7921-1331	Natural Science and Engineering Research Council of Canada [RGPIN 2014-03645]; Carleton University from the Canadian Institutes of Health Research	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Carleton University from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported with funds from the Natural Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) grant number RGPIN 2014-03645 and start-up funds from Carleton University (www.carleton.ca) to B.C.M. E.J.V. is the recipient of graduate studentship from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders were not involved in the study design.	Abou Faycal C, 2016, CURR OPIN ONCOL, V28, P58, DOI 10.1097/CCO.0000000000000254; Ben Yehuda S, 1998, RNA, V4, P1304; Ben-Yehuda S, 2000, GENETICS, V156, P1503; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Effenberger KA, 2016, WILEY INTERDISCIP RE; Effenberger KA, 2016, INTERCHANGEABLE SF3B; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; HARTWELL LH, 1973, GENETICS, V74, P267; Hashimoto K, 2010, TOXICOL IN VITRO, V24, P208, DOI 10.1016/j.tiv.2009.09.006; Hoskins AA, 2012, TRENDS BIOCHEM SCI, V37, P179, DOI 10.1016/j.tibs.2012.02.009; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Maguire SL, 2015, J PATHOL, V235, P571, DOI 10.1002/path.4483; Matlin AJ, 2007, ADV EXP MED BIOL, V623, P14, DOI 10.1007/978-0-387-77374-2_2; Melanson BD, 2011, RNA, V17, P2222, DOI 10.1261/rna.030122.111; Mizui Y, 2004, J ANTIBIOT, V57, P188, DOI 10.7164/antibiotics.57.188; Nakajima H, 1996, J ANTIBIOT, V49, P1204; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Pawellek A, 2014, J BIOL CHEM, V289, P34683, DOI 10.1074/jbc.M114.590976; RIEDER CL, 1992, J CELL SCI, V102, P387; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sakai Y, 2002, J ANTIBIOT, V55, P863, DOI 10.7164/antibiotics.55.863; Salton M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8103; Sato M, 2014, CANCER SCI, V105, P110, DOI 10.1111/cas.12317; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; Somma MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000126; Sperling R, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1377; Stubbert LJ, 2007, CELL CYCLE, V6, P1730, DOI 10.4161/cc.6.14.4427; Stubbert LJ, 2009, CELL CYCLE, V8, P2995; Suryadinata R, 2010, BIOSCIENCE REP, V30, P243, DOI 10.1042/BSR20090171; TAMURA T, 1995, ONCOGENE, V11, P1939; Tzang BS, 1999, DNA CELL BIOL, V18, P315, DOI 10.1089/104454999315376; VAISMAN N, 1995, MOL GEN GENET, V247, P123, DOI 10.1007/BF00705642; Yip BH, 2016, CURR PHARM DESIGN, V22, P2333, DOI 10.2174/1381612822666160226132112; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x	36	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191178	10.1371/journal.pone.0191178	http://dx.doi.org/10.1371/journal.pone.0191178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338026	Green Submitted, Green Published, gold			2022-12-27	WOS:000422652700038
J	Brown, TA; Galicia, MP; Thiemann, GW; Belt, ST; Yurkowski, DJ; Dyck, MG				Brown, Thomas A.; Galicia, Melissa P.; Thiemann, Gregory W.; Belt, Simon T.; Yurkowski, David J.; Dyck, Markus G.			High contributions of sea ice derived carbon in polar bear (&ITUrsus maritimus&IT) tissue	PLOS ONE			English	Article							BRANCHED ISOPRENOID ALKENES; ALGAE-PRODUCED CARBON; COD BOREOGADUS-SAIDA; WESTERN BARENTS SEA; CUMBERLAND SOUND; H-PRINT; FATTY-ACIDS; BIOMARKER; IDENTIFICATION; PHYTOPLANKTON	Polar bears (Ursus maritimus) rely upon Arctic sea ice as a physical habitat. Consequently, conservation assessments of polar bears identify the ongoing reduction in sea ice to represent a significant threat to their survival. However, the additional role of sea ice as a potential, indirect, source of energy to bears has been overlooked. Here we used the highly branched isoprenoid lipid biomarker-based index (H-Print) approach in combination with quantitative fatty acid signature analysis to show that sympagic (sea ice-associated), rather than pelagic, carbon contributions dominated the marine component of polar bear diet (72-100%; 99% CI, n = 55), irrespective of differences in diet composition. The lowest mean estimates of sympagic carbon were found in Baffin Bay bears, which were also exposed to the most rapidly increasing open water season. Therefore, our data illustrate that for future Arctic ecosystems that are likely to be characterised by reduced sea ice cover, polar bears will not only be impacted by a change in their physical habitat, but also potentially in the supply of energy to the ecosystems upon which they depend. This data represents the first quantifiable baseline that is critical for the assessment of likely ongoing changes in energy supply to Arctic predators as we move into an increasingly uncertain future for polar ecosystems.	[Brown, Thomas A.] Scottish Assoc Marine Sci, Marine Ecol & Chem, Oban, Argyll, Scotland; [Brown, Thomas A.; Belt, Simon T.] Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth, Devon, England; [Galicia, Melissa P.] York Univ, Dept Biol, Toronto, ON, Canada; [Thiemann, Gregory W.] York Univ, Fac Environm Studies, Toronto, ON, Canada; [Yurkowski, David J.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Dyck, Markus G.] Govt Nunavut, Dept Environm, Wildlife Res Sect, Igloolik, NU, Canada	UHI Millennium Institute; University of Plymouth; York University - Canada; York University - Canada; University of Manitoba	Brown, TA (corresponding author), Scottish Assoc Marine Sci, Marine Ecol & Chem, Oban, Argyll, Scotland.; Brown, TA (corresponding author), Univ Plymouth, Sch Geog Earth & Environm Sci, Plymouth, Devon, England.	thomas.brown@sams.ac.uk	Thiemann, Gregory/J-9517-2013; Galicia, Melissa/AAO-1888-2020	Galicia, Melissa/0000-0002-3505-2762; Yurkowski, David/0000-0003-2264-167X; Thiemann, Gregory/0000-0002-1888-900X; Brown, Thomas/0000-0003-0322-474X	Nunavut General Monitoring Plan; W. Garfield Weston Foundation; Environment and Climate Change Canada; Kenneth M. Molson Foundation; Natural Sciences and Engineering Research Council (NSERC) Canada; Leverhulme Trust [RPG-2014-021]	Nunavut General Monitoring Plan; W. Garfield Weston Foundation; Environment and Climate Change Canada; Kenneth M. Molson Foundation; Natural Sciences and Engineering Research Council (NSERC) Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Leverhulme Trust(Leverhulme Trust)	H-Print work was funded by the award of a Research Project Grant (RPG-2014-021) from the Leverhulme Trust to STB. QFASA work was funded by the Natural Sciences and Engineering Research Council (NSERC) Canada to GWT, Environment and Climate Change Canada, Kenneth M. Molson Foundation and Nunavut General Monitoring Plan with analysis performed at the Canadian Institute of Fisheries Technology, Dalhousie University. DJY was supported by The W. Garfield Weston Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstrup S, 2015, IUCN RED LIST THREAT; [Anonymous], 2021, LANG ENV STAT COMP; Belt ST, 2007, ORG GEOCHEM, V38, P16, DOI 10.1016/j.orggeochem.2006.09.013; Belt ST, 2017, ORG GEOCHEM, V110, P65, DOI 10.1016/j.orggeochem.2017.05.007; Belt ST, 2013, ORG GEOCHEM, V62, P33, DOI 10.1016/j.orggeochem.2013.07.002; Belt ST, 2000, CHEM COMMUN, P501, DOI 10.1039/a909670a; Belt ST, 2000, GEOCHIM COSMOCHIM AC, V64, P3839, DOI 10.1016/S0016-7037(00)00464-6; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Bromaghin JF, 2015, ECOL EVOL, V5, P1249, DOI 10.1002/ece3.1429; Brown TA, 2017, LIMNOL OCEANOGR, V62, P1606, DOI 10.1002/lno.10520; Brown TA, 2016, MAR ECOL PROG SER, V546, P17, DOI 10.3354/meps11668; Brown TA, 2014, LIMNOL OCEANOGR, V59, P1581, DOI 10.4319/lo.2014.59.5.1581; Brown TA, 2014, ENVIRON CHEM LETT, V12, P455, DOI 10.1007/s10311-014-0472-4; Brown TA, 2015, POLAR BIOL, V38, P37, DOI 10.1007/s00300-013-1352-2; Brown TA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5197; Brown TA, 2017, J PLANKTON RES, V39, P664, DOI 10.1093/plankt/fbx030; Brown TA, 2017, J EXP MAR BIOL ECOL, V488, P32, DOI 10.1016/j.jembe.2016.12.007; Brown TA, 2012, J PLANKTON RES, V34, P647, DOI 10.1093/plankt/fbs045; Brown TA, 2012, POLAR BIOL, V35, P131, DOI 10.1007/s00300-011-1045-7; Brown TA, 2011, POLAR BIOL, V34, P1857, DOI 10.1007/s00300-010-0942-5; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Campbell LM, 2005, SCI TOTAL ENVIRON, V351, P247, DOI 10.1016/j.scitotenv.2005.02.043; Carroll ML, 2012, POLAR BIOL, V35, P1259, DOI 10.1007/s00300-012-1171-x; Cherry SG, 2016, ECOL EVOL, V6, P5032, DOI 10.1002/ece3.2233; Fernandez-Mendez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107452; Fischbach AS, 2007, POLAR BIOL, V30, P1395, DOI 10.1007/s00300-007-0300-4; Forest A, 2011, J PLANKTON RES, V33, P161, DOI 10.1093/plankt/fbq103; Galicia MP, 2016, ECOL EVOL, V6, P6005, DOI 10.1002/ece3.2173; Galicia MP, 2015, POLAR BIOL, V38, P1983, DOI 10.1007/s00300-015-1757-1; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Grossi V, 2004, PHYTOCHEMISTRY, V65, P3049, DOI 10.1016/j.phytochem.2004.09.002; Hannah CG, 2009, ARCTIC, V62, P83; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Juul-Pedersen T, 2008, MAR ECOL PROG SER, V353, P13, DOI 10.3354/meps07165; Kohlbach D, 2017, PROG OCEANOGR, V152, P62, DOI 10.1016/j.pocean.2017.02.003; Kohlbach D, 2016, LIMNOL OCEANOGR, V61, P2027, DOI 10.1002/lno.10351; Kortsch S, 2012, P NATL ACAD SCI USA, V109, P14052, DOI 10.1073/pnas.1207509109; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; LEGENDRE L, 1992, POLAR BIOL, V12, P429; Marcoux M, 2012, MAR ECOL PROG SER, V471, P283, DOI 10.3354/meps10029; Matley JK, 2013, MAR BIOL, V160, P2993, DOI 10.1007/s00227-013-2289-2; McKinney MA, 2012, ENVIRON SCI TECHNOL, V46, P9914, DOI 10.1021/es302761p; McMahon KW, 2006, MAR ECOL PROG SER, V310, P1, DOI 10.3354/meps310001; Meier WN, 2017, SEA ICE, P664; Morata N, 2008, DEEP-SEA RES PT II, V55, P2381, DOI 10.1016/j.dsr2.2008.05.004; MUIR DCG, 1988, ENVIRON SCI TECHNOL, V22, P1071, DOI 10.1021/es00174a012; Obbard ME, 2016, ARCT SCI, V2, P15, DOI 10.1139/as-2015-0027; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0556; Renaud PE, 2008, DEEP-SEA RES PT II, V55, P2372, DOI 10.1016/j.dsr2.2008.05.017; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; SARGENT JR, 1981, MAR BIOL, V62, P131, DOI 10.1007/BF00388175; Sciullo L, 2016, J ZOOL, V300, P45, DOI 10.1111/jzo.12354; Soreide JE, 2006, PROG OCEANOGR, V71, P59, DOI 10.1016/j.pocean.2006.06.001; Stern HL, 2016, CRYOSPHERE, V10, P2027, DOI 10.5194/tc-10-2027-2016; Stewart D. B., 2007, Canadian Manuscript Report of Fisheries and Aquatic Sciences, V2796, P1; STIRLING I, 1993, ARCTIC, V46, P240; Sun MY, 2007, J MAR RES, V65, P561, DOI 10.1357/002224007782689094; SWG [Scientific Working Group to the Canada-Greenland Joint Commission on Polar Bear], 2016, 2016 REASS BAFF BAY; Tamelander T, 2009, POLAR BIOL, V32, P1261, DOI 10.1007/s00300-009-0622-5; Tremblay JE, 2006, PROG OCEANOGR, V71, P402, DOI 10.1016/j.pocean.2006.10.006; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; VOLKMAN JK, 1994, ORG GEOCHEM, V21, P407, DOI 10.1016/0146-6380(94)90202-X; Werner I, 1997, MAR ECOL PROG SER, V160, P93, DOI 10.3354/meps160093; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Yurkowski DJ, 2016, OECOLOGIA, V180, P631, DOI 10.1007/s00442-015-3384-5	69	32	32	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191631	10.1371/journal.pone.0191631	http://dx.doi.org/10.1371/journal.pone.0191631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360849	Green Published, gold			2022-12-27	WOS:000423161800044
J	Kim, SY; Kim, MS; Park, B; Kim, JH; Choi, HG				Kim, So Young; Kim, Min-Su; Park, Bumjung; Kim, Jin-Hwan; Choi, Hyo Geun			Lack of sleep is associated with internet use for leisure	PLOS ONE			English	Article							ADOLESCENT SLEEP; MEDIA USE; EMERGING ADULTS; DEPRIVATION; SYMPTOMS; BEHAVIORS; PATTERNS; EXPOSURE; QUALITY	Objective & para;& para;Previous studies have suggested that excessive internet use may cause lack of sleep. However, recent studies have hypothesized that lack of sleep may instigate internet use for leisure. To elucidate the potential effects of sleep time on internet use, we explored the different associations between sleep time and internet use according to its purpose.& para;& para;Methods & para;& para;The population-based, cross-sectional study group from the Korea Youth Risk Behavior Web-based Survey (KYRBWS) collected data from 57,425 middle school students in 2014 and 2015. Sleep time over the past 7 days was classified into the following groups: <7 h (6 h); >= 7 h, <8 h (7 h); >= 8 h, <9 h (8 h); and >= 9 h (9+ h). Internet use time per day was separately surveyed for leisure and for study and categorized as follows: 0 h; > 0 h, <= 1 h (1 h); > 1 h, <= 2 h (2 h); and >2 h (2+ h) per day. Information on age, sex, region of residence, body mass index (BMI), economic level, parental education level, stress level, school performance level, and sleep satisfaction were retrieved. The relationships between sleep time and internet use time for leisure/study were analyzed using multinomial logistic regression with complex sampling. In the subgroup analysis according to sleep satisfaction (good, normal, and poor), the associations of sleep time with internet use for leisure were analyzed using the same methods.& para;& para;Results & para;& para;Compared to 9+ h of sleep, less sleep was related to a long internet use time (2+ h) for leisure (adjusted odds ratio, AOR [95% confidence interval, Cl] of sleep: 8 h = 1.23 [1.14-1.32]; 7 h = 1.42 [1.31-1.54]; and 6 h = 1.56 [1.44-1.70]; P < 0.001). Conversely, a relationship between less sleep and a long internet use time (2+ h) for study was evident only for 6 h of sleep (AOR of sleep: 8 h = 0.84 [0.84-1.04]; 7 h = 1.05 [0.94-1.17]; and 6 h = 1.32 [1.271.59]; P < 0.001). In the subgroup analysis according to sleep satisfaction, less sleep was associated with a long internet use time for leisure in all sleep satisfaction groups, although the relationship was more significant in the lower sleep satisfaction group.& para;& para;Conclusion & para;& para;Less sleep was significantly related to long-term use of the internet for leisure, whereas this association was not definite for internet use for study. Furthermore, poor sleep quality potentiated the relationship between less sleep time and internet use for leisure.	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Kim, Min-Su] Korea Univ, Ansan Hosp, Dept Otorhinolaryngol Head & Neck Surg, Ansan, South Korea; [Park, Bumjung; Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Kim, Jin-Hwan] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Pochon Cha University; Korea University; Korea University Medicine (KU Medicine); Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860, 2017R1C1B1007696]; Hallym University Sacred Heart Hospital [HURF-2016-38]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860 and 2017R1C1B1007696) from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SK, 2013, HEALTH SERV INSIGHTS, V6, P99, DOI 10.4137/HSI.S11083; An J, 2014, J ADDICT MED, V8, P282, DOI 10.1097/ADM.0000000000000026; [Anonymous], 2009, RELIABILITY VALIDITY; Arora T, 2014, SLEEP MED, V15, P240, DOI 10.1016/j.sleep.2013.08.799; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Barnes JC, 2015, J YOUTH ADOLESCENCE, V44, P489, DOI 10.1007/s10964-014-0137-4; Bartel K, 2016, SLEEP MED, V26, P97, DOI 10.1016/j.sleep.2016.07.007; Bickham DS, 2015, INT J PUBLIC HEALTH, V60, P147, DOI 10.1007/s00038-014-0647-6; Blau Gary, 2006, J Allied Health, V35, P9; Bonnaire C, 2017, PSYCHIAT RES, V255, P104, DOI 10.1016/j.psychres.2017.05.030; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Centers for Disease Control and Prevention, BMI CHILDR TEENS; Chen YL, 2016, J SLEEP RES, V25, P458, DOI 10.1111/jsr.12388; de Bruin EJ, 2017, SLEEP MED REV, V32, P45, DOI 10.1016/j.smrv.2016.02.006; Gamble AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111700; Howland RH, 2011, J PSYCHOSOC NURS MEN, V49, P17, DOI 10.3928/02793695-20101208-01; Hysing M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006748; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174878; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135753; Kong IG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001965; Lam LT, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0444-1; Lemola S, 2015, J YOUTH ADOLESCENCE, V44, P405, DOI 10.1007/s10964-014-0176-x; Li W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117372; Matos MG, 2016, INT J PSYCHOL, V51, P323, DOI 10.1002/ijop.12167; Meldrum RC, 2015, J YOUTH ADOLESCENCE, V44, P465, DOI 10.1007/s10964-013-0024-4; Paiva T, 2016, SLEEP SCI, V9, P7, DOI 10.1016/j.slsci.2016.02.176; Paiva T, 2015, SLEEP MED, V16, P521, DOI 10.1016/j.sleep.2014.10.010; Park S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1143; Peach HD, 2013, J ADOLESCENT HEALTH, V53, P293, DOI 10.1016/j.jadohealth.2013.03.012; Rikkers W, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3058-1; Schneider LA, 2017, J BEHAV ADDICT, V6, P321, DOI 10.1556/2006.6.2017.035; Shochat T, 2010, ACTA PAEDIATR, V99, P1396, DOI 10.1111/j.1651-2227.2010.01821.x; Short MA, 2015, SLEEP MED, V16, P987, DOI 10.1016/j.sleep.2015.03.007; Tavernier R, 2014, J SLEEP RES, V23, P389, DOI 10.1111/jsr.12132; Van den Bulck Jan, 2010, Adolesc Med State Art Rev, V21, P418; Wagner DT, 2012, J APPL PSYCHOL, V97, P1068, DOI 10.1037/a0027557; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G; Yen CF, 2010, INT J EAT DISORDER, V43, P565, DOI 10.1002/eat.20683; Zhang HY, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01482	40	20	21	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191713	10.1371/journal.pone.0191713	http://dx.doi.org/10.1371/journal.pone.0191713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360882	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800054
J	Shen, XY; Zhu, XM; Wu, YN; Zhou, YQ; Yang, L; Wang, YN; Zheng, QL; Liu, YH; Cong, S; Xiao, NN; Zhao, QL				Shen, Xiaoying; Zhu, Xuemei; Wu, Yanni; Zhou, Yuqiu; Yang, Li; Wang, Yini; Zheng, Qiulan; Liu, Yinghui; Cong, Shen; Xiao, Ningning; Zhao, Qiuli			Effects of a psychological intervention programme on mental stress, coping style and immune function in percutaneous coronary intervention patients	PLOS ONE			English	Article							BREAST-CANCER; HEART-DISEASE; ANXIETY; DEPRESSION; TRIAL; MANAGEMENT; MUSIC; ANGER; RISK	Purpose This study aimed to assess the effects of a psychological intervention programme on the mental stress, coping style and cortisol and IL-2 levels of patients undergoing percutaneous coronary intervention (PCI). Methods A total of sixty cardiovascular patients scheduled for PCI with clear anxiety and depression screened by the Hospital Anxiety and Depression Scale were randomly divided into an experimental (n = 30) and control (n = 30) group. The participants in the experimental group received cognitive therapy, relaxation therapy and emotional support. Self-reported questionnaires, including the Self-Report Symptom Checklist (SCL-90) and the Medical Coping Mode Questionnaire (MCMQ), and levels of IL-2 and cortisol were collected at baseline and the day before discharge. Results Compared with the controls, patients in the intervention group had a better mental state and coping style (confrontation), higher levels of IL-2 and lower levels of cortisol (all P< 0.05). Conclusions The psychological intervention programme effectively improved mental state, reduced negative coping styles, increased levels of IL-2, and decreased cortisol levels in patients undergoing PCI. This programme may be an effective preoperative nursing intervention for PCI patients.	[Shen, Xiaoying; Zhu, Xuemei; Yang, Li; Wang, Yini; Zheng, Qiulan; Xiao, Ningning; Zhao, Qiuli] Harbin Med Univ, Coll Nursing, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Wu, Yanni; Liu, Yinghui; Cong, Shen] Harbin Med Univ, Nursing Dept, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Zhou, Yuqiu] Harbin Med Univ, Coll Nursing, Daqing Campus, Daqing, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Wu, YN (corresponding author), Harbin Med Univ, Nursing Dept, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China.	yanny0315@126.com			Project of Education Department of Heilongjiang province, China [11541192]; Foundation for the Heilongjiang Department of the Health; Second Affiliated Hospital of Harbin Medical University	Project of Education Department of Heilongjiang province, China; Foundation for the Heilongjiang Department of the Health; Second Affiliated Hospital of Harbin Medical University	This work was supported by Grant 11541192 from Project of Education Department of Heilongjiang province, China. The programme was financed by the Foundation for the Heilongjiang Department of the Health. The project has been completed with the support of the Second Affiliated Hospital of Harbin Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grant 11541192 from Project of Education Department of Heilongjiang province, China. The programme was financed by the Foundation for the Heilongjiang Department of the Health. The project has been completed with the support of the Second Affiliated Hospital of Harbin Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The registry: Chinese Clinical Trial Registry, registration number: ChiCTR-IOR-16007864. The authors confirm that all ongoing and related trials for this drug/intervention are registered.	Andersen BL, 2004, J CLIN ONCOL, V22, P3570, DOI 10.1200/JCO.2004.06.030; Astin F, 2005, HEART LUNG, V34, P393, DOI 10.1016/j.hrtlng.2005.05.002; Carrico AW, 2006, ANN BEHAV MED, V31, P155, DOI 10.1207/s15324796abm3102_7; Chan MF, 2007, HEART LUNG, V36, P431, DOI 10.1016/j.hrtlng.2007.05.003; [陈树林 Chen Shulin], 2003, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V29, P323; Cho MY, 2013, EVID-BASED COMPL ALT, V2013, P221; Cohen S, 2003, BRAIN BEHAV IMMUN, V17, P407, DOI 10.1016/S0889-1591(03)00110-7; Cruess DG, 2000, PSYCHOSOM MED, V62, P304, DOI 10.1097/00006842-200005000-00002; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; FEIFEL H, 1987, PSYCHOSOM MED, V49, P616, DOI 10.1097/00006842-198711000-00007; Fobair P, 2002, PSYCHO-ONCOLOGY, V11, P427, DOI 10.1002/pon.624; Gallagher R, 2010, EUR J CARDIOVASC NUR, V9, P38, DOI 10.1016/j.ejcnurse.2009.09.001; Hinrichsen Hendrik, 2003, Eat Behav, V4, P117, DOI 10.1016/S1471-0153(03)00016-3; Hojskov IE, 2015, EUROPEAN J CARDIOVAS, V15; Hua L, 2012, J ZHENGZHOU U; Hughes G, 2006, J EPIDEMIOLOGY COMMU; Ishihara S, 2003, HEART VESSELS, V18, P85, DOI 10.1007/s10380-002-0687-4; Jacobs AK, 2008, CATHETERIZATION CARD, V71, pE1; Kang JG, 2008, J CLIN ANESTH, V20, P12, DOI 10.1016/j.jclinane.2007.06.005; Lachenbruch P.A., 1988, STAT POWER ANAL BEHA; Lenzen M. J., 2002, EUR J CARDIOVASC NUR, V1, P195; Lerman R, 2012, ANN SURG ONCOL, V19, P373, DOI 10.1245/s10434-011-2051-2; Liu G, 2002, CHINESE MENTAL HLTH; Lunden Maud H, 2006, Clin Nurs Res, V15, P274; Maeda T, 2008, CANCER NURS, V31, pE27, DOI 10.1097/01.NCC.0000305746.49205.f8; Martinac M, 2014, ACTA CLIN CROAT, V53, P55; Prapavessis H, 2003, PSYCHOL SPORT EXERC, V4, P357, DOI 10.1016/S1469-0292(02)00020-1; Revisao AD, 2005, FACTORES PSICOSSOCIA; Serebruany VL, 2003, CIRCULATION, V108, P939, DOI 10.1161/01.CIR.0000085163.21752.0A; shen X, 2009, CHINESE BEHAV MED SC, V9, P18; Spindler H, 2007, J AFFECT DISORDERS, V99, P173, DOI 10.1016/j.jad.2006.09.009; Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260; Thorgaard Bitten, 2004, Eur J Cardiovasc Nurs, V3, P21; van Gestel YRBM, 2007, J AFFECT DISORDERS, V103, P197, DOI 10.1016/j.jad.2007.01.030; Wang Z., 1984, SYMPTOM CHECKLIST SC, V2, P68, DOI DOI 10.32388/SG7B5L]; Watkins LL, 2006, PSYCHOSOM MED, V68, P651, DOI 10.1097/01.psy.0000228342.53606.b3; Wu JL, 2005, CHINESE J CLIN REHAB; Ye WF., 1993, CHIN J BEHAV MED SCI, V2, P17, DOI [10.1097/NCC.0000000000000220, DOI 10.1097/NCC.0000000000000220]; Zhang X, 2009, EFFECT PSYCHOL BEHAV	39	12	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0187745	10.1371/journal.pone.0187745	http://dx.doi.org/10.1371/journal.pone.0187745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1TP	29357358	Green Published, Green Submitted, gold			2022-12-27	WOS:000422919500001
J	Carlsson, J; Svennerstam, H; Moritz, T; Egertsdotter, U; Ganeteg, U				Carlsson, Johanna; Svennerstam, Henrik; Moritz, Thomas; Egertsdotter, Ulrika; Ganeteg, Ulrika			Nitrogen uptake and assimilation in proliferating embryogenic cultures of Norway spruce-Investigating the specific role of glutamine (vol 12, e0181785, 2017)	PLOS ONE			English	Correction																		Carlsson J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181785	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191208	10.1371/journal.pone.0191208	http://dx.doi.org/10.1371/journal.pone.0191208			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351347	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300058
J	Contreras, C; Villasana, M; Hendzel, MJ; Carrero, G				Contreras, Carlos; Villasana, Minaya; Hendzel, Michael J.; Carrero, Gustavo			Using a model comparison approach to describe the assembly pathway for histone H1	PLOS ONE			English	Article							LINKER HISTONE; FLUORESCENCE RECOVERY; CHROMATIN-STRUCTURE; NUCLEAR PROTEINS; IN-VIVO; BINDING; HETEROCHROMATIN; NUCLEOSOME; EXCHANGE; MOBILITY	Histones H1 or linker histones are highly dynamic proteins that diffuse throughout the cell nucleus and associate with chromatin (DNA and associated proteins). This binding interaction of histone H1 with the chromatin is thought to regulate chromatin organization and DNA accessibility to transcription factors and has been proven to involve a kinetic process characterized by a population that associates weakly with chromatin and rapidly dissociates and another population that resides at a binding site for up to several minutes before dissociating. When considering differences between these two classes of interactions in a mathematical model for the purpose of describing and quantifying the dynamics of histone H1, it becomes apparent that there could be several assembly pathways that explain the kinetic data obtained in living cells. In this work, we model these different pathways using systems of reaction-diffusion equations and carry out a model comparison analysis using FRAP (fluorescence recovery after photobleaching) experimental data from different histone H1 variants to determine the most feasible mechanism to explain histone H1 binding to chromatin. The analysis favors four different chromatin assembly pathways for histone H1 which share common features and provide meaningful biological information on histone H1 dynamics. We show, using perturbation analysis, that the explicit consideration of high- and low-affinity associations of histone H1 with chromatin in the favored assembly pathways improves the interpretation of histone H1 experimental FRAP data. To illustrate the results, we use one of the favored models to assess the kinetic changes of histone H1 after core histone hyperacetylation, and conclude that this post-transcriptional modification does not affect significantly the transition of histone H1 from a weakly bound state to a tightly bound state.	[Contreras, Carlos] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada; [Villasana, Minaya] Univ Simon Bolivar, Dept Comp Cient & Estadist, Caracas, Miranda, Venezuela; [Hendzel, Michael J.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Carrero, Gustavo] Athabasca Univ, Fac Sci & Technol, Ctr Sci, Edmonton, AB, Canada	University of Alberta; Simon Bolivar University; University of Alberta; Athabasca University	Carrero, G (corresponding author), Athabasca Univ, Fac Sci & Technol, Ctr Sci, Edmonton, AB, Canada.	gustavoc@athabascau.ca	Hendzel, Michael/C-3391-2009	Hendzel, Michael/0000-0002-9603-7945; Villasana, Minaya/0000-0002-3909-8549	Athabasca University; Academic Research Fund [21233, 21717]; Canadian Cancer Society Research Institute	Athabasca University; Academic Research Fund(Ministry of Education, Singapore); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by Athabasca University, Academic Research Fund, grant numbers: 21233 and 21717 (url: http//research.athabascau.ca/internal/arf.php) (GC) and Canadian Cancer Society Research Institute (url:http://www. cancer.ca/research/) (MJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Beaudouin JL, 2006, BIOPHYS J, V90, P1878, DOI 10.1529/biophysj.105.071241; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Burnham K. P., 2002, MODEL SELECTION AND; Campbell RE., 2008, SCHOLARPEDIA, V3, P5410, DOI [10.4249/scholarpedia.5410, DOI 10.4249/SCHOLARPEDIA.5410]; Carrero G, 2004, B MATH BIOL, V66, P1515, DOI 10.1016/j.bulm.2004.02.005; Carrero G, 2004, METHOD ENZYMOL, V375, P415; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; Carrero G, 2009, AIP CONF PROC, V1168, P1306, DOI 10.1063/1.3241319; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Dou YL, 2002, J CELL BIOL, V158, P1161, DOI 10.1083/jcb.200202131; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Gonzalez-Perez V, 2011, INTEGR BIOL-UK, V3, P197, DOI 10.1039/c0ib00098a; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hashimoto H, 2010, NUCLEIC ACIDS RES, V38, P3533, DOI 10.1093/nar/gkq076; KOPPEL DE, 1979, BIOPHYS J, V28, P281, DOI 10.1016/S0006-3495(79)85176-0; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; PERRY CA, 1989, NUCLEIC ACIDS RES, V17, P4275, DOI 10.1093/nar/17.11.4275; Popova EY, 2013, J BIOL CHEM, V288, P17895, DOI 10.1074/jbc.M113.452144; Raghuram N, 2010, BIOCHEMISTRY-US, V49, P4420, DOI 10.1021/bi100296z; Raghuram N, 2009, BIOCHEM CELL BIOL, V87, P189, DOI 10.1139/O08-127; Rao J, 2007, BIOCHEM BIOPH RES CO, V363, P263, DOI 10.1016/j.bbrc.2007.08.120; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stasevich TJ, 2010, EMBO J, V29, P1225, DOI 10.1038/emboj.2010.24; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; Tsibidis GD, 2008, J THEOR BIOL, V253, P755, DOI 10.1016/j.jtbi.2008.04.010; Yokoe E, 1996, NAT BIOTECHNOL, V14, P1252, DOI 10.1038/nbt1096-1252	31	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191562	10.1371/journal.pone.0191562	http://dx.doi.org/10.1371/journal.pone.0191562			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352283	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300114
J	Cowling, BJ; Chui, CSL; Lim, WW; Wu, P; Hui, CKM; Peiris, JSM; Chan, EW				Cowling, Benjamin J.; Chui, Celine S. L.; Lim, Wey Wen; Wu, Peng; Hui, Christopher K. M.; Peiris, J. S. Malik; Chan, Esther W.			Use of influenza antivirals in patients hospitalized in Hong Kong, 2000-2015	PLOS ONE			English	Article							VIRUS-INFECTION; OSELTAMIVIR; RESISTANCE; MORTALITY; OUTCOMES; ADULTS; SEASON; RISK	Objectives We aimed to describe patterns in the usage of antivirals to treat influenza virus infection in hospitals in Hong Kong from 2000 through 2015. Methods We analyzed centralized electronic health records that included dispensation information and diagnosis codes. Information collected on admissions included patient age, sex, admission year and month, and medications dispensed, and were matched with the first 15 discharge diagnosis codes. We divided monthly admission episodes by relevant population denominators to obtain admission rates, and stratified analyses by drug type, age group, and diagnosis codes. Results Amantadine was used for influenza treatment in the early 2000s but changed with recommendations to avoid its use in 2006, and is now mainly used to treat Parkinson's disease. Oseltamivir usage increased substantially in 2009 and is now commonly used, with almost 40,000 hospitalizations treated with oseltamivir in the years 2012 through 2015, 66% of which was in persons >= 65 years of age. During the entire study period, of the 98,253 admission episodes in which oseltamivir was dispensed, 40,698 (41%) included a diagnosis code for influenza, and 80,283 (82%) included any diagnosis code for respiratory illness. Conclusions The amount of oseltamivir used from 2012 +/- 15 was comparable to a separate ecological estimate of around 13,000 influenza-associated hospitalizations per year on average. We did not have access to individual patient laboratory testing data.	[Cowling, Benjamin J.; Chui, Celine S. L.; Lim, Wey Wen; Wu, Peng; Peiris, J. S. Malik] Univ Hong Kong, WHO, Collaborating Ctr Infect Dis Epidemiol & Control, Sch Publ Hlth,Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Hui, Christopher K. M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Peiris, J. S. Malik] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Influenza Res, Hong Kong, Hong Kong, Peoples R China; [Chan, Esther W.] Univ Hong Kong, Ctr Safe Medicat Practice & Res, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; World Health Organization; University of Hong Kong; University of Hong Kong; University of Hong Kong	Cowling, BJ (corresponding author), Univ Hong Kong, WHO, Collaborating Ctr Infect Dis Epidemiol & Control, Sch Publ Hlth,Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	bcowling@hku.hk	Lim, Wey Wen/T-8379-2019; Chui, Celine SL/A-2046-2014; Chan, Esther Wai Yin/B-3522-2012; Peiris, Joseph Sriyal Malik/C-4380-2009; Cowling, Benjamin/C-4263-2009	Lim, Wey Wen/0000-0001-8514-2048; Chan, Esther Wai Yin/0000-0002-7602-9470; Chui, Sze Ling Celine/0000-0003-1513-8726; Wu, Peng/0000-0003-1157-9401; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Cowling, Benjamin/0000-0002-6297-7154	Health and Medical Research Fund [HKS-16-E10]; National Institute of General Medical Sciences [U54 GM088558]; Hong Kong Research Grants Council [T11-705/14 N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Health and Medical Research Fund; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Hong Kong Research Grants Council(Hong Kong Research Grants Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by a commissioned grant from the Health and Medical Research Fund (grant no. HKS-16-E10), and by grants from the National Institute of General Medical Sciences (grant no. U54 GM088558) and the Hong Kong Research Grants Council (project no. T11-705/14 N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Census and Statistics Department, 58 CENS STAT DEP; Chiu SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092914; Cowling BJ, 2017, CLIN INFECT DIS, V65, P300, DOI 10.1093/cid/cix312; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Greene SK, 2012, INFLUENZA OTHER RESP, V6, pe143, DOI 10.1111/j.1750-2659.2012.00390.x; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; Ison MG, 2017, CLIN CHEST MED, V38, P139, DOI 10.1016/j.ccm.2016.11.008; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Lau WCY, 2017, JAMA-J AM MED ASSOC, V317, P1151, DOI 10.1001/jama.2017.1363; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Takashita E, 2015, ANTIMICROB AGENTS CH, V59, P2607, DOI 10.1128/AAC.04836-14; Tam YH, 2017, CLIN INFECT DIS; Tsang Kenneth, 2004, Curr Opin Investig Drugs, V5, P179; Wong AYS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6926; Wong JY, 2013, AM J EPIDEMIOL, V177, P834, DOI 10.1093/aje/kws314; Wu P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01021-x; Yang L, 2015, VACCINE, V33, P6525, DOI 10.1016/j.vaccine.2015.10.012	20	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190306	10.1371/journal.pone.0190306	http://dx.doi.org/10.1371/journal.pone.0190306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351330	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300017
J	Han, SS; Park, GH; Lim, W; Kim, MS; Na, JI; Park, I; Chang, SE				Han, Seung Seog; Park, Gyeong Hun; Lim, Woohyung; Kim, Myoung Shin; Na, Jung Im; Park, Ilwoo; Chang, Sung Eun			Deep neural networks show an equivalent and often superior performance to dermatologists in onychomycosis diagnosis: Automatic construction of onychomycosis datasets by region-based convolutional deep neural network	PLOS ONE			English	Article							CULTURE	Although there have been reports of the successful diagnosis of skin disorders using deep learning, unrealistically large clinical image datasets are required for artificial intelligence (AI) training. We created datasets of standardized nail images using a region-based convolutional neural network (R-CNN) trained to distinguish the nail from the background. We used R-CNN to generate training datasets of 49,567 images, which we then used to fine-tune the ResNet-152 and VGG-19 models. The validation datasets comprised 100 and 194 images from Inje University (B1 and B2 datasets, respectively), 125 images from Hallym University (C dataset), and 939 images from Seoul National University (D dataset). The AI (ensemble model; ResNet-152 + VGG-19 + feedforward neural networks) results showed test sensitivity/ specificity/ area under the curve values of (96.0 / 94.7 / 0.98), (82.7 / 96.7 / 0.95), (92.3 / 79.3 / 0.93), (87.7 / 69.3 / 0.82) for the B1, B2, C, and D datasets. With a combination of the B1 and C datasets, the AI Youden index was significantly (p = 0.01) higher than that of 42 dermatologists doing the same assessment manually. For B1+C and B2+D dataset combinations, almost none of the dermatologists performed as well as the AI. By training with a dataset comprising 49,567 images, we achieved a diagnostic accuracy for onychomycosis using deep learning that was superior to that of most of the dermatologists who participated in this study.	[Park, Gyeong Hun] Hallym Univ, Dept Dermatol, Dongtan Sacred Heart Hosp, Coll Med, Dongtan, South Korea; [Lim, Woohyung] SK Telecom, HMI Tech Lab, Seoul, South Korea; [Kim, Myoung Shin] Inje Univ, Coll Med, Dept Dermatol, Sanggye Paik Hosp, Seoul, South Korea; [Na, Jung Im] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Park, Ilwoo] Chonnam Natl Univ, Med Sch & Hosp, Dept Radiol, Gwangju, South Korea; [Chang, Sung Eun] Univ Ulsan, Coll Med, Dept Dermatol, Asan Med Ctr, Seoul, South Korea	Hallym University; SK Group; SK Telecom; Inje University; Seoul National University (SNU); Chonnam National University; University of Ulsan	Chang, SE (corresponding author), Univ Ulsan, Coll Med, Dept Dermatol, Asan Med Ctr, Seoul, South Korea.	csesnumd@gmail.com	Han, Seung Seog/AAC-4185-2019; chang, sungeun/AAH-1247-2020		SK Telecom	SK Telecom	The authors received no specific funding for this work. SK Telecom provided support in the form of salaries for author WL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; BINDER M, 1994, BRIT J DERMATOL, V130, P460, DOI 10.1111/j.1365-2133.1994.tb03378.x; Borkowski P, 2001, J AM PODIAT MED ASSN, V91, P351, DOI 10.7547/87507315-91-7-351; Canziani A., 2016, ANAL DEEP NEURAL NET, DOI DOI 10.48550/ARXIV.1605.07678; Codella NCF, 2017, IBM J RES DEV, V61, DOI 10.1147/JRD.2017.2708299; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Girshick R., 2014, CVPR; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Jeelani S, 2015, MYCOSES, V58, P27, DOI 10.1111/myc.12251; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Karimzadegan-Nia M, 2007, AUSTRALAS J DERMATOL, V48, P18, DOI 10.1111/j.1440-0960.2007.00320.x; Lawry MA, 2000, ARCH DERMATOL, V136, P1112, DOI 10.1001/archderm.136.9.1112; Liao H., 2016, DEEP LEARNING APPROA; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Velasquez-Agudelo V, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2258-3; Zanardi D, 2008, AN BRAS DERMATOL, V83, P119, DOI 10.1590/S0365-05962008000200003	19	102	109	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191493	10.1371/journal.pone.0191493	http://dx.doi.org/10.1371/journal.pone.0191493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352285	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300098
J	Karthaus, M; Wascher, E; Getzmann, S				Karthaus, Melanie; Wascher, Edmund; Getzmann, Stephan			Proactive vs. reactive car driving: EEG evidence for different driving strategies of older drivers	PLOS ONE			English	Article							FRONTAL THETA; PERFORMANCE; AGE; FATIGUE; ATTENTION; RESPONSES; DEFICITS; ERRORS; ADULTS; SLEEP	Aging is associated with a large heterogeneity in the extent of age-related changes in sensory, motor, and cognitive functions. All these functions can influence the performance in complex tasks like car driving. The present study aims to identify potential differences in underlying cognitive processes that may explain inter-individual variability in driving performance. Younger and older participants performed a one-hour monotonous driving task in a driving simulator under varying crosswind conditions, while behavioral and electrophysiological data were recorded. Overall, younger and older drivers showed comparable driving performance ( lane keeping). However, there was a large difference in driving lane variability within the older group. Dividing the older group in two subgroups with low vs. high driving lane variability revealed differences between the two groups in electrophysiological correlates of mental workload, consumption of mental resources, and activation and sustaining of attention: Older drivers with high driving lane variability showed higher frontal Alpha and Theta activity than older drivers with low driving lane variability and-with increasing crosswind-a more pronounced decrease in Beta activity. These results suggest differences in driving strategies of older and younger drivers, with the older drivers using either a rather proactive and alert driving strategy (indicated by low driving lane variability and lower Alpha and Beta activity), or a rather reactive strategy (indicated by high driving lane variability and higher Alpha activity).	[Karthaus, Melanie; Wascher, Edmund; Getzmann, Stephan] TU Dortmund, Dept Ergon, IfADo Leibniz Res Ctr Working Environm & Human Fa, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Karthaus, M (corresponding author), TU Dortmund, Dept Ergon, IfADo Leibniz Res Ctr Working Environm & Human Fa, Dortmund, Germany.	karthaus@ifado.de	Wascher, Edmund/B-8457-2019; Wascher, Edmund/N-6848-2019	Wascher, Edmund/0000-0003-3616-9767; Getzmann, Stephan/0000-0002-6382-0183	German Research Foundation (DFG) [KA 412072-1]; Open Access Fund of the Leibniz Association; Open Access Fund of the Technical University of Dortmund	German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Fund of the Leibniz Association; Open Access Fund of the Technical University of Dortmund	This work was supported by a grant awarded to MK by the German Research Foundation (DFG http/www.dfg.de/, KA 412072-1). The publication of this article was supported by the Open Access Fund of the Leibniz Association and by the Open Access Fund of the Technical University of Dortmund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding for this study.	Anstey KJ, 2012, ACCIDENT ANAL PREV, V45, P766, DOI 10.1016/j.aap.2011.10.006; Anstey KJ, 2011, NEUROPSYCHOLOGY, V25, P613, DOI 10.1037/a0023835; Ball K, 2003, J AM GERIATR SOC, V51, P1499, DOI 10.1046/j.1532-5415.2003.51487.x; Belanger A, 2010, ACCIDENT ANAL PREV, V42, P809, DOI 10.1016/j.aap.2009.07.010; Borghini G, 2014, NEUROSCI BIOBEHAV R, V44, P58, DOI 10.1016/j.neubiorev.2012.10.003; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Centofanti SA, 2017, ACCIDENT ANAL PREV, V99, P416, DOI 10.1016/j.aap.2015.11.009; Federal Statistical Office of Germany, 2014, VERK UNF SEN STRASS; Fildes Brian, 2007, Annu Proc Assoc Adv Automot Med, V51, P559; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Garcia JO, 2017, NEUROIMAGE, V150, P239, DOI 10.1016/j.neuroimage.2017.02.057; Gola M, 2013, INT J PSYCHOPHYSIOL, V89, P334, DOI 10.1016/j.ijpsycho.2013.05.007; Goljahani A, 2012, NEUROIMAGE, V60, P774, DOI 10.1016/j.neuroimage.2011.12.001; Grandjean B., 1988, FITTING TASK MAN; Hahn M., 2013, AGE DIFFERENTIATED W, P299, DOI DOI 10.1007/978-3-642-35057-3_13; Hahn M, 2011, BRAIN RES, V1414, P66, DOI 10.1016/j.brainres.2011.07.051; Hanslmayr S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00074; Horberry T, 2006, ACCIDENT ANAL PREV, V38, P185, DOI 10.1016/j.aap.2005.09.007; Horrey WJ, 2006, J EXP PSYCHOL-APPL, V12, P67, DOI 10.1037/1076-898X.12.2.67; Huang YZ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00368; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Kardos Z, 2014, NEUROSCIENCE, V273, P152, DOI 10.1016/j.neuroscience.2014.04.071; Karthaus M, 2015, BERICHTE BUNDESANSTA; KELLY JW, 2006, ACM T APPL PERCEPT, V3, P83, DOI DOI 10.1145/1141897.1141898; Kilavik BE, 2013, EXP NEUROL, V245, P15, DOI 10.1016/j.expneurol.2012.09.014; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lal SKL, 2001, BIOL PSYCHOL, V55, P173, DOI 10.1016/S0301-0511(00)00085-5; Langford J, 2006, ACCIDENT ANAL PREV, V38, P574, DOI 10.1016/j.aap.2005.12.002; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Ott Brian R, 2010, Aging health, V6, P77, DOI 10.2217/ahe.09.83; Owsley C, 2001, ARCH OPHTHALMOL-CHIC, V119, P881; Park HL, 2003, INT J GERIATR PSYCH, V18, P1121, DOI 10.1002/gps.1023; Pattyn N, 2008, PHYSIOL BEHAV, V93, P369, DOI 10.1016/j.physbeh.2007.09.016; Pesonen M, 2006, NEUROSCI LETT, V399, P45, DOI 10.1016/j.neulet.2006.01.053; Picot A, 2008, IEEE ENG MED BIO, P3864, DOI 10.1109/IEMBS.2008.4650053; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Staplin L., 2012, 811468A DOT HS; Verwey WB, 1996, J EXP PSYCHOL-APPL, V2, P270, DOI 10.1037/1076-898X.2.3.270; Wascher E, 2016, ACCIDENT ANAL PREV, V91, P157, DOI 10.1016/j.aap.2016.02.029; Wascher E, 2014, BIOL PSYCHOL, V96, P57, DOI 10.1016/j.biopsycho.2013.11.010; West SK, 2010, J GERONTOL A-BIOL, V65, P179, DOI 10.1093/gerona/glp136; Wikman AS, 2005, OPTOMETRY VISION SCI, V82, P716, DOI 10.1097/01.opx.0000174721.33377.b8; Yao DZ, 2017, BRAIN TOPOGR, V30, P161, DOI 10.1007/s10548-016-0543-x; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	46	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191500	10.1371/journal.pone.0191500	http://dx.doi.org/10.1371/journal.pone.0191500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352314	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300100
J	Snijdewind, IJM; Smit, C; Godfried, MH; Bakker, R; Nellen, JFJB; Jaddoe, VWV; van Leeuwen, E; Reiss, P; Steegers, EAP; van der Ende, ME				Snijdewind, Ingrid J. M.; Smit, Colette; Godfried, Mieke H.; Bakker, Rachel; Nellen, Jeannine F. J. B.; Jaddoe, Vincent W. V.; van Leeuwen, Elisabeth; Reiss, Peter; Steegers, Eric A. P.; van der Ende, Marchina E.			Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PROTEASE INHIBITOR USE; LOW-BIRTH-WEIGHT; INFECTED WOMEN; HIV-1-INFECTED WOMEN; PREMATURE DELIVERY; PRETERM BIRTH; OUTCOMES; COHORT; METAANALYSIS	Background The benefits of combination anti-retroviral therapy (cART) in HIV-positive pregnant women (improved maternal health and prevention of mother to child transmission [pMTCT]) currently outweigh the adverse effects due to cART. As the variety of cART increases, however, the question arises as to which type of cART is safest for pregnant women and women of childbearing age. We studied the effect of timing and exposure to different classes of cART on adverse birth outcomes in a large HIV cohort in the Netherlands. Materials and methods We included singleton HEU infants registered in the ATHENA cohort from 1997 to 2015. Multivariate logistic regression analysis for single and multiple pregnancies was used to evaluate predictors of small for gestational age (SGA, birth weight < 10th percentile for gestational age), low birth weight and preterm delivery. Results A total of 1392 children born to 1022 mothers were included. Of these, 331 (23.8%) children were SGA. Women starting cART before conception had an increased risk of having a SGA infant compared to women starting cART after conception (OR 1.35, 95% CI 1.03-1.77, p = 0.03). The risk for SGA was highest in women who started a protease inhibitor-(PI) based regimen prior to pregnancy, compared with women who initiated PI-based cART during pregnancy. While the association of preterm delivery and preconception cART was significant in univariate analysis, on multivariate analysis only a non-significant trend was observed (OR 1.39, 95% CI 0.94-1.92, p = 0.06) in women who had started cART before compared to after conception. In multivariate analysis, the risk of low birth weight (OR 1.34, 95% CI 0.94-1.92, p = 0.11) was not significantly increased in women who had started cART prior to conception compared to after conception. Conclusion In our cohort of pregnant HIV-positive women, the use of cART prior to conception, most notably a PI-based regimen, was associated with intrauterine growth restriction resulting in SGA. Data showed a non-significant trend in the risk of PTD associated with preconception use of cART compared to its use after conception. More studies are needed with regard to the mechanisms taking place in the placenta during fetal growth in pregnant HIV-positive women using cART. It will only be with this knowledge that we can begin to understand the potential impact of HIV and cART on the fetus, in order to be able to determine the optimal individualised drug regimen for HIV-infected women of childbearing age.	[Snijdewind, Ingrid J. M.; van der Ende, Marchina E.] Erasmus MC, Dept Internal Med, Sect Infect Dis, Rotterdam, Netherlands; [Smit, Colette; Reiss, Peter] Stichting HIV Monitoring, Amsterdam, Netherlands; [Godfried, Mieke H.; Nellen, Jeannine F. J. B.; Reiss, Peter] Acad Med Ctr, Dept Internal Med & Infect Dis, Amsterdam, Netherlands; [Bakker, Rachel; Jaddoe, Vincent W. V.; Steegers, Eric A. P.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.] Erasmus MC, Dept Paediat, Rotterdam, Netherlands; [van Leeuwen, Elisabeth] Acad Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands; [Reiss, Peter] Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Reiss, Peter] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Steegers, Eric A. P.] Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	van der Ende, ME (corresponding author), Erasmus MC, Dept Internal Med, Sect Infect Dis, Rotterdam, Netherlands.	m.vanderende@erasmusmc.nl		van Leeuwen, Elisabeth/0000-0003-2463-9127	Dutch Health Ministry	Dutch Health Ministry	The authors received no specific funding for this work. The ATHENA database is supported by a grant from the Dutch Health Ministry and was set up and is maintained by Stichting HIV Monitoring. The funding sources of this study had no role in the study design, collection, data, or interpretation of the data, in the writing, or in the decision to submit the manuscript for publication.	Aaron E., 2012, Infectious Diseases in Obstetrics and Gynecology, V2012, P135030, DOI 10.1155/2012/135030; Boer K, 2007, BJOG-INT J OBSTET GY, V114, P148, DOI 10.1111/j.1471-0528.2006.01183.x; Briand N, 2009, AIDS, V23, P1235, DOI 10.1097/QAD.0b013e32832be0df; Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553; Chougrani I, 2013, HIV AIDS-RES PALLIAT, V5, P253, DOI 10.2147/HIV.S33058; Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045; de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708; Donati KD, 2004, LANCET INFECT DIS, V4, P213, DOI 10.1016/S1473-3099(04)00971-5; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Grosch-Woerner I, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00520.x; Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0; Kourtis AP, 2007, AIDS, V21, P607, DOI 10.1097/QAD.0b013e32802ef2f6; Kreitchmann R, 2014, BJOG-INT J OBSTET GY, V121, P1501, DOI 10.1111/1471-0528.12680; Lorenzi P, 1998, AIDS, V12, pF241, DOI 10.1097/00002030-199818000-00002; Machado ES, 2009, SEX TRANSM INFECT, V85, P82, DOI 10.1136/sti.2008.032300; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Ndirangu J, 2012, HUM REPROD, V27, P1846, DOI 10.1093/humrep/des090; Papp E, 2015, J INFECT DIS, V211, P10, DOI 10.1093/infdis/jiu393; Patel K, 2010, J INFECT DIS, V201, P1035, DOI 10.1086/651232; Phiri K, 2015, PEDIATR INFECT DIS J, V34, pE169, DOI 10.1097/INF.0000000000000712; Ronsholt FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065182; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Thorne C, 2004, AIDS, V18, P2337, DOI 10.1097/00002030-200411190-00019; Townsend CL, 2007, AIDS, V21, P1019, DOI 10.1097/QAD.0b013e328133884b; Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159; van der Merwe K, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-42; VanSighem AKA, 2013, MONITORING REPORT HU; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Watts DH, 2013, J INFECT DIS, V207, P612, DOI 10.1093/infdis/jis728	30	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191389	10.1371/journal.pone.0191389	http://dx.doi.org/10.1371/journal.pone.0191389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351561	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300080
J	Sauerland, M; Sagana, A; Sporer, SL; Wixted, JT				Sauerland, Melanie; Sagana, Anna; Sporer, Siegfried L.; Wixted, John T.			Decision time and confidence predict choosers' identification performance in photographic showups	PLOS ONE			English	Article							EYEWITNESS IDENTIFICATION; ACCURACY RELATIONSHIP; REMEMBER/KNOW JUDGMENTS; FACE RECOGNITION; POLICE LINEUPS; CALIBRATION; UPS; LATENCY; CURVES; MEMORY	In vast contrast to the multitude of lineup studies that report on the link between decision time, confidence, and identification accuracy, only a few studies looked at these associations for showups, with results varying widely across studies. We therefore set out to test the individual and combined value of decision time and post-decision confidence for diagnosing the accuracy of positive showup decisions using confidence-accuracy characteristic curves and Bayesian analyses. Three-hundred-eighty-four participants viewed a stimulus event and were subsequently presented with two showups which could be target-present or target-absent. As expected, we found a negative decision time-accuracy and a positive post-decision confidence-accuracy correlation for showup selections. Confidence-accuracy characteristic curves demonstrated the expected additive effect of combining both postdictors. Likewise, Bayesian analyses, taking into account all possible target-presence base rate values showed that fast and confident identification decisions were more diagnostic than slow or less confident decisions, with the combination of both being most diagnostic for postdicting accurate and inaccurate decisions. The postdictive value of decision time and post-decision confidence was higher when the prior probability that the suspect is the perpetrator was high compared to when the prior probability that the suspect is the perpetrator was low. The frequent use of showups in practice emphasizes the importance of these findings for court proceedings. Overall, these findings support the idea that courts should have most trust in showup identifications that were made fast and confidently, and least in showup identifications that were made slowly and with low confidence.	[Sauerland, Melanie; Sagana, Anna] Maastricht Univ, Fac Psychol & Neurosci, Dept Clin Psychol Sci, Maastricht, Netherlands; [Sporer, Siegfried L.] Univ Giessen, Dept Psychol & Sports Sci, Giessen, Germany; [Wixted, John T.] Univ Calif San Diego, Dept Psychol, San Diego, CA 92103 USA	Maastricht University; Justus Liebig University Giessen; University of California System; University of California San Diego	Sauerland, M (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Clin Psychol Sci, Maastricht, Netherlands.	melanie.sauerland@maastrichtuniversity.nl	Wixted, John/AAV-3458-2020; Sauerland, Melanie/ABD-9558-2020; Sauerland, Melanie/AAB-3877-2019; Sagana, Anna/V-4521-2019	Wixted, John/0000-0001-6282-5479; Sauerland, Melanie/0000-0002-7401-1365; Sagana, Anna/0000-0003-4776-8431				Behrman BW, 2001, LAW HUMAN BEHAV, V25, P475, DOI 10.1023/A:1012840831846; Brewer N, 2006, J EXP PSYCHOL-APPL, V12, P11, DOI 10.1037/1076-898X.12.1.11; Brewer N, 2002, J EXP PSYCHOL-APPL, V8, P44, DOI 10.1037//1076-898X.8.1.44; Brewer N, 2008, APPL COGNITIVE PSYCH, V22, P827, DOI 10.1002/acp.1486; Brewer N, 2010, LEGAL CRIMINOL PSYCH, V15, P77, DOI 10.1348/135532509X414765; Charman S. D., 2007, HDB EYEWITNESS PSYCH, VII, P219; Clark SE, 2012, PERSPECT PSYCHOL SCI, V7, P238, DOI 10.1177/1745691612439584; Crandall CS, 2016, J EXP SOC PSYCHOL, V66, P93, DOI 10.1016/j.jesp.2015.10.002; Davis JP, 2015, PSYCHOL CRIME LAW, V21, P9, DOI 10.1080/1068316X.2014.915322; Dodson CS, 2016, APPL COGNITIVE PSYCH, V30, P113, DOI 10.1002/acp.3178; Dunning D, 2002, J APPL PSYCHOL, V87, P951, DOI 10.1037//0021-9010.87.5.951; Dysart JE, 2002, J APPL PSYCHOL, V87, P170, DOI 10.1037//0021-9010.87.1.170; Dysart JE, 2006, APPL COGNITIVE PSYCH, V20, P1009, DOI 10.1002/acp.1241; Eisen ML, 2017, PSYCHOL PUBLIC POL L, V23, P1, DOI 10.1037/law0000115; Flowe HD, 2017, APPL COGNITIVE PSYCH, V31, P379, DOI 10.1002/acp.3332; Garrett B. L., 2011, CONVICTING INNOCENT; Green DM, 1966, SIGNAL DETECTION THE; Gronlund SD, 2012, J APPL RES MEM COGN, V1, P221, DOI 10.1016/j.jarmac.2012.09.003; Head ML, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002106; Key KN, 2017, APPL COGNITIVE PSYCH, V31, P59, DOI 10.1002/acp.3302; Key KN, 2015, PSYCHOL CRIME LAW, V21, P871, DOI 10.1080/1068316X.2015.1054387; Mickes L, 2015, J APPL RES MEM COGN, V4, P93, DOI 10.1016/j.jarmac.2015.01.003; Palmer MA, 2013, J EXP PSYCHOL-APPL, V19, P55, DOI 10.1037/a0031602; Sauer J, 2010, LAW HUMAN BEHAV, V34, P337, DOI 10.1007/s10979-009-9192-x; Sauer JD, 2015, WILEY SER PSYCH CR, P185; Sauerland M, 2007, PSYCHOL CRIME LAW, V13, P611, DOI 10.1080/10683160701264561; Sauerland M, 2012, LAW HUMAN BEHAV, V36, P394, DOI 10.1037/h0093926; Sauerland M, 2009, J EXP PSYCHOL-APPL, V15, P46, DOI 10.1037/a0014560; Simons DJ, 2014, PERSPECT PSYCHOL SCI, V9, P76, DOI 10.1177/1745691613514755; Smith AM, 2014, J EXP PSYCHOL-APPL, V20, P247, DOI 10.1037/xap0000018; SPORER SL, 1995, PSYCHOL BULL, V118, P315, DOI 10.1037/0033-2909.118.3.315; SPORER SL, 1992, EUR J SOC PSYCHOL, V22, P157, DOI 10.1002/ejsp.2420220205; Steblay N, 2003, LAW HUMAN BEHAV, V27, P523, DOI 10.1023/A:1025438223608; Valentine T, 2012, APPL COGNITIVE PSYCH, V26, P1, DOI 10.1002/acp.1796; Van Zandt T, 2000, J EXP PSYCHOL LEARN, V26, P582; Vickers D., 2014, DECISION PROCESSES V; Weber N, 2004, J EXP PSYCHOL-APPL, V10, P139, DOI 10.1037/1076-898X.10.3.139; Weber N, 2004, J EXP PSYCHOL-APPL, V10, P156, DOI 10.1037/1076-898X.10.3.156; Weber N, 2003, J APPL PSYCHOL, V88, P490, DOI 10.1037/0021-9010.88.3.490; Wells GL, 2015, LAW HUMAN BEHAV, V39, P99, DOI 10.1037/lhb0000125; Wells GL, 1999, PERS SOC PSYCHOL B, V25, P1115, DOI 10.1177/01461672992512005; Wells GL, 1998, LAW HUMAN BEHAV, V22, P603, DOI 10.1023/A:1025750605807; WELLS GL, 1990, PERS SOC PSYCHOL B, V16, P106, DOI 10.1177/0146167290161008; Wixted JT, 2017, PSYCHOL SCI PUBL INT, V18, P10, DOI 10.1177/1529100616686966; Wixted JT, 2016, P NATL ACAD SCI USA, V113, P304, DOI 10.1073/pnas.1516814112; Wixted JT, 2010, PSYCHOL REV, V117, P1025, DOI 10.1037/a0020874; Wixted JT, 2004, PSYCHON B REV, V11, P616, DOI 10.3758/BF03196616; Yarmey AD, 1996, LAW HUMAN BEHAV, V20, P459, DOI 10.1007/BF01498981	48	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190416	10.1371/journal.pone.0190416	http://dx.doi.org/10.1371/journal.pone.0190416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9PC	29346394	gold, Green Published, Green Submitted			2022-12-27	WOS:000422749500013
J	Schabort, DWP; Kilian, SG; du Preez, JC				Schabort, Du Toit W. P.; Kilian, Stephanus G.; du Preez, James C.			Gene regulation in Kluyveromyces marxianus in the context of chromosomes	PLOS ONE			English	Article							REPRESSOR; GROWTH; MIG1	Eukaryotes, including the unicellular eukaryotes such as yeasts, employ multiple levels of gene regulation. Regulation of chromatin structure through chromatin compaction cascades, and influenced by transcriptional insulators, might play a role in the coordinated regulation of genes situated at adjacent loci and expressed as a co-regulated cluster. Subtelomeric gene silencing, which has previously been described in the yeast Saccharomyces cerevisiae, is an example of this phenomenon. Transcription from a common regulatory element located around a shared intergenic region is another factor that could coordinate the transcription of genes at adjacent loci. Additionally, the presence of DNA binding sites for the same transcription factor may coordinate expression of multiple genes. Yeasts such as the industrially important Kluyveromyces marxianus may also display these modes of regulation, but this has not been explored to date. An exploration was done using a complete genome and RNA-seq data from a previous study of the transcriptional response to glucose or xylose as the carbon source in a defined culture medium, and investigating whether the species displays clusters of co-localised differentially expressed genes. Regions of possible subtelomeric silencing were evident, but were non-responsive to the carbon sources tested here. Additionally, glucose or xylose responsive clusters were discovered far from telomeres which contained some of the most significantly differentially expressed genes, encoding enzymes involved in the utilisation of alternative carbon sources such as the industrially important inulinase gene INU1. These clusters contained putative binding sites for the carbon source responsive transcription factors Mig1 and Adr1. Additionally, we investigated the potential contribution of common intergenic regions in co-regulation. Some observations were also made in terms of the evolutionary conservation of these clusters among yeast species and the presence of potential transcriptional insulators at the periphery of these clusters.	[Schabort, Du Toit W. P.; Kilian, Stephanus G.; du Preez, James C.] Univ Free State, Dept Microbial Biochem & Food Biotechnol, Bloemfontein, South Africa	University of the Free State	Schabort, DWP (corresponding author), Univ Free State, Dept Microbial Biochem & Food Biotechnol, Bloemfontein, South Africa.	dutoit.schabort@gmail.com			National Research Foundation of South Africa (ZA), CSPG - Thuthuka (PhD Track) [TTK20110831000026600, UID: 80657]	National Research Foundation of South Africa (ZA), CSPG - Thuthuka (PhD Track)	This work was supported by National Research Foundation of South Africa (ZA), CSPG - Thuthuka (PhD Track), http://www.nrf.ac.za/, Reference: TTK20110831000026600, UID: 80657, Awarded to: Mr. WPD Schabort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140829; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; CHENG C, 1994, MOL CELL BIOL, V14, P3842, DOI 10.1128/MCB.14.6.3842; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Cherry JM, 2011, NUCLEIC ACIDS RES, V1, P1; De Freitas JM, 2004, J BIOL CHEM, V279, P4450, DOI 10.1074/jbc.M212308200; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fonseca GG, 2008, APPL MICROBIOL BIOT, V79, P339, DOI 10.1007/s00253-008-1458-6; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lane Melanie M., 2010, Fungal Biology Reviews, V24, P17, DOI 10.1016/j.fbr.2010.01.001; Lepoivre C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-914; Lertwattanasakul N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0227-x; Lertwattanasakul N, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-20; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; NEHLIN JO, 1991, EMBO J, V10, P3373, DOI 10.1002/j.1460-2075.1991.tb04901.x; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Sasson O, 2003, NUCLEIC ACIDS RES, V31, P348, DOI 10.1093/nar/gkg096; Schabort DTWP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156242; Schabort DWP, 2017, THESIS; Smith JJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; Tu JL, 1996, MOL CELL BIOL, V16, P4199; van Bakel H, 2005, PHYSIOL GENOMICS, V22, P356, DOI 10.1152/physiolgenomics.00055.2005; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Yun CW, 2000, J BIOL CHEM, V275, P10709, DOI 10.1074/jbc.275.14.10709	31	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190913	10.1371/journal.pone.0190913	http://dx.doi.org/10.1371/journal.pone.0190913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346402	Green Submitted, Green Published, gold			2022-12-27	WOS:000422749500020
J	Okumura, N; Matsumoto, D; Fukui, Y; Teramoto, M; Imai, H; Kurosawa, T; Shimada, T; Kruse, F; Schlotzer-Schrehardt, U; Kinoshita, S; Koizumi, N				Okumura, Naoki; Matsumoto, Daiki; Fukui, Yuya; Teramoto, Masataka; Imai, Hirofumi; Kurosawa, Tetta; Shimada, Tomoki; Kruse, Friedrich; Schloetzer-Schrehardt, Ursula; Kinoshita, Shigeru; Koizumi, Noriko			Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; ROCK INHIBITOR; IN-VITRO; TRANSPLANTATION; KERATOPLASTY; MEMBRANE; SURVIVAL; ENABLES; SHEET	Corneal transparency is maintained by the corneal endothelium through its pump and barrier function. Severe corneal endothelial damage results in dysregulation of water flow and eventually causes corneal haziness and deterioration of visual function. In 2013, we initiated clinical research of cell-based therapy for treating corneal decompensation. In that study, we removed an 8-mm diameter section of damaged corneal endothelium without removing Descemet's membrane (the basement membrane of the corneal endothelium) and then injected cultured human corneal endothelial cells (CECs) into the anterior chamber. However, Descemet's membrane exhibits clinically abnormal structural features [i.e., multiple collagenous excrescences (guttae) and thickening] in patients with Fuchs endothelial corneal dystrophy (FECD) and the advanced cornea guttae adversely affects the quality of vision, even in patients without corneal edema. The turnover time of cornea guttae is also not certain. Therefore, we used a rabbit model to evaluate the feasibility of Descemet's membrane removal in the optical zone only, by performing a small 4-mm diameter descemetorhexis prior to CEC injection. We showed that the corneal endothelium is regenerated both on the corneal stroma (the area of Descemet's membrane removal) and on the intact peripheral Descemet's membrane, based on the expression of function-related markers and the restoration of corneal transparency. Recovery of the corneal transparency and central corneal thickness was delayed in areas of Descemet's membrane removal, but the cell density of the regenerated corneal endothelium and the thickness of the central corneal did not differ between the areas with and without residual Descemet's membrane at 14 days after CEC injection. Here, we demonstrate that removal of a pathological Descemet's membrane by a small descemetorhexis is a feasible procedure for use in combination with cell-based therapy. The current strategy might be beneficial for improving visual quality after CEC injection as a treatment for FECD.	[Okumura, Naoki; Matsumoto, Daiki; Fukui, Yuya; Teramoto, Masataka; Imai, Hirofumi; Kurosawa, Tetta; Shimada, Tomoki; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan; [Kruse, Friedrich; Schloetzer-Schrehardt, Ursula] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany; [Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kyoto, Japan	Doshisha University; University of Erlangen Nuremberg; Kyoto Prefectural University of Medicine	Koizumi, N (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan.	nkoizumi@mail.doshisha.ac.jp			Program for the Strategic Research Foundation at Private Universities from MEXT	Program for the Strategic Research Foundation at Private Universities from MEXT	This study was supported by the Program for the Strategic Research Foundation at Private Universities from MEXT (Koizumi, N. and Okumura, N.) (http://www.mext.go.jp/a_menu/Koutou/shinkou/07021403/002/1218299.htm).	ADAMIS AP, 1993, SURV OPHTHALMOL, V38, P149, DOI 10.1016/0039-6257(93)90099-S; [Anonymous], EYE BANK STAT REP; Dapena I, 2009, CURR OPIN OPHTHALMOL, V20, P299, DOI 10.1097/ICU.0b013e32832b8d18; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; DiPersio CM, 2016, CELL TISSUE RES, V365, P467, DOI 10.1007/s00441-016-2446-2; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Guell JL, 2014, OPHTHALMOL THER, V3, P1, DOI 10.1007/s40123-014-0022-y; HOGAN MJ, 1974, AM J OPHTHALMOL, V78, P363, DOI 10.1016/0002-9394(74)90224-4; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Liu SC, 2000, J CELL SCI, V113, P3563; Ljubimov AV, 2002, CORNEA, V21, P74, DOI 10.1097/00003226-200201000-00016; LORENZETTI DW, 1967, AM J OPHTHALMOL, V64, P1155, DOI 10.1016/0002-9394(67)93073-5; Melles GRJ, 2008, AM J OPHTHALMOL, V145, P222, DOI 10.1016/j.ajo.2007.09.021; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Mimura T, 2003, EXP EYE RES, V76, P745, DOI 10.1016/S0014-4835(03)00057-5; Nijm L. M., 2011, CORNEA, V2, P1321; Nishida T., 2011, CORNEA, P3; OKUMURA N, 2017, J OPHTHALMOL, V2017, DOI DOI 10.1155/2017/2646904; Okumura N, 2016, SCI REP-UK, V6, DOI 10.1038/srep26113; Okumura N, 2015, LAB INVEST, V95, P1291, DOI 10.1038/labinvest.2015.111; Okumura N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15005; Okumura N, 2015, INVEST OPHTH VIS SCI, V56, P2933, DOI 10.1167/iovs.14-15163; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Patel SV, 2012, EXP EYE RES, V95, P40, DOI 10.1016/j.exer.2011.05.013; Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x; Schlotzer-Schrehardt U, 2011, OPHTHALMOLOGY, V118, P1950, DOI 10.1016/j.ophtha.2011.03.025; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Wacker K, 2015, OPHTHALMOLOGY, V122, P1645, DOI 10.1016/j.ophtha.2015.05.005; Watanabe S, 2015, OPHTHALMOLOGY, V122, P2103, DOI 10.1016/j.ophtha.2015.06.019; Weller JM, 2014, INVEST OPHTH VIS SCI, V55, P3700, DOI 10.1167/iovs.14-14154	35	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191306	10.1371/journal.pone.0191306	http://dx.doi.org/10.1371/journal.pone.0191306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338061	Green Submitted, Green Published, gold			2022-12-27	WOS:000422652700048
J	Rivadeneira, MM; Nielsen, SN				Rivadeneira, Marcelo M.; Nielsen, Sven N.			Diversification dynamics, species sorting, and changes in the functional diversity of marine benthic gastropods during the Pliocene-Quaternary at temperate western South America (vol 12, e0187140, 2017)	PLOS ONE			English	Correction													Nielsen, Sven N/A-2187-2009	Nielsen, Sven N/0000-0003-2064-8050				Rivadeneira MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187140	1	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191525	10.1371/journal.pone.0191525	http://dx.doi.org/10.1371/journal.pone.0191525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338052	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700056
J	Yang, X; Chung, JY; Rai, U; Esumi, N				Yang, Xue; Chung, Jin-Yong; Rai, Usha; Esumi, Noriko			Cadherins in the retinal pigment epithelium (RPE) revisited: P-cadherin is the highly dominant cadherin expressed in human and mouse RPE in vivo	PLOS ONE			English	Article							JUVENILE MACULAR DYSTROPHY; TRANSCRIPTION FACTOR MITF; CELL-ADHESION MOLECULES; MESENCHYMAL TRANSITION; BETA-CATENIN; OXIDATIVE STRESS; N-CADHERIN; PROLIFERATIVE VITREORETINOPATHY; BEST1 EXPRESSION; EYE DEVELOPMENT	The retinal pigment epithelium (RPE) supports the health and function of retinal photoreceptors and is essential for normal vision. RPE cells are post-mitotic, terminally differentiated, and polarized epithelial cells. In pathological conditions, however, they lose their epithelial integrity, become dysfunctional, even dedifferentiate, and ultimately die. The integrity of epithelial cells is maintained, in part, by adherens junctions, which are composed of cadherin homodimers and p120-, beta-, and alpha-catenins linking to actin filaments. While E-cadherin is the major cadherin for forming the epithelial phenotype in most epithelial cell types, it has been reported that cadherin expression in RPE cells is different from other epithelial cells based on results with cultured RPE cells. In this study, we revisited the expression of cadherins in the RPE to clarify their relative contribution by measuring the absolute quantity of cDNAs produced from mRNAs of three classical cadherins (E-, N-, and P-cadherins) in the RPE in vivo. We found that P-cadherin (CDH3) is highly dominant in both mouse and human RPE in situ. The degree of dominance of P-cadherin is surprisingly large, with mouse Cdh3 and human CDH3 accounting for 82-85% and 92-93% of the total of the three cadherin mRNAs, respectively. We confirmed the expression of P-cadherin protein at the cell-cell border of mouse RPE in situ by immunofluorescence. Furthermore, we found that oxidative stress induces dissociation of P-cadherin and beta-catenin from the cell membrane and subsequent translocation of 8-catenin into the nucleus, resulting in activation of the canonical Wnt-beta-catenin pathway. This is the first report of absolute comparison of the expression of three cadherins in the RPE, and the results suggest that the physiological role of P-cadherin in the RPE needs to be reevaluated.	[Yang, Xue; Chung, Jin-Yong; Rai, Usha; Esumi, Noriko] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Esumi, N (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.	nesumi1@jhmi.edu		Chung, Jin-Yong/0000-0001-8149-584X; Esumi, Noriko/0000-0001-7995-4023	BrightFocus Foundation [M2015220]; US National Institutes of Health [EY001765]; Wilmer Pooled Professor Research Fund; Research to Prevent Blindness, Inc.	BrightFocus Foundation(BrightFocus Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wilmer Pooled Professor Research Fund; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB))	This work was supported by grants from the BrightFocus Foundation (M2015220 to NE), US National Institutes of Health (Core grant EY001765 to Wilmer Eye Institute), Wilmer Pooled Professor Research Fund (NE), and unrestricted funds from Research to Prevent Blindness, Inc. (Wilmer Eye Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst BD, 2001, J CELL SCI, V114, P629; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Bharti K, 2008, DEVELOPMENT, V135, P1169, DOI 10.1242/dev.014142; Blanco-Kelly F, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-016-0364-5; Burke JM, 2008, PROG RETIN EYE RES, V27, P579, DOI 10.1016/j.preteyeres.2008.08.002; Burke JM, 1999, INVEST OPHTH VIS SCI, V40, P2963; Burke JM, 2000, INVEST OPHTH VIS SCI, V41, P1945; CAMPOCHIARO PA, 1993, EXP EYE RES, V57, P539, DOI 10.1006/exer.1993.1158; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Datta S, 2017, PROG RETIN EYE RES; Esumi N, 2007, J BIOL CHEM, V282, P1838, DOI 10.1074/jbc.M609517200; Esumi N, 2009, HUM MOL GENET, V18, P128, DOI 10.1093/hmg/ddn323; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Greene WA, 2016, INVEST OPHTH VIS SCI, V57, P4428, DOI 10.1167/iovs.16-19192; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Ho TC, 2006, BIOCHEM BIOPH RES CO, V342, P372, DOI 10.1016/j.bbrc.2006.01.164; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Huang XG, 2012, BIOCHEM BIOPH RES CO, V419, P395, DOI 10.1016/j.bbrc.2012.02.033; Indelman M, 2002, J INVEST DERMATOL, V119, P1210, DOI 10.1046/j.1523-1747.2002.19528.x; Inumaru J, 2009, GENES CELLS, V14, P703, DOI 10.1111/j.1365-2443.2009.01303.x; Iwai-Takekoshi L, 2016, J COMP NEUROL, V524, P3696, DOI 10.1002/cne.24025; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; Kaida M, 2000, INVEST OPHTH VIS SCI, V41, P3215; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; Kim JW, 2008, GENE DEV, V22, P3147, DOI 10.1101/gad.1700108; Kimura K, 2015, J MOL MED, V93, P749, DOI 10.1007/s00109-015-1289-8; Kjaer KW, 2005, J MED GENET, V42, P292, DOI 10.1136/jmg.2004.027821; Kutty RK, 2016, MOL VIS, V22, P1156; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Maruotti J, 2012, PIGM CELL MELANOMA R, V25, P641, DOI 10.1111/j.1755-148X.2012.01033.x; Masuda T, 2010, J BIOL CHEM, V285, P26933, DOI 10.1074/jbc.M110.130294; McCrea PD, 2015, CURR TOP DEV BIOL, V112, P129, DOI 10.1016/bs.ctdb.2014.11.018; McKay BS, 1997, EXP EYE RES, V65, P661, DOI 10.1006/exer.1997.0374; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Mesa KR, 2015, NATURE, V522, P94, DOI 10.1038/nature14306; Mettu PS, 2012, MOL ASPECTS MED, V33, P376, DOI 10.1016/j.mam.2012.04.006; Miura Y, 2009, GRAEF ARCH CLIN EXP, V247, P641, DOI 10.1007/s00417-009-1041-6; Narimatsu T, 2013, INVEST OPHTH VIS SCI, V54, P4555, DOI 10.1167/iovs.12-11572; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; Radice GL, 2013, PROG MOL BIOL TRANSL, V116, P263, DOI 10.1016/B978-0-12-394311-8.00012-1; Ribeiro AS, 2013, J PATHOL, V229, P705, DOI 10.1002/path.4143; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Shimomura Y, 2008, DEVELOPMENT, V135, P743, DOI 10.1242/dev.006718; Singh MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23674; Sprecher E, 2001, NAT GENET, V29, P134, DOI 10.1038/ng716; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Tamiya S, 2016, EXP EYE RES, V142, P26, DOI 10.1016/j.exer.2015.02.008; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Theocharidis G, 2016, J INVEST DERMATOL, V136, P74, DOI 10.1038/JID.2015.352; Tinkle CL, 2008, P NATL ACAD SCI USA, V105, P15405, DOI 10.1073/pnas.0807374105; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Vieira AF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0448-4; Wang CXZ, 2012, EXP EYE RES, V102, P1, DOI 10.1016/j.exer.2012.06.003; Wei H, 2016, EXP EYE RES, V145, P450, DOI 10.1016/j.exer.2015.09.015; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Youn YH, 2006, INVEST OPHTH VIS SCI, V47, P2675, DOI 10.1167/iovs.05-1335; Zhang L, 2013, MOL VIS, V19, P1371; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou T, 2011, DIABETOLOGIA, V54, P459, DOI 10.1007/s00125-010-1943-1	73	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191279	10.1371/journal.pone.0191279	http://dx.doi.org/10.1371/journal.pone.0191279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338041	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700044
J	Miyazaki, Y; Tabuchi, T				Miyazaki, Yuki; Tabuchi, Takahiro			Educational gradients in the use of electronic cigarettes and heat-not-burn tobacco products in Japan	PLOS ONE			English	Article							ADULTS; COUNTRIES; AWARENESS; CANCER	Objectives In addition to electronic cigarettes (e-cigarettes), tobacco companies have recently begun to sell heat-not-burn tobacco products, Ploom and iQOS in Japan. Previous research has reported an inverse association between combustible cigarette smoking and educational attainment, but little is known about the association for e-cigarettes, especially heat-not-burn tobacco products. Our objective was to analyze the relationship between educational attainment and e-cigarette and heat-not-burn tobacco use. Setting An internet survey (randomly sampled research agency panelists) in Japan. Participants A total of 7338 respondents aged 18-69 years in 2015 (3632 men and 3706women). Primary measures Adjusted odds ratios (ORs) of educational attainment for current smoking (combustible cigarettes), e-cigarette ever-use, and heat-not-burn ever-use were calculated by multivariable logistic regression models using covariates including socio-demographic factors. Stratified analyses according to smoking status (combustible cigarettes) were additionally performed for e-cigarette ever-use and heat-not-burn tobacco product ever-use. Results Associations between educational attainment and e-cigarette ever-use or heat-not-burn tobacco ever-use are not straightforward, although these associations are not statistically significant except for one cell. For example, using "graduate school" education as a reference category, adjusted ORs for "high school" were 1.44 (95% confidence interval [Cl]: 0.85-2.44) for e-cigarettes ever-use and 0.75 (95% Cl:0.19-2.97) for heat-not-burn tobacco product ever-use. Among current smokers, compared with "graduate school" (reference), those with lower educational attainment showed 0.6 to 0.7 ORs for e-cigarette ever-use: e.g.,"4-year university" (OR = 0.54, 95% Cl:0.24-1.24) and "high school" (OR = 0.69, 95% Cl: 0.30-1.60). Among former smokers, lower education indicated higher ORs for both e-cigarettes and heat-not-burn tobacco ever-use. Conclusions This study provides baseline information on educational gradients of e-cigarette and heat-not-burn tobacco products, ever-use. As heat-not-burn tobacco products are increasing their market share in Japan, continuous monitoring of these products will be necessary.	[Miyazaki, Yuki] Osaka Univ, Sch Med, Suita, Osaka, Japan; [Tabuchi, Takahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Higashinari Ku, Osaka, Japan	Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Tabuchi, T (corresponding author), Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Higashinari Ku, Osaka, Japan.	tabuchitak@gmail.com		Tabuchi, Takahiro/0000-0002-1050-3125	Ministry of Health, Labour and Welfare [H28-008]; Ministry of Education, Culture, Sports, Science, and Technology [15K19256]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Ministry of Health, Labour and Welfare (URL: http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/index.html): Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus (H28-008) and the Ministry of Education, Culture, Sports, Science, and Technology (URL: http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm): grant-in-aid for Young Scientists B: number 15K19256. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKISON SE, 2013, AMERICAN JOURNAL OF, V10, P207; Agaku IT, 2014, DRUG ALCOHOL DEPEN, V139, P60, DOI 10.1016/j.drugalcdep.2014.03.003; Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; Borland R, 2006, TOB CONTROL, V15, P34, DOI 10.1136/tc.2004.008748; Caputi TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185735; Caputi TL, 2017, SDF, V12; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Eriksen M, 2012, SOCIETY; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Ikeda N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001160; Inoue M, 2012, ANN ONCOL, V23, P1362, DOI 10.1093/annonc/mdr437; Kagamimori S, 2009, SOC SCI MED, V68, P2152, DOI 10.1016/j.socscimed.2009.03.030; King BA, 2013, NICOTINE TOB RES, V15, P1623, DOI 10.1093/ntr/ntt013; Konstantinos FarsalinosE P K V V LH J, 2016, ELECTRONIC CIGARETTE, P1; Lee YO, 2014, PREV MED, V62, P14, DOI 10.1016/j.ypmed.2014.01.014; Minowa M, 2005, J NATL I PUBLIC HLTH, V54, P262; Nahler DMDPG. Food and Drug Administration (FDA), 2009, DICTIONARY OF PHARMA, P76; Pearson JL, 2012, AM J PUBLIC HEALTH, V102, P1758, DOI 10.2105/AJPH.2011.300526; Pepper JK, 2014, TOB CONTROL, V23, P375, DOI 10.1136/tobaccocontrol-2013-051122; Regan AK, 2013, TOB CONTROL, V22, P19, DOI 10.1136/tobaccocontrol-2011-050044; TABUCHI T, 2016, ADDICTION; Tabuchi T, 2017, J EPIDEMIOL, V27, P186, DOI 10.1016/j.je.2016.05.007	22	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191008	10.1371/journal.pone.0191008	http://dx.doi.org/10.1371/journal.pone.0191008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BY	29329351	Green Submitted, Green Published, gold			2022-12-27	WOS:000419954100031
J	Davey, DLJ; Wall, KM; Kilembe, W; Khu, NH; Brill, I; Vwalika, B; Chomba, E; Mulenga, J; Tichacek, A; Gorbach, PM; Allen, S				Davey, Dvora Leah Joseph; Wall, Kristin M.; Kilembe, William; Khu, Naw Htee; Brill, Ilene; Vwalika, Bellington; Chomba, Elwyn; Mulenga, Joseph; Tichacek, Amanda; Gorbach, Pamina M.; Allen, Susan			Difficult decisions: Evaluating individual and couple-level fertility intentions and HIV acquisition among HIV serodiscordant couples in Zambia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HUMAN-IMMUNODEFICIENCY-VIRUS; DISCORDANT COUPLES; POSITIVE WOMEN; ANTIRETROVIRAL THERAPY; GENITAL INFLAMMATION; SOUTH-AFRICA; HEALTH-CARE; RISK; TRANSMISSION	Introduction Attempts to conceive and pregnancy may increase HIV transmission to sex partners and infants. Our study evaluated the association between fertility intentions and HIV acquisition among Zambian HIV-serodiscordant couples. Methods We collected demographic, behavioral, clinical exposures, and data on fertility intentions in a cohort of HIV-serodiscordant couples in Lusaka, Zambia from 2005 to 2012. We evaluated factors associated with fertility intentions stratified by gender using multivariable logistic regression. Multivariable Cox proportional hazard models were used to evaluate the associations between fertility intentions and HIV acquisition controlling for a priori confounders and covariates that substantially (> 10%) changed the effect estimates in univariate analyses. Results Among 1,029 serodiscordant couples, 311 agreed that they wanted children in the future (30%), 368 agreed they did not want children (36%), and 344 couples disagreed about having children (34%), with men more likely than women to want children. Women wanting child (ren) was associated with increased odds of baseline pregnancy (adjusted odds ratio [aOR] = 4.80 (95% confidence interval [CI] = 2.93, 7.85)), fewer previous pregnancies (aOR = 0.85 per additional pregnancy (95% CI = 0.78, 0.93)), and partner fertility intention (aOR = 2.89 (95% CI = 2.14, 3.91)) adjusting for woman's age, literacy, years cohabiting and HIV status. Men wanting child(ren) was associated with younger age (aOR = 0.96 per year (95% CI = 0.93, 0.99)), fewer years cohabiting (aOR = 0.95 (95% CI = 0.92, 0.98)), number of previous partners' pregnancies (aOR = 0.90 (95% CI = 0.82, 0.98)), and partner fertility intention (aOR = 3.00 (95% CI = 2.21, 4.07)) adjusting for partner's age, literacy, HIV status and partner's baseline pregnancy. In adjusted survival analyses, HIV-negative women were more likely to seroconvert if they themselves wanted children (aHR = 2.36 (95% CI = 1.41, 3.96)) vs. did not want children, or if their partner wanted children (aHR = 2.34 (95% CI = 1.33, 4.11)) vs. did not want children, or if the couple agreed that they wanted children (aHR = 2.08 (95% CI = 1.01, 4.30)), adjusting for women's age, women's literacy, previous pregnancies and time in study. HIV-negative men were more likely to seroconvert if their female partner wanted a child in the next 12-months (aHR = 1.94 (95% CI = 1.02, 3.68)) vs. did not want children, and when both partners wanted children (aHR = 2.02 (CI = 1.09, 3.73)) vs. they did not want children, adjusting for men's age and literacy, couple income, number of live children, male circumcision status and time in study. Conclusion Women had increased risk of HIV acquisition if they and/or their partner wanted a child, while men had increased risk of HIV acquisition when their partner or if both partners agreed that they wanted children. Safer-conception interventions are needed to protect HIV uninfected women and men from HIV acquisition in HIV-serodiscordant couples who want children.	[Davey, Dvora Leah Joseph; Wall, Kristin M.; Kilembe, William; Khu, Naw Htee; Brill, Ilene; Vwalika, Bellington; Mulenga, Joseph; Tichacek, Amanda; Allen, Susan] Emory Univ, Sch Med, Dept Pathol & Lab Med, Rwanda Zambia HIV Res Grp, Atlanta, GA 30322 USA; [Davey, Dvora Leah Joseph; Wall, Kristin M.; Kilembe, William; Khu, Naw Htee; Brill, Ilene; Vwalika, Bellington; Mulenga, Joseph; Tichacek, Amanda; Allen, Susan] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Davey, Dvora Leah Joseph; Gorbach, Pamina M.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; [Davey, Dvora Leah Joseph] Univ Cape Town, Sch Publ Hlth & Family Med, Dept Biostat & Epidemiol, Cape Town, South Africa; [Wall, Kristin M.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Laney Grad Sch, Atlanta, GA 30322 USA; [Brill, Ilene] Univ Alabama Birmingham, Ryals Sch Publ Hlth, Dept Epidemiol, Birmingham, AL USA; [Vwalika, Bellington] Univ Zambia, Sch Med, Dept Gynecol & Obstet, Lusaka, Zambia; [Chomba, Elwyn] Univ Zambia, Sch Med, Dept Pediat, Lusaka, Zambia	Emory University; Emory University; Rollins School Public Health; University of California System; University of California Los Angeles; University of Cape Town; Emory University; Rollins School Public Health; University of Alabama System; University of Alabama Birmingham; University of Zambia; University of Zambia	Davey, DLJ (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Rwanda Zambia HIV Res Grp, Atlanta, GA 30322 USA.; Davey, DLJ (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.; Davey, DLJ (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA.; Davey, DLJ (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Dept Biostat & Epidemiol, Cape Town, South Africa.	dvoradavey@ucla.edu		Joseph-Davey, Dvora/0000-0001-6290-9293	National Institute of Child Health and Development [NICHD RO1 HD40125]; National Institute of Mental Health [NIMH R01 66767]; AIDS International Training and Research Program Fogarty International Center [D43 TW001042]; Emory Center for AIDS Research [P30 AI050409]; National Institute of Allergy and Infectious Diseases [NIAID R01 AI51231, NIAID R01 AI040951, NIAID R01 AI023980, NIAID R01 AI64060, NIAID R37 AI51231]; US Centers for Disease Control and Prevention [5U2GPS000758]; International AIDS Vaccine Initiative; American people through the United States Agency for International Development (USAID);  [NIH-NIAID-T32DA023356];  [NIH/FIC R25TW009340]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040125] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS000758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040951, R37AI051231, R01AI023980, R01AI064060, R01AI051231, P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH080634, R01MH066767] Funding Source: NIH RePORTER	National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AIDS International Training and Research Program Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Emory Center for AIDS Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); International AIDS Vaccine Initiative; American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institute of Child Health and Development (NICHD RO1 HD40125); National Institute of Mental Health (NIMH R01 66767); the AIDS International Training and Research Program Fogarty International Center (D43 TW001042); the Emory Center for AIDS Research (P30 AI050409); National Institute of Allergy and Infectious Diseases (NIAID R01 AI51231; NIAID R01 AI040951; NIAID R01 AI023980; NIAID R01 AI64060; NIAID R37 AI51231); the US Centers for Disease Control and Prevention (5U2GPS000758); and the International AIDS Vaccine Initiative. This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the International AIDS Vaccine Initiative and do not necessarily reflect the views of USAID or the United States Government. Co-authors were funded in part by all fund sources at one time or another, except for the lead author. Dr. Joseph Davey had funding support, including salary from NIH-NIAID-T32DA023356 and NIH/FIC R25TW009340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Berhan Y., BMC PUBLIC HLTH, V13, P409; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Brown J, 2016, AIDS EDUC PREV, V28, P524, DOI 10.1521/aeap.2016.28.6.524; Bujan L, 2007, AIDS, V21, P1909, DOI 10.1097/QAD.0b013e3282703879; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Chemaitelly H, 2014, EPIDEMICS-NETH, V6, P1, DOI 10.1016/j.epidem.2013.11.001; Chen WJ, 2010, SEX TRANSM INFECT, V86, pI22, DOI 10.1136/sti.2010.043620; Chetty T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1421-6; Cook R, 2014, CULT HEALTH SEX, V16, P741, DOI 10.1080/13691058.2014.902103; Demissie DB, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0382-2; Fiore JR, 2005, FERTIL STERIL, V84, P232, DOI 10.1016/j.fertnstert.2004.12.060; Keating MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039109; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Kendall T, 2014, JAIDS-J ACQ IMM DEF, V67, pS169, DOI 10.1097/QAI.0000000000000382; Khu NH, 2013, CONTRACEPTION, V88, P74, DOI 10.1016/j.contraception.2012.10.004; Kinuthia J, 2010, CURR HIV RES, V8, P510, DOI 10.2174/157016210793499213; Mantell JE, 2014, JAIDS-J ACQ IMM DEF, V67, pS202, DOI 10.1097/QAI.0000000000000369; Marston M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082219; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; Matthews LT, 2010, AIDS, V24, P1975, DOI 10.1097/QAD.0b013e32833bedeb; Melka AS, 2014, AFR J REPROD HEALTH, V18, P54; Mugo NR, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; Pintye J, 2015, AIDS PATIENT CARE ST, V29, P510, DOI 10.1089/apc.2015.0063; Savasi V, 2013, HUM REPROD UPDATE, V19, P136, DOI 10.1093/humupd/dms046; Schaan MM, 2012, AIDS CARE, V24, P1120, DOI 10.1080/09540121.2012.672814; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Schwartz SR, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.2.21291; Schwartz SR, 2014, AIDS, V28, pS277, DOI 10.1097/QAD.0000000000000330; Schwartz SR, 2012, AIDS BEHAV, V16, P69, DOI 10.1007/s10461-011-9981-3; Schwartz SR, 2015, INT J STD AIDS; Stephenson R, 2008, AIDS CARE, V20, P395, DOI 10.1080/09540120701593497; UNAIDS, 2013, REP GLOB AIDS EP; Vitorino RL, 2011, FERTIL STERIL, V95, P1684, DOI 10.1016/j.fertnstert.2011.01.127; Wall KM, 2017, INT J EPIDEMIOL, V46, P1593, DOI 10.1093/ije/dyx045; Wall KM, 2017, SEX TRANSM INFECT, V93, P259, DOI 10.1136/sextrans-2016-052743; Wall KM, 2015, CONTRACEPTION, V91, P480, DOI 10.1016/j.contraception.2015.02.004; Wall KM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001171; Zaba B, 2013, LANCET, V381, P1763, DOI 10.1016/S0140-6736(13)60803-X	40	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0189869	10.1371/journal.pone.0189869	http://dx.doi.org/10.1371/journal.pone.0189869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364895	Green Submitted, Green Published, gold			2022-12-27	WOS:000423412500006
J	Sala, A; Cabassi, CS; Santospirito, D; Polverini, E; Flisi, S; Cavirani, S; Taddei, S				Sala, Andrea; Cabassi, Clotilde Silvia; Santospirito, Davide; Polverini, Eugenia; Flisi, Sara; Cavirani, Sandro; Taddei, Simone			Novel Naja atra cardiotoxin 1 (CTX-1) derived antimicrobial peptides with broad spectrum activity	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTROSCOPY; PSEUDOMONAS-AERUGINOSA; MEMBRANE INTERACTIONS; LIPID-BILAYERS; MECHANISMS; RESISTANCE; BACTERIA; PATHOGENS; RESIDUES	Naja atra subsp. atra cardiotoxin 1 (CTX-1), produced by Chinese cobra snakes, belonging to Elapidae family, is included in the three-finger toxin family and exerts high cytotoxicity and antimicrobial activity too. Using as template mainly the tip and the subsequent beta-strand of the first "finger" of this toxin, different sequences of 20 amino acids linear peptides have been designed in order to avoid toxic effects but to maintain or even strengthen the partial antimicrobial activity already seen for the complete toxin. As a result, the sequence NCP-0 (Naja Cardiotoxin Peptide-0) was designed as ancestor and subsequently 4 other variant sequences of NCP-0 were developed. These synthesized variant sequences have shown microbicidal activity towards a panel of reference and field strains of Gram-positive and Gram-negative bacteria. The sequence named NCP-3, and its variants NCP-3a and NCP-3b, have shown the best antimicrobial activity, together with low cytotoxicity against eukaryotic cells and low hemolytic activity. Bactericidal activity has been demonstrated by minimum bactericidal concentration (MBC) assay at values below 10 mu g/ml for most of the tested bacterial strains. This potent antimicrobial activity was confirmed even for unicellular fungi Candida albicans, Candida glabrata and Malassezia pachydermatis (MBC 50-6.3 mu g/ml), and against the fast-growing mycobacteria Mycobacterium smegmatis and Mycobacterium fortuitum. Moreover, NCP-3 has shown virucidal activity on Bovine Herpesvirus 1 (BoHV1) belonging to Herpesviridae family. The bactericidal activity is maintained even in a high salt concentration medium (125 and 250 mM NaCl) and phosphate buffer with 20% Mueller Hinton (MH) medium against E. coli, methicillin resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa reference strains. Considering these in vitro obtained data, the search for active sequences within proteins presenting an intrinsic microbicidal activity could provide a new way for discovering a large number of novel and promising antimicrobial peptides families.	[Sala, Andrea; Cabassi, Clotilde Silvia; Santospirito, Davide; Flisi, Sara; Cavirani, Sandro; Taddei, Simone] Univ Parma, Dept Vet Sci, Parma, Italy; [Polverini, Eugenia] Univ Parma, Dept Math Phys & Comp Sci, Parma, Italy	University of Parma; University of Parma	Cabassi, CS (corresponding author), Univ Parma, Dept Vet Sci, Parma, Italy.	clotildesilvia.cabassi@unipr.it		Cabassi, Clotilde Silvia/0000-0002-1936-9858				Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Autelitano DJ, 2006, DRUG DISCOV TODAY, V11, P306, DOI 10.1016/j.drudis.2006.02.003; Bates IR, 2003, J BIOL CHEM, V278, P29041, DOI 10.1074/jbc.M302766200; Ben Ghorbal SK, 2013, CURR MICROBIOL, V67, P112, DOI 10.1007/s00284-013-0342-5; Bi X, 2013, J APPL MICROBIOL, V115, P663, DOI 10.1111/jam.12262; Broekaert WF, 1997, CRIT REV PLANT SCI, V16, P297, DOI 10.1080/713608148; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cabassi CS, 2015, PAK VET J, V35, P522; Chen LW, 2011, TOXICON, V58, P46, DOI 10.1016/j.toxicon.2011.04.021; Chia CSB, 2002, FEBS LETT, V512, P47, DOI 10.1016/S0014-5793(01)03313-0; Dubovskii PV, 2015, CELL MOL LIFE SCI, V72, P4501, DOI 10.1007/s00018-015-2016-x; DYSON HJ, 1991, ANNU REV BIOPHYS BIO, V20, P519; Efremov RG, 2002, BIOPHYS J, V83, P144, DOI 10.1016/S0006-3495(02)75156-4; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Francey T, 2000, J VET INTERN MED, V14, P177, DOI 10.1892/0891-6640(2000)014&lt;0177:TROBAA&gt;2.3.CO;2; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gautam A, 2015, METHODS MOL BIOL, V1324, P59, DOI 10.1007/978-1-4939-2806-4_4; Gofman Y, 2012, NUCLEIC ACIDS RES, V40, pW358, DOI 10.1093/nar/gks577; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Gorai B, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-3113-y; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HARVEY AL, 1982, TOXICON, V20, P379, DOI 10.1016/0041-0101(82)90001-0; Hiemstra P. S., 2013, ANTIMICROBIAL PEPTID; Huang YB, 2010, PROTEIN CELL, V1, P143, DOI 10.1007/s13238-010-0004-3; Khandelia H, 2006, PEPTIDES, V27, P1192, DOI 10.1016/j.peptides.2005.10.022; Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4; Mackessy S.P., 2021, HDB VENOMS TOXINS RE, V2nd; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; Mani R, 2006, BIOCHEMISTRY-US, V45, P8341, DOI 10.1021/bi060305b; MAO D, 1982, BIOCHEMISTRY-US, V21, P4960, DOI 10.1021/bi00263a020; Markey B, 2013, CLIN VET MICROBIOLOG, V2nd; Nathan C, 2014, NEW ENGL J MED, V371, P1761, DOI 10.1056/NEJMp1408040; Papagianni M, 2003, BIOTECHNOL ADV, V21, P465, DOI 10.1016/S0734-9750(03)00077-6; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/ERI.13.12, 10.1586/eri.13.12]; Petersen AD, 2002, J AM ANIM HOSP ASSOC, V38, P407, DOI 10.5326/0380407; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Romani AA, 2013, J PEPT SCI, V19, P554, DOI 10.1002/psc.2532; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shai Y, 1996, J BIOL CHEM, V271, P7305, DOI 10.1074/jbc.271.13.7305; Sharma VK, 2015, SOFT MATTER, V11, P6755, DOI 10.1039/c5sm01562f; Slaninova J, 2012, PEPTIDES, V33, P18, DOI 10.1016/j.peptides.2011.11.002; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STRAHILEVITZ J, 1994, BIOCHEMISTRY-US, V33, P10951, DOI 10.1021/bi00202a014; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Teuber M, 2001, CURR OPIN MICROBIOL, V4, P493, DOI 10.1016/S1369-5274(00)00241-1; Tommasi R, 2015, NAT REV DRUG DISCOV, V14, P529, DOI 10.1038/nrd4572; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; Waghu FH, 2016, NUCLEIC ACIDS RES, V44, pD1094, DOI 10.1093/nar/gkv1051; Watts JL, 2008, CLSI, V3, pM31; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Williams SC, 1998, J MICROBIOL METH, V32, P225, DOI 10.1016/S0167-7012(98)00014-1; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	59	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190778	10.1371/journal.pone.0190778	http://dx.doi.org/10.1371/journal.pone.0190778			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364903	Green Published, gold, Green Submitted			2022-12-27	WOS:000423412500023
J	Vater, A; Moritz, S; Roepke, S				Vater, Aline; Moritz, Steffen; Roepke, Stefan			Does a narcissism epidemic exist in modern western societies? Comparing narcissism and self-esteem in East and West Germany	PLOS ONE			English	Article							PERSONALITY-DISORDER; PATHOLOGICAL NARCISSISM; INDIVIDUALISM-COLLECTIVISM; PSYCHOMETRIC PROPERTIES; CRITERION VALIDITY; ENTERING ADULTHOOD; SHORT VERSION; LIFE EVENTS; ENHANCEMENT; INVENTORY	Narcissism scores are higher in individualistic cultures compared with more collectivistic cultures. However, the impact of sociocultural factors on narcissism and self-esteem has not been well described. Germany was formerly divided into two different social systems, each with distinct economic, political and national cultures, and was reunified in 1989/90. Between 1949 and 1989/90, West Germany had an individualistic culture, whereas East Germany had a more collectivistic culture. The German reunification provides an exceptional opportunity to investigate the impact of sociocultural and generational differences on narcissism and self-esteem. In this study, we used an anonymous online survey to assess grandiose narcissism with the Narcissistic Personality Inventory (NPI) and the Pathological Narcissism Inventory (PNI) to assess grandiose and vulnerable aspects of narcissism, and self-esteem with the Rosenberg Self-Esteem Scale (RSE) in 1,025 German individuals. Data were analyzed according to age and place of birth. Our results showed that grandiose narcissism was higher and self-esteem was lower in individuals who grew up in former West Germany compared with former East Germany. Further analyses indicated no significant differences in grandiose narcissism, vulnerable narcissism or self-esteem in individuals that entered school after the German reunification (<= 5 years of age in 1989). In the middle age cohort (6-18 years of age in 1989), significant differences in vulnerable narcissism, grandiose narcissism and self-esteem were observed. In the oldest age cohort (> 19 years of age in 1989), significant differences were only found in one of the two scales assessing grandiose narcissism (NPI). Our data provides empirical evidence that sociocultural factors are associated with differences in narcissism and self-esteem.	[Vater, Aline] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany; [Vater, Aline] Univ Potsdam, Dept Psychol, Potsdam, Germany; [Vater, Aline; Roepke, Stefan] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Campus Benjamin Franklin, Berlin, Germany; [Moritz, Steffen] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany	Free University of Berlin; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Vater, A (corresponding author), Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany.; Vater, A (corresponding author), Univ Potsdam, Dept Psychol, Potsdam, Germany.; Vater, A (corresponding author), Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Campus Benjamin Franklin, Berlin, Germany.	aline.vater@fu-berlin.de						Ackerman RA, 2011, ASSESSMENT, V18, P67, DOI 10.1177/1073191110382845; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychological Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596, 10.5771/0943-7444-2017-8-668]; American-Psychiatric-Association, 2000, DIAGN STAT MAN MENT; Back MD, 2011, EUR J PERSONALITY, V25, P90, DOI 10.1002/per.811; Back MD, 2010, J PERS SOC PSYCHOL, V98, P132, DOI 10.1037/a0016338; Bandura Albert, 1963, SOCIAL LEARNING PERS; Bianchi EC, 2015, PSYCHOL SCI, V26, P537, DOI 10.1177/0956797614568157; Bianchi EC, 2014, PSYCHOL SCI, V25, P1429, DOI 10.1177/0956797614532818; Brown RP, 2004, J RES PERS, V38, P585, DOI 10.1016/j.jrp.2003.11.002; Brummelman E, 2016, CURR DIR PSYCHOL SCI, V25, P8, DOI 10.1177/0963721415619737; Brummelman E, 2015, P NATL ACAD SCI USA, V112, P3659, DOI 10.1073/pnas.1420870112; Bundesamt S., 2012, GEBURTENTRENDS FAMIL; Cai HJ, 2012, EUR J PERSONALITY, V26, P529, DOI 10.1002/per.852; Cain NM, 2008, CLIN PSYCHOL REV, V28, P638, DOI 10.1016/j.cpr.2007.09.006; Caspi A., 2006, HDB CHILD PSYCHOL, VIII, P6; Clarke D, 2011, REMEMBERING THE GERMAN DEMOCRATIC REPUBLIC: DIVIDED MEMORY IN A UNITED GERMANY, P3; COHEN BJ, 1994, BRIT J PSYCHIAT, V165, P493, DOI 10.1192/bjp.165.4.493; Cramer P, 2011, J RES PERS, V45, P479, DOI 10.1016/j.jrp.2011.06.003; DeWall CN, 2011, PSYCHOL AESTHET CREA, V5, P200, DOI 10.1037/a0023195; DiNardo J, 2008, NEW PALGRAVE DICT EC; Donnellan MB, 2005, PSYCHOL SCI, V16, P328, DOI 10.1111/j.0956-7976.2005.01535.x; Dunning T, 2012, NATURAL EXPT SOCIAL, DOI 10.1017/CBO9781139084444; Edelstein RS, 2012, J PERS, V80, P1179, DOI 10.1111/j.1467-6494.2011.00755.x; FEATHER NT, 1993, SOC PSYCHOL QUART, V56, P65, DOI 10.2307/2786646; Foster JD, 2003, J RES PERS, V37, P469, DOI 10.1016/S0092-6566(03)00026-6; Friehe T, 2015, SOEPPAPERS; Gentile B, 2010, REV GEN PSYCHOL, V14, P261, DOI 10.1037/a0019919; Gorzig B, 2006, POST-COMMUNIST ECON, P449; Greenfield PM, 2009, DEV PSYCHOL, V45, P401, DOI 10.1037/a0014726; Hashmi A.A., 2013, INDIVIDUAL DIFFERENC, V11, P149, DOI DOI 10.17060/ijodaep.2014.n1.v3.514; Haussermann H, 1996, STADTENTWICKLUNG OST; Heine SJ, 1999, PSYCHOL REV, V106, P766, DOI 10.1037/0033-295X.106.4.766; Hepper EG, 2013, J CROSS CULT PSYCHOL, V44, P5, DOI 10.1177/0022022111428515; Hoerger M, 2010, CYBERPSYCH BEH SOC N, V13, P697, DOI 10.1089/cyber.2009.0445; Hofstede G., 1980, CULTURES CONSEQUENCE, DOI DOI 10.1016/S0005-7967(02)00184-5; Joinson A, 1999, BEHAV RES METH INS C, V31, P433, DOI 10.3758/BF03200723; Jokela M, 2017, P NATL ACAD SCI USA, V114, P6527, DOI 10.1073/pnas.1609994114; Kobayashi C, 2003, J CROSS CULT PSYCHOL, V34, P567, DOI 10.1177/0022022103256479; Kufner ACP, 2013, J PERS, V81, P184, DOI 10.1111/j.1467-6494.2012.00795.x; Kwan VSY, 2009, SELF IDENTITY, V8, P176, DOI 10.1080/15298860802504874; Lasch Christopher, 1979, CULTURE NARCISSISM; Markus H, SOCIAL PSYCHOL HDB B, V1006, P857; Miller JD, 2014, PSYCHOL ASSESSMENT, V26, P958, DOI 10.1037/a0036613; Miller JD, 2011, J PERS, V79, P1013, DOI 10.1111/j.1467-6494.2010.00711.x; Millon T., 1996, DISORDERS PERSONALIT; Morf CC, 2016, EXPANDING NOMOLOGICA; Newsom CR, 2003, J PERS ASSESS, V81, P74, DOI 10.1207/S15327752JPA8101_07; Oltmanns T. F, 2006, PERSONALITY PSYCHOPA, P71; Orth U, 2016, J PERS SOC PSYCHOL, V110, P133, DOI 10.1037/pspp0000038; Orth U, 2015, J PERS SOC PSYCHOL, V109, P707, DOI 10.1037/pspp0000049; Orth U, 2015, DEV PSYCHOL, V51, P248, DOI 10.1037/a0038481; Orth U, 2012, J PERS SOC PSYCHOL, V102, P1271, DOI 10.1037/a0025558; Orth U, 2010, J PERS SOC PSYCHOL, V98, P645, DOI 10.1037/a0018769; Otway LJ, 2006, PERS SOC PSYCHOL B, V32, P104, DOI 10.1177/0146167205279907; Paris J, 2014, PERSONAL DISORD, V5, P220, DOI 10.1037/a0028580; Park H, 2014, SOC PSYCHOL PERS SCI, V5, P310, DOI 10.1177/1948550613495419; Paulhus DL, 2004, MULTIVAR BEHAV RES, V39, P303, DOI 10.1207/s15327906mbr3902_7; Pincus AL, 2009, PSYCHOL ASSESSMENT, V21, P365, DOI 10.1037/a0016530; Putnam R., 2002, EVOLUTION SOCIAL CAP; RASKIN R, 1988, J PERS SOC PSYCHOL, V54, P890, DOI 10.1037/0022-3514.54.5.890; RASKIN RN, 1979, PSYCHOL REP, V45, P590, DOI 10.2466/pr0.1979.45.2.590; Roberts BW, 1997, J PERS SOC PSYCHOL, V72, P641, DOI 10.1037/0022-3514.72.3.641; Rosenberg M., 1965, SOC ADOLESCENT SELF; Rosenthal SA, 2011, J RES PERS, V45, P408, DOI 10.1016/j.jrp.2011.06.004; Rosenthal SA, 2010, J RES PERS, V44, P453, DOI 10.1016/j.jrp.2010.05.008; Schmitt DP, 2005, J PERS SOC PSYCHOL, V89, P623, DOI 10.1037/0022-3514.89.4.623; Schutz A, 2004, DIAGNOSTICA, V50, P202, DOI 10.1026/0012-1924.50.4.202; Sedikides C, 2004, J PERS SOC PSYCHOL, V87, P400, DOI 10.1037/0022-3514.87.3.400; Sedikides C, 2015, ADV MOTIV SCI, V2, P185, DOI 10.1016/bs.adms.2015.04.002; Shweder R.A.., 1991, THINKING CULTURES EX; Spangenberg L, 2013, PSYCHOTHER PSYCH MED, V63, P341, DOI 10.1055/s-0032-1333288; Specht J, 2014, J PERS SOC PSYCHOL, V107, P540, DOI 10.1037/a0036863; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; Stewart AJ, 2001, J ADULT DEV, V8, P23, DOI 10.1023/A:1026445704288; Stinson FS, 2008, J CLIN PSYCHIAT, V69, P1033, DOI 10.4088/JCP.v69n0701; Tafarodi RW, 1999, EUR J SOC PSYCHOL, V29, P797; Thomas KM, 2012, ASSESSMENT, V19, P135, DOI 10.1177/1073191112436664; Torney-Purta J.V., 2005, DEV POLITICAL ATTITU; Tracy JL, 2009, SELF IDENTITY, V8, P196, DOI 10.1080/15298860802505053; Trautwein U, 2006, J PERS SOC PSYCHOL, V90, P334, DOI 10.1037/0022-3514.90.2.334; Triandis H. C., 1995, INDIVIDUALISM COLLEC; Triandis HC, 2001, J PERS, V69, P907, DOI 10.1111/1467-6494.696169; Trull TJ, 2014, PERSONAL DISORD, V5, P230, DOI 10.1037/per0000009; Trull TJ, 2010, J PERS DISORD, V24, P412, DOI 10.1521/pedi.2010.24.4.412; Trzesniewski KH, 2010, PERSPECT PSYCHOL SCI, V5, P58, DOI 10.1177/1745691609356789; Twenge JM, 2015, SOC INDIC RES, V121, P437, DOI 10.1007/s11205-014-0647-1; Twenge JM, 2013, J CROSS CULT PSYCHOL, V44, P406, DOI 10.1177/0022022112455100; Twenge JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040181; Twenge JM, 2010, SOC PSYCHOL PERS SCI, V1, P99, DOI 10.1177/1948550609355719; Twenge JM, 2008, PSYCHOL SCI, V19, P1082, DOI 10.1111/j.1467-9280.2008.02204.x; Twenge JM, 2008, J RES PERS, V42, P1619, DOI 10.1016/j.jrp.2008.06.014; TWENGE JEAN M., 2009, NARCISSISM EPIDEMIC; Twenge JM, 2016, J PERSONALITY SOCIAL; Uhls Y.T., 2011, CYBERPSYCHOLOGY, V5; Vater A, 2013, J PERS ASSESS, V95, P301, DOI 10.1080/00223891.2012.732636; von Collani G., 2003, Z F R DIFFERENTIELLE, V24, P3, DOI [DOI 10.1024//0170-1789.24.1.3, 10.1024//0170-1789.24.1.3]; Wallace HM, 2002, J PERS SOC PSYCHOL, V82, P819, DOI 10.1037//0022-3514.82.5.819; Wilson MS, 2011, NEW ZEAL J PSYCHOL, V40, P89; WINK P, 1991, J PERS SOC PSYCHOL, V61, P590; Yamaguchi S, 2007, PSYCHOL SCI, V18, P498, DOI 10.1111/j.1467-9280.2007.01928.x; Zeigler-Hill V, 2013, J PERS ASSESS, V95, P249, DOI 10.1080/00223891.2012.717150	102	11	14	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0188287	10.1371/journal.pone.0188287	http://dx.doi.org/10.1371/journal.pone.0188287			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364885	gold, Green Published, Green Submitted			2022-12-27	WOS:000423412500002
J	Garcia-Sanjuan, S; Lillo-Crespo, M; Richert-Martinez, M; Sanjuan-Quiles, A				Garcia-Sanjuan, Sofia; Lillo-Crespo, Manuel; Richert-Martinez, Miguel; Sanjuan-Quiles, Angela			Healthcare professionals' views of the experiences of individuals living with Crohn's Disease in Spain. A qualitative study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SOCIAL SUPPORT; OF-LIFE; GASTROENTEROLOGISTS; PERCEPTIONS; MANAGEMENT; PEOPLE; GUIDELINES; NURSES; ROLES	Crohn's Disease (CD) in Spain lacks of a unified National Clinical Pathway and not even any early detection program and professional follow-up outpatient attention once it has been diagnosed. Little is known about the Spanish health professionals' views of the experiences of individuals living with Crohn's Disease nationwide and also about how the Spanish Health System faces this situation. A qualitative research method was conducted to explore this topic through in-depth interviews with eleven healthcare professionals, who represented different clinics treating people with CD from the province of Alicante (Spain). Three topics and seven sub-topics were derived from the analysis of the content emerging from the interviews. The three main topics were: the healthcare system as a hindrance for ongoing treatment of CD, the impact of the disease, support networks. The knowledge of CD gained by healthcare professionals, in the contexts studied here within, with regards to the psychosocial aspects and the experience of those living with the disease and their immediate circles, is poor, if not null on an academic level, becoming experiential on their incorporation into the professional field. Additionally, a priori, they lack the tools to address the doubts and concerns of patients from the moment of diagnosis through the ongoing care of the patient. Organizational hindrances, such as the lack of time and consensual guidelines for adequately monitoring CD patients in Alicante (Spain), further restrict the patient-professional relationship. Due to the consensus established by the National Agency regulating the contents of the Health Professions' Education and Training across the country, we are assuming that the phenomenon highlighted may be similar in other parts of Spain. Therefore, it can be said that healthcare professionals have a limited understanding of the impact of CD on the day-today life of those affected, not being considered a part of the CD patients' formal support network. Nonetheless, they are conscious of this limitation and advocate for multidisciplinary teams as the best means of attending to people living with CD. Our study outcomes may represent the first step onto identifying strategies and best practices for establishing an effective therapeutic relationship, as well as any hindering factors.	[Garcia-Sanjuan, Sofia; Lillo-Crespo, Manuel; Richert-Martinez, Miguel; Sanjuan-Quiles, Angela] Univ Alicante, Hlth Sci Fac, Nursing Dept, San Vicente Del Raspeig, Spain	Universitat d'Alacant	Garcia-Sanjuan, S (corresponding author), Univ Alicante, Hlth Sci Fac, Nursing Dept, San Vicente Del Raspeig, Spain.	sofia.garcia@ua.es	Richert, Maria/T-4989-2018; , sofia/A-4995-2019; LILLO-CRESPO, MANUEL/J-3260-2017	Richert, Maria/0000-0002-2256-4654; , sofia/0000-0001-7985-7864; LILLO-CRESPO, MANUEL/0000-0003-2053-2808	ISCIII-Subdireccion General de Evaluacion y Fomento de la investigacion el Fondo Europeo de Desarrollo Regional (FEDER); project "Diseno de una via clinica de patologias cronicas como la hipertension arterial y la enfermedad de Crohn. Orientacion a la gestion de procesos", State plan I+D+I Ministerio de Economia y Competittividad orientada a los Retos de la Sociedad [704753085-53085-45-514]	ISCIII-Subdireccion General de Evaluacion y Fomento de la investigacion el Fondo Europeo de Desarrollo Regional (FEDER); project "Diseno de una via clinica de patologias cronicas como la hipertension arterial y la enfermedad de Crohn. Orientacion a la gestion de procesos", State plan I+D+I Ministerio de Economia y Competittividad orientada a los Retos de la Sociedad	This study was funded by project "Diseno de una via clinica de patologias cronicas como la hipertension arterial y la enfermedad de Crohn. Orientacion a la gestion de procesos" (704753085-53085-45-514) integrated into the State plan I+D+I 2013-2016 Ministerio de Economia y Competittividad orientada a los Retos de la Sociedad and co-funded by ISCIII-Subdireccion General de Evaluacion y Fomento de la investigacion el Fondo Europeo de Desarrollo Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela J.A., 2002, TECNICAS ANALISIS CO; Andreu M, 2014, J CROHNS COLITIS, V8, P234, DOI 10.1016/j.crohns.2013.08.010; Belmartino S., 1987, PRIMERAS JORNADAS AT, P197; Bennett AL, 2015, WORLD J GASTROENTERO, V21, P4457, DOI 10.3748/wjg.v21.i15.4457; Bernabeu-Wittel M, 2014, REV CLIN ESP, V214, P328, DOI 10.1016/j.rce.2014.04.001; Bray J, CAN J GASTROENTEROL; Avila-Morales JC, 2017, IATREIA, V30, P216, DOI 10.17533/udea.iatreia.v30n2a11; Casellas F, 2003, REV ESP ENFERM DIG, V95, P476; Jorda FC, 2012, REV ESP ENFERM DIG, V104, P16, DOI 10.4321/s1130-01082012000100004; Corrales-Nevado D, 2012, GAC SANIT, V26, P63, DOI 10.1016/j.gaceta.2011.09.032; Czuber-Dochan W, 2014, J CROHNS COLITIS, V8, P835, DOI 10.1016/j.crohns.2014.01.004; De la Cuesta Benjumea C., 2001, INDEX ENFERM, V10, P20; De la Salud Asamblea Mundial., 2013, PROYECT PLAN ACC PRE; Dibley L, 2017, J CROHNS COLITIS, V11, P353, DOI 10.1093/ecco-jcc/jjw164; Dickman R, 2011, EUR J GASTROEN HEPAT, V23, P813, DOI 10.1097/MEG.0b013e328348a552; Dolak F, 2014, NEUROENDOCRINOL LETT, V35, P19; Dupuis M, 2009, CAN J GASTROENTEROL, V23, P805, DOI 10.1155/2009/384926; Ernst & Young Global Limited, 2016, ENF INFL INT SIT ACT; Fernandez A, 2015, GASTROENT HEPAT-BARC, V38, P534, DOI 10.1016/j.gastrohep.2015.03.001; Ferrer C, 2012, ESTRATEGIA ABORDAJE; Garcia-Sanjuan S, 2016, SALUD PUBLICA MEXICO, V58, P49, DOI 10.21149/spm.v58i1.7667; Garcia-Sanjuan S, 2016, CLIN NURS RES, V25, P79, DOI 10.1177/1054773814543828; Gassull MA, 2002, ENFERMEDAD INFLAMATO; Guba E, 1994, HDB QUALITATIVE RES, V6, P105; Hernandez AS, 2002, ATEN PRIM, V29, P522; Jelsness-Jorgensen LP, 2011, GASTROENT RES PRACT, V2011, P4920; Lesnovska KP, 2017, J CLIN NURS; Levy S, 2014, EUR J GASTROEN HEPAT, V26, P40, DOI 10.1097/MEG.0b013e328365ac70; Marteau P, 2013, EMC TRATADO MED, V17, P1, DOI DOI 10.1016/S1636-5410(13)65895-X; Martin-De-Carpi J, 2012, INFLAMM BOWEL DIS; Mayberry JF, 2013, ALIMENT PHARM THER, V37, P195, DOI 10.1111/apt.12102; Menendez SR, 2012, MED PROGRAMA FORMACI, V11, P293, DOI DOI 10.1016/S0304-5412(12)70301-3; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Moskovitz DN, 2000, DIS COLON RECTUM, V43, P517, DOI 10.1007/BF02237197; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; O'Connor M, 2013, J CROHNS COLITIS, V7, P744, DOI 10.1016/j.crohns.2013.06.004; Paley J, 1997, J ADV NURS, V26, P187, DOI 10.1046/j.1365-2648.1997.1997026187.x; Rabeharisoa V, 2002, REV INT CIENCIAS SOC, P171; Ricci C, 2008, DIGEST LIVER DIS, V40, pS285, DOI 10.1016/S1590-8658(08)60539-3; Rodriguez A., 2006, ARS MED, V12, P95; Sewitch MJ, 2001, AM J GASTROENTEROL, V96, P1470; Subasinghe D, 2010, SINGAP MED J, V51, P484; Sung JJY, 2010, J GASTROEN HEPATOL, V25, P183, DOI 10.1111/j.1440-1746.2009.06024.x; Teja LM., 2006, PERCEPCIONES ENFERMO, V7; Tew GA, 2016, INFLAMM BOWEL DIS, V22, P2933, DOI 10.1097/MIB.0000000000000962; Herrera AT, 2009, GASTROENT HEPAT-BARC, V32, P77, DOI 10.1016/j.gastrohep.2008.09.015; Vaucher C, 2016, SCAND J GASTROENTERO, V51, P1056, DOI 10.3109/00365521.2016.1147065; Vega-Angarita OM., 2011, AQUICHAN, V11; Vega-Angarita OM, 2009, ENFERM GLOB, V16	49	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190980	10.1371/journal.pone.0190980	http://dx.doi.org/10.1371/journal.pone.0190980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360881	Green Submitted, Green Published, gold			2022-12-27	WOS:000423161800013
J	Seraj, Z; Seyedarabi, A; Saboury, AA; Habibi-Rezaei, M; Ahmadian, S; Ghasemi, A				Seraj, Zahra; Seyedarabi, Arefeh; Saboury, Ali Akbar; Habibi-Rezaei, Mehran; Ahmadian, Shahin; Ghasemi, Atiyeh			Unraveling the novel effects of aroma from small molecules in preventing hen egg white lysozyme amyloid fibril formation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; IN-VITRO; PROTEIN AGGREGATION; ALPHA-SYNUCLEIN; ESSENTIAL OIL; INHIBITION; INACTIVATION; POLYPHENOLS; INHALATION	This study investigated for the first time the molecular effectiveness of 'aroma' from three small molecules including a phenol (phenyl ethyl alcohol; PEA) and an aldehyde (cinnamaldehyde; Cin) both containing an aromatic ring, and a diamine (N, N, N, N '-Tetramethylethylene-diamine; TEMED) at two different amounts (small; S and large; L) in preventing hen egg white lysozyme (HEWL) amyloid fibril formation using Thioflavin T and Nile red fluorescence assays, circular dichroism spectroscopy, SDS-polyacrylamide gel electrophoresis, atomic force microscopy, dynamic light scattering and HEWL activity test. Interestingly, the results revealed that (1) the aroma of PEA, identified as an active constituent of Rosa damascena, prevented fibril formation since PEA-L was able to trap the oligomeric form of HEWL in contrast to PEA-S where protofibrils but not mature fibrils were formed; (2) Cin, previously shown to prevent fibril formation in the liquid form, was also shown to do so in the aroma form by producing protofibrils and not mature fibrils in both Cin-L and Cin-S aroma forms and (3) the aroma of TEMED-L was able to retain HEWL's native structure completely and prevented both aggregation and fibril formation, while TEMED-S prevented HEWL fibril formation and instead directed the pathway towards amorphous aggregate formation. Furthermore, the ability to trap oligomeric species (by PEA-L aroma) is of great importance for further research as it provides routes for preventing the formation of toxic oligomeric intermediates along the fibrillation pathway. Last but not least, the novelty of this in vitro study on the effect of aroma at the molecular level with a unique experimental set-up using HEWL as a model protein in assessing amyloid fibril formation paves the way for more and detailed studies on the importance of aroma producing molecules and their effects.	[Seraj, Zahra; Seyedarabi, Arefeh; Saboury, Ali Akbar; Ahmadian, Shahin; Ghasemi, Atiyeh] Univ Tehran, Dept Biochem, Inst Biochem & Biophys, Tehran, Iran; [Habibi-Rezaei, Mehran] Univ Tehran, Sch Biol, Univ Coll Sci, Tehran, Iran	University of Tehran; University of Tehran	Seyedarabi, A (corresponding author), Univ Tehran, Dept Biochem, Inst Biochem & Biophys, Tehran, Iran.	a.seyedarabi@ut.ac.ir	Ahmadian, Shahin -/U-1582-2018; Saboury, Ali Akbar/L-6136-2019; Ahmadian, Shahin/Q-7578-2019	Ahmadian, Shahin -/0000-0002-3436-465X; Ahmadian, Shahin/0000-0002-3436-465X; rezaee, mehran/0000-0002-3720-4221; Saboury, Ali Akbar/0000-0003-0604-9465	research council of the University of Tehran	research council of the University of Tehran(University of Tehran)	This study was funded by the research council of the University of Tehran.; We thank Dr. Azam Rahimipour, for her advice on polyamines. We also appreciate Ms Malihe Behzadi for her advice on HEWL incubation method to obtain fibrillation in 24 hours using a Duran bottle. We acknowledge the financial support of the research council of the University of Tehran.	Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Borana MS, 2014, BBA-PROTEINS PROTEOM, V1844, P670, DOI 10.1016/j.bbapap.2014.01.009; Boskabady MH, 2011, IRAN J BASIC MED SCI, V14, P295; Chiti F, 2001, PROTEIN SCI, V10, P879, DOI 10.1110/ps.42401; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Edris AE, 2007, PHYTOTHER RES, V21, P308, DOI 10.1002/ptr.2072; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Emadi S, 2014, BIOCHEM BIOPH RES CO, V450, P1339, DOI 10.1016/j.bbrc.2014.06.133; Esfandiary Ebrahim, 2015, Adv Biomed Res, V4, P131, DOI 10.4103/2277-9175.161512; Estrada LD, 2007, CURR TOP MED CHEM, V7, P115, DOI 10.2174/156802607779318262; Forrester LT, 2014, AROMATHERAPY DEMENTI; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Knowles TPJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238301; Koo BS, 2004, BIOL PHARM BULL, V27, P515, DOI 10.1248/bpb.27.515; Koo BS, 2003, BIOL PHARM BULL, V26, P978, DOI 10.1248/bpb.26.978; Kudou M, 2003, EUR J BIOCHEM, V270, P4547, DOI 10.1046/j.1432-1033.2003.03850.x; Lee MS, 2012, MATURITAS, V71, P257, DOI 10.1016/j.maturitas.2011.12.018; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Liu R, 2012, CURR MED CHEM, V19, P4157, DOI 10.2174/092986712802430018; Luo JH, 2016, J BIOL CHEM, V291, P16485, DOI 10.1074/jbc.R116.714576; Luo JH, 2013, CHEM COMMUN, V49, P6507, DOI 10.1039/c3cc42325e; Mach H, 1995, ULTRAVIOLET ABSORPTI, P91; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; National Center for Biotechnology Information, PUBCHEM COMP DAT; Okanojo M, 2005, J BIOSCI BIOENG, V100, P556, DOI 10.1263/jbb.100.556; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Peterson DW, 2009, J ALZHEIMERS DIS, V17, P585, DOI 10.3233/JAD-2009-1083; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Ramshini H, 2015, BASIC CLIN NEUROSCI, V6, P29; Rebek J, 2009, P NATL ACAD SCI USA, V106, P10423, DOI 10.1073/pnas.0905341106; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SACKETT DL, 1987, ANAL BIOCHEM, V167, P228, DOI 10.1016/0003-2697(87)90157-6; SHIRAHAM.T, 1973, J IMMUNOL, V110, P21; SHIRAHAMA T, 1967, J CELL BIOL, V33, P679, DOI 10.1083/jcb.33.3.679; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Wang SSS, 2009, BIOCHEM BIOPH RES CO, V381, P639, DOI 10.1016/j.bbrc.2009.02.103; Wang SSS, 2009, BIOPHYS CHEM, V144, P78, DOI 10.1016/j.bpc.2009.06.010; Wawer J, 2014, INT J BIOL MACROMOL, V70, P214, DOI 10.1016/j.ijbiomac.2014.06.057	46	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0189754	10.1371/journal.pone.0189754	http://dx.doi.org/10.1371/journal.pone.0189754			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357364	Green Published, Green Submitted, gold			2022-12-27	WOS:000422919500002
J	Chen, ZK; Robinson, J; Calhoun, V				Chen, Zikuan; Robinson, Jennifer; Calhoun, Vince			Brain functional BOLD perturbation modelling for forward fMRI and inverse mapping	PLOS ONE			English	Article							SUSCEPTIBILITY; RECONSTRUCTION; ACTIVATION; MAGNITUDE; SPACE; IMAGE; MAP	Purpose To computationally separate dynamic brain functional BOLD responses from static background in a brain functional activity for forward fMRI signal analysis and inverse mapping. Methods A brain functional activity is represented in terms of magnetic source by a perturbation model chi = chi(0) + delta(chi), with d. for BOLD magnetic perturbations and. chi(0) for background. A brain fMRI experiment produces a timeseries of complex-valued images (T2* images), whereby we extract the BOLD phase signals (denoted by delta P) by a complex division. By solving an inverse problem, we reconstruct the BOLD delta chi dataset from the delta P dataset, and the brain. distribution from a (unwrapped) T2* phase image. Given a 4D dataset of task BOLD fMRI, we implement brain functional mapping by temporal correlation analysis. Results Through a high-field (7T) and high-resolution (0.5mm in plane) task fMRI experiment, we demonstrated in detail the BOLD perturbation model for fMRI phase signal separation (P + delta P) and reconstructing intrinsic brain magnetic source (chi and delta chi). We also provided to a low-field (3T) and low-resolution (2mm) task fMRI experiment in support of single-subject fMRI study. Our experiments show that the delta chi-depicted functional map reveals bidirectional BOLD. perturbations during the task performance. Conclusions The BOLD perturbation model allows us to separate fMRI phase signal (by complex division) and to perform inverse mapping for pure BOLD delta chi reconstruction for intrinsic functional. mapping. The full brain. reconstruction (from unwrapped fMRI phase) provides a new brain tissue image that allows to scrutinize the brain tissue idiosyncrasy for the pure BOLD delta chi response through an automatic function/structure co-localization.	[Chen, Zikuan] Mind Res Network, Albuquerque, NM 87106 USA; [Chen, Zikuan] LBERI, Albuquerque, NM USA; [Robinson, Jennifer] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Robinson, Jennifer] Auburn Univ, MRI Res Ctr, Auburn, AL 36849 USA; [Calhoun, Vince] Univ New Mexico, Dept Elect Comp Engn, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; Auburn University System; Auburn University; Auburn University System; Auburn University; University of New Mexico	Chen, ZK (corresponding author), Mind Res Network, Albuquerque, NM 87106 USA.; Chen, ZK (corresponding author), LBERI, Albuquerque, NM USA.	zchen@mrn.org	Calhoun, Vince D./ACN-9399-2022; chen, zikuan/AAS-7049-2021	Calhoun, Vince D./0000-0001-9058-0747; chen, zikuan/0000-0002-7566-216X	 [NIHP20GM103472]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103472] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge the funding support of NIHP20GM103472.	[Anonymous], 2017, NEUROIMAGE; Balla DZ, 2014, NEUROIMAGE, V100, P112, DOI 10.1016/j.neuroimage.2014.06.011; Bianciardi M, 2014, HUM BRAIN MAPP, V35, P2191, DOI 10.1002/hbm.22320; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P4, DOI 10.1002/mrm.1910340103; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton Richard B, 2010, Front Neuroenergetics, V2, P8, DOI 10.3389/fnene.2010.00008; Cai JF, 2009, MULTISCALE MODEL SIM, V8, P337, DOI 10.1137/090753504; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Chen Z, 2016, NUMERICAL SIMULATION; Chen Z, 2016, BIOMEDICAL PHYS ENG; Chen Z., 2014, REP MED IMAGING, V7, P41, DOI 10.2147/RMI.S54514; Chen Z., 2016, COMPUTED TOMOGAPHY; Chen Z, 2014, USA patent, Patent No. [8,886,283, B1, 8886283B1]; Chen ZK, 2015, MAGN RESON IMAGING, V33, P390, DOI 10.1016/j.mri.2015.01.016; Chen ZK, 2015, J NEUROSCI METH, V241, P85, DOI 10.1016/j.jneumeth.2014.12.014; Chen ZK, 2013, MAGN RESON INSIGHTS, V6, P65, DOI 10.4137/MRI.S11920; Chen ZK, 2013, J NEUROSCI METH, V216, P33, DOI 10.1016/j.jneumeth.2013.03.003; Chen ZK, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-8; Chen ZK, 2012, J COMPUT ASSIST TOMO, V36, P265, DOI 10.1097/RCT.0b013e3182455cab; Chen ZK, 2011, J NEUROSCI METH, V199, P363, DOI 10.1016/j.jneumeth.2011.05.018; Deistung A., 2016, NMR BIOMED; Finn ES, 2015, NAT NEUROSCI, V18, P1664, DOI 10.1038/nn.4135; Haacke E. M., 1999, MAGNETIC RESONANCE I; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Haacke EM, 2012, NEUROIMAGE, V62, P923, DOI 10.1016/j.neuroimage.2012.01.020; Langkammer C, 2015, NEUROIMAGE, V111, P622, DOI 10.1016/j.neuroimage.2015.02.041; Li W, 2015, NEUROIMAGE, V108, P111, DOI 10.1016/j.neuroimage.2014.12.043; Li W, 2014, NMR BIOMED, V27, P219, DOI 10.1002/nbm.3056; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Liu T, 2012, IEEE T MED IMAGING, V31, P816, DOI 10.1109/TMI.2011.2182523; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; Magnotta VA, 2006, J DIGIT IMAGING, V19, P140, DOI 10.1007/s10278-006-0264-x; Martindale J, 2008, MAGN RESON MED, V59, P607, DOI 10.1002/mrm.21512; Navarro MA, 2012, OPT EXPRESS, V20, P2556, DOI 10.1364/OE.20.002556; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Pathak AP, 2008, NEUROIMAGE, V40, P1130, DOI 10.1016/j.neuroimage.2008.01.022; Paul JS, 2015, MAGN RESON IMAGING, V33, P1114, DOI 10.1016/j.mri.2015.06.005; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Reitz JR, 1993, FOUDATIONS ELECTROMA; Schofield MA, 2003, OPT LETT, V28, P1194, DOI 10.1364/OL.28.001194; SEPULVEDA NG, 1994, IEEE T MAGN, V30, P5062, DOI 10.1109/20.334296; Sun H, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3619; Tang J, 2013, MAGN RESON MED, V69, P1396, DOI 10.1002/mrm.24384; Vogt N, 2015, NAT METHODS, V12, P1112, DOI 10.1038/nmeth.3677; Wharton S, 2010, MAGN RESON MED, V63, P1292, DOI 10.1002/mrm.22334	46	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191266	10.1371/journal.pone.0191266	http://dx.doi.org/10.1371/journal.pone.0191266			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351339	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300065
J	Shen, S; Cheng, CX; Yang, J; Yang, SL				Shen, Shi; Cheng, Changxiu; Yang, Jing; Yang, Shanli			Visualized analysis of developing trends and hot topics in natural disaster research	PLOS ONE			English	Article							GREAT SUMATRA EARTHQUAKE; INDIAN-OCEAN TSUNAMI; HAZARDS; KNOWLEDGE; SCIENCE; INFORMATION; SATELLITE; PATTERNS; SEQUENCE; IMPACT	This study visualized and analyzed the developing trends and hot topics in natural disaster research. 19694 natural disaster-related articles (January 1900 to June 2015) are indexed in the Web of Science database. The first step in this study is using complex networks to visualize and analyze these articles. CiteSpace and Gephi were employed to generate a countries collaboration network and a disciplines collaboration network, and then attached hot topics to countries and disciplines, respectively. The results show that USA, China, and Italy are the three major contributors to natural disaster research. "Prediction model", "social vulnerability", and "landslide inventory map" are three hot topics in recent years. They have attracted attention not only from large countries like China but also from small countries like Panama and Turkey. Comparing two hybrid networks provides details of natural disaster research. Scientists from USA and China use image data to research earthquakes. Indonesia and Germany collaboratively study tsunamis in the Indian Ocean. However, Indonesian studies focus on modeling and simulations, while German research focuses on early warning technology. This study also introduces an activity index (AI) and an attractive index (AAI) to generate time evolution trajectories of some major countries from 2000 to 2013 and evaluate their trends and performance. Four patterns of evolution are visible during this 14-year period. China and India show steadily rising contributions and impacts, USA and England show relatively decreasing research efforts and impacts, Japan and Australia show fluctuating activities and stable attraction, and Spain and Germany show fluctuating activities and increasing impacts.	[Shen, Shi; Cheng, Changxiu; Yang, Jing; Yang, Shanli] Beijing Normal Univ, Key Lab Environm Change & Nat Disaster, Beijing, Peoples R China; [Shen, Shi; Cheng, Changxiu; Yang, Jing; Yang, Shanli] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource, Beijing, Peoples R China; [Shen, Shi; Cheng, Changxiu; Yang, Jing; Yang, Shanli] Beijing Normal Univ, Fac Geog Sci, Ctr Geodata & Anal, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University	Cheng, CX (corresponding author), Beijing Normal Univ, Key Lab Environm Change & Nat Disaster, Beijing, Peoples R China.; Cheng, CX (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource, Beijing, Peoples R China.; Cheng, CX (corresponding author), Beijing Normal Univ, Fac Geog Sci, Ctr Geodata & Anal, Beijing, Peoples R China.	chengcx@bnu.edu.cn	Shen, Shi/W-4256-2019	Shen, Shi/0000-0001-9126-229X	National Natural Science Foundation of China [41771537]; National Key Research and Development Plan of China [2017YFB0504102]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China [grant numbers: 41771537], National Key Research and Development Plan of China [grant numbers 2017YFB0504102], and the Fundamental Research Funds for the Central Universities.	Alessio G, 2010, TERRA NOVA, V22, P43, DOI 10.1111/j.1365-3121.2009.00915.x; Alexander D, 1997, DISASTERS, V21, P284, DOI 10.1111/1467-7717.00064; Bastian M, 2009, INT AAAI C WEBL SOC; Bird DK, 2009, NAT HAZARD EARTH SYS, V9, P1307, DOI 10.5194/nhess-9-1307-2009; Boen T, 2006, EARTHQ SPECTRA, V22, pS803, DOI 10.1193/1.2211369; Bonnet E, 2001, REV GEOPHYS, V39, P347, DOI 10.1029/1999RG000074; Chen CM, 2014, EXPERT OPIN BIOL TH, V14, P1295, DOI 10.1517/14712598.2014.920813; Chen CM, 2014, EXPERT OPIN ORPHAN D, V2, P709, DOI 10.1517/21678707.2014.920251; Chen CM, 2014, J ASSOC INF SCI TECH, V65, P334, DOI 10.1002/asi.22968; Chen CM, 2013, TECHNOL ANAL STRATEG, V25, P619, DOI 10.1080/09537325.2013.801949; Chen CM, 2006, J AM SOC INF SCI TEC, V57, P359, DOI 10.1002/asi.20317; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Chen KH, 2011, J INFORMETR, V5, P233, DOI 10.1016/j.joi.2010.10.007; Ciurean RL, 2013, APPROACHES TO DISAST; Corbane C, 2011, PHOTOGRAMM ENG REM S, V77, P997, DOI 10.14358/PERS.77.10.0997; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Falck C, 2010, NAT HAZARD EARTH SYS, V10, P181, DOI 10.5194/nhess-10-181-2010; FRAME J D, 1977, Interciencia, V2, P143; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gall M, 2015, INT J DISAST RISK RE, V12, P255, DOI 10.1016/j.ijdrr.2015.01.010; Gallina V, 2016, J ENVIRON MANAGE, V168, P123, DOI 10.1016/j.jenvman.2015.11.011; Geiss C, 2013, NAT HAZARDS, V68, P7, DOI 10.1007/s11069-012-0322-2; Glanzel W, 2003, SCIENTOMETRICS, V57, P197, DOI 10.1023/A:1024185601555; Hanewinkel M, 2011, EUR J FOREST RES, V130, P329, DOI 10.1007/s10342-010-0392-1; Hanka W, 2010, NAT HAZARD EARTH SYS, V10, P2611, DOI 10.5194/nhess-10-2611-2010; Joyce KE, 2009, PROG PHYS GEOG, V33, P183, DOI 10.1177/0309133309339563; Kleinberg J, 2003, DATA MIN KNOWL DISC, V7, P373, DOI 10.1023/A:1024940629314; Kusdiantara R, 2012, AIP CONF PROC, V1450, P305, DOI 10.1063/1.4724159; Liu GY, 2014, NEURAL REGEN RES, V9, P1716, DOI 10.4103/1673-5374.141810; Liu GF, 2014, MALAYS J LIBR INF SC, V19, P87; Liu LY, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3153915; Manyena SB, 2006, DISASTERS, V30, P433; Mariucci MT, 2010, GEOPHYS J INT, V182, P1096, DOI 10.1111/j.1365-246X.2010.04679.x; Merz B, 2010, NAT HAZARD EARTH SYS, V10, P1697, DOI 10.5194/nhess-10-1697-2010; Meyer V, 2013, NAT HAZARD EARTH SYS, V13, P1351, DOI 10.5194/nhess-13-1351-2013; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Qian G, 2012, DISASTER ADV, V5, P704; Qiu H, 2009, SCIENTOMETRICS, V81, P601, DOI 10.1007/s11192-008-2207-4; SCHUBERT A, 1986, SCIENTOMETRICS, V9, P281, DOI 10.1007/BF02017249; Schweizer J, 2003, REV GEOPHYS, V41, DOI 10.1029/2002RG000123; Sengara IW, 2006, EARTHQ SPECTRA, V22, pS495, DOI 10.1193/1.2205199; Shabnam N, 2014, INT J DISAST RISK SC, V5, P157, DOI 10.1007/s13753-014-0022-5; She JH, 2014, J UNIVERS COMPUT SCI, V20, P2005; Small H, 2014, RES POLICY, V43, P1450, DOI 10.1016/j.respol.2014.02.005; Stoffel M, 2008, NAT HAZARD EARTH SYS, V8, P187, DOI 10.5194/nhess-8-187-2008; Topirceanu A, 2016, COMPUT COMMUN, V73, P167, DOI 10.1016/j.comcom.2015.07.002; Wang C, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3154558; Yang J, 2017 IEEE 2ND INTERN	48	26	29	9	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191250	10.1371/journal.pone.0191250	http://dx.doi.org/10.1371/journal.pone.0191250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351350	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300063
J	Yoshizaki, K; Koike, K; Kimura, R; Osumi, N				Yoshizaki, Kaichi; Koike, Kohei; Kimura, Ryuichi; Osumi, Noriko			Early postnatal vocalizations predict sociability and spatial memory in C57BL/6J mice: Individual differences in behavioral traits emerge early in development (vol 12, e0186798, 2017)	PLOS ONE			English	Correction															JSPS KAKENHI [25640002, 15K12764, 16H06530, 15K06694]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI Grant Number 25640002, 15K12764, 16H06530 (NO) and 15K06694 (KY).	Yoshizaki K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186798	1	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191702	10.1371/journal.pone.0191702	http://dx.doi.org/10.1371/journal.pone.0191702			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352309	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300124
J	Anadol, E; Lust, K; Boesecke, C; Schwarze-Zander, C; Mohr, R; Wasmuth, JC; Rockstroh, JK; Trebicka, J				Anadol, Evrim; Lust, Kristina; Boesecke, Christoph; Schwarze-Zander, Carolynne; Mohr, Raphael; Wasmuth, Jan-Christian; Rockstroh, Juergen Kurt; Trebicka, Jonel			Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients	PLOS ONE			English	Article							NONCIRRHOTIC PORTAL-HYPERTENSION; HCV-COINFECTED PATIENTS; C VIRUS; ANTIRETROVIRAL THERAPY; TRANSIENT ELASTOGRAPHY; VIRAL-HEPATITIS; HIV; DISEASE; PROGRESSION; DIDANOSINE	Introduction Combined antiretroviral therapy (cART) has improved survival in HIV-patients. While the first antiretrovirals, which became available in particular D-drugs (especially didanosine and stavudine) and unboosted protease inhibitors, may impair liver function, the modern cART seems to decrease liver fibrosis. This study assessed the influence of exposure to previous antiretrovirals on liver fibrosis in HIV-infected patients. Methods This observational cross-sectional single-center study recruited 333 HIV patients and assessed liver fibrosis using transient elastography (TE). Results 83% were male with a median age of 45, while 131 were co-infected with viral hepatitis. Overall, 18% had significant fibrosis and 7.5% had cirrhosis. 11% of HIV mono-infected patients had significant fibrosis and 2% had cirrhosis. HCV infection (OR: 5.3), history of exposure to didanosine (OR: 2.7) and HIV load below 40copies/mL (OR: 0.5) were independently associated with significant fibrosis, while HCV (OR: 5.8), exposure to didanosine (OR: 2.9) and azidothymidine (OR: 2.8) were independently associated with cirrhosis. Interestingly, in HIV mono-infected patients, a HIV-load below 40copies/mL (OR: 0.4) was independently associated with significant fibrosis, and didanosine (OR: 20.8) with cirrhosis. Conclusion In conclusion, history of exposure to didanosine and azidothymidine continues to have an impact on the presence of liver cirrhosis in HIV patients. However, HCV co-infection and ongoing HIV-replication have the strongest effect on development of significant fibrosis in these patients.	[Anadol, Evrim; Lust, Kristina; Boesecke, Christoph; Schwarze-Zander, Carolynne; Mohr, Raphael; Wasmuth, Jan-Christian; Rockstroh, Juergen Kurt; Trebicka, Jonel] Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany; [Boesecke, Christoph; Schwarze-Zander, Carolynne; Mohr, Raphael; Wasmuth, Jan-Christian; Rockstroh, Juergen Kurt] German Ctr Infect Res DZIF, Bonn, Germany; [Trebicka, Jonel] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Trebicka, Jonel] European Fdn Study Chron Liver Failure EF Clif, Barcelona, Spain; [Trebicka, Jonel] Inst Bioengn Catalonia, Barcelona, Spain	University of Bonn; German Center for Infection Research; University of Southern Denmark; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona	Trebicka, J (corresponding author), Univ Hosp Bonn, Dept Internal Med 1, Bonn, Germany.; Trebicka, J (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark.; Trebicka, J (corresponding author), European Fdn Study Chron Liver Failure EF Clif, Barcelona, Spain.; Trebicka, J (corresponding author), Inst Bioengn Catalonia, Barcelona, Spain.	jonel.trebicka@ukbonn.de		Trebicka, Jonel/0000-0002-7028-3881; Mohr, Raphael/0000-0003-2403-4275	German Center for Infection Research (DZIF); Deutsche Forschungsgemeinschaft [SFB TRR57 P18]; Cellex-Foundation	German Center for Infection Research (DZIF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cellex-Foundation	The study was supported by German Center for Infection Research (DZIF to J-K.R.), Deutsche Forschungsgemeinschaft (SFB TRR57 P18 to J.T) and Cellex-Foundation (to JT). The funders had no role in the study.	Anadol E, 2014, HEPATOLOGY; Aranzabal L, 2005, CLIN INFECT DIS, V40, P588, DOI 10.1086/427216; Balagopal A, 2009, AIDS, V23, P2397, DOI 10.1097/QAD.0b013e3283324344; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Castellares C, 2008, J VIRAL HEPATITIS, V15, P165, DOI 10.1111/j.1365-2893.2007.00903.x; Glassner A, 2013, J HEPATOL, V59, P427, DOI 10.1016/j.jhep.2013.04.029; Gupta D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091569; Han SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052720; Ingiliz P, 2009, HEPATOLOGY, V49, P436, DOI 10.1002/hep.22665; Jang JY, 2011, J HEPATOL, V54, P612, DOI 10.1016/j.jhep.2010.07.042; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Kirk GD, 2013, ANN INTERN MED, V158, P658, DOI 10.7326/0003-4819-158-9-201305070-00604; Kovari H, 2009, CLIN INFECT DIS, V49, P626, DOI 10.1086/603559; Lee LM, 2001, JAMA-J AM MED ASSOC, V285, P1308, DOI 10.1001/jama.285.10.1308; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; Loko MA, 2012, ANTIVIR THER, V17, P1335, DOI 10.3851/IMP2419; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Maida I, 2006, JAIDS-J ACQ IMM DEF, V42, P177, DOI 10.1097/01.qai.0000221683.44940.62; Mandorfer M, 2015, LIVER INT, V35, P876, DOI 10.1111/liv.12615; Merchante N, 2006, AIDS, V20, P49, DOI 10.1097/01.aids.0000198087.47454.e1; Merchante N, 2010, ANTIVIR THER, V15, P753, DOI 10.3851/IMP1612; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mohr R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002127; Pareja JFP, 2009, MED CLIN-BARCELONA, V132, P208, DOI 10.1016/j.medcli.2008.04.003; Redd AD, 2013, AIDS RES HUM RETROV, V29, P1026, DOI [10.1089/aid.2013.0004, 10.1089/AID.2013.0004]; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schiano TD, 2007, AM J GASTROENTEROL, V102, P2536, DOI 10.1111/j.1572-0241.2007.01428.x; Schwabl P, 2015, LIVER INT, V35, P381, DOI 10.1111/liv.12623; Suarez-Zarracina T, 2012, J VIRAL HEPATITIS, V19, P685, DOI 10.1111/j.1365-2893.2012.01596.x; Tural C, 2003, J VIRAL HEPATITIS, V10, P118, DOI 10.1046/j.1365-2893.2003.00413.x; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Vermehren J, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-27	32	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191118	10.1371/journal.pone.0191118	http://dx.doi.org/10.1371/journal.pone.0191118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346443	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500028
J	Bromberg, SE; Moraes, PRAD; Ades, F				Bromberg, Silvio Eduardo; Alves de Figueiredo Moraes, Patricia Rodrigues; Ades, Felipe			Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery	PLOS ONE			English	Article							FOLLOW-UP; MASTECTOMY; RADIOTHERAPY; FAILURE; SEROMA	The prime incision technique is an oncoplastic surgery aimed to remove both the breast tumor and the sentinel lymph node through one incision, thus providing better aesthetic results than the conventional breast conservative two incision technique. We retrospectively evaluated 2 cohorts of 60 consecutive breast cancer patients operated by either conventional breast conservative surgery (N = 26) or one incision surgery (N = 34). There were no recurrence or death events observed in any group. No difference was seen regarding the incidence of surgical complications. In the prime incision group the breast volume removed was significantly lower than in the conventional surgery group as well as was the surgical time and the number of dissected lymph nodes. Aesthetical results were better in the one incision group. Further prospective studies are needed to validate the one incision technique as a surgical option for selected early stage breast cancer patients.	[Bromberg, Silvio Eduardo; Alves de Figueiredo Moraes, Patricia Rodrigues; Ades, Felipe] Hosp Israelita Albert Einstein, Ctr Oncol, Sao Paulo, Brazil; [Bromberg, Silvio Eduardo] Univ Fed Estado Sao Paulo, Sao Paulo, Brazil; [Alves de Figueiredo Moraes, Patricia Rodrigues] Hosp Perola Byington, Ctr Referencia Saude Mulher, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Bromberg, SE (corresponding author), Hosp Israelita Albert Einstein, Ctr Oncol, Sao Paulo, Brazil.; Bromberg, SE (corresponding author), Univ Fed Estado Sao Paulo, Sao Paulo, Brazil.	sbromberg@einstein.br		Bromberg, Silvio/0000-0002-8215-6580				Arriagada R, 1996, J CLIN ONCOL, V14, P1558, DOI 10.1200/JCO.1996.14.5.1558; Aytac HO, 2016, CLIN BREAST CANCER, V16, pE187, DOI 10.1016/j.clbc.2016.05.019; Bromberg SE, 2016, WORLD J PLAST SURG, V5, P252; DEHAES JCJM, 1986, EUR J SURG ONCOL, V12, P337; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; Greenberg J, 2008, REV OBSTET GYNECOL, V1, P142; HOLLAND R, 1990, J CLIN ONCOL, V8, P113, DOI 10.1200/JCO.1990.8.1.113; Jiang L, 2015, NEW ENGL J MED, V373, P2186, DOI 10.1056/NEJMc1511344; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; Lavoue V, 2008, ANN SURG ONCOL, V15, P2556, DOI 10.1245/s10434-008-9994-y; Litiere S, 2012, LANCET ONCOL, V13, P412, DOI 10.1016/S1470-2045(12)70042-6; Noguchi M, 2010, BREAST CANCER-TOKYO, V17, P56, DOI 10.1007/s12282-009-0104-1; OLIVOTTO IA, 1989, INT J RADIAT ONCOL, V17, P747, DOI 10.1016/0360-3016(89)90061-8; Rankin JS, 2006, ANN SURG, V243, P418, DOI 10.1097/01.sla.0000201546.94163.00; ROSEN PP, 1975, CANCER, V35, P739, DOI 10.1002/1097-0142(197503)35:3<739::AID-CNCR2820350329>3.0.CO;2-5; VERONESI U, 1986, EUR J CANCER CLIN ON, V22, P1085, DOI 10.1016/0277-5379(86)90011-8; VERONESI U, 1995, EUR J CANCER, V31A, P1574, DOI 10.1016/0959-8049(95)00271-J; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; VUJICIC N, 1986, CLIN EXP METASTAS, V4, P221, DOI 10.1007/BF00117934	19	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191056	10.1371/journal.pone.0191056	http://dx.doi.org/10.1371/journal.pone.0191056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346403	Green Submitted, gold, Green Published			2022-12-27	WOS:000422749500024
J	Narayanaswamy, VP; Giatpaiboon, SA; Uhrig, J; Orwin, P; Wiesmann, W; Baker, SM; Townsend, SM				Narayanaswamy, Vidya P.; Giatpaiboon, Scott A.; Uhrig, John; Orwin, Paul; Wiesmann, William; Baker, Shenda M.; Townsend, Stacy M.			In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus	PLOS ONE			English	Article							LEVEL MUPIROCIN RESISTANCE; ANTIBIOTIC-RESISTANCE; BETA-LACTAMS; VANCOMYCIN; EPIDEMIOLOGY; INFECTIONS; CEFTAROLINE; COMBINATION; FITNESS; SUSCEPTIBILITY	The incidence of multidrug-resistant (MDR) organisms, including methicillin-resistant Staphylococcus aureus (MRSA), is a serious threat to public health. Progress in developing new therapeutics is being outpaced by antibiotic resistance development, and alternative agents that rapidly permeabilize bacteria hold tremendous potential for treating MDR infections. A new class of glycopolymers includes polycationic poly-N (acetyl, arginyl) glucosamine (PAAG) is under development as an alternative to traditional antibiotic strategies to treat MRSA infections. This study demonstrates the antibacterial activity of PAAG against clinical isolates of methicillin and mupirocin-resistant Staphylococcus aureus. Multidrug-resistant S. aureus was rapidly killed by PAAG, which completely eradicated 88% (15/17) of all tested strains (6-log reduction in CFU) in <= 12-hours at doses that are non-toxic to mammalian cells. PAAG also sensitized all the clinical MRSA strains (17/17) to oxacillin as demonstrated by the observed reduction in the oxacillin MIC to below the antibiotic resistance breakpoint. The effect of PAAG and standard antibiotics including vancomycin, oxacillin, mupirocin and bacitracin on MRSA permeability was studied by measuring propidium iodide (PI) uptake by bacterial cells. Antimicrobial resistance studies showed that S. aureus developed resistance to PAAG at a rate slower than to mupirocin but similar to bacitracin. PAAG was observed to resensitize drug-resistant S. aureus strains sampled from passage 13 and 20 of the multi-passage resistance study, reducing MICs of mupirocin and bacitracin below their clinical sensitivity breakpoints. This class of bacterial permeabilizing glycopolymers may provide a new tool in the battle against multidrug-resistant bacteria.	[Narayanaswamy, Vidya P.; Giatpaiboon, Scott A.; Wiesmann, William; Baker, Shenda M.; Townsend, Stacy M.] Synedgen Inc, Claremont, CA 91711 USA; [Uhrig, John] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Orwin, Paul] Calif State Univ San Bernardino, San Bernardino, CA 92407 USA; [Townsend, Stacy M.] Mol Sci Inst, San Jose, CA USA	Medical College of Wisconsin; California State University System; California State University San Bernardino	Narayanaswamy, VP (corresponding author), Synedgen Inc, Claremont, CA 91711 USA.	vn@synedgen.com		Uhrig, John/0000-0001-7630-0921; Narayanaswamy, Vidya/0000-0002-9165-5672; Baker, Shenda/0000-0002-9985-473X	Synedgen Inc.	Synedgen Inc.	The funders, through Synedgen Inc., provided support in the form of salaries for authors SMT, VPN, SG, SMB, and WPW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; [Anonymous], 2016, ANT RES; [Anonymous], EXCERPTA MED CURR CL; Aritaka N, 2001, ANTIMICROB AGENTS CH, V45, P1292, DOI 10.1128/AAC.45.4.1292-1294.2001; Barber KE, 2015, J ANTIMICROB CHEMOTH, V70, P311, DOI 10.1093/jac/dku322; BARR JG, 1990, EUR J CLIN MICROBIOL, V9, P804, DOI 10.1007/BF01967378; Baxter RM, 2013, J BIOMED MATER RES A, V101, P340, DOI 10.1002/jbm.a.34328; Bayer AS, 2000, INFECT IMMUN, V68, P3548, DOI 10.1128/IAI.68.6.3548-3553.2000; Besier S, 2005, ANTIMICROB AGENTS CH, V49, P1426, DOI 10.1128/AAC.49.4.1426-1431.2005; Burkatovskaya M, 2006, BIOMATERIALS, V27, P4157, DOI 10.1016/j.biomaterials.2006.03.028; Centers for Disease Control and Prevention, BIGG THREATS; Claudia S, 2015, PLOS ONE, V10; Climo MW, 1999, ANTIMICROB AGENTS CH, V43, P1747, DOI 10.1128/AAC.43.7.1747; Dasenbrook EC, 2010, JAMA-J AM MED ASSOC, V303, P2386, DOI 10.1001/jama.2010.791; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Dawson RM, 2011, INT J ANTIMICROB AG, V37, P432, DOI 10.1016/j.ijantimicag.2011.01.007; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; Domaracki BE, 1998, EUR J CLIN MICROBIOL, V17, P143; dosSantos KRN, 1996, INFECT CONT HOSP EP, V17, P813; Drago L, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-111; Eliopoulos G.M., 1991, ANTIBIOTICS LAB MED, V3rd Edn, P432; Farrell DJ, 2011, ANTIMICROB AGENTS CH, V55, P1177, DOI 10.1128/AAC.01285-10; Fischer TH, 2007, J BIOMED MATER RES A, V80A, P167, DOI 10.1002/jbm.a.30877; Frank PT, ANTIBIOTIC THERAPY M, V24, P249; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Gisby J, 2000, ANTIMICROB AGENTS CH, V44, P255, DOI 10.1128/AAC.44.2.255-260.2000; Han LL, 2007, J CLIN MICROBIOL, V45, P1350, DOI 10.1128/JCM.02274-06; Ho TT, 2012, J ANTIMICROB CHEMOTH, V67, P1267, DOI 10.1093/jac/dks006; Hurdle JG, 2004, ANTIMICROB AGENTS CH, V48, P4366, DOI 10.1128/AAC.48.11.4366-4376.2004; Jain R, 2014, PHARMACOTHERAPY, V34, P758, DOI 10.1002/phar.1435; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Kollef MH, 2007, CLIN INFECT DIS, V45, pS191, DOI 10.1086/519470; Kubicek-Sutherland JZ, 2017, J ANTIMICROB CHEMOTH, V72, P115, DOI 10.1093/jac/dkw381; Kumar A, 2010, CRIT CARE MED, V38, P1773, DOI 10.1097/CCM.0b013e3181eb3ccd; Liu C, 2008, CLIN INFECT DIS, V46, P1637, DOI 10.1086/587893; Maddin S, 1987, CONT DERMATOL    JUN, P32; MCRIPLEY RJ, 1976, ANTIMICROB AGENTS CH, V10, P38, DOI 10.1128/AAC.10.1.38; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260; Mishra NN, IN VITRO CROSS RESIS; Mohamed MF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29707; Narayanaswamy VP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179776; National Committee for Clinical Laboratory Standards, 2013, M100S23 CLSI; Nawrocki KL, 2014, ANTIBIOTICS-BASEL, V3, P461, DOI 10.3390/antibiotics3040461; Nilsson AI, 2006, P NATL ACAD SCI USA, V103, P6976, DOI 10.1073/pnas.0602171103; Noble L, 1999, INT J PHARM, V192, P173, DOI 10.1016/S0378-5173(99)00306-3; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pulido MR, 2013, J ANTIMICROB CHEMOTH, V68, P2710, DOI 10.1093/jac/dkt253; Reddy C. M., 2012, WORLD J SCI TECHNOLO, V2, P6; Rimawi RH, 2013, J CLIN PHARM THER, V38, P330, DOI 10.1111/jcpt.12062; Seah C, 2012, ANTIMICROB AGENTS CH, V56, P1916, DOI 10.1128/AAC.05325-11; Svetitsky S, 2009, ANTIMICROB AGENTS CH, V53, P4069, DOI 10.1128/AAC.00341-09; Tabuchi F, 2017, J ANTIBIOT, V70, P771, DOI 10.1038/ja.2017.7; Tang H, 2010, ACTA BIOMATER, V6, P2562, DOI 10.1016/j.actbio.2010.01.002; Thangamani S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22571; VANBLITTERSWIJK WJ, 1987, BIOCHEMISTRY-US, V26, P1746, DOI 10.1021/bi00380a038; Vasquez JE, 2000, INFECT CONT HOSP EP, V21, P459, DOI 10.1086/501788; Wertheim HFL, 2004, ANN INTERN MED, V140, P419, DOI 10.7326/0003-4819-140-6-200403160-00007; Yam FK, 2014, AM J HEALTH-SYST PH, V71, P1457, DOI 10.2146/ajhp130474	61	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191522	10.1371/journal.pone.0191522	http://dx.doi.org/10.1371/journal.pone.0191522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342216	Green Submitted, gold, Green Published			2022-12-27	WOS:000422653800070
J	Duku, SKO; Nketiah-Amponsah, E; Janssens, W; Pradhan, M				Duku, Stephen Kwasi Opoku; Nketiah-Amponsah, Edward; Janssens, Wendy; Pradhan, Menno			Perceptions of healthcare quality in Ghana: Does health insurance status matter?	PLOS ONE			English	Article							RURAL TANZANIA; BURKINA-FASO; SERVICES; ENROLLMENT; AFRICA; SCHEME; SATISFACTION	This study's objective is to provide an alternative explanation for the low enrolment in health insurance in Ghana by analysing differences in perceptions between the insured and uninsured of the non-technical quality of healthcare. It further explores the association between insurance status and perception of healthcare quality to ascertain whether insurance status matters in the perception of healthcare quality. Data from a survey of 1,903 households living in the catchment area of 64 health centres were used for the analysis. Two sample independent t-tests were employed to compare the average perceptions of the insured and uninsured on seven indicators of non-technical quality of healthcare. A generalised ordered logit regression, controlling for socio-economic characteristics and clustering at the health facility level, tested the association between insurance status and perceived quality of healthcare. The perceptions of the insured were found to be significantly more negative than the uninsured and those of the previously insured were significantly more negative than the never insured. Being insured was associated with a significantly lower perception of healthcare quality. Thus, once people are insured, they tend to perceive the quality of healthcare they receive as poor compared to those without insurance. This study demonstrated that health insurance status matters in the perceptions of healthcare quality. The findings also imply that perceptions of healthcare quality may be shaped by individual experiences at the health facilities, where the insured and uninsured may be treated differently. Health insurance then becomes less attractive due to the poor perception of the healthcare quality provided to individuals with insurance, resulting in low demand for health insurance in Ghana. Policy makers in Ghana should consider redesigning, reorganizing, and reengineering the National Healthcare Insurance Scheme to ensure the provision of better quality healthcare for both the insured and uninsured.	[Duku, Stephen Kwasi Opoku] Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; [Duku, Stephen Kwasi Opoku; Janssens, Wendy; Pradhan, Menno] Free Univ Amsterdam, Fac Econ & Business Adm, Amsterdam, Netherlands; [Duku, Stephen Kwasi Opoku] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Nketiah-Amponsah, Edward] Univ Ghana, Econ Dept, Legon, Ghana	University of Ghana; Vrije Universiteit Amsterdam; University of Ghana	Duku, SKO (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana.; Duku, SKO (corresponding author), Free Univ Amsterdam, Fac Econ & Business Adm, Amsterdam, Netherlands.; Duku, SKO (corresponding author), Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands.	stephen.duku@ghsmail.org	Nketiah-Amponsah, Edward/S-9239-2019	Janssens, Wendy/0000-0002-2085-8608; Nketiah-Amponsah, Edward/0000-0002-9754-1983	The Netherlands government through the Ministry of Foreign Affairs and the Science for Global Development (WOTRO), Netherlands Organization for Scientific Research (NWO), under the Global Health Policy and Systems Research (GHPHSR) programme [W07.45.104.00]; NWO/WOTRO Ghana project in the Netherlands [0029]	The Netherlands government through the Ministry of Foreign Affairs and the Science for Global Development (WOTRO), Netherlands Organization for Scientific Research (NWO), under the Global Health Policy and Systems Research (GHPHSR) programme; NWO/WOTRO Ghana project in the Netherlands	This study received financial support from The Netherlands government through the Ministry of Foreign Affairs and the Science for Global Development (WOTRO) which is a division of the Netherlands Organization for Scientific Research (NWO), under the Global Health Policy and Systems Research (GHPHSR) programme (Project no. W07.45.104.00). Financial support for the field data collection and analysis was provided by NWO/WOTRO Ghana project (No. 0029) in the Netherlands.	Agyepong IA, 2008, HEALTH POLICY PLANN, V23, P150, DOI 10.1093/heapol/czn002; Akin JS, 1999, HEALTH POLICY PLANN, V14, P135, DOI 10.1093/heapol/14.2.135; Alderman H, 1996, WORLD BANK RES OBSER, V11, P3, DOI 10.1093/wbro/11.1.3; Andaleeb SS, 2001, SOC SCI MED, V52, P1359, DOI 10.1016/S0277-9536(00)00235-5; [Anonymous], 2012, HLTH FINANCING GHANA; [Anonymous], 2016, WORLD DEV IND; Arhinful DK., 2003, THESIS LEIDEN U NETH; Atim C, 2008, HLTH FINANCING AFRIC, V20, P20; Basaza R, 2008, HEALTH POLICY, V87, P172, DOI 10.1016/j.healthpol.2007.12.008; Basu S, PLOS MED, V9; Boateng D, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-50; Bruce E, 2008, TECHNICAL REPORT SER, V9; Criel B, 2003, SOC SCI MED, V57, P1205, DOI 10.1016/S0277-9536(02)00495-1; D'Souza SC, 2012, J HEALTH MANAG, V14, P27, DOI 10.1177/097206341101400103; De Allegri M, 2006, B WORLD HEALTH ORGAN, V84, P852; Dong HJ, 2009, HEALTH POLICY, V92, P174, DOI 10.1016/j.healthpol.2009.03.013; Durairaj V, 2010, 2 WHO; Fenenga CJ, 2014, INT J HEALTH PLAN M, V29, P26, DOI 10.1002/hpm.2159; Franco LM, 2008, B WORLD HEALTH ORGAN, V86, P830, DOI 10.2471/BLT.08.051045; Ghana Statistical Services (GSS), 2011, 2010 POP HOUS CENS; Gottret P. E., 2006, HLTH FINANCING REVIS; GRONROOS C, 1984, EUR J MARKETING, V18, P36, DOI 10.1108/EUM0000000004784; Jehu-Appiah C, 2012, HEALTH POLICY PLANN, V27, P222, DOI 10.1093/heapol/czr032; Jehu-Appiah C, 2011, SOC SCI MED, V72, P157, DOI 10.1016/j.socscimed.2010.10.025; Klemick H, 2009, AM J AGR ECON, V91, P347, DOI 10.1111/j.1467-8276.2009.01252.x; Lavy V, 1991, EC MED CARE CHOICE Q, P627; Lavy V, 1994, 105 LSM WORLD BANK; Marshall GN, 1996, J CONSULT CLIN PSYCH, V64, P380; McIntyre D, 2008, B WORLD HEALTH ORGAN, V86, P817; Mensah J, 2010, GLOBAL DEV NETWORK 1; Missoni E, 2010, 4 WHO; National Health Insurance Authority, 2012, NAT HLTH INS AUTH 20; National Health Insurance Authority, 2014, NAT HLTH INS AUTH 20; Nguyen HTH, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-4; NHIA, 2009, NAT HLTH INS AUTH 20; Robyn PJ, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-31; Sahn DE, 2003, OXFORD B ECON STAT, V65, P241, DOI 10.1111/1468-0084.t01-2-00046; Sofaer S, 2005, ANNU REV PUBL HEALTH, V26, P513, DOI 10.1146/annurev.publhealth.25.050503.153958; Spaan E, 2012, B WORLD HEALTH ORGAN, V90, P685, DOI 10.2471/BLT.12.102301; Strasser S, 1993, Med Care Rev, V50, P219, DOI 10.1177/107755879305000205; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; 2010, WORLD HLTH REP HLTH, P1	43	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190911	10.1371/journal.pone.0190911	http://dx.doi.org/10.1371/journal.pone.0190911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338032	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700022
J	Legras, R; Gaudric, A; Woog, K				Legras, Richard; Gaudric, Alain; Woog, Kelly			Distribution of cone density, spacing and arrangement in adult healthy retinas with adaptive optics flood illumination	PLOS ONE			English	Article							PHOTORECEPTOR PACKING DENSITY; AXIAL LENGTH; ECCENTRICITY; VARIABILITY; TOPOGRAPHY; IMAGES; EYE	The aim of this article is to analyse cone density, spacing and arrangement using an adaptive optics flood illumination retina camera (rtx1 (TM)) on a healthy population. Cone density, cone spacing and packing arrangements were measured on the right retinas of 109 subjects at 2 degrees, 3 degrees, 4 degrees, 5 degrees and 6 degrees of eccentricity along 4 meridians. The effects of eccentricity, meridian, axial length, spherical equivalent, gender and age were evaluated. Cone density decreased on average from 28 884 +/- 3 692 cones/mm(2), at 2 degrees of eccentricity, to 15 843 +/- 1 598 cones/mm(2) at 6 degrees. A strong inter-individual variation, especially at 2, was observed. No important difference of cone density was observed between the nasal and temporal meridians or between the superior and inferior meridians. However, the horizontal and vertical meridians differed by around 14%(T-test, p<0.0001). Cone density, expressed in units of area, decreased as a function of axial length (r(2) = 0.60), but remained constant (r(2) = 0.05) when cone density is expressed in terms of visual angle supporting the hypothesis that the retina is stretched during the elongation of the eyeball. Gender did not modify the cone distribution. Cone density was slightly modified by age but only at 2 degrees. The older group showed a smaller density (7%). Cone spacing increased from 6,49 +/- 0,42 pm to 8,72 +/- 0,45 pm respectively between 2 degrees and 6 degrees of eccentricity. The mosaic of the retina is mainly triangularly arranged (i.e. cells with 5 to 7 neighbors) from 2 degrees to 6 degrees. Around half of the cells had 6 degrees neighbors.	[Legras, Richard; Woog, Kelly] Univ Paris Saclay, Univ Paris Sud, CNRS, Lab Aime Cotton,ENS Paris Saclay, Orsay, France; [Gaudric, Alain] Univ Paris Diderot, Hop Lariboisiere, AP HP, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Legras, R (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, Lab Aime Cotton,ENS Paris Saclay, Orsay, France.	richard.legras@u-psud.fr	LEGRAS, Richard/ABE-3424-2021	Gaudric, Alain/0000-0002-2486-4722; Legras, Richard/0000-0002-1430-3649	Initiative Doctorale Interdisciplinaire grant	Initiative Doctorale Interdisciplinaire grant	This project was founded by the Conseil General de l'Essonne (Action de Soutien a la Technologie eta la Recherche en Essonne) and by Imagine Eyes, Orsay, France. This research was supported by an Initiative Doctorale Interdisciplinaire grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altpeter E, 2000, VISION RES, V40, P1539, DOI 10.1016/S0042-6989(00)00059-6; Chui TYP, 2008, INVEST OPHTH VIS SCI, V49, P4679, DOI 10.1167/iovs.08-2135; Chui TYP, 2008, J OPT SOC AM A, V25, P3021, DOI 10.1364/JOSAA.25.003021; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; da Costa BLSA, 2000, VISION RES, V40, P2395, DOI 10.1016/S0042-6989(00)00104-8; Dabir S, 2014, EYE, V28, P1488, DOI 10.1038/eye.2014.229; Dabir S, 2015, INDIAN J OPHTHALMOL, V63, P423, DOI 10.4103/0301-4738.159876; DEBERG M, 2000, COMPUTATIONAL GEOMET; Feng S, 2015, INVEST OPHTH VIS SCI, V56, P5751, DOI 10.1167/iovs.15-16954; Garnier MB, 2014, CLIN EXP OPHTHALMOL, V42, P833, DOI 10.1111/ceo.12356; Garrioch R, 2012, OPTOMETRY VISION SCI, V89, P632, DOI 10.1097/OPX.0b013e3182540562; Guez J.-E., 1995, VISION RES S, V35, pS80; Jacob J, 2017, OSLI RETINA, V48, P45, DOI 10.3928/23258160-20161219-06; Kitaguchi Y, 2007, JPN J OPHTHALMOL, V51, P456, DOI 10.1007/s10384-007-0477-7; KUAN DT, 1985, IEEE T PATTERN ANAL, V7, P165, DOI 10.1109/TPAMI.1985.4767641; Li KY, 2007, J OPT SOC AM A, V24, P1358, DOI 10.1364/JOSAA.24.001358; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; Lindeberg T., 1994, SCALE SPACE THEORY C; Lombardo M, 2011, OPHTALMOLOGY; Lombardo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107402; Lombardo M, 2013, RETINA-J RET VIT DIS, V33, P1640, DOI 10.1097/IAE.0b013e3182807642; Lombardo M, 2013, OPHTHAL PHYSL OPT, V33, P516, DOI 10.1111/opo.12053; Lombardo M, 2012, J CATARACT REFR SURG, V38, P1147, DOI 10.1016/j.jcrs.2012.02.033; Muthiah MN, 2014, BRIT J OPHTHALMOL, V98, P1073, DOI 10.1136/bjophthalmol-2013-304615; Obata R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091873; Osterberg G., 1935, ACTA OPHTHALMOL, V6, P11; PandaJonas S, 1995, OPHTHALMOLOGY, V102, P1853, DOI 10.1016/S0161-6420(95)30784-1; Park SP, 2013, EXP EYE RES, V108, P1, DOI 10.1016/j.exer.2012.12.011; Rees AL, 2005, INT C SER, V1282, P694, DOI DOI 10.1016/JICS.2005.05.172; Song HX, 2011, INVEST OPHTH VIS SCI, V52, P7376, DOI 10.1167/iovs.11-7199; Supriya D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/968672; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Viard C, 2011, PROC SPIE, V7885, DOI 10.1117/12.874766; Wells-Gray EM, 2016, EYE, V30, P1135, DOI 10.1038/eye.2016.107; Wilkinson MO, 2016, J VISION, V16, DOI 10.1167/16.2.1; Zhang TJ, 2015, AM J OPHTHALMOL, V160, P290, DOI 10.1016/j.ajo.2015.04.034	38	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191141	10.1371/journal.pone.0191141	http://dx.doi.org/10.1371/journal.pone.0191141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338027	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700032
J	Kawasaki, M; Arata, N; Miyazaki, C; Mori, R; Kikuchi, T; Ogawa, Y; Ota, E				Kawasaki, Maki; Arata, Naoko; Miyazaki, Celine; Mori, Rintaro; Kikuchi, Toru; Ogawa, Yoshihiro; Ota, Erika			Obesity and abnormal glucose tolerance in offspring of diabetic mothers: A systematic review and meta-analysis	PLOS ONE			English	Review							MELLITUS; TYPE-1; OVERWEIGHT; RISK; PREGNANCY; ADIPOSITY; WOMEN; CHILDHOOD; HYPERGLYCEMIA; ADOLESCENTS	Background Rising prevalence of childhood obesity and type 2 diabetes mellitus (T2DM) is an emerging public health issue. Objectives To investigate the association of maternal hyperglycemia exposure during pregnancy with obesity and abnormal glucose tolerance in offspring, and the age at occurrence. Methods We searched MEDLINE and EMBASE for observational studies on obesity and diabetes in offspring of diabetic mothers (gestational diabetes mellitus (GDM), type 1 diabetes mellitus (T1DM) and T2DM), and those on non-diabetic mothers. We performed fixed effect meta-analysis for all studies except when heterogeneity was detected. The quality of studies was evaluated using the Risk of Bias Assessment Tool for Nonrandomized Studies (RoBANS) Results Twenty observational studies were included involving a total of 26,509 children. Offspring of GDM mother had higher BMI z-score in childhood (pooled MD: 0.14, 95% CI: 0.04-0.24, seven studies, 21,691children, low quality of evidence). Offspring of T1DM mothers had higher BMI z-score from prepubertal to adolescent (pooled MD: 0.35, 95% CI: 0.13-0.58, three studies, 844 children, low quality of evidence) compared with control. After adjustment for maternal pre-pregnancy BMI, this association remained in offspring of T1DM, but disappeared in those of GDM mothers. Offspring of GDM mother had higher 2-hour plasma glucose from prepubertal to early adulthood (pooled MD: 0.43 mmol/L, 95% CI: 0.18-0.69, five studies, 890 children), while those of T1DM mothers had higher rate of T2DM in 2 -5 years old to early adulthood (pooled odds ratio [OR], 6.10: 95% CI: 1.23-30.37, two studies, 448 children, very low quality of evidence) compared with control. As there was only one study with offspring of T2DM mothers, evidence is sparse. Limitations Only observational studies were included, with a few adequately adjusted for covariables. Conclusions Exposure to maternal hyperglycemia was associated with offspring obesity and abnormal glucose tolerance especially in offspring of T1DM mothers, but the evidence relies on observational studies with low quality of evidence only.	[Kawasaki, Maki; Miyazaki, Celine; Mori, Rintaro; Ota, Erika] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Kawasaki, Maki; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Tokyo, Japan; [Arata, Naoko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Div Maternal Med, Tokyo, Japan; [Kikuchi, Toru] Saitama Med Univ Hosp, Dept Pediat, Saitama, Japan; [Ogawa, Yoshihiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka, Japan; [Ota, Erika] St Lukes Int Univ, Grad Sch Nursing, Global Hlth Nursing, Tokyo, Japan	National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU); National Center for Child Health & Development - Japan; Saitama Medical University; Kyushu University; St. Luke's International Hospital	Arata, N (corresponding author), Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Div Maternal Med, Tokyo, Japan.	arata-n@ncchd.go.jp		Mori, Rintaro/0000-0001-7656-6156; Ogawa, Yoshihiro/0000-0002-0834-2836; Arata, Naoko/0000-0003-2667-7653	Research Promotion and Practical Use for Women's Health, Japan Agency for Medical Research and Development (AMED) [15gk0210010h0101/ 16gk02100012h0001]; National Center for Child Health and Development, Japan [26A-5]	Research Promotion and Practical Use for Women's Health, Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); National Center for Child Health and Development, Japan	This work was supported by a grant from Research Promotion and Practical Use for Women's Health, Japan Agency for Medical Research and Development (AMED) (grant number 15gk0210010h0101/ 16gk02100012h0001) and a grant from the National Center for Child Health and Development (grant number 26A-5), Japan.	Boerschmann H, 2010, DIABETES CARE, V33, P1845, DOI 10.2337/dc10-0139; Buinauskiene J, 2004, PEDIATR DIABETES, V5, P143, DOI 10.1111/j.1399-543X.2004.00054.x; Buzinaro EF, 2008, ARQ BRAS ENDOCRINOL, V52, P85, DOI 10.1590/S0004-27302008000100012; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Davis JN, 2013, J PEDIATR-US, V162, P741, DOI 10.1016/j.jpeds.2012.10.001; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; Gungor NK, 2014, J CLIN RES PEDIATR E, V6, P129, DOI [10.4274/jcrpe.1471, 10.4274/Jcrpe.1471]; Hakanen T, 2016, ACTA PAEDIATR, V105, P1166, DOI 10.1111/apa.13468; Holder T, 2014, DIABETOLOGIA; Hummel S, 2009, DIABETES CARE, V32, P921, DOI [10.2337/dc08-1943, 10.2337/dc09-1379]; Hunter WA, 2004, DIABETES CARE, V27, P1148, DOI 10.2337/diacare.27.5.1148; James M., 2000, STAT MODELS EPIDEMIO, P1; Khatib O, 2004, East Mediterr Health J, V10, P778; Kim SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/541308; Kim SY, 2013, J CLIN EPIDEMIOL, V66, P408, DOI 10.1016/j.jclinepi.2012.09.016; Landon MB, 2015, DIABETES CARE, V38, P445, DOI 10.2337/dc14-2159; Leng JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129536; Lindsay RS, 2010, DIABETES CARE, V33, P1080, DOI 10.2337/dc09-1766; Manderson JG, 2002, DIABETOLOGIA, V45, P991, DOI 10.1007/s00125-002-0865-y; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Page KA, 2014, J PEDIATR-US, V164, P807, DOI 10.1016/j.jpeds.2013.11.063; Patel S, 2012, DIABETES CARE, V35, P63, DOI 10.2337/dc11-1633; Pham MT, 2013, OBSTET GYNECOL, V121, P976, DOI 10.1097/AOG.0b013e31828bf70d; Philipps LH, 2011, DIABETOLOGIA, V54, P1957, DOI 10.1007/s00125-011-2180-y; Pirkola J, 2010, DIABETES CARE, V33, P1115, DOI 10.2337/dc09-1871; Rinaudo P, 2012, ANNU REV PHYSIOL, V74, P107, DOI 10.1146/annurev-physiol-020911-153245; Robins J.M., 2000, STAT MODELS EPIDEMIO, P1; Rodrigues S, 1998, CLIN INVEST MED, V21, P258; Sobngwi E, 2003, LANCET, V361, P1861, DOI 10.1016/S0140-6736(03)13505-2; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tam WH, 2010, DIABETES CARE, V33, P1382, DOI 10.2337/dc09-2343; Vlachova Z, 2015, DIABETOLOGIA, V58, P1454, DOI 10.1007/s00125-015-3589-5; Vos Miriam B, 2010, Curr Gastroenterol Rep, V12, P280, DOI 10.1007/s11894-010-0116-1; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.2.e9; Wright CS, 2009, AM J HYPERTENS, V22, P215, DOI 10.1038/ajh.2008.326; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	38	83	88	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190676	10.1371/journal.pone.0190676	http://dx.doi.org/10.1371/journal.pone.0190676			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329330	gold, Green Published, Green Submitted			2022-12-27	WOS:000419954100018
J	Jehangir, N; Yu, CY; Song, J; Shariati, MA; Binder, S; Beyer, J; Santini, V; Poston, K; Liao, YJ				Jehangir, Naz; Yu, Caroline Yizhu; Song, Jeehey; Shariati, Mohammad Ali; Binder, Steven; Beyer, Jill; Santini, Veronica; Poston, Kathleen; Liao, Yaping Joyce			Slower saccadic reading in Parkinson's disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; KING-DEVICK TEST; EYE-MOVEMENTS; GLAUCOMA; DEFICITS; COMPREHENSION; INVOLVEMENT; PREVALENCE; SPEED	Idiopathic Parkinson's Disease (PD) is characterized by degeneration of dopaminergic and other neurons, leading to motor and non-motor deficits. Abnormal eye movements in PD, including fixations, saccades, and convergence, are well described. However, saccadic reading, which requires serial and alternating saccades and fixations, is not well studied, despite its obvious impact on the quality of life. In this study, we assessed saccadic reading using variations of the King-Devick (KD) test, a rapid single digit number naming test, as a way to assess the ability to make serial left-to-right ocular motor movements necessary for reading. We recruited 42 treated PD patients and 80 age-matched controls and compared their reading times with a variety of measures, including age, duration of disease, Unified Parkinson's Disease Rating Scale (UPDRS), the National Eye Institute 25-Item Visual Functioning Questionnaire 25 (VFQ-25), and Montreal Cognitive assessment (MoCA) test. The subjects performed 4 trials of reading 120 single digit numbers aloud as fast as possible without making errors. In each trial, they read 3 pages (KD1, KD2, and KD3), and each page contained 40 numbers per page in 8 lines with 5 numbers/line. We found that PD patients read about 20% slower than controls on all tests (KD1, 2, and 3 tests) (p < 0.02), and both groups read irregularly spaced numbers slower than regularly spaced numbers. Having lines between numbers to guide reading (KD1 tests) did not impact reading time in both PD and controls, but increased visual crowding as a result of decreased spacing between numbers (KD3 tests) was associated with significantly slower reading times in both PD and control groups. Our study revealed that saccadic reading is slower in PD, but controls and PD patients are both impacted by visuospatial planning challenges posed by increased visual crowding and irregularity of number spacing. Reading time did not correlate with UPDRS or MoCA scores in PD patients but significantly correlated with age, duration of disease, and VFQ-25 scores. The presence of convergence insufficiency did not significantly correlate with reading time in PD patients, although on average there was slower reading time in those with convergence insufficiency by 8 s (p = 0.2613). We propose that a simple reading task using 120 single-digit numbers can be used as a screening tool in the clinical setting to assess functional ocular motor difficulties in Parkinson's disease that can have a profound impact on quality of life.	[Jehangir, Naz; Yu, Caroline Yizhu; Song, Jeehey; Shariati, Mohammad Ali; Binder, Steven; Beyer, Jill; Liao, Yaping Joyce] Stanford Univ, Sch Med, Dept Ophthalmol, Stanford, CA 94305 USA; [Santini, Veronica; Poston, Kathleen; Liao, Yaping Joyce] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA	Stanford University; Stanford University	Liao, YJ (corresponding author), Stanford Univ, Sch Med, Dept Ophthalmol, Stanford, CA 94305 USA.; Liao, YJ (corresponding author), Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA.	yjliao@stanford.edu	Shariati, Mohammad Ali/HCI-4375-2022	Poston, Kathleen/0000-0003-3424-7143	NANOS Pilot Grant; Michael J Fox foundation for Parkinson's disease research; NIH [AG047366, NS075097]; NATIONAL INSTITUTE ON AGING [P50AG047366] Funding Source: NIH RePORTER	NANOS Pilot Grant; Michael J Fox foundation for Parkinson's disease research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.Liao was supported by the NANOS Pilot Grant; K.L. Poston was supported by the Michael J Fox foundation for Parkinsons disease research and the NIH (AG047366 and NS075097); V. Santini was supported by the NIH (AG047366). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, NEUROLOGY, V75, P1062, DOI 10.1212/WNL.0b013e3181f39d0e; Almer Z, 2012, OPHTHALMOLOGY, V119, P178, DOI 10.1016/j.ophtha.2011.06.040; Barone P, 2011, MOVEMENT DISORD, V26, P2483, DOI 10.1002/mds.23919; Bodis-Wollner I, 2013, BEHAV NEUROSCI, V127, P139, DOI 10.1037/a0031225; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; Burani C, 2002, BRAIN LANG, V81, P568, DOI 10.1006/brln.2001.2548; Cameron IGM, 2012, NEUROIMAGE, V60, P1156, DOI 10.1016/j.neuroimage.2012.01.057; Chambers JM, 2010, NEUROPSYCHOLOGIA, V48, P887, DOI 10.1016/j.neuropsychologia.2009.11.006; Davies EC, 2012, NEUROLOGY, V78, pE103, DOI 10.1212/WNL.0b013e318251833d; Ding W, 2015, EUR REV MED PHARMACO, V19, P2275; Dodick D, 2017, J CHILD NEUROL, V32, P104, DOI 10.1177/0883073816668704; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2017, ALZ DIS ASSOC DIS, V31, P152, DOI 10.1097/WAD.0000000000000157; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Ganguly G, 2017, DRUG DES DEV THER, V11, P797, DOI 10.2147/DDDT.S130514; Giacomelli G, 2010, EUR J OPHTHALMOL, V20, P389, DOI 10.1177/112067211002000220; Grossman M, 1999, BRAIN COGNITION, V40, P387, DOI 10.1006/brcg.1999.1087; Grotheer M, 2016, NEUROIMAGE, V132, P314, DOI 10.1016/j.neuroimage.2016.02.069; Hainline C, 2017, J NEUROL, V264, P989, DOI 10.1007/s00415-017-8484-1; Howitt Scott, 2016, J Can Chiropr Assoc, V60, P322; HUNT LA, 1995, OPTOMETRY VISION SCI, V72, P92, DOI 10.1097/00006324-199502000-00008; Ikeda Masahiro, 2017, Am J Neurodegener Dis, V6, P9; Inzelberg R, 2004, VISION RES, V44, P2793, DOI 10.1016/j.visres.2004.06.009; KENNARD C, 1989, REV NEUROL, V145, P587; Krumholtz I, 2000, Optometry, V71, P426; Law C, 2017, CAN J NEUROL SCI, V44, P562, DOI 10.1017/cjn.2017.39; Lee C, 2003, BRAIN LANG, V85, P347, DOI 10.1016/S0093-934X(03)00063-4; Lemos J, 2016, BRAIN RES, V1648, P469, DOI 10.1016/j.brainres.2016.07.037; LEVIN BE, 1989, NEUROLOGY, V39, P557, DOI 10.1212/WNL.39.4.557; LIEBERMAN P, 1990, J NERV MENT DIS, V178, P360, DOI 10.1097/00005053-199006000-00003; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; Lovie-Kitchin JE, 2000, OPHTHAL PHYSL OPT, V20, P360, DOI 10.1016/S0275-5408(99)00088-5; Mailankody P, 2015, PARKINSONISM RELAT D, V21, P1164, DOI 10.1016/j.parkreldis.2015.08.002; Manenti R, 2016, MOVEMENT DISORD, V31, P715, DOI 10.1002/mds.26561; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Matsumoto H, 2011, MOVEMENT DISORD, V26, P1619, DOI 10.1002/mds.23683; Ming WD, 2016, INVEST OPHTH VIS SCI, V57, P5696, DOI 10.1167/iovs.16-20025; Montse A, 2001, J CLIN EXP NEUROPSYC, V23, P592, DOI 10.1076/jcen.23.5.592.1248; Moschos MM, 2011, EUR J OPHTHALMOL, V21, P24, DOI 10.5301/EJO.2010.1318; Moster S, 2014, J NEUROL SCI, V343, P105, DOI 10.1016/j.jns.2014.05.047; Murata N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170230; Murphy R, 2013, IRISH J MED SCI, V182, P415, DOI 10.1007/s11845-013-0902-5; Nowacka B, 2015, DOC OPHTHALMOL, V131, P95, DOI 10.1007/s10633-015-9503-0; Nowacka B, 2014, MED SCI MONITOR, V20, P2243, DOI 10.12659/MSM.890861; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Pasol J, 2011, CURR OPIN OPHTHALMOL, V22, P124, DOI 10.1097/ICU.0b013e328343c1a3; Piras F, 2009, NEUROPSYCHOLOGIA, V47, P1944, DOI 10.1016/j.neuropsychologia.2009.03.006; Pitcher TL, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-17; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Ramulu PY, 2013, INVEST OPHTH VIS SCI, V54, P673, DOI 10.1167/iovs.12-10617; Ramulu PY, 2013, INVEST OPHTH VIS SCI, V54, P666, DOI 10.1167/iovs.12-10618; Ramulu PY, 2009, ARCH OPHTHALMOL-CHIC, V127, P82, DOI 10.1001/archophthalmol.2008.523; RASCOL O, 1989, BRAIN, V112, P1193, DOI 10.1093/brain/112.5.1193; Shaunak S, 1999, MOVEMENT DISORD, V14, P80, DOI 10.1002/1531-8257(199901)14:1<80::AID-MDS1014>3.0.CO;2-M; Srivastava A, 2014, INDIAN J OPHTHALMOL, V62, P538, DOI 10.4103/0301-4738.133482; Vinuela-Navarro V, 2017, OPHTHAL PHYSL OPT, V37, P531, DOI 10.1111/opo.12392; Yu CY, 2016, PARKINSONISM RELAT D, V32, P130, DOI 10.1016/j.parkreldis.2016.08.008; Zhang TM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005400	59	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191005	10.1371/journal.pone.0191005	http://dx.doi.org/10.1371/journal.pone.0191005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364897	gold, Green Published, Green Submitted			2022-12-27	WOS:000423412500032
J	Bolotin, S; Feld, JJ; Garber, G; Wong, WWL; Guerra, FM; Mazzulli, T				Bolotin, Shelly; Feld, Jordan J.; Garber, Gary; Wong, William W. L.; Guerra, Fiona M.; Mazzulli, Tony			Population-based estimate of hepatitis C virus prevalence in Ontario, Canada	PLOS ONE			English	Article							INFECTION	Background & para;& para;Hepatitis C virus (HCV) is the most burdensome infectious illness in Canada. Current screening strategies miss a significant proportion of cases, leaving many undiagnosed. Elevated HCV prevalence in those born between 1945 and 1965 has prompted calls for birth-cohort screening in this group. However, Canada lacks population-level data to support this recommendation. We performed a serosurvey to obtain population-based HCV prevalence estimates in Ontario residents born between 1945-1974, to generate evidence for birth-cohort screening recommendations.& para;& para;Methods & para;& para;We tested anonymized residual sera in five-year age-sex bands from Ontario for anti-HCV antibody. We performed descriptive epidemiological analysis and used a logistic regression model to determine HCV risk-factors.& para;& para;Results & para;& para;Of 10,006 sera analyzed, 155 (1.55%, 95% confidence interval (CI) 1.32, 1.81) were positive for HCV antibody. Individuals born between 1950-1964 had a significantly higher combined prevalence of 1.92% (95% CI 1.56, 2.34) compared to 1.14% (95% CI 0.69, 1.77) (p = 0.04) for those born between 1970-1974. For males, comprising 107/155 (69.03%) of positive samples, the highest prevalence was 3.00% (95% CI 1.95, 4.39) for the 1960-1964 birth cohort. For females, the highest prevalence was 1.56% (95% CI 0.83, 2.65) for those born between 1955-1959. Male sex was significantly associated with positive HCV serostatus.& para;& para;Interpretation & para;& para;HCV prevalence in Ontario is highest among those in this birth cohort, and higher than previous estimates. The prevalence estimates presented in our study provide important data to underpin birth-cohort screening recommendations.	[Bolotin, Shelly; Garber, Gary; Guerra, Fiona M.; Mazzulli, Tony] Publ Hlth Ontario, Toronto, ON, Canada; [Bolotin, Shelly] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Feld, Jordan J.] Toronto Gen Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada; [Feld, Jordan J.] Univ Toronto, Sandra Rotman Ctr Global Hlth, Toronto, ON, Canada; [Garber, Gary] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Wong, William W. L.] Univ Waterloo, Sch Pharm, Kitchener, ON, Canada; [Mazzulli, Tony] Univ Hlth Network, Mt Sinai Hosp, Toronto, ON, Canada; [Mazzulli, Tony] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Waterloo; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto; University of Toronto	Bolotin, S (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Bolotin, S (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	shelly.bolotin@oahpp.ca	Feld, Jordan/AAH-5628-2020	Feld, Jordan/0000-0003-2640-2211; Wong, William W.L./0000-0003-4630-0052	Public Health Ontario Project Initiation Fund	Public Health Ontario Project Initiation Fund	Funding for this study was provided by a Public Health Ontario Project Initiation Fund grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branswell H, 2013, GLOBE MAIL; Buxton JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-225; Canadian Agency for Drugs and Technologies in Health (CADTH), 2015, HOLK OMB PAR RIT DAS; Canadian liver foundation, 2012, POS STAT HEP C TEST; CDC, 2015, TEST REC HEP C VIR I; Grad R, 2017, CAN MED ASSOC J, V189, pE594, DOI 10.1503/cmaj.161521; Grebely J, 2009, J VIRAL HEPATITIS, V16, P352, DOI 10.1111/j.1365-2893.2009.01080.x; Joy JB, 2016, LANCET INFECT DIS, V16, P698, DOI 10.1016/S1473-3099(16)00124-9; Klumpp K, 2011, HEPATITIS C: ANTIVIRAL DRUG DISCOVERY AND DEVELOPMENT, P293; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Minuk GY, 2003, CAN J GASTROENTEROL, V17, P707, DOI 10.1155/2003/350175; Myers RP, 2008, CAN J GASTROENTEROL, V22, P381, DOI 10.1155/2008/173153; O'Brien SF, 2008, TRANSFUSION, V48, P902, DOI 10.1111/j.1537-2995.2007.01618.x; Ontario Agency for Health Protection and Promotion (Public Health Ontario-PHO) Provincial Infectious Diseases Advisory Committee, 2014, REC PUBL HLTH RESP H; Ontario Ministry of Health and Long-Term Care IntelliHEALTH Ontario, 2012, POPULATION ESTIMATES; Public Health Agency of Canada, 2011, HEP C CAN 2005 2010; Remis RS, 2007, MODELLING INCIDENCE; Rotermann M, 2013, HEALTH REP, V24, P3; Shah HA, 2013, CAN MED ASSOC J, V185, P1325, DOI 10.1503/cmaj.121872; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Statistics Canada, 2016, TABL 051 0001 EST PO; Stewart Lynn A, 2015, CMAJ Open, V3, pE97, DOI 10.9778/cmajo.20140025; Trubnikov M, 2014, Can Commun Dis Rep, V40, P429; Trubnikov Max, 2014, CMAJ Open, V2, pE281, DOI 10.9778/cmajo.20140041; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; Wong WWL, 2015, CAN MED ASSOC J, V187, pE110, DOI 10.1503/cmaj.140711; Wood E, 2005, PUBLIC HEALTH, V119, P1111, DOI 10.1016/j.puhe.2005.05.006; World Health Organization, 2016, HEP C FACT SHEET	29	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191184	10.1371/journal.pone.0191184	http://dx.doi.org/10.1371/journal.pone.0191184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360823	Green Submitted, Green Published, gold			2022-12-27	WOS:000423161800018
J	Chalkias, S; Gorham, JM; Mazaika, E; Partenov, M; Deng, X; DePalma, S; McKean, D; Seidman, CE; Seidman, JG; Koralnik, IJ				Chalkias, Spyros; Gorham, Joshua M.; Mazaika, Erica; Partenov, Michael; Deng, Xin; DePalma, Steve; McKean, David; Seidman, Christine E.; Seidman, Jonathan G.; Koralnik, Igor J.			ViroFind: A novel target-enrichment deep-sequencing platform reveals a complex JC virus population in the brain of PML patients	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; MULTIPLE-SCLEROSIS; DNA; IMMUNOSUPPRESSION; POLYOMAVIRUSES; MUTATIONS; INFECTION; VARIANT; VIROME; TISSUE	Deep nucleotide sequencing enables the unbiased, broad-spectrum detection of viruses in clinical samples without requiring an a priori hypothesis for the source of infection. However, its use in clinical research applications is limited by low cost-effectiveness given that most of the sequencing information from clinical samples is related to the human genome, which renders the analysis of viral genomes challenging. To overcome this limitation we developed ViroFind, an in-solution target-enrichment platform for virus detection and discovery in clinical samples. ViroFind comprises 165,433 viral probes that cover the genomes of 535 selected DNA and RNA viruses that infect humans or could cause zoonosis. The ViroFind probes are used in a hybridization reaction to enrich viral sequences and therefore enhance the detection of viral genomes via deep sequencing. We used ViroFind to detect and analyze all viral populations in the brain of 5 patients with progressive multifocal leukoencephalopathy (PML) and of 18 control subjects with no known neurological disease. Compared to direct deep sequencing, by using ViroFind we enriched viral sequences present in the clinical samples up to 127-fold. We discovered highly complex polyoma virus JC populations in the PML brain samples with a remarkable degree of genetic divergence among the JC virus variants of each PML brain sample. Specifically for the viral capsid protein VP1 gene, we identified 24 single nucleotide substitutions, 12 of which were associated with amino acid changes. The most frequent (4 of 5 samples, 80%) amino acid change was D66H, which is associated with enhanced tissue tropism, and hence likely a viral fitness advantage, compared to other variants. Lastly, we also detected sparse JC virus sequences in 10 of 18 (55.5%) of control samples and sparse human herpes virus 6B (HHV6B) sequences in the brain of 11 of 18 (61.1%) control subjects. In sum, ViroFind enabled the in-depth analysis of all viral genomes in PML and control brain samples and allowed us to demonstrate a high degree of JC virus genetic divergence in vivo that has been previously underappreciated. ViroFind can be used to investigate the structure of the virome with unprecedented depth in health and disease state.	[Chalkias, Spyros; Deng, Xin; Koralnik, Igor J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Dept Med,Div NeuroImmunol, Boston, MA 02115 USA; [Chalkias, Spyros; Gorham, Joshua M.; Mazaika, Erica; Partenov, Michael; DePalma, Steve; McKean, David; Seidman, Christine E.; Seidman, Jonathan G.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Deng, Xin; Koralnik, Igor J.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Chalkias, Spyros] Biogen, Cambridge, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Rush University; Biogen	Koralnik, IJ (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Dept Med,Div NeuroImmunol, Boston, MA 02115 USA.; Koralnik, IJ (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	igor_koralnik@rush.edu		DePalma, Steven/0000-0002-0381-5016	Chief Scientific Officer Pilot Grants, Beth Israel Deaconess Medical Center [U01-HL098188, U01-HL098147, U01-HL098153, U01-HL098163, U01-HL098123, U01-HL098162]; Howard Hughes Medical Institute [NIH R01 NS047029, NS074995, R21 NS099787]; Biogen; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074995, R01NS047029] Funding Source: NIH RePORTER	Chief Scientific Officer Pilot Grants, Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Biogen(Biogen); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Chief Scientific Officer Pilot Grants, Beth Israel Deaconess Medical Center to Dr. S. Chalkias U01-HL098188, U01-HL098147, U01-HL098153, U01-HL098163, U01-HL098123, and U01-HL098162, to Dr. J. Seidman, the Howard Hughes Medical Institute to Dr. C. Seidman NIH R01 NS047029 and NS074995, R21 NS099787 and a research grant from Biogen to Dr. I. Koralnik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss J, 2011, PATHOLOGY, V43, P362, DOI 10.1097/PAT.0b013e3283463558; Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15; Chou SW, 2014, ANTIMICROB AGENTS CH, V58, P4697, DOI 10.1128/AAC.03214-14; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; Dang X, 2012, J GEN VIROL, V93, P175, DOI 10.1099/vir.0.037440-0; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Delbue S, 2009, J NEUROVIROL, V15, P51, DOI 10.1080/13550280802425467; Ferenczy MW, 2012, CLIN MICROBIOL REV, V25, P471, DOI 10.1128/CMR.05031-11; Gheuens S, 2013, ANNU REV PATHOL-MECH, V8, P189, DOI 10.1146/annurev-pathol-020712-164018; Gorelik L, 2011, J INFECT DIS, V204, P103, DOI 10.1093/infdis/jir198; Jelcic I, 2016, ANN NEUROL, V79, P404, DOI 10.1002/ana.24574; Jelcic I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8691; Lam WY, 2010, J CLIN VIROL, V48, P11, DOI 10.1016/j.jcv.2010.01.017; Leibovitch EC, 2014, CURR OPIN VIROL, V9, P127, DOI 10.1016/j.coviro.2014.09.016; Lipkin WI, 2015, VIROLOGY, V479, P194, DOI 10.1016/j.virol.2015.02.006; Marshall LJ, 2012, J GEN VIROL, V93, P651, DOI 10.1099/vir.0.035832-0; Marshall LJ, 2010, J GEN VIROL, V91, P3042, DOI 10.1099/vir.0.023184-0; McCrone JT, 2016, J VIROL, V90, P6884, DOI 10.1128/JVI.00667-16; Merelli E, 1997, J NEUROL, V244, P450, DOI 10.1007/s004150050121; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Nakamichi K, 2013, ARCH VIROL, V158, P639, DOI 10.1007/s00705-012-1532-3; Orton RJ, 2016, REV SCI TECH OIE, V35, P271, DOI 10.20506/rst.35.1.2432; Pal S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S17-S7; Parfenov M, 2015, CURR PROTOC HUM GENE, V86; Perez-Liz G, 2008, ANN NEUROL, V64, P379, DOI 10.1002/ana.21443; Ray U, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1720; Reid CE, 2011, J INFECT DIS, V204, P237, DOI 10.1093/infdis/jir256; Renzette N, 2014, CURR OPIN VIROL, V8, P109, DOI 10.1016/j.coviro.2014.08.001; Renzette N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003735; Sahoo MK, 2013, J CLIN MICROBIOL, V51, P3700, DOI 10.1128/JCM.01605-13; Sanders VJ, 1996, J NEUROVIROL, V2, P249, DOI 10.3109/13550289609146888; Sunyaev SR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000368; Takahashi K, 2017, J VIROL, V91, DOI [10.1128/JVI.01335-16, 10.1128/jvi.01335-16]; Tan CS, 2010, J VIROL, V84, P9200, DOI 10.1128/JVI.00609-10; Van Loy T, 2015, J VIROL, V89, P1340, DOI 10.1128/JVI.02565-14; Van Loy T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070950; Wharton KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155897; WHITE FA, 1992, J VIROL, V66, P5726, DOI 10.1128/JVI.66.10.5726-5734.1992; Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115; Yang X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-674	40	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0186945	10.1371/journal.pone.0186945	http://dx.doi.org/10.1371/journal.pone.0186945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360822	gold, Green Published, Green Submitted			2022-12-27	WOS:000423161800001
J	Ogunsemowo, O; Olaleye, DO; Odaibo, GN				Ogunsemowo, Olukunle; Olaleye, David O.; Odaibo, Georgina N.			Genetic diversity of human respiratory syncytial virus circulating among children in Ibadan, Nigeria	PLOS ONE			English	Article							G-PROTEIN; G-GLYCOPROTEIN; ON1 GENOTYPE; EPIDEMIOLOGY; DUPLICATION; SUBGROUP; SEASONS	Human respiratory syncytial virus (HRSV) is the most common viral cause of acute lower respiratory tract infections (LRTIs) in infants and young children however, without an effective vaccine licensed for human use till date. Information on the circulating genotypes of HRSV from regions with high-burden of infection is vital in the global efforts towards the development of protective vaccine. We report here the genotypes of HRSV circulating among children in Ibadan, the first of such from Nigeria. Nasopharyngeal and oropharyngeal swabs collected from 231 children presenting with respiratory infections in some health facilities for care as well as those attending immunization centers for routine vaccination in Ibadan, Nigeria were used for the study. The 2nd hypervariable (HVR2) region of the glycoprotein (G) gene of HRSV was amplified and sequenced using HRSV group specific primers. HRSV was detected in 41 out of the 231 samples. Thirty-three of the isolates were successfully subtyped(22 subtype A and 11 subtype B). Fourteen of the subtype A and all the subtype B were successfully sequenced and genotyped. Phylogenetic analysis showed that genotype ON1 with 72 nucleotide (nt) duplication was the major subgroup A virus (11 of 14) detected together with genotype NA2. All the HRSV subtype B detected belong to the BA genotype with characteristic 60nt duplication. The ON1 genotypes vary considerably from the prototype strain due to amino acid substitutions including T2921 which has not been reported elsewhere. The NA2 genotypes have mutations on four antigenic sites within the HVR2relative to the prototype A2. In conclusion, three genotypes of HRSV were found circulating in Ibadan, Nigeria. Additional study that will include isolates from other parts of the country will be done to determine the extent of genotype diversity of HRSV circulating in Nigeria.	[Ogunsemowo, Olukunle; Olaleye, David O.; Odaibo, Georgina N.] Univ Ibadan, Coll Med, Dept Virol, Ibadan, Nigeria	University of Ibadan	Odaibo, GN (corresponding author), Univ Ibadan, Coll Med, Dept Virol, Ibadan, Nigeria.	foreodaibo@hotmail.com			Medical Education Partnership Initiative in Nigeria (MEPIN) project - National Human Genome Research Institute of the National Institute of Health; Medical Education Partnership Initiative in Nigeria (MEPIN) project - Office of AIDS Research of the National Institute of Health; Health Resources and Services Administration (HRSA); Medical Education Partnership Initiative in Nigeria (MEPIN) project - Fogarty International Center of the National Institute of Health; Office of the U.S. Global AIDS Coordinator [R24TW008878]; FOGARTY INTERNATIONAL CENTER [R24TW008878] Funding Source: NIH RePORTER	Medical Education Partnership Initiative in Nigeria (MEPIN) project - National Human Genome Research Institute of the National Institute of Health; Medical Education Partnership Initiative in Nigeria (MEPIN) project - Office of AIDS Research of the National Institute of Health; Health Resources and Services Administration (HRSA)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Medical Education Partnership Initiative in Nigeria (MEPIN) project - Fogarty International Center of the National Institute of Health; Office of the U.S. Global AIDS Coordinator; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Writing of this paper was supported by the Medical Education Partnership Initiative in Nigeria (MEPIN) project funded by Fogarty International Center, the Office of AIDS Research, and the National Human Genome Research Institute of the National Institute of Health, the Health Resources and Services Administration (HRSA) and the Office of the U.S. Global AIDS Coordinator under Award Number R24TW008878. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074018; Agoti CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/eid2006.131438; Amarasinghe GK, 2018, ARCH VIROL, V163, P2283, DOI 10.1007/s00705-018-3814-x; Bigogo GM, 2013, J INFECT DIS, V208, pS207, DOI 10.1093/infdis/jit489; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; Cane P, 2007, RESP SYNCYTIAL VIRUS, P89; Cane PA, 1997, J MED VIROL, V51, P297, DOI 10.1002/(SICI)1096-9071(199704)51:4<297::AID-JMV7>3.0.CO;2-0; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Cui GL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.19; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Tran DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045436; Duvvuri VR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14268; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Fall A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157163; Human S, 2016, FUTUR VIROL; Khan WH, 2014, ORIGINAL RES ARTICLE, V3, P107; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419; MORRIS JA, 1956, P SOC EXP BIOL MED, V92, P544, DOI 10.3181/00379727-92-22538; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Ohno A, 2013, J CLIN VIROL, V57, P59, DOI 10.1016/j.jcv.2013.01.001; PALOMO C, 1991, J GEN VIROL, V72, P669, DOI 10.1099/0022-1317-72-3-669; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Ren L, 2014, INFECT GENET EVOL, V27, P339, DOI 10.1016/j.meegid.2014.07.030; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Scott PD, 2007, J MED VIROL, V79, P1943, DOI 10.1002/jmv.20999; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; Tamura K., 2011, MOL BIOL EVOLU UNPUB; Tapia LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090786; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Zheng YX, 2017, J MED VIROL, V89, P222, DOI 10.1002/jmv.24640	35	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191494	10.1371/journal.pone.0191494	http://dx.doi.org/10.1371/journal.pone.0191494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360861	gold, Green Submitted, Green Published			2022-12-27	WOS:000423161800034
J	Bourcier, E; Korb-Savoldelli, V; Hejblum, G; Fernandez, C; Hindlet, P				Bourcier, Elsa; Korb-Savoldelli, Virginie; Hejblum, Gilles; Fernandez, Christine; Hindlet, Patrick			A systematic review of regulatory and educational interventions to reduce the burden associated with the prescriptions of sedative-hypnotics in adults treated for sleep disorders	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; BENZODIAZEPINE USE; PRESCRIBING PATTERNS; CHRONIC INSOMNIA; MEDICATION USE; OLDER-PEOPLE; HALF-LIFE; DRUG-USE; RISK; IMPACT	Background The burden of Sedative-Hypnotics (SHs) has been known since the 1980s. Yet, their consumption remains high. A systematic review of the literature should help to assess efficient interventions to improve the appropriate use of SHs in sleep disorders. Objectives To identify and assess regulatory and educational interventions designed to improve the appropriate use of SHs for insomnia treatment. Methods We conducted a systematic review of the literature according to PRISMA guidelines. A systematic search covering the period 1980 +/- 2015 was carried out in Medline, Web of Science, Embase and PsycInfo. We included studies reporting the implementation of regulatory or educational strategies directed towards patients and/or healthcare professionals to improve the appropriate use of SHs to treat insomnia in the community, hospitals and nursing homes. Results Thirty-one studies were included: 23 assessed educational interventions (recommendations by mail/email, computer alerts, meetings, mass media campaigns, prescription profile), 8 assessed regulatory interventions (prescription rule restriction, end of reimbursement). The most recent was implemented in 2009. Restrictive prescription rules were effective to reduce the consumption of targeted SHs but led to a switch to other non-recommended SHs. Among educational interventions, only 3 studies out of 7 reported positive results of mono-faceted interventions; whereas, 13 out of the 16 multi-faceted interventions were reported as efficient: particularly, the active involvement of healthcare professionals and patients and the spread of information through mass media were successful. The risk of bias was high for 24 studies (mainly due to the design), moderate for 3 studies and weak for 4 studies. Conclusion Educational multifaceted studies are presented as the most efficient. But further better designed studies are needed to make evidence-based results more generalizable.	[Bourcier, Elsa; Hejblum, Gilles; Fernandez, Christine; Hindlet, Patrick] Sorbonne Univ, INSERM, IPLESP, UMR S1136, Paris, France; [Bourcier, Elsa; Fernandez, Christine; Hindlet, Patrick] Hop St Antoine, AP HP, Serv Pharm, Paris, France; [Bourcier, Elsa; Korb-Savoldelli, Virginie; Fernandez, Christine; Hindlet, Patrick] Univ Paris Sud, Fac Pharm, Chatenay Malabry, France; [Korb-Savoldelli, Virginie] Hop Europeen Georges Pompidou, AP HP, Serv Pharm, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Bourcier, E (corresponding author), Sorbonne Univ, INSERM, IPLESP, UMR S1136, Paris, France.; Bourcier, E (corresponding author), Hop St Antoine, AP HP, Serv Pharm, Paris, France.; Bourcier, E (corresponding author), Univ Paris Sud, Fac Pharm, Chatenay Malabry, France.	elsa.bourcier@aphp.fr	Korb-Savoldelli, Virginie/D-2134-2012; Hejblum, Gilles/N-6337-2017; Korb-Savoldelli, Virginie/AAW-7011-2021	Hejblum, Gilles/0000-0003-0127-1964; Korb-Savoldelli, Virginie/0000-0003-3496-6244	French National Agency for Medicines and Health Products Safety (Agence Nationale de Securite du Medicament et des Produits de Sante) [AAP-2016-005]	French National Agency for Medicines and Health Products Safety (Agence Nationale de Securite du Medicament et des Produits de Sante)	CF received a grant from the French National Agency for Medicines and Health Products Safety (Agence Nationale de Securite du Medicament et des Produits de Sante), grant number: AAP-2016-005, ansm.sante.fr. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini JV, 2007, J AM GERIATR SOC, V55, P43, DOI 10.1111/j.1532-5415.2006.01006.x; ANSM, ET LIEUX CONS BENZ F; Archambault P, 1999, REV PRATICIEN MED GE, V13, P495; AVORN J, 1992, NEW ENGL J MED, V327, P168, DOI 10.1056/NEJM199207163270306; Bertisch SM, 2014, SLEEP, V37, P343, DOI 10.5665/sleep.3410; Borson S, 1997, PSYCHIATR SERV, V48, P1289; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Bush DM, 2013, EMERGENCY DEP VISITS; CAREY DL, 1992, MED J AUSTRALIA, V156, P389, DOI 10.5694/j.1326-5377.1992.tb139841.x; Chang CM, 2013, BRIT J CLIN PHARMACO, V75, P1125, DOI 10.1111/j.1365-2125.2012.04410.x; Church MK, 2010, ALLERGY, V65, P459, DOI 10.1111/j.1398-9995.2009.02325.x; Clay E, 2013, EUR J CLIN PHARMACOL, V69, P1, DOI 10.1007/s00228-012-1424-1; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; de Gage SB, 2015, EXPERT OPIN DRUG SAF, V14, P733, DOI 10.1517/14740338.2015.1014796; de Gage SB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6231; de Vries OJ, 2013, AGE AGEING, V42, P764, DOI 10.1093/ageing/aft089; DEBURGH S, 1995, AUST J PUBLIC HEALTH, V19, P142; Dollman WB, 2005, J CLIN PHARM THER, V30, P425, DOI 10.1111/j.1365-2710.2005.00674.x; Eide E, 2001, PHARM WORLD SCI, V23, P227, DOI 10.1023/A:1015142211348; Fagnoni P, 2007, PHARM WORLD SCI, V29, P611, DOI 10.1007/s11096-007-9097-z; FERGUSON RI, 1995, PHARMACOECONOMICS, V7, P555, DOI 10.2165/00019053-199507060-00009; Fortuna RJ, 2009, J GEN INTERN MED, V24, P897, DOI 10.1007/s11606-009-1013-x; Gomm W, 2016, J ALZHEIMERS DIS, V54, P801, DOI 10.3233/JAD-151006; Gould RL, 2014, BRIT J PSYCHIAT, V204, P98, DOI 10.1192/bjp.bp.113.126003; Griffith DNW, 1996, AGE AGEING, V25, P490, DOI 10.1093/ageing/25.6.490; Higgins J, 2012, COCHRANE HDB SYSTEMA, P151; Hoebert JM, 2012, ANN FAM MED, V10, P42, DOI 10.1370/afm.1319; Holloway K, 2011, RATIONAL USE MED, P1; HOLM M, 1990, Scandinavian Journal of Primary Health Care, V8, P113, DOI 10.3109/02813439008994941; Jackson N, 2005, HEALTH PROMOT INT, V20, P367, DOI 10.1093/heapro/dai022; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Jorgensen VRK, 2007, CNS DRUGS, V21, P947, DOI 10.2165/00023210-200721110-00006; Jørgensen Viggo Rask Kragh, 2006, Pharmacy Pract (Granada), V4, P74, DOI 10.4321/s1885-642x2006000200004; Lagnaoui R, 2001, PHARMACOEPIDEM DR S, V10, P531, DOI 10.1002/pds.621; Landi F, 2005, J GERONTOL A-BIOL, V60, P622, DOI 10.1093/gerona/60.5.622; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; McDowell JA, 1998, J AM GERIATR SOC, V46, P700, DOI 10.1111/j.1532-5415.1998.tb03803.x; MCNUTT LA, 1994, J CLIN EPIDEMIOL, V47, P613, DOI 10.1016/0895-4356(94)90209-7; Monane M, 1998, JAMA-J AM MED ASSOC, V280, P1249, DOI 10.1001/jama.280.14.1249; Montgomery P, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003161, 10.1002/14651858.CD003161]; Olfson M, 2015, JAMA PSYCHIAT, V72, P136, DOI 10.1001/jamapsychiatry.2014.1763; Onen F, 1997, REV GERIATR, V22, P443; Oosterhuis A, 1997, SOC SCI MED, V45, P1223, DOI 10.1016/S0277-9536(97)00041-5; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Riemann D, 2017, J SLEEP RES; Riemann D, 2009, SLEEP MED REV, V13, P205, DOI 10.1016/j.smrv.2008.06.001; ROKSTAD K, 1995, J CLIN EPIDEMIOL, V48, P1061, DOI 10.1016/0895-4356(94)00238-L; Sateia MJ, 2017, J CLIN SLEEP MED, V13, P307, DOI 10.5664/jcsm.6470; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Seltzer J K, 2000, J Am Pharm Assoc (Wash), V40, P495; Shash D, 2016, ALZHEIMERS DEMENT, V12, P604, DOI 10.1016/j.jalz.2015.10.006; Shen WW, 2002, PSYCHIAT CLIN NEUROS, V56, P425, DOI 10.1046/j.1440-1819.2002.01032.x; Simons FER, 2004, NEW ENGL J MED, V351, P2203, DOI 10.1056/NEJMra033121; Sleath B, 1997, PATIENT EDUC COUNS, V31, P215, DOI 10.1016/S0738-3991(97)00029-3; Smith AJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-321; Smith AJ, 2010, FAM PRACT, V27, P320, DOI 10.1093/fampra/cmq007; Smith DH, 1998, MED CARE, V36, P1013, DOI 10.1097/00005650-199807000-00008; Snowdon J, 1999, MED J AUSTRALIA, V170, P299, DOI 10.5694/j.1326-5377.1999.tb127781.x; Somers A, 2011, EUR J CLIN PHARMACOL, V67, P723, DOI 10.1007/s00228-010-0983-2; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Victorri-Vigneau C, 2003, THERAPIE, V58, P425, DOI 10.2515/therapie:2003069; Wang PS, 2001, J AM GERIATR SOC, V49, P1685, DOI 10.1111/j.1532-5415.2001.49280.x; Wang PS, 2001, AM J PSYCHIAT, V158, P892, DOI 10.1176/appi.ajp.158.6.892; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; World Health Organization, 1972, INT DRUG MON ROL NAT; World Health Organization, 2000, SAF ASP GEN MOD FOOD, P1; Zisberg A, 2012, DRUG AGING, V29, P565, DOI 10.2165/11632350-000000000-00000; ZULLICH SG, 1992, ANN PHARMACOTHER, V26, P539; Zwar N A, 2000, Aust Fam Physician, V29, P1104	69	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191211	10.1371/journal.pone.0191211	http://dx.doi.org/10.1371/journal.pone.0191211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1TP	29357377	Green Published, gold, Green Submitted			2022-12-27	WOS:000422919500010
J	Chang, HC; Kung, CCH; Chang, TT; Jao, SC; Hsu, YT; Li, WS				Chang, Hui-Chuan; Kung, Camy C. -H.; Chang, Tzu-Ting; Jao, Shu-Chuan; Hsu, Yu-Ting; Li, Wen-Shan			Investigation of the proton relay system operative in human cystosolic aminopeptidase P	PLOS ONE			English	Article							COUPLED ELECTRON-TRANSFER; X-PROLYL-AMINOPEPTIDASE; CIRCULAR-DICHROISM SPECTRA; SITE-DIRECTED MUTANT; ESCHERICHIA-COLI; CHEMICAL RESCUE; ACTIVE-SITE; GUANIDINE-HYDROCHLORIDE; THERMAL-STABILITY; SECONDARY STRUCTURE	Aminopeptidase P, a metalloprotease, targets Xaa-Proline peptides for cleavage [1-4]. There are two forms of human AMPP, a membrane-bound form (hmAMPP) and a soluble cytosolic form (hcAMPP)[5]. Similar to the angiotensin-I-converting enzyme, AMPP plays an important role in the catabolism of inflammatory and vasoactive peptides, known as kinins. The plasma kinin, bradykinin, was used as the substrate to conduct enzymatic activity analyses and to determine the Michaelis constant (K-m) of 174 mu M and the catalytic rate constant (k(cat)) of 10.8 s(-1) for hcAMPP. Significant differences were observed in the activities of Y527F and R535A hcAMPP mutants, which displayed a 6-fold and 13.5-fold for decrease in turnover rate, respectively. Guanidine hydrochloride restored the activity of R535A hcAMPP, increasing the k(cat)/K-m 20-fold, yet it had no impact on the activities of the wild-type or Y527F mutant hcAMPPs. Activity restoration by guanidine derivatives followed the order guanidine hydrochloride >> methyl-guanidine > amino-guanidine > N-ethyl-guanidine. Overall, the results indicate the participation of R535 in the hydrogen bond network that forms a proton relay system. The quaternary structure of hcAMPP was determined by using analytical ultracentrifugation (AUC). The results show that alanine replacement of Arg535 destabilizes the hcAMPP dimer and that guanidine hydrochloride restores the native monomer-dimer equilibrium. It is proposed that Arg535 plays an important role in hcAMMP catalysis and in stabilization of the catalytically active dimeric state.	[Chang, Hui-Chuan; Kung, Camy C. -H.; Chang, Tzu-Ting; Hsu, Yu-Ting; Li, Wen-Shan] Acad Sinica, Inst Chem, Taipei, Taiwan; [Jao, Shu-Chuan] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Li, Wen-Shan] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Sun Yat Sen University	Li, WS (corresponding author), Acad Sinica, Inst Chem, Taipei, Taiwan.; Li, WS (corresponding author), Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan.	wenshan@gate.sinica.edu.tw	Li, Wen-Shan/F-1972-2015	Li, Wen-Shan/0000-0002-8359-4582	Academia Sinica; Ministry of Science and Technology (MOST, Taiwan) [MOST 103-2113-M-001-024-MY3, NSC 95-2113-M-001-018-MY3, MOST 105-0210-01-13-01]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology (MOST, Taiwan)	Dr. Wen-Shan Li is grateful for financial support of this study provided by the Academia Sinica and Ministry of Science and Technology (MOST, Taiwan, MOST 103-2113-M-001-024-MY3, NSC 95-2113-M-001-018-MY3 and MOST 105-0210-01-13-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAZAN JF, 1994, P NATL ACAD SCI USA, V91, P2473, DOI 10.1073/pnas.91.7.2473; Bertini I., 2007, BIOL INORGANIC CHEM; Boehlein SK, 1997, J BIOL CHEM, V272, P12384, DOI 10.1074/jbc.272.19.12384; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Chiang CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21581; Cobucci-Ponzano B, 2003, BIOCHEMISTRY-US, V42, P9525, DOI 10.1021/bi035036t; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15129, DOI 10.1021/bi0015865; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15121, DOI 10.1021/bi001585c; DEHM P, 1970, EUR J BIOCHEM, V17, P364, DOI 10.1111/j.1432-1033.1970.tb01174.x; Drinkwater N, 2016, BIOCHEM J, V473, P3189, DOI 10.1042/BCJ20160550; Ersahin C, 1999, J CARDIOVASC PHARM, V34, P604, DOI 10.1097/00005344-199910000-00019; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Gilmartin L, 1999, NEUROSCI RES, V34, P1, DOI 10.1016/S0168-0102(99)00025-5; GOWARD CR, 1994, EUR J BIOCHEM, V224, P249, DOI 10.1111/j.1432-1033.1994.tb20018.x; Graham SC, 2005, BIOCHEMISTRY-US, V44, P13820, DOI 10.1021/bi0512849; Graham SC, 2004, ACTA CRYSTALLOGR D, V60, P1770, DOI 10.1107/S0907444904018724; Graham SC, 2003, ACTA CRYSTALLOGR D, V59, P897, DOI 10.1107/S0907444903005870; Graham SC, 2008, ARCH BIOCHEM BIOPHYS, V469, P200, DOI 10.1016/j.abb.2007.10.009; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Griffiths J. R., 2016, ANAL PROTEIN POSTTRA; Hammes-Schiffer S, 2002, CHEMPHYSCHEM, V3, P33, DOI 10.1002/1439-7641(20020118)3:1<33::AID-CPHC33>3.0.CO;2-6; HARBECK HT, 1991, EUR J BIOCHEM, V198, P451, DOI 10.1111/j.1432-1033.1991.tb16035.x; HARDY F, 1994, PROTEIN ENG, V7, P425, DOI 10.1093/protein/7.3.425; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; HARPEL MR, 1994, BIOCHEMISTRY-US, V33, P5553, DOI 10.1021/bi00184a026; Hayes D, 1995, PROGRAM SEDNTERP SED; Hsu YT, 2008, CHEM BIODIVERS, V5, P1401, DOI 10.1002/cbdv.200890128; Huang LF, 2006, CHEMBIOCHEM, V7, P506, DOI 10.1002/cbic.200500412; Hung JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087134; Iyer S, 2015, FEBS OPEN BIO, V5, P292, DOI 10.1016/j.fob.2015.03.013; Jang JW, 2001, BIOTECHNOL APPL BIOC, V34, P81, DOI 10.1042/BA20010027; Jao SC, 2006, BIOCHEMISTRY-US, V45, P1547, DOI 10.1021/bi051786m; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kanyo ZF, 1996, NATURE, V383, P554, DOI 10.1038/383554a0; Kitamura S, 1999, AM J PHYSIOL-HEART C, V276, pH1664, DOI 10.1152/ajpheart.1999.276.5.H1664; Klimacek M, 2012, J BIOL CHEM, V287, P6655, DOI 10.1074/jbc.M111.289223; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Krogh BO, 2002, J BIOL CHEM, V277, P5711, DOI 10.1074/jbc.C100681200; Leferink NGH, 2011, BIOCHEMISTRY-US, V50, P4121, DOI 10.1021/bi200246f; Li X, 2008, J BIOL CHEM, V283, P22858, DOI 10.1074/jbc.M710274200; Lloyd GS, 1996, BIOCHEM PHARMACOL, V52, P229, DOI 10.1016/0006-2952(96)00180-3; LOK ASF, 1994, P NATL ACAD SCI USA, V91, P4077, DOI 10.1073/pnas.91.9.4077; Lowther WT, 2002, CHEM REV, V102, P4581, DOI 10.1021/cr0101757; MONERA OD, 1994, PROTEIN SCI, V3, P1984, DOI 10.1002/pro.5560031110; Nakamura A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500263; PHILLIPS MA, 1992, PROTEIN SCI, V1, P517; Plapp BV, 2010, ARCH BIOCHEM BIOPHYS, V493, P3, DOI 10.1016/j.abb.2009.07.001; Prechel MM, 1995, J PHARMACOL EXP THER, V275, P1136; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Reyes AC, 2015, J AM CHEM SOC, V137, P5312, DOI 10.1021/jacs.5b02202; Robbins JM, 2012, BIOCHEMISTRY-US, V51, P6378, DOI 10.1021/bi300138d; RUSU I, 1992, EUR J BIOCHEM, V210, P93, DOI 10.1111/j.1432-1033.1992.tb17395.x; Rynkiewicz MJ, 1996, BIOCHEMISTRY-US, V35, P16174, DOI 10.1021/bi961311i; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHERMAN MA, 1990, J BIOL CHEM, V265, P10659; Siegbahn PEM, 2010, CHEM REV, V110, P7040, DOI 10.1021/cr100070p; SIMMONS WH, 1992, J BIOL CHEM, V267, P4897; Spector S, 2000, BIOCHEMISTRY-US, V39, P872, DOI 10.1021/bi992091m; Sprinkle TJ, 2000, ARCH BIOCHEM BIOPHYS, V378, P51, DOI 10.1006/abbi.2000.1792; Sprinkle TJ, 1998, GENOMICS, V50, P114, DOI 10.1006/geno.1998.5302; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TANAKA T, 1992, BIOCHEMISTRY-US, V31, P2259, DOI 10.1021/bi00123a007; TANFORD C, 1966, J BIOL CHEM, V241, P1921; VANHOOF G, 1992, BIOCHEM PHARMACOL, V44, P479, DOI 10.1016/0006-2952(92)90439-P; WANG WY, 1995, J BIOL CHEM, V270, P13160, DOI 10.1074/jbc.270.22.13160; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; Wolfrum S, 2001, BRIT J PHARMACOL, V134, P370, DOI 10.1038/sj.bjp.0704236; Xiao LL, 2014, RSC ADV, V4, P41807, DOI 10.1039/c4ra08101c	69	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190816	10.1371/journal.pone.0190816	http://dx.doi.org/10.1371/journal.pone.0190816			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351301	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300029
J	Mohr, C; Friedrich, A; Wojnar, D; Kenar, E; Polatkan, AC; Codrea, MC; Czemmel, S; Kohlbacher, O; Nahnsen, S				Mohr, Christopher; Friedrich, Andreas; Wojnar, David; Kenar, Erhan; Polatkan, Aydin Can; Codrea, Marius Cosmin; Czemmel, Stefan; Kohlbacher, Oliver; Nahnsen, Sven			qPortal: A platform for data-driven biomedical research	PLOS ONE			English	Article							GENERATION; GENOMICS; GATEWAY	Modern biomedical research aims at drawing biological conclusions from large, highly complex biological datasets. It has become common practice to make extensive use of high-throughput technologies that produce big amounts of heterogeneous data. In addition to the ever-improving accuracy, methods are getting faster and cheaper, resulting in a steadily increasing need for scalable data management and easily accessible means of analysis. We present qPortal, a platform providing users with an intuitive way to manage and analyze quantitative biological data. The backend leverages a variety of concepts and technologies, such as relational databases, data stores, data models and means of data transfer, as well as front-end solutions to give users access to data management and easy-to-use analysis options. Users are empowered to conduct their experiments from the experimental design to the visualization of their results through the platform. Here, we illustrate the feature-rich portal by simulating a biomedical study based on publically available data. We demonstrate the software's strength in supporting the entire project life cycle. The software supports the project design and registration, empowers users to do all-digital project management and finally provides means to perform analysis. We compare our approach to Galaxy, one of the most widely used scientific workflow and analysis platforms in computational biology. Application of both systems to a small case study shows the differences between a data-driven approach (qPortal) and a workflow-driven approach (Galaxy). qPortal, a one-stop-shop solution for biomedical projects offers up-to-date analysis pipelines, quality control workflows, and visualization tools. Through intensive user interactions, appropriate data models have been developed. These models build the foundation of our biological data management system and provide possibilities to annotate data, query meta-data for statistics and future re-analysis on high-performance computing systems via coupling of workflow management systems. Integration of project and data management as well as workflow resources in one place present clear advantages over existing solutions.	[Mohr, Christopher; Friedrich, Andreas; Kohlbacher, Oliver] Univ Tubingen, Ctr Bioinformat Tubingen, Appl Bioinformat, Sand 14, D-72076 Tubingen, Germany; [Friedrich, Andreas; Wojnar, David; Kenar, Erhan; Polatkan, Aydin Can; Codrea, Marius Cosmin; Czemmel, Stefan; Kohlbacher, Oliver; Nahnsen, Sven] Univ Tubingen, Quantitat Biol Ctr QBiC, Morgenstelle 10, D-72076 Tubingen, Germany; [Kohlbacher, Oliver] Max Planck Inst Dev Biol, Max Planck Ring 5, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Max Planck Society	Mohr, C (corresponding author), Univ Tubingen, Ctr Bioinformat Tubingen, Appl Bioinformat, Sand 14, D-72076 Tubingen, Germany.	christopher.mohr@uni-tuebingen.de	Kohlbacher, Oliver/AAF-3297-2021	Kohlbacher, Oliver/0000-0003-1739-4598	Deutsche Forschungsgemeinschaft [KO-2313/6-1, KO-2313-2]; Deutsche Forschungsgemeinschaft (Institutional Strategy of the University of Tubingen) [ZUK 63]; Sonderforschungsbereich "Liver cancer" of the Deutsche Forschungsgemeinschaft (DFG) [SFB/TR 209]; German Ministry of Research and Education (BMBF) [01ZX1301F]; European Union (APERIM) [633592]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (Institutional Strategy of the University of Tubingen)(German Research Foundation (DFG)); Sonderforschungsbereich "Liver cancer" of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union (APERIM)	MCC, SC, DW, OK and SN acknowledge funding from Deutsche Forschungsgemeinschaft (core facilities initiative, KO-2313/6-1 and KO-2313-2, Institutional Strategy of the University of Tubingen, ZUK 63). SN acknowledges funding by the Sonderforschungsbereich SFB/TR 209 "Liver cancer" of the Deutsche Forschungsgemeinschaft (DFG). All authors acknowledge funding from Deutsche Forschungsgemeinschaft (Institutional Strategy of the University of Tubingen, ZUK 63). EK and OK acknowledge funding from the German Ministry of Research and Education (BMBF, grant no. 01ZX1301F). CM and OK acknowledge funding from the European Union (APERIM, contract no. 633592).	Abdelnur A, 2003, JSR 168 PORTLET SPEC, P15; AbuJamous B, 2015, INTEGRATIVE CLUSTER ANALYSIS IN BIOINFORMATICS, P1, DOI 10.1002/9781118906545; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andrews S., 2010, FASTQC QUALITY CONTR; Bauch A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-468; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Costa FF, 2014, DRUG DISCOV TODAY, V19, P433, DOI 10.1016/j.drudis.2013.10.012; Di Tommaso P, 2017, NAT BIOTECHNOL, V35, P316, DOI 10.1038/nbt.3820; Fleury M, P ACM IFIP USENIX 20, P344; Foundation TAS, AP TOMC; Friedrich A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/958302; Ganten PH, 2007, GNU GEN PUBLIC LICEN, P1079; Garijo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080278; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gronroos M, 2014, BOOK OF VAADIN, V7; Hursti J., P HELS U TECHN SEM N; Joly Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002549; Kacsuk P, 2012, J GRID COMPUT, V10, P601, DOI 10.1007/s10723-012-9240-5; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Krefting D, 2009, FUTURE GENER COMP SY, V25, P326, DOI 10.1016/j.future.2008.05.005; Kruger J, 2014, J CHEM THEORY COMPUT, V10, P2232, DOI 10.1021/ct500159h; Kruger J, 2013, DESKTOP GRID CONVERS; Kunszt P, 2015, CONCURR COMP-PRACT E, V27, P433, DOI 10.1002/cpe.3294; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leek JT, 2017, ANNU REV STAT APPL, V4, P109, DOI 10.1146/annurev-statistics-060116-054104; Leek JT, 2015, P NATL ACAD SCI USA, V112, P1645, DOI 10.1073/pnas.1421412111; Li H., 2013, ARXIV130333997; Madduri RK, 2014, CONCURR COMP-PRACT E, V26, P2266, DOI 10.1002/cpe.3274; Martens L, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.000133; Miller M.A., 2011, P 2011 TERAGRID C EX; Murri R, 2011, J GRID COMPUT, V9, P441, DOI 10.1007/s10723-011-9195-y; Nekrutenko A, 2012, NAT REV GENET, V13, P667, DOI 10.1038/nrg3305; Piccolo SR, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0135-4; Quandt A, 2007, STUD HEALTH TECHNOL, V126, P13; Quandt A, 2009, PROTEOMICS, V9, P2648, DOI 10.1002/pmic.200800207; Ramakrishnan C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-84; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Scholtalbers J, 2013, BIOINFORMATICS; Shah N, 2016, NAT BIOTECHNOL, V34, P803, DOI 10.1038/nbt.3603; Shahand S, 2013, DATA CTR SCI GATEWAY; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Szolek A, 2014, BIOINFORMATICS, V30, P3310, DOI 10.1093/bioinformatics/btu548; Tridgell Andrew, 1996, RSYNC ALGORITHM; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18	49	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191603	10.1371/journal.pone.0191603	http://dx.doi.org/10.1371/journal.pone.0191603			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352322	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300119
J	Shah, BS; Ashwood, HE; Harrop, SJ; Farrugia, DN; Paulsen, IT; Mabbutt, BC				Shah, Bhumika S.; Ashwood, Heather E.; Harrop, Stephen J.; Farrugia, Daniel N.; Paulsen, Ian T.; Mabbutt, Bridget C.			Crystal structure of a UDP-GlcNAc epimerase for surface polysaccharide biosynthesis in Acinetobacter baumannii	PLOS ONE			English	Article							PROTEIN; MECHANISM; LIPOPOLYSACCHARIDE; EPIDEMIOLOGY; REDUCTASE; SOFTWARE; SEQUENCE; STRAINS; FLAA1; CAPE	With new strains of Acinetobacter baumannii undergoing genomic analysis, it has been possible to define regions of genomic plasticity (RGPs), encoding specific adaptive elements. For a selected RGP from a community-derived isolate of A. baumannii, we outline sequences compatible with biosynthetic machinery of surface polysaccharides, specifically enzymes utilized in the dehydration and conversion of UDP-N-acetyl-D-glucosamine (UDP-D-GlcNAc). We have determined the crystal structure of one of these, the epimerase Ab-WbjB. This dehydratase belongs to the 'extended' short-chain dehydrogenase/reductase (SDR) family, related in fold to previously characterised enzymes CapE and FlaA1. Our 2.65 angstrom resolution structure of Ab-WbjB shows a hexamer, organised into a trimer of chain pairs, with coenzyme NADP+ occupying each chain. Specific active-site interactions between each coenzyme and a lysine quaternary group of a neighbouring chain interconnect adjacent dimers, so stabilising the hexameric form. We show UDP-GlcNAc to be a specific substrate for Ab-WbjB, with binding evident by ITC (K-a = 0.23 mu mol(-1)). The sequence of Ab-WbjB shows variation from the consensus active-site motifs of many SDR enzymes, demonstrating a likely catalytic role for a specific threonine sidechain (as an alternative to tyrosine) in the canonical active site chemistry of these epimerases.	[Shah, Bhumika S.; Ashwood, Heather E.; Farrugia, Daniel N.; Paulsen, Ian T.; Mabbutt, Bridget C.] Macquarie Univ, Dept Mol Sci, Sydney, NSW, Australia; [Harrop, Stephen J.] Univ New South Wales, Sch Phys, Sydney, NSW, Australia	Macquarie University; University of New South Wales Sydney	Mabbutt, BC (corresponding author), Macquarie Univ, Dept Mol Sci, Sydney, NSW, Australia.	bridget.mabbutt@mq.edu.au	; Paulsen, Ian/K-3832-2012	Ashwood, Heather/0000-0001-9722-629X; Paulsen, Ian/0000-0001-9015-9418; Shah, Bhumika/0000-0001-8968-440X	Australian Research Council grant [FL140100021]	Australian Research Council grant(Australian Research Council)	Australian Research Council grant FL140100021to ITP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brunelle JL, 2014, METHOD ENZYMOL, V541, P151, DOI 10.1016/B978-0-12-420119-4.00012-4; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Creuzenet C, 2000, J BIOL CHEM, V275, P34873, DOI 10.1074/jbc.M006369200; Dean CR, 1999, J BACTERIOL, V181, P4275, DOI 10.1128/JB.181.14.4275-4284.1999; DeLano WL, 2002, THE PYMOL MOLECULAR; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; Durante-Mangoni E, 2011, FUTURE MICROBIOL, V6, P407, DOI [10.2217/FMB.11.23, 10.2217/fmb.11.23]; Egger S, 2011, J BIOL CHEM, V286, P23877, DOI 10.1074/jbc.M111.234682; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falagas ME, 2007, EUR J CLIN MICROBIOL, V26, P857, DOI 10.1007/s10096-007-0365-6; Farrugia DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058628; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Giguere D, 2015, CARBOHYD RES, V418, P29, DOI 10.1016/j.carres.2015.10.001; Grimm C, 2000, J BIOL CHEM, V275, P41333, DOI 10.1074/jbc.M007559200; Haseley SR, 1997, EUR J BIOCHEM, V244, P147, DOI 10.1111/j.1432-1033.1997.00147.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Huang H, 2012, J ANTIMICROB CHEMOTH, V67, P2825, DOI 10.1093/jac/dks327; Imperi F, 2011, IUBMB LIFE, V63, P1068, DOI 10.1002/iub.531; Ishiyama N, 2006, J BIOL CHEM, V281, P24489, DOI 10.1074/jbc.M602393200; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Jornvall H, 1999, FEBS LETT, V445, P261, DOI 10.1016/S0014-5793(99)00130-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kenyon JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062160; Kneidinger B, 2003, J BIOL CHEM, V278, P3615, DOI 10.1074/jbc.M203867200; Kroger C, 2016, GENES, V8; LEE CR, 2017, FRONT CELL INFECT MI, V7; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McPherson A, 2006, J STRUCT BIOL, V156, P387, DOI 10.1016/j.jsb.2006.09.006; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Merkx-Jacques A, 2004, J BACTERIOL, V186, P2253, DOI 10.1128/JB.186.8.2253-2265.2004; Miyafusa T, 2013, FEBS LETT, V587, P3824, DOI 10.1016/j.febslet.2013.10.009; Miyafusa T, 2013, BIOSCIENCE REP, V33, P463, DOI 10.1042/BSR20130017; Mulrooney EF, 2005, J BIOL CHEM, V280, P19535, DOI 10.1074/jbc.M500612200; Naas T, 2005, J CLIN MICROBIOL, V43, P4826, DOI 10.1128/JCM.43.9.4826-4829.2005; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oppermann UCT, 1997, BIOCHEMISTRY-US, V36, P34, DOI 10.1021/bi961803v; Pantophlet R, 1999, CLIN DIAGN LAB IMMUN, V6, P323, DOI 10.1128/CDLI.6.3.323-329.1999; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Sennett NC, 2012, BIOCHEMISTRY-US, V51, P9364, DOI 10.1021/bi301067w; Shah BS, 2014, ACTA CRYSTALLOGR F, V70, P1318, DOI 10.1107/S2053230X14019785; Singh S, 2012, NAT PROD REP, V29, P1201, DOI 10.1039/c2np20039b; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Weber BS, 2016, J BACTERIOL, V198, P880, DOI 10.1128/JB.00906-15; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	57	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191610	10.1371/journal.pone.0191610	http://dx.doi.org/10.1371/journal.pone.0191610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352301	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300120
J	Loeffert, ST; Vanhems, P; Tissot, E; Dananche, C; Cassier, P; Benet, T; Perraud, M; Thibaudon, M; Gustin, MP				Loeffert, Sophie Tiphaine; Vanhems, Philippe; Tissot, Estelle; Dananche, Cedric; Cassier, Pierre; Benet, Thomas; Perraud, Michel; Thibaudon, Michel; Gustin, Marie-Paule			Evaluation of Hirst-type spore traps in outdoor Aspergillaceae monitoring during large demolition work in hospital	PLOS ONE			English	Article							FUMIGATUS	Demolition can generate fungal spore suspensions in association with various adverse health effects, such as high risk of invasive aspergillosis in immunocompromised patients. One block of Edouard Herriot Hospital was entirely demolished. The aim of the present study was to evaluate Hirst-type spore traps utility in monitoring outdoor Aspergillaceae (Aspergillus spp. + Penicillium spp.) spores in part of Edouard Herriot Hospital (Lyon, France) undergoing major demolition. Three periods were scheduled in 2015: (A) Gutting of building and asbestos removal, (B) Demolition of floors, (C) Excavation and earthwork. Outdoor Aspergillaceae fungal load was monitored by cultivable (Air Ideal (R), bioMerieux) and non-cultivable methods (Lanzoni VPPS-2000, Analyzair (R), Bologna, Italy). Differences of Aspergillaceae recorded with Hirst-type spore traps were observed between Gerland and Edouard Herriot Hospital. Differences between Aspergillaceae were recorded between day time and night time at Gerland and Edouard Herriot Hospital. Daily paired differences between Aspergillaceae recorded with non-cultivable methodology at Edouard Herriot Hospital and in an area without demolition work were significant in Period A vs Period B (p = 10-4) and Period A vs Period C (p = 10 - 4). Weak correlation of daily Aspergillaceae recorded by both methods at Edouard Herriot Hospital was significant only for Period C (r = 0.26, p = 0.048, n = 58). Meteorological parameters and type of demolition works were found to heavily influenced Aspergillaceae dispersion. Non-cultivable methodology is a promising tool for outdoor Aspergillaceae scrutiny during major demolition work in hospital, helping infection control staff to rapidly implement control measures.	[Loeffert, Sophie Tiphaine; Vanhems, Philippe; Dananche, Cedric; Gustin, Marie-Paule] Univ Lyon 1, ENS Lyon, CIRI, CNRS UMR5308,INSERM U1111,Lab Pathogenes Emergent, Lyon, France; [Vanhems, Philippe; Dananche, Cedric; Benet, Thomas] Grp Hosp Edouard Herriot, Unite Hyg Epidemiol & Prevent, Lyon, France; [Tissot, Estelle] Analyzair, Lyon, France; [Cassier, Pierre; Perraud, Michel] Grp Hosp Edouard Herriot, Lab Biol Secur Environm, Lyon, France; [Thibaudon, Michel] Reseau Natl Surveillance Aerobiol, Brussieu, France; [Gustin, Marie-Paule] Univ Lyon 1, Fac Pharm, ISPB, Dept Sante Publ, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Loeffert, ST (corresponding author), Univ Lyon 1, ENS Lyon, CIRI, CNRS UMR5308,INSERM U1111,Lab Pathogenes Emergent, Lyon, France.	sophie.loeffert01@chu-lyon.fr		Dananche, Cedric/0000-0002-0791-6391	Laboratoires ANIOS	Laboratoires ANIOS	Laboratoires ANIOS provided funding in the form of salaries to first author ST Loeffert. Laboratoires ANIOS did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Additionally, Analyzair provided funding in the form of salaries to co-author Estelle Tissot. Analyzair did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Analyzair is the society to which we rent the Hirst collector. The lab technician (Estelle Tissot) from Analyzair was responsible for the implementation and control of the Hirst collector at our hospital. The specific roles of these authors are articulated in the 'author contributions' section.	Bellanger AP, 2012, J OCCUP ENVIRON HYG, V9, pD7, DOI 10.1080/15459624.2012.636727; Boff C, 2012, AM J INFECT CONTROL, V40, P1016, DOI 10.1016/j.ajic.2012.01.029; Brenier-Pinchart MP, 2009, AM J INFECT CONTROL, V37, P631, DOI 10.1016/j.ajic.2009.03.013; Bryant R.B., 1989, AEROBIOLOGIA, V5, P123; Dananche C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177263; Elvira-Rendueles B, 2013, ANN AGR ENV MED, V20, P664; Rodriguez SF, 2011, GRANA, V50, P202, DOI 10.1080/00173134.2011.596218; Fernandez-Rodriguez S, 2014, FUNGAL ECOL, V7, P16, DOI 10.1016/j.funeco.2013.11.004; Gangneux JP, 2012, J MYCOL MED, V22, P64, DOI 10.1016/j.mycmed.2012.01.003; Grinn-Gofron A, 2008, INT J BIOMETEOROL, V52, P859, DOI 10.1007/s00484-008-0182-3; Grinn-Gofron A, 2011, AEROBIOLOGIA, V27, P67, DOI 10.1007/s10453-010-9177-8; Hameed AAA, 2012, SCI TOTAL ENVIRON, V414, P696, DOI 10.1016/j.scitotenv.2011.10.042; HIRST JM, 1952, ANN APPL BIOL, V39, P257, DOI 10.1111/j.1744-7348.1952.tb00904.x; HOLM S, 1979, SCAND J STAT, V6, P65; Lang-Yona N, 2012, ATMOS CHEM PHYS, V12, P2681, DOI 10.5194/acp-12-2681-2012; Marr KA, 2002, INFECT DIS CLIN N AM, V16, P875, DOI 10.1016/S0891-5520(02)00035-1; STREIFEL AJ, 1983, APPL ENVIRON MICROB, V46, P375, DOI 10.1128/AEM.46.2.375-378.1983; Molina RT, 2013, GRANA, V52, P59, DOI 10.1080/00173134.2012.718359; Molina RT, 2010, GRANA, V49, P134, DOI 10.1080/00173131003617390; Vonberg RP, 2006, J HOSP INFECT, V63, P246, DOI 10.1016/j.jhin.2006.02.014	20	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191135	10.1371/journal.pone.0191135	http://dx.doi.org/10.1371/journal.pone.0191135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346411	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500031
J	Mundhenk, L; Erickson, NA; Klymiuk, N; Gruber, AD				Mundhenk, Lars; Erickson, Nancy A.; Klymiuk, Nikolai; Gruber, Achim D.			Interspecies diversity of chloride channel regulators, calcium-activated 3 genes	PLOS ONE			English	Article							MEMBRANE-PROTEINS; FUNCTIONAL-CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; RESPIRATORY-DISEASE; LUNG METASTASIS; PLUNC GENE; FAMILY; EXPRESSION; CLONING; MCLCA3	Members of the chloride channel regulators, calcium-activated (CLCA) family, have been implicated in diverse biomedical conditions, including chronic inflammatory airway diseases such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis, the activation of macrophages, and the growth and metastatic spread of tumor cells. Several observations, however, could not be repeated across species boundaries and increasing evidence suggests that select CLCA genes are particularly prone to dynamic species-specific evolvements. Here, we systematically characterized structural and expressional differences of the CLCA3 gene across mammalian species, revealing a spectrum of gene duplications, e.g., in mice and cows, and of gene silencing via diverse chromosomal modifications in pigs and many primates, including humans. In contrast, expression of a canonical CLCA3 protein from a single functional gene seems to be evolutionarily retained in carnivores, rabbits, guinea pigs, and horses. As an accepted asthma model, we chose the cat to establish the tissue and cellular expression pattern of the CLCA3 protein which was primarily found in mucin-producing cells of the respiratory tract and in stratified epithelia of the esophagus. Our results suggest that, among developmental differences in other CLCA genes, the CLCA3 gene possesses a particularly high dynamic evolutionary diversity with pivotal consequences for humans and other primates that seem to lack a CLCA3 protein. Our data also help to explain previous contradictory results on CLCA3 obtained from different species and warrant caution in extrapolating data from animal models in conditions where CLCA3 may be involved.	[Mundhenk, Lars; Erickson, Nancy A.; Gruber, Achim D.] Free Univ Berlin, Fac Vet Med, Dept Vet Pathol, Berlin, Germany; [Klymiuk, Nikolai] Ludwig Maximilians Univ Munchen, Inst Mol Anim Breeding & Biotechnol, Oberschleissheim, Germany; [Erickson, Nancy A.] German Rheumatism Res Ctr Berlin, Berlin, Germany	Free University of Berlin; University of Munich; Deutsches Rheuma-Forschungszentrum (DRFZ)	Mundhenk, L (corresponding author), Free Univ Berlin, Fac Vet Med, Dept Vet Pathol, Berlin, Germany.	lars.mundhenk@fu-berlin.de	Klymiuk, Nikolai/AAB-8345-2022; Gruber, Achim D./ABA-4514-2021	Klymiuk, Nikolai/0000-0003-3532-1659; 	German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB-TR 84 Z1b, MU 3015/1-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft) grants SFB-TR 84 Z1b to ADG and MU 3015/1-1 to LM, ADG http://www.dfg.de/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany M, 2003, J BIOL CHEM, V278, P49406, DOI 10.1074/jbc.M309086200; Abdel-Ghany M, 2002, J BIOL CHEM, V277, P34391, DOI 10.1074/jbc.M205307200; Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Anton F, 2005, J HISTOCHEM CYTOCHEM, V53, P1011, DOI 10.1369/jhc.4A6599.2005; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bingle CD, 2004, PROTEIN SCI, V13, P422, DOI 10.1110/ps.03332704; Bingle CD, 2011, BIOCHEM SOC T, V39, P961, DOI 10.1042/BST0390961; Bingle L, 2011, BIOCHEM SOC T, V39, P1023, DOI 10.1042/BST0391023; Bothe MK, 2008, J HISTOCHEM CYTOCHEM, V56, P495, DOI 10.1369/jhc.2008.950592; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Braun J, 2010, HISTOCHEM CELL BIOL, V133, P285, DOI 10.1007/s00418-009-0667-0; Britto CJ, 2015, AM J RESP CELL MOL, V52, P525, DOI 10.1165/rcmb.2014-0297RT; Ching JCH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083130; Connon CJ, 2004, J HISTOCHEM CYTOCHEM, V52, P415, DOI 10.1177/002215540405200313; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Dietert K, 2015, HISTOCHEM CELL BIOL, V143, P277, DOI 10.1007/s00418-014-1279-x; Dietert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102606; Elble RC, 1997, J BIOL CHEM, V272, P27853, DOI 10.1074/jbc.272.44.27853; Elble RC, 2002, J BIOL CHEM, V277, P18586, DOI 10.1074/jbc.M200829200; Erickson NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131991; Furuya M, 2010, J IMMUNOL, V185, P5769, DOI 10.4049/jimmunol.1002226; Gandhi R, 1998, J BIOL CHEM, V273, P32096, DOI 10.1074/jbc.273.48.32096; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Gruber AD, 1998, HISTOCHEM CELL BIOL, V110, P43, DOI 10.1007/s004180050263; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Gruber AD, 1999, BBA-GENE STRUCT EXPR, V1444, P418, DOI 10.1016/S0167-4781(99)00008-1; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LeClair EE, 2001, BIOCHEM BIOPH RES CO, V284, P792, DOI 10.1006/bbrc.2001.5024; Lee D, 1999, BIOCHEM BIOPH RES CO, V264, P933, DOI 10.1006/bbrc.1999.1583; Leverkoehne I, 2002, HISTOCHEM CELL BIOL, V118, P11, DOI 10.1007/s00418-002-0420-4; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plog S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140050; Plog S, 2012, CELL TISSUE RES, V350, P445, DOI 10.1007/s00441-012-1482-9; Plog S, 2012, J HISTOCHEM CYTOCHEM, V60, P45, DOI 10.1369/0022155411426455; Plog S, 2009, J HISTOCHEM CYTOCHEM, V57, P1169, DOI 10.1369/jhc.2009.954594; Roussa E, 2010, J HISTOCHEM CYTOCHEM, V58, P653, DOI 10.1369/jhc.2010.955211; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Williams K, 2016, J PATHOL, V238, P220, DOI 10.1002/path.4658; Yang B, 2015, CANCER-AM CANCER SOC, V121, P1570, DOI 10.1002/cncr.29235; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083943; ZHU DZ, 1992, J CLIN INVEST, V89, P1718, DOI 10.1172/JCI115773; ZHU DZ, 1991, P NATL ACAD SCI USA, V88, P9568, DOI 10.1073/pnas.88.21.9568	51	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191512	10.1371/journal.pone.0191512	http://dx.doi.org/10.1371/journal.pone.0191512			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346439	gold, Green Submitted, Green Published			2022-12-27	WOS:000422749500058
J	Roux, D; Schaefers, M; Clark, BS; Weatherholt, M; Renaud, D; Scott, D; LiPuma, JJ; Priebe, G; Gerard, C; Yoder-Himes, DR				Roux, Damien; Schaefers, Matthew; Clark, Bradley S.; Weatherholt, Molly; Renaud, Diane; Scott, David; LiPuma, John J.; Priebe, Gregory; Gerard, Craig; Yoder-Himes, Deborah R.			A putative lateral flagella of the cystic fibrosis pathogen Burkholderia dolosa regulates swimming motility and host cytokine production	PLOS ONE			English	Article							HOMOSERINE LACTONE PRODUCTION; CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; ORNIBACTIN BIOSYNTHESIS; EPITHELIAL-CELLS; POLAR FLAGELLA; GENE-CLUSTER; SP-NOV.; CENOCEPACIA	Burkholderia dolosa caused an outbreak in the cystic fibrosis clinic at Boston Children's Hospital and was associated with high mortality in these patients. This species is part of a larger complex of opportunistic pathogens known as the Burkholderia cepacia complex (Bcc). Compared to other species in the Bcc, B. dolosa is highly transmissible; thus understanding its virulence mechanisms is important for preventing future outbreaks. The genome of one of the outbreak strains, AU0158, revealed a homolog of the lafA gene encoding a putative lateral flagellin, which, in other non-Bcc species, is used for movement on solid surfaces, attachment to host cells, or movement inside host cells. Here, we analyzed the conservation of the lafA gene and protein sequences, which are distinct from those of the polar flagella, and found lafA homologs to be present in numerous beta-proteobacteria but notably absent from most other Bcc species. A lafA deletion mutant in B. dolosa showed a greater swimming motility than wild-type due to an increase in the number of polar flagella, but did not appear to contribute to biofilm formation, host cell invasion, or murine lung colonization or persistence over time. However, the lafA gene was important for cytokine production in human peripheral blood mononuclear cells, suggesting it may have a role in recognition by the human immune response.	[Clark, Bradley S.; Weatherholt, Molly; Yoder-Himes, Deborah R.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Roux, Damien] INSERM, IAME, UMR 1137, Paris, France; [Roux, Damien] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Roux, Damien] Louis Mourier Hosp, AP HP, Intens Care Unit, Colombes, France; [Schaefers, Matthew; Priebe, Gregory] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Crit Care Med, Boston, MA USA; [Schaefers, Matthew; Priebe, Gregory] Harvard Med Sch, Dept Anesthesia, Boston, MA USA; [Renaud, Diane; Scott, David] Univ Louisville, Sch Dent, Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [LiPuma, John J.] Univ Michigan, Div Pediat, Ann Arbor, MI 48109 USA; [Gerard, Craig] Boston Childrens Hosp, Div Resp Dis, Boston, MA USA	University of Louisville; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Louisville; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital	Yoder-Himes, DR (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	deborah.yoder-himes@louisville.edu	Scott, David/GYU-8656-2022; Schaefers, Matthew/AAU-8213-2021; Roux, Damien/C-5618-2014; Roux, Damien/L-3671-2014; Priebe, Gregory/AAG-4027-2021	Schaefers, Matthew/0000-0001-7454-4180; Roux, Damien/0000-0002-6103-6416; Roux, Damien/0000-0002-6103-6416; Priebe, Gregory/0000-0001-9831-0354; Scott, David A./0000-0003-1007-2756; Yoder-Himes, Deborah/0000-0001-9576-3833	William Randolph Hearst Fund; Societe de Reanimation de Lang ue Francaise; University of Louisville [RIG50895]; Slifka Family Fund; Cystic Fibrosis Foundation [PRIEBE13I0, YODERH10F0]	William Randolph Hearst Fund; Societe de Reanimation de Lang ue Francaise; University of Louisville; Slifka Family Fund; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by the William Randolph Hearst Fund (https://www.hearstfdn.org/) and the Societe de Reanimation de Lang ue Francaise (http://www.srlf.org/en/home/) (DR), the University of Louisville (http://louisville.edu/) (DRYH; RIG50895, MW), the Slifka Family Fund (http://www.slifkafounciation.org/) (CG), and the Cystic Fibrosis Foundation (https://www.cff.org/) (CG; PRIEBE13I0, GPP; YODERH10F0, DRYH; JJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We applied the SDC approach for the sequence of authors. This work was supported by the William Randolph Hearst Fund and the Societe de Reanimation de Langue Francaise (DR), the University of Louisville (RIG50895, MW), the Slifka Family Fund (CG), and the Cystic Fibrosis Foundation (CG; PRIEBE13I0, GPP; YODERH10F0, DRYH; JJL). We also thank Maria Ericson for her assistance with the electron microscopy.	Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Agnoli K, 2012, MOL MICROBIOL, V83, P362, DOI 10.1111/j.1365-2958.2011.07937.x; Agnoli K, 2014, APPL ENVIRON MICROB, V80, P1340, DOI 10.1128/AEM.03330-13; Altarriba M, 2003, MICROB PATHOGENESIS, V34, P249, DOI 10.1016/S0882-4010(03)00047-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Araque-Calderon Y, 2008, MED SCI MONITOR, V14, pBR49; Atsumi T, 1996, J BACTERIOL, V178, P5024, DOI 10.1128/jb.178.16.5024-5026.1996; Bamford S, 2007, CELL MICROBIOL, V9, P532, DOI 10.1111/j.1462-5822.2006.00808.x; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Biddick R, 2003, FEMS MICROBIOL LETT, V228, P57, DOI 10.1016/S0378-1097(03)00724-9; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Burns JL, 1996, INFECT IMMUN, V64, P4054, DOI 10.1128/IAI.64.10.4054-4059.1996; Canals R, 2006, J BACTERIOL, V188, P852, DOI 10.1128/JB.188.3.852-862.2006; Canals R, 2006, J BACTERIOL, V188, P542, DOI 10.1128/JB.188.2.542-555.2006; Caraher E, 2007, J CYST FIBROS, V6, P49, DOI 10.1016/j.jcf.2006.05.007; Choi KH, 2006, NAT PROTOC, V1, P162, DOI 10.1038/nprot.2006.25; Conway BAD, 2002, J BACTERIOL, V184, P5678, DOI 10.1128/JB.184.20.5678-5685.2002; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; De Smet B, 2015, INT J SYST EVOL MICR, V65, P2265, DOI 10.1099/ijs.0.000251; Delputte PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016827; Deng YY, 2010, APPL ENVIRON MICROB, V76, P4675, DOI 10.1128/AEM.00480-10; Deng YY, 2009, J BACTERIOL, V191, P7270, DOI 10.1128/JB.00681-09; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Duff C, 2006, MICROB PATHOGENESIS, V41, P183, DOI 10.1016/j.micpath.2006.07.005; Eberl L, 2006, INT J MED MICROBIOL, V296, P103, DOI 10.1016/j.ijmm.2006.01.035; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Gavin R, 2003, FEMS MICROBIOL LETT, V224, P77, DOI 10.1016/S0378-1097(03)00418-X; Gavin R, 2002, MOL MICROBIOL, V43, P383, DOI 10.1046/j.1365-2958.2002.02750.x; Gill JJ, 2011, J BACTERIOL, V193, P5300, DOI 10.1128/JB.05287-11; Glendinning KJ, 2004, FEMS MICROBIOL LETT, V235, P229, DOI 10.1016/j.femsle.2004.04.039; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GOVAN JRW, 1993, LANCET, V342, P15, DOI 10.1016/0140-6736(93)91881-L; Gutierrez MG, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00078; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Huang YJ, 2016, CLIN CHEST MED, V37, P59, DOI 10.1016/j.ccm.2015.10.003; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hutcherson JA, 2016, MOL ORAL MICROBIOL, V31, P354, DOI 10.1111/omi.12135; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Jacchieri SG, 2003, J BACTERIOL, V185, P4243, DOI 10.1128/JB.185.14.4243-4247.2003; Jang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087623; Johnson S. L., 2015, Genome Announcements, V3, pe00159; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kalish LA, 2006, AM J RESP CRIT CARE, V173, P421, DOI 10.1164/rccm.200503-344OC; Kim JM, 2015, J IND MICROBIOL BIOT, V42, P905, DOI 10.1007/s10295-015-1605-x; Kirov SM, 2002, J BACTERIOL, V184, P547, DOI 10.1128/JB.184.2.547-555.2002; Kopp BT, 2012, BIOCHEM BIOPH RES CO, V424, P221, DOI 10.1016/j.bbrc.2012.06.066; Lamothe J, 2007, CELL MICROBIOL, V9, P40, DOI 10.1111/j.1462-5822.2006.00766.x; Lamothe J, 2008, MICROBIOL-SGM, V154, P3825, DOI 10.1099/mic.0.2008/023200-0; Lefebre MD, 2001, MICROBIOL-SGM, V147, P97, DOI 10.1099/00221287-147-1-97; Leitao JH, 2008, EUR J CLIN MICROBIOL, V27, P1101, DOI 10.1007/s10096-008-0552-0; Lewenza S, 2001, J BACTERIOL, V183, P2212, DOI 10.1128/JB.183.7.2212-2218.2001; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lopez CM, 2009, APPL ENVIRON MICROB, V75, P6496, DOI 10.1128/AEM.01669-09; Mahenthiralingam E, 1997, J CLIN MICROBIOL, V35, P808, DOI 10.1128/JCM.35.4.808-816.1997; Malott RJ, 2009, J BACTERIOL, V191, P2447, DOI 10.1128/JB.01746-08; MCCARTER L, 1988, CELL, V54, P345, DOI 10.1016/0092-8674(88)90197-3; Merino S, 2006, FEMS MICROBIOL LETT, V263, P127, DOI 10.1111/j.1574-6968.2006.00403.x; Miller DA, 2003, J ROY SOC MED, V96, P57; O'Grady EP, 2011, J BACTERIOL, V193, P163, DOI 10.1128/JB.00852-10; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Pallen MJ, 2005, TRENDS MICROBIOL, V13, P143, DOI 10.1016/j.tim.2005.02.008; Park KS, 2005, INFECT IMMUN, V73, P5754, DOI 10.1128/IAI.73.9.5754-5761.2005; Parsons YN, 2001, FEMS MICROBIOL LETT, V203, P103, DOI 10.1111/j.1574-6968.2001.tb10827.x; Partridge JD, 2015, MBIO, V6, DOI 10.1128/mBio.02367-14; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Ren CP, 2005, J BACTERIOL, V187, P1430, DOI 10.1128/JB.187.4.1430-1440.2005; Roux D, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00765-16; Schaefers MM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006116; Scotet V, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-14; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurnik D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003582; SMITH DL, 1993, J CLIN MICROBIOL, V31, P3017, DOI 10.1128/JCM.31.11.3017-3022.1993; Sokol PA, 1999, INFECT IMMUN, V67, P4443, DOI 10.1128/IAI.67.9.4443-4455.1999; SOKOL PA, 1992, J MED MICROBIOL, V36, P184, DOI 10.1099/00222615-36-3-184; Sokol PA, 2000, INFECT IMMUN, V68, P6554, DOI 10.1128/IAI.68.12.6554-6560.2000; Song WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep40878; Stewart BJ, 2003, J BACTERIOL, V185, P4508, DOI 10.1128/JB.185.15.4508-4518.2003; Tomich M, 2003, INFECT IMMUN, V71, P1405, DOI 10.1128/IAI.71.3.1405-1415.2003; Tomich M, 2002, INFECT IMMUN, V70, P1799, DOI 10.1128/IAI.70.4.1799-1806.2002; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Vandivier RW, 2009, AM J PHYSIOL-LUNG C, V297, pL677, DOI 10.1152/ajplung.00030.2009; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; Vermis K, 2004, INT J SYST EVOL MICR, V54, P689, DOI 10.1099/ijs.0.02888-0; Wilhelms M, 2013, J BACTERIOL, V195, P1436, DOI 10.1128/JB.01994-12; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, p2.4.1, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Zhang L, 2015, CELL MOL IMMUNOL, V12, P625, DOI 10.1038/cmi.2014.76	95	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0189810	10.1371/journal.pone.0189810	http://dx.doi.org/10.1371/journal.pone.0189810			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346379	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500005
J	He, YZ; Dou, GS; Huang, QY; Zhang, XY; Ye, YF; Qian, MC; Ying, XH				He, Yunzhen; Dou, Guanshen; Huang, Qiaoyun; Zhang, Xinyu; Ye, Yingfeng; Qian, Mengcen; Ying, Xiaohua			Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study	PLOS ONE			English	Article							MARKUP DRUG POLICY; INTERRUPTED TIME-SERIES; IMPACT	Background Healthcare system reform of Sanming city has become a leading healthcare reform model in China. It has developed a rigorous pharmaceutical reform consisted of the Zero Mark-up Drug Policy and the Centralized Procurement of Medicine Policy to bring down drug expenses and total health expenditures. However, despite the credit and much attention have been given to Sanming's pharmaceutical reform, its impact still remains unclear. Therefore, the purpose of this study was to explore the impact of the pharmaceutical reform of Sanming on both drug and total health expenditures. Methods Interrupted time series analysis with three segments divided by two intervention points was employed to evaluate the impact of the pharmaceutical reform. Segment 1 was the pre reform period which captured the baseline information. Segment 2 occurred after the first intervention point when the Zero Mark-up Drug Policy was implemented, whereas Segment 3 was after the implementation of the Centralized Procurement of Medicine Policy. Primary outcomes are outpatient drug expenditure, outpatient total health expenditure, inpatient drug expenditure, and inpatient total health expenditure. Data spanning from May 2012 to May 2014 are included. Results Both drug and total health expenditures exhibited rising trends before any policy was carried out. The launch of Zero Mark-up Drug Policy led to significant instant reductions in levels of outpatient drug expenditure (coefficient = -6,602.99, p<0.01), outpatient total health expenditure (coefficient = -9,958.58, p<0.05), inpatient drug expenditure (coefficient = -7,520.90, p<0.01), and inpatient total health expenditure (coefficient = -16,737, p<0.01). Moreover, the previous upward trends were changed into downward trends for inpatient drug expenditure (coefficient = -2,747.02, p = 0.00) and total health expenditure (coefficient = -3,069.29, p = 0.12). However, after the implementation of Centralized Procurement of Medicine Policy, we observed no significant instant level changes and also, the inpatient drug expenditure (coefficient = 372.95, p = 0.01) and total health expenditure (coefficient = 788.76, p = 0.06) resumed upward trends again. Conclusions Although the pharmaceutical reform could control or reduced drug expenditure and total health expenditure in short term, expenditures gradually resumed growing again and reached or even exceeded their baseline levels of pre-reform period, indicating the effect became weakened or even faded out in long term. In all, the pharmaceutical reform as a whole failed to meet its goal of combating sharp growth of drug and total health expenditure.	[He, Yunzhen; Dou, Guanshen; Huang, Qiaoyun; Zhang, Xinyu; Ye, Yingfeng; Qian, Mengcen; Ying, Xiaohua] Fudan Univ, Sch Publ Hlth, Dept Hlth Econ, Shanghai, Peoples R China	Fudan University	Qian, MC; Ying, XH (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Hlth Econ, Shanghai, Peoples R China.	qianmengcen@fudan.edu.cn; xhying@fudan.edu.cn						China National Health Development Research Center, 2009, CHIN NAT HLTH ACC RE; China National Health Development Research Center, 2008, CHIN NAT HLTH ACC RE; Ding J, 2015, CHINESE HLTH EC, V34, P68; Fu C, 2013, CHINESE HOSP MANAGEM, V33, P4; Hill R. C., 2008, PRINCIPLES ECONOMETR; Jiang Q, 2012, BMC HEALTH SERV RES, P12; KING ML, 1981, ECONOMETRICA, V49, P1571, DOI 10.2307/1911419; Klynveld Peat Marwick Goerdeler, 2016, SANMING REAL STORY G; Kutner M. H., 2004, APPL LINEAR REGRESSI; [郎颖 Lang Ying], 2010, [中国药房, China Pharmacy], V21, P3374; Li L, 2013, CHINESE J NEWS REPOR, P38; Ma J, 2014, CHINESE J HLTH EC RE, P34; Mao W, 2015, ZERO MARK UP POLICY; Mao WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117710; Ministry of Health, 2010, CHIN HLTH STAT YB; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wang JY, 2015, INDIAN J PHARMACOL, V47, P535, DOI 10.4103/0253-7613.165192; Wang Z, 2017, CHINESE J HLTH POLIC, V8, P21; Wooldridge J, 2009, INTRO ECONOMETRICS M, V181; World Bank Group, 2017, DEEP HLTH REF CHIN B; Yang CJ, 2017, TROP MED INT HEALTH, V22, P180, DOI 10.1111/tmi.12817; Yang ZP, 2012, LANCET, V379, pE13, DOI 10.1016/S0140-6736(11)60137-2; Yao H., 2003, CHINESE HOSP MANAGEM, V23, P11; Yi HM, 2015, HEALTH AFFAIR, V34, P1391, DOI 10.1377/hlthaff.2014.1114; Zhang X., 2014, INT J ANTENN PROPAG, V2014, P1, DOI DOI 10.4018/IJIIT.2014070101; Zhou ZL, 2015, J ASIAN PUBLIC POLIC, V8, P102, DOI 10.1080/17516234.2015.1005561	26	22	24	9	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190320	10.1371/journal.pone.0190320	http://dx.doi.org/10.1371/journal.pone.0190320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338038	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700007
J	Saita, K; Morishita, T; Arima, H; Hyakutake, K; Ogata, T; Yagi, K; Shiota, E; Inoue, T				Saita, Kazuya; Morishita, Takashi; Arima, Hisatomi; Hyakutake, Koichi; Ogata, Toshiyasu; Yagi, Kenji; Shiota, Etsuji; Inoue, Tooru			Biofeedback effect of hybrid assistive limb in stroke rehabilitation: A proof of concept study using functional near infrared spectroscopy	PLOS ONE			English	Article							INDUCED MOVEMENT THERAPY; RANDOMIZED-TRIAL; MOTOR RECOVERY; PERFORMANCE; HEMIPLEGIA; BRAIN; FMRI	Introduction Robot-assisted rehabilitation has been increasingly drawing attention in the field of neurorehabilitation. The hybrid assistive limb (HAL) is an exoskeleton robot developed based on the "interactive biofeedback" theory, and several studies have shown its efficacy for patients with stroke. We aimed to investigate the mechanisms of the facilitative effect of neurorehabilitation using a single-joint HAL (HAL-SJ) and functional near-infrared spectroscopy (fNIRS). Materials and methods Subacute stroke patients admitted to our hospital were assessed in this study for HAL eligibility. We evaluated motor-related cortical activity using an fNIRS system at baseline and immediately after HAL-SJ treatment on the same day. Cortical activity was determined through the relative changes in the hemoglobin concentrations. For statistical analysis, we compared the number of flexion/extension movements before and immediately after HALSJ treatment using paired t-test. fNIRS used both the methods of statistical parametric mapping and random effect analysis. Results We finally included 10 patients (eight men, two women; mean age: 66.8 12.0 years). The mean number of flexion/extension movements within 15 s increased significantly from 4.2 +/- 3.1 to 5.3 +/- 4.1 immediately after training. fNIRS showed increased cortical activation in the primary motor cortex of the ipsilesional hemisphere immediately after HAL-SJ treatment compared to the baseline condition. Conclusions This study is the first to support the concept of the biofeedback effect from the perspective of changes in cortical activity measured with an fNIRS system. The biofeedback effect of HAL immediately increased the task-related cortical activity, and this may address the functional recovery. Further studies are warranted to support our findings.	[Saita, Kazuya; Morishita, Takashi; Hyakutake, Koichi; Yagi, Kenji; Inoue, Tooru] Fukuoka Univ, Dept Neurosurg, Fac Med, Fukuoka, Japan; [Saita, Kazuya; Hyakutake, Koichi; Shiota, Etsuji] Fukuoka Univ Hosp, Dept Rehabil Med, Fukuoka, Japan; [Arima, Hisatomi] Fukuoka Univ, Dept Prevent Med & Publ Hlth, Fac Med, Fukuoka, Japan; [Ogata, Toshiyasu] Fukuoka Univ, Fac Med, Dept Neurol, Fukuoka, Japan	Fukuoka University; Fukuoka University; Fukuoka University; Fukuoka University	Morishita, T (corresponding author), Fukuoka Univ, Dept Neurosurg, Fac Med, Fukuoka, Japan.	tmorishita@fukuoka-u.ac.jp	SAITA, KAZUYA/AAM-8606-2021; LUO, JINGJING/AAZ-6697-2021	SAITA, KAZUYA/0000-0002-7663-7513; LUO, JINGJING/0000-0002-3222-1276	Japan Society for Promotion of Science; St. Luke Life Science Institute; Nakatomi foundation; Takeda Science Foundation; Uehara Memorial Foundation; Central Research Institute of Fukuoka University	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); St. Luke Life Science Institute; Nakatomi foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Central Research Institute of Fukuoka University	Dr. Morishita has no disclosures related to this study. Dr. Morishita has received grant supports from Japan Society for Promotion of Science, St. Luke Life Science Institute, Nakatomi foundation, Takeda Science Foundation, the Uehara Memorial Foundation, and the Central Research Institute of Fukuoka University. He has received honoraria from Medtronic as a consultant within the past 12 months. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basteris A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Fujimoto H, 2014, NEUROIMAGE, V85, P547, DOI 10.1016/j.neuroimage.2013.05.014; Fukuda H, 2016, ASSIST TECHNOL, V28, P53, DOI 10.1080/10400435.2015.1080768; Kawamoto H, 2010, IEEE ENG MED BIO, P462, DOI 10.1109/IEMBS.2010.5626191; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Leff DR, 2011, NEUROIMAGE, V54, P2922, DOI 10.1016/j.neuroimage.2010.10.058; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032234; Morishita T., 2016, NEUROL MED CHIR TOKY; Morishita T, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00629; Obrig H, 2014, NEUROIMAGE, V85, P535, DOI 10.1016/j.neuroimage.2013.03.045; Saita K, 2017, J NEUROL SCI, V373, P182, DOI 10.1016/j.jns.2016.12.056; Sitaram R, 2017, NAT REV NEUROSCI, V18, P86, DOI 10.1038/nrn.2016.164; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Tak S, 2010, PHYS MED BIOL, V55, P3249, DOI 10.1088/0031-9155/55/11/017; Takahashi K, 2016, STROKE, V47, P1385, DOI 10.1161/STROKEAHA.115.012520; Takebayashi T, 2015, TOP STROKE REHABIL, V22, P18, DOI 10.1179/1074935714Z.0000000028; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Ueba T, 2013, NEUROL MED-CHIR, V53, P287, DOI 10.2176/nmc.53.287; Wahl AS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00381; Wall A, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00048; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Watanabe H, 2014, ARCH PHYS MED REHAB, V95, P2006, DOI 10.1016/j.apmr.2014.07.002; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098; Wolf SL, 2008, LANCET NEUROL, V7, P33, DOI 10.1016/S1474-4422(07)70294-6	34	30	31	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191361	10.1371/journal.pone.0191361	http://dx.doi.org/10.1371/journal.pone.0191361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338060	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700051
J	Brenk-Franz, K; Ehrenthal, J; Freund, T; Schneider, N; Strauss, B; Tiesler, F; Schauenburg, H; Gensichen, J				Brenk-Franz, Katja; Ehrenthal, Johannes; Freund, Tobias; Schneider, Nico; Strauss, Bernhard; Tiesler, Fabian; Schauenburg, Henning; Gensichen, Jochen			Evaluation of the short form of "Experience in Close Relationships" (Revised, German Version "ECR-RD12") - A tool to measure adult attachment in primary care	PLOS ONE			English	Article							SELF; ADJUSTMENT; DISTRESS; VALIDITY; PATTERNS; MEDICINE; SUPPORT	Attachment theory helps us to understand patients' health behavior. Attachment styles might explain patient differences in coping behavior, self-treatment, or patient-provider relationships. In primary care time constrains are relevant. A short instrument may facilitate screening and assessment in daily medical practice. The aim of this study was to evaluate a 12-item short version of the Experience in Close Relationships-revised (ECR-R-D) to be used in primary care settings. We included 249 patients from ten general practices in central Germany into a cross-sectional study. Exploratory factor analysis was performed to evaluate the factor structure of the ECR-items. Cronbach's alpha was used to assess internal consistency. The results related to the short form of the ECR are in line with those of the German full-length version of the measure (ECR-RD 36). Internal consistencies were in an adequate range. The ECR short form can be recommended as a screening measure of attachment styles in primary care.	[Brenk-Franz, Katja; Schneider, Nico; Strauss, Bernhard; Tiesler, Fabian] Jena Univ Hosp, Inst Psychosocial Med & Psychotherapy, Jena, Germany; [Brenk-Franz, Katja; Schneider, Nico; Tiesler, Fabian; Gensichen, Jochen] Jena Univ Hosp, Inst Gen Practice & Family Med, Jena, Germany; [Ehrenthal, Johannes] Univ Klagenfurt, Dept Clin Psychol Psychotherapy & Psychoanal, Klagenfurt, Austria; [Freund, Tobias] Univ Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Schauenburg, Henning] Heidelberg Univ, Clin Gen Internal Med & Psychosomat, Heidelberg, Germany; [Gensichen, Jochen] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Gen Practice & Family Med, Munich, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Klagenfurt; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Munich	Brenk-Franz, K (corresponding author), Jena Univ Hosp, Inst Psychosocial Med & Psychotherapy, Jena, Germany.; Brenk-Franz, K (corresponding author), Jena Univ Hosp, Inst Gen Practice & Family Med, Jena, Germany.	katja.brenk-franz@med.uni-jena.de	Ehrenthal, Johannes C./HHC-3877-2022	Ehrenthal, Johannes C./0000-0002-9428-3763				AINSWORT.MD, 1970, CHILD DEV, V41, P49, DOI 10.2307/1127388; Bandura A., 1977, COGNITIVE THERAPY RE, V1, P287, DOI [10.1007/BF01663995, DOI 10.1007/BF01663995]; Barber N, 2005, J CLIN PHARM THER, V30, P533, DOI 10.1111/j.1365-2710.2005.00681.x; Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; BOWLBY J, 1977, BRIT J PSYCHIAT, V130, P201, DOI 10.1192/bjp.130.3.201; Brenk-Franz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136723; Brennan K., 1998, ATTACHMENT THEORY CL; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Cureton E.E., 1983, FACTOR ANAL APPL APP; Daniel SIF, 2006, CLIN PSYCHOL REV, V26, P968, DOI 10.1016/j.cpr.2006.02.001; Ehrenthal Johannes C, 2009, Psychother Psychosom Med Psychol, V59, P215, DOI 10.1055/s-2008-1067425; Fraley, 2012, INFORM EXPERIENCES C; Fraley RC, 2000, J PERS SOC PSYCHOL, V78, P350, DOI 10.1037/0022-3514.78.2.350; Grol R, 2000, BRIT J GEN PRACT, V50, P882; Hing E, 2007, OFFICE BASED MED PRA; Hunter J., 2016, IMPROVING PATIENT TR; Levy KN, 2011, J CLIN PSYCHOL, V67, P193, DOI 10.1002/jclp.20756; Liaw WR, 2016, ANN FAM MED, V14, P8, DOI 10.1370/afm.1839; Lopez FG, 2002, J COUNS PSYCHOL, V49, P355, DOI 10.1037//0022-0167.49.3.355; Lopez FG, 2000, J COUNS PSYCHOL, V47, P283, DOI 10.1037//0022-0167.47.3.283; Maunder RG, 2001, PSYCHOSOM MED, V63, P556, DOI 10.1097/00006842-200107000-00006; Meredith PJ, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0326-y; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; National Association of Statutory Health Insurance Physicians, 2014, STAT INF FED REG PHY; Nicholls W, 2014, PSYCHO-ONCOLOGY, V23, P1083, DOI 10.1002/pon.3664; Pandhi N, 2006, J AM BOARD FAM MED, V19, P390, DOI 10.3122/jabfm.19.4.390; Petersen Y, 2006, GERONTOLOGY, V52, P111, DOI 10.1159/000090957; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Schwarzer R., 1992, SELF EFFICACY THOUGH; Sibley CG, 2005, PERS SOC PSYCHOL B, V31, P1524, DOI 10.1177/0146167205276865; Sirois FM, 2016, J HEALTH PSYCHOL, V21, P821, DOI 10.1177/1359105314539531; Smith AEM, 2010, CLIN PSYCHOL REV, V30, P326, DOI 10.1016/j.cpr.2009.12.007; Strauss B., 2016, IMPROVING PATIENT TR; Vogel DL, 2005, J COUNS PSYCHOL, V52, P347, DOI 10.1037/0022-0167.52.3.347	34	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191254	10.1371/journal.pone.0191254	http://dx.doi.org/10.1371/journal.pone.0191254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360832	Green Submitted, Green Published, gold			2022-12-27	WOS:000423161800020
J	Gomes, SE; Pereira, DM; Roma-Rodrigues, C; Fernandes, AR; Borralho, PM; Rodrigues, CMP				Gomes, Sofia E.; Pereira, Diane M.; Roma-Rodrigues, Catarina; Fernandes, Alexandra R.; Borralho, Pedro M.; Rodrigues, Cecilia M. P.			Convergence of miR-143 overexpression, oxidative stress and cell death in HCT116 human colon cancer cells	PLOS ONE			English	Article							COLORECTAL-CANCER; SUPEROXIDE-DISMUTASE-1 SOD1; DOWN-REGULATION; TUMOR-GROWTH; MICRORNAS; DYSREGULATION; ANGIOGENESIS; TARGETS; RNA; TUMORIGENESIS	MicroRNAs (miRNAs) regulate a wide variety of biological processes, including tumourigenesis. Altered miRNA expression is associated with deregulation of signalling pathways, which in turn cause abnormal cell growth and de-differentiation, contributing to cancer. miR-143 and miR-145 are anti-tumourigenic and influence the sensitivity of tumour cells to chemotherapy and targeted therapy. Comparative proteomic analysis was performed in HCT116 human colon cancer cells stably transduced with miR-143 or miR-145 compared to Empty control cells. Further, Gene Ontology and pathway enrichment analysis indicated that proteins involved in specific cell signalling pathways such as cell death, response to oxidative stress, and protein folding might be modulated by these miRNAs. In particular, antioxidant enzyme superoxide dismutase 1 (SOD1) was downregulated by stable expression of either miR-143 or miR-145. Further, SOD1 gain-of-function experiments rescued cells from miR-143-induced oxidative stress. Moreover, miR-143 overexpression increased oxaliplatin-induced apoptosis associated with reactive oxygen species generation, which was abrogated by genetic and pharmacological inhibition of oxidative stress. Overall, miR-143 might circumvent resistance of colon cancer cells to oxaliplatin via increased oxidative stress in HCT116 human colon cancer cells.	[Gomes, Sofia E.; Pereira, Diane M.; Borralho, Pedro M.; Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Res Inst Med iMed ULisboa, Lisbon, Portugal; [Roma-Rodrigues, Catarina; Fernandes, Alexandra R.] Univ Nova Lisboa, Fac Sci & Technol, Dept Ciencias Vida, UCIBIO, Caparica, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa	Rodrigues, CMP (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med iMed ULisboa, Lisbon, Portugal.; Fernandes, AR (corresponding author), Univ Nova Lisboa, Fac Sci & Technol, Dept Ciencias Vida, UCIBIO, Caparica, Portugal.	ma.fernandes@fct.unl.pt; cmprodrigues@ff.ulisboa.pt	Rodrigues, Cecilia MP/M-3572-2013; Fernandes, Alexandra R/C-7465-2011; Roma-Rodrigues, Catarina/AAT-5658-2021; Roma-Rodrigues, Catarina/S-6144-2016; Borralho, Pedro/AAJ-2829-2021; iMed.ULisboa, CellFun/A-4244-2014; Pereira, Diane M/L-5220-2013; Borralho, Pedro/C-2727-2011	Rodrigues, Cecilia MP/0000-0002-4829-754X; Fernandes, Alexandra R/0000-0003-2054-4438; Roma-Rodrigues, Catarina/0000-0002-8676-6562; Roma-Rodrigues, Catarina/0000-0002-8676-6562; Pereira, Diane M/0000-0002-4151-4775; Borralho, Pedro/0000-0003-4488-7240	European Structural and Investment Funds through the COMPETE Programme [SAICTPAC/0019/2015]; National Funds through Fundacao para a Ciencia e a Tecnologia (FCT); FEDER [POCI-01-0145-FEDER-007728]; FCT [UID/DTP/04138/2013, UID/Multi/04378/2013, SFRH/BD/88619/2012, SFRH/BD/96517/2013]	European Structural and Investment Funds through the COMPETE Programme; National Funds through Fundacao para a Ciencia e a Tecnologia (FCT); FEDER(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Programme grant SAICTPAC/0019/2015 funded by European Structural and Investment Funds through the COMPETE Programme and by National Funds through Fundacao para a Ciencia e a Tecnologia (FCT, http://www.fct.pt) (CMPR), iMed.ULisboa funded by FCT (UID/DTP/04138/2013) (CR), UCIBIO funded by FCT (UID/Multi/04378/2013) (ARF) and co-funded by FEDER under PT2020 Partnership Agreement POCI-01-0145-FEDER-007728, and fellowships SFRH/BD/88619/2012 (SEG) and SFRH/BD/96517/2013 (DMP) from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2014, ONCOTARGET, V5, P872, DOI 10.18632/oncotarget.1825; Akao Y, 2009, LEUKEMIA RES, V33, P1530, DOI 10.1016/j.leukres.2009.04.019; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borralho PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023787; Borralho PM, 2009, FEBS J, V276, P6689, DOI 10.1111/j.1742-4658.2009.07383.x; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Brozovic A, 2010, CRIT REV TOXICOL, V40, P347, DOI 10.3109/10408441003601836; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Conde J, 2014, NANOTOXICOLOGY, V8, P521, DOI 10.3109/17435390.2013.802821; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Das AV, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0247-4; Donate F, 2008, BRIT J CANCER, V98, P776, DOI 10.1038/sj.bjc.6604226; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Glasauer A, 2014, J CLIN INVEST, V124, P117, DOI 10.1172/JCI71714; Gomes SE, 2016, ONCOTARGET, V7, P9369, DOI 10.18632/oncotarget.7010; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Iio A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-136; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Juarez JC, 2006, CLIN CANCER RES, V12, P4974, DOI 10.1158/1078-0432.CCR-06-0171; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kent OA, 2013, ONCOGENE, V32, P2576, DOI 10.1038/onc.2012.266; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Larabee SM, 2015, STEM CELLS DEV, V24, P354, DOI 10.1089/scd.2014.0051; Li Rong, 2012, J WUHAN U SCI EDIT S, VS2, P145, DOI DOI 10.1371/J0URNAL.P0NE.0044907; Liang G, 2016, GENE THER, V23, P829, DOI 10.1038/gt.2016.60; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Lu WD, 2014, CANCER LETT, V343, P190, DOI 10.1016/j.canlet.2013.10.002; Mendo AS, 2015, J BIOL INORG CHEM, V20, P935, DOI 10.1007/s00775-015-1277-z; Michael MZ, 2003, MOL CANCER RES, V1, P882; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Pagliuca A, 2013, ONCOGENE, V32, P4806, DOI 10.1038/onc.2012.495; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002; Pramanik D, 2011, MOL CANCER THER, V10, P1470, DOI 10.1158/1535-7163.MCT-11-0152; Qian X, 2013, CELL CYCLE, V12, P1385, DOI 10.4161/cc.24477; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sajesh BV, 2015, ONCOTARGET, V6, P27907, DOI 10.18632/oncotarget.4875; Sajesh BV, 2013, GENETICS, V195, P757, DOI 10.1534/genetics.113.156836; Shaw AT, 2011, P NATL ACAD SCI USA, V108, P8773, DOI 10.1073/pnas.1105941108; Somwar R, 2011, P NATL ACAD SCI USA, V108, P16375, DOI 10.1073/pnas.1113554108; Sudbery I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-175; Tian SS, 2016, INT J CARDIOL, V211, P115, DOI 10.1016/j.ijcard.2016.02.141; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vaz AR, 2015, MOL NEUROBIOL, V51, P864, DOI 10.1007/s12035-014-8731-8; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098; Xu Q, 2012, NUCLEIC ACIDS RES, V40, P761, DOI 10.1093/nar/gkr730; Zaman MS, 2010, BRIT J CANCER, V103, P256, DOI 10.1038/sj.bjc.6605742; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhu HY, 2011, MOL CANCER RES, V9, P960, DOI 10.1158/1541-7786.MCR-10-0531	54	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191607	10.1371/journal.pone.0191607	http://dx.doi.org/10.1371/journal.pone.0191607			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360852	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800040
J	Moreno-Amador, JL; Tellez, N; Marin, S; Aloy-Reverte, C; Semino, C; Nacher, M; Montanya, E				Luis Moreno-Amador, Jose; Tellez, Noelia; Marin, Sandra; Aloy-Reverte, Caterina; Semino, Carlos; Nacher, Montserrat; Montanya, Eduard			Epithelial to mesenchymal transition in human endocrine islet cells	PLOS ONE			English	Article							BETA-CELLS; PANCREATIC ALPHA; EXPRESSION; CONVERSION; DEDIFFERENTIATION; DIFFERENTIATION; PLASTICITY; IDENTITY	Background & para;& para;beta-cells undergo an epithelial to mesenchymal transition (EMT) when expanded in monolayer culture and give rise to highly proliferative mesenchymal cells that retain the potential to redifferentiate into insulin-producing cells.& para;& para;Objective & para;& para;To investigate whether EMT takes place in the endocrine non-beta-cells of human islets.& para;& para;Methodology & para;& para;Human islets isolated from 12 multiorgan donors were dissociated into single cells, purified by magnetic cell sorting, and cultured in monolayer.& para;& para;Results & para;& para;Co-expression of insulin and the mesenchymal marker vimentin was identified within the first passage (p1) and increased subsequently (insulin(+)vimentin(+)7.2 +/- 6% at p1; 43 +/- 15% at p4). The endocrine non-beta-cells did also co-express vimentin (glucagon(+)vimentin(+) 59 +/- 1.5% and 93 +/- 6%, somatostatin+vimentin+ 16 +/- 9.4% and 90 +/- 10% at p1 and p4 respectively; PP(+)vimentin(+) 74 +/- 14% at p1; 88 +/- 12% at p2). The percentage of cells expressing only endocrine markers was progressively reduced (0.6 +/- 0.2% insulin(+), 0.2 +/- 0.1 % glucagon(+), and 0.3 +/- 0.2% somatostatin(+) cells at p4, and 0.7 +/- 0.3% PP+ cells at p2. Changes in gene expression were also indicated of EMT, with reduced expression of endocrine markers and the epithelial marker CDH-1 (p<0.01), and increased expression of mesenchymal markers (CDH-2, SNA12, ZEB1, ZEB2, VIM, NT5E and ACTA2; p<0.05). Treatment with the EMT inhibitor A83-01 significantly reduced the percentage of co-expressing cells and preserved the expression of endocrine markers.& para;& para;Conclusions & para;& para;In adult human islets, all four enocrine islet cell types undergo EMT when islet cells are expanded in monolayer conditions. The presence of EMT in all islet endocrine cells could be relevant to design of strategies aiming to re-differentiate the expanded islet cells towards a beta-cell phenotype.	[Luis Moreno-Amador, Jose; Tellez, Noelia; Marin, Sandra; Nacher, Montserrat; Montanya, Eduard] Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Luis Moreno-Amador, Jose; Tellez, Noelia; Marin, Sandra; Nacher, Montserrat; Montanya, Eduard] CIBER Diabet & Enfermedades Metab Asociadas CIBERD, Madrid, Spain; [Aloy-Reverte, Caterina; Semino, Carlos] Univ Ramon Llull, IQS Sch Engn, Barcelona, Spain; [Nacher, Montserrat; Montanya, Eduard] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain; [Montanya, Eduard] Univ Barcelona, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universitat Ramon Llull; Institut Quimic de Sarria; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Nacher, M; Montanya, E (corresponding author), Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain.; Nacher, M; Montanya, E (corresponding author), CIBER Diabet & Enfermedades Metab Asociadas CIBERD, Madrid, Spain.; Nacher, M; Montanya, E (corresponding author), Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain.; Montanya, E (corresponding author), Univ Barcelona, Barcelona, Spain.	montanya@ub.edu; mnacher@belivitgehospital.cat	Semino, Carlos/AAF-2298-2019; Tellez, Noelia/C-1029-2008	Tellez, Noelia/0000-0001-7879-3256; Montanya, Eduard/0000-0003-2518-9076	Ministry of Business and Knowledge (AGAUR) of the Government of Catalonia under the European Social Fund program (European Community); European Community under the ERDF operational program (European Regional Development Fund, FEDER) "a PLOS way to build Europe"; Instituto de Salud Carlos III (Carlos III Health Institute) (ISCiii) grants [PI13/00108, PI16/00462]; ACCIO (Catalonia Trade Investment; Generalitat de Catalunya); Fundacio La Marato TV3 Grant [PR084/12]	Ministry of Business and Knowledge (AGAUR) of the Government of Catalonia under the European Social Fund program (European Community); European Community under the ERDF operational program (European Regional Development Fund, FEDER) "a PLOS way to build Europe"; Instituto de Salud Carlos III (Carlos III Health Institute) (ISCiii) grants; ACCIO (Catalonia Trade Investment; Generalitat de Catalunya); Fundacio La Marato TV3 Grant	This project was supported by Fundacio La Marato TV3 Grant PR084/12 (EM,CS), Instituto de Salud Carlos III (Carlos III Health Institute) (ISCiii) grants PI13/00108 (EM) and PI16/00462 (EM), ACCIO (Catalonia Trade & Investment; Generalitat de Catalunya) in the context of ADVANCE.CAT (EM), and the European Community under the ERDF operational program (European Regional Development Fund, FEDER) "a PLOS way to build Europe". SM is the recipient of a predoctoral grant from the Secretariat for Universities and Research of the Ministry of Business and Knowledge (AGAUR) of the Government of Catalonia under the European Social Fund program (European Community). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee M, 2009, DIABETOLOGIA, V52, P621, DOI 10.1007/s00125-009-1259-1; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Ben-Othman N, 2017, CELL, P1; Bramswig NC, 2013, J CLIN INVEST, V123, P1275, DOI 10.1172/JCI66514; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Cinti F, 2016, J CLIN ENDOCR METAB, V101, P1044, DOI 10.1210/jc.2015-2860; CIRULLI V, 1994, J CELL SCI, V107, P1429; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Corritore E, 2014, CELL REPROGRAM, V16, P456, DOI 10.1089/cell.2014.0025; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Fanjul M, 2010, J HISTOCHEM CYTOCHEM, V58, P807, DOI 10.1369/jhc.2010.955807; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Goto M, 2004, TRANSPLANTATION, V78, P1367, DOI 10.1097/01.TP.0000140882.53773.DC; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Hunter CS, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00035; Nacher M, 2016, CELL TRANSPLANT, V25, P343, DOI 10.3727/096368915X688119; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roefs M, 2017, J ENDOCRINOL; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Spijker HS, 2015, DIABETES, V64, P2928, DOI 10.2337/db14-1752; Spijker HS, 2013, DIABETES, V62, P2471, DOI 10.2337/db12-1001; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; White MG, 2013, DIABETES CARE, V36, P3818, DOI 10.2337/dc13-0705; Yang YP, 2011, GENE DEV, V25, P1680, DOI 10.1101/gad.16875711; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	30	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191104	10.1371/journal.pone.0191104	http://dx.doi.org/10.1371/journal.pone.0191104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360826	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800016
J	Al-Harrasi, I; Al-Yahyai, R; Yaish, MW				Al-Harrasi, Ibtisam; Al-Yahyai, Rashid; Yaish, Mahmoud W.			Differential DNA methylation and transcription profiles in date palm roots exposed to salinity	PLOS ONE			English	Article							PHOENIX-DACTYLIFERA L.; GENOMIC DNA; ARABIDOPSIS; PLANTS; STRESS; 5-METHYLCYTOSINE; RESOLUTION; ADAPTATION; MECHANISMS; EXPRESSION	As a salt-adaptive plant, the date palm (Phoenix dactylifera L.) requires a suitable mechanism to adapt to the stress of saline soils. There is growing evidence that DNA methylation plays an important role in regulating gene expression in response to abiotic stresses, including salinity. Thus, the present study sought to examine the differential methylation status that occurs in the date palm genome when plants are exposed to salinity, and to identify salinity responsive genes that are regulated by DNA methylation. To achieve these, whole-genome bisulfite sequencing (WGBS) was employed and mRNA was sequenced from salinity-treated and untreated roots. The WGBS analysis included 324,987,795 and 317,056,091 total reads of the control and the salinity-treated samples, respectively. The analysis covered about 81% of the total genomic DNA with about 40% of mapping efficiency of the sequenced reads and an average read depth of 17-fold coverage per DNA strand, and with a bisulfite conversion rate of around 99%. The level of methylation within the differentially methylated regions (DMRs) was significantly (p < 0.05, FDR <= 0.05) increased in response to salinity specifically at the mCHG and mCHH sequence contexts. Consistently, the mass spectrometry and the enzyme-linked immunosorbent assay (ELISA) showed that there was a significant (p < 0.05) increase in the global DNA methylation in response to salinity. mRNA sequencing revealed the presence of 6,405 differentially regulated genes with a significant value (p < 0.001, FDR <= 0.05) in response to salinity. Integration of high-resolution methylome and transcriptome analyses revealed a negative correlation between mCG methylation located within the promoters and the gene expression, while a positive correlation was noticed between mCHG/mCHH methylation rations and gene expression specifically when plants grew under control conditions. Therefore, the methylome and transcriptome relationships vary based on the methylated sequence context, the methylated region within the gene, the protein-coding ability of the gene, and the salinity treatment. These results provide insights into interplay among DNA methylation and gene expression, and highlight the effect of salinity on the nature of this relationship, which may involve other genetic and epigenetic players under salt stress conditions. The results obtained from this project provide the first draft map of the differential methylome and transcriptome of date palm when exposed to an abiotic stress.	[Al-Harrasi, Ibtisam; Yaish, Mahmoud W.] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman; [Al-Yahyai, Rashid] Sultan Qaboos Univ, Dept Crop Sci, Coll Agr & Marine Sci, Muscat, Oman	Sultan Qaboos University; Sultan Qaboos University	Yaish, MW (corresponding author), Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman.	myaish@squ.edu.om	Harrasi, Ibtisam Al/AAX-3483-2020; Al-Yahyai, Rashid/B-9273-2011; Yaish, Mahmoud W/F-7168-2014	Al-Yahyai, Rashid/0000-0001-7628-6218; Yaish, Mahmoud W/0000-0002-5171-3014; Al Harrasi, Ibtisam/0000-0002-7300-6185	Research Council of Oman (TRC) [151]	Research Council of Oman (TRC)	This work was supported by a generous grant from the Research Council of Oman (TRC) number 151	Al Harrasi I, 2017, METHODS MOL BIOL, V1631, P121, DOI 10.1007/978-1-4939-7136-7_7; Al Kharusi L, 2017, FORESTS, V8, DOI 10.3390/f8040136; Al-Lawati A, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15018299; Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; Assaha DVM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00509; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Erdmann RM, 2014, G3; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Fojtova M, 2001, PLANT SCI, V160, P585, DOI 10.1016/S0168-9452(00)00411-8; Ganie SA, 2016, FUNCT INTEGR GENOMIC, V16, P1, DOI 10.1007/s10142-015-0460-1; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Guo XL, 2009, PLANTA, V230, P227, DOI 10.1007/s00425-009-0934-2; Hardcastle TJ, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-16; He YP, 2015, ANNU REV GENOM HUM G, V16, P55, DOI 10.1146/annurev-genom-090413-025437; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Khan S, 2007, AFR J BIOTECHNOL, V6, P175; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kumar S, 2017, DNA CELL BIOL; Kumari A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00537; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; LEUTWILER LS, 1984, MOL GEN GENET, V194, P15, DOI 10.1007/BF00383491; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084620; Lu XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139582; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pandey G, 2016, PLANT CELL REP; Poliseno L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002858; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Saze H, 2012, PLANT CELL PHYSIOL, V53, P766, DOI 10.1093/pcp/pcs008; Secco D, 2015, ELIFE, V4, DOI 10.7554/eLife.09343; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Song Y, 2015, J EXP BOT; Sperling O, 2014, ENVIRON EXP BOT, V99, P100, DOI 10.1016/j.envexpbot.2013.10.014; Stepien P, 2009, PLANT PHYSIOL, V149, P1154, DOI 10.1104/pp.108.132407; Stevens M, 2013, GENOME RES, V23, P1541, DOI 10.1101/gr.152231.112; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tran H, 2014, ADV BIOINFORMATICS, V2014, P11; Urich MA, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.114; Viggiano L, 2017, RNA TECHNOL, P281, DOI 10.1007/978-3-319-55520-1_15; WAGNER I, 1981, BIOCHIM BIOPHYS ACTA, V654, P52, DOI 10.1016/0005-2787(81)90135-0; Wang J, 2014, PLOS ONE, V9; Wang MC, 2008, PROTEOMICS, V8, P1470, DOI 10.1002/pmic.200700569; Xiao Y, 2012, PLANT OMICS, V5, P584; Yaish MW, 2015, GENET MOL RES, V14, P9943, DOI 10.4238/2015.August.19.30; Yaish MW, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01983; Yaish MW, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3633-6; Yaish MW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00946; Yaish MW, 2014, METHODS MOL BIOL, V1062, P285, DOI 10.1007/978-1-62703-580-4_16; Yaish MW, 2011, J EXP BOT, V62, P3727, DOI 10.1093/jxb/err177; Yaish MWF, 2009, PLANT J, V59, P123, DOI 10.1111/j.1365-313X.2009.03860.x; YAISH MW, 2015, FRONT PLANT SCI, V6; Yang M, 2010, PLOS ONE, V5; Yong WS, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0075-3; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107; Zhang Q, 2011, J PROTEOME RES, V10, P46, DOI 10.1021/pr101052y; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhong L., 2007, J WUHAN BOT RES, V1, P19; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929; Ziller MJ, 2015, NAT METHODS, V12, P230, DOI [10.1038/NMETH.3152, 10.1038/nmeth.3152]	75	28	28	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191492	10.1371/journal.pone.0191492	http://dx.doi.org/10.1371/journal.pone.0191492			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352281	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300097
J	Myers, KA; McGlade, A; Neubauer, BA; Lal, D; Berkovic, SF; Scheffer, IE; Hildebrand, MS				Myers, Kenneth A.; McGlade, Amelia; Neubauer, Bernd A.; Lal, Dennis; Berkovic, Samuel F.; Scheffer, Ingrid E.; Hildebrand, Michael S.			KANSL1 variation is not a major contributing factor in self-limited focal epilepsy syndromes of childhood	PLOS ONE			English	Article							ROLANDIC EPILEPSY; PROTEIN; ACETYLATION	Background KANSL1 haploinsufficiency causes Koolen-de Vries syndrome (KdVS), characterized by dysmorphic features and intellectual disability; amiable personality, congenital malformations and seizures also commonly occur. The epilepsy phenotypic spectrum in KdVS is broad, but most individuals have focal seizures with some having a phenotype resembling the self-limited focal epilepsies of childhood (SFEC). We hypothesized that variants in KANSL1 contribute to pathogenesis of SFEC. Materials and methods We screened KANSL1 for single nucleotide variants in 90 patients with SFEC. We then screened a cohort of 208 patients with two specific SFEC syndromes, childhood epilepsy with centrotemporal spikes (CECTS) and atypical childhood epilepsy with centrotemporal spikes (ACECTS) for KANSL1 variants. The second cohort was also used to evaluate minor allelic variants that appeared overrepresented in the initial cohort. Results One variant, p.Lys104Thr, was predicted damaging and appeared overrepresented in our 90-patient cohort compared to Genome Aggregation Database (gnomAD) allele frequency (0.217 to 0.116, with no homozygotes in gnomAD). However, there was no difference in p. Lys104Thr allele frequency in the follow-up CECTS/ACECTS cohort and controls. Four rare KANSL1 variants of uncertain significance were identified in the CECTS/ACECTS cohort. Discussion Our data do not support a major role for KANSL1 variants in pathogenesis of SFEC.	[Myers, Kenneth A.; McGlade, Amelia; Berkovic, Samuel F.; Scheffer, Ingrid E.; Hildebrand, Michael S.] Univ Melbourne, Dept Med, Epilepsy Res Ctr, Austin Hlth, Heidelberg, Vic, Australia; [Neubauer, Bernd A.] Univ Kinderklin Giessen & Marburg, Abt Kinderneurol Sozialpadiatrie & Epileptol, Giessen, Germany; [Lal, Dennis] Broad Inst Harvard & MIT, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Lal, Dennis] Massachusetts Gen Hosp, Analyt Translat Genet Unit, Boston, MA 02114 USA; [Lal, Dennis] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Scheffer, Ingrid E.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic, Australia; [Scheffer, Ingrid E.] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University Hospital of Giessen & Marburg; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Cologne; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health	Myers, KA (corresponding author), Univ Melbourne, Dept Med, Epilepsy Res Ctr, Austin Hlth, Heidelberg, Vic, Australia.	sfu.ken1@gmail.com	jiang, yu/HGU-0029-2022; Neubauer, Bernd/AAZ-9391-2020; Scheffer, Ingrid E/G-1668-2013	Scheffer, Ingrid E/0000-0002-2311-2174; Myers, Kenneth/0000-0001-7831-4593; Hildebrand, Michael/0000-0003-2739-0515; Berkovic, Samuel/0000-0003-4580-841X	Supporting Families with Koolen-de Vries syndrome; Australian National Health and Medical Research Council Program Grant (NHMRC) [628952]; Citizens United for Research in Epilepsy (CURE) [439534]	Supporting Families with Koolen-de Vries syndrome; Australian National Health and Medical Research Council Program Grant (NHMRC); Citizens United for Research in Epilepsy (CURE)	This research was supported by a grant from Supporting Families with Koolen-de Vries syndrome (https://supportingkdvs.org/). Additional support came from an Australian National Health and Medical Research Council Program Grant (NHMRC; https://www.nhmrc.gov.au/; grant number 628952). Dr. Myers also holds a Taking Flight Award from Citizens United for Research in Epilepsy (CURE; http://www.cureepilepsy.org/; grant number 439534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the patients and their families for contributing to this research. This research was supported by a grant from Supporting Families with Koolen-de Vries syndrome (https://supportingkdvs.org/). Additional support came from an Australian National Health and Medical Research Council Program Grant (NHMRC; https://www.nhmrc.gov.au/; grant number 628952). Dr. Myers also holds a Taking Flight Award from Citizens United for Research in Epilepsy (CURE; http://www.cureepilepsy.org/;grant number 439534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; [Anonymous], 2014, INT LEAG EP; Bali B, 2007, EPILEPSIA, V48, P2266; Bureau Michelle, 2012, EPILEPTIC SYNDROMES; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Koolen DA, 2008, J MED GENET, V45, P710, DOI 10.1136/jmg.2008.058701; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Myers K. A., 2017, EPILEPSIA; Reinthaler EM, 2015, ANN NEUROL, V77, P972, DOI 10.1002/ana.24395; REUTENS DC, 1992, EPILEPSIA, V33, P1065, DOI 10.1111/j.1528-1157.1992.tb01760.x; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Tan TY, 2009, J MED GENET, V46, P480, DOI 10.1136/jmg.2008.065391	14	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191546	10.1371/journal.pone.0191546	http://dx.doi.org/10.1371/journal.pone.0191546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352316	Green Published, gold			2022-12-27	WOS:000422911300111
J	Turenne, N				Turenne, Nicolas			The rumour spectrum	PLOS ONE			English	Article							MISINFORMATION	Rumour is an old social phenomenon used in politics and other public spaces. It has been studied for only hundred years by sociologists and psychologists by qualitative means. Social media platforms open new opportunities to improve quantitative analyses. We scanned all scientific literature to find relevant features. We made a quantitative screening of some specific rumours (in French and in English). Firstly, we identified some sources of information to find them. Secondly, we compiled different reference, rumouring and event datasets. Thirdly, we considered two facets of a rumour: the way it can spread to other users, and the syntagmatic content that may or may not be specific for a rumour. We found 53 features, clustered into six categories, which are able to describe a rumour message. The spread of a rumour is multi-harmonic having different frequencies and spikes, and can survive several years. Combinations of words (n-grams and skip-grams) are not typical of expressivity between rumours and news but study of lexical transition from a time period to the next goes in the sense of transmission pattern as described by Allport theory of transmission. A rumour can be interpreted as a speech act but with transmission patterns.	[Turenne, Nicolas] Univ Paris Est, LISIS, INRA, F-77454 Marne La Vallee, France	INRAE; Universite Gustave-Eiffel; ESIEE Paris	Turenne, N (corresponding author), Univ Paris Est, LISIS, INRA, F-77454 Marne La Vallee, France.	nturenne@u-pem.fr		turenne, nicolas/0000-0003-1229-5590	LabEx SITES	LabEx SITES	This work was supported by LabEx SITES - master grant.	Acemoglu D, 2010, GAME ECON BEHAV, V70, P194, DOI 10.1016/j.geb.2010.01.005; Allport G. W., 1947, PSYCHOL RUMOR, P247; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Bernard P., 2002, 3 INT C LANG RES EV; Bernardi D., 2012, NARRATIVE LANDSCAPES; Black W. J., 2012, P 8 INT C LANG RES E; Bordia P, 2004, SOC PSYCHOL QUART, V67, P33, DOI 10.1177/019027250406700105; Budak C., 2011, PROC 20 INT C WORLD, P665, DOI 10.1145/1963405.1963499; Burnard Lou, 2000, BRIT NATL CORPUS USE; Campion-Vincent V, 2005, RELIABLE SOURCES NEW; Castillo C., 2011, PROC 20 INT C WORLD, P675, DOI DOI 10.1145/1963405.1963500; Charniak E., 1996, STAT LANGUAGE LEARNI; Chen YY, 2014, J COMPUT, V9, P441, DOI 10.4304/jcp.9.2.441-446; Chierichetti F, 2009, LECT NOTES COMPUT SC, V5556, P375, DOI 10.1007/978-3-642-02930-1_31; Collier N, 2008, BIOINFORMATICS, V24, P2940, DOI 10.1093/bioinformatics/btn534; Davies M., 2020, CORPUS CONT AM ENGLI; De Domenico M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02980; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Emilio Serrano, 2015, P 24 INT C WORLD WID; Finn Samantha, 2014, ARXIV PREPRINT ARXIV; Friggeri Adrien, 2014, 8 INT AAAI C WEBL SO; Froissart P, 2004, CAHIERS GREDAM; Gaiffe B, 2009, TEI EST REPUBLICAIN; Gaildraud L, 2009, EUR S COMP INT ECIS; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Heiderich D, 2004, RUMOR INTERNET UNDER; Jin F, 2014, COMPUTER, V47, P90, DOI 10.1109/MC.2014.361; Kirkpatrick C, 1932, AM J SOCIOL, V38, P194, DOI 10.1086/216029; Knapp RH, 1944, PUBLIC OPIN QUART, V8, P22, DOI 10.1086/265665; Kostka J, 2008, LECT NOTES COMPUT SC, V5058, P185, DOI 10.1007/978-3-540-69355-0_16; Kurihara S, 2014, WWW 14 COMPANION; Kwon S., 2013, DAT MIN ICDM 2013 IE; Langston J., 2016, TWITTERSPHERE DOES L; Lee J., 2013, INFORM SYSTEMS FRONT, V17, P997; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Maimon OZ, 2005, DATA MINING KNOWLEDG; Manning C, 1999, FDN STAT NATURAL LAN; Menczer F, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16 COMPANION), P717, DOI 10.1145/2872518.2890092; Metaxas PT, 2010, LECT NOTES BUS INF P, V45, P170; Morin E, 1969, LA RUMEUR D ORLEANS; Nadamoto A, 2013, P INT C INF INT WEB; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Paavola J, 2015, PROCEEDINGS OF THE 14TH EUROPEAN CONFERENCE ON CYBER WARFARE AND SECURITY (ECCWS-2015), P213; Petkovic T, 2005, 27 INT CONV MIPRO 20, P117; Procter R., 2017, ARXIV170400656; Qazvinian V., 2011, P C EMP METH NAT LAN, P1589; Ratkiewicz J., 2010, ARXIV10113768; Resnick P., 2014, COMP JOURN S 2014; ROSNOW RL, 1991, AM PSYCHOL, V46, P484, DOI 10.1037/0003-066X.46.5.484; Searle John R, 1985, EXPRESSION MEANING S; Seo E, 2012, PROC SPIE, V8389, DOI 10.1117/12.919823; Silverman C., 2016, EMERGENT REAL TIME R; Spiro ES, 2012, PROCEEDINGS OF THE 3RD ANNUAL ACM WEB SCIENCE CONFERENCE, 2012, P275; Starbird K., 2014, ICONFERENCE 2014 P, P654, DOI [DOI 10.9776/14308, 10.9776/14308]; Stern William L., 1902, Z GES STRAFRECHT, V22, P315; Takayasu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121443; Turenne N., 2016, TEXT DATA ANAL R; Vosoughi S, P 10 AAAI C WEBL SOC; Vukovic M, 2009, LECT NOTES ARTIF INT, V5711, P318, DOI 10.1007/978-3-642-04595-0_39; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040301; Zhao LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124978	63	14	14	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0189080	10.1371/journal.pone.0189080	http://dx.doi.org/10.1371/journal.pone.0189080			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351289	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300007
J	Jobst-Schwan, T; Schmidt, JM; Schneider, R; Hoogstraten, CA; Ullmann, JFP; Schapiro, D; Majmundar, AJ; Kolb, A; Eddy, K; Shril, S; Braun, DA; Poduri, A; Hildebrandt, F				Jobst-Schwan, Tilman; Schmidt, Johanna Magdalena; Schneider, Ronen; Hoogstraten, Charlotte A.; Ullmann, Jeremy F. P.; Schapiro, David; Majmundar, Amar J.; Kolb, Amy; Eddy, Kaitlyn; Shril, Shirlee; Braun, Daniela A.; Poduri, Annapurna; Hildebrandt, Friedhelm			Acute multi-sgRNA knockdown of KEOPS complex genes reproduces the microcephaly phenotype of the stable knockout zebrafish model	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; NEXT-GENERATION; WEB TOOL; DNA; CRISPR; MUTATIONS; SCREENS; REPAIR; CHOPCHOP; LEUKEMIA	Until recently, morpholino oligonucleotides have been widely employed in zebrafish as an acute and efficient loss-of-function assay. However, off-target effects and reproducibility issues when compared to stable knockout lines have compromised their further use. Here we employed an acute CRISPR/Cas approach using multiple single guide RNAs targeting simultaneously different positions in two exemplar genes (osgep or tprkb) to increase the likelihood of generating mutations on both alleles in the injected F0 generation and to achieve a similar effect as morpholinos but with the reproducibility of stable lines. This multi single guide RNA approach resulted in median likelihoods for at least one mutation on each allele of >99% and sgRNA specific insertion/deletion profiles as revealed by deep-sequencing. Immunoblot showed a significant reduction for Osgep and Tprkb proteins. For both genes, the acute multi-sgRNA knockout recapitulated the microcephaly phenotype and reduction in survival that we observed previously in stable knockout lines, though milder in the acute multi- sgRNA knockout. Finally, we quantify the degree of mutagenesis by deep sequencing, and provide a mathematical model to quantitate the chance for a biallelic lossof- function mutation. Our findings can be generalized to acute and stable CRISPR/Cas targeting for any zebrafish gene of interest.	[Jobst-Schwan, Tilman; Schmidt, Johanna Magdalena; Schneider, Ronen; Hoogstraten, Charlotte A.; Schapiro, David; Majmundar, Amar J.; Kolb, Amy; Eddy, Kaitlyn; Shril, Shirlee; Braun, Daniela A.; Hildebrandt, Friedhelm] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Ullmann, Jeremy F. P.; Poduri, Annapurna] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Epilepsy Genet Program, Boston, MA USA; [Ullmann, Jeremy F. P.; Poduri, Annapurna] Harvard Med Sch, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Neurol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Hildebrandt, F (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA.	friedhelm.hildebrandt@childrens.harvard.edu	Hoogstraten, Charlotte A/F-6553-2018; Jobst-Schwan, Tilman/AAF-6364-2020; Schneider, Ronen/ABD-6649-2020; Shril, Shirlee/Q-5825-2016; Ullmann, Jeremy/B-9799-2015	Hoogstraten, Charlotte A/0000-0002-6976-6026; Jobst-Schwan, Tilman/0000-0001-9802-6783; Ullmann, Jeremy/0000-0002-3073-9151	National Institutes of Health [DK076683, T32DK007726-31A1]; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft [Jo 1324/1-1]; Harvard Stem Cell Institute Kidney Group Inter-laboratory Post-doctoral Fellowship; Translational Research Program, Boston Childrens Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Harvard Stem Cell Institute Kidney Group Inter-laboratory Post-doctoral Fellowship; Translational Research Program, Boston Childrens Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the National Institutes of Health to F.H. (DK076683, www.ncbi.nlm.nih.gov) and by the Howard Hughes Medical Institute (www.hhmi.org) to F.H. F.H. is the William E. Harmon Professor. T.J.S. is supported by a grant of the Deutsche Forschungsgemeinschaft (Jo 1324/1-1, www.dfg.de). A.M. is supported by the National Institutes of Health funded Training Grant T32DK007726-31A1 (www.ncbi.nlm.nih.gov) and the Harvard Stem Cell Institute Kidney Group Inter-laboratory Post-doctoral Fellowship (https://hsci.harvard.edu). A.P. is supported by the Translational Research Program, Boston Childrens Hospital (http://www.childrenshospital.org/research-and-innovation/research/icctr/centers-services/translational-research-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aanes H, 2014, BRIEF FUNCT GENOMICS, V13, P95, DOI 10.1093/bfgp/elt049; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bentley J, 2004, NUCLEIC ACIDS RES, V32, P5249, DOI 10.1093/nar/gkh842; Braun DA, 2017, NAT GENET, V49, P1529, DOI 10.1038/ng.3933; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gebruers E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083293; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; He MD, 2015, MUTAT RES-FUND MOL M, V780, P86, DOI 10.1016/j.mrfmmm.2015.08.004; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Liang L, 2008, NUCLEIC ACIDS RES, V36, P3297, DOI 10.1093/nar/gkn184; Mattarucchi E, 2008, GENE CHROMOSOME CANC, V47, P625, DOI 10.1002/gcc.20568; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Mishima Y, 2016, MOL CELL, V61, P874, DOI 10.1016/j.molcel.2016.02.027; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Peterson RT, 2011, METHOD CELL BIOL, V105, P525, DOI 10.1016/B978-0-12-381320-6.00023-0; Pfeifer J.D., 2006, MOL GENETIC TESTING; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shah AN, 2016, METHOD CELL BIOL, V135, P89, DOI 10.1016/bs.mcb.2016.01.008; Shah AN, 2015, NAT METHODS, V12, P535, DOI 10.1038/nmeth.3360; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Stainier DYR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007000; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020	38	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191503	10.1371/journal.pone.0191503	http://dx.doi.org/10.1371/journal.pone.0191503			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346415	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500057
J	Stella, JL; Bauer, AE; Croney, CC				Stella, Judith L.; Bauer, Amy E.; Croney, Candace C.			A cross-sectional study to estimate prevalence of periodontal disease in a population of dogs (Canis familiaris) in commercial breeding facilities in Indiana and Illinois	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; GINGIVAL HEALTH; PLAQUE; FREQUENCY; VALIDITY; MODEL; CATS	The objectives of this cross-sectional study were: 1) to estimate the prevalence and characterize the severity of periodontal disease in a population of dogs housed in commercial breeding facilities; 2) to characterize PD preventive care utilized by facility owners; and 3) to assess inter-rater reliability of a visual scoring assessment tool. Adult dogs (N = 445) representing 42 breeds at 24 CB facilities in Indiana and Illinois were assessed. Periodontal disease was scored visually using the American Veterinary Dental Collage 0-IV scale. Inter-rater reliability was assessed on 198 dogs and facility owners were asked to provide information about the preventive care utilized. The overall prevalence of periodontal disease (Grades I-IV) was 86.3% (95% CI: 82.9, 89.3). An ordered logistic regression analysis found age (OR = 1.4; 95% CI 1.24, 1.54; P<0.0001), facility (OR = 1.13; 95% CI 1.09, 1.18; P<0.0001), sex (OR = 1.7; 95% CI 1.12, 2.65; P = 0.013), and non-professional dental scaling (OR = 2.82; 95% CI 1.34, 5.91; P = 0.006) to be statistically significant. Inter-rater reliability analysis found agreement to be 86.2%, with a weighted kappa of 0.4731 (95% CI 0.3847, 0.5615) indicating moderate agreement. Risk of periodontal disease increased with increasing age. Additionally, a trend toward decreasing risk with increasing weight was also found, although it was not statistically significant. The trends identified agree with studies that have evaluated periodontal disease in the companion dog population and do not support the assumption that the dental health of dogs in commercial breeding facilities is worse than that of the population as a whole. Although there were few cases of severe periodontal disease and all facilities employed some type of preventive care in this sample, the large number of dogs with some degree of disease (Grades I-IV) suggests that further investigation of preventive care is warranted.	[Stella, Judith L.] Purdue Univ, USDA, APHIS, W Lafayette, IN 47907 USA; [Bauer, Amy E.; Croney, Candace C.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Stella, JL (corresponding author), Purdue Univ, USDA, APHIS, W Lafayette, IN 47907 USA.	Judith.l.stella@aphis.usda.gov			Pet Food Institute; World Pet Association	Pet Food Institute; World Pet Association	This study was supported by funding from Pet Food Institute and World Pet Association. Funding sources did not have any involvement in the design or conduct of the study; collection, analysis, or interpretation of the data; writing or approval of the manuscript; or decision to submit the manuscript for publication.	AAFCO, 2014, AAFCO METHODS SUBSTA; American Veterinary Dental College (AVDC), POS STAT; American Veterinary Dental College (AVDC), HOM CAR; Brown WY, 2005, J VET DENT, V22, P16, DOI 10.1177/089875640502200102; Diez M, 2015, J SMALL ANIM PRACT, V56, P463, DOI 10.1111/jsap.12365; Genco R, 2002, J AM DENT ASSOC, V133, p14S, DOI 10.14219/jada.archive.2002.0375; Glickman LT, 2011, PREV VET MED, V99, P193, DOI 10.1016/j.prevetmed.2011.01.011; Glickman LT, 2009, JAVMA-J AM VET MED A, V234, P486, DOI 10.2460/javma.234.4.486; Harvey C E, 1994, J Vet Dent, V11, P94; Harvey CE, 1998, VET CLIN N AM-SMALL, V28, P1111, DOI 10.1016/S0195-5616(98)50105-2; Hennet P, 2002, J VET DENT, V19, P11, DOI 10.1177/089875640201900101; Hennet P, 2001, J VET DENT, V18, P61, DOI 10.1177/089875640101800201; Hope CK, 2014, SCI WORLD J, DOI 10.1155/2014/374694; Humane Society Veterinary Medical Association (HSVMC), HUSB MED CONC PUPP M; Johnston N., 2006, Veterinary Times, V36, P10; Kyllar M, 2005, VET MED-CZECH, V50, P496, DOI 10.17221/5654-VETMED; Logan EI, 2002, J VET DENT, V19, P15, DOI 10.1177/089875640201900102; Logan EI, 2006, VET CLIN N AM-SMALL, V36, P1385, DOI 10.1016/j.cvsm.2006.09.002; Lund EM, 1999, J AM VET MED ASSOC, V214, P1336; Meagher RK, 2009, APPL ANIM BEHAV SCI, V119, P1, DOI 10.1016/j.applanim.2009.02.026; Miller B R, 1994, J Vet Dent, V11, P18; National Research Council, 2006, NUTR REQ DOGS CATS; Niemiec B. A., 2013, Veterinary periodontology, P175; Niemiec BA, 2008, TOP COMPANION ANIM M, V23, P72, DOI 10.1053/j.tcam.2008.02.003; O'Neill DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090501; Packer RMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137496; Peddle GD, 2009, JAVMA-J AM VET MED A, V234, P1525, DOI 10.2460/javma.234.12.1525; Radnai M, 2004, J CLIN PERIODONTOL, V31, P736, DOI 10.1111/j.1600-051X.2004.00564.x; Rawlinson JE, 2011, JAVMA-J AM VET MED A, V238, P601, DOI 10.2460/javma.238.5.601; Roudebush P, 2005, J VET DENT, V22, P6, DOI 10.1177/089875640502200101; Scannapieco Frank A, 2005, Dent Clin North Am, V49, P533, DOI 10.1016/j.cden.2005.03.002; Sim J, 2005, PHYS THER, V85, P257; Smithson A. J., 2008, UK Vet: Companion Animal, V13, P65; TROMP JAH, 1986, J CLIN PERIODONTOL, V13, P164, DOI 10.1111/j.1600-051X.1986.tb01451.x; TROMP JAH, 1986, J CLIN PERIODONTOL, V13, P190, DOI 10.1111/j.1600-051X.1986.tb01458.x; Westfelt E, 1998, J CLIN PERIODONTOL, V25, P536, DOI 10.1111/j.1600-051X.1998.tb02484.x; Whyte A, 2014, VET J, V201, P118, DOI 10.1016/j.tvjl.2014.05.005; Wiggs RB., 1997, VET DENT PRINCIPLES, P186; Xiong X, 2006, BJOG-INT J OBSTET GY, V113, P135, DOI 10.1111/j.1471-0528.2005.00827.x	39	28	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191395	10.1371/journal.pone.0191395	http://dx.doi.org/10.1371/journal.pone.0191395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346448	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500046
J	Ohyama, Y; Ito, J; Kitano, VJ; Shimada, J; Hakeda, Y				Ohyama, Yoko; Ito, Junta; Kitano, Victor J.; Shimada, Jun; Hakeda, Yoshiyuki			The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors	PLOS ONE			English	Article							NADPH OXIDASE; ANGIOTENSIN-II; PROMOTING OSTEOCLASTOGENESIS; RHEUMATOID-ARTHRITIS; RECEPTOR ACTIVATOR; ASCORBIC-ACID; HIP FRACTURE; MUSCLE-CELLS; RISK-FACTORS; IN-VITRO	Inflammatory bone diseases, including rheumatoid arthritis, periodontitis and peri-implantitis, are associated not only with the production of inflammatory cytokines but also with local oxidative status, which is defined by intracellular reactive oxygen species (ROS). Osteoclast differentiation has been reported to be related to increased intracellular ROS levels in osteoclast lineage cells. Sudachitin, which is a polymethoxyflavone derived from Citrus sudachi, possesses antioxidant properties and regulates various functions in mammalian cells. However, the effects of sudachitin on inflammatory bone destruction and osteoclastogenesis remain unknown. In calvaria inflamed by a local lipopolysaccharide (LPS) injection, inflammation -induced bone destruction and the accompanying elevated expression of osteoclastogenesis-related genes were reduced by the co-administration of sudachitin and LPS. Moreover, sudachitin inhibited osteoclast formation in cultures of isolated osteoblasts and osteoclast precursors. However, sudachitin rather increased the expression of receptor activator of NF-kappa B ligand (RANKL), which is an important molecule triggering osteoclast differentiation, and the mRNA ratio of RANKL/osteoprotegerin that is a decoy receptor for RANKL, in the isolated osteoblasts, suggesting the presence of additional target cells. When osteoclast formation was induced from osteoclast precursors derived from bone marrow cells in the presence of soluble RANKL and macrophage colony-stimulating factor, sudachitin inhibited osteoclastogenesis without influencing cell viability. Consistently, the expression of osteoclast differentiation-related molecules including c-fos, NFATcl, cathepsin K and osteoclast fusion proteins such as DC-STAMP and Atp6v0d2 was reduced by sudachitin. In addition, sudachitin decreased activation of MAPKs such as Erk and JNK and the ROS production evoked by RANKL in osteoclast lineage cells. Our findings suggest that sudachitin is a useful agent for the treatment of anti-inflammatory bone destruction.	[Ohyama, Yoko; Ito, Junta; Kitano, Victor J.; Hakeda, Yoshiyuki] Meikai Univ, Div Oral Anat, Sch Dent, Sakado, Saitama, Japan; [Ohyama, Yoko; Kitano, Victor J.; Shimada, Jun] Meikai Univ, Div Oral & Maxillofacial Surg, Sch Dent, Sakado, Saitama, Japan; [Ito, Junta] Josai Univ, Fac Pharm & Pharmaceut Sci, Dept Clin Dietet & Human Nutr, Sakado, Saitama, Japan	Meikai University; Meikai University; Josai University	Ito, J; Hakeda, Y (corresponding author), Meikai Univ, Div Oral Anat, Sch Dent, Sakado, Saitama, Japan.; Ito, J (corresponding author), Josai Univ, Fac Pharm & Pharmaceut Sci, Dept Clin Dietet & Human Nutr, Sakado, Saitama, Japan.	junta@josai.ac.jp; y-hakeda@dent.meikai.ac.jp			Japanese Ministry of Education, Science, and Sports [16H05505, 16K20677]	Japanese Ministry of Education, Science, and Sports	This study was supported by a Grant-in Aid for Scientific Research (B) (16H05505 to YH) and a Grant-in-Aid for Young Scientists (B) (16K20677 to J. I.) from the Japanese Ministry of Education, Science, and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; El-Benna J, 2016, IMMUNOL REV, V273, P180, DOI 10.1111/imr.12447; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Goettsch C, 2013, J CLIN INVEST, V123, P4731, DOI 10.1172/JCI67603; Gummersbach C, 2009, DIFFERENTIATION, V77, P115, DOI 10.1016/j.diff.2008.09.009; Harada S, 2011, J PHARMACOL SCI, V115, P89, DOI 10.1254/jphs.10193SC; Hayashi T, 2002, J BIOL CHEM, V277, P27880, DOI 10.1074/jbc.M203836200; Hayashida C, 2014, J BIOL CHEM, V289, P11545, DOI 10.1074/jbc.M113.523811; Horcajada Marie-Noelle, 2012, Curr Mol Pharmacol, V5, P205; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; JOHNELL O, 1995, J BONE MINER RES, V10, P1802, DOI 10.1002/jbmr.5650101125; Jung UJ, 2004, J NUTR, V134, P2499, DOI 10.1093/jn/134.10.2499; Kanis J, 1999, OSTEOPOROSIS INT, V9, P45, DOI 10.1007/s001980050115; Kikuta J, 2013, J CLIN INVEST, V123, P866, DOI 10.1172/JCI65054; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Kim T, 2010, BIOCHEM BIOPH RES CO, V403, P73, DOI 10.1016/j.bbrc.2010.10.117; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kyaw M, 2001, HYPERTENS RES, V24, P251, DOI 10.1291/hypres.24.251; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Le Nihouannen D, 2010, BONE, V46, P1336, DOI 10.1016/j.bone.2009.11.021; Lee JH, 2010, MOL PHARMACOL, V77, P17, DOI 10.1124/mol.109.057877; Lee JH, 2009, J BIOL CHEM, V284, P13725, DOI 10.1074/jbc.M806941200; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lee YS, 2010, BIOCHEM PHARMACOL, V79, P1674, DOI 10.1016/j.bcp.2010.01.034; Liu T, 2016, J BIOCHEM, V160, P315, DOI 10.1093/jb/mvw040; Markatseli TE, 2014, CLIN EXP RHEUMATOL, V32, P415; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; MATTIA CJ, 1991, BIOCHEM PHARMACOL, V42, P879, DOI 10.1016/0006-2952(91)90048-A; Mensah KA, 2010, J CELL PHYSIOL, V223, P76, DOI 10.1002/jcp.22012; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Nakagawa H, 2006, J NAT PROD, V69, P1177, DOI 10.1021/np060217s; Nakayachi M, 2015, BONE, V75, P170, DOI 10.1016/j.bone.2015.02.025; Oka Y, 2012, J PHARMACOL SCI, V118, P55, DOI 10.1254/jphs.11082FP; Romagnoli C, 2013, FEBS J, V280, P867, DOI 10.1111/febs.12075; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Sasaki H, 2009, J MED INVESTIG, V56, P33, DOI 10.2152/jmi.56.33; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takarada T, 2007, EUR J PHARMACOL, V575, P1, DOI 10.1016/j.ejphar.2007.07.041; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tominari T, 2012, J PHARMACOL SCI, V119, P390, DOI 10.1254/jphs.11188SC; Tsutsumi R, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-32; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Wang HD, 2016, MOL CELLS, V39, P508, DOI 10.14348/molcells.2016.2170; Weaver Connie M., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P239, DOI 10.1080/21551197.2012.698220; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yanagihara N, 2014, J PHARMACOL SCI, V124, P123, DOI 10.1254/jphs.13R17CP; Yang EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086062; Yang S, 2001, J BIOL CHEM, V276, P5452, DOI 10.1074/jbc.M001004200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yuasa K, 2012, BIOSCI BIOTECH BIOCH, V76, P598, DOI 10.1271/bbb.110800	61	24	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191192	10.1371/journal.pone.0191192	http://dx.doi.org/10.1371/journal.pone.0191192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342179	Green Submitted, Green Published, gold			2022-12-27	WOS:000422653800050
J	Persaud, N; Meaney, C; El-Emam, K; Moineddin, R; Thorpe, K				Persaud, Navindra; Meaney, Christopher; El-Emam, Khaled; Moineddin, Rahim; Thorpe, Kevin			Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: Prespecified analyses and reanalysis	PLOS ONE			English	Article							PROTOCOLS; OUTCOMES	Background Doxylamine-pyridoxine is recommended as a first line treatment for nausea and vomiting during pregnancy and it is commonly prescribed. We re-analysed the findings of a previously reported superiority trial of doxylamine-pyridoxine for the treatment of nausea and vomiting during pregnancy using the clinical study report obtained from Health Canada. Methods and findings We re-analysed individual level data for a parallel arm randomized controlled trial that was conducted in six outpatient obstetrical practices in the United States. Pregnant women between 7 and 14 weeks of gestation with moderate nausea and vomiting of pregnancy symptoms. The active treatment was a tablet containing both doxylamine 10 mg and pyridoxine 10 mg taken between 2 and 4 times per day for 14 days depending on symptoms. The control was an identical placebo tablet taken using the same instructions. The primary outcome measure was improvement in nausea and vomiting of symptoms scores using the 13-point pregnancy unique quantification of emesis scale between baseline and 14 days using an ANCOVA. 140 participants were randomized into each group. Data for 131 active treatment participants and 125 control participants were analysed. On the final day of the trial, 101 active treatment participants and 86 control participants provided primary outcome measures. There was greater improvement in symptoms scores with doxylamine-pyridoxine compared with placebo (0.73 points; 95% CI 0.21 to 1.25) when last observation carried forward imputation was used for missing data but the difference is not statistically significant using other approaches to missing data (e.g. 0.38; 95% CI -0.08 to 0.84 using complete data). Conclusions There is a trend towards efficacy for nausea and vomiting symptoms with doxylamine-pyridoxine compared with placebo but the statistical significance of the difference depends on the method of handling missing data and the magnitude of the difference suggests that there is no clinically important benefit employing the prespecified minimal clinically important difference or "expected difference" of 3 points.	[Persaud, Navindra] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada; [Persaud, Navindra] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Meaney, Christopher; Moineddin, Rahim] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [El-Emam, Khaled] Univ Ottawa, Childrens Hosp, Eastern Ontario Res Inst, Dept Pediat, Ottawa, ON, Canada; [Thorpe, Kevin] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto	Persaud, N (corresponding author), St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada.; Persaud, N (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.	nav.persaud@utoronto.ca	Meaney, Christopher/R-8349-2018	Meaney, Christopher/0000-0002-5429-5233; Thorpe, Kevin/0000-0002-7586-3893	Physicians' Services Incorporated Graham Farquharson Knowledge Translation Fellowship	Physicians' Services Incorporated Graham Farquharson Knowledge Translation Fellowship	NP was supported by a Physicians' Services Incorporated Graham Farquharson Knowledge Translation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Altman Douglas G, 2009, Open Med, V3, pe51; [Anonymous], 2015, Obstet Gynecol, V126, pe12, DOI 10.1097/AOG.0000000000001048; Bell ML, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-118; Birkeland E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119962; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; DOSHI P, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F2865; Ebrahimi N, 2009, J OBSTET GYNAECOL CA, V31, P803, DOI 10.1016/S1701-2163(16)34298-0; Fitzmaurice G, 2009, CH CRC HANDB MOD STA, P1; Health Canada, 2016, SCI ADV PAN DICL SAP; Koren G, 2005, J Obstet Gynaecol, V25, P241; Koren G, 2016, AM J OBSTET GYNECOL, V214, P664, DOI 10.1016/j.ajog.2016.01.186; Koren G, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0488-1; Koren G, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.030; Lee J, 2000, Can J Clin Pharmacol, V7, P205; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Matthews A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007575.pub4; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Mon-Son-Hing M, 2002, J GEN INTERN MED, V17, P469, DOI 10.1046/j.1525-1497.2002.11111.x; Persaud N, 2014, J OBSTET GYNAECOL CA, V36, P343, DOI 10.1016/S1701-2163(15)30611-3; R Development Core Team, 2009, R LANG ENV STAT COMP; ROBINS JM, 1995, J AM STAT ASSOC, V90, P122, DOI 10.2307/2291135; Smith C, 2004, OBSTET GYNECOL, V103, P639, DOI 10.1097/01.AOG.0000118307.19798.EC; Smolina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128312; Sripramote Manit, 2003, J Med Assoc Thai, V86, P846; U.S. Food and Drug Administration, DRUG APPR PACK DICL	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189978	10.1371/journal.pone.0189978	http://dx.doi.org/10.1371/journal.pone.0189978			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342163	Green Published, gold			2022-12-27	WOS:000422653800014
J	Emran, KM; Al-Harbi, AK				Emran, Khadijah M.; Al-Harbi, Albandaree K.			Outstanding resistance and passivation behaviour of new Fe-Co metal-metal glassy alloys in alkaline media	PLOS ONE			English	Article							CORROSION-RESISTANCE; BULK; COBALT; FILMS	The electrochemical behavior of the oxide layers on two metal-metal glassy alloys, Fe78Co9Cr10Mo2Al1 (VX9)and Fe49Co49V2 (VX50) (at.%), were studied using electrochemical techniques including electrochemical frequency modulation (EFM), electrochemical impedance spectroscopy (EIS) and cyclic polarization (CP) measurements. The morphology and composition of the alloy surfaces were investigated using X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM) and atomic force microscopy (AFM). The corrosion rate and surface roughness of both alloys increased as the concentration of NaOH in aqueous solution was raised. The presence of some protective elements in the composition of the alloys led to the formation of a spontaneous passive layer on the alloy surface. The higher resistance values of both alloys were associated with the magnitude of the dielectric properties of the passive films formed on their surfaces. Both alloys are classified as having outstanding resistance to corrosion, which results from the formation of a passive film that acts as an efficient barrier to corrosion in alkaline solution.	[Emran, Khadijah M.; Al-Harbi, Albandaree K.] Taibah Univ, Chem Dept, Coll Sci, Al Madinah Al Monawarah, Saudi Arabia	Taibah University	Emran, KM (corresponding author), Taibah Univ, Chem Dept, Coll Sci, Al Madinah Al Monawarah, Saudi Arabia.	kabdalsamad@taibahu.edu.sa	Emran, Khadijah/AAA-3437-2021; Emran, Khadijah/AAB-4044-2022	Emran, Khadijah/0000-0003-3672-9744; 				Biesinger MC, 2011, APPL SURF SCI, V257, P2717, DOI 10.1016/j.apsusc.2010.10.051; Fontana M., 1987, CORROSION ENG; Gallant D, 2006, J PHYS CHEM B, V110, P6871, DOI 10.1021/jp056689h; Gostin PF, 2010, CORROS SCI, V52, P273, DOI 10.1016/j.corsci.2009.09.016; Guo SF, 2013, J NON-CRYST SOLIDS, V369, P29, DOI 10.1016/j.jnoncrysol.2013.02.026; INOUE A, 1995, MATER T JIM, V36, P1180, DOI 10.2320/matertrans1989.36.1180; Inoue A, 2001, MAT SCI ENG A-STRUCT, V304, P1, DOI 10.1016/S0921-5093(00)01551-3; Kim KH, 2011, CORROS SCI, V53, P3576, DOI 10.1016/j.corsci.2011.07.001; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; Li G, 2010, SCI CHINA PHYS MECH, V53, P435, DOI 10.1007/s11433-010-0139-5; Moulder J. F., 1995, HDB XRAY PHOTOELECTR; OHTSUKA T, 1981, J ELECTROCHEM SOC, V128, P2522, DOI 10.1149/1.2127284; Schroeder T., 2004, J SURFACE SCI, V552, P1, DOI DOI 10.1016/J; Suryanarayana C, 2013, INT MATER REV, V58, P131, DOI 10.1179/1743280412Y.0000000007; Suryanarayana C, 2011, BULK METALLIC GLASSES, P1, DOI 10.1201/9781420085976-1; Wang HJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2786598; Wang WH, 2007, PROG MATER SCI, V52, P540, DOI 10.1016/j.pmatsci.2006.07.003; Wang WH, 2004, MAT SCI ENG R, V44, P45, DOI 10.1016/j.mser.2004.03.001; Xu T, 2015, J NON-CRYST SOLIDS, V410, P20, DOI 10.1016/j.jnoncrysol.2014.12.006; Xu T, 2015, J ALLOY COMPD, V625, P318, DOI 10.1016/j.jallcom.2014.09.166	20	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0187567	10.1371/journal.pone.0187567	http://dx.doi.org/10.1371/journal.pone.0187567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29337992	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700001
J	Ahmad, M; Suhaimi, SN; Chu, TL; Aziz, NA; Kornain, NKM; Samiulla, DS; Lo, KW; Ng, CH; Khoo, ASB				Ahmad, Munirah; Suhaimi, Shazlan-Noor; Chu, Tai-Lin; Aziz, Norazlin Abdul; Kornain, Noor-Kaslina Mohd; Samiulla, D. S.; Lo, Kwok-Wai; Ng, Chew-Hee; Khoo, Alan Soo-Beng			Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma	PLOS ONE			English	Article							IN-VITRO; ANTITUMOR-ACTIVITY; ANTICANCER AGENTS; DRUG-RESISTANCE; VIVO; MECHANISMS; CANCER; LIGAND; DNA; CYTOTOXICITY	Copper(II) ternary complex, [Cu(phen)(C-dmg)(H2O)]NO3 was evaluated against a panel of cell lines, tested for in vivo efficacy in nasopharyngeal carcinoma xenograft models as well as for toxicity in NOD scid gamma mice. The Cu(II) complex displayed broad spectrum cytotoxicity against multiple cancer types, including lung, colon, central nervous system, melanoma, ovarian, and prostate cancer cell lines in the NCI-60 panel. The Cu(II) complex did not cause significant induction of cytochrome P450 (CYP) 3A and 1A enzymes but moderately inhibited CYP isoforms 1A2, 2C9, 2C19, 2D6, 2B6, 2C8 and 3A4. The complex significantly inhibited tumor growth in nasopharyngeal carcinoma xenograft bearing mice models at doses which were well tolerated without causing significant or permanent toxic side effects. However, higher doses which resulted in better inhibition of tumor growth also resulted in toxicity.	[Ahmad, Munirah; Suhaimi, Shazlan-Noor; Chu, Tai-Lin; Aziz, Norazlin Abdul; Khoo, Alan Soo-Beng] Inst Med Res, Canc Res Ctr, Mol Pathol Unit, Kuala Lumpur, Malaysia; [Kornain, Noor-Kaslina Mohd] Univ Teknol MARA, Dept Pathol, Fac Med, Sungai Buloh, Selangor, Malaysia; [Samiulla, D. S.] Aurigene Discovery Technol Ltd, Bangalore, Karnataka, India; [Lo, Kwok-Wai] Chinese Univ Hong Kong, State Key Lab Oncol South China, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Lo, Kwok-Wai] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Ng, Chew-Hee] Int Med Univ, Sch Pharm, Dept Pharmaceut Chem, Kuala Lumpur, Malaysia; [Khoo, Alan Soo-Beng] Int Med Univ, Inst Res Dev & Innovat, Kuala Lumpur, Malaysia	Kementerian Kesihatan Malaysia; Universiti Teknologi MARA; Aurigene Discovery Technologies Limited; Chinese University of Hong Kong; State Key Lab Oncology South China; Chinese University of Hong Kong; International Medical University Malaysia; International Medical University Malaysia	Khoo, ASB (corresponding author), Inst Med Res, Canc Res Ctr, Mol Pathol Unit, Kuala Lumpur, Malaysia.; Ng, CH (corresponding author), Int Med Univ, Sch Pharm, Dept Pharmaceut Chem, Kuala Lumpur, Malaysia.; Khoo, ASB (corresponding author), Int Med Univ, Inst Res Dev & Innovat, Kuala Lumpur, Malaysia.	ngchewhee@imu.edu.my; alankhoo@imr.gov.my	Aziz, Norazlin Abdul/I-7743-2019; Suhaimi, Shazlan Noor/AAE-2079-2022	Abdul Aziz, Norazlin/0000-0001-8137-2399; Suhaimi, Shazlan-Noor/0000-0003-0426-0056; Lo, Kwok Wai/0000-0002-3488-6124	Ministry of Health Malaysia [JPP12-046, NMRR-13-898-17054]; Ministry of Science, Technology and Innovation eScience [02-02-SF0033, 02-02-09-SF0036]; Aurigene Discovery Technologies Limited	Ministry of Health Malaysia; Ministry of Science, Technology and Innovation eScience; Aurigene Discovery Technologies Limited	This work was supported by Ministry of Health Malaysia (JPP12-046; NMRR-13-898-17054) and Ministry of Science, Technology and Innovation eScience grants (02-02-SF0033; 02-02-09-SF0036). The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Aurigene Discovery Technologies Limited provided support in the form of salaries for author [DSS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The salaries of authors [MA, SNS, TLC, NAA, NKMK, KWL, CHN, ASBK] were through their respective institutes independent of the grants. The specific roles of these authors are articulated in the 'author contributions' section.	Allardyce CS, 2016, DALTON T, V45, P3201, DOI 10.1039/c5dt03919c; Azizah AM, 2016, MALAYSIAN NATIONAL C; Beijnen JH, 2004, LANCET ONCOL, V5, P489, DOI 10.1016/S1470-2045(04)01528-1; Bjorkhem-Bergman L, 2014, DRUG METAB PHARMACOK, V29, P352, DOI 10.2133/dmpk.DMPK-13-SH-138; BONNEY RJ, 1974, IN VITRO CELL DEV B, V9, P399; Cao S, 2014, BRIT J CANCER, V110, P1733, DOI 10.1038/bjc.2014.85; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Denoyer D, 2015, METALLOMICS, V7, P1459, DOI 10.1039/c5mt00149h; El-Naga RN, 2014, TOXICOL APPL PHARM, V274, P87, DOI 10.1016/j.taap.2013.10.031; Bravo-Gomez ME, 2012, J MEX CHEM SOC, V56, P85; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gandin V, 2015, METALLOMICS, V7, P1497, DOI 10.1039/c5mt00163c; Hambley TW, 2007, DALTON T, P4929, DOI 10.1039/b706075k; Hearn JM, 2013, ACS CHEM BIOL, V8, P1335, DOI 10.1021/cb400070a; Hoen Peter A.Chr. 't, 2000, Biochemical Pharmacology, V60, P1509; Holbeck SL, 2010, MOL CANCER THER, V9, P1451, DOI 10.1158/1535-7163.MCT-10-0106; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hu PC, 2016, RSC ADV, V6, P29963, DOI 10.1039/c6ra02571d; HUANG DP, 1980, INT J CANCER, V26, P127, DOI 10.1002/ijc.2910260202; Jia L, 2016, J INORG BIOCHEM, V159, P107, DOI 10.1016/j.jinorgbio.2016.02.033; Jiang W, 2009, 2009 IEEE PULSED POWER CONFERENCE, VOLS 1 AND 2, P1, DOI 10.1109/PPC.2009.5386209; Kelly GL, 2014, GENE DEV, V28, P58, DOI 10.1101/gad.232009.113; Khoo ASB, 2013, ADV EXP MED BIOL, V778, P1; KNOX RJ, 1986, CANCER RES, V46, P1972; Krikavova R, 2016, RSC ADV, V6, P3899, DOI 10.1039/c5ra22141b; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Lu C, 2001, CHEM-BIOL INTERACT, V134, P271, DOI 10.1016/S0009-2797(01)00162-4; Ma P, 2009, J BIOMED NANOTECHNOL, V5, P151, DOI 10.1166/jbn.2009.1021; Medici S, 2015, COORDIN CHEM REV, V284, P329, DOI 10.1016/j.ccr.2014.08.002; Nagababu P, 2015, J MED CHEM, V58, P5226, DOI 10.1021/acs.jmedchem.5b00651; Ng CH, 2016, Malaysia patent, Patent No. [MY-157886-A, 157886]; Ng CH, 2014, METALLOMICS, V6, P892, DOI 10.1039/c3mt00276d; Palanimuthu D, 2013, J MED CHEM, V56, P722, DOI 10.1021/jm300938r; Pua K C, 2008, Med J Malaysia, V63 Suppl C, P59; Qin QP, 2015, METALLOMICS, V7, P1124, DOI 10.1039/c5mt00027k; Raman N, 2010, EUR J MED CHEM, V45, P5438, DOI 10.1016/j.ejmech.2010.09.004; Santini C, 2014, CHEM REV, V114, P815, DOI 10.1021/cr400135x; Sava G, 2012, DALTON T, V41, P8226, DOI 10.1039/c2dt30075c; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Silva-Platas C, 2016, J BIOENERG BIOMEMBR, V48, P43, DOI 10.1007/s10863-015-9640-x; Slator C, 2016, ACS CHEM BIOL, V11, P159, DOI 10.1021/acschembio.5b00513; Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a; Spreckelmeyer S, 2014, MOLECULES, V19, P15584, DOI 10.3390/molecules191015584; Tang LL, 2016, CANCER LETT, V374, P22, DOI 10.1016/j.canlet.2016.01.040; Tao XF, 2014, RSC ADV, V4, P54026, DOI 10.1039/c4ra09160d; U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research (CDER), 2012, GUIDANCE FOR INDUSTR; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Yom SS, 2014, CLINICAL INSIGHTS NA; Zaidi Y, 2014, METALLOMICS, V6, P1469, DOI 10.1039/c4mt00035h; Zaki M, 2016, INORG CHIM ACTA, V444, P1, DOI 10.1016/j.ica.2016.01.006	51	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191295	10.1371/journal.pone.0191295	http://dx.doi.org/10.1371/journal.pone.0191295			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329342	Green Published, Green Submitted, gold			2022-12-27	WOS:000419954100056
J	Yoo, Y; Park, HJ; Park, S; Cho, MJ; Cho, SJ; Lee, JY; Choi, SH; Lee, JY				Yoo, Yongjoon; Park, Hyeon-Ju; Park, Soowon; Cho, Maeng Je; Cho, Seong-Jin; Lee, Ji Yeon; Choi, Soo-Hee; Lee, Jun-Young			Interpersonal trauma moderates the relationship between personality factors and suicidality of individuals with posttraumatic stress disorder	PLOS ONE			English	Article							SOCIAL SUPPORT; MENTAL-DISORDERS; IDEATION; TRAITS; RISK; PTSD; PREVALENCE; DEPRESSION; MILITARY; EXPOSURE	Individuals with posttraumatic stress disorder (PTSD) are more prone to suicidal ideation and behavior. While those who have experienced interpersonal trauma exhibit more suicidality than those who have experienced non-interpersonal trauma, it is unclear how the traumatic effects are related to an individual's personality characteristics. This study examined the association between interpersonal trauma and personality factors with suicidality, and elucidated the moderating role of interpersonal trauma in individuals with PTSD. The study included 6,022 participants from the Korean Epidemiologic Catchment Area Study 2011. The Korean Version of Composite International Diagnostic Interview was used for the survey, including the participants' history of suicidality, the traumas they have experienced, and their PTSD symptoms. The 11-item version of the Big Five Inventory (BFI-11) was used to assess the participants' personality factors. 76 individuals were diagnosed with PTSD, while 810 had been exposed to trauma but were not diagnosed with any DSM-IV mental disorder. Among the individuals with PTSD, those who had experienced interpersonal trauma were more likely to have suicidal ideation than those who had experienced non-interpersonal trauma (p =.020; odds ratio [OR] = 3.643;95% confidence interval of OR = [1.226, 10.825]). High agreeableness and conscientiousness predicted less suicidality in those exposed to non-interpersonal trauma, while predicting more suicidality in those exposed to interpersonal trauma. Clinicians examining individuals with PTSD should pay closer attention to the trauma that they have experienced, as well as their personality factors, to provide appropriate treatment.	[Yoo, Yongjoon] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Park, Hyeon-Ju; Lee, Ji Yeon; Lee, Jun-Young] SMG SNU Boramae Med Ctr, Dept Psychiat, Seoul, South Korea; [Park, Soowon] Sejong Univ, Dept Educ, Seoul, South Korea; [Cho, Maeng Je; Choi, Soo-Hee; Lee, Jun-Young] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Cho, Seong-Jin] Gachon Med Sch, Dept Psychiat, Incheon, South Korea; [Lee, Jun-Young] Seoul Natl Univ, Neurosci Res Inst, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Sejong University; Seoul National University (SNU); Gachon University; Seoul National University (SNU)	Lee, JY (corresponding author), SMG SNU Boramae Med Ctr, Dept Psychiat, Seoul, South Korea.; Choi, SH; Lee, JY (corresponding author), Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea.; Lee, JY (corresponding author), Seoul Natl Univ, Neurosci Res Inst, Coll Med, Seoul, South Korea.	soohchoi@snu.ac.kr; benji@snu.ac.kr	Lee, Jun-Young/N-5963-2019; Yoo, Yongjoon/P-6767-2016	Lee, Jun-Young/0000-0002-5893-3124; Yoo, Yongjoon/0000-0001-6193-5262; Park, Soowon/0000-0002-3348-940X	Korea Mental Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HM14C2624]; SNUH research fund [05-2012-0050]	Korea Mental Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; SNUH research fund	This study was supported by a grant of the Korea Mental Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HM14C2624; http://www.mhrnd.re.kr/xe/) and the SNUH research fund (05-2012-0050; http://bri.snuh.org/pub/_/singlecont/view.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahadi S., 1994, DEVELOPING STRUCTURE, P189; Allport G. W., 1937, PERSONALITY PSYCHOL; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Amir M, 1999, PSYCHOTHER PSYCHOSOM, V68, P76, DOI 10.1159/000012316; Ayub N, 2015, PERSONAL MENT HEALTH, V9, P308, DOI 10.1002/pmh.1301; Baxter AJ, 2013, PSYCHOL MED, V43, P897, DOI 10.1017/S003329171200147X; Bebbington PE, 2009, AM J PSYCHIAT, V166, P1135, DOI 10.1176/appi.ajp.2009.09030310; Benjet C, 2016, PSYCHOL MED, V46, P327, DOI 10.1017/S0033291715001981; Bentley KH, 2016, CLIN PSYCHOL REV, V43, P30, DOI 10.1016/j.cpr.2015.11.008; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Briere J, 2015, J TRAUMA DISSOCIATIO, V16, P153, DOI 10.1080/15299732.2014.970265; Cain NM, 2013, J PERS ASSESS, V95, P640, DOI 10.1080/00223891.2013.821073; Cho MJ, 2015, PSYCHIAT INVEST, V12, P164, DOI 10.4306/pi.2015.12.2.164; Cho MJ, 2002, J KOREAN NEUROPSYCHI, V41, P123; Costa PT., 1992, REVISED NEO PERSONAL; Cougle JR, 2009, J PSYCHIATR RES, V43, P825, DOI 10.1016/j.jpsychires.2008.12.004; Davidson JRT, 2004, J NEUROPSYCH CLIN N, V16, P135, DOI 10.1176/appi.neuropsych.16.2.135; Forbes D, 2014, J CLIN PSYCHIAT, V75, P147, DOI 10.4088/JCP.13m08374; Forbes D, 2012, J CLIN PSYCHIAT, V73, P372, DOI 10.4088/JCP.10m06640; Fowler JC, 2013, J AFFECT DISORDERS, V149, P313, DOI 10.1016/j.jad.2013.01.045; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hayes A.F., 2013, INTRO MEDIATION MODE; Hirsch JK, 2011, J AM COLL HEALTH, V59, P393, DOI 10.1080/07448481.2010.515635; Hopwood CJ, 2013, J PERS DISORD, V27, P270, DOI 10.1521/pedi.2013.27.3.270; Jackson JJ, 2012, PSYCHOL SCI, V23, P270, DOI 10.1177/0956797611423545; Jaksic N, 2012, PSYCHIAT DANUB, V24, P256; Jensen-Campbell LA, 2003, J PERS, V71, P1059, DOI 10.1111/1467-6494.7106007; Jensen-Campbell LA, 2007, J RES PERS, V41, P403, DOI 10.1016/j.jrp.2006.05.001; John OP., 1991, BIG 5 INVENTORY VERS; Kerby DS, 2003, PERS INDIV DIFFER, V35, P249, DOI 10.1016/S0191-8869(02)00174-5; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; 김선영, 2010, [Journal of Korean Society of Biological Psychiatry, 생물정신의학], V17, P15; Korean National Statistical Office, 2010, REP POP HOUS CENS 20; Kotler M, 2001, J NERV MENT DIS, V189, P162, DOI 10.1097/00005053-200103000-00004; Krysinska K, 2010, ARCH SUICIDE RES, V14, P1, DOI 10.1080/13811110903478997; Lee HS, 2012, PSYCHIAT INVEST, V9, P361, DOI 10.4306/pi.2012.9.4.361; Luthra R, 2009, J INTERPERS VIOLENCE, V24, P1919, DOI 10.1177/0886260508325494; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; McCann SJH, 2010, ARCH SUICIDE RES, V14, P368, DOI 10.1080/13811118.2010.524070; McLean CP, 2017, J AFFECT DISORDERS, V208, P392, DOI 10.1016/j.jad.2016.08.061; Min MO, 2014, DRUG ALCOHOL DEPEN, V142, P277, DOI 10.1016/j.drugalcdep.2014.06.032; Mueser KT, 1998, J CONSULT CLIN PSYCH, V66, P493, DOI 10.1037/0022-006X.66.3.493; O'Connor RC, 2014, LANCET PSYCHIAT, V1, P73, DOI 10.1016/S2215-0366(14)70222-6; Panagioti M, 2015, PSYCHIAT RES, V227, P302, DOI 10.1016/j.psychres.2015.02.019; Panagioti M, 2009, CLIN PSYCHOL REV, V29, P471, DOI 10.1016/j.cpr.2009.05.001; Piedmont RL, 1998, REVISED NEO PERSONAL, P113; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; RESNICK HS, 1993, J CONSULT CLIN PSYCH, V61, P984, DOI 10.1037/0022-006X.61.6.984; Sadock BJ, 2015, KAPLAN SADOCKS SYNOP, P763; Schumm JA, 2006, J TRAUMA STRESS, V19, P825, DOI 10.1002/jts.20159; Sharma K, 2019, J EARTHQ ENG, V23, P512, DOI 10.1080/13632469.2017.1342299; Shea MT, 1996, DSM 4 SOURCEBOOK, V2, P849; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Stepp SD, 2008, SUICIDE LIFE-THREAT, V38, P592, DOI 10.1521/suli.2008.38.5.592; Stewart S, 2005, ADV MENT HEALTH, V4, P108, DOI 10.5172/jamh.4.2.108; Sun RCF, 2007, BRIT J GUID COUNS, V35, P299, DOI 10.1080/03069880701384452; Talbot NL, 2004, AM J GERIAT PSYCHIAT, V12, P536, DOI 10.1176/appi.ajgp.12.5.536; Voracek M, 2006, PERCEPT MOTOR SKILL, V102, P609, DOI 10.2466/PMS.102.2.609-610; WHO-WORLD HEALTH ORGANIZATION, 2002, MULT INT STUD SUIC B; Widera-Wysoczanska A, 2010, INTERPERSONAL TRAUMA, P15; Wills JL, 2016, J TRAUMA STRESS, V29, P185, DOI 10.1002/jts.22089; Woodward MJ, 2015, J ANXIETY DISORD, V35, P60, DOI 10.1016/j.janxdis.2015.09.002; Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024	66	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191198	10.1371/journal.pone.0191198	http://dx.doi.org/10.1371/journal.pone.0191198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BY	29329352	Green Published, gold, Green Submitted			2022-12-27	WOS:000419954100046
J	Mao, P; Feng, H; Xu, S; Liu, JH; Li, HY; Zhang, YY; Ye, YY				Mao, Pan; Feng, Hui; Xu, Shuang; Liu, Jianghong; Li, Huayan; Zhang, Yaying; Ye, Yiyan			Well-child care delivery in the community in China: Related factors and quality analysis of services	PLOS ONE			English	Article							ANTICIPATORY GUIDANCE; EMERGENCY-DEPARTMENT; YOUNG-CHILDREN; HEALTH; PARENTS; PEDIATRICIANS	Well-child health care services are essential for maintaining optimum child health and development. This study's aim was to evaluate the quality of such services and identify factors affecting service quality from the perspective of well-child health care providers located in China's Hunan Province. To achieve this, a qualitative descriptive method was employed, with 22 well-child health care providers being recruited, using purposive sampling, from among the provinces' government community health centers. The participants completed individual semi-structured interviews lasting approximately 25-30 minutes that were designed to obtain their views on well-child health care administration in the province. Then, the interview transcripts were analyzed thematically. The main finding was that participants felt that the delivery of well-child health care services in Hunan Province is insufficient. Factors they mentioned as negatively affecting the delivery of such services included the region's fragmented primary health care system, inadequate attention to this issue from parents and community health care center managers, and a lack of specialized well-childcare knowledge. Thus, currently, well-child health care is not being successfully implemented in Hunan Province; consequently, in order to successfully implement well-child health care in this region, community health care centers should invest more resources and funding, particularly into education programs for well-child health care providers.	[Mao, Pan] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China; [Feng, Hui; Xu, Shuang; Li, Huayan; Zhang, Yaying] Cent S Univ, Xiangya Sch Nursing, Changsha, Hunan, Peoples R China; [Feng, Hui] Cent S Univ, Hlth Serv Res Ctr, Changsha, Hunan, Peoples R China; [Liu, Jianghong] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Liu, Jianghong] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Li, Huayan] Peking Univ, Peoples Hosp, Beijing, Peoples R China; [Zhang, Yaying] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Ye, Yiyan] Bei Nuo Hosp, Changsha, Hunan, Peoples R China	Zhengzhou University; Central South University; Central South University; University of Pennsylvania; University of Pennsylvania; Peking University; Central South University	Feng, H (corresponding author), Cent S Univ, Xiangya Sch Nursing, Changsha, Hunan, Peoples R China.; Feng, H (corresponding author), Cent S Univ, Hlth Serv Res Ctr, Changsha, Hunan, Peoples R China.	feng.hui@csu.edu.cn			Bei Nuo children's hospital; Jin An Funds through the Program 'Improving the quality of well-child health care service in community health care centers in Changsha, Hunan, China' [73801005]	Bei Nuo children's hospital; Jin An Funds through the Program 'Improving the quality of well-child health care service in community health care centers in Changsha, Hunan, China'	The study was co-funded by the Bei Nuo children's hospital and Jin An Funds through the Program 'Improving the quality of well-child health care service in community health care centers in Changsha, Hunan, China,' fund number 73801005. The Chin s had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.& para;& para;The study was co-funded by the Bei Nuo Children's Hospital and Jin An Funds through the program "improving the quality of well-child health care services provided in community health care centers in Changsha, Hunan, China".	American Academy of Pediatrics Committee on Psychosocial Aspects of Child and Family Health, 2007, GUID HLTH SUP 3 ELK; Cao WL, 2009, CHINA MED HERALD, V11, P167; Centers for Medicare & Medicaid Services, EPSDT BEN; Chen X., 2014, J APPL MATH, V2014, P1, DOI DOI 10.1061/(ASCE)MT.1943-5533.0000778; [陈笑辉 CHEN Xiao-hui], 2008, [中国全科医学, Chinese General Practice], V11, P2188; Clavering EK, 2007, QUAL HEALTH RES, V17, P400, DOI 10.1177/1049732306298380; Combs-Orme T, 2011, CLIN PEDIATR, V50, P729, DOI 10.1177/0009922811403302; Cuttler L, 2007, ARCH PEDIAT ADOL MED, V161, P630, DOI 10.1001/archpedi.161.7.630; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Flynn HA, 2004, GEN HOSP PSYCHIAT, V26, P316, DOI 10.1016/j.genhosppsych.2004.03.009; Gan L, 2012, CHINESE J CHILD HLTH, V2, P187; Goldfeld SR, 2003, J PAEDIATR CHILD H, V39, P249, DOI 10.1046/j.1440-1754.2003.00146.x; GREEN M, 2000, BRIGHT FUTURES GUIDE; Hagan JF, 2008, BRIGHT FUTURES GUIDE; He JN, 2012, CHINESE FOREIGN MED, V15, P145; Kuo AA, 2006, PEDIATRICS, V118, P1692, DOI 10.1542/peds.2006-0620; Li H, 2012, CHINA HLTH CARE NUTR, V12, P5518; Li J, 2011, CHINA COMMUN, V8, P122; Li Q., 2010, CHINA EC Q, V1, P341; Logan JE, 2008, HEALTH SERV RES, V43, P656, DOI 10.1111/j.1475-6773.2007.00790.x; McCain G C, 1988, Appl Nurs Res, V1, P146; Ministry of Health, 2011, NAT SPEC PUBL HLTH S; Morse J. M., 1995, QUALITATIVE RES METH; Moyer VA, 2004, PEDIATRICS, V114, P1511, DOI 10.1542/peds.2004-1076; National Health and Family Planning Commission of the People's Republic of China, 2011, 2011 COUNTR PUBL HLT; National Health and Family Planning Commission of the People's Republic of China, 2010, WELL CHILD HLTH CAR; National Research Council and Institute of Medicine, 2004, CHILDR HLTH NAT WEAL; National Statistics Department, 2014, CHIN STAT YB 2014; Nelson CS, 2003, CURR OPIN PEDIATR, V15, P630, DOI 10.1097/00008480-200312000-00015; NICE, 2007, ANT POSTN MENT HLTH; Olson LM, 2004, PEDIATRICS, V113, P1907; Ritchie J, 1994, ANAL QUALITATIVE DAT, P173, DOI DOI 10.4324/9780203413081; Sand N, 2005, PEDIATRICS, V116, P174, DOI 10.1542/peds.2004-1809; Schempf AH, 2007, ARCH PEDIAT ADOL MED, V161, P50, DOI 10.1001/archpedi.161.1.50; Schmied V, 2010, J CLIN NURS, V19, P3516, DOI 10.1111/j.1365-2702.2010.03321.x; Squires J., AGES STAGES QUESTION, VThird; Squires J., 2002, AGES STAGES QUESTION; Squires J., 1999, AGES STAGES QUESTION; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; Wang AH, 2006, CHINESE J CHILD HLTH, V14, P324; Wang YH, 2013, CHINESE J CHILD HLTH, V3, P167; Wertlieb D, 2003, PEDIATRICS, V111, P1572; Xing T., 2015, SPORTS SCI, V36, P112; Yang Q, 2008, CHINESE J CHILD HLTH, V16, P3; Zhang L., 2016, BREASTFEEDING SUPPOR, P1; Zhang YY., 2012, CHINESE J CHILD HLTH, V20, P424	46	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190396	10.1371/journal.pone.0190396	http://dx.doi.org/10.1371/journal.pone.0190396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360836	Green Submitted, Green Published, gold			2022-12-27	WOS:000423161800007
J	Hameed, Z; Saleem, S; Mirza, J; Mustafa, MS; Qamar-Ul-Islam				Hameed, Zabit; Saleem, Saqib; Mirza, Jawad; Mustafa, Muhammad Salman; Qamar-Ul-Islam			Characterisation of ictal and interictal states of epilepsy: A system dynamic approach of principal dynamic modes analysis	PLOS ONE			English	Article							IMPAIRED CONSCIOUSNESS; BRAIN SYSTEMS; EEG; SEIZURE; COHERENCE; DISEASES; ABSENCE; ONSET	Epilepsy is a brain disorder characterised by the recurrent and unpredictable interruptions of normal brain function, called epileptic seizures. The present study attempts to derive new diagnostic indices which may delineate between ictal and interictal states of epilepsy. To achieve this, the nonlinear modeling approach of global principal dynamic modes (PDMs) is adopted to examine the functional connectivity of the temporal and frontal lobes with the occipital brain segment using an ensemble of paediatric EEGs having the presence of epileptic seizure. The distinct spectral characteristics of global PDMs are found to be in line with the neural rhythms of brain dynamics. Moreover, we find that the linear trends of associated nonlinear functions (ANFs) associated with the 2nd and 4th global PDMs (representing delta, theta and alpha bands) of Fp1-F3 may differentiate between ictal and interictal states of epilepsy. These findings suggest that global PDMs and their associated ANFs may offer potential utility as diagnostic neural measures for ictal and interictal states of epilepsy.	[Hameed, Zabit; Qamar-Ul-Islam] Inst Space Technol, Dept Elect Engn, Islamabad, Pakistan; [Saleem, Saqib] COMSATS Inst Informat Technol, Dept Elect Engn, Sahiwal, Pakistan; [Saleem, Saqib] Univ Otago, Dept Surg & Anaesthesia, Ctr Translat Physiol, Wellington, New Zealand; [Mirza, Jawad] COMSATS Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan; [Mustafa, Muhammad Salman] COMSATS Inst Informat Technol, Dept Mech Engn, Sahiwal, Pakistan	COMSATS University Islamabad (CUI); University of Otago; COMSATS University Islamabad (CUI); COMSATS University Islamabad (CUI)	Saleem, S (corresponding author), COMSATS Inst Informat Technol, Dept Elect Engn, Sahiwal, Pakistan.; Saleem, S (corresponding author), Univ Otago, Dept Surg & Anaesthesia, Ctr Translat Physiol, Wellington, New Zealand.	ssaleem@ciitsahiwal.edu.pk	Hameed, Zabit/AAG-9952-2019; Mirza, Jawad/AAS-7597-2021; Saleem, Saqib/M-4377-2016	Hameed, Zabit/0000-0003-2514-1064; 				Adebimpe A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00143; Adeli H, 2003, J NEUROSCI METH, V123, P69, DOI 10.1016/S0165-0270(02)00340-0; Al-Jumeily D., 2015, SCI WORLD J, V2015; Altunay S, 2010, EXPERT SYST APPL, V37, P5661, DOI 10.1016/j.eswa.2010.02.045; Angarita-Jaimes N, 2014, MED ENG PHYS, V36, P607, DOI 10.1016/j.medengphy.2013.12.012; Austin JK, 2011, EPILEPSY BEHAV, V21, P373, DOI 10.1016/j.yebeh.2011.05.028; Barnes GN, 2008, NAT CLIN PRACT NEURO, V4, P650, DOI 10.1038/ncpneuro0947; Bartolomei F, 2001, CLIN NEUROPHYSIOL, V112, P1746, DOI 10.1016/S1388-2457(01)00591-0; Bhattacharyya A, 2017, IEEE T BIO-MED ENG, V64, P2003, DOI 10.1109/TBME.2017.2650259; Blumenfeld H, 2012, LANCET NEUROL, V11, P814, DOI 10.1016/S1474-4422(12)70188-6; Bromfield EB, 2006, INTRO EPILEPSY; CAO YZ, 2016, CHAOS, V26, DOI DOI 10.1063/1.4967734; Chang NF, 2012, IEEE ENG MED BIO, P5162, DOI 10.1109/EMBC.2012.6347156; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Coben R, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00194; Costa JCG, 2014, COMPUTATIONAL MATH M, V2014; Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201; da Silva FHL, 2003, IEEE T BIO-MED ENG, V50, P540, DOI 10.1109/TBME.2003.810703; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019; Devinsky O, 1993, NEUROLOGIC CLIN; Englot DJ, 2010, BRAIN, V133, P3764, DOI 10.1093/brain/awq316; Fan DG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12618; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Gotman J, 1997, ELECTROEN CLIN NEURO, V103, P356, DOI 10.1016/S0013-4694(97)00003-9; Greene BR, 2008, CLIN NEUROPHYSIOL, V119, P1248, DOI 10.1016/j.clinph.2008.02.001; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Holler Y, 2015, FRONTIERS HUMAN NEUR, V9; Kang Y, 2015, IEEE J TRANSL ENG HE, V3, DOI 10.1109/JTEHM.2015.2401005; Kitayama M, 2003, PEDIATR NEUROL, V29, P326, DOI 10.1016/S0887-8994(03)00277-7; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; LIU A, 1992, ELECTROEN CLIN NEURO, V82, P30, DOI 10.1016/0013-4694(92)90179-L; Marmarelis VZ, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0180; Marmarelis VZ, 2013, ANN BIOMED ENG, V41, P1029, DOI 10.1007/s10439-012-0736-8; Marmarelis V.Z., 2004, NONLINEAR DYNAMIC MO, V10; Marmarelis VZ, 2013, J COMPUT NEUROSCI, V34, P73, DOI 10.1007/s10827-012-0407-7; Marmarelis Vz, 2012, Open Biomed Eng J, V6, P42, DOI 10.2174/1874230001206010042; Marmarelis VZ, 1997, ANN BIOMED ENG, V25, P239, DOI 10.1007/BF02648038; Michel CM, 2012, NEUROIMAGE, V61, P371, DOI 10.1016/j.neuroimage.2011.12.039; Mitsis GD, 2002, ANN BIOMED ENG, V30, P272, DOI 10.1114/1.1458591; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Murta T, 2012, NEUROIMAGE, V62, P1634, DOI 10.1016/j.neuroimage.2012.05.053; Saab ME, 2005, CLIN NEUROPHYSIOL, V116, P427, DOI 10.1016/j.clinph.2004.08.004; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; Sakkalis V, 2009, IEEE T INF TECHNOL B, V13, P433, DOI 10.1109/TITB.2008.923141; Saleem S, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00685; Saleem S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139470; Sankari Z, 2012, CLIN EEG NEUROSCI, V43, P268, DOI 10.1177/1550059412444970; Schmidt H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003947; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Shoeb A, 2004, EPILEPSY BEHAV, V5, P483, DOI 10.1016/j.yebeh.2004.05.005; Shoeb A. H., 2010, P 27 INT C INT C MAC, P975, DOI DOI 10.0RG/PAPERS/; Shoeb A. Hossam, 2009, APPL MACHINE LEARNIN; Song D, 2013, J COMPUT NEUROSCI, V35, P335, DOI 10.1007/s10827-013-0455-7; Stretton J, 2012, EPILEPSY RES, V98, P1, DOI 10.1016/j.eplepsyres.2011.10.009; Subasi A, 2010, EXPERT SYST APPL, V37, P8659, DOI 10.1016/j.eswa.2010.06.065; Taylor PN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114316; Terry JR, 2012, EPILEPSIA, V53, pe166, DOI 10.1111/j.1528-1167.2012.03560.x; Thodoroff P., 2016, MACHINE LEARNING HEA, P178, DOI DOI 10.1016/J.CLINPH.2018.10.010; Vingerhoets G, 2006, SEIZURE-EUR J EPILEP, V15, P221, DOI 10.1016/j.seizure.2006.02.012; Wang Z, 2017, FRONTIERS COMPUTATIO, V11; Wendling F, 2001, CLIN NEUROPHYSIOL, V112, P1201, DOI 10.1016/S1388-2457(01)00547-8; Wendling F, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00154; WHO, 2001, WHO INT CLASS FUNCT; Yaffe RB, 2015, CLIN NEUROPHYSIOL, V126, P227, DOI 10.1016/j.clinph.2014.09.009	68	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191392	10.1371/journal.pone.0191392	http://dx.doi.org/10.1371/journal.pone.0191392			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351559	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300082
J	Nardo, AE; Anon, MC; Parisi, G				Nardo, Agustina E.; Cristina Anon, M.; Parisi, Gustavo			Large-scale mapping of bioactive peptides in structural and sequence space	PLOS ONE			English	Article							BIOLOGICALLY-ACTIVE PEPTIDES; PROTEIN SUPERFAMILIES; FOOD PROTEINS; CATH DATABASE; PREDICTION; PLANT; IDENTIFICATION; PURIFICATION; PRECURSORS; GENERATION	Health-enhancing potential bioactive peptide (BP) has driven an interest in food proteins as well as in the development of predictive methods. Research in this area has been especially active to use them as components in functional foods. Apparently, BPs do not have a given biological function in the containing proteins and they do not evolve under independent evolutionary constraints. In this work we performed a large-scale mapping of BPs in sequence and structural space. Using well curated BP deposited in BIOPEP database, we searched for exact matches in non-redundant sequences databases. Proteins containing BPs, were used in fold-recognition methods to predict the corresponding folds and BPs occurrences were mapped. We found that fold distribution of BP occurrences possibly reflects sequence relative abundance in databases. However, we also found that proteins with 5 or more than 5 BP in their sequences correspond to well populated protein folds, called superfolds. Also, we found that in well populated superfamilies, BPs tend to adopt similar locations in the protein fold, suggesting the existence of hotspots. We think that our results could contribute to the development of new bioinformatics pipeline to improve BP detection.	[Nardo, Agustina E.; Parisi, Gustavo] Univ Nacl Quilmes, CONICET, Dept Ciencia & Tecnol, Bernal, Argentina; [Nardo, Agustina E.; Cristina Anon, M.] Univ Nacl La Plata, Fac Ciencias Exactas, Comis Invest Cientif CONICET, Ctr Invest & Desarrollo Criotecnol Alimentos, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Parisi, G (corresponding author), Univ Nacl Quilmes, CONICET, Dept Ciencia & Tecnol, Bernal, Argentina.	gusparisi@gmail.com	Nardo, Agustina E./C-7712-2017	Nardo, Agustina E./0000-0001-9003-6004; parisi, gustavo/0000-0001-7444-1624	Agencia de Ciencia y Tecnologia [PICT-2014-3430]; Universidad Nacional de Quilmes [1402/15]	Agencia de Ciencia y Tecnologia; Universidad Nacional de Quilmes	This work was supported by grants from Agencia de Ciencia y Tecnologia (PICT-2014-3430) and Universidad Nacional de Quilmes (1402/15) to GP, GP, MCA are researchers and AEN a Postdoctoral fellow of CONICET.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arroume N, 2016, CURR OPIN FOOD SCI, V7, P101, DOI 10.1016/j.cofs.2016.02.005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bougle D, 2017, CRIT REV FOOD SCI, V57, P335, DOI 10.1080/10408398.2013.873766; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Cicero A.F.G., 2016, BR J PHARM; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; Dave LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098922; Drew K, 2011, GENOME RES, V21, P1981, DOI 10.1101/gr.121475.111; Dziuba J, 2004, ACTA ALIMENT HUNG, V33, P227, DOI 10.1556/AAlim.33.2004.3.3; Dziuba J, 1999, NAHRUNG, V43, P190, DOI [10.1002/(SICI)1521-3803(19990601)43:3&lt;190::AID-FOOD190&gt;3.0.CO;2-A, 10.1002/(SICI)1521-3803(19990601)43:3<190::AID-FOOD190>3.3.CO;2-1]; Furnham N, 2012, NUCLEIC ACIDS RES, V40, pD776, DOI 10.1093/nar/gkr852; He R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091051; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Iwaniak A, 2009, FOOD SCI TECHNOL INT, V15, P179, DOI 10.1177/1082013208106320; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Karelin AA, 1998, FEBS LETT, V428, P7, DOI 10.1016/S0014-5793(98)00486-4; Korhonen H, 2006, INT DAIRY J, V16, P945, DOI 10.1016/j.idairyj.2005.10.012; Ladunga I, 1997, PROTEIN ENG, V10, P187, DOI 10.1093/protein/10.3.187; Li YW, 2011, J MOL STRUCT, V998, P53, DOI 10.1016/j.molstruc.2011.05.011; Magner A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08166; Martirosyan DM, 2015, FUNCT FOODS HEALTH D, V5, P209; Meisel H, 2004, BIOFACTORS, V21, P55, DOI 10.1002/biof.552210111; Miner-Williams WM, 2014, NUTR RES REV, V27, P308, DOI 10.1017/S0954422414000225; Minkiewicz P, 2008, J AOAC INT, V91, P965; Minkiewicz P, 2015, INT J MOL SCI, V16, P20748, DOI 10.3390/ijms160920748; Moller NP, 2008, EUR J NUTR, V47, P171, DOI 10.1007/s00394-008-0710-2; Mooney C, 2013, BIOINFORMATICS, V29, P1120, DOI 10.1093/bioinformatics/btt103; Orengo C A, 2003, Methods Biochem Anal, V44, P249; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Orengo CA, 1999, NUCLEIC ACIDS RES, V27, P275, DOI 10.1093/nar/27.1.275; Pak VV, 2012, AMINO ACIDS, V43, P2015, DOI 10.1007/s00726-012-1276-0; Pownall TL, 2011, FOOD RES INT, V44, P1069, DOI 10.1016/j.foodres.2011.03.017; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; Shahidi F, 2008, J AOAC INT, V91, P914; Shtatland T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-280; de Castro RJS, 2015, FOOD RES INT, V74, P185, DOI 10.1016/j.foodres.2015.05.013; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Udenigwe CC, 2017, TRENDS FOOD SCI TECH, V69, P74, DOI 10.1016/j.tifs.2017.09.001; Udenigwe CC, 2013, PROCESS BIOCHEM, V48, P1794, DOI 10.1016/j.procbio.2013.08.013; Udenigwe CC, 2012, J FOOD SCI, V77, pR11, DOI 10.1111/j.1750-3841.2011.02455.x; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wang WY, 2005, COMPR REV FOOD SCI F, V4, P63, DOI 10.1111/j.1541-4337.2005.tb00075.x; Wolf YI, 2000, J MOL BIOL, V299, P897, DOI 10.1006/jmbi.2000.3786; Yoshikawa M, 2015, PEPTIDES, V72, P208, DOI 10.1016/j.peptides.2015.07.013; ZIOUDROU C, 1979, J BIOL CHEM, V254, P2446	47	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191063	10.1371/journal.pone.0191063	http://dx.doi.org/10.1371/journal.pone.0191063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351315	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300043
J	Ngcobo, S; Wolvaardt, JE; Bac, M; Webb, E				Ngcobo, Sanele; Wolvaardt, Jacqueline Elizabeth; Bac, Martin; Webb, Elize			The quality of voluntary medical male circumcision done by mid-level workers in Tshwane District, South Africa: A retrospective analysis	PLOS ONE			English	Article							ADULT MALE CIRCUMCISION; HIV PREVENTION; KISUMU; UGANDA; TRIAL; KENYA; RAKAI; MEN	Background Voluntary medical male circumcision (VMMC) reduces the acquisition of human immunodeficiency virus (HIV) in heterosexual men by up to 60%. One HIV infection is averted for every 5 to 15 VMMCs. To conduct VMMCs in large populations, large numbers of trained healthcare professionals are needed. Countries in Sub-Saharan Africa have a high burden of HIV and a shortage of healthcare professionals, creating a healthcare conundrum. To bridge this gap, South Africa launched a new cadre of mid-level medical worker called Clinical Associates (CA). We assessed the ability of CAs to perform circumcisions of adequate quality and their subsequent usefulness to meet the demands of VMMCs in a population with a high HIV burden. Methods We conducted a retrospective analysis, reviewing patient files (n = 4850) of surgical VMMCs conducted over a 16-month period. Patient files were sourced from clinics and hospitals that provided free VMMCs in Tshwane district in South Africa. Findings Clinical associates performed 88.66% of the circumcisions and doctors performed the remaining 11.34% (p < 0.001). The number of adverse events did not differ between the two groups. Data on intra-operative adverse events were available for 4 738 patients. Of these, 341 (7.2%) experienced intra-operative adverse events. For the whole sample, 44 (8.1%, n = 543) adverse events occurred during circumcisions done by doctors and 297 (7.1%, n = 4195) occurred during circumcisions done by CAs (p = 0.385). Clinical associates performed circumcisions in shorter times (duration: 14.63 minutes) compared to doctors (duration: 15.25 minutes, t = -7.46; p < 0.001). Recorded pain, bleeding, swelling, infection and wound destruction did not differ between clients circumcised by CAs and doctors. This study is limited by the use of data from a single district. Conclusions Clinical associates contribute to the demands for high numbers of VMMCs in Tshwane district, South Africa. Clinical associates perform VMMCs at a clinical standard that is comparable to circumcisions performed by doctors.	[Ngcobo, Sanele; Wolvaardt, Jacqueline Elizabeth; Webb, Elize] Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa; [Bac, Martin] Univ Pretoria, Fac Hlth Sci, Sch Med, Dept Family Med, Pretoria, South Africa; [Webb, Elize] Univ Pretoria, Fac Hlth Sci, Pretoria, South Africa	University of Pretoria; University of Pretoria; University of Pretoria	Wolvaardt, JE (corresponding author), Univ Pretoria, Fac Hlth Sci, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa.	liz.wolvaardt@up.ac.za		Ngcobo, Sanele/0000-0002-5968-0181; Wolvaardt, Jacqueline/0000-0002-3157-8863	American International Health Alliance (AIHA)	American International Health Alliance (AIHA)	Funding for this study was received from the American International Health Alliance (AIHA); http://www.aiha.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso YN, 2016, JAIDS-J ACQ IMM DEF, V73, P564, DOI 10.1097/QAI.0000000000001144; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bateman C, 2015, SAMJ S AFR MED J, V105, P623, DOI [10.7196/SAMJnew.8123, 10.7196/SAMJNEW.8123]; Curran K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001129; Daviauda E, 2008, B WORLD HEALTH ORGAN, V86, P46, DOI 10.2471/BLT.07.042283; Doherty J, 2012, SAMJ S AFR MED J, V102, P833, DOI [10.7196/SAMJ.5960, 10.7196/samj.5960]; Ford N, 2012, AIDS, V26, P559, DOI 10.1097/QAD.0b013e32834f3264; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Krieger JN, 2005, BJU INT, V96, P1109, DOI 10.1111/j.1464-410X.2005.05810.x; Krill AJ, 2011, THESCIENTIFICWORLDJO, V11, P2458, DOI 10.1100/2011/373829; Mutabazi V, 2014, AFR J REPROD HEALTH, V18, P61; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Phili R, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19275; Population Services International (PSI) and the College of Surgeons of East Central and Southern Africa (COSECSA), 2016, ADV EV ACT GUID VOL; Rech D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084271; Tchuenche M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160207; Venter F, 2012, SAMJ, V102	20	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190795	10.1371/journal.pone.0190795	http://dx.doi.org/10.1371/journal.pone.0190795			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351311	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300025
J	Padmakumar, M; Brain, KL; Young, JS; Manchanda, R				Padmakumar, Mithun; Brain, Keith L.; Young, John S.; Manchanda, Rohit			A four-component model of the action potential in mouse detrusor smooth muscle cell	PLOS ONE			English	Article							URINARY-BLADDER; PURINERGIC NEUROTRANSMISSION; MECHANICAL-ACTIVITY; EVOKED-POTENTIALS; NEURONS; ACETYLCHOLINE; INHIBITION; ACTIVATION; DECREASE; RAT	Background and hypothesis Detrusor smooth muscle cells (DSMCs) of the urinary bladder are electrically connected to one another via gap junctions and form a three dimensional syncytium. DSMCs exhibit spontaneous electrical activity, including passive depolarizations and action potentials. The shapes of spontaneous action potentials (sAPs) observed from a single DSM cell can vary widely. The biophysical origins of this variability, and the precise components which contribute to the complex shapes observed are not known. To address these questions, the basic components which constitute the sAPs were investigated. We hypothesized that linear combinations of scaled versions of these basic components can produce sAP shapes observed in the syncytium. Methods and results The basic components were identified as spontaneous evoked junction potentials (sEJP), native AP (nAP), slow after hyperpolarization (sAHP) and very slow after hyperpolarization (vsAHP). The experimental recordings were grouped into two sets: a training data set and a testing data set. A training set was used to estimate the components, and a test set to evaluate the efficiency of the estimated components. We found that a linear combination of the identified components when appropriately amplified and time shifted replicated various AP shapes to a high degree of similarity, as quantified by the root mean square error (RMSE) measure. Conclusions We conclude that the four basic components D sEJP, nAP, sAHP, and vsAHP D identified and isolated in this work are necessary and sufficient to replicate all varieties of the sAPs recorded experimentally in DSMCs. This model has the potential to generate testable hypotheses that can help identify the physiological processes underlying various features of the sAPs. Further, this model also provides a means to classify the sAPs into various shape classes.	[Padmakumar, Mithun; Manchanda, Rohit] Indian Inst Technol, Dept Biosci & Bioengn, Mumbai, Maharashtra, India; [Brain, Keith L.] Univ Birmingham, Coll Med & Dent Sci, Inst Clin Sci, Birmingham, W Midlands, England; [Young, John S.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; University of Birmingham; University of Portsmouth	Brain, KL (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Clin Sci, Birmingham, W Midlands, England.	k.l.brain@bham.ac.uk	Brain, Keith L./AFU-7168-2022; Young, John S./J-2529-2013	Brain, Keith L./0000-0002-0906-7012; Young, John S./0000-0002-2711-9701; Padmakumar, Mithun/0000-0002-5305-4542	Department of Biotechnology (DBT), India [BT/PR12973/MED/122/47/2016]; UKIERI [UKUTP20110055]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); UKIERI(UK Research & Innovation (UKRI))	The work was supported by grants from the Department of Biotechnology (DBT, http://www.dbtindia.nic.in/), India (BT/PR12973/MED/122/47/2016) to Rohit Manchanda and the UKIERI (UKUTP20110055, http://www.ukieri.org/) to Rohit Manchanda and Keith L. Brain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alian M, 1996, NEUROSCI LETT, V218, P103, DOI 10.1016/S0304-3940(96)13129-3; [Anonymous], 1998, PHYSL EXCITABLE CELL; Appukuttan S, 2015, J COMPUT NEUROSCI, V38, P167, DOI 10.1007/s10827-014-0532-6; BENNETT MR, 1973, PHILOS T ROY SOC B, V265, P25, DOI 10.1098/rstb.1973.0006; Bennett MR, 1972, AUTONOMIC NEUROMUSCU; CALLAHAN SM, 1981, BRIT J PHARMACOL, V74, P353, DOI 10.1111/j.1476-5381.1981.tb09978.x; COWAN WD, 1983, CAN J PHYSIOL PHARM, V61, P1236, DOI 10.1139/y83-182; CREED KE, 1983, J PHYSIOL-LONDON, V338, P149, DOI 10.1113/jphysiol.1983.sp014666; De Biasi M, 2000, EUR J PHARMACOL, V393, P137, DOI 10.1016/S0014-2999(00)00008-X; DODD J, 1983, J PHYSIOL-LONDON, V334, P271, DOI 10.1113/jphysiol.1983.sp014494; Drake MJ, 2017, BJU INT, V119, P22, DOI 10.1111/bju.13598; FATT P, 1951, J PHYSIOL-LONDON, V115, P320, DOI 10.1113/jphysiol.1951.sp004675; Ford Anthony P D W, 2011, Handb Exp Pharmacol, P485, DOI 10.1007/978-3-642-16499-6_22; Fry C H, 1998, Int Urogynecol J Pelvic Floor Dysfunct, V9, P291, DOI 10.1007/BF01901509; FUJII K, 1990, BRIT J PHARMACOL, V99, P779, DOI 10.1111/j.1476-5381.1990.tb13006.x; GILPIN CJ, 1983, J ANAT, V137, P705; Guyton A.C., 2006, TXB MED PHYSL; Hanani Menachem, 2000, Journal of Basic and Clinical Physiology and Pharmacology, V11, P321; HARTZELL HC, 1977, J PHYSIOL-LONDON, V271, P817, DOI 10.1113/jphysiol.1977.sp012027; Hayase M, 2009, J UROLOGY, V181, P2355, DOI 10.1016/j.juro.2009.01.013; Heppner TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC110; HORN JP, 1981, NATURE, V292, P625, DOI 10.1038/292625a0; JEFFREYS DA, 1972, EXP BRAIN RES, V16, P1; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; MANCHANDA R, 1995, CURR SCI INDIA, V69, P140; Meng E, 2008, NEUROUROL URODYNAM, V27, P79, DOI 10.1002/nau.20456; MILNER P, 1991, NEUROSCIENCE, V43, P661, DOI 10.1016/0306-4522(91)90324-H; Ochodnicky P, 2013, ACTA PHYSIOL, V207, P16, DOI 10.1111/apha.12010; Padmakumar M, 2017, INT J COMPUTER THEOR, V9, P115; Padmakumar M., 2012, SIGN PROC COMM SPCOM, P1; Padmakumar M, 2016, 2016 INTERNATIONAL CONFERENCE ON SYSTEMS IN MEDICINE AND BIOLOGY (ICSMB), P148, DOI 10.1109/ICSMB.2016.7915109; Padmakumar M, 2015, PROCEEDINGS OF THE 2015 IEEE RECENT ADVANCES IN INTELLIGENT COMPUTATIONAL SYSTEMS (RAICS), P212, DOI 10.1109/RAICS.2015.7488416; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Petkov GV, 2001, AM J PHYSIOL-REG I, V280, pR1427, DOI 10.1152/ajpregu.2001.280.5.R1427; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; SJOGREN C, 1982, J UROLOGY, V128, P1368, DOI 10.1016/S0022-5347(17)53509-0; Spiess Andrej-Nikolai, 2010, BMC Pharmacology, V10, P6, DOI 10.1186/1471-2210-10-6; Takagi H, 2016, EUR J PHARMACOL, V789, P179, DOI 10.1016/j.ejphar.2016.07.041; Thorneloe KS, 2003, J PHYSIOL-LONDON, V549, P65, DOI 10.1113/jphysiol.2003.039859; Trenado C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168151; URSILLO RC, 1961, AM J PHYSIOL, V201, P408, DOI 10.1152/ajplegacy.1961.201.3.408; VIDAL JJ, 1977, P IEEE, V65, P633, DOI 10.1109/PROC.1977.10542; Wuest M, 2005, J UROLOGY, V173, P2182, DOI 10.1097/01.ju.0000158126.53702.e4; Yoshida M, 2001, EXP GERONTOL, V36, P99, DOI 10.1016/S0531-5565(00)00175-3; Young JS, 2008, J PHYSIOL-LONDON, V586, P5743, DOI 10.1113/jphysiol.2008.162040	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190016	10.1371/journal.pone.0190016	http://dx.doi.org/10.1371/journal.pone.0190016			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351282	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300014
J	Wang, B; Liu, JJ; Liu, L; Xu, SM; Huang, WY				Wang, Bin; Liu, Juanjuan; Liu, Li; Xu, Shiming; Huang, Wenyu			An approach to localization for ensemble-based data assimilation	PLOS ONE			English	Article							VARIATIONAL DATA ASSIMILATION; ADAPTIVE COVARIANCE INFLATION; ATMOSPHERIC DATA ASSIMILATION; SEQUENTIAL DATA ASSIMILATION; KALMAN FILTER; NONLOCAL OBSERVATIONS; ERROR-CORRECTION; SMALL MODEL; IMPLEMENTATION; CONSTRUCTION	Localization techniques are commonly used in ensemble-based data assimilation (e.g., the Ensemble Kalman Filter (EnKF) method) because of insufficient ensemble samples. They can effectively ameliorate the spurious long-range correlations between the background and observations. However, localization is very expensive when the problem to be solved is of high dimension (say 10(6) or higher) for assimilating observations simultaneously. To reduce the cost of localization for high-dimension problems, an approach is proposed in this paper, which approximately expands the correlation function of the localization matrix using a limited number of principal eigenvectors so that the Schur product between the localization matrix and a high-dimension covariance matrix is reduced to the sum of a series of Schur products between two simple vectors. These eigenvectors are actually the sine functions with different periods and phases. Numerical experiments show that when the number of principal eigenvectors used reaches 20, the approximate expansion of the correlation function is very close to the exact one in the one-dimensional (1D) and two-dimensional (2D) cases. The new approach is then applied to localization in the EnKF method, and its performance is evaluated in assimilation-cycle experiments with the Lorenz-96 model and single assimilation experiments using a barotropic shallow water model. The results suggest that the approach is feasible in providing comparable assimilation analysis with far less cost.	[Wang, Bin; Liu, Juanjuan] Inst Atmospher Phys, LASG, Beijing, Peoples R China; [Wang, Bin; Liu, Li; Xu, Shiming; Huang, Wenyu] Tsinghua Univ, Dept Earth Syst Sci, Minist Educ, Key Lab Earth Syst Modeling, Beijing, Peoples R China; [Wang, Bin; Liu, Juanjuan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Tsinghua University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, JJ (corresponding author), Inst Atmospher Phys, LASG, Beijing, Peoples R China.; Liu, JJ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	ljjxgg@mail.iap.ac.cn	Wang, Bin/P-9121-2014; 娟娟, 刘/AAH-7366-2019; Huang, Wenyu/M-7584-2014; Wang, Bin/D-9724-2012	Wang, Bin/0000-0001-7374-3786; Huang, Wenyu/0000-0001-9722-5502; Wang, Bin/0000-0002-3133-7197	National Natural Science Foundation of China; National Basic Research Program of China (973 Program) [91530204, 2014CB441302]; National Natural Science Foundation of China [91737307]; China Meteorological Administration for the R&D Special Fund for Public Welfare Industry (Meteorology) [GYHY(QX)201406015]; National Basic Research Program of China [2015CB954102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Meteorological Administration for the R&D Special Fund for Public Welfare Industry (Meteorology); National Basic Research Program of China(National Basic Research Program of China)	BW acknowledges the National Natural Science Foundation of China and the National Basic Research Program of China (973 Program) under Grant No. 91530204 and Grant No. 2014CB441302, respectively. JL is grateful to the National Natural Science Foundation of China (No. 91737307), the China Meteorological Administration for the R&D Special Fund for Public Welfare Industry (Meteorology) under Grant No. GYHY(QX)201406015. This work was also supported by the National Basic Research Program of China Grant No. 2015CB954102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, TELLUS A, V59, P210, DOI 10.1111/j.1600-0870.2006.00216.x; Anderson JL, 2012, MON WEATHER REV, V140, P2359, DOI 10.1175/MWR-D-11-00013.1; Anderson JL, 2009, TELLUS A, V61, P72, DOI 10.1111/j.1600-0870.2008.00361.x; Anderson JL, 2001, MON WEATHER REV, V129, P2884, DOI 10.1175/1520-0493(2001)129<2884:AEAKFF>2.0.CO;2; Anderson JL, 1999, MON WEATHER REV, V127, P2741, DOI 10.1175/1520-0493(1999)127<2741:AMCIOT>2.0.CO;2; Bergemann K, 2010, Q J ROY METEOR SOC, V136, P701, DOI 10.1002/qj.591; Bishop CH, 2007, Q J ROY METEOR SOC, V133, P2029, DOI 10.1002/qj.169; Bishop CH, 2011, MON WEATHER REV, V139, P573, DOI 10.1175/2010MWR3405.1; Buehner M, 2005, Q J ROY METEOR SOC, V131, P1013, DOI 10.1256/qj.04.15; Buehner M, 2010, MON WEATHER REV, V138, P1550, DOI 10.1175/2009MWR3157.1; Buehner M, 2010, MON WEATHER REV, V138, P1567, DOI 10.1175/2009MWR3158.1; Campbell WF, 2010, MON WEATHER REV, V138, P282, DOI 10.1175/2009MWR3017.1; Constantinescu EM, 2007, Q J ROY METEOR SOC, V133, P1245, DOI 10.1002/qj.77; EVENSEN G, 1994, J GEOPHYS RES-OCEANS, V99, P10143, DOI 10.1029/94JC00572; Evensen G, 2009, THE ENSEMBLE KALMAN; Fertig EJ, 2007, TELLUS A, V59, P719, DOI 10.1111/J.1600-0870.2007.00260.x; Gaspari G, 1999, Q J ROY METEOR SOC, V125, P723, DOI 10.1002/qj.49712555417; Hamill TM, 2001, MON WEATHER REV, V129, P2776, DOI 10.1175/1520-0493(2001)129<2776:DDFOBE>2.0.CO;2; Houtekamer PL, 1998, MON WEATHER REV, V126, P796, DOI 10.1175/1520-0493(1998)126<0796:DAUAEK>2.0.CO;2; Houtekamer PL, 2001, MON WEATHER REV, V129, P123, DOI 10.1175/1520-0493(2001)129<0123:ASEKFF>2.0.CO;2; Kalnay E, 2007, TELLUS A, V59, P758, DOI 10.1111/J.1600-0870.2007.00261.X; Keppenne CL, 2000, MON WEATHER REV, V128, P1971, DOI 10.1175/1520-0493(2000)128<1971:DAIAPE>2.0.CO;2; Kuhl DD, 2013, MON WEATHER REV, V141, P2740, DOI 10.1175/MWR-D-12-00182.1; Lawson WG, 2004, MON WEATHER REV, V132, P1966, DOI 10.1175/1520-0493(2004)132<1966:IOSADF>2.0.CO;2; Liu CS, 2009, MON WEATHER REV, V137, P1687, DOI 10.1175/2008MWR2699.1; Liu JJ, 2011, TELLUS A, V63, P256, DOI 10.1111/j.1600-0870.2010.00487.x; Lorenz EN, 1998, J ATMOS SCI, V55, P399, DOI 10.1175/1520-0469(1998)055<0399:OSFSWO>2.0.CO;2; Lorenz EN., 1996, P SEM PRED READ UK 4, Vvol. 1, DOI DOI 10.1017/CBO9780511617652.004; Miyoshi T, 2007, SOLA, V3, P37, DOI 10.2151/sola.2007-010; Oke PR, 2007, OCEAN DYNAM, V57, P32, DOI 10.1007/s10236-006-0088-8; Ott E, 2004, TELLUS A, V56, P415, DOI 10.1111/j.1600-0870.2004.00076.x; Pham DT, 2001, MON WEATHER REV, V129, P1194, DOI 10.1175/1520-0493(2001)129<1194:SMFSDA>2.0.CO;2; Sang HY, 2012, J R STAT SOC B, V74, P111, DOI 10.1111/j.1467-9868.2011.01007.x; Wang B, 2003, CHINESE SCI BULL, V48, P1016, DOI 10.1360/02wd0414; Wang B, 2010, ADV ATMOS SCI, V27, P715, DOI 10.1007/s00376-009-9122-3; Wang B, 2010, MON WEATHER REV, V138, P1043, DOI 10.1175/2009MWR3022.1; Wang XG, 2003, J ATMOS SCI, V60, P1140, DOI 10.1175/1520-0469(2003)060<1140:ACOBAE>2.0.CO;2; Whitaker JS, 2002, MON WEATHER REV, V130, P1913, DOI 10.1175/1520-0493(2002)130<1913:EDAWPO>2.0.CO;2; Zhang FQ, 2009, ADV ATMOS SCI, V26, P1, DOI 10.1007/s00376-009-0001-8; Zhu JA, 2011, TELLUS A, V63, P244, DOI 10.1111/j.1600-0870.2010.00486.x	41	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191088	10.1371/journal.pone.0191088	http://dx.doi.org/10.1371/journal.pone.0191088			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351306	Green Submitted, gold, Green Published			2022-12-27	WOS:000422911300048
J	Zhuang, H; Yago, M; Settele, J; Li, X; Ueshima, R; Grishin, NV; Wang, M				Zhuang, Hailing; Yago, Masaya; Settele, Josef; Li, Xiushan; Ueshima, Rei; Grishin, Nick V.; Wang, Min			Species richness of Eurasian Zephyrus hairstreaks (Lepidoptera: Lycaenidae: Theclini) with implications on historical biogeography: An NDM/VNDM approach	PLOS ONE			English	Article							PLANT DIVERSITY; DISTRIBUTION PATTERNS; ENDEMISM; AREAS; BIODIVERSITY; CONSERVATION; REFUGIA; CHINA; GENUS	Aim A database based on distributional records of Eurasian Zephyrus hairstreaks (Lepidoptera: Lycaenidae: Theclini) was compiled to analyse their areas of endemism (AoEs), species richness and distribution patterns, to explore their locations of past glacial refugia and dispersal routes. Methods Over 2000 Zephyrus hairstreaks occurrences are analysed using the NDM/VNDM algorithm, for the recognition of AoEs. Species richness was calculated by using the option 'Number of different classes' to count the different classes of a variable presented in each 3.0 degrees x 3.0 degrees grid cell, and GIS software was used to visualize distribution patterns of endemic species. Results Centres of species richness of Zephyrus hairstreaks are situated in the eastern Qinghai-Tibet Plateau (EQTP), Hengduan Mountain Region (HDMR) and the Qinling Mountain Region (QLMR). Latitudinal gradients in species richness show normal distribution with the peak between 25 degrees N and 35 degrees N in the temperate zone, gradually decreasing towards the poles. Moreover, most parts of central and southern China, especially the area of QLMR-EQTP-HDMR, were identified as AoEs that may have played a significant role as refugia during Quaternary global cooling. There are four major distributional patterns of Zephyrus hairstreaks in Eurasia: Sino-Japanese, Sino-Himalayan, high-mountain and a combined distribution covering all three patterns. Conclusions Zephyrus hairstreaks probably originated at least 23-24 Myr ago in E. Asia between 25 degrees N to 35 degrees N in the temperate zone. Cenozoic orogenies caused rapid speciation of this tribe and extrusion of the Indochina block resulted in vicariance between the Sino-Japanese and the Sino-Himalayan patterns. The four distribution patterns provided two possible dispersal directions: Sino-Japanese dispersal and Sino-Himalayan dispersal.	[Zhuang, Hailing; Wang, Min] South China Agr Univ, Coll Agr, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Zhuang, Hailing; Yago, Masaya] Univ Tokyo, Univ Museum, Tokyo, Japan; [Settele, Josef; Li, Xiushan] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Saxony Anhalt, Germany; [Settele, Josef] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Settele, Josef] Univ Philippines Los Banos, Inst Biol Sci, Laguna, Philippines; [Ueshima, Rei] Univ Tokyo, Grad Sch Sci, Inst Biol Sci, Tokyo, Japan; [Grishin, Nick V.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	South China Agricultural University; University of Tokyo; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of the Philippines System; University of the Philippines Los Banos; University of Tokyo; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, M (corresponding author), South China Agr Univ, Coll Agr, Dept Entomol, Guangzhou, Guangdong, Peoples R China.	minwang@scau.edu.cn	Settele, Josef/A-6371-2009; Li, Xiushan/AAA-3856-2021	Settele, Josef/0000-0002-8624-4983; 	Chinese National Natural Science Foundation [40971037]; CSC (China Scholarship Council, Liujinfa) [[2015] 3022];  [26440207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM127390] Funding Source: NIH RePORTER	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); CSC (China Scholarship Council, Liujinfa); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported Grant-in-Aid for Scientific Research (C) (No. 26440207 to MY), (http://www.um.u-tokyo.ac.jp/people/faculty_yago.html). This funder provided the idea, fund and resources and participated writing original draft and revision. This work was also supported by the Chinese National Natural Science Foundation (No. 40971037 to MW). This funder provided the idea, fund, resource and participated filed survey, confirmed test. Lastly, it was funded by the CSC (China Scholarship Council, Liujinfa [2015] 3022 to HZ. This funder conducted almost all aspects of this research expect, resources and validation.	Asano S, 2014, GEKKAN MUSHI, V521, P6; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; CRACRAFT J, 1991, Australian Systematic Botany, V4, P211, DOI 10.1071/SB9910211; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; do Prado JR, 2015, J BIOGEOGR, V42, P540, DOI 10.1111/jbi.12424; Ebach MC, 2006, J BIOGEOGR, V33, P761, DOI 10.1111/j.1365-2699.2006.01477.x; ELIOT J N, 1973, Bulletin of the British Museum (Natural History) Entomology, V28, P371; Escalante T, 2013, BIOL J LINN SOC, V110, P485, DOI 10.1111/bij.12142; Fortey R. A., 1998, P43; Glasby CJ, 1999, J BIOGEOGR, V26, P507, DOI 10.1046/j.1365-2699.1999.00297.x; Goloboff P, 2005, NDM VNDM VER 2 5 SOF; Harada Motohiro, 2012, Gekkan-Mushi, V497, P9; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hasegawa Takashi, 2014, Butterflies (Teinopalpus), V67, P4; Hasegawa Takashi, 2013, Butterflies (Teinopalpus), V63, P4; Hasegawa Takashi, 2009, Gekkan-Mushi, V461, P9; HIjMAns R.J., 2012, DIVA GIS VERSION 7 5; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; HOLLOWAY JD, 1987, BIOL J LINN SOC, V30, P325, DOI 10.1111/j.1095-8312.1987.tb00306.x; Holloway JD, 1998, HDB ZOOLOGY NATURAL, V1, P423; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; Hsu YF, 2015, ZOOTAXA, V4027, P130, DOI 10.11646/zootaxa.4027.1.6; Hsu YF, 2009, ZOOTAXA, P45, DOI 10.11646/zootaxa.1983.1.3; Huang XL, 2008, J BIOGEOGR, V35, P230, DOI 10.1111/j.1365-2699.2007.01776.x; Katayama Toshihiko, 2011, Butterflies (Teinopalpus), V59, P8; Kim S, 2006, J LEPID SOC, V16, P33; Kim S, 2009, J LEPID SOC, V18, P1; Koiwaya S, 2007, MUSHI SHAS ICONOGRAP, V5; Koiwaya S., 2013, GEKKAN MUSHI, V509, P4; Koiwaya S., 2013, GEKKAN MUSHI, V512, P10; Koiwaya Satoshi, 2012, Gekkan-Mushi, V502, P28; Koiwaya Satoshi, 2014, Gekkan-Mushi, V521, P21; Koiwaya Satoshi, 2011, Gekkan-Mushi, V485, P4; Koiwaya Satoshi, 2010, Butterflies (Teinopalpus), V56, P4; Lei FM, 2003, BIODIVERS CONSERV, V12, P239, DOI 10.1023/A:1021928801558; Li Heng, 1999, Acta Botanica Yunnanica, V21, P407; Li XW, 1997, ANN MO BOT GARD, V84, P888, DOI 10.2307/2992033; Linder HP, 2001, J BIOGEOGR, V28, P169, DOI 10.1046/j.1365-2699.2001.00527.x; Liu J, 2013, PROCEEDINGS OF THE 2013 INTERNATIONAL CONFERENCE ON ENERGY, P16, DOI 10.1109/AMS.2013.9; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Metcalfe Ian, 1998, P25; Morrone JJ, 2006, ANNU REV ENTOMOL, V51, P467, DOI 10.1146/annurev.ento.50.071803.130447; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakamura Norio, 2011, Butterflies (Teinopalpus), V57, P22; Platnick N., 1991, AUSTR SYSTEMATIC BOT, V4, P11; SAIGUSA T, 1982, ENTOMOL GEN, V8, P59; Saito Motoki, 2011, Butterflies (Teinopalpus), V57, P57; Scheldeman X., 2010, TRAINING MANUAL SPAT; Shirozu T., 1956, Sieboldia Fukuoka, V1, P329; Shirozu T, 1980, ZEPHYRUS HAIRSTREAKS; Shizuya Hideo, 2010, Gekkan-Mushi, V473, P13; Sinev S.Yu., 2008, CATALOGUE LEPIDOPTER; Singh Arun P., 2009, Journal of Threatened Taxa, V1, P37; Szumik CA, 2002, SYST BIOL, V51, P806, DOI 10.1080/10635150290102483; Szumik CA, 2004, SYST BIOL, V53, P968, DOI 10.1080/10635150490888859; Tanaka T, 1954, REVISIO AURANTIACEAR, VIX, P141; Tribsch A, 2003, TAXON, V52, P477, DOI 10.2307/3647447; Tribsch A, 2004, J BIOGEOGR, V31, P747, DOI 10.1111/j.1365-2699.2004.01065.x; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Wallace AR, 2010, PHYS GEOGRAPHY MALAY; WANG M., 2012, BUTTERFLIES GUANGXI; Wang M, 2009, BUTTERFLIES MOTHS, V60, P125; Whitmore T.C., 1987, BIOGEOGRAPHICAL EVOL, P5; Yin A, 2000, ANNU REV EARTH PL SC, V28, P211, DOI 10.1146/annurev.earth.28.1.211; Yokochi Takashi, 2015, Butterflies (Teinopalpus), V70, P17; Yokochi Takashi, 2015, Butterflies (Teinopalpus), V69, P9; Zhu HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068283; [朱华 Zhu Hua], 2003, [地球科学进展, Advance in Earth Sciences], V18, P870; Zhuang HL, 2015, ZOOTAXA, V3985, P142, DOI 10.11646/zootaxa.3985.1.8	74	6	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191049	10.1371/journal.pone.0191049	http://dx.doi.org/10.1371/journal.pone.0191049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351314	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300041
J	Holmes, CB; Yiannoutsos, CT; Elul, B; Bukusi, E; Ssali, J; Kambugu, A; Musick, BS; Cohen, C; Williams, C; Diero, L; Padian, N; Wools-Kaloustian, KK				Holmes, Charles B.; Yiannoutsos, Constantin T.; Elul, Batya; Bukusi, Elizabeth; Ssali, John; Kambugu, Andrew; Musick, Beverly S.; Cohen, Craig; Williams, Carolyn; Diero, Lameck; Padian, Nancy; Wools-Kaloustian, Kara K.			Increased prevalence of pregnancy and comparative risk of program attrition among individuals starting HIV treatment in East Africa	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; FOLLOW-UP; SOUTH-AFRICA; WOMEN; RETENTION; CARE; SERVICES; MALAWI; COHORT	Background The World Health Organization now recommends initiating all pregnant women on life-long antiretroviral therapy (ART), yet there is limited information about the characteristics and program outcomes of pregnant women already on ART in Africa. Our hypothesis was that pregnant women comprised an increasing proportion of those starting ART, and that subgroups of these women were at higher risk for program attrition. Methods and findings We used the International Epidemiology Databases to Evaluate AIDS-East Africa (IeDEAEA) to conduct a retrospective cohort study including HIV care and treatment programs in Kenya, Uganda, and Tanzania. The cohort consecutively included HIV-infected individuals 13 years or older starting ART 2004-2014. We examined trends over time in the proportion pregnant, their characteristics and program attrition rates compared to others initiating and already receiving ART. 156,474 HIV-infected individuals (67.0% women) started ART. The proportion of individuals starting ART who were pregnant women rose from 5.3% in 2004 to 12.2% in 2014. Mean CD4 cell counts at ART initiation, weighted for annual program size, increased from 2004 to 2014, led by non-pregnant women (annual increase 20 cells/mm(3)) and men (17 cells/mm(3) annually), with lower rates of change in pregnant women (10 cells/mm(3) per year) (p<0.0001). There was no significant difference in the cumulative incidence of program attrition at 6 months among pregnant women starting ART and non-pregnant women. However, healthy pregnant women starting ART (WHO stage 1/2) had a higher rate of attrition rate (9.6%), compared with healthy non-pregnant women (6.5%); in contrast among women with WHO stage 3/4 disease, pregnant women had lower attrition (8.4%) than non-pregnant women (14.4%). Among women who initiated ART when healthy and remained in care for six months, subsequent six-month attrition was slightly higher among pregnant women at ART start (3.5%) compared to those who were not pregnant (2.4%), (absolute difference 1.1%, 95% CI 0.7%-1.5%). Conclusions Pregnant women comprise an increasing proportion of those initiating ART in Africa, and pregnant women starting ART while healthy are at higher risk for program attrition than nonpregnant women. As ART programs further expand access to healthier pregnant women, further studies are needed to better understand the drivers of loss among this high risk group of women to optimize retention.	[Holmes, Charles B.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Holmes, Charles B.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Holmes, Charles B.] Georgetown Univ, Sch Med, Washington, DC 20057 USA; [Yiannoutsos, Constantin T.] Indiana Univ, RM Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Elul, Batya] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Bukusi, Elizabeth] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Ssali, John] Masaka Reg Hosp, Masaka, Uganda; [Kambugu, Andrew] Infect Dis Inst, Kampala, Uganda; [Musick, Beverly S.; Wools-Kaloustian, Kara K.] Indiana Univ, Sch Med, Indianapolis, IN 46202 USA; [Cohen, Craig] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Williams, Carolyn] NIAID, Bethesda, MD 20892 USA; [Diero, Lameck] Acad Model Providing Access Hlth Care AMPATH, Eldoret, Kenya; [Padian, Nancy] Univ Calif Berkeley, Berkeley, CA 94720 USA	Johns Hopkins University; Georgetown University; Indiana University System; Indiana University-Purdue University Indianapolis; Columbia University; Kenya Medical Research Institute; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Berkeley	Holmes, CB (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.; Holmes, CB (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.; Holmes, CB (corresponding author), Georgetown Univ, Sch Med, Washington, DC 20057 USA.	cholme13@jhmi.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069911] Funding Source: NIH RePORTER; NIAID NIH HHS [U01 AI069911, P30 AI027763] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Fox MP, 2012, TROP MED INT HEALTH, V17, P1235, DOI 10.1111/j.1365-3156.2012.03055.x; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-46; GFATM, 2011, MAK DIFF REG RES REP; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Kim MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148466; Llenas-Garcia J, 2016, TROP MED INT HEALTH, V21, P1003, DOI 10.1111/tmi.12728; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Odeny TA, 2014, AIDS, V28, P2307, DOI 10.1097/QAD.0000000000000409; PEPFAR, 2013, 9 ANN REP C PEPFAR; Phillips T, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19242; Shroufi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064717; Stinson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063328; Stinson K, 2012, AJAR-AFR J AIDS RES, V11, P65, DOI 10.2989/16085906.2012.671263; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Toro PL, 2010, AIDS, V24, P515, DOI 10.1097/QAD.0b013e3283350ecd; Wang BX, 2011, SAMJ S AFR MED J, V101, P253, DOI 10.7196/SAMJ.4078; Westreich D, 2012, JAIDS-J ACQ IMM DEF, V60, P489, DOI 10.1097/QAI.0b013e318256b310; Wools-Kaloustian K, 2009, AIDS, V23, P195, DOI 10.1097/QAD.0b013e32831cc0e6; World Health Organization, 2015, CONS GUID US ANT DRU	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190828	10.1371/journal.pone.0190828	http://dx.doi.org/10.1371/journal.pone.0190828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342180	gold, Green Published, Green Submitted			2022-12-27	WOS:000422653800034
J	Jing, XL; Lin, SJ; Zhang, H; Koerting, C; Yu, ZG				Jing, Xiaoli; Lin, Senjie; Zhang, Huan; Koerting, Claudia; Yu, Zhigang			Utilization of urea and expression profiles of related genes in the dinoflagellate Prorocentrum donghaiense (vol 12, e0187837, 2017)	PLOS ONE			English	Correction													Lin, Senjie/A-7466-2011					Jing XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187837	1	1	1	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191521	10.1371/journal.pone.0191521	http://dx.doi.org/10.1371/journal.pone.0191521			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338050	gold, Green Published, Green Submitted			2022-12-27	WOS:000422652700055
J	Marcussen, M; Sonderkaer, M; Bodker, JS; Andersen, M; Nielsen, S; Vesteghem, C; Christiansen, I; Bergmann, OJ; Bogsted, M; Dybkaer, K; Vyberg, M; Johnsen, HE				Marcussen, Mette; Sonderkaer, Mads; Bodker, Julie Stove; Andersen, Maria; Nielsen, Soren; Vesteghem, Charles; Christiansen, Ilse; Bergmann, Olav Jonas; Bogsted, Martin; Dybkear, Karen; Vyberg, Mogens; Johnsen, Hans Erik			Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; NECK-CANCER; RECEIVING RADIOTHERAPY; HEAD; CHEMOTHERAPY; MECHANISMS; OUTCOMES; DAHANCA; BLOOD	Background Radiation-therapy (RT) induces mucositis, a clinically challenging condition with limited prophylactic interventions and no predictive tests. In this pilot study, we applied global gene-expression analysis on serial human oral mucosa tissue and blood cells from patients with tonsil squamous cell cancer (TSCC) to identify genes involved in mucositis pathogenesis. Methods and findings Eight patients with TSCC each provided consecutive buccal biopsies and blood cells before, after 7 days of RT treatment, and 20 days following RT. We monitored clinical mucositis and performed gene-expression analysis on tissue samples. We obtained control tissue from nine healthy individuals. After RT, expression was upregulated in apoptosis inducer and inhibitor genes, EDA2R and MDM2, and in POLH, a DNA-repair polymerase. Expression was downregulated in six members of the histone cluster family, e.g., HIST1H3B. Gene expression related to proliferation and differentiation was altered, including MKI67 (downregulated), which encodes the Ki-67-proliferation marker, and KRT16 (upregulated), which encodes keratin16. These alterations were not associated with the clinical mucositis grade. However, the expression of LY6G6C, which encodes a surface immunoregulatory protein, was upregulated before treatment in three cases of clinical none/mild mucositis, but not in four cases of ulcerative mucositis. Conclusion RT caused molecular changes related to apoptosis, DNA-damage, DNA-repair, and proliferation without a correlation to the severity of clinical mucositis. LY6G6C may be a potential protective biomarker for ulcerative mucositis. Based on these results, our study model of consecutive human biopsies will be useful in designing a prospective clinical validation trial to characterize molecular mucositis and identify predictive biomarkers.	[Marcussen, Mette; Bogsted, Martin; Dybkear, Karen; Vyberg, Mogens; Johnsen, Hans Erik] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Sonderkaer, Mads; Bodker, Julie Stove; Vesteghem, Charles; Bogsted, Martin; Dybkear, Karen; Vyberg, Mogens; Johnsen, Hans Erik] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark; [Bodker, Julie Stove; Vesteghem, Charles; Christiansen, Ilse; Bogsted, Martin; Dybkear, Karen; Vyberg, Mogens; Johnsen, Hans Erik] Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark; [Andersen, Maria] Aalborg Univ Hosp, Dept Oncol, Aalborg, Denmark; [Nielsen, Soren] Aalborg Univ Hosp, Inst Pathol, Aalborg, Denmark; [Bergmann, Olav Jonas] Aarhus Univ, Fac Hlth Sci, Sch Dent, Aarhus, Denmark	Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aarhus University	Marcussen, M (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.	mette.marcussen@rn.dk		Sonderkaer, Mads/0000-0002-9309-7459; Bogsted, Martin/0000-0001-9192-1814; marcussen, mette/0000-0003-0795-2293; Vesteghem, Charles/0000-0003-2301-9081; Dybkaer, Karen/0000-0003-2488-435X	Det Obelske Familiefond [25042]	Det Obelske Familiefond	Grant no 25042 recived from Det Obelske Familiefond (http://obel.com/) to Mette Marcussen. The funders has no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendstein H, 2005, LARYNGOSCOPE, V115, P2183, DOI 10.1097/01.MLG.0000181507.69620.14; Acauan MD, 2015, ARCH ORAL BIOL, V60, P1802, DOI 10.1016/j.archoralbio.2015.09.014; Alisoltani A, 2014, PLOSONE; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhide SA, 2012, RADIOTHER ONCOL, V103, P88, DOI 10.1016/j.radonc.2011.12.027; Bonan PRF, 2007, ORAL DIS, V13, P170, DOI 10.1111/j.1601-0825.2006.01254.x; Bonan PRF, 2006, ORAL SURG ORAL MED O, V101, P207, DOI 10.1016/j.tripleo.2005.03.033; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dorr W, 2002, INT J RADIAT ONCOL, V52, P911, DOI 10.1016/S0360-3016(01)02721-3; Elad S, 2016, SUPPORT CARE CANCER, V24, P4825, DOI 10.1007/s00520-016-3337-5; Elting LS, 2007, INT J RADIAT ONCOL, V68, P1110, DOI 10.1016/j.ijrobp.2007.01.053; Gagliardi F, 2017, CRIT REV ONCOL HEMAT, V109, P63, DOI 10.1016/j.critrevonc.2016.11.013; Garnaes E, 2015, INT J CANCER, V136, P2196, DOI 10.1002/ijc.29254; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gregoire V, 2010, ANN ONCOL, V21, pv184, DOI 10.1093/annonc/mdq185; Gregoire V, 2014, RADIOTHER ONCOL, V110, P172, DOI 10.1016/j.radonc.2013.10.010; Handschel J, 2001, EUR J ORAL SCI, V109, P95, DOI 10.1034/j.1600-0722.2001.00975.x; Handschel J, 2001, J PATHOL, V193, P242; Kabacik S, 2011, INT J RADIAT BIOL, V87, P115, DOI 10.3109/09553002.2010.519424; Kennedy WR, 2016, EUR ARCH OTO-RHINO-L, V273, P2117, DOI 10.1007/s00405-016-4027-0; Kouloulias V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/401261; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Lee MLT, 2002, STAT MED, V21, P3543, DOI 10.1002/sim.1335; Li ML, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-5; Manikantan K, 2009, CANCER TREAT REV, V35, P639, DOI 10.1016/j.ctrv.2009.04.010; Marcussen M, 2017, SYSTEMATIC IN PRESS; Marcussen M, 2017, PLOS ONE; Mortensen HR, 2012, RADIOTHER ONCOL, V103, P69, DOI 10.1016/j.radonc.2012.01.002; Murphy BA, 2009, J PAIN SYMPTOM MANAG, V38, P522, DOI 10.1016/j.jpainsymman.2008.12.004; Nag S, 2013, J BIOMED RES, V27, P254, DOI 10.7555/JBR.27.20130030; Prott FJ, 2002, INT J RADIAT ONCOL, V54, P203, DOI 10.1016/S0360-3016(02)02867-5; Quinn B, 2007, EUR J ONCOL NURS, V11, pS10, DOI 10.1016/S1462-3889(07)70003-0; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sonis S, 2007, ORAL ONCOL, V43, P289, DOI 10.1016/j.oraloncology.2006.03.014; Sonis ST, 2002, CELL PROLIFERAT, V35, P93, DOI 10.1046/j.1365-2184.35.s1.10.x; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST., 2013, AM SOC CLIN ONCOL ED, DOI [10.1200/EdBook_AM.2013.33.e236, DOI 10.1200/EDBOOK_AM.2013.33.E236]; Su C, 2004, EMBO J, V23, P1133, DOI 10.1038/sj.emboj.7600120; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanikawa C, 2009, ONCOGENE, V28, P3081, DOI 10.1038/onc.2009.154; TCHAKAROV L, 1990, FEBS LETT, V268, P209, DOI 10.1016/0014-5793(90)81010-L; Trotti A, 2003, RADIOTHER ONCOL, V66, P253, DOI 10.1016/S0167-8140(02)00404-8; Tudor D, 2004, J INVEST DERM SYMP P, V9, P208, DOI 10.1111/j.1087-0024.2004.09310.x; Xanthinaki A, 2008, SUPPORT CARE CANCER, V16, P1025, DOI 10.1007/s00520-007-0379-8; Yeoh ASJ, 2005, INT J RADIAT ONCOL, V63, P1295, DOI 10.1016/j.ijrobp.2005.04.041	48	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190709	10.1371/journal.pone.0190709	http://dx.doi.org/10.1371/journal.pone.0190709			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338018	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700017
J	Meyers, LC; Brown, AM; Moneta-Koehler, L; Chalkley, R				Meyers, Lindsay C.; Brown, Abigail M.; Moneta-Koehler, Liane; Chalkley, Roger			Survey of checkpoints along the pathway to diverse biomedical research faculty	PLOS ONE			English	Article								There is a persistent shortage of underrepresented minority (URM) faculty who are involved in basic biomedical research at medical schools. We examined the entire training pathway of potential candidates to identify the points of greatest loss. Using a range of recent national data sources, including the National Science Foundation's Survey of Earned Doctorates and Survey of Doctoral Recipients, we analyzed the demographics of the population of interest, specifically those from URM backgrounds with an interest in biomedical sciences. We examined the URM population from high school graduates through undergraduate, graduate, and postdoctoral training as well as the URM population in basic science tenure track faculty positions at medical schools. We find that URM and non-URM trainees are equally likely to transition into doctoral programs, to receive their doctoral degree, and to secure a postdoctoral position. However, the analysis reveals that the diversions from developing a faculty career are found primarily at two clearly identifiable places, specifically during undergraduate education and in transition from postdoctoral fellowship to tenure track faculty in the basic sciences at medical schools. We suggest focusing additional interventions on these two stages along the educational pathway.	[Meyers, Lindsay C.; Brown, Abigail M.; Moneta-Koehler, Liane; Chalkley, Roger] Vanderbilt Univ, Sch Med, Off Biomed Res Educ & Training, Nashville, TN 37235 USA; [Chalkley, Roger] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Chalkley, R (corresponding author), Vanderbilt Univ, Sch Med, Off Biomed Res Educ & Training, Nashville, TN 37235 USA.; Chalkley, R (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA.	roger.chalkley@vanderbilt.edu		Brown, Abigail/0000-0001-9504-3465; Meyers, Lindsay/0000-0002-5911-231X	National Institutes of Health [5R25GM062459-15]; Broadening Experiences in Scientific Training, The Vanderbilt Aspire Program [4DP7OD018423-04]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP7OD018423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broadening Experiences in Scientific Training, The Vanderbilt Aspire Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health: 5R25GM062459-15 Initiative for Maximizing Student Development (to Roger Chalkley) and 4DP7OD018423-04 Broadening Experiences in Scientific Training, The Vanderbilt Aspire Program (to Roger Chalkley).	Chen X., 2013, 2014001 NCES US DEP; Diversity matters, NAT I HLTH DIV EXTR; Eberle-Sudre K., 2015, RISING TIDE DO COLL; Garrison H, 2013, CBE-LIFE SCI EDUC, V12, P357, DOI 10.1187/cbe.12-12-0207; Gibbs KD, 2016, ELIFE, V5, DOI 10.7554/eLife.21393; Lorden JF, 2011, ASSESSMENT RES DOCTO, P29; National Academy of Sciences, 2011, EXP UND MIN PART AM; National Center for Education Statistics, 2015, TRENDS HIGH SCH DROP, P50; National Institutes of Health, 2017, ACT NEUR NETW OP CON, V1; Offord C, 2017, THE SCIENTIST   0101; Philippidis A., GENETIC ENG BIO 0818; Weeden K., 2016, NO 96 BLACK TENURED; Xierali IM, 2016, AM ASS MED COLL, V16, P3	13	38	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190606	10.1371/journal.pone.0190606	http://dx.doi.org/10.1371/journal.pone.0190606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338019	Green Submitted, Green Published, gold			2022-12-27	WOS:000422652700016
J	Pont, I; Calatayud-Pascual, A; Lopez-Castellano, A; Albelda, EP; Garcia-Espana, E; Marti-Bonmat, L; Frias, JC; Albelda, MT				Pont, Isabel; Calatayud-Pascual, Aracely; Lopez-Castellano, Alicia; Albelda, Elena P.; Garcia-Espana, Enrique; Marti-Bonmat, Luis; Frias, Juan C.; Teresa Albelda, M.			Anti-angiogenic drug loaded liposomes: Nanotherapy for early atherosclerotic lesions in mice	PLOS ONE			English	Article							METHIONINE AMINOPEPTIDASE; CARDIOVASCULAR-DISEASE; SCAVENGER RECEPTOR; CONTRAST AGENTS; IN-VIVO; FUMAGILLIN; MACROPHAGE; NANOPARTICLES; NEOVASCULARIZATION; TNP-470	Fumagillin-loaded liposomes were injected into ApoE-KO mice. The animals were divided into several groups to test the efficacy of this anti-angiogenic drug for early treatment of atherosclerotic lesions. Statistical analysis of the lesions revealed a decrease in the lesion size after 5 weeks of treatment.	[Pont, Isabel; Garcia-Espana, Enrique] Univ Valencia, Inst Ciencia Mol, Valencia, Spain; [Calatayud-Pascual, Aracely; Lopez-Castellano, Alicia] Univ Cardenal Herrera CEU, CEU Univ, Dept Fisiol Farmacol & Toxicol, Alfara Del Patriarca, Spain; [Albelda, Elena P.] Hosp Lluis Alcanyis, Dept Anestesiol, Valencia, Spain; [Marti-Bonmat, Luis; Frias, Juan C.; Teresa Albelda, M.] Hosp Univ Polite cnico LaFe, Grp Invest Biomed Imagen, Valencia, Spain; [Frias, Juan C.] Univ Cardenal Herrera CEU, CEU Univ, Dept Ciencias Biomed, Alfara Del Patriarca, Spain	University of Valencia; Universidad CEU Cardenal Herrera; Universidad CEU Cardenal Herrera	Frias, JC; Albelda, MT (corresponding author), Hosp Univ Polite cnico LaFe, Grp Invest Biomed Imagen, Valencia, Spain.; Frias, JC (corresponding author), Univ Cardenal Herrera CEU, CEU Univ, Dept Ciencias Biomed, Alfara Del Patriarca, Spain.	juan.frias@uchceu.es; teresa.albelda@uv.es	Frias, Juan C/K-8003-2019; Stefanadis, Christodoulos/ABH-2232-2020; Frias, Juan/F-9778-2016; Pont Niclos, Isabel/O-8638-2016; García-España, Enrique V./F-5473-2016; Gimeno, Maria Teresa Albelda/J-5929-2012; Pascual, Maria Aracely Calatayud/AAC-3326-2020; Lopez Castellano, Alicia/F-9549-2016	Frias, Juan C/0000-0002-2948-5086; Stefanadis, Christodoulos/0000-0001-5974-6454; Frias, Juan/0000-0002-2948-5086; Pont Niclos, Isabel/0000-0001-5573-4990; García-España, Enrique V./0000-0002-4601-6505; Gimeno, Maria Teresa Albelda/0000-0002-9572-8912; Pascual, Maria Aracely Calatayud/0000-0002-6328-7622; Lopez Castellano, Alicia/0000-0003-0601-1440	Spanish MINECO; ISCIII; FEDER [CSD2010-000652010, CP13/00216]; Unidad de Excelencia Maria de Maeztu [MDM-2015-0538]; Fundacio Gent per Gent	Spanish MINECO(Spanish Government); ISCIII(Instituto de Salud Carlos III); FEDER(European Commission); Unidad de Excelencia Maria de Maeztu(Spanish Government); Fundacio Gent per Gent	financial support by the Spanish MINECO, ISCIII, FEDER (Projects Consolider-I ngenio CSD2010-000652010 (EGE) and Project CP13/00216 (MTA), and " Unidad de Excelencia Maria de Maeztu" MDM-2015-0538) and Fundacio Gent per Gent (JCF).	Amirbekian V, 2007, P NATL ACAD SCI USA, V104, P961, DOI 10.1073/pnas.0606281104; BRACKETT JM, 1988, J AGR FOOD CHEM, V36, P762, DOI 10.1021/jf00082a022; Briley-Saebo KC, 2009, J PHYS CHEM B, V113, P6283, DOI 10.1021/jp8108286; Deveza L, 2012, THERANOSTICS, V2, P801, DOI 10.7150/thno.4419; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Gianolio E, 2007, CHEM-EUR J, V13, P5785, DOI 10.1002/chem.200601277; Gonzalez-Navarro H, 2010, J AM COLL CARDIOL, V55, P2258, DOI 10.1016/j.jacc.2010.01.026; Griffith EC, 1998, P NATL ACAD SCI USA, V95, P15183, DOI 10.1073/pnas.95.26.15183; IBM Corp, IBM SPSS STAT WIND V; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Katsi VK, 2014, ANTIANGIO DRUG DISC, V2, P268; Kilarski WW, 2012, ANGIOGENESIS, V15, P643, DOI 10.1007/s10456-012-9287-8; Kruger EA, 2000, EXPERT OPIN INV DRUG, V9, P1383, DOI 10.1517/13543784.9.6.1383; Lipinski MJ, 2006, J NUCL CARDIOL, V13, P699, DOI 10.1016/j.nuclcard.2006.07.004; Lipinski MJ, 2006, MAGN RESON MED, V56, P601, DOI 10.1002/mrm.20995; Lipinski MJ, 2009, JACC-CARDIOVASC IMAG, V2, P637, DOI 10.1016/j.jcmg.2008.08.009; Lobatto ME, 2010, MOL PHARMACEUT, V7, P2020, DOI 10.1021/mp100309y; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Pant S, 2013, BIOCH BASIS THERAPEU, P209; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Patel A, 2014, ANAT PHYSL, V4, P147; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; Sin N, 1997, P NATL ACAD SCI USA, V94, P6099, DOI 10.1073/pnas.94.12.6099; Tang J, 2012, CURR CARDIOVASC IMAG, V5, P19, DOI 10.1007/s12410-011-9120-6; Albelda MT, 2014, CHEM SOC REV, V43, P2858, DOI 10.1039/c3cs60410a; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Winter PM, 2008, JACC-CARDIOVASC IMAG, V1, P624, DOI 10.1016/j.jcmg.2008.06.003; Zhou HF, 2014, ACS NANO, V8, P7305, DOI 10.1021/nn502372n; Zhou HF, 2012, BIOMATERIALS, V33, P8632, DOI 10.1016/j.biomaterials.2012.08.005	29	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190540	10.1371/journal.pone.0190540	http://dx.doi.org/10.1371/journal.pone.0190540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338009	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700014
J	Torres, SMF; Furrow, E; Souza, CP; Granick, JL; de Jong, EP; Griffin, TJ; Wang, X				Torres, Sheila M. F.; Furrow, Eva; Souza, Clarissa P.; Granick, Jennifer L.; de Jong, Ebbing P.; Griffin, Timothy J.; Wang, Xiong			Salivary proteomics of healthy dogs: An in depth catalog	PLOS ONE			English	Article							FREE-FLOW ELECTROPHORESIS; PEPTIDOGLYCAN RECOGNITION PROTEINS; 2-DIMENSIONAL GEL-ELECTROPHORESIS; ANTIMICROBIAL PEPTIDES; LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS; STREPTOCOCCUS-MUTANS; PAROTID-SALIVA; MUCIN; IDENTIFICATION	Objective To provide an in-depth catalog of the salivary proteome and endogenous peptidome of healthy dogs, evaluate proteins and peptides with antimicrobial properties, and compare the most common salivary proteins and peptides between different breed phylogeny groups. Methods 36 healthy dogs without evidence of periodontal disease representing four breed phylogeny groups, based upon single nucleotide polymorphism haplotypes (ancient, herding/sight-hound, and two miscellaneous groups). Saliva collected from dogs was pooled by phylogeny group and analyzed using nanoscale liquid chromatography-tandem mass spectrometry. Resulting tandem mass spectra were compared to databases for identification of endogenous peptides and inferred proteins. Results 2,491 proteins and endogenous peptides were found in the saliva of healthy dogs with no periodontal disease. All dog phylogeny groups' saliva was rich in proteins and peptides with antimicrobial functions. The ancient breeds group was distinct in that it contained unique proteins and was missing many proteins and peptides present in the other groups. Conclusions and clinical relevance Using a sophisticated nanoscale liquid chromatography-tandem mass spectrometry, we were able to identify 10-fold more salivary proteins than previously reported in dogs. Seven of the top 10 most abundant proteins or peptides serve immune functions and many more with various antimicrobial mechanisms were found. This is the most comprehensive analysis of healthy canine saliva to date, and will provide the groundwork forfuture studies analyzing salivary proteins and endogenous peptides in diseasestates.	[Torres, Sheila M. F.; Furrow, Eva; Souza, Clarissa P.; Granick, Jennifer L.] Univ Minnesota, Coll Vet Med, Vet Clin Sci Dept, St Paul, MN 55108 USA; [Souza, Clarissa P.] Colorado State Univ, Coll Vet Med, Clin Sci Dept, Ft Collins, CO 80523 USA; [de Jong, Ebbing P.; Griffin, Timothy J.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [de Jong, Ebbing P.] SUNY Upstate Med Univ, Dept Biochem & Mol Biochem, Syracuse, NY 13210 USA; [Wang, Xiong] Univ Minnesota, Dept Vet Biomed Sci, St Paul, MN 55108 USA; [Wang, Xiong] Minnesota Dept Hlth, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Colorado State University; University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Minnesota Department of Health (MHD)	Torres, SMF (corresponding author), Univ Minnesota, Coll Vet Med, Vet Clin Sci Dept, St Paul, MN 55108 USA.	torre009@umn.edu	Furrow, Eva/W-9963-2018	Granick, Jennifer/0000-0001-8330-3848; Griffin, Timothy/0000-0001-6801-2559; Torres, Sheila/0000-0002-9004-9304; Furrow, Eva/0000-0002-7339-2354	Office of the Director, National Institute of Health (NIH) [K010D019912]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019912] Funding Source: NIH RePORTER	Office of the Director, National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was self-funded by the corresponding author. Partial funding for E.F. was provided by the Office of the Director, National Institute of Health (NIH) under award number K010D019912. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tarawneh SK, 2011, OMICS, V15, P353, DOI 10.1089/omi.2010.0134; Alterman A, 2012, ARCH ORAL BIOL, V57, P663, DOI 10.1016/j.archoralbio.2011.12.008; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Ang CS, 2011, J PROTEOME RES, V10, P5059, DOI 10.1021/pr200516d; Asano Masatake, 2011, J Oral Sci, V53, P147; Bingle L, 2009, HISTOCHEM CELL BIOL, V132, P339, DOI 10.1007/s00418-009-0610-4; Cabras T, 2009, J PROTEOME RES, V8, P4126, DOI 10.1021/pr900212u; Camisasca DR, 2017, J PROTEOMICS, V151, P43, DOI 10.1016/j.jprot.2016.07.029; Cargile BJ, 2004, ELECTROPHORESIS, V25, P936, DOI 10.1002/elps.200305722; Castagnola M, 2011, TRENDS BIOTECHNOL, V29, P409, DOI 10.1016/j.tibtech.2011.04.002; Cho HR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181765; Csosz E, 2017, J PROTEOMICS, V153, P30, DOI 10.1016/j.jprot.2016.08.009; Culp DJ, 2015, J BIOL CHEM, V290, P2993, DOI 10.1074/jbc.M114.597906; da Costa JP, 2015, APPL MICROBIOL BIOT, V99, P2023, DOI 10.1007/s00253-015-6375-x; de Sousa-Pereira P, 2015, PROTEOMICS, V15, P1598, DOI 10.1002/pmic.201400083; de Sousa-Pereira P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109050; de Sousa-Pereira P, 2013, ARCH ORAL BIOL, V58, P451, DOI 10.1016/j.archoralbio.2012.12.011; den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; ERICSON D, 1984, INFECT IMMUN, V46, P526, DOI 10.1128/IAI.46.2.526-530.1984; Ghafouri B, 2003, PROTEOMICS, V3, P1003, DOI 10.1002/pmic.200300426; Gonzalez-Begne M, 2011, J PROTEOME RES, V10, P5031, DOI 10.1021/pr200505t; Gorr SU, 2009, PERIODONTOL 2000, V51, P152, DOI 10.1111/j.1600-0757.2009.00310.x; Groenink J, 1996, ANTON LEEUW INT J G, V70, P79, DOI 10.1007/BF00393572; Guo T, 2006, J PROTEOME RES, V5, P1469, DOI 10.1021/pr060065m; Gutierrez AM, 2011, VET J, V187, P356, DOI 10.1016/j.tvjl.2009.12.020; Hardt M, 2005, BIOCHEMISTRY-US, V44, P2885, DOI 10.1021/bi048176r; Hardt M, 2005, ANAL CHEM, V77, P4947, DOI 10.1021/ac050161r; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Hekman JP, 2012, APPL ANIM BEHAV SCI, V141, P149, DOI 10.1016/j.applanim.2012.08.007; Heo SM, 2013, INFECT IMMUN, V81, P1364, DOI 10.1128/IAI.00825-12; Hirtz C, 2005, J PHYSIOL BIOCHEM, V61, P469, DOI 10.1007/BF03168453; Hornshoj H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-30; Hu S, 2005, PROTEOMICS, V5, P1714, DOI 10.1002/pmic.200401037; Jacobs R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160546; Jehmlich N, 2013, J PERIODONTAL RES, V48, P392, DOI 10.1111/jre.12025; Ji S, 2007, J PERIODONTAL RES, V42, P410, DOI 10.1111/j.1600-0765.2006.00962.x; Katsiougiannis S, 2016, RHEUM DIS CLIN N AM, V42, P449, DOI 10.1016/j.rdc.2016.03.004; Khurshid Z, 2016, SAUDI PHARM J, V24, P515, DOI 10.1016/j.jsps.2015.02.015; Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169; Lamy E, 2011, J ANIM PHYSIOL AN N, V95, P304, DOI 10.1111/j.1439-0396.2010.01055.x; Lamy E, 2009, PHYSIOL BEHAV, V98, P393, DOI 10.1016/j.physbeh.2009.07.002; Lamy E, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-65; Leonard BC, 2012, J INNATE IMMUN, V4, P248, DOI 10.1159/000334566; Lima DP, 2010, INT J INFECT DIS, V14, pE184, DOI 10.1016/j.ijid.2009.04.022; Loseva OI, 1998, ELECTROPHORESIS, V19, P1127, DOI 10.1002/elps.1150190712; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Manconi B, 2013, J PROTEOMICS, V91, P536, DOI 10.1016/j.jprot.2013.08.009; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; Messana I, 2008, J SEP SCI, V31, P1948, DOI 10.1002/jssc.200800100; Messana I, 2015, J PROTEOME RES, V14, P1666, DOI 10.1021/pr501270x; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Moritz RL, 2004, ANAL CHEM, V76, P4811, DOI 10.1021/ac049717l; Moshier A, 1996, CURR MICROBIOL, V33, P200, DOI 10.1007/s002849900100; Mostowy S, 2015, NAT REV IMMUNOL, V15, P559, DOI 10.1038/nri3877; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Ostrander EA, 2005, GENOME RES, V15, P1706, DOI 10.1101/gr.3736605; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Podzimek S, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/9179632; Quintana M, 2009, J PROTEOMICS, V72, P822, DOI 10.1016/j.jprot.2009.05.004; REDDY MS, 1993, CRIT REV ORAL BIOL M, V4, P315, DOI 10.1177/10454411930040030901; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Santoro D, 2011, VET DERMATOL, V22, P61, DOI 10.1111/j.1365-3164.2010.00911.x; SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; Sivadasan P, 2015, J PROTEOMICS, V127, P89, DOI 10.1016/j.jprot.2015.05.039; Vitorino R, 2004, PROTEOMICS, V4, P1109, DOI 10.1002/pmic.200300638; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang QH, 2015, CLIN CHIM ACTA, V438, P214, DOI 10.1016/j.cca.2014.08.037; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Wilmarth PA, 2004, J PROTEOME RES, V3, P1017, DOI 10.1021/pr049911o; Wingate KV, 2009, VET DERMATOL, V20, P19, DOI 10.1111/j.1365-3164.2008.00707.x; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xie HW, 2005, MOL CELL PROTEOMICS, V4, P1826, DOI 10.1074/mcp.D500008-MCP200; Yao Y, 2003, J BIOL CHEM, V278, P5300, DOI 10.1074/jbc.M206333200; Zhang Y, 2016, PERIODONTOL 2000, V70, P38, DOI 10.1111/prd.12099	78	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191307	10.1371/journal.pone.0191307	http://dx.doi.org/10.1371/journal.pone.0191307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329347	Green Submitted, gold, Green Published			2022-12-27	WOS:000419954100057
J	Najman, JM; Bor, W; Ahmadabadi, Z; Williams, GM; Alati, R; Mamun, AA; Scott, JG; Clavarino, AM				Najman, Jake M.; Bor, William; Ahmadabadi, Zohre; Williams, Gail M.; Alati, Rosa; Mamun, Abdullah A.; Scott, James G.; Clavarino, Alexandra M.			The inter- and intra- generational transmission of family poverty and hardship (adversity): A prospective 30 year study	PLOS ONE			English	Article							UNITED-STATES; CHILD HEALTH; SOCIOECONOMIC INEQUALITIES; SOCIAL-CLASS; MORTALITY; EXPLANATIONS; PATTERNS; STRESS	Background & para;& para;Children exposed to family poverty have been found to have higher morbidity and mortality rates, poorer mental health and cognitive outcomes and reduced life chances across a wide range of life domains. There is, however, very little known about the extent to which poverty is experienced by children over their early life course, particularly in community samples. This study tracks changes in family poverty and the main factors that predict family poverty (adverse life experiences) over a 30-year period since the birth of the study child.& para;& para;Methods & para;& para;Data are from a prospective, longitudinal, birth cohort study conducted in Brisbane, Australia. Consecutive families were recruited at the mothers' first obstetrical visit at one of two major obstetrical hospitals in Brisbane. Data are available for 2087 families with complete data at the 30-year follow-up. Poverty was measured using family income at each time point (adjusted for inflation).& para;& para;Findings & para;& para;Poverty affects about 20% of families at any time point. It is common for families to move in and out of poverty, as their circumstances are affected by such adversities as unemployment and marital breakdown. Over the period of the study about half the families in the study experienced poverty on at least one occasion. Only a very small minority of families experienced persistent poverty over the 30-year duration of the study. Logistic regressions with time lag show that family poverty predicts subsequent adversities and adverse events predict subsequent poverty.& para;& para;Conclusions & para;& para;Experiences of poverty and adversity are common and may vary greatly over the child's early life course. In assessing the health consequences of poverty, it is important to distinguish the timing and chronicity of early life course experiences of poverty and adversity.	[Najman, Jake M.; Ahmadabadi, Zohre; Williams, Gail M.; Alati, Rosa; Mamun, Abdullah A.] Univ Queensland, Fac Med, Sch Publ Hlth, Brisbane, Qld, Australia; [Najman, Jake M.] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia; [Bor, William] Mater Hosp, Brisbane, Qld, Australia; [Bor, William] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Scott, James G.] Univ Queensland, Fac Med, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Scott, James G.] Royal Brisbane & Womens Hosp, Metro North Mental Hlth Serv, Brisbane, Qld, Australia; [Clavarino, Alexandra M.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland	Najman, JM (corresponding author), Univ Queensland, Fac Med, Sch Publ Hlth, Brisbane, Qld, Australia.; Najman, JM (corresponding author), Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia.	J.najman@uq.edu.au	Najman, Jackob M./B-1527-2008; Bor, William/J-2215-2015; Mamun, Abdullah/HHM-9898-2022; Alati, Rosa/A-2335-2014; Williams, Gail/S-8833-2019; Mamun, Abdullah A/A-4673-2011; Ahmadabadi, Zohre/AAK-1840-2020; Scott, James G/D-5900-2012; Ahmadabadi, Zohre/AAD-1339-2022; Clavarino, Alexandra/F-1411-2010	Najman, Jackob M./0000-0001-7079-2080; Bor, William/0000-0003-2134-7487; Alati, Rosa/0000-0002-9240-3450; Williams, Gail/0000-0002-4822-5263; Mamun, Abdullah A/0000-0002-1535-8086; Scott, James G/0000-0002-0744-0688; Ahmadabadi, Zohre/0000-0001-5585-3682; Clavarino, Alexandra/0000-0002-1145-5946	National Health and Medical Research Council of Australia [511177, 631507]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia - grant 511177 received by AC GW AR JN AM and WB, https://www.nhmrc.gov.au/ and the National Health and Medical Research Council of Australia grant-631507 received by AAM MO JMN RA GMW HM, https://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; ANTONOVSKY A, 1967, MILBANK FUND Q, V45, P31, DOI 10.2307/3348839; Australian Council of Social Service, 2014, POV AUSTR; Bird K., 2007, INTERGENERATIONAL TR; Boggess S., 1999, CYCLES DISADVANTAGE; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; BrooksGunn J, 1997, FUTURE CHILD, V7, P55, DOI 10.2307/1602387; Cherlin AJ, 2010, J MARRIAGE FAM, V72, P403, DOI 10.1111/j.1741-3737.2010.00710.x; Condliffe S, 2008, AM ECON REV, V98, P1605, DOI 10.1257/aer.98.4.1605; Corcoran ME, 1997, FUTURE CHILD, V7, P40, DOI 10.2307/1602386; Currie J, 2003, AM ECON REV, V93, P1813, DOI 10.1257/000282803322655563; Duncan GJ, 1998, AM SOCIOL REV, V63, P406, DOI 10.2307/2657556; Edin K, 2000, SOC PROBL, V47, P112, DOI 10.1525/sp.2000.47.1.03x0282v; Elo IT, 2009, ANNU REV SOCIOL, V35, P553, DOI 10.1146/annurev-soc-070308-115929; Evans GW, 2002, CHILD DEV, V73, P1238, DOI 10.1111/1467-8624.00469; Harper C, 2003, WORLD DEV, V31, P535, DOI 10.1016/S0305-750X(03)00010-X; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Institute for Research on Poverty University of Wisconsin-Madison, 2014, WHO IS POOR; KESSLER RC, 1993, PSYCHOL MED, V23, P679, DOI 10.1017/S0033291700025460; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; McHugo GJ, 2005, J BEHAV HEALTH SER R, V32, P113, DOI 10.1007/BF02287261; Najman JM, 2015, INT J EPIDEMIOL, V44, P78, DOI 10.1093/ije/dyu234; Papanastasiou SA, 2010, 1 INT C POL EC; Poulton R, 2005, INT J EPIDEMIOL, V34, P344, DOI 10.1093/ije/dyi044; Poverty Lines: Australia. Poverty Lines: Australia, 2013, POV LIN AUSTR REP ME; Power C, 2005, INT J EPIDEMIOL, V34, P335, DOI 10.1093/ije/dyh394; Rothstein J, 2012, ILR REV, V65, P467, DOI 10.1177/001979391206500301; Saiepour N, 2018, TBA UNPUB; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Selye H, 1956, J BONE JOINT SURG; Thoits PA, 2010, J HEALTH SOC BEHAV, V51, pS41, DOI 10.1177/0022146510383499; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7	32	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190504	10.1371/journal.pone.0190504	http://dx.doi.org/10.1371/journal.pone.0190504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360828	gold, Green Submitted, Green Published			2022-12-27	WOS:000423161800009
J	Uthman, RT; Sutton, AJ; Jackson, LJ; Uthman, OA				Uthman, Rashidah T.; Sutton, Andrew J.; Jackson, Louise J.; Uthman, Olalekan A.			Does directly administered antiretroviral therapy represent good value for money in sub-Saharan Africa? A cost-utility and value of information analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADHERENCE; HEALTH; HIV; METAANALYSIS; INFECTION; INTERVENTIONS; TRIALS; SF-36	Background & para;& para;Successful antiretroviral therapy (ART) relies on the optimal level of ART adherence to achieve reliable viral suppression, avert HIV drug resistance, and prevent avoidable deaths. It has been shown that there are various groups of people living with HIV at high-risk of nonadherence to ART in sub-Saharan Africa. The objective of this study was to examine the cost effectiveness and value-of-information of directly administered antiretroviral therapy (DAART) versus self-administered ART among people living with HIV, at high risk of nonadherence to ART in sub-Saharan Africa.& para;& para;Methods and findings & para;& para;A Markov model was developed that describes the transition between HIV stages based on the CD4 count, along with direct costs, quality of life and the mortality rate associated with DAART in comparison with self-administered ART. Data used in the model were derived from the published literature. A health system perspective was employed using a life-time time horizon. Probabilistic sensitivity analysis was performed to determine the impact of parameter uncertainty. Value of information analysis was also conducted. The expected cost of self-administered ART and DAART were $5,200 and $15,500 and the expected QALYs gained were 8.52 and 9.75 respectively, giving an incremental cost effectiveness ratio of $8,400 per QALY gained. The analysis demonstrated that the annual cost DAART needs to be priced below $200 per patient to be cost-effective. The probability that DAART was cost-effective was 1% for a willingness to pay threshold of $5,096 for sub-Saharan Africa. The value of information associated with the cost of DAART and its effectiveness was substantial.& para;& para;Conclusions & para;& para;From the perspective of the health care payer in sub-Saharan Africa, DAART cannot be regarded as cost-effective based on current information. The value of information analysis showed that further research will be worthwhile and potentially cost-effective in resolving the uncertainty about whether or not to adopt DAART.	[Uthman, Rashidah T.; Jackson, Louise J.] Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Hlth Econ Unit, Birmingham, W Midlands, England; [Sutton, Andrew J.] Univ Leeds, Leeds Inst Hlth Sci, Hlth Econ Unit, Leeds, W Yorkshire, England; [Uthman, Olalekan A.] Univ Warwick, Warwick Med Sch, Div Hlth Sci, WCAHRD, Coventry, W Midlands, England	University of Birmingham; University of Leeds; University of Warwick	Uthman, OA (corresponding author), Univ Warwick, Warwick Med Sch, Div Hlth Sci, WCAHRD, Coventry, W Midlands, England.	olalekan.uthman@warwick.ac.uk	Uthman, Olalekan/N-5584-2019	Uthman, Olalekan/0000-0002-8567-3081; Jackson, Louise/0000-0001-8492-0020	National Institute of Health Research using Official Development Assistance (ODA) funding; Wellcome Trust Institutional Strategic Support Funding	National Institute of Health Research using Official Development Assistance (ODA) funding; Wellcome Trust Institutional Strategic Support Funding	Olalekan Uthman is supported by the National Institute of Health Research using Official Development Assistance (ODA) funding. Olalekan Uthman is supported by Wellcome Trust Institutional Strategic Support Funding. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Wellcome Trust.	Alistar SS, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-46; Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; [Anonymous], 2015, COIN NEWS MEDIA; [Anonymous], 2012, REGIONAL FACT SHEETS; [Anonymous], 2014, FACT SHEET GLOBAL ST; [Anonymous], 2014, UNAID GAP REP; ASSA AIDS MODEL, 2008, ASSA2008 AIDS DEM MO; Athan E, 2010, AIDS, V24, P1887, DOI 10.1097/QAD.0b013e32833b25ed; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Berg KM, 2011, DRUG ALCOHOL DEPEN, V113, P192, DOI 10.1016/j.drugalcdep.2010.07.025; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Briggs A, 2006, DECISION MODELLING H; Evans DB, 2005, BMJ-BRIT MED J, V331, P1137, DOI 10.1136/bmj.331.7525.1137; Ford N, 2009, LANCET, V374, P2064, DOI 10.1016/S0140-6736(09)61671-8; Galarraga O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S5; Goshu A.T., 2013, J DATA SCI, V11, P269, DOI [10.6339/JDS.201304_11(2).0004, DOI 10.6339/JDS.201304_11(2).0004]; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hart JE, 2010, JAIDS-J ACQ IMM DEF, V54, P167, DOI 10.1097/QAI.0b013e3181d9a330; Jelsma J, 2005, AIDS CARE, V17, P579, DOI 10.1080/09540120412331319714; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; McCabe CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010154; Medecins SF, 2015, UNTANGLING WEB ANTIR, P17; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Naimark DMJ, 2008, MED DECIS MAKING, V28, P706, DOI 10.1177/0272989X08315241; Naimark DMJ, 2013, MED DECIS MAKING, V33, P961, DOI 10.1177/0272989X13501558; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; Sun X, 2008, EUR J HEALTH ECON, V9, P313, DOI 10.1007/s10198-007-0078-x; Tang YH, 2008, J ADV NURS, V62, P74, DOI 10.1111/j.1365-2648.2007.04526.x; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Umar N, 2011, J PUBLIC HEALTH AFR, V2, P78, DOI 10.4081/jphia.2011.e19; UNAIDS, 2014, GLOB STAT HARM RED 2; Vijayaraghavan A, 2007, JAIDS-J ACQ IMM DEF, V46, P91; World Health Organization, 1994, WHO TUB PROGR FRAM E	39	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191465	10.1371/journal.pone.0191465	http://dx.doi.org/10.1371/journal.pone.0191465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360841	gold, Green Published, Green Submitted			2022-12-27	WOS:000423161800033
J	Zhang, AL; Yang, XM; Li, QX; Yang, Y; Zhao, G; Wang, B; Wu, DC				Zhang, Ailian; Yang, Xiumei; Li, Quanxiao; Yang, Yu; Zhao, Gan; Wang, Bin; Wu, Daocheng			Immunostimulatory activity of water-extractable polysaccharides from &ITCistanche deserticola&IT as a plant adjuvant &ITin vitro&IT and &ITin vivo&IT	PLOS ONE			English	Article							LYCIUM-BARBARUM POLYSACCHARIDES; DENDRITIC CELLS; ANTIINFLAMMATORY ACTIVITY; CISTANCHE-DESERTICOLA; DELTA INULIN; IN-VITRO; VACCINES; GINSENG; IMMUNITY; SCIENCE	A safe and effective vaccine adjuvant is important in modern vaccines. Various Chinese herbal polysaccharides can activate the immune system. Cistanche deserticola (CD) is a traditional Chinese herb and an adjuvant candidate. Here, we confirmed that water-extractable polysaccharides of CD (WPCD) could modulate immune responses in vitro and in vivo. In a dose-dependent manner, WPCD significantly promoted the maturation and function of murine marrow-derived dendritic cells (BM-DCs) through up-regulating the expression levels of MHC-II, CD86, CD80, and CD40, allogenic T cell proliferation, and the yields of IL-12 and TNF-alpha via toll-like receptor4 (TLR4), as indicated by in vitro experiments. In addition, its immunomodulatory activity was also observed in mice. WPCD effectively improved the titers of IgG, IgG(1) and IgG(2a) and markedly enhanced the proliferation of T and B cells, the production of IFN-gamma and IL-4 in CD4(+) T cells and the expression level of IFN-gamma in CD8(+) T cells better than Alum. Furthermore, WPCD could markedly up-regulate the expression levels of CD40 and CD80 on DCs in spleen and down-regulate the Treg frequency. The study suggests that polysaccharides of Cistanche deserticola are a safe and effective vaccine adjuvant for eliciting both humoral immunity and cellular immunity by activating DCs via TLR4 signaling pathway.	[Zhang, Ailian; Yang, Xiumei; Li, Quanxiao; Yang, Yu] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Xinjiang, Peoples R China; [Zhao, Gan; Wang, Bin] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol, Shanghai, Peoples R China; [Wu, Daocheng] Xi An Jiao Tong Univ, Coll Life Sci & Technol, Xian, Shanxi, Peoples R China	Xinjiang University; Fudan University; Xi'an Jiaotong University	Zhang, AL (corresponding author), Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Xinjiang, Peoples R China.; Wu, DC (corresponding author), Xi An Jiao Tong Univ, Coll Life Sci & Technol, Xian, Shanxi, Peoples R China.	xjzal@163.com; wudaocheng@mail.xjtu.edu.cn			National Natural Science Foundation of China [31660259, 31360224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31660259, 31360224).	Alving CR, 2012, CURR OPIN IMMUNOL, V24, P310, DOI 10.1016/j.coi.2012.03.008; Bo RN, 2016, INT J BIOL MACROMOL, V85, P294, DOI 10.1016/j.ijbiomac.2015.12.089; Borchers AT, 1997, AM J CLIN NUTR, V66, P1303, DOI 10.1093/ajcn/66.6.1303; Bougandoura A, 2016, FITOTERAPIA, V109, P248, DOI 10.1016/j.fitote.2016.01.010; Chang WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122374; De Gregorio E, 2008, EUR J IMMUNOL, V38, P2068, DOI 10.1002/eji.200838648; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Honda-Okubo Y, 2015, J VIROL, V89, P2995, DOI 10.1128/JVI.02980-14; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hunter RL, 2002, VACCINE, V20, pS7, DOI 10.1016/S0264-410X(02)00164-0; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jiang Y, 2009, J CHROMATOGR A, V1216, P1970, DOI 10.1016/j.chroma.2008.07.031; Jin ML, 2014, INT J BIOL MACROMOL, V64, P257, DOI 10.1016/j.ijbiomac.2013.12.002; Kim JY, 2011, CANCER LETT, V313, P226, DOI 10.1016/j.canlet.2011.09.009; Lim TS, 2004, J MED FOOD, V7, P1, DOI 10.1089/109662004322984626; Lin CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132589; Lin LW, 2002, J ETHNOPHARMACOL, V83, P177, DOI 10.1016/S0378-8741(02)00147-2; Nan ZD, 2013, FITOTERAPIA, V89, P167, DOI 10.1016/j.fitote.2013.05.008; Plotkin S, 2014, P NATL ACAD SCI USA, V111, P12283, DOI 10.1073/pnas.1400472111; Rappuoli R, 2014, P NATL ACAD SCI USA, V111, P12282, DOI 10.1073/pnas.1413559111; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Saade F, 2013, VACCINE, V31, P1999, DOI 10.1016/j.vaccine.2012.12.077; Steinman RM, 2008, IMMUNITY, V29, P319, DOI 10.1016/j.immuni.2008.08.001; Su CX, 2014, VET IMMUNOL IMMUNOP, V158, P98, DOI 10.1016/j.vetimm.2013.05.006; Wang T, 2012, AM J CHINESE MED, V40, P1123, DOI 10.1142/S0192415X12500838; Wang XZ, 2016, CELL MOL IMMUNOL, V13, P849, DOI 10.1038/cmi.2015.64; Wang ZZ, 2013, INT J BIOL MACROMOL, V53, P93, DOI 10.1016/j.ijbiomac.2012.11.009; Wei W, 2016, J ETHNOPHARMACOL, V179, P243, DOI 10.1016/j.jep.2015.12.060; Zhang AL, 2017, VACCINE, V35, P1037, DOI 10.1016/j.vaccine.2017.01.002; Zhang AL, 2011, VACCINE, V29, P6785, DOI 10.1016/j.vaccine.2010.12.061; Zhang QH, 2016, INT J BIOL MACROMOL, V93, P459, DOI 10.1016/j.ijbiomac.2016.08.052; Zhang WJ, 2016, INT J BIOL MACROMOL, V93, P448, DOI 10.1016/j.ijbiomac.2016.08.079	35	20	24	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191356	10.1371/journal.pone.0191356	http://dx.doi.org/10.1371/journal.pone.0191356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360858	gold, Green Submitted, Green Published			2022-12-27	WOS:000423161800025
J	Aqra, I; Herawan, T; Ghani, NA; Akhunzada, A; Ali, A; Bin Razali, R; Ilahi, M; Choo, KKR				Aqra, Iyad; Herawan, Tutut; Ghani, Norjihan Abdul; Akhunzada, Adnan; Ali, Akhtar; Bin Razali, Ramdan; Ilahi, Manzoor; Choo, Kim-Kwang Raymond			A novel association rule mining approach using TID intermediate itemset	PLOS ONE			English	Article							MULTIPLE MINIMUM SUPPORTS; ALGORITHM; DATABASES	Designing an efficient association rule mining (ARM) algorithm for multilevel knowledge-based transactional databases that is appropriate for real-world deployments is of paramount concern. However, dynamic decision making that needs to modify the threshold either to minimize or maximize the output knowledge certainly necessitates the extant state-of-the-art algorithms to rescan the entire database. Subsequently, the process incurs heavy computation cost and is not feasible for real-time applications. The paper addresses efficiently the problem of threshold dynamic updation for a given purpose. The paper contributes by presenting a novel ARM approach that creates an intermediate itemset and applies a threshold to extract categorical frequent itemsets with diverse threshold values. Thus, improving the overall efficiency as we no longer needs to scan the whole database. After the entire itemset is built, we are able to obtain real support without the need of rebuilding the itemset (e.g. Itemset list is intersected to obtain the actual support). Moreover, the algorithm supports to extract many frequent itemsets according to a pre-determined minimum support with an independent purpose. Additionally, the experimental results of our proposed approach demonstrate the capability to be deployed in any mining system in a fully parallel mode; consequently, increasing the efficiency of the real-time association rules discovery process. The proposed approach outperforms the extant state-of-the-art and shows promising results that reduce computation cost, increase accuracy, and produce all possible itemsets.	[Aqra, Iyad; Herawan, Tutut; Ghani, Norjihan Abdul] Univ Malaya, Dept Informat Syst, Kuala Lumpur, Malaysia; [Akhunzada, Adnan; Ilahi, Manzoor] CIIT Ctr Hlth Res, Dept Comp Sci, Islamabad, Pakistan; [Ali, Akhtar; Bin Razali, Ramdan] Univ Malaysia Pahang, Fac Elect Elect Engn, Pekan, Malaysia; [Choo, Kim-Kwang Raymond] Univ Texas San Antonio, Dept Informat Syst & Cyber Secur, San Antonio, TX USA	Universiti Malaya; COMSATS University Islamabad (CUI); Universiti Malaysia Pahang; University of Texas System; University of Texas at San Antonio (UTSA)	Akhunzada, A (corresponding author), CIIT Ctr Hlth Res, Dept Comp Sci, Islamabad, Pakistan.	a.qureshi@comsats.edu.pk	Akhunzada, Adnan/N-7917-2017; GHANI, NORJIHAN ABDUL/B-9381-2010; Herawan, Tutut/AAB-6534-2021; Choo, Kim-Kwang Raymond/A-3634-2009	Akhunzada, Adnan/0000-0001-8370-9290; GHANI, NORJIHAN ABDUL/0000-0002-0804-3916; Herawan, Tutut/0000-0001-9262-9137; Choo, Kim-Kwang Raymond/0000-0001-9208-5336; Aqra, Iyad/0000-0003-0735-6600				Agrawal R, 1994, P INT C VER LARG DAT; Agrawal R., 1993, ACM SIGMOD RECORD; Alcala-Fdez J, 2009, FUZZY SET SYST, V160, P905, DOI 10.1016/j.fss.2008.05.012; Chen FZ, 2014, KNOWL-BASED SYST, V67, P16, DOI 10.1016/j.knosys.2014.06.013; Chen MS, 1996, IEEE T KNOWL DATA EN, V8, P866, DOI 10.1109/69.553155; Chung KY, 2014, MULTIMED TOOLS APPL, V71, P889, DOI 10.1007/s11042-011-0885-z; Nguyen D, 2014, EXPERT SYST APPL, V41, P4716, DOI 10.1016/j.eswa.2014.01.038; Gatzioura A, 2015, IEEE INTELL SYST, V30, P20, DOI 10.1109/MIS.2014.57; Hu YH, 2006, DECIS SUPPORT SYST, V42, P1, DOI 10.1016/j.dss.2004.09.007; Jermain C, 2001, ASS MINING SUPPORT T; Kuo RJ, 2011, APPL SOFT COMPUT, V11, P326, DOI 10.1016/j.asoc.2009.11.023; Lee YC, 2005, INT J APPROX REASON, V40, P44, DOI 10.1016/j.ijar.2004.11.006; Lin CW, 2015, ADV ENG INFORM, V29, P16, DOI 10.1016/j.aei.2014.08.003; Liu B., 1999, P 5 ACM SIGKDD INT C; Luna JM, 2015, APPL INTELL, V42, P501, DOI 10.1007/s10489-014-0603-4; Management ISP, 2009, INT SCM PROJ MAN; Luna JM, 2014, INTEGR COMPUT-AID E, V21, P321, DOI 10.3233/ICA-140467; Park JS, 1997, P 6 INT C INF KNOWL; Qodmanan HR, 2011, EXPERT SYST APPL, V38, P288, DOI 10.1016/j.eswa.2010.06.060; RAVI VK, 2015, MIDDLE-EAST J SCI RE, V23, P88, DOI DOI 10.5829/idosi.mejsr.2015.23.01.22038; Schlegel B, 2013, P 9 INT WORKSH DAT M; Soysal OM, 2015, EXPERT SYST APPL, V42, P2582, DOI 10.1016/j.eswa.2014.10.049; Stanisic P, 2015, INFORM TECHNOLOGY CO, V37; Wan JF, 2014, IEEE COMMUN MAG, V52, P106, DOI 10.1109/MCOM.2014.6871677; Weng C-H, 2015, APPL INTELL, P1; Yan XW, 2009, EXPERT SYST APPL, V36, P3066, DOI 10.1016/j.eswa.2008.01.028; Zaki MJ, 2000, IEEE T KNOWL DATA EN, V12, P372, DOI 10.1109/69.846291; Zaki MJ, 2000, ADVANCES IN DISTRIBUTED AND PARALLEL KNOWLEDGE DISCOVERY, P339; Zaki MJ, 1997, NEW ALGORITHMS FAST	31	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0179703	10.1371/journal.pone.0179703	http://dx.doi.org/10.1371/journal.pone.0179703			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351287	Green Submitted, gold, Green Published			2022-12-27	WOS:000422911300001
J	Ates, D; Aldemir, S; Alsaleh, A; Erdogmus, S; Nemli, S; Kahriman, A; Ozkan, H; Vandenberg, A; Tanyolac, B				Ates, Duygu; Aldemir, Secil; Alsaleh, Ahmad; Erdogmus, Semih; Nemli, Seda; Kahriman, Abdullah; Ozkan, Hakan; Vandenberg, Albert; Tanyolac, Bahattin			A consensus linkage map of lentil based on DArT markers from three RIL mapping populations	PLOS ONE			English	Article							EST-SSR MARKERS; HIGH-DENSITY; GENETIC SIMILARITY; ASCOCHYTA BLIGHT; AFLP MARKERS; MICROSATELLITE; QTL; IDENTIFICATION; CONSTRUCTION; RESISTANCE	Background Lentil (Lens culinaris ssp. culinaris Medikus) is a diploid (2n = 2x = 14), self-pollinating grain legume with a haploid genome size of about 4 Gbp and is grown throughout the world with current annual production of 4.9 million tonnes. Materials and methods A consensus map of lentil (Lens culinaris ssp. culinaris Medikus) was constructed using three different lentils recombinant inbred line (RIL) populations, including "CDC Redberry" x "ILL7502" (LR8), "ILL8006" x "CDC Milestone" (LR11) and "PI320937 "x "Eston" (LR39). Results The lentil consensus map was composed of 9,793 DArT markers, covered a total of 977.47 cM with an average distance of 0.10 cM between adjacent markers and constructed 7 linkage groups representing 7 chromosomes of the lentil genome. The consensus map had no gap larger than 12.67 cM and only 5 gaps were found to be between 12.67 cM and 6.0 cM (on LG3 and LG4). The localization of the SNP markers on the lentil consensus map were in general consistent with their localization on the three individual genetic linkage maps and the lentil consensus map has longer map length, higher marker density and shorter average distance between the adjacent markers compared to the component linkage maps. Conclusion This high-density consensus map could provide insight into the lentil genome. The consensus map could also help to construct a physical map using a Bacterial Artificial Chromosome library and map based cloning studies. Sequence information of DArT may help localization of orientation scaffolds from Next Generation Sequencing data.	[Ates, Duygu; Aldemir, Secil; Erdogmus, Semih; Tanyolac, Bahattin] Ege Univ, Fac Engn, Dept Bioengn, Izmir, Turkey; [Alsaleh, Ahmad; Ozkan, Hakan] Cukurova Univ, Fac Agr, Dept Field Crops, Adana, Turkey; [Nemli, Seda] Gumushane Univ, Dept Bieoengn & Genet, Gumushane, Turkey; [Kahriman, Abdullah] Harran Univ, Fac Agr, Dept Field Crops, Sanli Urfa, Turkey; [Vandenberg, Albert] Univ Saskatchewan, Crop Dev Ctr, Saskatoon, SK, Canada	Ege University; Cukurova University; Gumushane University; Harran University; University of Saskatchewan	Tanyolac, B (corresponding author), Ege Univ, Fac Engn, Dept Bioengn, Izmir, Turkey.	bahattin.tanyolac@ege.edu.tr	ÖZKAN, Hakan/C-8510-2011; Kahraman, Abdullah/AAB-1400-2020; Aldemir, Seçil/AAZ-4351-2020; ALSALEH, Ahmad/AAB-6508-2021; ALSALEH, Ahmad/CAA-2655-2022; Aldemir, Secil/AAE-6246-2019; Tanyolac, Bahattin/J-1321-2019; Tanyolac, Bahattin/AAD-3762-2019	ÖZKAN, Hakan/0000-0003-3530-2626; ALSALEH, Ahmad/0000-0001-7078-3221; ALSALEH, Ahmad/0000-0001-7078-3221; Aldemir, Secil/0000-0003-1025-4875; Tanyolac, Bahattin/0000-0002-4368-0988; Vandenberg, Albert/0000-0001-6177-1392	Scientific and Technological Research Council of Turkey (TUBITAK) [COST-1110446]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The study was supported by The Scientific and Technological Research Council of Turkey (TUBITAK), project no. COST-1110446. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) with project no COST-1110446.	Alavi-Kia SS, 2008, BIOTECHNOL BIOTEC EQ, V22, P795, DOI 10.1080/13102818.2008.10817555; Aldemir S, 2017, TURK J AGRIC FOR, V41, P243, DOI 10.3906/tar-1610-33; Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; Arumuganathan K, 1991, PLANT MOL BIOL REPOR, V9; Ates D., 2016, PLOS ONE, V11; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bayer M, 2011, BIOINFORMATICS, V27, P1307, DOI 10.1093/bioinformatics/btr111; Biswas MK, 2010, GENET RESOUR CROP EV, V57, P963, DOI 10.1007/s10722-010-9533-0; Blenda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045739; Branco CJS, 2007, J APPL GENET, V48, P107, DOI 10.1007/BF03194667; D'Onofrio C, 2010, TREE GENET GENOMES, V6, P451, DOI 10.1007/s11295-009-0263-4; Davis GL, 1999, GENETICS, P152; Duran Y, 2004, THEOR APPL GENET, V108, P1265, DOI 10.1007/s00122-003-1542-3; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Eujayl I, 1998, THEOR APPL GENET, V97, P83, DOI 10.1007/s001220050869; FAO, 2016, FAO STAT DAT; Ferreira A, 2006, GENET MOL BIOL, V29, P187, DOI 10.1590/S1415-47572006000100033; Fratini R, 2007, SPAN J AGRIC RES, V5, P348; Gaur R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13387; Gautami B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041213; Gupta D, 2012, MOL BREEDING, V30, P429, DOI 10.1007/s11032-011-9634-2; Gupta M, 2012, J GENET, V91, P279, DOI 10.1007/s12041-012-0180-4; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; HAVEY MJ, 1989, THEOR APPL GENET, V77, P395, DOI 10.1007/BF00305835; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Isobe S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-57; Karakoy T, 2012, SCI WORLD J, V2012, P9; Kosambi D.D., 2016, DD KOSAMBI R RAMASWA, P125, DOI [10.1007/978-81-322-3676-4_16, DOI 10.1007/978-81-322-3676-4_16]; Kumar S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00078; Liu B.-H., 1998, STAT GENOMICS LINKAG; Liu H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-104; Lombard V, 2001, THEOR APPL GENET, P103; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Millan T, 2010, EUPHYTICA, V175, P175, DOI 10.1007/s10681-010-0157-4; Paran I, 2004, MOL BREEDING, V13, P251, DOI 10.1023/B:MOLB.0000022526.30914.31; Pootakham W, 2015, FRONT PLANT SCI, P6; Qaim M, 2007, AGR ECON-BLACKWELL, V37, P119, DOI 10.1111/j.1574-0862.2007.00239.x; Rajaram V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-159; Raman H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-277; Rubeena, 2006, PLANT BREEDING, V125, P506, DOI 10.1111/j.1439-0523.2006.01259.x; Rubeena, 2003, THEOR APPL GENET, V107, P910, DOI 10.1007/s00122-003-1326-9; Satovic Z, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-932; Sen Gupta D, 2016, CROP J, V4, P425, DOI 10.1016/j.cj.2016.06.012; Sharpe AG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-192; Shirasawa K, 2013, DNA RES, V20, P173, DOI 10.1093/dnares/dss042; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Sudheesh S, 2016, FRONT PLANT SCI, P7; Sudheesh S, 2015, PLANT MOL BIOL REP, V33, P1391, DOI 10.1007/s11105-014-0837-7; TANKSLEY SD, 1989, BIO-TECHNOL, V7, P257, DOI 10.1038/nbt0389-257; Tanyolac B., 2010, J AGR BIOTECHNOL SUS, V2, P1; Temel HY, 2014, P PLANT AN GEN C 22, P358; Truco MJ, 2007, THEOR APPL GENET, V115, P735, DOI 10.1007/s00122-007-0599-9; Tullu A, 2008, CROP SCI, V48, P2254, DOI 10.2135/cropsci2007.11.0628; Tullu A, 2006, CAN J PLANT PATHOL, V28, P588, DOI 10.1080/07060660609507337; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Verma P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139666; Vezzulli S, 2008, THEOR APPL GENET, V117, P499, DOI 10.1007/s00122-008-0794-3; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Wu PZ, 2015, PLANT J, V81, P810, DOI 10.1111/tpj.12761; Xu ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-108; Yap IV, 2003, GENETICS, P165	66	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e191375	10.1371/journal.pone.0191375	http://dx.doi.org/10.1371/journal.pone.0191375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351563	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300077
J	Mihaylov, IB; Mellon, EA; Yechieli, R; Portelance, L				Mihaylov, Ivaylo B.; Mellon, Eric A.; Yechieli, Raphael; Portelance, Lorraine			Automated inverse optimization facilitates lower doses to normal tissue in pancreatic stereotactic body radiotherapy	PLOS ONE			English	Article							ORDER CONSTRAINED OPTIMIZATION; MODULATED RADIATION-THERAPY; PROSTATE-CANCER; LUNG IMRT; QUALITY; PLANS	Purpose Inverse planning is trial-and-error iterative process. This work introduces a fully automated inverse optimization approach, where the treatment plan is closely tailored to the unique patient anatomy. The auto-optimization is applied to pancreatic stereotactic body radiotherapy (SBRT). Materials and methods The automation is based on stepwise reduction of dose-volume histograms (DVHs). Five uniformly spaced points, from 1% to 70% of the organ at risk (OAR) volumes, are used. Doses to those DVH points are iteratively decreased through multiple optimization runs. With each optimization run the doses to the OARs are decreased, while the dose homogeneity over the target is increased. The iterative process is terminated when a pre-specified dose heterogeneity over the target is reached. Twelve pancreatic cases were retrospectively studied. Doses to the target, maximum doses to duodenum, bowel, stomach, and spinal cord were evaluated. In addition, mean doses to liver and kidneys were tallied. The auto-optimized plans were compared to the actual treatment plans, which are based on national protocols. Results The prescription dose to 95% of the planning target volume (PTV) is the same for the treatment and the auto-optimized plans. The average difference for maximum doses to duodenum, bowel, stomach, and spinal cord are -4.6 Gy, -1.8 Gy, -1.6 Gy, and -2.4 Gy respectively. The negative sign indicates lower doses with the auto-optimization. The average differences in the mean doses to liver and kidneys are -0.6 Gy, and -1.1 Gy to -1.5 Gy respectively. Conclusions Automated inverse optimization holds great potential for personalization and tailoring of radiotherapy to particular patient anatomies. It can be utilized for normal tissue sparing or for an isotoxic dose escalation.	[Mihaylov, Ivaylo B.; Mellon, Eric A.; Yechieli, Raphael; Portelance, Lorraine] Univ Miami, Dept Radiat Oncol, Miami, FL 33152 USA	University of Miami	Mihaylov, IB (corresponding author), Univ Miami, Dept Radiat Oncol, Miami, FL 33152 USA.	i.mihaylov@med.miami.edu		Mihaylov, Ivaylo/0000-0003-4518-5902	NIH [R01 CA163370]; Philips Radiation Oncology Systems; NATIONAL CANCER INSTITUTE [R01CA163370] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philips Radiation Oncology Systems; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by NIH grant R01 CA163370 and in part by Philips Radiation Oncology Systems to IBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen P, 1997, ACTA ONCOL, V36, P1, DOI 10.1080/0284186X.1997.11835454; American Cancer Society, 2016, CANC FACTS FIGURES 2; Appenzoller LM, 2012, MED PHYS, V39, P7446, DOI 10.1118/1.4761864; Brown JM, 1998, CANCER RES, V58, P1408; Butler Laura E, 2004, J Appl Clin Med Phys, V5, P16, DOI 10.1120/jacmp.26.146; Chanyavanich V, 2011, MED PHYS, V38, P2515, DOI 10.1118/1.3574874; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Forster J, 2001, MED PHYS, V28, P28, DOI 10.1118/1.1333413; Fredriksson A, 2012, PHYS MED BIOL, V57, P7799, DOI 10.1088/0031-9155/57/23/7799; Good D, 2013, INT J RADIAT ONCOL, V87, P176, DOI 10.1016/j.ijrobp.2013.03.015; Hodapp N, 2012, STRAHLENTHER ONKOL, V188, P97, DOI 10.1007/s00066-011-0015-x; Le QT, 2004, CANCER METAST REV, V23, P293, DOI 10.1023/B:CANC.0000031768.89246.d7; Li TR, 2013, MED PHYS, V40, DOI 10.1118/1.4823473; Lu RZ, 2008, PHYS MED BIOL, V53, P6749, DOI 10.1088/0031-9155/53/23/007; Mihaylov IB, 2008, MED PHYS, V35, P3722, DOI 10.1118/1.2956710; Mihaylov IB, 2007, MED PHYS, V34, P1244, DOI 10.1118/1.2712413; Mihaylov IB, 2015, PHYS MED BIOL, V60, P3927, DOI 10.1088/0031-9155/60/10/3927; MIHAYLOV IB, 2014, FRONT ONCOL, V4, P22467; Mihaylov IB, 2012, INT J RADIAT ONCOL, V82, P1292, DOI 10.1016/j.ijrobp.2010.06.020; Mihaylov IB, 2010, INT J RADIAT ONCOL, V77, P285, DOI 10.1016/j.ijrobp.2009.08.021; Mihaylov IB, 2009, RADIOTHER ONCOL, V93, P147, DOI 10.1016/j.radonc.2009.05.008; Moore KL, 2011, INT J RADIAT ONCOL, V81, P545, DOI 10.1016/j.ijrobp.2010.11.030; Niemierko A, 1997, MED PHYS, V24, P103, DOI 10.1118/1.598063; Niemierko A, 1999, MED PHYS, V26, P1100, DOI DOI 10.1118/1.598063; Petit SF, 2012, RADIOTHER ONCOL, V102, P38, DOI 10.1016/j.radonc.2011.05.025; Purdie TG, 2011, INT J RADIAT ONCOL, V81, P575, DOI 10.1016/j.ijrobp.2010.11.016; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rivera L, 2013, MED PHYS, V40, DOI 10.1118/1.4788653; Song Y, 2016, RADIOTHER ONCOL, V119, P531, DOI 10.1016/j.radonc.2016.04.010; Stabenau H, 2011, MED PHYS, V38, P2731, DOI 10.1118/1.3575416; Wu BB, 2011, INT J RADIAT ONCOL, V79, P1241, DOI 10.1016/j.ijrobp.2010.05.026; Wu QW, 2000, MED PHYS, V27, P701, DOI 10.1118/1.598932; Xhaferllari I, 2013, J APPL CLIN MED PHYS, V14, P176, DOI 10.1120/jacmp.v14i1.4052; Yuan LL, 2015, PHYS MED BIOL, V60, P1831, DOI 10.1088/0031-9155/60/5/1831; Zhang XD, 2011, PHYS MED BIOL, V56, P3873, DOI 10.1088/0031-9155/56/13/009; Zhu XF, 2011, MED PHYS, V38, P719, DOI 10.1118/1.3539749	36	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191036	10.1371/journal.pone.0191036	http://dx.doi.org/10.1371/journal.pone.0191036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351303	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300040
J	Qian, QJ; You, ZY; Ye, LP; Che, JQ; Wang, YR; Wang, SH; Zhong, BX				Qian, Qiujie; You, Zhengying; Ye, Lupeng; Che, Jiaqian; Wang, Yiran; Wang, Shaohua; Zhong, Boxiong			High-efficiency production of human serum albumin in the posterior silk glands of transgenic silkworms, Bombyx mori L	PLOS ONE			English	Article							RECOMBINANT PROTEINS; EXPRESSION SYSTEM; H-CHAIN; FIBROIN; COCOON; GENE; SECRETION; SEQUENCE; CELLS	Human serum albumin (HSA) is an important biological preparation with a variety of biological functions in clinical applications. In this study, the mRNA of a fusion transposase derived from the pESNT-PBase plasmid and a pBHSA plasmid containing the HSA gene under the control of a fibroin light chain (FL) promoter were co-injected into fertilized eggs. Fifty-six transgenic silkworm pedigrees expressing theexogenous recombinant HSA (rHSA) in the posterior silk glands (PSGs) with stable inheritance were successfully obtained. The SDS-PAGE and Western blot results confirmed that the rHSA was secreted into the transgenic silkworm cocoon, and the rHSA could be easily extracted with phosphate-buffered saline (PBS). In our research, the isolated highest amount rHSA constituted up to 29.1% of the total soluble protein of the cocoon shell, indicating that the transgenic silkworm produced an average of 17.4 mu g/mg of rHSA in the cocoon shell. The production of soluble rHSA in the PSGs by means of generating transgenic silkworms is a novel approach, whereby a large amount of virus-free and functional HSA can be produced through the simple rearing of silkworms.	[Qian, Qiujie; You, Zhengying; Ye, Lupeng; Che, Jiaqian; Wang, Shaohua; Zhong, Boxiong] Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Qian, Qiujie] Haining Sericulture Technol Extens Stn Zhejiang P, Haining, Zhejiang, Peoples R China; [Wang, Yiran] Zhejiang Univ, Dept Food Sci & Nutr, Fuli Inst Food Sci, Zhejiang Key Lab Agrofood Proc, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhong, BX (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China.	bxzhong@zju.edu.cn	wang, yi/GVT-8516-2022; Wang, Yijun/GXW-1763-2022; Wang, Yin/HCI-9352-2022; wang, yixuan/GXW-2866-2022; Wang, Yixuan/GZK-6559-2022	Ye, Lupeng/0000-0003-3901-6598	National Basic Research Program of China [2012CB114601]; China Postdoctoral Science Foundation [2016M591989]	National Basic Research Program of China(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the grants from the National Basic Research Program of China (No.2012CB114601) and the China Postdoctoral Science Foundation (No.2016M591989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the grants from the National Basic Research Program of China (No.2012CB114601); the China Postdoctoral Science Foundation (No.2016M591989).	Cai C, 2006, J DRUG TARGET, V14, P55, DOI 10.1080/10611860600613324; Chamberland ME, 2001, EMERG INFECT DIS, V7, P552, DOI 10.3201/eid0703.010331; DEGAUDIO AR, 1995, INT J ARTIF ORGANS, V18, P216, DOI 10.1177/039139889501800407; Erstad BL, 1996, PHARMACOTHERAPY, V16, P996; FLEER R, 1991, BIO-TECHNOL, V9, P968, DOI 10.1038/nbt1091-968; Galvan DL, 2009, J IMMUNOTHER, V32, P837, DOI 10.1097/CJI.0b013e3181b2914c; Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2; GRZELAK K, 1995, COMP BIOCHEM PHYS B, V110, P671, DOI 10.1016/0305-0491(94)00215-G; He Y, 2011, P NATL ACAD SCI USA, V108, P19078, DOI 10.1073/pnas.1109736108; Iizuka M, 2009, FEBS J, V276, P5806, DOI 10.1111/j.1742-4658.2009.07262.x; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; KIKUCHI Y, 1992, GENE, V110, P151, DOI 10.1016/0378-1119(92)90642-3; Kobayashi K, 2006, BIOLOGICALS, V34, P55, DOI 10.1016/j.biologicals.2005.08.021; Kurihara H, 2007, BIOCHEM BIOPH RES CO, V355, P976, DOI 10.1016/j.bbrc.2007.02.055; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Moghaddassi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089631; Ogawa S, 2007, J BIOTECHNOL, V128, P531, DOI 10.1016/j.jbiotec.2006.10.019; Royer C, 2005, TRANSGENIC RES, V14, P463, DOI 10.1007/s11248-005-4351-4; SPRAGUE KU, 1975, BIOCHEMISTRY-US, V14, P925, DOI 10.1021/bi00676a008; Subramanian GM, 2007, NAT BIOTECHNOL, V25, P1411, DOI 10.1038/nbt1364; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Tatematsu K, 2010, TRANSGENIC RES, V19, P473, DOI 10.1007/s11248-009-9328-2; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; Wang F, 2013, TRANSGENIC RES, V22, P925, DOI 10.1007/s11248-013-9695-6; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wu XJ, 2012, TRANSGENIC RES, V21, P1359, DOI 10.1007/s11248-012-9612-4; Xu HF, 2014, TRANSGENIC RES, V23, P697, DOI 10.1007/s11248-014-9826-8; Ye LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep17172; You ZY, 2017, TRANSGENIC RES, V26, P653, DOI 10.1007/s11248-017-0034-1; Zhao AC, 2010, TRANSGENIC RES, V19, P29, DOI 10.1007/s11248-009-9295-7	31	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191507	10.1371/journal.pone.0191507	http://dx.doi.org/10.1371/journal.pone.0191507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352308	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300104
J	Cormode, G; Dasgupta, A; Goyal, A; Lee, CH				Cormode, Graham; Dasgupta, Anirban; Goyal, Amit; Lee, Chi Hoon			An evaluation of multi-probe locality sensitive hashing for computing similarities over web-scale query logs	PLOS ONE			English	Article								Many modern applications of AI such as web search, mobile browsing, image processing, and natural language processing rely on finding similar items from a large database of complex objects. Due to the very large scale of data involved (e.g., users' queries from commercial search engines), computing such near or nearest neighbors is a non-trivial task, as the computational cost grows significantly with the number of items. To address this challenge, we adopt Locality Sensitive Hashing (a.k.a, LSH) methods and evaluate four variants in a distributed computing environment (specifically, Hadoop). We identify several optimizations which improve performance, suitable for deployment in very large scale settings. The experimental results demonstrate our variants of LSH achieve the robust performance with better recall compared with "vanilla" LSH, even when using the same amount of space.	[Cormode, Graham] Univ Warwick, Dept Comp Sci, Coventry, W Midlands, England; [Dasgupta, Anirban] IIT Gandhinagar, Comp Sci & Engn, Gandhinagar, India; [Goyal, Amit; Lee, Chi Hoon] Yahoo Res, Sunnyvale, CA USA	University of Warwick; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Gandhinagar	Cormode, G (corresponding author), Univ Warwick, Dept Comp Sci, Coventry, W Midlands, England.	G.Cormode@warwick.ac.uk	Dasgupta, Anirba/AAN-9090-2020	Dasgupta, Anirba/0000-0002-8494-3692; Cormode, Graham/0000-0002-0698-0922	European Research Council [ERC-2014-CoG 647557]; Yahoo Faculty Research and Engagement Program; Royal Society Wolfson Research Merit Award	European Research Council(European Research Council (ERC)European Commission); Yahoo Faculty Research and Engagement Program; Royal Society Wolfson Research Merit Award(Royal Society of London)	This work of GC is supported in part by European Research Council grant ERC-2014-CoG 647557, the Yahoo Faculty Research and Engagement Program and a Royal Society Wolfson Research Merit Award. These funders did not have any role in the development and execution of this work. The work of AD, AG, CHL was carried out while they were employed by Yahoo Research. Yahoo provided the query log data used to evaluate the compared methods. The funder provided support in the form of salaries for authors AD, AG, CHL, and computing resources, but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Achlioptas D, 2003, J COMPUT SYST SCI, V66, P671, DOI 10.1016/S0022-0000(03)00025-4; Agirre E, 2009, P HLT NAACL; Ahmad F, 2005, HUM LANG TECHN C C E; Andoni A, 2008, COMMUN ACM, V51, P117, DOI 10.1145/1327452.1327494; Bahmani B., 2012, P 21 ACM INT C INFOR, P2174, DOI [10.1145/2396761.2398596, DOI 10.1145/2396761.2398596]; Charikar M.S., 2002, P 34 ANN ACM S THEOR, V34, P380, DOI DOI 10.1145/509907.509965; Ganitkevitch J, 2013, N AM ASS COMPUTATION; Goyal A, 2012, C EMP METH NAT LANG; Indyk P., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P604, DOI 10.1145/276698.276876; Jain A, 2011, ACM SIGIR C RES DEV; Jones R, 2006, ACM INT C WORLD WID; Lee C, 2011, C INF KNOWL MAN; Li Y, 2012, ACM SIGIR C RES DEV; Ly Q., 2007, P 23 INT C VER LARG, P950; Moran S, 2013, ANN M ASS COMP LING; Panigrahy R, 2006, PROCEEDINGS OF THE SEVENTHEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1186, DOI 10.1145/1109557.1109688; Pass G, 2006, INT C SCAL INF SYST; Petrovi S, 2010, HUMAN LANGUAGE TECHN, P181; Petrovic S, 2012, C N AM CHAPT ASS COM; Ravichandran D, ANN M ASS COMP LING; Song Y, 2012, ACM INT C WEB SEARCH; Song Y, 2011, PROCEEDINGS OF THE 34TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL (SIGIR'11), P815; Sundaram N, 2013, PROC VLDB ENDOW, V6, P1930, DOI 10.14778/2556549.2556574; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934; Van Durme B, 2010, ACL; Van Durme B, 2011, ACL; Velikovich L, 2010, HUMAN LANGUAGE TECHN; Weinberger K., 2009, P 26 ANN INT C MACH, P1113, DOI DOI 10.1145/1553374.1553516; Zadeh RB, 2013, J MACH LEARN RES, V14, P1605	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191175	10.1371/journal.pone.0191175	http://dx.doi.org/10.1371/journal.pone.0191175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346410	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500034
J	Herbert, JA; Mitchell, AM; Ritchie, R; Ma, JT; Ross-Hutchinson, K; Mitchell, TJ				Herbert, Jenny A.; Mitchell, Andrea M.; Ritchie, Ryan; Ma, Jiangtao; Ross-Hutchinson, Kirsty; Mitchell, Timothy J.			Expression of the lux genes in Streptococcus pneumoniae modulates pilus expression and virulence	PLOS ONE			English	Article							COLI CHEMOSTAT CULTURES; PROTEIN-KINASE STKP; ESCHERICHIA-COLI; BACTERIAL BIOLUMINESCENCE; PNEUMOCOCCAL PILUS; LACTOCOCCUS-LACTIS; GLUCOSE-METABOLISM; NADH AVAILABILITY; INVASIVE DISEASE; IN-VIVO	Bioluminescence has been harnessed for use in bacterial reporter systems and for in vivo imaging of infection in animal models. Strain Xen35, a bioluminescent derivative of Streptococcus pneumoniae serotype 4 strain TIGR4 was previously constructed for use for in vivo imaging of infections in animal models. We have shown that strain Xen35 is less virulent than its parent TIGR4 and that this is associated with the expression of the genes for bioluminescence. The expression of the luxA-E genes in the pneumococcus reduces virulence and down regulates the expression of the pneumococcal pilus.	[Herbert, Jenny A.; Mitchell, Andrea M.; Mitchell, Timothy J.] Univ Birmingham, Coll Med & Dent Sci, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Herbert, Jenny A.; Mitchell, Andrea M.; Ritchie, Ryan; Ma, Jiangtao; Ross-Hutchinson, Kirsty; Mitchell, Timothy J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Mitchell, Andrea M.] Univ Birmingham, Coll Med & Dent Sci, Infrastruct & Facil, Birmingham, W Midlands, England	University of Birmingham; University of Glasgow; University of Birmingham	Mitchell, TJ (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Microbiol & Infect, Birmingham, W Midlands, England.; Mitchell, TJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	t.j.mitchell@bham.ac.uk		Herbert, Jenny/0000-0003-4179-775X; Mitchell, Andrea/0000-0002-2530-4460	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work was funded using a PhD studentship for Dr Jenny Herbert from the Biotechnology and Biological Sciences Research Council (BBSRC).; We would like to thank Ms Julie Glabraith and Dr Pawel Herzyk of the Glasgow Polyomics Facility for their help in processing DNA samples and running the sequencing for the WGS and RNA-seq, and post sequencing processing. We would also like to thank the BBSRC for funding.	Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Barman Tarani Kanta, 2011, Indian J Med Res, V134, P688, DOI 10.4103/0971-5916.90997; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Basset A, 2011, INFECT IMMUN, V79, P2974, DOI 10.1128/IAI.05117-11; Beilharz K, 2012, P NATL ACAD SCI USA, V109, pE905, DOI 10.1073/pnas.1119172109; Berrios-Rivera SJ, 2002, METAB ENG, V4, P230, DOI 10.1006/mben.2002.0228; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Blue CE, 2003, INFECT IMMUN, V71, P4405, DOI 10.1128/IAI.71.8.4405-4413.2003; BOYLAN M, 1989, PHOTOCHEM PHOTOBIOL, V49, P681, DOI 10.1111/j.1751-1097.1989.tb08441.x; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; Chi F, 2007, J BACTERIOL, V189, P6085, DOI 10.1128/JB.00468-07; Croucher NJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002745; De Angelis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021269; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Guiral S, 2006, MICROBIOL-SGM, V152, P343, DOI 10.1099/mic.0.28433-0; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hendriksen WT, 2007, J BACTERIOL, V189, P1382, DOI 10.1128/JB.01144-06; Henken S, 2010, ANTIMICROB AGENTS CH, V54, P3155, DOI 10.1128/AAC.00310-10; Herbert JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127212; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; JABLONSKI E, 1977, BIOCHEMISTRY-US, V16, P2932, DOI 10.1021/bi00632a020; Johnson AW, 2013, ANN OTO RHINOL LARYN, V122, P344, DOI 10.1177/000348941312200510; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; MICHALISZYN GA, 1977, J BIOL CHEM, V252, P7495; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Molzen TE, 2011, INFECT IMMUN, V79, P288, DOI 10.1128/IAI.00631-10; Neves AR, 2002, APPL ENVIRON MICROB, V68, P6332, DOI 10.1128/AEM.68.12.6332-6342.2002; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Orihuela CJ, 2003, SCAND J INFECT DIS, V35, P647, DOI 10.1080/00365540310015854; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Ramos A, 2004, MICROBIOL-SGM, V150, P1103, DOI 10.1099/mic.0.26695-0; Ramos-Montanez S, 2010, J BACTERIOL, V192, P6390, DOI 10.1128/JB.00995-10; Read HM, 2016, PEERJ, V4, DOI 10.7717/peerj.2130; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Saanchez AM, 2005, J BIOTECHNOL, V117, P395, DOI 10.1016/j.jbiotec.2005.02.006; Sandgren A, 2005, J INFECT DIS, V192, P791, DOI 10.1086/432513; Saskova L, 2007, J BACTERIOL, V189, P4168, DOI 10.1128/JB.01616-06; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; van der Linden M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008286; Vemuri GN, 2006, APPL ENVIRON MICROB, V72, P3653, DOI 10.1128/AEM.72.5.3653-3661.2006	51	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189426	10.1371/journal.pone.0189426	http://dx.doi.org/10.1371/journal.pone.0189426			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342160	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800007
J	Lee, EY; Choi, HY; Cho, H; Kim, BH; Ki, M				Lee, Eun-young; Choi, Hwa Young; Cho, Hyunsoon; Kim, Bo Hyun; Ki, Moran			Health behavior associated with liver enzymes among obese Korean adolescents, 2009-2014	PLOS ONE			English	Article							DISEASE; CHILDREN; PREVALENCE; DIET	Aims Obesity is major risk factor for liver health. This study aimed to clarify whether specific health behaviors were associated with liver function in obese adolescents in Korea. Methods Based on national school health examination data from 2009 to 2014, 25,142 obese or overweight students were examined for aspartate transaminase and alanine transaminase levels, and health behaviors. Multiple logistic regression was used to calculate the odds ratio for liver enzyme elevation. Results Subjects who thought of themselves as "very fat" had a 1.6 times higher odds ratio for liver enzyme elevations than those who thought of themselves as "normal." Those who consumed fast food 3 to 5 times weekly had 1.3 times higher odds ratio (OR = 1.27, 95% confidence interval = 1.05-1.54) for the elevation of ALT than those who did not consume fast food. Those who took sugar-sweetened beverage 3 to 5 times weekly had 1.2 times higher odds ratio (OR = 1.24, 95% confidence interval = 1.07-1.42) for the elevation of ALT than those who did not take it. Those who played computer game more than 2 hours a day showed 1.1 times higher odds ratio (OR = 1.10, 95% confidence interval = 1.01-1.21) for the elevation of ALT than those who did not. Conclusions Specific food item and its frequency of consumption were identified for the positive and negative association with the elevation of liver enzymes. Self-image of body shape, sleeping time and need of help for alcohol or smoking problems also showed substantial association with the elevation.	[Lee, Eun-young; Choi, Hwa Young; Cho, Hyunsoon; Ki, Moran] Natl Canc Ctr Goyang, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea; [Kim, Bo Hyun] Natl Canc Ctr Goyang, Ctr Liver Canc, Goyang, South Korea		Ki, M (corresponding author), Natl Canc Ctr Goyang, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea.	moranki@ncc.re.kr	Ki, Moran/R-6600-2019	Ki, Moran/0000-0002-8892-7104	National Cancer Center, Korea [NCC-1410860]; International Cooperation & Education Program of National Cancer Center, Korea [NCCRI.NCCI 52210-52211]	National Cancer Center, Korea; International Cooperation & Education Program of National Cancer Center, Korea	This work was supported in part by grants from the National Cancer Center, Korea (NCC-1410860) and International Cooperation & Education Program (#NCCRI.NCCI 52210-52211, 2017) of National Cancer Center, Korea.	Ahmad A, 2015, J ORAL SCI, V57, P335, DOI 10.2334/josnusd.57.335; [Anonymous], 2014, RES SCH HLTH EX 2014; [Anonymous], 2015, 11 KOR YOUTH BEH WEB, P204; Fraser A, 2007, GASTROENTEROLOGY, V133, P1814, DOI 10.1053/j.gastro.2007.08.077; Gibson PS, 2015, NUTRIENTS, V7, P9721, DOI 10.3390/nu7125494; Iwata KA Toyoto, ASS DIETARY LIFESTYL; Ma JT, 2015, J HEPATOL, V63, P462, DOI 10.1016/j.jhep.2015.03.032; Navarro-Jarabo JM, 2013, J GASTROEN HEPATOL, V28, P1532, DOI 10.1111/jgh.12276; Martins C, 2015, J SPORT SCI MED, V14, P103; Nho HN, 2009, PEDIATR GASTROENTERO, V12, P207, DOI 10.5223/kjpgn.2009.12.2.207; Oddy WH, 2013, AM J GASTROENTEROL, V108, P778, DOI 10.1038/ajg.2013.95; Park HS, 2005, AM J CLIN NUTR, V82, P1046, DOI 10.1093/ajcn/82.5.1046; Park NH, 2010, INTERVIROLOGY, V53, P20, DOI 10.1159/000252780; Park SH, 2012, J PEDIATR GASTR NUTR, V55, P668, DOI 10.1097/MPG.0b013e3182660669; Reinehr T, 2009, ARCH DIS CHILD, V94, P437, DOI 10.1136/adc.2008.143594; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Vere CC, 2009, WORLD J GASTROENTERO, V15, P2980, DOI 10.3748/wjg.15.2980; Wiener RC, 2016, INT J INFLAMM, V2016, DOI 10.1155/2016/3901402	18	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190535	10.1371/journal.pone.0190535	http://dx.doi.org/10.1371/journal.pone.0190535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342171	gold, Green Published, Green Submitted			2022-12-27	WOS:000422653800025
J	Nasrabadi, T; Ruegner, H; Schwientek, M; Bennett, J; Valipour, SF; Grathwohl, P				Nasrabadi, Touraj; Ruegner, Hermann; Schwientek, Marc; Bennett, Jeremy; Valipour, Shahin Fazel; Grathwohl, Peter			Bulk metal concentrations versus total suspended solids in rivers: Time-invariant & catchment-specific relationships	PLOS ONE			English	Article							PARTICULATE MATTER; HEAVY-METALS; SURFACE SEDIMENTS; TRACE-METALS; WATER; FLUXES; CONTAMINATION; SPECIATION; ESTUARY; TRANSPORT	Suspended particles in rivers can act as carriers of potentially bioavailable metal species and are thus an emerging area of interest in river system monitoring. The delineation of bulk metals concentrations in river water into dissolved and particulate components is also important for risk assessment. Linear relationships between bulk metal concentrations in water (C-w,C-tot) and total suspended solids (TSS) in water can be used to easily evaluate dissolved (C-w, intercept) and particle-bound metal fluxes (C-SUS, slope) in streams (C-w,C-tot = C-w(+) CSUSTSS). In this study, we apply this principle to catchments in Iran (Haraz) and Germany (Ammer, Goldersbach, and Steinlach) that show differences in geology, geochemistry, land use and hydrological characteristics. For each catchment, particle-bound and dissolved concentrations for a suite of metals in water were calculated based on linear regressions of total suspended solids and total metal concentrations. Results were replicable across sampling campaigns in different years and seasons (between 2013 and 2016) and could be reproduced in a laboratory sedimentation experiment. C(SUS)values generally showed little variability in different catchments and agree well with soil background values for some metals (e.g. lead and nickel) while other metals (e.g. copper) indicate anthropogenic influences. C(w)was elevated in the Haraz (Iran) catchment, indicating higher bioavailability and potential human and ecological health concerns (where higher values of C-SUS/C(w)are considered as a risk indicator).	[Nasrabadi, Touraj; Valipour, Shahin Fazel] Univ Tehran, Grad Fac Environm, Tehran, Iran; [Ruegner, Hermann; Schwientek, Marc; Bennett, Jeremy; Grathwohl, Peter] Univ Tubingen, Ctr Appl Geosci, Tubingen, Germany	University of Tehran; Eberhard Karls University of Tubingen	Nasrabadi, T (corresponding author), Univ Tehran, Grad Fac Environm, Tehran, Iran.	tnasrabadi@ut.ac.ir	Ruegner, Hermann/C-4422-2013; Nasrabadi, Touraj/S-3745-2018	Ruegner, Hermann/0000-0003-1806-9412; Nasrabadi, Touraj/0000-0002-0829-6278; Bennett, Jeremy/0000-0001-5211-450X; Grathwohl, Peter/0000-0002-9712-8339	EU FP7 Collaborative Project GLOBAQUA [603629]; Collaborative Research Center CAMPOS (Project P1: Rivers) - German Research Foundation (DFG) [1253, SFB 1253/1 2017]	EU FP7 Collaborative Project GLOBAQUA; Collaborative Research Center CAMPOS (Project P1: Rivers) - German Research Foundation (DFG)	This research was financially supported by the EU FP7 Collaborative Project GLOBAQUA (Grant Agreement no 603629) and the Collaborative Research Center 1253 CAMPOS (Project P1: Rivers), funded by the German Research Foundation (DFG, Grant Agreement SFB 1253/1 2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay H, 2003, WATER RES, V37, P813, DOI 10.1016/S0043-1354(02)00392-5; Balzer W, 2013, CONT SHELF RES, V57, P73, DOI 10.1016/j.csr.2012.04.005; Beck M, 2013, MAR POLLUT BULL, V70, P100, DOI 10.1016/j.marpolbul.2013.02.017; Beltaos S, 2016, COLD REG SCI TECHNOL, V123, P164, DOI 10.1016/j.coldregions.2015.12.009; Cheng QL, 2017, ENVIRON SCI POLLUT R, V24, P17446, DOI 10.1007/s11356-017-9059-5; David T, 2013, ENVIRON EARTH SCI, V69, P479, DOI 10.1007/s12665-013-2447-3; Davidson J, 2004, GEOL SOC AM BULL, V116, P16, DOI 10.1130/B25344.1; DIN, 2007, 38402A24 DIN; DIN EN ISO, 2007, 11885 DIN EN ISO; dos Anjos VE, 2012, AQUAT GEOCHEM, V18, P407, DOI 10.1007/s10498-012-9161-8; Duodu GO, 2017, MAR POLLUT BULL, V117, P523, DOI 10.1016/j.marpolbul.2017.02.017; EPA (Environmental Protection Agency), 1992, SW846 EPA; EU, 2013, OFFICIAL J EUROPEAN; Gaillardet J., 2014, TREATISE GEOCHEMISTR, V2nd, DOI [10.1016/B0-08-043751-6/05165-3, DOI 10.1016/B0-08-043751-6/05165-3]; Gallaher B. M., 2004, CERRO GRANDE FIRE IM, DOI [10.2172/835908, DOI 10.2172/835908]; Gao XL, 2015, CONT SHELF RES, V104, P25, DOI 10.1016/j.csr.2015.05.005; Gardner CB, 2004, ENVIRON SCI TECHNOL, V38, P5319, DOI 10.1021/es0497835; Grathwohl P, 2013, ENVIRON EARTH SCI, V69, P317, DOI 10.1007/s12665-013-2281-7; Helali MA, 2016, MAR POLLUT BULL, V104, P171, DOI 10.1016/j.marpolbul.2016.01.041; Hong S, 2016, MAR POLLUT BULL, V108, P155, DOI 10.1016/j.marpolbul.2016.04.035; Ji H, 2016, J GEOCHEM EXPLOR, V169, P123, DOI 10.1016/j.gexplo.2016.07.018; Joshi UM, 2010, CHEMOSPHERE, V80, P310, DOI 10.1016/j.chemosphere.2010.03.059; Karbassi A. R., 2005, J ENV HLTH SCI ENG, V2, P255; LABO, 2003, HINT AN ORG SCHADST; Le Cloarec MF, 2007, SCI TOTAL ENVIRON, V375, P125, DOI 10.1016/j.scitotenv.2006.12.020; Liu C, 2016, CHEMOSPHERE, V144, P2329, DOI 10.1016/j.chemosphere.2015.11.010; Lotze T, 1999, THESIS; Meyer T, 2011, WATER RES, V45, P1147, DOI 10.1016/j.watres.2010.11.004; Michel P, 1999, HIGH RESOLUTION PROF, P19; Mohseni-Bandpei A, 2013, INT J ENVIRON RES, V7, P1029; Muller G., 1969, GEO J, V2, P108, DOI DOI 10.1055/S-2007-1023171; Musselman R., 2012, RMRSRN49 USDA FOR SE, P12; Nasrabadi T, 2016, APPL GEOCHEM, V68, P1, DOI 10.1016/j.apgeochem.2016.03.003; Nasrabadi T, 2015, INT J ENVIRON RES, V9, P385; Nasrabadi T, 2010, ENVIRON MONIT ASSESS, V171, P395, DOI 10.1007/s10661-009-1286-x; Nasrabadi T, 2010, ENVIRON EARTH SCI, V59, P1111, DOI 10.1007/s12665-009-0101-x; Pinedo-Gonzalez P, 2017, APPL GEOCHEM, V83, P62, DOI 10.1016/j.apgeochem.2016.07.016; Pourabadehei M, 2016, CHEMOSPHERE, V153, P58, DOI 10.1016/j.chemosphere.2016.03.026; Quesada S, 2014, SCI TOTAL ENVIRON, V473, P381, DOI 10.1016/j.scitotenv.2013.11.040; Robinson B, 1995, CHEM SPEC BIOAVAILAB, V7, P89, DOI 10.1080/09542299.1995.11083250; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; Rugner H, 2014, SCI TOTAL ENVIRON, V490, P191, DOI 10.1016/j.scitotenv.2014.04.110; Rugner H, 2013, ENVIRON EARTH SCI, V69, P373, DOI 10.1007/s12665-013-2307-1; Rule KL, 2006, CHEMOSPHERE, V63, P64, DOI 10.1016/j.chemosphere.2005.07.052; Schwientek M, 2017, SCI TOTAL ENVIRON, V601, P636, DOI 10.1016/j.scitotenv.2017.05.208; Schwientek M, 2013, ENVIRON POLLUT, V172, P155, DOI 10.1016/j.envpol.2012.09.004; Stubblefield AP, 2007, HYDROL PROCESS, V21, P281, DOI 10.1002/hyp.6234; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; US Environmental Protection Agency, 1971, 1602 US EPA; US EPA, 1999, 2002 US EPA OFF WAT; Walling DE, 2005, SCI TOTAL ENVIRON, V344, P159, DOI 10.1016/j.scitotenv.2005.02.011; Wang HT, 2015, MAR POLLUT BULL, V93, P250, DOI 10.1016/j.marpolbul.2015.01.026; Yoon VK, 2008, J ENVIRON ENG, V134, P961, DOI 10.1061/(ASCE)0733-9372(2008)134:12(961); Zhang C, 2014, ENVIRON INT, V73, P270, DOI 10.1016/j.envint.2014.08.010; Zhang FB, 2014, GEOMORPHOLOGY, V206, P392, DOI 10.1016/j.geomorph.2013.10.012	55	26	27	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191314	10.1371/journal.pone.0191314	http://dx.doi.org/10.1371/journal.pone.0191314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342204	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800060
J	Chen, F; Yang, M; Li, Q; Pan, J; Li, XS; Meng, Q				Chen, Fei; Yang, Min; Li, Qian; Pan, Jay; Li, Xiaosong; Meng, Qun			Does providing more services increase the primary hospitals' revenue? An assessment of national essential medicine policy based on 2,675 counties in China	PLOS ONE			English	Article							MULTILEVEL ANALYSIS; SOCIAL EPIDEMIOLOGY; CARE FACILITIES; PROVINCE; IMPACT	Objective To understand whether the increased outpatient service provision (OSP) brings in enough additional income (excluding income from essential medicine) for primary hospitals (INCOME) to compensate for reduced costs of medicine. Methods The two outcomes, annual OSP and INCOME for the period of 2008-2012, were collected from 34,506 primary hospitals in 2,675 counties in 31 provinces in China by the national surveillance system. The data had a four-level hierarchical structure; time points were nested within primary hospital, hospitals within county, and counties within province. We fitted bivariate five-level random effects regression models to examine correlations between OSP and INCOME in terms of their mean values and dose-response effects of the essential medicine policy (EMP). We adjusted for the effects of time period and selected hospital resources. Findings The estimated correlation coefficients between the two outcomes' mean values were strongly positive among provinces (r = 0.910), moderately positive among counties (r = 0.380), and none among hospitals (r = 0.002) and time (r = 0.007). The correlation between their policy effects was weakly positive among provinces (r = 0.234), but none at the county and hospital levels. However, there were markedly negative correlation coefficients between the mean and policy effects at -0.328 for OSP and -0.541 for INCOME at the hospital level. Conclusion There was no evidence to suggest an association between the two outcomes in terms of their mean values and dose-response effects of EMP at the hospital level. This indicated that increased OSP did not bring enough additional INCOME. Sustainable mechanisms to for this work.	[Chen, Fei; Pan, Jay; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Yang, Min; Li, Qian; Pan, Jay] Sichuan Univ, West China Res Ctr Rural Hlth Dev, Chengdu, Sichuan, Peoples R China; [Meng, Qun] Natl Hlth & Family Planning Commiss China, Ctr Hlth Informat & Stat, Beijing, Peoples R China	Sichuan University; Sichuan University	Li, XS (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China.; Yang, M (corresponding author), Sichuan Univ, West China Res Ctr Rural Hlth Dev, Chengdu, Sichuan, Peoples R China.	yangmin2013@scu.edu.cn; lixiaosong1101@126.com	Pan, Jay/Z-4492-2019	Pan, Jay/0000-0001-9501-1535				Ai-tian Y, 2011, CHINESE HLTH EC, V04, P20; Chen L, 2012, CHINESE J HLTH POLIC, V4, P7; China Central Government, 2009, IMPL PLAN REC PRIOR; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Du N, 2015, CHINA EC STUDIES, V1, P8; Fang Y, 2013, LANCET GLOB HEALTH, V1, pE227, DOI 10.1016/S2214-109X(13)70072-X; Gai X, 2005, PSYCHOL SCI, V28, P429; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Goldstein H, 2009, STAT MODEL, V9, P173, DOI 10.1177/1471082X0800900301; Hipgrave D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001337; Huang Donghong, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P222, DOI 10.11817/j.issn.1672-7347.2015.02.018; [金芳 Jin Fang], 2004, [中国卫生统计, Chinese Journal of Health Statistics], V21, P204; [金有豫 Jin Youyu], 2011, [中国药房, China Pharmacy], V22, P293; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Liu H, 2012, CHINESE J DRUG EVALU, V29, P270; Liu Z, 2014, CHINESE HLTH EC, V33, P8; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Ministry of Health of China, 2011, EST NAT ESS MED SYST; National Bureau of Statistics of China, 2013, CHIN CIT STAT YB 201; National Health and Family Planning Commission, 2013, NAT HLTH FAM PLAN CO; Rasbash J., 2012, USERS GUIDE MLWIN VE; Rasbash J, 2009, MLWIN VERSION 21; Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588; Singer J.D., 2003, APPL LONGITUDINAL DA; Song Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0507-3; Song Yan, 2014, J Pharm Policy Pract, V7, P12, DOI 10.1186/2052-3211-7-12; Tang YQ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-183; Wang S, 2011, CHINESE J HLTH POLIC, V4, P30; Wang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090365; Xu SM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1073-z; Yang C, 2012, CHIN J HLTH POLICY, V05, P35; Yang H, 2014, PRACTICAL PREVENTIVE, V21, P1405; Yang L, 2013, B WORLD HEALTH ORGAN, V91, P184, DOI 10.2471/BLT.11.097998; Yang LP, 2013, HEALTH POLICY PLANN, V28, P750, DOI 10.1093/heapol/czs116; Yang M, 2015, LANCET, V386, P28, DOI 10.1016/S0140-6736(15)00606-6; Yu F, 2011, CHINESE HLTH EC, V1, P18; Yu W, 2015, SHANGHAI MED PHARM J, V3, P16; [曾丽 Zeng Li], 2011, [中国药房, China Pharmacy], V22, P3758; Zhou L, 2013, CHONGQING MED, V5, P20; Zhou Z, 2015, PLOS ONE, V10	41	0	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190855	10.1371/journal.pone.0190855	http://dx.doi.org/10.1371/journal.pone.0190855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338028	gold, Green Published, Green Submitted			2022-12-27	WOS:000422652700021
J	Sulik, J				Sulik, Justin			Cognitive mechanisms for inferring the meaning of novel signals during symbolisation	PLOS ONE			English	Article							RIGHT-HEMISPHERE; NEURAL ACTIVITY; INSIGHT; SENTENCE; LANGUAGE; AHA; INFERENCES; CONSTRAINT; EVOLUTION; CONTEXT	As participants repeatedly interact using graphical signals (as in a game of Pictionary), the signals gradually shift from being iconic (or motivated) to being symbolic (or arbitrary). The aim here is to test experimentally whether this change in the form of the signal implies a concomitant shift in the inferential mechanisms needed to understand it. The results show that, during early, iconic stages, there is more reliance on creative inferential processes associated with insight problem solving, and that the recruitment of these cognitive mechanisms decreases over time. The variation in inferential mechanism is not predicted by the sign's visual complexity or iconicity, but by its familiarity, and by the complexity of the relevant mental representations. The discussion explores implications for pragmatics, language evolution, and iconicity research.	[Sulik, Justin] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Sulik, Justin] Royal Holloway Univ London, Dept Psychol, London, England	Max Planck Society; University of London; Royal Holloway University London	Sulik, J (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.; Sulik, J (corresponding author), Royal Holloway Univ London, Dept Psychol, London, England.	justin.sulik@gmail.com		Sulik, Justin/0000-0002-0978-9496	Skye Foundation, South Africa; Max Planck Institute for Psycholinguistics	Skye Foundation, South Africa; Max Planck Institute for Psycholinguistics(Max Planck Society)	The author gratefully acknowledges a bursary from the Skye Foundation, South Africa, that contributed towards his PhD (during which this experiment was conducted), and a stipend from the Max Planck Institute for Psycholinguistics that supported him while it was written up. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SPEAKING OUR MINDS; Ansburg PI, 2003, PERS INDIV DIFFER, V34, P1141, DOI 10.1016/S0191-8869(02)00104-6; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D., 2011, IME4 LINEAR MIXED EF; BEEMAN M, 1994, J COGNITIVE NEUROSCI, V6, P26, DOI 10.1162/jocn.1994.6.1.26; BEEMAN M, 1993, BRAIN LANG, V44, P80, DOI 10.1006/brln.1993.1006; Bonawitz EB, 2010, COGNITION IN FLUX, P2260; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Bowden EM, 2003, BEHAV RES METH INS C, V35, P634, DOI 10.3758/BF03195543; Bowden EM, 2003, PSYCHON B REV, V10, P730, DOI 10.3758/BF03196539; Campos DG, 2011, SYNTHESE, V180, P419, DOI 10.1007/s11229-009-9709-3; Cuskley C., 2013, OXFORD HDB SYNAESTHE, P869, DOI DOI 10.1093/OXFORDHB/9780199603329.013.0043; Danek AH, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2016.02077; Danek AH, 2013, PSYCHOL RES-PSYCH FO, V77, P659, DOI 10.1007/s00426-012-0454-8; Davidson, 1995, NATURE INSIGHT, P157, DOI 10.7551/mitpress/4879.003.0009; De Deyne S, 2012, BEHAV RES METHODS, V45, P450; Eco U., 1997, KANT PLATYPUS ESSAYS; Eco Umberto., 1978, THEORY SEMIOTICS; Emmorey K, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0301; Faust M, 1998, BRAIN LANG, V62, P149, DOI 10.1006/brln.1997.1892; Faust M, 1998, NEUROPSYCHOLOGIA, V36, P827, DOI 10.1016/S0028-3932(98)00042-6; Faust M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00511; Fay N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071781; Fay N, 2010, COGNITIVE SCI, V34, P351, DOI 10.1111/j.1551-6709.2009.01090.x; Federmeier KD, 1999, COGNITIVE BRAIN RES, V8, P373, DOI 10.1016/S0926-6410(99)00036-1; Garrod S, 2007, COGNITIVE SCI, V31, P961, DOI 10.1080/03640210701703659; Gilhooly KJ, 2015, THINK REASONING, V21, P1, DOI 10.1080/13546783.2014.966758; Gilhooly KJ, 2009, THINK REASONING, V15, P355, DOI 10.1080/13546780903178615; Gilhooly KJ, 2005, THINK REASONING, V11, P279, DOI 10.1080/13546780442000187; Goodman ND, 2016, TRENDS COGN SCI, V20, P818, DOI 10.1016/j.tics.2016.08.005; JAUSOVEC N, 1995, CREATIVITY RES J, V8, P11, DOI 10.1207/s15326934crj0801_2; Jung-Beeman M, 2005, TRENDS COGN SCI, V9, P512, DOI 10.1016/j.tics.2005.09.009; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; KAPLAN CA, 1990, COGNITIVE PSYCHOL, V22, P374, DOI 10.1016/0010-0285(90)90008-R; KAPLAN JA, 1990, BRAIN LANG, V38, P315, DOI 10.1016/0093-934X(90)90117-Y; Kircher TTJ, 2001, NEUROPSYCHOLOGIA, V39, P798, DOI 10.1016/S0028-3932(01)00014-8; Kita S, EV LANG P 8 INT C EV; Knoblich G, 2001, MEM COGNITION, V29, P1000, DOI 10.3758/BF03195762; Kounios J, 2008, NEUROPSYCHOLOGIA, V46, P281, DOI 10.1016/j.neuropsychologia.2007.07.013; Kounios J, 2006, PSYCHOL SCI, V17, P882, DOI 10.1111/j.1467-9280.2006.01798.x; Kounios J, 2009, CURR DIR PSYCHOL SCI, V18, P210, DOI 10.1111/j.1467-8721.2009.01638.x; Kuznetsova, 2015, IMERTEST TESTS RANDO; Kwisthout J, 2012, J PROBL SOLVING, V5, P18, DOI 10.7771/1932-6246.1141; Levinson SC., 2006, ROOTS HUM SOC CULT C, P39, DOI [DOI 10.3389/FPSYG.2015.00731, DOI 10.4324/9781003135517-3]; MacGregor JN, 2008, BEHAV RES METHODS, V40, P263, DOI 10.3758/BRM.40.1.263; Mashal N, 2007, BRAIN LANG, V100, P115, DOI 10.1016/j.bandl.2005.10.005; Mashal N, 2009, LATERALITY, V14, P573, DOI 10.1080/13576500902734645; Mashal N, 2005, NEUROPSYCHOLOGIA, V43, P2084, DOI 10.1016/j.neuropsychologia.2005.03.019; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; METCALFE J, 1987, MEM COGNITION, V15, P238, DOI 10.3758/BF03197722; Navarro DJ, 2011, PSYCHOL REV, V118, P120, DOI 10.1037/a0021110; Noordzij ML, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.014.2009; Ohlsson S., 1992, ADV PSYCHOL THINKING, V1, DOI DOI 10.1017/CB09780511780295; Ortega G, 2015, LANG COGN NEUROSCI, V30, P574, DOI 10.1080/23273798.2014.959533; Peirce Charles S., 1955, PHILOS WRITINGS PEIR, P98; Pelli DG, 2006, VISION RES, V46, P4646, DOI 10.1016/j.visres.2006.04.023; Perlman M, 2014, GESTURE, V14, P320, DOI 10.1075/gest.14.3.03per; Perniss P, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00227; Quine W., 1960, WORD OBJECT; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richards I. A, 1936, PHILOS RHETORIC; Salvi C, 2016, THINK REASONING, V22, P443, DOI 10.1080/13546783.2016.1141798; Salvi C, 2015, PSYCHON B REV, V22, P1814, DOI 10.3758/s13423-015-0845-0; SONESSON G, 2006, SIGN SYST STUD, V34, P135; Sperber D., 1995, RELEVANCE COMMUNICAT, V2nd ed.; Stolk A, 2013, P NATL ACAD SCI USA, V110, P14574, DOI 10.1073/pnas.1303170110; Sulik J, PERSPECTIVE TA UNPUB; Sulik J., COGNITIVE DIFF UNPUB; Virtue S, 2006, MEM COGNITION, V34, P1341, DOI 10.3758/BF03193276; Webb ME, 2016, FRONT PSYCHOL, P7; Wegbreit E., 2014, J PROBL SOLV, V4, P94; Xu F, 2007, PSYCHOL REV, V114, P245, DOI 10.1037/0033-295X.114.2.245; Xu J, 2005, NEUROIMAGE, V25, P1002, DOI 10.1016/j.neuroimage.2004.12.013; Zlatev J, 2008, J PHYSIOL-PARIS, V102, P137, DOI 10.1016/j.jphysparis.2008.03.016	75	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0189540	10.1371/journal.pone.0189540	http://dx.doi.org/10.1371/journal.pone.0189540			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29337998	Green Submitted, Green Published, gold			2022-12-27	WOS:000422652700002
J	Afolabi, LT; Saeed, F; Hashim, H; Petinrin, OO				Afolabi, Lateefat Temitope; Saeed, Faisal; Hashim, Haslinda; Petinrin, Olutomilayo Olayemi			Ensemble learning method for the prediction of new bioactive molecules	PLOS ONE			English	Article							SIMILARITY; KINASE; CLASSIFICATION; INHIBITORS; SELECTION; DOCKING; BINDING; SIZE	Pharmacologically active molecules can provide remedies for a range of different illnesses and infections. Therefore, the search for such bioactive molecules has been an enduring mission. As such, there is a need to employ a more suitable, reliable, and robust classification method for enhancing the prediction of the existence of new bioactive molecules. In this paper, we adopt a recently developed combination of different boosting methods (Adaboost) for the prediction of new bioactive molecules. We conducted the research experiments utilizing the widely used MDL Drug Data Report (MDDR) database. The proposed boosting method generated better results than other machine learning methods. This finding suggests that the method is suitable for inclusion among the in silico tools for use in cheminformatics, computational chemistry and molecular biology.	[Afolabi, Lateefat Temitope] Al Hikmah Univ, Coll Nat Sci, Dept Phys Sci, Ilorin, Nigeria; [Saeed, Faisal] Taibah Univ, Coll Comp Sci & Engn, Medina, Saudi Arabia; [Saeed, Faisal; Hashim, Haslinda; Petinrin, Olutomilayo Olayemi] Univ Teknol Malaysia, Informat Syst Dept, Fac Comp, Skudai, Johor, Malaysia; [Hashim, Haslinda] Kolej Yayasan Pelajaran Johor, KM16,Jalan Kulai Kota Tinggi, Kota Tinggi, Johor, Malaysia	Taibah University; Universiti Teknologi Malaysia	Saeed, F (corresponding author), Taibah Univ, Coll Comp Sci & Engn, Medina, Saudi Arabia.; Saeed, F (corresponding author), Univ Teknol Malaysia, Informat Syst Dept, Fac Comp, Skudai, Johor, Malaysia.	fsaeed@taibahu.edu.sa	Saeed, Faisal/ABB-6958-2020	Saeed, Faisal/0000-0002-2822-1708; Petinrin, Olutomilayo Olayemi/0000-0001-8402-9713	Ministry of Higher Education (Malaysia) [Q.J130000.2528.16H74]; Research Management Center, Universiti Teknologi Malaysia (UTM)	Ministry of Higher Education (Malaysia)(Ministry of Education, Malaysia); Research Management Center, Universiti Teknologi Malaysia (UTM)	This work was funded by Q.J130000.2528.16H74 from the Ministry of Higher Education (Malaysia) and Research Management Center, Universiti Teknologi Malaysia (UTM): http://rmc.utm.my/.	Abdo A, 2014, J CHEM INF MODEL, V54, P30, DOI 10.1021/ci4004909; Ahmed A, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-19; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; Bender A, 2004, J CHEM INF COMP SCI, V44, P170, DOI 10.1021/ci034207y; Bologa Cristian G, 2012, Methods Mol Biol, V910, P125, DOI 10.1007/978-1-61779-965-5_7; Bruce CL, 2007, J CHEM INF MODEL, V47, P219, DOI 10.1021/ci600332j; Buchwald F, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-22; Burden FR, 1999, J CHEM INF COMP SCI, V39, P236, DOI 10.1021/ci980070d; Cao DS, 2010, CHEMOMETR INTELL LAB, V103, P129, DOI 10.1016/j.chemolab.2010.06.008; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Feinstein WP, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0067-5; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; Glick M, 2004, J BIOMOL SCREEN, V9, P32, DOI 10.1177/1087057103260590; Harper G, 2001, J CHEM INF COMP SCI, V41, P1295, DOI 10.1021/ci000397q; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Jung Y, 2015, CHEM BIOL DRUG DES, V85, P574, DOI 10.1111/cbdd.12445; Krasowski MD, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-22; Kubinyi H., 2008, VIRTUAL SCREENING BI, V10; Kurczab R, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-32; Lavecchia A, 2015, DRUG DISCOV TODAY, V20, P318, DOI 10.1016/j.drudis.2014.10.012; Lin HF, 2015, DEV CELL, V32, P772, DOI 10.1016/j.devcel.2015.03.004; Liu B., 2016, BIOINFORMATICS ADV A; Liu B, 2017, ONCOTARGET, V8, P13338, DOI 10.18632/oncotarget.14524; Liu B, 2016, IEEE T NANOBIOSCI, V15, P328, DOI 10.1109/TNB.2016.2555951; Malhat M.G., INF SYST INFOS 2014; Marinov GK, 2015, DEV CELL, V32, P765, DOI 10.1016/j.devcel.2015.01.013; Metivier JP, 2015, J CHEM INF MODEL, V55, P925, DOI 10.1021/ci500611v; Nidhi, 2006, J CHEM INF MODEL, V46, P1124, DOI 10.1021/ci060003g; Papadatos G, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/s13321-014-0040-8; Pasquinelli M. A., TARGET, V1, P3; Pires DEV, 2015, J MED CHEM, V58, P4066, DOI 10.1021/acs.jmedchem.5b00104; Reynolds CR, 2012, J CHEMINFORMATICS, V4, pO10; ROGERS D, 1994, J CHEM INF COMP SCI, V34, P854, DOI 10.1021/ci00020a020; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Sammut C., 2011, ENCY MACHINE LEARNIN, DOI [10.1007/978-0-387-30164-8-469, DOI 10.1007/978-0-387-30164-8_469, DOI 10.1007/978-0-387-30164-8469]; Schierz AC, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-21; Schneider G, 2002, DRUG DISCOV TODAY, V7, P64, DOI 10.1016/S1359-6446(02)00004-1; Schneider G, 2000, ANGEW CHEM INT EDIT, V39, P4130, DOI 10.1002/1521-3773(20001117)39:22<4130::AID-ANIE4130>3.0.CO;2-E; Sci Tegic Accelrys Inc, MDL DRUG DAT REP MDD; Sherhod R, 2014, J CHEM INF MODEL, V54, P1864, DOI 10.1021/ci5001828; Sheridan RP, 2002, DRUG DISCOV TODAY, V7, P903, DOI 10.1016/S1359-6446(02)02411-X; Smusz S, 2015, BIOORG MED CHEM LETT, V25, P1827, DOI 10.1016/j.bmcl.2015.03.049; Smusz S, 2013, CHEMOMETR INTELL LAB, V128, P89, DOI 10.1016/j.chemolab.2013.08.003; Stumpfe D, 2011, METH PRIN MED CHEM, V48, P293; Takigawa I, 2013, DRUG DISCOV TODAY, V18, P50, DOI 10.1016/j.drudis.2012.07.016; Wang F., 2015, IEEE T NANOBIOSCIENC, V14; Watanabe T., 2014, MOL CELL, V56; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Willett P, 2006, DRUG DISCOV TODAY, V11, P1046, DOI 10.1016/j.drudis.2006.10.005; Willett P, 2007, J CHEM INF MODEL, V47, P1961, DOI 10.1021/ci700087v; Xia XY, 2004, J MED CHEM, V47, P4463, DOI 10.1021/jm0303195; Zhang Z., 2010, 2 INT C COMP ENG TEC	52	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0189538	10.1371/journal.pone.0189538	http://dx.doi.org/10.1371/journal.pone.0189538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329334	Green Submitted, gold, Green Published			2022-12-27	WOS:000419954100008
J	Kyrklund, M; Kummu, O; Kankaanpaa, J; Akhi, R; Nissinen, A; Turunen, SP; Pussinen, P; Wang, CG; Horkko, S				Kyrklund, Mikael; Kummu, Outi; Kankaanpaa, Jari; Akhi, Ramin; Nissinen, Antti; Turunen, S. Pauliina; Pussinen, Pirkko; Wang, Chunguang; Horkko, Sohvi			Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein	PLOS ONE			English	Article							FC-ALPHA-RI; NATURAL ANTIBODIES; PERIODONTAL-DISEASE; ATHEROSCLEROSIS; INTERLEUKIN-6; CELLS; PROTEINS; IMMUNITY; INFLAMMATION; MECHANISMS	Treatment of periodontitis has beneficial effects on systemic inflammation markers that relate to progression of atherosclerosis. We aimed to investigate whether immunization with A hemagglutinin domain (Rgp44) of Porphyromonas gingivalis (Pg), a major etiologic agent of periodontitis, would lead to an antibody response cross-reacting with oxidized low-density lipoprotein (OxLDL) and how it would affect the progression of atherosclerosis in low-density lipoprotein receptor-deficient (LDLR-/-) mice. The data revealed a prominent IgM but not IgG response to malondialdehyde-acetaldehyde modified LDL (MAA-LDL) after Rgp44 and Pg immunizations, implying that Rgp44/Pgand MAA adducts may share cross-reactive epitopes that prompt IgM antibody production and consequently confer atheroprotection. A significant negative association was observed between atherosclerotic lesion and plasma IgA to Rgp44 in Rgp44 immunized mice, supporting further the anti-atherogenic effect of Rgp44 immunization. Plasma IgA levels to Rgp44 and to Pg in both Rgp44-and Pg-immunized mice were significantly higher than those in saline control, suggesting that IgA to Rgp44 could be a surrogate marker of immunization in Pg-immunized mice. Distinct antibody responses in plasma IgA levels to MAA-LDL, to Pg lipopolysaccharides (Pg-LPS), and to phosphocholine (PCho) were observed after Rgp44 and Pg immunizations, indicating that different immunogenic components between Rpg44 and Pg may behave differently in regard of their roles in the development of atherosclerosis. Immunization with Rgp44 also displayed atheroprotective features in modulation of plaque size through association with plasma levels of IL-1 alpha whereas whole Pg bacteria achieved through regulation of antiinflammatory cytokine levels of IL-5 and IL-10. The present study may contribute to refining therapeutic approaches aiming to modulate immune responses and inflammatory/antiinflammatory processes in atherosclerosis.	[Kyrklund, Mikael; Kummu, Outi; Kankaanpaa, Jari; Akhi, Ramin; Nissinen, Antti; Turunen, S. Pauliina; Wang, Chunguang; Horkko, Sohvi] Univ Oulu, Fac Med, Res Unit Biomed, Med Microbiol & Immunol, Oulu, Finland; [Kyrklund, Mikael; Kummu, Outi; Kankaanpaa, Jari; Akhi, Ramin; Nissinen, Antti; Turunen, S. Pauliina; Wang, Chunguang; Horkko, Sohvi] Univ Hosp, Med Res Ctr, Oulu, Finland; [Kyrklund, Mikael; Kummu, Outi; Kankaanpaa, Jari; Akhi, Ramin; Nissinen, Antti; Turunen, S. Pauliina; Wang, Chunguang; Horkko, Sohvi] Univ Hosp, Nordlab Oulu, Oulu, Finland; [Kyrklund, Mikael; Kummu, Outi; Kankaanpaa, Jari; Akhi, Ramin; Nissinen, Antti; Turunen, S. Pauliina; Wang, Chunguang; Horkko, Sohvi] Univ Oulu, Oulu, Finland; [Pussinen, Pirkko] Univ Helsinki, Oral & Maxillofacial Dis, Helsinki, Finland; [Pussinen, Pirkko] Helsinki Univ Hosp, Helsinki, Finland; [Turunen, S. Pauliina] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet	Wang, CG; Horkko, S (corresponding author), Univ Oulu, Fac Med, Res Unit Biomed, Med Microbiol & Immunol, Oulu, Finland.; Wang, CG; Horkko, S (corresponding author), Univ Hosp, Med Res Ctr, Oulu, Finland.; Wang, CG; Horkko, S (corresponding author), Univ Hosp, Nordlab Oulu, Oulu, Finland.; Wang, CG; Horkko, S (corresponding author), Univ Oulu, Oulu, Finland.	chunguang.wang@oulu.fi; sohvi.horkko@oulu.fi	Wang, Chunguang/AAE-7054-2020; Wang, Chunguang/AAE-6997-2020	Wang, Chunguang/0000-0001-5569-321X; Pussinen, Pirkko/0000-0003-3563-1876; Akhi, Ramin/0000-0003-1783-5330; Nissinen, Antti/0000-0003-4771-2753; Turunen, S. Pauliina/0000-0001-8060-9876; Kummu, Outi/0000-0003-0327-3496	Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research	This study was funded by Sigrid Juselius Foundation and Finnish Foundation for Cardiovascular Research. Sigrid Juselius Foundation webpage: http://sigridjuselius.fi/sv/Finnish Foundation for Cardiovascular Research (Sydantutkimussaatio) webpage: http://www.sydantutkimussaatio.fi/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhi R, 2017, J CLIN PERIODONTOL, V44, P682, DOI 10.1111/jcpe.12748; Amar S, 2015, MOL ORAL MICROBIOL, V30, P171, DOI 10.1111/omi.12087; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Antoniak DT, 2015, FREE RADICAL BIO MED, V89, P409, DOI 10.1016/j.freeradbiomed.2015.09.003; Binder CJ, 2010, J CLIN IMMUNOL, V30, pS56, DOI 10.1007/s10875-010-9396-3; Binder CJ, 2005, J LIPID RES, V46, P1353, DOI 10.1194/jlr.R500005-JLR200; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; de Faire U, 2009, ANN NY ACAD SCI, V1173, P292, DOI 10.1111/j.1749-6632.2009.04748.x; Deshpande Rajashri G., 1998, Invasion and Metastasis, V18, P57, DOI 10.1159/000024499; Duryee MJ, 2010, FREE RADICAL BIO MED, V49, P1480, DOI 10.1016/j.freeradbiomed.2010.08.001; Elhage R, 2001, ATHEROSCLEROSIS, V156, P315, DOI 10.1016/S0021-9150(00)00682-1; Foey AD, 2017, ARCH ORAL BIOL, V73, P282, DOI 10.1016/j.archoralbio.2016.10.029; Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Lichtman AH, 2013, J CLIN INVEST, V123, P27, DOI 10.1172/JCI63108; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Mallat Z, 1999, ARTERIOSCL THROM VAS, V19, P611, DOI 10.1161/01.ATV.19.3.611; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; Miyamoto T, 2006, INFECT IMMUN, V74, P1376, DOI 10.1128/IAI.74.2.1376-1380.2006; Nikoopour E, 2015, CYTOKINE, V74, P35, DOI 10.1016/j.cyto.2014.09.007; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Piconi S, 2009, FASEB J, V23, P1196, DOI 10.1096/fj.08-119578; Pussinen PJ, 2007, ATHEROSCLEROSIS, V193, P222, DOI 10.1016/j.atherosclerosis.2006.06.027; Pussinen PJ, 2004, EUR J CARDIOV PREV R, V11, P408, DOI 10.1097/00149831-200410000-00008; Qian K, 2008, J LEUKOCYTE BIOL, V84, P1492, DOI 10.1189/jlb.0508327; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Shimomoto T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172172; Silveira A, 2015, ATHEROSCLEROSIS, V239, P125, DOI 10.1016/j.atherosclerosis.2014.12.046; Tsiantoulas D, 2014, CIRC RES, V114, P1743, DOI 10.1161/CIRCRESAHA.113.301145; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P2218, DOI 10.1016/j.jacc.2012.08.979; Turunen SP, 2015, INNATE IMMUN-LONDON, V21, P370, DOI 10.1177/1753425914542444; Turunen SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034910; van Egmond M, 2000, NAT MED, V6, P680, DOI 10.1038/76261; Wang C, 2015, SCI BULL, V60, P2016, DOI 10.1007/s11434-015-0941-6; Wang CG, 2017, METHODS MOL BIOL, V1643, P155, DOI 10.1007/978-1-4939-7180-0_12; Wang CG, 2013, INT IMMUNOL, V25, P575, DOI 10.1093/intimm/dxt022; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Zhang D, 2008, INNATE IMMUN-LONDON, V14, P99, DOI 10.1177/1753425907088244	49	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191216	10.1371/journal.pone.0191216	http://dx.doi.org/10.1371/journal.pone.0191216			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329335	Green Published, gold, Green Submitted			2022-12-27	WOS:000419954100051
J	Robles, MD; Turner, DS; Haney, JA				Robles, Marcos D.; Turner, Dale S.; Haney, Jeanmarie A.			A century of changing flows: Forest management changed flow magnitudes and warming advanced the timing of flow in a southwestern US river (vol 12, e0187875, 2017)	PLOS ONE			English	Correction																		Robles MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187875	1	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191443	10.1371/journal.pone.0191443	http://dx.doi.org/10.1371/journal.pone.0191443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329341	Green Published, Green Submitted, gold			2022-12-27	WOS:000419954100061
J	Buxton, AS; Groombridge, JJ; Griffiths, RA				Buxton, Andrew S.; Groombridge, Jim J.; Griffiths, Richard A.			Seasonal variation in environmental DNA detection in sediment and water samples	PLOS ONE			English	Article							GREAT CRESTED NEWT; EXTRACTION METHODS; EXTRACELLULAR DNA; SITE OCCUPANCY; CLAY-MINERALS; EDNA; CONSERVATION; DEGRADATION; PERSISTENCE; ADSORPTION	The use of aquatic environmental DNA (eDNA) to detect the presence of species depends on the seasonal activity of the species in the sampled habitat. eDNA may persist in sediments for longer than it does in water, and analysing sediment could potentially extend the seasonal window for species assessment. Using the great crested newt as a model, we compare how detection probability changes across the seasons in eDNA samples collected from both pond water and pond sediments. Detection of both aquatic and sedimentary eDNA varied through the year, peaking in the summer (July), with its lowest point in the winter (January): in all seasons, detection probability of eDNA from water exceeded that from sediment. Detection probability of eDNA also varied between study areas, and according to great crested newt habitat suitability and sediment type. As aquatic and sedimentary eDNA show the same seasonal fluctuations, the patterns observed in both sample types likely reflect current or recent presence of the target species. However, given the low detection probabilities found in the autumn and winter we would not recommend using either aquatic or sedimentary eDNA for year-round sampling without further refinement and testing of the methods.	[Buxton, Andrew S.; Groombridge, Jim J.; Griffiths, Richard A.] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Marlowe Bldg, Canterbury, Kent, England	University of Kent	Buxton, AS (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Marlowe Bldg, Canterbury, Kent, England.	asb40@kent.ac.uk			University of Kent; NERC [NBAF010001] Funding Source: UKRI	University of Kent; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We would like to dedicate this paper to Sir Martin Wood (FRS) and Lady Audrey Wood in the year of their 90th Birthdays for their contribution to science, technology and nature conservation. We would like to thank them for their financial support of their grandson, Andrew Buxton's PhD project of which this paper is part. This work was also made possible with funding directly from the University of Kent where Professor Jim Groombridge and Professor Richard Griffiths, are academic staff. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Carpenter LL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-30; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Boessenkool S, 2014, CONSERV BIOL, V28, P446, DOI 10.1111/cobi.12195; Burnham K P, 2003, MODEL SELECT MULTIMO; Buxton AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183371; Buxton AS, 2017, SCI REP-UK, V7, DOI 10.1038/srep46294; Cai P, 2006, ENVIRON SCI TECHNOL, V40, P2971, DOI 10.1021/es0522985; Chaves L, 2010, EXTRACTION GENOMIC D; Corinaldesi C, 2011, MOL ECOL, V20, P642, DOI 10.1111/j.1365-294X.2010.04958.x; Crecchio C, 1998, SOIL BIOL BIOCHEM, V30, P1061, DOI 10.1016/S0038-0717(97)00248-4; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Eland LE, 2012, WATER RES, V46, P5355, DOI 10.1016/j.watres.2012.07.023; English Nature, 2001, GREAT CREST NEWT MIT; Fiske IJ, 2011, J STAT SOFTW, V43, P1; GREAVES M. P., 1969, Soil Biology and Biochemistry, V1, P317, DOI 10.1016/0038-0717(69)90014-5; Griffiths R. A., 2016, WC1108 DEFR PROJ; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Hinlo R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179251; Hofreiter M, 2003, CURR BIOL, V13, pR693, DOI 10.1016/j.cub.2003.08.039; Hunter MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132144; ISAO K, 1990, NATURE, V345, P242, DOI 10.1038/345242a0; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Johnson PTJ, 2011, CONSERV BIOL, V25, P556, DOI 10.1111/j.1523-1739.2010.01645.x; Jorgensen T, 2012, MOL ECOL, V21, P1980, DOI 10.1111/j.1365-294X.2011.05278.x; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; LaMotte Company, 2017, SOIL TEXT TEST 1067; Levy-Booth DJ, 2007, SOIL BIOL BIOCHEM, V39, P2977, DOI 10.1016/j.soilbio.2007.06.020; Lewis B., 2007, NERR001; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; LORENZ MG, 1987, APPL ENVIRON MICROB, V53, P2948, DOI 10.1128/AEM.53.12.2948-2952.1987; Lydolph MC, 2005, APPL ENVIRON MICROB, V71, P1012, DOI 10.1128/AEM.71.2.1012-1017.2005; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.1890/0012-9658(2002)083[2387:HSDPBI]2.0.CO;2; Maggi F, 2013, J GEOPHYS RES-OCEANS, V118, P2118, DOI 10.1002/jgrc.20086; Marchetti MP, 2004, ECOL APPL, V14, P1507, DOI 10.1890/03-5173; Matisoo-Smith E, 2008, QUATERN INT, V184, P139, DOI 10.1016/j.quaint.2007.09.013; Mazerolle M. J., 2017, AICCMODAVG MODEL SEL; Oldham RS, 2000, HERPETOL J, V10, P143; PAGET E, 1992, FEMS MICROBIOL LETT, V97, P31, DOI 10.1111/j.1574-6968.1992.tb05435.x; Parducci L, 2013, MOL ECOL, V22, P3511, DOI 10.1111/mec.12298; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; R Development Core Team, 2016, R LANG ENV STAT COMP; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; RECORBET G, 1993, APPL ENVIRON MICROB, V59, P4289, DOI 10.1128/AEM.59.12.4289-4294.1993; Rees Helen C., 2017, BMC Research Notes, V10, P327, DOI 10.1186/s13104-017-2657-y; Rees HC, 2014, ECOL EVOL, V4, P4023, DOI 10.1002/ece3.1272; ROMANOWSKI G, 1991, APPL ENVIRON MICROB, V57, P1057, DOI 10.1128/AEM.57.4.1057-1061.1991; Saeki K, 2010, CURRENT RES TECHNOLO, V1, P188; Schmelzle MC, 2016, MOL ECOL RESOUR, V16, P895, DOI 10.1111/1755-0998.12501; Schmidt BR, 2013, METHODS ECOL EVOL, V4, P646, DOI 10.1111/2041-210X.12052; STEFFAN RJ, 1988, APPL ENVIRON MICROB, V54, P2908, DOI 10.1128/AEM.54.12.2908-2915.1988; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Unglaub B, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0103-3; United States Department of Agriculture, SOIL TEXT CALC; Voros J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170945; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2	67	44	48	9	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191737	10.1371/journal.pone.0191737	http://dx.doi.org/10.1371/journal.pone.0191737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352294	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300126
J	Fang, D; Sun, RY; Wilson, JR				Fang, Di; Sun, Renyuan; Wilson, Jeffrey R.			Joint modeling of correlated binary outcomes: The case of contraceptive use and HIV knowledge in Bangladesh	PLOS ONE			English	Article								Recent advances in statistical methods enable the study of correlation among outcomes through joint modeling, thereby addressing spillover effects. By joint modeling, we refer to simultaneously analyzing two or more different response variables emanating from the same individual. Using the 2011 Bangladesh Demographic and Health Survey, we jointly address spillover effects between contraceptive use (CUC) and knowledge of HIV and other sexually transmitted diseases. Jointly modeling these two outcomes is appropriate because certain types of contraceptive use contribute to the prevention of HIV and STDs and the knowledge and awareness of HIV and STDs typically lead to protection during sexual intercourse. In particular, we compared the differences as they pertained to the interpretive advantage of modeling the spillover effects of joint modeling HIV and CUC as opposed to addressing them separately. We also identified risk factors that determine contraceptive use and knowledge of HIV and STDs among women in Bangladesh. We found that by jointly modeling the correlation between HIV knowledge and contraceptive use, the importance of education decreased. The HIV prevention program had a spillover effect on CUC: what seemed to be impacted by education can be partially contributed to one's exposure to HIV knowledge. The joint model revealed a less significant impact of covariates as opposed to both separate models and standard models. Additionally, we found a spillover effect that would have otherwise been undiscovered if we did not jointly model. These findings further suggested that the simultaneous impact of correlated outcomes can be adequately addressed for the commonality between different responses and deflate, which is otherwise overestimated when examined separately.	[Fang, Di] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA; [Sun, Renyuan] Arizona State Univ, Sch Math & Stat Sci, Tempe, AZ USA; [Wilson, Jeffrey R.] Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA	University of Arkansas System; University of Arkansas Fayetteville; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Wilson, JR (corresponding author), Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA.	jeffrey.wilson@asu.edu		Fang, Di/0000-0002-0717-7576	National Institute of Health Alzheimer's Consortium [NHS0007]	National Institute of Health Alzheimer's Consortium	The authors appreciate support from the National Institute of Health Alzheimer's Consortium Fellowship Grant (Grant No. NHS0007).	[Anonymous], 2013, DEM HLTH SURV BDHS; Azim T, 2008, J HEALTH POPUL NUTR, V26, P311; Dunson DB, 2003, BIOMETRICS, V59, P521, DOI 10.1111/1541-0420.00062; Gardiner JC, 4352013 SAS GLOB FOR; Ghebremichael M, 2015, J APPL STAT, V42, P2180, DOI 10.1080/02664763.2015.1022138; Gueorguieva RV, 2001, J AM STAT ASSOC, V96, P1102, DOI 10.1198/016214501753208762; Guo X, 2004, AM STAT, V58, P16, DOI 10.1198/0003130042854; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Hubbard RA, 2009, J AM STAT ASSOC, V104, P912, DOI 10.1198/jasa.2009.ap08423; Irimata K, 2017, J APPL STAT IN PRESS; Khan HR., 2011, J DATA SCI, V9, P93; Khan HTA, 1997, CONTRACEPTION, V55, P91, DOI 10.1016/S0010-7824(96)00278-8; Liang Y, 2009, BIOMETRICS, V65, P377, DOI 10.1111/j.1541-0420.2008.01104.x; Song X, 2002, BIOMETRICS, V58, P742, DOI 10.1111/j.0006-341X.2002.00742.x; Stephenson R, 2007, AM J PUBLIC HEALTH, V97, P1233, DOI 10.2105/AJPH.2005.071522; WONG GY, 1985, J AM STAT ASSOC, V80, P513, DOI 10.2307/2288464; Zhu M, 0262014 SAS I INC	17	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190917	10.1371/journal.pone.0190917	http://dx.doi.org/10.1371/journal.pone.0190917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351328	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300031
J	Sirico, F; Miressi, S; Castaldo, C; Spera, R; Montagnani, S; Di Meglio, F; Nurzynska, D				Sirico, Felice; Miressi, Salvatore; Castaldo, Clotilde; Spera, Rocco; Montagnani, Stefania; Di Meglio, Franca; Nurzynska, Daria			Habits and beliefs related to food supplements: Results of a survey among Italian students of different education fields and levels	PLOS ONE			English	Article							USE DIETARY-SUPPLEMENTS; ENERGY DRINKS; SAFETY; ADULTS	The increasing availability of food supplements, aggressive media advertising, and common beliefs that these substances have only positive effects on health and sport performance indicate a need for continuous monitoring of this phenomenon. The aim of this study was to investigate the habits and beliefs related to diet supplementation among medical, health professional, and other university/high school students by means of a cross-sectional anonymous survey online. Among the respondents aware of supplements, 37.4% were taking or had taken them in the past. Food supplement use was more common among university students (in particular, those in health professional graduate courses) than high school students. Individual sport practice, rather than team sport, was associated with higher likelihood of food supplement use. Multivitamins were most commonly used, while weight-loss formulations were the least popular. Strikingly, filling nutrient gaps was statistically not considered the main reason for taking food supplements. Instead, they were used to enhance mental performance or enhance well-being. There was statistical evidence that students not enrolled in health or medical professional studies strongly agreed more often than medical students that taking food supplements prevents illness. These results indicate a striking difference between the evidence-based and personal reasons for food supplement use. Arguably, it calls for an improvement in education about diet supplementation and a change in attitude of health care providers to its implementation.	[Sirico, Felice; Miressi, Salvatore; Castaldo, Clotilde; Spera, Rocco; Montagnani, Stefania; Di Meglio, Franca; Nurzynska, Daria] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy	University of Naples Federico II	Sirico, F (corresponding author), Univ Naples Federico II, Dept Publ Hlth, Naples, Italy.	sirico.felice@gmail.com	Nurzynska, Daria/A-2161-2010; Sirico, Felice/O-9705-2019; saez, lourdes basurto/AAO-6641-2020	Nurzynska, Daria/0000-0003-1092-6168; Sirico, Felice/0000-0001-6801-3308; Castaldo, Clotilde/0000-0003-1475-5036				Ashar BH, 2007, ARCH INTERN MED, V167, P966, DOI 10.1001/archinte.167.9.966; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; Barnes PM, 2008, NATL HLTH STAT REPOR, P1; Biesalski HK, 2017, NUTRITION, V33, P76, DOI 10.1016/j.nut.2016.02.013; Cellini M, 2013, MED SCI SPORT EXER, V45, P23, DOI 10.1249/MSS.0b013e318269904f; Chiba T, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0239-4; Conner M, 2001, SOC SCI MED, V52, P621, DOI 10.1016/S0277-9536(00)00165-9; Council for Responsible Nutrition, CRN 2016 ANN SURV DI; Dickinson A, 2014, J AM COLL NUTR, V33, P176, DOI 10.1080/07315724.2013.875423; Duchan E, 2010, PHYSICIAN SPORTSMED, V38, P171, DOI 10.3810/psm.2010.06.1796; European Food Safety Authority, DIET REF VAL NUTR SU; European Food Safety Authority, US SUPPL OTH MIN VIT; European Food Safety Authority, OP PUBL CONS REL EV; Food and Drug Administration, 2016, FED REG MAY 27, V81, P33742; Frey A, 2017, PUBLIC HEALTH NUTR, V20, P2173, DOI [10.1017/S1368980017001021, 10.1017/s1368980017001021]; Greger JL, 2001, J NUTR, V131, p1339S, DOI 10.1093/jn/131.4.1339S; Haller CA, 2008, J MED TOXICOL, V4, P84, DOI 10.1007/BF03160960; Kang HG, 2017, FOOD NUTR RES, V61, DOI 10.1080/16546628.2017.1361769; Kirk Sara, 1998, Proceedings of the Nutrition Society, V57, p54A; Nichter M, 2006, CULT MED PSYCHIAT, V30, P175, DOI 10.1007/s11013-006-9016-0; Pajor EM, 2017, APPETITE, V114, P161, DOI 10.1016/j.appet.2017.03.036; Rao N, 2017, J MED TOXICOL, V13, P227, DOI 10.1007/s13181-017-0623-7; Richards Gareth, 2016, Journal of Caffeine Research, V6, P49, DOI 10.1089/jcr.2015.0033; Schwingshackl L, 2017, ADV NUTR, V8, P27, DOI 10.3945/an.116.013516; Scientific Committee on Food; Scientific Panel on Dietetic Products Nutrition and Allergies, TOL UPP INT LEV VIT; Sebastian RS, 2007, J AM DIET ASSOC, V107, P1322, DOI 10.1016/j.jada.2007.05.010; The European Food Safety Authority, FOOD SUPPL; Troppmann L, 2002, J AM DIET ASSOC, V102, P818, DOI 10.1016/S0002-8223(02)90183-5; Ulbricht C, 2008, CURR DRUG METAB, V9, P1063, DOI 10.2174/138920008786927785	29	48	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191424	10.1371/journal.pone.0191424	http://dx.doi.org/10.1371/journal.pone.0191424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351568	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300088
J	Duarte, K; Monnez, JM; Albuisson, E				Duarte, Kevin; Monnez, Jean-Marie; Albuisson, Eliane			Sequential linear regression with online standardized data	PLOS ONE			English	Article							STOCHASTIC-APPROXIMATION	The present study addresses the problem of sequential least square multidimensional linear regression, particularly in the case of a data stream, using a stochastic approximation process. To avoid the phenomenon of numerical explosion which can be encountered and to reduce the computing time in order to take into account a maximum of arriving data, we propose using a process with online standardized data instead of raw data and the use of several observations per step or all observations until the current step. Herein, we define and study the almost sure convergence of three processes with online standardized data: a classical process with a variable step-size and use of a varying number of observations per step, an averaged process with a constant step-size and use of a varying number of observations per step, and a process with a variable or constant step-size and use of all observations until the current step. Their convergence is obtained under more general assumptions than classical ones. These processes are compared to classical processes on 11 datasets for a fixed total number of observations used and thereafter for a fixed processing time. Analyses indicate that the third-defined process typically yields the best results.	[Duarte, Kevin; Monnez, Jean-Marie; Albuisson, Eliane] Univ Lorraine, Inst Elie Cartan Lorraine, UMR 7502, F-54506 Vandoeuvre Les Nancy, France; [Duarte, Kevin; Monnez, Jean-Marie] INRIA, Project Team BIGS, F-54600 Villers Les Nancy, France; [Duarte, Kevin; Monnez, Jean-Marie] Univ Lorraine, Ctr Invest Clin Plurithemat 1433, INSERM U1116, Nancy, France; [Monnez, Jean-Marie] Univ Lorraine, Inst Univ Technol Nancy Charlemagne, F-54052 Nancy, France; [Albuisson, Eliane] CHRU Nancy, Pole S2R, BIOBASE, Vandoeuvre Les Nancy, France; [Albuisson, Eliane] InSciDenS, Fac Med, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Lorraine; Inria; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine; CHU de Nancy; Universite de Lorraine	Duarte, K (corresponding author), Univ Lorraine, Inst Elie Cartan Lorraine, UMR 7502, F-54506 Vandoeuvre Les Nancy, France.; Duarte, K (corresponding author), INRIA, Project Team BIGS, F-54600 Villers Les Nancy, France.; Duarte, K (corresponding author), Univ Lorraine, Ctr Invest Clin Plurithemat 1433, INSERM U1116, Nancy, France.	k.duarte@chru-nancy.fr			French National Research Agency (ANR) as part of the second "Investissements d'Avenir" programme [ANR-15-RHU-0004]	French National Research Agency (ANR) as part of the second "Investissements d'Avenir" programme(French National Research Agency (ANR))	This work is supported by a public grant overseen by the French National Research Agency (ANR) as part of the second "Investissements d'Avenir" programme (reference: ANR-15-RHU-0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ARXIV E PRINTS; Bach F., 2013, ADV NEURAL INFORM PR, V26, P773; Bottou L, 2017, ARXIV160604838V2; Bottou U, 2005, APPL STOCH MODEL BUS, V21, P137, DOI 10.1002/asmb.538; Duchi J, 2011, J MACH LEARN RES, V12, P2121; Gyorfi L, 1996, SIAM J CONTROL OPTIM, V34, P31, DOI 10.1137/S0363012992226661; Johnson R., 2013, ADV NEURAL INF PROCE, V26, P315; LJUNG L, 1984, IEEE T INFORM THEORY, V30, P151, DOI 10.1109/TIT.1984.1056895; Monnez JM, 1979, STAT ANAL DONNEES, V4, P11; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; POLYAK BT, 1990, AUTOMAT REM CONTR+, V51, P937; POLYAK BT, 1992, SIAM J CONTROL OPTIM, V30, P838, DOI 10.1137/0330046; Robbins H., 1971, P S OH STAT U COL O, P233, DOI DOI 10.1016/B978-0-12-604550-5.50015-8; Schmetterer L., 1969, MULTIVARIATE ANAL, P443; VENTER JH, 1966, ANN MATH STAT, V37, P1534, DOI 10.1214/aoms/1177699145; Xu W., 2011, ARXIV11072490V2	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191186	10.1371/journal.pone.0191186	http://dx.doi.org/10.1371/journal.pone.0191186			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346392	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500035
J	Fores, R; Alzamora, MT; Pera, G; Baena-Diez, JM; Mundet-Tuduri, X; Toran, P				Fores, Rosa; Teresa Alzamora, Maria; Pera, Guillem; Miguel Baena-Diez, Jose; Mundet-Tuduri, Xavier; Toran, Pere			Contribution of the ankle-brachial index to improve the prediction of coronary risk: The ARTPER cohort	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; HEART-DISEASE; CARDIOVASCULAR-DISEASE; TASK-FORCE; OCCLUSIVE DISEASE; EUROPEAN-SOCIETY; ASSOCIATION; MORTALITY; MARKERS; EVENTS	Background The different cardiovascular risk prediction scales currently available are not sufficiently sensitive. Aim The aim of the present study was to analyze the contribution of the ankle-brachial index (ABI) added to the Framingham and REGICOR risk scales for the reclassification of cardiovascular risk after a 9-year follow up of a Mediterranean population with low cardiovascular risk. Design and setting A population-based prospective cohort study was performed in the province of Barcelona, Spain. Method A total of 3,786 subjects >49 years were recruited from 2006-2008. Baseline ABI was performed and cardiovascular risk was calculated with the Framingham and REGICOR scales. The participants were followed until November 2016 by telephone and review of the clinical history every 6 months to confirm the possible appearance of cardiovascular events. Results 2,716 individuals participated in the study. There were 126 incidental cases of first coronary events (5%) during follow up. The incidence of coronary events in patients with ABI <0.9 was 4-fold greater than that of subjects with a normal ABI (17.2/1,000 persons-year versus 4.8/1,000 persons-year). Improvement in the predictive capacity of REGICOR scale was observed on including ABI in the model, obtaining a net reclassification improvement of 7% (95% confidence interval 0%-13%) for REGICOR+ ABI. Framingham + ABI obtained a NRI of 4% (-2%-11%). Conclusion The results of the present study support the addition of the ABI as a tool to help in the reclassification of cardiovascular risk and to confirm the greater incidence of coronary events in patients with ABI < 0.9.	[Fores, Rosa; Teresa Alzamora, Maria] Inst Catala Salut, Direccio Atencio Primaria Barcelones Nord & Mares, Ctr Atencio Primaria Riu Nord Riu Sud Santa Colom, Barcelona, Spain; [Fores, Rosa; Teresa Alzamora, Maria; Pera, Guillem; Toran, Pere] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Metropolitana Nord, Mataro, Spain; [Fores, Rosa; Mundet-Tuduri, Xavier] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Miguel Baena-Diez, Jose] Inst Catala Salut, Direccio Atencio Primaria Barcelona Ciutat, Ctr Atencio Primaria La Marina, Barcelona, Spain; [Miguel Baena-Diez, Jose] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Barcelona, Spain; [Mundet-Tuduri, Xavier] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Barcelona, Barcelona, Spain	Autonomous University of Barcelona	Fores, R (corresponding author), Inst Catala Salut, Direccio Atencio Primaria Barcelones Nord & Mares, Ctr Atencio Primaria Riu Nord Riu Sud Santa Colom, Barcelona, Spain.; Fores, R (corresponding author), Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Metropolitana Nord, Mataro, Spain.; Fores, R (corresponding author), Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain.	rfores.bnm.ics@gencat.cat	Torán-Monserrat, Pere/AAY-4396-2021	Torán-Monserrat, Pere/0000-0002-9865-7427; Pera, Guillem/0000-0003-3188-7268; Fores Raurell, Rosa/0000-0001-7803-7442	Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain); National Research Program; Technical, Scientific and Innovation Research National Plan [PI15/00510]; European Union ERDF funds	Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain)(Spanish Government); National Research Program; Technical, Scientific and Innovation Research National Plan; European Union ERDF funds(European Commission)	This project received a research grant from the Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain), awarded in the 2015 call under the Health Strategy Action 2013-2016, within the National Research Program oriented to Societal Challenges, within the Technical, Scientific and Innovation Research National Plan 2013-2016, with reference PI15/00510 (to MTA), co-funded with European Union ERDF funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alzamora MT, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-348; [Anonymous], 2012, BRIT MED J, DOI DOI 10.1136/BMJ.E4181; Baena-Diez JM, 2011, REV ESP CARDIOL, V64, P186, DOI 10.1016/j.recesp.2010.10.024; Calonge N, 2009, ANN INTERN MED, V151, P474, DOI 10.7326/0003-4819-151-7-200910060-00008; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Criqui MH, 2010, J AM COLL CARDIOL, V56, P1506, DOI 10.1016/j.jacc.2010.04.060; Davies JH, 2017, BRIT J GEN PRACT, V67, pE103, DOI 10.3399/bjgp17X689137; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2014, EUR J PREV CARDIOL, V21, P310, DOI 10.1177/2047487313516564; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hirsch AT, 2006, CIRCULATION, V113, P1474, DOI 10.1161/CIRCULATIONAHA.106.173994; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Lee AJ, 2004, CIRCULATION, V110, P3075, DOI 10.1161/01.CIR.0000143102.38256.DE; Lin JS, 2013, ANN INTERN MED, V159, P333, DOI 10.7326/0003-4819-159-5-201309030-00007; Marrugat J, 2003, J EPIDEMIOL COMMUN H, V57, P634, DOI 10.1136/jech.57.8.634; Marrugat J, 2011, REV ESP CARDIOL, V64, P385, DOI 10.1016/j.recesp.2010.12.011; Marrugat J, 2007, J EPIDEMIOL COMMUN H, V61, P40, DOI 10.1136/jech.2005.038505; Merino J, 2008, EUR J VASC ENDOVASC, V36, P71, DOI 10.1016/j.ejvs.2008.01.029; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Murphy TP, 2012, ATHEROSCLEROSIS, V220, P160, DOI 10.1016/j.atherosclerosis.2011.10.037; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Peters SAE, 2012, HEART, V98, P177, DOI 10.1136/heartjnl-2011-300747; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1016/j.atherosclerosis.2016.05.037, 10.1177/2047487316653709]; Rodondi N, 2010, AM J EPIDEMIOL, V171, P540, DOI 10.1093/aje/kwp428; Taxes dIncidencia i prevalenqa a lAtencio Prima ria, 2002, TAX INC PREV AT PRIM; Alzamora MT, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-119; Alzamora MT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-38; Velescu A, 2015, ATHEROSCLEROSIS, V241, P357, DOI 10.1016/j.atherosclerosis.2015.05.017; Vlachopoulos C, 2015, ATHEROSCLEROSIS, V241, P507, DOI 10.1016/j.atherosclerosis.2015.05.007; Weatherley Beth D, 2007, BMC Cardiovasc Disord, V7, P3, DOI 10.1186/1471-2261-7-3; Wierzbicki AS, 2012, INT J CLIN PRACT, V66, P622, DOI 10.1111/j.1742-1241.2012.02956.x; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yeboah J, 2015, CIRCULATION, V132, P916, DOI 10.1161/CIRCULATIONAHA.115.016846; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	40	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191283	10.1371/journal.pone.0191283	http://dx.doi.org/10.1371/journal.pone.0191283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338049	Green Submitted, Green Published, gold			2022-12-27	WOS:000422652700046
J	Graham, RMA; Hiley, L; Rathnayake, IU; Jennison, AV				Graham, Rikki M. A.; Hiley, Lester; Rathnayake, Irani U.; Jennison, Amy V.			Comparative genomics identifies distinct lineages of S. Enteritidis from Queensland, Australia	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; SALMONELLA-ENTERITIDIS; ANTIMICROBIAL RESISTANCE; HOST ADAPTATION; VIRULENCE GENES; SEQUENCE; STRAINS; MODEL; TYPHIMURIUM; MUTAGENESIS	Salmonella enterica is a major cause of gastroenteritis and foodborne illness in Australia where notification rates in the state of Queensland are the highest in the country. S. Enteritidis is among the five most common serotypes reported in Queensland and it is a priority for epidemiological surveillance due to concerns regarding its emergence in Australia. Using whole genome sequencing, we have analysed the genomic epidemiology of 217 S. Enteritidis isolates from Queensland, and observed that they fall into three distinct clades, which we have differentiated as Clades A, B and C. Phage types and MLST sequence types differed between the clades and comparative genomic analysis has shown that each has a unique profile of prophage and genomic islands. Several of the phage regions present in the S. Enteritidis reference strain P125109 were absent in Clades A and C, and these clades also had difference in the presence of pathogenicity islands, containing complete SPI-6 and SPI-19 regions, while P125109 does not. Antimicrobial resistance markers were found in 39 isolates, all but one of which belonged to Clade B. Phylogenetic analysis of the Queensland isolates in the context of 170 international strains showed that Queensland Clade B isolates group together with the previously identified global Glade, while the other two clades are distinct and appear largely restricted to Australia. Locally sourced environmental isolates included in this analysis all belonged to Clades A and C, which is consistent with the theory that these clades are a source of locally acquired infection, while Clade B isolates are mostly travel related.	[Graham, Rikki M. A.; Hiley, Lester; Rathnayake, Irani U.; Jennison, Amy V.] Queensland Dept Hlth, Publ Hlth Microbiol Forens & Sci Serv, Coopers Plains, Qld, Australia	Queensland Health	Graham, RMA (corresponding author), Queensland Dept Hlth, Publ Hlth Microbiol Forens & Sci Serv, Coopers Plains, Qld, Australia.	rikki.graham@health.qld.gov.au						Abraham S, 2014, INT J ANTIMICROB AG, V43, P126, DOI 10.1016/j.ijantimicag.2013.10.014; Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Agron PG, 2001, APPL ENVIRON MICROB, V67, P4984, DOI 10.1128/AEM.67.11.4984-4991.2001; Allard MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055254; [Anonymous], 1996, Commun Dis Rep CDR Wkly, V6, P109; Asai T, 2008, NEW MICROBIOL, V31, P555; Ashton PM, 2016, PEERJ, V4, DOI 10.7717/peerj.1752; Astridge K, 2015, COMMUN DIS INTELL, V39, pE236; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bell R, 2010, COMMUN DIS INTELL, V34, P396; Ben Salem R, 2017, J INFECT PUBLIC HEAL, V10, P855, DOI 10.1016/j.jiph.2017.01.012; Betancor L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-237; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Crump JA, 2011, ANTIMICROB AGENTS CH, V55, P1148, DOI 10.1128/AAC.01333-10; Deng XY, 2014, EMERG INFECT DIS, V20, P1481, DOI 10.3201/eid2009.131095; Department of Health, 2015, AUSTR NAT NOT DIS CA; Feasey NA, 2016, NAT GENET, V48, P1211, DOI 10.1038/ng.3644; Ford L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163989; Fuentes JA, 2008, RES MICROBIOL, V159, P279, DOI 10.1016/j.resmic.2008.02.006; Hanna LF, 2012, APPL ENVIRON MICROB, V78, P1785, DOI 10.1128/AEM.07241-11; Hendriksen RS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-92; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Hur J, 2011, VET J, V189, P306, DOI 10.1016/j.tvjl.2010.07.017; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Kwag SI, 2008, J VET MED SCI, V70, P1031, DOI 10.1292/jvms.70.1031; Langridge GC, 2015, P NATL ACAD SCI USA, V112, P863, DOI 10.1073/pnas.1416707112; Magnet S, 1999, J BACTERIOL, V181, P6650, DOI 10.1128/JB.181.21.6650-6655.1999; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Marttinen P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr928; Matthews TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126883; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Olson AB, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-87; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Porwollik S, 2005, J BACTERIOL, V187, P6545, DOI 10.1128/JB.187.18.6545-6555.2005; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Santiviago CA, 2010, J BACTERIOL, V192, P2246, DOI 10.1128/JB.00270-09; Shah DH, 2012, INFECT IMMUN, V80, P4203, DOI 10.1128/IAI.00790-12; Shah DH, 2005, MICROBIOL-SGM, V151, P3957, DOI 10.1099/mic.0.28126-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Thong KL, 2016, MICROB DRUG RESIST, V22, P259, DOI 10.1089/mdr.2015.0158; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Vishwakarma V, 2012, INFECT IMMUN, V80, P3236, DOI 10.1128/IAI.00180-12; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang S, 2015, J CLIN MICROBIOLOGY; Zheng J, 2007, EMERG INFECT DIS, V13, P1932, DOI 10.3201/eid1312.070185; Zheng J, 2014, J CLIN MICROBIOL, V52, P1490, DOI 10.1128/JCM.00051-14; Zou M, 2012, FOODBORNE PATHOG DIS, V9, P232, DOI 10.1089/fpd.2011.1012	52	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191042	10.1371/journal.pone.0191042	http://dx.doi.org/10.1371/journal.pone.0191042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338017	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700026
J	Farshadpour, F; Taherkhani, R; Ravanbod, MR; Eghbali, SS; Taherkhani, S; Mandavi, E				Farshadpour, Fatemeh; Taherkhani, Reza; Ravanbod, Mohamad Reza; Eghbali, Seyed Sajjad; Taherkhani, Sakineh; Mandavi, Easa			Prevalence, risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran	PLOS ONE			English	Article							HIGHLY PREVALENT; SEROPREVALENCE; PCR; EPIDEMIOLOGY; ANTIBODIES; AFRICA	Background Although Iran is reported to be an endemic country for hepatitis E virus (HEV), data on the prevalence of HEV infection among pregnant women are scarce and the epidemiology of HEV is unknown in most parts of the country. Therefore, this study was conducted to elucidate the prevalence, risk factors and genotypic pattern of HEV infection among pregnant women resident in the northern shores of Persian Gulf. This is the first report on the epidemiology of HEV infection among pregnant women in this territory. Methods From October 2016 to May 2017, 1331 pregnant women participated in this study. The mean age +/- SD of participants was 27.93 +/- 5.7 years with a range of 14-45 years. Serum samples of pregnant women were screened for the presence of anti-HEV total antibodies, anti-HEV IgG and anti-HEV IgM using commercially available ELISA kits (DIA.PRO, Milan, Italy). All anti-HEV IgG and anti-HEV IgM positive samples were tested for HEV RNA using two independent reverse transcriptase polymerase chain reaction (RT-PCR) assays, targeting ORF2 and ORF3 of HEV genome. In addition, 92 anti-HEV seronegative samples as well as 50 pooled seronegative samples were evaluated by two independent RT-PCR assays for validation of results. Results Of the 1331 pregnant women, 84 women (6.3%, 95% Cl: 5.1%-7.7%) were positive for anti-HEV antibodies, of which 83 women had anti-HEV IgG, and 11 women (0.83%, 95% Cl: 0.47%-1.47%) had anti-HEV IgM. The highest rate of HEV seroprevalence was observed among Afghan immigrants (68.0%), uneducated pregnant women (46.51 %) and those residents in Bushehr city (8.75%). All anti-HEV IgG and/or IgM positive samples were found to be negative for HEV RNA. In addition, all of the evaluated anti-HEV seronegative samples were negative for HEV RNA. HEV seropositivity among pregnant women was statistically associated with age, ethnicity, place of residence,number of pregnancies, and level of education. So that, low education levels, Afghan, residence in Bushehr city, age group >34 years, and more parities were risk factors for exposure to HEV. In contrast, HEV seropositivity was not associated with stage of gestation, history of abortion, and time of sampling. Conclusion The northern shores of Persian Gulf in Iran, with HEV seroprevalence of 6.3%, can be classified as an endemic geographical region for hepatitis E, and residents of Bushehr city, Afghan immigrants and uneducated women are the main at-risk populations in this territory.	[Farshadpour, Fatemeh; Taherkhani, Reza; Eghbali, Seyed Sajjad] Bushehr Univ Med Sci, Persian Gulf Trop Med Res Ctr, Bushehr, Iran; [Ravanbod, Mohamad Reza] Bushehr Univ Med Sci, Sch Med, Dept Internal Med, Bushehr, Iran; [Taherkhani, Sakineh] Shahroud Univ Med Sci, Sch Nursing & Midwifery, Reprod Hlth & Midwifery Dept, Shahroud, Iran; [Mandavi, Easa] Bushehr Univ Med Sci, Student Res Comm, Bushehr, Iran	Shahroud University Medical Sciences	Taherkhani, R (corresponding author), Bushehr Univ Med Sci, Persian Gulf Trop Med Res Ctr, Bushehr, Iran.	taherkhanireza2005@yahoo.com	Taherkhani, Sakineh/P-3990-2018; Eghnali, Sajjad/H-2810-2018	Taherkhani, Sakineh/0000-0003-3161-0963; 	Deputy Research and Affairs of Bushehr University of Medical Sciences [3253]	Deputy Research and Affairs of Bushehr University of Medical Sciences	This study was supported financially by the Deputy Research and Affairs of Bushehr University of Medical Sciences with grant number 3253. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180078; Adjei AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-108; Ahmed A, 2015, INT J HEPATOL, V2015, DOI 10.1155/2015/872431; Alvarado-Esquivel C, 2014, ANN HEPATOL, V13, P510, DOI 10.1016/S1665-2681(19)31250-5; Asaei S, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.19311v2; Begum N, 2009, INDIAN J MED RES, V130, P709; Caron M, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-158; Cevrioglu AS, 2004, J OBSTET GYNAECOL RE, V30, P48, DOI 10.1111/j.1341-8076.2004.00155.x; De Paschale M, 2016, TROP MED INT HEALTH, V21, P108, DOI 10.1111/tmi.12632; Eick A, 2010, J INFECT DIS, V202, P1302, DOI 10.1086/656598; Farshadpour Fatemeh, 2015, Hepat Res Treat, V2015, P759589, DOI 10.1155/2015/759589; Ghezeldasht SA, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10255; Gu GY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1308-y; Huang FF, 2002, J CLIN MICROBIOL, V40, P1326, DOI 10.1128/JCM.40.4.1326-1332.2002; Inoue J, 2006, J VIROL METHODS, V137, P325, DOI 10.1016/j.jviromet.2006.07.004; Kamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13; Khameneh ZRostamzadeh, 2013, IRAN HEPAT MON, V13; Kumar A, 2010, JIMSA, V23, P281; Kumar RM, 2001, EUR J OBSTET GYN R B, V100, P9, DOI 10.1016/S0301-2115(01)00448-1; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lee Ga Young, 2015, World J Virol, V4, P343, DOI 10.5501/wjv.v4.i4.343; Mamani M., 2015, AVICENNA J CLIN MICR, V2, P25339, DOI [10.17795/ajcmi-25339, DOI 10.17795/AJCMI-25339]; Marano G, 2015, BLOOD TRANSFUS-ITALY, V13, P6, DOI 10.2450/2014.0063-14; Lindemann MLM, 2010, J MED VIROL, V82, P1666, DOI 10.1002/jmv.21840; Musa AO, 2016, MEDITERR J BIO, V1, P83; Navaneethan U, 2008, LIVER INT, V28, P1190, DOI 10.1111/j.1478-3231.2008.01840.x; Rasti M, 2014, JENTASHAPIR J HLTH R, V5, P101; Renou C, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-68; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P95, DOI 10.1016/j.trstmh.2004.12.005; Tabarraei A, NORTH EAST OF CASPIA; Taherkhani R, 2016, J CLIN TRANSL HEPATO, V4, P269, DOI 10.14218/JCTH.2016.00013; Taherkhani R, 2016, WORLD J GASTROENTERO, V22, P5143, DOI 10.3748/wjg.v22.i22.5143; Taherkhani R, 2014, ANN LAB MED, V34, P118, DOI 10.3343/alm.2014.34.2.118; Perez-Gracia MT, 2015, J CLIN TRANSL HEPATO, V3, P117, DOI 10.14218/JCTH.2015.00009; Teshale EH, 2011, WORLD J HEPATOL, V3, P285, DOI 10.4254/wjh.v3.i12.285; Yazbek S, 2016, INFECTION, V44, P11, DOI 10.1007/s15010-015-0807-5	36	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191090	10.1371/journal.pone.0191090	http://dx.doi.org/10.1371/journal.pone.0191090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329329	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000419954100037
J	Perry, BD; Rahnert, JA; Xie, Y; Zheng, B; Woodworth-Hobbs, ME; Price, SR				Perry, Ben D.; Rahnert, Jill A.; Xie, Yang; Zheng, Bin; Woodworth-Hobbs, Myra E.; Price, S. Russ			Palmitate-induced ER stress and inhibition of protein synthesis in cultured myotubes does not require Toll-like receptor 4	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; INDUCED INFLAMMATION; MYOKINE GENES; ACTIVATION; EXPRESSION; CASPASE-3; TAK-242; ATROPHY	Saturated fatty acids, such as palmitate, are elevated in metabolically dysfunctional conditions like type 2 diabetes mellitus. Palmitate has been shown to impair insulin sensitivity and suppress protein synthesis while upregulating proteolytic systems in skeletal muscle. Increased sarco/endoplasmic reticulum (ER) stress and subsequent activation of the unfolded protein response may contribute to the palmitate-induced impairment of muscle protein synthesis. In some cell types, ER stress occurs through activation of the Toll-like receptor 4 (TLR4). Given the link between ER stress and suppression of protein synthesis, we investigated whether palmitate induces markers of ER stress and protein synthesis by activating TLR4 in cultured mouse C2C12 myotubes. Myotubes were treated with vehicle, a TLR4-specific ligand (lipopolysaccharides), palmitate, or a combination of palmitate plus a TLR4-specific inhibitor (TAK-242). Inflammatory indicators of TLR4 activation (IL-6 and TNF-alpha) and markers of ER stress were measured, and protein synthesis was assessed using puromycin incorporation. Palmitate substantially increased the levels of IL-6, TNF-alpha, CHOP, XBP1 s, and ATF 4 mRNAs and augmented the levels of CHOP, XBP1 s, phospho-PERK and phospho-elF2 alpha proteins. The TLR4 antagonist attenuated both acute palmitate and LPS-induced increases in IL-6 and TNF alpha, but did not reduce ER stress signaling with either 6 h or 24 h palmitate treatment. Similarly, treating myotubes with palmitate for 6 h caused a 43% decline in protein synthesis consistent with an increase in phospho-elF2 alpha, and the TLR4 antagonist did not alter these responses. These results suggest that palmitate does not induce ER stress through TLR4 in muscle, and that palmitate impairs protein synthesis in skeletal muscle in part by induction of ER stress.	[Perry, Ben D.; Rahnert, Jill A.; Xie, Yang; Zheng, Bin; Woodworth-Hobbs, Myra E.; Price, S. Russ] Emory Univ, Dept Med, Renal Div, Atlanta, GA 30322 USA; [Woodworth-Hobbs, Myra E.] Emory Univ, Emory Coll Arts & Sci, Ctr Study Human Hlth, Atlanta, GA 30322 USA; [Price, S. Russ] Atlanta VA Med Ctr, Decatur, GA 30033 USA; [Price, S. Russ] East Carolina Univ, Dept Biochem & Mol Biol, Brody Sch Med, Greenville, NC 27858 USA	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; University of North Carolina; East Carolina University	Price, SR (corresponding author), Emory Univ, Dept Med, Renal Div, Atlanta, GA 30322 USA.; Price, SR (corresponding author), Atlanta VA Med Ctr, Decatur, GA 30033 USA.; Price, SR (corresponding author), East Carolina Univ, Dept Biochem & Mol Biol, Brody Sch Med, Greenville, NC 27858 USA.	Pricest17@ecu.edu		Perry, Ben/0000-0002-2834-8004	National Institutes of Health [R01 DK95610, T32 DK007656]; Department of Veteran's Affairs Merit [X01BX001456]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran's Affairs Merit(US Department of Veterans Affairs)	This study was funded through the following grants: Professor Russ Price was awarded a National Institutes of Health R01 DK95610, and Department of Veteran's Affairs Merit X01BX001456 and Dr. Ben Perry was awarded a National Institutes of Health T32 DK007656 fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrazi A, 2014, J BIOL CHEM, V289, P9584, DOI 10.1074/jbc.M113.526517; Almurdhi MM, 2016, DIABETES CARE, V39, P441, DOI 10.2337/dc15-0995; BRODIE C, 1990, CELL MOL NEUROBIOL, V10, P217, DOI 10.1007/BF00734575; Bryner RW, 2012, ISRN OBES, V2012, P647348; Cao SS, 2016, J CELL PHYSIOL, V231, P288, DOI 10.1002/jcp.25098; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Deldicque L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020993; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Ebert SM, 2015, J BIOL CHEM, V290, P25497, DOI 10.1074/jbc.M115.681445; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; FALHOLT K, 1988, DIABETIC MED, V5, P27, DOI 10.1111/j.1464-5491.1988.tb00936.x; Fox DK, 2014, AM J PHYSIOL-ENDOC M, V307, pE245, DOI 10.1152/ajpendo.00010.2014; Gao YM, 2008, J APPL PHYSIOL, V105, P1772, DOI 10.1152/japplphysiol.90636.2008; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hussey SE, 2014, DIABETOLOGIA, V57, P582, DOI 10.1007/s00125-013-3111-x; Hussey SE, 2013, BIOSCIENCE REP, V33, P37, DOI 10.1042/BSR20120098; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; KANNEL WB, 1985, AM HEART J, V110, P1100, DOI 10.1016/0002-8703(85)90224-8; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kozlov AV, 2009, BBA-MOL BASIS DIS, V1792, P521, DOI 10.1016/j.bbadis.2009.03.004; Kuribayashi JS, 2008, MOL IMMUNOL, V45, P2990, DOI 10.1016/j.molimm.2008.01.013; Kwon B, 2015, BIOCHIMIE, V118, P141, DOI 10.1016/j.biochi.2015.09.006; Leamy AK, 2014, J LIPID RES, V55, P1478, DOI 10.1194/jlr.M050237; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Nozhenko Y, 2015, CELL PHYSIOL BIOCHEM, V35, P92, DOI 10.1159/000369678; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patsouris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110653; Perry BD, 2016, EXERC IMMUNOL REV, V22, P94; Pierre N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065061; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sadeghi A, 2017, J CELL BIOCHEM, V118, P2654, DOI 10.1002/jcb.25868; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Santomauro ATMG, 1999, DIABETES, V48, P1836, DOI 10.2337/diabetes.48.9.1836; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tardif N, 2014, AGING CELL, V13, P1001, DOI 10.1111/acel.12263; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Urano F, 2000, J CELL SCI, V113, P3697; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Wang XNH, 2010, J BIOL CHEM, V285, P21249, DOI 10.1074/jbc.M109.041707; Woo CW, 2012, NAT CELL BIOL, V14, P192, DOI 10.1038/ncb2408; Woodworth-Hobbs ME, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13530; Woodworth-Hobbs ME, 2014, J NUTR BIOCHEM, V25, P868, DOI 10.1016/j.jnutbio.2014.03.017; Yang M, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-104; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010; Zhang Q, 2016, DIS MARKERS, V2016, P1, DOI 10.1155/2016/3547096; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480	59	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191313	10.1371/journal.pone.0191313	http://dx.doi.org/10.1371/journal.pone.0191313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329354	gold, Green Published, Green Submitted			2022-12-27	WOS:000419954100059
J	Kim, EK; Moon, S; Kim, DK; Zhang, XL; Kim, J				Kim, Eun Kyoung; Moon, Sook; Kim, Do Kyeong; Zhang, Xianglan; Kim, Jin			CXCL1 induces senescence of cancer-associated fibroblasts via autocrine loops in oral squamous cell carcinoma	PLOS ONE			English	Article							STROMAL FIBROBLASTS; EPITHELIAL-CELLS; TUMOR STROMA; TGF-BETA; PROGRESSION; TUMORIGENESIS; GROWTH; METASTASIS; ACTIVATION; TRANSITION	Cancer-associated fibroblasts (CAFs) have emerged as one of the main factors related to cancer progression, however, the conversion mechanism of normal fibroblasts (NOFs) to CAFs has not been well elucidated. The aim of this study was to investigate the underlying mechanism of CAF transformation from NOFs in oral squamous cell carcinoma (OSCC). This study found that NOFs exposed to OSCC cells transformed to senescent cells. The cytokine antibody array showed the highest secretion levels of IL-6 and CXCL1 in NOFs co-cultured with OSCC cells. Despite that both IL-6 and CXCL1 induced the senescent phenotype of CAFs, CXCL1 secretion showed a cancer-specific response to transform NOFs into CAFs in OSCC, whereas IL-6 secretion was eventuated by common co-culture condition. Further, CXCL1 was released from NOFs co-cultured with OSCC cells, however, CXCL1 was undetectable in mono-cultured NOFs or co-cultured OSCC cells with NOFs. Taken together, this study demonstrates that CXCL1 can transform NOFs into senescent CAFs via an autocrine mechanism. These data might contribute to further understanding of CAFs and to development of a potential therapeutic approach targeting cancer cells-CAFs interactions.	[Kim, Eun Kyoung; Moon, Sook; Kim, Do Kyeong; Zhang, Xianglan; Kim, Jin] Yonsei Univ, Coll Dent, Dept Oral Pathol, Oral Canc Res Inst, Seoul, South Korea; [Moon, Sook] Sorabol Coll, Coll Nursing Healthcare, Dept Dent Hyg, Gyeongju, South Korea; [Zhang, Xianglan] Yanbian Univ Hosp, Dept Pathol, Yanji, Jilin, Peoples R China	Yonsei University; Yonsei University Health System; Yanbian University	Kim, J (corresponding author), Yonsei Univ, Coll Dent, Dept Oral Pathol, Oral Canc Res Inst, Seoul, South Korea.	jink@yuhs.ac			Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0094027]	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by the Priority Research Centers Program through the National Research Foundation of Korea (NRF)(http://www.nrf.re.kr/) funded by the Ministry of Education, Science and Technology [2009-0094027]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JY, 2014, NEOPLASIA, V16, P928, DOI 10.1016/j.neo.2014.09.003; Bandapalli OR, 2012, CYTOKINE, V57, P46, DOI 10.1016/j.cyto.2011.10.019; Chaudhri VK, 2013, MOL CANCER RES, V11, P579, DOI 10.1158/1541-7786.MCR-12-0437-T; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Dean JP, 2008, BRIT J CANCER, V98, P245, DOI 10.1038/sj.bjc.6604087; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Hassona Y, 2013, CARCINOGENESIS, V34, P1286, DOI 10.1093/carcin/bgt035; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Illeperuma RP, 2015, INT J CANCER, V137, P2545, DOI 10.1002/ijc.29636; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kolar M, 2012, BIOL CELL, V104, P738, DOI 10.1111/boc.201200018; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P599, DOI 10.14670/HH-17.599; Lee EJ, 2005, EXP MOL MED, V37, P379, DOI 10.1038/emm.2005.48; Liu J, 2012, J CELL SCI, V125, P376, DOI 10.1242/jcs.089466; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Olumi AF, 1999, CANCER RES, V59, P5002; Opdenakker G, 2004, INT J DEV BIOL, V48, P519, DOI 10.1387/ijdb.041796go; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635; Ren CX, 2013, EUR J CANCER, V49, P3889, DOI 10.1016/j.ejca.2013.07.140; Rojas A, 2011, ONCOGENE, V30, P2345, DOI 10.1038/onc.2010.605; Son HK, 2015, J CELL BIOCHEM, V116, P2552, DOI 10.1002/jcb.25200; Taddei ML, 2014, MOL ONCOL, V8, P1729, DOI 10.1016/j.molonc.2014.07.009; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103; Zhang HF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.180; Zhou B, 2014, J ORAL PATHOL MED, V43, P585, DOI 10.1111/jop.12172	30	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0188847	10.1371/journal.pone.0188847	http://dx.doi.org/10.1371/journal.pone.0188847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360827	Green Published, gold, Green Submitted			2022-12-27	WOS:000423161800003
J	Han, Y; Kim, HJ; Kong, KA; Kim, SJ; Lee, SH; Ryu, YJ; Lee, JH; Kim, Y; Shim, SS; Chang, JH				Han, Yeji; Kim, Hyun Jung; Kong, Kyoung Ae; Kim, Soo Jung; Lee, Su Hwan; Ryu, Yon Ju; Lee, Jin Hwa; Kim, Yookyoung; Shim, Sung Shine; Chang, Jung Hyun			Diagnosis of small pulmonary lesions by transbronchial lung biopsy with radial endobronchial ultrasound and virtual bronchoscopic navigation versus CT-guided transthoracic needle biopsy: A systematic review and meta-analysis	PLOS ONE			English	Review							20 MM; GUIDANCE-SYSTEM; CUTTING NEEDLE; RISK-FACTORS; NODULES; YIELD; ULTRASONOGRAPHY; SHEATH; TOMOGRAPHY; ASPIRATION	Background Advances in bronchoscopy and CT-guided lung biopsy have improved the evaluation of small pulmonary lesions (PLs), leading to an increase in preoperative histological diagnosis. We aimed to evaluate the efficacy and safety of transbronchial lung biopsy using radial endobronchial ultrasound and virtual bronchoscopic navigation (TBLB-rEBUS& VBN) and CT-guided transthoracic needle biopsy (CT-TNB) for tissue diagnosis of small PLs. Methods A systematic search was performed in five electronic databases, including MEDLINE, EMBASE, Cochrane Library Central Register of Controlled Trials, Web of Science, and Scopus, for relevant studies in May 2016; the selected articles were assessed using meta-analysis. The articles were limited to those published after 2000 that studied small PLs <= 3 cm in diameter. Results From 7345 records, 9 articles on the bronchoscopic (BR) approach and 15 articles on the percutaneous (PC) approach were selected. The pooled diagnostic yield was 75% (95% confidence interval [CI], 69 +/- 80) using the BR approach and 93% (95% CI, 90 +/- 96) using the PC approach. For PLs <= 2 cm, the PC approach (pooled diagnostic yield: 92%, 95% CI: 88 +/- 95) was superior to the BR approach (66%, 95% CI: 55 +/- 76). However, for PLs > 2 cm but <= 3 cm, the diagnostic yield using the BR approach was improved to 81% (95% CI, 75 +/- 85). Complications of pneumothorax and hemorrhage were rare with the BR approach but common with the PC approach. Conclusions CT-TNB was superior to TBLB-rEBUS&VBN for the evaluation of small PLs. However, for lesions greater than 2 cm, the BR approach may be considered considering its diagnostic yield of over 80% and the low risk of procedure-related complications.	[Han, Yeji; Kim, Soo Jung; Lee, Su Hwan; Ryu, Yon Ju; Lee, Jin Hwa; Chang, Jung Hyun] Ewha Womans Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea; [Kim, Hyun Jung] Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Kong, Kyoung Ae] Ewha Womans Univ, Dept Prevent Med, Sch Med, Seoul, South Korea; [Kim, Yookyoung; Shim, Sung Shine] Ewha Womans Univ, Dept Radiol, Sch Med, Seoul, South Korea	Ewha Womans University; Korea University; Korea University Medicine (KU Medicine); Ewha Womans University; Ewha Womans University	Chang, JH (corresponding author), Ewha Womans Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea.	hs1017@ewha.ac.kr		Lee, Su Hwan/0000-0002-3487-2574				Alberg AJ, 2013, CHEST, V143, pE1, DOI 10.1378/chest.12-2345; Asahina H, 2005, CHEST, V128, P1761, DOI 10.1378/chest.128.3.1761; Asano F, 2008, LUNG CANCER, V60, P366, DOI 10.1016/j.lungcan.2007.10.022; Asano F, 2015, INTERNAL MED, V54, P1021, DOI 10.2169/internalmedicine.54.3497; Baaklini WA, 2000, CHEST, V117, P1049, DOI 10.1378/chest.117.4.1049; Chen CH, 2015, J THORAC DIS, V7, pS418, DOI 10.3978/j.issn.2072-1439.2015.12.13; Choi JW, 2012, AM J ROENTGENOL, V199, pW322, DOI 10.2214/AJR.11.7576; Choi MJ, 2012, BRIT J RADIOL, V85, pE182, DOI 10.1259/bjr/95413532; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Eberhardt R, 2007, AM J RESP CRIT CARE, V176, P36, DOI 10.1164/rccm.200612-1866OC; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fielding DI, 2012, INTERN MED J, V42, P894, DOI 10.1111/j.1445-5994.2011.02707.x; Fukusumi M, 2016, J BRONCHOL INTERN PU, V23, P92, DOI 10.1097/LBR.0000000000000273; Gex G, 2014, RESPIRATION, V87, P165, DOI 10.1159/000355710; Gilbert C, 2014, RESPIROLOGY, V19, P636, DOI 10.1111/resp.12301; Gould MK, 2015, AM J RESP CRIT CARE, V192, P1208, DOI 10.1164/rccm.201505-0990OC; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Herth FJF, 2002, EUR RESPIR J, V20, P972, DOI 10.1183/09031936.02.00032001; Hiraki T, 2009, CHEST, V136, P1612, DOI 10.1378/chest.09-0370; Hwang HS, 2010, AM J ROENTGENOL, V195, pW400, DOI 10.2214/AJR.09.3963; Inoue D, 2012, EUR J RADIOL, V81, P354, DOI 10.1016/j.ejrad.2010.11.025; Ishida T, 2011, THORAX, V66, P1072, DOI 10.1136/thx.2010.145490; Jiao DC, 2016, ACTA RADIOL, V57, P677, DOI 10.1177/0284185115603419; Kikuchi E, 2004, EUR RESPIR J, V24, P533, DOI 10.1183/09031936.04.00138603; Laurent F, 2000, CLIN RADIOL, V55, P281, DOI 10.1053/crad.1999.0368; Lee SM, 2014, RADIOLOGY, V271, P291, DOI 10.1148/radiol.13131265; Matsumoto Y, 2017, CLIN RESPIR J, V11, P185, DOI 10.1111/crj.12321; Memoli JSW, 2012, CHEST, V142, P385, DOI 10.1378/chest.11-1764; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Mondoni M, 2016, EUR RESPIR J, V48, P196, DOI 10.1183/13993003.00051-2016; Nour-Eldin NEA, 2016, CARDIOVASC INTER RAD, V39, P261, DOI 10.1007/s00270-015-1167-3; Ohno Y, 2003, AM J ROENTGENOL, V180, P1665, DOI 10.2214/ajr.180.6.1801665; Oki M, 2015, AM J RESP CRIT CARE, V192, P468, DOI 10.1164/rccm.201502-0205OC; Oshige M, 2011, J BRONCHOL INTERN PU, V18, P196, DOI 10.1097/LBR.0b013e3182198f24; Pastorino U, 2003, LANCET, V362, P593, DOI 10.1016/S0140-6736(03)14188-8; Rivera MP, 2013, CHEST, V143, pE142, DOI 10.1378/chest.12-2353; Rotolo N, 2016, EUR RADIOL, V26, P381, DOI 10.1007/s00330-015-3861-6; Steinfort DP, 2011, EUR RESPIR J, V37, P902, DOI 10.1183/09031936.00075310; Steinfort DP, 2011, RESP MED, V105, P1704, DOI 10.1016/j.rmed.2011.08.008; Takeshita J, 2015, AM J ROENTGENOL, V204, P29, DOI 10.2214/AJR.14.13151; Tamiya M, 2013, RESPIROLOGY, V18, P834, DOI 10.1111/resp.12095; Tomiyama N, 2006, EUR J RADIOL, V59, P60, DOI 10.1016/j.ejrad.2006.02.001; Tukey MH, 2012, RESP MED, V106, P1559, DOI 10.1016/j.rmed.2012.08.008; Um SJ, 2009, KOREAN J RADIOL, V10, P81, DOI 10.3348/kjr.2009.10.1.81; Wang C, 2016, J THORAC DIS, V8, P2758, DOI 10.21037/jtd.2016.09.52; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wiener Renda Soylemez, 2013, Clin Pulm Med, V20, P29; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003; Wu CC, 2011, AM J ROENTGENOL, V196, pW678, DOI 10.2214/AJR.10.4659; Yamagami T, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20139006; Yamagami T, 2003, CHEST, V124, P147, DOI 10.1378/chest.124.1.147; Yang W, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004383; Yoshimatsu R, 2008, BRIT J RADIOL, V81, P107, DOI 10.1259/bjr/944470077; Zhang HF, 2016, CLIN RADIOL, V71, pE1, DOI 10.1016/j.crad.2015.09.009	54	46	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191590	10.1371/journal.pone.0191590	http://dx.doi.org/10.1371/journal.pone.0191590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357388	Green Published, Green Submitted, gold			2022-12-27	WOS:000422919500017
J	Datta, S; Seed, B				Datta, Sandip; Seed, Brian			Influence of multiplicative stochastic variation on translational elongation rates	PLOS ONE			English	Article							SINGLE-MOLECULE LEVEL; GENE-EXPRESSION; MESSENGER-RNA; ESCHERICHIA-COLI; CODON USAGE; PROTEIN EXPRESSION; EUKARYOTIC TRANSLATION; LOGNORMAL-DISTRIBUTION; BIOLOGICAL NOISE; RIBOSOME	Experimental data indicate that stochastic effects exerted at the level of translation contribute substantially to the variation in abundance of proteins expressed at moderate to high levels. This study analyzes the theoretical consequences of fluctuations in residue-specific elongation rates during translation. A simple analytical framework shows that rate variation during elongation gives rise to protein production rates that consist of sums of products of random variables. Simulations show that because the contribution to total variation of products of random variables greatly exceeds that of sums of random variables, the overall distribution exhibits approximately log-normal behavior. Empirical fits of the data can be satisfied by either sums of log-normal distributions, or sums of log-normal and log-logistic distributions. Elongation rate stochastic variation offers an accounting for a major component of biological variation. The analysis provided here highlights a probability distribution that is a natural extension of the Poisson and has broad applicability to many types of multiplicative noise processes.	[Datta, Sandip; Seed, Brian] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Seed, B (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.	bseed@ccib.mgh.harvard.edu		Seed, Brian/0000-0002-9279-1940				Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Aitken AC., 1939, P ROY SOC EDINB, V58, P161; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Baldi P, 2002, DNA MICROARRAYS GENE; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Beaulieu NC, 2004, IEEE T VEH TECHNOL, V53, P479, DOI 10.1109/TVT.2004.823494; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Boehm AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-214; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chou T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.198101; Chou T, 2003, BIOPHYS J, V85, P755, DOI 10.1016/S0006-3495(03)74518-4; CHRISTENSEN AK, 1987, AM J ANAT, V178, P1, DOI 10.1002/aja.1001780102; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DE BOOR C., 2005, SURV APPROX THEORY, V1, P46; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feller W., 2008, INTRO PROBABILITY TH, V2; Fenton LF., 1960, IRE T COMMUN SYST, V8, P57, DOI [DOI 10.1109/TCOM.1960.1097606, 10.1109/TCOM.1960.1097606]; Gilchrist MA, 2006, J THEOR BIOL, V239, P417, DOI 10.1016/j.jtbi.2005.08.007; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; HEYDE CC, 1963, J ROY STAT SOC B, V25, P392; Hilfinger A, 2011, P NATL ACAD SCI USA, V108, P12167, DOI 10.1073/pnas.1018832108; Huang B, 2007, SCIENCE, V315, P81, DOI 10.1126/science.1133992; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jung K., 2005, REVSTAT-STAT J, V3, P99; Jung K, 2006, REVSTAT-STAT J, V4, P67; Kahan W, 1974, COURSE NOTES A UNPUB, V228A; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Laidler K. J., 1987, CHEM KINETICS; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Mitarai N, 2008, J MOL BIOL, V382, P236, DOI 10.1016/j.jmb.2008.06.068; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nurenberg E, 2013, TRENDS BIOCHEM SCI, V38, P64, DOI 10.1016/j.tibs.2012.11.003; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PHILIPPS GR, 1965, NATURE, V205, P567, DOI 10.1038/205567a0; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Rajkowitsch L, 2004, J MOL BIOL, V335, P71, DOI 10.1016/j.jmb.2003.10.049; Richter JD, 2015, CELL, V163, P292, DOI 10.1016/j.cell.2015.09.041; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SCHWARTZ SC, 1982, AT&T TECH J, V61, P1441, DOI 10.1002/j.1538-7305.1982.tb04353.x; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shaw LB, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021910; Shiku H, 2010, FEBS LETT, V584, P4000, DOI 10.1016/j.febslet.2010.08.008; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wohlgemuth I, 2011, PHILOS T R SOC B, V366, P2979, DOI 10.1098/rstb.2011.0138; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	65	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191152	10.1371/journal.pone.0191152	http://dx.doi.org/10.1371/journal.pone.0191152			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351322	Green Submitted, gold, Green Published			2022-12-27	WOS:000422911300052
J	Ghasemi-Roudsari, S; Al-Shimary, A; Varcoe, B; Byrom, R; Kearney, L; Kearney, M				Ghasemi-Roudsari, Shima; Al-Shimary, Abbas; Varcoe, Benjamin; Byrom, Rowena; Kearney, Lorraine; Kearney, Mark			A portable prototype magnetometer to differentiate ischemic and non-ischemic heart disease in patients with chest pain	PLOS ONE			English	Article							MAGNETOCARDIOGRAPHY; VALIDATION	Background Magnetocardiography (MCG) is a non-invasive technique used to measure and map cardiac magnetic fields. We describe the predictive performance of a portable prototype magnetometer designed for use in acute and routine clinical settings. We assessed the predictive ability of the measurements derived from the magnetometer for the ruling-out of healthy subjects and patients whose chest pain has a non-ischemic origin from those with ischemic heart disease (IHD). Methods MCG data were analyzed from a technical performance study, a pilot clinical study, and a young healthy reference group. Participants were grouped to enable differentiation of those with IHD versus non-IHD versus controls: Group A (70 IHD patients); Group B (69 controls); Group C (37 young healthy volunteers). Scans were recorded in an unshielded room. Between-group differences were explored using analysis of variance. The ability of 10 candidate MCG predictors to predict normal/abnormal cases was analyzed using logistic regression. Predictive performance was internally validated using repeated five-fold cross-validation. Results Three MCG predictors showed a significant difference between patients and age-matched controls (P<0.001); eight predictors showed a significant difference between patients and young healthy volunteers (P<0.001). Logistic regression comparing patients with controls yielded a specificity of 35.0%, sensitivity of 95.4%, and negative predictive value for the ruling-out of IHD of 97.8% (area under the curve 0.78). Conclusion This analysis represents a preliminary indication that the portable magnetometer can help rule-out healthy subjects and patients whose chest pain has a non-ischemic origin from those with IHD.	[Ghasemi-Roudsari, Shima; Al-Shimary, Abbas; Varcoe, Benjamin] Univ Leeds, Dept Phys & Astron, Leeds, W Yorkshire, England; [Byrom, Rowena; Kearney, Lorraine; Kearney, Mark] Univ Leeds, Leeds Inst Cardiovascu & Metab Med, Div Cardiovasc & Diabet Res, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Al-Shimary, A (corresponding author), Univ Leeds, Dept Phys & Astron, Leeds, W Yorkshire, England.; Al-Shimary, A (corresponding author), Creavo Med Technol Ltd, Coventry, W Midlands, England.	abbas.alshimary@creavomedtech.com		Varcoe, Benjamin/0000-0001-7056-7238	Medical Technologies Innovation & Knowledge Centre (IKC); Engineering and Physical Sciences Research Council (EPSRC) [EP/G032483/1, EP/I019103/1, EP/J017620/1]; Creavo Medical Technologies Ltd., UK; Leeds University; Creavo Medical Technologies Ltd.; Bollin Strategies - Creavo Medical Technologies Ltd.; EPSRC [EP/I019103/1, EP/J017620/1] Funding Source: UKRI	Medical Technologies Innovation & Knowledge Centre (IKC); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Creavo Medical Technologies Ltd., UK; Leeds University; Creavo Medical Technologies Ltd.; Bollin Strategies - Creavo Medical Technologies Ltd.; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by the Medical Technologies Innovation & Knowledge Centre (IKC): http://www.medical-technologies.leeds.ac.uk/, and was funded by the Engineering and Physical Sciences Research Council (EPSRC): https://www.epsrc.ac.uk/, grant numbers EP/G032483/1, EP/I019103/1, and EP/J017620/1, and was funded by Creavo Medical Technologies Ltd., UK (formerly Quantum Imaging Ltd., UK). This publication combined data from two studies conducted at the University of Leeds and Leeds General Infirmary. Professor Mark Kearney, British Heart Foundation Professor of Cardiovascular and Diabetes Research and Director of Leeds Institute of Cardiovascular and Metabolic Medicine, was the lead investigator for both studies. The first study was Leeds University funded and managed. Creavo Medical Technologies Ltd.: http://www.creavomedtech.com/ (formerly known as Quantum Imaging Ltd.) were sponsors of the second study, but the study was designed and run by Leeds General Infirmary and data management and monitoring function was performed by the North American Science Associates Ltd. (NAMSA), an external independent contract research organisation. The protocol for this study was clearly defined a priori and is available for review in a nationally recognised registry (protocol NCT02359773 available on ClinicalTrials.gov). Data were analysed for this publication by author(s), who are now employees of Creavo Medical Technologies Ltd., but who were not employed by the company at the time of the studies. The manuscript development was supported by Bollin Strategies funded by Creavo Medical Technologies Ltd., but under editorial control of the authors. The guidance and input by Professor Kearney and his colleagues on the interpretation and publication of these data maintained independence of interpretation from the funder.	Agarwal R, 2012, ANN NONINVAS ELECTRO, V17, P291, DOI 10.1111/j.1542-474X.2012.00538.x; Alday EAP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160999; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Backus BE, 2013, INT J CARDIOL, V168, P2153, DOI 10.1016/j.ijcard.2013.01.255; Ekelund Ulf, 2012, BMC Res Notes, V5, P420, DOI 10.1186/1756-0500-5-420; Fenici R, 2013, INT J CARDIOL, V168, P5113, DOI 10.1016/j.ijcard.2013.07.238; Fenici R, 2004, Neurol Clin Neurophysiol, V2004, P7; Fenici R, 2005, EXPERT REV MOL DIAGN, V5, P291, DOI 10.1586/14737159.5.3.291; Hanninen H, 2000, INT J BIOELECTROMAGN, V2; Harrell FE, 2015, SPRINGER SER STAT, P219, DOI 10.1007/978-3-319-19425-7_10; Kandori A, 2008, PACE, V31, P422, DOI 10.1111/j.1540-8159.2008.01011.x; Kim Doosang, 2007, Interact Cardiovasc Thorac Surg, V6, P274, DOI 10.1510/icvts.2006.142869; Lim HK, 2009, AM J CARDIOL, V103, P448, DOI 10.1016/j.amjcard.2008.10.013; Lindahl B, 2013, CLIN CHEM LAB MED, V51, P1699, DOI 10.1515/cclm-2013-0074; Malmivuo P., 1995, BIOELECTROMAGNETISM, DOI [DOI 10.1093/ACPROF:OSO/9780195058239.001.0001, 10.1093/acprof:oso/9780195058239.001.0001]; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Mooney TW, 2017, BIOMED PHYS IN PRESS; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Rohacek M, 2012, EMERG MED INT, V2012, DOI DOI 10.1155/2012/975614; Six AJ, 2012, NETH HEART J, V20, P499, DOI 10.1007/s12471-012-0322-6; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Xu RY, 2013, J GERIATR CARDIOL, V10, P102, DOI [10.3969/j.issn.1671-5411.2013.01.015, 10.3724/SP.J.1263.2012.11101]; Yamada S, 2005, INTERNAL MED, V44, P1; Zymlinski R, 2017, INT J CARDIOL, V230, P646, DOI 10.1016/j.ijcard.2017.01.012	24	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191241	10.1371/journal.pone.0191241	http://dx.doi.org/10.1371/journal.pone.0191241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351337	Green Published, gold			2022-12-27	WOS:000422911300061
J	Spoorenberg, SLW; Wynia, K; Uittenbroek, RJ; Kremer, HPH; Reijneveld, SA				Spoorenberg, Sophie L. W.; Wynia, Klaske; Uittenbroek, Ronald J.; Kremer, Hubertus P. H.; Reijneveld, Sijmen A.			Effects of a population-based, person-centred and integrated care service on health, wellbeing and self-management of community-living older adults: A randomised controlled trial on Embrace	PLOS ONE			English	Article							QUALITY-OF-LIFE; AGING IN-PLACE; ELDERLY-PEOPLE; PERCEIVED CONTROL; CHRONIC ILLNESS; HOME VISITS; MODEL; OUTCOMES; COMPLEX; FRAILTY	Objective To evaluate the effects of the population-based, person-centred and integrated care service 'Embrace' at twelve months on three domains comprising health, wellbeing and self-management among community-living older people. Methods Embrace supports older adults to age in place. A multidisciplinary team provides care and support, with intensity depending on the older adults' risk profile. A randomised controlled trial was conducted in fifteen general practices in the Netherlands. Older adults (>= 75 years) were included and stratified into three risk profiles: Robust, Frail and Complex care needs, and randomised to Embrace or care as usual (CAU). Outcomes were recorded in three domains. The EuroQol-5D-3L and visual analogue scale, INTERMED for the Elderly Self-Assessment, Groningen Frailty Indicator and Katz-15 were used for the domain 'Health.' The Groningen Well-being Indicator and two quality of life questions measured 'Wellbeing.' The Self-Management Ability Scale and Partners in Health scale for older adults (PIH-OA) were used for 'Self-management.' Primary and secondary outcome measurements differed per risk profile. Data were analysed with multilevel mixed-model techniques using intention-to-treat and complete case analyses, for the whole sample and per risk profile. Results 1456 eligible older adults participated (49%) and were randomized to Embrace (n(T0) = 747, n(T1) = 570, mean age 80.6 years (SD 4.5), 54.2% female) and CAU (n(T0) = 709, n (T1) = 561, mean age 80.8 years (SD 4.7), 55.6% female). Embrace participants showed a greater-but clinically irrelevant-improvement in self-management (PIH-OA Knowledge subscale effect size [ES] = 0.14), and a greater-but clinically relevant-deterioration in health (ADL ES = 0.10; physical ADL ES = 0.13) compared to CAU. No differences in change in wellbeing were observed. This picture was also found in the risk profiles. Complete case analyses showed comparable results. Conclusions This study found no clear benefits to receiving person-centred and integrated care for twelve months for the domains of health, wellbeing and self-management in community-living older adults.	[Spoorenberg, Sophie L. W.; Wynia, Klaske; Uittenbroek, Ronald J.; Reijneveld, Sijmen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands; [Wynia, Klaske; Kremer, Hubertus P. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen; University of Groningen	Spoorenberg, SLW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands.	s.l.w.spoorenberg@umcg.nl		Reijneveld, Sijmen/0000-0002-1206-7523	Netherlands Organisation for Health Research and Development (ZonMw) [314010201]; Dutch Healthcare Authority (NZa) [300-1021]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Healthcare Authority (NZa)	The Embrace study was funded by the Netherlands Organisation for Health Research and Development (ZonMw: grant number 314010201; http://www.zonmw.nl). The health care professionals involved are funded by the Dutch Healthcare Authority (NZa: file number 300-1021; http://www.nza.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Battersby MW., 2003, AUSTR J PRIM HLTH, V9, P41, DOI [10.1071/PY03022, DOI 10.1071/PY03022]; Beard JR, 2015, LANCET, V385, P658, DOI 10.1016/S0140-6736(14)61461-6; Beland F, 2006, J GERONTOL A-BIOL, V61, P367, DOI 10.1093/gerona/61.4.367; Bernabei R, 1998, BMJ-BRIT MED J, V316, P1348, DOI 10.1136/bmj.316.7141.1348; Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Bjornberg A, 2015, EURO HLTH CONSUMER I; Bleijenberg N, 2016, J AM GERIATR SOC, V64, P1779, DOI 10.1111/jgs.14325; Boult C, 2013, J GEN INTERN MED, V28, P612, DOI 10.1007/s11606-012-2287-y; Bouman A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-74; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Chen YX, 2014, J SOC PERS RELAT, V31, P141, DOI 10.1177/0265407513488728; Claassens L, 2014, J AGING STUD, V31, P159, DOI 10.1016/j.jaging.2014.09.008; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Counsell SR, 2007, JAMA-J AM MED ASSOC, V298, P2623, DOI 10.1001/jama.298.22.2623; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; Devlin NJ, 2007, EQ 5D VALUE SETS INV, DOI 10.1007/1-4020-5511-0; Eklund K, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-76; GUSTAFSSON M, 2013, BMC HLTH SERV RES, V13; Hammar Teija, 2007, Int J Integr Care, V7, pe29; Haywood KL, 2005, J EVAL CLIN PRACT, V11, P315, DOI 10.1111/j.1365-2753.2005.00538.x; Hoogendijk EO, 2016, EUR J INTERN MED, V28, P43, DOI 10.1016/j.ejim.2015.10.023; Huss A, 2008, J GERONTOL A-BIOL, V63, P298, DOI 10.1093/gerona/63.3.298; Kang M, 2008, J ATHL TRAINING, V43, P215, DOI 10.4085/1062-6050-43.2.215; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Laan W, 2014, J NUTR HEALTH AGING, V18, P848, DOI [10.1007/s12603-014-0558-5, 10.1007/s12603-014-0479-3]; Lachman ME, 2006, CURR DIR PSYCHOL SCI, V15, P282, DOI 10.1111/j.1467-8721.2006.00453.x; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Leveille SG, 1998, J AM GERIATR SOC, V46, P1191, DOI 10.1111/j.1532-5415.1998.tb04533.x; Lin JS, 2012, J AM GERIATR SOC, V60, P2157, DOI 10.1111/j.1532-5415.2012.04214.x; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Lofqvist C, 2013, GERONTOLOGIST, V53, P919, DOI 10.1093/geront/gnt034; Metzelthin SF, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5264; Middel B, 2001, J EVAL CLIN PRACT, V7, P399, DOI 10.1046/j.1365-2753.2001.00298.x; Nolte E, 2008, CARING PEOPLE CHRONI, P222; Nolte E., 2008, CARING PEOPLE CHRONI, P64; Peters LL, 2013, J PSYCHOSOM RES, V74, P518, DOI 10.1016/j.jpsychores.2013.02.003; Peters LL, 2012, J AM MED DIR ASSOC, V13, P546, DOI 10.1016/j.jamda.2012.04.007; Polit DF, 2010, RES NURS HEALTH, V33, P355, DOI 10.1002/nur.20386; Schafer Willemijn, 2010, Health Syst Transit, V12, pv; Schols J M G A, 2004, J Am Med Dir Assoc, V5, P207, DOI 10.1097/01.JAM.0000123031.43619.60; Schuurmans H, 2005, QUAL LIFE RES, V14, P2215, DOI 10.1007/s11136-005-8166-9; Singh D, 2006, IMPROVING CARE PEOPL; Sixsmith J, 2014, SOC SCI MED, V106, P1, DOI 10.1016/j.socscimed.2014.01.006; Spoorenberg SLW, 2015, DISABIL REHABIL, V37, P2337, DOI 10.3109/09638288.2015.1024337; Spoorenberg SLW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137803; Spoorenberg SLW, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-62; Steverink N, 2001, GERONTOLOGIST, V41, P236; Steverink N., SELF MANAGEMENT ABIL; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; Tai-Seale M, 2007, HEALTH SERV RES, V42, P1871, DOI 10.1111/j.1475-6773.2006.00689.x; Tappenden P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16200; Toseland RW, 1997, GERONTOLOGIST, V37, P324, DOI 10.1093/geront/37.3.324; Uittenbroek RJ, 2016, J GEN INTERN MED; Uittenbroek RJ, 2016, HEALTH EXPECT, V19, P962, DOI 10.1111/hex.12391; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2; van Haastregt JCM, 2000, BMJ-BRIT MED J, V320, P754, DOI 10.1136/bmj.320.7237.754; Veldman K, HLTH EXPECT; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wiles JL, 2012, GERONTOLOGIST, V52, P357, DOI 10.1093/geront/gnr098; Wolinsky FD, 2003, J GERONTOL B-PSYCHOL, V58, pS212, DOI 10.1093/geronb/58.4.S212; You EC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-395	65	30	30	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190751	10.1371/journal.pone.0190751	http://dx.doi.org/10.1371/journal.pone.0190751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351295	gold, Green Submitted, Green Published			2022-12-27	WOS:000422911300023
J	Yakabe, M; Ogawa, S; Ota, H; Iijima, K; Eto, M; Ouchi, Y; Akishita, M				Yakabe, Mitsutaka; Ogawa, Sumito; Ota, Hidetaka; Iijima, Katsuya; Eto, Masato; Ouchi, Yasuyoshi; Akishita, Masahiro			Inhibition of interleukin-6 decreases atrogene expression and ameliorates tail suspension-induced skeletal muscle atrophy	PLOS ONE			English	Article							HYDROXY-BETA-METHYLBUTYRATE; UBIQUITIN LIGASES; GENE-EXPRESSION; SATELLITE CELLS; AGED RATS; IMMOBILIZATION; RECOVERY; MURF1; ATROGIN-1; RECEPTOR	Background Interleukin-6 (IL-6) is an inflammatory cytokine. Whether systemic IL-6 affects atrogene expression and disuse-induced skeletal muscle atrophy is unclear. Methods Tail-suspended mice were used as a disuse-induced muscle atrophy model. We administered anti-mouse IL-6 receptor antibody, beta-hydroxy-beta-methylbutyrate (HMB) and vitamin D to the mice and examined the effects on atrogene expression and muscle atrophy. Results Serum IL-6 levels were elevated in the mice. Inhibition of IL-6 receptor suppressed muscle RING finger 1 (MuRF1) expression and prevented muscle atrophy. HMB and vitamin D inhibited the serum IL-6 surge, downregulated the expression of MuRF1 and atrogin-1 in the soleus muscle, and ameliorated atrophy in the mice. Conclusion Systemic IL-6 affects MuRF1 expression and disuse-induced muscle atrophy.	[Yakabe, Mitsutaka; Ogawa, Sumito; Ota, Hidetaka; Iijima, Katsuya; Eto, Masato; Ouchi, Yasuyoshi; Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan; [Ouchi, Yasuyoshi] Toranomon Gen Hosp, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Minato Ku, Tokyo, Japan	University of Tokyo; Toranomon Hospital	Ogawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo, Japan.	suogawa-tky@umin.ac.jp						AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Alway SE, 2013, EXP GERONTOL, V48, P973, DOI 10.1016/j.exger.2013.06.005; AMIDON GL, 1991, J CLIN PHARMACOL, V31, P968, DOI 10.1002/j.1552-4604.1991.tb03658.x; Aversa Z, 2012, BIOCHEM BIOPH RES CO, V423, P739, DOI 10.1016/j.bbrc.2012.06.029; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Baptista IL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076752; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; CANTINI M, 1995, BIOCHEM BIOPH RES CO, V216, P49, DOI 10.1006/bbrc.1995.2590; Castelo-Branco C, 2014, GYNECOL ENDOCRINOL, V30, P16, DOI 10.3109/09513590.2013.852531; Choi M, 2013, CYTOKINE, V63, P27, DOI 10.1016/j.cyto.2013.03.018; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Clavel S, 2006, MECH AGEING DEV, V127, P794, DOI 10.1016/j.mad.2006.07.005; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Curtis E, 2015, J CELL PHYSIOL, V230, P2618, DOI 10.1002/jcp.25001; Deever DB, 2002, ACTA ASTRONAUT, V50, P445; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Fu LJ, 2009, BONE, V44, P893, DOI 10.1016/j.bone.2009.01.378; Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Grano M, 2002, CALCIFIED TISSUE INT, V70, P176, DOI 10.1007/s00223-001-2034-6; Guo TZ, 2014, J PAIN, V15, P1033, DOI 10.1016/j.jpain.2014.07.004; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; Hanson AM, 2013, MUSCLE NERVE, V48, P393, DOI 10.1002/mus.23753; Hao YL, 2011, AM J PHYSIOL-REG I, V301, pR701, DOI 10.1152/ajpregu.00840.2010; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayakawa N, 2015, BIOMED RES-TOKYO, V36, P71, DOI 10.2220/biomedres.36.71; Jonsdottir IH, 2000, J PHYSIOL-LONDON, V528, P157, DOI 10.1111/j.1469-7793.2000.00157.x; Kang C, 2013, J APPL PHYSIOL, V115, P1618, DOI 10.1152/japplphysiol.01354.2012; Kraemer WJ, 2015, J AM COLL NUTR, V34, P91, DOI 10.1080/07315724.2014.938790; Li W, 2009, AM J PHYSIOL-CELL PH, V297, pC706, DOI 10.1152/ajpcell.00626.2008; Lloyd SA, 2014, J BONE MINER RES, V29, P1118, DOI 10.1002/jbmr.2113; Mitsutaka Y, 2015, BIOMEDICAL SCI, V1, P1, DOI DOI 10.11648/J.RNAT.20150101.11; Morey-Holton ER, 1998, BONE, V22, p83S, DOI 10.1016/S8756-3282(98)00019-2; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Nilwik R, 2013, EXP GERONTOL, V48, P492, DOI 10.1016/j.exger.2013.02.012; Noh KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102947; Okamoto T, 2011, J PHYSIOL SCI, V61, P537, DOI 10.1007/s12576-011-0175-6; Rivera CA, 2003, J APPL PHYSIOL, V95, P1656, DOI 10.1152/japplphysiol.00302.2003; Russ DW, 2015, APPL PHYSIOL NUTR ME, V40, P1294, DOI 10.1139/apnm-2015-0391; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Somody L, 1998, EUR J APPL PHYSIOL, V78, P296, DOI 10.1007/s004210050423; Tando T, 2016, J BIOL CHEM, V291, P12184, DOI 10.1074/jbc.M115.680579; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; Tukaj S, 2012, ACTA BIOCHIM POL, V59, P395; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wagatsuma A, 2008, PHYSIOL RES, V57, P613, DOI 10.33549/physiolres.931288; White JP, 2009, ACTA PHYSIOL, V197, P321, DOI 10.1111/j.1748-1716.2009.02029.x; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	54	36	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191318	10.1371/journal.pone.0191318	http://dx.doi.org/10.1371/journal.pone.0191318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351340	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300071
J	Flo, V; Bosch, J; Arnan, X; Primante, C; Gonzalez, AMM; Barril-Graells, H; Rodrigo, A				Flo, Victor; Bosch, Jordi; Arnan, Xavier; Primante, Clara; Martin Gonzalez, Ana M.; Barril-Graells, Helena; Rodrigo, Anselm			Yearly fluctuations of flower landscape in a Mediterranean scrubland: Consequences for floral resource availability	PLOS ONE			English	Article							POLLINATOR VISITATION RATE; CLIMATE-CHANGE; POPULATION-SIZE; EMERGENCE TIME; SEED SET; PHENOLOGY; DIVERSITY; HYMENOPTERA; TEMPERATURE; COMPETITION	Species flower production and flowering phenology vary from year to year due to extrinsic factors. Inter-annual variability in flowering patterns may have important consequences for attractiveness to pollinators, and ultimately, plant reproductive output. To understand the consequences of flowering pattern variability, a community approach is necessary because pollinator flower choice is highly dependent on flower context. Our objectives were: 1) To quantify yearly variability in flower density and phenology; 2) To evaluate whether changes in flowering patterns result in significant changes in pollen/nectar composition. We monitored weekly flowering patterns in a Mediterranean scrubland community (23 species) over 8 years. Floral resource availability was estimated based on field measures of pollen and nectar production per flower. We analysed inter-annual variation in flowering phenology (duration and date of peak bloom) and flower production, and inter-annual and monthly variability in flower, pollen and nectar species composition. We also investigated potential phylogenetic effects on inter-annual variability of flowering patterns. We found dramatic variation in yearly flower production both at the species and community levels. There was also substantial variation in flowering phenology. Importantly, yearly fluctuations were far from synchronous across species, and resulted in significant changes in floral resources availability and composition at the community level. Changes were especially pronounced late in the season, at a time when flowers are scarce and pollinator visitation rates are particularly high. We discuss the consequences of our findings for pollinator visitation and plant reproductive success in the current scenario of climate change.	[Flo, Victor; Bosch, Jordi; Arnan, Xavier; Primante, Clara; Martin Gonzalez, Ana M.; Barril-Graells, Helena; Rodrigo, Anselm] CREAF, Ctr Ecol Res & Forestry Applicat, Campus UAB, Bellaterra, Spain; [Martin Gonzalez, Ana M.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Univ Pk, Copenhagen O, Denmark; [Rodrigo, Anselm] Autonomous Univ Barcelona, Ecol Unit, Bellaterra, Spain	Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Copenhagen; Autonomous University of Barcelona	Flo, V (corresponding author), CREAF, Ctr Ecol Res & Forestry Applicat, Campus UAB, Bellaterra, Spain.	v.flo@creaf.uab.cat	Flo, Víctor/AAX-5065-2021; ramon, anna/O-1249-2019; Rodrigo, Anselm/AAH-1553-2022; Arnan, Xavier/N-7829-2013; Gonzalez, Ana M. Martin/A-7827-2010; Rodrigo, Anselm/AFL-9450-2022; Bosch, Jordi/K-8752-2016	Flo, Víctor/0000-0003-1908-4577; Arnan, Xavier/0000-0002-9904-274X; Gonzalez, Ana M. Martin/0000-0001-9429-7180; Bosch, Jordi/0000-0002-8088-9457; Rodrigo, Anselm/0000-0001-6341-0363	Spanish MICINN [CGL2005-00491, CSD2008-0040, CGL2009-12646]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The Spanish MICINN supported this study through projects CGL2005-00491, CSD2008-0040 and CGL2009-12646.	Albrectsen BR, 2008, OIKOS, V117, P473, DOI 10.1111/j.2008.0030-1299.16381.x; Aldridge G, 2011, J ECOL, V99, P905, DOI 10.1111/j.1365-2745.2011.01826.x; Arnan X, 2014, BOT J LINN SOC, V175, P395, DOI 10.1111/boj.12173; ARROYO J, 1990, Lagascalia, V16, P25; Bartomeus I, 2011, P NATL ACAD SCI USA, V108, P20645, DOI 10.1073/pnas.1115559108; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bell JM, 2005, ECOLOGY, V86, P762, DOI 10.1890/04-0694; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bosch J, 2003, ENVIRON ENTOMOL, V32, P711, DOI 10.1603/0046-225X-32.4.711; Bosch J, 2004, APIDOLOGIE, V35, P469, DOI 10.1051/apido:2004035; Bosch J, 2008, ANIM BEHAV, V75, P809, DOI 10.1016/j.anbehav.2007.06.018; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; Bruckman D, 2014, OECOLOGIA, V176, P465, DOI 10.1007/s00442-014-3023-6; Cam W, 2012, PHYLOMATIC V3; CaraDonna PJ, 2014, P NATL ACAD SCI USA, V111, P4916, DOI 10.1073/pnas.1323073111; Chen Y, 2017, J ELECTR COMPUT ENG, V2017, P1, DOI 10.1155/2017/9547869; Crimmins TM, 2010, J ECOL, V98, P1042, DOI 10.1111/j.1365-2745.2010.01696.x; Diekmann M, 1996, CAN J BOT, V74, P528, DOI 10.1139/b96-067; Diez JM, 2012, ECOL LETT, V15, P545, DOI 10.1111/j.1461-0248.2012.01765.x; Ebeling A, 2011, BASIC APPL ECOL, V12, P300, DOI 10.1016/j.baae.2011.04.005; Engel EC, 2003, AM J BOT, V90, P1612, DOI 10.3732/ajb.90.11.1612; Filella I, 2013, SCI REP-UK, V3, DOI 10.1038/srep03434; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; Forrest J, 2010, ECOLOGY, V91, P431, DOI 10.1890/09-0099.1; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gomez JM, 1999, ECOLOGY, V80, P796, DOI 10.2307/177018; Goodell K, 2003, OECOLOGIA, V134, P518, DOI 10.1007/s00442-002-1159-2; Gordo O, 2010, GLOBAL CHANGE BIOL, V16, P1082, DOI 10.1111/j.1365-2486.2009.02084.x; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; HERRERA C M, 1987, Anales del Jardin Botanico de Madrid, V44, P49; Hoerling M, 2012, J CLIMATE, V25, P2146, DOI 10.1175/JCLI-D-11-00296.1; Inouye DW, 2003, AM J BOT, V90, P905, DOI 10.3732/ajb.90.6.905; Karron JD, 2006, AM J BOT, V93, P1306, DOI 10.3732/ajb.93.9.1306; Khanduri VP, 2013, SCI WORLD J, DOI 10.1155/2013/350157; KOCHMER JP, 1986, ECOL MONOGR, V56, P303, DOI 10.2307/1942549; Kumar S, 2011, BIOINFORMATICS, V27, P2023, DOI 10.1093/bioinformatics/btr315; Kunin WE, 1997, J ECOL, V85, P225, DOI 10.2307/2960653; Law B, 2000, AUSTRAL ECOL, V25, P160, DOI 10.1111/j.1442-9993.2000.tb00016.x; Lazaro A, 2013, OECOLOGIA, V173, P881, DOI 10.1007/s00442-013-2652-5; Lazaro A, 2010, AM J BOT, V97, P760, DOI 10.3732/ajb.0900263; Lazaro A, 2009, OIKOS, V118, P691, DOI 10.1111/j.1600-0706.2008.17168.x; Lesica P, 2010, J ARID ENVIRON, V74, P1013, DOI 10.1016/j.jaridenv.2010.02.002; Gonzalez AMM, 2012, OIKOS, V121, P2001, DOI 10.1111/j.1600-0706.2012.20279.x; Miller-Rushing AJ, 2008, J ECOL, V96, P1289, DOI 10.1111/j.1365-2745.2008.01436.x; Mitchell RJ, 2009, ANN BOT-LONDON, V103, P1403, DOI 10.1093/aob/mcp062; Moeller DA, 2004, ECOLOGY, V85, P3289, DOI 10.1890/03-0810; Ohashi K, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P274, DOI 10.1017/CBO9780511542268.015; Oksanen AJ, 2014, PACKAGE VEGAN; Olsen KM, 1997, OECOLOGIA, V109, P114, DOI [10.1007/s004420050065, 10.1007/PL00008811]; Penuelas J, 2004, NEW PHYTOL, V161, P837, DOI 10.1111/j.1469-8137.2004.01003.x; PETANIDOU T, 1995, AM J BOT, V82, P607, DOI 10.2307/2445419; Petanidou T, 2014, ACTA OECOL, V59, P104, DOI 10.1016/j.actao.2014.06.001; Peterson JH, 2006, ENVIRON ENTOMOL, V35, P1404, DOI 10.1603/0046-225X(2006)35[1404:IORLOS]2.0.CO;2; Petraglia A, 2013, PLANT ECOL DIVERS, V6, P475, DOI 10.1080/17550874.2013.795628; Prieto P, 2008, ANN BOT-LONDON, V102, P275, DOI 10.1093/aob/mcn090; Rafferty NE, 2013, ECOL EVOL, V3, P3183, DOI 10.1002/ece3.668; Rathcke B., 1983, P305; Revell MLJ, 2016, PACKAGE PHYTOOLS; Sahli HF, 2006, OECOLOGIA, V148, P365, DOI 10.1007/s00442-006-0396-1; Sardans J, 2005, ENVIRON EXP BOT, V53, P1, DOI 10.1016/j.envexpbot.2004.02.007; Scaven VL, 2013, CURR ZOOL, V59, P418, DOI 10.1093/czoolo/59.3.418; SCHEMSKE DW, 1981, ECOLOGY, V62, P946, DOI 10.2307/1936993; Schmid B, 2016, ECOGRAPHY, V39, P619, DOI 10.1111/ecog.01621; SCHMITT J, 1980, EVOLUTION, V34, P934, DOI 10.1111/j.1558-5646.1980.tb04031.x; Seidelmann K, 2006, BEHAV ECOL, V17, P839, DOI 10.1093/beheco/arl017; Sgolastra F, 2010, J INSECT PHYSIOL, V56, P185, DOI 10.1016/j.jinsphys.2009.10.001; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Stefanescu C, 2003, GLOBAL CHANGE BIOL, V9, P1494, DOI 10.1046/j.1365-2486.2003.00682.x; WALKER AK, 1974, CROP SCI, V14, P235, DOI 10.2135/cropsci1974.0011183X001400020020x; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003; Zurbuchen A, 2010, J ANIM ECOL, V79, P674, DOI 10.1111/j.1365-2656.2010.01675.x; Zywiec M, 2012, OECOLOGIA, V169, P713, DOI 10.1007/s00442-011-2232-5	75	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191268	10.1371/journal.pone.0191268	http://dx.doi.org/10.1371/journal.pone.0191268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346453	gold, Green Published, Green Submitted			2022-12-27	WOS:000422749500039
J	Li, TS; Zhao, J; Yang, JY; Ma, X; Dai, QY; Huang, H; Wang, LN; Liu, P				Li, Taishun; Zhao, Jun; Yang, Jiaying; Ma, Xu; Dai, Qiaoyun; Huang, Hao; Wang, Lina; Liu, Pei			A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer (vol 11, e0153314, 2016)	PLOS ONE			English	Correction									[Li, Taishun; Liu, Pei] Southeast Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Liu, P (corresponding author), Southeast Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.							Li TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153314	1	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							0191579	10.1371/journal.pone.0191579	http://dx.doi.org/10.1371/journal.pone.0191579			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342211	Green Submitted, Green Published, gold			2022-12-27	WOS:000422653800072
J	Mayorova, TD; Smith, CL; Hammar, K; Winters, CA; Pivovarova, NB; Aronova, MA; Leapman, RD; Reese, TS				Mayorova, Tatiana D.; Smith, Carolyn L.; Hammar, Katherine; Winters, Christine A.; Pivovarova, Natalia B.; Aronova, Maria A.; Leapman, Richard D.; Reese, Thomas S.			Cells containing aragonite crystals mediate responses to gravity in Trichoplax adhaerens (Placozoa), an animal lacking neurons and synapses	PLOS ONE			English	Article							CALCIUM-SULFATE HEMIHYDRATE; ELECTRON-MICROSCOPE; STATOCYST; STATOLITHS; TRANSDUCTION; BIOMINERALIZATION; PLATYHELMINTHES; ULTRASTRUCTURE; EVOLUTIONARY; ADAPTATION	Trichoplax adhaerens has only six cell types. The function as well as the structure of crystal cells, the least numerous cell type, presented an enigma. Crystal cells are arrayed around the perimeter of the animal and each contains a birefringent crystal. Crystal cells resemble lithocytes in other animals so we looked for evidence they are gravity sensors. Confocal microscopy showed that their cup-shaped nuclei are oriented toward the edge of the animal, and that the crystal shifts downward under the influence of gravity. Some animals spontaneously lack crystal cells and these animals behaved differently upon being tilted vertically than animals with a typical number of crystal cells. EM revealed crystal cell contacts with fiber cells and epithelial cells but these contacts lacked features of synapses. EM spectroscopic analyses showed that crystals consist of the aragonite form of calcium carbonate. We thus provide behavioral evidence that Trichoplax are able to sense gravity, and that crystal cells are likely to be their gravity receptors. Moreover, because placozoans are thought to have evolved during Ediacaran or Cryogenian eras associated with aragonite seas, and their crystals are made of aragonite, they may have acquired gravity sensors during this early era.	[Mayorova, Tatiana D.; Smith, Carolyn L.; Winters, Christine A.; Pivovarova, Natalia B.; Reese, Thomas S.] NINDS, Lab Neurobiol, NIH, Bethesda, MD 20892 USA; [Mayorova, Tatiana D.] Russian Acad Sci, Koltzov Inst Dev Biol, Lab Dev Neurobiol, Moscow, Russia; [Hammar, Katherine] Marine Biol Lab, Cent Microscopy Facil, Woods Hole, MA 02543 USA; [Aronova, Maria A.; Leapman, Richard D.] Natl Inst Biomed Imaging & Bioengn, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Marine Biological Laboratory - Woods Hole; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Mayorova, TD (corresponding author), NINDS, Lab Neurobiol, NIH, Bethesda, MD 20892 USA.; Mayorova, TD (corresponding author), Russian Acad Sci, Koltzov Inst Dev Biol, Lab Dev Neurobiol, Moscow, Russia.	mayorova@wsbs-msu.ru		Mayorova, Tatiana/0000-0003-4132-0222	intramural research program of the NIH, NINDS; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002972] Funding Source: NIH RePORTER	intramural research program of the NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the intramural research program of the NIH, NINDS.	Achatz JG, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-27; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Aronova MZ, 2009, J EVOL BIOCHEM PHYS+, V45, P179, DOI 10.1134/S0022093009020017; Baldwin KL, 2013, AM J BOT, V100, P126, DOI 10.3732/ajb.1200318; Becker A, 2005, DALTON T, P1545, DOI 10.1039/b416246c; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; BERNER RA, 1975, GEOCHIM COSMOCHIM AC, V39, P489, DOI 10.1016/0016-7037(75)90102-7; Brandes JA, 2010, J SYNCHROTRON RADIAT, V17, P676, DOI 10.1107/S0909049510020029; BRAUN M, 1993, PROTOPLASMA, V174, P50, DOI 10.1007/BF01404042; Bru E, 1981, ZOOMORPHOLOGY, V97, P75; BUCHHOLZ K, 1995, Z NATURFORSCH C, V50, P282; Budelmann B.-U., 1988, P757; CAMPBELL RD, 1972, NATURE, V238, P49, DOI 10.1038/238049a0; DEGENS ET, 1969, MAR BIOL, V2, P105, DOI 10.1007/BF00347005; EAKIN RM, 1971, Z ZELLFORSCH MIK ANA, V112, P287; EHLERS U, 1991, HYDROBIOLOGIA, V227, P263, DOI 10.1007/BF00027611; Erwin DH, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0036; FENCHEL T, 1986, J PROTOZOOL, V33, P69, DOI 10.1111/j.1550-7408.1986.tb05560.x; FERRERO E, 1973, ZOOL SCR, V2, P5, DOI 10.1111/j.1463-6409.1973.tb00793.x; FERRERO EA, 1985, ACTA ZOOL-STOCKHOLM, V66, P75, DOI 10.1111/j.1463-6395.1985.tb00826.x; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gal J, 2000, VISION RES, V40, P843, DOI 10.1016/S0042-6989(99)00216-3; GARVIE LAJ, 1994, AM MINERAL, V79, P411; Hader DP, 2005, ADV SPACE RES-SERIES, V36, P1182, DOI 10.1016/j.asr.2005.03.081; Hader DP, 2001, ADV SPACE RES-SERIES, V27, P861, DOI 10.1016/S0273-1177(01)00149-1; Hahn Mark E., 2017, Current Opinion in Toxicology, V2, P58, DOI 10.1016/j.cotox.2017.02.003; HANLON RT, 1989, J EXP BIOL, V141, P187; Hemmersbach R., 2006, SIGNAL TRANSDUCT, V6, P432, DOI [10.1002/sita.200600106, DOI 10.1002/SITA.200600106]; Heyland A, 2014, METHODS MOL BIOL, V1128, P45, DOI 10.1007/978-1-62703-974-1_4; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Kristan WB, 2016, CURR BIOL, V26, pR949, DOI 10.1016/j.cub.2016.05.030; Leitz G, 2009, PLANT CELL, V21, P843, DOI 10.1105/tpc.108.065052; MARMO F, 1983, CELL TISSUE RES, V233, P35; Martinez P, 2017, OXFORD RES ENCY NEUR; NAKAHARA H, 1979, ANAT REC, V193, P233, DOI 10.1002/ar.1091930205; PEARSE VB, 1994, T AM MICROSC SOC, V113, P385, DOI 10.2307/3226631; Pearse VB, 2007, INTEGR COMP BIOL, V47, P677, DOI 10.1093/icb/icm015; Pedrozo HA, 1996, HEARING RES, V102, P51, DOI 10.1016/S0378-5955(96)00147-5; Peng G., 2014, MOL PHYLOGENET EVOL; Pivovarova NB, 2013, JOVE-J VIS EXP, DOI 10.3791/50807; Porter SM, 2007, SCIENCE, V316, P1302, DOI 10.1126/science.1137284; RASSAT J, 1979, ZOOMORPHOLOGIE, V93, P59, DOI 10.1007/BF02568675; Ries JB, 2008, GEOBIOLOGY, V6, P106, DOI 10.1111/j.1472-4669.2007.00134.x; ROHDE K, 1993, AUST J ZOOL, V41, P215, DOI 10.1071/ZO9930215; RUTHMANN A, 1986, ZOOMORPHOLOGY, V106, P115, DOI 10.1007/BF00312113; Senatore A, 2017, J EXP BIOL, V220, P3381, DOI 10.1242/jeb.162396; SINGLA CL, 1975, CELL TISSUE RES, V158, P391; Smith CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136098; Smith CL, 2014, CURR BIOL, V24, P1565, DOI 10.1016/j.cub.2014.05.046; Speiser DI, 2014, J NAT HIST, V48, P2899, DOI 10.1080/00222933.2014.959572; Speiser DI, 2011, CURR BIOL, V21, P665, DOI 10.1016/j.cub.2011.03.033; Sperlagh B, 1996, SEMIN NEUROSCI, V8, P175, DOI 10.1006/smns.1996.0023; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Tamm SL, 2014, BIOL BULL-US, V227, P7, DOI 10.1086/BBLv227n1p7; Tatsumi H, 2014, PLANT BIOLOGY, V16, P18, DOI 10.1111/plb.12095; Tiemann H, 2002, J CHEM SOC DALTON, P1266, DOI 10.1039/b111524c; Tiemann H, 2006, ZOOL ANZ, V245, P13, DOI 10.1016/j.jcz.2006.03.001; Toyota M, 2013, AM J BOT, V100, P111, DOI 10.3732/ajb.1200408; Ueda T, 1999, BIOSYSTEMS, V54, P65, DOI 10.1016/S0303-2647(99)00066-0; Vinnikov YA., 1974, SENSORY RECEPTION, P272; Wood R, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0059	61	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190905	10.1371/journal.pone.0190905	http://dx.doi.org/10.1371/journal.pone.0190905			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342202	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800036
J	Yang, J; Du, L; Gong, W; Shi, S; Sun, J; Chen, BW				Yang, Jian; Du, Lin; Gong, Wei; Shi, Shuo; Sun, Jia; Chen, Biwu			Potential of vegetation indices combined with laser-induced fluorescence parameters for monitoring leaf nitrogen content in paddy rice	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; NONDESTRUCTIVE ESTIMATION; CANOPY REFLECTANCE; USE EFFICIENCY; GREEN PLANTS; SOIL QUALITY; CROP YIELD; PERFORMANCE; MANAGEMENT; SPECTRA	Nitrogen (N) is important for the growth of crops. Leaf nitrogen content (LNC) serves as a crucial indicator of the growth status of crops and can help determine the dose of N fertilizer. Laser-induced fluorescence (LIF) technology and the reflectance spectra of crops are widely used to detect the biochemical content of leaves. Many vegetation indices (Vls) and fluorescence parameters have been developed to estimate LNC. However, the comparison among Vls and between fluorescence parameters and Vls has been rarely studied in the estimation of LNC. In this study, the performances of several published empirical Vls and fluorescence parameters for the estimation of paddy rice LNC were analyzed using the support vector machine (SVM) algorithm. Then, the optimal Vls (TVI, MTVII, MTVI2, and MSAVI) and fluorescence parameters (F735/F460 and F685/F460), which were suitable for LNC monitoring in this study, were chosen. In addition, the combination of the Vls and fluorescence parameters was proposed as the input variables in the SVM model and used to estimate the LNC. Experimental results exhibited the promising potential of the LIF technology combined with reflectance for the accurate estimation of LNC, which provided guidance for monitoring the LNC.	[Yang, Jian; Du, Lin] China Univ Geosci, Fac Informat Engn, Wuhan, Hubei, Peoples R China; [Yang, Jian; Gong, Wei; Shi, Shuo; Sun, Jia; Chen, Biwu] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Hubei, Peoples R China; [Gong, Wei; Shi, Shuo] Collaborat Innovat Ctr Geospatial Technol, Wuhan, Hubei, Peoples R China	China University of Geosciences; Wuhan University	Yang, J (corresponding author), China Univ Geosci, Fac Informat Engn, Wuhan, Hubei, Peoples R China.; Yang, J (corresponding author), Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Hubei, Peoples R China.	wind_yang@whu.edu.cn	Yang, Jian/AAO-1667-2020		Open Fund of State Laboratory of Information Engineering in Surveying, Mapping and Remote Sensing, Wuhan University [17R05]; Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) [CUG170661]; National Natural Science Foundation of China [41571370]; Natural Science Foundation of Hubei Province [2015CFA002]	Open Fund of State Laboratory of Information Engineering in Surveying, Mapping and Remote Sensing, Wuhan University; Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan)(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the Open Fund of State Laboratory of Information Engineering in Surveying, Mapping and Remote Sensing, Wuhan University (grant number 17R05 to Dr. Jian Yang), Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) (grant number CUG170661 to Dr. Jian Yang), the National Natural Science Foundation of China (grant number 41571370 to Shuo Shi), the Natural Science Foundation of Hubei Province (grant number 2015CFA002 to Wei Gong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2003, IEEE J SEL TOP QUANT, V9, P154, DOI 10.1109/JSTQE.2003.813318; Cao Q, 2013, FIELD CROP RES, V154, P133, DOI 10.1016/j.fcr.2013.08.005; Cendrero-Mateo MP, 2016, J EXP BOT, V67, P275, DOI 10.1093/jxb/erv456; CHAPPELLE EW, 1984, APPL OPTICS, V23, P134, DOI 10.1364/AO.23.000134; CHAPPELLE EW, 1991, REMOTE SENS ENVIRON, V36, P213, DOI 10.1016/0034-4257(91)90058-E; Du L, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8060526; Ehlert D, 2009, PRECIS AGRIC, V10, P395, DOI 10.1007/s11119-009-9114-4; Farkas DL, 2010, SPIE, V7568; Gaulton R, 2013, REMOTE SENS ENVIRON, V132, P32, DOI 10.1016/j.rse.2013.01.001; Gill MK, 2006, J AM WATER RESOUR AS, V42, P1033, DOI 10.1111/j.1752-1688.2006.tb04512.x; Gitelson AA, 1999, REMOTE SENS ENVIRON, V69, P296, DOI 10.1016/S0034-4257(99)00023-1; Gong W, 2012, ISPRS J PHOTOGRAMM, V69, P1, DOI 10.1016/j.isprsjprs.2012.02.001; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; Huang M, 2013, FIELD CROP RES, V146, P10, DOI 10.1016/j.fcr.2013.03.007; JAMIESON PD, 1991, FIELD CROP RES, V27, P337, DOI 10.1016/0378-4290(91)90040-3; Kalaji HM, 2014, PHOTOSYNTH RES, V122, P121, DOI 10.1007/s11120-014-0024-6; Kira O, 2015, INT J APPL EARTH OBS, V38, P251, DOI 10.1016/j.jag.2015.01.003; Kumar K, 2000, ADV AGRON, V68, P197; Li F, 2008, FIELD CROP RES, V106, P77, DOI 10.1016/j.fcr.2007.11.001; Li F, 2014, EUR J AGRON, V52, P198, DOI 10.1016/j.eja.2013.09.006; Li W, 2014, REMOTE SENS LETT, V5, P693, DOI 10.1080/2150704X.2014.960608; Liang XQ, 2013, FIELD CROP RES, V146, P66, DOI 10.1016/j.fcr.2013.03.002; LICHTENTHALER HK, 1988, CRC CR REV ANAL CHEM, V19, pS29, DOI 10.1080/15476510.1988.10401466; Ma YY, 2012, IEEE J-STARS, V5, P1849, DOI 10.1109/JSTARS.2012.2206572; Malenovsky Z, 2009, J EXP BOT, V60, P2987, DOI 10.1093/jxb/erp156; Malhi SS, 2006, SOIL TILL RES, V90, P171, DOI 10.1016/j.still.2005.09.001; MCMURTREY JE, 1994, REMOTE SENS ENVIRON, V47, P36, DOI 10.1016/0034-4257(94)90125-2; Morsdorf F, 2006, REMOTE SENS ENVIRON, V104, P50, DOI 10.1016/j.rse.2006.04.019; Mulla DJ, 2013, BIOSYST ENG, V114, P358, DOI 10.1016/j.biosystemseng.2012.08.009; Nevalainen O., 2013, ISPRS ANN PHOTOGRAM, VII-5/W2, P205, DOI DOI 10.5194/ISPRSANNALS-II-5-W2-205-2013; Pacheco-Labrador J, 2014, INT J APPL EARTH OBS, V26, P105, DOI 10.1016/j.jag.2013.05.013; Pedros R, 2008, PHOTOCH PHOTOBIO SCI, V7, P498, DOI 10.1039/b719506k; Pu R, 2003, INT J REMOTE SENS, V24, P1799, DOI 10.1080/01431160210155965; SINCLAIR TR, 1989, CROP SCI, V29, P90, DOI 10.2135/cropsci1989.0011183X002900010023x; Song SL, 2011, ISPRS J PHOTOGRAMM, V66, P672, DOI 10.1016/j.isprsjprs.2011.05.002; Stroppiana D, 2009, FIELD CROP RES, V111, P119, DOI 10.1016/j.fcr.2008.11.004; Tian YC, 2011, FIELD CROP RES, V120, P299, DOI 10.1016/j.fcr.2010.11.002; Tian YC, 2014, PLANT SOIL, V376, P193, DOI 10.1007/s11104-013-1937-0; Tremblay N, 2012, AGRON SUSTAIN DEV, V32, P451, DOI 10.1007/s13593-011-0041-1; Vidakovic B, 1998, IEEE T SIGNAL PROCES, V46, P2549, DOI 10.1109/78.709544; Vijayalakshmi P, 2015, FIELD CROP RES, V179, P132, DOI 10.1016/j.fcr.2015.04.012; Wang JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08391; Wang JJ, 2015, REMOTE SENS-BASEL, V7, P5901, DOI 10.3390/rs70505901; Wu CY, 2008, AGR FOREST METEOROL, V148, P1230, DOI 10.1016/j.agrformet.2008.03.005; Yang J, 2015, PLANT SOIL ENVIRON, V61, P182, DOI 10.17221/7/2015-PSE; Yang J, 2016, SCI REP, V6, P144; Yang J, 2016, OPT EXPRESS, V24, P19354, DOI 10.1364/OE.24.019354; Yang XH, 2011, SCI CHINA LIFE SCI, V54, P272, DOI 10.1007/s11427-011-4135-4; Yl QX, 2007, ENVIRON SCI TECHNOL, V41, P6770, DOI 10.1021/es070144e; Zhao KG, 2013, REMOTE SENS ENVIRON, V132, P102, DOI 10.1016/j.rse.2012.12.026; Zhu X, 2015, ISPRS J PHOTOGRAMM, V110, P14, DOI 10.1016/j.isprsjprs.2015.10.001; Zhu Y, 2006, CAN J PLANT SCI, V86, P1037, DOI 10.4141/P05-157; Zivcak M, 2014, PLANT SOIL ENVIRON, V60, P210, DOI 10.17221/73/2014-PSE	54	15	15	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191068	10.1371/journal.pone.0191068	http://dx.doi.org/10.1371/journal.pone.0191068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342190	gold, Green Submitted, Green Published			2022-12-27	WOS:000422653800043
J	Alesina, A; Giuliano, P; Nunn, N				Alesina, Alberto; Giuliano, Paola; Nunn, Nathan			Traditional agricultural practices and the sex ratio today	PLOS ONE			English	Article							MISSING WOMEN; SON PREFERENCE; SLAVE-TRADE; INDIA; CHINA; ORIGINS; BIRTH; AFRICA; INVESTMENT; CHILDREN	We study the historical origins of cross-country differences in the male-to-female sex ratio. Our analysis focuses on the use of the plough in traditional agriculture. In societies that did not use the plough, women tended to participate in agriculture as actively as men. By contrast, in societies that used the plough, men specialized in agricultural work, due to the physical strength needed to pull the plough or control the animal that pulls it. We hypothesize that this difference caused plough-using societies to value boys more than girls. Today, this belief is reflected in male-biased sex ratios, which arise due to sex-selective abortion or infanticide, or gender-differences in access to family resources, which results in higher mortality rates for girls. Testing this hypothesis, we show that descendants of societies that traditionally practiced plough agriculture today have higher average male-to-female sex ratios. We find that this effect systematically increases in magnitude and statistical significance as one looks at older cohorts. Estimates using instrumental variables confirm our findings from multivariate OLS analysis.	[Alesina, Alberto; Nunn, Nathan] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Alesina, Alberto; Giuliano, Paola; Nunn, Nathan] NBER, Cambridge, MA 02138 USA; [Giuliano, Paola] UCLA, Anderson Sch Management, Los Angeles, CA 90095 USA	Harvard University; National Bureau of Economic Research; University of California System; University of California Los Angeles	Giuliano, P (corresponding author), NBER, Cambridge, MA 02138 USA.; Giuliano, P (corresponding author), UCLA, Anderson Sch Management, Los Angeles, CA 90095 USA.	paola.giuliano@anderson.ucla.edu	Giuliano, Paola/J-3159-2013	Nunn, Nathan/0000-0002-5101-9866; giuliano, paola/0000-0002-3809-4108				Alesina A, 2013, Q J ECON, V128, P469, DOI 10.1093/qje/qjt005; Anderson S, 2010, REV ECON STUD, V77, P1262, DOI 10.1111/j.1467-937X.2010.00609.x; [Anonymous], 2007, WOMANS ROLE EC DEV; Bahrami-Rad D, 2017, TABULATED NONSENSE T; CHAHNAZARIAN A, 1988, SOC BIOL, V35, P214; Chu JH, 2001, POPUL DEV REV, V27, P259; Conley TG, 1999, J ECONOMETRICS, V92, P1, DOI 10.1016/S0304-4076(98)00084-0; Dalton JT, 2014, ECON DEV CULT CHANGE, V62, P599, DOI 10.1086/676531; Das Gupta M, 2005, POPUL DEV REV, V31, P529; Das Gupta M, 2003, J DEV STUD, V40, P153, DOI 10.1080/00220380412331293807; DasGupta M, 1997, POP STUD-J DEMOG, V51, P307, DOI 10.1080/0032472031000150076; DASGUPTA M, 1987, POPUL DEV REV, V13, P77; DICKEMANN M, 1979, EVOLUTIONARY BIOL HU, P321; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Fischer G, 2002, GLOBAL AGROECOLOGICA; Freese J, 1999, AM J SOCIOL, V104, P1704, DOI 10.1086/210221; Galor O, 2016, AM ECON REV, V106, P3064, DOI 10.1257/aer.20150020; GAULIN SJC, 1991, AM J PHYS ANTHROPOL, V85, P61, DOI 10.1002/ajpa.1330850108; Green E, 2013, INT POLIT SCI REV, V34, P235, DOI 10.1177/0192512112455075; Henry C. K. Jeya, 1996, LONG TERM CONSEQUENC; HULL TH, 1990, POPUL DEV REV, V16, P63, DOI 10.2307/1972529; JAMES WH, 1987, HUM BIOL, V59, P721; Jayachandran S, 2017, AM ECON REV, V107, P2600, DOI 10.1257/aer.20151282; Jayachandran S, 2011, Q J ECON, V126, P1485, DOI 10.1093/qje/qjr029; Lazarus J, SEX RATIOS CONCEPTS; Mace R, 2005, EVOLUTION CULTURAL D; Mulder MB, 1998, HUM NATURE-INT BIOS, V9, P119, DOI 10.1007/s12110-998-1001-6; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Nisbett Richard E., 1996, CULTURE HONOR PSYCHO; Nunn N, 2008, Q J ECON, V123, P139, DOI 10.1162/qjec.2008.123.1.139; Nunn N, 2011, AM ECON REV, V101, P3221, DOI 10.1257/aer.101.7.3221; PRYOR FL, 1985, COMP STUD SOC HIST, V27, P727, DOI 10.1017/S0010417500011749; Qian N, 2008, Q J ECON, V123, P1251, DOI 10.1162/qjec.2008.123.3.1251; Ramakrishnan S, 2011, HEART, V97, P1920, DOI 10.1136/hrt.2011.224410; Rohlfs C, 2010, J DEV ECON, V92, P82, DOI 10.1016/j.jdeveco.2008.11.005; ROSENZWEIG MR, 1982, AM ECON REV, V72, P803; SEN A, 1992, BRIT MED J, V304, P587, DOI 10.1136/bmj.304.6827.587; SEN A, 1990, NEW YORK REV BOOKS, V37, P61; SMITH MS, 1987, ETHOL SOCIOBIOL, V8, P171, DOI 10.1016/0162-3095(87)90042-2; Spolaore E, 2009, Q J ECON, V124, P469, DOI 10.1162/qjec.2009.124.2.469; Talhelm T, 2014, SCIENCE, V344, P603, DOI 10.1126/science.1246850; Teso E., J EUROPEAN IN PRESS; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Voigtlander N, 2012, Q J ECON, V127, P1339, DOI 10.1093/qje/qjs019; ZENG Y, 1993, POPUL DEV REV, V19, P283	45	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190510	10.1371/journal.pone.0190510	http://dx.doi.org/10.1371/journal.pone.0190510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338023	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700012
J	Kuraszkiewicz, B; Chen, JJJS; Goszczynska, H; Wang, YL; Piotrkiewicz, M				Kuraszkiewicz, Bozenna; Chen, Jia-Jin Jason; Goszczynska, Hanna; Wang, Yu-Lin; Piotrkiewicz, Maria			Bilateral changes in afterhyperpolarization duration of spinal motoneurones in post-stroke patients	PLOS ONE			English	Article							STROKE SURVIVORS; DISCHARGE VARIABILITY; MOTOR UNITS; TIME-COURSE; PATTERN; DECOMPOSITION; RECOVERY	This paper extends the observations presented in the previously published work on the afterhyperpolarization (AHP) duration changes in motoneurones (MNs) on the paretic (more affected) side of 11 post-stroke patients by the same analysis on the non-paretic (less affected) side. The estimated AHP duration for patients' MNs supplying more-affected muscles was significantly longer than control values and the elongation decreased with patient age and disorder duration. For MNs supplying less-affected muscles, dependency of AHP duration on age was closer to the control data, but the scatter was substantially bigger. However, the AHP duration estimate of less-affected MNs tended to be longer than that of controls in the short time elapsed since the stroke, and shorter than controls in the long time. Our results thus suggest that the spinal MNs on both sides respond to the cerebral stroke rapidly with prolongation of AHP duration, which tends to normalize with time, in line with functional recovery. This suggestion is in concert with the published research on post-stroke changes in brain hemispheres. To our knowledge, these dependencies have never been investigated before. Since the number of our data was limited, the observed trends should be verified in a larger sample of patients and such a verification could take into account the suggestions for data analysis that we provide in this paper. Our data are in line with the earlier published research on MN firing characteristics post-stroke and support the conclusion that the MUs of the muscles at the non-paretic side are also affected and cannot be considered a suitable control for the MUs on the paretic side.	[Kuraszkiewicz, Bozenna; Goszczynska, Hanna; Piotrkiewicz, Maria] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Chen, Jia-Jin Jason] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan, Taiwan; [Wang, Yu-Lin] Chi Mei Med Ctr, Dept Rehabil, Tainan, Taiwan; [Wang, Yu-Lin] Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; National Cheng Kung University; Chi Mei Hospital; Southern Taiwan University of Science & Technology	Piotrkiewicz, M (corresponding author), Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland.	masia@ibib.waw.pl	Piotrkiewicz, Maria/A-6349-2008; Kuraszkiewicz, Bozenna/AAD-7390-2019	Piotrkiewicz, Maria/0000-0001-9340-1724; Kuraszkiewicz, Bozenna/0000-0002-0570-9655; Goszczynska, Hanna/0000-0003-1106-2672				ANDREASSEN S, 1978, MUSCLE NERVE, V1, P416, DOI 10.1002/mus.880010514; Grefkes C, 2014, LANCET NEUROL, V13, P206, DOI 10.1016/S1474-4422(13)70264-3; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Hu XG, 2015, CLIN NEUROPHYSIOL, V126, P1599, DOI 10.1016/j.clinph.2014.11.005; Hultborn H, 1992, Curr Opin Neurobiol, V2, P770, DOI 10.1016/0959-4388(92)90132-5; Ivanova TD, 2014, CLIN NEUROPHYSIOL, V125, P544, DOI 10.1016/j.clinph.2013.08.017; Kuraszkiewicz B, 2012, LECT N BIOINFORMAT, V7339, P209; Liang LY, 2010, J MED BIOL ENG, V30, P17; McNeal DW, 2010, J COMP NEUROL, V518, P586, DOI 10.1002/cne.22218; McNulty PA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00518; Mierzejewska J., 2001, BIOCYBERN BIOMED ENG, V21, P53; Mlozniak D, 2015, BIOCYBERN BIOMED ENG, V35, P22, DOI 10.1016/j.bbe.2014.05.002; PERSON RS, 1972, ELECTROEN CLIN NEURO, V32, P471, DOI 10.1016/0013-4694(72)90058-2; Piotrkiewicz M, 1999, J PHYSIOLOGY-PARIS, V93, P125, DOI 10.1016/S0928-4257(99)80143-0; Piotrkiewicz M, 1999, CLIN NEUROPHYSIOL, V110, P1111, DOI 10.1016/S1388-2457(99)00051-6; Piotrkiewicz M, 2012, BIOCYBERN BIOMED ENG, V32, P43; Piotrkiewicz M, 2011, J PHYSIOL-LONDON, V589, P2745, DOI 10.1113/jphysiol.2011.204891; Powers RK, 2000, J PHYSIOL-LONDON, V528, P131, DOI 10.1111/j.1469-7793.2000.t01-1-00131.x; Sun TY, 2000, MUSCLE NERVE, V23, P1057, DOI 10.1002/1097-4598(200007)23:7<1057::AID-MUS8>3.0.CO;2-A; Suresh AK, 2014, J NEUROPHYSIOL, V112, P1447, DOI 10.1152/jn.01091.2012; Suresh NL, 2015, EXP BRAIN RES, V233, P15, DOI 10.1007/s00221-014-4061-3; Tokizane T, 1964, FUNCTIONAL DIFFERENT	22	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0189845	10.1371/journal.pone.0189845	http://dx.doi.org/10.1371/journal.pone.0189845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338007	gold, Green Published			2022-12-27	WOS:000422652700004
J	Cui, B; Wang, CX; Zhao, X; Yao, JW; Zeng, ZH; Wang, Y; Sun, CJ; Liu, GQ; Cui, HX				Cui, Bo; Wang, Chunxin; Zhao, Xiang; Yao, Junwei; Zeng, Zhanghua; Wang, Yan; Sun, Changjiao; Liu, Guoqiang; Cui, Haixin			Characterization and evaluation of avermectin solid nanodispersion prepared by microprecipitation and lyophilisation techniques	PLOS ONE			English	Article							BENZOTRIAZOLE UV-STABILIZERS; CONTROLLED-RELEASE; ABAMECTIN; WATER; NANOSUSPENSIONS; PHOTOSTABILITY; MICROCAPSULES; NANOPARTICLES; FLOCCULATION; FORMULATION	Poorly water-soluble and photosensitive pesticide compounds are difficult to formulate as solvent-free nanoformulations with high efficacy. A avermectin solid nanodispersion with a mean particle size of 188 nm was developed by microprecipitation and lyophilisation techniques. The suspensibility and wetting time of the solid nanodispersion in water were 99.8% and 13 s, respectively, superior to those of conventional water dispersible granules and wettable powders. The anti-photolysis performance of the nanoformulation was twice that of the technical material, and the biological activity against diamondback moths was more than 1.5 times that of the conventional solid formulations while taking LC 50 as the evaluation index. Moreover, the formulation composition substantially decreased the surfactant content and avoided organic solvents. Microprecipitation combined with lyophilisation is an easy and promising method to construct solid nanoformulations for pesticides with poor water solubility and environmental sensitivity. The application of the highly effective solid nanodispersion in crop production will have a great potential in reducing chemical residues and environmental pollution.	[Cui, Bo; Wang, Chunxin; Zhao, Xiang; Yao, Junwei; Zeng, Zhanghua; Wang, Yan; Sun, Changjiao; Liu, Guoqiang; Cui, Haixin] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS	Cui, HX (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing, Peoples R China.	cuihaixin@caas.cn			National Key Research and Development Program of China [2017YFD0201207, 2016YFD0200502]	National Key Research and Development Program of China	This research was supported by National Key Research and Development Program of China (No. 2017YFD0201207 and 2016YFD0200502). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS MW, 1995, PESTIC SCI, V43, P141, DOI 10.1002/ps.2780430207; Cao J, 2015, ACS APPL MATER INTER, V7, P9546, DOI 10.1021/acsami.5b00940; Chingunpituk J., 2007, WALAILAK J SCI TECHN, V4, P139, DOI [10.2004/wjst.v4i2.94, DOI 10.2004/WJST.V4I2.94]; Cowan-Ellsberry C, 2014, CRIT REV ENV SCI TEC, V44, P1893, DOI 10.1080/10739149.2013.803777; Cui B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160877; Cui B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135953; Demchak RJ, 1997, J AGR FOOD CHEM, V45, P260, DOI 10.1021/jf960356n; Dickinson E, 1997, J COLLOID INTERF SCI, V185, P515, DOI 10.1006/jcis.1996.4605; Dong LF, 2013, MOD AGR, V12, P14; Fan TF, 2014, J POROUS MAT, V21, P113, DOI 10.1007/s10934-013-9754-7; Fent K, 2014, SCI TOTAL ENVIRON, V482, P125, DOI 10.1016/j.scitotenv.2014.02.109; Gasic S., 2011, Pesticidi i Fitomedicina, V26, P409, DOI 10.2298/PIF1104409G; He HY, 2004, J CONTROL RELEASE, V95, P391, DOI 10.1016/j.jconrel.2003.12.004; He S, 2013, J MATER CHEM B, V1, P1270, DOI 10.1039/c2tb00234e; Hirata-Koizumi Mutsuko, 2009, Congenital Anomalies, V49, P247, DOI 10.1111/j.1741-4520.2009.00248.x; Jia X, 2014, ACS APPL MATER INTER, V6, P19552, DOI 10.1021/am506458t; Kocbek P, 2006, INT J PHARMACEUT, V312, P179, DOI 10.1016/j.ijpharm.2006.01.008; LASOTA JA, 1990, ACT LEIDENS, V59, P217; Lee MK, 2010, INT J PHARMACEUT, V384, P173, DOI 10.1016/j.ijpharm.2009.09.041; Leuner C, 2000, EUR J PHARM BIOPHARM, V50, P47, DOI 10.1016/S0939-6411(00)00076-X; Li H, 2011, CHIN J APPL CHEM, V29, P327; Li SuXia, 2013, Acta Phytophylacica Sinica, V40, P575; Li Y, 2016, ADV MATER TECHNOL-US, V1, DOI 10.1002/admt.201600102; Li ZZ, 2006, J CONTROL RELEASE, V111, P81, DOI 10.1016/j.jconrel.2005.10.020; [刘学涛 Liu Xuetao], 2006, [生态学杂志, Chinese Journal of Ecology], V25, P185; Margni M, 2002, AGR ECOSYST ENVIRON, V93, P379, DOI 10.1016/S0167-8809(01)00336-X; McClements DJ, 2010, ADV COLLOID INTERFAC, V159, P213, DOI 10.1016/j.cis.2010.06.010; Mishra PR, 2009, INT J PHARMACEUT, V371, P182, DOI 10.1016/j.ijpharm.2008.12.030; Mitri K, 2011, INT J PHARMACEUT, V420, P141, DOI 10.1016/j.ijpharm.2011.08.026; Mogul MG, 1996, RESOUR CONSERV RECY, V16, P289, DOI 10.1016/0921-3449(95)00063-1; Nakata H, 2010, J ENVIRON MONITOR, V12, P2088, DOI 10.1039/c0em00170h; NOLEN GA, 1989, DRUG CHEM TOXICOL, V12, P95, DOI 10.3109/01480548908999147; Pan ZZ, 2015, J NANOMATER, V2015, DOI 10.1155/2015/123496; Pardeike J, 2010, INT J PHARMACEUT, V391, P322, DOI 10.1016/j.ijpharm.2010.03.002; PUTTER I, 1981, EXPERIENTIA, V37, P963, DOI 10.1007/BF01971780; Rezende D, 2016, EXP APPL ACAROL, V69, P297, DOI 10.1007/s10493-016-0039-0; Rundfeldt C, 2013, EUR J PHARM BIOPHARM, V83, P44, DOI 10.1016/j.ejpb.2012.09.018; Santiago LG, 2002, BRAZ J CHEM ENG, V19, P411, DOI 10.1590/S0104-66322002000400009; Serajuddin ATM, 1999, J PHARM SCI-US, V88, P1058, DOI 10.1021/js980403l; Sharma P, 2011, INT J PHARMACEUT, V408, P138, DOI 10.1016/j.ijpharm.2011.01.032; Silva HD, 2012, FOOD BIOPROCESS TECH, V5, P854, DOI 10.1007/s11947-011-0683-7; Talekar M, 2012, EUR J PHARM SCI, V47, P824, DOI 10.1016/j.ejps.2012.09.015; Tanpradit N, 2015, THERIOGENOLOGY, V83, P1553, DOI 10.1016/j.theriogenology.2015.01.035; Tong JH, 1999, PESTICIDES, V38, P38; Valenzuela AI, 2000, J CHROMATOGR A, V871, P57, DOI 10.1016/S0021-9673(99)01190-5; Verma S, 2009, INT J PHARMACEUT, V380, P216, DOI 10.1016/j.ijpharm.2009.07.005; Xu X, 2014, FINE SPEC CHEM, V22, P11; Yan YF, 2013, COLLOID SURFACE B, V102, P341, DOI 10.1016/j.colsurfb.2012.07.043; Yue PF, 2013, INT J PHARMACEUT, V443, P279, DOI 10.1016/j.ijpharm.2012.12.036; Zhang H, 2011, INT J PHARMACEUT, V415, P293, DOI 10.1016/j.ijpharm.2011.05.075; Zhang XG, 2011, J AGR FOOD CHEM, V59, P1308, DOI 10.1021/jf1034459; Zhang Y, 2016, RSC ADV, V6, P69889, DOI 10.1039/c6ra08413c; Zhuang ZX, 2009, CHEM J CHINESE U, V30, P332	53	15	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191742	10.1371/journal.pone.0191742	http://dx.doi.org/10.1371/journal.pone.0191742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360866	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800059
J	Davison, KM; Holloway, C; Gondara, L; Hatcher, AS				Davison, Karen M.; Holloway, Cliff; Gondara, Lovedeep; Hatcher, Anne S.			Independent associations and effect modification between lifetime substance use and recent mood disorder diagnosis with household food insecurity	PLOS ONE			English	Article							NEGATIVE DRUG-USERS; MENTAL-HEALTH; WELFARE RECIPIENTS; DUAL DIAGNOSIS; NUTRITION; ADULTS; INSUFFICIENCY; INCOME; CONSEQUENCES; DEPRESSION	Poor mental health and substance use are associated with food insecurity, however, their potential combined effects have not been studied. This study explored independent associations and effect modification between lifetime substance use and mood disorder in relation to food insecurity. Poisson regression analysis of data from British Columbia respondents (n = 13,450; 12 years+) in the 2007/08 Canadian Community Health Survey was conducted. Measures included The Household Food Security Survey Module (7.3% food insecure), recent diagnosis of a mood disorder (self-reported; 9.5%), lifetime use of cannabis, cocaine/crack, ecstasy, hallucinogens, and speed, any lifetime substance use, sociodemographic covariates, and the interaction terms of mood disorder by substance. For those with recent diagnosis of a mood disorder the prevalence of lifetime substance use ranged between 1.2 to 5.7% and were significantly higher than those without recent mood disorder diagnosis or lifetime use of substances (p's < 0.05). For respondents with a recent mood disorder diagnosis or who used cannabis, food insecurity prevalence was higher compared to the general sample (p < 0.001); prevalence was lower for cocaine/crack use (p < 0.05). Significant effect modification was found between mood disorder with cannabis, ecstasy, hallucinogen and any substance use over the lifetime (PRs 0.51 to 0.64, p's 0.022 to 0.001). Independent associations were found for cocaine/crack and speed use (PRs 1.68, p's < 0.001) and mood disorder (PRs 2.02, p's < 0.001). Based on these findings and the existing literature, future study about coping and resilience in the context of substance use, mental health, and food insecurity may lead to the development of relevant interventions aimed at mental well-being and food security.	[Davison, Karen M.] Univ British Columbia, Sch Nursing, Vancouver, BC, Canada; [Davison, Karen M.] Kwantlen Polytech Univ, Dept Biol, Hlth Sci Program, Surrey, BC, Canada; [Davison, Karen M.] Univ Hawaii Manoa, Fulbright Canada Res Chair, Honolulu, HI 96822 USA; [Holloway, Cliff] Univ Ontario Inst Technol, Fac Hlth Sci, Oshawa, ON, Canada; [Gondara, Lovedeep] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC, Canada; [Hatcher, Anne S.] Metropolitan State Univ Denver, Ctr Addict Studies, Dept Human Serv, Denver, CO USA; [Davison, Karen M.] Kwantlen Polytech Univ, Biol Dept, Surrey, BC, Canada	University of British Columbia; University of Hawaii System; University of Hawaii Manoa; Ontario Tech University; Simon Fraser University; Metropolitan State University of Denver	Davison, KM (corresponding author), Univ British Columbia, Sch Nursing, Vancouver, BC, Canada.; Davison, KM (corresponding author), Kwantlen Polytech Univ, Dept Biol, Hlth Sci Program, Surrey, BC, Canada.; Davison, KM (corresponding author), Univ Hawaii Manoa, Fulbright Canada Res Chair, Honolulu, HI 96822 USA.; Davison, KM (corresponding author), Kwantlen Polytech Univ, Biol Dept, Surrey, BC, Canada.	karen.davison@kpu.ca		Holloway, Courtney Jean/0000-0003-3661-1957	Canadian Institutes of Health Research Intersections of Mental Health Perspectives in Addictions Research Training (IMPART) postdoctoral fellowship; Canadian Institues for Health Research's Intersections of Mental Health Perspectives in Addictions Research Training Program	Canadian Institutes of Health Research Intersections of Mental Health Perspectives in Addictions Research Training (IMPART) postdoctoral fellowship; Canadian Institues for Health Research's Intersections of Mental Health Perspectives in Addictions Research Training Program	KMD's work was supported by a Canadian Institutes of Health Research Intersections of Mental Health Perspectives in Addictions Research Training (IMPART) postdoctoral fellowship.& para;& para;This study was part of Karen Davison's postdoctoral work funded by the Canadian Institues for Health Research's Intersections of Mental Health Perspectives in Addictions Research Training Program. Gratitude is extended to Catherine (Katie) Goldie, Brittany Bingham, and Alina Sotskova for their early work on this project that included submitting the proposal to Statistics Canada and initial data analysis.	Agrawal A, 2008, ADDICTION, V103, P1069, DOI 10.1111/j.1360-0443.2008.02213.x; Alaimo K, 2002, J NUTR, V132, P719, DOI 10.1093/jn/132.4.719; *AM DIET ASS DIET, 2000, MAN CLIN DIET; American Dental Association, 2008, METH US METH MOUTH; Anema A, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-20; Baker A, 2004, ADDICTION, V99, P875, DOI 10.1111/j.1360-0443.2004.00741.x; Bove CF, 2006, WOMEN HEALTH, V44, P57, DOI 10.1300/J013v44n01_04; Broussard CA, 2010, J POVERTY, V14, P443, DOI 10.1080/10875549.2010.518003; Brown DR, 2015, SOC SCI MED, V133, P202, DOI 10.1016/j.socscimed.2015.03.058; Canadian Center on Substance Abuse, 2009, SUBSTANCE ABUSE CANA; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Chilton M, 2007, J NUTR EDUC BEHAV, V39, P116, DOI 10.1016/j.jneb.2006.11.005; Coelho JS, 2006, APPETITE, V47, P352, DOI 10.1016/j.appet.2006.05.015; Cornish JW, 1996, ANNU REV PUBL HEALTH, V17, P259; Cortes-Briones JA, 2015, BIOL PSYCHIAT, V78, P805, DOI 10.1016/j.biopsych.2015.03.023; Davis B., 1994, Agriculture and Human Values, V11, P50, DOI 10.1007/BF01530416; Davison KM, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0059-x; Davison KM, 2015, SOC PSYCH PSYCH EPID, V50, P963, DOI 10.1007/s00127-015-1018-1; Davison KM, 2014, GEN HOSP PSYCHIAT, V36, P411, DOI 10.1016/j.genhosppsych.2014.04.001; Davison KM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-80; Davison KM, 2011, J AM COLL NUTR, V30, P547, DOI 10.1080/07315724.2011.10720001; Davison KM, 2012, 2 DIET CAN; Drake RE, 2000, SCHIZOPHRENIA BULL, V26, P105, DOI 10.1093/oxfordjournals.schbul.a033429; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; FOLTIN RW, 1988, APPETITE, V11, P1, DOI 10.1016/S0195-6663(88)80017-5; GELBERG L, 1995, PUBLIC HEALTH REP, V110, P448; Gregg L, 2007, CLIN PSYCHOL REV, V27, P494, DOI 10.1016/j.cpr.2006.09.004; Hadley C, 2012, AM J PHYS ANTHROPOL, V149, P72, DOI 10.1002/ajpa.22161; Hamelin A.-M., 2009, CANADIAN J URBAN RES, V18, P1; Hammond RA, 2012, P NATL ACAD SCI USA, V109, P12356, DOI 10.1073/pnas.0913003109; Hankin B.L., 2005, DEV PSYCHOPATHOLOGY; Hart CL, 2012, NEUROPSYCHOPHARMACOL, V37, P586, DOI 10.1038/npp.2011.276; Hatcher AS, 2008, NUTR ADDICTIONS GUID; Hawrelak Jason A, 2004, Altern Med Rev, V9, P180; Health Canada, 2012, HOUS FOOD SEC SURV M; Heflin CM, 2005, SOC SCI MED, V61, P1971, DOI 10.1016/j.socscimed.2005.04.014; HELLER J, 1991, APPETITE, V17, P23, DOI 10.1016/0195-6663(91)90081-3; Hendricks KM, 2010, J AM COLL NUTR, V29, P136, DOI 10.1080/07315724.2010.10719827; Heslin KC, 2003, J HEALTH CARE POOR U, V14, P34, DOI 10.1177/1049208902238822; Huddleston-Casas C, 2009, PUBLIC HEALTH NUTR, V12, P1133, DOI 10.1017/S1368980008003650; Hussain Fahmida, 2012, General Dentistry, V60, P334; Kraybill K, 2003, PROVIDING TREATMENT; Liu XC, 2005, J AFFECT DISORDERS, V86, P195, DOI 10.1016/j.jad.2005.01.016; Logan AC, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-22; Maes M, 2013, ACTA PSYCHIAT SCAND, V127, P344, DOI 10.1111/j.1600-0447.2012.01908.x; Melchior M, 2009, PEDIATRICS, V124, pE564, DOI 10.1542/peds.2009-0583; Muirhead V, 2009, COMMUNITY DENT ORAL, V37, P294, DOI 10.1111/j.1600-0528.2009.00479.x; Pelayo-Teran JM, 2010, PSYCHIAT RES, V179, P291, DOI 10.1016/j.psychres.2009.08.022; Petra AI, 2015, CLIN THER, V37, P984, DOI 10.1016/j.clinthera.2015.04.002; Polivy J, 1996, J AM DIET ASSOC, V96, P589, DOI 10.1016/S0002-8223(96)00161-7; Pryor L, 2016, SOC PSYCH PSYCH EPID, V51, P1073, DOI 10.1007/s00127-016-1249-9; Runnels VivienE., 2011, CANADIAN J COMMUNITY, V30, DOI DOI 10.7870/CJCMH-2011-0011; Saeland M, 2011, BRIT J NUTR, V105, P618, DOI 10.1017/S0007114510003971; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; SANTOLARIAFERNANDEZ FJ, 1995, DRUG ALCOHOL DEPEN, V38, P11, DOI 10.1016/0376-8716(94)01088-3; Siefert K, 2004, J HEALTH SOC BEHAV, V45, P171, DOI 10.1177/002214650404500204; Slopen N, 2010, J AM ACAD CHILD PSY, V49, P444, DOI 10.1016/j.jaac.2010.01.018; StataCorp, 2021, STATA STAT SOFTWARE; Statistics Canada, 2015, CAN COMM HLTH SURV A; Statistics Canada Health Statistics Division, 2008, CAN COMM HLTH SURV C; Strike C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1058; Stuff JE, 2004, J NUTR, V134, P2330, DOI 10.1093/jn/134.9.2330; Tang AM, 2011, DRUG ALCOHOL DEPEN, V118, P73, DOI 10.1016/j.drugalcdep.2011.02.020; Tang AM, 2010, AM J DRUG ALCOHOL AB, V36, P78, DOI 10.3109/00952990903544851; Tarasuk V., 2012, HOUSEHOLD FOOD INSEC; Tarasuk V, 2010, APPL PHYSIOL NUTR ME, V35, P172, DOI 10.1139/H10-002; Tomasi D, 2015, HUM BRAIN MAPP, V36, P120, DOI 10.1002/hbm.22617; TRACY JI, 1995, CLIN PSYCHOL REV, V15, P67, DOI 10.1016/0272-7358(95)00001-6; Vogenthaler NS, 2010, PUBLIC HEALTH NUTR, V13, P1478, DOI 10.1017/S1368980009993181; Volpe GE, 2014, J STUD ALCOHOL DRUGS, V75, P347, DOI 10.15288/jsad.2014.75.347; Weaver LJ, 2009, ECOL FOOD NUTR, V48, P263, DOI 10.1080/03670240903001167; Weiser Mark, 2005, Dialogues Clin Neurosci, V7, P81; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; WIECHA JL, 1991, PUBLIC HEALTH REP, V106, P364; YAGO KB, 1981, J CLIN PSYCHIAT, V42, P193	75	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191072	10.1371/journal.pone.0191072	http://dx.doi.org/10.1371/journal.pone.0191072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360862	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800015
J	Kant, AK; Graubard, BI				Kant, Ashima K.; Graubard, Barry I.			A prospective study of frequency of eating restaurant prepared meals and subsequent 9-year risk of all-cause and cardiometabolic mortality in US adults	PLOS ONE			English	Article							FAST-FOOD CONSUMPTION; OUT-OF-HOME; METABOLIC RISK; DIETARY; ASSOCIATION; ENERGY; OUTCOMES; QUALITY; MENU; ENVIRONMENTS	Restaurant prepared foods are known to be energy-dense and high in fat and sodium, but lower in protective nutrients. There is evidence of higher risk of adiposity, type II diabetes, and heart disease in frequent consumers of restaurant meals. However, the risk of mortality as a long-term health consequence of frequent consumption of restaurant meals has not been examined. We examined the prospective risk of all-cause and coronary heart disease, cerebrovascular disease and diabetes (cardiometabolic) mortality in relation to frequency of eating restaurant prepared meals in a national cohort. We used frequency of eating restaurant prepared meals information collected in the National Health and Nutrition Examination Surveys, conducted from 1999-2004, with mortality follow-up completed through Dec. 31, 2011 (baseline age >= 40y; n = 9107). We estimated the relative hazard of all-cause and cardiometabolic mortality associated with weekly frequency of eating restaurant meals using Cox-proportional hazards regression methods to adjust for multiple covariates. All analyses accounted for complex survey design and included sample weights. Over 33% of all respondents reported eating >= 3 restaurant prepared meals/week. In this cohort, 2200 deaths due to all causes and 665 cardiometabolic deaths occurred over a median follow-up of 9 years. The covariate-adjusted hazard ratio of all cause or cardiometabolic mortality in men and women reporters of <1 or 1-2 restaurant prepared meals did not differ from those reporting >= 3 meals/week (P>0.05). The results were robust to effect modification by baseline BMI, years of education, and baseline morbidity. Expectedly, the 24-h dietary intakes of whole grains, fruits, dietary fiber, folate, vitamin C, potassium and magnesium at baseline were lower, but energy, energy density, and energy from fat were higher in more frequent restaurant meal reporters (P<0.05). Baseline serum HDL cholesterol, folate, and some carotenoids were inversely associated with the frequency of eating restaurant prepared meals (P<0.05); however, serum concentrations of total cholesterol, triglycerides, fasting glucose, insulin, glycated hemoglobin, and c-reactive protein were unrelated (P<0.05). The weekly frequency of eating restaurant prepared meals and prospective risk of mortality after 9 years were not related in this cohort.	[Kant, Ashima K.] CUNY Queens Coll, Dept Family Nutr & Exercise Sci, Flushing, NY 11367 USA; [Graubard, Barry I.] NCI, Div Canc Epidemiol & Genet, Biostat Branch, NIH, Bethesda, MD 20892 USA	City University of New York (CUNY) System; Queens College NY (CUNY); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kant, AK (corresponding author), CUNY Queens Coll, Dept Family Nutr & Exercise Sci, Flushing, NY 11367 USA.	ashima.kant@qc.cuny.edu		Kant, Ashima/0000-0003-4141-2063	Professional Staff Congress of the City University of New York [69741-00 47]; intramural research program of the Department of Health and Human Services, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIACP010181] Funding Source: NIH RePORTER	Professional Staff Congress of the City University of New York; intramural research program of the Department of Health and Human Services, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Professional Staff Congress of the City University of New York, research award #69741-00 47 (https://www.rfcuny.org/rfwebsite/research/content.aspx?catID=1190) (Kant); and intramural research program of the Department of Health and Human Services, National Cancer Institute, NIH (Graubard). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern M, 2011, J RURAL HEALTH, V27, P367, DOI 10.1111/j.1748-0361.2011.00378.x; Alter DA, 2005, CAN J PUBLIC HEALTH, V96, P173, DOI 10.1007/BF03403684; An R, 2016, EUR J CLIN NUTR, V70, P97, DOI 10.1038/ejcn.2015.104; [Anonymous], 2017, SUD REL 11 0; [Anonymous], IND DIET PHYS ACT BE; Auchincloss AH, 2014, J NUTR EDUC BEHAV, V46, P75, DOI 10.1016/j.jneb.2013.10.008; Bezerra IN, 2012, NUTR REV, V70, P65, DOI 10.1111/j.1753-4887.2011.00459.x; Bleich SN, 2016, AM J PREV MED, V50, pE1, DOI 10.1016/j.amepre.2015.05.007; Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357; Brown WV, 2015, J CLIN LIPIDOL, V9, P3, DOI 10.1016/j.jacl.2014.12.002; Centers for Disease Control and Prevention National Center for Environmental Health Division of Laboratory Sciences, 2012, 2 NAT REP BIOCH IND; Cohen DA, 2014, AM J PUBLIC HEALTH, V104, P586, DOI 10.2105/AJPH.2013.301692; Dominguez LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092354; Duffey KJ, 2009, J NUTR, V139, P2113, DOI 10.3945/jn.109.109520; Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Hamano T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056680; Hattori A, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120123; Hearst MO, 2013, AM J PREV MED, V44, P589, DOI 10.1016/j.amepre.2013.01.028; Kant AK, 2015, INT J OBESITY, V39, P820, DOI 10.1038/ijo.2014.183; Kant AK, 2004, PREV MED, V38, P243, DOI 10.1016/j.ypmed.2003.10.004; Kirkpatrick SI, 2014, PUBLIC HEALTH NUTR, V17, P924, DOI 10.1017/S1368980012005563; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Korn EL., 1999, ANAL HLTH SURVEYS; Krishnan S, 2010, AM J CLIN NUTR, V91, P465, DOI 10.3945/ajcn.2009.28682; Lachat C, 2012, OBES REV, V13, P329, DOI 10.1111/j.1467-789X.2011.00953.x; Li FZ, 2009, AM J HEALTH PROMOT, V23, P203, DOI 10.4278/ajhp.071214133; Lin B.-H., 2012, BOOK NUTR QUALITY FO, VEIB-105; Mehta NK, 2008, AM J PREV MED, V34, P127, DOI 10.1016/j.amepre.2007.09.031; Meyer KA, 2015, HEALTH PLACE, V33, P9, DOI 10.1016/j.healthplace.2015.01.004; Moore LV, 2009, AM J EPIDEMIOL, V170, P29, DOI 10.1093/aje/kwp090; Morgenstern LB, 2009, ANN NEUROL, V66, P165, DOI 10.1002/ana.21726; Nago ES, 2014, CRIT REV FOOD SCI, V54, P1103, DOI 10.1080/10408398.2011.627095; National Center for Health Statistics, QUEST DAT REL DOC; National Center for Health Statistics, NHANES RESP RAT POP; National Center for Health Statistics, 2015, OFF AN EP PUBL US LI; National Center for Health Statistics, 2013, OFF AN EP NCHS 2011; Odegaard AO, 2012, CIRCULATION, V126, P182, DOI 10.1161/CIRCULATIONAHA.111.084004; Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1; Parcina M, 2015, NUTR RES PRACT, V9, P165, DOI 10.4162/nrp.2015.9.2.165; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Poti JM, 2014, AM J CLIN NUTR, V99, P162, DOI 10.3945/ajcn.113.071928; Rudolph TK, 2007, AM J CLIN NUTR, V86, P334, DOI 10.1093/ajcn/86.2.334; Scourboutakos MJ, 2013, JAMA INTERN MED, V173, P1373, DOI 10.1001/jamainternmed.2013.6159; Smith KJ, 2012, EUR J CLIN NUTR, V66, P577, DOI 10.1038/ejcn.2011.202; The Third National Health and Nutrition Examination Survey (NHANES III), 2005, LINK MORT FIL MATCH; Tiwari A, 2017, AM J PREV MED, V52, P616, DOI 10.1016/j.amepre.2017.01.017; URBAN LE, 2014, PREV CHRONIC DIS, V11, P40202, DOI DOI 10.5888/PCD11.140202; Urban LE, 2016, J ACAD NUTR DIET, V116, P590, DOI 10.1016/j.jand.2015.11.009; Wolfson JA, 2015, PUBLIC HEALTH NUTR, V18, P1397, DOI 10.1017/S1368980014001943; Wu HW, 2013, PUBLIC HEALTH NUTR, V16, P87, DOI 10.1017/S136898001200122X; Zong G, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002052	52	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191584	10.1371/journal.pone.0191584	http://dx.doi.org/10.1371/journal.pone.0191584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360850	gold, Green Published			2022-12-27	WOS:000423161800038
J	Pugliese, M; Ramsay, T; Johnson, D; Dowlatshahi, D				Pugliese, Michael; Ramsay, Tim; Johnson, Dylan; Dowlatshahi, Dar			Mobile tablet-based therapies following stroke: A systematic scoping review of administrative methods and patient experiences	PLOS ONE			English	Review							SELF-DIRECTED THERAPY; CHRONIC APHASIA; REHABILITATION; COMPUTERS; RECOVERY; TELEREHABILITATION; SURVIVORS; PROGRAM; IPAD	Background and purpose Stroke survivors are often left with deficits requiring rehabilitation to recover function and yet, many are unable to access rehabilitative therapies. Mobile tablet-based therapies (MTBTs) may be a resource-efficient means of improving access to timely rehabilitation. It is unclear what MTBTs have been attempted following stroke, how they were administered, and how patients experienced the therapies. The review summarizes studies of MTBTs following stroke in terms of administrative methods and patient experiences to inform treatment feasibility. Methods Articles were eligible if they reported the results of an MTBT attempted with stroke participants. Six research databases were searched along with grey literature sources, trial registries, and article references. Intervention administration details and patient experiences were summarized. Results The search returned 903 articles of which 23 were eligible for inclusion. Most studies were small, observational, and enrolled chronic stroke patients. Interventions commonly targeted communication, cognition, or fine-motor skills. Therapies tended to be personalized based on patient deficits using commercially available applications. The complexity of therapy instructions, fine-motor requirements, and unreliability of internet or cellular connections were identified as common barriers to tablet-based care. Conclusions Stroke patients responded positively to MTBTs in both the inpatient and home settings. However, some support from therapists or caregivers may be required for patients to overcome barriers to care. Feasibility studies should continue to identify the administrative methods that minimize barriers to care and maximize patient adherence to prescribed therapy regiments.	[Pugliese, Michael; Ramsay, Tim; Johnson, Dylan; Dowlatshahi, Dar] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Ramsay, Tim] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Dowlatshahi, Dar] Ottawa Hosp, Res Inst, Neurosci Program, Ottawa, ON, Canada; [Dowlatshahi, Dar] Ottawa Hosp, Med Neurol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Pugliese, M (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	mpugl038@uottawa.ca		Ramsay, Tim/0000-0001-8478-8170; Dowlatshahi, Dar/0000-0003-1379-3612; Pugliese, Michael/0000-0003-2794-1436; Johnson, Dylan/0000-0003-1196-6962	Canadian Institutes of Health Research Canadian Graduate Scholarship Master's Award; University of Ottawa Ontario Graduate Scholarship; University of Ottawa Brain and Mind Research Institute; Canadian Partnership for Stroke Recovery; University of Ottawa Department of Medicine	Canadian Institutes of Health Research Canadian Graduate Scholarship Master's Award; University of Ottawa Ontario Graduate Scholarship; University of Ottawa Brain and Mind Research Institute; Canadian Partnership for Stroke Recovery; University of Ottawa Department of Medicine	This work was supported by a Canadian Institutes of Health Research Canadian Graduate Scholarship Master's Award (http://www.cihr-irsc.gc.ca/e/49440.html; M.P.), a University of Ottawa Ontario Graduate Scholarship (https://www.uottawa.ca/graduate-studies/students/awards/ontario-graduate-scholarship; M.P.), the University of Ottawa Brain and Mind Research Institute (https://www.uottawa.ca/brain/; D.D), the Canadian Partnership for Stroke Recovery (http://www.canadianstroke.ca/en/; D.D.), and the University of Ottawa Department of Medicine (https://med.uottawa.ca/en; D.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G, 2010, PLOS ONE, V5; Ansari MT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000151; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Carabeo CGG, 2014, SIMULAT GAMING, V45, P151, DOI 10.1177/1046878114531102; Choi YH, 2016, RESTOR NEUROL NEUROS, V34, P455, DOI 10.3233/RNN-150626; Choi YH, 2016, TELEMED E-HEALTH, V22, P434, DOI 10.1089/tmj.2015.0138; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Consensus Panel on the Stroke Rehabilitation System, 2007, TIM IS FUNCT REP CON; Crotty M, 2014, J TELEMED TELECARE, V20, P370, DOI 10.1177/1357633X14552382; Davis B, INT BRAIN INJ ASS C, P1; Des Roches CA, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01015; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Foley N, EVIDENCE BASED SYSTE; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Hiyamizu M, 2013, CEREBROVASC DIS, V35, P778; Hoover EL, 2014, SEMIN SPEECH LANG, V35, P25, DOI 10.1055/s-0033-1362990; Jang SH, 2016, SOMATOSENS MOT RES, V33, P124, DOI 10.1080/08990220.2016.1197117; Janssen H, 2016, INT J STROKE, V11, P15; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P27, DOI 10.1016/S0003-9993(95)80038-7; Katalinic O, 2013, J TELEMED TELECARE, V19, P418, DOI 10.1177/1357633X13506513; Kizony R, 2016, J NEUROL PHYS THER, V40, P31, DOI 10.1097/NPT.0000000000000110; Kurland J, 2014, SEMIN SPEECH LANG, V35, P51, DOI 10.1055/s-0033-1362991; Lavoie M, 2016, NEUROCASE, V22, P109, DOI 10.1080/13554794.2015.1051055; Lawrence M, 2013, INT J STROKE, V8, P465, DOI 10.1111/ijs.12135; Mallet KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167950; Mallet KH, 2016, INT J STROKE, V11, P73; McCormick SA, 2016, STROKE, V47; Mehrholz J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub3; Mehrholz J, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006876.pub4, 10.1002/14651858.CD006876.pub3]; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Rand D., 2013, 2013 International Conference on Virtual Rehabilitation (ICVR), P109, DOI 10.1109/ICVR.2013.6662068; Routhier S, 2016, APHASIOLOGY, V30, P269, DOI 10.1080/02687038.2014.973361; Salaris M, 2016, INT J STROKE, V11, P21; Salaris M, 2016, INT J STROKE, V11, P13; Salter K, EVIDENCE BASED SYSTE; Stark BC, 2018, NEUROPSYCHOL REHABIL, V28, P818, DOI 10.1080/09602011.2016.1146150; Teasell R, EVIDENCE BASED SYSTE; The Heart and Stroke Foundation, 2014, CAN STORK BEST PRACT; White JH, 2015, DISABIL REHABIL, V37, P593, DOI 10.3109/09638288.2014.935876; Williams AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057447; Xie J., 2007, Morbidity and Mortality Weekly Report, V56, P504	44	22	22	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191566	10.1371/journal.pone.0191566	http://dx.doi.org/10.1371/journal.pone.0191566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360872	gold, Green Submitted, Green Published			2022-12-27	WOS:000423161800037
J	Gils, T; Bossard, C; Verdonck, K; Owiti, P; Casteels, I; Mashako, M; van Cutsem, G; Ellman, T				Gils, Tinne; Bossard, Claire; Verdonck, Kristien; Owiti, Philip; Casteels, Ilse; Mashako, Maria; van Cutsem, Gilles; Ellman, Tom			Stockouts of HIV commodities in public health facilities in Kinshasa: Barriers to end HIV	PLOS ONE			English	Article							SUPPLY CHAIN; OUTCOMES; AFRICA; IMPACT; LEVEL	Stockouts of HIV commodities increase the risk of treatment interruption, antiretroviral resistance, treatment failure, morbidity and mortality. The study objective was to assess the magnitude and duration of stockouts of HIV medicines and diagnostic tests in public facilities in Kinshasa, Democratic Republic of the Congo. This was a cross-sectional survey involving visits to facilities and warehouses in April and May 2015. All zonal warehouses, all public facilities with more than 200 patients on antiretroviral treatment (ART) (high-burden facilities) and a purposive sample of facilities with 200 or fewer patients (low-burden facilities) in Kinshasa were selected. We focused on three adult ART formulations, cotrimoxazole tablets, and HIV diagnostic tests. Availability of items was determined by physical check, while stockout duration until the day of the survey visit was verified with stock cards. In case of ART stockouts, we asked the pharmacist in charge what the facility coping strategy was for patients needing those medicines. The study included 28 high-burden facilities and 64 lowburden facilities, together serving around 22000 ART patients. During the study period, a national shortage of the newly introduced first-line regimen Tenofovir-Lamivudine-Efavirenz resulted in stockouts of this regimen in 56% of high-burden and 43% of low-burden facilities, lasting a median of 36 (interquartile range 29 +/- 90) and 44 days (interquartile range 24 +/- 90) until the day of the survey visit, respectively. Each of the other investigated commodities were found out of stock in at least two low-burden and two high-burden facilities. In 30/41 (73%) of stockout cases, the commodity was absent at the facility but present at the upstream warehouse. In 30/57 (54%) of ART stockout cases, patients did not receive any medicines. In some cases, patients were switched to different ART formulations or regimens. Stockouts of HIV commodities were common in the visited facilities. Introduction of new ART regimens needs additional planning.	[Gils, Tinne; Bossard, Claire; van Cutsem, Gilles; Ellman, Tom] Southern Africa Med Unit, Med Sans Frontieres, Cape Town, South Africa; [Verdonck, Kristien] Inst Trop Med, Antwerp, Belgium; [Owiti, Philip] Acad Model Providing Access Healthcare, Eldoret, Kenya; [Owiti, Philip] Int Union TB & Lung Dis, Paris, France; [Casteels, Ilse; Mashako, Maria] Operat Ctr Brussels, Med Sans Frontieres, Kinshasa, DEM REP CONGO	Institute of Tropical Medicine (ITM)	Gils, T (corresponding author), Southern Africa Med Unit, Med Sans Frontieres, Cape Town, South Africa.	tinnegils@gmail.com	Gils, Tinne/GYU-8606-2022; Verdonck, Kristien/AAN-8937-2020; Van Cutsem, Gilles/ABB-1171-2021	Gils, Tinne/0000-0002-5518-9600; Verdonck, Kristien/0000-0003-1153-4078; Van Cutsem, Gilles/0000-0002-8972-4480	United Kingdom's Department for International Development (DFID); The Union; MSF; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	United Kingdom's Department for International Development (DFID); The Union; MSF; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The training model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins sans Frontieres (MSF). The specific SORT IT program which resulted in this publication was implemented by: Medecins Sans Frontieres, Brussels Operational Center, Luxembourg and the Centre for Operational Research, The Union, Paris, France. Mentorship and the coordination/facilitation of these SORT IT workshops were provided through the Centre for Operational Research, The Union, Paris, France; the Operational Research Unit (LuxOR), AMPATH, Eldoret, Kenya; Institute of Tropical Medicine, Antwerp, Belgium; University of Gondar, Ethiopia; School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA; Luke International, Malawi office; The Centre for International Health, University of Bergen, Norway; and the Northern State Medical University, Arkhangelsh, Russia. The program was funded by the United Kingdom's Department for International Development (DFID), The Union, MSF and La Fondation Veuve Emile Metz-Tesch (Luxembourg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, RAPP DISP IND ACC SU; Assi TM, 2013, VACCINE, V31, P2828, DOI 10.1016/j.vaccine.2013.04.011; Bekker LG, 2014, ANTIVIR THER, V19, P105, DOI 10.3851/IMP2905; Berhanemeskel Eyerusalem, 2016, J Pharm Policy Pract, V9, P11, DOI 10.1186/s40545-016-0060-z; Birgli ag, 2017, EV MED SHORT EUR MOR; Bogaert P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125691; Boyer S, 2011, SOC SCI MED, V72, P1383, DOI 10.1016/j.socscimed.2011.02.030; Brennan AT, 2017, TROP MED INT HEALTH, V22, P241, DOI 10.1111/tmi.12811; Clay PG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001677; Daff BM, 2014, GLOB HEALTH-SCI PRAC, V2, P245, DOI 10.9745/GHSP-D-13-00171; Fleck F, 2009, B WORLD HEALTH ORGAN, V87, P6, DOI 10.2471/BLT.09.020109; Githinji S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054066; Hassani AS, 2015, JAIDS-J ACQ IMM DEF, V68, pS257, DOI 10.1097/QAI.0000000000000486; Jamieson D, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20917; Jiamsakul A, 2016, TROP MED INT HEALTH, V21, P662, DOI 10.1111/tmi.12690; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Joint United Nations Programme on HIV and AIDS, 2014, UNAIDS 90 90 90 AMB; Kaufmann GR, 2011, AIDS, V25, P441, DOI 10.1097/QAD.0b013e3283430013; Kranzer K, 2011, TROP MED INT HEALTH, V16, P1297, DOI 10.1111/j.1365-3156.2011.02828.x; Lepere P, 2017, MED SANTE TROP, V27, P117, DOI 10.1684/mst.2017.0675; Malati C, 2017, CURR OPIN HIV AIDS, V12, P408, DOI 10.1097/COH.0000000000000387; Medecins Sans Frontieres, 2017, ET LIEUX DISP INTR E; MESI, 2015, NAT ART PROGR DAT DR; Ministere de la Sante, 2016, PLAN URG TRAIT ARV; Ministere de la Sante, 2013, GUID NAT TRAIT ARX I; Mori A. T., 2014, J PHARM POLICY PRACT, V7, P1; Muhamadi L, 2010, HEALTH POLICY, V97, P187, DOI 10.1016/j.healthpol.2010.06.003; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Raffi F, 2016, J ANTIMICROB CHEMOTH, P1; Schouten Erik J, 2011, J Int AIDS Soc, V14 Suppl 1, pS4, DOI 10.1186/1758-2652-14-S1-S4; Shieshia M, 2014, J GLOBAL HLTH, V4; Smith J, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0178-4; Stop Stock Outs. Medecins sans South African HIV Clinicians Society Rural Doctors Association Section27 Treatment Action Campaign Rural Health Advocacy Project, 2015, 3 MED SANS FRONT S A; UCOP+ FORUM SIDA UNAIDS, 2015, PAR US PREST ACC QUA; United Nations Statistics Division, 2016, DRC COUNTR PROF; USAID/DELIVER Project, 2009, DEL TEAM TOPP BRING; Velen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064459; Village Reach, 2015, EXPL NEW DISTR MOD V; WHO, 2016, GLOB REP EARL WARN I; WHO, 2017, M REP TECHN DEF SHOR; World Health Organization, 2014, ACC ANT TREATM LOW M; World Health Organization, 2016, WHA6925 WHO; Yadav P, 2015, HLTH SYSTEMS REFORM, V1, P98	43	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191294	10.1371/journal.pone.0191294	http://dx.doi.org/10.1371/journal.pone.0191294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351338	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300069
J	Ramirez-Ramirez, A; Sanchez-Serrano, E; Loaiza-Flores, G; Plazola-Camacho, N; Rodriguez-Delgado, RG; Figueroa-Damian, R; Dominguez-Castro, M; Lopez-Martinez, M; Flores-Garcia, Z; Hernandez-Pineda, J				Ramirez-Ramirez, Alicia; Sanchez-Serrano, Elias; Loaiza-Flores, Giselle; Plazola-Camacho, Noemi; Georgina Rodriguez-Delgado, Rosa; Figueroa-Damian, Ricardo; Dominguez-Castro, Mauricio; Lopez-Martinez, Margarita; Flores-Garcia, Zayra; Hernandez-Pineda, Jessica			Simultaneous quantification of four antiretroviral drugs in breast milk samples from HIV-positive women by an ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method	PLOS ONE			English	Article							CLINICAL-APPLICATION; LC-MS/MS; PHARMACOKINETICS; VALIDATION; PREGNANCY; SPOTS	The primary strategy to avoid mother-to-child transmission of human immunodeficiency virus (HIV) through breastfeeding is administration of highly active antiretroviral therapy (HAART) to HIV-positive pregnant women. Because significant changes in the pharmacokinetics of antiretroviral (ARV) drugs occur during pregnancy, quantifying HAART and the viral load in breast milk in this population is essential. Here, we developed an analytical assay for the simultaneous quantification of four ARV drugs in breast milk using ultra-performance liquid chromatography coupled to tandem mass spectrometry. We validated this method following Mexican and international guidelines. ARV drugs. We extracted the ARV drugs from 200 mu L samples of breast milk and detected these drugs in a triple quadrupole mass spectrometer with positive electrospray ionization. The validated concentration ranges (ng/mL) for zidovudine, lamivudine, lopinavir, and ritonavir were 12.5-750, 50-2500, 100-5000 and 5 to 250, respectively. Additionally, the absolute recovery percentages (and matrix effects) were 91.4 (8.39), 88.78 (28.75), 91.38 (11.77) and 89.78 (12.37), respectively. We determined that ARV drugs are stable for 24 h at 8 degrees C and 24 degrees C for 15 days at - 80 degrees C. This methodology had the capacity for simultaneous detection; separation; and accurate, precise quantification of ARV drugs in human breast milk samples according to Mexican standard laws and United States Food and Drug Administration guidelines.	[Ramirez-Ramirez, Alicia; Plazola-Camacho, Noemi; Georgina Rodriguez-Delgado, Rosa; Figueroa-Damian, Ricardo; Hernandez-Pineda, Jessica] Natl Inst Perinatol, Dept Infectol & Immunol, Mexico City, DF, Mexico; [Sanchez-Serrano, Elias; Loaiza-Flores, Giselle] Univ Nacl Autonoma Mexico, Chem Fac, Mexico City, DF, Mexico; [Dominguez-Castro, Mauricio; Lopez-Martinez, Margarita] Natl Inst Perinatol, Dept Physiol & Cellular Dev, Mexico City, DF, Mexico; [Flores-Garcia, Zayra] Univ Nacl Autonoma Mexico, Fac Higher Educ, Cuautitlan, Mexico State, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Hernandez-Pineda, J (corresponding author), Natl Inst Perinatol, Dept Infectol & Immunol, Mexico City, DF, Mexico.	jesspinq@yahoo.com.mx	Hernández-Pineda, Jessica/AAT-1090-2020; HERNÁNDEZ-PINEDA, JESSICA/AAS-2439-2020; Ramirez-Ramirez, Alicia/J-3768-2017	Hernández-Pineda, Jessica/0000-0003-3698-0912; Ramirez-Ramirez, Alicia/0000-0002-5111-8936; Dominguez Castro, Mauricio/0000-0001-5659-8468	Institute Nacional de Perinatologia (INPer, Mexico) [(478) 212250-3120771]; Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) [SALUD-14-01-234292]	Institute Nacional de Perinatologia (INPer, Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors also acknowledge the Institute Nacional de Perinatologia (INPer, Mexico, http://www.inper.mx/) project (478) 212250-3120771 to Jessica Hernandez-Pineda and Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico, http://www.conacyt.gob.mx/) project SALUD-14-01-234292 to Jessica Hernandez-Pineda for support. MAMH thanks CONACYT for providing a graduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaway JE, 2012, J CHROMATOGR B, V883, P33, DOI 10.1016/j.jchromb.2011.09.041; [Anonymous], 2011, COCHRANE DATABASE SY; [Anonymous], 2014, COCHRANE DATABASE SY; Bazzoli C, 2010, CLIN PHARMACOKINET, V49, P17, DOI 10.2165/11318110-000000000-00000; Becka Chandra M, 2015, J Int Assoc Provid AIDS Care, V14, P72, DOI 10.1177/2325957414557262; Buckoreelall K, 2012, CLIN PHARMACOKINET, V51, P639, DOI 10.1007/s40262-012-0002-0; Decosterd LA, 2016, TRAC-TREND ANAL CHEM, V84, P5, DOI 10.1016/j.trac.2016.03.019; Giuliano M, 2007, JAIDS-J ACQ IMM DEF, V44, P286, DOI 10.1097/QAI.0b013e31802c5441; Hennet T, 2016, TRENDS BIOCHEM SCI, V41, P508, DOI 10.1016/j.tibs.2016.02.008; Jevtovic D, 2010, BIOMED PHARMACOTHER, V64, P692, DOI 10.1016/j.biopha.2010.08.004; Koehn J, 2015, ANTIMICROB AGENTS CH, V59, P6682, DOI 10.1128/AAC.00869-15; Mirochnick M, 2009, ANTIMICROB AGENTS CH, V53, P1170, DOI 10.1128/AAC.01117-08; Mugwanya KK, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002132; Olagunju A, 2015, J ANTIMICROB CHEMOTH, V70, P2816, DOI 10.1093/jac/dkv174; Olagunju A, 2015, J ANTIMICROB CHEMOTH, V70, P555, DOI 10.1093/jac/dku420; Roustit M, 2008, BRIT J CLIN PHARMACO, V66, P179, DOI 10.1111/j.1365-2125.2008.03220.x; Slater Mackenzie, 2010, Paediatr Drugs, V12, P1, DOI 10.2165/11316130-000000000-00000; Vazquez-Rosales JG, 2016, GUIA PRACTICA CLIN C, V246, P1; Wahl A, 2015, J VIROL, V89, P10868, DOI 10.1128/JVI.01702-15; Waitt CJ, 2015, J ANTIMICROB CHEMOTH, V70, P1928, DOI 10.1093/jac/dkv080; Widdrington J, 2011, J INFECTION, V62, P87, DOI 10.1016/j.jinf.2010.11.001	21	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191236	10.1371/journal.pone.0191236	http://dx.doi.org/10.1371/journal.pone.0191236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351333	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300060
J	Sadatsafavi, M; Xie, H; Etminan, M; Johnson, K; FitzGerald, JM				Sadatsafavi, Mohsen; Xie, Hui; Etminan, Mahyar; Johnson, Kate; FitzGerald, J. Mark		Canadian Resp Res Network	The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology	PLOS ONE			English	Article							RECURRENT EVENTS; COPD; PREVENTION	Background There is minimal evidence on the extent to which the occurrence of a severe acute exacerbation of COPD that results in hospitalization affects the subsequent disease course. Previous studies on this topic did not generate causally-interpretable estimates. Our aim was to use corrected methodology to update previously reported estimates of the associations between previous and future exacerbations in these patients. Methods Using administrative health data in British Columbia, Canada (1997-2012), we constructed a cohort of patients with at least one severe exacerbation, defined as an episode of inpatient care with the main diagnosis of COPD based on international classification of diseases (ICD) codes. We applied a random-effects 'joint frailty' survival model that is particularly developed for the analysis of recurrent events in the presence of competing risk of death and heterogeneity among individuals in their rate of events. Previous severe exacerbations entered the model as dummy-coded time-dependent covariates, and the model was adjusted for several observable patient and disease characteristics. Results 35,994 individuals (mean age at baseline 73.7, 49.8% female, average follow-up 3.21 years) contributed 34,271 severe exacerbations during follow-up. The first event was associated with a hazard ratio (HR) of 1.75 (95% CI 1.69-1.82) for the risk of future severe exacerbations. This risk decreased to HR = 1.36 (95% CI 1.30-1.42) for the second event and to 1.18 (95% CI 1.12-1.25) for the third event. The first two severe exacerbations that occurred during follow-up were also significantly associated with increased risk of all-cause mortality. There was substantial heterogeneity in the individual-specific rate of severe exacerbations. Even after adjusting for observable characteristics, individuals in the 97.5th percentile of exacerbation rate had 5.6 times higher rate of severe exacerbations than those in the 2.5th percentile. Conclusions Using robust statistical methodology that controlled for heterogeneity in exacerbation rates among individuals, we demonstrated potential causal associations among past and future severe exacerbations, albeit the magnitude of association was noticeably lower than previously reported. The prevention of severe exacerbations has the potential to modify the disease trajectory.	[Sadatsafavi, Mohsen; Johnson, Kate] Univ British Columbia, Fac Pharmaceut Sci, Resp Evaluat Sci Program, Vancouver, BC, Canada; [Sadatsafavi, Mohsen; Etminan, Mahyar; FitzGerald, J. Mark] Univ British Columbia, Fac Med, Inst Heart & Lung Hlth, Vancouver, BC, Canada; [Sadatsafavi, Mohsen; FitzGerald, J. Mark] Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Xie, Hui] Simon Fraser Univ, Fac Hlth Sci, Biostat Div, Burnaby, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Simon Fraser University	Sadatsafavi, M (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Resp Evaluat Sci Program, Vancouver, BC, Canada.; Sadatsafavi, M (corresponding author), Univ British Columbia, Fac Med, Inst Heart & Lung Hlth, Vancouver, BC, Canada.; Sadatsafavi, M (corresponding author), Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada.	msafavi@mail.ubc.ca	Sadatsafayi, Mohsen/AAZ-1593-2020	Sadatsafayi, Mohsen/0000-0002-0419-7862; , hui/0000-0003-3328-7135	Operating Grant from Canadian Institutes of Health Research (CIHR [142238]; Canadian Respiratory Research Network (CRRN); CIHR - Institute of Circulatory and Respiratory Health; Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS); British Columbia Lung Association; Boehringer-lngelheim Canada Ltd; AstraZeneca Canada Inc.; Novartis Canada Ltd.; GlaxoSmithKline Inc.; New Investigator Award from CIHR; Michael Smith Foundation for Health Research	Operating Grant from Canadian Institutes of Health Research (CIHR; Canadian Respiratory Research Network (CRRN); CIHR - Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS); British Columbia Lung Association; Boehringer-lngelheim Canada Ltd; AstraZeneca Canada Inc.(AstraZeneca); Novartis Canada Ltd.; GlaxoSmithKline Inc.(GlaxoSmithKline); New Investigator Award from CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This study was funded by an Operating Grant from the Canadian Institutes of Health Research (CIHR, #142238) and funds from the Canadian Respiratory Research Network (CRRN) (Mohsen Sadatsafavi); CRRN is supported by grants from CIHR - Institute of Circulatory and Respiratory Health; Canadian Lung Association (CLA)/Canadian Thoracic Society (CTS); British Columbia Lung Association; and Industry Partners Boehringer-lngelheim Canada Ltd, AstraZeneca Canada Inc., and Novartis Canada Ltd. Funding for training of graduate students and new investigators within the network was supported by the above funding sponsors and as well by GlaxoSmithKline Inc. Mohsen Sadatsafavi is supported by a New Investigator Award from CIHR and a Scholar Award from Michael Smith Foundation for Health Research. The funders had no role in the study design, data collection and analysis, or preparation of the manuscript.	Aaron SD, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5237; Albert RK, 2011, NEW ENGL J MED, V365, P689, DOI 10.1056/NEJMoa1104623; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; BC Vital Statistics Agency, 2014, VIT STAT DEATHS V2; British Columbia Ministry of Health, 2014, MED SERV PLAN MSP PA; British Columbia Ministry of Health, 2014, CONS FIL MSP REG PRE; Canadian Institute for Health Information, 2014, DISCH ABSTR DAT HOSP; Canadian Institute for Health Information, 2009, TOO EARL TOO SMALL P; Canadian Thoracic Society, 2010, HUM EC BURD COPD; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Government of Canada SC, 2011, POP URB RUR PROV TER; Hougaard P, 1995, Lifetime Data Anal, V1, P255; Huang XL, 2007, BIOMETRICS, V63, P389, DOI 10.1111/j.1541-0420.2006.00719.x; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Kerkhof M, 2015, INT J CHRONIC OBSTR, V10, P2439, DOI 10.2147/COPD.S94259; Khakban A, 2015, CHEST, V148, P640, DOI 10.1378/chest.15-0721; Liu L, 2004, BIOMETRICS, V60, P747, DOI 10.1111/j.0006-341X.2004.00225.x; Lu L, 2008, ANAL CORRELATED RECU; Rennard Stephen I, 2004, Proc Am Thorac Soc, V1, P88, DOI 10.1513/pats.2306026; Sadatsafavi M, 2014, THORAX; Sadatsafavi M, AM J EPIDEMIOL; Suissa S, 2012, THORAX, V67, P957, DOI 10.1136/thoraxjnl-2011-201518; VAUPEL JW, 1985, AM STAT, V39, P176, DOI 10.2307/2683925; Williams JI, 1996, INVENTORY STUDIES AC	25	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191243	10.1371/journal.pone.0191243	http://dx.doi.org/10.1371/journal.pone.0191243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351331	gold, Green Submitted, Green Published			2022-12-27	WOS:000422911300062
J	Varanasi, SK; Jaggi, U; Hay, N; Rouse, BT				Varanasi, Siva Karthik; Jaggi, Ujjaldeep; Hay, Nissim; Rouse, Barry T.			Hexokinase II may be dispensable for CD4 T cell responses against a virus infection	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; MITOCHONDRIA; LYMPHOCYTES; MICE; HK2	Activation of CD4 T cells leads to their metabolic reprogramming which includes enhanced glycolysis, catalyzed through hexokinase enzymes. Studies in some systems indicate that the HK2 isoform is the most up regulated isoform in activated T cells and in this report the relevance of this finding is evaluated in an infectious disease model. Genetic ablation of HK2 was achieved in only T cells and the outcome was evaluated by measures of T cell function. Our results show that CD4 T cells from both HK2 depleted and WT animals displayed similar responses to in vitro stimulation and yielded similar levels of Th1, Treg or Th17 subsets when differentiated in vitro. A modest increase in the levels of proliferation was observed in CD4 T cells lacking HK2. Deletion of HK2 led to enhanced levels of HK1 indicative of a compensatory mechanism. Finally, CD4 T cell mediated immuno-inflammatory responses to a virus infection were similar between WT and HK2 KO animals. The observations that the expression of HK2 appears non-essential for CD4 T cell responses against virus infections is of interest since it suggests that targeting HK2 for cancer therapy may not have untoward effects on CD4 T cell mediated immune response against virus infections.	[Varanasi, Siva Karthik; Rouse, Barry T.] Univ Tennessee, Dept Genome Sci & Technol, Knoxville, TN 37996 USA; [Jaggi, Ujjaldeep; Rouse, Barry T.] Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, Knoxville, TN 37996 USA; [Hay, Nissim] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rouse, BT (corresponding author), Univ Tennessee, Dept Genome Sci & Technol, Knoxville, TN 37996 USA.; Rouse, BT (corresponding author), Univ Tennessee, Dept Biomed & Diagnost Sci, Coll Vet Med, Knoxville, TN 37996 USA.	btr@utk.edu			National Institutes of Health Grant [EY 005093]; NATIONAL CANCER INSTITUTE [R01CA206167] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000733] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant EY 005093 (to Barry T Rouse).	Anderson M, 2016, ONCOTARGET; Ardehali H, 1996, J BIOL CHEM, V271, P1849, DOI 10.1074/jbc.271.4.1849; Bhela S, 2014, J IMMUNOL, V192, P2734, DOI 10.4049/jimmunol.1302326; BONNEAU RH, 1989, J VIROL, V63, P1480, DOI 10.1128/JVI.63.3.1480-1484.1989; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Cheung EC, 2012, P NATL ACAD SCI USA, V109, P20491, DOI 10.1073/pnas.1206530109; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Fueger PT, 2003, AM J PHYSIOL-ENDOC M, V285, pE958, DOI 10.1152/ajpendo.00190.2003; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; HANKE T, 1991, J VIROL, V65, P1177, DOI 10.1128/JVI.65.3.1177-1186.1991; Jones LL, 2016, J IMMUNOL, V196, P2973, DOI 10.4049/jimmunol.1402953; KATZEN HM, 1965, P NATL ACAD SCI USA, V54, P1218, DOI 10.1073/pnas.54.4.1218; Kumaraguru U, 2004, J IMMUNOL, V172, P3719, DOI 10.4049/jimmunol.172.6.3719; MARJANOVIC S, 1990, BIOCHIM BIOPHYS ACTA, V1087, P1, DOI 10.1016/0167-4781(90)90113-G; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Ros S, 2013, CANCER DISCOV, V3, P1105, DOI 10.1158/2159-8290.CD-13-0565; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; Varanasi SK, 2017, J VIROL, V91, DOI 10.1128/JVI.02367-16; Varanasi SK, 2017, J IMMUNOL	23	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191533	10.1371/journal.pone.0191533	http://dx.doi.org/10.1371/journal.pone.0191533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352298	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300109
J	Sanfins, E; Correia, A; Gunnarsson, SB; Vilanova, M; Cedervall, T				Sanfins, Elodie; Correia, Alexandra; Gunnarsson, Stefan B.; Vilanova, Manuel; Cedervall, Tommy			Nanoparticle effect on neutrophil produced myeloperoxidase	PLOS ONE			English	Article							GOLD NANOPARTICLES; PROTEIN CORONA; SIZE; DENSITY; CHEMISTRY; BEHAVIOR; CELLS; KILL	Nanoparticles affect the immune system as they may interact directly with immune cells and activate them. However, it is possible that nanoparticles also interact with released cytokines and immunologically active enzymes. To test this hypothesis, the activity of myeloperoxidase released from activated neutrophils was measured in the presence of nanoparticles with different chemistry and size. In high concentrations of nanoparticles, myeloperoxidase activity is decreased whereas in low concentrations of nanoparticles the activity is increased. The effect of the nanoparticles on myeloperoxidase is dependent on the total protein concentration as low concentrations of bovine serum albumin together with nanoparticles further increase the myeloperoxidase activity. The results herein show that nanoparticles affect the immune response not only at the cellular level but also on released immune effectors. In particular, they show that the nanoparticle effect on myeloperoxidase activity in the neutrophil degranulation environment is the result of an intricate interplay between the enzyme and protein concentrations in the environment and the available surface area on the nanoparticle.	[Sanfins, Elodie; Gunnarsson, Stefan B.; Cedervall, Tommy] Lund Univ, Biochem & Struct Biol, Lund, Sweden; [Sanfins, Elodie; Gunnarsson, Stefan B.; Cedervall, Tommy] Lund Univ, NanoLund, Lund, Sweden; [Sanfins, Elodie] Univ Paris Saclay, CEA, Inst Francois Jacob, Fontenay Aux Roses, France; [Correia, Alexandra; Vilanova, Manuel] Univ Porto, ICBAS, Oporto, Portugal; [Correia, Alexandra; Vilanova, Manuel] Univ Porto, I3S Inst Invest & Inovacao Saude, Oporto, Portugal; [Correia, Alexandra; Vilanova, Manuel] Univ Porto, IBMC, Oporto, Portugal	Lund University; Lund University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto	Sanfins, E; Cedervall, T (corresponding author), Lund Univ, Biochem & Struct Biol, Lund, Sweden.; Sanfins, E; Cedervall, T (corresponding author), Lund Univ, NanoLund, Lund, Sweden.; Sanfins, E (corresponding author), Univ Paris Saclay, CEA, Inst Francois Jacob, Fontenay Aux Roses, France.	elodie.sanfins@cea.fr; tommy.cedervall@biochemistry.lu.se	Vilanova, Manuel/D-2127-2013; Cedervall, Tommy/AAT-9766-2021; Correia, Alexandra/AID-6313-2022	Vilanova, Manuel/0000-0001-7007-306X; Cedervall, Tommy/0000-0003-2255-8446; Correia, Alexandra/0000-0003-0408-6262	FCT [SFRH/BPD/91623/2012]; NanoLund at Lund University; People Programme (Marie Curie Actions) of the European Union'sSeventh Framework Programme (FP7) [608153]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NanoLund at Lund University; People Programme (Marie Curie Actions) of the European Union'sSeventh Framework Programme (FP7)	AC was supported by FCT fellowship SFRH/BPD/91623/2012. This work was supported by grants from the NanoLund at Lund University. SBG was funded by People Programme (Marie Curie Actions) of the European Union'sSeventh Framework Programme (FP7/2007-2013) under REA grant agreementn 608153, PhD4Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Alexandra Correia was supported by FCT fellowship SFRH/BPD/91623/2012. Stefan B. Gunnarsson was supported by People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no 608153, PhD4Energy. This work was supported by grants from the NanoLund at Lund University	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Cedervall T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032254; Cukalevski R, 2011, LANGMUIR, V27, P14360, DOI 10.1021/la203290a; Dinauer Mary C, 2005, Hematology Am Soc Hematol Educ Program, P89; Dobrovolskaia MA, 2009, NANOMED-NANOTECHNOL, V5, P106, DOI 10.1016/j.nano.2008.08.001; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Fang RNH, 2016, ANNU REV CHEM BIOMOL, V7, P305, DOI 10.1146/annurev-chembioeng-080615-034446; Ferreira SA, 2013, NANOMED-NANOTECHNOL, V9, P159, DOI 10.1016/j.nano.2012.06.001; Gomez-Lopez N, 2014, CELL MOL IMMUNOL, V11, P571, DOI 10.1038/cmi.2014.46; Gottschalk F, 2011, J ENVIRON MONITOR, V13, P1145, DOI 10.1039/c0em00547a; Hazen SL, 1996, J BIOL CHEM, V271, P23080, DOI 10.1074/jbc.271.38.23080; Hazen SL, 1996, J CLIN INVEST, V98, P1283, DOI 10.1172/JCI118914; Johannssen T, 2017, TRENDS BIOTECHNOL, V35, P334, DOI 10.1016/j.tibtech.2016.10.002; Ju-Nam Y, 2008, SCI TOTAL ENVIRON, V400, P396, DOI 10.1016/j.scitotenv.2008.06.042; Kaplan MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4325; Kim ND, 2015, TRENDS IMMUNOL, V36, P547, DOI 10.1016/j.it.2015.07.007; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Lekstrom-Himes JA, 2000, NEW ENGL J MED, V343, P1703, DOI 10.1056/NEJM200012073432307; Liu F, 2015, ACS APPL MATER INTER, V7, P3717, DOI 10.1021/am5084545; Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Moghimi SM, 2011, ADV DRUG DELIVER REV, V63, P1000, DOI 10.1016/j.addr.2011.06.002; Nasir I, 2015, NANOSCALE, V7, P17504, DOI 10.1039/c5nr05360a; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nauseef WM, 2004, JPN J INFECT DIS, V57, pS4; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]; Newby AC, 2015, MATRIX BIOL, V44-46, P157, DOI 10.1016/j.matbio.2015.01.015; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; Oslakovic C, 2012, NANOMED-NANOTECHNOL, V8, P981, DOI 10.1016/j.nano.2011.12.001; Papandrea VA, 2009, SMALL WEINH BERGSTR, V5, P470; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Parker H, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00424; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Rahat MA, 2016, MEDIAT INFLAMM MEDIA, V2016; Saha B, 2015, ANALYST, V140, P532, DOI 10.1039/c4an01639d; Sanfins E, 2014, NANO LETT, V14, P4736, DOI 10.1021/nl501863u; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shang W, 2007, NANO LETT, V7, P1991, DOI 10.1021/nl070777r; Shen CC, 2011, INT J NANOMED, V6, P1229, DOI 10.2147/IJN.S21019; Wolf-Grosse S, 2017, INT J NANOMED, V12, P3927, DOI 10.2147/IJN.S136453; Yue H, 2015, VACCINE, V33, P5927, DOI 10.1016/j.vaccine.2015.07.100	42	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191445	10.1371/journal.pone.0191445	http://dx.doi.org/10.1371/journal.pone.0191445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346422	Green Published, gold			2022-12-27	WOS:000422749500052
J	Amar, A; Zlochiver, S; Barnea, O				Amar, Ani; Zlochiver, Sharon; Barnea, Ofer			Mechano-electric feedback effects in a three-dimensional (3D) model of the contracting cardiac ventricle	PLOS ONE			English	Article							CELLULAR MECHANISMS; ARRHYTHMIAS; MYOCYTES; HEART; INDUCTION; DYNAMICS; CURRENTS; STRETCH; LENGTH	Mechano-electric feedback affects the electrophysiological and mechanical function of the heart and the cellular, tissue, and organ properties. To determine the main factors that contribute to this effect, this study investigated the changes in the action potential characteristics of the ventricle during contraction. A model of stretch-activated channels was incorporated into a three-dimensional multiscale model of the contracting ventricle to assess the effect of different preload lengths on the electrophysiological behavior. The model describes the initiation and propagation of the electrical impulse, as well as the passive (stretch) and active (contraction) changes in the cardiac mechanics. Simulations were performed to quantify the relationship between the cellular activation and recovery patterns as well as the action potential durations at different preload lengths in normal and heart failure pathological conditions. The simulation results showed that heart failure significantly affected the excitation propagation parameters compared to normal condition. The results showed that the mechano-electrical feedback effects appear to be most important in failing hearts with low ejection fraction.	[Amar, Ani; Zlochiver, Sharon; Barnea, Ofer] Tel Aviv Univ, Dept Biomed Engn, Fac Engn, Tel Aviv, Israel	Tel Aviv University	Barnea, O (corresponding author), Tel Aviv Univ, Dept Biomed Engn, Fac Engn, Tel Aviv, Israel.	barneao@eng.tau.ac.il	Amar, Ani/AAC-3581-2021	Amar, Ani/0000-0002-9149-2666				Amar A, 2012, IEEE 27 CONV EL EL E; Amar A, 2015, CARDIOVASC ENG TECHN, V6, P401, DOI 10.1007/s13239-015-0247-5; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; DEAN JW, 1990, J PHYSIOL-LONDON, V429, P387, DOI 10.1113/jphysiol.1990.sp018263; FRANZ MR, 1989, CARDIOVASC RES, V23, P213, DOI 10.1093/cvr/23.3.213; Garny A, 2004, ANN NY ACAD SCI, V1015, P133, DOI 10.1196/annals.1302.011; HANSEN DE, 1993, AM J PHYSIOL, V264, pH423, DOI 10.1152/ajpheart.1993.264.2.H423; Healy SN, 2005, EUROPACE, V7, pS128, DOI 10.1016/j.eupc.2005.03.019; Hu Y, 2013, 2013 2ND INTERNATIONAL SYMPOSIUM ON INSTRUMENTATION AND MEASUREMENT, SENSOR NETWORK AND AUTOMATION (IMSNA), P8, DOI 10.1109/IMSNA.2013.6742806; Isenberg G, 2003, PROG BIOPHYS MOL BIO, V82, P43, DOI 10.1016/S0079-6107(03)00004-X; Jie X, 2010, CIRC RES, V106, P185, DOI 10.1161/CIRCRESAHA.109.210864; Keldermann RH, 2010, AM J PHYSIOL-HEART C, V299, pH134, DOI 10.1152/ajpheart.00862.2009; Kohl P, 1998, CAN J CARDIOL, V14, P111; Li WH, 2004, J MOL HISTOL, V35, P679; Negroni JA, 1996, J MOL CELL CARDIOL, V28, P915, DOI 10.1006/jmcc.1996.0086; Noble D, 1998, CAN J CARDIOL, V14, P123; SACHS F, 1994, CELL MECHANICS AND CELLULAR ENGINEERING, P308; Shim EB, 2007, J PHYSIOL SCI, V57, P275, DOI 10.2170/physiolsci.RP006007; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; WHITE E, 1993, EXP PHYSIOL, V78, P65, DOI 10.1113/expphysiol.1993.sp003671; Wickenden AD, 1998, CARDIOVASC RES, V37, P312, DOI 10.1016/S0008-6363(97)00256-3; Witman S, 2011, COMPUT METHOD BIOMEC, V14, P957, DOI 10.1080/10255842.2010.502893; Zeng T, 2000, AM J PHYSIOL-HEART C, V278, pH548, DOI 10.1152/ajpheart.2000.278.2.H548; Zlochiver S, 2010, CARDIOVASC ENG, V10, P190, DOI 10.1007/s10558-010-9104-1	24	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191238	10.1371/journal.pone.0191238	http://dx.doi.org/10.1371/journal.pone.0191238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342222	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800054
J	Ashraf, MI; Sinha, S				Ashraf, Md Izhar; Sinha, Sitabhra			The "handedness" of language: Directional symmetry breaking of sign usage in words	PLOS ONE			English	Article							ENTROPY; SCRIPT	Language, which allows complex ideas to be communicated through symbolic sequences, is a characteristic feature of our species and manifested in a multitude of forms. Using large written corpora for many different languages and scripts, we show that the occurrence probability distributions of signs at the left and right ends of words have a distinct heterogeneous nature. Characterizing this asymmetry using quantitative inequality measures, viz. information entropy and the Gini index, we show that the beginning of a word is less restrictive in sign usage than the end. This property is not simply attributable to the use of common affixes as it is seen even when only word roots are considered. We use the existence of this asymmetry to infer the direction of writing in undeciphered inscriptions that agrees with the archaeological evidence. Unlike traditional investigations of phonotactic constraints which focus on language-specific patterns, our study reveals a property valid across languages and writing systems. As both language and writing are unique aspects of our species, this universal signature may reflect an innate feature of the human cognitive phenomenon.	[Ashraf, Md Izhar; Sinha, Sitabhra] Inst Math Sci, Madras, Tamil Nadu, India; [Ashraf, Md Izhar] BS Abdur Rahman Univ, Madras, Tamil Nadu, India; [Sinha, Sitabhra] Natl Inst Adv Studies, Bengaluru, Karnataka, India	Institute of Mathematical Sciences (IMSc) India; B. S. Abdur Rahman Crescent Institute of Science & Technology	Sinha, S (corresponding author), Inst Math Sci, Madras, Tamil Nadu, India.; Sinha, S (corresponding author), Natl Inst Adv Studies, Bengaluru, Karnataka, India.	sitabhra@imsc.res.in		Sinha, Sitabhra/0000-0002-3004-1079	IMSc PRISM project - Department of Atomic Energy, Government of India	IMSc PRISM project - Department of Atomic Energy, Government of India	This work was partially supported by the IMSc PRISM project funded by the Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; We thank P. P. Divakaran, Deepak Dhar, Iravatham Mahadevan, Shakti N. Menon, Adwait Mevada, Ganesh Ramachandran and Chandrasekhar Subramanian for helpful discussions and suggestions. We also thank Bryan K. Wells for allowing the use of the IVC sequence database compiled by him. This work was partially supported by the IMSc PRISM project funded by the Department of Atomic Energy, Government of India.	[Anonymous], 2010, PATTERN THEORY STOCH; Breiman L., 1984, CLASSIFICATION REGRE; BROWN MC, 1994, SOC SCI MED, V38, P1243, DOI 10.1016/0277-9536(94)90189-9; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Coulmas F., 1996, BLACKWELL ENCY WRITI; Daniels PT., 1996, WORLDS WRITING SYSTE, V81, P588; Deacon T., 1997, SYMBOLIC SPECIES COE; DEFRANCIS J, 1994, LINGUISTICS, V32, P549, DOI 10.1515/ling.1994.32.3.549; Dodds PS, 2015, P NATL ACAD SCI USA, V112, P2389, DOI 10.1073/pnas.1411678112; Dunbar R., 1996, GROOMING GOSSIP EVOL; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Gini C, 2012, J ECON INEQUAL, V10, P421; Heaps Harold Stanley, 1978, INFORM RETRIEVAL COM; Hunter G, 1934, SCRIPT HARAPPA MOHEN; Lawler A, 2004, SCIENCE, V306, P2026, DOI 10.1126/science.306.5704.2026; Mahadevan I., 1977, MEMOIRS ARCHAEOLOGIC, V77; McMahon A., 2002, INTRO ENGLISH PHONOL; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Parpola A. H. S., 1994, DECIPHERING INDUS SC; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; Plag Ingo, 2003, WORD FORMATION ENGLI; Possehl Gregory L., 2002, INDUS CIVILIZATION C; Rao RPN, 2009, SCIENCE, V324, P1165, DOI 10.1126/science.1170391; Robinson A., 2009, WRITING AND SCRIPT; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; Schurmann T, 1996, FRACTALS, V4, P1, DOI 10.1142/S0218348X96000029; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sinha S., 2011, ECONOPHYSICS INTRO; Sinha S, 2011, COMPUT SPEECH LANG, V25, P639, DOI 10.1016/j.csl.2010.05.007; Unger J. M., 2004, IDEOGRAM CHINESE CHA; Wells BK., 2015, ARCHAEOLOGY EPIGRAPH, DOI 10.2307/j.ctvr43jmf; Zipf G. K., 1932, SELECTED STUDIES PRI	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190735	10.1371/journal.pone.0190735	http://dx.doi.org/10.1371/journal.pone.0190735			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342176	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800032
J	Gracy, D; Fabian, A; Basch, CH; Scigliano, M; MacLean, SA; MacKenzie, RK; Redlener, IE				Gracy, Delaney; Fabian, Anupa; Basch, Corey Hannah; Scigliano, Maria; MacLean, Sarah A.; MacKenzie, Rachel K.; Redlener, Irwin E.			Missed opportunities: Do states require screening of children for health conditions that interfere with learning?	PLOS ONE			English	Article							ADVERSE CHILDHOOD EXPERIENCES; BLOOD LEAD LEVELS; EDUCATIONAL-ATTAINMENT; ACADEMIC-PERFORMANCE; SCHOOL PERFORMANCE; MENTAL-DISORDERS; FOOD INSECURITY; UNITED-STATES; HEARING-LOSS; ORAL-HEALTH	Strong evidence supports the existence of Health Barriers to Learning (HBLs)-health conditions that when untreated or unmanaged can interfere with a child's ability to learn and succeed in school. These HBLs include vision and hearing deficits, uncontrolled asthma, mental and behavioral problems, dental pain, persistent hunger, and the effects of lead exposure. However, 19% of US children aged 6 to 11 did not receive their annual checkup in the past year. School requirements for health screenings can help identify children with HBLs. This study explores which states require health screening for children in elementary school, and the extent to which the 7 HBLs are included. Methods Investigators reviewed websites of state departments of health and education, and legislation for all 50 states and DC. For states with mandated screenings and a required form, investigators applied structured analysis to assess HBL inclusion. Results No state mandated that schools require screening for all 7 HBLs. Less than half (49%) required comprehensive school health examinations and only 12 states plus DC required a specific form. Of these, 12 of the forms required documentation of vision screening, 11 of hearing screening, and 12 of dental screening. Ten forms asked about asthma and 9 required documentation of lead testing. Seven asked about general well-being, emotional problems, or mental health. None addressed hunger. When including states without comprehensive school health examination requirements, the most commonly required HBL screenings were for vision (80% of states; includes DC), hearing (75% of states; includes DC) and dental (24% of state; includes DC). Conclusion The lack of state mandated requirements for regular student health screening represents a missed opportunity to identify children with HBLs. Without state mandates, accompanying comprehensive forms, and protocols, children continue to be at risk of untreated health conditions that can undermine their success in school.	[Gracy, Delaney; Fabian, Anupa; Scigliano, Maria; MacKenzie, Rachel K.; Redlener, Irwin E.] Childrens Hlth Fund, New York, NY 10027 USA; [Basch, Corey Hannah] William Paterson Univ, Dept Publ Hlth, New York, NY USA; [MacLean, Sarah A.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Redlener, Irwin E.] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA	Columbia University; Columbia University	Gracy, D (corresponding author), Childrens Hlth Fund, New York, NY 10027 USA.	dgracy@chfund.org						Advisory Committee on Childhood Lead Poisoning Prevention of the Centers for Disease Control and Prevention, 2012, LOW LEV LEAD EXP HAR; Alaimo K, 2001, PEDIATRICS, V108, P44; Ashiabi G., 2005, J CHILD POVERTY, V11, P3, DOI [10.1080/1079612042000333027, DOI 10.1080/1079612042000333027]; Asthma and Allergy Foundation of America, 2016, STAT HON ROLL REP AS; Barnhardt C, 2005, OPTOMETRY VISION SCI, V82, P138, DOI 10.1097/01.OPX.0000153266.50875.53; Basch CE, 2015, HLTH BARRIERS LEARNI; Basch CE, 2011, J SCHOOL HEALTH, V81, P593, DOI 10.1111/j.1746-1561.2011.00632.x; Basch CE, 2011, J SCHOOL HEALTH, V81, P599, DOI 10.1111/j.1746-1561.2011.00633.x; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Bethell CD, 2014, HEALTH AFFAIR, V33, P2106, DOI 10.1377/hlthaff.2014.0914; Blodgett C, 2014, ADVERSE CHILDHOOD EX; Bodack MI, 2010, OPTOMETRY, V81, P476, DOI 10.1016/j.optm.2010.05.006; Booth M, 2008, STATE LAWS DENT FEMI; Brandon RN, 2001, HLTH LEARN STATE REQ; Breslau J, 2008, J PSYCHIATR RES, V42, P708, DOI 10.1016/j.jpsychires.2008.01.016; Bright Futures American Academy of Pediatrics, 2017, REC PREV PED HLTH CA; Bright Futures American Academy of Pediatrics, 2017, REC PREV PED HLHT CA; Bright K., 2011, AM ACAD AUDIOLOGY CH; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Centers for Disease Control and Prevention (CDC) and National Center for Health Statistics (NCHS), 2015, NAT HLTH NUTR EX SUR; Choi T B, 1995, J Am Optom Assoc, V66, P484; Coleman-Jensen A., 2016, ERR215 USDA EC RES S; COUNCIL COMMUNITY PEDIAT, 2015, PEDIATRICS, V136, pE1431, DOI 10.1542/peds.2015-3301; Council On Community P, 2016, PEDIATRICS, P137; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Diette GB, 2000, ARCH PEDIAT ADOL MED, V154, P923, DOI 10.1001/archpedi.154.9.923; Esch P, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0237-4; Evens A, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0008-9; Gracy D, 2017, HLTH BARRIERS LEARNI; Green DR, 2007, PUBLIC HEALTH REP, V122, P198, DOI 10.1177/003335490712200209; Hagan Jr JF, 2007, BRIGHT FUTURES; Halterman JS, 2001, AMBUL PEDIATR, V1, P201, DOI 10.1367/1539-4409(2001)001<0201:SRAUCW>2.0.CO;2; Henning-Smith C, 2016, J CHILD HEALTH CARE, V20, P185, DOI 10.1177/1367493514563855; Jackson SL, 2011, AM J PUBLIC HEALTH, V101, P1900, DOI 10.2105/AJPH.2010.200915; Jyoti DF, 2005, J NUTR, V135, P2831, DOI 10.1093/jn/135.12.2831; Kerker BD, 2015, ACAD PEDIATR, V15, P510, DOI 10.1016/j.acap.2015.05.005; Kleinman RE, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e3; Krumholtz I, 2000, Optometry, V71, P426; Kulp MT, 2016, OPHTHALMOLOGY, V123, P681, DOI 10.1016/j.ophtha.2015.11.023; Lanphear BP, 2000, PUBLIC HEALTH REP, V115, P521, DOI 10.1093/phr/115.6.521; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Lieu JEC, 2004, ARCH OTOLARYNGOL, V130, P524, DOI 10.1001/archotol.130.5.524; Lieu JEC, 2010, PEDIATRICS, V125, pE1348, DOI 10.1542/peds.2009-2448; Locker D, 2004, J PUBLIC HEALTH DENT, V64, P63, DOI 10.1111/j.1752-7325.2004.tb02729.x; McLaine P, 2013, PEDIATRICS, V131, P1081, DOI 10.1542/peds.2012-2277; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Meijer AM, 2004, PERS INDIV DIFFER, V37, P95, DOI 10.1016/j.paid.2003.08.002; Mensah George A, 2004, Prev Chronic Dis, V1, pA13; Michael SL, 2015, J SCHOOL HEALTH, V85, P740, DOI 10.1111/josh.12309; Miranda ML, 2009, NEUROTOXICOLOGY, V30, P1019, DOI 10.1016/j.neuro.2009.07.012; National Center for Environmental Health, 2015, NIM PERC ASTHM REL M; National Health Interview Survey-Child and Family Core NHIS-Child, 2014, NAT HLTH INT SURV CH; Ou SR, 2008, SCHOOL PSYCHOL QUART, V23, P199, DOI 10.1037/1045-3830.23.2.199; Pizzarello L, 1998, J AAPOS, V2, P372, DOI 10.1016/S1091-8531(98)90038-6; Pourat Nadereh, 2009, Policy Brief UCLA Cent Health Policy Res, P1; Preslan MW, 1996, OPHTHALMOLOGY, V103, P105, DOI 10.1016/S0161-6420(96)30753-7; Redlener I, 2016, UNFINISHED BUSINESS; Ruderman M., 2016, CHILDRENS VISION EYE, V1st; Seirawan H, 2012, AM J PUBLIC HEALTH, V102, P1729, DOI 10.2105/AJPH.2011.300478; Sekhar DL, 2016, J ADOLESCENT HEALTH, V59, P362, DOI 10.1016/j.jadohealth.2016.02.002; Sekhar DL, 2013, J COMMUN HEALTH, V38, P569, DOI 10.1007/s10900-013-9652-6; Simon AE, 2015, PSYCHIAT SERV, V66, P930, DOI 10.1176/appi.ps.201400342; Szefler SJ, 2011, ANN ALLERG ASTHMA IM, V107, P110, DOI 10.1016/j.anai.2011.04.008; Taras H, 2005, J SCHOOL HEALTH, V75, P296, DOI 10.1111/j.1746-1561.2005.00041.x; Third Expert Panel on the Management of Asthma National Asthma Education and Prevention Program Coordinating Committee, 2007, 3 US DEP HHS NAT I H; Wheeler W, 2013, MMWR-MORBID MORTAL W, V62, P245; Winicki J, 2003, CONTEMP ECON POLICY, V21, P145, DOI 10.1093/cep/byg001; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654	68	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190254	10.1371/journal.pone.0190254	http://dx.doi.org/10.1371/journal.pone.0190254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8II	29342147	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800016
J	Nixon, LJ; Morrison, WR; Rice, KB; Brockerhoff, EG; Leskey, TC; Guzman, F; Khrimian, A; Goldson, S; Rostas, M				Nixon, Laura J.; Morrison, William R.; Rice, Kevin B.; Brockerhoff, Eckehard G.; Leskey, Tracy C.; Guzman, Filadelfo; Khrimian, Ashot; Goldson, Stephen; Rostas, Michael			Identification of volatiles released by diapausing brown marmorated stink bug, Halyomorpha halys (Hemiptera: Pentatomidae)	PLOS ONE			English	Article							1855 HETEROPTERA-PENTATOMIDAE; CHEMICAL DEFENSE; STAL; COMPONENTS; ECOLOGY	The brown marmorated stink bug, Halyomorpha halys, is an agricultural and urban pest that has become widely established as an invasive species of major concern in the USA and across Europe. This species forms large aggregations when entering diapause, and it is often these aggregations that are found by officials conducting inspections of internationally shipped freight. Identifying the presence of diapausing aggregations of H. halys using their emissions of volatile organic compounds (VOCs) may be a potential means for detecting and intercepting them during international freight inspections. Headspace samples were collected from aggregations of diapausing H. halys using volatile collection traps (VCTs) and solid phase microextraction. The only compound detected in all samples was tridecane, with small amounts of (E)-2-decenal found in most samples. We also monitored the release of defensive odors, following mechanical agitation of diapausing and diapause-disrupted adult H. halys. Diapausing groups were significantly more likely to release defensive odors than diapause-disrupted groups. The predominant compounds consistently found from both groups were tridecane, (E)-2-decenal, and 4-oxo-(E)-2-hexenal, with a small abundance of dodecane. Our findings show that diapausing H. halys do release defensive compounds, and suggest that volatile sampling may be feasible to detect H. halys in freight.	[Nixon, Laura J.; Goldson, Stephen; Rostas, Michael] Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand; [Nixon, Laura J.; Brockerhoff, Eckehard G.] Better Border Biosecur Collaborat, Christchurch, New Zealand; [Morrison, William R.] USDA ARS, Ctr Grain & Anim Hlth, Manhattan, KS USA; [Morrison, William R.; Rice, Kevin B.; Leskey, Tracy C.] USDA, Appalachian Fruit Res Stn, Kearneysville, WV USA; [Brockerhoff, Eckehard G.] Scion, New Zealand Forest Res Inst, Christchurch, New Zealand; [Guzman, Filadelfo; Khrimian, Ashot] USDA ARS, NEA, IIBBL, 10300 Baltimore Blvd, Beltsville, MD USA; [Goldson, Stephen] AgResearch, Christchurch, New Zealand	Lincoln University - New Zealand; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Scion; United States Department of Agriculture (USDA); AgResearch - New Zealand	Nixon, LJ (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand.; Nixon, LJ (corresponding author), Better Border Biosecur Collaborat, Christchurch, New Zealand.	laura.nixon@lincolnuni.ac.nz	Rostas, Michael/B-6769-2008; Morrison, William R/H-8596-2019; Brockerhoff, Eckehard Gustav/C-1528-2009	Rostas, Michael/0000-0001-9722-6513; Morrison, William R/0000-0002-1663-8741; Brockerhoff, Eckehard Gustav/0000-0002-5962-3208	New Zealand government via Ministry of Business, Innovation, and Employment core [C04X1104]; Better Border Biosecurity Collaboration; National Institue of Farming and Agriculture Speciality Crop Research Initiative CAP Grant [2011-51181-30937]	New Zealand government via Ministry of Business, Innovation, and Employment core; Better Border Biosecurity Collaboration; National Institue of Farming and Agriculture Speciality Crop Research Initiative CAP Grant	Contributions by L.J.N. and E.G.B. were supported by the New Zealand government via Ministry of Business, Innovation, and Employment core funding to Plant and Food Research and Scion (contract C04X1104), respectively, and the Better Border Biosecurity Collaboration (www.b3nz.org). Contributions by K.R. and W.R.M. were supported by National Institue of Farming and Agriculture Speciality Crop Research Initiative CAP Grant (#2011-51181-30937). The funders had no role in study design, data collection and analysis, decision to publisg, or preparation of manuscript.	Aigner J. D., 2016, Journal of Agricultural and Urban Entomology, V32, P1, DOI 10.3954/1523-5475-32.1.1; ALDRICH JR, 1988, ANNU REV ENTOMOL, V33, P211, DOI 10.1146/annurev.en.33.010188.001235; Baldwin RL, 2014, J DAIRY SCI, V97, P1877, DOI 10.3168/jds.2013-7545; Bergh JC, 2017, ENTOMOL EXP APPL, V162, P336, DOI 10.1111/eea.12539; Biasioli F, 2011, TRAC-TREND ANAL CHEM, V30, P1003, DOI 10.1016/j.trac.2011.04.005; BORGES M, 1992, EXPERIENTIA, V48, P893, DOI 10.1007/BF02118429; da Silva RA, 2015, J INVERTEBR PATHOL, V127, P93, DOI 10.1016/j.jip.2015.03.009; Direct P., 2011, ANAL CHEM, V30, P945; Faundez Eduardo I., 2017, Arquivos Entomoloxicos, V17, P305; Gapon D.A., 2016, ENTOMOL REV, V96, P1086, DOI [10.1134/S001387381608011X, DOI 10.1134/S001387381608011X]; Gunawardena NE, 2017, J NATL SCI FDN, V20; Harris C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140876; Haye T, 2015, J PEST SCI, V88, P665, DOI 10.1007/s10340-015-0670-2; Henderson WG, 2010, COMPUT ELECTRON AGR, V70, P157, DOI 10.1016/j.compag.2009.09.019; Krall BS, 1999, J CHEM ECOL, V25, P2477, DOI 10.1023/A:1020822107806; Lampson B. D., 2014, J INSECTS, V2014; Lampson B.D., 2017, ADV ENTOMOL, V05, P75, DOI [10.4236/ae.2017.53007, DOI 10.4236/AE.2017.53007]; Lee DH, 2015, B ENTOMOL RES, V105, P566, DOI 10.1017/S0007485315000462; Lee DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091575; Lee DH, 2013, ENVIRON ENTOMOL, V42, P627, DOI 10.1603/EN13006; Millar JG, 2005, TOP CURR CHEM, V240, P37, DOI 10.1007/b98315; Milonas P. G., 2014, Bulletin OEPP, V44, P183, DOI 10.1111/epp.12129; Mohekar P, 2017, J AGR FOOD CHEM, V65, P872, DOI 10.1021/acs.jafc.6b04268; Moreira JA, 2005, J CHEM ECOL, V31, P965, DOI 10.1007/s10886-004-1978-1; Morrison WR, 2017, J ECON ENTOMOL, V110, P1002, DOI 10.1093/jee/tox097; Nielsen AL, 2017, ECOL EVOL, V7, P6680, DOI 10.1002/ece3.3125; Nielsen AL, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00165; Rice KB, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14002; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Simov Nikolay, 2016, Ecologica Montenegrina, V9, P51; TSUYUKI T, 1965, AGR BIOL CHEM TOKYO, V29, P419, DOI 10.1080/00021369.1965.10858405; Valentin RE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10315-z; Vetek G, 2014, ZOOTAXA, V 3780, P194, DOI 10.11646/zootaxa.3780.1.8; Vichi S, 2007, FOOD CHEM, V102, P1260, DOI 10.1016/j.foodchem.2006.07.023; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	35	15	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191223	10.1371/journal.pone.0191223	http://dx.doi.org/10.1371/journal.pone.0191223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342183	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800053
J	Orioli, R; Cremona, G; Ciancarella, L; Solimini, AG				Orioli, Riccardo; Cremona, Giuseppe; Ciancarella, Luisella; Solimini, Angelo G.			Association between PM10, PM2.5, NO2, O-3 and self-reported diabetes in Italy: A cross-sectional, ecological study	PLOS ONE			English	Article							FINE PARTICULATE MATTER; LONG-TERM EXPOSURE; AIR-POLLUTION EXPOSURE; INSULIN-RESISTANCE; MELLITUS; INFLAMMATION; RISK; PREVALENCE; ATHEROSCLEROSIS; HYPERTENSION	Introduction Air pollution represents a serious threat to health on a global scale, being responsible for a large portion of the global burden of disease from environmental factors. Current evidence about the association between air pollution exposure and Diabetes Mellitus (DM) is still controversial. We aimed to evaluate the association between area-level ambient air pollution and self-reported DM in a large population sample in Italy. Materials and methods We extracted information about self-reported and physician diagnosed DM, risk factors and socio-economic status from 12 surveys conducted nationwide between 1999 and 2013. We obtained annual averaged air pollution levels for the years 2003, 2005, 2007 and 2010 from the AMS-MINNI national integrated model, which simulates the dispersion and transformation of pollutants. The original maps, with a resolution of 4 x 4 km2, were normalized and aggregated at the municipality class of each Italian region, in order to match the survey data. We fit logistic regression models with a hierarchical structure to estimate the relationship between PM10, PM2.5, NO2 and 03 four-years mean levels and the risk of being affected by DM. Results We included 376,157 individuals aged more than 45 years. There were 39,969 cases of DM, with an average regional prevalence of 9.8% and a positive geographical North-to-South gradient, opposite to that of pollutants' concentrations. For each 10 fag/m3 increase, the resulting ORs were 1.04 (95% CI 1.01-1.07) for PM10, 1.04 (95% CI 1.02-1.07) for PM2.5, 1.03 (95% CI 1.01-1.05) for NO2 and 1.06 (95% CI 1.01-1.11) for 03, after accounting for relevant individual risk factors. The associations were robust to adjustment for other pollutants in two-pollutant models tested (ozone plus each other pollutant). Conclusions We observed a significant positive association between each examined pollutant and prevalent DM. Risk estimates were consistent with current evidence, and robust to sensitivity analysis. Our study adds evidence about the effects of air pollution on diabetes and suggests a possible role of ozone as an independent factor associated with the development of DM. Such relationship is of great interest for public health and deserves further investigation.	[Orioli, Riccardo; Solimini, Angelo G.] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Cremona, Giuseppe; Ciancarella, Luisella] Natl Agcy New Technol Energy & Sustainable Econ D, Sustainable Terr & Prod Syst Dept, Bologna, Italy	Sapienza University Rome; Italian National Agency New Technical Energy & Sustainable Economics Development	Orioli, R (corresponding author), Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.	riccardo.orioli@uniroma1.it	Solimini, Angelo G/C-9290-2018	Solimini, Angelo/0000-0002-5281-7624; Ciancarella, Luisella/0000-0002-7123-0909				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Andersen ZJ, 2012, DIABETES CARE, V35, P92, DOI 10.2337/dc11-1155; Balti EV, 2014, DIABETES RES CLIN PR, V106, P161, DOI 10.1016/j.diabres.2014.08.010; BARON AD, 1995, J CLIN INVEST, V96, P786, DOI 10.1172/JCI118124; Bass V, 2013, TOXICOL APPL PHARM, V273, P551, DOI 10.1016/j.taap.2013.09.029; Bauer M, 2010, J AM COLL CARDIOL, V56, P1803, DOI 10.1016/j.jacc.2010.04.065; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Brook RD, 2008, J OCCUP ENVIRON MED, V50, P32, DOI 10.1097/JOM.0b013e31815dba70; Bui DS, 2013, RESPIROLOGY, V18, P1101, DOI 10.1111/resp.12108; Chen H, 2013, ENVIRON HEALTH PERSP, V121, P804, DOI 10.1289/ehp.1205958; Coogan PF, 2012, CIRCULATION, V125, P767, DOI 10.1161/CIRCULATIONAHA.111.052753; Dijkema MBA, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-76; Dubowsky SD, 2006, ENVIRON HEALTH PERSP, V114, P992, DOI 10.1289/ehp.8469; Eze IC, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0120-5; Eze IC, 2015, ENVIRON HEALTH PERSP, V123, P381, DOI 10.1289/ehp.1307823; Eze IC, 2014, ENVIRON INT, V70, P95, DOI 10.1016/j.envint.2014.05.014; Gariazzo C, 2007, ATMOS ENVIRON, V41, P6432, DOI 10.1016/j.atmosenv.2007.06.005; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Hansen AB, 2016, ENVIRON INT, V91, P243, DOI 10.1016/j.envint.2016.02.036; ISTAT, 2015, EP NAT DIAB FACT SHE; ISTAT, 2013, MULT SURV HOUS HLTH; Janghorbani M, 2014, EUR J EPIDEMIOL, V29, P231, DOI 10.1007/s10654-014-9907-2; Jerrett M, 2017, ENVIRON INT, V102, P42, DOI 10.1016/j.envint.2016.12.011; Kelishadi R, 2009, ATHEROSCLEROSIS, V203, P311, DOI 10.1016/j.atherosclerosis.2008.06.022; Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689; Kunzli N, 2009, THORAX, V64, P664, DOI 10.1136/thx.2008.110031; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lockwood AH, 2002, DIABETES CARE, V25, P1487, DOI 10.2337/diacare.25.8.1487; Miller DB, 2016, AM J RESP CRIT CARE, P1; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Mircea M, 2014, ATMOS ENVIRON, V84, P178, DOI 10.1016/j.atmosenv.2013.11.006; Mircea M, 2011, HARMO 2011 P 14 INT, P52; Pearson JF, 2010, DIABETES CARE, V33, P2196, DOI 10.2337/dc10-0698; Piersanti A, 2012, 6 BIENN M INT ENV MO, V2012, P1375; Puett RC, 2011, ENVIRON HEALTH PERSP, V119, P384, DOI 10.1289/ehp.1002344; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190; Rao XQ, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0603-8; Schikowski T, 2014, EUR RESPIR J, V44, P614, DOI 10.1183/09031936.00132213; Silibello C, 2008, ENVIRON MODELL SOFTW, V23, P333, DOI 10.1016/j.envsoft.2007.04.002; Solimini AG, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2018-5; Steinvil A, 2008, ENVIRON RES, V106, P51, DOI 10.1016/j.envres.2007.08.006; Sullivan JH, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-3; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015; Thomson EM, 2016, TOXICOL SCI; Weinmayr G, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0031-x; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; World Health Organization, 2016, GLOB REP DIAB, V978, P88; Zanini G, 2005, MODSIM 2005: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION: ADVANCES AND APPLICATIONS FOR MANAGEMENT AND DECISION MAKING, P2005; Zanobetti A, 2008, ENV HLTH, V7, P48, DOI DOI 10.1186/1476-069X-7-48	53	34	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191112	10.1371/journal.pone.0191112	http://dx.doi.org/10.1371/journal.pone.0191112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342195	Green Submitted, Green Published, gold			2022-12-27	WOS:000422653800046
J	Wang, CY; Klistorner, A; Ly, L; Barnett, MH				Wang, Chenyu; Klistorner, Alexander; Ly, Linda; Barnett, Michael H.			White matter tract-specific quantitative analysis in multiple sclerosis: Comparison of optic radiation reconstruction techniques	PLOS ONE			English	Article							DIFFUSION MRI; TEMPORAL-LOBE; HUMAN BRAIN; TRACTOGRAPHY; VARIABILITY; DISABILITY; ANATOMY; DELINEATION; VISION; ROBUST	The posterior visual pathway is commonly affected by multiple sclerosis (MS) pathology that results in measurable clinical and electrophysiological impairment. Due to its highly structured retinotopic mapping, the visual pathway represents an ideal substrate for investigating patho-mechanisms in MS. Therefore, a reliable and robust imaging segmentation method for in-vivo delineation of the optic radiations (OR) is needed. However, diffusion based tractography approaches, which are typically used for OR segmentation are confounded by the presence of focal white matter lesions. Current solutions require complex acquisition paradigms and demand expert image analysis, limiting application in both clinical trials and clinical practice. In the current study, using data acquired in a clinical setting on a 3T scanner, we optimised and compared two approaches for optic radiation (OR) reconstruction: individual probabilistic tractography-based and template-based methods. OR segmentation results were applied to subjects with MS and volumetric and diffusivity parameters were compared between OR segmentation techniques. Despite differences in reconstructed OR volumes, both OR lesion volume and OR diffusivity measurements in MS subjects were highly comparable using optimised probabilistic tractography-based, and template-based, methods. The choice of OR reconstruction technique should be determined primarily by the research question and the nature of the available dataset. Template-based approaches are particularly suited to the semi-automated analysis of large image datasets and have utility even in the absence of dMRI acquisitions. Individual tractography methods, while more complex than template based OR reconstruction, permit measurement of diffusivity changes	[Wang, Chenyu; Klistorner, Alexander; Ly, Linda; Barnett, Michael H.] Sydney Neuroimaging Anal Ctr, Sydney, NSW, Australia; [Wang, Chenyu; Ly, Linda; Barnett, Michael H.] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Klistorner, Alexander] Univ Sydney, Save Sight Inst, Dept Ophthalmol, Sydney, NSW, Australia; [Klistorner, Alexander] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW, Australia	University of Sydney; University of Sydney; Macquarie University	Barnett, MH (corresponding author), Sydney Neuroimaging Anal Ctr, Sydney, NSW, Australia.; Barnett, MH (corresponding author), Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia.	michael@sydneyneurology.com.au		Klistorner, Alexander/0000-0003-0361-6399	Research Training Program Stipend (RTP), Australia; National Multiple Sclerosis Society (NMSS) grant [RG 4716A6/3T]; Novartis "Save Neuron" Grant [CT 3437]; Novartis "Optic Radiation in MS" Grant; Sydney Eye Hospital foundation grant; Sydney Medical School Foundation grant	Research Training Program Stipend (RTP), Australia; National Multiple Sclerosis Society (NMSS) grant; Novartis "Save Neuron" Grant; Novartis "Optic Radiation in MS" Grant; Sydney Eye Hospital foundation grant; Sydney Medical School Foundation grant	CW was supported by Research Training Program Stipend (RTP), Australia. The work was partially supported by National Multiple Sclerosis Society (NMSS) grant RG 4716A6/3T, Novartis "Save Neuron" Grant CT 3437, Novartis "Optic Radiation in MS" Grant, Sydney Eye Hospital foundation grant, Sydney Medical School Foundation grant.	Alvarez I, 2015, BRAIN STRUCT FUNCT, V220, P2519, DOI 10.1007/s00429-014-0799-4; Anderson AW, 2005, MAGN RESON MED, V54, P1194, DOI 10.1002/mrm.20667; Arrigo A, 2016, INVEST OPHTH VIS SCI, V57, P1, DOI 10.1167/iovs.15-18082; Balcer LJ, 2015, BRAIN, V138, P11, DOI 10.1093/brain/awu335; Bassi L, 2008, BRAIN, V131, P573, DOI 10.1093/brain/awm327; Battaglini M, 2012, HUM BRAIN MAPP, V33, P2062, DOI 10.1002/hbm.21344; Burgel U, 1999, NEUROIMAGE, V10, P489, DOI 10.1006/nimg.1999.0497; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Chamberland M, 2017, HUM BRAIN MAPP, V38, P509, DOI 10.1002/hbm.23399; Clatworthy PL, 2010, NEUROIMAGE, V49, P2001, DOI 10.1016/j.neuroimage.2009.10.083; Coetzee T, 2015, LANCET NEUROL, V14, P132, DOI 10.1016/S1474-4422(14)70323-0; Coubard OA, 2005, J VISION, V5, P1, DOI 10.1167/5.1.1; Dayan M, 2015, BRAIN STRUCT FUNCT, V220, P291, DOI 10.1007/s00429-013-0655-y; de Gervai PD, 2014, EPILEPSY RES, V108, P872, DOI 10.1016/j.eplepsyres.2014.03.006; EBELING U, 1988, ACTA NEUROCHIR, V92, P29, DOI 10.1007/BF01401969; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Harrison DM, 2013, J NEUROL, V260, P397, DOI 10.1007/s00415-012-6638-8; Hofer S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00015; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Ide S, 2012, ACAD RADIOL, V19, P1283, DOI 10.1016/j.acra.2012.05.018; Kammen A, 2016, NEUROIMAGE, V125, P767, DOI 10.1016/j.neuroimage.2015.11.005; Klistorner A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149245; Klistorner A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122114; Klistorner A, 2014, NEUROLOGY, V82, P2165, DOI 10.1212/WNL.0000000000000522; Lagana MM, 2012, J NEUROIMAGING, V22, P355, DOI 10.1111/j.1552-6569.2011.00650.x; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Lim JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118948; Martinez-Heras E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137064; Martinez-Lapiscina EH, 2014, MULT SCLER J, V20, P1678, DOI 10.1177/1352458514542862; Mori N, 2009, INVEST RADIOL, V44, P140, DOI 10.1097/RLI.0b013e318193ff25; Nilsson D, 2007, EPILEPSY RES, V77, P11, DOI 10.1016/j.eplepsyres.2007.07.012; Parraga RG, 2012, NEUROSURGERY, V71, P160, DOI 10.1227/NEU.0b013e3182556fde; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Peltier J, 2006, J NEUROSURG, V105, P294, DOI 10.3171/jns.2006.105.2.294; Reich DS, 2010, NEUROIMAGE, V49, P3047, DOI 10.1016/j.neuroimage.2009.11.043; Rubino PA, 2005, NEUROSURGERY, V57, P219, DOI 10.1227/01.NEU.0000176415.83417.16; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.9.15; Shiee N, 2011, I S BIOMED IMAGING, P1488, DOI 10.1109/ISBI.2011.5872682; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Tax CMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101524; Toga AW, 2012, NEUROSURGERY, V71, P1, DOI 10.1227/NEU.0b013e318258e9ff; Toosy AT, 2004, NEUROIMAGE, V21, P1452, DOI 10.1016/j.neuroimage.2003.11.022; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Wilson M, 2003, J NEUROL NEUROSUR PS, V74, P203, DOI 10.1136/jnnp.74.2.203; Winston GP, 2012, ANN NEUROL, V71, P334, DOI 10.1002/ana.22619; Wu W, 2011, NEUROSURGERY, V70, P145; Yamamoto T, 2005, AM J OPHTHALMOL, V140, P781, DOI 10.1016/j.ajo.2005.05.018; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790	49	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191131	10.1371/journal.pone.0191131	http://dx.doi.org/10.1371/journal.pone.0191131			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342192	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800048
J	Yapp, M; Rennie, G; Hennessy, MP; Kalloniatis, M; Zangerl, B				Yapp, Michael; Rennie, George; Hennessy, Michael P.; Kalloniatis, Michael; Zangerl, Barbara			The impact of optic nerve and related characteristics on disc area measurements derived from different imaging techniques	PLOS ONE			English	Article							SCANNING LASER OPHTHALMOSCOPY; RETINAL VESSEL DIAMETER; COHERENCE-TOMOGRAPHY; GLAUCOMA PATIENTS; MARGIN ANATOMY; TILTED DISCS; NORMAL EYES; RIM AREA; DOMAIN; SIZE	Purpose Optic nerve head (ONH) assessment and its interpretation in healthy patients and those with glaucoma remains a pivotal topic specifically considering rapid advancements in imaging technologies. We undertook a large-scale, mixed cohort, comparative study to assess the correlation of optic disc measurements between different imaging modalities and investigated the impact of patient and disc associated parameters. Methods ONH sizes were obtained from one randomly selected eye of each of 209 patients using stereophotography, confocal scanning laser ophthalmoscopy and two different optical coherence tomographers (OCT). Patient related data, glaucoma status and optic disc variables, specifically oblique insertion, torsion, presence of beta PPA and spherical equivalent were recorded. Measurements between imaging modalities were analysed using Pearson correlation, linear regression analysis and Blend-Altman plots. Individual variables were compared applying multivariate regression analysis, ANOVA and chi square statistics was used to determine correlations between patient and clinical characteristics. Results Absolute measurements significantly differed between imaging modalities generally producing smaller measurements for OCT derived measurements of Bruch's membrane opening (BMO). Pairwise correlations between imaging modalities were between 0.83 and 0.93 for discs without myopia, oblique insertion, or beta PPA. These features impacted on measurements for individual modalities and consequently contributed to inconsistencies and variability. Conclusion In comparison to planimetry, OCT derived BMO measurements are more variable in the presence of oblique insertion, beta PPA or magnification errors due to myopia. Impact of these factors, however, differs between instruments and needs to be considered to accurately interpret optic disc features in particular within the context of glaucoma diagnosis.	[Yapp, Michael; Rennie, George; Hennessy, Michael P.; Kalloniatis, Michael; Zangerl, Barbara] UNSW Australia, Ctr Eye Hlth, Sydney, NSW, Australia; [Yapp, Michael; Kalloniatis, Michael; Zangerl, Barbara] UNSW Australia, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Rennie, George] Royal Prince Alfred Hosp, Camperdown, NSW, Australia; [Hennessy, Michael P.] Prince Wales Hosp, Dept Ophthalmol, Randwick, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Zangerl, B (corresponding author), UNSW Australia, Ctr Eye Hlth, Sydney, NSW, Australia.; Zangerl, B (corresponding author), UNSW Australia, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	bzangerl@cfeh.com.au	Hennessy, Michael/AAN-8444-2021; Rennie, George/W-1210-2019; Zangerl, Barbara/K-7433-2016	Kalloniatis, Michael/0000-0002-5264-4639; Zangerl, Barbara/0000-0002-7470-6298; Hennessy, Michael/0000-0003-2750-9344	National Health and Medical Research Council [1033224]; University of New South Wales Faculty Research Grant	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales Faculty Research Grant	This study was supported through National Health and Medical Research Council grant 1033224 and a University of New South Wales Faculty Research Grant held by Dr.Zangerl.	Agrawal A, 2016, INVEST OPHTH VIS SCI, V57; Ansari-Shahrezaei S, 2001, INVEST OPHTH VIS SCI, V42, P153; Barkana Y, 2006, AM J OPHTHALMOL, V142, P375, DOI 10.1016/j.ajo.2006.03.065; Bartling H, 2008, ACTA OPHTHALMOL, V86, P837, DOI 10.1111/j.1755-3768.2007.01146.x; Garas A, 2011, J GLAUCOMA, V20, P80, DOI 10.1097/IJG.0b013e3181d787fd; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P643, DOI 10.1136/bjo.82.6.643; Gmeiner JM, 2016, INVEST OPHTH VIS SCI, V57; Hoffmann EM, 2007, SURV OPHTHALMOL, V52, P32, DOI 10.1016/j.survophthal.2006.10.002; Hu ZH, 2010, INVEST OPHTH VIS SCI, V51, P5708, DOI 10.1167/iovs.09-4838; Hwang YH, 2012, J GLAUCOMA, V21, P260, DOI 10.1097/IJG.0b013e31820719e1; Jamous KF, 2015, CLIN EXP OPHTHALMOL, V43, P308, DOI 10.1111/ceo.12466; Jamous KF, 2014, OPHTHAL PHYSL OPT, V34, P580, DOI 10.1111/opo.12146; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P1599; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P1604; Jonas JB, 1998, BRIT J OPHTHALMOL, V82, P362, DOI 10.1136/bjo.82.4.362; Jonas JB, 2000, PROG RETIN EYE RES, V19, P1, DOI 10.1016/S1350-9462(99)00002-6; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; Law SK, 2010, ARCH OPHTHALMOL-CHIC, V128, P141, DOI 10.1001/archophthalmol.2009.340; Lee M, 2013, CURR EYE RES, V38, P605, DOI 10.3109/02713683.2013.769059; Leung CKS, 2007, INVEST OPHTH VIS SCI, V48, P3178, DOI 10.1167/iovs.06-1315; Moghimi S, 2012, INVEST OPHTH VIS SCI, V53, P4519, DOI 10.1167/iovs.11-8362; Neubauer AS, 2006, OPHTHAL PHYSL OPT, V26, P13, DOI 10.1111/j.1475-1313.2005.00339.x; Rebolleda G, 2016, CLIN OPHTHALMOL, V10, P2417, DOI 10.2147/OPTH.S120237; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Reis ASC, 2017, ACTA OPHTHALMOLOGICA; Resch H, 2012, ACTA OPHTHALMOL, V90, pe225, DOI 10.1111/j.1755-3768.2012.02385.x; Samarawickrama C, 2009, J GLAUCOMA, V18, P571, DOI 10.1097/IJG.0b013e3181996da6; Savini G, 2013, J GLAUCOMA, V22, P384, DOI 10.1097/IJG.0b013e31824c9423; Schuman JS, 2003, AM J OPHTHALMOL, V135, P504, DOI 10.1016/S0002-9394(02)02093-7; Sharma A, 2011, OPHTHALMOLOGY, V118, P1348, DOI 10.1016/j.ophtha.2010.12.008; Shin HY, 2015, BRIT J OPHTHALMOL, V99, P69, DOI 10.1136/bjophthalmol-2014-305259; Strouthidis NG, 2009, INVEST OPHTH VIS SCI, V50, P4709, DOI 10.1167/iovs.09-3586; Vihanninjoki K, 1997, ACTA OPHTHALMOL SCAN, V75, P512; Witmer MT, 2010, SURV OPHTHALMOL, V55, P403, DOI 10.1016/j.survophthal.2010.01.002; Young M, 2014, J GLAUCOMA, V23, P360, DOI 10.1097/IJG.0b013e31829484a4	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190273	10.1371/journal.pone.0190273	http://dx.doi.org/10.1371/journal.pone.0190273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342153	Green Published, gold			2022-12-27	WOS:000422653800017
J	Baghirov, H; Snipstad, S; Sulheim, E; Berg, S; Hansen, R; Thorsen, F; Morch, Y; Davies, CD; Aslund, AKO				Baghirov, Habib; Snipstad, Sofie; Sulheim, Einar; Berg, Sigrid; Hansen, Rune; Thorsen, Frits; Morch, Yrr; Davies, Catharina de Lange; Aslund, Andreas K. O.			Ultrasound-mediated delivery and distribution of polymeric nanoparticles in the normal brain parenchyma of a metastatic brain tumour model	PLOS ONE			English	Article							FOCUSED ULTRASOUND; DRUG-DELIVERY; STABILIZED MICROBUBBLES; IMAGE-ANALYSIS; BLOOD; BARRIER; DISRUPTION; PERMEABILITY; MECHANISM; DISCOVERY	The treatment of brain diseases is hindered by the blood-brain barrier (BBB) preventing most drugs from entering the brain. Focused ultrasound (FUS) with microbubbles can open the BBB safely and reversibly. Systemic drug injection might induce toxicity, but encapsulation into nanoparticles reduces accumulation in normal tissue. Here we used a novel platform based on poly(2-ethyl-butyl cyanoacrylate) nanoparticle-stabilized microbubbles to permeabilize the BBB in a melanoma brain metastasis model. With a dual-frequency ultrasound transducer generating FUS at 1.1 MHz and 7.8 MHz, we opened the BBB using nanoparticle-microbubbles and low-frequency FUS, and applied high-frequency FUS to generate acoustic radiation force and push nanoparticles through the extracellular matrix. Using con focal microscopy and image analysis, we quantified nanoparticle extravasation and distribution in the brain parenchyma. We also evaluated haemorrhage, as well as the expression of P-glycoprotein, a key BBB component. FUS and microbubbles distributed nanoparticles in the brain parenchyma, and the distribution depended on the extent of BBB opening. The results from acoustic radiation force were not conclusive, but in a few animals some effect could be detected. P-glycoprotein was not significantly altered immediately after sonication. In summary, FUS with our nanoparticle-stabilized microbubbles can achieve accumulation and displacement of nanoparticles in the brain parenchyma.	[Baghirov, Habib; Snipstad, Sofie; Sulheim, Einar; Davies, Catharina de Lange; Aslund, Andreas K. O.] Norwegian Univ Sci & Technol NTNU, Dept Phys, Trondheim, Norway; [Sulheim, Einar; Morch, Yrr] SINTEF Mat & Chem, Trondheim, Norway; [Berg, Sigrid; Hansen, Rune] SINTEF Med Technol, Trondheim, Norway; [Berg, Sigrid; Hansen, Rune] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Thorsen, Frits] Univ Bergen, Dept Biomed, Mol Imaging Ctr, Bergen, Norway; [Thorsen, Frits] Univ Bergen, Dept Biomed, Kristian Gerhard Jebsen Brain Tumour Res Ctr, Bergen, Norway; [Baghirov, Habib] Univ Coll Cork, Sch Pharm, Cork, Ireland	Norwegian University of Science & Technology (NTNU); SINTEF; SINTEF; Norwegian University of Science & Technology (NTNU); University of Bergen; University of Bergen; University College Cork	Davies, CD (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Phys, Trondheim, Norway.	catharina.davies@ntnu.no	Åslund, Andreas/M-4483-2019	Åslund, Andreas/0000-0001-5222-9307; Thorsen, Frits/0000-0002-7762-3703; Baghirov, Habib/0000-0002-3441-9825; Davies, Catharina/0000-0003-4371-5025; Morch, Yrr/0000-0001-5182-7276	Research Council of Norway [220005, 240316, 226159]; Central Norway Regional Health Authority	Research Council of Norway(Research Council of Norway); Central Norway Regional Health Authority	This study was funded by The Research Council of Norway, https://www.forskningsradet.no/no/Forsiden/1173185591033 (NANO2021 project number 220005, FRIMEDBIO project number 240316 and BIOTEK2021 project number 226159), and The Central Norway Regional Health Authority, https://helse-midt.no/.	Aryal M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166061; Aslund AKO, 2017, MOL PHARMACEUT, V14, P2560, DOI 10.1021/acs.molpharmaceut.6b01085; Aslund AKO, 2015, J CONTROL RELEASE, V220, P287, DOI 10.1016/j.jconrel.2015.10.047; Baghirov H, 2017, COLLOID SURFACE B, V150, P373, DOI 10.1016/j.colsurfb.2016.10.051; Burke CW, 2014, MOL THER, V22, P321, DOI 10.1038/mt.2013.259; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Chen H, 2014, J CEREBR BLOOD F MET, V34, P1197, DOI 10.1038/jcbfm.2014.71; Cho H, 2016, SCI REP-UK, V6, DOI 10.1038/srep31201; Choi JJ, 2010, ULTRASOUND MED BIOL, V36, P58, DOI 10.1016/j.ultrasmedbio.2009.08.006; Crowder KC, 2005, ULTRASOUND MED BIOL, V31, P1693, DOI 10.1016/j.ultrasmedbio.2005.07.022; Dayton P, 1999, ULTRASOUND MED BIOL, V25, P1195, DOI 10.1016/S0301-5629(99)00062-9; Dayton PA, 2006, MOL IMAGING, V5, P160, DOI 10.2310/7290.2006.00019; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Diaz RJ, 2014, NANOMED-NANOTECHNOL, V10, P1075, DOI 10.1016/j.nano.2013.12.006; Enochs WS, 1997, RADIOLOGY, V204, P417, DOI 10.1148/radiology.204.2.9240529; Etame AB, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.10.FOCUS11252; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Hynynen K, 2008, ADV DRUG DELIVER REV, V60, P1209, DOI 10.1016/j.addr.2008.03.010; Hynynen K, 2007, EXPERT OPIN DRUG DEL, V4, P27, DOI 10.1517/17425247.4.1.27; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; KANTE B, 1982, J PHARM SCI, V71, P786, DOI 10.1002/jps.2600710716; Klymchenko AS, 2012, RSC ADV, V2, P11876, DOI [10.1039/C2RA21544F, 10.1039/c2ra21544f]; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Lammers T, 2015, ADV FUNCT MATER, V25, P36, DOI 10.1002/adfm.201401199; Laquintana V, 2009, EXPERT OPIN DRUG DEL, V6, P1017, DOI 10.1517/17425240903167942; Leighton T. G., 1994, ACOUSTIC BUBBLE, P531; Lum AFH, 2006, J CONTROL RELEASE, V111, P128, DOI 10.1016/j.jconrel.2005.11.006; Maeda H, 2016, MICROCIRCULATION, V23, P173, DOI 10.1111/micc.12228; Marty B, 2012, J CEREBR BLOOD F MET, V32, P1948, DOI 10.1038/jcbfm.2012.100; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mead BP, 2016, J CONTROL RELEASE, V223, P109, DOI 10.1016/j.jconrel.2015.12.034; Morch Y, 2015, CONTRAST MEDIA MOL I, V10, P356, DOI 10.1002/cmmi.1639; Nance E, 2014, J CONTROL RELEASE, V189, P123, DOI 10.1016/j.jconrel.2014.06.031; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Rychak JJ, 2005, IEEE T ULTRASON FERR, V52, P421, DOI 10.1109/TUFFC.2005.1417264; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shortencarier MJ, 2004, IEEE T ULTRASON FERR, V51, P822, DOI 10.1109/TUFFC.2004.1320741; Snipstad S, 2017, ULTRASOUND MED BIOL, V43, P2651, DOI 10.1016/j.ultrasmedbio.2017.06.029; Soma E, 2012, RSC DRUG DISCOV, V22, P591, DOI 10.1039/9781849735292-00591; Sulheim E, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-015-0156-7; Sun TM, 2014, ANGEW CHEM INT EDIT, V53, P12320, DOI 10.1002/anie.201403036; Thorsen F, 2013, J CONTROL RELEASE, V172, P812, DOI 10.1016/j.jconrel.2013.10.019; Wang J, 2011, NEUROPATH APPL NEURO, V37, P189, DOI 10.1111/j.1365-2990.2010.01119.x; Wilhelm S, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.14; Yildirimer L, 2011, NANO TODAY, V6, P585, DOI 10.1016/j.nantod.2011.10.001; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]	49	32	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191102	10.1371/journal.pone.0191102	http://dx.doi.org/10.1371/journal.pone.0191102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338016	gold, Green Published, Green Submitted			2022-12-27	WOS:000422652700031
J	de Luis, M; Bartolome, C; Cardo, OG; Alvarez-Jimenez, J				de Luis, Miguel; Bartolome, Carmen; Garcia Cardo, Oscar; Alvarez-Jimenez, Julio			Gypsophila bermejoi G. Lopez: A possible case of speciation repressed by bioclimatic factors	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; POTENTIAL DISTRIBUTIONS; HYBRIDIZATION; MECHANISMS; PREVALENCE; POLYPLOIDY; EVOLUTION; HABITAT; HYBRID; ROOTS	Gypsophila bermejoi G. Lopez is an allopolyploid species derived from the parental G. struthium L. subsp. struthium and G. tomentosa L. All these plants are gypsophytes endemic to the Iberian Peninsula of particular ecological, evolutionary and biochemical interest. In this study, we present evidence of a possible repression on the process of G. bermejoi speciation by climatic factors. We modelled the ecological niches of the three taxa considered here using a maximum entropy approach and employing a series of bioclimatic variables. Subsequently, we projected these models onto the geographical space of the Iberian Peninsula in the present age and at two past ages: the Last Glacial Maximum and the mid-Holocene period. Furthermore, we compared these niches using the statistical method devised by Warren to calculate their degree of overlap. We also evaluated the evolution of the bioclimatic habitat suitability at those sites were the soil favors the growth of these species. Both the maximum entropy model and the degree of overlap indicated that the ecological behavior of the hybrid differs notably from that of the parental species. During the Last Glacial Maximum, the two parental species appear to take refuge in the western coastal strip of the Peninsula, a region in which there are virtually no sites where G. bermejoi could potentially be found. However, in the mid-Holocene period the suitability of G. bermejoi to sites with favorable soils shifts from almost null to a strong adaptation, a clear change in this tendency. These results suggest that the ecological niches of hybrid allopolyploids can be considerably different to those of their parental species, which may have evolutionary and ecologically relevant consequences. The data obtained indicate that certain bioclimatic variables may possibly repress the processes by which new species are formed. The difference in the ecological niche of G. bermejoi with respect to its parental species prevented it from prospering during the Last Glacial Maximum. However, the climatic change in the mid-Holocene period released this block and as such, it permitted the new species to establish itself. Accordingly, we favor a recent origin of the current populations of G. bermejoi.	[de Luis, Miguel; Bartolome, Carmen; Alvarez-Jimenez, Julio] Univ Alcala, Fac Biol C Ambientales & Quim, Dept Ciencias Vida, Alcala De Henares, Madrid, Spain; [Garcia Cardo, Oscar] Empresa Publ Gest Ambiental Castilla La Mancha GE, Cuenca, Spain	Universidad de Alcala	Bartolome, C (corresponding author), Univ Alcala, Fac Biol C Ambientales & Quim, Dept Ciencias Vida, Alcala De Henares, Madrid, Spain.	carmen.bartolome@uah.es		de Luis, Miguel/0000-0002-5591-5721; Bartolome Esteban, Carmen/0000-0003-3204-7797				Acebes B, 1998, J NAT PROD, V61, P1557, DOI 10.1021/np9705221; Acebes B, 1998, PHYTOCHEMISTRY, V49, P2077, DOI 10.1016/S0031-9422(98)00404-X; Alcantar V. J. P, 2014, TEMAS CIENCIA Y TECN, V18, P17; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2014, EVOLUTIONARY BIOL GE, DOI DOI 10.1007/978-3-319-07623-2_5; Arieh Ben-Naim, 2012, ENTROPY 2 LAW; Audesirk T, 2002, BIOL UNDERSTANDING L; BENNETT MD, 1987, NEW PHYTOL, V106, P177, DOI 10.1111/j.1469-8137.1987.tb04689.x; Boscaiu M, 2010, B U AGR SCI VET MED, V67, P1843, DOI DOI 10.15835/BUASVMCN-H0RT:4903; Bosso L, 2017, FOREST ECOL MANAG, V400, P655, DOI 10.1016/j.foreco.2017.06.044; Bueno ML, 2017, ECOGRAPHY, V40, P403, DOI 10.1111/ecog.01860; Castro S., 2014, Ecosistemas, V23, P67, DOI 10.7818/ECOS.2014.23-3.09; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; CUBERO J. I., 2003, INTRO MEJORA GENETIC, V2013th; Cuevas E., 2013, BIOLOGICAS, V14, P7; Curtis H., 2008, CURTIS BIOL, V7th; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ferrandis P., 2005, INVEST AGRAR-SIST R, V14, P195; Ficetola GF, 2010, GLOBAL CHANGE BIOL, V16, P528, DOI 10.1111/j.1365-2486.2009.01957.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Freeman S., 2007, EVOLUTIONARY ANAL; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gomez JM, 1996, OECOLOGIA, V105, P236, DOI 10.1007/BF00328552; Gonzalez G. Lopez, 1984, AN JARDIN BOT MADRID, V41, P35; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Griffiths AJF., 2005, INTRO GENETIC ANAL, DOI 10.1021/bi00201a011; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Horvitz N, 2017, J ECOL, V105, P85, DOI 10.1111/1365-2745.12692; Hutchinson G.E., 1978, INTRO POPULATION ECO; Kadereit JW, 2006, NEW PHYTOL, V169, P431, DOI 10.1111/j.1469-8137.2005.01604.x; Kaky E, 2016, J ARID ENVIRON, V135, P140, DOI 10.1016/j.jaridenv.2016.09.001; Kovalsky IE, 2014, B SOC ARGENT BOT, V49, P227; Lacadena JR., 1996, CITOGENETICA; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Martinez-Hernandez F, 2011, BIODIVERS CONSERV, V20, P1353, DOI 10.1007/s10531-011-0031-2; Mason AS, 2015, TRENDS BIOTECHNOL, V33, P436, DOI 10.1016/j.tibtech.2015.06.004; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Moreno-Amat E, 2017, QUATERNARY SCI REV, V170, P56, DOI 10.1016/j.quascirev.2017.06.022; Moruno F, 2011, NOT BOT HORTI AGROBO, V39, P18; Mota J.F., 2011, DIVERSIDAD VEGETAL Y; Mota JF, 2003, PHYTOCOENOLOGIA, V33, P13, DOI 10.1127/0340-269X/2003/0033-0013; Mota JF, 2016, LAZAROA, V37, P7, DOI 10.5209/LAZA.54044; NOVAK SJ, 1991, AM J BOT, V78, P1586, DOI 10.2307/2444984; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Petitpierre B, 2017, GLOBAL ECOL BIOGEOGR, V26, P275, DOI 10.1111/geb.12530; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; QGIS Development Team, 2009, QGIS GEOGR INF SYST; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Raven P, 1991, BIOL PLANTAS; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Royzar C, 2016, FOREST ECOL MANAG, V369, P20, DOI 10.1016/j.foreco.2016.03.030; Sadava D, 2009, VIDA CIENCIA BIOL; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Sattler MC, 2016, PLANTA, V243, P281, DOI 10.1007/s00425-015-2450-x; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Serrahima Ignasi, 2011, Boletin de la SEA, V48, P375; Smeraldo S, 2017, J NATURE CONSERVATIO; Smith AB, 2017, GLOBAL CHANGE BIOL, V23, P4365, DOI 10.1111/gcb.13666; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stohlgren TJ, 2010, RISK ANAL, V30, P224, DOI 10.1111/j.1539-6924.2009.01343.x; Thompson GD, 2011, DIVERS DISTRIB, V17, P1001, DOI 10.1111/j.1472-4642.2011.00820.x; UDVARDY MFD, 1959, ECOLOGY, V40, P725, DOI 10.2307/1929830; Van der Vaart AW, 2000, ASYMPTOTIC STAT, V3; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Washburn JD, 2014, PLANT REPROD, V27, P1, DOI 10.1007/s00497-013-0237-4; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Zutta BR, 2017, FORESTS, V8, DOI 10.3390/f8070232	72	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190536	10.1371/journal.pone.0190536	http://dx.doi.org/10.1371/journal.pone.0190536			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338010	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700013
J	Goldman, SM; Henderson, BEP; Walters, TJ; Corona, BT				Goldman, Stephen M.; Henderson, Beth E. P.; Walters, Thomas J.; Corona, Benjamin T.			Co-delivery of a laminin-111 supplemented hyaluronic acid based hydrogel with minced muscle graft in the treatment of volumetric muscle loss injury	PLOS ONE			English	Article							SKELETAL-MUSCLES; MODEL; REPAIR; CELLS; TRANSPLANTATION; REGENERATION; ISCHEMIA; RECOVERY; SCAFFOLD; PROTEIN	Minced muscle autografting mediates de novo myofiber regeneration and promotes partial recovery of neuromuscular strength after volumetric muscle loss injury (VML). A major limitation of this approach is the availability of sufficient donor tissue for the treatment of relatively large VMLs without inducing donor site morbidity. This study evaluated a laminin-111 supplemented hyaluronic acid based hydrogel (HA+LMN) as a putative myoconductive scaffolding to be co-delivered with minced muscle grafts. In a rat tibialis anterior muscle VML model, delivery of a reduced dose of minced muscle graft (50% of VML defect) within HA+LMN resulted in a 42% improvement of peak tetanic torque production over unrepaired VML affected limbs. However, the improvement in strength was not improved compared to a 50% minced graft-only control group. Moreover, histological analysis revealed that the improvement in in vivo functional capacity mediated by minced grafts in HA+LMN was not accompanied by a particularly robust graft mediated regenerative response as determined through donor cell tracking of the GFP+ grafting material. Characterization of the spatial distribution and density of macrophage and satellite cell populations indicated that the combination therapy damps the heightened macrophage response while re-establishing satellite content 14 days after VML to a level consistent with an endogenously healing ischemia-reperfusion induced muscle injury. Moreover, regional analysis revealed that the combination therapy increased satellite cell density mostly in the remaining musculature, as opposed to the defect area. Based on the results, the following salient conclusions were drawn: 1) functional recovery mediated by the combination therapy is likely due to a superposition of de novo muscle fiber regeneration and augmented repair of muscle fibers within the remaining musculature, and 2) The capacity for VML therapies to augment regeneration and repair within the remaining musculature may have significant clinical impact and warrants further exploration.	[Goldman, Stephen M.; Henderson, Beth E. P.; Walters, Thomas J.; Corona, Benjamin T.] US Army, Inst Surg Res, Jbsa Ft Sam Houston, TX 78234 USA		Corona, BT (corresponding author), US Army, Inst Surg Res, Jbsa Ft Sam Houston, TX 78234 USA.	benjamin.t.corona.civ@mail.mil	Goldman, Stephen/AAT-7318-2020	Goldman, Stephen/0000-0002-2244-1443	United States Army Medical Research and Materiel Command, Clinical and Rehabilitative Medicine Research Program [C_003_USAISR]	United States Army Medical Research and Materiel Command, Clinical and Rehabilitative Medicine Research Program	This work was supported by award C_003_USAISR to BTC from the United States Army Medical Research and Materiel Command, Clinical and Rehabilitative Medicine Research Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson BM, 1972, REGENERATION MINCED; Corona BT, 2013, AM J PHYSIOL-CELL PH, V305, pC761, DOI 10.1152/ajpcell.00189.2013; Corona BT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13249; Corona BT, 2015, CELLS TISSUES ORGANS, V202, P180, DOI 10.1159/000443925; Corona BT, 2015, J REHABIL RES DEV, V52, P785, DOI 10.1682/JRRD.2014.07.0165; Corona BT, 2014, MUSCLE NERVE, V49, P919, DOI 10.1002/mus.24160; Corona BT, 2016, BIOMATERIALS; Criswell TL, 2012, AM J PATHOL, V180, P787, DOI 10.1016/j.ajpath.2011.10.012; FAULKNER JA, 1983, EXP NEUROL, V80, P682, DOI 10.1016/0014-4886(83)90318-7; Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038; Garg K, 2015, J ORTHOP RES, V33, P40, DOI 10.1002/jor.22730; Garg K, 2014, CELL TISSUE RES, V358, P857, DOI 10.1007/s00441-014-2006-6; GHINS E, 1984, J MUSCLE RES CELL M, V5, P711, DOI 10.1007/BF00713929; GHINS E, 1986, J MUSCLE RES CELL M, V7, P151, DOI 10.1007/BF01753416; Goldman SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186593; Goldman SM, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0589-z; Greising SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13306-2; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; Hurtgen BJ, 2016, J MUSCULOSKEL NEURON, V16, P122; Hurtgen BJ, 2015, ORTH RES SOC ANN M L; Hurtgen BJ, 2016, J MUSCULOSKELETAL NE; Hurtgen BJ, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13362; Hurtgen BJ, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1617-y; Johnson WL, 2008, J BIOMECH, V41, P610, DOI 10.1016/j.jbiomech.2007.10.004; Kasukonis B, 2016, TISSUE ENG PT A, V22, P1151, DOI 10.1089/ten.tea.2016.0134; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lim AYT, 2006, MUSCLE NERVE, V33, P377, DOI 10.1002/mus.20468; LOWE DA, 1995, J APPL PHYSIOL, V79, P1260, DOI 10.1152/jappl.1995.79.4.1260; MESSINA LM, 1991, CIRC RES, V68, P1600, DOI 10.1161/01.RES.68.6.1600; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Pilia M, 2014, EUR CELLS MATER, V28, P11, DOI 10.22203/eCM.v028a02; Plant DR, 2006, MUSCLE NERVE, V34, P577, DOI 10.1002/mus.20616; Pollot BE, 2016, J TRAUMA ACUTE CARE; Pollot BE, 2016, J TRAUMA ACUTE CARE, V81, pS184, DOI 10.1097/TA.0000000000001212; Prestwich Glenn D, 2008, Organogenesis, V4, P42; Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831; Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002; Shu XZ, 2004, BIOMATERIALS, V25, P1339, DOI 10.1016/j.biomaterials.2003.08.014; Silva-Barbosa SD, 2008, TRANSPLANTATION, V85, P566, DOI 10.1097/TP.0b013e31815fee50; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; VRACKO R, 1972, J CELL BIOL, V55, P406, DOI 10.1083/jcb.55.2.406; Walters TJ, 2015, MUSCLE NERVE, V52, P640, DOI 10.1002/mus.24581; Ward CL, 2016, J ORTHOP TRAUMA, V30, pE396, DOI 10.1097/BOT.0000000000000673; Ward CL, 2015, BIORESEARCH OPEN ACC, V4, P198, DOI 10.1089/biores.2015.0009; Zou K, 2014, STEM CELL TRANSL MED, V3, P1013, DOI 10.5966/sctm.2014-0044	47	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191245	10.1371/journal.pone.0191245	http://dx.doi.org/10.1371/journal.pone.0191245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329332	Green Submitted, Green Published, gold			2022-12-27	WOS:000419954100054
J	Hart, EAC; Lakerveld, J; McKee, M; Oppert, JM; Rutter, H; Charreire, H; Veenhoven, R; Bardos, H; Compernolle, S; De Bourdeaudhuij, I; Brug, J; Mackenbach, JD				Hart, Eva Anna Christina; Lakerveld, Jeroen; McKee, Martin; Oppert, Jean-Michel; Rutter, Harry; Charreire, Helene; Veenhoven, Ruut; Bardos, Helga; Compernolle, Sofie; De Bourdeaudhuij, Ilse; Brug, Johannes; Mackenbach, Joreintje Dingena			Contextual correlates of happiness in European adults	PLOS ONE			English	Article							ROAD TRAFFIC NOISE; NEIGHBORHOOD CHARACTERISTICS; VIRTUAL AUDIT; HEALTH; ENVIRONMENT; DETERMINANTS; ASSOCIATIONS; ANNOYANCE; MISMATCH; AREA	Objectives We aimed to examine the associations of both objectively assessed and perceived physical and social neighborhood characteristics with happiness in European adults. In addition, we aimed to study how these associations differed among subgroups. Methods Participants (N = 6037) of the cross-sectional SPOTLIGHT survey reported on their level of happiness using a 5-point Likert scale, and on perceived physical and social environmental neighborhood characteristics. Objective physical environmental characteristics were assessed using a Google Street View-based neighborhood audit. Associations of 14 physical and social environmental characteristics with happiness were analyzed using multivariable multinomial regression analyses with clustered standard errors. Results Living in neighborhoods with higher levels of aesthetics and more water and green space was associated with being very happy. Individuals who perceived their neighborhood to be safer, more functional and more aesthetic were more likely to be very happy. The associations of functionality and aesthetics with happiness were strongest in the Ghent region (Belgium), the Randstad (the Netherlands) and Greater London (United Kingdom). Perceived absence of air pollution was only associated with higher levels of happiness in more highly educated participants. Individuals with a larger social network, more social cohesion and who trusted their neighbors were more likely to be very happy. The association between social networks and happiness was somewhat stronger in men than in women. In general, the associations between environmental characteristics and happiness had similar directions and sizes across socio-economic and socio-demographic subgroups. Conclusions This European study provided evidence that both objectively assessed and perceived physical and social characteristics of the neighborhood environment are associated with the happiness of its residents.	[Hart, Eva Anna Christina; Lakerveld, Jeroen; Brug, Johannes; Mackenbach, Joreintje Dingena] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands; [McKee, Martin; Rutter, Harry] London Sch Hyg & Trop Med, ECOHOST Ctr Hlth & Social Change, London, England; [Oppert, Jean-Michel; Charreire, Helene] Univ Paris 13, Inserm U1153, Ctr Rech Epidemiol & Stat, Cnam,COMUE Sorbonne Paris Cite,EREN,Inra U1125, Bobigny, France; [Oppert, Jean-Michel] Univ Paris 06, Univ Pierre & Marie Curie, Sorbonne Univ, Paris, France; [Oppert, Jean-Michel] Hop La Pitie Salpetriere, AP HP, Inst Cardiometabolism & Nutr, Dept Nutr, Paris, France; [Charreire, Helene] Paris Est Univ, Urban Sch Paris, Lab Urba, UPEC, Creteil, France; [Veenhoven, Ruut] Erasmus Univ, Erasmus Happiness Econ Res Org, Rotterdam, Netherlands; [Veenhoven, Ruut] North West Univ, Optentia Res, Vanderbijlpark, South Africa; [Bardos, Helga] Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Debrecen, Hungary; [Compernolle, Sofie; De Bourdeaudhuij, Ilse] Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium; [Brug, Johannes] Univ Amsterdam, Amsterdam Sch Commun Res ASCoR, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of London; London School of Hygiene & Tropical Medicine; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Erasmus University Rotterdam; North West University - South Africa; University of Debrecen; Ghent University; University of Amsterdam	Mackenbach, JD (corresponding author), Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands.	j.mackenbach@vumc.nl	Mackenbach, Joreintje Dingena/U-9131-2019; Charreire, Helene/F-3037-2017; Helga, Bárdos/AAH-4049-2021; Rutter, Harry/HCI-8765-2022; Veenhoven, Ruut/F-5052-2013; McKee, Marc D/E-2187-2011; Brug, Johannes/A-8242-2018; Mckee, Martin/E-6673-2018; De+Bourdeaudhuij, Ilse/AAC-5528-2019	Mackenbach, Joreintje Dingena/0000-0002-2783-721X; Charreire, Helene/0000-0002-1260-9812; Veenhoven, Ruut/0000-0002-5159-393X; McKee, Marc D/0000-0001-8349-965X; Brug, Johannes/0000-0002-1904-7349; Mckee, Martin/0000-0002-0121-9683; De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Lakerveld, Jeroen/0000-0002-8551-6748; Rutter, Harry/0000-0002-9322-0656; Compernolle, Sofie/0000-0001-7742-2592; Reis, AlessanRSS/0000-0001-8486-7469	Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-twostage) [278186]	Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-twostage)	The SPOTLIGHT project is funded by the Seventh Framework Programme (CORDIS FP7) of the European Commission, HEALTH (FP7-HEALTH-2011-twostage), Grant agreement no. 278186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Khalek AM, 2006, SOC BEHAV PERSONAL, V34, P139, DOI 10.2224/sbp.2006.34.2.139; Angner E, 2013, EUR J PHILOS SCI, V3, P221, DOI 10.1007/s13194-013-0065-2; Ball K, 2008, PREV MED, V47, P294, DOI 10.1016/j.ypmed.2008.05.001; Beenackers MA, 2013, HEALTH EDUC RES, V28, P220, DOI 10.1093/her/cyt002; Bethlehem JR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-52; Beyer KMM, 2014, INT J ENV RES PUB HE, V11, P3453, DOI 10.3390/ijerph110303453; Bodner TE, 2008, STRUCT EQU MODELING, V15, P651, DOI 10.1080/10705510802339072; Brereton F, 2008, ECOL ECON, V65, P386, DOI 10.1016/j.ecolecon.2007.07.008; Cunado J, 2013, SOC INDIC RES, V112, P549, DOI 10.1007/s11205-012-0038-4; Curl CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069778; Delhey J, 2016, INT J PSYCHOL, V51, P163, DOI 10.1002/ijop.12149; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Eibich P, 2016, GERONTOLOGY, V62, P362, DOI 10.1159/000438700; Fararouei M, 2013, J ADOLESCENCE, V36, P1187, DOI 10.1016/j.adolescence.2013.09.006; Farhud DD, 2014, IRAN J PUBLIC HEALTH, V43, P1468; Feuillet T, 2016, OBES REV, V17, P19, DOI 10.1111/obr.12378; Fredrickson BL, 2004, PHILOS T R SOC B, V359, P1367, DOI 10.1098/rstb.2004.1512; Grant N, 2009, INT J BEHAV MED, V16, P259, DOI 10.1007/s12529-009-9032-x; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Helliwell J., 2015, WORLD HAPPINESS REPO, P12; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Hogan MJ, 2016, SOC SCI MED, V162, P168, DOI 10.1016/j.socscimed.2016.06.030; Horelli L, 2006, EUR REV APPL PSYCHOL, V56, P15, DOI 10.1016/j.erap.2005.02.012; INGLEHART R, 2000, GENES CULTURE DEMOCR; Inglehart R, 2002, INT J COMP SOCIOL, V43, P391, DOI 10.1177/002071520204300309; Kellert S. R., 1997, VALUE LIFE BIOL DIVE; King LA, 1998, J PERS SOC PSYCHOL, V75, P156, DOI 10.1037/0022-3514.75.1.156; Kye SY, 2014, INT J PUBLIC HEALTH, V59, P731, DOI 10.1007/s00038-014-0588-0; Lakerveld J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008505; Lakerveld J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-793; Lawrence EM, 2015, SOC SCI MED, V145, P115, DOI 10.1016/j.socscimed.2015.09.020; Leonardi F., 1999, SOCIAL INDICATORS RE, V48, P189, DOI DOI 10.1023/A:1006977717925; Leyden KM, 2011, URBAN AFF REV, V47, P861, DOI 10.1177/1078087411403120; Ludwig J, 2012, SCIENCE, V337, P1505, DOI 10.1126/science.1224648; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Mackenbach JD, 2016, OBES REV, V17, P96, DOI 10.1111/obr.12373; Mackenbach JD, 2016, OBES REV, V17, P42, DOI 10.1111/obr.12375; MacKerron G, 2013, GLOBAL ENVIRON CHANG, V23, P992, DOI 10.1016/j.gloenvcha.2013.03.010; Marselle MR, 2015, INT J ENV RES PUB HE, V12, P106, DOI 10.3390/ijerph120100106; Mollenkopf Heidrun, 2005, Eur J Ageing, V2, P120, DOI 10.1007/s10433-005-0029-2; Newton, 2007, WELLBEING NATURAL EN; Ohrstrom E, 2004, J ACOUST SOC AM, V115, P719, DOI 10.1121/1.1639333; Ouis D, 2001, J ENVIRON PSYCHOL, V21, P101, DOI 10.1006/jevp.2000.0187; Pikora T, 2003, SOC SCI MED, V56, P1693, DOI 10.1016/S0277-9536(02)00163-6; Prasad M., 2016, ASIAN J MULTIDISCIP, V4, P41; Richards J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1391-4; Roda C, 2016, OBES REV, V17, P31, DOI 10.1111/obr.12376; Rodriguez-Pose A, 2014, J HAPPINESS STUD, V15, P357, DOI 10.1007/s10902-013-9426-y; Roux AVD, 2007, REV EPIDEMIOL SANTE, V55, P13, DOI 10.1016/j.respe.2006.12.003; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Rubin D. B., 2004, MULTIPLE IMPUTATION; Ryan L, 2001, SOC INDIC RES, V55, P185, DOI 10.1023/A:1011002123169; Spittaels H, 2009, INT J BEHAV NUTR PHY, V6; StataCorp, 2011, STAT STAT SOFTW REL, P173; Van Dyck D, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-70; Veenhoven, 2016, WORLD DATABASE HAPPI; Veenhoven R, 2008, J HAPPINESS STUD, V9, P449, DOI 10.1007/s10902-006-9042-1; Veenhoven R, 1984, CONDITIONS HAPPINESS, P12, DOI DOI 10.1007/978-94-009-6432-7_2; Veenhoven R., 2015, ACCEPTED MEASURES HA, P15; Veenhoven R, 2015, INT J PSYCHOL, V50, P379, DOI 10.1002/ijop.12161; Wayman JC., 2003, MULTIPLE IMPUTATION; Weden MA, 2008, SOC SCI MED, V66, P1256, DOI 10.1016/j.socscimed.2007.11.041; Welsch H, 2006, ECOL ECON, V58, P801, DOI 10.1016/j.ecolecon.2005.09.006; Wen M, 2006, SOC SCI MED, V63, P2575, DOI 10.1016/j.socscimed.2006.06.025; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Williams J, 2005, J URBAN DES, V10, P195, DOI 10.1080/13574800500086998; Wilson E. O., 1984, HARV U PRESS, DOI DOI 10.2307/J.CTVK12S6H; Winters J V., 2015, IZA DISCUSS PAP; Zelenski JM, 2014, ENVIRON BEHAV, V46, P3, DOI 10.1177/0013916512451901	71	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190387	10.1371/journal.pone.0190387	http://dx.doi.org/10.1371/journal.pone.0190387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364899	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000423412500013
J	Touzain, F; Le Devendec, L; de Boisseson, C; Baron, S; Jouy, E; Perrin-Guyomard, A; Blanchard, Y; Kempf, I				Touzain, Fabrice; Le Devendec, Laetitia; de Boisseson, Claire; Baron, Sandrine; Jouy, Eric; Perrin-Guyomard, Agnes; Blanchard, Yannick; Kempf, Isabelle			Characterization of plasmids harboring &ITbla&ITcCTX-M and &ITbla&ITCMY genes in &ITE. coli&IT from French broilers	PLOS ONE			English	Article							ESCHERICHIA-COLI; EXTENDED-SPECTRUM; BETA-LACTAMASE; MULTIDRUG-RESISTANCE; SALMONELLA-ENTERICA; DNA-SEQUENCE; VIRULENCE; PREVALENCE; ANIMALS; POULTRY	Resistance to extended-spectrum cephalosporins (ESC) is a global health issue. The aim of this study was to analyze and compare plasmids coding for resistance to ESC isolated from 16 avian commensal and 17 avian pathogenic Escherichia coli (APEC) strains obtained respectively at slaughterhouse or from diseased broilers in 2010-2012. Plasmid DNA was used to transform E. coli DH5alpha, and the resistances of the transformants were determined. The sequences of the ESC-resistance plasmids prepared from transformants were obtained by Illumina (33 plasmids) or PacBio (1 plasmid). Results showed that 29 of these plasmids contained the bla(CTX-M-1) gene and belonged to the IncI1/ST3 type, with 27 and 20 of them carrying the sul2 or tet(A) genes respectively. Despite their diverse origins, several plasmids showed very high percentages of identity. None of the bla(CTX-M-1)-containing plasmid contained APEC virulence genes, although some of them were detected in the parental strains. Three plasmids had the bla(CMY-2) gene, but no other resistance gene. They belonged to IncB/O/K/Z-like or IncFIA/FIB replicon types. The bla(CMY-2) IncFIA/FIB plasmid was obtained from a strain isolated from a diseased broiler and also containing a bla(CTX-M-1) IncI1/ST3 plasmid. Importantly APEC virulence genes (sitA-D, iucA-D, iutA, hlyF, ompT, etsA-C, iss, iroB-E, iroN, cvaA-C and cvi) were detected on the bla(CMY-2) plasmid. In conclusion, our results show the dominance and high similarity of bla(CTX-M-1) IncI1/ST3 plasmids, and the worrying presence of APEC virulence genes on a bla(CMY-2) plasmid.	[Touzain, Fabrice; Le Devendec, Laetitia; de Boisseson, Claire; Baron, Sandrine; Jouy, Eric; Blanchard, Yannick; Kempf, Isabelle] ANSES, Ploufragan Lab, Ploufragan, France; [Touzain, Fabrice; Le Devendec, Laetitia; de Boisseson, Claire; Baron, Sandrine; Jouy, Eric; Perrin-Guyomard, Agnes; Blanchard, Yannick; Kempf, Isabelle] Univ Bretagne Loire, Rennes, France; [Perrin-Guyomard, Agnes] ANSES, Fougeres Lab, Fougeres, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Fougeres	Kempf, I (corresponding author), ANSES, Ploufragan Lab, Ploufragan, France.; Kempf, I (corresponding author), Univ Bretagne Loire, Rennes, France.	isabelle.kempf@anses.fr	Baron, Sandrine/L-7608-2019	Perrin, Agnes/0000-0002-4078-188X; Kempf, Isabelle/0000-0002-8912-3044	France Genomique National infrastructure, "Investissement d'avenir" program [ANR-10-INBS-09]; Conseil Departemental des Cotes d'Armor; ANSES	France Genomique National infrastructure, "Investissement d'avenir" program(French National Research Agency (ANR)); Conseil Departemental des Cotes d'Armor(Region Bretagne); ANSES	This work was supported by ANSES, in the framework of joint research for the CoVetLab (Club 5) network; Conseil Departemental des Cotes d'Armor. Genomics platform at the Nantes (Biogenouest Genomics) core facility for its technical support in Mi-seq NGS sequencing. This Work, for pacbio sequencing part was supported by France Genomique National infrastructure, funded as part of "Investissement d'avenir" program managed by Agence Nationale pour la Recherche (contrat ANR-10-INBS-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum M, 2014, P 10 C SOC FRANC MIC; ANSES, 2016, RAPPORT; Anses-ANMV, 2014, SUIV VENT MED VET CO; Baron S, 2016, VET MICROBIOL, V185, P29, DOI 10.1016/j.vetmic.2016.01.020; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; BEJ AK, 1991, APPL ENVIRON MICROB, V57, P1013, DOI 10.1128/AEM.57.4.1013-1017.1991; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chauvin C, 2013, ANTIMICROB AGENTS CH, V57, P6351, DOI 10.1128/AAC.01460-13; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clinical and Laboratory Standards Institute (CLSI), 2020, VET01S2 CLSI; Dahmen S, 2012, J ANTIMICROB CHEMOTH, V67, P3011, DOI 10.1093/jac/dks308; Day MJ, 2016, J ANTIMICROB CHEMOTH, V71, P1178, DOI 10.1093/jac/dkv485; de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776; de Toro M, 2013, INT J ANTIMICROB AG, V42, P167, DOI 10.1016/j.ijantimicag.2013.04.016; Dheilly A, 2012, ANTIMICROB AGENTS CH, V56, P189, DOI 10.1128/AAC.05617-11; Dierikx CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079005; European Food Safety Authority, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4380; Girlich D, 2007, APPL ENVIRON MICROB, V73, P4681, DOI 10.1128/AEM.02491-06; Hansen KH, 2016, APPL ENVIRON MICROB, V82, P4705, DOI 10.1128/AEM.00495-16; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Kojima A, 2005, ANTIMICROB AGENTS CH, V49, P3533, DOI 10.1128/AAC.49.8.3533-3537.2005; Kubasova T, 2014, PLASMID, V76, P8, DOI 10.1016/j.plasmid.2014.08.003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Madec JY, 2015, ANTIMICROB AGENTS CH, V59, P5860, DOI 10.1128/AAC.00819-15; Mariette J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-462; Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533; Mo SS, 2014, VET MICROBIOL, V171, P315, DOI 10.1016/j.vetmic.2014.02.002; RIVERA IG, 1995, APPL ENVIRON MICROB, V61, P2898, DOI 10.1128/AEM.61.8.2898-2904.1995; Rodriguez I, 2014, INT J ANTIMICROB AG, V43, P553, DOI 10.1016/j.ijantimicag.2014.02.019; Seiffert SN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00407; Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001; Sidjabat HE, 2014, INT J ANTIMICROB AG, V44, P203, DOI 10.1016/j.ijantimicag.2014.04.016; Smith H, 2015, ANTIMICROB AGENTS CH, V59, P5357, DOI 10.1128/AAC.05006-14; TAKAHASHI S, 1984, J CLIN MICROBIOL, V20, P608, DOI 10.1128/JCM.20.4.608-613.1984; Verdet C, 2009, ANTIMICROB AGENTS CH, V53, P4002, DOI 10.1128/AAC.00753-08; Wang J, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00716; Wang J, 2014, J ANTIMICROB CHEMOTH, V69, P2658, DOI 10.1093/jac/dku206; Wang XR, 2014, J GLOB ANTIMICROB RE, V2, P57, DOI 10.1016/j.jgar.2013.10.004; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI DOI 10.1093/jac/dki412; Zamorano L, 2015, ANTIMICROB AGENTS CH, V59, P5260, DOI 10.1128/AAC.00562-15	46	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0188768	10.1371/journal.pone.0188768	http://dx.doi.org/10.1371/journal.pone.0188768			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360838	Green Submitted, Green Published, gold			2022-12-27	WOS:000423161800002
J	Gong, H; Wang, H; Wang, YX; Bai, X; Liu, B; He, JF; Wu, JH; Qi, WM; Zhang, WG				Gong, Husile; Wang, Hong; Wang, YueXing; Bai, Xue; Liu, Bin; He, JinFeng; Wu, JiangHong; Qi, WangMei; Zhang, WenGuang			Skin transcriptome reveals the dynamic changes in the Wnt pathway during integument morphogenesis of chick embryos	PLOS ONE			English	Article							PLANAR CELL POLARITY; HAIR FOLLICLE; GENE-EXPRESSION; WNT/BETA-CATENIN; FEATHER BUDS; RNA-SEQ; DIFFERENTIATION; PROLIFERATION; PATTERNS; TIME	Avian species have a unique integument covered with feathers. Skin morphogenesis is a successive and complex process. To date, most studies have focused on a single developmental point or stage. Fewer studies have focused on whole transcriptomes based on the time-course of embryo integument development. To analyze the global changes in gene expression profiles, we sequenced the transcriptome of chicken embryo skin samples from day 6 to day 21 of incubation and identified 5830 differentially expressed genes (DEGs). Hierarchical clustering showed that E6 to E14 is the critical period of feather follicle morphogenesis. According to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of the DEGs, two kinds of Wnt signaling pathways (a canonical pathway and a non-canonical pathway) changed during feather follicle and feather morphogenesis. The gene expression level of inhibitors and ligands related to the Wnt signaling pathway varied significantly during embryonic development. The results revealed a staggered phase relationship between the canonical pathway and the non-canonical pathway from E9 to E14. These analyses shed new light on the gene regulatory mechanism and provided fundamental data related to integument morphogenesis of chickens.	[Gong, Husile; Wang, Hong; Wang, YueXing; Bai, Xue; Liu, Bin; Zhang, WenGuang] Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Peoples R China; [Gong, Husile; Wu, JiangHong] Inner Mongolia Acad Agr & Anim Husb Sci, Anim Husb Inst, Hohhot, Peoples R China; [He, JinFeng; Qi, WangMei] Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Peoples R China; [Wu, JiangHong] Chinese Acad Sci, Inner Mongolia Prataculture Res Ctr, Hohhot, Peoples R China	Inner Mongolia Agricultural University; Inner Mongolia Agricultural University; Chinese Academy of Sciences	Zhang, WG (corresponding author), Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Peoples R China.; Wu, JH (corresponding author), Inner Mongolia Acad Agr & Anim Husb Sci, Anim Husb Inst, Hohhot, Peoples R China.; Qi, WM (corresponding author), Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Peoples R China.; Wu, JH (corresponding author), Chinese Acad Sci, Inner Mongolia Prataculture Res Ctr, Hohhot, Peoples R China.	wujianghonglong@126.com; qiwangmei@imau.edu.cn; atcgnmbi@aliyun.com	wu, Jianghong/E-7587-2015	wu, Jianghong/0000-0003-4027-2345	National Natural Science Foundation of China [31260538, 30960246, 31560622, 31672385, 31560623]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31260538, 30960246, 31560622, and 31672385 to WZ) and (Grant No. 31560623 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Angonin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074666; Bak SS, 2015, EXP DERMATOL, V24, P550, DOI 10.1111/exd.12707; Beaton H, 2016, AM J PHYSL RENAL PHY, V311; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bisson JA, 2015, DEV BIOL, V398, P80, DOI 10.1016/j.ydbio.2014.11.015; Botchkarev VA, 2002, J INVEST DERMATOL, V118, P3, DOI 10.1046/j.1523-1747.2002.01645.x; Cai SX, 2014, J CELL PHYSIOL, V229, P791, DOI 10.1002/jcp.24500; Chang H, 2016, DEV BIOL, V409, P181, DOI 10.1016/j.ydbio.2015.10.027; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; DAVIDSON D, 1983, J EMBRYOL EXP MORPH, V74, P245; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Devenport D, 2011, NAT CELL BIOL, V13, P893, DOI 10.1038/ncb2284; Fu HD, 2016, J MOL HISTOL, V47, P1; Ghosh S., 2016, ANAL RNA SEQ DATA US, P339; Guha U, 2004, AM J PATHOL, V165, P729, DOI 10.1016/S0002-9440(10)63336-6; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ishida K, 2016, DEV GROWTH DIFFER, V58, P303, DOI 10.1111/dgd.12275; Johansson JA, 2014, SEMIN CELL DEV BIOL, V25, P3, DOI 10.1016/j.semcdb.2013.12.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kim JY, 2005, DIFFERENTIATION, V73, P240, DOI 10.1111/j.1432-0436.2005.00020.x; Komiya Yuko, 2008, Organogenesis, V4, P68; Kwack MH, 2017, EXPT DERMATOLOGY; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Li Y, 2016, CHINESE MED J-PEKING, V129, P1200, DOI 10.4103/0366-6999.181974; Lin CM, 2006, CURR OPIN CELL BIOL, V18, P730, DOI 10.1016/j.ceb.2006.10.009; LINSENMAYER TF, 1972, DEV BIOL, V27, P244, DOI 10.1016/0012-1606(72)90101-7; Liu QY, 2016, BIOL TRACE ELEM RES, V171, P380, DOI 10.1007/s12011-015-0555-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lyros O, 2016, DYSREGULATION WNT5A; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007; Mukhopadhyay A, 2013, DEV BIOL, V373, P373, DOI 10.1016/j.ydbio.2012.10.024; Nalesso G, 2017, ANN RHEUM DIS, V76, P218, DOI 10.1136/annrheumdis-2015-208577; Nikolayeva O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6_3; Ravni A, 2009, J INVEST DERMATOL, V129, P2507, DOI 10.1038/jid.2009.84; Saito-Diaz K, 2013, GROWTH FACTORS, V31, P1, DOI 10.3109/08977194.2012.752737; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; SENGEL P, 1990, International Journal of Developmental Biology, V34, P33; Shin D, 2014, J MOL CELL BIOL, V6, P338, DOI 10.1093/jmcb/mju023; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takabayashi Y, 2016, CLIN COSMET INVESTI, V9, P127, DOI 10.2147/CCID.S108187; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Van AR, 2012, DEV BIOL, V369, P101; Wang YS, 2010, DEVELOPMENT, V137, P4091, DOI 10.1242/dev.057455; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Xing YZ, 2016, INT J MED SCI, V13, P603, DOI 10.7150/ijms.15571; Xu ZJ, 2015, ELIFE, V4, DOI 10.7554/eLife.10567; Yan L, 2016, EXPT THERAPEUTIC MED, V12; Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196; Yuan YA, 2011, INT J MOL MED, V27, P63, DOI 10.3892/ijmm.2010.560; Zhang HH, 2016, BIOCHIMIE, V127, P10, DOI 10.1016/j.biochi.2016.04.015; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011	59	16	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190933	10.1371/journal.pone.0190933	http://dx.doi.org/10.1371/journal.pone.0190933			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351308	gold, Green Submitted, Green Published			2022-12-27	WOS:000422911300032
J	Mizuno, S; Kunisawa, S; Sasaki, N; Fushimi, K; Imanaka, Y				Mizuno, Seiko; Kunisawa, Susumu; Sasaki, Noriko; Fushimi, Kiyohide; Imanaka, Yuichi			Effects of night-time and weekend admissions on in-hospital mortality in acute myocardial infarction patients in Japan	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; OUTCOMES; TIME; INTERVENTION; REPERFUSION; SURVIVAL; ROUTINE	Background Patients admitted to hospital during off-hours may experience poorer quality of care and clinical outcomes. However, few studies have examined the variations in clinical processes and outcomes across admission times and days of the week in acute myocardial infarction (AMI) patients. This study aimed to comparatively analyze the effect of weekend and weekday admissions stratified by admission time on in-hospital mortality in AMI patients. Methods and results Using a large nationwide administrative database, we analyzed 103,908 AMI patients admitted to 639 Japanese acute care hospitals between April 2011 and March 2015. We divided patients into the following 4 groups: weekday daytime admissions, weekday night-time admissions, weekend daytime admissions, and weekend night-time admissions. A hierarchical logistic regression model was used to comparatively examine in-hospital mortality among the groups after adjusting for age, sex, ambulance use, Killip class, comorbidities, and the number of cardiologists in the admitting hospital. In addition, we also calculated and compared the adjusted odds ratios of various AMI therapies among the groups. The in-hospital mortality rate of weekend daytime admissions was higher than those admitted during other times (weekday daytime: 6.8%; weekday night-time; 6.5%, weekend daytime; 7.6%; weekend night-time: 6.6%; P < 0.001), even after adjusting for the covariates (adjusted odds ratio for weekend daytime admissions: 1.10; 95% confidence interval: 1.03 +/- 1.19). The prescription rates of guideline-based medications provided on the first day of admission were higher in night-time admissions than in daytime admissions. Conclusions In-hospital mortality rates were higher in AMI patients admitted during weekend daytime hours when compared with patients admitted during other times. Furthermore, patients admitted during daytime hours had lower prescription rates of guideline-based medications. Our findings indicate that weekend daytime admissions may be a potential target for improvement in the Japanese healthcare system.	[Mizuno, Seiko; Kunisawa, Susumu; Sasaki, Noriko; Imanaka, Yuichi] Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Kyoto, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Bunkyo Ku, Tokyo, Japan	Kyoto University; Tokyo Medical & Dental University (TMDU)	Imanaka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Sakyo Ku, Kyoto, Japan.	imanaka-y@umin.net	Sasaki, Noriko/GYU-0438-2022; KUNISAWA, Susumu/HCH-1094-2022; SASAKI, Noriko/HCH-1462-2022		Health Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan [H27-iryoippan-001, 7 H29-seisaku-shitei-009]; Japan Society for the Promotion of Science [16H02634]	Health Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Health Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan (H27-iryoippan-001, 7 H29-seisaku-shitei-009; http://www.mhlw.go.jp), and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (16H02634; https.//www.jsps.go.jp/j-grantsinaid/). YI received this funding. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aylin P, 2010, QUAL SAF HEALTH CARE, V19, P213, DOI 10.1136/qshc.2008.028639; Berger A, 2008, AM J CARDIOL, V101, P422, DOI 10.1016/j.amjcard.2007.09.092; Bray BD, 2016, LANCET, V388, P170, DOI 10.1016/S0140-6736(16)30443-3; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511; Isogai T, 2015, INT J CARDIOL, V179, P315, DOI 10.1016/j.ijcard.2014.11.070; Jneid H, 2008, CIRCULATION, V117, P2502, DOI 10.1161/CIRCULATIONAHA.107.752113; Khanna R, 2011, J HOSP MED, V6, P10, DOI 10.1002/jhm.833; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; Kunisawa S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166269; Maggs F, 2010, J ROY COLL PHYS EDIN, V40, P115, DOI 10.4997/JRCPE.2010.205; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; MHLW, HEIS 28 NEND SHINR N; Mizuno S, 2016, INT J CARDIOL, V220, P929, DOI 10.1016/j.ijcard.2016.06.168; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; OECD, HLTH GLANC 2015; Office J cabinet, KOK NO KYUUJ NI TSUI; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Robinson EJ, 2016, BMJ QUAL SAF, V25, P832, DOI 10.1136/bmjqs-2015-004223; Ross JS, 2010, MED CARE, V48, P652, DOI 10.1097/MLR.0b013e3181dbe35d; Ryan JW, 2005, CIRCULATION, V112, P3049, DOI 10.1161/CIRCULATIONAHA.105.582346; Sasaki N, 2013, CAN J CARDIOL, V29, P1055, DOI 10.1016/j.cjca.2012.11.021; Seghieri C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-170; Sorita A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7393; Sorita A, 2015, AM HEART J, V169, P62, DOI 10.1016/j.ahj.2014.08.012; Ui S, 2005, CIRC J, V69, P95, DOI 10.1253/circj.69.95; Vest-Hansen B, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006731; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492	29	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191460	10.1371/journal.pone.0191460	http://dx.doi.org/10.1371/journal.pone.0191460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351557	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300093
J	Naran, NH; Haagensen, M; Crowther, NJ				Naran, Nitien H.; Haagensen, Mark; Crowther, Nigel J.			Steatosis in South African women: How much and why?	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; UNITED-STATES; ECTOPIC FAT; PREVALENCE; ADIPONECTIN; HOMEOSTASIS; GLUCOSE; PLASMA	Background Globally, steatosis is the commonest type of liver pathology and is closely associated with obesity and the metabolic syndrome. Obesity is common in urban African females but no data is available on hepatic fat content in this population group when compared to other ethnic groups. The aim of this study was therefore to compare hepatic fat content in woman from different ethnic groups in South Africa and to characterise the principle determinants of liver fat. Materials and methods A convenience sample of 106 (48 Indian, 29 African and 29 Caucasian) female volunteers aged 20 +/- 60 years and having no history of cardiometabolic disorders were recruited. Hepatic fat was determined from CT scans using the liver-spleen attenuation ratio (LAR), which decreases with increasing levels of hepatic fat. Anthropometric and cardiometabolic parameters were measured with insulin resistance determined using the HOMA index and dysglycaemia defined as fasting glucose >= 5.60 mmol/L. Results The African subjects had significantly lower hepatic fat content (LAR as median [interquartile range]: 1.35 [1.28, 1.41]) than the Indian (1.22 [1.10, 1.35]; p<0.005) and Caucasian (1.27 [1.16, 1.33]; p<0.05) females even though they had significantly higher BMIs than both groups (p<0.0005 and p<0.05, respectively). Linear regression showed that: subcutaneous abdominal fat was a significant (unstandardised beta = 0.007; p = 0.03) negative, whilst insulin resistance (beta = - 0.97; p = 0.01) and dysglycaemia (beta = - 3.58; p = 0.01) were significant positive determinants of liver fat; higher hepatic fat levels in subjects with the metabolic syndrome were explained by insulin resistance and dysglycaemia. Discussion African ethnicity is associated with low liver fat content. Subcutaneous abdominal fat protects against steatosis, possibly by acting as a triglyceride reservoir. Insulin resistance and dysglycaemia lead to greater hepatic fat deposition and explain higher liver fat levels in subjects with the metabolic syndrome. These observations must be further investigated in longitudinal surveys.	[Naran, Nitien H.; Crowther, Nigel J.] Univ Witwatersrand, Fac Hlth Sci, Natl Hlth Lab Serv, Dept Chem Pathol, Johannesburg, South Africa; [Haagensen, Mark] Univ Witwatersrand, Donald Gordon Med Ctr, Dept Radiol, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand	Crowther, NJ (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Natl Hlth Lab Serv, Dept Chem Pathol, Johannesburg, South Africa.	nigel.crowther@nhls.ac.za		Crowther, Nigel/0000-0002-5766-1745	South African Medical Research Council	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the South African Medical Research Council (http://wm.mrc.ac.za/).	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amarapurkar Deepak N, 2004, Trop Gastroenterol, V25, P130; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Bugianesi E, 2010, CURR PHARM DESIGN, V16, P1941, DOI 10.2174/138161210791208875; Byrne CD, 2012, DIABETIC MED, V29, P1098, DOI 10.1111/j.1464-5491.2012.03732.x; Byrne CD, 2013, P NUTR SOC, V72, P412, DOI 10.1017/S0029665113001249; Davidson LE, 2006, J APPL PHYSIOL, V100, P864, DOI 10.1152/japplphysiol.00986.2005; Duman DG, 2006, DIGEST DIS SCI, V51, P346, DOI 10.1007/s10620-006-3136-9; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; Gradidge PJL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162247; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Han MAT, 2017, EXPERT REV CLIN PHAR, V10, P379, DOI 10.1080/17512433.2017.1299573; Hart CL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1240; Kruger FC, 2010, SAMJ S AFR MED J, V100, P168, DOI 10.7196/SAMJ.1422; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Liu B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c912; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Middleton MS, 2017, GASTROENTEROLOGY, V153, P753, DOI 10.1053/j.gastro.2017.06.005; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Naran NH, 2003, J SOC ENDOCRINOLOGY, V8, P30; Nguyen GC, 2008, HEPATOLOGY, V47, P1058, DOI 10.1002/hep.22223; Nseir W, 2014, WORLD J GASTROENTERO, V20, P9338, DOI 10.3748/wjg.v20.i28.9338; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Schneider ALC, 2014, OBESITY, V22, P292, DOI 10.1002/oby.20426; Shisana O, 2014, S AFRICAN NATL HLTH; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228; Tao C, 2014, BEST PRACT RES CL EN, V28, P43, DOI 10.1016/j.beem.2013.11.003; Treeprasertsuk S, 2011, DIGEST DIS SCI, V56, P35, DOI 10.1007/s10620-010-1241-2; Waisberg R, 2011, HORM METAB RES, V43, P660, DOI 10.1055/s-0031-1283139; Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09284; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49; ZELBERSAGI S, 2009, J HEPATOL S1, V50, pS375	43	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191388	10.1371/journal.pone.0191388	http://dx.doi.org/10.1371/journal.pone.0191388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351564	Green Submitted, gold, Green Published			2022-12-27	WOS:000422911300079
J	Yamamoto, T; Okada, T; Fushimi, Y; Yamamoto, A; Fujimoto, K; Okuchi, S; Fukutomi, H; Takahashi, JC; Funaki, T; Miyamoto, S; Stalder, AF; Natsuaki, Y; Speier, P; Togashi, K				Yamamoto, Takayuki; Okada, Tomohisa; Fushimi, Yasutaka; Yamamoto, Akira; Fujimoto, Koji; Okuchi, Sachi; Fukutomi, Hikaru; Takahashi, Jun C.; Funaki, Takeshi; Miyamoto, Susumu; Stalder, Aurelien F.; Natsuaki, Yutaka; Speier, Peter; Togashi, Kaori			Magnetic resonance angiography with compressed sensing: An evaluation of moyamoya disease	PLOS ONE			English	Article							FREE PRECESSION ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; MR-ANGIOGRAPHY; RECONSTRUCTION; DIAGNOSIS; OPTIMIZATION; ACQUISITION; VESSELS; 3T	Compressed sensing (CS) reconstructions of under-sampled measurements generate missing data based on assumptions of image sparsity. Non-contrast time-of-flight MR angiography (TOF-MRA) is a good candidate for CS based acceleration, as MRA images feature bright trees of sparse vessels over a well-suppressed anatomical background signal. A short scan time derived from CS is beneficial for patients of moyamoya disease (MMD) because of the frequency of MR scans. The purpose of this study was to investigate the reliability of TOF-MRA with CS in the evaluation of MMD. Twenty-two patients were examined using TOF-MRA with CS (CS-TOF) and parallel imaging (PI-TOF). The acceleration factors were 3 (CS3) and 5 (CS5) for CS-TOF, and 3 (PI3) for PI-TOF. Two neuroradiologists evaluated the MMD grading according to stenosis/occlusion scores using the modified Houkin's system, and the visibility of moyamoya vessels (MMVs) using a 3-point scale. Concordance was calculated with Cohen's.. The numbers of MMVs in the basal ganglia were compared using Bland-Altman analysis and Wilcoxon's signed-rank tests. MRA scan times were 4: 07, 3: 53, and 2: 42 for PI3, CS3, and CS5, respectively. CS-reconstruction completed within 10 minutes. MMD grading and MMV visibility scales showed excellent correlation (k>.966). Although the number of MMVs was significantly higher in CS3 than in PI3 (p <.0001) and CS5 (p <.0001), Bland-Altman analysis showed a good agreement between PI3, CS3, and CS5. Compressed sensing can accelerate TOF-MRA with improved visualization of small collaterals in equivalent time (CS3) or equivalent results in a shorter scan time (CS5).	[Yamamoto, Takayuki; Okada, Tomohisa; Fushimi, Yasutaka; Yamamoto, Akira; Fujimoto, Koji; Okuchi, Sachi; Fukutomi, Hikaru; Takahashi, Jun C.; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Takahashi, Jun C.] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Suita, Osaka, Japan; [Funaki, Takeshi; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan; [Stalder, Aurelien F.] Siemens Ltd China, Shanghai, Peoples R China; [Natsuaki, Yutaka] Siemens Med Solut USA Inc, Huntington Beach, CA USA; [Speier, Peter] Siemens Healthcare, Erlangen, Germany	Kyoto University; National Cerebral & Cardiovascular Center - Japan; Kyoto University; Siemens AG; Siemens AG; Siemens AG; Siemens Germany	Okada, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan.	tomokada@kuhp.kyoto-u.ac.jp	Stalder, Aurelien F/A-7071-2010; Fushimi, Yasutaka/L-8922-2017; Okada, Tomohisa/C-5939-2008	Stalder, Aurelien F/0000-0002-0590-2746; Fushimi, Yasutaka/0000-0002-1982-3168; Fukutomi, Hikaru/0000-0003-4262-3890; Okuchi, Sachi/0000-0002-0831-195X; Okada, Tomohisa/0000-0003-2312-5677; YAMAMOTO, Takayuki/0000-0003-0306-3691	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [25120002]	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Initiative for High-Dimensional Data-Driven Science through Deepening of Sparse Modeling" of The Ministry of Education, Culture, Sports, Science and Technology, Japan was provided to K.T. (MEXT grant number 25120002) ((http://sparse-modeling.jp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy NO, 2015, MAGN RESON MED, V74, P614, DOI 10.1002/mrm.25803; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Cho BK, 2010, MOYAMOYA DISEASE UPDATE, P1, DOI 10.1007/978-4-431-99703-0; Cukur T, 2009, MAGN RESON MED, V61, P1122, DOI 10.1002/mrm.21907; Fushimi Y, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3774; Fushimi Y, 2016, INVEST RADIOL, V51, P228, DOI 10.1097/RLI.0000000000000226; Gratz M, 2017, EUR RADIOL, V27, P1004, DOI 10.1007/s00330-016-4398-z; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Houkin K, 2005, CEREBROVASC DIS, V20, P347, DOI 10.1159/000087935; Hutter J, 2015, MAGN RESON MATER PHY, V28, P437, DOI 10.1007/s10334-014-0477-9; Ilicak E, 2016, NMR BIOMED, V29, P532, DOI 10.1002/nbm.3497; Jin QN, 2011, NEUROL MED-CHIR, V51, P195, DOI 10.2176/nmc.51.195; Kang CK, 2016, APPL MAGN RESON, V47, P201, DOI 10.1007/s00723-015-0742-8; Kikuta K, 2008, NEUROSURGERY, V62, P1434, DOI [10.1227/01.NEU.0000232775.06672.F4, 10.1227/01.neu.0000333807.64530.39]; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Mikami T, 2013, J STROKE CEREBROVASC, V22, P862, DOI 10.1016/j.jstrokecerebrovasdis.2012.07.010; Moghari MH, 2016, MAGN RESON MED, V75, P2086, DOI 10.1002/mrm.25800; Okada T, 2009, EUR J RADIOL, V71, P486, DOI 10.1016/j.ejrad.2008.06.005; Okuchi S, 2014, ACAD RADIOL, V21, P812, DOI 10.1016/j.acra.2014.03.007; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rapacchi S, 2015, MAGN RESON MED, V74, P474, DOI 10.1002/mrm.25414; Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis, 2012, Neurol Med Chir (Tokyo), V52, P245; Saeki N, 2000, J CLIN NEUROSCI, V7, P112, DOI 10.1054/jocn.1999.0160; Sawada T, 2012, NEURORADIOLOGY, V54, P1089, DOI 10.1007/s00234-012-1020-1; Seo N, 2017, J MAGN RESON IMAGING, V46, P1289, DOI 10.1002/jmri.25672; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Stalder AF, 2015, P 23 ANN M ISMRM TOR, P3606; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Vincenti G, 2014, JACC-CARDIOVASC IMAG, V7, P882, DOI 10.1016/j.jcmg.2014.04.016; Wang J, 2001, P 1 WURZB WORKSH PAR, P89; YAMADA I, 1992, RADIOLOGY, V184, P773, DOI 10.1148/radiology.184.3.1509066; Yamamoto T, 2016, INVEST RADIOL, V51, P372, DOI 10.1097/RLI.0000000000000221	33	27	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0189493	10.1371/journal.pone.0189493	http://dx.doi.org/10.1371/journal.pone.0189493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351284	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300009
J	Holcomb, J; Doughan, M; Spellmon, N; Lewis, B; Perry, E; Zhang, YX; Nico, L; Wan, JM; Chakravarthy, S; Shang, WF; Miao, Q; Stemmler, T; Yang, Z				Holcomb, Joshua; Doughan, Maysaa; Spellmon, Nicholas; Lewis, Brianne; Perry, Emerson; Zhang, Yingxue; Nico, Lindsey; Wan, Junmei; Chakravarthy, Srinivas; Shang, Weifeng; Miao, Qing; Stemmler, Timothy; Yang, Zhe			SAXS analysis of a soluble cytosolic NgBR construct including extracellular and transmembrane domains	PLOS ONE			English	Article							NOGO-B RECEPTOR; BIOLOGICAL MACROMOLECULES; MEMBRANE-PROTEINS; IDENTIFICATION; GLYCOSYLATION; ACTIVATION; TOPOLOGY; PROMOTES	The Nogo-B receptor (NgBR) is involved in oncogenic Ras signaling through directly binding to farnesylated Ras. It recruits farnesylated Ras to the non-lipid-raft membrane for interaction with downstream effectors. However, the cytosolic domain of NgBR itself is only partially folded. The lack of several conserved secondary structural elements makes this domain unlikely to form a complete farnesyl binding pocket. We find that inclusion of the extracellular and transmembrane domains that contain additional conserved residues to the cytosolic region results in a well folded protein with a similar size and shape to the E. coli cis-isoprenyl transferase (UPPs). Small Angle X-ray Scattering (SAXS) analysis reveals the radius of gyration (R-g) of our NgBR construct to be 18.2 A with a maximum particle dimension (D-max) of 61.0 A. Ab initio shape modeling returns a globular molecular envelope with an estimated molecular weight of 23.0 kD closely correlated with the calculated molecular weight. Both Kratky plot and pair distribution function of NgBR scattering reveal a bell shaped peak which is characteristic of a single globularly folded protein. In addition, circular dichroism (CD) analysis reveals that our construct has the secondary structure contents similar to the UPPs. However, this result does not agree with the currently accepted topological orientation of NgBR which might partition this construct into three separate domains. This discrepancy suggests another possible NgBR topology and lends insight into a potential molecular basis of how NgBR facilitates farnesylated Ras recruitment.	[Holcomb, Joshua; Doughan, Maysaa; Spellmon, Nicholas; Perry, Emerson; Zhang, Yingxue; Wan, Junmei; Yang, Zhe] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Lewis, Brianne; Nico, Lindsey; Stemmler, Timothy] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI USA; [Chakravarthy, Srinivas; Shang, Weifeng] IIT, Ctr Synchrotron Radiat Res & Instrumentat, Chicago, IL 60616 USA; [Chakravarthy, Srinivas; Shang, Weifeng] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA; [Miao, Qing] Med Coll Wisconsin, Dept Surg, Childrens Res Inst, Milwaukee, WI 53226 USA	Wayne State University; Wayne State University; Illinois Institute of Technology; Illinois Institute of Technology; Medical College of Wisconsin	Yang, Z (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	zyang@med.wayne.edu	Lewis, Brianne/AAU-5344-2021; Miao, Qing/K-3186-2019	Miao, Qing/0000-0002-3125-1238; Stemmler, Timothy/0000-0002-6298-088X; Lewis, Brianne/0000-0003-1584-6407	National Institutes of Health [GM103622, 1S100D018090-01, R01HL108938, R01DK112971]; T32 training grant [HL120822]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120822, R01HL108938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant number GM103622 (for access to the BioCAT beamline), 1S100D018090-01 (for use of the PILATUS-3-1M detector), R01HL108938 (to QM) and R01DK112971 (to QM) and T32 training grant HL120822 (to JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health grant number GM103622 (for access to the BioCAT beamline), 1S100D018090-01 (for use of the PILATUS-3-1M detector), R01HL108938 (to QM) and R01DK112971 (to QM) and T32 training grant HL120822 (to JH).	Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bogdanov M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404103; Dong CY, 2016, ONCOTARGET, V7, P8850, DOI 10.18632/oncotarget.7091; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Guo RT, 2005, J BIOL CHEM, V280, P20762, DOI 10.1074/jbc.M502121200; Harrison KD, 2011, EMBO J, V30, P2490, DOI 10.1038/emboj.2011.147; Harrison KD, 2009, CELL METAB, V10, P208, DOI 10.1016/j.cmet.2009.07.003; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Jiang YY, 2016, METHODS MOL BIOL, V1366, P207, DOI 10.1007/978-1-4939-3127-9_16; Li MF, 2007, BIOCHEM BIOPH RES CO, V360, P128, DOI 10.1016/j.bbrc.2007.06.031; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Park EJ, 2016, EMBO REP, V17, P167, DOI 10.15252/embr.201540789; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rana U, 2016, DEV BIOL, V410, P190, DOI 10.1016/j.ydbio.2015.12.023; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Schuldiner S, 2012, TRENDS BIOCHEM SCI, V37, P215, DOI 10.1016/j.tibs.2012.02.006; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Vitrac H, 2015, P NATL ACAD SCI USA, V112, P13874, DOI 10.1073/pnas.1512994112; Wang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078083; Zhao B, 2017, ONCOGENE, V36, P3406, DOI 10.1038/onc.2016.484; Zhao BF, 2010, BLOOD, V116, P5423, DOI 10.1182/blood-2010-02-271577	24	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191371	10.1371/journal.pone.0191371	http://dx.doi.org/10.1371/journal.pone.0191371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346419	gold, Green Submitted, Green Published			2022-12-27	WOS:000422749500045
J	Lin, W; McBroome, J; Rehman, M; Johnson, BR				Lin, Wei; McBroome, Jakob; Rehman, Mahwish; Johnson, Brian R.			Africanized bees extend their distribution in California	PLOS ONE			English	Article							APIS-MELLIFERA L.; HONEY-BEE; MITOCHONDRIAL-DNA; UNITED-STATES; HYMENOPTERA; APIDAE; IDENTIFICATION; POPULATIONS; BRAZIL; LIMITS	Africanized honey bees (Apis mellifera) arrived in the western hemisphere in the 1950s and quickly spread north reaching California in the 1990s. These bees are highly defensive and somewhat more difficult to manage for commercial purposes than the European honey bees traditionally kept. The arrival of these bees and their potentially replacing European bees over much of the state is thus of great concern. After a 25 year period of little systematic sampling, a recent small scale study found Africanized honey bees in the Bay Area of California, far north of their last recorded distribution. The purpose of the present study was to expand this study by conducting more intensive sampling of bees from across northern California. We found Africanized honey bees as far north as Napa and Sacramento. We also found Africanized bees in all counties south of these counties. Africanized honey bees were particularly abundant in parts of the central valley and Monterey. This work suggests the northern spread of Africanized honey bees may not have stopped. They may still be moving north at a slow rate, although due to the long gaps in sampling it is currently impossible to tell for certain. Future work should routinely monitor the distribution of these bees to distinguish between these two possibilities.	[Lin, Wei; McBroome, Jakob; Johnson, Brian R.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Rehman, Mahwish] Agr Res Inst, Dept Entomol, Peshawar, Pakistan	University of California System; University of California Davis	Johnson, BR (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.	brnjohnson@ucdavis.edu		McBroome, Jakob/0000-0002-5002-5156	University of California Agriculture and Natural Resources; Hatch grant [CA-D-ENM 2161-H]	University of California Agriculture and Natural Resources; Hatch grant	This work was funded by a grant from the University of California Agriculture and Natural Resources (Edwin C. Pohle Fund), and a Hatch grant to Brian Johnson (CA-D-ENM 2161-H).	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Clarke KE, 2002, EVOLUTION, V56, P1462; Collet T, 2006, HEREDITY, V97, P329, DOI 10.1038/sj.hdy.6800875; DeJong D, 1996, BEE WORLD, V77, P67, DOI 10.1080/0005772X.1996.11099289; Delaney DA, 2009, ANN ENTOMOL SOC AM, V102, P666, DOI 10.1603/008.102.0411; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; KERR WE, 1982, AM BEE J, V122, P196; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kono Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137407; Meixner MD, 1991, J APICULT RES, V52, P1; Nielsen DI, 2000, ANN ENTOMOL SOC AM, V93, P1, DOI 10.1603/0013-8746(2000)093[0001:IPCRBM]2.0.CO;2; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pinto MA, 2007, ANN ENTOMOL SOC AM, V100, P289, DOI 10.1603/0013-8746(2007)100[289:HBHAOA]2.0.CO;2; Pinto MA, 2003, ANN ENTOMOL SOC AM, V96, P679, DOI 10.1603/0013-8746(2003)096[0679:IOAHBH]2.0.CO;2; Rangel J, 2016, ECOL EVOL, V6, P2158, DOI 10.1002/ece3.1974; RINDERER TE, 1993, SCI AM, V269, P84, DOI 10.1038/scientificamerican1293-84; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; SCHUMACHER MJ, 1995, ARCH INTERN MED, V155, P2038, DOI 10.1001/archinte.155.19.2038; Seeley T.D., 1985, HONEY BEE ECOLOGY; Sheppard WS, 2000, ANN ENTOMOL SOC AM, V93, P159, DOI 10.1603/0013-8746(2000)093[0159:IOADBI]2.0.CO;2; TAYLOR OR, 1984, BEE WORLD, V65, P38, DOI 10.1080/0005772X.1984.11098769; Visscher P.K., 1997, CALIF AGR, V51, P22, DOI [10.3733/ca.v051n01p22, DOI 10.3733/CA.V051N01P22]; WINSTON ML, 1992, ANNU REV ENTOMOL, V37, P173, DOI 10.1146/annurev.en.37.010192.001133	24	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190604	10.1371/journal.pone.0190604	http://dx.doi.org/10.1371/journal.pone.0190604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346390	gold, Green Published, Green Submitted			2022-12-27	WOS:000422749500015
J	Ma, J; Zhou, P; Ahmad, B; Ren, GD; Wang, CN				Ma, Jun; Zhou, Ping; Ahmad, Bashir; Ren, Guodong; Wang, Chunni			Chaos and multi-scroll attractors in RCL-shunted junction coupled Jerk circuit connected by memristor	PLOS ONE			English	Article							NEURONAL NETWORK; SECURE COMMUNICATION; JOSEPHSON-JUNCTION; BACKSTEPPING DESIGN; NEURAL OSCILLATORS; DYNAMICAL-SYSTEMS; ELECTRIC-ACTIVITY; CANONIC MODELS; TIME-DELAY; SYNCHRONIZATION	In this paper, a new four-variable dynamical system is proposed to set chaotic circuit composed of memristor and Josephson junction, and the dependence of chaotic behaviors on nonlinearity is investigated. A magnetic flux-controlled memristor is used to couple with the RCL-shunted junction circuit, and the dynamical behaviors can be modulated by changing the coupling intensity between the memristor and the RCL-shunted junction. Bifurcation diagram and Lyapunov exponent are calculated to confirm the emergence of chaos in the improved dynamical system. The outputs and dynamical behaviors can be controlled by the initial setting and external stimulus as well. As a result, chaos can be suppressed and spiking occurs in the sampled outputs under negative feedback, while applying positive feedback type via memristor can be effective to trigger chaos. Furthermore, it is found that the number of multi-attractors in the Jerk circuit can be modulated when memristor coupling is applied on the circuit. These results indicate that memristor coupling can be effective to control chaotic circuits and it is also useful to reproduce dynamical behaviors for neuronal activities.	[Ma, Jun; Zhou, Ping] Chongqing Univ Posts & Telecommun, Sch Sci, Chongqing, Peoples R China; [Ma, Jun; Ren, Guodong; Wang, Chunni] Lanzhou Univ Technol, Dept Phys, Lanzhou, Gansu, Peoples R China; [Ahmad, Bashir] King Abdulaziz Univ, Dept Math, NAAM Res Grp, Jeddah, Saudi Arabia	Chongqing University of Posts & Telecommunications; Lanzhou University of Technology; King Abdulaziz University	Ma, J (corresponding author), Chongqing Univ Posts & Telecommun, Sch Sci, Chongqing, Peoples R China.; Ma, J (corresponding author), Lanzhou Univ Technol, Dept Phys, Lanzhou, Gansu, Peoples R China.	hyperchaos@163.com	Zhou, Ping/G-8298-2011; Wang, Chunni/J-2666-2012; Ahmad, Bashir/B-1977-2012; Ma, Jun/G-2376-2010	Zhou, Ping/0000-0002-9103-9546; Wang, Chunni/0000-0002-4688-7888; Ahmad, Bashir/0000-0001-5350-2977; Ma, Jun/0000-0002-6127-000X	National Natural Science Foundation of China [11672122, 11365014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is supported by National Natural Science Foundation of China under Grant Nos. 11672122 and 11365014. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkers JM, 2003, CURR BIOL, V13, pR433, DOI 10.1016/S0960-9822(03)00363-4; Biswas D, 2016, NONLINEAR DYNAM, V83, P2331, DOI 10.1007/s11071-015-2484-4; Boichenko V. A., 2005, DIMENSION THEORY ORD; Camara BI, 2016, PHYSICA A, V461, P374, DOI 10.1016/j.physa.2016.05.054; Chen G, 2017, INT J BIFURCAT CHAOS, V27, DOI 10.1142/S0218127417501152; Chen JX, 2018, COMMUN NONLINEAR SCI, V54, P202, DOI 10.1016/j.cnsns.2017.05.034; Chen P, 2016, NONLINEAR DYNAM, V86, P725, DOI 10.1007/s11071-016-2933-8; Christini DJ, 1996, PHYS REV E, V53, pR49, DOI 10.1103/PhysRevE.53.R49; Chua L, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S021812741230011X; Correia M J, 2010, INT J BIFURCAT CHAOS, V20, P2395; Crotty P, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011914; Fairhurst D, 2010, MATH MODEL NAT PHENO, V5, P146, DOI 10.1051/mmnp/20105206; Gambuzza LV, 2015, INT J BIFURCAT CHAOS, V25, DOI 10.1142/S0218127415501011; Guo SL, 2017, CHAOS SOLITON FRACT, V105, P120, DOI 10.1016/j.chaos.2017.10.019; Hao YH, 2010, NEUROCOMPUTING, V73, P2998, DOI 10.1016/j.neucom.2010.07.011; Hassan MF, 2016, NONLINEAR DYNAM, V83, P2183, DOI 10.1007/s11071-015-2474-6; Herrmann CS, 2004, INT J BIFURCAT CHAOS, V14, P623, DOI 10.1142/S0218127404009338; Itoh M, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413300012; Itoh M, 2008, INT J BIFURCAT CHAOS, V18, P3183, DOI 10.1142/S0218127408022354; Kawaguchi T., 2011, PHYSICA C, V471, P21; Khan M, 2015, NONLINEAR DYNAM, V82, P527, DOI 10.1007/s11071-015-2173-3; Kondo S, 2017, J THEOR BIOL, V414, P120, DOI 10.1016/j.jtbi.2016.11.003; Leonov GA, 2015, EUR PHYS J-SPEC TOP, V224, P1421, DOI 10.1140/epjst/e2015-02470-3; Li D, 2016, NEUROCOMPUTING, V216, P39, DOI 10.1016/j.neucom.2016.07.013; Li F, 2012, NONLINEAR DYNAM, V69, P2169, DOI 10.1007/s11071-012-0417-z; Li QD, 2015, NONLINEAR DYNAM, V79, P2295, DOI 10.1007/s11071-014-1812-4; Liu ST, 2014, NONLINEAR DYNAM, V76, P1087, DOI 10.1007/s11071-013-1192-1; Lu L, 2017, PHYSICA A, V469, P429, DOI 10.1016/j.physa.2016.11.093; Lv M, 2016, NONLINEAR DYNAM, V85, P1479, DOI 10.1007/s11071-016-2773-6; Lv M, 2016, NEUROCOMPUTING, V205, P375, DOI 10.1016/j.neucom.2016.05.004; Ma J, 2017, NONLINEAR DYNAM, V89, P1569, DOI 10.1007/s11071-017-3565-3; Ma J, 2017, CHAOS, V27, DOI 10.1063/1.4983469; Ma J, 2017, INT J MOD PHYS B, V31, DOI 10.1142/S0217979216502519; Ma J, 2017, APPL MATH COMPUT, V298, P65, DOI 10.1016/j.amc.2016.11.004; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; Ma J, 2015, CHAOS SOLITON FRACT, V80, P31, DOI 10.1016/j.chaos.2015.02.005; Ma J, 2015, NEUROCOMPUTING, V167, P378, DOI 10.1016/j.neucom.2015.04.056; Ma J, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979214502397; Ma J, 2014, NONLINEAR DYNAM, V76, P1951, DOI 10.1007/s11071-014-1260-1; Ma J, 2011, COMMUN NONLINEAR SCI, V16, P3770, DOI 10.1016/j.cnsns.2010.12.030; Ma J, 2010, APPL MATH COMPUT, V215, P3318, DOI 10.1016/j.amc.2009.10.020; Machura L, 2010, PHYSICA E, V42, P590, DOI 10.1016/j.physe.2009.06.062; Mengue AD, 2012, NONLINEAR DYNAM, V70, P1241, DOI 10.1007/s11071-012-0528-6; Mobayen S, 2017, ASIAN J CONTROL; Mobayen S, 2017, J VIB CONTROL, V23, P2912, DOI 10.1177/1077546315623887; Mobayen S, 2016, COMPLEXITY, V21, P14, DOI 10.1002/cplx.21624; Mofid O, 2017, J VIBRATION CONTROL; Muthuswamy B, 2009, IETE TECH REV, V26, P417, DOI 10.4103/0256-4602.57827; Nakata M, 1999, CHALLENGES FOR THE 21ST CENTURY, VOL I, P113; Nazzal JM, 2007, CHAOS SOLITON FRACT, V33, P695, DOI 10.1016/j.chaos.2006.01.071; Njah AN, 2010, PHYSICA C, V470, P558, DOI 10.1016/j.physc.2010.05.009; Pogromsky A, 1999, INT J BIFURCAT CHAOS, V9, P629, DOI 10.1142/S0218127499000444; PYRAGAS K, 1993, PHYS LETT A, V180, P99, DOI 10.1016/0375-9601(93)90501-P; Ren GD, 2015, ACTA PHYS SIN-CH ED, V64, DOI 10.7498/aps.64.058702; Ren GD, 2017, NONLINEAR DYNAM, V88, P893, DOI 10.1007/s11071-016-3283-2; Savi MA, 2002, INT J BIFURCAT CHAOS, V12, P645, DOI 10.1142/S0218127402004607; Shi XR, 2012, NONLINEAR DYNAM, V69, P1177, DOI 10.1007/s11071-012-0339-9; Song XL, 2015, SCI CHINA TECHNOL SC, V58, P1007, DOI 10.1007/s11431-015-5826-z; Sprott JC, 2000, PHYS LETT A, V266, P19, DOI 10.1016/S0375-9601(00)00026-8; Sprott JC, 2000, AM J PHYS, V68, P758, DOI 10.1119/1.19538; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Tavazoei MS, 2008, PHYS LETT A, V372, P798, DOI 10.1016/j.physleta.2007.08.040; Tyukin I, 2010, INT J NEURAL SYST, V20, P193, DOI 10.1142/S0129065710002358; Ucar A, 2007, CHAOS SOLITON FRACT, V31, P105, DOI 10.1016/j.chaos.2005.09.035; Vincent UE, 2008, PHYSICA C, V468, P374, DOI 10.1016/j.physc.2007.11.012; Vincent UE, 2007, PHYSICA D, V231, P130, DOI 10.1016/j.physd.2007.04.003; Wang CN, 2012, DYNAM SYST, V27, P253, DOI 10.1080/14689367.2012.667788; Wang CN, 2018, INT J MOD PHYS B, V32, DOI 10.1142/S0217979218300037; Wang CN, 2017, COMPLEXITY, DOI 10.1155/2017/5436737; Wang CN, 2015, COMPLEXITY, V21, P370, DOI 10.1002/cplx.21572; Wang CN, 2014, COMPLEXITY, V20, P64, DOI 10.1002/cplx.21497; Wang GP, 2015, NONLINEAR DYNAM, V81, P1453, DOI 10.1007/s11071-015-2080-7; Wang HT, 2014, CHAOS, V24, DOI 10.1063/1.4892769; Wang Y, 2017, NONLINEAR DYNAM, V89, P1967, DOI 10.1007/s11071-017-3564-4; Whan CB, 1996, PHYS REV E, V53, P405, DOI 10.1103/PhysRevE.53.405; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Wu FQ, 2017, PHYSICA A, V469, P81, DOI 10.1016/j.physa.2016.11.056; Wu FQ, 2016, SCI REP-UK, V6, DOI 10.1038/s41598-016-0031-2; Xiao WW, 2016, SCI CHINA TECHNOL SC, V59, P1943, DOI 10.1007/s11431-016-6046-x; Xu Y, 2017, CHAOS SOLITON FRACT, V104, P435, DOI 10.1016/j.chaos.2017.09.002; Yang XS, 2006, CHAOS SOLITON FRACT, V27, P25, DOI 10.1016/j.chaos.2005.04.017; Yu HT, 2013, NEUROCOMPUTING, V99, P178, DOI 10.1016/j.neucom.2012.03.019; Yu WT, 2016, EPL-EUROPHYS LETT, V114, DOI 10.1209/0295-5075/114/50006; Yuan F, 2016, INT J BIFURCAT CHAOS, V26, DOI 10.1142/S0218127416501303; Zhang QY, 2014, NONLINEAR DYNAM, V78, P1489, DOI 10.1007/s11071-014-1530-y; Zheng QQ, 2015, COMPUT MATH APPL, V70, P1082, DOI 10.1016/j.camwa.2015.06.031; Zhou L, 2016, NONLINEAR DYNAM, V85, P2653, DOI 10.1007/s11071-016-2852-8	87	45	46	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191120	10.1371/journal.pone.0191120	http://dx.doi.org/10.1371/journal.pone.0191120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342178	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800047
J	Nugroho, A; Erasmus, V; Coulter, RWS; Koirala, S; Nampaisan, O; Pamungkas, W; Richardus, JH				Nugroho, Adi; Erasmus, Vicki; Coulter, Robert W. S.; Koirala, Sushil; Nampaisan, Oranuch; Pamungkas, Wirastra; Richardus, Jan Hendrik			Driving factors of retention in care among HIV-positive MSM and transwomen in Indonesia: A cross-sectional study	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT ACCESS; TRANSGENDER WOMEN; VIRAL LOAD; HEALTH INFORMATION; INTERNET USE; SEX; MEN; TREAT; ENGAGEMENT; PREVENTION	Little is known about the prevalence of and factors that influence retention in HIV-related care among Indonesian men who have sex with men (MSM) and transgender women (trans women, or waria in Indonesian term). Therefore, we explored the driving factors of retention in care among HIV-positive MSM and waria in Indonesia. This cross-sectional study involved 298 self-reported HIV-positive MSM (n = 165) and waria (n = 133). Participants were recruited using targeted sampling and interviewed using a structured questionnaire. We applied a four-step model building process using multivariable logistic regression to examine how sociodemographic, predisposing, enabling, and reinforcing factors were associated with retention in care. Overall, 78.5% of participants were linked to HIV care within 3 months after diagnosis or earlier, and 66.4% were adequately retained in care (at least one health care visit every three months once a person is diagnosed with HIV). Being on antiretroviral therapy (adjusted odds ratio [AOR] = 6.00; 95% confidence interval [CI]: 2.93-12.3), using the Internet to find HIV-related information (AOR = 2.15; 95% CI: 1.00-4.59), and having medical insurance (AOR = 2.84; 95% CI: 1.27-6.34) were associated with adequate retention in care. Involvement with an HIV-related organization was associated negatively with retention in care (AOR = 0.47; 95% CI: 0.24-0.95). Future interventions should increase health insurance coverage and utilize the Internet to help MSM and waria to remain in HIV-related care, thereby assisting them in achieving viral suppression.	[Nugroho, Adi; Erasmus, Vicki; Richardus, Jan Hendrik] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Nugroho, Adi] Lambung Mangkurat Univ, Sch Publ Hlth, Med Fac, Banjarbaru, Indonesia; [Nugroho, Adi; Pamungkas, Wirastra] GWL INA Network, Jakarta, Indonesia; [Coulter, Robert W. S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA; [Coulter, Robert W. S.] Univ Pittsburgh, Grad Sch Publ Hlth, Ctr LGBT Hlth Res, Pittsburgh, PA USA; [Koirala, Sushil; Nampaisan, Oranuch] Asia Pacific Network People Living HIV AIDS, Bangkok, Thailand	Erasmus University Rotterdam; Erasmus MC; Universitas Lambung Mangkurat; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nugroho, A (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.; Nugroho, A (corresponding author), Lambung Mangkurat Univ, Sch Publ Hlth, Med Fac, Banjarbaru, Indonesia.; Nugroho, A (corresponding author), GWL INA Network, Jakarta, Indonesia.	a.nugroho@erasmusmc.nl	Richardus, Jan Hendrik/AAE-1278-2021; Coulter, Robert WS/H-4532-2019	Richardus, Jan Hendrik/0000-0003-0564-6313; Coulter, Robert WS/0000-0001-8350-0075; Nugroho, Adi/0000-0002-6717-5740	Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) round 10 grant for Asia & the Pacific through Monitoring Treatment Access (MATA) Project; National Institute on Drug Abuse [F31DA037647]	Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) round 10 grant for Asia & the Pacific through Monitoring Treatment Access (MATA) Project; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was made possible with support from the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) round 10 grant for Asia & the Pacific through Monitoring Treatment Access (MATA) Project. Robert W.S. Coulter's contribution in this manuscript was also supported by the National Institute on Drug Abuse (award F31DA037647 at the National Institutes of Health (NIH). The opinions expressed in this work are those of the authors and do not necessarily represent those of our funders. The funders had no role in study design, data analysis, or preparation of the manuscript.	AIDS Data Hub, 2014, COUNTR PROF IND HIV; Alliance China, COMM RESP HIV MEN WH; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2009, ENS UN ACC COMPR HIV; Ayala G, 2014, J AIDS CLIN RES, V5, P8, DOI DOI 10.4172/2155-6113.1000331; Belzer ME, 2014, AIDS BEHAV, V18, P686, DOI 10.1007/s10461-013-0661-3; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Brennan A, 2015, AIDS BEHAV, V19, P104, DOI 10.1007/s10461-014-0814-z; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Chakrapani V, 2014, AIDS CARE, V26, P835, DOI 10.1080/09540121.2013.861573; Chakrapani V, 2011, AIDS CARE, V23, P1687, DOI 10.1080/09540121.2011.582076; Chow JY, 2016, INT J STD AIDS, V27, P1039, DOI 10.1177/0956462416645727; Christopoulos KA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0718-6; Christopoulos KA, 2011, CLIN INFECT DIS, V52, pS214, DOI 10.1093/cid/ciq045; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dabis F, 2014, LANCET GLOB HEALTH, V2, pE2, DOI 10.1016/S2214-109X(13)70178-5; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Glanz K, 1995, 053896 NIH; Gurol-Urganci I, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007458.pub3; Halkitis PN, 2014, AIDS CARE, V26, P1426, DOI 10.1080/09540121.2014.921276; Hallett TB, 2013, JAIDS-J ACQ IMM DEF, V63, pS228, DOI 10.1097/QAI.0b013e318298721b; Harper GW, 2013, AIDS BEHAV, V17, P213, DOI 10.1007/s10461-011-0071-3; Horvath KJ, 2012, AIDS BEHAV, V16, P900, DOI 10.1007/s10461-012-0164-7; Horvath KJ, 2009, AIDS PATIENT CARE ST, V23, P1033, DOI 10.1089/apc.2009.0163; Hussen SA, 2015, AIDS PATIENT CARE ST, V29, P77, DOI 10.1089/apc.2014.0117; Kalichman SC, 2002, PATIENT EDUC COUNS, V46, P109, DOI 10.1016/S0738-3991(01)00134-3; Kalichman SC, 2002, AIDS EDUC PREV, V14, P51, DOI 10.1521/aeap.14.1.51.24335; Kohut A., 2013, GLOBAL DIVIDE HOMOSE; Lessells RJ, 2011, JAIDS-J ACQ IMM DEF, V56, pE79, DOI 10.1097/QAI.0b013e3182075ae2; Maek-a-nantawat W, 2014, AIDS CARE, V26, P1298, DOI 10.1080/09540121.2014.911810; Mbuagbaw L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0654-6; Ministry of Health of the Republic of Indonesia, 2011, CARD DIS RISK FACT C, V1; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; National AIDS Commission of Indonesia, 2014, GLOB AIDS RESP PROGR; Parchure R, 2015, AIDS CARE, V27, P716, DOI 10.1080/09540121.2014.996518; Perera AI, 2014, AIDS PATIENT CARE ST, V28, P579, DOI 10.1089/apc.2014.0156; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Santos GM, 2014, SEX TRANSM INFECT, V90, P430, DOI 10.1136/sextrans-2013-051342; Schwarcz S, 2011, AIDS CARE, V23, P892, DOI 10.1080/09540121.2010.534436; Sevelius JM, 2014, AIDS CARE, V26, P976, DOI 10.1080/09540121.2014.896451; Sevelius JM, 2014, ANN BEHAV MED, V47, P5, DOI 10.1007/s12160-013-9565-8; Stricker SM, 2014, AIDS BEHAV, V18, pS465, DOI 10.1007/s10461-013-0598-6; Tominari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069603; Udeagu CCN, 2013, AIDS, V27, P2271, DOI 10.1097/QAD.0b013e328362fdde; van der Kop ML, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003155; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070; Wei CY, 2014, AIDS CARE, V26, P372, DOI 10.1080/09540121.2013.824538; Wohl AR, 2011, AIDS BEHAV, V15, P1098, DOI 10.1007/s10461-010-9833-6; Wong NS, 2017, AIDS BEHAV; World Health Organization, 2010, ANT THER HIV INF AD; Yang GLL, 2015, ASIA-PAC J PUBLIC HE, V27, p86S, DOI 10.1177/1010539514548758; Yehia BR, 2013, CLIN INFECT DIS, V57, P774, DOI 10.1093/cid/cit363; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	55	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191255	10.1371/journal.pone.0191255	http://dx.doi.org/10.1371/journal.pone.0191255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8II	29342172	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800056
J	Vicari, S; Piccini, G; Mercuri, E; Battini, R; Chieffo, D; Bulgheroni, S; Pecini, C; Lucibello, S; Lenzi, S; Moriconi, F; Pane, M; D'Amico, A; Astrea, G; Baranello, G; Riva, D; Cioni, G; Alfieri, P				Vicari, Stefano; Piccini, Giorgia; Mercuri, Eugenio; Battini, Roberta; Chieffo, Daniela; Bulgheroni, Sara; Pecini, Chiara; Lucibello, Simona; Lenzi, Sara; Moriconi, Federica; Pane, Marika; D'Amico, Adele; Astrea, Guja; Baranello, Giovanni; Riva, Daria; Cioni, Giovanni; Alfieri, Paolo			Implicit learning deficit in children with Duchenne muscular dystrophy: Evidence for a cerebellar cognitive impairment?	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; PARKINSONS-DISEASE; BRAIN; DISORDER; LESIONS; PET; LOCALIZATION; ATTENTION; NETWORKS; ABILITY	This study aimed at comparing implicit sequence learning in individuals affected by Duchenne Muscular Dystrophy without intellectual disability and age-matched typically developing children. A modified version of the Serial Reaction Time task was administered to 32 Duchenne children and 37 controls of comparable chronological age. The Duchenne group showed a reduced rate of implicit learning even if in the absence of global intellectual disability. This finding provides further evidence of the involvement of specific aspects of cognitive function in Duchenne muscular dystrophy and on its possible neurobiological substrate.	[Vicari, Stefano; Piccini, Giorgia; Alfieri, Paolo] Bambino Gesu Pediat Hosp, IRCCS, Child Neuropsychiat Unit, Dept Neurosci, Rome, Italy; [Mercuri, Eugenio; Chieffo, Daniela; Lucibello, Simona; Moriconi, Federica; Pane, Marika] Catholic Univ, Pediat Neurol Unit, Rome, Italy; [Mercuri, Eugenio; Chieffo, Daniela; Lucibello, Simona; Moriconi, Federica; Pane, Marika] Nemo Ctr, Rome, Italy; [Battini, Roberta; Pecini, Chiara; Lenzi, Sara; Astrea, Guja; Cioni, Giovanni] IRCCS Stella Maris, Dept Dev Neurosci, Pisa, Italy; [Battini, Roberta; Cioni, Giovanni] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Bulgheroni, Sara; Baranello, Giovanni; Riva, Daria] IRCCS Fdn Ist Neurol C Besta, Dev Neurol Div, Milan, Italy; [D'Amico, Adele] Bambino Gesu Pediat Hosp, IRCCS, Dept Neurosci, Neuromuscular & Neurodegenerat Dis Unit, Rome, Italy	IRCCS Bambino Gesu; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Fondazione Stella Maris; University of Pisa; IRCCS Bambino Gesu	Alfieri, P (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Child Neuropsychiat Unit, Dept Neurosci, Rome, Italy.	paolo.alfieri@opbg.net	Astrea, Guja/F-8960-2019; battini, roberta/P-9095-2017; Lucibello, Simona/AAB-6848-2022; Lenzi, Sara/AAB-6181-2020; Cioni, Giovanni/A-4178-2015; Astrea, Guja/K-7339-2014; Vicari, Stefano/J-3008-2012; Pecini, Chiara/AAD-7805-2021; Bulgheroni, Sara/AAV-2402-2021; Mercuri, Eugenio/G-1351-2015	Astrea, Guja/0000-0001-8588-0323; battini, roberta/0000-0002-7889-1355; Lucibello, Simona/0000-0003-0970-5755; Lenzi, Sara/0000-0002-5740-2831; Cioni, Giovanni/0000-0002-6526-5566; Astrea, Guja/0000-0001-8588-0323; Bulgheroni, Sara/0000-0002-0905-8810; PECINI, CHIARA/0000-0002-7857-7884; Pane, Marika/0000-0002-4851-6124; Mercuri, Eugenio/0000-0002-9851-5365				Astrea G, 2015, RES DEV DISABIL, V45-46, P168, DOI 10.1016/j.ridd.2015.07.025; Battini R, 2018, NEUROMUSCUL IN PRESS; Billard C, 1998, DEV MED CHILD NEUROL, V40, P12, DOI 10.1111/j.1469-8749.1998.tb15351.x; Bodranghien F, 2016, CEREBELLUM, V15, P369, DOI 10.1007/s12311-015-0687-3; Colombo P, 2017, EUR J PAEDIATR NEURO, V21, P639, DOI 10.1016/j.ejpn.2017.02.007; Cyrulnik SE, 2008, NEUROSCI BIOBEHAV R, V32, P486, DOI 10.1016/j.neubiorev.2007.09.001; D'Angelo MG, 2011, PEDIATR NEUROL, V45, P292, DOI 10.1016/j.pediatrneurol.2011.08.003; Daoud F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006574; Daoud F, 2009, HUM MOL GENET, V18, P3779, DOI 10.1093/hmg/ddp320; Doyon J, 1996, EUR J NEUROSCI, V8, P637, DOI 10.1111/j.1460-9568.1996.tb01249.x; De Moura MCDS, 2010, DEV MED CHILD NEUROL, V52, pe10, DOI 10.1111/j.1469-8749.2009.03540.x; Exner C, 2002, LEARN MEMORY, V9, P376, DOI 10.1101/lm.48402; Ferrucci R, 2013, CEREBELLUM, V12, P485, DOI 10.1007/s12311-012-0436-9; Gomez-Beldarrain M, 1998, EXP BRAIN RES, V120, P25, DOI 10.1007/s002210050374; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; HODGSON SV, 1992, NEUROMUSCULAR DISORD, V2, P269, DOI 10.1016/0960-8966(92)90059-F; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; HUARD J, 1992, NEUROSCI LETT, V137, P105, DOI 10.1016/0304-3940(92)90309-U; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; KIM TW, 1995, ANN NEUROL, V38, P446, DOI 10.1002/ana.410380315; KIM TW, 1992, P NATL ACAD SCI USA, V89, P11642, DOI 10.1073/pnas.89.23.11642; Leggio M, 2015, CEREBELLUM, V14, P35, DOI 10.1007/s12311-014-0616-x; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; Magri F, 2011, J NEUROL, V258, P1610, DOI 10.1007/s00415-011-5979-z; Menghini D, 2006, NEUROIMAGE, V33, P1218, DOI 10.1016/j.neuroimage.2006.08.024; Moizard MP, 1998, AM J MED GENET, V80, P32, DOI 10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y; Molinari M, 1997, BRAIN, V120, P1753, DOI 10.1093/brain/120.10.1753; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Pane M, 2012, J PEDIATR-US, V161, P705, DOI 10.1016/j.jpeds.2012.03.020; PASCUALLEONE A, 1993, ANN NEUROL, V34, P594, DOI 10.1002/ana.410340414; Piccini G, 2015, RES DEV DISABIL, V36, P55, DOI 10.1016/j.ridd.2014.09.021; Quintero-Gallego E.A., 2006, BEHAV BRAIN FUNCT, V2, P1; Rauch SL, 1997, J NEUROPSYCH CLIN N, V9, P568; RAUCH SL, 1995, COMPR PSYCHIAT, V36, P141, DOI 10.1016/S0010-440X(95)90109-4; Ricotti V, 2011, DEV MED CHILD NEUROL, V53, P12, DOI 10.1111/j.1469-8749.2010.03836.x; Riva D, 1998, CORTEX, V34, P279, DOI 10.1016/S0010-9452(08)70755-X; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Schara U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126528; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shin JC, 2003, J COGNITIVE NEUROSCI, V15, P1232, DOI 10.1162/089892903322598175; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Taylor PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008803; TINSLEY JM, 1993, CURR OPIN GENET DEV, V3, P484, DOI 10.1016/0959-437X(93)90124-8; Torriero S, 2007, NEUROPSYCHOLOGIA, V45, P1208, DOI 10.1016/j.neuropsychologia.2006.10.007; Tzvi E, 2015, NEUROIMAGE, V122, P52, DOI 10.1016/j.neuroimage.2015.07.077; Vicari S, 2007, J INTELL DISABIL RES, V51, P932, DOI 10.1111/j.1365-2788.2007.01003.x; Vicari S, 2005, J NEUROL NEUROSUR PS, V76, P1392, DOI 10.1136/jnnp.2004.061093; Vicari S, 2001, NEUROPSYCHOLOGIA, V39, P665, DOI 10.1016/S0028-3932(01)00012-4; Vicari S, 2000, NEUROPSYCHOLOGIA, V38, P240, DOI 10.1016/S0028-3932(99)00081-0	50	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191164	10.1371/journal.pone.0191164	http://dx.doi.org/10.1371/journal.pone.0191164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338029	Green Published, gold			2022-12-27	WOS:000422652700034
J	Xie, JF; Robertson, JM; Chen, CW; Zhang, WX; Coopersmith, CM; Ford, ML				Xie, Jianfeng; Robertson, Jennifer M.; Chen, Ching-wen; Zhang, Wenxiao; Coopersmith, Craig M.; Ford, Mandy L.			Pre-existing malignancy results in increased prevalence of distinct populations of CD4(+)T cells during sepsis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; REGULATORY T-CELLS; INFILTRATING LYMPHOCYTES; INHIBITORY RECEPTORS; IMPROVES SURVIVAL; PROGNOSTIC VALUE; CANCER-PATIENTS; SEPTIC SHOCK; MORTALITY; PD-1	The presence of pre-existing malignancy in murine hosts results in increased immune dys-regulation and risk of mortality following a septic insult. Based on the known systemic immunologic changes that occur in cancer hosts, we hypothesized that the presence of preexisting malignancy would result in phenotypic and functional changes in CD4(+)T cell responses following sepsis. In order to conduct a non-biased, unsupervised analysis of phenotypic differences between CD4(+)T cell compartments, cohorts of mice were injected with LLC1 tumor cells and tumors were allowed to grow for 3 weeks. These cancer hosts and age-matched non-cancer controls were then subjected to CLP. Splenocytes were harvested at 24h post CLP and flow cytometry and SPADE (Spanning-tree Progression Analysis of Density-normalized Events) were used to analyze populations of CD4(+) cells most different between the two groups. Results indicated that relative to non-cancer controls, cancer mice contained more resting memory CD4(+)T cells, more activated CD4(+) effectors, and fewer naive CD4(+)T cells during sepsis, suggesting that the CD4(+) T cell compartment in cancer septic hosts is one of increased activation and differentiation. Moreover, cancer septic animals exhibited expansion of two distinct subsets of CD4(+) T cells relative to previously healthy septic controls. Specifically, we identified increases in both a PD-1(hi) population and a distinct 2B4(hi) BTLA(hi) LAG-3(hi) population in cancer septic animals. By combining phenotypic analysis of exhaustion markers with functional analysis of cytokine production, we found that PD-1(+) CD4(+) cells in cancer hosts failed to make any cytokines following CLP, while the 2B4(+)PD-1(lo) cells in cancer mice secreted increased TNF during sepsis. In sum, the immunophenotypic landscape of cancer septic animals is characterized by both increased CD4(+)T cell activation and exhaustion, findings that may underlie the observed increased mortality in mice with pre-existing malignancy following sepsis.	[Xie, Jianfeng; Robertson, Jennifer M.; Chen, Ching-wen; Zhang, Wenxiao; Coopersmith, Craig M.; Ford, Mandy L.] Emory Univ, Dept Surg, Atlanta, GA 30322 USA	Emory University	Ford, ML (corresponding author), Emory Univ, Dept Surg, Atlanta, GA 30322 USA.	mandy.ford@emory.edu	Chen, Ching-wen/ABH-8484-2020	Robertson, Jennifer/0000-0002-1613-0091	National Institutes of Health grants [GM104323, GM109779, GM113228, GM072808, GM095442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072808, R01GM113228, T32GM095442, R01GM104323, R01GM109779] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health grants GM104323, GM109779, and GM113228 (to MLF and CMC), GM072808 and GM095442 (to CMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Chang K, 2014, CRIT CARE, V18, DOI 10.1186/cc13176; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; Chang KY, 2013, J BIOMED SCI, V20, DOI [10.1186/1423-0127-20-43, 10.5953/JMJH.2013.20.1.1]; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Danai PA, 2006, CHEST, V129, P1432, DOI 10.1378/chest.129.6.1432; de Montmollin E, 2013, SHOCK, V39, P250, DOI 10.1097/SHK.0b013e3182866d32; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Fabre J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091433; Fan J, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/8596181; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Fourcade J, 2012, CANCER RES, V72, P887, DOI 10.1158/0008-5472.CAN-11-2637; Fox AC, 2011, J IMMUNOL, V187, P1950, DOI 10.4049/jimmunol.1003391; Fox AC, 2010, CRIT CARE MED, V38, P886, DOI 10.1097/CCM.0b013e3181c8fdb1; Gao DN, 2015, INT J CLIN EXP MED, V8, P18998; Goyert SM, 2010, J LEUKOCYTE BIOL, V88, P225, DOI 10.1189/jlb.0410240; Grau GE, 1997, NAT MED, V3, P1193, DOI 10.1038/nm1197-1193; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Lyons JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149069; Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733; Mittal R, 2015, J SURG RES, V195, P541, DOI 10.1016/j.jss.2015.02.004; Molinaro R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133227; Monaghan SF, 2012, SHOCK, V38, P117, DOI 10.1097/SHK.0b013e31825de6a3; Monaghan SF, 2012, ANN SURG, V255, P158, DOI 10.1097/SLA.0b013e31823433ca; Monneret G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1370-x; Nair JR, 2011, J IMMUNOL, V187, P1243, DOI 10.4049/jimmunol.1100016; Patera AC, 2016, J LEUKOC BIOL; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Remick DG, 2005, INFECT IMMUN, V73, P2751, DOI 10.1128/IAI.73.5.2751-2757.2005; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Rhee C, 2017, JAMA; Rosolem MM, 2012, J CRIT CARE, V27, P301, DOI 10.1016/j.jcrc.2011.06.014; Safdar A, 2001, CRIT CARE CLIN, V17, P531, DOI 10.1016/S0749-0704(05)70198-6; Serbanescu MA, 2016, J LEUKOC BIOL; Shang B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15179; Shubin NJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13131; Shubin NJ, 2012, J LEUKOCYTE BIOL, V92, P593, DOI 10.1189/jlb.1211641; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Stieglitz D, 2015, IMMUN INFLAMM DIS, V3, P374, DOI 10.1002/iid3.75; Tang LX, 2014, J LEUKOCYTE BIOL, V96, P809, DOI 10.1189/jlb.4MA1213-647RR; Torres VBL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164537; Torres VBL, 2015, ANN AM THORAC SOC, V12, P1185, DOI 10.1513/AnnalsATS.201501-046OC; Wang F, 2016, AM J PHYSIOL-GASTR L, V311, pG237, DOI 10.1152/ajpgi.00371.2015; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Williams MD, 2004, CRIT CARE, V8, pR291, DOI 10.1186/cc2893; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Young JS, 2016, SHOCK, V45, P534, DOI 10.1097/SHK.0000000000000553	54	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191065	10.1371/journal.pone.0191065	http://dx.doi.org/10.1371/journal.pone.0191065			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338031	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700029
J	Friedlander, AM; Ballesteros, E; Bell, TW; Giddens, J; Henning, B; Hune, M; Munoz, A; Salinas-de-Leon, P; Sala, E				Friedlander, Alan M.; Ballesteros, Enric; Bell, Tom W.; Giddens, Jonatha; Henning, Brad; Hune, Mathias; Munoz, Alex; Salinas-de-Leon, Pelayo; Sala, Enric			Marine biodiversity at the end of the world: Cape Horn and Diego Ramirez islands	PLOS ONE			English	Article							SALMON ONCORHYNCHUS-TSHAWYTSCHA; KELP MACROCYSTIS-PYRIFERA; TIERRA-DEL-FUEGO; GIANT-KELP; ENVIRONMENTAL CONTROLS; SOUTH-AMERICA; SEA OTTERS; CHILE; PATTERNS; MAGELLAN	The vast and complex coast of the Magellan Region of extreme southern Chile possesses a diversity of habitats including fjords, deep channels, and extensive kelp forests, with a unique mix of temperate and sub-Antarctic species. The Cape Horn and Diego Ramirez archipelagos are the most southerly locations in the Americas, with the southernmost kelp forests, and some of the least explored places on earth. The giant kelp Macrocystis pyrifera plays a key role in structuring the ecological communities of the entire region, with the large brown seaweed Lessonia spp. forming dense understories. Kelp densities were highest around Cape Horn, followed by Diego Ramirez, and lowest within the fjord region of Francisco Coloane Marine Park (mean canopy densities of 2.51 kg m(-2), 2.29 kg m(-2), and 2.14 kg m(-2), respectively). There were clear differences in marine communities among these sub-regions, with the lowest diversity in the fjords. We observed 18 species of nearshore fishes, with average species richness nearly 50% higher at Diego Ramirez compared with Cape Horn and Francisco Coloane. The number of individual fishes was nearly 10 times higher at Diego Ramirez and 4 times higher at Cape Horn compared with the fjords. Drop-cam surveys of mesophotic depths (53 +/- 105 m) identified 30 taxa from 25 families, 15 classes, and 7 phyla. While much of these deeper habitats consisted of soft sediment and cobble, in rocky habitats, echinoderms, mollusks, bryozoans, and sponges were common. The southern hagfish (Myxine australis) was the most frequently encountered of the deep-sea fishes (50% of deployments), and while the Fueguian sprat (Sprattus fuegensis) was the most abundant fish species, its distribution was patchy. The Cape Horn and Diego Ramirez archipelagos represent some of the last intact sub-Antarctic ecosystems remaining and a recently declared large protected area will help ensure the health of this unique region.	[Friedlander, Alan M.; Munoz, Alex; Salinas-de-Leon, Pelayo; Sala, Enric] Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA; [Friedlander, Alan M.; Giddens, Jonatha] Univ Hawaii, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Ballesteros, Enric] CSIC, Ctr Estudis Avancats CEAB, Blanes, Spain; [Bell, Tom W.] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA; [Henning, Brad] Natl Geog Soc, Remote Imaging Team, Washington, DC USA; [Hune, Mathias] Fdn Ictiol, Santiago, Chile; [Salinas-de-Leon, Pelayo] Charles Darwin Res Stn, Puerto Ayora, Galapagos Islan, Ecuador	National Geographic Society; University of Hawaii System; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of California System; University of California Los Angeles; National Geographic Society	Friedlander, AM (corresponding author), Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA.; Friedlander, AM (corresponding author), Univ Hawaii, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA.	alan.friedlander@hawaii.edu	Bell, Tom/AAD-2551-2020; Hüne, Mathias/ABE-6000-2020		Brooks Foundation; Keith Campbell Foundation for the Environment; Case Foundation; Leonardo DiCaprio Foundation; Davidoff; Don Quixote Foundation; Roger and Rosemary Enrico Foundation; Helmsley Charitable Trust; Lindblad Expeditions-National Geographic Fund; Philip Stephenson Foundation; Vicki and Roger Sant; Waitt Foundation; National Geographic Society; Chilean Navy; Tercera Zona Naval; Governor Jorge Flies of the Magellan and Chilean Antarctic Region	Brooks Foundation; Keith Campbell Foundation for the Environment; Case Foundation; Leonardo DiCaprio Foundation; Davidoff; Don Quixote Foundation; Roger and Rosemary Enrico Foundation; Helmsley Charitable Trust; Lindblad Expeditions-National Geographic Fund; Philip Stephenson Foundation; Vicki and Roger Sant; Waitt Foundation; National Geographic Society(National Geographic Society); Chilean Navy; Tercera Zona Naval; Governor Jorge Flies of the Magellan and Chilean Antarctic Region	We received funding from The Brooks Foundation, The Keith Campbell Foundation for the Environment, The Case Foundation, Leonardo DiCaprio Foundation, Davidoff, The Don Quixote Foundation, Roger and Rosemary Enrico Foundation, Helmsley Charitable Trust, Lindblad Expeditions-National Geographic Fund, Philip Stephenson Foundation, Vicki and Roger Sant, The Waitt Foundation, and The National Geographic Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Chilean Navy for sponsoring this expedition, especially to Commander Andres Rodrigo for advice and guidance in planning, as well as the support provided by the Tercera Zona Naval. We would also like to express our gratitude for the support provided by Governor Jorge Flies of the Magellan and Chilean Antarctic Region, along with the Minister of the Environment Marcelo Mena, the former Minister of the Environment Pablo Badenier, and Alejandra Figueroa, the director of the Natural Resources and Biodiversity Division. Additionally, we would like to acknowledge and thank the captain and crew of the M/Y Plan B and the Waitt Foundation for providing the platform for this expedition, as well as their tirelessly work to help make the expedition a success. Finally, we wish to thank and congratulate the President of Chile, Michelle Bachelet, for her leadership in the conservation of Chile's ocean and in her decision to protect the waters around Cabo de Hornos and Diego Ramirez islands to the southern end of the zone economic zone of Chile.	Acevedo J, 2007, MAR MAMMAL SCI, V23, P453, DOI 10.1111/j.1748-7692.2007.00116.x; Aguayo-Lobo A, 2008, REV BIOL MAR OCEANOG, V43, P653; Fernandez DA, 2010, BIOL INVASIONS, V12, P2991, DOI 10.1007/s10530-010-9731-x; Alheit J, 2012, HAKE BIOL FISHERIES; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Antezana T, 1999, SCI MAR, V63, P23, DOI 10.3989/scimar.1999.63s123; Arkema KK, 2009, ECOLOGY, V90, P3126, DOI 10.1890/08-1213.1; Asche F, 1986, JPN J ICHTHYOL; Bell TW, 2015, J BIOGEOGR, V42, P2010, DOI 10.1111/jbi.12550; Bell TW, 2015, REMOTE SENS ENVIRON, V167, P218, DOI 10.1016/j.rse.2015.05.003; Bernstein WJ, 2009, SPLENDID EXCHANGE TR; Boswall J, 1975, BIOL PENGUINS, P271; Buschmann AH, 1995, THESIS; Buschmann AH, 2009, OCEAN COAST MANAGE, V52, P243, DOI 10.1016/j.ocecoaman.2009.03.002; Callicott JB, 2007, PHILOS T R SOC B, V362, P321, DOI 10.1098/rstb.2006.1989; Canete JI, 2017, LAT AM J AQUAT RES, V45, P79, DOI 10.3856/vol45-issue1-fulltext-8; Casaux R, 2006, ANTARCT SCI, V18, P3, DOI 10.1017/S0954102006000010; Casaux R, 2003, POLAR BIOL, V26, P49, DOI 10.1007/s00300-002-0442-3; Castilla J.C., 1985, P407; Castilla J.C., 1982, Echinoderms, P257; Castilla JC, 2000, REV CHIL HIST NAT, V73, P585; Cavanaugh KC, 2011, MAR ECOL PROG SER, V429, P1, DOI 10.3354/meps09141; Ciancio J, 2010, LIMNOL OCEANOGR, V55, P2181, DOI 10.4319/lo.2010.55.5.2181; Ciancio JE, 2008, LIMNOL OCEANOGR, V53, P788, DOI 10.4319/lo.2008.53.2.0788; Clark AH, 2011, CLIPPER SHIP ERA EPI; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Croxall J, 2009, ATLAS MAR PATAGONICO; Cunningham SA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001147; Darwin CR, 1832, J REMARKS 1832 1836; DAYTON PK, 1975, ECOL MONOGR, V45, P137, DOI 10.2307/1942404; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; DAYTON PK, 1985, ECOL MONOGR, V55, P447, DOI 10.2307/2937131; Edgar GJ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700419; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fernandez M, 2000, REV CHIL HIST NAT, V73, P797; Fleming DK, 2002, HDB MARITIME EC BUSI, P63; Foster MS, 2010, J EXP MAR BIOL ECOL, V393, P59, DOI 10.1016/j.jembe.2010.07.002; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; FROESE R., 2012, FISHBASE; Gerard VA, 1997, J PHYCOL, V33, P800, DOI 10.1111/j.0022-3646.1997.00800.x; Gobierno de Chile, 2007, CONSERVACION BIODIVE, P136; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; Graham MH, 2007, OCEANOGR MAR BIOL, V45, P39; Guarderas AP, 2008, CONSERV BIOL, V22, P1630, DOI 10.1111/j.1523-1739.2008.01023.x; Guglielmo Letterio, 1992, Memorie di Biologia Marina e di Oceanografia, V19, P157; HARO D, 2013, I PATAGONIA, V41, P77; Haussermann V., 2009, MARINE BENTHIC FAUNA; Henriquez V, 2016, ICES J MAR SCI, V73, P1074, DOI 10.1093/icesjms/fsv270; Hepburn CD, 2005, MAR ECOL PROG SER, V302, P37, DOI 10.3354/meps302037; HOLBROOK SJ, 1990, B MAR SCI, V47, P104; Hune M, 2015, POLAR BIOL, V38, P1613, DOI 10.1007/s00300-015-1726-8; Hune M, 2012, REV BIOL MAR OCEANOG, V47, P451; J Hidalgo, 1996, ETNOGRAFIA SOC INDIG; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; King PP, 1831, J ROYAL GEOGRAPHICAL, V1, P155; Kirkwood R, 2007, WATERBIRDS, V30, P259, DOI 10.1675/1524-4695(2007)30[259:EOSRAM]2.0.CO;2; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; Ling SD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0269; Lloris D., 1991, ICTIOFAUNA CANAL BEA; Ludwig JA., 1998, STAT ECOLOGY; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; Mardones FO, 2009, DIS AQUAT ORGAN, V84, P105, DOI 10.3354/dao02040; McEwan C., 1997, PATAGONIA NATURAL HI; Mead G.W., 1970, SCI EXPLORATION S PA, P236; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0021326, 10.1371/journal.pone.0018318]; Moran E, 2000, J ROY ANTHROPOL INST, V6, P534; MORENO CA, 1984, MAR ECOL PROG SER, V15, P99, DOI 10.3354/meps015099; Navarrete AH, 2014, REV CHIL HIST NAT, V87, DOI 10.1186/0717-6317-87-2; Niklitschek EJ, 2013, REV AQUACULT, V5, P172, DOI 10.1111/raq.12012; Pequeno German, 2000, Ciencia y Tecnologia del Mar, V22, P165; Perez-Matus A, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1808; Pielou E., 1977, MATH ECOLOGY; Pollack G, 2008, MAR POLICY, V32, P233, DOI 10.1016/j.marpol.2007.09.013; Rabassa J, 2000, QUATERN INT, V68, P217, DOI 10.1016/S1040-6182(00)00046-X; Reed DC, 2008, ECOLOGY, V89, P2493, DOI 10.1890/07-1106.1; Reed DC, 2011, ECOLOGY, V92, P2108, DOI 10.1890/11-0377.1; Riccialdelli L, 2017, POLAR BIOL, V40, P807, DOI 10.1007/s00300-016-2007-x; Rios C, 2007, POLAR BIOL, V31, P89, DOI 10.1007/s00300-007-0337-4; Ríos Carlos, 2003, Rev. biol. mar. oceanogr., V38, P1; Roberts DA, 1998, REMOTE SENS ENVIRON, V65, P267, DOI 10.1016/S0034-4257(98)00037-6; Robertson G, 2014, BIOL CONSERV, V169, P319, DOI 10.1016/j.biocon.2013.12.002; Rozzi R, 2008, FRONT ECOL ENVIRON, V6, P131, DOI 10.1890/070020; Rozzi R, 2006, ECOL SOC, V11; Rozzi R, 2012, BIOSCIENCE, V62, P226, DOI 10.1525/bio.2012.62.3.4; Rydell RA, 1952, CAPE HORN PACIFIC RI; SANTELICES B, 1984, MAR ECOL PROG SER, V14, P175, DOI 10.3354/meps014175; Silander Jr JA, 2000, ENCY BIODIVERSITY, V5, P607; Soto D, 2001, ECOL APPL, V11, P1750, DOI 10.2307/3061093; Soto D, 2007, REV CHIL HIST NAT, V80, P81; Steneck RS, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P315; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Tegner MJ, 1996, TRENDS ECOL EVOL, V11, P278, DOI 10.1016/0169-5347(96)30029-3; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Tissot BN, 2007, J EXP MAR BIOL ECOL, V352, P50, DOI 10.1016/j.jembe.2007.06.032; Tognelli MF, 2009, BIOL CONSERV, V142, P3147, DOI 10.1016/j.biocon.2009.08.016; Vasquez JA, 1997, REV CHIL HIST NAT, V70, P41; VASQUEZ JA, 1984, MAR ECOL PROG SER, V19, P55, DOI 10.3354/meps019055; Vasquez JA, 1984, MEDIO AMBIENTE, V7, P47; Veblen T.T., 1996, ECOLOGY BIOGEOGRAPHY; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Vila AR, 2016, ORYX, V50, P308, DOI 10.1017/S0030605314000908; Waters JM, 2008, J BIOGEOGR, V35, P417, DOI 10.1111/j.1365-2699.2007.01724.x; Young M, 2016, ECOL MONOGR, V86, P45, DOI 10.1890/15-0267.1; Zappettini EO, 2009, REV ASOC GEOL ARGENT, V64; Zar J. H., 2007, BIOSTATISTICAL ANAL	108	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0189930	10.1371/journal.pone.0189930	http://dx.doi.org/10.1371/journal.pone.0189930			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364902	Green Published, Green Submitted, gold			2022-12-27	WOS:000423412500007
J	Roh, HF; Nam, SH; Kim, JM				Roh, Hyunsuk Frank; Nam, Seung Hyuk; Kim, Jung Mogg			Robot-assisted laparoscopic surgery versus conventional laparoscopic surgery in randomized controlled trials: A systematic review and meta-analysis	PLOS ONE			English	Review							PELVIC ORGAN PROLAPSE; SHORT-TERM OUTCOMES; NISSEN FUNDOPLICATION; RADICAL PROSTATECTOMY; CLINICAL-TRIAL; RECTAL-CANCER; HYSTERECTOMY; SACROCOLPOPEXY; CHOLECYSTECTOMY; ADRENALECTOMY	Importance This review provides a comprehensive comparison of treatment outcomes between robot-assisted laparoscopic surgery (RLS) and conventional laparoscopic surgery (CLS) based on randomly-controlled trials (RCTs). Objectives We employed RCTs to provide a systematic review that will enable the relevant community to weigh the effectiveness and efficacy of surgical robotics in controversial fields on surgical procedures both overall and on each individual surgical procedure. Evidence review A search was conducted for RCTs in PubMed, EMBASE, and Cochrane databases from 1981 to 2016. Among a total of 1,517 articles, 27 clinical reports with a mean sample size of 65 patients per report (32.7 patients who underwent RLS and 32.5 who underwent CLS), met the inclusion criteria. Findings CLS shows significant advantages in total operative time, net operative time, total complication rate, and operative cost (p < 0.05 in all cases), whereas the estimated blood loss was less in RLS (p < 0.05). As subgroup analyses, conversion rate on colectomy and length of hospital stay on hysterectomy statistically favors RLS (p < 0.05). Conclusions Despite higher operative cost, RLS does not result in statistically better treatment outcomes, with the exception of lower estimated blood loss. Operative time and total complication rate are significantly more favorable with CLS.	[Roh, Hyunsuk Frank] Hanyang Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Roh, Hyunsuk Frank; Kim, Jung Mogg] Grad Sch Biomed Sci & Engn, Seoul, South Korea; [Nam, Seung Hyuk] Hanyang Univ, Guri Hosp, Dept Thorac & Cardiovasc Surg, Guri, Gyunggi, South Korea; [Roh, Hyunsuk Frank; Kim, Jung Mogg] Hanyang Univ, Coll Med, Dept Microbiol & Biomed Sci, Seoul, South Korea	Hanyang University; Hanyang University; Hanyang University	Kim, JM (corresponding author), Grad Sch Biomed Sci & Engn, Seoul, South Korea.; Kim, JM (corresponding author), Hanyang Univ, Coll Med, Dept Microbiol & Biomed Sci, Seoul, South Korea.	jungmogg@hanyang.ac.kr	Dangal, Ganesh/O-1989-2017; Kim, Jung M/D-3112-2015	Dangal, Ganesh/0000-0002-5834-5525; Kim, Jung M/0000-0002-6506-7519; Roh, Hyunsuk/0000-0002-8527-6553	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST), Republic of Korea [NRF-2015R1D1A1A01058565]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST), Republic of Korea	We state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please note that this research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (NRF-2015R1D1A1A01058565), Republic of Korea. The role of the National Research Foundation (http://www.nrf.re.kr/eng/main) is to promote an independent research to benefit basic science research. In this regard, we state that any individual, other than the three authors, and the funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aiono S, 2002, SURG ENDOSC, V16, P1267, DOI 10.1007/s00464-001-9174-7; Albright BB, 2016, J MINIM INVAS GYN, V23, P18, DOI 10.1016/j.jmig.2015.08.003; Allan C, 2016, UROL INT, V96, P373, DOI 10.1159/000435861; Martinez-Maestre MA, 2014, SURG INNOV, V21, P250, DOI 10.1177/1553350613492023; Anger JT, 2014, OBSTET GYNECOL, V123, P5, DOI 10.1097/AOG.0000000000000006; Ansari MT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000151; Asimakopoulos AD, 2011, J SEXUAL MED; Asimakopoulos AD, 2011, J SEX MED, V8, P1503, DOI 10.1111/j.1743-6109.2011.02215.x; Baik SH, 2008, SURG ENDOSC, V22, P1601, DOI 10.1007/s00464-008-9752-z; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bhattu AS, 2015, J ENDOUROL, V29, P1334, DOI 10.1089/end.2015.0213; Braga LHP, 2009, EUR UROL, V56, P848, DOI 10.1016/j.eururo.2009.03.063; Brandao LF, 2014, EUR UROL, V65, P1154, DOI 10.1016/j.eururo.2013.09.021; Broholm M, 2016, SURG LAPARO ENDO PER, V26, P117, DOI 10.1097/SLE.0000000000000248; Cadiere GB, 2001, SURG ENDOSC, V15, P918, DOI 10.1007/s004640000217; Callewaert G, 2016, GYNECOL SURG, V13, P115, DOI 10.1007/s10397-016-0930-z; Cao C, 2012, ANN CARDIOTHORAC SUR, V1, P3, DOI 10.3978/j.issn.2225-319X.2012.04.03; Chuan L, 2014, MINIM INVASIV THER, P1; Cundy TP, 2014, J PEDIATR SURG, V49, P646, DOI 10.1016/j.jpedsurg.2013.12.014; Draaisma WA, 2006, BRIT J SURG, V93, P1351, DOI 10.1002/bjs.5535; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El Nakadi I, 2006, WORLD J SURG, V30, P1050, DOI 10.1007/s00268-005-7950-6; Finkelstein Julia, 2010, Rev Urol, V12, P35; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Huang X, 2017, SURG ENDOSC, V31, P1045, DOI 10.1007/s00464-016-5125-1; Rodriguez RMJ, 2011, CIR ESPAN, V89, P432, DOI 10.1016/j.ciresp.2011.01.017; Khan MS, 2016, EUR UROL, V69, P613, DOI 10.1016/j.eururo.2015.07.038; Kudsi OY, 2016, SURG ENDOSC; Lee SH, 2015, ANN SURG TREAT RES, V89, P190, DOI 10.4174/astr.2015.89.4.190; Liao GX, 2013, ASIAN PAC J CANCER P, V14, P4871, DOI 10.7314/APJCP.2013.14.8.4871; Liao GX, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-122; Lim S, 2016, ANN SURG TREAT RES, V90, P328, DOI 10.4174/astr.2016.90.6.328; Lin S, 2011, WORLD J GASTROENTERO, V17, P5214, DOI 10.3748/wjg.v17.i47.5214; Liu HQ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011422; Lonnerfors C, 2015, J MINIM INVAS GYN, V22, P78, DOI 10.1016/j.jmig.2014.07.010; Maenpaa MM, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.06.005; Makela-Kaikkonen J, 2016, COLORECTAL DIS, V18, P1010, DOI 10.1111/codi.13309; Markar SR, 2010, INT J MED ROBOT COMP, V6, P125, DOI 10.1002/rcs.309; Moran PS, 2013, INT J UROL, V20, P312, DOI 10.1111/iju.12070; Morino M, 2006, BRIT J SURG, V93, P553, DOI 10.1002/bjs.5325; Morino M, 2004, SURG ENDOSC, V18, P1742, DOI 10.1007/s00464-004-9046-z; Muller-Stich BP, 2007, SURG ENDOSC, V21, P1800, DOI 10.1007/s00464-007-9268-y; Nio D, 2004, SURG ENDOSC, V18, P379, DOI 10.1007/s00464-003-9133-6; O'Neill M, 2013, ARCH GYNECOL OBSTET, V287, P907, DOI 10.1007/s00404-012-2681-z; Paraiso MFR, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.008; Paraiso MFR, 2011, OBSTET GYNECOL, V118, P1005, DOI 10.1097/AOG.0b013e318231537c; Park JS, 2012, BRIT J SURG, V99, P1219, DOI 10.1002/bjs.8841; Patriti A, 2009, JSLS-J SOC LAPAROEND, V13, P176; Pietrabissa A, 2016, SURG ENDOSC, V30, P3089, DOI 10.1007/s00464-015-4601-3; Porpiglia F, 2013, EUR UROL, V63, P606, DOI 10.1016/j.eururo.2012.07.007; Ran L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108361; Roh HF, 2017, EUR J CARDIO-THORAC, V52, P673, DOI 10.1093/ejcts/ezx209; Sanchez Barry R, 2005, Surg Obes Relat Dis, V1, P549, DOI 10.1016/j.soard.2005.08.008; Salinas CS, 2013, ADV UROL, V2013, DOI 10.1155/2013/105651; Sarlos D, 2012, OBSTET GYNECOL, V120, P604, DOI 10.1097/AOG.0b013e318265b61a; Serati M, 2014, EUR UROL, V66, P303, DOI 10.1016/j.eururo.2014.02.053; Tekkis PP, 2005, ANN SURG, V242, P83, DOI 10.1097/01.sla.0000167857.14690.68; Wang ZH, 2012, ANZ J SURG, V82, P112, DOI 10.1111/j.1445-2197.2011.05964.x; Xiong BH, 2012, SURG ONCOL, V21, P274, DOI 10.1016/j.suronc.2012.05.004	59	53	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191628	10.1371/journal.pone.0191628	http://dx.doi.org/10.1371/journal.pone.0191628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360840	Green Published, gold, Green Submitted			2022-12-27	WOS:000423161800043
J	Sahib, AK; Erb, M; Marquetand, J; Martin, P; Elshahabi, A; Klamer, S; Vulliemoz, S; Scheffler, K; Ethofer, T; Focke, NK				Sahib, Ashish Kaul; Erb, Michael; Marquetand, Justus; Martin, Pascal; Elshahabi, Adham; Klamer, Silke; Vulliemoz, Serge; Scheffler, Klaus; Ethofer, Thomas; Focke, Niels K.			Evaluating the impact of fast-fMRI on dynamic functional connectivity in an event-based paradigm	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; PULSE ARTIFACT; BRAIN; TIME; SYSTEM; BOLD; MRI	The human brain is known to contain several functional networks that interact dynamically. Therefore, it is desirable to analyze the temporal features of these networks by dynamic functional connectivity (dFC). A sliding window approach was used in an event-related fMRI (visual stimulation using checkerboards) to assess the impact of repetition time (TR) and window size on the temporal features of BOLD dFC. In addition, we also examined the spatial distribution of dFC and tested the feasibility of this approach for the analysis of interictal epileptiforme discharges. 15 healthy controls (visual stimulation paradigm) and three patients with epilepsy (EEG-fMRI) were measured with EPI-fMRI. We calculated the functional connectivity degree (FCD) by determining the total number of connections of a given voxel above a predefined threshold based on Pearson correlation. FCD could capture hemodynamic changes relative to stimulus onset in controls. A significant effect of TR and window size was observed on FCD estimates. At a conventional TR of 2.6 s, FCD values were marginal compared to FCD values using sub-seconds TRs achievable with multiband (MB) fMRI. Concerning window sizes, a specific maximum of FCD values (inverted u-shape behavior) was found for each TR, indicating a limit to the possible gain in FCD for increasing window size. In patients, a dynamic FCD change was found relative to the onset of epilepti-form EEG patterns, which was compatible with their clinical semiology. Our findings indicate that dynamic FCD transients are better detectable with sub-second TR than conventional TR. This approach was capable of capturing neuronal connectivity across various regions of the brain, indicating a potential to study the temporal characteristics of interictal epileptiform discharges and seizures in epilepsy patients or other brain diseases with brief events.	[Sahib, Ashish Kaul; Ethofer, Thomas; Focke, Niels K.] Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Sahib, Ashish Kaul; Erb, Michael; Scheffler, Klaus; Ethofer, Thomas] Univ Hosp Tuebingen, Dept Biomed Magnet Resonance, Tubingen, Germany; [Sahib, Ashish Kaul; Marquetand, Justus; Martin, Pascal; Elshahabi, Adham; Klamer, Silke; Focke, Niels K.] Univ Hosp Tuebingen, Dept Neurol Epileptol, Tubingen, Germany; [Sahib, Ashish Kaul; Marquetand, Justus; Martin, Pascal; Elshahabi, Adham; Klamer, Silke; Focke, Niels K.] Hertie Inst Clin Brain Res, Tubingen, Germany; [Sahib, Ashish Kaul] Univ Tubingen, Grad Sch Neural & Behav Sci, Int Max Planck Res Sch, Tubingen, Germany; [Elshahabi, Adham] Univ Tubingen, MEG Ctr, Tubingen, Germany; [Vulliemoz, Serge] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland; [Scheffler, Klaus] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Focke, Niels K.] Univ Med, Clin Neurophysiol, Gottingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; University of Geneva; Max Planck Society	Focke, NK (corresponding author), Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany.; Focke, NK (corresponding author), Univ Hosp Tuebingen, Dept Neurol Epileptol, Tubingen, Germany.; Focke, NK (corresponding author), Hertie Inst Clin Brain Res, Tubingen, Germany.; Focke, NK (corresponding author), Univ Med, Clin Neurophysiol, Gottingen, Germany.	niels.focke@med.uni-goettingen.de	Focke, Niels/AAO-7012-2020; Ethofer, Silke/AAC-4570-2022	Ethofer, Silke/0000-0002-6726-0531; Sahib, Ashish Kaul/0000-0003-0622-9634; Scheffler, Klaus/0000-0001-6316-8773	Werner Reichardt Centre for Integrative Neuroscience (CIN grant: Pool-Project); DFG [CIN EXC 307]; Swiss National Science Foundation [320030-169198]; Gottingen University	Werner Reichardt Centre for Integrative Neuroscience (CIN grant: Pool-Project); DFG(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gottingen University	This work was supported by the Werner Reichardt Centre for Integrative Neuroscience (CIN grant: Pool-Project 2012-10) and the DFG (CIN EXC 307) for NF. Support for SV was provided by the Swiss National Science Foundation grant 320030-169198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We also acknowledge support by the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Beall EB, 2007, NEUROIMAGE, V37, P1286, DOI 10.1016/j.neuroimage.2007.07.004; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Boubela RN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00168; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Constable RT, 2001, MAGNET RESON MED, V46, P748, DOI 10.1002/mrm.1253; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Di X, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00543; Di X, 2015, BRAIN STRUCT FUNCT, V220, P37, DOI 10.1007/s00429-013-0634-3; Feinberg DA, 2013, J MAGN RESON, V229, P90, DOI 10.1016/j.jmr.2013.02.002; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Handwerker DA, 2012, NEUROIMAGE, V63, P1712, DOI 10.1016/j.neuroimage.2012.06.078; Hawco CS, 2007, NEUROIMAGE, V35, P1450, DOI 10.1016/j.neuroimage.2006.12.042; Hindriks R, 2016, NEUROIMAGE, V127, P242, DOI 10.1016/j.neuroimage.2015.11.055; Iannotti GR, 2015, BRAIN TOPOGR, V28, P21, DOI 10.1007/s10548-014-0409-z; Kalcher K, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00301; Kang J, 2011, NEUROIMAGE, V56, P1222, DOI 10.1016/j.neuroimage.2011.03.033; Khalili-Mahani N, 2013, NEUROIMAGE, V65, P499, DOI 10.1016/j.neuroimage.2012.09.044; Kiviniemi V, 2011, BRAIN CONNECT, V1, P339, DOI 10.1089/brain.2011.0036; Laufs H, 2012, CURR OPIN NEUROL, V25, P194, DOI 10.1097/WCO.0b013e3283515db9; Liao W, 2014, BRAIN CONNECT, V4, P780, DOI 10.1089/brain.2014.0253; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Niazy RK, 2005, NEUROIMAGE, V28, P720, DOI 10.1016/j.neuroimage.2005.06.067; Nierhaus T, 2013, NEUROIMAGE, V74, P70, DOI 10.1016/j.neuroimage.2013.02.016; Sahib AK, 2016, MAGNETIC RESONANCE M; Sakoglu U, 2010, MAGN RESON MATER PHY, V23, P351, DOI 10.1007/s10334-010-0197-8; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zhang ZG, 2011, IEEE T BIO-MED ENG, V58, P557, DOI 10.1109/TBME.2010.2089686	35	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0190480	10.1371/journal.pone.0190480	http://dx.doi.org/10.1371/journal.pone.0190480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357371	Green Published, gold			2022-12-27	WOS:000422919500004
J	Christensen, A; Mariani, P; Payne, MR				Christensen, Asbjorn; Mariani, Patrizio; Payne, Mark R.			A generic framework for individual-based modelling and physical-biological interaction	PLOS ONE			English	Article							EUROPEAN CONTINENTAL-SHELF; HERRING SPAWNING COMPONENTS; NORTH-SEA; PARTICLE-TRACKING; MORTALITY; TRANSPORT; ECOSYSTEM; DYNAMICS; LARVAL; VARIABILITY	The increased availability of high-resolution ocean data globally has enabled more detailed analyses of physical-biological interactions and their consequences to the ecosystem. We present IBMlib, which is a versatile, portable and computationally effective framework for conducting Lagrangian simulations in the marine environment. The purpose of the framework is to handle complex individual-level biological models of organisms, combined with realistic 3D oceanographic model of physics and biogeochemistry describing the environment of the organisms without assumptions about spatial or temporal scales. The opensource framework features a minimal robust interface to facilitate the coupling between individual-level biological models and oceanographic models, and we provide application examples including forward/backward simulations, habitat connectivity calculations, assessing ocean conditions, comparison of physical circulation models, model ensemble runs and recently posterior Eulerian simulations using the IBMlib framework. We present the code design ideas behind the longevity of the code, our implementation experiences, as well as code performance benchmarking. The framework may contribute substantially to progresses in representing, understanding, predicting and eventually managing marine ecosystems.	[Christensen, Asbjorn; Mariani, Patrizio; Payne, Mark R.] Tech Univ Denmark, DTU Aqua, Kgs, Lyngby, Denmark	Technical University of Denmark	Christensen, A (corresponding author), Tech Univ Denmark, DTU Aqua, Kgs, Lyngby, Denmark.	asc@aqua.dtu.dk	Payne, Mark/C-6844-2008; Mariani, Patrizio/AAP-2007-2021	Payne, Mark/0000-0001-5795-2481; Mariani, Patrizio/0000-0002-8015-1583; Christensen, Asbjorn/0000-0002-4286-7409	EU [283291, 283367, 287844]; project GUDP-VIND - Ministry of Environment and Food of Denmark	EU(European Commission); project GUDP-VIND - Ministry of Environment and Food of Denmark	AC and PM kindly acknowledge financial support from the EU FP7 projects, OpEc (contract no: 283291), MyOceanFO (contract no: 283367), and COCONET (contract no: 287844) and AC acknowledges additional support from the project GUDP-VIND funded by the Ministry of Environment and Food of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JI, 2001, SARSIA, V86, P423, DOI 10.1080/00364827.2001.10420484; Berg P., 2012, 1211 DMI; Berline L, 2013, MAR POLLUT BULL, V70, P90, DOI 10.1016/j.marpolbul.2013.02.016; Bierman SM, 2010, ICES J MAR SCI, V67, P885, DOI 10.1093/icesjms/fsp300; Blanke B, 1997, J PHYS OCEANOGR, V27, P1038, DOI 10.1175/1520-0485(1997)027<1038:KOTPEU>2.0.CO;2; Blanke B, 2008, ARIANE USER MANUAL; Bolle LJ, 2009, MAR ECOL PROG SER, V390, P195, DOI 10.3354/meps08177; Bruggeman J, 2014, ENVIRON MODELL SOFTW, V61, P249, DOI 10.1016/j.envsoft.2014.04.002; Christensen A, 2008, CAN J FISH AQUAT SCI, V65, P1498, DOI 10.1139/F08-073; Christensen A, 2007, MAR ECOL PROG SER, V347, P221, DOI 10.3354/meps06980; Cushing DH, 1975, MARINE ECOLOGY FISHE; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Fassler SMM, 2011, FISH OCEANOGR, V20, P530, DOI 10.1111/j.1365-2419.2011.00600.x; Fiksen O, 2007, MAR ECOL PROG SER; Forbriger T., 2014, LIBTIME DATE TIME CA; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gamma E., 1994, DESIGN PATTERNS ELEM; Gibson RN, 2003, HYDROBIOLOGIA, V503, P153, DOI 10.1023/B:HYDR.0000008488.33614.62; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hemmer-Hansen J, 2015, DTU AQUA; HILL AE, 1991, MAR ECOL PROG SER, V75, P39, DOI 10.3354/meps075039; Hoffle H, 2014, ICEJ MARINE SCI J; Hoffle H, 2013, MAR BIOL RES, V9, P629, DOI 10.1080/17451000.2013.765576; Holt JT, 2001, J GEOPHYS RES-OCEANS, V106, P14015, DOI 10.1029/2000JC000304; Hufnagl M, 2013, J SEA RES, V84, P26, DOI 10.1016/j.seares.2012.10.007; Jahnke M, 2016, MAR ENVIRON RES, V117, P54, DOI 10.1016/j.marenvres.2016.04.004; Korotaev G, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001508; Lange U., 1997, DEUT HYDROGR Z, V49, P251, DOI [10.1007/BF02764037, DOI 10.1007/BF02764037]; Larsen J, 2007, J MARINE SYST, V65, P122, DOI 10.1016/j.jmarsys.2005.09.013; Lenth R., 2019, Journal of Statistical Software, V60, P1; Maar M, 2014, PROG OCEANOGR, V124, P78, DOI 10.1016/j.pocean.2014.03.002; Mariani P, 2005, DEEP-SEA RES PT II, V52, P1287, DOI 10.1016/j.dsr2.2005.01.007; Nielsen R, 2004, MAR ECOL PROG SER, V278, P261, DOI 10.3354/meps278261; North EW, 2008, MAR ECOL PROG SER, V359, P99, DOI 10.3354/meps07317; North EW, 2011, GEOPHYS MONOGR SER, V195, P217, DOI 10.1029/2011GM001102; North EW, 2009, MANUAL RECOMMENDED P, P295; OGUZ T, 1995, J GEOPHYS RES-OCEANS, V100, P6845, DOI 10.1029/95JC00022; Oguz T, 2001, ECOL MODEL, V144, P295, DOI 10.1016/S0304-3800(01)00378-7; Palacz AP, 2017, PLOS ONE IN PRESS; Payne MR, 2013, MAR ECOL PROG SER, V489, P197, DOI 10.3354/meps10392; Payne MR, 2010, ICES J MAR SCI, V67, P1939, DOI 10.1093/icesjms/fsq036; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PRESS WH, 1992, NUMERICAL RECIPES; Railsback S., 2012, AGENT BASED INDIVIDU; Schrum C, 1999, TELLUS A, V51, P526, DOI 10.1034/j.1600-0870.1992.00006.x; Schrum C, 2006, J MAR SYS; She J, 2007, J MARINE SYST, V65, P450, DOI 10.1016/j.jmarsys.2006.01.017; Siddorn JR, 2007, J MARINE SYST, V65, P417, DOI 10.1016/j.jmarsys.2006.01.018; SKOGEN MD, 1995, ESTUAR COAST SHELF S, V41, P545, DOI 10.1016/0272-7714(95)90026-8; Skogen MD, 1998, USERS GUIDE NORWECOM, P18; Stips A, 2004, OCEAN DYNAM, V54, P266, DOI 10.1007/s10236-003-0077-0; Thygesen UH, 2011, J MARINE SYST, V88, P159, DOI 10.1016/j.jmarsys.2011.03.009; Ulrich C, 2016, J SEA RES IN PRESS; van Deurs M, 2013, MAR ECOL PROG SER, V487, P123, DOI 10.3354/meps10390; Visser AW, 1997, MAR ECOL PROG SER, V158, P275, DOI 10.3354/meps158275	57	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0189956	10.1371/journal.pone.0189956	http://dx.doi.org/10.1371/journal.pone.0189956			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351280	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300012
J	Liu, JX; Wu, ZB; Dong, J; Wu, J; Wen, DX				Liu, Jiaxi; Wu, Zhibo; Dong, Jian; Wu, Jin; Wen, Dongxin			An energy-efficient failure detector for vehicular cloud computing	PLOS ONE			English	Article							SERVICE; INFRASTRUCTURE; QUALITY; SYSTEMS	Failure detectors are one of the fundamental components for maintaining the high availability of vehicular cloud computing. In vehicular cloud computing, lots of RSUs are deployed along the road to improve the connectivity. Many of them are equipped with solar battery due to the unavailability or excess expense of wired electrical power. So it is important to reduce the battery consumption of RSU. However, the existing failure detection algorithms are not designed to save battery consumption RSU. To solve this problem, a new energyefficient failure detector 2E-FD has been proposed specifically for vehicular cloud computing. 2E-FD does not only provide acceptable failure detection service, but also saves the battery consumption of RSU. Through the comparative experiments, the results show that our failure detector has better performance in terms of speed, accuracy and battery consumption.	[Liu, Jiaxi; Wu, Zhibo; Dong, Jian; Wu, Jin; Wen, Dongxin] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China	Harbin Institute of Technology	Dong, J (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.	hitljx@gmail.com			National Natural Science Foundation of China [61100029, 61370085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (61100029) (http://www.nsfc.gov.cn/); Jian Dong is responsible for organizing and implementing the project. This work was also supported by the National Natural Science Foundation of China (61370085) (http://www.nsfc.gov.cn/); Dongxin Wen is responsible for organizing and implementing the project.; This work was supported by the National Natural Science Foundation of China (No. 61100029 and 61370085).	Abhale Ashwini, 2013, INT J ADV RES COMPUT, V3, P1056; Arif S, 2012, IEEE T PARALL DISTR, V23, P2067, DOI 10.1109/TPDS.2012.47; Atallah R, 2016, IEEE T VEH TECHNOL, P4592; Atallah R, 2016, IEEE WIREL COMMUN, V23, P70, DOI 10.1109/MWC.2016.7462487; Azimifar M, 2015, IEEE T VEH TECHNOL, V65, P780; Chandra TD, 1996, J ACM, V43, P225, DOI 10.1145/226643.226647; Chen W, 2002, IEEE T COMPUT, V51, P561, DOI 10.1109/TC.2002.1004595; Deng J, 2010, IEEE GLOBE WORK, P1601, DOI 10.1109/GLOCOMW.2010.5700210; Felber P., 1999, Proceedings of the International Symposium on Distributed Objects and Applications, P132, DOI 10.1109/DOA.1999.794001; Gerla M., 2013, 2013 International Conference on Computing, Networking and Communications (ICNC 2013), P1123, DOI 10.1109/ICCNC.2013.6504250; Ghazizadeh P., 2014, P 1 INT WORKSH MOB S, P7, DOI [DOI 10.1145/2633675.2633681, 10.1145/2633675.2633681]; Ghazizadeh P, 2015, 2015 IEEE 12TH INTERNATIONAL CONFERENCE ON SERVICES COMPUTING (SCC 2015), P17, DOI 10.1109/SCC.2015.13; Gu L, 2013, IEEE GLOBE WORK, P403, DOI 10.1109/GLOCOMW.2013.6825021; Hammad AA, 2012, IEEE T VEH TECHNOL, V62, P1289; Hayashibara N, 2004, REL DISTR SYST 2004, P66, DOI 10.1109/RELDIS.2004.1353004; Hyndman RJ, 2002, INT J FORECASTING, V18, P439, DOI 10.1016/S0169-2070(01)00110-8; Jayasinghe Deepal, 2013, 2013 IEEE International Conference on Services Computing (SCC), P575, DOI 10.1109/SCC.2013.102; JiSu Park, 2011, Proceedings 2011 25th IEEE International Conference on Advanced Information Networking and Applications Workshops (WAINA 2011), P520, DOI 10.1109/WAINA.2011.10; Karagiannis G, 2011, IEEE COMMUN SURV TUT, V13, P584, DOI 10.1109/SURV.2011.061411.00019; Khezrian A, 2015, IEEE T VEH TECHNOL, V64, P1942, DOI 10.1109/TVT.2014.2333665; Lavinia Andrei, 2010, Proceedings of the Fourth International Conference on Complex, Intelligent and Software Intensive Systems (CISIS 2010), P482, DOI 10.1109/CISIS.2010.29; Malik S., 2011, Proceedings of the 2011 IEEE World Congress on Services (SERVICES 2011), P280, DOI 10.1109/SERVICES.2011.108; Mekki T, 2016, VEHICULAR COMMU 1223; Olariu S, 2013, MOBILE AD HOC NETWOR; Olariu S, 2011, INT J PERVASIVE COMP, V7, P7, DOI 10.1108/17427371111123577; Peirce S., 2007, VEHICLE INFRASTRUCTU; Qian J, 2016, EURASIP J WIREL COMM, P1, DOI 10.1186/s13638-016-0650-0; Refaat T. K., 2014, IEEE S COMP COMM ISC, P1, DOI [DOI 10.1109/ISCC.2014.6912651, 10.1109/ISCC.2014.6912651]; Refaat TK, 2016, VEH COMMUN, V4, P47, DOI 10.1016/j.vehcom.2016.05.001; Ren X, 2012, SENSORS-BASEL, V12, P5815, DOI 10.3390/s120505815; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Suryawanshi R., 2015, INT J SCI ENG TECH R, V4, P3225; Takeuchi K, 2008, IEEE J SEL AREA COMM, V26, P486, DOI 10.1109/JSAC.2008.080407; Tomsic AZ, 2015, INT PARALL DISTRIB P, P885, DOI 10.1109/IPDPS.2015.74; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Whaiduzzaman M, 2014, J NETW COMPUT APPL, V40, P325, DOI 10.1016/j.jnca.2013.08.004; Xiong N, 2007, ED FD IMPROVING PHI; Xiong NX, 2012, INT PARALL DISTRIB P, P668, DOI 10.1109/IPDPS.2012.126; Xiong NX, 2009, IEEE J SEL AREA COMM, V27, P495, DOI 10.1109/JSAC.2009.090512; Ye T, 2016, MOBILE INFORM SYSTEM; Yu R, 2015, IEEE T IND ELECTRON, V62, P7938, DOI 10.1109/TIE.2015.2481792; Zou F., 2011, P 5 INT C UB INF MAN, P64, DOI [10.1145/1968613.1968691, DOI 10.1145/1968613.1968691]	42	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191577	10.1371/journal.pone.0191577	http://dx.doi.org/10.1371/journal.pone.0191577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352282	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300116
J	Sun, GW; Sima, GZ; Wu, CH; Fan, YZ; Tan, Y; Wang, Z; Cheng, G; Li, J				Sun, Guangwei; Sima, Guozhong; Wu, Chunhui; Fan, Yongzhong; Tan, Yong; Wang, Zhong; Cheng, Gang; Li, Jie			Decreased MiR-17 in glioma cells increased cell viability and migration by increasing the expression of Cyclin D1, p-Akt and Akt	PLOS ONE			English	Article							DISEASE; MICRORNAS; CLUSTER	Background The activating mutations of micro RNA (miR)-17 have been revealed in tumors such as human non-Hodgkin's lymphoma and T cell leukemia. However, it is unclear about the role of miR-17 in glioma cells. The current study aimed to investigate effects of miR-17 mimics or inhibitor on the viability and migration of rat glioma C6 cells, and explore possible mechanisms. Methods The expression of miR-17 in rat glioma C6 cells and normal brain tissue was detected by quantitative PCR. Protein expression of Cyclin D1 in rat glioma C6 cells and normal brain tissue was measured by Western Blot. Glioma C6 cells were transfected with MiR-17 mimics or inhibitor. Cells that were not transfected (Lipofectamine only) and cells that were transfected with nonsense RNA negative control served as control. MTT assay was utilized to detect cell viability, and cell wound scratch assay was utilized to examine the migration index. In addition, protein expression of Cyclin D1, p-Akt and Akt in MiR-17 mimics or inhibitor- transfected glioma C6 cells was detected by Western Blot. This study had been approved by the Medical Ethics Committee of the First Affiliated Hospital of Soochow University. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. Results The expression of miR-17 was significantly lower, whereas the expression of Cyclin D1 was significantly higher in glioma C6 cells compared to normal brain tissue. MiR-17 mimics decreased the viability and migration of glioma C6 cells markedly at 48 h. In addition, MiR-17 inhibitor increased the viability and migration of glioma C6 cells at 24 and 48 h. The protein expression of Cyclin D1, p-Akt and Akt in glioma C6 cells decreased after transfection with miR-17 mimics for 72 h, and increased after transfection with miR-17 inhibitor for 72 h. Conclusions The reduced miR-17 levels in glioma cells increased cell viability and migration, which correlates with increased expression of Cyclin D1, p-Akt and Akt.	[Sun, Guangwei; Wang, Zhong; Cheng, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China; [Sun, Guangwei; Wang, Zhong; Cheng, Gang; Li, Jie] Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Peoples R China; [Sun, Guangwei; Sima, Guozhong; Wu, Chunhui; Fan, Yongzhong; Tan, Yong; Li, Jie] Danyang Peoples Hosp, Dept Neurosurg, Danyang Shi, Peoples R China	Soochow University - China; Soochow University - China	Wang, Z (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou, Peoples R China.; Wang, Z (corresponding author), Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou, Peoples R China.	wangzhong065@sina.com						Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Goodenberger ML, 2012, CANCER GENET-NY, V205, P613, DOI 10.1016/j.cancergen.2012.10.009; Hammond SM, 2006, CANCER CHEMOTH PHARM, V58, pS63, DOI 10.1007/s00280-006-0318-2; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Karami F, 2016, CHEM BIOL DRUG DES, V87, P317, DOI 10.1111/cbdd.12671; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shimura T, 2016, ONCOTARGET, V7, P3559, DOI 10.18632/oncotarget.6518; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang CL, 2006, P NATL ACAD SCI USA, V103, P18680, DOI 10.1073/pnas.0609030103; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yu ZR, 2014, ONCOTARGET, V5, P1083, DOI 10.18632/oncotarget.1804	16	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190515	10.1371/journal.pone.0190515	http://dx.doi.org/10.1371/journal.pone.0190515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351283	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300020
J	Wang, X; Luo, RF; Liu, CF; Zhang, LX; Yue, A; Medina, A; Rozelle, S				Wang, Xu; Luo, Renfu; Liu, Chengfang; Zhang, Linxiu; Yue, Ai; Medina, Alexis; Rozelle, Scott			Using daily text messages to improve adherence to infant micronutrient powder (MNP) packets in rural western China: A cluster-randomized controlled trial	PLOS ONE			English	Article							CHILD UNDERNUTRITION; PILOT PROGRAM; HEALTH; REMINDERS; ANEMIA; SUPPLEMENTATION; INTERVENTIONS; GRANDPARENTS; MEDICATION; ASTHMA	Objective To evaluate the effectiveness of daily text messages as a means to improve caregivers' adherence to infant micronutrient powder (MNP) in rural Shaanxi Province of China. Methodology 638 infants aged 6 +/- 11 months in 234 villages were involved in a cluster-randomized controlled trial (RCT). All caregivers were given free infant MNP packets at baseline in April 2013 and the follow-up survey was in July 2013. We randomly assigned 318 infants in 117 villages to treatment group (receiving daily text message) and 320 infants in the other 117 villages as control group. Results On average, daily text messages increased the number of MNP packets fed (marginal effect = 4.63; 95% confidence interval (CI) = 0.16, 9.10). The text message is more likely to increase the consumption of MNP packets if the primary caregiver was the mother (marginal effect = 12.19; 95% CI = 0.69, 23.68). Receiving the text message appears to significantly increase the likelihood of full adherence when the primary caregiver can either check (odds ratio = 2.93; 95% CI = 1.34, 6.40) or knows how to send (odds ratio = 3.26; 95% CI = 1.53, 6.97) text messages. Conclusion Daily text messages improved the consumption of infant MNP packets. However, the impact was not large enough to increase the probability of caregivers being fully adherent to the feeding instruction, which is to feed 5 +/- 7 packets per week as recommended. In addition, when the mother is the caregiver and when the caregiver can check or knows how to send text messages there is greater adherence by the primary caregivers.	[Wang, Xu] World Bank Grp, Educ Global Practices East & South Africa, Washington, DC USA; [Luo, Renfu; Liu, Chengfang] Peking Univ, Sch Adv Agr Sci, China Ctr Agr Policy, Beijing, Peoples R China; [Zhang, Linxiu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Ctr Chinese Agr Policy, Beijing, Peoples R China; [Yue, Ai] Shaanxi Normal Univ, CEEE, Xian, Shaanxi, Peoples R China; [Medina, Alexis; Rozelle, Scott] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA	The World Bank; Peking University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Shaanxi Normal University; Stanford University	Luo, RF (corresponding author), Peking Univ, Sch Adv Agr Sci, China Ctr Agr Policy, Beijing, Peoples R China.	luorf.ccap@pku.edu.cn	ZHANG, LIN/GYD-9123-2022		National Natural Science Foundation of China [71473239, 71473240]; International Initiative for Impact Evaluation [PW2.04.01.02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Initiative for Impact Evaluation	We are grateful for project funding from the National Natural Science Foundation of China (grant numbers 71473239 and 71473240) and the International Initiative for Impact Evaluation (PW2.04.01.02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsana K, 2014, ASIA PAC J CLIN NUTR, V23, P377, DOI 10.6133/apjcn.2014.23.3.22; Angdembe MR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1752-z; [Anonymous], CHIN J CHILD HLTH CA; Armstrong AW, 2009, ARCH DERMATOL, V145, P1230, DOI 10.1001/archdermatol.2009.269; Avula R, 2011, J NUTR, V141, P680, DOI 10.3945/jn.109.116954; Bigna JJR, 2014, LANCET INFECT DIS, V14, P600, DOI 10.1016/S1473-3099(14)70741-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bonvecchio A, 2007, J NUTR, V137, P440, DOI 10.1093/jn/137.2.440; Cameron A. C., 2010, MICROECONOMETRICS US; Chen FNA, 2011, SOC FORCES, V90, P571, DOI 10.1093/sf/sor012; China Internet Network Information Center, 2012, SURV REP DEV CHIN MO; Christensen L, 2013, ARCH ARGENT PEDIATR, V111, P288, DOI [10.5546/aap.2013.xx, 10.5546/aap.2013.288, 10.5546/aap.2013.eng.288]; Creed-Kanashiro H., 2016, CHILD NUTR, V12, P152, DOI [10.1111/mcn.1221726522502, DOI 10.1111/MCN.1221726522502]; De-Regil Luz Maria, 2013, Evid Based Child Health, V8, P112, DOI 10.1002/ebch.1895; Dong Caixia, 2013, Wei Sheng Yan Jiu, V42, P596; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Foreman KF, 2012, CLIN THER, V34, P1084, DOI 10.1016/j.clinthera.2012.04.007; Galler JR, 2012, NUTR NEUROSCI, V15, P186, DOI 10.1179/1476830512Y.0000000012; Head KJ, 2013, SOC SCI MED, V97, P41, DOI 10.1016/j.socscimed.2013.08.003; Horne R, 2002, PSYCHOL HEALTH, V17, P17, DOI 10.1080/08870440290001502; Hou MY, 2010, OBSTET GYNECOL, V116, P633, DOI 10.1097/AOG.0b013e3181eb6b0f; Huamán-Espino Lucio, 2012, Rev. perú. med. exp. salud publica, V29, P314; Jones COH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038636; Kong G, 2014, ADDICT BEHAV, V39, P907, DOI 10.1016/j.addbeh.2013.11.024; Lee T., 2005, J ELECTRON COMMER RE, V6, P165, DOI DOI 10.1145/1964921.1964953; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Li Q, 2009, PEDIATRICS, V123, pE685, DOI 10.1542/peds.2008-3007; Lim MSC, 2008, INT J STD AIDS, V19, P287, DOI 10.1258/ijsa.2007.007264; Luo RF, 2012, ECON DEV CULT CHANGE, V60, P735, DOI 10.1086/665606; Montes JM, 2012, PSYCHIAT RES, V200, P89, DOI 10.1016/j.psychres.2012.07.034; Ministry of Health People's Republic of China, 2012, NAT REP NUTR STAT CH; Mirkovic KR, 2016, PUBLIC HEALTH NUTR, V19, P1768, DOI 10.1017/S1368980015003572; Mo D, 2014, WORLD DEV, V64, P766, DOI 10.1016/j.worlddev.2014.07.015; Munayco César V, 2013, Rev. perú. med. exp. salud publica, V30, P229; Pasricha SR, 2013, BLOOD, V121, P2607, DOI 10.1182/blood-2012-09-453522; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rawat R, 2013, ANN NUTR METAB, V63, P220; Rettie R., 2005, J TARGETING MEASUREM, V13, P304, DOI DOI 10.1057/PALGRAVE.JT.5740158; Siekmans K, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12464; Spybrook J., 2008, OPTIMAL DESIGN LONGI; Strandbygaard U, 2010, RESP MED, V104, P166, DOI 10.1016/j.rmed.2009.10.003; UNICEF, 1999, STAT WORLDS CHILDR F; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang Lijuan, 2011, Wei Sheng Yan Jiu, V40, P61; Weaver RK, 2014, GOVERNANCE, V27, P243, DOI 10.1111/gove.12032; Xu L, 2011, INT J SOC WELF, V20, pS148, DOI 10.1111/j.1468-2397.2011.00809.x; Yue A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153385; Zhang Qiannan, 2015, Wei Sheng Yan Jiu, V44, P970; Zhou H, 2016, AM J PUBLIC HEALTH, V106, P1256, DOI 10.2105/AJPH.2016.303140	49	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191549	10.1371/journal.pone.0191549	http://dx.doi.org/10.1371/journal.pone.0191549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29352304	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300112
J	Chang, HJ; Shin, HS; Kim, TH; Yoo, JY; Teasley, HE; Zhao, JJ; Ha, UH; Jeong, JW				Chang, Hye Jin; Shin, Hee Sung; Kim, Tae Hoon; Yoo, Jung-Yoon; Teasley, Hanna E.; Zhao, Jean J.; Ha, Un-Hwan; Jeong, Jae-Wook			Pik3ca is required for mouse uterine gland development and pregnancy	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; PROGESTERONE-RECEPTOR; BLASTOCYST IMPLANTATION; ENDOMETRIAL CARCINOMA; BIOLOGICAL ROLES; HIGH-FREQUENCY; BREAST-CANCER; GROWTH; FOXA2; MUTATIONS	The PI3K/AKT signaling pathway plays a critical role in the maintenance of equilibrium between cell survival and apoptosis. The Pik3ca gene is mutated in a range of human cancers. It has been found to be oncogenic, and mutations lead to constitutive activation of the PI3K/AKT pathway. The expression patterns of PIK3CA proteins in the uterus of mice during early pregnancy indicate that it may play a role in the regulation of glandular epithelial cells, which is required to support uterine receptivity. To further investigate the role of Pik3ca in uterine function, Pik3ca was conditionally ablated only in the PGR-positive cells (Pgr(cre/+)Pik3ca(f/f); Pik3ca(d/d)). A defect of uterine gland development and decidualization led to subfertility observed in Pik3ca(d/d) mice. Pik3ca(d/d) mice showed significantly decreased uterine weight compared to Pik3ca(f/f) mice. Interestingly, a significant decrease of gland numbers were detected in Pik3ca(d/d) mice compared to control mice. In addition, we found a decrease of Foxa2 expression, which is a known uterine gland marker in Pik3ca(d/d) mice. Furthermore, the excessive proliferation of endometrial epithelial cells was observed in Pik3ca(d/d) mice. Our studies suggest that Pik3ca has a critical role in uterine gland development and female fertility.	[Chang, Hye Jin; Shin, Hee Sung; Kim, Tae Hoon; Yoo, Jung-Yoon; Teasley, Hanna E.; Jeong, Jae-Wook] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI 49546 USA; [Chang, Hye Jin] Seoul Natl Univ, Bundang Hosp, Hlth Promot Ctr, Seongnam, South Korea; [Shin, Hee Sung; Ha, Un-Hwan] Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea; [Yoo, Jung-Yoon] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Teasley, Hanna E.] Kalamazoo Coll, Dept Biol, Kalamazoo, MI 49007 USA; [Zhao, Jean J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Michigan State University; Seoul National University (SNU); Korea University; Yonsei University; Yonsei University Health System; Kalamazoo College; Harvard University; Dana-Farber Cancer Institute	Jeong, JW (corresponding author), Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI 49546 USA.; Ha, UH (corresponding author), Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea.	haunhwan@korea.ac.kr; jeongj@msu.edu	Ha, Un-Hwan/ABH-8017-2020	Yoo, Jung-Yoon/0000-0001-9366-3863; Jeong, Jae-Wook/0000-0002-5368-6478	NICHD [R01HD084478]; National Research Foundation of Korea [NRF-2016R1A2B4007539]; BK21 plus program of the Ministry of Education, Korea; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084478] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Research Foundation of Korea(National Research Foundation of Korea); BK21 plus program of the Ministry of Education, Korea; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NICHD R01HD084478 (to J.W.J) and the National Research Foundation of Korea grant (NRF-2016R1A2B4007539) and the BK21 plus program of the Ministry of Education, Korea (to U.H.H).	Acosta-Martinez Maricedes, 2011, Front Endocrinol (Lausanne), V2, P110, DOI 10.3389/fendo.2011.00110; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bartol FF, 1999, J REPROD FERTIL, P287; Bastidas-Ponce A, 2017, MOL METAB, V6, P524, DOI 10.1016/j.molmet.2017.03.007; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; BRANHAM WS, 1985, ENDOCRINOLOGY, V117, P2229, DOI 10.1210/endo-117-5-2229; BRODY JR, 1989, AM J ANAT, V186, P1, DOI 10.1002/aja.1001860102; Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cardone L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037526; Carta L, 2004, BIOL REPROD, V71, P444, DOI 10.1095/biolreprod.103.026534; Catasus L, 2008, MODERN PATHOL, V21, P131, DOI 10.1038/modpathol.3800992; Chang C F, 2016, Mol Biol (Mosk), V50, P457, DOI 10.7868/S0026898416030058; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cizkova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015647; Cooke PS, 2013, MOL HUM REPROD, V19, P547, DOI 10.1093/molehr/gat031; CUNHA GR, 1976, INT REV CYTOL, V47, P137, DOI 10.1016/S0074-7696(08)60088-1; Ding Y, 2016, CYTOTECHNOLOGY, V68, P2037, DOI 10.1007/s10616-016-9944-7; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Filant J, 2014, INT J DEV BIOL, V58, P107, DOI 10.1387/ijdb.130344ts; Filant J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097089; FINN CA, 1967, J ENDOCRINOL, V39, P593, DOI 10.1677/joe.0.0390593; Franco HL, 2012, FASEB J, V26, P1218, DOI 10.1096/fj.11-193334; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; Growdon WB, 2011, GYNECOL ONCOL, V121, P212, DOI 10.1016/j.ygyno.2010.11.039; Hu JB, 2004, BIOL REPROD, V70, P1870, DOI 10.1095/biolreprod.103.026336; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Jeong JW, 2008, ONCOGENE; Jones SR, 2000, ENDOCRINOLOGY, V141, P637, DOI 10.1210/en.141.2.637; Kelleher AM, 2017, P NATL ACAD SCI USA, V114, pE1018, DOI 10.1073/pnas.1618433114; Kelleher AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38078; Kim TH, 2010, ONCOGENE, V29, P3770, DOI 10.1038/onc.2010.126; Kim T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005278; Kurita T, 2001, DEV BIOL, V240, P194, DOI 10.1006/dbio.2001.0458; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Miller C, 1998, DEVELOPMENT, V125, P3201; Nelson VLB, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3756089; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620; RIDER V, 1994, J ENDOCRINOL, V140, P239, DOI 10.1677/joe.0.1400239; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schneider MR, 2008, CYTOKINE GROWTH F R, V19, P173, DOI 10.1016/j.cytogfr.2008.01.003; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Spencer TE, 2014, SEMIN REPROD MED, V32, P346, DOI 10.1055/s-0034-1376354; Spencer TE, 2012, MOL CELL ENDOCRINOL, V354, P34, DOI 10.1016/j.mce.2011.09.035; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Vogt PK, 2011, CURR TOP MICROBIOL, V347, P79, DOI 10.1007/82_2010_80; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103	52	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191433	10.1371/journal.pone.0191433	http://dx.doi.org/10.1371/journal.pone.0191433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346447	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500050
J	Sridharan, J; Haremaki, T; Weinstein, DC				Sridharan, Jyotsna; Haremaki, Tomomi; Weinstein, Daniel C.			Cloning and spatiotemporal expression of Xenopus laevis Apolipoprotein CI	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; TRIGLYCERIDE-RICH LIPOPROTEINS; IN-SITU HYBRIDIZATION; APOC-I; ALZHEIMERS-DISEASE; TRANSGENIC MICE; GENE; INHIBITION; EMBRYOS; HYPERLIPIDEMIA	Apolipoprotein CI (ApoCI) belongs to the Apolipoprotein superfamily, members of which are involved in lipid transport, uptake and homeostasis. Excessive ApoCI has been implicated in atherosclerosis and Alzheimer's disease in humans. In this study we report the isolation of Xenopus laevis apoCI and describe the expression pattern of this gene during early development, using reverse transcription polymerase chain reaction and whole mount in situ hybridization. Xenopus apoCI is enriched in the dorsal ectoderm during gastrulation, and is subsequently expressed in sensory placodes, neural tube and cranial neural crest. These data suggest as yet uncharacterized roles for ApoCI during early vertebrate embryogenesis.	[Sridharan, Jyotsna; Haremaki, Tomomi; Weinstein, Daniel C.] CUNY Queens Coll, Biol Dept, Flushing, NY 11367 USA; [Sridharan, Jyotsna] Thermo Fisher Sci, San Diego, CA USA; [Haremaki, Tomomi] Rockefeller Univ, Lab Stem Cell Biol & Mol Embryol, New York, NY 10021 USA	City University of New York (CUNY) System; Queens College NY (CUNY); Thermo Fisher Scientific; Rockefeller University	Weinstein, DC (corresponding author), CUNY Queens Coll, Biol Dept, Flushing, NY 11367 USA.	daniel.weinstein@qc.cuny.edu		Weinstein, Daniel/0000-0001-7832-9285	National Institute of General Medical Sciences, National Institutes of Health [R15GM124577]; Queens College of the City University of New York; Queens College; National Institutes of Health; PHS grant [R15GM124577]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM124577] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Queens College of the City University of New York; Queens College; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (https://www.nigms.nih.gov/Pages/default.aspx, National Institutes of Health, R15GM124577 to Daniel C Weinstein and by Queens College of the City University of New York. Funds from Queens College supported the study design, data collection, and analysis. Funds from the National Institutes of Health supported data analysis and preparation of the manuscript.; We are grateful to A. Dickinson for helpful advice on Xenopus face and head anatomy. This work is supported by PHS grant R15GM124577 (to DCW) and by Queens College of the City University of New York.	Abildayeva K, 2008, J LIPID RES, V49, P856, DOI 10.1194/jlr.M700518-JLR200; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; BRESLOW JL, 1988, PHYSIOL REV, V68, P85, DOI 10.1152/physrev.1988.68.1.85; Dickinson A, 2007, SEMIN CELL DEV BIOL, V18, P525, DOI 10.1016/j.semcdb.2007.04.002; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Gould SE, 1997, CELL MOL LIFE SCI, V53, P319, DOI 10.1007/PL00000609; Hamsten A, 2005, J AM COLL CARDIOL, V45, P1013, DOI 10.1016/j.jacc.2004.12.049; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; Jong MC, 1999, BIOCHEM J, V338, P281, DOI 10.1042/0264-6021:3380281; Ki CS, 2002, NEUROSCI LETT, V319, P75, DOI 10.1016/S0304-3940(01)02559-9; KNOTT TJ, 1984, NUCLEIC ACIDS RES, V12, P3909, DOI 10.1093/nar/12.9.3909; Koga M, 2007, DEV GROWTH DIFFER, V49, P635, DOI 10.1111/j.1440-169x.2007.00958.x; LAUER SJ, 1988, J BIOL CHEM, V263, P7277; Linker C, 2000, DEV BIOL, V224, P215, DOI 10.1006/dbio.2000.9723; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Poduslo SE, 1998, NEUROCHEM RES, V23, P361, DOI 10.1023/A:1022409617539; Schlosser G, 2004, DEV BIOL, V271, P439, DOI 10.1016/j.ydbio.2004.04.013; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; SLACK JMW, 1992, DEVELOPMENT, P143; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Wang Y, 2008, FISH PHYSIOL BIOCHEM, V34, P339, DOI 10.1007/s10695-007-9193-y; WEISGRABER KH, 1990, J BIOL CHEM, V265, P22453; Westerterp Marit, 2007, Atherosclerosis, V195, pe9, DOI 10.1016/j.atherosclerosis.2007.01.015; Westerterp M, 2006, J LIPID RES, V47, P1203, DOI 10.1194/jlr.M500434-JLR200; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Xu Y, 1999, J LIPID RES, V40, P50	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191470	10.1371/journal.pone.0191470	http://dx.doi.org/10.1371/journal.pone.0191470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346450	gold, Green Published			2022-12-27	WOS:000422749500054
J	Wanzira, H; Eganyu, T; Mulebeke, R; Bukenya, F; Echodu, D; Adoke, Y				Wanzira, Humphrey; Eganyu, Thomas; Mulebeke, Ronald; Bukenya, Fred; Echodu, Dorothy; Adoke, Yeka			Long lasting insecticidal bed nets ownership, access and use in a high malaria transmission setting before and after a mass distribution campaign in Uganda	PLOS ONE			English	Article							CHILD-MORTALITY; WESTERN KENYA; MORBIDITY; COVERAGE	Introduction Uganda is conducting a second mass LLIN distribution campaign and Katakwi district recently received LLINs as part of this activity. This study was conducted to measure the success of the campaign in this setting, an area of high transmission, with the objectives to estimate LLIN ownership, access and use pre and post campaign implementation. Methods Two identical cross sectional surveys, based on the Malaria Indicator Survey methodology, were conducted in three sub-counties in this district (Kapujan, Magoro and Toroma), six months apart, one before and another after the mass distribution campaign. Data on three main LLIN indicators including; household LLIN ownership, population with access to an LLIN and use were collected using a household and a women's questionnaire identical to the Malaria Indicator Survey. Results A total of 601 and 607 households were randomly selected in survey one and two respectively. At baseline, 60.57% (56.53-64.50) of households owned at least one net for every two persons who stayed in the household the night before the survey which significantly increased to 70.35% (66.54-73.96) after the campaign (p = 0.001). Similarly, the percentage of the household population with access to an LLIN significantly increased from 84.76% (82.99-86.52) to 91.57% (90.33-92.81), p = 0.001 and the percentage of household population that slept under an LLIN the night before the survey also significantly increased from 56.85% (55.06-58.82) to 81.72% (76.75-83.21), p = 0.001. Conclusion The LLIN mass campaign successfully achieved the national target of over eighty-five percent of the population with access to an LLIN in this setting, however, universal household coverage and use were fourteen and three percent points less than the national target respectively. This is useful for malaria programs to consider during the planning of future campaigns by tailoring efforts around deficient areas like mechanisms to increase universal coverage and behavior change communication.	[Wanzira, Humphrey; Eganyu, Thomas; Mulebeke, Ronald; Bukenya, Fred; Echodu, Dorothy] Pilgrim Africa, Kampala, Uganda; [Adoke, Yeka] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	Makerere University	Wanzira, H (corresponding author), Pilgrim Africa, Kampala, Uganda.	wanzirah@yahoo.com	Wanzira, Humphrey/AAF-1373-2020; Mulebeke, Ronald/ABE-6099-2021	Wanzira, Humphrey/0000-0003-1074-5340; Echodu, Dorothy/0000-0002-0597-6120	Bill and Melinda Gates Foundation [OPP1148566]; DE	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); DE	This study was made possible through the funding from the Bill and Melinda Gates Foundation, OPP1148566, https.//www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2016/04/0001148566. This funding was received by DE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, UG MAL RED STRAT PLA; [Anonymous], UG MAL IND SURV 2014; [Anonymous], 2012, TOOLK MASS DISTR CAM; [Anonymous], 2013, WHO REC ACH UN COV L; Bennett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037927; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Gimnig JE, 2003, AM J TROP MED HYG, V68; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hwang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011692; Koenker H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-1; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Ministry of Health, UG HLTH MAN INF SYST; Ministry of Health, MAL IND SURV 2009; Ministry of Health, 2015, MASS DISTR LONG LAST; Ministry of Health, 2016, DET IMPL GUID UN COV; Ministry of Health, 2015, NIG MAL IND SURV; Ministry of Health, TANZ DEM HLTH SURV M; Ministry of Health, KEN MAL IND SURV 201; Ministry of Health, 2013, MASS DISTR LONG LAST; Mugisa M, 2012, PAN AFR MED J S1, V13; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P10, DOI 10.4269/ajtmh.2003.68.10; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Wanzira H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1360-0; WHO (World Health Organization), 2013, METH MAINT COV LONG; World Health Organization, 2012, WORLD MAL REP 2012	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191191	10.1371/journal.pone.0191191	http://dx.doi.org/10.1371/journal.pone.0191191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346408	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500036
J	Wu, Y; Sescousse, G; Yu, HB; Clark, L; Li, H				Wu, Yin; Sescousse, Guillaume; Yu, Hongbo; Clark, Luke; Li, Hong			Cognitive distortions and gambling near-misses in Internet Gaming Disorder: A preliminary study	PLOS ONE			English	Article							INCENTIVE-SENSITIZATION; PATHOLOGICAL GAMBLERS; STRUCTURAL CHARACTERISTICS; BEHAVIORAL ADDICTION; GAMES; OUTCOMES; AROUSAL; PREFERENCES; IMPULSIVITY; PERSISTENCE	Increased cognitive distortions (i.e. biased processing of chance, probability and skill) are a key psychopathological process in disordered gambling. The present study investigated state and trait aspects of cognitive distortions in 22 individuals with Internet Gaming Disorder (IGD) and 22 healthy controls. Participants completed the Gambling Related Cognitions Scale as a trait measure of cognitive distortions, and played a slot machine task delivering wins, near-misses and full-misses. Ratings of pleasure ("liking") and motivation to play ("wanting") were taken following the different outcomes, and gambling persistence was measured after a mandatory phase. IGD was associated with elevated trait cognitive distortions, in particular skill-oriented cognitions. On the slot machine task, the IGD group showed increased "wanting" ratings compared with control participants, while the two groups did not differ regarding their "liking" of the game. The IGD group displayed increased persistence on the slot machine task. Near-miss outcomes did not elicit stronger motivation to play compared to full-miss outcomes overall, and there was no group difference on this measure. However, a near-miss position effect was observed, such that near-misses stopping before the payline were rated as more motivating than near-misses that stopped after the payline, and this differentiation was attenuated in the IGD group, suggesting possible counterfactual thinking deficits in this group. These data provide preliminary evidence for increased incentive motivation and cognitive distortions in IGD, at least in the context of a chance-based gambling environment.	[Wu, Yin; Li, Hong] Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen, Peoples R China; [Wu, Yin; Li, Hong] Shenzhen Univ, Shenzhen Key Lab Affect & Social Cognit Sci, Shenzhen, Peoples R China; [Sescousse, Guillaume] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Yu, Hongbo] Univ Oxford, Dept Expt Psychol, Oxford, England; [Clark, Luke] Univ British Columbia, Ctr Gambling Res UBC, Dept Psychol, Vancouver, BC, Canada	Shenzhen University; Shenzhen University; Radboud University Nijmegen; University of Oxford; University of British Columbia	Wu, Y; Li, H (corresponding author), Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen, Peoples R China.; Wu, Y; Li, H (corresponding author), Shenzhen Univ, Shenzhen Key Lab Affect & Social Cognit Sci, Shenzhen, Peoples R China.	yinwu0407@gmail.com; lihongszu@szu.edu.cn	Sescousse, Guillaume/J-1721-2012	Sescousse, Guillaume/0000-0002-8556-3755; Wu, Yin/0000-0002-6364-4597	National Natural Science Foundation of China [31600923]; Shenzhen Philosophy and Social Science Foundation [135C019]; Shenzhen University Natural Science Research Fund [2016073]; Shenzhen University Social and Humanity Science Research Fund [17QNFC44]; VENI grant from the Netherlands Organisation for Scientific Research (NWO); Newton International Fellowship from the Royal Society [NF160700]; British Columbia Lottery Corporation; Province of British Columbia government	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Philosophy and Social Science Foundation; Shenzhen University Natural Science Research Fund; Shenzhen University Social and Humanity Science Research Fund; VENI grant from the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Newton International Fellowship from the Royal Society; British Columbia Lottery Corporation; Province of British Columbia government	YW was supported by National Natural Science Foundation of China (31600923), Shenzhen Philosophy and Social Science Foundation (135C019), Shenzhen University Natural Science Research Fund (2016073) and Shenzhen University Social and Humanity Science Research Fund (17QNFC44). GS was supported by a VENI grant from the Netherlands Organisation for Scientific Research (NWO). HY was supported by a Newton International Fellowship from the Royal Society (NF160700). The Centre for Gambling Research at UBC, which provided salary support for LC, is supported by funding from the British Columbia Lottery Corporation and the Province of British Columbia government. Corporation and the Province of British Columbia government, which provided salary support for LC; the funding bodies did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	ANDERSON G, 1984, BRIT J PSYCHOL, V75, P401, DOI 10.1111/j.2044-8295.1984.tb01910.x; Bailey K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00609; Billieux J, 2012, BRIT J PSYCHOL, V103, P412, DOI 10.1111/j.2044-8295.2011.02083.x; Billieux J, 2011, PSYCHOPATHOLOGY, V44, P165, DOI 10.1159/000322525; Chase HW, 2010, J NEUROSCI, V30, P6180, DOI 10.1523/JNEUROSCI.5758-09.2010; Choi SW, 2014, J BEHAV ADDICT, V3, P246, DOI 10.1556/JBA.3.2014.4.6; Clark L, 2014, ANN NY ACAD SCI, V1327, P46, DOI 10.1111/nyas.12558; Clark L, 2013, J BEHAV DECIS MAKING, V26, P442, DOI 10.1002/bdm.1774; Clark L, 2010, PHILOS T R SOC B, V365, P319, DOI 10.1098/rstb.2009.0147; Clark L, 2009, NEURON, V61, P481, DOI 10.1016/j.neuron.2008.12.031; Cote Denis, 2003, J Gambl Stud, V19, P433, DOI 10.1023/A:1026384011003; Dong GH, 2017, BIOL PSYCHIAT-COGN N, V2, P404, DOI 10.1016/j.bpsc.2017.01.002; Dreier M, 2017, ADDICT BEHAV, V64, P328, DOI 10.1016/j.addbeh.2016.03.008; Epstude K, 2008, PERS SOC PSYCHOL REV, V12, P168, DOI 10.1177/1088868308316091; Ferguson CJ, 2011, J PSYCHIATR RES, V45, P1573, DOI 10.1016/j.jpsychires.2011.09.005; Ferris J., 2001, CANADIAN PROBLEM GAM, DOI DOI 10.1007/S10899-010-9224-Y; Field M, 2009, PSYCHOL BULL, V135, P589, DOI 10.1037/a0015843; Goodie AS, 2013, PSYCHOL ADDICT BEHAV, V27, P730, DOI 10.1037/a0031892; Gupta R, 1996, J Gambl Stud, V12, P375, DOI 10.1007/BF01539183; Habib R, 2010, J EXP ANAL BEHAV, V93, P313, DOI 10.1901/jeab.2010.93-313; Irvine MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075914; Joukhador J, 2003, PSYCHOL REP, V92, P1203, DOI 10.2466/PR0.92.3.1203-1214; Kassinove JI, 2001, PSYCHOL ADDICT BEHAV, V15, P155, DOI 10.1037/0893-164X.15.2.155; King D, 2010, INT J MENT HEALTH AD, V8, P90, DOI 10.1007/s11469-009-9206-4; King DL, 2014, CLIN PSYCHOL REV, V34, P298, DOI 10.1016/j.cpr.2014.03.006; King DL, 2012, J GAMBL STUD, V28, P421, DOI 10.1007/s10899-011-9271-z; Ko CH, 2005, J NERV MENT DIS, V193, P273, DOI 10.1097/01.nmd.0000158373.85150.57; Ladouceur R, 2003, ADDICTION, V98, P733, DOI 10.1046/j.1360-0443.2003.00412.x; Limbrick-Oldfield EH, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.256; Liu L, 2017, ADDICT BIOL, V22, P791, DOI 10.1111/adb.12338; Loba P, 2001, J Gambl Stud, V17, P297, DOI 10.1023/A:1013639729908; Michalczuk R, 2011, PSYCHOL MED, V41, P2625, DOI 10.1017/S003329171100095X; Moore SM, 1999, PSYCHOL ADDICT BEHAV, V13, P339, DOI 10.1037/0893-164X.13.4.339; Myrseth H, 2010, J GAMBL STUD, V26, P561, DOI 10.1007/s10899-010-9180-6; Owens MD, 2012, GAMING LAW REV, V16, P114, DOI 10.1089/glre.2012.1634; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Petry NM, 2014, ADDICTION, V109, P1399, DOI 10.1111/add.12457; Petry NM, 2013, ADDICTION, V108, P1186, DOI 10.1111/add.12162; Przybylski AK, 2017, AM J PSYCHIAT, V174, P230, DOI 10.1176/appi.ajp.2016.16020224; Raylu N, 2004, ADDICTION, V99, P757, DOI 10.1111/j.1360-0443.2004.00753.x; Reid R. L, 1986, J GAMBLING BEHAV, V2, P32, DOI [DOI 10.1007/BF01019932, 10.1007/BF01019932]; Robbins TW, 2015, CURR OPIN NEUROBIOL, V30, P66, DOI 10.1016/j.conb.2014.09.005; Robinson TE, 2001, ADDICTION, V96, P103, DOI 10.1046/j.1360-0443.2001.9611038.x; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Sescousse G, 2016, NEUROPSYCHOPHARMACOL, V41, P2614, DOI 10.1038/npp.2016.43; Sharman S, 2016, J GAMBL STUD, V32, P823, DOI 10.1007/s10899-015-9578-2; Thomsen KR, 2014, NEUROSCI BIOBEHAV R, V45, P343, DOI 10.1016/j.neubiorev.2014.07.009; Tochkov K, 2009, JUDGM DECIS MAK, V4, P227; Wood RTA, 2004, CYBERPSYCHOL BEHAV, V7, P1, DOI 10.1089/109493104322820057; Wu Y, 2017, J BEHAV DECIS MAKING, V30, P855, DOI 10.1002/bdm.2010; Wulfert E, 2005, PSYCHOL ADDICT BEHAV, V19, P311, DOI 10.1037/0893-164X.19.3.311; Yakovenko I, 2016, INT GAMBL STUD, V9795, P1; Young KS., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	53	10	10	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191110	10.1371/journal.pone.0191110	http://dx.doi.org/10.1371/journal.pone.0191110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9PC	29346434	gold, Green Published, Green Submitted			2022-12-27	WOS:000422749500027
J	Chaorattanakawee, S; Nuchnoi, P; Hananantachai, H; Tumkosit, U; Saunders, D; Naka, I; Ohashi, J; Patarapotikul, J				Chaorattanakawee, Suwanna; Nuchnoi, Pornlada; Hananantachai, Hathairad; Tumkosit, Uranan; Saunders, David; Naka, Izumi; Ohashi, Jun; Patarapotikul, Jintana			Sequence variation in Plasmodium falciparum merozoite surface protein-2 is associated with virulence causing severe and cerebral malaria	PLOS ONE			English	Article							GENETIC DIVERSITY; VACCINE CANDIDATE; CLINICAL MALARIA; ANTIBODIES; INFECTIONS; COMPLEXITY; PATTERNS; CHILDREN; LOCUS; SURFACE-ANTIGEN-2	Parasite virulence, an important factor contributing to the severity of Plasmodium falciparum infection, varies among P. falciparum strains. Relatively little is known regarding markers of virulence capable of identifying strains responsible for severe malaria. We investigated the effects of genetic variations in the P.f. merozoite surface protein 2 gene (msp2) on virulence, as it was previously postulated as a factor. We analyzed 300 msp2 sequences of single P. falciparum clone infection from patients with uncomplicated disease as well as those admitted for severe malaria with and without cerebral disease. The association of msp2 variations with disease severity was examined. We found that the N allele at codon 8 of Block 2 in the FC27-like msp2 gene was significantly associated with severe disease without cerebral complications (odds ratio = 2.73, P = 0.039), while the K allele at codon 17 of Block 4 in the 3D7-like msp2 gene was associated with cerebral malaria (odds ratio = 3.52, P = 0.024). The data suggests possible roles for the associated alleles on parasite invasion processes and immune-mediated pathogenicity. Multiplicity of infection was found to associate with severe disease without cerebral complications, but not cerebral malaria. Variations in the msp2-FC27-block 2-8N and 3D7-block 4-17K allele appear to be parasite virulence markers, and may be useful in determining the likelihood for severe and cerebral malaria. Their interactions with potential host factors for severe diseases should also be explored.	[Chaorattanakawee, Suwanna] Thammasat Univ, Fac Allied Hlth Sci, Dept Med Technol, Rangsit, Patumthani, Thailand; [Chaorattanakawee, Suwanna] Mahidol Univ, Fac Publ Hlth, Dept Parasitol & Entomol, Bangkok, Thailand; [Nuchnoi, Pornlada] Mahidol Univ, Fac Med Technol, Dept Clin Microscopy, Nakhon Pathum, Thailand; [Hananantachai, Hathairad] Mahidol Univ, Fac Trop Med, Dept Social & Environm Med, Bangkok, Thailand; [Tumkosit, Uranan; Patarapotikul, Jintana] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Saunders, David] US Army Med Mat Dev Act, Ft Detrick, MD USA; [Naka, Izumi; Ohashi, Jun] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; [Tumkosit, Uranan] Thailand Japan Res Collaborat Ctr Emerging & Reem, Dept Med Sci, Sect Viral Infect, Nonthaburi, Thailand	Thammasat University; Mahidol University; Mahidol University; Mahidol University; Mahidol University; United States Department of Defense; United States Army; University of Tokyo	Chaorattanakawee, S (corresponding author), Thammasat Univ, Fac Allied Hlth Sci, Dept Med Technol, Rangsit, Patumthani, Thailand.; Chaorattanakawee, S (corresponding author), Mahidol Univ, Fac Publ Hlth, Dept Parasitol & Entomol, Bangkok, Thailand.	suwann67@yahoo.com	Nuchnoi, Pornlada/K-7125-2017	Nuchnoi, Pornlada/0000-0002-1123-1037	Thammasat university research grant; Thailand Research Fund through Royal Golden Jubilee PhD programme; China Medical Board (CMB), Faculty of Public Health, Mahidol University, Bangkok, Thailand	Thammasat university research grant; Thailand Research Fund through Royal Golden Jubilee PhD programme; China Medical Board (CMB), Faculty of Public Health, Mahidol University, Bangkok, Thailand	This study was supported by the Thammasat university research grant and the Thailand Research Fund through the Royal Golden Jubilee PhD programme. The study was partially supported for publication by the China Medical Board (CMB), Faculty of Public Health, Mahidol University, Bangkok, Thailand.	A-Elbasit IE, 2007, PARASITOL RES, V102, P29, DOI 10.1007/s00436-007-0716-3; Agrawal S, 2017, J INFECT DIS, V216, P468, DOI 10.1093/infdis/jix334; Amodu OK, 2008, ANN TROP MED PARASIT, V102, P95, DOI 10.1179/136485908X252340; Anong DN, 2010, ANN TROP MED PARASIT, V104, P25, DOI 10.1179/136485910X12607012373876; Auburn S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032891; Balam S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-510; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Boehringer S, 2000, HUM GENET, V107, P197, DOI 10.1007/s004390000353; Cornejo OE, 2015, GENOME BIOL EVOL, V7, P106, DOI 10.1093/gbe/evu267; Courtin D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007590; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; ENGELBRECHT F, 1995, EXP PARASITOL, V81, P90, DOI 10.1006/expr.1995.1096; EPPING RJ, 1988, MOL BIOCHEM PARASIT, V28, P1, DOI 10.1016/0166-6851(88)90173-9; Farnert A, 2001, T ROY SOC TROP MED H, V95, P225, DOI 10.1016/S0035-9203(01)90175-0; Farooq U, 2006, EXP PARASITOL, V112, P139, DOI 10.1016/j.exppara.2005.10.002; Felger I, 1997, J MOL EVOL, V45, P154, DOI 10.1007/PL00006215; Ferreira MU, 2007, EXP PARASITOL, V115, P32, DOI 10.1016/j.exppara.2006.05.003; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; GUPTA S, 1994, P NATL ACAD SCI USA, V91, P3715, DOI 10.1073/pnas.91.9.3715; Gurling H, 2007, SCHIZOPHR RES, V89, P357, DOI 10.1016/j.schres.2006.08.024; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Hamid MMA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1641-z; Hoffmann EHE, 2001, ANN TROP MED PARASIT, V95, P117, DOI 10.1080/00034980120045833; Issifou S, 2003, PARASITOL RES, V90, P423, DOI 10.1007/s00436-003-0854-1; Kang JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-131; Kiwuwa MS, 2013, PARASITOL RES, V112, P1691, DOI 10.1007/s00436-013-3325-3; Koller DL, 2004, J BONE MINER RES, V19, P1291, DOI 10.1359/JBMR.040409; Liljander A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-78; Maitland K, 2004, ACTA TROP, V90, P131, DOI 10.1016/j.actatropica.2003.11.010; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Montgomery J, 2006, J INFECT DIS, V194, P115, DOI 10.1086/504689; Murray L, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1324-4; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; Ocampo M, 2000, J PEPT RES, V55, P216, DOI 10.1034/j.1399-3011.2000.00174.x; Osier FHA, 2010, PARASITE IMMUNOL, V32, P193, DOI 10.1111/j.1365-3024.2009.01178.x; Paul REL, 1998, AM J TROP MED HYG, V58, P195, DOI 10.4269/ajtmh.1998.58.195; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Putaporntip C, 2008, GENE, V427, P51, DOI 10.1016/j.gene.2008.09.009; Ranjit MR, 2005, T ROY SOC TROP MED H, V99, P389, DOI 10.1016/j.trstmh.2004.09.010; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Rout R, 2009, TROP BIOMED, V26, P165; Scopel KKG, 2007, AM J TROP MED HYG, V76, P1084, DOI 10.4269/ajtmh.2007.76.1084; Shigidi MMT, 2004, AM J TROP MED HYG, V71, P754, DOI 10.4269/ajtmh.2004.71.754; Silverman EK, 2000, AM J RESP CELL MOL, V22, P645, DOI 10.1165/ajrcmb.22.6.f191; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; Tsuchiya N, 2002, IMMUNOL REV, V190, P169, DOI 10.1034/j.1600-065X.2002.19013.x; Wang ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33891	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190418	10.1371/journal.pone.0190418	http://dx.doi.org/10.1371/journal.pone.0190418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342212	Green Submitted, gold, Green Published			2022-12-27	WOS:000422653800022
J	Jones, DC; Scanteianu, A; DiStefano, M; Bouhaddou, M; Birtwistle, MR				Jones, DeAnalisa C.; Scanteianu, Adriana; DiStefano, Matthew; Bouhaddou, Mehdi; Birtwistle, Marc R.			Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma	PLOS ONE			English	Article							CANCER; MODELS; MUTATIONS; THERAPY; GENOME	Current treatments for glioblastoma multiforme (GBM)-an aggressive form of brain cancer-are minimally effective and yield a median survival of 14.6 months and a two-year survival rate of 30%. Given the severity of GBM and the limitations of its treatment, there is a need for the discovery of novel drug targets for GBM and more personalized treatment approaches based on the characteristics of an individual's tumor. Most receptor tyrosine kinases-such as EGFR-act as oncogenes, but publicly available data from the Cancer Cell Line Encyclopedia (CCLE) indicates copy number loss in the ERBB4 RTK gene across dozens of GBM cell lines, suggesting a potential tumor suppressor role. This loss is mutually exclusive with loss of its cognate ligand NRG1 in CCLE as well, more strongly suggesting a functional role. The availability of higher resolution copy number data from clinical GBM patients in The Cancer Genome Atlas (TCGA) revealed that a region in Intron 1 of the ERBB4 gene was deleted in 69.1% of tumor samples harboring ERBB4 copy number loss; however, it was also found to be deleted in the matched normal tissue samples from these GBM patients (n = 81). Using the DECIPHER Genome Browser, we also discovered that this mutation occurs at approximately the same frequency in the general population as it does in the disease population. We conclude from these results that this loss in Intron 1 of the ERBB4 gene is neither a de novo driver mutation nor a predisposing factor to GBM, despite the indications from CCLE. A biological role of this significantly occurring genetic alteration is still unknown. While this is a negative result, the broader conclusion is that while copy number data from large cell line-based data repositories may yield compelling hypotheses, careful follow up with higher resolution copy number assays, patient data, and general population analyses are essential to codify initial hypotheses prior to investing experimental resources.	[Jones, DeAnalisa C.; Scanteianu, Adriana; DiStefano, Matthew; Bouhaddou, Mehdi; Birtwistle, Marc R.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Birtwistle, MR (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA.	marc.birtwistle@mssm.edu		Scanteianu, Adriana/0000-0001-5491-0227; Jones, DeAnalisa/0000-0002-8737-6152; Birtwistle, Marc/0000-0002-0341-0705; Bouhaddou, Mehdi/0000-0002-9526-1427	National Institute of General Medical Sciences [R25GM064118]; Diversity Supplement to National Institutes of Health [R01GM104184]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104184, R25GM064118] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Diversity Supplement to National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institute of General Medical Sciences award number R25GM064118 (DCJ) and a Diversity Supplement to National Institutes of Health award number R01GM104184 (MRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], BIOINF PIP COP NUMB; Balani S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15422; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barrette AM, 2018, ACS CHEM NEUROSCI, V9, P118, DOI 10.1021/acschemneuro.7b00197; Bean JC, 2014, J NEUROSCI, V34, P13549, DOI 10.1523/JNEUROSCI.2021-14.2014; Birtwistle MR, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.51; Birtwistle M. R., SYSTEMS PHARM PHARM; Bouhaddou M., 2017, BIORXIV; Bouhaddou M, 2016, AAPS ADV PHARM SCI, V23, P105, DOI 10.1007/978-3-319-44534-2_6; Bouhaddou M, 2016, NATURE, V540, pE9, DOI 10.1038/nature20580; Bowers G, 2001, ONCOGENE, V20, P1388, DOI 10.1038/sj.onc.1204255; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen L., 2017, CELLULAR MOL IMMUNOL; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Davies MA, 2010, ONCOGENE, V29, P5545, DOI 10.1038/onc.2010.323; Firth H. V., 2009, AM J HUMAN GENETICS; Gallo JM, 2015, WIRES SYST BIOL MED, V7, P243, DOI 10.1002/wsbm.1300; Gharwan H, 2016, NAT REV CLIN ONCOL, V13, P209, DOI 10.1038/nrclinonc.2015.213; Haskins JW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005770; Huang NC., 2011, THESIS; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Levin VA, 2015, NEURO-ONCOLOGY, V17, P1, DOI 10.1093/neuonc/nov169; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Ricci C, 2000, INT J CANCER, V87, P29, DOI 10.1002/1097-0215(20000701)87:1<29::AID-IJC5>3.3.CO;2-A; Xie Y, 2015, EBIOMEDICINE, V2, P1351, DOI 10.1016/j.ebiom.2015.08.026; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871	28	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190664	10.1371/journal.pone.0190664	http://dx.doi.org/10.1371/journal.pone.0190664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342193	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800030
J	Parsons, DM; MacDonald, I; Buckthought, D; Middleton, C				Parsons, Darren M.; MacDonald, Iain; Buckthought, Dane; Middleton, Crispin			Do nursery habitats provide shelter from flow for juvenile fish?	PLOS ONE			English	Article							NEW-ZEALAND ESTUARY; SNAPPER CHRYSOPHRYS-AURATUS; MARINE NURSERIES; PAGRUS-AURATUS; ZOOPLANKTON; MANAGEMENT; TURBULENCE; ABUNDANCE; BEHAVIOR; COASTAL	Juvenile fish nurseries are an essential life stage requirement for the maintenance of many fish populations. With many inshore habitats globally in decline, optimising habitat management by increasing our understanding of the relationship between juvenile fish and nursery habitats may be a prudent approach. Previous research on post-settlement snapper (Chrysophrys auratus) has suggested that structure may provide a water flow refuge, allowing snapper to access high water flow sites that will also have a high flux of their pelagic prey. We investigated this hypothesis by describing how Artificial Seagrass Units (ASUs) modified water flow while also using a multi-camera set up to quantify snapper position in relation to this water flow environment. Horizontal water flow was reduced on the down-current side of ASUs, but only at the height of the seagrass canopy. While the highest abundance of snapper did occur down-current of the ASUs, many snapper also occupied other locations or were too high in the water column to receive any refuge from water flow. The proportion of snapper within the water column was potentially driven by strategy to access zooplankton prey, being higher on the up-current side of ASUs and on flood tides. It is possible that post-settlement snapper alternate position to provide opportunities for both feeding and flow refuging. An alternative explanation relates to an observed interaction between post settlement snapper and a predator, which demonstrated that snapper can utilise habitat structure when threatened. The nature of this relationship, and its overall importance in determining the value of nursery habitats to post-settlement snapper remains an elusive next step.	[Parsons, Darren M.; Buckthought, Dane] NIWA, Auckland, New Zealand; [Parsons, Darren M.] Univ Auckland, Inst Marine Sci, Auckland, New Zealand; [MacDonald, Iain] NIWA, Hamilton, New Zealand; [Middleton, Crispin] NIWA, Bream Bay, Ruakaka, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Auckland; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Parsons, DM (corresponding author), NIWA, Auckland, New Zealand.; Parsons, DM (corresponding author), Univ Auckland, Inst Marine Sci, Auckland, New Zealand.	darren.parsons@niwa.co.nz		Parsons, Darren/0000-0002-4030-512X	NIWA's Coasts and Oceans research programme 3	NIWA's Coasts and Oceans research programme 3	Funding was provided by NIWA's Coasts and Oceans research programme 3 (2016/17 Statement of Corporate Intent). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrhman MA, 2003, MAR ECOL PROG SER, V248, P67, DOI 10.3354/meps248067; Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; Anderson MJ, 2008, J EXP MAR BIOL ECOL, V366, P16, DOI 10.1016/j.jembe.2008.07.006; Asaeda T, 2005, T AM FISH SOC, V134, P537, DOI 10.1577/T03-083.1; Banas NS, 2007, MAR ECOL PROG SER, V341, P123, DOI 10.3354/meps341123; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bray R.N, 1981, FISHERY B, V78, P829; CARLSON DJ, 1984, CAN J FISH AQUAT SCI, V41, P1523, DOI 10.1139/f84-188; Clarke RD, 2005, MAR BIOL, V146, P1145, DOI 10.1007/s00227-004-1528-y; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; FAUSCH KD, 1981, CAN J FISH AQUAT SCI, V38, P1220, DOI 10.1139/f81-164; FRANCIS MP, 1994, NEW ZEAL J MAR FRESH, V28, P201, DOI 10.1080/00288330.1994.9516608; GAMBI MC, 1990, MAR ECOL PROG SER, V61, P159, DOI 10.3354/meps061159; Ghisalberti M, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000871; Goring DG, 2002, J HYDRAUL ENG-ASCE, V128, P117, DOI 10.1061/(ASCE)0733-9429(2002)128:1(117); Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; HUNTLEY DA, 1988, J PHYS OCEANOGR, V18, P339, DOI 10.1175/1520-0485(1988)018<0339:AMIDMF>2.0.CO;2; KAMERMANS P, 1994, MAR ECOL PROG SER, V104, P63, DOI 10.3354/meps104063; KINGSFORD MJ, 1988, MAR ECOL PROG SER, V48, P103, DOI 10.3354/meps048103; Lundquist C, 2012, PREDICTING SUITABLE; Morrison M., 2014, NZ AQUATIC ENV BIODI; Morrison MA, 2009, NZ AQUATIC ENV BIODI; Nagelkerken I., ECOLOGICAL CONNECTIV; Parsons DM, 2016, NEW ZEAL J MAR FRESH, V50, P358, DOI 10.1080/00288330.2016.1146310; Parsons DM, 2014, NEW ZEAL J MAR FRESH, V48, P256, DOI 10.1080/00288330.2014.892013; Parsons DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122137; Parsons DM, 2013, MAR ECOL-EVOL PERSP, V34, P492, DOI 10.1111/maec.12050; PETERSON CH, 1991, ESTUAR COAST SHELF S, V32, P405, DOI 10.1016/0272-7714(91)90052-D; Prins TC, 1996, MAR ECOL PROG SER, V142, P121, DOI 10.3354/meps142121; Rosenberg A, 2000, B MAR SCI, V66, P535; Sim-Smith CJ, 2013, MAR FRESHWATER RES, V64, P1003, DOI 10.1071/MF12345; Tennekes H., 1972, 1 COURSE TURBULENCE; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Trevethan M, 2007, ESTUAR COAST SHELF S, V73, P341, DOI 10.1016/j.ecss.2007.01.014; Usmar NR, 2012, NEW ZEAL J MAR FRESH, V46, P31, DOI 10.1080/00288330.2011.587824; Voulgaris G, 1998, J ATMOS OCEAN TECH, V15, P272, DOI 10.1175/1520-0426(1998)015<0272:EOTADV>2.0.CO;2; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	38	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0186889	10.1371/journal.pone.0186889	http://dx.doi.org/10.1371/journal.pone.0186889			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342152	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800002
J	Moussaid, M; Campero, AN; Almaatouq, A				Moussaid, Mehdi; Campero, Alejandro Noriega; Almaatouq, Abdullah			Dynamical networks of influence in small group discussions	PLOS ONE			English	Article							DECISION-MAKING; SOCIAL-INFLUENCE; JUDGMENT; POLARIZATION; PERFORMANCE; OPINIONS; SCIENCE; ADVICE	In many domains of life, business and management, numerous problems are addressed by small groups of individuals engaged in face-to-face discussions. While research in social psychology has a long history of studying the determinants of small group performances, the internal dynamics that govern a group discussion are not yet well understood. Here, we rely on computational methods based on network analyses and opinion dynamics to describe how individuals influence each other during a group discussion. We consider the situation in which a small group of three individuals engages in a discussion to solve an estimation task. We propose a model describing how group members gradually influence each other and revise their judgments over the course of the discussion. The main component of the model is an influence network-a weighted, directed graph that determines the extent to which individuals influence each other during the discussion. In simulations, we first study the optimal structure of the influence network that yields the best group performances. Then, we implement a social learning process by which individuals adapt to the past performance of their peers, thereby affecting the structure of the influence network in the long run. We explore the mechanisms underlying the emergence of efficient or maladaptive networks and show that the influence network can converge towards the optimal one, but only when individuals exhibit a social discounting bias by downgrading the relative performances of their peers. Finally, we find a late-speaker effect, whereby individuals who speak later in the discussion are perceived more positively in the long run and are thus more influential. The numerous predictions of the model can serve as a basis for future experiments, and this work opens research on small group discussion to computational social sciences.	[Moussaid, Mehdi] Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany; [Campero, Alejandro Noriega; Almaatouq, Abdullah] MIT, Cambridge, MA 02139 USA	Max Planck Society; Massachusetts Institute of Technology (MIT)	Moussaid, M (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Rat, Berlin, Germany.	moussaid@mpib-berlin.mpg.de	Almaatouq, Abdullah/ABB-4234-2021	Almaatouq, Abdullah/0000-0002-8467-9123	German Research Foundation (DFG), priority program on New Frameworks of Rationality [SPP 1516, HE 2768/7-2]	German Research Foundation (DFG), priority program on New Frameworks of Rationality	This research was supported by a grant from the German Research Foundation (DFG) as part of the priority program on New Frameworks of Rationality (SPP 1516) awarded to Ralph Hertwigand Thorsten Pachur (HE 2768/7-2). The fundershad no role in study design, data collection andanalysis, decision to publish, or preparation of themanuscript	Abelson RP, 1964, CONTRIBUTIONS MATH P; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; BURNSTEIN E, 1977, J EXP SOC PSYCHOL, V13, P315, DOI 10.1016/0022-1031(77)90002-6; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Clement RJG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077943; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; DEGROOT MH, 1974, J AM STAT ASSOC, V69, P118, DOI 10.2307/2285509; FRENCH JRP, 1956, PSYCHOL REV, V63, P181, DOI 10.1037/h0046123; Friedkin N. E., 2011, SOCIAL INFLUENCE NET, DOI [10.1017/CBO9780511976735, DOI 10.1017/CBO9780511976735]; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Hautz WE, 2015, JAMA-J AM MED ASSOC, V313, P303, DOI 10.1001/jama.2014.15770; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; ISENBERG DJ, 1986, J PERS SOC PSYCHOL, V50, P1141, DOI 10.1037/0022-3514.50.6.1141; Janis IL, 1982, GROUPTHINK PSYCHOL S; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Kim T, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P457; Klein N, 2015, P NATL ACAD SCI USA, V112, P7460, DOI 10.1073/pnas.1504048112; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Mason WA, 2007, PERS SOC PSYCHOL REV, V11, P279, DOI 10.1177/1088868307301032; Max H, 2008, JUDGMENT MANAGERIAL; Moussaid M, 2017, P NATL ACAD SCI USA, V114, P4117, DOI 10.1073/pnas.1611998114; Moussaid M, 2015, P NATL ACAD SCI USA, V112, P5631, DOI 10.1073/pnas.1421883112; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078433; Pentland A, 2012, HARVARD BUS REV, V90, P61; Soll JB, 2009, J EXP PSYCHOL LEARN, V35, P780, DOI 10.1037/a0015145; STASSER G, 1985, J PERS SOC PSYCHOL, V48, P1467, DOI 10.1037/0022-3514.48.6.1467; STASSER G, 1992, J PERS SOC PSYCHOL, V63, P426, DOI 10.1037/0022-3514.63.3.426; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Weisbuch G, 2003, INTERACTING AGENTS C; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Yaniv I, 2000, ORGAN BEHAV HUM DEC, V83, P260, DOI 10.1006/obhd.2000.2909	37	2	2	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190541	10.1371/journal.pone.0190541	http://dx.doi.org/10.1371/journal.pone.0190541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338013	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700015
J	Beaton, LE; Azma, S; Marinkovic, K				Beaton, Lauren E.; Azma, Sheeva; Marinkovic, Ksenija			When the brain changes its mind: Oscillatory dynamics of conflict processing and response switching in a flanker task during alcohol challenge	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL NETWORK; MEDIAL FRONTAL-CORTEX; MOVEMENT-RELATED POTENTIALS; AUTOMATIC MOTOR ACTIVATION; HUMAN SENSORIMOTOR-CORTEX; SURFACE-BASED ANALYSIS; EXECUTIVE FUNCTIONS; CORTICAL SURFACE; STROOP TASK	Despite the subjective experience of being in full and deliberate control of our actions, our daily routines rely on a continuous and interactive engagement of sensory evaluation and response preparation streams. They unfold automatically and unconsciously and are seamlessly integrated with cognitive control which is mobilized by stimuli that evoke ambiguity or response conflict. Methods with high spatio-temporal sensitivity are needed to provide insight into the interplay between automatic and controlled processing. This study used anatomically-constrained MEG to examine the underlying neural dynamics in a flanker task that manipulated S-R incongruity at the stimulus (SI) and response levels (Rl). Though irrelevant, flankers evoked automatic preparation of motor plans which had to be suppressed and reversed following the target presentation on Rl trials. Event-related source power estimates in beta (15-25 Hz) frequency band in the sensorimotor cortex tracked motor preparation and response in real time and revealed switching from the incorrectly-primed to the correctly-responding hemisphere. In contrast, theta oscillations (4-7 Hz) were sensitive to the levels of incongruity as the medial and ventrolateral frontal cortices were especially activated by response conflict. These two areas are key to cognitive control and their integrated contributions to response inhibition and switching were revealed by phase-locked co-oscillations. These processes were pharmacologically manipulated with a moderate alcohol beverage or a placebo administered to healthy social drinkers. Alcohol selectively decreased accuracy to response conflict. It strongly attenuated theta oscillations during decision making and partly re-sculpted relative contributions of the frontal network without affecting the motor switching process subserved by beta band. Our results indicate that motor preparation is initiated automatically even when counterproductive but that it is monitored and regulated by the prefrontal cognitive control processes under conflict. They further confirm that the regulative top-down functions are particularly vulnerable to alcohol intoxication.	[Beaton, Lauren E.; Marinkovic, Ksenija] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Azma, Sheeva; Marinkovic, Ksenija] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Marinkovic, Ksenija] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Marinkovic, Ksenija] San Diego State Univ, San Diego, CA 92182 USA	California State University System; San Diego State University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego; California State University System; San Diego State University	Marinkovic, K (corresponding author), San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA.; Marinkovic, K (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.; Marinkovic, K (corresponding author), Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA.; Marinkovic, K (corresponding author), San Diego State Univ, San Diego, CA 92182 USA.	kmarinkovic@mail.sdsu.edu	Marinkovic, Ksenija/AAD-4701-2020	Marinkovic, Ksenija/0000-0003-1658-4496	National Institutes of Health [R01-AA016624]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health (R01-AA016624) to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Amodeo LR, 2017, BEHAV BRAIN RES, V330, P25, DOI 10.1016/j.bbr.2017.05.007; Archambault PS, 2015, VISION RES, V110, P244, DOI 10.1016/j.visres.2014.09.009; Ariani G, 2015, J NEUROSCI, V35, P14160, DOI 10.1523/JNEUROSCI.0596-15.2015; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Barchiesi G, 2015, NEUROPSYCHOLOGIA, V69, P93, DOI 10.1016/j.neuropsychologia.2015.01.030; Barchiesi G, 2013, SOC COGN AFFECT NEUR, V8, P711, DOI 10.1093/scan/nss049; Bartholow BD, 2003, BIOL PSYCHOL, V64, P167, DOI 10.1016/S0301-0511(03)00108-X; Becker Howard C, 2014, Handb Clin Neurol, V125, P133, DOI 10.1016/B978-0-444-62619-6.00009-4; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Burle B, 2004, BRAIN COGNITION, V56, P153, DOI 10.1016/j.bandc.2004.06.004; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Chanraud Sandra, 2014, Handb Clin Neurol, V125, P369, DOI 10.1016/B978-0-444-62619-6.00022-7; Cheyne DO, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00237; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Cisek P, 2007, PROG BRAIN RES, V165, P475, DOI 10.1016/S0079-6123(06)65030-9; Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; COLES MGH, 1988, BIOL PSYCHOL, V26, P69, DOI 10.1016/0301-0511(88)90014-2; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desoto MC, 2001, J COGNITIVE NEUROSCI, V13, P523, DOI 10.1162/08989290152001934; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Ehlers CL, 2012, BRAIN RES, V1450, P67, DOI 10.1016/j.brainres.2012.02.039; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Erika-Florence M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5073; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Field M, 2010, ALCOHOL CLIN EXP RES, V34, P1346, DOI 10.1111/j.1530-0277.2010.01218.x; Fillmore Mark T, 2003, Behav Cogn Neurosci Rev, V2, P179, DOI 10.1177/1534582303257007; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fodor JA, 1983, MODULARITY OF MIND A; Fogelson N, 2006, CEREB CORTEX, V16, P64, DOI 10.1093/cercor/bhi084; Gibson J.J, 1977, PERCEIVING ACTING KN, P62; Goodale MA, 1998, CURR BIOL, V8, pR489, DOI 10.1016/S0960-9822(98)70314-8; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Grent-'t-Jong T, 2013, NEUROIMAGE, V83, P27, DOI 10.1016/j.neuroimage.2013.06.051; Halgren E, 2015, NEUROPSYCHOLOGIA, V76, P108, DOI 10.1016/j.neuropsychologia.2015.03.021; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hasselmo ME, 2014, NEUROIMAGE, V85, P656, DOI 10.1016/j.neuroimage.2013.06.022; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; Isabella S, 2015, NEUROIMAGE, V118, P268, DOI 10.1016/j.neuroimage.2015.05.081; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167; Jenkinson N, 2011, TRENDS NEUROSCI, V34, P611, DOI 10.1016/j.tins.2011.09.003; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; Jentsch JD, 2014, NEUROPHARMACOLOGY, V76, P479, DOI 10.1016/j.neuropharm.2013.05.022; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Kato Y, 2006, EXP BRAIN RES, V168, P51, DOI 10.1007/s00221-005-0090-2; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kilavik BE, 2013, EXP NEUROL, V245, P15, DOI 10.1016/j.expneurol.2012.09.014; Klopp J, 2000, HUM BRAIN MAPP, V11, P286, DOI 10.1002/1097-0193(200012)11:4<286::AID-HBM80>3.3.CO;2-I; KOELEGA HS, 1995, PSYCHOPHARMACOLOGY, V118, P233, DOI 10.1007/BF02245951; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kovacevic S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043957; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Le Berre AP, 2017, ALCOHOL CLIN EXP RES, V41, P1432, DOI 10.1111/acer.13431; Leunissen I, 2013, HUM BRAIN MAPP, V34, P1254, DOI 10.1002/hbm.21508; Liang J, 2014, ACTA PHARMACOL SIN, V35, P981, DOI 10.1038/aps.2014.50; Lin FH, 2004, NEUROIMAGE, V23, P582, DOI 10.1016/j.neuroimage.2004.04.027; Lyvers M, 2000, EXP CLIN PSYCHOPHARM, V8, P225, DOI 10.1037/1064-1297.8.2.225; Marinkovic K, 2004, NEUROSCIENTIST, V10, P142, DOI 10.1177/1073858403261018; Marinkovic K, 2001, ALCOHOL ALCOHOLISM, V36, P529, DOI 10.1093/alcalc/36.6.529; Marinkovic K, 2000, J STUD ALCOHOL, V61, P24, DOI 10.15288/jsa.2000.61.24; Marinkovic K, 2012, J ADDICT RES THER SU; Marinkovic K., 2014, MAGNETOENCEPHALOGRAP; Marinkovic K, 2013, PSYCHOPHARMACOLOGY, V230, P487, DOI 10.1007/s00213-013-3173-y; Marinkovic K, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00121; Marinkovic K, 2010, IFMBE PROC, V28, P374; Marinkovic K, 2012, HUM BRAIN MAPP, V33, P319, DOI 10.1002/hbm.21213; MARTIN CS, 1993, ALCOHOL CLIN EXP RES, V17, P140, DOI 10.1111/j.1530-0277.1993.tb00739.x; Mattler U, 2003, EXP BRAIN RES, V151, P272, DOI 10.1007/s00221-003-1486-5; McBride J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00082; McBride J, 2012, Q J EXP PSYCHOL, V65, P13, DOI 10.1080/17470218.2011.588336; McDermott TJ, 2017, NEUROIMAGE, V156, P277, DOI 10.1016/j.neuroimage.2017.05.014; Medalla M, 2009, NEURON, V61, P609, DOI 10.1016/j.neuron.2009.01.006; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Michelet T, 2010, J NEUROPHYSIOL, V104, P119, DOI 10.1152/jn.00819.2009; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morsella E., 2011, OXFORD HDB SOCIAL NE, P335, DOI DOI 10.1093/OXFORDHB/9780195342161.013; Most Dana, 2014, Handb Clin Neurol, V125, P89, DOI 10.1016/B978-0-444-62619-6.00006-9; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Neta M, 2015, J NEUROSCI, V35, P253, DOI 10.1523/JNEUROSCI.1313-14.2015; Neumann J, 2005, HUM BRAIN MAPP, V25, P165, DOI 10.1002/hbm.20133; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nigbur R, 2012, J COGNITIVE NEUROSCI, V24, P1264, DOI 10.1162/jocn_a_00128; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Osiurak F, 2017, NEUROSCI BIOBEHAV RE; Papadelis C, 2016, BRAIN RES, V1650, P252, DOI 10.1016/j.brainres.2016.09.011; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rickenbacher E, 2011, ALCOHOL, V45, P725, DOI 10.1016/j.alcohol.2011.04.002; Ridderinkhof KR, 2011, WIRES COGN SCI, V2, P174, DOI 10.1002/wcs.99; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Roberto M, 2017, NEUROPHARMACOLOGY, V122, P85, DOI 10.1016/j.neuropharm.2017.01.013; Roger C, 2014, PSYCHOPHYSIOLOGY, V51, P746, DOI 10.1111/psyp.12224; Rosen BQ, 2016, ALCOHOL CLIN EXP RES, V40, P743, DOI 10.1111/acer.13014; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Schneider W, 2003, COGNITIVE SCI, V27, P525, DOI 10.1016/S0364-0213(03)00011-9; SHIFFRIN RM, 1984, PSYCHOL REV, V91, P269, DOI 10.1037/0033-295X.91.2.269; Singh A, BAYES FACTOR DIENES; SMID HGOM, 1990, ACTA PSYCHOL, V74, P169, DOI 10.1016/0001-6918(90)90005-Z; Srinivasan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055247; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Sumner P, 2008, NEUROSCIENTIST, V14, P474, DOI 10.1177/1073858408314435; Sundermann B, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-119; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Taylor PCJ, 2007, CEREB CORTEX, V17, P391, DOI 10.1093/cercor/bhj156; Ubaldi S, 2015, CEREB CORTEX, V25, P1032, DOI 10.1093/cercor/bht295; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; van Zoest W, 2012, J VISION, V12, DOI 10.1167/12.8.16; van Zoest W, 2010, CONSCIOUS COGN, V19, P861, DOI 10.1016/j.concog.2010.04.001; Verleger R, 2009, EUR J NEUROSCI, V30, P318, DOI 10.1111/j.1460-9568.2009.06817.x; Wang CM, 2005, J NEUROSCI, V25, P604, DOI 10.1523/JNEUROSCI.4151-04.2005; Yeung N., 2013, OXFORD HDB COGNITIVE, V2, P275, DOI DOI 10.1093/OXFORDHB/9780199988709.013.0018	134	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191200	10.1371/journal.pone.0191200	http://dx.doi.org/10.1371/journal.pone.0191200			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BY	29329355	Green Published, Green Submitted, gold			2022-12-27	WOS:000419954100047
J	Jardim, E; Eero, M; Silva, A; Ulrich, C; Pawlowski, L; Holmes, SJ; Ibaibarriaga, L; De Oliveira, JAAA; Riveiro, I; Alzorriz, N; Citores, L; Scott, F; Uriarte, A; Carrera, P; Duhamel, E; Mosqueira, I				Jardim, Ernesto; Eero, Margit; Silva, Alexandra; Ulrich, Clara; Pawlowski, Lionel; Holmes, Steven J.; Ibaibarriaga, Leire; De Oliveira, Jose A. A. A.; Riveiro, Isabel; Alzorriz, Nekane; Citores, Leire; Scott, Finlay; Uriarte, Andres; Carrera, Pablo; Duhamel, Erwan; Mosqueira, Iago			Testing spatial heterogeneity with stock assessment models	PLOS ONE			English	Article							COD GADUS-MORHUA; SARDINE SARDINA-PILCHARDUS; NORTH-SEA; ATLANTIC COD; POPULATION-STRUCTURE; GEOGRAPHIC VARIABILITY; NORTHEASTERN ATLANTIC; FISH; DYNAMICS; WEST	This paper describes a methodology that combines meta-population theory and stock assessment models to gain insights about spatial heterogeneity of the meta-population in an operational time frame. The methodology was tested with stochastic simulations for different degrees of connectivity between sub-populations and applied to two case studies, North Sea cod (Gadus morua) and Northeast Atlantic sardine (Sardina pilchardus). Considering that the biological components of a population can be partitioned into discrete spatial units, we extended this idea into a property of additivity of sub-population abundances. If the additivity results hold true for putative sub-populations, then assessment results based on sub-populations will provide information to develop and monitor the implementation of finer scale/local management. The simulation study confirmed that when sub-populations are independent and not too heterogeneous with regards to productivity, the sum of stock assessment model estimates of sub-populations' SSB is similar to the SSB estimates of the meta-population. It also showed that a strong diffusion process can be detected and that the stronger the connection between SSB and recruitment, the better the diffusion process will be detected. On the other hand it showed that weak to moderate diffusion processes are not easy to identify and large differences between sub-populations productivities may be confounded with weak diffusion processes. The application to North Sea cod and Atlantic sardine exemplified how much insight can be gained. In both cases the results obtained were sufficiently robust to support the regional analysis.	[Jardim, Ernesto; Holmes, Steven J.; Alzorriz, Nekane; Scott, Finlay; Mosqueira, Iago] European Commiss, JRC, Via Enrico Fermi 2749, I-21027 Ispra, VA, Italy; [Eero, Margit; Ulrich, Clara] Tech Univ Denmark DTU AQUA, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Silva, Alexandra] IPMA, Av Dr Alfredo Magalhaes Ramalho 6, P-1449006 Lisbon, Portugal; [Pawlowski, Lionel; Duhamel, Erwan] IFREMER, Lab Technol & Biol Halieut, 8 Rue Francois Toullec, F-56100 Lorient, France; [Ibaibarriaga, Leire; Citores, Leire] AZTI Tecnalia, Marine Res Div, Sukarrieta 48395, Bizkaia, Spain; [De Oliveira, Jose A. A. A.] CEFAS, Lowestoft Lab, Pakefield Rd, Lowestoft NR33 0HT, Suffolk, England; [Riveiro, Isabel; Carrera, Pablo] IEO, Ctr Oceanog Vigo, Subida Radio Faro 50, Vigo 36390, Spain; [Uriarte, Andres] AZTI Tecnalia, Marine Res Div, Pasaia 20110, Gipuzkoa, Spain; [Citores, Leire] BCAM, Mazarredo 14, E-48009 Bilbao, Basque Country, Spain	European Commission Joint Research Centre; EC JRC ISPRA Site; Technical University of Denmark; Instituto Portugues do Mar e da Atmosfera; Ifremer; AZTI; Centre for Environment Fisheries & Aquaculture Science; Spanish Institute of Oceanography; AZTI; Basque Center for Applied Mathematics (BCAM)	Jardim, E (corresponding author), European Commiss, JRC, Via Enrico Fermi 2749, I-21027 Ispra, VA, Italy.	ernesto.jardim@ec.europa.eu	Ibaibarriaga, Leire/C-2483-2009; Jardim, Ernesto/X-9764-2019; Ulrich, Clara/F-3583-2011; Uriarte, Ainhize/AAF-5750-2021; Eero, Margit/AAK-2845-2021; Silva, Alexandra/I-4326-2017	Ibaibarriaga, Leire/0000-0001-5619-1174; Ulrich, Clara/0000-0001-7598-2051; Uriarte, Ainhize/0000-0002-9596-6451; Eero, Margit/0000-0002-1848-0597; Carrera, Pablo/0000-0001-8819-6690; Jardim, Ernesto/0000-0003-4695-825X; Duhamel, Erwan/0000-0001-6990-628X; Silva, Alexandra/0000-0002-2950-1429; Riveiro, I. (Isabel)/0000-0002-8905-072X; Mosqueira, Iago/0000-0002-3252-0591	European Union Data Collection Framework (EC) [199/2008]; AZTI Foundation; Basque Government BERC programme; Spanish Ministry of Economy and Competitiveness (MINECO) BCAM Severo Ochoa excellence accreditation [SEV-2013-0323]; PELAGI project - Basque Government (Economic Development and Infrastructure Department)	European Union Data Collection Framework (EC); AZTI Foundation; Basque Government BERC programme(Basque Government); Spanish Ministry of Economy and Competitiveness (MINECO) BCAM Severo Ochoa excellence accreditation(Spanish Government); PELAGI project - Basque Government (Economic Development and Infrastructure Department)	European Union Data Collection Framework (EC) 199/2008 funded the collection of the data used in this work. LC is supported by a doctoral grant from AZTI Foundation, the Basque Government BERC 2014-2017 programme and by the Spanish Ministry of Economy and Competitiveness (MINECO) BCAM Severo Ochoa excellence accreditation SEV-2013-0323. LI and AU work was partly supported by the PELAGI project funded by the Basque Government (Economic Development and Infrastructure Department). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], QUANTITATIVE FISHERI; [Anonymous], 2006, Q5RS 2002 000818; Atarhouch T, 2006, MOL PHYLOGENET EVOL, V39, P373, DOI 10.1016/j.ympev.2005.08.003; Bernal M, 2007, PROG OCEANOGR, V74, P210, DOI 10.1016/j.pocean.2007.04.018; Beverton RJH, 1957, DYNAMICS EXPLOITATED; Cadrin SX, 2009, FISH FISH SER, V31, P405, DOI 10.1007/978-1-4020-9210-7_22; Carrera P, 2003, SCI MAR, V67, P245, DOI 10.3989/scimar.2003.67s1245; Cope JM, 2011, FISH RES, V107, P22, DOI 10.1016/j.fishres.2010.10.002; Correia AT, 2014, FISH RES, V149, P76, DOI 10.1016/j.fishres.2013.09.016; Cressie N., 2011, STAT SPATIO TEMPORAL; Cunningham CL, 2007, AFR J MAR SCI, V29, P347, DOI 10.2989/AJMS.2007.29.3.4.334; de Moor CL, 2015, AFR J MAR SCI, V37, P41, DOI 10.2989/1814232X.2015.1009166; Deroba JJ, 2015, ICES J MAR SCI, V72, P19, DOI 10.1093/icesjms/fst237; FRANCIS RIC, 1992, CAN J FISH AQUAT SCI, V49, P922, DOI 10.1139/f92-102; Goethel DR, 2015, ICES J MAR SCI, V72, P164, DOI 10.1093/icesjms/fsu014; Goethel DR, 2011, REV FISH SCI, V19, P119, DOI 10.1080/10641262.2011.557451; Guan WJ, 2013, CAN J FISH AQUAT SCI, V70, P1178, DOI 10.1139/cjfas-2012-0364; Haddon M., 2011, MODELLING QUANTITATI; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Heath MR, 2008, FISH RES, V93, P92, DOI 10.1016/j.fishres.2008.02.014; Heath MR, 2014, ICES J MAR SCI, V71, P794, DOI 10.1093/icesjms/fst185; Holmes SJ, 2014, ICES J MAR SCI, V71, P1433, DOI 10.1093/icesjms/fsu075; Hulson PJF, 2013, CAN J FISH AQUAT SCI, V70, P1402, DOI 10.1139/cjfas-2013-0020; Hutchinson WF, 2003, P ROY SOC B-BIOL SCI, V270, P2125, DOI 10.1098/rspb.2003.2493; Hutchinson WF, 2001, MAR ECOL PROG SER, V223, P251, DOI 10.3354/meps223251; ICES, 2015, BENCHM WORKSH N SEA; ICES, 2015, STOCK ANN COD SUB 4; ICES, 2016, 2016SSGIEOM31 ICES C; ICES, 2017, BENCHM WORKSH PEL ST; ICES, 2006, 2006ACFM36 ICES CM; ICES, 2012, BENCHM WORKSH PEL ST; Jardim E, 2015, ICES J MAR SCI, V72, P232, DOI 10.1093/icesjms/fsu050; Jemaa S, 2015, J SEA RES, V96, P11, DOI 10.1016/j.seares.2014.11.002; Jennings S., 2001, MARINE FISHERIES ECO; Kasapidis P, 2014, BIOLOGY AND ECOLOGY OF SARDINES AND ANCHOVIES, P43; Kell L., 2017, FLIFE METHODS MODELL; Kell LT, 2007, ICES J MAR SCI, V64, P640, DOI 10.1093/icesjms/fsm012; Kerr LA, 2010, ICES J MAR SCI, V67, P1631, DOI 10.1093/icesjms/fsq053; Li Y, 2015, ICES J MAR SCI, V72, P70, DOI 10.1093/icesjms/fsu057; Garcia-Garcia LM, 2016, FISH RES, V173, P250, DOI 10.1016/j.fishres.2015.10.002; Methot RD, 2013, FISH RES, V142, P86, DOI 10.1016/j.fishres.2012.10.012; Neat FC, 2014, J APPL ECOL, V51, P1564, DOI 10.1111/1365-2664.12343; Nedreaas K., 2008, Fisken og Havet, V5, P1; Nielsen EE, 2009, MAR ECOL PROG SER, V376, P213, DOI 10.3354/meps07798; Oliveira PB, 2008, REMOTE SENS ENVIRON, V112, P3376, DOI 10.1016/j.rse.2007.09.018; Petitgas P., 2010, 306 ICES; Poulsen NA, 2011, MAR ECOL PROG SER, V436, P231, DOI 10.3354/meps09246; Punt AE, 2015, FISH RES, V168, P85, DOI 10.1016/j.fishres.2015.04.002; Quinn T.J., 1999, BIOL RES MANAG SER; Righton DA, 2010, MAR ECOL PROG SER, V420, P1, DOI 10.3354/meps08889; Santos AMP, 2007, PROG OCEANOGR, V74, P192, DOI 10.1016/j.pocean.2007.04.008; Silva A, 2008, FISH RES, V90, P56, DOI 10.1016/j.fishres.2007.09.011; Silva A, 2006, ICES J MAR SCI, V63, P663, DOI 10.1016/j.icesjms.2006.01.005; Silva A, 2009, ICES J MAR SCI, V66, P495, DOI 10.1093/icesjms/fsn225; SILVA ALD, 2007, THESIS; Stratoudakis Y, 2007, MAR BIOL, V152, P201, DOI 10.1007/s00227-007-0674-4; Szuwalski CS, 2015, FISH RES, V164, P135, DOI 10.1016/j.fishres.2014.10.020; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Wright PJ, 2006, J FISH BIOL, V69, P181, DOI 10.1111/j.1095-8649.2006.01262.x; Wright PJ, 2011, ICES J MAR SCI, V68, P1918, DOI 10.1093/icesjms/fsr111; Wright PJ, 2006, FISH RES, V77, P148, DOI 10.1016/j.fishres.2005.10.008; Ying YP, 2011, CAN J FISH AQUAT SCI, V68, P2101, DOI 10.1139/F2011-116; Yoneda M, 2004, MAR ECOL PROG SER, V276, P237, DOI 10.3354/meps276237	64	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190791	10.1371/journal.pone.0190791	http://dx.doi.org/10.1371/journal.pone.0190791			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364901	gold, Green Published, Green Submitted			2022-12-27	WOS:000423412500024
J	Cabral, AL; Jordan, MC; Larson, G; Somers, DJ; Humphreys, DG; McCartney, CA				Cabral, Adrian L.; Jordan, Mark C.; Larson, Gary; Somers, Daryl J.; Humphreys, D. Gavin; McCartney, Curt A.			Relationship between QTL for grain shape, grain weight, test weight, milling yield, and plant height in the spring wheat cross RL4452/'ACDomain'	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; CHROMOSOMAL LOCATION; DWARFING GENES; KERNEL SIZE; NORIN 10; SEED SIZE; MAJOR QTL; RICE; LENGTH; WIDTH	Kernel morphology characteristics of wheat are complex and quantitatively inherited. A doubled haploid (DH) population of the cross RL4452/'AC Domain' was used to study the genetic basis of seed shape. Quantitative trait loci (QTL) analyses were conducted on a total of 18 traits: 14 grain shape traits, flour yield (Fyd), and three agronomic traits (Plant height [Plht], 1000 Grain weight [Gwt], Test weight [Twt]), using data from trial locations at Glenlea, Brandon, and Morden in Manitoba, Canada, between 1999 and 2004. Kernel shape was studied through digital image analysis with an Acurum (R) grain analyzer. Plht, Gwt, Twt, Fyd, and grain shape QTL were correlated with each other and QTL analysis revealed that QTL for these traits often mapped to the same genetic locations. The most significant QTL for the grain shape traits were located on chromosomes 4B and 4D, each accounting for up to 24.4% and 53.3% of the total phenotypic variation, respectively. In addition, the most significant QTL for Plht, Gwt, and Twt were all detected on chromosome 4D at the Rht-D1 locus. Rht-D1b decreased Plht, Gwt, Twt, and kernel width relative to the RhtD1a allele. A narrow genetic interval on chromosome 4B contained significant QTL for grain shape, Gwt, and Plht. The 'AC Domain' allele reduced Plht, Gwt, kernel length and width traits, but had no detectable effect on Twt. The data indicated that this variation was inconsistent with segregation at Rht-B1. Numerous QTL were identified that control these traits in this population.	[Cabral, Adrian L.; Jordan, Mark C.; McCartney, Curt A.] Agr & Agri Food Canada, Morden Res & Dev Ctr, Morden, MB, Canada; [Larson, Gary] Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada; [Somers, Daryl J.] Vineland Res & Innovat Ctr, Vineland Stn, ON, Canada; [Humphreys, D. Gavin] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada; [Cabral, Adrian L.] Natl Res Council Canada, Saskatoon, SK, Canada	Agriculture & Agri Food Canada; Agriculture & Agri Food Canada; Agriculture & Agri Food Canada; National Research Council Canada	McCartney, CA (corresponding author), Agr & Agri Food Canada, Morden Res & Dev Ctr, Morden, MB, Canada.	Curt.McCartney@agr.gc.ca	CABRAL, ADRIAN L/E-6983-2011	CABRAL, ADRIAN L/0000-0003-4550-7721; McCartney, Curt/0000-0002-9482-3133	Canadian Triticum Advancement through Genomics (CTAG), a Genome Prairie project; Saskatchewan Ministry of Agriculture; Western Grains Research Foundation; Genome Canada	Canadian Triticum Advancement through Genomics (CTAG), a Genome Prairie project; Saskatchewan Ministry of Agriculture; Western Grains Research Foundation; Genome Canada(Genome Canada)	CM and MJ were were funded as part of Canadian Triticum Advancement through Genomics (CTAG), a Genome Prairie project funded by Genome Canada, Saskatchewan Ministry of Agriculture, and Western Grains Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammiraju JSS, 2001, THEOR APPL GENET, V102, P726, DOI 10.1007/s001220051703; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; BORLAUG NE, 1983, SCIENCE, V219, P689, DOI 10.1126/science.219.4585.689; Botwright T, 2001, AUST J PLANT PHYSIOL, V28, P417; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Cabral AL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0340-1; Campbell KG, 1999, CROP SCI, V39, P1184, DOI 10.2135/cropsci1999.0011183X003900040039x; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Dholakia BB, 2003, PLANT BREEDING, V122, P392, DOI 10.1046/j.1439-0523.2003.00896.x; EVANS LE, 1972, CAN J PLANT SCI, V52, P1081, DOI 10.4141/cjps72-184; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; FISCHER RA, 1990, EUPHYTICA, V46, P51, DOI 10.1007/BF00057618; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; GALE MD, 1976, HEREDITY, V37, P283, DOI 10.1038/hdy.1976.88; GALE MD, 1975, HEREDITY, V35, P417, DOI 10.1038/hdy.1975.112; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; Kokko EG, 2007, Patent No. [US 7218775 B2, 7218775]; Kumar A, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.07.0058; LANDER ES, 1989, GENETICS, V121, P185; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; MARSHALL DR, 1986, AUST J AGR RES, V37, P331, DOI 10.1071/AR9860331; McCartney CA, 2006, PLANT BREEDING, V125, P565, DOI 10.1111/j.1439-0523.2006.01256.x; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; MCVITTIE JA, 1978, HEREDITY, V40, P67, DOI 10.1038/hdy.1978.8; MIRALLES DJ, 1995, FIELD CROP RES, V43, P55, DOI 10.1016/0378-4290(95)00041-N; MORRIS R, 1972, CROP SCI, V12, P247, DOI 10.2135/cropsci1972.0011183X001200020032x; Okamoto Y, 2013, BREEDING SCI, V63, P423, DOI 10.1270/jsbbs.63.423; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; PINTHUS MJ, 1983, THEOR APPL GENET, V66, P153, DOI 10.1007/BF00265191; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Rebetzke GJ, 2001, AUST J AGR RES, V52, P1221, DOI 10.1071/AR01042; REITZ LP, 1968, CROP SCI, V8, P686, DOI 10.2135/cropsci1968.0011183X000800060014x; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Townley-Smith TF, 2008, CAN J PLANT SCI, V88, P347, DOI 10.4141/CJPS07004; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Williams K, 2014, CROP SCI, V54, P98, DOI 10.2135/cropsci2012.10.0609; YOUSSEFIAN S, 1992, FIELD CROP RES, V28, P191, DOI 10.1016/0378-4290(92)90040-G; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x; Zhang YJ, 2014, MOL BREEDING, V34, P1097, DOI 10.1007/s11032-014-0102-7	46	39	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0190681	10.1371/journal.pone.0190681	http://dx.doi.org/10.1371/journal.pone.0190681			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357369	Green Published, Green Submitted, gold			2022-12-27	WOS:000422919500006
J	Law, YN; Jian, HB; Lo, NWS; Ip, M; Chan, MMY; Kam, KM; Wu, XH				Law, Yan Nei; Jian, Hanbin; Lo, Norman W. S.; Ip, Margaret; Chan, Mia Mei Yuk; Kam, Kai Man; Wu, Xiaohua			Low cost automated whole smear microscopy screening system for detection of acid fast bacilli	PLOS ONE			English	Article								Background In countries with high tuberculosis (TB) burden, there is urgent need for rapid, large-scale screening to detect smear-positive patients. We developed a computer-aided whole smear screening system that focuses in real-time, captures images and provides diagnostic grading, for both bright-field and fluorescence microscopy for detection of acid-fast-bacilli (AFB) from respiratory specimens. Objectives To evaluate the performance of dual-mode screening system in AFB diagnostic algorithms on concentrated smears with auramine O (AO) staining, as well as direct smears with AO and Ziehl-Neelsen (ZN) staining, using mycobacterial culture results as gold standard. Methods Adult patient sputum samples requesting for M. tuberculosis cultures were divided into three batches for staining: direct AO-stained, direct ZN-stained and concentrated smears AO-stained. All slides were graded by an experienced microscopist, in parallel with the automated whole smear screening system. Sensitivity and specificity of a TB diagnostic algorithm in using the screening system alone, and in combination with a microscopist, were evaluated. Results Of 488 direct AO-stained smears, 228 were culture positive. These yielded a sensitivity of 81.6% and specificity of 74.2%. Of 334 direct smears with ZN staining, 142 were culture positive, which gave a sensitivity of 70.4% and specificity of 76.6%. Of 505 concentrated smears with AO staining, 250 were culture positive, giving a sensitivity of 86.4% and specificity of 71.0%. To further improve performance, machine grading was confirmed by manual smear grading when the number of AFBs detected fell within an uncertainty range. These combined results gave significant improvement in specificity (AO-direct: 85.4%; ZN-direct: 85.4%; AO-concentrated: 92.5%) and slight improvement in sensitivity while requiring only limited manual workload. Conclusion Our system achieved high sensitivity without substantially compromising specificity when compared to culture results. Significant improvement in specificity was obtained when uncertain results were confirmed by manual smear grading. This approach had potential to substantially reduce workload of microscopists in high burden countries.	[Law, Yan Nei; Jian, Hanbin; Wu, Xiaohua] Hong Kong Appl Sci & Technol Res Inst Co Ltd ASTR, Hong Kong, Hong Kong, Peoples R China; [Lo, Norman W. S.; Ip, Margaret] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chan, Mia Mei Yuk; Kam, Kai Man] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Fac Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong Applied Science & Technology Research Institute Company Limited (ASTRI); Chinese University of Hong Kong; Chinese University of Hong Kong	Kam, KM (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Fac Med, Hong Kong, Hong Kong, Peoples R China.	kmkam@cuhk.edu.hk	Ip, Margaret/K-1096-2013	Ip, Margaret/0000-0003-1291-6537	Innovation and Technology Fund; Health and Medical Research Fund [CU-15-C3]	Innovation and Technology Fund; Health and Medical Research Fund	This research was supported by the Innovation and Technology Fund to Xiaohua Wu. Kai Man Kam received support from Health and Medical Research Fund, CU-15-C3.	Chang J, 2012, MICCAI; Ismail NA, 2015, AM J RESP CRIT CARE, V191, P1443, DOI 10.1164/rccm.201502-0390OC; Law YSB, 2016, NURSE EDUC PRACT, V20, P1, DOI 10.1016/j.nepr.2016.06.001; Lewis JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050173; Lumb R, 2013, LAB DIAGNOSIS TUBERC, P3; Pangilinan C, 2011, ISPHT; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Tadrous PJ, 2010, AM J CLIN PATHOL, V133, P849, DOI 10.1309/AJCPMR3BLVBH8THV; Uddin Mohammad Khaja Mafij, 2013, BMC Res Notes, V6, P291, DOI 10.1186/1756-0500-6-291; Van Deun A, 2007, PRIORITIES TUBERCULO, P11; WHO, 2017, GLOB TUB REP; World Health Organization (WHO), 2015, TUB DIAGN TECHN MARK, V4th	12	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0190988	10.1371/journal.pone.0190988	http://dx.doi.org/10.1371/journal.pone.0190988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357378	Green Published, gold, Green Submitted			2022-12-27	WOS:000422919500008
J	Jasinski, M; Kulik, M; Wojciechowska, M; Stolarski, R; Trylska, J				Jasinski, Maciej; Kulik, Marta; Wojciechowska, Monika; Stolarski, Ryszard; Trylska, Joanna			Interactions of 2 '-O-methyl oligoribonucleotides with the RNA models of the 30S subunit A-site	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PEPTIDE NUCLEIC-ACIDS; DOUBLE-STRANDED-RNA; 16S RIBOSOMAL-RNA; VANT-HOFF; CALORIMETRIC ENTHALPIES; AMINOGLYCOSIDE ANTIBIOTICS; SIGNIFICANT DISCREPANCIES; STRUCTURAL BASIS; HYGROMYCIN-B	Synthetic oligonucleotides targeting functional regions of the prokaryotic rRNA could be promising antimicrobial agents. Indeed, such oligonucleotides were proven to inhibit bacterial growth. 2'-O-methylated (2'-O-Me) oligoribonucleotides with a sequence complementary to the decoding site in 16S rRNA were reported as inhibitors of bacterial translation. However, the binding mode and structures of the formed complexes, as well as the level of selectivity of the oligonucleotides between the prokaryotic and eukaryotic target, were not determined. We have analyzed three 2'-O-Me oligoribonucleotides designed to hybridize with the models of the prokaryotic rRNA containing two neighboring aminoglycoside binding pockets. One pocket is the paromomycin/kanamycin binding site corresponding to the decoding site in the small ribosomal subunit and the other one is the close-by hygromycin B binding site whose dynamics has not been previously reported. Molecular dynamics (MD) simulations, as well as isothermal titration calorimetry, gel electrophoresis and spectroscopic studies have shown that the eukaryotic rRNA model is less conformationally stable (in terms of hydrogen bonds and stacking interactions) than the corresponding prokaryotic one. In MD simulations of the eukaryotic construct, the nucleotide U1498, which plays an important role in correct positioning of mRNA during translation, is flexible and spontaneously flips out into the solvent. In solution studies, the 2'-O-Me oligoribonucleotides did not interact with the double stranded rRNA models but all formed stable complexes with the single-stranded prokaryotic target. 2'-O-Me oligoribonucleotides with one and two mismatches bound less tightly to the eukaryotic target. This shows that at least three mismatches between the 2'-O-Me oligoribonucleotide and eukaryotic rRNA are required to ensure target selectivity. The results also suggest that, in the ribosome environment, the strand invasion is the preferred binding mode of 2'-O-Me oligoribonucleotides targeting the aminoglycoside binding sites in 16S rRNA.	[Jasinski, Maciej; Kulik, Marta; Wojciechowska, Monika; Trylska, Joanna] Univ Warsaw, Ctr New Technol, Warsaw, Poland; [Jasinski, Maciej] Univ Warsaw, Coll Inter Fac Individual Studies Math & Nat Sci, Warsaw, Poland; [Stolarski, Ryszard] Univ Warsaw, Fac Phys, Inst Expt Phys, Dept Biophys, Warsaw, Poland; [Kulik, Marta] RIKEN, Wako, Saitama 3510198, Japan	University of Warsaw; University of Warsaw; University of Warsaw; RIKEN	Trylska, J (corresponding author), Univ Warsaw, Ctr New Technol, Warsaw, Poland.	joanna@cent.uw.edu.pl	Kulik, Marta/I-5589-2018; Trylska, Joanna/AAI-6785-2021	Kulik, Marta/0000-0003-2381-7665; Trylska, Joanna/0000-0002-1464-5323; Jasinski, Maciej/0000-0001-6467-2752; Wojciechowska, Monika/0000-0002-6255-6421; Stolarski, Ryszard/0000-0002-3272-5140	National Science Centre [DEC-2014/12/VV/ST5/00589]; CeNT BST funds; European Social Fund [UDA-POKL.04.01.01-00-072/09-00]; Interdisciplinary Centre for Mathematical and Computational Modelling [G31-4, GA65-17]	National Science Centre(National Science Centre, Poland); CeNT BST funds; European Social Fund(European Social Fund (ESF)); Interdisciplinary Centre for Mathematical and Computational Modelling	J. T and M. W. thank the National Science Centre (grant no DEC-2014/12/VV/ST5/00589 in Symfonia call) and CeNT BST funds. M. J. thanks the European Social Fund (contract no UDA-POKL.04.01.01-00-072/09-00). Simulations were performed at the Interdisciplinary Centre for Mathematical and Computational Modelling (grants G31-4 and GA65-17) and Centre of New Technologies, University of Warsaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J. T and M. W. thank the National Science Centre (grant no DEC-2014/12/W/ST5/00589 in Symfonia call) and CeNT BST funds. M. J. thanks the European Social Fund (contract no UDA-POKL.04.01.01-00-072/09-00). Simulations were performed at the Interdisciplinary Centre for Mathematical and Computational Modelling (grants G31-4 and GA65-17) and Centre of New Technologies, University of Warsaw.	Abelian A, 2004, BIOCHEM J, V383, P201, DOI 10.1042/BJ20040246; Becker B, 2013, ACS CHEM BIOL, V8, P105, DOI 10.1021/cb3005116; Behrens S, 2003, APPL ENVIRON MICROB, V69, P1748, DOI 10.1128/AEM.69.3.1748-1758.2003; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; Blin G, 2010, IEEE ACM T COMPUT BI, V7, P309, DOI 10.1109/TCBB.2008.28; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Buske FA, 2011, RNA BIOL, V8, P427, DOI 10.4161/rna.8.3.14999; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chaires JB, 1997, BIOPHYS CHEM, V64, P15, DOI 10.1016/S0301-4622(96)02205-3; Chandrika NT, 2016, MEDCHEMCOMM, V7, P50, DOI 10.1039/c5md00453e; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dibrov SM, 2010, NUCLEIC ACIDS RES, V38, P4458, DOI 10.1093/nar/gkq159; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480; Francois B, 2005, NUCLEIC ACIDS RES, V33, P5677, DOI 10.1093/nar/gki862; FREIRE E, 1990, ANAL CHEM, V62, pA950, DOI 10.1021/ac00217a002; Garneau-Tsodikova S, 2016, MEDCHEMCOMM, V7, P11, DOI 10.1039/c5md00344j; Gorska A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv559; Grossfield A, 2009, ANN REP COMP CHEM, V5, P23, DOI 10.1016/S1574-1400(09)00502-7; Gupta P, 2012, BIOCHEMISTRY-US, V51, P63, DOI 10.1021/bi201570a; Hansen J, 2016, PHYS CHEM CHEM PHYS, V18, P10270, DOI 10.1039/c5cp07285a; Hess B, 2002, J CHEM PHYS, V116, P209, DOI 10.1063/1.1421362; Hobbie SN, 2007, NUCLEIC ACIDS RES, V35, P6086, DOI 10.1093/nar/gkm658; Horn JR, 2001, BIOCHEMISTRY-US, V40, P1774, DOI 10.1021/bi002408e; Horn JR, 2002, BIOCHEMISTRY-US, V41, P7501, DOI 10.1021/bi025626b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hussain T, 2016, CELL, V167, P133, DOI 10.1016/j.cell.2016.08.074; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaul M, 2004, J AM CHEM SOC, V126, P3447, DOI 10.1021/ja030568i; Kietrys Anna M., 2009, Biotechnologia (Poznan), P48; Knapp B, 2011, J COMPUT BIOL, V18, P997, DOI 10.1089/cmb.2010.0237; Kondo J, 2008, NUCLEIC ACIDS RES, V36, P2654, DOI 10.1093/nar/gkn112; Kulik M, 2015, BIOPHYS J, V108, P655, DOI 10.1016/j.bpj.2014.12.020; Leontis NB, 2003, CURR OPIN STRUC BIOL, V13, P300, DOI 10.1016/S0959-440X(03)00076-9; Li M, 2009, BIOCHEMISTRY-US, V48, P8299, DOI 10.1021/bi900982t; Liljas A, 2004, STRUCTURAL ASPECTS P; Liu YF, 1997, BIOPHYS CHEM, V64, P121, DOI 10.1016/S0301-4622(96)02229-6; LIU YF, 1995, PROTEIN SCI, V4, P2559, DOI 10.1002/pro.5560041212; Llano-Sotelo B, 2009, J MOL BIOL, V391, P813, DOI 10.1016/j.jmb.2009.06.069; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Mikulecky PJ, 2006, BIOPOLYMERS, V82, P38, DOI 10.1002/bip.20457; Mikulecky PJ, 2006, BIOCHEMISTRY-US, V45, P604, DOI 10.1021/bi0517178; Mura C, 2008, NUCLEIC ACIDS RES, V36, P4941, DOI 10.1093/nar/gkn473; Murray JB, 2006, CHEM BIOL, V13, P129, DOI 10.1016/j.chembiol.2005.11.004; NAGHIBI H, 1995, P NATL ACAD SCI USA, V92, P5597, DOI 10.1073/pnas.92.12.5597; Narayanan BC, 2014, NUCLEIC ACIDS RES, V42, pD114, DOI 10.1093/nar/gkt980; Noy A, 2009, PHYS CHEM CHEM PHYS, V11, P10596, DOI 10.1039/b912067j; Panecka J, 2015, BIOCHIMIE, V112, P96, DOI 10.1016/j.biochi.2015.02.021; Panecka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111811; Panecka J, 2014, J PHYS CHEM B, V118, P6687, DOI 10.1021/jp5030685; Panecka J, 2011, J PHYS CHEM B, V115, P532, DOI 10.1021/jp106404u; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfister P, 2003, ANTIMICROB AGENTS CH, V47, P1496, DOI 10.1128/AAC.47.5.1496-1502.2003; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; Reblova K, 2006, BIOPOLYMERS, V82, P504, DOI 10.1002/bip.20503; Robbins TJ, 2013, J BIOMOL STRUCT DYN, V31, P1311, DOI 10.1080/07391102.2012.732344; Romanowska J, 2008, J PHYS CHEM B, V112, P15227, DOI 10.1021/jp806814s; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanbonmatsu KY, 2006, BIOCHIMIE, V88, P1053, DOI 10.1016/j.biochi.2006.06.012; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sharp K, 2001, PROTEIN SCI, V10, P661, DOI 10.1110/ps.37801; Song K, 2009, J CHEM THEORY COMPUT, V5, P3105, DOI 10.1021/ct9001575; Sulc P, 2015, BIOPHYS J, V108, P1238, DOI 10.1016/j.bpj.2015.01.023; Thoduka SG, 2017, BIOPOLYMERS, V107, DOI 10.1002/bip.23004; Trylska J, 2016, BIOCHEM SOC T, V44, P987, DOI 10.1042/BST20160087; Trylska J, 2013, ACS CHEM BIOL, V8, P1101, DOI 10.1021/cb400163t; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Zeng XC, 2014, J MOL BIOL, V426, P3201, DOI 10.1016/j.jmb.2014.04.029; Zengeya T, 2014, METHODS MOL BIOL, V1050, P83, DOI 10.1007/978-1-62703-553-8_7; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086; Zhou Y, 2013, NUCLEIC ACIDS RES, V41, P6664, DOI 10.1093/nar/gkt352	84	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191138	10.1371/journal.pone.0191138	http://dx.doi.org/10.1371/journal.pone.0191138			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351348	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300051
J	Kondo, Y; Higa, S; Iwasaki, T; Matsumoto, T; Maehara, K; Harada, A; Baba, Y; Fujita, M; Ohkawa, Y				Kondo, Yukari; Higa, Shinichiro; Iwasaki, Takeshi; Matsumoto, Tomoya; Maehara, Kazumitsu; Harada, Akihito; Baba, Yoshihiro; Fujita, Masatoshi; Ohkawa, Yasuyuki			Sensitive detection of fluorescence in western blotting by merging images	PLOS ONE			English	Article							CHEMILUMINESCENT; PROTEINS	The western blotting technique is widely used to analyze protein expression levels and protein molecular weight. The chemiluminescence method is mainly used for detection due to its high sensitivity and ease of manipulation, but it is unsuitable for detailed analyses because it cannot be used to detect multiple proteins simultaneously. Recently, more attention has been paid to the fluorescence detection method because it is more quantitative and is suitable for the detection of multiple proteins simultaneously. However, fluorescence detection can be limited by poor image resolution and low detection sensitivity. Here, we describe a method to detect fluorescence in western blots using fluorescence microscopy to obtain high-resolution images. In this method, filters and fluorescent dyes are optimized to enhance detection sensitivity to a level similar to that of the chemiluminescence method.	[Kondo, Yukari; Higa, Shinichiro; Iwasaki, Takeshi; Maehara, Kazumitsu; Harada, Akihito; Ohkawa, Yasuyuki] Kyushu Univ, Med Inst Bioregulat, Div Transcript, Fukuoka, Japan; [Higa, Shinichiro; Fujita, Masatoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Cellular Biochem, Fukuoka, Japan; [Matsumoto, Tomoya] Keyence, Microscope Div, Sales Dept, Osaka, Japan; [Baba, Yoshihiro] Kyushu Univ, Med Inst Bioregulat, Div Immunol & Genome Biol, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University	Ohkawa, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Transcript, Fukuoka, Japan.	yohkawa@bioreg.kyushu-u.ac.jp	Ohkawa, Yasuyuki/ABG-1839-2021	Ohkawa, Yasuyuki/0000-0001-6440-9954; Maehara, Kazumitsu/0000-0002-2933-5176; Iwasaki, Takeshi/0000-0001-5277-2932	JSPS CREST [JPMJCR16G1]; MEXT/JSPS KAKENHI [JP25116010, JP25132709, JP25118518, JP26290064, JP17H03608, JP17K19356, JP16H01219, JP15K18457, JP16K18479, JP16H01577, JP16H01550]; Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from Japan Agency for Medical Research and Development [17943646]; Grants-in-Aid for Scientific Research [17K19356, 16K18479, 25116010] Funding Source: KAKEN	JSPS CREST(Core Research for Evolutional Science and Technology (CREST)); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS CREST (http://www.jst.go.jp/kisoken/crest/en/index.html) [JPMJCR16G1] to Y.O., MEXT/JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html) [JP25116010, JP25132709, JP25118518, JP26290064, JP17H03608 and JP17K19356 to Y.O., JP16H01219 and JP15K18457 to A.H., JP16K18479, JP16H01577 and JP16H01550 to K.M.]. This research is partially supported by the Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from Japan Agency for Medical Research and Development (http://www.amed.go.jp/) [17943646 to Y.O. and Y.B.]. Keyence Corporation only provided financial support in the form of salaries for T.M., and technical support and advice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; BRONSTEIN I, 1989, CLIN CHEM, V35, P1441; Eaton SL, 2014, JOVE-J VIS EXP, DOI 10.3791/52099; Gingrich JC, 2000, BIOTECHNIQUES, V29, P636, DOI 10.2144/00293pf02; Kislinger T, 2005, MOL CELL PROTEOMICS, V4, P887, DOI 10.1074/mcp.M400182-MCP200; KRICKA LJ, 1991, CLIN CHEM, V37, P1472; Taylor SC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/361590; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wagatsuma A, 2011, MOL CELL BIOCHEM, V358, P265, DOI 10.1007/s11010-011-0977-0	9	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191532	10.1371/journal.pone.0191532	http://dx.doi.org/10.1371/journal.pone.0191532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352284	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300108
J	Song, S; Hong, S; Jang, J; Yeom, JH; Park, N; Lee, J; Lim, Y; Jeon, JY; Choi, HK; Lee, M; Ha, NC; Lee, K				Song, Saemee; Hong, Seokho; Jang, Jinyang; Yeom, Ji-Hyun; Park, Nohra; Lee, Jaejin; Lim, Yeri; Jeon, Jun-Yeong; Choi, Hyung-Kyoon; Lee, Minho; Ha, Nam-Chul; Lee, Kangseok			Functional implications of hexameric assembly of RraA proteins from Vibrio vulnificus (vol 12, e0190064, 2017)	PLOS ONE			English	Correction													Lee, Minho/AAK-4109-2021	Lee, Minho/0000-0002-8404-5702				Song S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190064	1	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191775	10.1371/journal.pone.0191775	http://dx.doi.org/10.1371/journal.pone.0191775			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352305	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300131
J	Chen, HC; Qian, CX; Liang, CY; Kang, WC				Chen, Huaicheng; Qian, Chunxiang; Liang, Chengyao; Kang, Wence			An approach for predicting the compressive strength of cement-based materials exposed to sulfate attack	PLOS ONE			English	Article							CONCRETE STRENGTH; RESISTANCE TEST; PERFORMANCE; MACHINE	In this paper, a support vector machine (SVM) model which can be used to predict the compressive strength of mortars exposed to sulfate attack was established. An accelerated corrosion test was applied to collect compressive strength data. For predicting the compressive strength of mortars, a total of 638 data samples obtained from experiment was chosen as a dataset to establish a SVM model. The values of the coefficient of determination, the mean absolute error, the mean absolute percentage error and the root mean square error were used for evaluating the predictive accuracy. The main factors affecting the predicted compressive strength were obtained by sensitivity analysis. A SVM model was calibrated, validated, and finally established. Moreover, the performance of the SVM model was compared to an artificial neural network (ANN) model. Results show that the prediction values from the SVM model were close to the experimental values; the main factors sensitive to concrete compressive strength were exposure time, water-cement ratio and sulfate ions; the performance of the SVM model was better than the ANN model. The SVM model developed in this study can be potentially used for predicting the compressive strength of cement-based materials servicing in harsh environments.	[Chen, Huaicheng; Qian, Chunxiang; Liang, Chengyao; Kang, Wence] Southeast Univ, Sch Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Chen, Huaicheng; Qian, Chunxiang; Liang, Chengyao; Kang, Wence] Southeast Univ, Res Inst Green Construct Mat, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Qian, CX (corresponding author), Southeast Univ, Sch Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China.; Qian, CX (corresponding author), Southeast Univ, Res Inst Green Construct Mat, Nanjing, Jiangsu, Peoples R China.	cxqian@seu.edu.cn		Qian, Chunxiang/0000-0002-7547-5890; Chen, HuaiCheng/0000-0001-7308-9833	National Program on Key Basic Research Project of China [2015C66551002]	National Program on Key Basic Research Project of China(National Basic Research Program of China)	The authors appreciate the financial support from the National Program on Key Basic Research Project of China (Grant No. 2015C66551002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors appreciate the financial support from the National Program on Key Basic Research Project of China (Grant No. 2015CB6551002).	Ahmadi-Nedushan B, 2012, ENG APPL ARTIF INTEL, V25, P1073, DOI 10.1016/j.engappai.2012.01.012; Alshihri MM, 2009, CONSTR BUILD MATER, V23, P2214, DOI 10.1016/j.conbuildmat.2008.12.003; [Anonymous], 2008, 7492008 GBT; [Anonymous], 2003, 500812002 GBT; Bassuoni MT, 2016, CEMENT CONCRETE RES, V79, P395, DOI 10.1016/j.cemconres.2015.02.006; Beddoe RE, 2005, CEMENT CONCRETE RES, V35, P2333, DOI 10.1016/j.cemconres.2005.04.002; Bellmann F, 2006, CEMENT CONCRETE RES, V36, P358, DOI 10.1016/j.cemconres.2005.04.006; Cao LJ, 2003, IEEE T NEURAL NETWOR, V14, P1506, DOI 10.1109/TNN.2003.820556; Chauvin Y, 1995, J ASSOC INF SCI TECH, V48, P88; Cheng MY, 2012, AUTOMAT CONSTR, V28, P106, DOI 10.1016/j.autcon.2012.07.004; Chou JS, 2014, CONSTR BUILD MATER, V73, P771, DOI 10.1016/j.conbuildmat.2014.09.054; Davis J, 1996, J COGNITIVE NEUROSCI, V8, P383, DOI 10.1162/jocn.1996.8.4.383a; Gupta SM, 2013, P WORLD ACAD SCI ENG, V25, P1; Kaushik S.K., 1995, CEMENT CONCRETE COMP, V17, P177, DOI [10.1016/0958-9465(95)00015-5, DOI 10.1016/0958-9465(95)00015-5]; Kecman V, 2001, LEAMING SOFT COMPUTI; Lee ST, 2008, CAN J CIVIL ENG, V35, P1210, DOI 10.1139/L08-065; Liong SY, 2000, J COMPUT CIVIL ENG, V14, P1, DOI 10.1061/(ASCE)0887-3801(2000)14:1(1); Loser R, 2016, MATER STRUCT, V49, P3445, DOI 10.1617/s11527-015-0731-2; Park D, 2010, COMPUT-AIDED CIV INF, V14, P357; Poupard O, 2006, CEMENT CONCRETE RES, V36, P504, DOI 10.1016/j.cemconres.2005.11.004; Prasad BKR, 2009, CONSTR BUILD MATER, V23, P117, DOI 10.1016/j.conbuildmat.2008.01.014; Ravi V, 2008, ADV BANKING TECHNOLO; Sarkar M, 1998, PATTERN RECOGN LETT, V19, P43, DOI 10.1016/S0167-8655(97)00151-7; Sobhani J, 2010, CONSTR BUILD MATER, V24, P709, DOI 10.1016/j.conbuildmat.2009.10.037; Steenbergen RDJM, 2012, STRUCT CONCRETE, V13, P27, DOI 10.1002/suco.201100031; Tawie R, 2010, CONSTR BUILD MATER, V24, P1746, DOI 10.1016/j.conbuildmat.2010.02.014; Thomas MDA, 2008, ACI MATER J, V105, P628; Ueda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112659; Vapnik V, 1997, ADV NEUR IN, V9, P281; Yan KZ, 2010, CONSTR BUILD MATER, V24, P1479, DOI 10.1016/j.conbuildmat.2010.01.006; Yassin M, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING, INFORMATICS, COMMUNICATION AND ENERGY SYSTEMS (SPICES), DOI 10.1109/DFT.2015.7315143; Yeh IC, 1998, J MATER CIVIL ENG, V10, P263, DOI 10.1061/(ASCE)0899-1561(1998)10:4(263); Yeh IC, 1998, CEMENT CONCRETE RES, V28, P1797, DOI 10.1016/S0008-8846(98)00165-3; Zhan Y, 2015, 5 INT C CIV ENG TRAN	34	21	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191370	10.1371/journal.pone.0191370	http://dx.doi.org/10.1371/journal.pone.0191370			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346451	Green Submitted, Green Published, gold			2022-12-27	WOS:000422749500044
J	Hildenbrand, G; Metzler, P; Pilarczyk, G; Bobu, V; Kriz, W; Hosser, H; Fleckenstein, J; Krufczik, M; Bestvater, F; Wenz, F; Hausmann, M				Hildenbrand, Georg; Metzler, Philipp; Pilarczyk, Goetz; Bobu, Vladimir; Kriz, Wilhelm; Hosser, Hiltraud; Fleckenstein, Jens; Krufczik, Matthias; Bestvater, Felix; Wenz, Frederik; Hausmann, Michael			Dose enhancement effects of gold nanoparticles specifically targeting RNA in breast cancer cells	PLOS ONE			English	Article							GADOLINIUM-BASED NANOPARTICLES; LOCALIZATION MICROSCOPY; RADIATION-THERAPY; CELLULAR UPTAKE; COPY NUMBER; RADIOTHERAPY; DEPENDENCE; GENE; NANOSTRUCTURES; CARCINOMA	Localization microscopy has shown to be capable of systematic investigations on the arrangement and counting of cellular uptake of gold nanoparticles (GNP) with nanometer resolution. In this article, we show that the application of specially modified RNA targeting gold nanoparticles ("SmartFlares") can result in ring like shaped GNP arrangements around the cell nucleus. Transmission electron microscopy revealed GNP accumulation in vicinity to the intracellular membrane structures including them of the endoplasmatic reticulum. A quantification of the radio therapeutic dose enhancement as a proof of principle was conducted with gamma H2AX foci analysis: The application of both-SmartFlares and unmodified GNPs-lead to a significant dose enhancement with a factor of up to 1.2 times the dose deposition compared to non-treated breast cancer cells. This enhancement effect was even more pronounced for SmartFlares. Furthermore, it was shown that a magnetic field of 1 Tesla simultaneously applied during irradiation has no detectable influence on neither the structure nor the dose enhancement dealt by gold nanoparticles.	[Hildenbrand, Georg; Metzler, Philipp; Pilarczyk, Goetz; Krufczik, Matthias; Hausmann, Michael] Heidelberg Univ, Fac Phys & Astron, Kirchhoff Inst Phys, Heidelberg, Germany; [Hildenbrand, Georg; Bobu, Vladimir; Fleckenstein, Jens; Wenz, Frederik] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Dept Radiat Oncol, Mannheim, Germany; [Kriz, Wilhelm; Hosser, Hiltraud] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Dept Neuroanat, Mannheim, Germany; [Bestvater, Felix] German Canc Res Ctr, Light Microscopy Fac, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Hildenbrand, G; Hausmann, M (corresponding author), Heidelberg Univ, Fac Phys & Astron, Kirchhoff Inst Phys, Heidelberg, Germany.; Hildenbrand, G (corresponding author), Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Dept Radiat Oncol, Mannheim, Germany.	georg.hildenbrand@umm.de; hausmann@kip.uni-heidelberg	Bobu, Vladimir/V-2696-2019		Innovation Fund "Frontier" of the Heidelberg University within the excellence initiative of the Deutsche Forschungsgemeinschaft (DFG); Deutsche Forschungsgemeinschaft; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg; Innovation Fond "Frontier" of the Heidelberg University within the excellence initiative of the Deutsche Forschungsgemeinschaft (DFG)	Innovation Fund "Frontier" of the Heidelberg University within the excellence initiative of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg; Innovation Fond "Frontier" of the Heidelberg University within the excellence initiative of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The support of the Innovation Fund "Frontier" of the Heidelberg University within the excellence initiative of the Deutsche Forschungsgemeinschaft (DFG) to Georg Hildenbrand and Michael Hausmann is gratefully acknowledged. In addition, we acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding programme Open Access Publishing, by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The support of the Innovation Fond "Frontier" of the Heidelberg University within the excellence initiative of the Deutsche Forschungsgemeinschaft (DFG) to Georg Hildenbrand and Michael Hausmann is gratefully acknowledged. Furthermore the authors are indebted to the Indian Nigerian agricultural health connection Salawu & Salawu visiting the European Center of Feasibility Studies, Strasburg, for continuous promotion of abstract quality [32].	Abdelhalim M.A.K., 2012, J NANOMED NANOTECHOL, V3, DOI DOI 10.4172/2157-7439.1000133; [Anonymous], 1908, BIOMETRIKA, V6, P1; Arosio D, 2011, BIOCONJUGATE CHEM, V22, P664, DOI 10.1021/bc100448r; Bartolome J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.247203; Burger N, 2014, NANOMED-NANOTECHNOL, V10, P1365, DOI 10.1016/j.nano.2014.03.011; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Chithrani DB, 2010, RECENT PAT NANOTECH, V4, P171, DOI 10.2174/187221010792483726; Chithrani DB, 2010, MOL MEMBR BIOL, V27, P299, DOI 10.3109/09687688.2010.507787; Chithrani DB, 2010, RADIAT RES, V173, P719, DOI 10.1667/RR1984.1; Cho SH, 2005, PHYS MED BIOL, V50, pN163, DOI 10.1088/0031-9155/50/15/N01; Cremer C, 2011, BIOTECHNOL J, V6, P1037, DOI 10.1002/biot.201100031; Dahmen V, 2012, INT J RADIAT BIOL, V88, P972, DOI 10.3109/09553002.2012.702298; Grull F., P 21 INT C FIELD PRO, P1; Hainfeld JF, 2008, J PHARM PHARMACOL, V60, P977, DOI 10.1211/jpp.60.8.0005; Hainfeld JF, 2013, NANOMEDICINE-UK, V8, P1601, DOI [10.2217/nnm.12.165, 10.2217/NNM.12.165]; Hainfeld JF, 2010, PHYS MED BIOL, V55, P3045, DOI 10.1088/0031-9155/55/11/004; Hainfeld JF, 2004, PHYS MED BIOL, V49, pN309, DOI 10.1088/0031-9155/49/18/N03; He H, 2008, ANAL CHEM, V80, P5951, DOI 10.1021/ac8005796; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hossain M, 2012, J PHYS CHEM C, V116, P23047, DOI 10.1021/jp306543q; Jain PK, 2007, PLASMONICS, V2, P107, DOI 10.1007/s11468-007-9031-1; Kaufmann R, 2011, J MICROSC-OXFORD, V242, P46, DOI 10.1111/j.1365-2818.2010.03436.x; Kaufmann R., 2009, P SOC PHOTO-OPT INS, V7185; Kaufmann R, 2011, MICRON, V42, P348, DOI 10.1016/j.micron.2010.03.006; Lagendijk JJW, 2014, PHYS MED BIOL, V59, pR349, DOI 10.1088/0031-9155/59/21/R349; Li CY, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.174446; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Merck-Millipore, 2015, TECHN GUID MAN; Mladenov E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00113; Moser F, 2016, BIOPHYS J, V110, P947, DOI 10.1016/j.bpj.2016.01.004; Muller P, 2012, CURRENT MICROSCOPY C, V1, P3; Ngwa W, 2017, INT J RADIAT ONCOL, V97, P624, DOI 10.1016/j.ijrobp.2016.10.034; Ngwa W, 2014, NANOMEDICINE-UK, V9, P1063, DOI [10.2217/NNM.14.55, 10.2217/nnm.14.55]; Nikitaki Z, 2016, FREE RADICAL RES; Nikjoo H, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/075006; Porcel E, 2014, NANOMED-NANOTECHNOL, V10, P1601, DOI 10.1016/j.nano.2014.05.005; Prigodich AE, 2012, ANAL CHEM, V84, P2062, DOI 10.1021/ac202648w; Raaijmakers AJE, 2008, PHYS MED BIOL, V53, P909, DOI 10.1088/0031-9155/53/4/006; Roa W, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/37/375101; Salawu EO, 2011, IIOAB J, V2, P63; Sancey L, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140134; SCHMID G, 1992, CHEM REV, V92, P1709, DOI 10.1021/cr00016a002; Seferos DS, 2007, J AM CHEM SOC, V129, P15477, DOI 10.1021/ja0776529; Selim ME, 2012, ASIAN PAC J CANCER P, V13, P1617, DOI 10.7314/APJCP.2012.13.4.1617; Stefancikova L, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0215-8; Stefancikova Lenka, 2014, Cancer Nanotechnol, V5, P6, DOI 10.1186/s12645-014-0006-6; Stuhlmuller M, 2015, NANOSCALE, V7, P17938, DOI 10.1039/c5nr04141d; SZOLLOSI J, 1995, CANCER RES, V55, P5400; TSUDA H, 1990, CANCER, V65, P1794, DOI 10.1002/1097-0142(19900415)65:8<1794::AID-CNCR2820650821>3.0.CO;2-Y; Wenz F, 2001, ONKOLOGIE, V24, P51, DOI 10.1159/000055187; Zygmanski P, 2013, PHYS MED BIOL, V58, P7961, DOI 10.1088/0031-9155/58/22/7961	52	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190183	10.1371/journal.pone.0190183	http://dx.doi.org/10.1371/journal.pone.0190183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346397	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500010
J	Merdad, L; Ali, MM				Merdad, Leena; Ali, Mohamed M.			Timing of maternal death: Levels, trends, and ecological correlates using sibling data from 34 sub-Saharan African countries	PLOS ONE			English	Article							ANTENATAL CARE; MORTALITY; HEALTH; STRATEGIES; PREGNANCY; OUTCOMES	Millennium Development Goal 5 has not been universally achieved, particularly in sub-Saharan Africa. Understanding whether maternal deaths occur during pregnancy, childbirth, or puerperium is important to effectively plan maternal health programs and allocate resources. Our main research objectives are to (1) describe the proportions and rates of mortality for the antepartum, intrapartum, and postpartum periods; (2) document how these trends vary by sub-region; and (3) investigate ecological correlations between these rates and maternal care interventions. We used data from the Demographic and Health Survey program, which comprises 84 surveys from 34 sub-Saharan African countries conducted between 1990 and 2014. We calculated age-standardized maternal mortality rates and time-specific maternal mortality rates and proportions, and we assessed correlations with maternal care coverage. We found high levels of maternal mortality in all three periods. Time-specific maternal mortality rates varied by country and region, with some showing an orderly decline in all three periods and others exhibiting alarming increases in antepartum and postpartum mortality. Ecological analysis showed that antenatal care coverage was significantly associated with low antepartum mortality, whereas the presence of a skilled attendant at childbirth was significantly associated with low postpartum mortality. In sub-Saharan Africa, maternal deaths occur at high rates in all three risk periods, and vary substantially by country and region. The provision of maternal care is a predictor of time-specific maternal mortality. These results confirm the need for country-specific interventions during the continuum of care to achieve the global commitment to eliminating preventable maternal mortality.	[Merdad, Leena] King Abdulaziz Univ, Fac Dent, Dept Dent Publ Hlth, Jeddah, Saudi Arabia; [Ali, Mohamed M.] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland	King Abdulaziz University; World Health Organization	Ali, MM (corresponding author), World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland.	alim@who.int	Merdad, Leena/P-7659-2014	Merdad, Leena/0000-0002-3270-0736	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Bailey PE, 2015, BMC PREGNANCY CHILDB, V15, DOI [10.1186/s12884-015-0725-7, 10.1186/s12884-016-1035-4]; Bank TW, 2016, GNI PER CAP PPP CURR; Bell JS, 2008, TROP MED INT HEALTH, V13, P31, DOI 10.1111/j.1365-3156.2008.02085.x; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; De Brouwere V, 1998, TROP MED INT HEALTH, V3, P771, DOI 10.1046/j.1365-3156.1998.00310.x; Dogba M, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-7; Dowswell T, 2015, COCHRANE DB SYST REV, V2015; Gerdts C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053346; Graham WJ, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-12; Helleringer S, 2014, DEMOGRAPHY, V51, P387, DOI 10.1007/s13524-013-0268-3; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Hoj L, 2003, BJOG-INT J OBSTET GY, V110, P995, DOI 10.1016/S1470-0328(03)03907-7; International I, DHS PROGR DEM HLTH S; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Lassi ZS, 2015, COCHRANE DB SYST REV, V2015; Maine D, 1996, STUD FAMILY PLANN, V27, P179, DOI 10.2307/2137952; Mbuagbaw LCE, 2011, MATERN CHILD HLTH J, V15, P1427, DOI 10.1007/s10995-010-0707-3; Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044; Mohammed AA, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-102; Okusanya BO, 2013, J MATERN-FETAL NEO M, V26, P885, DOI 10.3109/14767058.2013.765851; Oye-Adeniran BA, 2011, J OBSTET GYNAECOL, V31, P315, DOI 10.3109/01443615.2011.561381; Saifuddin A, 2014, DHS METHODOLOGICAL R, V13; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Scott S, 2009, TROP MED INT HEALTH, V14, P1523, DOI 10.1111/j.1365-3156.2009.02402.x; United Nations, 2015, ESAPWP241 UN; WHO, 2022, WHO RECOMMENDATIONS; WHO (World Health Organization), 2015, STRAT END PREV MAT M; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization, 2015, GLOB STRAT WOM CHILD	31	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189416	10.1371/journal.pone.0189416	http://dx.doi.org/10.1371/journal.pone.0189416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342157	gold, Green Published, Green Submitted			2022-12-27	WOS:000422653800006
J	Moretta, T; Buodo, G				Moretta, Tania; Buodo, Giulia			Autonomic stress reactivity and craving in individuals with problematic Internet use	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PSYCHOLOGICAL STRESS; ADDICTION DISORDER; ALCOHOL-USE; SCALE; ASSOCIATION; PREVALENCE; SYMPTOMS; MODELS; MARKER	The link between autonomic stress reactivity and subjective urge/craving has been less systematically examined in behavioral addictions (i.e. problematic Internet use) than in substance use disorders. The present study investigated whether problematic Internet users (PU) show enhanced autonomic stress reactivity than non-PU, indexed by lower Heart Rate Variability (HRV) and higher Skin Conductance Level (SCL) reactivity during the Trier Social Stress Test (TSST), whether greater reactivity is related to stronger Internet craving, and whether problematic Internet usage is associated with some dysfunctional psychological features. Based on their Internet Addiction Test scores, participants were divided into PU (N = 24) and non-PU (N = 21). Their heart rate and skin conductance were continuously recorded during baseline, social stressors, and recovery. Craving for Internet usage were collected using a Likert scale before and after the TSST. The SDNN, an overall measure of HRV, was significantly lower in PU than non-PU during baseline, but not during and after stressful task. Furthermore, only among PU a significant negative correlation emerged between SDNN during recovery and craving ratings after the test. No group differences emerged for SCL. Lastly, PU endorsed more mood, obsessive-compulsive, and alcohol related problems. Our findings suggest that problems in controlling one's use of the Internet may be related to reduced autonomic balance at rest. Moreover, our results provide new insights into the characterization of craving in PIU, indicating the existence of a relationship between craving for Internet usage and reduced autonomic flexibility.	[Moretta, Tania; Buodo, Giulia] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Moretta, T (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	tania.moretta@phd.unipd.it	Moretta, Tania/M-5427-2019	Moretta, Tania/0000-0002-4734-1545				Akin A., 2011, INT ONLINE J ED SCI, V3, P138; Bagiella E, 2000, PSYCHOPHYSIOLOGY, V37, P13, DOI 10.1017/S0048577200980648; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bastiani L, 2013, ADDICT BEHAV, V38, P2060, DOI 10.1016/j.addbeh.2012.12.016; Bates D, 2014, FITTING LINEAR MIXED, P1; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Berntson GG, 2004, DYNAMIC ELECTROCARDIOGRAPHY, P57, DOI 10.1002/9780470987483.ch7; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bottesi G, 2015, COMPR PSYCHIAT, V60, P170, DOI 10.1016/j.comppsych.2015.04.005; Bressi C, 1996, J PSYCHOSOM RES, V41, P551, DOI 10.1016/S0022-3999(96)00228-0; Cacioppo J. T., 2007, HDB PSYCHOPHYSIOLOGY, V44; Camm AJ, 1996, CIRCULATION, V93, P1043; Cano MA, 2014, EXP CLIN PSYCHOPHARM, V22, P332, DOI 10.1037/a0036749; Cash H, 2012, CURR PSYCHIATRY REV, V8, P292, DOI 10.2174/157340012803520513; Chamberlain SR, 2016, EUR NEUROPSYCHOPHARM, V26, P841, DOI 10.1016/j.euroneuro.2015.08.013; Cohen Sheldon, 1995, MEASURING STRESS GUI, P3; D'Orta Isabella, 2015, Addict Behav Rep, V2, P19, DOI 10.1016/j.abrep.2015.04.003; Davey HM, 2007, J CLIN EPIDEMIOL, V60, P356, DOI 10.1016/j.jclinepi.2006.07.015; Dawkins L, 2016, PSYCHOL ADDICT BEHAV, V30, P101, DOI 10.1037/adb0000112; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Ferraro G, 2007, CYBERPSYCHOL BEHAV, V10, P170, DOI 10.1089/cpb.2006.9972; Fossati A, 2001, J CLIN PSYCHOL, V57, P815, DOI 10.1002/jclp.1051; JACOBS SC, 1994, AM HEART J, V128, P1170, DOI 10.1016/0002-8703(94)90748-X; Jorgenson AG, 2016, CHILD ADOL PSYCH CL, V25, P509, DOI 10.1016/j.chc.2016.03.004; Kardefelt-Winther D, 2017, PSYCHIAT CLIN NEUROS, V71, P459, DOI 10.1111/pcn.12413; Kim BS, 2016, PSYCHIAT RES, V244, P249, DOI 10.1016/j.psychres.2016.07.009; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Ko CH, 2008, CYBERPSYCHOL BEHAV, V11, P571, DOI 10.1089/cpb.2008.0199; Kuss DJ, 2014, CURR PHARM DESIGN, V20, P4026, DOI 10.2174/13816128113199990617; Kuss DJ, 2016, WORLD J PSYCHIATR, V6, P143, DOI 10.5498/wjp.v6.i1.143; LaRose R, 2015, HBK COMMUN MEDIA, P365; LaRose R, 2010, COMMUN THEOR, V20, P194, DOI 10.1111/j.1468-2885.2010.01360.x; LAZARUS RS, 1963, PSYCHOSOM MED, V25, P19, DOI 10.1097/00006842-196301000-00004; Li DP, 2016, COMPUT HUM BEHAV, V63, P408, DOI 10.1016/j.chb.2016.05.070; Mantsch JR, 2016, NEUROPSYCHOPHARMACOL, V41, P335, DOI 10.1038/npp.2015.142; Meerkerk GJ, 2009, CYBERPSYCHOL BEHAV, V12, P1, DOI 10.1089/cpb.2008.0181; Morey R. D., 2014, R PACKAGE VERSION, V09, P8, DOI DOI 10.3758/BF03193811; Niu GF, 2016, ADDICT BEHAV, V62, P1, DOI 10.1016/j.addbeh.2016.06.012; Poli R, 2012, NORD J PSYCHIAT, V66, P55, DOI 10.3109/08039488.2011.605169; Potenza MN, 2006, ADDICTION, V101, P142, DOI 10.1111/j.1360-0443.2006.01591.x; Quintana DS, 2013, DRUG ALCOHOL DEPEN, V132, P395, DOI 10.1016/j.drugalcdep.2013.02.025; R Development Core Team, 2009, R LANG ENV STAT COMP; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Schwabe L, 2012, J NEUROSCI, V32, P10146, DOI 10.1523/JNEUROSCI.1304-12.2012; Schwabe L, 2011, EXP CLIN PSYCHOPHARM, V19, P53, DOI 10.1037/a0022212; Schwabe L, 2010, J COGNITIVE NEUROSCI, V22, P1362, DOI 10.1162/jocn.2009.21278; Shapira NA, 2000, J AFFECT DISORDERS, V57, P267, DOI 10.1016/S0165-0327(99)00107-X; Sica C, 2009, J ANXIETY DISORD, V23, P204, DOI 10.1016/j.janxdis.2008.07.001; Sinha R, 2000, PSYCHOPHARMACOLOGY, V152, P140, DOI 10.1007/s002130000499; Sinha R, 2009, NEUROPSYCHOPHARMACOL, V34, P1198, DOI 10.1038/npp.2008.78; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Stavropoulos V, 2016, EUR J DEV PSYCHOL, V13, P99, DOI 10.1080/17405629.2015.1066670; Struzzo P., 2006, B FARMACODIPENDENZE, V29, P20; Taylor RN, 2014, PERS INDIVID DIF S, V60, pS50, DOI DOI 10.1016/J.PAID.2013.07.203; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Tiffany ST, 2012, ANN NY ACAD SCI, V1248, P1, DOI 10.1111/j.1749-6632.2011.06298.x; Van Rooij AJ, 2014, J BEHAV ADDICT, V3, P203, DOI 10.1556/JBA.3.2014.4.1; Velezmoro R, 2010, COMPUT HUM BEHAV, V26, P1526, DOI 10.1016/j.chb.2010.05.020; Venables W. N., 2002, MODERN APPL STAT S I, Vfourth; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Weber CS, 2010, EUR J APPL PHYSIOL, V109, P201, DOI 10.1007/s00421-009-1341-x; Wolfling K., 2010, PREVENTION DIAGNOSTI, P212; Yau Yvonne H C, 2012, Minerva Psichiatr, V53, P153; Young KS., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Zhou Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155495	66	23	25	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190951	10.1371/journal.pone.0190951	http://dx.doi.org/10.1371/journal.pone.0190951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338020	gold, Green Published, Green Submitted			2022-12-27	WOS:000422652700024
J	Gorbet, DJ; Sergio, LE				Gorbet, Diana J.; Sergio, Lauren E.			Move faster, think later: Women who play action video games have quicker visually-guided responses with later onset visuomotor-related brain activity	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; GENDER-DIFFERENCES; SEX-DIFFERENCES; CORTICAL CONNECTIONS; PARKINSONS-DISEASE; ACUTE STROKE; MOVEMENTS; ATTENTION; PERFORMANCE; EXPERIENCE	A history of action video game (AVG) playing is associated with improvements in several visuospatial and attention-related skills and these improvements may be transferable to unrelated tasks. These facts make video games a potential medium for skill-training and rehabilitation. However, examinations of the neural correlates underlying these observations are almost non-existent in the visuomotor system. Further, the vast majority of studies on the effects of a history of AVG play have been done using almost exclusively male participants. Therefore, to begin to fill these gaps in the literature, we present findings from two experiments. In the first, we use functional MRI to examine brain activity in experienced, female AVG players during visually-guided reaching. In the second, we examine the kinematics of visually-guided reaching in this population. Imaging data demonstrate that relative to women who do not play, AVG players have less motor-related preparatory activity in the cuneus, middle occipital gyrus, and cerebellum. This decrease is correlated with estimates of time spent playing. Further, these correlations are strongest during the performance of a visuomotor mapping that spatially dissociates eye and arm movements. However, further examinations of the full time-course of visuomotor-related activity in the AVG players revealed that the decreased activity during motor preparation likely results from a later onset of activity in AVG players, which occurs closer to beginning motor execution relative to the non-playing group. Further, the data presented here suggest that this later onset of preparatory activity represents greater neural efficiency that is associated with faster visually-guided responses.	[Gorbet, Diana J.; Sergio, Lauren E.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Gorbet, Diana J.; Sergio, Lauren E.] York Univ, Ctr Vis Res, Toronto, ON, Canada	York University - Canada; York University - Canada	Gorbet, DJ (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.; Gorbet, DJ (corresponding author), York Univ, Ctr Vis Res, Toronto, ON, Canada.	gorbetd@yorku.ca	Sergio, Lauren/AAK-3274-2020	Gorbet, Diana/0000-0001-6906-2056	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, Discovery Grant to LS (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsters JH, 2011, J NEUROSCI, V31, P2305, DOI 10.1523/JNEUROSCI.4358-10.2011; Barrett Kevin M, 2007, J Stroke Cerebrovasc Dis, V16, P34, DOI 10.1016/j.jstrokecerebrovasdis.2006.11.002; Basak C, 2008, PSYCHOL AGING, V23, P765, DOI 10.1037/a0013494; Bavelier D, 2012, VISION RES, V61, P132, DOI 10.1016/j.visres.2011.08.007; Bavelier D, 2013, NATURE, V494, P425, DOI 10.1038/494425a; Bavelier D, 2012, ANNU REV NEUROSCI, V35, P391, DOI 10.1146/annurev-neuro-060909-152832; Bejjanki VR, 2014, P NATL ACAD SCI USA, V111, P16961, DOI 10.1073/pnas.1417056111; Bernabo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071192; Bialystok E, 2006, CAN J EXP PSYCHOL, V60, P68, DOI 10.1037/cjep2006008; Boot WR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00226; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; BOOT WR, 2013, FRONT PSYCHOL, V4; Brown GG, 2004, J CLIN EXP NEUROPSYC, V26, P356, DOI 10.1080/13803390490510086; Buckley D, 2010, VISION RES, V50, P548, DOI 10.1016/j.visres.2009.11.018; Carey DP, 1997, CORTEX, V33, P639, DOI 10.1016/S0010-9452(08)70722-6; Castel AD, 2005, ACTA PSYCHOL, V119, P217, DOI 10.1016/j.actpsy.2005.02.004; Chen Y, 2014, J NEUROSCI, V34, P12515, DOI 10.1523/JNEUROSCI.1445-14.2014; Chisholm JD, 2015, ACTA PSYCHOL, V159, P93, DOI 10.1016/j.actpsy.2015.06.001; CLARK JE, 1987, J GERONTOL, V42, P82, DOI 10.1093/geronj/42.1.82; Clark K, 2011, ACTA PSYCHOL, V136, P67, DOI 10.1016/j.actpsy.2010.10.003; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; de Jong BM, 2001, NEUROIMAGE, V14, P1128, DOI 10.1006/nimg.2001.0911; De Lisi R, 2002, J GENET PSYCHOL, V163, P272, DOI 10.1080/00221320209598683; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Dillard C, 2016, DISABIL REHABIL, V8288, P1; Donohue SE, 2010, ATTEN PERCEPT PSYCHO, V72, P1120, DOI 10.3758/APP.72.4.1120; DORVAL M, 1986, PERCEPT MOTOR SKILL, V62, P159, DOI 10.2466/pms.1986.62.1.159; DUSTMAN RE, 1992, J GERONTOL, V47, pP168, DOI 10.1093/geronj/47.3.P168; Dye MWG, 2009, NEUROPSYCHOLOGIA, V47, P1780, DOI 10.1016/j.neuropsychologia.2009.02.002; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Fischer E, 2012, NEURON, V73, P1228, DOI 10.1016/j.neuron.2012.01.022; Fritz SL, 2013, TOP STROKE REHABIL, V20, P218, DOI 10.1310/tsr2003-218; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; Gobel EW, 2011, NEUROIMAGE, V58, P1150, DOI 10.1016/j.neuroimage.2011.06.090; Gong DK, 2015, SCI REP-UK, V5, DOI 10.1038/srep09763; GOPHER D, 1994, HUM FACTORS, V36, P387, DOI 10.1177/001872089403600301; Gorbet DJ, 2016, BEHAV BRAIN RES, V298, P229, DOI 10.1016/j.bbr.2015.11.012; Gorbet DJ, 2007, EUR J NEUROSCI, V25, P1228, DOI 10.1111/j.1460-9568.2007.05358.x; Gorbet DJ, 2011, EXP BRAIN RES, V212, P315, DOI 10.1007/s00221-011-2731-y; Gorbet DJ, 2010, EXP BRAIN RES, V202, P633, DOI 10.1007/s00221-010-2170-1; Granek JA, 2010, CORTEX, V46, P1165, DOI 10.1016/j.cortex.2009.10.009; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green CS, 2006, J EXP PSYCHOL HUMAN, V32, P1465, DOI 10.1037/0096-1523.32.6.1465; Green CS, 2010, CURR BIOL, V20, P1573, DOI 10.1016/j.cub.2010.07.040; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Greenfield PM, 1994, J APPL DEV PSYCHOL, V15, P105, DOI [10.1016/0193-3973(94)90008-6, DOI 10.1016/0193-3973(94)90008-6]; GREENFIELD PM, 1994, J APPL DEV PSYCHOL, V15, P87, DOI DOI 10.1016/0193-3973(94)90007-8; Grigorova V, 2013, J MOTOR BEHAV, V45, P101, DOI 10.1080/00222895.2012.750590; Haaxma CA, 2007, J NEUROL NEUROSUR PS, V78, P819, DOI 10.1136/jnnp.2006.103788; HAIER RJ, 1992, BRAIN RES, V570, P134, DOI 10.1016/0006-8993(92)90573-R; Harwell D, 2014, WASHINGTON POST; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Hoeft F, 2008, J PSYCHIATR RES, V42, P253, DOI 10.1016/j.jpsychires.2007.11.010; Hubert-Wallander B, 2011, WIRES COGN SCI, V2, P222, DOI 10.1002/wcs.116; Irons JL, 2011, AUST J PSYCHOL, V63, P224, DOI 10.1111/j.1742-9536.2011.00001.x; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Karle JW, 2010, ACTA PSYCHOL, V134, P70, DOI 10.1016/j.actpsy.2009.12.007; Kennedy AM, 2011, J SURG EDUC, V68, P414, DOI 10.1016/j.jsurg.2011.03.009; Kim YH, 2015, J NEUROSCI, V35, P10485, DOI 10.1523/JNEUROSCI.3340-14.2015; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Kuhn S, 2014, MOL PSYCHIATR, V19, P842, DOI 10.1038/mp.2013.100; Labiche LA, 2002, ANN EMERG MED, V40, P453, DOI 10.1067/mem.2002.128682; Lacquaniti F, 1997, NEUROIMAGE, V5, P129, DOI 10.1006/nimg.1996.0254; Latham AJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00629; Latham AJ, 2014, ATTEN PERCEPT PSYCHO, V76, P2193, DOI 10.3758/s13414-014-0789-x; Lee H, 2012, BEHAV BRAIN RES, V232, P348, DOI 10.1016/j.bbr.2012.03.043; Levac DE, 2013, PHYSIOTHER THEOR PR, V29, P504, DOI 10.3109/09593985.2012.762078; Li RJ, 2010, J VISION, V10, DOI 10.1167/10.14.33; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; Liu MY, 2009, RESTOR NEUROL NEUROS, V27, P163, DOI 10.3233/RNN-2009-0467; Lucas K, 2004, COMMUN RES, V31, P499, DOI 10.1177/0093650204267930; Medendorp WP, 2005, J NEUROPHYSIOL, V93, P954, DOI 10.1152/jn.00725.2004; Miall RC, 2001, NAT NEUROSCI, V4, P638, DOI 10.1038/88465; Mishra J, 2011, J NEUROSCI, V31, P992, DOI 10.1523/JNEUROSCI.4834-10.2011; Monaco S, 2014, CEREB CORTEX, V24, P1540, DOI 10.1093/cercor/bht006; Morris MC, 2015, J SURG EDUC, V72, P198, DOI 10.1016/j.jsurg.2014.09.007; Neggers SFW, 2001, J NEUROPHYSIOL, V86, P961, DOI 10.1152/jn.2001.86.2.961; Okagaki Lynn, 1994, J APPL DEV PSYCHOL, V15, P33, DOI DOI 10.1016/0193-3973(94)90005-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Passarelli L, 2011, J NEUROSCI, V31, P1790, DOI 10.1523/JNEUROSCI.4784-10.2011; Petrini K, 2011, NEUROIMAGE, V56, P1480, DOI 10.1016/j.neuroimage.2011.03.009; Pitzalis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060241; Quaiser-Pohl C, 2006, PERS INDIV DIFFER, V40, P609, DOI 10.1016/j.paid.2005.07.015; Scherberger H, 2007, J NEUROSCI, V27, P2001, DOI 10.1523/JNEUROSCI.4274-06.2007; Schubert T, 2015, ACTA PSYCHOL, V157, P200, DOI 10.1016/j.actpsy.2015.03.005; Sinanaj I, 2015, CONSCIOUS COGN, V36, P327, DOI 10.1016/j.concog.2015.07.012; Spencer A., 2009, J ARTICLES SUPPORT N, V6, P1; Striemer CL, 2015, NEUROPSYCHOLOGIA, V69, P9, DOI 10.1016/j.neuropsychologia.2015.01.024; Subrahmanyam K., 1994, J APPL DEV PSYCHOL, V15, P13, DOI DOI 10.1016/0193-3973(94)90004-3; Sungur H, 2012, ACTA PSYCHOL, V139, P327, DOI 10.1016/j.actpsy.2011.12.002; Tanaka S, 2013, PLOS ONE, V8, P4, DOI DOI 10.1371/J0URNAL.P0NE.0066998; Thorson CM, 2011, J LAPAROENDOSC ADV S, V21, P329, DOI 10.1089/lap.2010.0368; Vesia M, 2012, EXP BRAIN RES, V221, P1, DOI 10.1007/s00221-012-3158-9; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982	96	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0189110	10.1371/journal.pone.0189110	http://dx.doi.org/10.1371/journal.pone.0189110			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364891	Green Published, gold, Green Submitted			2022-12-27	WOS:000423412500004
J	Behan, FP; Maden-Wilkinson, TM; Pain, MTG; Folland, JP				Behan, Fearghal P.; Maden-Wilkinson, Thomas M.; Pain, Matt T. G.; Folland, Jonathan P.			Sex differences in muscle morphology of the knee flexors and knee extensors	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; FEMALE TEAM HANDBALL; ANGULAR VELOCITY; TORQUE RATIOS; STRAIN INJURY; YOUNG MEN; LOWER LEG; IN-VIVO; STRENGTH; QUADRICEPS	Introduction & para;& para;Females experience higher risk of anterior cruciate ligament (ACL) injuries; males experience higher risk of hamstring strain injuries. Differences in injury may be partially due to sex differences in knee flexor (KF) to knee extensor (KE) muscle size ratio and the proportional size of constituent muscles.& para;& para;Purpose & para;& para;To compare the absolute and proportional size, and mass distribution, of individual KE and KF muscles, as well as overall size and balance (size ratio) of these muscle groups between the sexes.& para;& para;Methods & para;& para;T1-weighted axial plane MR images (1.5T) of healthy untrained young males and females (32 vs 34) were acquired to determine thigh muscle anatomical cross-sectional area (ACSA). Maximal ACSA (ACSAmax) of constituent muscles, summated for KF and KE muscle groups, and the KF:KE ratio were calculated.& para;& para;Results & para;& para; Females had 25.3% smaller KE ACSAmax (70.9 +/- 12.1 vs 93.6 +/- 10.3 cm(2); P<0.001) and 29.6% smaller KF ACSAmax than males (38.8 +/- 7.3cm(2) vs 55.1 +/- 7.3cm(2); P<0.001). Consequently, females had lower KF:KE ACSA ratio (P = 0.031). There were sex differences in the proportional size of 2/4 KE and 5/6 KF. In females, vastus lateralis (VL), biceps femoris long-head (BFlh) and semimembranosus (SM) were a greater proportion and sartorius (SA), gracilis (GR) and biceps femoris short-head (BFsh) a smaller proportion of their respective muscle groups compared to males (All P<0.05).& para;& para;Conclusion & para;& para;Sex differences in KF:KE ACSAmax ratio may contribute to increased risk of ACL injury in females. Sex discrepancies in absolute and proportional size of SA, GR, VL and BFlh may contribute further anatomical explanations for sex differences in injury incidence.	[Behan, Fearghal P.; Folland, Jonathan P.] Loughborough Univ Technol, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Loughborough, Leics, England; [Behan, Fearghal P.; Pain, Matt T. G.; Folland, Jonathan P.] Loughborough Univ Technol, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Maden-Wilkinson, Thomas M.] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Collegiate Campus, Sheffield, S Yorkshire, England	Loughborough University; Loughborough University; Sheffield Hallam University	Behan, FP (corresponding author), Loughborough Univ Technol, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Loughborough, Leics, England.; Behan, FP (corresponding author), Loughborough Univ Technol, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England.	F.Behan@lboro.ac.uk		Maden-Wilkinson, Thomas/0000-0002-6191-045X; Behan, Fearghal/0000-0001-9578-5725	Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis; Arthritis Research UK	Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis(Versus Arthritis); Arthritis Research UK(Versus Arthritis)	Arthritis Research UK funded the research.& para;& para; This research was funded by The Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis.	Aagaard P, 2001, J PHYSIOL-LONDON, V534, P613, DOI 10.1111/j.1469-7793.2001.t01-1-00613.x; Aagaard P, 1998, AM J SPORT MED, V26, P231, DOI 10.1177/03635465980260021201; Akagi R, 2013, INT J SPORTS MED, V34, P449, DOI 10.1055/s-0032-1327654; Akagi R, 2012, INT J SPORTS MED, V33, P386, DOI 10.1055/s-0031-1299700; Andrade MD, 2012, J SPORT SCI, V30, P547, DOI 10.1080/02640414.2011.644249; Arendt E, 2009, AM J SPORTS MED, V23, P694; Balshaw TG, 2016, J APPL PHYSIOL, V120, P1364, DOI 10.1152/japplphysiol.00091.2016; Barnouin Y, 2014, J MAGN RESON IMAGING, V40, P239, DOI 10.1002/jmri.24370; Besier TF, 2003, MED SCI SPORT EXER, V35, P119, DOI 10.1097/00005768-200301000-00019; Blackburn JT, 2009, CLIN BIOMECH, V24, P65, DOI 10.1016/j.clinbiomech.2008.10.001; Buchanan TS, 1997, J ORTHOPAED RES, V15, P11, DOI 10.1002/jor.1100150103; Calmels PM, 1997, ARCH PHYS MED REHAB, V78, P1224, DOI 10.1016/S0003-9993(97)90336-1; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Croisier JL, 2008, AM J SPORT MED, V36, P1469, DOI 10.1177/0363546508316764; DeMorat G, 2004, AM J SPORT MED, V32, P477, DOI 10.1177/0363546503258928; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Edouard P, 2016, BRIT J SPORT MED, V50, P619, DOI 10.1136/bjsports-2015-095559; Erskine RM, 2014, EUR J APPL PHYSIOL, V114, P1239, DOI 10.1007/s00421-014-2855-4; Evangelidis PE, 2016, EUR J APPL PHYSIOL, V116, P593, DOI 10.1007/s00421-015-3321-7; Hannah R, 2015, EUR J APPL PHYSIOL, V115, P837, DOI 10.1007/s00421-014-3063-y; Heiderscheit BC, 2005, CLIN BIOMECH, V20, P1072, DOI 10.1016/j.clinbiomech.2005.07.005; Hewett TE, 2008, J SCI MED SPORT, V11, P452, DOI 10.1016/j.jsams.2007.04.009; Hoshikawa Y, 2011, J PHYSIOL ANTHROPOL, V30, P47, DOI 10.2114/jpa2.30.47; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Koulouris G, 2007, AM J SPORT MED, V35, P1500, DOI 10.1177/0363546507301258; Krosshaug T, 2007, SCAND J MED SCI SPOR, V17, P508, DOI 10.1111/j.1600-0838.2006.00558.x; Lloyd DG, 2001, J BIOMECH, V34, P1257, DOI 10.1016/S0021-9290(01)00095-1; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Lube J, 2016, SURG RADIOL ANAT, V38, P97, DOI 10.1007/s00276-015-1526-4; MacWilliams BA, 1999, J ORTHOPAED RES, V17, P817, DOI 10.1002/jor.1100170605; Mersmann F, 2015, SCAND J MED SCI SPOR, V25, pe208, DOI 10.1111/sms.12285; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Myklebust G, 2003, CLIN J SPORT MED, V13, P71, DOI 10.1097/00042752-200303000-00002; Round JM, 1999, ANN HUM BIOL, V26, P49, DOI 10.1080/030144699282976; Satterthwaite P, 1999, BRIT J SPORT MED, V33, P22, DOI 10.1136/bjsm.33.1.22; Schache AG, 2009, GAIT POSTURE, V29, P332, DOI 10.1016/j.gaitpost.2008.10.054; Serpell BG, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0804-y; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Verrall GM, 2003, AM J SPORT MED, V31, P969, DOI 10.1177/03635465030310063701; Withrow TJ, 2008, J BONE JOINT SURG AM, V90A, P815, DOI 10.2106/JBJS.F.01352; Wretenberg P, 1996, CLIN BIOMECH, V11, P439, DOI 10.1016/S0268-0033(96)00030-7; Wu R, 2016, AGE, V38, DOI 10.1007/s11357-016-9921-2; Zhang LQ, 2001, J BIOMECH, V34, P1107, DOI 10.1016/S0021-9290(01)00080-X	44	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190903	10.1371/journal.pone.0190903	http://dx.doi.org/10.1371/journal.pone.0190903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360834	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000423161800010
J	Liu, F; Yang, YJ; Gao, JW; Ma, CL; Bi, YP				Liu, Fang; Yang, Yuanjun; Gao, Jianwei; Ma, Changle; Bi, Yuping			A comparative transcriptome analysis of a wild purple potato and its red mutant provides insight into the mechanism of anthocyanin transformation	PLOS ONE			English	Article							LOOP-HELIX COFACTORS; SOLANUM-TUBEROSUM L.; HPLC-DAD; BIOSYNTHESIS GENES; ACCUMULATION; ANTIOXIDANT; ARABIDOPSIS; EXPRESSION; ARCHITECTURE; ACTIVATION	In this study, a red mutant was obtained through in vitro regeneration of a wild purple potato. High-performance liquid chromatography and Mass spectrometry analysis revealed that pelargonidin-3-O-glucoside and petunidin-3-O-glucoside were main anthocyanins in the mutant and wild type tubers, respectively. In order to thoroughly understand the mechanism of anthocyanin transformation in two materials, a comparative transcriptome analysis of the mutant and wild type was carried out through high-throughput RNA sequencing, and 295 differentially expressed genes (DEGs) were obtained. Real-time qRT-PCR validation of DEGs was consistent with the transcriptome date. The DEGs mainly influenced biological and metabolic pathways, including phenylpropanoid biosynthesis and translation, and biosynthesis of flavone and flavonol. In anthocyanin biosynthetic pathway, the analysis of structural genes expressions showed that three genes, one encoding phenylalanine ammonia-lyase, one encoding 4-coumarate-CoA ligase and one encoding flavonoid 3 ',5 '-hydroxylasem were significantly down-regulated in the mutant; one gene encoding phenylalanine ammonia-lyase was significantly up-regulated. Moreover, the transcription factors, such as bZIP family, MYB family, LOB family, MADS family, zf-HD family and C2H2 family, were significantly regulated in anthocyanin transformation. Response proteins of hormone, such as gibberellin, abscisic acid and brassinosteroid, were also significantly regulated in anthocyanin transformation. The information contributes to discovering the candidate genes in anthocyanin transformation, which can serve as a comprehensive resource for molecular mechanism research of anthocyanin transformation in potatoes.	[Liu, Fang; Ma, Changle; Bi, Yuping] Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China; [Liu, Fang; Yang, Yuanjun; Gao, Jianwei] Shandong Acad Agr Sci, Shandong Key Lab Greenhouse Vegetable Biol, Inst Vegetables & Flowers, Shandong Branch,Natl Vegetable Improvement Ctr, Jinan, Shandong, Peoples R China; [Bi, Yuping] Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Shandong, Peoples R China	Shandong Normal University; Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Ma, CL; Bi, YP (corresponding author), Shandong Normal Univ, Coll Life Sci, Jinan, Shandong, Peoples R China.; Bi, YP (corresponding author), Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Shandong, Peoples R China.	changlema@yahoo.com; yupingbi@qq.com			"Modern Agriculture Industrial Technology System Funding of Shandong Province" - Shandong Provincial Department of Agriculture [SDAIT-10-022-05]; "Youth Funding of Shandong Academy of Agricultural Sciences" - Shandong Academy of Agricultural Sciences [2014QNM13]	"Modern Agriculture Industrial Technology System Funding of Shandong Province" - Shandong Provincial Department of Agriculture; "Youth Funding of Shandong Academy of Agricultural Sciences" - Shandong Academy of Agricultural Sciences	This work was supported by two fundings. One was the "Youth Funding of Shandong Academy of Agricultural Sciences (Grant No. 2014QNM13)" sponsored by Shandong Academy of Agricultural Sciences. The other funding is "Modern Agriculture Industrial Technology System Funding of Shandong Province (Grant No. SDAIT-10-022-05)" sponsored by Shandong Provincial Department of Agriculture.	Azuma A, 2009, PLANT SCI, V176, P470, DOI 10.1016/j.plantsci.2008.12.015; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Bontempo P, 2013, FOOD CHEM TOXICOL, V55, P304, DOI 10.1016/j.fct.2012.12.048; Brown CR, 2007, HORTSCIENCE, V42, P1733, DOI 10.21273/HORTSCI.42.7.1733; Castellarin SD, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-46; D'Amelia V, 2014, PLANT J, V80, P527, DOI 10.1111/tpj.12653; De Jong WS, 2003, THEOR APPL GENET, V107, P1375, DOI 10.1007/s00122-003-1395-9; DODDS K. S., 1955, JOUR GENETICS, V53, P136, DOI 10.1007/BF02981517; DODDS K. S., 1956, Journal of Genetics, V54, P27, DOI 10.1007/BF02981699; DrogeLaser W, 1997, EMBO J, V16, P726, DOI 10.1093/emboj/16.4.726; Fogelman E, 2015, PHYSIOL PLANTARUM, V153, P616, DOI 10.1111/ppl.12265; Garcia-Beneytez E, 2003, J AGR FOOD CHEM, V51, P5622, DOI 10.1021/jf0302207; Han KH, 2006, BRIT J NUTR, V96, P1125, DOI 10.1017/BJN20061928; Han KH, 2006, BIOSCI BIOTECH BIOCH, V70, P2285, DOI 10.1271/bbb.60097; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; HURST HC, 1994, PROTEIN PROFILE, V1, P123; Jaakola L, 2010, PLANT PHYSIOL, V153, P1619, DOI 10.1104/pp.110.158279; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Jung CS, 2009, THEOR APPL GENET, V120, P45, DOI 10.1007/s00122-009-1158-3; Jung CS, 2005, THEOR APPL GENET, V110, P269, DOI 10.1007/s00122-004-1829-z; Koyama K, 2010, FUNCT INTEGR GENOMIC, V10, P367, DOI 10.1007/s10142-009-0145-8; Kyoungwon C, 2016, J EXP BOT; Lalusin AG, 2006, MOL GENET GENOMICS, V275, P44, DOI 10.1007/s00438-005-0080-x; Lee JH, 2009, FOOD CHEM, V112, P226, DOI 10.1016/j.foodchem.2008.05.056; Lee MJ, 2013, J AGR FOOD CHEM, V61, P3148, DOI 10.1021/jf3055455; Li W, 2014, J INTEGR PLANT BIOL, V56, P364, DOI 10.1111/jipb.12136; Liu Y, 2015, PLOS ONE; Liu YH, 2016, J EXP BOT, V67, P2159, DOI 10.1093/jxb/erw014; Lu QN, 2006, AFR J BIOTECHNOL, V5, P811; Lukaszewicz M, ANTIOXIDANT CAPACITY, V52, P1526; MARTIN C, 1993, PLANT CELL, V5, P1253, DOI 10.1105/tpc.5.10.1253; Momose M, 2010, GENETICS, V186, P59, DOI 10.1534/genetics.110.117606; Palma-Silva C, 2016, MOL ECOL RESOUR, V16, P1012, DOI 10.1111/1755-0998.12504; Pan ZJ, 2014, NEW PHYTOL, V202, P1024, DOI 10.1111/nph.12723; Peng ZH, 2011, J INTEGR PLANT BIOL, V53, P632, DOI 10.1111/j.1744-7909.2011.01042.x; Pertuzatti PB, 2016, J FUNCT FOODS, V26, P506, DOI 10.1016/j.jff.2016.07.026; [秦玉海 Qin Yuhai], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P3276; Ramirez JE, 2015, FOOD CHEM, V176, P106, DOI 10.1016/j.foodchem.2014.12.039; Rommens CM, 2008, PLANT BIOTECHNOL J, V6, P870, DOI 10.1111/j.1467-7652.2008.00362.x; Salaman RN, 1911, MOL GEN GENET, V5, P192; Sasaki K, 2014, PLANT MOL BIOL, V86, P319, DOI 10.1007/s11103-014-0231-8; Shen XJ, 2014, PLANT CELL PHYSIOL, V55, P862, DOI 10.1093/pcp/pcu013; Shimada Y, 2001, PLANT CELL REP, V20, P456, DOI 10.1007/s002990100319; Shin DH, 2013, FEBS LETT, V587, P1543, DOI 10.1016/j.febslet.2013.03.037; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Stobiecki M, 2003, PHYTOCHEMISTRY, V62, P959, DOI 10.1016/S0031-9422(02)00720-3; Sun YY, 2017, MOL GENET GENOMICS, V292, P215, DOI 10.1007/s00438-016-1268-y; Tonelli C, 2007, P 18 INT C AR RES, P176; Wada T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109093; Wei Q, 2012, PLANT BIOTECHNOL REP, V6, P69, DOI 10.1007/s11816-011-0201-4; Wessinger CA, 2015, MOL BIOL EVOL, V32, P347, DOI 10.1093/molbev/msu298; Yan J, 2014, SCI HORTIC-AMSTERDAM, V165, P218, DOI 10.1016/j.scienta.2013.11.018; Yoshida K, 2015, PLANT PHYSIOL, V167, P693, DOI 10.1104/pp.114.253674; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang HY, 2011, PLANT J, V65, P346, DOI 10.1111/j.1365-313X.2010.04426.x; Zhang Y, 2011, J PLANT PHYSL, V4, P367; Zhang YF, 2009, THEOR APPL GENET, V119, P143, DOI 10.1007/s00122-009-1024-3; Zhang YQ, 2011, PLANT SIGNAL BEHAV, V6, P632, DOI 10.4161/psb.6.5.14343	60	21	25	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191406	10.1371/journal.pone.0191406	http://dx.doi.org/10.1371/journal.pone.0191406			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360842	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800029
J	Verma, V; Kaur, C; Grover, P; Gupta, A; Chaudhary, VK				Verma, Vaishali; Kaur, Charanpreet; Grover, Payal; Gupta, Amita; Chaudhary, Vijay K.			Biotin-tagged proteins: Reagents for efficient ELISA-based serodiagnosis and phage display-based affinity selection	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; IN-VIVO; ESCHERICHIA-COLI; HOLOENZYME SYNTHETASE; ANTIBODY FRAGMENTS; FUSION PROTEINS; BRIDGING ELISA; HUMAN SERA; EXPRESSION; PURIFICATION	The high-affinity interaction between biotin and streptavidin has opened avenues for using recombinant proteins with site-specific biotinylation to achieve efficient and directional immobilization. The site-specific biotinylation of proteins carrying a 15 amino acid long Biotin Acceptor Peptide tag (BAP; also known as AviTag) is effected on a specific lysine either by co-expressing the E. coli BirA enzyme in vivo or by using purified recombinant E. coli BirA enzyme in the presence of ATP and biotin in vitro. In this paper, we have designed a T7 promoter-lac operator-based expression vector for rapid and efficient cloning, and high-level cytosolic expression of proteins carrying a C-terminal BAP tag in E. coli with TEV protease cleavable N-terminal deca-histidine tag, useful for initial purification. Furthermore, a robust three-step purification pipeline integrated with well-optimized protocols for TEV protease-based H10 tag removal, and recombinant BirA enzyme-based site-specific in vitro biotinylation is described to obtain highly pure biotinylated proteins. Most importantly, the paper demonstrates superior sensitivities in indirect ELISA with directional and efficient immobilization of biotin-tagged proteins on streptavidin-coated surfaces in comparison to passive immobilization. The use of biotin-tagged proteins through specific immobilization also allows more efficient selection of binders from a phage-displayed naive antibody library. In addition, for both these applications, specific immobilization requires much less amount of protein as compared to passive immobilization and can be easily multiplexed. The simplified strategy described here for the production of highly pure biotin-tagged proteins will find use in numerous applications, including those, which may require immobilization of multiple proteins simultaneously on a solid surface.	[Verma, Vaishali; Kaur, Charanpreet; Grover, Payal; Gupta, Amita; Chaudhary, Vijay K.] Univ Delhi, CIIDRET, South Campus, New Delhi, India; [Verma, Vaishali; Kaur, Charanpreet; Grover, Payal; Gupta, Amita; Chaudhary, Vijay K.] Univ Delhi, Dept Biochem, South Campus, New Delhi, India	University of Delhi; University of Delhi	Gupta, A; Chaudhary, VK (corresponding author), Univ Delhi, CIIDRET, South Campus, New Delhi, India.; Gupta, A; Chaudhary, VK (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	amitagupta@south.du.ac.in; vkchaudhary@south.du.ac.in	Verma, Vaishali/ABH-2408-2021	Verma, Vaishali/0000-0001-5076-7435	Council of Scientific and Industrial Research, India; Delhi University Research and Development grant; Council of Scientific and Industrial Research (CSIR-NMITLI), India; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Delhi University Research and Development grant; Council of Scientific and Industrial Research (CSIR-NMITLI), India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by grants from the Department of Biotechnology, Government of India, Council of Scientific and Industrial Research (CSIR-NMITLI), India, and Delhi University Research and Development grant to VKC and AG.W is the recipient of a research fellowship from Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Bouda LMP, 2003, J IMMUNOL METHODS, V283, P115, DOI 10.1016/j.jim.2003.08.019; BARKER DF, 1981, J MOL BIOL, V146, P451, DOI 10.1016/0022-2836(81)90042-5; Batra G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-64; Batra G, 2010, PROTEIN EXPRES PURIF, V74, P99, DOI 10.1016/j.pep.2010.04.017; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Butler JE, 2000, METHODS, V22, P4, DOI 10.1006/meth.2000.1031; Chaudhary VK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111538; Clavijo A, 2004, J VIROL METHODS, V120, P217, DOI 10.1016/j.jviromet.2004.05.007; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Cronan JE, 2001, J BIOL CHEM, V276, P37355, DOI 10.1074/jbc.M106353200; Cull MG, 2000, METHOD ENZYMOL, V326, P430; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; Dundas CM, 2013, APPL MICROBIOL BIOT, V97, P9343, DOI 10.1007/s00253-013-5232-z; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Graslund S, 2017, METHODS MOL BIOL, V1586, P337, DOI 10.1007/978-1-4939-6887-9_22; Gross J, 2006, J IMMUNOL METHODS, V313, P176, DOI 10.1016/j.jim.2006.04.008; Gupta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075212; Haque A, 2012, NAT PROTOC, V7, P2127, DOI 10.1038/nprot.2012.132; Houghton RL, 2002, CLIN DIAGN LAB IMMUN, V9, P883, DOI 10.1128/CDLI.9.4.883-891.2002; Ikonomova SP, 2016, J IMMUNOL METHODS, V435, P7, DOI 10.1016/j.jim.2016.04.012; Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12; Kimura R, 2010, JPN J INFECT DIS, V63, P41; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; LI SJ, 1992, J BIOL CHEM, V267, P855; Li YF, 2012, PROTEIN EXPRES PURIF, V82, P162, DOI 10.1016/j.pep.2011.12.008; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; Postel A, 2011, ANAL BIOCHEM, V411, P22, DOI 10.1016/j.ab.2010.12.022; Qureshi MH, 2002, PROTEIN EXPRES PURIF, V25, P409, DOI 10.1016/S1046-5928(02)00021-9; Rohman M, 2000, PROTEIN EXPRES PURIF, V20, P45, DOI 10.1006/prep.2000.1271; Rossi S, 2005, AM J CLIN PATHOL, V124, P295, DOI 10.1309/NR8HN08GDPVEMU08; Salminen T, 2016, J VIROL METHODS, V228, P67, DOI 10.1016/j.jviromet.2015.11.015; Schetters H, 1999, BIOMOL ENG, V16, P73, DOI 10.1016/S1050-3862(99)00034-0; Scholle MD, 2004, PROTEIN EXPRES PURIF, V37, P243, DOI 10.1016/j.pep.2004.05.012; Shin SK, 2010, J PHARMACEUT BIOMED, V52, P289, DOI 10.1016/j.jpba.2010.01.022; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; Staudt N, 2014, BIOCHEM BIOPH RES CO, V445, P785, DOI 10.1016/j.bbrc.2013.12.033; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tsao KL, 1996, GENE, V169, P59, DOI 10.1016/0378-1119(95)00762-8; Tykvart J, 2012, PROTEIN EXPRES PURIF, V82, P106, DOI 10.1016/j.pep.2011.11.016; Yano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156716; Zhong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139695; Zhou FB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15349	45	5	5	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191315	10.1371/journal.pone.0191315	http://dx.doi.org/10.1371/journal.pone.0191315			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360877	Green Published, gold, Green Submitted			2022-12-27	WOS:000423161800023
J	Jacobi, CLJ; Stein, C				Jacobi, Charlotte Louise Justine; Stein, Christoph			Inflammatory-linked changes in CpG island methylation of three opioid peptide genes in a rat model for pain	PLOS ONE			English	Article							BETA-ENDORPHIN; MESSENGER-RNA; IMMUNE CELLS; PROOPIOMELANOCORTIN GENE; PROSTATE-CANCER; IN-VIVO; EXPRESSION; PROMOTER; DNA; TRANSCRIPTION	Expression of the opioid peptide genes proopiomelanocortin (Pomc), proenkephalin (Penk), and prodynorphin (Pdyn), in immune cells plays a key role in endogenous pain control. In a rat model of painful unilateral paw inflammation, we isolated cells from popliteal lymph nodes and evaluated the role of C(p)G island C5-methylation on the transcriptional activation of those genes. Using methylated DNA immunoprecipitation, we sorted gDNA into methylated (me) and non-me fractions and then determined the C(p)G island methylation status of each fraction via quantitative Real Time-PCR (qRT-PCR). In silico analysis by MethPrimer software identified one C(p)G island in Pdyn and three each in Pomc and Penk. No substantial changes in C5-methylation of any gene were observed. In conclusion, the C(p)G island methylation status does not seem to be a key regulator of opioid gene activation in immune cells during peripheral tissue inflammation.	[Jacobi, Charlotte Louise Justine; Stein, Christoph] Charite Univ Med Berlin, Klin Anasthesiol & Operat Intens Med, Campus Benjamin Franklin, Berlin, Germany; [Jacobi, Charlotte Louise Justine] Charite Univ Med Berlin, Klin Neonatol, Campus Virchow Klinikum, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jacobi, CLJ (corresponding author), Charite Univ Med Berlin, Klin Anasthesiol & Operat Intens Med, Campus Benjamin Franklin, Berlin, Germany.; Jacobi, CLJ (corresponding author), Charite Univ Med Berlin, Klin Neonatol, Campus Virchow Klinikum, Berlin, Germany.	charlotte.jacobi@charite.de		Stein, Christoph/0000-0001-5240-6836	Bundesministerium fur Bildung und Forschung [01EC1403E/F]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (https://www.bmbf.de/; grant number 01EC1403E/F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIL H, 1984, ANNU REV NEUROSCI, V7, P223, DOI 10.1146/annurev.ne.07.030184.001255; Amaravadi L, 1999, DNA CELL BIOL, V18, P875, DOI 10.1089/104454999314737; Ashour N, 2014, PROSTATE, V74, P1171, DOI 10.1002/pros.22833; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Cabot PJ, 1997, J CLIN INVEST, V100, P142, DOI 10.1172/JCI119506; Chadzinska M, 2005, IMMUNOL LETT, V101, P185, DOI 10.1016/j.imlet.2005.05.009; Chan RM, 1997, MOL BRAIN RES, V45, P50, DOI 10.1016/S0169-328X(96)00236-7; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; HEIJNEN CJ, 1991, IMMUNOL REV, V119, P41, DOI 10.1111/j.1600-065X.1991.tb00577.x; Hurd YL, 1996, NEUROSCIENCE, V72, P767, DOI 10.1016/0306-4522(96)00002-4; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kuehnen P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002543; LaMendola J, 1997, FEBS LETT, V404, P19, DOI 10.1016/S0014-5793(97)00078-1; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; LOLAIT SJ, 1986, J CLIN INVEST, V77, P1776, DOI 10.1172/JCI112501; Maddila SC, 2016, J NEUROIMMUNE PHARM, P1; Mizoguchi Y, 2007, HORM RES, V67, P257, DOI 10.1159/000098548; Mousa SA, 2002, J NEUROIMMUNOL, V126, P5, DOI 10.1016/S0165-5728(02)00049-8; Newell-Price J, 2001, MOL ENDOCRINOL, V15, P338, DOI 10.1210/me.15.2.338; Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758; Olkhov-Mitsel E, 2012, CANCER MED-US, V1, P237, DOI 10.1002/cam4.22; Roperch JP, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-566; SCHAFER M, 1994, P NATL ACAD SCI USA, V91, P4219, DOI 10.1073/pnas.91.10.4219; Sehgal N, 2011, PAIN PHYSICIAN, V14, P249; Sitte N, 2007, J NEUROIMMUNOL, V183, P133, DOI 10.1016/j.jneuroim.2006.11.033; Smith EM, 2003, ADV EXP MED BIOL, V521, P51; Smith EM, 2008, BRAIN BEHAV IMMUN, V22, P3, DOI 10.1016/j.bbi.2007.08.005; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; STEIN C, 1993, ANESTH ANALG, V76, P182; STEIN C, 1995, NEW ENGL J MED, V332, P1685, DOI 10.1056/NEJM199506223322506; Stein C, 2011, PHARMACOL REV, V63, P860, DOI 10.1124/pr.110.003145; Strathdee G, 2004, CARCINOGENESIS, V25, P693, DOI 10.1093/carcin/bgh066; Taqi MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039605; Taqi MM, 2011, ADDICT BIOL, V16, P499, DOI 10.1111/j.1369-1600.2011.00323.x; VINDROLA O, 1994, NEUROPEPTIDES, V27, P235, DOI 10.1016/0143-4179(94)90004-3; WEBER E, 1982, NATURE, V299, P77, DOI 10.1038/299077a0; Yuferov V, 2010, PHARMACOGENET GENOM, V21, P1; Zhang X, 2010, PROSTATE, V70, P765, DOI 10.1002/pros.21109; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191698	10.1371/journal.pone.0191698	http://dx.doi.org/10.1371/journal.pone.0191698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352321	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300123
J	Nieto, JA; Zhu, J; Duan, B; Li, JS; Zhou, P; Paka, L; Yamin, MA; Goldberg, ID; Narayan, P				Nieto, Jake A.; Zhu, Janice; Duan, Bin; Li, Jingsong; Zhou, Ping; Paka, Latha; Yamin, Michael A.; Goldberg, Itzhak D.; Narayan, Prakash			A modified elliptical formula to estimate kidney collagen content in a model of chronic kidney disease	PLOS ONE			English	Article							CKD	The extent of scarring or renal interstitial collagen deposition in chronic kidney disease (CKD) can only be ascertained by highly invasive, painful and sometimes risky, tissue biopsy. Interestingly, while CKD-related abnormalities in kidney size can often be visualized using ultrasound, not only does the ellipsoid formula used today underestimate true renal size, but the calculated renal size does not inform tubulointerstitial collagen content. We used coronal kidney sections from healthy mice and mice with kidney disease to develop a new formula for estimating renal parenchymal area. While treating the kidney as an ellipse with the major axis (a) the polar distance, this technique involves extending the minor axis (b) into the renal pelvis to obtain a new minor axis, be. The calculated renal parenchymal area is remarkably similar to the true or measured area. Biochemically determined kidney collagen content revealed a strong and positive correlation with the calculated renal parenchymal area. Picrosirius red staining for tubulointerstitial collagen also correlated with calculated renal parenchymal area. The extent of renal scarring, i.e. kidney interstitial collagen content, can now be computed by making just two axial measurements which can easily be accomplished via noninvasive imaging of this organ.	[Nieto, Jake A.; Zhu, Janice; Duan, Bin; Li, Jingsong; Zhou, Ping; Paka, Latha; Yamin, Michael A.; Goldberg, Itzhak D.; Narayan, Prakash] Angion Biomed Corp, Dept Preclin Res, Uniondale, NY 11553 USA		Narayan, P (corresponding author), Angion Biomed Corp, Dept Preclin Res, Uniondale, NY 11553 USA.	pnarayan@angion.com		Narayan, Prakash/0000-0002-7007-0245	National Institute of Diabetes and Digestive and Kidney Diseases [2R44DK085771-02A1]; Department of Defense [W81XWH-14-1-0411]; Angion Biomedica Corp., NY	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Defense(United States Department of Defense); Angion Biomedica Corp., NY	This study was funded in part by awards 2R44DK085771-02A1 (National Institute of Diabetes and Digestive and Kidney Diseases) and W81XWH-14-1-0411 (Department of Defense) made to PN. Additional funding was provided by Angion Biomedica Corp., NY in the form of salaries for authors BD, JSL, PZ, LP, MAY, IDG and PN. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2012, GFR CALCULATORS SERU; Chapman AB, 2011, SEMIN NEPHROL, V31, P237, DOI 10.1016/j.semnephrol.2011.05.003; Cheong B, 2007, CLIN J AM SOC NEPHRO, V2, P38, DOI 10.2215/CJN.00930306; Fleck M, 2002, EXP TOXICOL PATHOL, V54, P15, DOI 10.1078/0940-2993-00227; Greene T, 2014, AM J KIDNEY DIS, V64, P867, DOI 10.1053/j.ajkd.2014.08.019; Hewitson TD, 2016, LIFE SCI, V158, P130, DOI 10.1016/j.lfs.2016.06.022; Hisamichi M, 2017, FASEB J, V31, P72, DOI 10.1096/fj.201600684RR; Khati Nadia J, 2005, Ultrasound Q, V21, P227, DOI 10.1097/01.wnq.0000186666.61037.f6; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Moorthy HK, 2011, INDIAN J UROL, V27, P169, DOI 10.4103/0970-1591.82832; Peters B, 2014, ACTA RADIOL, V55, P890, DOI 10.1177/0284185113506190; RAIJ L, 1989, KIDNEY INT, V36, P582, DOI 10.1038/ki.1989.234; Tuma J, 2006, Praxis (Bern 1994), V95, P721	13	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190815	10.1371/journal.pone.0190815	http://dx.doi.org/10.1371/journal.pone.0190815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351309	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300028
J	Peraldo-Neia, C; Cavalloni, G; Fenocchio, E; Cagnazzo, C; Gammaitoni, L; Cereda, S; Nasti, G; Satolli, MA; Aprile, G; Reni, M; Avallone, A; Spadi, R; Venesio, T; Martin, V; Doglioni, C; Frattini, M; Aglietta, M; Leone, F				Peraldo-Neia, Caterina; Cavalloni, Giuliana; Fenocchio, Elisabetta; Cagnazzo, Celeste; Gammaitoni, Loretta; Cereda, Stefano; Nasti, Guglielmo; Satolli, Maria Antonietta; Aprile, Giuseppe; Reni, Michele; Avallone, Antonio; Spadi, Rosella; Venesio, Tiziana; Martin, Vittoria; Doglioni, Claudio; Frattini, Milo; Aglietta, Massimo; Leone, Francesco			Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; METASTATIC COLORECTAL-CANCER; CELL LUNG-CANCER; RANDOMIZED PHASE-II; GENE COPY NUMBER; TRACT CANCER; WILD-TYPE; CETUXIMAB TREATMENT; CLINICAL-OUTCOMES; HER2 EXPRESSION	The association of anti-EGFR to gemcitabine and oxaliplatin (GEMOX) chemotherapy did not improve survival in biliary tract carcinoma (BTC) patients. Multiple mechanisms might be involved in the resistance to anti-EGFR. Here, we explored the mutation profile of EGFR extracellular domain (ECD), of tyrosine kinase domain (TKD), and its amplification status. EGFR mutational status of exons 12, 18-21 was analyzed in 57 tumors by Sanger sequencing. EGFR amplification was evaluated in 37 tumors by Fluorescent In Situ Hybridization (FISH). Kaplan-Meier curves were calculated using the log-rank test. Six patients had mutations in exon 12 of EGFR ECD and 7 in EGFR TKD. Neither EGFR ECD nor TKD mutations affected progression free survival (PFS) or overall survival (OS) in the entire population. In the panitumumab plus GEMOX (P-GEMOX) arm, ECD mutated patients had a worse OS, while EGFR TKD mutated patients had a trend towards shorter PFS and OS. Overall, the presence of mutations in EGFR or in its transducers did not affect PFS or OS, while the extrahepatic cholangiocarcinoma (ECC) mutated patients had a worse prognosis compared to WT. Nineteen out of 37 tumors were EGFR amplified, but the amplification did not correlate with survival. ECC EGFR amplified patients had improved OS, whereas the amplification significantly correlated with poor PFS (p = 0.03) in gallbladder carcinoma patients. The high molecular heterogeneity is a predominant feature of BTC: the alterations found in this work seem to have a prognostic impact rather than a predictive role towards anti-EGFR therapy.	[Peraldo-Neia, Caterina; Cavalloni, Giuliana; Gammaitoni, Loretta; Aglietta, Massimo; Leone, Francesco] IRCCS Inst Candiolo, Fdn Piemonte Oncol FPO, Med Oncol, Candiolo, Italy; [Fenocchio, Elisabetta; Aglietta, Massimo; Leone, Francesco] Univ Turin, IRCCS Inst Candiolo, Dept Oncol, Candiolo, Italy; [Cagnazzo, Celeste] IRCCS Inst Candiolo, Fdn Piemonte Oncol FPO, Clin Res Off, Candiolo, Italy; [Cereda, Stefano; Reni, Michele] IRCCS Osped San Raffaele, Dept Med Oncol, Milan, Italy; [Nasti, Guglielmo; Avallone, Antonio] Natl Canc Inst G Pascale, Dept Abdominal Oncol, Naples, Italy; [Satolli, Maria Antonietta; Spadi, Rosella] Univ Hosp Citta Salu & Sci, Med Oncol Div 1, Turin, Italy; [Aprile, Giuseppe] San Bortolo Hosp ULSS8 East Dist, Dept Oncol, Vicenza, Italy; [Venesio, Tiziana] IRCCS Inst Candiolo, Fdn Piemonte Oncol FPO, Pathol Unit, Candiolo, Italy; [Martin, Vittoria; Frattini, Milo] Inst Pathol, Locarno, Switzerland; [Doglioni, Claudio] IRCCS Osped San Raffaele, Pathol Unit, Milan, Italy	IRCCS Fondazione del Piemonte per l'Oncologia; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Fondazione Pascale; A.O.U. Citta della Salute e della Scienza di Torino; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; IRCCS Fondazione del Piemonte per l'Oncologia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Peraldo-Neia, C (corresponding author), IRCCS Inst Candiolo, Fdn Piemonte Oncol FPO, Med Oncol, Candiolo, Italy.	caterina.peraldoneia@ircc.it	Cagnazzo, Celeste/ABG-3258-2020; Reni, Michele/J-8296-2016; Venesio, Tiziana/AAB-7568-2020; Cagnazzo, Celeste/AAY-2032-2021; Cagnazzo, Celeste/ABE-7187-2020; Leone, Francesco/AAB-2355-2022; Spadi, Rosella/AHD-6311-2022; SATOLLI, MARIA ANTONIETTA/AHE-0053-2022; Peraldo-Neia, Caterina/AAB-5226-2022; Avallone, Antonio/K-4662-2016	Reni, Michele/0000-0002-6463-0293; Venesio, Tiziana/0000-0002-9035-056X; Cagnazzo, Celeste/0000-0003-4055-3139; Leone, Francesco/0000-0001-5422-9706; Fenocchio, Elisabetta/0000-0001-6679-0955; Avallone, Antonio/0000-0001-6188-5664; Peraldo-Neia, Caterina/0000-0002-5484-2030; Cavalloni, Giuliana/0000-0002-9965-3436; AGLIETTA, Massimo/0000-0002-2255-7972	5 per Mille 2010 Ministero della Salute, Fondazione Piemontese per la Ricerca sul Cancro (FPRC)-Onlus grant; Associazione Italiana Ricerca sul Cancro-AlRC 5X1000-Ministry of Health, FPO grant; Universita di Torino anno [LEOF_RIC_LOC_14_01]	5 per Mille 2010 Ministero della Salute, Fondazione Piemontese per la Ricerca sul Cancro (FPRC)-Onlus grant; Associazione Italiana Ricerca sul Cancro-AlRC 5X1000-Ministry of Health, FPO grant; Universita di Torino anno	This work was supported by a 5 per Mille 2010 Ministero della Salute, Fondazione Piemontese per la Ricerca sul Cancro (FPRC)-Onlus grant and a Associazione Italiana Ricerca sul Cancro-AlRC 5X1000 2010-Ministry of Health, FPO grant to MA. FL received a grant from Universita di Torino anno 2014 (Fondo per la ricerca locale (Linea B), LEOF_RIC_LOC_14_01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2017, INT J CANCER, V140, P922, DOI 10.1002/ijc.30507; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Arena S, 2015, CLIN CANCER RES, V21, P2157, DOI 10.1158/1078-0432.CCR-14-2821; Boldrini L, 2009, ONCOL REP, V22, P683, DOI 10.3892/or_00000488; Chen JS, 2015, ANN ONCOL, V26, P943, DOI 10.1093/annonc/mdv035; CHEN LW, 2016, MEDICINE, V95, P22467, DOI DOI 10.1097/MD; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Fu M, 2014, VIRCHOWS ARCH, V464, P575, DOI 10.1007/s00428-014-1566-x; Gajadhar AS, 2012, MOL CANCER RES, V10, P428, DOI 10.1158/1541-7786.MCR-11-0531; Goss G, 2009, J CLIN ONCOL, V27, P2253, DOI 10.1200/JCO.2008.18.4408; Gruenberger B, 2010, LANCET ONCOL, V11, P1142, DOI 10.1016/S1470-2045(10)70247-3; Harder J, 2009, WORLD J GASTROENTERO, V15, P4511, DOI 10.3748/wjg.15.4511; Italiano A, 2008, ANN SURG ONCOL, V15, P649, DOI 10.1245/s10434-007-9667-2; Jain A, 2016, J GASTROINTEST ONCOL, V7, P797, DOI 10.21037/jgo.2016.09.01; Jiang Z, 2013, PLOS ONE, V8; Kennecke H, 2013, CURR ONCOL, V20, P326, DOI 10.3747/co.20.1600; Kim ST, 2015, TRANSL ONCOL, V8, P40, DOI 10.1016/j.tranon.2014.12.003; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Lee CK, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw279; Lee J, 2012, LANCET ONCOL, V13, P181, DOI 10.1016/S1470-2045(11)70301-1; Leone F, 2006, CLIN CANCER RES, V12, P1680, DOI 10.1158/1078-0432.CCR-05-1692; Leone F, 2015, CANCER; Liao JB, 2016, APPL IMMUNOHISTOCHEM; Locatelli-Sanchez M, 2013, LUNG, V191, P491, DOI 10.1007/s00408-013-9482-4; Ludovini V, 2008, J THORAC ONCOL, V3, P452, DOI 10.1097/JTO.0b013e318169e341; Luraghi P., 2017, CLIN CANC RES; Malka D, 2014, LANCET ONCOL, V15, P819, DOI 10.1016/S1470-2045(14)70212-8; Metzger B, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-144; Nakazawa K, 2005, J PATHOL, V206, P356, DOI 10.1002/path.1779; Nie F, 2009, J DIGEST DIS, V10, P247, DOI 10.1111/j.1751-2980.2009.00393.x; Pignochino Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-631; Qi WX, 2015, CURR MED RES OPIN, V31, P25, DOI 10.1185/03007995.2014.978448; Santoro A, 2015, ANN ONCOL, V26, P542, DOI 10.1093/annonc/mdu576; Scartozzi M, 2011, BRIT J CANCER, V104, P1786, DOI 10.1038/bjc.2011.161; Sharma A, 2010, J CLIN ONCOL, V28, P4581, DOI 10.1200/JCO.2010.29.3605; Sohal DPS, 2013, ANN ONCOL, V24, P3061, DOI 10.1093/annonc/mdt416; Valle JW, 2014, ANN ONCOL, V25, P391, DOI 10.1093/annonc/mdt540; Valle JW, 2015, LANCET ONCOL, V16, P967, DOI 10.1016/S1470-2045(15)00139-4; Yang J, 2016, TUMOR BIOL, V37, P11645, DOI 10.1007/s13277-016-5140-9; Yang XQ, 2014, ONCOL REP, V32, P700, DOI 10.3892/or.2014.3261; Yoon JH, 2004, J HEPATOL, V41, P808, DOI 10.1016/j.jhep.2004.07.016; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129; Zhao N, 2014, LUNG CANCER, V85, P66, DOI 10.1016/j.lungcan.2014.03.026	45	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191593	10.1371/journal.pone.0191593	http://dx.doi.org/10.1371/journal.pone.0191593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352306	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300118
J	Sun, MS; Xue, YK; Bogdan, P; Tang, J; Wang, YZ; Lin, X				Sun, Mengshu; Xue, Yuankun; Bogdan, Paul; Tang, Jian; Wang, Yanzhi; Lin, Xue			Hierarchical and hybrid energy storage devices in data centers: Architecture, control and provisioning	PLOS ONE			English	Article							POWER MANAGEMENT; MITIGATION	Recently, a new approach has been introduced that leverages and over-provisions energy storage devices (ESDs) in data centers for performing power capping and facilitating capex/opex reductions, without performance overhead. To fully realize the potential benefits of the hierarchical ESD structure, we propose a comprehensive design, control, and provisioning framework including (i) designing power delivery architecture supporting hierarchical ESD structure and hybrid ESDs for some levels, as well as (ii) control and provisioning of the hierarchical ESD structure including run-time ESD charging/discharging control and design-time determination of ESD types, homogeneous/hybrid options, ESD provisioning at each level. Experiments have been conducted using real Google data center workloads based on realistic data center specifications.	[Sun, Mengshu; Lin, Xue] Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA; [Xue, Yuankun; Bogdan, Paul] Univ Southern Calif, Ming Hsieh Dept Elect Engn, Los Angeles, CA USA; [Tang, Jian; Wang, Yanzhi] Syracuse Univ, Dept Elect Engn & Comp Sci, Syracuse, NY USA	Northeastern University; University of Southern California; Syracuse University	Lin, X (corresponding author), Northeastern Univ, Dept Elect & Comp Engn, Boston, MA 02115 USA.	xue.lin@northeastern.edu	Bogdan, Paul/V-6865-2019; Xue, Yuankun/AAZ-9626-2021; Xue, Yuankun/AEZ-9718-2022					Aksanli B., 2013, GREEN COMP C IGCC 20, P1; Aksanli B, 2013, I S MOD ANAL SIM COM, P242, DOI 10.1109/MASCOTS.2013.32; [Anonymous], 2012, GOOGLE CLUSTER DATA; Barroso L. A., 2013, SYNTHESIS LECT COMPU, V8, P1, DOI DOI 10.2200/S00516ED2V01Y201306CAC024; Barroso LA, 2007, COMPUTER, V40, P33, DOI 10.1109/MC.2007.443; Chen HS, 2009, PROG NAT SCI-MATER, V19, P291, DOI 10.1016/j.pnsc.2008.07.014; Cochran R, 2011, INT SYMP MICROARCH, P175; Consolidated Edison Company of New York Inc, 2012, SERV CLASS 1 RES REL; Cormen T., 2009, INTRO ALGORITHMS; Di Wang, 2012, Performance Evaluation Review, V40, P187, DOI 10.1145/2318857.2254780; Fan XB, 2007, CONF PROC INT SYMP C, P13, DOI 10.1145/1273440.1250665; Fortenbery B., 2008, DC POWER IMPROVED DA; Gandhi A, 2010, PERFORM EVALUATION, V67, P1155, DOI 10.1016/j.peva.2010.08.009; Gandhi A, 2009, PERF E R SI, V37, P157; Govindan S, 2012, ASPLOS XVII: SEVENTEENTH INTERNATIONAL CONFERENCE ON ARCHITECTURAL SUPPORT FOR PROGRAMMING LANGUAGES AND OPERATING SYSTEMS, P75; Govindan S, 2011, ISCA 2011: PROCEEDINGS OF THE 38TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P341, DOI 10.1145/2024723.2000105; Hu XS, 2017, IEEE POWER ENERGY M, V15, P20, DOI 10.1109/MPE.2017.2708812; Hu XS, 2017, MECH SYST SIGNAL PR, V87, P4, DOI 10.1016/j.ymssp.2016.03.004; Kok J, 2005, AAMAS, V2005, P75, DOI DOI 10.1145/1082473.1082807; Kontorinis V, 2012, CONF PROC INT SYMP C, P488, DOI 10.1109/ISCA.2012.6237042; Koushanfar F, 2010, DES AUT CON, P629; Li C, 2013, INT S HIGH PERF COMP, P35, DOI 10.1109/HPCA.2013.6522305; Li C, 2011, INT S HIGH PERF COMP, P205, DOI 10.1109/HPCA.2011.5749729; Linden D., 2002, HDB BATTERIES; Liu LJ, 2015, 2015 ACM/IEEE 42ND ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE (ISCA), P463, DOI 10.1145/2749469.2750384; Meisner D, 2011, ISCA 2011: PROCEEDINGS OF THE 38TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P319, DOI 10.1145/2024723.2000103; Meisner D, 2009, ACM SIGPLAN NOTICES, V44, P205, DOI 10.1145/1508284.1508269; Miller R., 2011, MICROSOFT REVEALS IT; Pedram Massoud, 2010, Proceedings of the 16th ACM/IEEE International Symposium on Low Power Electronics and Design (ISLPED 2010), P363, DOI 10.1145/1840845.1840924; Pedram M, 2010, GREEN COMP WORKSH CO; Ramadass P, 2003, J POWER SOURCES, V123, P230, DOI 10.1016/S0378-7753(03)00531-7; Ranganathan P, 2006, CONF PROC INT SYMP C, P66, DOI 10.1145/1150019.1136492; Ton M., 2005, HIGH PERFORMANCE BUI; Wang Y, 2012, IEEE INT SYMP NANO, P109; Xie Q, 2012, DES AUT TEST EUROPE, P1060; Zhang L, 2016, J POWER SOURCES, V314, P28, DOI 10.1016/j.jpowsour.2016.01.066; Zhang L, 2015, J POWER SOURCES, V274, P899, DOI 10.1016/j.jpowsour.2014.10.170; Zou CF, 2017, ENERGY, V141, P250, DOI [10.1016/j.energy.2017.0.9.048, 10.1016/j.energy.2017.09.048]	38	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191450	10.1371/journal.pone.0191450	http://dx.doi.org/10.1371/journal.pone.0191450			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351553	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300092
J	Talamini, F; Altoe, G; Carretti, B; Grassi, M				Talamini, Francesca; Altoe, Gianmarco; Carretti, Barbara; Grassi, Massimo			Musicians have better memory than nonmusicians: A meta-analysis (vol 12, e0186773, 2017)	PLOS ONE			English	Correction													Talamini, Francesca/AFP-2094-2022; carretti, barbara/AFW-2063-2022; Grassi, Massimo/I-8234-2012	carretti, barbara/0000-0001-5147-7544; 				Talamini F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186773	1	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191776	10.1371/journal.pone.0191776	http://dx.doi.org/10.1371/journal.pone.0191776			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352315	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300132
J	Yeh, CH; Hsieh, LP; Lin, MC; Wei, TS; Lin, HC; Chang, CC; Hsing, CH				Yeh, Ching-Hua; Hsieh, Liang-Po; Lin, Ming-Chung; Wei, Tsui-Shan; Lin, Hui-Ching; Chang, Chia-Cheng; Hsing, Chung-Hsi			Dexmedetomidine reduces lipopolysaccharide induced neuroinflammation, sickness behavior, and anhedonia	PLOS ONE			English	Article							DEPRESSIVE-LIKE BEHAVIOR; AGED MICE; SYSTEMIC INFLAMMATION; MICROGLIA ACTIVATION; COGNITIVE IMPAIRMENT; ANIMAL-MODEL; BRAIN; EXPRESSION; INVOLVEMENT; DISEASE	Background Peripheral innate immune response may induce sickness behavior through activating microglia, excessive cytokines production, and neuroinflammation. Dexmedetomidine (Dex) has anti-inflammatory effect. We investigated the effects of Dex on lipopolysaccharide (LPS)induced neuroinflammation and sickness behavior in mice. Materials and methods BALB/c mice were intraperitoneally (i.p.) injected with Dex (50 ug/kg) or vehicle. One hour later, the mice were injected (i.p.) with Escherichia coli LPS (0.33 mg/kg) or saline (n = 6 in each group). We analyzed the food and water intake, body weight loss, and sucrose preference of the mice for 24h. We also determined microglia activation and cytokines expression in the brains of the mice. In vitro, we determine cytokines expression in LPS-treated BV-2 microglial cells with or without Dex treatment. Results In the Dex-pretreated mice, LPS-induced sickness behavior (anorexia, weight loss, and social withdrawal) were attenuated and microglial activation was lower than vehicle control. The mRNA expression of TNF-alpha, MCP-1, indoleamine 2, 3 dioxygenase (IDO), caspase-3, and iNOS were increased in the brain of LPS-challenged mice, which were reduced by Dex but not vehicle. Conclusion Dexmedetomidine diminished LPS-induced neuroinflammation in the mouse brain and modulated the cytokine-associated changes in sickness behavior.	[Yeh, Ching-Hua; Hsieh, Liang-Po] Da Yeh Univ, Dept Med Bot & Hlth Applicat, Changhua, Taiwan; [Yeh, Ching-Hua] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yeh, Ching-Hua; Wei, Tsui-Shan; Chang, Chia-Cheng; Hsing, Chung-Hsi] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Hsieh, Liang-Po] Cheng Ching Gen Hosp, Dept Neurol, Taichung, Taiwan; [Lin, Ming-Chung; Chang, Chia-Cheng; Hsing, Chung-Hsi] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Lin, Hui-Ching] Natl Yang Ming Univ, Sch Med, Dept & Inst Physiol, Taipei, Taiwan; [Lin, Hui-Ching] Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan; [Lin, Hui-Ching] Taipei Med Univ, Coll Med Sci & Technol, Ctr Neurotrauma & Neuroregenerat, Neural Regenerat Med, Taipei, Taiwan	Da Yeh University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chi Mei Hospital; Chi Mei Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Medical University	Hsing, CH (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Hsing, CH (corresponding author), Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan.	hsing@mail.chimei.org.tw			Taiwan Ministry of Science and Technology [MOST 104-2314-B-384-005]	Taiwan Ministry of Science and Technology	This work was supported by grant MOST 104-2314-B-384-005 from the Taiwan Ministry of Science and Technology to CH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aantaa R, 2006, EUR J ANAESTH, V23, P361, DOI 10.1017/S0265021506000378; Abraham J, 2008, NEUROBIOL AGING, V29, P614, DOI 10.1016/j.neurobiolaging.2006.11.002; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Biesmans S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271359; Bret-Dibat JL, 2000, PHYSIOL BEHAV, V69, P325, DOI 10.1016/S0031-9384(00)00212-2; Buerkle H, 1998, BRIT J ANAESTH, V81, P208, DOI 10.1093/bja/81.2.208; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Carollo DS, 2008, CURR OPIN ANESTHESIO, V21, P457, DOI 10.1097/ACO.0b013e328305e3ef; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; Craft TKS, 2006, BIOL PSYCHIAT, V60, P812, DOI 10.1016/j.biopsych.2006.03.011; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; De La Garza R, 2005, NEUROSCI BIOBEHAV R, V29, P761, DOI 10.1016/j.neubiorev.2005.03.016; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Gertler R, 2001, Proc (Bayl Univ Med Cent), V14, P13; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Golden TR, 2009, ANTIOXID REDOX SIGN, V11, P555, DOI [10.1089/ars.2008.2256, 10.1089/ARS.2008.2256]; Guadagno J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.59; Hernandes MS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-36; Hsing CH, 2012, AM J PHYSIOL-RENAL, V303, pF1443, DOI 10.1152/ajprenal.00143.2012; Huang Y, 2008, NEUROBIOL AGING, V29, P1744, DOI 10.1016/j.neurobiolaging.2007.04.012; Hwang L, 2013, INT J MOL MED, V31, P1047, DOI 10.3892/ijmm.2013.1301; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kelley KW, 2003, BRAIN BEHAV IMMUN, V17, pS112; Kraft AD, 2011, INT J ENV RES PUB HE, V8, P2980, DOI 10.3390/ijerph8072980; Lai YC, 2009, J SURG RES, V154, P212, DOI 10.1016/j.jss.2008.07.010; LAYE S, 1994, MOL BRAIN RES, V27, P157, DOI 10.1016/0169-328X(94)90197-X; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Ma DQ, 2004, EUR J PHARMACOL, V502, P87, DOI 10.1016/j.ejphar.2004.08.044; Maes M, 2000, PSYCHIAT RES, V96, P245, DOI 10.1016/S0165-1781(00)00216-X; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Ohsawa K, 2000, J CELL SCI, V113, P3073; Peng M, 2013, J SURG RES, V179, pE219, DOI 10.1016/j.jss.2012.05.047; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sanders RD, 2009, ANESTHESIOLOGY, V110, P1077, DOI 10.1097/ALN.0b013e31819daedd; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Shukry M, 2005, PEDIATR ANESTH, V15, P1098, DOI 10.1111/j.1460-9592.2005.01660.x; Skalisz LL, 2002, PROG NEURO-PSYCHOPH, V26, P879, DOI 10.1016/S0278-5846(01)00333-5; Straub RH, 1997, J NEUROCHEM, V68, P1633; Taniguchi T, 2004, CRIT CARE MED, V32, P1322, DOI 10.1097/01.CCM.0000128579.84228.2A; Venero JL, 2013, DEV NEUROSCI-BASEL, V35, P88, DOI 10.1159/000346155; Xiang H, 2014, INFLAMMATION, V37, P1763, DOI 10.1007/s10753-014-9906-1	52	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191070	10.1371/journal.pone.0191070	http://dx.doi.org/10.1371/journal.pone.0191070			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351316	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300044
J	Chen, JJ; OuYang, H; An, XM; Liu, SX				Chen, Jianjun; OuYang, Hui; An, Xuemei; Liu, Shixi			Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6	PLOS ONE			English	Article							BREAST-CANCER CELL; MULTIDRUG-RESISTANCE; NONCODING RNA; EXPRESSION; LINES; COMPLEX; TUMORIGENESIS; ASSOCIATION; DOXORUBICIN; SUFFICIENT	Background Vault is the largest nonicosahedral cytosolic nucleoprotein particle, which is widely involved in induction of chemoresistance and lead to failure in long-term chemotherapy. Vault contains three different major vault proteins (MVPs) and four vault RNAs paralogues (vtRNAs, vtRNA1-1, vtRNA1-2, vtRNA1-3 and vtRNA2-1). Disruption of the MVPs do not induce hypersensitivity while expression of vtRNAs contributes to cells' drug resistance, indicates that vtRNAs, but not MVPs play an important role in causing drug resistance. Polypyrimidine tract binding protein associated splicing factor (PSF) contributes to cell sensitivity to chemotherapy by its transcriptional activity, promotes us to figure out its potential association with vtRNAs. Methods We investigate the interaction between PSF and vtRNAs by electrophoretic mobility shift assays (EMSA) and RNA-immunoprecipitation (IP), and showed the binding between PSF and vtRNAs. Chromatin Immunoprecipitation (ChIP) was performed to detect the effects of vtRNAs on the interaction of PSF with GAGE6 promoter. The role of vtRNAs on chemoresistance in MCF-7 was detected by CCK-8 and EdU staining. The independent role of vtRNAs with MVP is detected by MVP or vtRNAs knockdown. Results The complex with vtRNA1-1 releases PSF, allowing transcription of GAGE6 to proceed. Then we showed that induction of GAGE6 caused drug resistance by promoting cell proliferation and colony formation in soft agar. Ectopic expression of shRNA targets to vtRNA1-1 further confirmed the role of vtRNA1-1 in regulating PSF transcriptional activity independent with the expression of MVP. By vtRNA1-1 or MVP knockdown, it is revealed that vtRNA1-1 caused chemoresistance independent of MVP. Furthermore, knockdown of GAGE6 does not cause drug resistance, indicates the GAGE6 is directly involved in cell proliferation, but not the drug resistance. Conclusion These results suggest that vtRNAs regulates cell proliferation, drug resistance, and possibly other physiological processes of humans, by complex formation with PSF.	[Chen, Jianjun; Liu, Shixi] Sichuan Univ, West China Hosp, Dept ENT, Chengdu, Sichuan, Peoples R China; [OuYang, Hui] First Peoples Hosp Neijiang, Dept ENT, Neijiang, Peoples R China; [An, Xuemei] Chengdu Univ, TCM, Dept Neurol, Chengdu, Sichuan, Peoples R China	Sichuan University; Chengdu University	Liu, SX (corresponding author), Sichuan Univ, West China Hosp, Dept ENT, Chengdu, Sichuan, Peoples R China.	liushixi1983@163.com						Abbondanza C, 1998, J CELL BIOL, V141, P1301, DOI 10.1083/jcb.141.6.1301; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Christine H, 1999, J CELL BIOL, V144, P1163; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Gopinath SCB, 2010, MOL CANCER RES, V8, P1536, DOI 10.1158/1541-7786.MCR-10-0242; Han M, 2012, J CONTROL RELEASE, V163, P136, DOI 10.1016/j.jconrel.2012.08.020; Hu Y, 2002, INT J CANCER, V97, P149, DOI 10.1002/ijc.1590; Huffman KE, 2005, BIOCHEMISTRY-US, V44, P2253, DOI 10.1021/bi047948g; Izquierdo MA, 1996, AM J PATHOL, V148, P877; Izquierdo MA, 1996, INT J CANCER, V65, P230; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Ji Q, 2014, BRIT J CANCER, V111, P736, DOI 10.1038/bjc.2014.383; KEDERSHA NL, 1986, ANAL BIOCHEM, V156, P161, DOI 10.1016/0003-2697(86)90168-5; KEDERSHA NL, 1991, J CELL BIOL, V112, P225, DOI 10.1083/jcb.112.2.225; KEDERSHA NL, 1986, J CELL BIOL, V103, P699, DOI 10.1083/jcb.103.3.699; Kickhoefer VA, 1998, J BIOL CHEM, V273, P8971, DOI 10.1074/jbc.273.15.8971; Kitazono M, 1999, JNCI-J NATL CANCER I, V91, P1647, DOI 10.1093/jnci/91.19.1647; Li L, 2009, P NATL ACAD SCI USA, V106, P12956, DOI 10.1073/pnas.0906005106; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Ohno N, 2001, BLOOD, V98, P1160, DOI 10.1182/blood.V98.4.1160; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Poderycki MJ, 2005, NUCLEIC ACIDS RES, V33, P893, DOI 10.1093/nar/gki234; Sherman-Baust CA, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-21; Shoham T, 2003, ANN NY ACAD SCI, V996, P245, DOI 10.1111/j.1749-6632.2003.tb03253.x; Siva AC, 2001, INT J CANCER, V92, P195, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1168>3.0.CO;2-7; Song X, 2005, P NATL ACAD SCI USA, V102, P12189, DOI 10.1073/pnas.0505179102; Steiner E, 2006, CURR DRUG TARGETS, V7, P923, DOI 10.2174/138945006778019345; TAYLOR CW, 1991, BRIT J CANCER, V63, P923, DOI 10.1038/bjc.1991.202; TAYLOR PD, 1994, BRIT J PHARMACOL, V111, P35, DOI 10.1111/j.1476-5381.1994.tb14020.x; van Zon A, 2001, J BIOL CHEM, V276, P37715, DOI 10.1074/jbc.M106055200; VERSANTVOORT CHM, 1995, INT J CANCER, V61, P375, DOI 10.1002/ijc.2910610317; Wang G, 2009, P NATL ACAD SCI USA, V106, P16794, DOI 10.1073/pnas.0909022106; ZIJLSTRA JG, 1987, CANCER RES, V47, P1780	35	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191325	10.1371/journal.pone.0191325	http://dx.doi.org/10.1371/journal.pone.0191325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346433	Green Submitted, gold, Green Published			2022-12-27	WOS:000422749500041
J	Maymo, JL; Riedel, R; Perez-Perez, A; Magatti, M; Maskin, B; Duenas, JL; Parolini, O; Sanchez-Margalet, V; Varone, CL				Maymo, Julieta L.; Riedel, Rodrigo; Perez-Perez, Antonio; Magatti, Marta; Maskin, Bernardo; Luis Duenas, Jose; Parolini, Ornella; Sanchez-Margalet, Victor; Varone, Cecilia L.			Proliferation and survival of human amniotic epithelial cells during their hepatic differentiation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HEPATOCYTE-LIKE CELLS; EPIDERMAL-GROWTH-FACTOR; HUMAN FETAL MEMBRANES; ACUTE LIVER-FAILURE; PROGENITOR CELLS; CYCLE REGULATION; IMMUNOMODULATORY PROPERTIES; SIGNALING PATHWAY; TERM PLACENTA	Stem cells derived from placental tissues are an attractive source of cells for regenerative medicine. Amniotic epithelial cells isolated from human amnion (hAECs) have desirable and competitive characteristics that make them stand out between other stem cells. They have the ability to differentiate toward all three germ layers, they are not tumorigenic and they have immunosuppressive properties. Although liver transplantation is the best way to treat acute and chronic hepatic failure patients, there are several obstacles. Recently, stem cells have been spotlighted as alternative source of hepatocytes because of their potential for hepatogenic differentiation. In this work, we aimed to study the proliferation and survival of the hAECs during their hepatic differentiation. We have also analyzed the changes in pluripotency and hepatic markers. We differentiated amniotic cells applying a specific hepatic differentiation (HD) protocol. We determined by qRT-PCR that hAECs express significant levels of SOX-2, OCT-4 and NANOG during at least 15 days in culture and these pluripotent markers diminish during HD. SSEA-4 expression was reduced during HD, measured by immunofluorescence. Morphological characteristics became more similar to hepatic ones in differentiated cells and representative hepatic markers significantly augmented their expression, measured by qRT-PCR and Western blot. Cells achieved a differentiation efficiency of 75%. We observed that HD induced proliferation and promoted survival of hAECs, during 30 days in culture, evaluated by 3 H-thymidine incorporation and MTT assay. HD also promoted changes in hAECs cell cycle. Cyclin D1 expression increased, while p21 and p53 levels were reduced. Immunofluorescence analysis showed that Ki-67 expression was upregulated during HD. Finally, ERK 1/2 phosphorylation, which is intimately linked to proliferation and cell survival, augmented during all HD process and the inhibition of this signaling pathway affected not only proliferation but also differentiation. Our results suggest that HD promotes proliferation and survival of hAECs, providing important evidence about the mechanisms governing their hepatic differentiation. We bring new knowledge concerning some of the optimal transplantation conditions for these hepatic like cells.	[Maymo, Julieta L.; Riedel, Rodrigo; Varone, Cecilia L.] Univ Buenos Aires, Fac Ciencias Exactas & Nat IQUIBICEN, CONICET, Inst Quim Biol, Ciudad Univ Pabellon 2,4 Piso, RA-1428 Buenos Aires, DF, Argentina; [Maymo, Julieta L.; Riedel, Rodrigo; Varone, Cecilia L.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Ciudad Univ Pabellon 2,4 Piso, RA-1428 Buenos Aires, DF, Argentina; [Perez-Perez, Antonio; Sanchez-Margalet, Victor] Univ Seville, Hosp Univ Virgen Macarena, Fac Med, Dept Bioqum Med & Biol Mol, Ave Sanchez Pizjuan 4, E-41009 Seville, Spain; [Magatti, Marta; Parolini, Ornella] Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy; [Maskin, Bernardo] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Luis Duenas, Jose] Hosp Univ Virgen Macarena, Serv Ginecol & Obstet, Seville, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Hospital Universitario Virgen Macarena; University of Sevilla; Hospital Universitario Virgen Macarena	Maymo, JL (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat IQUIBICEN, CONICET, Inst Quim Biol, Ciudad Univ Pabellon 2,4 Piso, RA-1428 Buenos Aires, DF, Argentina.; Maymo, JL (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Ciudad Univ Pabellon 2,4 Piso, RA-1428 Buenos Aires, DF, Argentina.	jmaymo@qb.fcen.uba.ar	Sánchez-Margalet, Victor/AAB-9986-2021; Dueñas-Díez, José-Luis/E-6320-2010; Maymo, Julieta/AAU-3777-2020; PAROLINI, ORNELLA/ABI-7862-2020	Sánchez-Margalet, Victor/0000-0001-8638-8680; Dueñas-Díez, José-Luis/0000-0001-7596-6289; Maymo, Julieta/0000-0003-1308-9887; PAROLINI, ORNELLA/0000-0002-5211-6430; Perez Perez, Antonio/0000-0002-5660-735X	Subsidio a la Investigacion Biomedica Fundacion F. Fiorini; Subsidio a la Investigacion Fundacion A. Roemmers; Proyectos de Investigacion Cientifica y Tecnologica [PICT-2013-0231]; Proyectos de investigacion plurianuales [PIP 0217/14 (20142016) CONICET]; Proyecto UBACyT [20122015, 20020110100022]; Instituto de Salud Carlos III, Spain [PS09/00119, PI12/00172];  [PICT 2012-1366]	Subsidio a la Investigacion Biomedica Fundacion F. Fiorini; Subsidio a la Investigacion Fundacion A. Roemmers; Proyectos de Investigacion Cientifica y Tecnologica; Proyectos de investigacion plurianuales; Proyecto UBACyT; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); 	This work was supported by Subsidio a la Investigacion Biomedica Fundacion F. Fiorini, J.M., http://www.fff.org.ar/; Subsidio a la Investigacion Fundacion A. Roemmers 2012, 2015, J.M., http://www.roemmers.com.ar/es/compromiso/fundacion/investigacion; Proyectos de Investigacion Cientifica y Tecnologica (2013-2015) PICT-2013-0231 (JOVEN), J.M.; PICT 2012-1366, C.V., http://www.agencia.mincyt.gob.ar/frontend/agencia/convocatoria/369; Proyectos de investigacion plurianuales PIP 0217/14 (20142016) CONICET, C.V., J.M., http://convocatorias.conicet.gov.ar/investigacion-y-desarrollo/; Proyecto UBACyT (20122015), Grupo consolidado 20020110100022, C.V., http://www.uba.ar/secyt/contenido.php?id=42 & Instituto de Salud Carlos III (PS09/00119; PI12/00172), Spain, V.S.M., http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-financiacion/convocatorias-ayudas-accion-estrategica-salud.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Antoniadou E, 2016, BEST PRACT RES CL OB, V31, P13, DOI 10.1016/j.bpobgyn.2015.08.014; Asahina K, 2004, GENES CELLS, V9, P1297, DOI 10.1111/j.1365-2443.2004.00809.x; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Banas RA, 2008, HUM IMMUNOL, V69, P321, DOI 10.1016/j.humimm.2008.04.007; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Bilir BM, 2000, LIVER TRANSPLANT, V6, P32, DOI 10.1016/S1527-6465(00)80030-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brolen G, 2010, J BIOTECHNOL, V145, P284, DOI 10.1016/j.jbiotec.2009.11.007; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Carbone A, 2014, CURR STEM CELL RES T, V9, P297, DOI 10.2174/1574888X0904140429142451; Cargnoni A, 2009, CELL TRANSPLANT, V18, P1147, DOI 10.3727/096368909X12483162196764; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; Chien CC, 2006, STEM CELLS, V24, P1759, DOI 10.1634/stemcells.2005-0521; Chun JS, 2004, METH MOLEC MED, V100, P291; Dalton S, 2015, TRENDS CELL BIOL, V25, P592, DOI 10.1016/j.tcb.2015.07.007; DELLAQUILA ML, 1982, EXP CELL RES, V137, P441, DOI 10.1016/0014-4827(82)90047-7; Delo DM, 2006, METHOD ENZYMOL, V419, P426, DOI 10.1016/S0076-6879(06)19017-5; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Evangelista M, 2008, CYTOTECHNOLOGY, V58, P33, DOI 10.1007/s10616-008-9162-z; Fatimah SS, 2012, J BIOSCI BIOENG, V114, P220, DOI 10.1016/j.jbiosc.2012.03.021; Fatimah SS, 2010, HUM CELL, V23, P141, DOI 10.1111/j.1749-0774.2010.00096.x; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Fierabracci A, 2015, EXPERT OPIN BIOL TH, V15, P613, DOI 10.1517/14712598.2015.1000856; Gao W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112698; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; GERDES J, 1984, J IMMUNOL, V133, P1710; Hakomori S, 2004, GLYCOCONJUGATE J, V21, P125, DOI 10.1023/B:GLYC.0000044844.95878.cf; Hansen K, 2008, LIVER TRANSPLANT, V14, P713, DOI 10.1002/lt.21520; Harding A, 2017, STEM CELLS, V35, P909, DOI 10.1002/stem.2577; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hengstler Jan G, 2005, Expert Opin Drug Metab Toxicol, V1, P61, DOI 10.1517/17425255.1.1.61; Hennerbichler S, 2014, CELL TISSUE BANK, V15, P175, DOI 10.1007/s10561-014-9441-1; Hindley C, 2013, BIOCHEM J, V451, P135, DOI 10.1042/BJ20121627; Hori J, 2006, CORNEA, V25, pS53, DOI 10.1097/01.ico.0000247214.31757.5c; Huang HI, 2007, CURR PROTOC STEM CEL; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Insausti CL, 2014, STEM CELLS CLONING, V7, P53, DOI 10.2147/SCCAA.S58696; Izumi M, 2009, J REPROD IMMUNOL, V81, P39, DOI 10.1016/j.jri.2009.02.007; Kakishita K, 2000, EXP NEUROL, V165, P27, DOI 10.1006/exnr.2000.7449; Lee WM, 2012, SEMIN RESP CRIT CARE, V33, P36, DOI 10.1055/s-0032-1301733; LI Y, 1994, ONCOGENE, V9, P2261; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lin JS, 2015, J GASTROEN HEPATOL, V30, P1673, DOI 10.1111/jgh.12991; Liu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035758; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu T, 2014, GENET MOL RES, V13, P415, DOI 10.4238/2014.January.21.9; Garcia-Castro IL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146082; Malek Antoine, 2011, J Stem Cells, V6, P75; Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-6; Manuelpillai U, 2011, PLACENTA, V32, pS320, DOI 10.1016/j.placenta.2011.04.010; Manuelpillai U, 2010, CELL TRANSPLANT, V19, P1157, DOI 10.3727/096368910X504496; MARCHESE C, 1990, J CELL PHYSIOL, V144, P326, DOI 10.1002/jcp.1041440219; Marongiu F, 2011, HEPATOLOGY, V53, P1719, DOI 10.1002/hep.24255; Marongiu M, 2015, STEM CELLS DEV, V24, P1429, DOI 10.1089/scd.2014.0532; Matikainen Tiina, 2005, Toxicol Appl Pharmacol, V207, P544, DOI 10.1016/j.taap.2005.01.039; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Miki T, 2006, STEM CELL REV, V2, P133, DOI 10.1007/s12015-006-0020-0; Miki Toshio, 2009, V481, P155, DOI 10.1007/978-1-59745-201-4_13; Murphy S., 2010, CURR PROTOC STEM CEL; Ochsenbein-Kolble N, 2003, J PERINAT MED, V31, P287, DOI 10.1515/JPM.2003.040; Oliveira MS, 2015, WORLD J STEM CELLS, V7, P769, DOI 10.4252/wjsc.v7.i4.769; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Park HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132992; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Parolini O, 2010, STEM CELLS DEV, V19, P143, DOI 10.1089/scd.2009.0404; Parolini O, 2009, REGEN MED, V4, P275, DOI 10.2217/17460751.4.2.275; Peng SL, 2009, CELL PHYSIOL BIOCHEM, V23, P165, DOI 10.1159/000204105; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Rescan C, 2001, MOL BIOL CELL, V12, P725, DOI 10.1091/mbc.12.3.725; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; SAKURAGAWA N, 1992, BRAIN DEV-JPN, V14, P7, DOI 10.1016/S0387-7604(12)80272-5; Sakuragawa N, 2000, J HUM GENET, V45, P171, DOI 10.1007/s100380050205; Sakuragawa N, 2004, J NEUROSCI RES, V78, P208, DOI 10.1002/jnr.20257; Sankar V, 2003, NEUROSCIENCE, V118, P11, DOI 10.1016/S0306-4522(02)00929-6; SCAGGIANTE B, 1987, TRANSPLANTATION, V44, P59, DOI 10.1097/00007890-198707000-00014; Si JW, 2015, WORLD J STEM CELLS, V7, P149, DOI 10.4252/wjsc.v7.i1.149; Simat S F, 2008, Med J Malaysia, V63 Suppl A, P53; Strom SC, 2006, CELL TRANSPLANT, V15, pS105; Strom SC, 1999, SEMIN LIVER DIS, V19, P39, DOI 10.1055/s-2007-1007096; Tabatabaei Meraj, 2014, Avicenna Journal of Medical Biotechnology, V6, P10; Takahashi N, 2002, CELL TRANSPLANT, V11, P443; Takashima S, 2004, CELL STRUCT FUNCT, V29, P73, DOI 10.1247/csf.29.73; Tee JY, 2013, CURR STEM CELL RES T, V8, P91; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CR0070034; Torok NJ, 2008, J GASTROENTEROL, V43, P315, DOI 10.1007/s00535-008-2181-x; Tsujimura T, 2009, J PHYSIOL-LONDON, V587, P805, DOI 10.1113/jphysiol.2008.165324; Vaghjiani V, 2014, STEM CELLS DEV, V23, P866, DOI 10.1089/scd.2013.0485; Wang H, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20165988, 10.1590/1414-431x20165988]; Wang Jia-Ping, 2014, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V22, P187, DOI 10.7534/j.issn.1009-2137.2014.01.036; Wang Y, 2009, AM J PHYSIOL-CELL PH, V297, pC1284, DOI 10.1152/ajpcell.00183.2009; Wei JP, 2003, CELL TRANSPLANT, V12, P545, DOI 10.3727/000000003108747000; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Yu SJ, 2009, CELL TRANSPLANT, V18, P111, DOI 10.3727/096368909788341243; Zhang ZZ, 2013, J CELL PHYSIOL, V228, P298, DOI 10.1002/jcp.24150; Zhou JJ, 2011, INT ORTHOP, V35, P941, DOI 10.1007/s00264-010-1116-3; Zhu CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep35489	102	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191489	10.1371/journal.pone.0191489	http://dx.doi.org/10.1371/journal.pone.0191489			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346426	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500055
J	Otegbeye, F; Ojo, E; Moreton, S; Mackowski, N; Lee, DA; de Lima, M; Wald, DN				Otegbeye, Folashade; Ojo, Evelyn; Moreton, Stephen; Mackowski, Nathan; Lee, Dean A.; de Lima, Marcos; Wald, David N.			Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SMALL-MOLECULE INHIBITOR; VIVO; THROMBOPOIETIN; CYTOTOXICITY; TGF-BETA-1; EXPANSION; NKG2D	Natural killer cells harnessed from healthy individuals can be expanded ex vivo using various platforms to produce large doses for adoptive transfer into cancer patients. During such expansion, NK cells are increasingly activated and more efficient at killing cancer cells. Adoptive transfer however introduces these activated cells into a highly immunosuppressive tumor microenvironment mediated in part by excessive transforming growth factor beta (TGF-beta) from both cancer cells and their surrounding stroma. This microenvironment ultimately limits the clinical efficacy of NK cell therapy. In this study, we examined the use of a TGF-beta receptor kinase inhibitor, LY2157299, in preserving the cytotoxic function of ex vivo expanded, highly activated NK cells following sustained exposure to pathologic levels of TGF-beta in vitro and in a liver metastases model of colon cancer. Using myeloid leukemia and colon cancer cell lines, we show that the TGF-beta driven impairment of NK cell cytotoxicity is mitigated by LY2157299. We demonstrate this effect using quantitative cytotoxicity assays as well as by showing a preserved activated phenotype with high NKG2D/ CD16 expression and enhanced cytokine production. In a mouse liver metastases model of colon cancer, we observed significantly improved eradication of liver metastases in mice treated with adoptive NK cells combined with LY2157299 compared with mice receiving NK cells or TGF beta inhibition alone. We propose that the therapeutic efficacy of adoptive NK cell therapy clinically will be markedly enhanced by complementary approaches targeting TGF-beta signaling in vivo.	[Otegbeye, Folashade; de Lima, Marcos] Univ Hosp Cleveland, Med Ctr, Dept Med, Div Hematol & Oncol, Cleveland, OH 44106 USA; [Otegbeye, Folashade; Ojo, Evelyn; Moreton, Stephen; Mackowski, Nathan; de Lima, Marcos; Wald, David N.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Lee, Dean A.] Nationwide Childrens Hosp, Div Hematol Oncol, Columbus, OH USA; [Wald, David N.] Univ Hosp Cleveland, Med Ctr, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Otegbeye, F (corresponding author), Univ Hosp Cleveland, Med Ctr, Dept Med, Div Hematol & Oncol, Cleveland, OH 44106 USA.; Otegbeye, F (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	folashade.otegbeye@uhhospitals.org; dnw@case.edu		Otegbeye, Folashade/0000-0002-9978-4719; Lee, Darrall/0000-0002-6990-4441	American Society of Hematology (Research Training Award for Fellows); Leukemia and Lymphoma Society; Case Comprehensive Cancer Center GI SPORE grant; Tissue Resources, Cytometry and Imaging Microscopy; Hematopoietic Biorepository and Cellular Therapy Core Facilites of the Case Comprehensive Cancer Center [P30 CA043703]; NATIONAL CANCER INSTITUTE [P50CA150964, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021559] Funding Source: NIH RePORTER	American Society of Hematology (Research Training Award for Fellows); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Case Comprehensive Cancer Center GI SPORE grant; Tissue Resources, Cytometry and Imaging Microscopy; Hematopoietic Biorepository and Cellular Therapy Core Facilites of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	FO receives salary support for this research effort through grant funding from the American Society of Hematology (Research Training Award for Fellows). The work was funded partially through a grant to DNW from the Leukemia and Lymphoma Society. Research-grade LY2157299 was provided by Lilly Oncology. Colon cancer studies were supported by a Case Comprehensive Cancer Center GI SPORE grant awarded to DNW. Tissue analysis was supported by the Tissue Resources, Cytometry and Imaging Microscopy and the Hematopoietic Biorepository and Cellular Therapy Core Facilites of the Case Comprehensive Cancer Center (P30 CA043703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2005, LEUKEMIA, V19, P1558, DOI 10.1038/sj.leu.2403875; Baginska J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00490; BELLONE G, 1995, J IMMUNOL, V155, P1066; Bergmann L, 1995, EXP HEMATOL, V23, P1574; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Childs RW, 2013, HEMATOL-AM SOC HEMAT, P234, DOI 10.1182/asheducation-2013.1.234; Cho D, 2009, KOREAN J LAB MED, V29, P89, DOI 10.3343/kjlm.2009.29.2.89; Chretien AS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00122; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Dasgupta S, 2005, J IMMUNOL, V175, P5541, DOI 10.4049/jimmunol.175.8.5541; Dong M, 2006, BLOOD, V107, P4589, DOI 10.1182/blood-2005-10-4169; Geller MA, 2011, IMMUNOTHERAPY-UK, V3, P1445, DOI [10.2217/IMT.11.131, 10.2217/imt.11.131]; Herbertz S, 2015, DRUG DES DEV THER, V9, P4479, DOI 10.2147/DDDT.S86621; Hirayama Y, 2003, AM J HEMATOL, V73, P285, DOI 10.1002/ajh.10345; Hong CS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00160; Kang L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00101; Knorr DA, 2014, SEMIN IMMUNOL, V26, P161, DOI 10.1016/j.smim.2014.02.002; Konjevic G, 2012, IMMUNOL RES, V52, P139, DOI 10.1007/s12026-012-8285-7; Lapteva N, 2012, CYTOTHERAPY, V14, P1131, DOI 10.3109/14653249.2012.700767; Lee HM, 2014, CELL IMMUNOL, V290, P52, DOI 10.1016/j.cellimm.2014.05.001; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Narai S, 2002, INT J CANCER, V97, P508, DOI 10.1002/ijc.1631; Park CY, 2011, CANCER SCI, V102, P1889, DOI 10.1111/j.1349-7006.2011.02014.x; Shah N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076781; Somanchi SS, 2011, J VIS EXP; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Szmania S, 2015, J IMMUNOTHER, V38, P24, DOI 10.1097/CJI.0000000000000059; Tomchuck S, 2013, J IMMUNOL, V190; Trotta R, 2008, J IMMUNOL, V181, P3784, DOI 10.4049/jimmunol.181.6.3784; Yang B, 2013, INT IMMUNOPHARMACOL, V17, P198, DOI 10.1016/j.intimp.2013.06.003; Yoon JH, 2013, EMBO MOL MED, V5, P1720, DOI 10.1002/emmm.201302524	31	75	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191358	10.1371/journal.pone.0191358	http://dx.doi.org/10.1371/journal.pone.0191358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342200	gold, Green Published, Green Submitted			2022-12-27	WOS:000422653800067
J	Almeida, VM; Frutuoso, MA; Marana, SR				Almeida, Vitor M.; Frutuoso, Maira A.; Marana, Sandro R.			Search for independent (beta/alpha)(4) subdomains in a (beta/alpha)(8) barrel beta-glucosidase	PLOS ONE			English	Article							LINEAR EXTRAPOLATION METHOD; TRIOSEPHOSPHATE ISOMERASE; SUBSTRATE-SPECIFICITY; HALF-BARRELS; PROTEIN; RESIDUES; FOLD; GLYCOSIDASE; EVOLUTION; ENZYMES	Proteins that fold as (beta/alpha)(8) barrels are thought to have evolved from half-barrels that underwent duplication and fusion events. The evidence is particularly clear for small barrels, which have almost identical halves. Additionally, computational calculations of the thermodynamic stability of these structures in the presence of denaturants have revealed that (beta/alpha)(8) barrels contain two subunits or domains corresponding to half -barrels. Hence, within (beta/alpha)(8) barrels, half -barrels are self-contained units. Here, we tested this hypothesis using 6-glucosidase from the bacterium Thermotoga maritima (bglTm), which has a (beta/alpha)(8) barrel structure. Mutations were introduced to disrupt the noncovalent contacts between its halves and reveal the presence of two domains within bglTm, thus resulting in the creation of mutants T1 (containing W12A and I217A mutations) and T2 (containing W12A, H195A, I217A and F404A mutations). Mutants T1 and T2 were properly folded, as indicated by their fluorescence spectra and enzyme kinetic parameters. T1 and wild-type bglTm were equally stable, as shown by the results of thermal inactivation, differential scanning fluorimetry and guanidine hydrochloride denaturation experiments. However, T2 showed a first-order inactivation at 80 degrees C, a single melting temperature of 82 degrees C and only one transition concentration (c(50)) in 2.4 M guanidine hydrochloride. Additionally, T1 and T2 exhibited a cooperative denaturation process that followed a two-state model (m-values equal to 1.4 and 1.6 kcal/mol/M, respectively), similar to that of wild-type bglTm (1.2 kcal/mol/M). Hence, T1 and T2 each denatured as a single unit, although they contained different degrees of disruption between their halves. In conclusion, bglTm halves are equivalent in terms of their thermal and chemical stability; thus, their separate contributions to (beta/alpha)(8) barrel unfolding cannot be disentangled.	[Almeida, Vitor M.; Frutuoso, Maira A.; Marana, Sandro R.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Marana, SR (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil.	srmarana@iq.usp.br	Frutuoso, Maira Artischeff/O-1473-2015; Frutuoso, Maira Artischeff/I-2654-2016; Marana, Sandro/D-3867-2012	Marana, Sandro/0000-0002-5117-1921; Almeida, Vitor Medeiros/0000-0003-4972-3341	FAPESP (Fundagao de Amparo a Pesquisa do Estado de Sao Paulo) [14/19439-5, 16/22365-9]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior)	FAPESP (Fundagao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was supported by FAPESP (Fundagao de Amparo a Pesquisa do Estado de Sao Paulo; Grants 14/19439-5 and 16/22365-9), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and CAPES (Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma S, 2008, J MOL BIOL, V382, P458, DOI 10.1016/j.jmb.2008.07.040; Beton D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139673; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Frutuoso MA, 2013, PROTEIN PEPTIDE LETT, V20, P102, DOI 10.2174/092986613804096757; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goldman AD, 2016, J MOL EVOL, V82, P17, DOI 10.1007/s00239-015-9722-8; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Hocker B, 2004, P NATL ACAD SCI USA, V101, P16448, DOI 10.1073/pnas.0405832101; Hocker B, 2001, CURR OPIN BIOTECH, V12, P376, DOI 10.1016/S0958-1669(00)00230-5; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Leatherbarrow R.J, 1987, ENZFITTER NONLINEAR; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marana SR, 2002, EUR J BIOCHEM, V269, P3705, DOI 10.1046/j.1432-1033.2002.03061.x; Mendonca LMF, 2008, FEBS J, V275, P2536, DOI 10.1111/j.1742-4658.2008.06402.x; MURZIN AG, 1994, J MOL BIOL, V236, P1369, DOI 10.1016/0022-2836(94)90064-7; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Ochoa-Leyva A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070582; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Pace CN, 2005, PROTEIN FOLDING HANDBOOK, P45, DOI 10.1002/9783527619498.ch3; Pace CN, 2000, PROTEINS, P1; Pan H, 2004, J MOL BIOL, V336, P1251, DOI 10.1016/j.jmb.2003.12.076; Porter LL, 2012, P NATL ACAD SCI USA, V109, P9420, DOI 10.1073/pnas.1202604109; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Segel IH., 1993, ENZYME KINETICS BEHA; Seitz T, 2007, J MOL BIOL, V372, P114, DOI 10.1016/j.jmb.2007.06.036; Sharma P, 2016, FEBS J, V283, P4340, DOI 10.1111/febs.13927; Shukla A, 2004, PROTEINS, V55, P548, DOI 10.1002/prot.20066; Smith MA, 2013, PROTEIN SCI, V22, P231, DOI 10.1002/pro.2202; Souza VP, 2016, FEBS J, V283, P1124, DOI 10.1111/febs.13659; Sperl JM, 2013, FEBS LETT, V587, P2798, DOI 10.1016/j.febslet.2013.06.022; Tamaki FK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096627; Vega MC, 2003, CURR OPIN CHEM BIOL, V7, P694, DOI 10.1016/j.cbpa.2003.10.004; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Zechel DL, 2003, J AM CHEM SOC, V125, P14313, DOI 10.1021/ja036833h; Zitzewitz JA, 1999, PROTEIN SCI, V8, P1200, DOI 10.1110/ps.8.6.1200	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191282	10.1371/Journal.pone.0191282	http://dx.doi.org/10.1371/Journal.pone.0191282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338043	gold, Green Published, Green Submitted			2022-12-27	WOS:000422652700045
J	Granger, BL				Granger, Bruce L.			Accessibility and contribution to glucan masking of natural and genetically tagged versions of yeast wall protein 1 of Candida albicans	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; CELL-WALL; BETA-GLUCAN; IN-VITRO; FUNGAL PATHOGENS; GENE-EXPRESSION; KINASE PATHWAY; ALS ADHESINS; RECOGNITION	Yeast wall protein 1 (Ywp1) is an abundant glycoprotein of the cell wall of the yeast form of Candida albicans, the most prevalent fungal pathogen of humans. Antibodies that bind to the polypeptide backbone of isolated Ywp1 show little binding to intact yeast cells, presumably because the Ywp1 epitopes are masked by the polysaccharides of the mannoproteins that form the outer layer of the cell wall. Rare cells do exhibit much greater anti-Ywp1 binding, however, and one of these was isolated and characterized. No differences were seen in its Ywp1, but it exhibited greater adhesiveness, sensitivity to wall perturbing agents, and exposure of its underlying beta-1,3-glucan layer to external antibodies. The molecular basis for this greater epitope accessibility has not been determined, but has facilitated exploration of how these properties change as a function of cell growth and morphology. In addition, previously engineered strains with reduced quantities of Ywp1 in their cell walls were also found to have greater beta-1,3-glucan exposure, indicating that Ywp1 itself contributes to the masking of wall epitopes, which may be important for understanding the anti-adhesive effect of Ywp1. Ectopic production of Ywp1 by hyphae, which reduces the adhesivity of these filamentous forms of C. albicans, was similarly found to reduce exposure of the beta-1,3-glucan in their walls. To monitor Ywp1 in the cell wall irrespective of its accessibility, green fluorescent protein (Gfp) was genetically inserted into wall-anchored Ywp1 using a bifunctional cassette that also allowed production from a single transfection of a soluble, anchor-free version. The wall-anchored Ywp1 -Gfp-Ywp1 accumulated in the wall of the yeast forms but not hyphae, and appeared to have properties similar to native Ywp1, including its adhesion-inhibiting effect. Some pseudohyphal walls also detectably accumulated this probe. Strains of C. albicans w\Vr tandem hemagglutinin (HA) epitopes inserted into wall-anchored Ywp1 were previously created by others, and were further explored here. As above, rare cells with much greater accessibility of the HA epitopes were isolated, and also found to exhibit greater exposure of Ywp1 and beta-1,3-glucan. The placement of the HA cassette inhibited the normal N-glycosylation and propeptide cleavage of Ywp1, but the wall-anchored Ywp1-HA-Ywp1 still accumulated in the cell wall of yeast forms. Bifunctional transformation cassettes were used to additionally tag these molecules with Gfp, generating soluble Ywp1 -HA-Gfp and wall-anchored Ywp1- HA-Gfp-Ywp1 molecules. The former revealed unexpected electrophoretic properties caused by the HA insertion, while the latter further highlighted differences between the presence of a tagged Ywp1 molecule (as revealed by Gfp fluorescence) and its accessibility in the cell wall to externally applied antibodies specific for HA, Gfp and Ywp1, with accessibility being greatest in the rapidly expanding walls of budding daughter cells. These strains and results increase our understanding of cell wall properties and how C. albicans masks itself from recognition by the human immune system.	[Granger, Bruce L.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Granger, BL (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	bgranger@montana.edu		Granger, Bruce/0000-0002-9308-0331				Abbey D, 2011, G3-GENES GENOM GENET, V1, P523, DOI 10.1534/g3.111.000885; Angiolella L, 2005, J CHEMOTHERAPY, V17, P409, DOI 10.1179/joc.2005.17.4.409; Ballou ER, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.238; Beaussart A, 2012, ACS NANO, V6, P10950, DOI 10.1021/nn304505s; Beucher B, 2009, FEMS IMMUNOL MED MIC, V55, P314, DOI 10.1111/j.1574-695X.2008.00502.x; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Boisrame A, 2011, EUKARYOT CELL, V10, P1317, DOI 10.1128/EC.05044-11; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Caminero A, 2014, YEAST, V31, P137, DOI 10.1002/yea.3003; Carlisle PL, 2013, MOL BIOL CELL, V24, P246, DOI 10.1091/mbc.E12-01-0065; Cassone A, 2013, NAT REV MICROBIOL, V11, P884, DOI 10.1038/nrmicro3156; Coleman DA, 2012, FEMS IMMUNOL MED MIC, V64, P321, DOI 10.1111/j.1574-695X.2011.00914.x; Coleman DA, 2010, MICROBIOL-SGM, V156, P3645, DOI 10.1099/mic.0.043851-0; Coleman DA, 2009, J MICROBIOL METH, V78, P71, DOI 10.1016/j.mimet.2009.05.002; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Cutler JE, 2007, NAT REV MICROBIOL, V5, P13, DOI 10.1038/nrmicro1537; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Davis SE, 2014, INFECT IMMUN, V82, P4405, DOI 10.1128/IAI.01612-14; de Groot PWJ, 2013, EUKARYOT CELL, V12, P470, DOI 10.1128/EC.00364-12; de Groot PWJ, 2004, EUKARYOT CELL, V3, P955, DOI 10.1128/EC.3.4.955-965.2004; De Nobel Hans, 1994, Trends in Cell Biology, V4, P42, DOI 10.1016/0962-8924(94)90003-5; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Deslauriers N, 1996, MICROBIOL-SGM, V142, P1239, DOI 10.1099/13500872-142-5-1239; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Douglas LM, 2007, EUKARYOT CELL, V6, P2214, DOI 10.1128/EC.00284-06; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Frieman MB, 2002, MOL MICROBIOL, V46, P479, DOI 10.1046/j.1365-2958.2002.03166.x; Fu Y, 2002, MOL MICROBIOL, V44, P61, DOI 10.1046/j.1365-2958.2002.02873.x; Galan-Diez M, 2010, INFECT IMMUN, V78, P1426, DOI 10.1128/IAI.00989-09; Ganguly S, 2011, EUKARYOT CELL, V10, P1448, DOI 10.1128/EC.05196-11; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Garcia MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017632; Gelis S, 2012, FUNGAL GENET BIOL, V49, P322, DOI 10.1016/j.fgb.2012.01.010; Gerami-Nejad M, 2012, YEAST, V29, P303, DOI 10.1002/yea.2910; Gerami-Nejad M, 2009, YEAST, V26, P399, DOI 10.1002/yea.1674; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gomathinayagam S, 2014, APPL MICROBIOL BIOT, V98, P2545, DOI 10.1007/s00253-013-5478-5; Gonzalez M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-213; Gonzalez M, 2010, YEAST, V27, P583, DOI 10.1002/yea.1797; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Granger BL, 2005, MICROBIOL-SGM, V151, P1631, DOI 10.1099/mic.0.27663-0; Granger BL, 2012, EUKARYOT CELL, V11, P795, DOI 10.1128/EC.00026-12; Green CB, 2005, MICROBIOL-SGM, V151, P1051, DOI 10.1099/mic.0.27696-0; Grumaz C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-212; Hall RA, 2015, MOL MICROBIOL, V97, P7, DOI 10.1111/mmi.13020; Hall RA, 2013, MOL MICROBIOL, V90, P1147, DOI 10.1111/mmi.12426; Hall RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003276; Han Y, 1997, INFECT IMMUN, V65, P4100, DOI 10.1128/IAI.65.10.4100-4107.1997; Han Y, 2000, INFECT IMMUN, V68, P1649, DOI 10.1128/IAI.68.3.1649-1654.2000; Hasim S, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00601-16; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Hopke A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005644; Hoyer LL, 1998, J BACTERIOL, V180, P5334, DOI 10.1128/JB.180.20.5334-5343.1998; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Ibrahim AS, 2013, VACCINE, V31, P5549, DOI 10.1016/j.vaccine.2013.09.016; Ikeh M, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030048; Ikeh MAC, 2016, MOL BIOL CELL, V27, P2784, DOI 10.1091/mbc.E16-05-0266; Kapitan M, 2016, MICROBIOL-SGM, V162, P1310, DOI 10.1099/mic.0.000329; Kapteyn JC, 2000, MOL MICROBIOL, V35, P601, DOI 10.1046/j.1365-2958.2000.01729.x; Klippel N, 2010, MICROBIOL-SGM, V156, P3432, DOI 10.1099/mic.0.040006-0; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Kumamoto CA, 2005, ANNU REV MICROBIOL, V59, P113, DOI 10.1146/annurev.micro.59.030804.121034; Lamarre C, 2000, MOL MICROBIOL, V35, P444, DOI 10.1046/j.1365-2958.2000.01715.x; Lavigne LM, 2006, J IMMUNOL, V177, P8667, DOI 10.4049/jimmunol.177.12.8667; Li F, 2008, MICROBIOL-SGM, V154, P1193, DOI 10.1099/mic.0.2007/013789-0; Li F, 2007, EUKARYOT CELL, V6, P931, DOI 10.1128/EC.00049-07; Lin JF, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9213034; Lipke PN, 2012, TRENDS MICROBIOL, V20, P59, DOI 10.1016/j.tim.2011.10.002; Machova E, 2015, CARBOHYD RES, V408, P12, DOI 10.1016/j.carres.2015.03.001; Maddi A, 2009, FUNGAL GENET BIOL, V46, P768, DOI 10.1016/j.fgb.2009.06.005; Mao YX, 2008, EUKARYOT CELL, V7, P1906, DOI 10.1128/EC.00148-08; Mao YX, 2003, MOL MICROBIOL, V50, P1617, DOI 10.1046/j.1365-2958.2003.03794.x; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; McLellan CA, 2012, ACS CHEM BIOL, V7, P1520, DOI 10.1021/cb300235m; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; Monniot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082395; Moreno-Ruiz E, 2009, MICROBIOL-SGM, V155, P2004, DOI 10.1099/mic.0.028902-0; Muzzey D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r97; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Noble SM, 2017, NAT REV MICROBIOL, V15, P96, DOI 10.1038/nrmicro.2016.157; Oh SH, 2005, MICROBIOL-SGM, V151, P673, DOI 10.1099/mic.0.27680-0; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Pappas HC, 2016, ANTIMICROB AGENTS CH, V60, P4519, DOI 10.1128/AAC.00317-16; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Richard ML, 2007, EUKARYOT CELL, V6, P119, DOI 10.1128/EC.00297-06; Roman E, 2016, VIRULENCE, V7, P558, DOI 10.1080/21505594.2016.1163458; Rosenbach A, 2010, EUKARYOT CELL, V9, P1075, DOI 10.1128/EC.00034-10; Sanchez Philip, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P80, DOI 10.1089/mab.2013.0089; Schild L, 2011, EUKARYOT CELL, V10, P98, DOI 10.1128/EC.00210-10; Sem X, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00186; Shahana S, 2013, FUNGAL GENET BIOL, V56, P107, DOI 10.1016/j.fgb.2013.03.009; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shen H, 2015, INFECT IMMUN, V83, P2694, DOI 10.1128/IAI.00097-15; Sherrington SL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006403; SHIBATA N, 1992, BIOCHEMISTRY-US, V31, P5680, DOI 10.1021/bi00139a036; SHIBATA N, 1995, J BIOL CHEM, V270, P1113, DOI 10.1074/jbc.270.3.1113; Singleton DR, 2005, EUKARYOT CELL, V4, P639, DOI 10.1128/EC.4.4.639-648.2005; Spellberg BJ, 2006, J INFECT DIS, V194, P256, DOI 10.1086/504691; Staab JF, 2003, MICROBIOL-SGM, V149, P2977, DOI 10.1099/mic.0.26445-0; Staab JF, 1996, J BIOL CHEM, V271, P6298, DOI 10.1074/jbc.271.11.6298; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Tournu H, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00276-17, 10.1128/msphere.00276-17]; Wester MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188599; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xin H, 2006, INFECT IMMUN, V74, P4310, DOI 10.1128/IAI.00234-06; Xin H, 2016, VACCINE, V34, P245, DOI 10.1016/j.vaccine.2015.11.035; Xin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035106; Xu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063736; Zhang SK, 2016, 2016 12TH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY (ICNC-FSKD), P1, DOI 10.1109/FSKD.2016.7603141	123	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191194	10.1371/journal.pone.0191194	http://dx.doi.org/10.1371/journal.pone.0191194			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329339	Green Published, Green Submitted, gold			2022-12-27	WOS:000419954100045
J	Wohland, J; Reyers, M; Marker, C; Witthaut, D				Wohland, Jan; Reyers, Mark; Maerker, Carolin; Witthaut, Dirk			Natural wind variability triggered drop in German redispatch volume and costs from 2015 to 2016	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; ENERGY-SYSTEM; CLIMATE-CHANGE; SOLAR POWER; ELECTRICITY; REANALYSIS; INTEGRATION; POTENTIALS; EUROPE; IMPACT	Avoiding dangerous climate change necessitates the decarbonization of electricity systems within the next few decades. In Germany, this decarbonization is based on an increased exploitation of variable renewable electricity sources such as wind and solar power. While system security has remained constantly high, the integration of renewables causes additional costs. In 2015, the costs of grid management saw an all time high of about (sic) 1 billion. Despite the addition of renewable capacity, these costs dropped substantially in 2016. We thus investigate the effect of natural climate variability on grid management costs in this study. We show that the decline is triggered by natural wind variability focusing on redispatch as a main cost driver. In particular, we find that 2016 was a weak year in terms of wind generation averages and the occurrence of westerly circulation weather types. Moreover, we show that a simple model based on the wind generation time series is skillful in detecting redispatch events on timescales of weeks and beyond. As a consequence, alterations in annual redispatch costs in the order of hundreds of millions of euros need to be understood and communicated as a normal feature of the current system due to natural wind variability.	[Wohland, Jan; Maerker, Carolin; Witthaut, Dirk] Forschungszentrum Julich, Inst Energy & Climate Res IEK STE, Julich, Germany; [Wohland, Jan; Witthaut, Dirk] Univ Cologne, Inst Theoret Phys, Cologne, Germany; [Reyers, Mark] Univ Cologne, Inst Geophys & Meteorol, Cologne, Germany	Helmholtz Association; Research Center Julich; University of Cologne; University of Cologne	Wohland, J (corresponding author), Forschungszentrum Julich, Inst Energy & Climate Res IEK STE, Julich, Germany.; Wohland, J (corresponding author), Univ Cologne, Inst Theoret Phys, Cologne, Germany.	j.wohland@fz-juelich.de	Witthaut, Dirk/AAA-8073-2020; Witthaut, Dirk/I-3783-2012; UzK, IGMK/HGU-4003-2022	Witthaut, Dirk/0000-0002-3623-5341; Witthaut, Dirk/0000-0002-3623-5341; Wohland, Jan/0000-0001-8336-0009; Marker, Carolin/0000-0002-7521-0307	Helmholtz Association;  [VH-NG-1025]	Helmholtz Association(Helmholtz Association); 	This work was supported by the Helmholtz Association (via the joint initiative ''Energy System 2050 - A Contribution of the Research Field Energy'' and the grant no. VH-NG-1025 to D. Witthaut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen GB, 2015, ENERGY, V93, P1074, DOI 10.1016/j.energy.2015.09.071; [Anonymous], 2022, CLIM CHANG 2022 MIT; BDEW, 2017, RED DEUTSCHL AUSW TR; Becker S, 2015, ENERGY, V81, P437, DOI 10.1016/j.energy.2014.12.056; Becker S, 2014, ENERGY, V72, P443, DOI 10.1016/j.energy.2014.05.067; Bild, 2016, BILD; Bloomfield HC, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/124025; Bundesnetzagentur, 2017, QUART NETZ SYST VIER; Bundesnetzagentur, 2017, WINDSEEG 1 AUSS BEST; Bundesnetzagentur, 2016, MON 2016; Bundestag, 2016, ENTW GES EINF AUSS S; Cannon DJ, 2015, RENEW ENERG, V75, P767, DOI 10.1016/j.renene.2014.10.024; Coady MrDavid., 2015, LARGE ARE GLOBAL ENE, V15, DOI [10.5089/9781513532196.001, DOI 10.5089/9781513532196.001]; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Elsner P, 2015, FLEXIBILITAETSKONZEP; Ely CR, 2013, ENERG POLICY, V62, P1420, DOI 10.1016/j.enpol.2013.06.037; Farneti R, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.441; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FAZ, 2016, FAZ; Focus Money, 2015, FOCUS MONEY; Fraunhofer ISE, 2017, JAEHRLICHER ANTEIL E; Gerhardt N., 2017, ANAL EUROPAISCHEN 95; Gonzalez-Aparicio I, 2017, APPL ENERG, V199, P155, DOI 10.1016/j.apenergy.2017.04.066; Grams CM, 2017, NAT CLIM CHANGE, V7, P557, DOI [10.1038/nclimate3338, 10.1038/NCLIMATE3338]; Gulagi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180611; Handelsblatt, 2016, HANDELSBLATT; Handelsblatt, 2016, HOCHSPANNUNG IM STRO; Hdidouan D, 2017, RENEW ENERG, V101, P575, DOI 10.1016/j.renene.2016.09.003; Heise, 2017, DEUTL HOEH KOST NOT; Heise, 2016, KAMP GEG STROMN BLAC; Hoersch J, 2017, ARXIV17041881; Huber M, 2014, ENERGY, V69, P236, DOI 10.1016/j.energy.2014.02.109; IEA, 2017, REN INF OV; Jacobson MZ, 2015, P NATL ACAD SCI USA, V112, P15060, DOI 10.1073/pnas.1510028112; Jerez S, 2013, ENRGY PROCED, V40, P48, DOI 10.1016/j.egypro.2013.08.007; Jerez S, 2013, J APPL METEOROL CLIM, V52, P2204, DOI 10.1175/JAMC-D-12-0257.1; JONES PD, 1993, INT J CLIMATOL, V13, P655, DOI 10.1002/joc.3370130606; Kemfert C, 2016, GUTACHTEN AUFTRAG HE; Lazard, 2016, LAZ LEV COSTS EN AN; Lempert RJ, 2010, FUTURIST, V44, P47; Mavromatakis F, 2010, RENEW ENERG, V35, P1387, DOI 10.1016/j.renene.2009.11.010; Milan P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.138701; Milligan M, 2015, IEEE POWER ENERGY M, V13, P78, DOI 10.1109/MPE.2015.2462311; Moemken J, 2017, WIND SPEED WIND ENER; Moemken J, 2016, TELLUS A, V68, DOI 10.3402/tellusa.v68.29199; Molod A, 2015, GEOSCI MODEL DEV, V8, P1339, DOI 10.5194/gmd-8-1339-2015; Nahmmacher P, 2016, ENERGY, V112, P430, DOI 10.1016/j.energy.2016.06.081; Netztransparenz, 2017, NETZTR RED; Barbosa LDNS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173820; OPSD, 2017, REN POW PLANTS; OPSD, 2017, DAT PLATF TIM SER; ORESKES N, 1994, SCIENCE, V263, P641, DOI 10.1126/science.263.5147.641; Peings Y, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034018; Pesch T, 2014, EUR PHYS J-SPEC TOP, V223, P2561, DOI 10.1140/epjst/e2014-02214-y; Pfenninger S, 2017, APPL ENERG, V197, P1, DOI 10.1016/j.apenergy.2017.03.051; Pfenninger S, 2014, NAT CLIM CHANGE, V4, P689, DOI [10.1038/NCLIMATE2276, 10.1038/nclimate2276]; Pietzcker RC, 2017, ENERG ECON, V64, P583, DOI 10.1016/j.eneco.2016.11.018; Poncelet K, 2016, APPL ENERG, V162, P631, DOI 10.1016/j.apenergy.2015.10.100; Rasmussen MG, 2012, ENERG POLICY, V51, P642, DOI 10.1016/j.enpol.2012.09.009; Reyers M, 2016, INT J CLIMATOL, V36, P783, DOI 10.1002/joc.4382; Reyers M, 2015, INT J CLIMATOL, V35, P229, DOI 10.1002/joc.3975; Rockstrom J, 2017, SCIENCE, V355, P1269, DOI 10.1126/science.aah3443; Rodriguez RA, 2014, RENEW ENERG, V63, P467, DOI 10.1016/j.renene.2013.10.005; Roenz B, 1992, REGRESSIONS KORRELAT; Rogelj J, 2016, NATURE, V534, P631, DOI 10.1038/nature18307; Rogelj J, 2015, NAT CLIM CHANGE, V5, P519, DOI 10.1038/nclimate2572; Schlachtberger DP, 2017, ENERGY, V134, P469, DOI 10.1016/j.energy.2017.06.004; Schleussner CF, 2016, NAT CLIM CHANGE, V6, P827, DOI 10.1038/NCLIMATE3096; Stegen KS, 2013, ENERG POLICY, V61, P1481, DOI 10.1016/j.enpol.2013.06.130; Thornton HE, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa69c6; Ueckerdt F, 2017, ENERG ECON, V64, P665, DOI 10.1016/j.eneco.2016.05.012; Ueckerdt F, 2013, ENERGY, V63, P61, DOI 10.1016/j.energy.2013.10.072; Weber J., 2017, ARXIV171103294; Weber J., 2017, ARXIV171105569; Weitemeyer S, 2015, RENEW ENERG, V75, P14, DOI 10.1016/j.renene.2014.09.028; Welt, 2015, WELT; Wenz L, 2017, P NATL ACAD SCI USA, V114, pE7910, DOI 10.1073/pnas.1704339114; Wohland J, 2017, EARTH SYST DYNAM, V8, P1047, DOI 10.5194/esd-8-1047-2017	79	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190707	10.1371/journal.pone.0190707	http://dx.doi.org/10.1371/journal.pone.0190707			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BY	29329349	Green Published, gold, Green Submitted			2022-12-27	WOS:000419954100020
J	Lima, SGC; Sousa-Lima, RS; Tokumaru, RS; Nogueira, SLG; Nogueira, SSC				Lima, Stella G. C.; Sousa-Lima, Renata S.; Tokumaru, Rosana S.; Nogueira-Filho, Sergio L. G.; Nogueira, Selene S. C.			Vocal complexity and sociality in spotted paca (Cuniculus paca)	PLOS ONE			English	Article							CTENOMYS-TALARUM RODENTIA; COMMUNICATIVE COMPLEXITY; BEHAVIORAL-RESPONSES; OCTODON-DEGUS; TRACT LENGTH; EVOLUTION; REPERTOIRE; VOCALIZATIONS; CONSTRAINTS; POPULATION	The evolution of sociality is related to many ecological factors that act on animals as selective forces, thus driving the formation of groups. Group size will depend on the payoffs of group living. The Social Complexity Hypothesis for Communication (SCHC) predicts that increases in group size will be related to increases in the complexity of the communication among individuals. This hypothesis, which was confirmed in some mammal societies, may be useful to trace sociality in the spotted paca (Cuniculus paca), a Neotropical caviomorph rodent reported as solitary. There are, however, sightings of groups in the wild, and farmers easily form groups of spotted paca in captivity. Thus, we aimed to describe the acoustic repertoire of captive spotted paca to test the SCHC and to obtain insights about the sociability of this species. Moreover, we aimed to verify the relationship between group size and acoustic repertoire size of caviomorph rodents, to better understand the evolution of sociality in this taxon. We predicted that spotted paca should display a complex acoustic repertoire, given their social behavior in captivity and group sightings in the wild. We also predicted that in caviomorph species the group size would increase with acoustic repertoire, supporting the SCHC. We performed a Linear Discriminant Analysis (LDA) based on acoustic parameters of the vocalizations recorded. In addition, we applied an independent contrasts approach to investigate sociality in spotted paca following the social complexity hypothesis, independent of phylogeny. Our analysis showed that the spotted paca's acoustic repertoire contains seven vocal types and one mechanical signal. The broad acoustic repertoire of the spotted paca might have evolved given the species' ability to live in groups. The relationship between group size and the size of the acoustic repertoires of caviomorph species was confirmed, providing additional support for the SCHC in yet another group of diverse mammals-caviomorph rodents.	[Lima, Stella G. C.; Sousa-Lima, Renata S.] Univ Fed Rio Grande do Norte, Lab Bioacust, Dept Fisiol & Comportamento, Programa Posgrad Psicobiol, Natal, RN, Brazil; [Tokumaru, Rosana S.] Univ Fed Esprito Santo, Dept Psicol Social & Desenvolvimento, Vitoria, ES, Brazil; [Nogueira-Filho, Sergio L. G.; Nogueira, Selene S. C.] Univ Estadual Santa Cruz, Lab Etol Aplicada, Dept Ciencias Biol, Ilheus, BA, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Espirito Santo; Universidade Estadual de Santa Cruz	Nogueira, SSC (corresponding author), Univ Estadual Santa Cruz, Lab Etol Aplicada, Dept Ciencias Biol, Ilheus, BA, Brazil.	seleneuesc@gmail.com	Sousa-Lima, Renata S./O-7550-2015; Nogueira, Selene/W-5237-2019; Nogueira, Selene/I-1843-2013; Nogueira-Filho, Sérgio L.G./F-6264-2014; Sousa-Lima, Renata/AAD-4096-2020	Sousa-Lima, Renata S./0000-0002-2638-1695; Nogueira, Selene/0000-0001-8078-4172; Nogueira, Selene/0000-0001-8078-4172; Nogueira-Filho, Sergio/0000-0001-5392-0773	Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD); UESC; National Council for Scientific and Technological Development (CNPq) [300587/2009-0, 306154/2010-2]; CAPES [88881.119854/2016-01, 88881.119838/2016-01]	Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD); UESC; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES/PNPD), UESC and the National Council for Scientific and Technological Development (CNPq) (Processes #300587/2009-0 and #306154/2010-2). Selene Nogueira and Sergio Nogueira-Filho received grant from CAPES (Processes #88881.119854/2016-01 and #88881.119838/2016-01, respectively). The funding agencies hadno role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Alencar Jr RN, 2011, THESIS; Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aquino Rolando, 2009, Rev. peru biol., V16, P67; Arnold K, 2012, BRAIN LANG, V120, P303, DOI 10.1016/j.bandl.2011.10.001; Asher MR, 2004, J MAMMAL, V85, P788, DOI 10.1644/BNS-012; Barros KS, 2011, ETHOLOGY, V117, P83, DOI 10.1111/j.1439-0310.2010.01853.x; Beck-King H, 1999, BIOTROPICA, V31, P675, DOI 10.1111/j.1744-7429.1999.tb00417.x; Begall S, 1999, J MAMMAL, V80, P210, DOI 10.2307/1383221; Blumstein DT, 1997, AM NAT, V150, P179, DOI 10.1086/286062; Boersma P., 2013, PRAAT DOING PHONETIC; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; BUSCH C, 1989, J MAMMAL, V70, P204, DOI 10.2307/1381691; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Charif R. A., 2008, RAVEN PRO 1 3 USERS; David-Barrett D, 2013, P R SOC B, V280; DUBOST G, 1988, J ZOOL, V214, P107, DOI 10.1111/j.1469-7998.1988.tb04990.x; Ebensperger LA, 2006, BEHAV ECOL, V17, P410, DOI 10.1093/beheco/arj048; Ebensperger LA, 2002, OIKOS, V98, P491, DOI 10.1034/j.1600-0706.2002.980313.x; Ebensperger LA, 2001, ACTA THERIOL, V46, P115, DOI 10.1007/BF03192423; Ebensperger LA, 2011, J MAMMAL, V92, P21, DOI 10.1644/09-MAMM-S-383.1; Ebenspherger LA, 2001, BEHAV ECOL, V12, P227, DOI 10.1093/beheco/12.2.227; Eisenberg J. F., 1974, Symposia of the Zoological Society of London, P211; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; EMMONS L, 2016, IUCN RED LIST THREAT; Emmons LH, 1997, NEOTROPICAL RAINFORE, P322; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Felsenstein J., 2003, INFERRING PHYLOGENIE, P1; Feng AS, 2009, ETHOLOGY, V115, P1015, DOI 10.1111/j.1439-0310.2009.01692.x; Figueroa-de Leon AF, 2016, REV MEX BIODIVERS, V87, P1062, DOI 10.1016/j.rmb.2016.07.009; Fischer J, 2016, ANIM BEHAV, V124, P1; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Foster EA, 2012, ANIM BEHAV, V83, P731, DOI 10.1016/j.anbehav.2011.12.021; Francescoli G, SOCIOBIOLOGY CAVIOMO; Freeberg TM, 2006, PSYCHOL SCI, V17, P557, DOI 10.1111/j.1467-9280.2006.01743.x; Freeberg TM, 2012, PHILOS T R SOC B, V367, P1785, DOI 10.1098/rstb.2011.0213; Gallina S, 2012, REV BIOL TROP, V60, P1345; Krause J., 2002, LIVING GROUPS, P1; Leuchtenberger C, 2016, MAMMALIA, P1, DOI DOI 10.1515/MAMMALIA-2015-0129; Leuchtenberger C, 2014, J ACOUST SOC AM, V136, P2861, DOI 10.1121/1.4896518; Lima S., 2016, THESIS; Long CV, 2007, BIOACOUSTICS, V16, P223, DOI 10.1080/09524622.2007.9753579; Maher CR, 2016, SOCIOBIOLOGY OF CAVIOMORPH RODENTS: AN INTEGRATIVE APPROACH, P28; Manser MB, 2014, ADV STUD BEHAV, V46, P281, DOI 10.1016/B978-0-12-800286-5.00006-7; May-Collado LJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-136; McComb K, 2005, BIOL LETTERS, V1, P381, DOI 10.1098/rsbl.2005.0366; McGarigal K., 2000, MULTIVARIATE STAT WI, P1; MONES A, 1986, Mammalian Species, P1, DOI 10.2307/3503784; Monticelli PF, 2013, BIOACOUSTICS, V22, P49, DOI 10.1080/09524622.2012.711516; Morrell LJ, 2011, P ROY SOC B-BIOL SCI, V278, P605, DOI 10.1098/rspb.2010.1605; Nogueira Filho SLG, 1999, CRIAC PACAS AGOUTI P, P1; Nowak RM, 1999, WALKERS MAMMALS WORL, P1; NOYMEIR I, 1975, J ECOL, V63, P779, DOI 10.2307/2258601; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Patton James L., 2015, P726; Pollard KA, 2012, PHILOS T R SOC B, V367, P1869, DOI 10.1098/rstb.2011.0221; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Queirolo D., 2008, IUCN RED LIST THREAT; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 2004, J ACOUST SOC AM, V115, P411, DOI 10.1121/1.1635838; Riede T, 1999, J EXP BIOL, V202, P2859; Rowe DL, 2002, MOL BIOL EVOL, V19, P263, DOI 10.1093/oxfordjournals.molbev.a004080; Rubenstein D. R., 2017, COMP SOCIAL EVOLUTIO; Schleich CE, 2002, J ETHOL, V20, P123, DOI 10.1007/s10164-002-0064-9; Schradin C, 2012, MOL ECOL, V21, P541, DOI 10.1111/j.1365-294X.2011.05256.x; Sih A, 2013, ANIM BEHAV, V85, P1077, DOI 10.1016/j.anbehav.2013.02.017; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Smith JE, 2017, COMPARATIVE SOCIAL EVOLUTION, P284; SMYTHE N, 1987, APPL ANIM BEHAV SCI, V17, P155, DOI 10.1016/0168-1591(87)90017-7; Smythe N, 1995, DOMESTICACION CRIA P, P1; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Tomasco IH, 2017, GENE, V628, P275, DOI 10.1016/j.gene.2017.07.057; Topping MG, 1999, CAN J ZOOL, V77, P480, DOI 10.1139/cjz-77-3-480; Veitl Silke, 2000, Bioacoustics, V11, P129; Verdade Luciano M., 1996, Revista Brasileira de Biologia, V56, P1; Wilkinson GS, 2003, ANIMAL SOCIAL COMPLEXITY, P322	79	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190961	10.1371/journal.pone.0190961	http://dx.doi.org/10.1371/journal.pone.0190961			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT8OQ	29364898	Green Published, gold, Green Submitted			2022-12-27	WOS:000423412500029
J	Zhou, J; Bethune, MT; Malkova, N; Sutherland, AM; Comin-Anduix, B; Su, YP; Baltimore, D; Ribas, A; Heath, JR				Zhou, Jing; Bethune, Michael T.; Malkova, Natalia; Sutherland, Alexander M.; Comin-Anduix, Begonya; Su, Yapeng; Baltimore, David; Ribas, Antoni; Heath, James R.			A kinetic investigation of interacting, stimulated T cells identifies conditions for rapid functional enhancement, minimal phenotype differentiation, and improved adoptive cell transfer tumor eradication	PLOS ONE			English	Article							IN-VIVO; TRANSCRIPTION FACTOR; DENDRITIC CELLS; LYMPH-NODES; IMMUNOLOGICAL SYNAPSE; HUMAN EFFECTOR; MEMORY; IMMUNOTHERAPY; CANCER; RECEPTOR	For adoptive cell transfer (ACT) immunotherapy of tumor-reactive T cells, an effective therapeutic outcome depends upon cell dose, cell expansion in vivo through a minimally differentiated phenotype, long term persistence, and strong cytolytic effector function. An incomplete understanding of the biological coupling between T cell expansion, differentiation, and response to stimulation hinders the co-optimization of these factors. We report on a biophysical investigation of how the short-term kinetics of T cell functional activation, through molecular stimulation and cell-cell interactions, competes with phenotype differentiation. T cells receive molecular stimulation for a few minutes to a few hours in bulk culture. Following this priming period, the cells are then analyzed at the transcriptional level, or isolated as single cells, with continuing molecular stimulation, within microchambers for analysis via 11-plex secreted protein assays. We resolve a rapid feedback mechanism, promoted by T cell-T cell contact interactions, which strongly amplifies T cell functional performance while yielding only minimal phenotype differentiation. When tested in mouse models of ACT, optimally primed T cells lead to complete tumor eradication. A similar kinetic process is identified in CD8(+) and CD4(+) T cells collected from a patient with metastatic melanoma.	[Zhou, Jing; Bethune, Michael T.; Sutherland, Alexander M.; Su, Yapeng; Baltimore, David; Ribas, Antoni; Heath, James R.] CALTECH, NanoSyst Biol Canc Ctr, Pasadena, CA 91125 USA; [Zhou, Jing; Malkova, Natalia; Sutherland, Alexander M.; Su, Yapeng; Heath, James R.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Bethune, Michael T.; Baltimore, David] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Comin-Anduix, Begonya; Ribas, Antoni] Univ Calif Los Angeles, Johnsson Comprehens Canc Ctr, David Geffen Sch Med, Los Angeles, CA 90095 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Heath, JR (corresponding author), CALTECH, NanoSyst Biol Canc Ctr, Pasadena, CA 91125 USA.; Heath, JR (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	heath@caltech.edu		Su, Yapeng/0000-0002-6305-8467; Heath, James/0000-0001-5356-4385	National Cancer Institute [R01 CA170689, 5U54 CA119347, 1U54 CA199090-01, CA-16042, AI-28697]; Stand Up 2 Cancer [SU2C-AACR-DT1012]; Jean Perkins Foundation; NATIONAL CANCER INSTITUTE [P30CA016042, R35CA197633] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up 2 Cancer; Jean Perkins Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute, grant #'s: R01 CA1 70689, 5U54 CA119347, 1U54 CA199090-01, CA-16042, AI-28697; Jean Perkins Foundation; and Stand Up 2 Cancer SU2C-AACR-DT1012.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Bailey RC, 2007, J AM CHEM SOC, V129, P1959, DOI 10.1021/ja065930i; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Butler MO, 2014, IMMUNOL REV, V257, P191, DOI 10.1111/imr.12129; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chodon T, 2014, CLIN CANCER RES, V20, P2457, DOI 10.1158/1078-0432.CCR-13-3017; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Crompton JG, 2014, IMMUNOL REV, V257, P264, DOI 10.1111/imr.12135; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gerard A, 2013, NAT IMMUNOL, V14, P356, DOI 10.1038/ni.2547; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Ibarrondo FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076829; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Johnson RA., 2007, APPL MULTIVARIATE ST; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Klebanoff CA, 2009, BLOOD, V114, P1776, DOI 10.1182/blood-2008-12-192419; Ma C, 2013, CANCER DISCOV, V3, P418, DOI 10.1158/2159-8290.CD-12-0383; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rossi J, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-2990; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Smirnov P, 2006, MAGN RESON MED, V56, P498, DOI 10.1002/mrm.20996; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Vinay DS, 2014, BMB REP, V47, P122, DOI 10.5483/BMBRep.2014.47.3.283; Voehringer D, 2002, BLOOD, V100, P3698, DOI 10.1182/blood-2002-02-0657; Xiao ZG, 2007, J EXP MED, V204, P2667, DOI 10.1084/jem.20062376; Xue Q, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0293-7; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu YW, 2014, CLIN CANCER RES, V20, P3, DOI 10.1158/1078-0432.CCR-13-2573	54	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191634	10.1371/journal.pone.0191634	http://dx.doi.org/10.1371/journal.pone.0191634			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360859	Green Submitted, Green Published, gold			2022-12-27	WOS:000423161800046
J	Darwiche, W; Gay-Queheillard, J; Delanaud, S; El Sabbouri, HE; Khachfe, H; Joumaa, W; Bach, V; Ramadan, W				Darwiche, Walaa; Gay-Queheillard, Jerome; Delanaud, Stephane; El Sabbouri, Hiba El Khayat; Khachfe, Hassan; Joumaa, Wissam; Bach, Veronique; Ramadan, Wiam			Impact of chronic exposure to the pesticide chlorpyrifos on respiratory parameters and sleep apnea in juvenile and adult rats	PLOS ONE			English	Article							ORGANOPHOSPHORUS PESTICIDES; DEVELOPMENTAL NEUROTOXICITY; CHOLINESTERASE INHIBITION; TOXICITY; BRAIN; PATHWAYS; CHILDREN; INSECTICIDES; VENTILATION; DIAPHRAGM	The widely used organophosphorus pesticide chlorpyrifos (CPF) is often detected in food. CPF inhibits acetylcholinesterase and can modify muscle contractility and respiratory patterns. We studied the effects of chronic exposure to CPF on respiratory parameters and diaphragm contractility in 21-and 60-days old rats. Pregnant rats were exposed to oral CPF (1 or 5 mg/kg/day: CPF-1 or CPF-5 groups vs vehicle: controls) from gestation onset up to weaning of the pups that were individually gavaged (CPF or vehicle) thereafter. Two developmental time points were studied: weaning (day 21) and adulthood (day 60). Whole-body plethysmography was used to score breathing patterns and apnea index during sleep. Then, diaphragm strips were dissected for the assessment of contractility and acetylcholinesterase activity. Results showed that the sleep apnea index was higher in CPF-exposed rats than in controls. In adult rats, the expiratory time and tidal volume were higher in CPF-exposed animals than in controls. At both ages, the diaphragm's amplitude of contraction and fatigability index were higher in the CPF-5 group, due to lower acetylcholinesterase activity. We conclude that chronic exposure to CPF is associated with higher sleep apnea index and diaphragm contractility, and modifies respiratory patterns in sleeping juvenile and adult rats.	[Darwiche, Walaa; Gay-Queheillard, Jerome; Delanaud, Stephane; El Sabbouri, Hiba El Khayat; Bach, Veronique] INERIS, PeriTox Perinatal & Risques Tox, UMR I 01, Amiens, France; [Darwiche, Walaa; El Sabbouri, Hiba El Khayat; Joumaa, Wissam; Ramadan, Wiam] Lebanese Univ, Fac Sci, Environm Physiotox Grp, Rammal Hassan Rammal Lab,PhyToxE, Nabatieh, Lebanon; [Khachfe, Hassan; Ramadan, Wiam] Lebanese Int Univ, LIBRA, Beirut, Lebanon	Institut National de l'Environnement Industriel et des Risques (INERIS); Lebanese University	Darwiche, W (corresponding author), INERIS, PeriTox Perinatal & Risques Tox, UMR I 01, Amiens, France.; Darwiche, W (corresponding author), Lebanese Univ, Fac Sci, Environm Physiotox Grp, Rammal Hassan Rammal Lab,PhyToxE, Nabatieh, Lebanon.	walaa.darwiche@u-picardie.fr	stepahne, delanaud/AAD-2762-2022; Bach, Veronique/AAD-5958-2022	EL KHAYAT EL SABBOURI, Hiba/0000-0001-7566-1688; Bach, Veronique/0000-0002-0684-0305; Darwiche, Walaa/0000-0002-8647-2468	Agence Universitaire de la Francophonie; Association pour la Specialisation et l'Orientation Scientifique (Beirut, Lebanon); FHU "1000 premiers jours de vie"	Agence Universitaire de la Francophonie; Association pour la Specialisation et l'Orientation Scientifique (Beirut, Lebanon); FHU "1000 premiers jours de vie"	WD received a postgraduate fellowship from the Agence Universitaire de la Francophonie (Bureau Moyen-Orient) and the Association pour la Specialisation et l'Orientation Scientifique (Beirut, Lebanon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor Jean-Pierre Libert, Professor Pierre Tourneux and Dr. Hussein Ghamlouch for valuable discussions. WD received a postgraduate fellowship from the Agence Universitaire de la Francophonie and the Association pour la Specialisation et l'Orientation Scientifique (Beirut, Lebanon). We also thank the FHU "1000 premiers jours de vie" for their financial support.	BARTHOLOMEW PM, 1985, TOXICOL APPL PHARM, V81, P147, DOI 10.1016/0041-008X(85)90129-2; Berton T, 2014, ENVIRON RES, V132, P311, DOI 10.1016/j.envres.2014.03.034; Bird SB, 2003, ACAD EMERG MED, V10, P295, DOI 10.1111/j.1553-2712.2003.tb01338.x; Bolles HG, 1999, J AGR FOOD CHEM, V47, P1817, DOI 10.1021/jf980962d; Bouvier G, 2006, J EXPO SCI ENV EPID, V16, P417, DOI 10.1038/sj.jes.7500473; BURD PF, 1987, J PHYSIOL-LONDON, V391, P429, DOI 10.1113/jphysiol.1987.sp016747; Carey JL, 2013, RESP PHYSIOL NEUROBI, V189, P403, DOI 10.1016/j.resp.2013.07.022; CHAMBERS JE, 1994, LIFE SCI, V54, P1357, DOI 10.1016/0024-3205(94)00515-X; CHAMBERS JE, 1989, J BIOCHEM TOXICOL, V4, P201, DOI 10.1002/jbt.2570040310; Christon J, 1996, J APPL PHYSIOL, V80, P2102, DOI 10.1152/jappl.1996.80.6.2102; COCHRAN RC, 1995, FOOD CHEM TOXICOL, V33, P165, DOI 10.1016/0278-6915(94)00124-7; CURZIDASCALOVA L, 1983, BIOL NEONATE, V44, P325; DRORBAUGH JE, 1955, PEDIATRICS, V16, P81; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Farag AT, 2003, REPROD TOXICOL, V17, P203, DOI 10.1016/S0890-6238(02)00121-1; Gaspari RJ, 2011, NEUROTOXICOLOGY, V32, P206, DOI 10.1016/j.neuro.2011.01.005; GILLIS RA, 1988, J PHARMACOL EXP THER, V247, P765; Hara Y, 2013, AM J OTOLARYNG, V34, P537, DOI 10.1016/j.amjoto.2013.01.014; Houze P, 2008, TOXICOL APPL PHARM, V233, P186, DOI 10.1016/j.taap.2008.08.006; Hulse EJ, 2014, AM J RESP CRIT CARE, V190, P1342, DOI 10.1164/rccm.201406-1150CI; Lu CS, 2008, ENVIRON HEALTH PERSP, V116, P537, DOI 10.1289/ehp.10912; McGuire M, 1998, EXP PHYSIOL, V83, P481, DOI 10.1113/expphysiol.1998.sp004131; MENDELSON WB, 1988, PHYSIOL BEHAV, V43, P229, DOI 10.1016/0031-9384(88)90243-0; Moser VC, 1998, TOXICOL SCI, V46, P211, DOI 10.1006/toxs.1998.2526; Nougadere A, 2012, ENVIRON INT, V45, P135, DOI 10.1016/j.envint.2012.02.001; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; POPE CN, 1991, TOXICOLOGY, V68, P51, DOI 10.1016/0300-483X(91)90061-5; Pope CN, 1999, J TOXICOL ENV HEAL B, V2, P161, DOI 10.1080/109374099281205; Proskocil BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010562; Qiao D, 2002, ENVIRON HEALTH PERSP, V110, P1097, DOI 10.1289/ehp.021101097; Ramadan W, 2006, RESP PHYSIOL NEUROBI, V150, P52, DOI 10.1016/j.resp.2005.02.011; Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338; Segura P, 1999, N-S ARCH PHARMACOL, V360, P699, DOI 10.1007/s002109900101; Slotkin TA, 2007, BRAIN RES BULL, V72, P232, DOI 10.1016/j.brainresbull.2007.01.005; Spyer KM, 2009, PHILOS T R SOC B, V364, P2603, DOI 10.1098/rstb.2009.0082; Tang J, 1999, TOXICOL SCI, V51, P265, DOI 10.1093/toxsci/51.2.265; Villa AF, 2007, TOXICOLOGY, V232, P37, DOI 10.1016/j.tox.2006.12.006; Weldon RH, 2011, J ENVIRON MONITOR, V13, P3136, DOI 10.1039/c1em10469a; Whyatt RM, 2004, ENVIRON HEALTH PERSP, V112, P1125, DOI 10.1289/ehp.6641; WRIGHT PG, 1954, J PHYSIOL-LONDON, V126, P52, DOI 10.1113/jphysiol.1954.sp005191	40	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191237	10.1371/journal.pone.0191237	http://dx.doi.org/10.1371/journal.pone.0191237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357379	gold, Green Published, Green Submitted			2022-12-27	WOS:000422919500011
J	Berry, NT; Hubal, M; Wideman, L				Berry, Nathaniel T.; Hubal, Monica; Wideman, Laurie			The effects of an acute exercise bout on GH and IGF-1 in prediabetic and healthy African Americans: A pilot study investigating gene expression	PLOS ONE			English	Article							HORMONE-RELEASING-HORMONE; HUMAN GROWTH-HORMONE; BODY-COMPOSITION; DIABETES-MELLITUS; BINDING-PROTEINS; DEFICIENT ADULTS; FACTOR-I; INSULIN; RESISTANCE; PATHOPHYSIOLOGY	The incidence of pre-diabetes (PD) and Type-2 Diabetes Mellitus (T2D) is a worldwide epidemic. African American (AA) individuals are disproportionately more likely to become diabetic than other ethnic groups. Over the long-term, metabolic complications related to diabetes result in significant alterations in growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Considering the limited exercise-related studies in the area of gene expression changes with disease progression, the objective of this study was to examine differences in exercise-induced gene expression related to the GH and IGF-1 pathways in peripheral blood mononuclear cells (PBMCs) of healthy (CON) and PD AA individuals. Design: Ten subjects [5 PD (age = 35 +/- 9.3 yr, BMI = 32.1 +/- 4.0, FBG = 101.8 +/- 1.3 mg/dl) and 5 CON (age = 31 +/- 9.4 yr, BMI = 29.4 +/- 5.2, FBG = 82.8 +/- 9.7 mg/dl)] had blood drawn for RNA isolation prior to exercise (Pre), immediately following acute moderate intensity exercise on a treadmill (Post-1), 6-hours post (Post-6), and 24-hours post (Post-24). Isolation of mRNA from PBMCs was performed using ficoll separation, while the profiling of mRNA expression was performed using Illumina beadchip arrays with standard protocols. Scan results were statistically analyzed for a specific list of genes related to GH and IGF-1. GH and IGF-1 protein levels were also assessed in each sample. To address issues of normality, all GH and IGF-1 data were log-transformed prior to analysis. Statistical significance was set at p<0.05. Results: Group differences for GH2 variant 2 (p = 0.070) and GH2 variant 3 (p = 0.059) were coupled with significant alterations in IGF-1 mRNA over time (p = 0.024). A significant interaction between group and time was observed for GHRH mRNA (p = 0.008). No group differences were observed in GH AUC (p = 0.649),.GH (p = 0.331), GHrec (p = 0.294), or IGF-1 AUC (p = 0.865), representing a similar exercise-induced GH and IGF-1 response for both groups. Conclusions: Analysis of GH and IGF-1 related-gene expression indicates that mild elevations in fasting blood glucose and exercise-induced alterations in gene expression are impacted by the prediabetic state.	[Berry, Nathaniel T.; Wideman, Laurie] Univ N Carolina, Greensboro, NC 27412 USA; [Hubal, Monica] George Washington Univ, Milken Inst, Sch Publ Hlth, Washington, DC USA; [Hubal, Monica] Childrens Natl Med Ctr, Washington, DC 20010 USA	University of North Carolina; University of North Carolina Greensboro; George Washington University; Children's National Health System	Berry, NT (corresponding author), Univ N Carolina, Greensboro, NC 27412 USA.	ntberry@uncg.edu		Berry, Nathaniel/0000-0001-8089-1955; Hubal, Monica/0000-0001-6579-6036	National Institutes of Health - National Center on Minority Health and Health Disparities [P20MD002289]; National Institutes of Health - National Center for Medical Rehabilitation Research / National Institute of Neurological Disorders and Stroke [2R23HD050846-06]; National Institutes of Health - National Institute of Neurological Disorders and Stroke [1P30HD40677-06]	National Institutes of Health - National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institutes of Health - National Center for Medical Rehabilitation Research / National Institute of Neurological Disorders and Stroke; National Institutes of Health - National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health - National Center on Minority Health and Health Disparities P20MD002289 (TRIAD Center for Health Disparities) (https://www.nimhd.nih.gov) to LW; National Institutes of Health - National Center for Medical Rehabilitation Research / National Institute of Neurological Disorders and Stroke 2R23HD050846-06 (Core Molecular & Functional Outcome Measures in Rehabilitation Medicine) (https://www.nichd.nih.gov/about/org/ncmrr/Pages/overview.aspx, https://www.ninds.nih.gov); and National Institutes of Health - National Institute of Neurological Disorders and Stroke 1P30HD40677-06 (Intellectual & Developmental Disabilities Research) (https://www.ninds.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; ASPLIN CM, 1989, J CLIN ENDOCR METAB, V69, P239, DOI 10.1210/jcem-69-2-239; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; BINNERTS A, 1992, CLIN ENDOCRINOL, V37, P79, DOI 10.1111/j.1365-2265.1992.tb02287.x; Biondi-Zoccai GGL, 2003, J AM COLL CARDIOL, V41, P1071, DOI 10.1016/S0735-1097(03)00088-3; Carlson LA, 2011, EUR J APPL PHYSIOL, V111, P2919, DOI 10.1007/s00421-011-1923-2; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Carroll PV, 1998, CLIN ENDOCRINOL, V49, P739, DOI 10.1046/j.1365-2265.1998.00600.x; Centers for Disease Control and Prevention (CDC), 2011, NAT DIAB FACT SHEET; CHONG PKK, 1994, CLIN ENDOCRINOL, V40, P103, DOI 10.1111/j.1365-2265.1994.tb02451.x; Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c; Connolly PH, 2004, J APPL PHYSIOL, V97, P1461, DOI 10.1152/japplphysiol.00316.2004; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daugaard JR, 2004, PFLUG ARCH EUR J PHY, V447, P452, DOI 10.1007/s00424-003-1195-8; DELA F, 1993, J PHYSIOL-LONDON, V469, P615, DOI 10.1113/jphysiol.1993.sp019833; Drogan D, 2016, AM J EPIDEMIOL, V183, P553, DOI 10.1093/aje/kwv188; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Green HJ, 2008, AM J PHYSIOL-REG I, V295, pR1238, DOI 10.1152/ajpregu.00171.2008; HANSEN AP, 1971, J CLIN INVEST, V50, P1806, DOI 10.1172/JCI106671; HANSEN AP, 1970, J CLIN INVEST, V49, P1467, DOI 10.1172/JCI106364; HANSEN AP, 1973, DIABETES, V22, P619, DOI 10.2337/diab.22.8.619; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Hara K, 2016, EXPERT OPIN THER TAR, V20, P255, DOI 10.1517/14728222.2016.1098618; Hertel JK, 2008, DIABETOLOGIA, V51, P971, DOI 10.1007/s00125-008-0982-3; HOFFMAN DM, 1995, J CLIN ENDOCR METAB, V80, P72, DOI 10.1210/jc.80.1.72; HSIEH SD, 1995, INT J OBESITY, V19, P585; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; Kraniou GN, 2004, EXP PHYSIOL, V89, P559, DOI 10.1113/expphysiol.2004.027409; Moraes PA, 2014, LIFE SCI, V114, P36, DOI 10.1016/j.lfs.2014.07.040; O'Gorman DJ, 2006, DIABETOLOGIA, V49, P2983, DOI 10.1007/s00125-006-0457-3; PRESS M, 1984, NEW ENGL J MED, V310, P810, DOI 10.1056/NEJM198403293101302; Radom-Aizik S, 1985, J APPL PHYSIOL, V104, P236; Radom-Aizik S, 2012, CTS-CLIN TRANSL SCI, V5, P32, DOI 10.1111/j.1752-8062.2011.00384.x; Rajpathak SN, 2009, DIABETES-METAB RES, V25, P3, DOI 10.1002/dmrr.919; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Takamura T, 2007, BIOCHEM BIOPH RES CO, V361, P379, DOI 10.1016/j.bbrc.2007.07.006; TANNENBAUM GS, 1990, METABOLISM, V39, P35, DOI 10.1016/0026-0495(90)90206-R; Team RDC, 2008, RA LANGUAGE AND ENVI; Wang DD, 2015, INT J CLIN EXP MED, V8, P8243; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002; Wideman L, 2002, SPORTS MED, V32, P987, DOI 10.2165/00007256-200232150-00003; YALOW RS, 1965, ANN NY ACAD SCI, V131, P357, DOI 10.1111/j.1749-6632.1965.tb34803.x; ZEITLER P, 1991, P NATL ACAD SCI USA, V88, P8920, DOI 10.1073/pnas.88.20.8920; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	48	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191331	10.1371/journal.pone.0191331	http://dx.doi.org/10.1371/journal.pone.0191331			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351335	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300073
J	Carleton, WC; Campbell, D; Collard, M				Carleton, W. Christopher; Campbell, David; Collard, Mark			Radiocarbon dating uncertainty and the reliability of the PEWMA method of time-series analysis for research on long-term human-environment interaction	PLOS ONE			English	Article							CALIBRATION; DROUGHT	Statistical time-series analysis has the potential to improve our understanding of humanenvironment interaction in deep time. However, radiocarbon dating-the most common chronometric technique in archaeological and palaeoenvironmental research-creates challenges for established statistical methods. The methods assume that observations in a time-series are precisely dated, but this assumption is often violated when calibrated radiocarbon dates are used because they usually have highly irregular uncertainties. As a result, it is unclear whether the methods can be reliably used on radiocarbon-dated time-series. With this in mind, we conducted a large simulation study to investigate the impact of chronological uncertainty on a potentially useful time-series method. The method is a type of regression involving a prediction algorithm called the Poisson Exponentially Weighted Moving Average (PEMWA). It is designed for use with count time-series data, which makes it applicable to a wide range of questions about human-environment interaction in deep time. Our simulations suggest that the PEWMA method can often correctly identify relationships between time-series despite chronological uncertainty. When two time-series are correlated with a coefficient of 0.25, the method is able to identify that relationship correctly 20 +/- 30% of the time, providing the time-series contain low noise levels. With correlations of around 0.5, it is capable of correctly identifying correlations despite chronological uncertainty more than 90% of the time. While further testing is desirable, these findings indicate that the method can be used to test hypotheses about long-term human-environment interaction with a reasonable degree of confidence.	[Carleton, W. Christopher; Collard, Mark] Simon Fraser Univ, Dept Archaeol, Univ Dr, Burnaby, BC, Canada; [Campbell, David] Simon Fraser Univ, Dept Stat & Actuarial Sci, Univ Dr, Burnaby, BC, Canada	Simon Fraser University; Simon Fraser University	Collard, M (corresponding author), Simon Fraser Univ, Dept Archaeol, Univ Dr, Burnaby, BC, Canada.	mcollard@sfu.ca		Campbell, David/0000-0001-8722-4450; Carleton, William/0000-0001-7463-8638; Collard, Mark/0000-0002-2725-4989	Social Sciences and Humanities Research Council of Canada [767-2011-0159, 895-2011-1009]; Natural Sciences and Engineering Research Council of Canada [RGPIN04040-2014]; Canada Research Chairs Program [228117, 231256]; Canada Foundation for Innovation [203808]; British Columbia Knowledge Development Fund [862-804231]; Simon Fraser University [14518]; Simon Fraser University's Community Trust Endowment Fund [14518]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Simon Fraser University; Simon Fraser University's Community Trust Endowment Fund	We received financial support from the Social Sciences and Humanities Research Council of Canada (767-2011-0159 and 895-2011-1009), the Natural Sciences and Engineering Research Council of Canada (RGPIN04040-2014), the Canada Research Chairs Program (228117 and 231256), the Canada Foundation for Innovation (203808), the British Columbia Knowledge Development Fund (862-804231), and Simon Fraser University (14518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our anonymous reviewers and academic editor for their advice. We received financial support from the Social Sciences and Humanities Research Council of Canada (767-2011-0159 and 895-2011-1009), the Natural Sciences and Engineering Research Council of Canada (RGPIN04040-2014), the Canada Research Chairs Program (228117 and 231256), the Canada Foundation for Innovation (203808), the British Columbia Knowledge Development Fund (862-804231), and Simon Fraser University's Community Trust Endowment Fund (14518).	Aitken M. J., 1990, SCI BASED DATING ARC; Aitken MJ, 1997, ADV ARC MUS, V2, P1; Akaike H., 2011, INT ENCY STAT SCI, P25, DOI DOI 10.1007/978-3-642-04898-2_110; Blaauw M, 2007, HOLOCENE, V17, P283, DOI 10.1177/0959683607075857; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; Bradley R. S., 1999, PALEOCLIMATOLOGY REC; Brandt PT, 2000, AM J POLIT SCI, V44, P823, DOI 10.2307/2669284; Buck C.E., 1996, BAYESIAN APPROACH IN; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Carleton WC, 2017, QUATERNARY SCI REV, V163, P209, DOI 10.1016/j.quascirev.2017.02.022; Carleton WC, 2014, QUATERNARY SCI REV, V105, P151, DOI 10.1016/j.quascirev.2014.09.032; Chatfield C, 2009, ANAL TIME SERIES INT; Cronin TM, 2013, PALEOCLIMATES UNDERS; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Haug G. H., 2001, Science, V293, P1304, DOI 10.1126/science.1059725; Hodell DA, 2005, QUATERNARY SCI REV, V24, P1413, DOI 10.1016/j.quascirev.2004.10.013; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Kennett DJ, 2012, SCIENCE, V338, P788, DOI 10.1126/science.1226299; Kingman J., 1993, POISSON PROCESSES; Klein JL., 1997, STAT VISIONS TIME HI; Martin Simon, 2008, CHRONICLE MAYA KINGS, V2nd; Mudelsee M, 2014, ATMOS OCEAN SCI LIB, V51, P1, DOI 10.1007/978-3-319-04450-7; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pickup M, 2014, INTRODUCTION TO TIME; R Core Team, 2015, R LANGUAGE ENV STAT; Ramsey CB, 2006, ANTIQUITY, V80, P783, DOI 10.1017/S0003598X00094424; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Schulz M, 2002, COMPUT GEOSCI-UK, V28, P421, DOI 10.1016/S0098-3004(01)00044-9; Taylor RE, 1997, CHRONOMETRIC DATING; Telford RJ, 2004, HOLOCENE, V14, P296, DOI 10.1191/0959683604hl707fa; Telford RJ, 2004, QUATERNARY SCI REV, V23, P1, DOI 10.1016/j.quascirev.2003.11.003; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Webster D, 2000, J WORLD PREHIST, V14, P65, DOI 10.1023/A:1007813518630; Wurtzel JB, 2013, GEOPHYS RES LETT, V40, P5954, DOI 10.1002/2013GL058458	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191055	10.1371/journal.pone.0191055	http://dx.doi.org/10.1371/journal.pone.0191055			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351329	gold, Green Submitted, Green Published			2022-12-27	WOS:000422911300042
J	Costa, LA; Foni, NO; Antonioli, E; de Carvalho, RT; Paiao, ID; Lenza, M; Ferretti, M				Costa, Lauro Augusto; Foni, Noel Oizerovici; Antonioli, Eliane; de Carvalho, Rogerio Teixeira; Paiao, Isabela Dias; Lenza, Mario; Ferretti, Mario			Analysis of 500 anterior cruciate ligament reconstructions from a private institutional register	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; ACL RECONSTRUCTION; MENISCAL TEARS; SURGICAL TECHNIQUE; UNITED-STATES; PARTIAL MENISCECTOMY; SEX-DIFFERENCES; TRENDS; KNEE; OUTCOMES	Purpose The aims of this study are to describe the epidemiological characteristics of anterior cruciate ligament reconstructions in a private hospital in Brazil and to determine trends in medical practice for comparison with previous studies. Methods We retrospectively reviewed the anterior cruciate ligament institutional register to obtain data from all patients who underwent primary anterior cruciate ligament reconstruction from July 2014 to June 2016. Descriptive statistics were used to summarize the sample. Specific statistical tests were used to assess associations between the meniscal lesion and other variables. Results During the study period, 72.6% out of 500 patients were male. The mean age at surgery was 35.1 years. The mean age was higher among females than among males (37.3 +/- 12.1 vs 34.3 +/- 10.8 years). The median time from injury to surgery was 44 days. The most common femoral and tibial fixations used were suspensory fixation (60.8%) and interference screw (96%), respectively. The most commonly used graft was hamstring tendon (70.2%), followed by bone-patellar tendon-bone (28.8%). A meniscal lesion was noted in 44.8% of cases. Partial meniscectomy was performed in 69.5% of meniscal lesions, and meniscal repair was performed in 14.1% of lesions. The mean length of hospital stay was 1.4 days. The proportion of men in the group of patients with an associated meniscal lesion was higher than that in the group of patients without a meniscal lesion (p = 0.007). Conclusions In this study, we identified that the vast majority of surgeries were performed in male patients in all age groups, and patients older than 30 years and with a short time from injury to surgery predominated. Concerning surgical technique, we noted a low rate of meniscal repair and a higher preference for the use of hamstring graft and suspensory fixation on the femoral side.	[Costa, Lauro Augusto; Foni, Noel Oizerovici; Antonioli, Eliane; de Carvalho, Rogerio Teixeira; Paiao, Isabela Dias; Lenza, Mario; Ferretti, Mario] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil	Hospital Israelita Albert Einstein	Ferretti, M (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil.	mario.ferretti@einstein.br	Antonioli, Eliane/C-9152-2012; Costa, Lauro/AAA-3297-2022; Ferretti, Mario/U-8212-2018; Lenza, Mario/K-3174-2013; de CARVALHO, ROGERIO Teixeira/E-2662-2015	Antonioli, Eliane/0000-0002-8563-877X; Costa, Lauro/0000-0002-7624-6678; de CARVALHO, ROGERIO Teixeira/0000-0001-8387-7104; Lenza, Mario/0000-0003-3497-2206				Abrams GD, 2013, AM J SPORT MED, V41, P2333, DOI 10.1177/0363546513495641; Ageberg E, 2010, AM J SPORT MED, V38, P1334, DOI 10.1177/0363546510361218; Ahlden M, 2012, AM J SPORT MED, V40, P2230, DOI 10.1177/0363546512457348; Lopes TJA, 2016, REV BRAS MED ESPORTE, V22, P297, DOI 10.1590/1517-869220162204159074; Andersson D, 2009, ARTHROSCOPY, V25, P653, DOI 10.1016/j.arthro.2009.04.066; Astur DC, 2013, SAO PAULO MED J, V131, P257, DOI 10.1590/1516-3180.2013.1314498; Brambilla L, 2015, AM J SPORT MED, V43, P2966, DOI 10.1177/0363546515608483; Budny J, 2016, J KNEE SURG, V1, P1; Buller LT, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967114563664; Martimbianco ALC, 2014, PHYS THER SPORT, V15, P261, DOI 10.1016/j.ptsp.2014.02.008; Coskunsu D, 2010, ACTA ORTHOP TRAUMATO, V44, P458, DOI 10.3944/AOTT.2010.2388; Csintalan Rick P, 2008, Perm J, V12, P17; DeAngelis JP, 2007, CLIN SPORT MED, V26, P587, DOI 10.1016/j.csm.2007.06.005; Desai N, 2014, KNEE SURG SPORT TR A, V22, P379, DOI 10.1007/s00167-013-2803-6; Dhawan A, 2003, AM J SPORT MED, V31, P419, DOI 10.1177/03635465030310031601; Kim Ha Sung, 2013, Knee Surg Relat Res, V25, P165, DOI 10.5792/ksrr.2013.25.4.165; Fetzer Gary B, 2009, J Knee Surg, V22, P180; Ghodadra N, 2013, J KNEE SURG, V26, P185, DOI 10.1055/s-0032-1327450; Gianotti SM, 2009, J SCI MED SPORT, V12, P622, DOI 10.1016/j.jsams.2008.07.005; Granan LP, 2008, AM J SPORT MED, V36, P308, DOI 10.1177/0363546507308939; Granan LP, 2012, ACTA ORTHOP, V83, P577, DOI 10.3109/17453674.2012.741451; Granan LP, 2009, ACTA ORTHOP, V80, P563, DOI 10.3109/17453670903350107; Hagino T, 2015, ARCH ORTHOP TRAUM SU, V135, P1701, DOI 10.1007/s00402-015-2309-4; Janssen KW, 2012, SCAND J MED SCI SPOR, V22, P495, DOI 10.1111/j.1600-0838.2010.01253.x; Kluczynski MA, 2013, AM J SPORT MED, V41, P2759, DOI 10.1177/0363546513503448; Kvist J, 2014, ARTHROSCOPY, V30, P803, DOI 10.1016/j.arthro.2014.02.036; Leathers MP, 2015, J KNEE SURG, V28, P390, DOI 10.1055/s-0035-1544193; Lind M, 2009, KNEE SURG SPORT TR A, V17, P117, DOI 10.1007/s00167-008-0654-3; Lunebourg A, 2016, ARCH ORTHOP TRAUM SU, V136, P1709, DOI 10.1007/s00402-016-2552-3; Lyman S, 2009, J BONE JOINT SURG AM, V91A, P2321, DOI 10.2106/JBJS.H.00539; Magnussen RA, 2010, KNEE SURG SPORT TR A, V18, P98, DOI 10.1007/s00167-009-0919-5; Maletis GB, 2013, BONE JOINT J, V95B, P623, DOI 10.1302/0301-620X.95B5.30872; Maletis GB, 2015, AM J SPORT MED, V43, P641, DOI 10.1177/0363546514561745; Maletis GB, 2013, AM J SPORT MED, V41, P2090, DOI 10.1177/0363546513493589; Mall NA, 2014, AM J SPORT MED, V42, P2363, DOI 10.1177/0363546514542796; McCormack RG, 2006, ARTHROSCOPY, V22, P889, DOI 10.1016/j.arthro.2006.05.004; Mei Y, 2013, CHINESE MED J-PEKING, V126, P4487; Middleton KK, 2014, KNEE SURG SPORT TR A, V22, P1467, DOI 10.1007/s00167-014-2846-3; Mulford JS, 2013, KNEE SURG SPORT TR A, V21, P1882, DOI 10.1007/s00167-012-2212-2; Nordenvall R, 2017, AM J SPORT MED, V45, P535, DOI 10.1177/0363546516672651; Nordenvall R, 2012, AM J SPORT MED, V40, P1808, DOI 10.1177/0363546512449306; Noyes FR, 2012, ARTHROSCOPY, V28, P123, DOI 10.1016/j.arthro.2011.08.292; Oiestad BE, 2009, AM J SPORT MED, V37, P1434, DOI 10.1177/0363546509338827; Parker BR, 2016, AM J SPORT MED, V44, P1717, DOI 10.1177/0363546516638082; Paxton ES, 2011, ARTHROSCOPY, V27, P1275, DOI 10.1016/j.arthro.2011.03.088; Samuelsson K, 2009, ARTHROSCOPY, V25, P1139, DOI 10.1016/j.arthro.2009.07.021; Sanders TL, 2016, AM J SPORT MED, V44, P1502, DOI 10.1177/0363546516629944; Scillia AJ, 2015, ORTHOPEDICS, P1; Seng K, 2008, ARTHROSCOPY, V24, P914, DOI 10.1016/j.arthro.2008.01.021; Smith JP, 2001, AM J SPORT MED, V29, P415, DOI 10.1177/03635465010290040501; Stein T, 2010, AM J SPORT MED, V38, P1542, DOI 10.1177/0363546510364052; Straw R, 2003, KNEE, V10, P283, DOI 10.1016/S0968-0160(02)00150-3; Tibor L, 2016, J BONE JOINT SURG AM, V98, P1079, DOI 10.2106/JBJS.15.00881; Vascellari A, 2017, KNEE SURG SPORT TR A, V25, P2520, DOI 10.1007/s00167-016-4007-3; Wright RW, 2015, SPORTS HEALTH, V7, P239, DOI 10.1177/1941738113517855; Xie XB, 2015, KNEE, V22, P100, DOI 10.1016/j.knee.2014.11.014; Yoon Kyoung Ho, 2014, Knee Surg Relat Res, V26, P68, DOI 10.5792/ksrr.2014.26.2.68	57	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191414	10.1371/journal.pone.0191414	http://dx.doi.org/10.1371/journal.pone.0191414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351558	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300087
J	Geltsch, N; Elek, Z; Manczinger, L; Vagvolgyi, C; Moskat, C				Geltsch, Nikoletta; Elek, Zoltan; Manczinger, Laszlo; Vagvolgyi, Csaba; Moskat, Csaba			Common cuckoos (Cuculus canorus) affect the bacterial diversity of the eggshells of their great reed warbler (Acrocephalus arundinaceus) hosts	PLOS ONE			English	Article							MICROBIAL DIVERSITY; BROOD PARASITISM; EGGS; INCUBATION; BEHAVIOR; COMMUNITIES; REJECTION; SUCCESS; SURFACE; GROWTH	The common cuckoo (Cuculus canorus) is an avian brood parasite, laying its eggs in the nests of other bird species, where these hosts incubate the parasitic eggs, feed and rear the nestlings. The appearance of a cuckoo egg in a host nest may change the bacterial community in the nest. This may have consequences on the hatchability of host eggs, even when hosts reject the parasitic egg, typically within six days after parasitism. The present study revealed the bacterial community of cuckoo eggshells and those of the great reed warbler (Acrocephalus arundinaceus), one of the main hosts of cuckoos. We compared host eggs from non-parasitized clutches, as well as host and cuckoo eggs from parasitized clutches. As incubation may change bacterial assemblages on eggshells, we compared these egg types in two stages: the egg-laying stage, when incubation has not been started, and the mid-incubation stage (ca. on days 5 +/- 7 in incubation), where heat from the incubating female dries eggshells. Our results obtained by the 16S rRNA gene sequencing technique showed that fresh host and cuckoo eggs had partially different bacterial communities, but they became more similar during incubation in parasitized nests. Cluster analysis revealed that fresh cuckoo eggs and incubated host eggs in unparasitized nests (where no cuckoo effect could have happened) were the most dissimilar from the other groups of eggs. Cuckoo eggs did not reduce the hatchability of great reed warbler eggs. Our results on the cuckoo-great reed warbler relationship supported the idea that brood parasites may change bacterial microbiota in the host nest. Further studies should reveal how bacterial communities of cuckoo eggshells may vary by host-specific races (gentes) of cuckoos.	[Geltsch, Nikoletta; Elek, Zoltan; Moskat, Csaba] MTA ELTE MTM Ecol Res Grp, Budapest, Hungary; [Geltsch, Nikoletta] Univ Szeged, Fac Sci & Informat, Dept Ecol, Szeged, Hungary; [Manczinger, Laszlo; Vagvolgyi, Csaba] Univ Szeged, Fac Sci & Informat, Dept Microbiol, Szeged, Hungary	Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Szeged University; Szeged University	Moskat, C (corresponding author), MTA ELTE MTM Ecol Res Grp, Budapest, Hungary.	moskat@nhmus.hu	Vagvolgyi, Csaba/L-8497-2018; Elek, Zoltan/A-5899-2011	Vagvolgyi, Csaba/0000-0003-0009-7773; Elek, Zoltan/0000-0001-6026-6300	National Research, Development and Innovation Office, Hungary [NN118194]; Hungarian National Science Fund (OTKA) [83217, GINOP-2.3.3.-15-2016-00006]	National Research, Development and Innovation Office, Hungary(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian National Science Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The study was supported by the National Research, Development and Innovation Office, Hungary to C.M. (grant No. NN118194). Additional funding was provided by the Hungarian National Science Fund (OTKA, No. 83217 to C.M.) and GINOP-2.3.3.-15-2016-00006 (to C. V. and L.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson MG, 2009, PLOS ONE, V4, pA67, DOI 10.1371/journal.pone.0007725; Archie EA, 2011, ANIM BEHAV, V82, P425, DOI 10.1016/j.anbehav.2011.05.029; Baggott GK, 2002, OX ORN SER, V13, P179; Benskin CMH, 2015, ECOL EVOL, V5, P821, DOI 10.1002/ece3.1384; Board R. G., 1994, P43; Brandl HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114861; COLLINS MD, 1983, J GEN MICROBIOL, V129, P3427; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Cramp S, 1985, HDB EUROPE MIDDLE E; D'Alba L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0687; D'Alba L, 2010, NATURWISSENSCHAFTEN, V97, P1089, DOI 10.1007/s00114-010-0735-2; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Geltsch N, 2016, BIRD STUDY, V63, P46, DOI 10.1080/00063657.2015.1125851; Goodenough AE, 2012, MICROB ECOL, V63, P986, DOI 10.1007/s00248-011-9992-7; Goodenough AE, 2010, MICROB ECOL, V59, P221, DOI 10.1007/s00248-009-9591-z; Greenacre M., 2013, MULTIVARIATE ANAL EC; Grizard S, 2014, ECOL EVOL, V4, P1140, DOI 10.1002/ece3.1011; Hargitai R, 2010, J AVIAN BIOL, V41, P177, DOI 10.1111/j.1600-048X.2009.04818.x; Honza M, 2001, J AVIAN BIOL, V32, P249, DOI 10.1111/j.0908-8857.2001.320307.x; Honza M, 2007, J AVIAN BIOL, V38, P385, DOI 10.1111/j.2007.0908-8857.03901.x; Hugenholtz P, 2002, GENOME BIOL, V3; Igic B, 2017, J ZOOL, V301, P165, DOI 10.1111/jzo.12408; LEE W, 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0090581; Li DL, 2016, EVOL ECOL, V30, P905, DOI 10.1007/s10682-016-9850-7; Martinez-Garcia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158158; Aviles JM, 2009, ANIM BEHAV, V78, P993, DOI 10.1016/j.anbehav.2009.07.020; Moskat C, 2002, IBIS, V144, P614, DOI 10.1046/j.1474-919X.2002.00085.x; Moskat C, 2009, ANIM BEHAV, V77, P1281, DOI 10.1016/j.anbehav.2009.01.030; Moskat C, 2008, J AVIAN BIOL, V39, P663, DOI 10.1111/j.1600-048X.2008.04359.x; Potter BA, 2017, OPEN ORNITHOL J, V2017, P10; Potter Beth A., 2017, Open Ornithology Journal, V10, P23; Potter Beth A., 2014, Open Ornithology Journal, V7, P40, DOI 10.2174/1874453201407010040; Potter Beth A., 2013, Open Ornithology Journal, V6, P32; R Development Core Team RDC, 2013, R A LANGUAGE AND ENV; Ripley B. D., 1996, PATTERN RECOGNITION; Ruiz-De-Castaneda R, 2011, BEHAV PROCESS, V88, P142, DOI 10.1016/j.beproc.2011.08.012; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Shawkey MD, 2005, MICROB ECOL, V50, P40, DOI 10.1007/s00248-004-0089-4; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Singleton DR, 1998, J FIELD ORNITHOL, V69, P71; Soler JJ, 2011, BIOL J LINN SOC, V103, P836, DOI 10.1111/j.1095-8312.2011.01672.x; Soler M, 1997, ANIM BEHAV, V54, P1227, DOI 10.1006/anbe.1997.0524; Takasu F, 2009, BIOL J LINN SOC, V98, P291, DOI 10.1111/j.1095-8312.2009.01288.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torok J, 2004, ETHOL ECOL EVOL, V16, P271; Venables W.N., 2002, MODERN APPL STAT S, VFourth; Vishnivetskaya TA, 2009, EXTREMOPHILES, V13, P541, DOI 10.1007/s00792-009-0243-5; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zolei A, 2015, J AVIAN BIOL, V46, P570, DOI 10.1111/jav.00673	51	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191364	10.1371/journal.pone.0191364	http://dx.doi.org/10.1371/journal.pone.0191364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351548	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000422911300075
J	Gopinathan, U; Redalen, KR; Troseid, AM; Kierulf, P; Brandtzaeg, P; Ree, AH; Berg, JP; Ovstebo, R				Gopinathan, Unni; Redalen, Kathrine Roe; Troseid, Anne-Marie; Kierulf, Peter; Brandtzaeg, Petter; Ree, Anne Hansen; Berg, Jens Petter; Ovstebo, Reidun			Large-scale reduction of tyrosine kinase activities in human monocytes stimulated in vitro with N-meningitidis	PLOS ONE			English	Article							SYSTEMIC MENINGOCOCCAL DISEASE; INDUCED CYTOKINE PRODUCTION; GENE-EXPRESSION PROFILES; NEISSERIA-MENINGITIDIS; SIGNAL-TRANSDUCTION; ENDOTOXIN TOLERANCE; CELL RESPONSES; SEPTIC SHOCK; PHOSPHORYLATION; INTERLEUKIN-10	N. meningitidis induces extensive gene expression changes in human monocytes, suggesting that complex networks of signaling pathways are activated during meningococcal sepsis. These effects are modulated by the anti-inflammatory cytokine interleukin-10 (IL-10). To further study changes in signal transduction suggested by mRNA data, we used kinase substrate arrays to identify composite kinase activities induced by lysates from a primary human monocyte model system. Cell lysates were prepared from monocytes treated with the following experimental conditions: 10 6 N. meningitidis/mL, 25 ng/mL IL-10, 10 6 N. meningitidis/mL in combination with 25 ng/mL IL-10, and vehicle. Lysates were subjected to kinase activity profiling with Tyrosine Kinase PamChip (R) arrays containing 144 kinase peptide substrates. In our experimental model, we were not able to detect a statistically significant large-scale change in ex vivo array peptide phosphorylation by lysates from monocytes treated for 15 minutes. Targets of the IL-10 anti-inflammatory response were not identified. A profound inhibition of array peptide phosphorylation by monocytes treated for 60 minutes was identified, suggesting low activity of a large number of kinases associated with different signaling pathways and immune cell functions, including STAT3 activity, Nf-kappa B and VEGF signaling, and PTEN signaling activity. The peptide representing ZBTB16, which was reduced in phosphorylation by lysates from all three experimental conditions, was in Ingenuity Pathway Analysis identified to be linked to reduced cytokine release and mRNA levels of tumor necrosis factor (TNF), IL-6, and CXCL10. Further studies should investigate changes in tyrosine kinase-mediated signal transduction in human immune cells, in order to evaluate the potential clinical application of kinome profiling in the study of systemic inflammatory responses to pathogens.	[Gopinathan, Unni; Troseid, Anne-Marie; Kierulf, Peter; Brandtzaeg, Petter; Berg, Jens Petter; Ovstebo, Reidun] Oslo Univ Hosp, Sect Res, Dept Med Biochem, Blood Cell Res Grp, Oslo, Norway; [Gopinathan, Unni; Kierulf, Peter; Brandtzaeg, Petter; Ree, Anne Hansen; Berg, Jens Petter] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Redalen, Kathrine Roe; Ree, Anne Hansen] Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway; [Brandtzaeg, Petter] Oslo Univ Hosp, Dept Pediat, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Gopinathan, U (corresponding author), Oslo Univ Hosp, Sect Res, Dept Med Biochem, Blood Cell Res Grp, Oslo, Norway.; Gopinathan, U (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	unni.gnathan@gmail.com	Berg, Jens P/G-1455-2012; Redalen, Kathrine Roe/AAA-6623-2019; Redalen, Kathrine/F-3383-2017	Berg, Jens P/0000-0003-0157-5888; Ree, Anne H./0000-0002-8264-3223; Redalen, Kathrine/0000-0002-1172-4632	Wedel Jarlsbergs Fond; University of Oslo	Wedel Jarlsbergs Fond; University of Oslo	This work was supported by Wedel Jarlsbergs Fond. The University of Oslo's Open Access Publishing Fund covered the open access fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault R, 2011, PROTEOMICS, V11, P4595, DOI 10.1002/pmic.201100296; BEATY CD, 1994, EUR J IMMUNOL, V24, P1278, DOI 10.1002/eji.1830240606; Bjerre A, 2003, J ENDOTOXIN RES, V9, P155, DOI 10.1179/096805103125001559; Brandtzaeg P, 1996, J EXP MED, V184, P51, DOI 10.1084/jem.184.1.51; Brandtzaeg P, 2001, J ENDOTOXIN RES, V7, P401, DOI 10.1177/09680519010070060401; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; Buckler JL, 2008, IMMUNOL REV, V224, P239, DOI 10.1111/j.1600-065X.2008.00650.x; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; de Greeff SC, 2008, EUR J CLIN MICROBIOL, V27, P985, DOI 10.1007/s10096-008-0535-1; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; DONG ZY, 1993, J EXP MED, V177, P1071, DOI 10.1084/jem.177.4.1071; Duverger A, 2014, J VIROL, V88, P364, DOI 10.1128/JVI.02682-13; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; GASPERINI S, 1995, BIOCHEM BIOPH RES CO, V209, P87, DOI 10.1006/bbrc.1995.1474; GENG Y, 1994, P NATL ACAD SCI USA, V91, P8602, DOI 10.1073/pnas.91.18.8602; Gopinathan U, 2015, INNATE IMMUN-LONDON, V21, P429, DOI 10.1177/1753425914547743; Gopinathan U, 2012, INFECT IMMUN, V80, P4046, DOI 10.1128/IAI.00386-12; Hackett SJ, 2002, ARCH DIS CHILD, V86, P44, DOI 10.1136/adc.86.1.44; Hazeki K, 2003, EUR J IMMUNOL, V33, P740, DOI 10.1002/eji.200323375; Henriksson CE, 2006, THROMB HAEMOSTASIS, V96, P29, DOI 10.1160/TH06-01-0052; Hoogendijk AJ, 2011, MOL MED, V17, P741, DOI 10.2119/molmed.2011.00011; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; IPATM of QIAGEN's Ingenuity Pathway Analysis, 2016, CALCULATING INTERPRE; Keel M, 1997, BLOOD, V90, P3356, DOI 10.1182/blood.V90.9.3356; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; LEHMANN AK, 1995, INFECT IMMUN, V63, P2109, DOI 10.1128/IAI.63.6.2109-2112.1995; Lund PK, 2000, SCAND J CLIN LAB INV, V60, P357, DOI 10.1080/003655100750019260; Lund PK, 2001, J IMMUNOL METHODS, V252, P45, DOI 10.1016/S0022-1759(01)00330-1; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maslove DM, 2014, TRENDS MOL MED, V20, P204, DOI 10.1016/j.molmed.2014.01.006; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Okamura H, 2007, CELL BIOL INT, V31, P119, DOI 10.1016/j.cellbi.2006.09.014; Ovstebo R, 2004, J CLIN MICROBIOL, V42, P2980, DOI 10.1128/JCM.42.7.2980-2987.2004; Ovstebo R, 2008, INFECT IMMUN, V76, P2685, DOI 10.1128/IAI.01625-07; Ovstebo R, 2012, INNATE IMMUN-LONDON, V18, P580, DOI 10.1177/1753425911428230; Parikh K, 2010, CANCER RES, V70, P2575, DOI 10.1158/0008-5472.CAN-09-3989; Piersma SR, 2010, ANAL BIOANAL CHEM, V397, P3163, DOI 10.1007/s00216-010-3784-7; Prabhakar U, 2005, DNA CELL BIOL, V24, P410, DOI 10.1089/dna.2005.24.410; Ree AH, 2015, CRIT REV ONCOL HEMAT, V95, P114, DOI 10.1016/j.critrevonc.2015.01.003; Roe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063723; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Sadler AJ, 2015, P NATL ACAD SCI USA, V112, P1535, DOI 10.1073/pnas.1409728112; Shrestha S, 2015, NAT IMMUNOL, V16, P178, DOI 10.1038/ni.3076; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Tang BM, 2010, CRIT CARE, V14, DOI 10.1186/cc9392; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Wong HR, 2013, PEDIATR RES, V73, P564, DOI 10.1038/pr.2013.11; Xagorari A, 2002, BRIT J PHARMACOL, V136, P1058, DOI 10.1038/sj.bjp.0704803; Xiong Y, 2015, J INNATE IMMUN; Xu DK, 2009, IMMUNITY, V30, P802, DOI 10.1016/j.immuni.2009.04.013	53	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0181912	10.1371/journal.pone.0181912	http://dx.doi.org/10.1371/journal.pone.0181912			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29357362	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300002
J	Holm, S; Hilty, LM; Lemm, R; Thees, O				Holm, Stefan; Hilty, Lorenz M.; Lemm, Renato; Thees, Oliver			Empirical validation of an agent-based model of wood markets in Switzerland	PLOS ONE			English	Article							EXPLANATION; PREDICTION; PROTOCOL	We present an agent-based model of wood markets and show our efforts to validate this model using empirical data from different sources, including interviews, workshops, experiments, and official statistics. Own surveys closed gaps where data was not available. Our approach to model validation used a variety of techniques, including the replication of historical production amounts, prices, and survey results, as well as a historical case study of a large sawmill entering the market and becoming insolvent only a few years later. Validating the model using this case provided additional insights, showing how the model can be used to simulate scenarios of resource availability and resource allocation. We conclude that the outcome of the rigorous validation qualifies the model to simulate scenarios concerning resource availability and allocation in our study region.	[Holm, Stefan; Lemm, Renato; Thees, Oliver] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Holm, Stefan; Hilty, Lorenz M.] Univ Zurich, Dept Informat, Zurich, Switzerland; [Hilty, Lorenz M.] Swiss Fed Labs Mat Sci & Technol EMPA, St Gallen, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Holm, S (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland.	stefan.holm@wsl.ch		Hilty, Lorenz/0000-0001-5020-0586; Holm, Stefan/0000-0001-8104-896X	Swiss National Science Foundation through its National Research Program "Resource Wood" [NRP 66]	Swiss National Science Foundation through its National Research Program "Resource Wood"	This work is part of the project "An economic analysis of Swiss wood markets," which is funded by the Swiss National Science Foundation through its National Research Program "Resource Wood" (NRP 66, http://www.nfp66.ch/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, AR GROSSS ZEITR; [Anonymous], [No title captured]; AXELROD R, 1980, J CONFLICT RESOLUT, V24, P3, DOI 10.1177/002200278002400101; BFS (Swiss Federal Statistical Office), 2015, FORSTFL NACH EIG KAN; BFS (Swiss Federal Statistical Office), 2015, RUNDH SCHN RESTH SAG; Bianchi Carlo, 2007, Computational Economics, V30, P245, DOI 10.1007/s10614-007-9097-z; Boero R, 2005, JASSS-J ARTIF SOC S, V8; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Chrissafis T, 2015, PUB ADMIN INF TECH, V10, P57, DOI 10.1007/978-3-319-12784-2_4; Epstein JM, 2008, JASSS-J ARTIF SOC S, V11; Evers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026189; Fagiolo G., 2006, LEM WORKING PAPER SE; Fehler M., 2010, THESIS; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; GRUNBAUM A, 1962, PHILOS SCI, V29, P146, DOI 10.1086/287858; Heath B, 2009, JASSS-J ARTIF SOC S, V12, pA143; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Holm S, 2016, JASSS-J ARTIF SOC S, V19, DOI 10.18564/jasss.3121; Janssen MA, 2006, ECOL SOC, V11; Kelly RA, 2013, ENVIRON MODELL SOFTW, V47, P159, DOI 10.1016/j.envsoft.2013.05.005; Klugl F, 2008, APPLIED COMPUTING 2008, VOLS 1-3, P39; Kostadinov F, 2014, FOREST POLICY ECON, V38, P105, DOI 10.1016/j.forpol.2013.08.001; Laurie AJ, 2003, URBAN STUD, V40, P2687, DOI 10.1080/0042098032000146849; Macal CM, 2016, J SIMUL, V10, P144, DOI 10.1057/jos.2016.7; Macal C, 2014, WINT SIMUL C PROC, P6, DOI 10.1109/WSC.2014.7019874; Moss S., 2005, LECTURE NOTES IN COM, V3415; Moss S., 2000, MICROBIAL APPROACHES, P1; Muller B, 2013, ENVIRON MODELL SOFTW, V48, P37, DOI 10.1016/j.envsoft.2013.06.003; Muller B, 2014, ENVIRON MODELL SOFTW, V55, P156, DOI 10.1016/j.envsoft.2014.01.029; Page B., 1991, DISKRETE SIMULATION; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Railsback S.F., 2011, AGENT BASED INDIVIDU; Sargent RG, 2005, PROCEEDINGS OF THE 2005 WINTER SIMULATION CONFERENCE, VOLS 1-4, P130, DOI 10.1109/WSC.2005.1574246; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; SCRIVEN M, 1959, SCIENCE, V130, P477, DOI 10.1126/science.130.3374.477; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Silver Nate, 2012, SIGNAL NOISE WHY SO; Troitzsch KG, 2004, ESM'2004: 18TH EUROPEAN SIMULATION MULTICONFERENCE, P265; van Vliet J, 2016, ENVIRON MODELL SOFTW, V82, P174, DOI 10.1016/j.envsoft.2016.04.017; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; Windrum P, 2007, JASSS-J ARTIF SOC S, V10; [WSL BUWAL], 2001, LOTH ORK 1999 ER; Zeigler B., 2000, THEORY MODELING SIMU	45	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190605	10.1371/journal.pone.0190605	http://dx.doi.org/10.1371/journal.pone.0190605			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351300	gold, Green Published, Green Accepted			2022-12-27	WOS:000422911300021
J	Liu, JM; Liu, J; Wang, GA; Liu, GY; Zhou, HJ; Fan, Y; Liang, FX; Wang, H				Liu, Jianmin; Liu, Jing; Wang, Guang'an; Liu, Guangya; Zhou, Huanjiao; Fan, Yun; Liang, Fengxia; Wang, Hua			Electroacupuncture at Guanyuan (CV 4), Zusanli (ST 36) and Baihui (DU 20) regulate the aging-related changes in gene expression profile of the hippocampus in sub-acutely aging rats	PLOS ONE			English	Article							BRAIN; DISEASE; MODEL	To investigate the molecular mechanisms of sub-acutely aging and demonstrate the effect of electroacupuncture (EA) at the Guanyuan (CV 4), Zusanli (ST 36) and Baihui (DU 20) acupoint on the sub-acutely aging brain, cDNA microarrays and bioinformatics analyses were carried out. Thirty Sprague-Dawley (SD) male rats were selected and randomly divided into three groups: the control group (C), the sub-acutely aging model group (M) and the electroacupuncture group (M+EA). Sub-acutely aging model rats were obtained by D-galactose s.c. injection continuously for 40 days. Total RNA was extracted from the hippocampus area of brains in three groups for cDNA microarrays. The data of different groups were compared and analyzed by differential expression analysis, Gene ontology (GO) term enrichment, Kyoto Encyclopedia of Genes Genomes (KEGG) pathway enrichment and quantitative real-time PCR. According to the results, 4052 DE genes were identified in our study. Among them, there were 3079 differentially expressed (DE) genes between group M and group C, and these genes are associated with the aging of rats. Moreover, 983 genes were expressed differently in group M+EA compared with group M, revealing that points stimuli could regulate gene expression in brain with aging. Gene ontology (GO) term enrichment and KEGG enrichment were performed to further classify the differential expression genes. Important GO terms and KEGG pathways connected with sub-acutely aging EA effects were identified. At last, 3 significant differentially expressed genes were selected for real-time quantitative PCR to clarify the cDNA microarray results. In conclusion, the cDNA microarray data first compared and analyzed the differences of gene expression profile in the hippocampus of rats in different groups, which contribute to our knowledge on the molecular mechanisms of EA towards sub-acutely aging.	[Liu, Jianmin; Liu, Jing; Liu, Guangya; Zhou, Huanjiao; Fan, Yun; Liang, Fengxia; Wang, Hua] Hubei Univ Chinese Med, Acupuncture Moxibust & Orthoped Coll, Wuhan, Hubei, Peoples R China; [Liu, Jianmin; Liu, Jing; Liu, Guangya; Liang, Fengxia; Wang, Hua] Hubei Prov Collaborat Innovat Ctr Prevent Treatme, Wuhan, Hubei, Peoples R China; [Wang, Guang'an] Henan Univ Chinese Med, Clin Med Coll 3, Zhengzhou, Henan, Peoples R China	Hubei University of Chinese Medicine; Henan University of Traditional Chinese Medicine	Wang, H (corresponding author), Hubei Univ Chinese Med, Acupuncture Moxibust & Orthoped Coll, Wuhan, Hubei, Peoples R China.; Wang, H (corresponding author), Hubei Prov Collaborat Innovat Ctr Prevent Treatme, Wuhan, Hubei, Peoples R China.	huang.edu@hotmail.com	Liang, Feng/GZK-4305-2022; Liang, Fenghua/HHM-3798-2022		scientific research guidance projects of Hubei province [B2016111]	scientific research guidance projects of Hubei province	This work was supported by 2016 scientific research guidance projects of Hubei province (No. B2016111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by 2016 scientific research guidance projects of Hubei province (NO. B2016111).	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Arnold CR, 2014, EXP GERONTOL, V54, P75, DOI 10.1016/j.exger.2014.01.018; Brasnjevic I, 2006, ALZHEIMERS DEMENTI S, V2, pS619; Cheng HY, 2008, NEUROSCI LETT, V432, P111, DOI 10.1016/j.neulet.2007.12.009; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Ding XR, 2006, NEUROSCI LETT, V399, P11, DOI 10.1016/j.neulet.2006.01.067; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Hai F, 2005, BEHAV BRAIN RES, V157, P245; Homeier D, 2014, CLIN GERIATR MED, V30, P671, DOI 10.1016/j.cger.2014.08.001; Jiang QQ, 2000, MODERN REHABILITATIO, V4, P1690; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Liang F, 2015, EVID-BASED COMPL ALT, V2015, P530; Liu Jian-Min, 2009, Zhen Ci Yan Jiu, V34, P242; [刘静 Liu Jing], 2014, [电子显微学报, Journal of Chinese Electronic Microscopy Society], V33, P69; Liu JM, 2014, SHANGHAI J ACUPUNCTU, V33, P66; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mcdonald J L, 2015, EVIDENCE BASED COMPL, V2015; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Pawelec G, 2008, EXP GERONTOL, V43, P34, DOI 10.1016/j.exger.2007.09.609; Roberts SB, 2001, J GERONTOL A-BIOL, V56, P66, DOI 10.1093/gerona/56.suppl_1.66; Sarkar S, 2006, MECH AGEING DEV, V127, P391, DOI 10.1016/j.mad.2005.12.010; Sidler Corinne, 2013, Frontiers in Genetics, V4, P211, DOI 10.3389/fgene.2013.00211; Stahl EC, 2015, ORGANOGENESIS, V11, P159, DOI 10.1080/15476278.2015.1120046; Tang HT, 2010, SHANGHAI J ACU MOX, V29, P573; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Wang Hua, 2012, Zhen Ci Yan Jiu, V37, P266; Wang Jia-you, 2011, Zhen Ci Yan Jiu, V36, P36; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; World Health Organization, 2002, AC REV AN REP CONTR; [吴焕林 WU Huanlin], 2008, [中医杂志, Journal of Traditional Chinese Medicine], V49, P622; Xiao Ling, 2012, Zhongguo Zhen Jiu, V32, P435; Yang Hua-Yuan, 2008, Zhen Ci Yan Jiu, V33, P186; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yu JC, 2005, PHYSIOL BEHAV, V86, P434, DOI 10.1016/j.physbeh.2005.07.015; Zhang XH, 2005, CHINESE J GERONTOLOG, V8, P933; Zhu MF, 2015, EVIDENCE BASED COMPL, V2015; Zhu Ya-zhen, 2007, Fudan Xuebao (Yixueban), V34, P617	39	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191623	10.1371/journal.pone.0191623	http://dx.doi.org/10.1371/journal.pone.0191623			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352289	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300121
J	Kumar, S; Choudhary, AK; Rana, KS; Sarker, A; Singh, M				Kumar, Sandeep; Choudhary, Anil Kumar; Rana, Kuldeep Singh; Sarker, Ashutosh; Singh, Mohar			Bio-fortification potential of global wild annual lentil core collection	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; BIOFORTIFICATION	Lentil, generally known as poor man's' meat due to its high protein value is also a good source of dietary fiber, antioxidants and vitamins along with fast cooking characteristics. It could be used globally as a staple food crop to eradicate hidden hunger, if this nutritionally rich crop is further enriched with essential minerals. This requires identification of essential mineral rich germplasm. So, in the present study, a core set of 96 wild accessions extracted from 405 global wild annual collections comprising different species was analyzed to determine its bio-fortification potential. Impressive variation (mg/100 g) was observed for different minerals including Na (30-318), K (138.29-1578), P (37.50-593.75), Ca (4.74-188.75), Mg (15-159), Fe (2.82-14.12), Zn (1.29-12.62), Cu (0.5-7.12), Mn (1.22-9.99), Mo (1.02-11.89), Ni (0.16-3.49), Pb (0.01-0.58), Cd (0-0.03), Co (0-0.63) and As (0-0.02). Hierarchical clustering revealed high intra-and inter-specific variability. Further, correlation study showed positive significant association among minerals and between minerals including agro-morphological traits. Accessions representation from Turkey and Syria had maximum variability for different minerals. Diversity analysis exhibited wide geographical variations across gene-pool in core set. Potential use of the identified trait-specific genetic resources could be initial genetic material, for genetic base broadening and biofortification of cultivated lentil.	[Kumar, Sandeep] ICAR Natl Bur Plant Genet Resources, New Delhi, India; [Choudhary, Anil Kumar; Rana, Kuldeep Singh] ICAR Indian Agr Res Inst, Dept Agron, New Delhi, India; [Sarker, Ashutosh] Int Ctr Agr Res Dry Areas, SACRP, DPS Marg Pusa Campus, New Delhi, India; [Singh, Mohar] ICAR Natl Bur Plant Genet Resources, Reg Stn, Shimla, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Singh, M (corresponding author), ICAR Natl Bur Plant Genet Resources, Reg Stn, Shimla, India.	singhmohar_2003@yahoo.com		singh, mohar/0000-0002-5644-9144	Department of Agriculture Cooperation and Farmers' right; Indian Council of Agricultural Research; International Centre for Agricultural Research in Dry Area, India office New Delhi	Department of Agriculture Cooperation and Farmers' right(Department of Agriculture Cooperation & Farmers Welfare (DACFW), India); Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR)); International Centre for Agricultural Research in Dry Area, India office New Delhi	The authors acknowledge the help and support provided by Department of Agriculture Cooperation and Farmers' right, Indian Council of Agricultural Research and International Centre for Agricultural Research in Dry Area, India office New Delhi. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright SC, 2010, DATA ANAL DECISION M, P1061; Alghamdi SS, 2014, INT J MOL SCI, V15, P277, DOI 10.3390/ijms15010277; [Anonymous], 2009, ICRISAT ARCH REP; Burton G.W., 1952, P 6 INT GRASSLAND C, V1, P227; Cabrera C, 2003, SCI TOTAL ENVIRON, V308, P1, DOI 10.1016/S0048-9697(02)00611-3; Cundeva K, 2007, J BRAZIL CHEM SOC, V18, P1207, DOI 10.1590/S0103-50532007000600015; Distelfeld A, 2007, PHYSIOL PLANTARUM, V129, P635, DOI 10.1111/j.1399-3054.2006.00841.x; Dutta M., 2015, ADV WHEAT GENETICS G, P33, DOI 10.1007/978-4-431-55675-6_4; Erskine W, 1997, EUPHYTICA, V93, P107, DOI 10.1023/A:1002939704321; FAO, 2014, FAO STAT DAT; Fennema OR, 2000, FOOD CHEM; Gupta DS, 2017, FRONT PLANT SCI, V8, P1; International Zinc Consultative Group, 2004, FOOD NUTR BULL, V25, pS99, DOI DOI 10.1177/15648265040251S205; Jitendra Kumar, 2016, Biofortification of food crops, P147; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Karakoy Tolga, 2012, ScientificWorldJournal, V2012, P710412, DOI 10.1100/2012/710412; Laghetti G., 2008, EUR J PLANT SCI BIOT, V2, P48; Leshe S., 2014, AFRICAN J CHEM ED, V4, P16; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Pogatschnik C, 2014, PRACT GASTROENTEROL, V38, P27; Singh A, 2017, J PLANT BIOCHEM BIOT, V26, P199, DOI 10.1007/s13562-016-0382-6; Singh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107781; Stehle P, 2016, EUR J CLIN NUTR, V70, P886, DOI 10.1038/ejcn.2016.53; Toklu F, 2009, PLANT BREEDING, V128, P178, DOI 10.1111/j.1439-0523.2008.01548.x; Upadhyaya HD, 2011, FIELD CROP RES, V124, P459, DOI 10.1016/j.fcr.2011.08.004; Vadivel V, 2001, FOOD CHEM, V74, P507, DOI 10.1016/S0308-8146(01)00175-3; Vieira EA, 2007, GENET MOL BIOL, V30, P392, DOI 10.1590/S1415-47572007000300016; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Yang XE, 2007, ENVIRON GEOCHEM HLTH, V29, P413, DOI 10.1007/s10653-007-9086-0; Yucel C, 2009, TURK J AGRIC FOR, V33, P525, DOI 10.3906/tar-0901-8; ZARCINAS BA, 1987, COMMUN SOIL SCI PLAN, V18, P131, DOI 10.1080/00103628709367806; Zia-Ul-Haq M, 2011, PAK J BOT, V43, P1563	32	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191122	10.1371/journal.pone.0191122	http://dx.doi.org/10.1371/journal.pone.0191122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346404	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500029
J	Teshima, T; Matsumoto, H; Koyama, H				Teshima, Takahiro; Matsumoto, Hirotaka; Koyama, Hidekazu			Soluble factors from adipose tissue-derived mesenchymal stem cells promote canine hepatocellular carcinoma cell proliferation and invasion	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; IN-VITRO; REGENERATIVE MEDICINE; SIGNALING PATHWAYS; HUMAN CANCER; BONE-MARROW; GROWTH; EXPRESSION; SECRETOME; FIBROSIS	The potential effects of adipose tissue-derived mesenchymal stem cells (AT-MSCs) on the growth and invasion of canine tumours including hepatocellular carcinoma (HCC) are not yet understood. Moreover in humans, the functional contribution of AT-MSCs to malignancies remains controversial. The purpose of this study was to investigate the effects of AT-MSCs on the proliferation and invasion of canine HCC cells in vitro. The effect of AT-MSCs on mRNA levels of factors related to HCC progression were also evaluated. Conditioned medium from AT-MSCs (AT-MSC-CM) significantly enhanced canine HCC cell proliferation and invasion. Moreover, mRNA expression levels of transforming growth factor-beta 1, epidermal growth factor A, hepatocyte growth factor, platelet-derived growth factor-beta, vascular endothelial growth factor, and insulin-like growth factor 2 were 2.3 +/- 0.4, 2.0 +/- 0.5, 5.7 +/- 1.9, 1.7 +/- 0.2, 2.1 +/- 0.4, and 1.4 +/- 0.3 times higher, respectively (P < 0.05). The mRNA expression level of MMP-2 also increased (to 4.0 +/- 1.2 times control levels) in canine HCC cells co-cultured with AT-MSCs, but MMP-9 mRNA significantly decreased (to 0.5 +/- 0.1 times control levels). These findings suggest that soluble factors from AT-MSCs promote the proliferation and invasion of canine HCC cells.	[Teshima, Takahiro; Matsumoto, Hirotaka; Koyama, Hidekazu] Nippon Vet & Life Sci Univ, Fac Vet Sci, Sch Vet Med, Dept Vet Clin Med,Lab Vet Internal Med, Musashino, Tokyo, Japan	Nippon Veterinary & Life Science University	Teshima, T (corresponding author), Nippon Vet & Life Sci Univ, Fac Vet Sci, Sch Vet Med, Dept Vet Clin Med,Lab Vet Internal Med, Musashino, Tokyo, Japan.	teshima63@nvlu.ac.jp		Teshima, Takahiro/0000-0001-9646-6785	Japan Society for the Promotion of Science KAKENHI Grant [16K18808]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TT received Japan Society for the Promotion of Science KAKENHI Grant Number 16K18808 (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Chen GF, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0040-2; Chen RX, 2012, ANN SURG ONCOL, V19, pS375, DOI 10.1245/s10434-011-1836-7; Galuppo R, 2014, DIGEST DIS SCI, V59, P1688, DOI 10.1007/s10620-014-3058-x; Gao J, 2013, MOL CELL BIOCHEM, V376, P21, DOI 10.1007/s11010-012-1545-y; Harn HJ, 2012, CELL TRANSPLANT, V21, P2753, DOI 10.3727/096368912X652959; Huang PX, 2014, J CELL MOL MED, V18, P218, DOI 10.1111/jcmm.12153; Ji SQ, 2013, BRAZ J MED BIOL RES, V46, P758, DOI 10.1590/1414-431X20132907; Kapur SK, 2013, BIOCHIMIE, V95, P2222, DOI 10.1016/j.biochi.2013.06.001; Katsuda T, 2014, METHODS MOL BIOL, V1213, P57, DOI 10.1007/978-1-4939-1453-1_6; Kisiel AH, 2012, AM J VET RES, V73, P1305, DOI 10.2460/ajvr.73.8.1305; Kohga K, 2010, J HEPATOL, V52, P872, DOI 10.1016/j.jhep.2009.12.030; Kudo M, 2012, WORLD J GASTROENTERO, V18, P6005, DOI 10.3748/wjg.v18.i42.6005; Li GC, 2010, CANCER SCI, V101, P2546, DOI 10.1111/j.1349-7006.2010.01738.x; Liptak J. M., 2007, WITHROW MACEWENS SMA, P483; Liptak JM, 2004, JAVMA-J AM VET MED A, V225, P1225, DOI 10.2460/javma.2004.225.1225; Llovet JM, 2014, CANCER CELL, V25, P560, DOI 10.1016/j.ccr.2014.04.019; Maass T, 2011, INT J CANCER, V128, P1259, DOI 10.1002/ijc.25469; Makridakis M, 2013, BBA-PROTEINS PROTEOM, V1834, P2380, DOI 10.1016/j.bbapap.2013.01.032; Marx C, 2015, STEM CELLS DEV, V24, P803, DOI 10.1089/scd.2014.0407; Michishita M, 2014, RES VET SCI, V96, P315, DOI 10.1016/j.rvsc.2014.01.004; Miyazono K, 2000, J CELL SCI, V113, P1101; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Moeini A, 2012, LIVER CANCER, V1, P83, DOI 10.1159/000342405; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Neupane M, 2008, TISSUE ENG PT A, V14, P1007, DOI [10.1089/ten.tea.2007.0207, 10.1089/tea.2007.0207]; Niess H, 2011, ANN SURG, V254, P767, DOI 10.1097/SLA.0b013e3182368c4f; Okada H, 2012, CANCER RES, V72, P4459, DOI 10.1158/0008-5472.CAN-12-0028; Okura H, 2015, BIOCHEM BIOPH RES CO, V456, P860, DOI 10.1016/j.bbrc.2014.11.122; Roomi MW, 2009, ONCOL REP, V21, P1323, DOI 10.3892/or_00000358; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; SCHIRMACHER P, 1992, CANCER RES, V52, P2549; Schweizer R, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/120949; Screven R, 2014, VET IMMUNOL IMMUNOP, V161, P21, DOI 10.1016/j.vetimm.2014.06.002; Sun XY, 2011, ANTICANCER RES, V31, P3705; Takemitsu H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-150; Venepalli NK, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/341636; Volarevic V, 2014, STEM CELLS, V32, P2818, DOI 10.1002/stem.1818; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang D, 2015, J DIGEST DIS, V16, P489, DOI 10.1111/1751-2980.12268; Zhao P, 2010, CANCER SCI, V101, P387, DOI 10.1111/j.1349-7006.2009.01420.x; Zhao WX, 2012, CANCER BIOTHER RADIO, V27, P606, DOI 10.1089/cbr.2011.1150	42	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191539	10.1371/journal.pone.0191539	http://dx.doi.org/10.1371/journal.pone.0191539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346427	Green Submitted, gold, Green Published			2022-12-27	WOS:000422749500061
J	Kohli, N; Crisp, Z; Riordan, R; Li, M; Alaniz, RC; Jayaraman, A				Kohli, Nandita; Crisp, Zeni; Riordan, Rebekah; Li, Michael; Alaniz, Robert C.; Jayaraman, Arul			The microbiota metabolite indole inhibits Salmonella virulence: Involvement of the PhoPQ two-component system	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI O157-H7; GENE-EXPRESSION; COLONIZATION RESISTANCE; GASTROINTESTINAL-TRACT; INTESTINAL COLONIZATION; CLOSTRIDIUM-DIFFICILE; SEROTYPE TYPHIMURIUM; INVASION GENES	The microbial community present in the gastrointestinal tract is an important component of the host defense against pathogen infections. We previously demonstrated that indole, a microbial metabolite of tryptophan, reduces enterohemorrhagic Escherichia coli O157:H7 attachment to intestinal epithelial cells and biofilm formation, suggesting that indole may be an effector/attenuator of colonization for a number of enteric pathogens. Here, we report that indole attenuates Salmonella Typhimurium (Salmonella) virulence and invasion as well as increases resistance to colonization in host cells. Indole-exposed Salmonella colonized mice less effectively compared to solvent-treated controls, as evident by competitive index values less than 1 in multiple organs. Indole-exposed Salmonella demonstrated 160-fold less invasion of HeLa epithelial cells and 2-fold less invasion of J774A. 1 macrophages compared to solvent-treated controls. However, indole did not affect Salmonella intracellular survival in J774A. 1 macrophages suggesting that indole primarily affects Salmonella invasion. The decrease in invasion was corroborated by a decrease in expression of multiple Salmonella Pathogenicity Island-1 (SPI-1) genes. We also identified that the effect of indole was mediated by both PhoPQ-dependent and independent mechanisms. Indole also synergistically enhanced the inhibitory effect of a short chain fatty acid cocktail on SPI-1 gene expression. Lastly, indole-treated HeLa cells were 70% more resistant to Salmonella invasion suggesting that indole also increases resistance of epithelial cells to colonization. Our results demonstrate that indole is an important microbiota metabolite that has direct anti-infective effects on Salmonella and host cells, revealing novel mechanisms of pathogen colonization resistance.	[Kohli, Nandita; Li, Michael; Jayaraman, Arul] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; [Crisp, Zeni; Riordan, Rebekah; Alaniz, Robert C.; Jayaraman, Arul] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77845 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Jayaraman, A (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.; Alaniz, RC; Jayaraman, A (corresponding author), Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77845 USA.	alaniz@medicine.tamhsc.edu; arulj@tamu.edu						Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; ARGENZIO RA, 1975, AM J PHYSIOL, V228, P454, DOI 10.1152/ajplegacy.1975.228.2.454; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; BERNET MF, 1994, GUT, V35, P483, DOI 10.1136/gut.35.4.483; Bogomolnaya LM, 2008, MOL MICROBIOL, V70, P1105, DOI 10.1111/j.1365-2958.2008.06461.x; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Darkoh C, 2015, APPL ENVIRON MICROB, V81, P8093, DOI 10.1128/AEM.02787-15; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983; Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006; Gong HS, 2010, J BASIC MICROB, V50, pS37, DOI 10.1002/jobm.201000130; Groisman EA, 2006, NAT REV MICROBIOL, V4, P705, DOI 10.1038/nrmicro1478; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Huang Y, 2008, J BACTERIOL, V190, P4233, DOI 10.1128/JB.00205-08; Hung CC, 2013, MOL MICROBIOL, V87, P1045, DOI 10.1111/mmi.12149; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kanamaru K, 2000, MOL MICROBIOL, V38, P805, DOI 10.1046/j.1365-2958.2000.02171.x; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Lee YK, 2003, J MED MICROBIOL, V52, P925, DOI 10.1099/jmm.0.05009-0; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lostroh CP, 2001, MICROBES INFECT, V3, P1281; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Nikaido E, 2008, J BIOL CHEM, V283, P24245, DOI 10.1074/jbc.M804544200; Nikaido E, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-5; Oh S, 2012, J APPL MICROBIOL, V113, P622, DOI 10.1111/j.1365-2672.2012.05372.x; Rea MC, 2010, P NATL ACAD SCI USA, V107, P9352, DOI 10.1073/pnas.0913554107; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; SNELL EE, 1975, ADV ENZYMOL RAMB, V42, P287; Sridharan GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6492; Stecher B, 2005, INFECT IMMUN, V73, P3228, DOI 10.1128/IAI.73.6.3228-3241.2005; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Sun Y, 2013, ADV APPL MICROBIOL, V85, P93, DOI 10.1016/B978-0-12-407672-3.00003-4; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Van Deun K, 2008, BRIT J NUTR, V100, P480, DOI 10.1017/S0007114508921693; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Vega NM, 2013, P NATL ACAD SCI USA, V110, P14420, DOI 10.1073/pnas.1308085110; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; WHITT DD, 1975, APPL MICROBIOL, V30, P609, DOI 10.1128/AEM.30.4.609-615.1975; WILSON KH, 1988, INFECT IMMUN, V56, P2610, DOI 10.1128/IAI.56.10.2610-2614.1988	54	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190613	10.1371/journal.pone.0190613	http://dx.doi.org/10.1371/journal.pone.0190613			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342189	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800026
J	Prioreschi, A; Munthali, RJ; Kagura, J; Said-Mohamed, R; Rolfe, ED; Micklesfield, LK; Norris, SA				Prioreschi, Alessandra; Munthali, Richard J.; Kagura, Juliana; Said-Mohamed, Rihlat; Rolfe, Emanuella De Lucia; Micklesfield, Lisa K.; Norris, Shane A.			The associations between adult body composition and abdominal adiposity outcomes, and relative weight gain and linear growth from birth to age 22 in the Birth to Twenty Plus cohort, South Africa	PLOS ONE			English	Article							CHILDHOOD GROWTH; RISK-FACTORS; MASS INDEX; LATER LIFE; SIZE; FETAL; COUNTRIES; INFANT; NUTRITION; CHILDREN	Background The growing prevalence of overweight and obesity in low- or middle-income countries precipitates the need to examine early life predictors of adiposity. Objectives To examine growth trajectories from birth, and associations with adult body composition in the Birth to Twenty Plus Cohort, Soweto, South Africa. Methods Complete data at year 22 was available for 1088 participants (536 males and 537 females). Conditional weight and height indices were generated indicative of relative rate of growth between years 0-2, 2-5, 5-8, 8-18, and 18-22. Whole body composition was measured at year 22 (range 21-25 years) using dual energy x-ray absorptiometry (DXA). Total fat free soft tissue mass (FFSTM), fat mass, and abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were recorded. Results Birth weight was positively associated with FFSTM and fat mass at year 22 (beta = 0.11, p<0.01 and beta = 0.10, p<0.01 respectively). Relative weight gain from birth to year 22 was positively associated with FFSTM, fat mass, VAT, and SAT at year 22. Relative linear growth from birth to year 22 was positively associated with FFSTM at year 22. Relative linear growth from birth to year 2 was positively associated with VAT at year 22. Being born small for gestational age and being stunted at age 2 years were inversely associated with FFSTM at year 22. Conclusions The importance of optimal birth weight and growth tempos during early life for later life body composition, and the detrimental effects of pre- and postnatal growth restriction are clear; yet contemporary weight-gain most strongly predicted adult body composition. Thus interventions should target body composition trajectories during childhood and prevent excessive weight gain in early adulthood.	[Prioreschi, Alessandra; Munthali, Richard J.; Kagura, Juliana; Said-Mohamed, Rihlat; Micklesfield, Lisa K.; Norris, Shane A.] Univ Witwatersrand, MRC WITS Dev Pathways Hlth Res Unit, Dept Paediat, Sch Clin Med,Fac Hlth Sci, Johannesburg, South Africa; [Rolfe, Emanuella De Lucia] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Inst Metab Sci, Cambridge Biomed Campus, Cambridge, England	University of Witwatersrand; University of Cambridge	Prioreschi, A (corresponding author), Univ Witwatersrand, MRC WITS Dev Pathways Hlth Res Unit, Dept Paediat, Sch Clin Med,Fac Hlth Sci, Johannesburg, South Africa.	alessandra.prioreschi@wits.ac.za	Munthali, Richard/AAU-6205-2021; Micklesfield, Lisa/AAR-8262-2021; Norris, Shane/C-4664-2014	Munthali, Richard/0000-0001-8492-7409; Micklesfield, Lisa/0000-0002-4994-0779; Norris, Shane/0000-0001-7124-3788; SAID MOHAMED, Rihlat/0000-0003-1592-5412; Prioreschi, Alessandra/0000-0002-6913-0706	DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa; Claude Leon Foundation; Medical Research Council [MC_UU_12015/2]; Wellcome Trust (UK); University of the Witwatersrand; South African Medical Research Council; Human Sciences Research Council; MRC [MC_UU_12015/2] Funding Source: UKRI	DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa; Claude Leon Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (UK)(Wellcome Trust); University of the Witwatersrand; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Sciences Research Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The support of the DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa towards this research is hereby acknowledged by AP. The Claude Leon Foundation also supported the work of AP. EDLR is supported by the Medical Research Council (Unit Programme number MC_UU_12015/2). Birth to Twenty Plus cohort was funded by the Wellcome Trust (UK), University of the Witwatersrand, South African Medical Research Council and the Human Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The support of the DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa towards this research is hereby acknowledged by AP. Opinions expressed and conclusions arrived at, are those of the authors and are not to be attributed to the CoE in Human Development. The Claude Leon Foundation also supported the work of AP. EDLR is supported by the Medical Research Council (Unit Programme number MC_UU_12015/2).	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; de Franca GVA, 2016, INT J OBESITY, V40, P14, DOI 10.1038/ijo.2015.192; de Franca GVA, 2014, OBES REV, V15, P77, DOI 10.1111/obr.12109; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Brown LD, 2014, J ENDOCRINOL, V221, pR13, DOI 10.1530/JOE-13-0567; Corvalan C, 2007, INT J EPIDEMIOL, V36, P550, DOI 10.1093/ije/dym010; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; FALL CHD, 1995, BRIT MED J, V310, P428, DOI 10.1136/bmj.310.6977.428; Jones LL, 2009, AM J HUM BIOL, V21, P395, DOI 10.1002/ajhb.20868; Kolcic Ivana, 2012, J Glob Health, V2, P020303, DOI 10.7189/jogh.02.020303; Kuzawa CW, 2012, AM J HUM BIOL, V24, P5, DOI 10.1002/ajhb.21227; Li HJ, 2003, AM J CLIN NUTR, V77, P1498, DOI 10.1093/ajcn/77.6.1498; Micklesfield LK, 2012, OBESITY, V20, P1109, DOI 10.1038/oby.2011.367; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Munthali RJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3337-x; Musa MG, 2016, J DEV ORIG HLTH DIS, V7, P132, DOI 10.1017/S2040174415007953; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Popkin BM, 1996, J NUTR, V126, P3009, DOI 10.1093/jn/126.12.3009; Pradeilles R, 2014, CHILDREN YOUTH ENV, V24, P173, DOI DOI 10.7721/CHILYOUTENVI.24.3.0173; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Shisana O, 2013, S AFRICAN NATL HLTH; Simmons R, 2008, SEMIN PERINATOL, V32, P371, DOI 10.1053/j.semperi.2008.08.004; Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840; Victora CG, 2001, INT J EPIDEMIOL, V30, P217, DOI 10.1093/ije/30.2.217; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233	30	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190483	10.1371/journal.pone.0190483	http://dx.doi.org/10.1371/journal.pone.0190483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338002	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700010
J	Frech, S; Kreft, D; Guthoff, RF; Doblhammerz, G				Frech, Stefanie; Kreft, Daniel; Guthoff, Rudolf F.; Doblhammerz, Gabriele			Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients-An observational cohort study	PLOS ONE			English	Article							PERSISTENCE; MEDICATIONS; NONADHERENCE; PREVALENCE; REGIMENS	The goal of this study was to assess the adherence of primary open-angle glaucoma (POAG) patients to medication, and to determine co-factors influencing adherence, using a representative sample of members of the largest German public health insurer. The observational cohort study was based on a longitudinal dataset from 2010-2013 and included 250,000 insured persons aged 50 and older with 10,120 diagnosed POAG patients. Uni-and multivariate analysis was performed to investigate several aspects of glaucoma, such as prevalence, adherence, and co-factors influencing adherence. The main outcome measured adherence with prescriptions filled within a year. Multivariate panel regression analysis was used to determine the co-factors influencing this adherence. Prevalence of POAG was 3.36% [Cl: 3.28-3.43%], with 2.91% [Cl: 2.81-3.01%] for males and 3.71% [Cl: 3.61-3.81 %] for females, increasing with age. The mean level of adherence in terms of prescriptions filled was 66.5% [Cl: 65.50-67.60%]. The results of this analysis revealed a significant influence of age, duration of the disease, care need, distance to death, and multimorbidity as co-factors of non-adherence, whereas gender had no influence. The analysis provided detailed information about POAG health care aspects concerning prevalence and adherence. The most endangered risk groups for non-adherence were patients aged 50-59, patients older than 80 years, patients with a longer duration of POAG, patients with care needs, and patients with three or more severe diseases in addition to glaucoma. To know the predictors responsible for an increased risk to develop POAG is of importance for all persons involved in health care management. Therefore effective strategies to increase awareness of patients and medical care personnel about non-adherence and the importance of a regular and continuous medication to avoid further nerve fiber damage and possible blindness have to be developed.	[Frech, Stefanie; Guthoff, Rudolf F.] Rostock Univ, Dept Ophthalmol, Med Ctr, Rostock, Germany; [Kreft, Daniel; Doblhammerz, Gabriele] Univ Rostock, Inst Sociol & Demog, Rostock, Germany; [Kreft, Daniel; Doblhammerz, Gabriele] Rostock Ctr Study Demog Change, Rostock, Germany; [Doblhammerz, Gabriele] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	University of Rostock; University of Rostock; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Frech, S (corresponding author), Rostock Univ, Dept Ophthalmol, Med Ctr, Rostock, Germany.	Stefanie.frech@med.uni-rostock.de						Alany RG, 2013, CURR MED RES OPIN, V29, P1187, DOI 10.1185/03007995.2013.818968; Alhewiti Abdullah, 2014, Int J Family Med, V2014, P479596, DOI 10.1155/2014/479596; Baltagi BH, 2013, ECONOMETRIC ANAL PAN, V5th; Boland MV, 2014, JAMA OPHTHALMOL, V132, P838, DOI 10.1001/jamaophthalmol.2014.856; Brown MT, 2011, MAYO CLIN PROC, V86, P304, DOI 10.4065/mcp.2010.0575; Budenz DL, 2013, JAMA OPHTHALMOL, V131, P651, DOI 10.1001/jamaophthalmol.2013.1686; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; Dietlein TS, 2016, KLIN MONATSBL AUGENH, V233, P138, DOI 10.1055/s-0041-110447; Distelhorst JS, 2003, AM FAM PHYSICIAN, V67, P1937; Friedman DS, 2007, INVEST OPHTH VIS SCI, V48, P5052, DOI 10.1167/iovs.07-0290; Friedman DS, 2006, ARCH OPHTHALMOL-CHIC, V124, P1625, DOI 10.1001/archopht.124.11.1625; GURWITZ JH, 1993, AM J PUBLIC HEALTH, V83, P711, DOI 10.2105/AJPH.83.5.711; Haynes R B, 2002, Cochrane Database Syst Rev, pCD000011; Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018; Jampel HD, 2003, ARCH OPHTHALMOL-CHIC, V121, P540, DOI 10.1001/archopht.121.4.540; Kholdebarin R, 2008, CAN J OPHTHALMOL, V43, P454, DOI [10.1139/i08-076, 10.3129/i08-076]; King A, 2013, BMJ-BRIT MED J, P346; Lanzl I, 2012, OPHTHALMOLOGE, V109, P1087, DOI 10.1007/s00347-012-2641-9; Lawrence SD, 2013, GLAUCOMA TODAY; Lem S, 1984, ALSO SPRACH GOLEM; Lu VH, 2010, AM J OPHTHALMOL, V150, P569, DOI 10.1016/j.ajo.2010.05.005; Mohindroo Chirayu, 2015, J Curr Glaucoma Pract, V9, P33, DOI 10.5005/jp-journals-10008-1181; Nordstrom BL, 2005, AM J OPHTHALMOL, V140, P598, DOI 10.1016/j.ajo.2005.04.051; Okeke CO, 2009, OPHTHALMOLOGY, V116, P191, DOI 10.1016/j.ophtha.2008.09.004; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rees G, 2014, J GLAUCOMA, V23, P293, DOI 10.1097/IJG.0b013e3182741f1c; Rees G, 2010, OPHTHALMOLOGY, V117, P903, DOI 10.1016/j.ophtha.2009.10.038; Robin A, 2011, INDIAN J OPHTHALMOL, V59, pS93, DOI 10.4103/0301-4738.73693; Schwartz GR, 2008, SURV OPHTHALMOL, V53, pS57, DOI 10.1016/j.survophthal.2008.08.002; Sheer R, 2016, J MANAG CARE SPEC PH, V22, P808, DOI 10.18553/jmcp.2016.22.7.808; Stryker JE, 2010, J GLAUCOMA, V19, P66, DOI 10.1097/IJG.0b013e31819c4679; Taylor SA, 2002, J OCUL PHARMACOL TH, V18, P401, DOI 10.1089/10807680260362687; Tsai JC, 2003, J GLAUCOMA, V12, P393, DOI 10.1097/00061198-200310000-00001; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Vrijens B, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00100; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wilensky J, 2006, AM J OPHTHALMOL, V141, pS28, DOI 10.1016/j.ajo.2005.09.011; Wolfram C, 2012, OPHTHALMOLOGE, V109, P271, DOI 10.1007/s00347-011-2521-8	38	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191185	10.1371/journal.pone.0191185	http://dx.doi.org/10.1371/journal.pone.0191185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329338	Green Submitted, Green Published, gold			2022-12-27	WOS:000419954100044
J	Liu, ZL; Dugan, B; Masiello, CA; Wahab, LM; Gonnermann, HM; Nittrouer, JA				Liu, Zuolin; Dugan, Brandon; Masiello, Caroline A.; Wahab, Leila M.; Gonnermann, Helge M.; Nittrouer, Jeffrey A.			Effect of freeze-thaw cycling on grain size of biochar	PLOS ONE			English	Article							PARTICLE-SIZE; WATER-CONTENT; SOIL; CHARCOAL; IMPACT	Biochar may improve soil hydrology by altering soil porosity, density, hydraulic conductivity, and water-holding capacity. These properties are associated with the grain size distributions of both soil and biochar, and therefore may change as biochar weathers. Here we report how freeze-thaw (F-T) cycling impacts the grain size of pine, mesquite, miscanthus, and sewage waste biochars under two drainage conditions: undrained (all biochars) and a gravity-drained experiment (mesquite biochar only). In the undrained experiment plant biochars showed a decrease in median grain size and a change in grain-size distribution consistent with the flaking off of thin layers from the biochar surface. Biochar grain size distribution changed from unimodal to bimodal, with lower peaks and wider distributions. For plant biochars the median grain size decreased by up to 45.8% and the grain aspect ratio increased by up to 22.4% after 20 F-T cycles. F-T cycling did not change the grain size or aspect ratio of sewage waste biochar. We also observed changes in the skeletal density of biochars (maximum increase of 1.3%), envelope density (maximum decrease of 12.2%), and intraporosity (porosity inside particles, maximum increase of 3.2%). In the drained experiment, mesquite biochar exhibited a decrease of median grain size (up to 4.2%) and no change of aspect ratio after 10 F-T cycles. We also document a positive relationship between grain size decrease and initial water content, suggesting that, biochar properties that increase water content, like high intraporosity and pore connectivity large intrapores, and hydrophilicity, combined with undrained conditions and frequent F-T cycles may increase biochar breakdown. The observed changes in biochar particle size and shape can be expected to alter hydrologic properties, and thus may impact both plant growth and the hydrologic cycle.	[Liu, Zuolin; Dugan, Brandon; Masiello, Caroline A.; Wahab, Leila M.; Gonnermann, Helge M.; Nittrouer, Jeffrey A.] Rice Univ, Dept Earth Environm & Planetary Sci, Houston, TX 77005 USA; [Masiello, Caroline A.] Rice Univ, Dept Chem & Biosci, Houston, TX USA; [Dugan, Brandon] Colorado Sch Mines, Dept Geophys, Golden, CO 80401 USA	Rice University; Rice University; Colorado School of Mines	Liu, ZL (corresponding author), Rice Univ, Dept Earth Environm & Planetary Sci, Houston, TX 77005 USA.	zl17@rice.edu	Gonnermann, Helge M/B-1054-2012		United States National Science Foundation [NSF-EAR-0911685]	United States National Science Foundation(National Science Foundation (NSF))	This study was funded by United States National Science Foundation with fund number NSF-EAR-0911685 received by CAM and BD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abel S, 2013, GEODERMA, V202, P183, DOI 10.1016/j.geoderma.2013.03.003; Ajayi AE, 2016, SOIL TILL RES, V155, P166, DOI 10.1016/j.still.2015.08.007; Barnes RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108340; Bayat H, 2015, J HYDROL, V529, P872, DOI 10.1016/j.jhydrol.2015.08.067; Berner R.A., 2012, GLOBAL ENV WATER AIR, Vsecond; Brewer CE, 2014, BIOMASS BIOENERG, V66, P176, DOI 10.1016/j.biombioe.2014.03.059; BULLOCK MS, 1988, SOIL SCI SOC AM J, V52, P770, DOI 10.2136/sssaj1988.03615995005200030031x; Carcaillet C, 2001, HOLOCENE, V11, P231, DOI 10.1191/095968301674071040; Githinji L, 2014, ARCH AGRON SOIL SCI, V60, P457, DOI 10.1080/03650340.2013.821698; Haley JS, 2011, CLIMATOLOGY FREEZE T; Jones DL, 2011, SOIL BIOL BIOCHEM, V43, P804, DOI 10.1016/j.soilbio.2010.12.015; Kameyama K, 2014, EUR J SOIL SCI, V65, P105, DOI 10.1111/ejss.12083; Kinney TJ, 2012, BIOMASS BIOENERG, V41, P34, DOI 10.1016/j.biombioe.2012.01.033; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Lehmann J., 2009, BIOCHAR ENV MANAGEME, DOI DOI 10.1007/S13593-016-0372-Z; Lim TJ, 2016, CHEMOSPHERE, V142, P136, DOI 10.1016/j.chemosphere.2015.06.069; Liu J, 2012, J PLANT NUTR SOIL SC, V175, P698, DOI 10.1002/jpln.201100172; Liu ZL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179079; Liu ZL, 2016, J HYDROL, V533, P461, DOI 10.1016/j.jhydrol.2015.12.007; Molina M, 2009, P NATL ACAD SCI USA, V106, P20616, DOI 10.1073/pnas.0902568106; Ponge JF, 2006, SOIL BIOL BIOCHEM, V38, P2008, DOI 10.1016/j.soilbio.2005.12.024; Spokas KA, 2014, ENVIRON SCI TECH LET, V1, P326, DOI 10.1021/ez500199t; Sun H, 2012, IND ENG CHEM RES, V51, P3587, DOI 10.1021/ie201309r; Vipulanandan C, 2009, J GEOTECH GEOENVIRON, V135, P1190, DOI 10.1061/(ASCE)GT.1943-5606.0000064; Wang DJ, 2013, ENVIRON SCI TECHNOL, V47, P821, DOI 10.1021/es303794d; Woolf D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1053	26	13	14	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191246	10.1371/journal.pone.0191246	http://dx.doi.org/10.1371/journal.pone.0191246			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329343	Green Published, gold, Green Submitted			2022-12-27	WOS:000419954100055
J	Xu, XY; Gao, P; Zhu, XK; Guo, WS; Ding, JF; Li, CY				Xu, Xiangying; Gao, Ping; Zhu, Xinkai; Guo, Wenshan; Ding, Jinfeng; Li, Chunyan			Estimating the responses of winter wheat yields to moisture variations in the past 35 years in Jiangsu Province of China	PLOS ONE			English	Article							PRECIPITATION EVAPOTRANSPIRATION INDEX; DROUGHT RISK-ASSESSMENT; SOIL-MOISTURE; MAIZE YIELD; CLIMATE; MODELS; IMPACT; INDICATORS; EVENTS; CORN	Jiangsu is an important agricultural province in China. Winter wheat, as the second major grain crop in the province, is greatly affected by moisture variations. The objective of this study was to investigate whether there were significant trends in changes in the moisture conditions during wheat growing seasons over the past decades and how the wheat yields responded to different moisture levels by means of a popular drought index, the Standardized Precipitation Evapotranspiration Index (SPEI). The study started with a trend analysis and quantification of the moisture conditions with the Mann-Kendall test and Sen's Slope method, respectively. Then, correlation analysis was carried out to determine the relationship between de-trended wheat yields and multi-scalar SPEI. Finally, a multivariate panel regression model was established to reveal the quantitative yield responses to moisture variations. The results showed that the moisture conditions in Jiangsu were generally at a normal level, but this century appeared slightly drier in because of the relatively high temperatures. There was a significant correlation between short time scale SPEI values and wheat yields. Among the three critical stages of wheat development, the SPEI values in the late growth stage (April-June) had a closer linkage to the yields than in the seedling stage (Octo-ber-November) and the over-wintering stage (December-February). Moreover, the yield responses displayed an asymmetric characteristic, namely, moisture excess led to higher yield losses compared to moisture deficit in this region. The maximum yield increment could be obtained under the moisture level of slight drought according to the 3-month SPEI at the late growth stage, while extreme wetting resulted in the most severe yield losses. The moisture conditions in the first 15 years of the 21st century were more favorable than in the last 20 years of the 20th century for wheat production in Jiangsu.	[Xu, Xiangying; Zhu, Xinkai; Guo, Wenshan; Ding, Jinfeng; Li, Chunyan] Yangzhou Univ, Wheat Res Inst, Jiangsu Prov Key Lab Crop Genet & Physiol, Yangzhou, Jiangsu, Peoples R China; [Gao, Ping] Meteorol Bur Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Yangzhou University	Guo, WS (corresponding author), Yangzhou Univ, Wheat Res Inst, Jiangsu Prov Key Lab Crop Genet & Physiol, Yangzhou, Jiangsu, Peoples R China.	guows@yzu.edu.cn			National Key Research and Development Program of China - Ministry of Science and Technology of the People's Republic of China [2016YFD0300107]; Specialized Research Fund for the Doctoral Program of Higher Education - Ministry of Education of the People's Republic of China [20133250110001]; National Natural Science Foundation of China - committee of National Natural Science Foundation of China [31401317]; project "Jiangsu Agricultural Industry Technology System"	National Key Research and Development Program of China - Ministry of Science and Technology of the People's Republic of China; Specialized Research Fund for the Doctoral Program of Higher Education - Ministry of Education of the People's Republic of China; National Natural Science Foundation of China - committee of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project "Jiangsu Agricultural Industry Technology System"	This work was supported by the National Key Research and Development Program of China (2016YFD0300107), which was funded by the Ministry of Science and Technology of the People's Republic of China (http://www.most.gov.cn/) and the receiver is Guo WS. It was also supported by the Specialized Research Fund for the Doctoral Program of Higher Education (doctoral supervisor) (no: 20133250110001), which was funded by the Ministry of Education of the People's Republic of China (http://www.moe.gov.cn/) with the receiver Guo WS. In addition, it was supported by the National Natural Science Foundation of China (no: 31401317), which was provided by the committee of National Natural Science Foundation of China (http://www.nsfc.gov.cn/) with the receiver Ding JF. It was also funded by the project "Jiangsu Agricultural Industry Technology System" with the receiver Guo WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun BJ, 2013, CLIM DYNAM, V41, P277, DOI 10.1007/s00382-012-1523-9; Akinremi OO, 1996, CAN J SOIL SCI, V76, P285, DOI 10.4141/cjss96-035; ALLEY WM, 1985, WATER RESOUR BULL, V21, P105; Begueria S., 2009, SPEI CALCULATOR; Begueria S, 2017, SPEI CALCULATION OF; Begueria S, 2014, INT J CLIMATOL, V34, P3001, DOI 10.1002/joc.3887; Cai RH, 2014, J AGR RESOUR ECON, V39, P230; China Meterological Administration, CLIMATE DAILY DATA S; Chinese Academy of Agricultural Sciences, THE MAIN CROP GROWTH; Cohn AS, 2016, NAT CLIM CHANGE, V6, P601, DOI [10.1038/nclimate2934, 10.1038/NCLIMATE2934]; Danneberg, 2012, ADV GEOSCIENCES, V31, P49, DOI [10.5194/adgeo-31-49-2012, DOI 10.5194/ADGE0-31-49-2012]; Du J, 2013, STOCH ENV RES RISK A, V27, P377, DOI 10.1007/s00477-012-0589-6; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Geng Ting, 2012, Journal of Triticeae Crops, V32, P1183; Ghahramani A, 2016, AGR SYST, V146, P142, DOI 10.1016/j.agsy.2016.05.011; Guttman NB, 1998, J AM WATER RESOUR AS, V34, P113, DOI 10.1111/j.1752-1688.1998.tb05964.x; Huang KC, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/024011; Inoue T, 2004, PHOTOSYNTHETICA, V42, P99, DOI 10.1023/B:PHOT.0000040576.52128.ed; Jiang D, 2006, PEDOSPHERE, V16, P25, DOI 10.1016/S1002-0160(06)60022-2; Jiangsu Climate Center, 2015, CLIMATE ASSESSMENT O; Jiangsu Climate Center, MONITORING OF RECENT; Li D, 2015, CHINESE AGR SCI B, V31, P56; [刘金涛 Liu Jintao], 2016, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V44, P246; [刘珂 Liu Ke], 2015, [大气科学, Chinese Journal of Atmospheric Sciences], V39, P23; Lloyd-Hughes B, 2002, INT J CLIMATOL, V22, P1571, DOI 10.1002/joc.846; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Lu E, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038817; McKee TB, 1993, 8 C APPL CLIM 17 JA, V17, P179, DOI DOI 10.1111/J.1467-7717.1988.TB00685; Ming B, 2015, J INTEGR AGR, V14, P660, DOI 10.1016/S2095-3119(14)60778-4; Mkhabela M, 2010, AGR FOREST METEOROL, V150, P399, DOI 10.1016/j.agrformet.2010.01.001; Patel NR, 2007, METEOROL APPL, V14, P329, DOI 10.1002/met.33; Potop V, 2011, THEOR APPL CLIMATOL, V105, P469, DOI 10.1007/s00704-011-0403-2; Potopova V, 2015, AGR FOREST METEOROL, V202, P26, DOI 10.1016/j.agrformet.2014.11.022; Poudel S, 2016, CLIMATE, V4, DOI 10.3390/cli4010013; Ray DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6989; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Seiler RA, 2002, INT J CLIMATOL, V22, P1365, DOI 10.1002/joc.799; Shang ZhaoTang, 2015, Jiangsu Agricultural Sciences, V43, P56; Sohn SJ, 2013, GEOPHYS RES LETT, V40, P579, DOI 10.1002/grl.50133; Spinoni J, 2013, ADV SCI RES, V10, P21, DOI 10.5194/asr-10-21-2013; Sun L, 2012, INT J CLIMATOL, V32, P1628, DOI 10.1002/joc.2385; [田红 Tian Hong], 2005, [中国海洋大学学报. 自然科学版, Journal of Ocean University of China], V35, P539; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; Vicente-Serrano SM, 2017, CLIM DYNAM, V48, P405, DOI 10.1007/s00382-016-3082-y; Vicente-Serrano SM, 2012, EARTH INTERACT, V16, DOI 10.1175/2012EI000434.1; Vicente-Serrano SM, 2010, AGR FOREST METEOROL, V150, P614, DOI 10.1016/j.agrformet.2010.02.002; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Wang HS, 2015, J HYDROMETEOROL, V16, P1397, DOI 10.1175/JHM-D-14-0076.1; [王文 Wang Wen], 2010, [高原气象, Plateau Meteorology], V29, P1587; Wang X, 2015, ECOL INDIC, V57, P100, DOI 10.1016/j.ecolind.2015.04.023; Wu H, 2004, INT J CLIMATOL, V24, P723, DOI 10.1002/joc.1028; [吴洪颜 Wu Hongyan], 2012, [生态学报, Acta Ecologica Sinica], V32, P1871; [杨扬 YANG Yang], 2007, [水科学进展, Advances in Water Science], V18, P52; Yu MX, 2014, INT J CLIMATOL, V34, P545, DOI 10.1002/joc.3701; Zhang Y, 2016, INT J ELEC POWER, V78, P215, DOI 10.1016/j.ijepes.2015.11.095; [邹兵 Zou Bing], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P63	58	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191217	10.1371/journal.pone.0191217	http://dx.doi.org/10.1371/journal.pone.0191217			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329353	Green Submitted, Green Published, gold			2022-12-27	WOS:000419954100052
J	Ultee, KHJ; Tjeertes, EKM; Goncalves, FB; Rouwet, EV; Hoofwijk, AGM; Stolker, RJ; Verhagen, HJM; Hoeks, SE				Ultee, Klaas H. J.; Tjeertes, Elke K. M.; Goncalves, Frederico Bastos; Rouwet, Ellen V.; Hoofwijk, Anton G. M.; Stolker, Robert Jan; Verhagen, Hence J. M.; Hoeks, Sanne E.			The relation between household income and surgical outcome in the Dutch setting of equal access to and provision of healthcare	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CORONARY-HEART-DISEASE; SOCIOECONOMIC-STATUS; CARDIOVASCULAR MORTALITY; RACIAL DISPARITIES; COLORECTAL-CANCER; AIR-POLLUTION; RISK-FACTOR; INEQUALITIES; SURGERY	Background The impact of socioeconomic disparities on surgical outcome in the absence of healthcare inequality remains unclear. Therefore, we set out to determine the association between socioeconomic status (SES), reflected by household income, and overall survival after surgery in the Dutch setting of equal access and provision of care. Additionally, we aim to assess whether SES is associated with cause-specific survival and major 30-day complications. Methods Patients undergoing surgery between March 2005 and December 2006 in a general teaching hospital in the Netherlands were prospectively included. Adjusted logistic and cox regression analyses were used to assess the independent association of SES +/- quantified by gross household income +/- with major 30-day complications and long-term postoperative survival. Results A total of 3929 patients were included, with a median follow-up of 6.3 years. Low household income was associated with worse survival in continuous analysis (HR: 1.05 per 10.000 euro decrease in income, 95% CI: 1.01 +/- 1.10) and in income quartile analysis (HR: 1.58, 95% CI: 1.08 +/- 2.31, first [i.e. lowest] quartile relative to the fourth quartile). Similarly, low income patients were at higher risk of cardiovascular death (HR: 1.26 per 10.000 decrease in income, 95% CI: 1.07 +/- 1.48, first income quartile: HR: 3.10, 95% CI: 1.04 +/- 9.22). Household income was not independently associated with cancer-related mortality and major 30day complications. Conclusions Low SES, quantified by gross household income, is associated with increased overall and cardiovascular mortality risks among surgical patients. Considering the equality of care provided by this study setting, the associated survival hazards can be attributed to patient and provider factors, rather than disparities in healthcare. Increased physician awareness of SES as a risk factor in preoperative decision-making and focus on improving established SES-related risk factors may improve surgical outcome of low SES patients.	[Ultee, Klaas H. J.; Goncalves, Frederico Bastos; Rouwet, Ellen V.; Verhagen, Hence J. M.] Erasmus Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands; [Tjeertes, Elke K. M.; Stolker, Robert Jan; Hoeks, Sanne E.] Erasmus Univ, Med Ctr, Dept Anaesthesiol, Rotterdam, Netherlands; [Goncalves, Frederico Bastos] Ctr Hosp Lisboa Cent, Hosp Santa Marta, Dept Surg, Lisbon, Portugal; [Hoofwijk, Anton G. M.] Zuyderland, Dept Surg, Sittard, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa	Hoeks, SE (corresponding author), Erasmus Univ, Med Ctr, Dept Anaesthesiol, Rotterdam, Netherlands.	s.hoeks@erasmusmc.nl	Bastos Gonçalves, Frederico/GXV-0941-2022; Hoeks, Sanne/AAM-3313-2020; Bastos Gonçalves, Fredrico/AAC-6172-2022	Bastos Gonçalves, Fredrico/0000-0002-9825-9007				Ancona C, 2000, J EPIDEMIOL COMMUN H, V54, P930, DOI 10.1136/jech.54.12.930; Artinian NT, 2002, HEART LUNG, V31, P161, DOI 10.1067/mhl.2002.123672; Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Baquet CR, 2000, CANCER, V88, P1256, DOI 10.1002/(SICI)1097-0142(20000301)88:5+<1256::AID-CNCR13>3.0.CO;2-3; Begaj I, 2013, KIDNEY INT, V84, P803, DOI 10.1038/ki.2013.176; Begley C, 2011, EPILEPSIA, V52, P957, DOI 10.1111/j.1528-1167.2010.02968.x; Birkmeyer NJO, 2008, MED CARE, V46, P893, DOI 10.1097/MLR.0b013e31817925b0; Boersma E, 2005, AM J MED, V118, P1134, DOI 10.1016/j.amjmed.2005.01.064; Braveman PA, 2003, J HEALTH POPUL NUTR, V21, P181; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Burgess DJ, 2004, J GEN INTERN MED, V19, P1154, DOI 10.1111/j.1525-1497.2004.30227.x; Chevreul K., 2010, HLTH SYST TRANSIT, V12, P1, DOI DOI 10.1038/KI.2015.25; Davis PD CS Karen, 2010, MIRROR WALL PERFORMA; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Du XL, 2007, CANCER, V110, P660, DOI 10.1002/cncr.22826; Durkin, 1999, Br J Surg, V86, P702; Forrest LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001376; Freimuth VS, 2004, AM J PUBLIC HEALTH, V94, P2053, DOI 10.2105/AJPH.94.12.2053; Gallo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039013; Geyer S, 2000, J EPIDEMIOL COMMUN H, V54, P299, DOI 10.1136/jech.54.4.299; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; Hajat A, 2013, ENVIRON HEALTH PERSP, V121, P1325, DOI 10.1289/ehp.1206337; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; Harteloh P, 2010, EUR J EPIDEMIOL, V25, P531, DOI 10.1007/s10654-010-9445-5; Henry AJ, 2011, J VASC SURG, V53, P330, DOI 10.1016/j.jvs.2010.08.077; Hines R, 2014, AM J PUBLIC HEALTH, V104, pE63, DOI 10.2105/AJPH.2013.301572; Horton TC, 2007, J HAND SURG-BRIT EUR, V32E, P256, DOI 10.1016/j.jhsb.2006.10.005; Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084; Johnson-Lawrence V, 2013, ANN EPIDEMIOL, V23, P167, DOI 10.1016/j.annepidem.2013.02.004; Kapral MK, 2002, STROKE, V33, P268, DOI 10.1161/hs0102.101169; Kilbourne AM, 2006, AM J PUBLIC HEALTH, V96, P2113, DOI 10.2105/AJPH.2005.077628; Kuper H, 2003, J EPIDEMIOL COMMUN H, V57, P147, DOI 10.1136/jech.57.2.147; Lantz PM, 2005, J HEALTH SOC BEHAV, V46, P274, DOI 10.1177/002214650504600305; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lazzarino AI, 2013, JAMA INTERN MED, V173, P22, DOI 10.1001/2013.jamainternmed.951; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; Marmot MG, 2008, DIABETOLOGIA, V51, P1980, DOI 10.1007/s00125-008-1144-3; Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Morris AM, 2010, J AM COLL SURGEONS, V211, P105, DOI 10.1016/j.jamcollsurg.2010.02.051; Murray TC, 2012, J BEHAV MED, V35, P63, DOI 10.1007/s10865-011-9327-7; Nguyen LL, 2010, J VASC SURG, V51, p36S, DOI 10.1016/j.jvs.2010.02.003; Rautio N, 2012, PRIM CARE DIABETES, V6, P277, DOI 10.1016/j.pcd.2012.07.002; Ricciuto LE, 2007, SOC SCI MED, V64, P186, DOI 10.1016/j.socscimed.2006.08.020; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Roy M, 2014, INT J ENV RES PUB HE, V11, P4825, DOI 10.3390/ijerph110504825; Russ TC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4933; Saban KL, 2014, AGING DIS, V5, P346, DOI 10.14336/AD.2014.0500346; Sabanayagam C, 2012, J HEALTH POPUL NUTR, V30, P82, DOI 10.3329/jhpn.v30i1.11280; Sharpe KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089513; Spark JI, 2002, EUR J VASC ENDOVASC, V24, P535, DOI 10.1053/ejvs.2002.1755; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stringhini S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102858; Tjeertes EEKM, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0096-7; Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623; Ultee KHJ, 2015, EUR J VASC ENDOVASC, V50, P615, DOI 10.1016/j.ejvs.2015.07.006; Wamala S, 2007, INT J QUAL HEALTH C, V19, P134, DOI 10.1093/intqhc/mzm011; Wang DD, 2014, JAMA INTERN MED, V174, P1587, DOI 10.1001/jamainternmed.2014.3422; WILENSKY GR, 1991, JAMA-J AM MED ASSOC, V266, P3404; Woodside JV, 2012, PREV MED, V54, P247, DOI 10.1016/j.ypmed.2012.01.017; Yang R, 2010, CANCER-AM CANCER SOC, V116, P2437, DOI 10.1002/cncr.24986	64	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191464	10.1371/journal.pone.0191464	http://dx.doi.org/10.1371/journal.pone.0191464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1TP	29357383	Green Published, Green Submitted, gold			2022-12-27	WOS:000422919500015
J	Bonnet-Serrano, F; Diedisheim, M; Mallone, R; Larger, E				Bonnet-Serrano, Fideline; Diedisheim, Marc; Mallone, Roberto; Larger, Etienne			Decreased alpha-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: An analysis based on the nPOD repository	PLOS ONE			English	Article							GLUCAGON-RESPONSE; EUROPEAN SUBJECTS; ORGAN DONORS; INSULIN; HYPOGLYCEMIA; OBESITY; HUMANS; HEMIPANCREATECTOMY; HYPERGLYCEMIA; INFILTRATION	Background and aims Abnormal glucagon secretion and functional alterations of the exocrine pancreas have been described in patients with type 1 diabetes (T1D), but their respective anatomical substrata have seldom been investigated. Our aim was to develop an automated morphometric analysis process to characterize the anatomy of alpha-cell and exocrine pancreas in patients with T1D, using the publicly available slides of the Network for Pancreatic Organ Donors (nPOD). Materials and methods The ratio of beta- and alpha-cell area to total tissue area were quantified in 75 patients with T1D (thereafter patients) and 66 control subjects (thereafter controls), on 2 insulin-stained and 4 glucagon-stained slides from both the head and the tail of the pancreas. The beta- and alpha-cell masses were calculated in the 66 patients and the 50 controls for which the pancreas weight was available. Non-exocrine-non-endocrine tissue area (i.e. non-acinar, non-insular tissue) to total tissue area ratio was evaluated on both insulin-and glucagon-stained slides. Results were expressed as mean +/- SD. Results An automated quantification method was set up using the R software and was validated by quantification of beta-cell mass, a well characterized parameter. beta-cell mass was 29.6 +/- 112 mg in patients and 628 +/- 717 mg in controls (p<0.0001). alpha-cell mass was 181 +/- 176 mg in patients and 349 +/- 241mg in controls (p<0.0001). Non-exocrine-non-endocrine area to total tissue area ratio was 39 +/- 9% in patients and 29 +/- 10% in controls (p<0.0001) and increased with age in both groups, with no correlation with diabetes duration in patients. Conclusion The absolute alpha-cell mass was lower in patients compared to controls, in proportion to the decrease in pancreas weight observed in patients. Non-exocrine-non-endocrine area to total tissue area ratio increased with age in both groups but was higher in patients at all ages.	[Bonnet-Serrano, Fideline] DHU AUTHORS, Hop Cochin, AP HP, UF Hormonol, Paris, France; [Bonnet-Serrano, Fideline; Diedisheim, Marc; Mallone, Roberto; Larger, Etienne] DHU AUTHORS, Hop Cochin, AP HP, Serv Diabetol, Paris, France; [Diedisheim, Marc; Mallone, Roberto; Larger, Etienne] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Diedisheim, Marc; Mallone, Roberto; Larger, Etienne] INSERM, U1016, Paris, France; [Diedisheim, Marc; Mallone, Roberto; Larger, Etienne] Cochin Inst, CNRS, UMR8104, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Larger, E (corresponding author), DHU AUTHORS, Hop Cochin, AP HP, Serv Diabetol, Paris, France.; Larger, E (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Larger, E (corresponding author), INSERM, U1016, Paris, France.; Larger, E (corresponding author), Cochin Inst, CNRS, UMR8104, Paris, France.	etienne.larger@aphp.fr	Mallone, Roberto/H-4430-2013; Diedisheim, Marc/ABC-6996-2020	Mallone, Roberto/0000-0002-9846-8861; 	JDRF	JDRF(Juvenile Diabetes Research Foundation)	This research was performed with the support of the Network for Pancreatic Organ Donors with Diabetes (nPOD), a collaborative type 1 diabetes research project sponsored by JDRF. Organ Procurement Organizations partnering with nPOD to provide research resources are listed at www.jdrfnpod.org/for-partners/npod-partners.	Altobelli E, 1998, J CLIN ULTRASOUND, V26, P391, DOI 10.1002/(SICI)1097-0096(199810)26:8<391::AID-JCU3>3.0.CO;2-D; Banarer S, 2002, DIABETES, V51, P958, DOI 10.2337/diabetes.51.4.958; Brown RJ, 2008, DIABETES CARE, V31, P1403, DOI 10.2337/dc08-0575; Campbell-Thompson M, 2016, DIABETES, V65, P719, DOI 10.2337/db15-0779; Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; Campbell-Thompson ML, 2016, DIABETOLOGIA, V59, P217, DOI 10.1007/s00125-015-3752-z; Cryer PE, 2012, ENDOCRINOLOGY, V153, P1039, DOI 10.1210/en.2011-1499; Diedisheim M, 2016, J CLIN ENDOCR METAB, V101, P1390, DOI 10.1210/jc.2015-3756; Faerch K, 2016, DIABETES, V65, P3473, DOI 10.2337/db16-0240; FONSECA V, 1985, BRIT MED J, V291, P1240, DOI 10.1136/bmj.291.6504.1240; Fredheim S, 2015, DIABETOLOGIA, V58, P828, DOI 10.1007/s00125-014-3486-3; Gaglia JL, 2011, J CLIN INVEST, V121, P442, DOI 10.1172/JCI44339; GERICH JE, 1973, SCIENCE, V182, P171, DOI 10.1126/science.182.4108.171; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Inaishi J, 2016, J CLIN ENDOCR METAB, V101, P2874, DOI 10.1210/jc.2016-1374; KENDALL DM, 1990, NEW ENGL J MED, V322, P898, DOI 10.1056/NEJM199003293221305; Kramer CK, 2014, DIABETES CARE, V37, P1076, DOI 10.2337/dc13-2339; Kumar AF, 2008, DIABETES CARE, V31, P1639, DOI 10.2337/dc07-2453; Lam NN, 2017, TRANSPLANTATION, V101, P588, DOI 10.1097/TP.0000000000001155; Larger E, 2012, DIABETIC MED, V29, P1047, DOI 10.1111/j.1464-5491.2012.03597.x; Lund A, 2016, DIABETES, V65, P585, DOI 10.2337/db15-1541; ORCI L, 1976, P NATL ACAD SCI USA, V73, P1338, DOI 10.1073/pnas.73.4.1338; Philippe MF, 2011, PANCREAS, V40, P359, DOI 10.1097/MPA.0b013e3182072032; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; RAHIER J, 1983, DIABETOLOGIA, V24, P366; RAVAZZOLA M, 1981, DIABETES, V30, P879, DOI 10.2337/diabetes.30.10.879; Rodriguez-Calvo T, 2014, DIABETES, V63, P3880, DOI 10.2337/db14-0549; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; SEAQUIST ER, 1992, J CLIN INVEST, V89, P1761, DOI 10.1172/JCI115779; Skog O, 2017, DIABETES OBES METAB, P1; UNGER RH, 1970, J CLIN INVEST, V49, P837, DOI 10.1172/JCI106297; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Waguri M, 1997, ENDOCR J, V44, P23, DOI 10.1507/endocrj.44.23	34	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191528	10.1371/journal.pone.0191528	http://dx.doi.org/10.1371/journal.pone.0191528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352311	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300107
J	Grebenko, A; Dremov, V; Barzilovich, P; Bubis, A; Sidoruk, K; Voeikova, T; Gagkaeva, Z; Chernov, T; Korostylev, E; Gorshunov, B; Motovilov, K				Grebenko, Artem; Dremov, Vyacheslav; Barzilovich, Petr; Bubis, Anton; Sidoruk, Konstantin; Voeikova, Tatiyana; Gagkaeva, Zarina; Chernov, Timur; Korostylev, Evgeny; Gorshunov, Boris; Motovilov, Konstantin			Impedance spectroscopy of single bacterial nanofilament reveals water-mediated charge transfer	PLOS ONE			English	Article							SHEWANELLA-ONEIDENSIS MR-1; EXTRACELLULAR ELECTRON-TRANSPORT; GEOBACTER-SULFURREDUCENS; PEPTIDE FIBRILS; OUTER-MEMBRANE; NANOWIRES; CONDUCTION; PROTEIN; CYTOCHROME; BIOFILMS	For decades respiratory chain and photosystems were the main firing field of the studies devoted to mechanisms of electron transfer in proteins. The concept of conjugated lateral electron and transverse proton transport during cellular respiration and photosynthesis, which was formulated in the beginning of 1960-s, has been confirmed by thousands of experiments. However, charge transfer in recently discovered bacterial nanofilaments produced by various electrogenic bacteria is regarded currently outside of electron and proton conjugation concept. Here we report the new study of charge transfer within nanofilaments produced by Shewanella oneidensis MR-1 conducted in atmosphere of different relative humidity (RH). We utilize impedance spectroscopy and DC (direct current) transport measurements to find out the peculiarities of conductivity and Raman spectroscopy to analyze the nanofilaments' composition. Data analysis demonstrates that apparent conductivity of nanofilaments has crucial sensitivity to humidity and contains several components including one with unusual behavior which we assign to electron transport. We demonstrate that in the case of Shewanella oneidensis MR-1 charge transfer within these objects is strongly mediated by water. Basing on current data analysis of conductivity we conclude that the studied filaments of Shewanella oneidensis MR-1 are capable of hybrid (conjugated) electron and ion conductivity.	[Grebenko, Artem; Dremov, Vyacheslav; Barzilovich, Petr; Bubis, Anton; Gagkaeva, Zarina; Chernov, Timur; Korostylev, Evgeny; Gorshunov, Boris; Motovilov, Konstantin] Moscow Inst Phys & Technol, Inst lane 9, Dolgoprudnyi, Russia; [Grebenko, Artem; Dremov, Vyacheslav; Bubis, Anton] RAS, Inst Solid State Phys, Acad Osipyana St 2, Chernogolovka, Russia; [Barzilovich, Petr; Chernov, Timur] RAS, Inst Problems Chem Phys, Acad Semenov Ave 1, Chernogolovka, Russia; [Sidoruk, Konstantin; Voeikova, Tatiyana] Inst Genet & Select Ind Microorganisms, Sci Ctr Russian Federat Res, 1st Dorozhniy Pr 1, Moscow, Russia	Moscow Institute of Physics & Technology; Russian Academy of Sciences; Osipyan Institute of Solid State Physics RAS; Russian Academy of Sciences; Institute of Problems of Chemical Physics of the Russian Academy of Sciences; National Research Centre - Kurchatov Institute; Institute of Genetics & Selection of Industrial Microorganisms	Grebenko, A (corresponding author), Moscow Inst Phys & Technol, Inst lane 9, Dolgoprudnyi, Russia.; Grebenko, A (corresponding author), RAS, Inst Solid State Phys, Acad Osipyana St 2, Chernogolovka, Russia.	grebenko@phystech.edu; k.a.motovilov@gmail.com	Voeikova, Tatyana/AAX-5925-2021; Gorshunov, Boris P./J-3928-2013; Gagkayeva, Zarina/F-5297-2018; Motovilov, Konstantin/AAP-1218-2021; Motovilov, Konstantin A/I-8083-2015; Сидорук, Константин/CAH-4222-2022; Grebenko, Artem/I-7377-2015	Voeikova, Tatyana/0000-0001-8864-9266; Gorshunov, Boris P./0000-0001-8882-3930; Gagkayeva, Zarina/0000-0002-6973-4884; Motovilov, Konstantin A/0000-0001-7460-7524; Сидорук, Константин/0000-0001-8952-5409; Grebenko, Artem/0000-0003-3193-4386; Chernov, Timur/0000-0002-7784-7045	OPTEC; Russian Ministry of Education and Science (Program 5 top 100) [N3.9896.2017/BY, 14Y.26.31.0007]; RFBR [16-34-00812, 15-02-04285, 15-52-78023, 16-32-00805, 13-02-12127]; Ministry of Education and Science of the Russian Federation [RFMEFI59417X0014]; Ministry of Education and Science of the Russian Federation	OPTEC; Russian Ministry of Education and Science (Program 5 top 100); RFBR(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	This work is funded by OPTEC grant for young scientists, Russian Ministry of Education and Science (Program 5 top 100), grant N3.9896.2017/BY and grant No.14Y.26.31.0007, RFBR Grants Nr. 16-34-00812, 15-02-04285, 15-52-78023, 16-32-00805 and 13-02-12127. This work was performed using equipment of MIPT Shared Facilities Center and with financial support from the Ministry of Education and Science of the Russian Federation (Grant No. RFMEFI59417X0014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was performed using equipment of MIPT Shared Facilities Center and with financial support from the Ministry of Education and Science of the Russian Federation. We want to thank Aleksander Van'kov for SERS measurements, Evgeniy Ukshe for impedance interpretation and help with equivalent scheme calculations, Yulia Komarova for Focused Ion Beam FEI Versa 3D operation, Danila Matveev for Carl Zeiss Supra 50 VP electron microscope operation and Ivan Ohrimenko for the assistance with the procedure of extraction and purification of nanofilaments. We also want to thank Galina Tsirlina for fruitful discussions.	Adhikari RY, 2016, RSC ADV, V6, P8363, DOI 10.1039/c5ra28092c; Alvarez-Paggi D, 2014, BBA-BIOENERGETICS, V1837, P1196, DOI 10.1016/j.bbabio.2014.01.019; Amit M, 2014, ADV FUNCT MATER, V24, P5873, DOI 10.1002/adfm.201401111; Amit M, 2014, ISR J CHEM, V54, P703, DOI 10.1002/ijch.201400025; Ashkenasy N, 2006, SMALL, V2, P99, DOI 10.1002/smll.200500252; Barsoukov E, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, P1, DOI 10.1002/0471716243; Breuer M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1117; Brunel D, 2011, MICROELECTRON ENG, V88, P1569, DOI 10.1016/j.mee.2011.03.011; Canet-Ferrer J, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/39/395703; EATON P, 2010, PROGR SURFACE SCI, V41, P3; Edwards PP, 2008, ANGEW CHEM INT EDIT, V47, P6758, DOI 10.1002/anie.200703177; El-Naggar MY, 2008, BIOPHYS J, V95, pL10, DOI 10.1529/biophysj.108.134411; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; Firer-Sherwood MA, 2011, J PHYS CHEM B, V115, P11208, DOI 10.1021/jp203603r; Gates BD, 2004, ANNU REV MATER RES, V34, P339, DOI 10.1146/annurev.matsci.34.052803.091100; Gorby Y, 2006, P NATL ACAD SCI USA, V106, P9535; Gralnick JA, 2007, MOL MICROBIOL, V65, P1, DOI 10.1111/j.1365-2958.2007.05778.x; Ing NL, 2017, PHYS CHEM CHEM PHYS, V19, P21791, DOI 10.1039/c7cp03651e; Ivnitski D, 2016, ANGEW CHEM INT EDIT, V55, P9988, DOI 10.1002/anie.201604833; Kotloski NJ, 2013, MBIO, V4, DOI 10.1128/mBio.00553-12; Lampa-Pastirk S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23517; Lebedev N, 2015, J POLYM SCI POL PHYS, V53, P1706, DOI 10.1002/polb.23809; Leung KM, 2013, NANO LETT, V13, P2407, DOI 10.1021/nl400237p; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Long Y, 2010, REV ELECT TRANSPORT; Malvankar NS, 2012, CHEMSUSCHEM, V5, P1039, DOI 10.1002/cssc.201100733; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Malvankar NS, 2015, STRUCTURAL BASIS MET, V6, P1; Malvankar NS, 2014, NAT NANOTECHNOL, P1; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Morishita A, 2016, J ELECTROCHEM SOC, V163, pG166, DOI 10.1149/2.1251610jes; Mostert AB, 2012, P NATL ACAD SCI USA, V109, P8943, DOI 10.1073/pnas.1119948109; Motovilov KA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15693-y; Phan H, 2016, PHYS CHEM CHEM PHYS, V18, P17815, DOI 10.1039/c6cp03583c; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; Polizzi NF, 2012, FARADAY DISCUSS, V155, P43, DOI 10.1039/c1fd00098e; Powell M.R., 1970, BIOENERGETICS, V1, P493, DOI [DOI 10.1007/BF01517187, 10.1007/BF01517187]; Preciado-Flores S, 2011, CHEM COMMUN, V47, P4129, DOI 10.1039/c0cc05517d; Ravindranath SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016634; Reardon PN, 2013, J BIOL CHEM, V288, P29260, DOI 10.1074/jbc.M113.498527; Richardson DJ, 2012, MOL MICROBIOL, V85, P201, DOI 10.1111/j.1365-2958.2012.08088.x; Richter H, 2009, ENERG ENVIRON SCI, V2, P506, DOI 10.1039/b816647a; Rienecker SB, 2015, J PHYS CHEM B, V119, P14994, DOI 10.1021/acs.jpcb.5b08970; ROSENBERG B, 1969, ANN NY ACAD SCI, V158, P161, DOI 10.1111/j.1749-6632.1969.tb56221.x; Shah A, 2015, CHEM SOC REV, V44, P1015, DOI 10.1039/c4cs00297k; Shi L, 2006, J BACTERIOL, V188, P4705, DOI 10.1128/JB.01966-05; SPIRO TG, 1976, J AM CHEM SOC, V98, P5482, DOI 10.1021/ja00434a013; Stepanova M, 2011, NANOFABRICATION TECH; Subramanian P, 2017, BIORXIV; Uchiyama T, 2006, VIB SPECTROSC, V42, P192, DOI 10.1016/j.vibspec.2006.02.008; Ukshe E, 1975, RUSS CHEM REV, VXLIV, P1979; Wang YM, 2013, LANGMUIR, V29, P950, DOI 10.1021/la303779y; Yardeni JL, 2016, NANOSCALE, V8, P2358, DOI 10.1039/c5nr06750b; Yates MD, 2016, ENERG ENVIRON SCI, V9, P3544, DOI 10.1039/c6ee02106a; Yates MD, 2015, PHYS CHEM CHEM PHYS, V17, P32564, DOI 10.1039/c5cp05152e; Yoho RA, 2014, CHEMSUSCHEM, V7, P3413, DOI 10.1002/cssc.201402589	57	7	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191289	10.1371/journal.pone.0191289	http://dx.doi.org/10.1371/journal.pone.0191289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351332	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300067
J	Kumar, P; van Son, M; Zheng, TT; Valdink, D; Raap, J; Kros, A; Huber, M				Kumar, Pravin; van Son, Martin; Zheng, Tingting; Valdink, Dayenne; Raap, Jan; Kros, Alexander; Huber, Martina			Coiled-coil formation of the membrane-fusion K/E peptides viewed by electron paramagnetic resonance	PLOS ONE			English	Article							COMPREHENSIVE SOFTWARE PACKAGE; DISTANCE MEASUREMENTS; EPR SPECTROSCOPY; DRUG-DELIVERY; PROTEIN; MODEL; BIOMACROMOLECULES; PEPTAIBOLS; MACHINERY; LIPOSOMES	The interaction of the complementary K (Ac-(KIAALKE)(3)-GW-NH2) and E (Ac-(EIAALEK)(3)-GY-NH2) peptides, components of the zipper of an artificial membrane fusion system (Robson Marsden H. et al. Angew Chemie Int Ed. 2009) is investigated by electron paramagnetic resonance (EPR). By frozen solution continuous-wave EPR and double electron-electron resonance (DEER), the distance between spin labels attached to the K-and to the E-peptide is measured. Three constructs of spin-labelled K-and E-peptides are used in five combinations for low temperature investigations. The K/E heterodimers are found to be parallel, in agreement with previous studies. Also, K homodimers in parallel orientation were observed, a finding that was not reported before. Comparison to room-temperature, solution EPR shows that the latter method is less specific to detect this peptide-peptide interaction. Combining frozen solution cw-EPR for short distances (1.8 nm to 2.0 nm) and DEER for longer distances thus proves versatile to detect the zipper interaction in membrane fusion. As the methodology can be applied to membrane samples, the approach presented suggests itself for in-situ studies of the complete membrane fusion process, opening up new avenues for the study of membrane fusion.	[Kumar, Pravin; van Son, Martin; Huber, Martina] Leiden Univ, Dept Phys, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands; [Zheng, Tingting; Valdink, Dayenne; Raap, Jan; Kros, Alexander] Leiden Univ, Leiden Inst Chem, Dept Supramol & Biomat Chem, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Huber, M (corresponding author), Leiden Univ, Dept Phys, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands.	huber@physics.leidenuniv.nl		kros, alexander/0000-0002-3983-3048; Kumar, Pravin/0000-0002-7966-578X	Foundation for Fundamental Research on Matter; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [10SMPA04]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), ECHO Grant [700.58.014]	Foundation for Fundamental Research on Matter(FOM (The Netherlands)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), ECHO Grant	This work was supported by the Foundation for Fundamental Research on Matter, which is part of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), grant 10SMPA04 (https://www.nwo.nl/) to PK and the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), ECHO Grant 700.58.014 (https://www.nwo.nl/) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagneris C, 2015, J BIOL CHEM, V290, P16539, DOI 10.1074/jbc.M114.622928; Bagneris C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3465; Banham JE, 2008, J MAGN RESON, V191, P202, DOI 10.1016/j.jmr.2007.11.023; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Gahloth D, 2016, STRUCTURE, V24, P2115, DOI 10.1016/j.str.2016.10.006; Hadley EB, 2008, P NATL ACAD SCI USA, V105, P530, DOI 10.1073/pnas.0709068105; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Huber M, 2013, R SOC CHEM, P115; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2002, CHEMPHYSCHEM, V3, P927, DOI 10.1002/1439-7641(20021115)3:11<927::AID-CPHC927>3.0.CO;2-Q; Jeschke G, 2002, MACROMOL RAPID COMM, V23, P227, DOI 10.1002/1521-3927(20020301)23:4<227::AID-MARC227>3.0.CO;2-D; Jeschke G, 2002, J MAGN RESON, V155, P72, DOI 10.1006/jmre.2001.2498; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Lindhout DA, 2004, BIOPOLYMERS, V75, P367, DOI 10.1002/bip.20150; Litowski JR, 2002, J BIOL CHEM, V277, P37272, DOI 10.1074/jbc.M204257200; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Marsden HR, 2008, J AM CHEM SOC, V130, P9386, DOI 10.1021/ja800254w; Marsden HR, 2009, ANGEW CHEM INT EDIT, V48, P2330, DOI 10.1002/anie.200804493; Milov AD, 2007, CHEM BIODIVERS, V4, P1243, DOI 10.1002/cbdv.200790107; Milov AD, 2016, BIOPOLYMERS, V106, P6, DOI 10.1002/bip.22713; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Rabe M, 2016, BIOPHYS J, V111, P2162, DOI 10.1016/j.bpj.2016.10.010; Rabe M, 2015, BIOPOLYMERS, V104, P65, DOI 10.1002/bip.22598; Rabe M, 2014, LANGMUIR, V30, P7724, DOI 10.1021/la500987c; SANSOM MSP, 1993, EUR BIOPHYS J BIOPHY, V22, P105, DOI 10.1007/BF00196915; Schiemann O, 2007, Q REV BIOPHYS, V40, P1, DOI 10.1017/S003358350700460X; Shi L, 2013, NAT PROTOC, V8, P935, DOI 10.1038/nprot.2013.048; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Steigmiller S, 2005, BBA-BIOENERGETICS, V1708, P143, DOI 10.1016/j.bbabio.2005.03.013; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; SUDHOF TC, 1993, CELL, V75, P1; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Versluis F, 2013, J AM CHEM SOC, V135, P8057, DOI 10.1021/ja4031227; Ward R, 2014, BIOPHYS J, V106, P834, DOI [10.1016/j.bpj.2014.01.008, 10.1016/j.bpj.20t4.01.008]; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yang J, 2016, ACS CENTRAL SCI, V2, P621, DOI 10.1021/acscentsci.6b00172; Yang J, 2016, ACS NANO, V10, P7428, DOI 10.1021/acsnano.6b01410; Zheng T., 2014, THESIS; Zheng TT, 2015, ORG BIOMOL CHEM, V13, P1159, DOI 10.1039/c4ob02125h	42	6	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191197	10.1371/journal.pone.0191197	http://dx.doi.org/10.1371/journal.pone.0191197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351320	gold, Green Published			2022-12-27	WOS:000422911300056
J	Merentie, M; Rissanen, R; Lottonen-Raikaslehto, L; Huusko, J; Gurzeler, E; Turunen, MP; Holappa, L; Makinen, P; Yla-Herttuala, S				Merentie, Mari; Rissanen, Riina; Lottonen-Raikaslehto, Line; Huusko, Jenni; Gurzeler, Erika; Turunen, Mikko P.; Holappa, Lari; Makinen, Petri; Yla-Herttuala, Seppo			Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice	PLOS ONE			English	Article							GROWTH FACTOR-D; MYOCARDIAL-INFARCTION; RNA INTERFERENCE; TIPTOP TRIAL; GENE-THERAPY; IN-VIVO; ANGIOGENESIS; INHIBITION; SYSTEM; NEOVASCULARIZATION	Vascular endothelial growth factor-A (VEGF-A) is the master regulator of angiogenesis, vascular permeability and growth. However, its role in mature blood vessels is still not well understood. To better understand the role of VEGF-A in the adult vasculature, we generated a VEGF-A knockdown mouse model carrying a doxycycline (dox)-regulatable short hairpin RNA (shRNA) transgene, which silences VEGF-A. The aim was to find the critical level of VEGF-A reduction for vascular well-being in vivo. In vitro, the dox-inducible lentiviral shRNA vector decreased VEGF-A expression efficiently and dose-dependently in mouse endothelial cells and cardiomyocytes. In the generated transgenic mice plasma VEGF-A levels decreased shortly after the dox treatment but returned back to normal after two weeks. VEGF-A expression decreased shortly after the dox treatment only in some tissues. Surprisingly, increasing the dox exposure time and dose led to elevated VEGF-A expression in some tissues of both wildtype and knockdown mice, suggesting that dox itself has an effect on VEGF-A expression. When the effect of dox on VEGF-A levels was further tested in naive/ non-transduced cells, the dox administration led to a decreased VEGF-A expression in endothelial cells but to an increased expression in cardiomyocytes. In conclusion, the VEGF-A knockdown was achieved in a dox-regulatable fashion with a VEGF-A shRNA vector in vitro, but not in the knockdown mouse model in vivo. Dox itself was found to regulate VEGF-A expression explaining the unexpected results in mice. The effect of dox on VEGF-A levels might at least partly explain its previously reported beneficial effects on myocardial and brain ischemia. Also, this effect on VEGF-A should be taken into account in all studies using dox-regulated vectors.	[Merentie, Mari; Rissanen, Riina; Lottonen-Raikaslehto, Line; Huusko, Jenni; Gurzeler, Erika; Turunen, Mikko P.; Holappa, Lari; Makinen, Petri; Yla-Herttuala, Seppo] Univ Eastern Finland, Fac Hlth Sci, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Yla-Herttuala, Seppo] Kuopio Univ Hosp, Gene Therapy Unit, Kuopio, Finland; [Yla-Herttuala, Seppo] Kuopio Univ Hosp, Heart Ctr, Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Yla-Herttuala, S (corresponding author), Univ Eastern Finland, Fac Hlth Sci, AI Virtanen Inst Mol Sci, Kuopio, Finland.; Yla-Herttuala, S (corresponding author), Kuopio Univ Hosp, Gene Therapy Unit, Kuopio, Finland.; Yla-Herttuala, S (corresponding author), Kuopio Univ Hosp, Heart Ctr, Kuopio, Finland.	seppo.ylaherttuala@uef.fi		Gurzeler, Erika/0000-0002-9772-6654	Finnish Academy of Excellence; ERC; EATRIS infrastructure National Virus Vector Laboratory for lentivirus production; Finnish Cultural Foundation; Aarne Koskelo Foundation; University of Kuopio Foundation; Finnish Foundation for Cardiovascular Research; Finnish Medical Foundation; Ida Montin Foundation; Paavo Nurmi Foudation; North Savo Regional Fund	Finnish Academy of Excellence; ERC(European Research Council (ERC)European Commission); EATRIS infrastructure National Virus Vector Laboratory for lentivirus production; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Aarne Koskelo Foundation; University of Kuopio Foundation; Finnish Foundation for Cardiovascular Research; Finnish Medical Foundation; Ida Montin Foundation; Paavo Nurmi Foudation; North Savo Regional Fund	This study was supported by Finnish Academy of Excellence, ERC and EATRIS infrastructure National Virus Vector Laboratory for lentivirus production, Finnish Cultural Foundation, Aarne Koskelo Foundation, University of Kuopio Foundation, Finnish Foundation for Cardiovascular Research, Finnish Medical Foundation, Ida Montin Foundation, Paavo Nurmi Foudation, and the North Savo Regional Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cerisano G, 2015, INT J CARDIOL, V197, P147, DOI 10.1016/j.ijcard.2015.06.024; Cerisano G, 2014, EUR HEART J, V35, P184, DOI 10.1093/eurheartj/eht420; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Corbel SY, 2002, CURR OPIN BIOTECH, V13, P448, DOI 10.1016/S0958-1669(02)00361-0; Dijkstra MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06238; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Filleur S, 2003, CANCER RES, V63, P3919; Frka K, 2009, J BIOTECHNOL, V141, P8, DOI 10.1016/j.jbiotec.2009.02.013; Griffin MO, 2011, PHARMACOL RES, V63, P102, DOI 10.1016/j.phrs.2010.10.004; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Huusko J, 2007, GENERATION OF TRANSG, P91; Karkkainen AM, 2009, BLOOD, V113, P4468, DOI 10.1182/blood-2008-07-171108; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; Kim B, 2004, AM J PATHOL, V165, P2177, DOI 10.1016/S0002-9440(10)63267-1; Koistinaho M, 2005, J CEREBR BLOOD F MET, V25, P460, DOI 10.1038/sj.jcbfm.9600040; Koponen JK, 2003, GENE THER, V10, P459, DOI 10.1038/sj.gt.3301889; Kotimaa AA, 2012, J GENE MED, V14, P182, DOI 10.1002/jgm.2608; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Nanda N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151539; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Ratner M, 2004, NAT BIOTECHNOL, V22, P1198, DOI 10.1038/nbt1004-1198; Reich S, 2003, MOL VIS, V9, P210; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Singh N, 2007, CORNEA, V26, P65; Smith GA, 2015, J INHERIT METAB DIS; Stechmiller J, 2010, BIOL RES NURS, V11, P336, DOI 10.1177/1099800409346333; Turunen MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089979; Villarreal FJ, 2003, CIRCULATION, V108, P1487, DOI 10.1161/01.CIR.0000089090.05757.34; Wideroe M, 2012, EUR J NEUROSCI, V36, P2006, DOI 10.1111/j.1460-9568.2012.08114.x; Yla-Herttuala S, 2017, EUR HEART J, V38, P1365, DOI 10.1093/eurheartj/ehw547; Yla-Herttuala S, 2017, MOL THER, V25, P1095, DOI 10.1016/j.ymthe.2017.03.027; Yoo JY, 2007, MOL THER, V15, P295, DOI 10.1038/sj.mt.6300023	43	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190981	10.1371/journal.pone.0190981	http://dx.doi.org/10.1371/journal.pone.0190981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351307	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300034
J	Monico, J; Miller, B; Rezeanu, L; May, W; Sullivan, DC				Monico, Jesus; Miller, Brandon; Rezeanu, Luminita; May, Warren; Sullivan, Donna C.			Fibroblast growth factor receptor 1 amplification in laryngeal squamous cell carcinoma	PLOS ONE			English	Article							FGFR1 AMPLIFICATION; GENE AMPLIFICATION; EXPRESSION; BREAST; HEAD; QUANTITATION; SENSITIVITY; SMOKING; CANCER	Fibroblast growth factor receptor 1 (FGFR1) has been noted to be amplified in a variety of squamous cell carcinomas (SCCa) of the head, neck, and lung and increased copy number (CN) is a predictor of poor outcomes. FGFR1 is a therapeutic target for lung SCCa and inhibition therapy is currently in clinical trials. Absolute quantification of FGFR1 from formalin fixed paraffin embedded (FFPE) tissue of laryngeal SCCa was examined in this retrospective study. A droplet digital polymerase chain reaction (ddPCR) was used for absolute quantitation of the FGFR1 gene CN. Of the 74 samples analyzed, FGFR1 CN analysis revealed 54% of samples had CN greater than 2 copies/cell (1.8 +/- 2.2 copies/cell), and 38% had CN values greater than 3. The mean and standard deviation FGFR1 CN was 4.17 +/- 1.46 CN for African American patients (n = 41) and 3.78 +/- 1.85 CN for Caucasian patients (n = 31). Further, 60.9% of specimens from African Americans demonstrated increased FGFR1 CN compared to 48.4% of Caucasians. Two SCCA samples from Native American demonstrated increased FGFR1 CN (4.19 and 3.01 CN). The level of FGFR1 amplification did not correlate with tumor stage, lymph node staging, or metastasis. In this population, the proportion of patient samples with an FGFR1 amplification was three times higher than in reported for SCCA of the head and neck. Further, increased FGFR1 CN was observed in two racial groups not previously reported: African Americans and Native Americans. However, FGFR1 amplification is not prognostic in laryngeal squamous cell carcinomas.	[Monico, Jesus; Rezeanu, Luminita] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Miller, Brandon] Univ Mississippi, Med Ctr, Dept Otolaryngol & Commun Sci, Jackson, MS 39216 USA; [May, Warren] Univ Mississippi, Med Ctr, Dept Biostat, Jackson, MS 39216 USA; [Sullivan, Donna C.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Monico, J (corresponding author), Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA.	jmonico@umc.edu		Sullivan, Donna/0000-0001-5413-4176				Bonin S, 2003, J CLIN PATHOL-MOL PA, V56, P184, DOI 10.1136/mp.56.3.184; Craddock KJ, 2013, J THORAC ONCOL, V8, P1371, DOI 10.1097/JTO.0b013e3182a46fe9; Freier K, 2007, ORAL ONCOL, V43, P60, DOI 10.1016/j.oraloncology.2006.01.005; Goke F, 2015, CLIN CANCER RES, V21, P4356, DOI 10.1158/1078-0432.CCR-14-3357; Goke F, 2013, MODERN PATHOL, V26, P1298, DOI 10.1038/modpathol.2013.58; Goke F, 2012, CHEST, V142, P1020, DOI 10.1378/chest.11-2943; Heredia NJ, 2013, METHODS, V59, pS20, DOI 10.1016/j.ymeth.2012.09.012; Ipenburg NA, 2016, TARGET ONCOL, V11, P17, DOI 10.1007/s11523-015-0374-9; Kim HR, 2013, J CLIN ONCOL, V31, P731, DOI 10.1200/JCO.2012.43.8622; Kim Y, 2015, IEEE T VEH TECHNOL, V64, P2, DOI 10.1109/TVT.2014.2321346; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Nadauld L, 2012, TRANSL MED, V2, P107; Pirker R, 2010, LANCET ONCOL, V11, P121; Russell PA, 2014, MODERN PATHOL, V27, P1621, DOI 10.1038/modpathol.2014.71; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Seiwert TY, 2015, CLIN CANCER RES, V21, P632, DOI 10.1158/1078-0432.CCR-13-3310; Seo AN, 2014, VIRCHOWS ARCH, V465, P547, DOI 10.1007/s00428-014-1634-2; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Weiss J, 2010, SCI TRANSL MED, V2, P1; Young RJ, 2013, ORAL ONCOL, V49, P576, DOI 10.1016/j.oraloncology.2013.01.006; Zhu YZ, 2016, EXP MOL PATHOL, V100, P287, DOI 10.1016/j.yexmp.2015.11.027	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0186185	10.1371/journal.pone.0186185	http://dx.doi.org/10.1371/journal.pone.0186185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351293	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300003
J	Sierra, LJ; Brown, AG; Barila, GO; Anton, L; Barnum, CE; Shetye, SS; Soslowsky, LJ; Elovitz, MA				Sierra, Luz-Jeannette; Brown, Amy G.; Barila, Guillermo O.; Anton, Lauren; Barnum, Carrie E.; Shetye, Snehal S.; Soslowsky, Louis J.; Elovitz, Michal A.			Colonization of the cervicovaginal space with Gardnerella vaginalis leads to local inflammation and cervical remodeling in pregnant mice	PLOS ONE			English	Article							SPONTANEOUS PRETERM BIRTH; BACTERIAL VAGINOSIS; MEDROXYPROGESTERONE ACETATE; MYCOPLASMA-HOMINIS; MOUSE MODEL; WOMEN; LABOR; PARTURITION; INFECTION; ASSOCIATION	The role of the cervicovaginal (CV) microbiome in regulating cervical function during pregnancy is poorly understood. Gardnerella vaginalis (G. vaginalis) is the most common bacteria associated with the diagnosis of bacterial vaginosis (BV). While BV has been associated with preterm birth (PTB), clinical trials targeting BV do not decrease PTB rates. It remains unknown if G. vaginalis is capable of triggering molecular, biomechanical and cellular events that could lead to PTB. The objective of this study was to determine if cervicovaginal colonization with G. vaginalis, in pregnant mice, induced cervical remodeling and modified cervical function. CD-1 timed-pregnant mice received a 5X10(8) CFU/mL intravaginal inoculation of G. vaginalis or control on embryonic day 12 (E12) and E13. On E15, the mice were sacrificed and cervicovaginal fluid (CVF), amniotic fluid (AF), cervix, uterus, placentas and fetal membranes (FM) were collected. Genomic DNA was isolated from the CVF, placenta, uterus and FM and QPCR was performed to confirm colonization. IL-6 was measured in the CVF and AF and soluble e-cadherin (seCAD) was assessed in the CVF by ELISA. RNA was extracted from the cervices to evaluate IL-10, IL-8, IL-1 beta, TNF-alpha, Tff-1, SPINK-5, HAS-1 and LOX expression via QPCR. Mucicarmine and trichrome staining was used to assess cervical mucin and collagen. Biomechanical properties of the cervix were studied using quasi-static tensile load-to-failure biomechanical tests. G. vaginalis successfully colonized the CV space. This colonization induced immune responses (increased IL-6 levels in CVF and AF, increased mRNA expression of cervical cytokines), altered the epithelial barrier (increased seCAD in the CVF), induced cervical remodeling (increased mucin production, altered collagen) and altered cervical biomechanical properties (a decrease in biomechanical modulus and an increase in maximum strain). The ability of G. vaginalis to induce these molecular, immune, cellular and biomechanical changes suggests that this bacterium may play a pathogenic role in premature cervical remodeling leading to PTB.	[Sierra, Luz-Jeannette; Brown, Amy G.; Barila, Guillermo O.; Anton, Lauren; Elovitz, Michal A.] Univ Penn, Maternal Child Hlth Res Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA; [Barnum, Carrie E.; Shetye, Snehal S.; Soslowsky, Louis J.] Univ Penn, McKay Orthoped Res Lab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Sierra, LJ (corresponding author), Univ Penn, Maternal Child Hlth Res Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA.	luzjeasi@pennmedicine.upenn.edu	Shetye, Snehal/AAJ-3805-2020	Elovitz, Michal/0000-0001-7554-7180; Shetye, Snehal/0000-0001-7469-3039	March of Dimes Prematurity Research Center at the University of Pennsylvania [22-FY17-890]; Maternal and Child Health Research Center at the University of Pennsylvania; Penn Center for Musculoskeletal Disorders [P30 AR069619]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR069619] Funding Source: NIH RePORTER	March of Dimes Prematurity Research Center at the University of Pennsylvania; Maternal and Child Health Research Center at the University of Pennsylvania; Penn Center for Musculoskeletal Disorders; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This paper was supported in part by the March of Dimes Prematurity Research Center at the University of Pennsylvania (22-FY17-890) (M. A. Elovitr), The Maternal and Child Health Research Center at the University of Pennsylvania and the Penn Center for Musculoskeletal Disorders (P30 AR069619) (L. J. Soslowsky). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Children's Hospital of Philadelphia Pathology core, especially Socrates Agrio and Elizabeth A. Tomeski. This paper was supported in part by the March of Dimes Prematurity Research Center at the University of Pennsylvania (22-FY17-890), The Maternity and Child Health Research Center at the University of Pennsylvania and the Penn Center for Musculoskeletal Disorders (P30 AR069619).	Abramovici A, 2015, AM J PERINAT, V32, P1119, DOI 10.1055/s-0035-1549294; Akgul Y, 2014, J CLIN INVEST, V124, P5481, DOI 10.1172/JCI78765; Akins ML, 2011, BIOL REPROD, V84, P1053, DOI 10.1095/biolreprod.110.089599; Al-Harthi L, 1998, J INFECT DIS, V178, P1343, DOI 10.1086/314444; Al-Harthi L, 1999, J ACQ IMMUN DEF SYND, V21, P194, DOI 10.1097/00126334-199907010-00003; Anton L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03217-7; Bai GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036934; Barmeyer C, 2017, J GASTROENTEROL, V52, P1090, DOI 10.1007/s00535-017-1309-2; Barmeyer C, 2015, SEMIN CELL DEV BIOL, V42, P30, DOI 10.1016/j.semcdb.2015.05.006; Barnum CE, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036473; Bastek JA, 2013, OBSTET GYNECOL, V122, P283, DOI 10.1097/AOG.0b013e31829ab714; Behrman RE, 2007, PRETERM BIRTH CAUSES; Brabant G, 2016, J GYNECOL OBST BIO R, V45, P1247, DOI 10.1016/j.jgyn.2016.09.014; Breshears LM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0608-0; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Burgmeier C, 2015, J PEDIATR SURG, V50, P478, DOI 10.1016/j.jpedsurg.2014.08.015; Callahan BJ, 2017, P NATL ACAD SCI USA, V114, P9966, DOI 10.1073/pnas.1705899114; Cohn JA, 2005, JAIDS-J ACQ IMM DEF, V39, P340, DOI 10.1097/01.qai.0000146599.47925.e0; Cornick S, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.982426; de Tejada BM, 1998, MED CLIN-BARCELONA, V110, P201; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Durer U, 2007, CELL PHYSIOL BIOCHEM, V20, P329, DOI 10.1159/000107519; Elovitz M, 2004, AM J OBSTET GYNECOL, V190, P693, DOI 10.1016/j.ajog.2003.10.693; Elovitz MA, 2008, J MATERN-FETAL NEO M, V21, P223, DOI 10.1080/14767050801923680; Favata M, 2006, J ORTHOP RES, V24, P2124, DOI 10.1002/jor.20271; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Gilbert NM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006238; Gilbert NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059539; Gonzalez JM, 2009, BIOL REPROD, V81, P1226, DOI 10.1095/biolreprod.108.075309; Hardy L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172522; Hilbert DW, 2017, EUR J CLIN MICROBIOL, V36, P1269, DOI 10.1007/s10096-017-2933-8; HOLST E, 1994, J CLIN MICROBIOL, V32, P176, DOI 10.1128/JCM.32.1.176-186.1994; Isik G, 2016, J CYTOL, V33, P135, DOI 10.4103/0970-9371.188050; Kimberlin DF, 1998, SEMIN PERINATOL, V22, P242, DOI 10.1016/S0146-0005(98)80012-8; Lechuga S, 2017, BBA-MOL CELL RES, V1864, P1183, DOI 10.1016/j.bbamcr.2017.03.007; Luettig J, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.977176; Luong ML, 2010, J OBSTET GYNAECOL CA, V32, P313, DOI 10.1016/S1701-2163(16)34474-7; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; McDonald HM, 1997, BRIT J OBSTET GYNAEC, V104, P1391, DOI 10.1111/j.1471-0528.1997.tb11009.x; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mielczarek E, 2016, INFECTION, V44, P447, DOI 10.1007/s15010-015-0860-0; Nallasamy S, 2017, ENDOCRINOLOGY, V158, P950, DOI 10.1210/en.2016-1930; Nallasamy S, 2017, SEMIN REPROD MED, V35, P190, DOI 10.1055/s-0037-1599091; Nelson DB, 2016, ANAEROBE, V42, P67, DOI 10.1016/j.anaerobe.2016.09.001; Nelson DB, 2009, J PERINAT MED, V37, P130, DOI 10.1515/JPM.2009.026; Nold C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.036; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Read CP, 2007, REPRODUCTION, V134, P327, DOI 10.1530/REP-07-0032; Reid G, 2003, AM J OBSTET GYNECOL, V189, P1202, DOI 10.1067/S0002-9378(03)00495-2; Robinson LS, 2016, GENOME ANNOUNCEMENTS, V4; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Sha BE, 2005, J CLIN MICROBIOL, V43, P4607, DOI 10.1128/JCM.43.9.4607-4612.2005; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; St John EP, 2009, VIROLOGY, V385, P22, DOI 10.1016/j.virol.2008.08.031; Straach KJ, 2005, GLYCOBIOLOGY, V15, P55, DOI 10.1093/glycob/cwh137; Thorsen P, 2006, J MATERN-FETAL NEO M, V19, P1, DOI 10.1080/14767050500361604; Timmons Brenda C, 2007, Reprod Sci, V14, P53, DOI 10.1177/1933719107309587; Timmons BC, 2007, ENDOCRINOLOGY, V148, P1278, DOI 10.1210/en.2006-0851; Timmons BC, 2014, ENDOCRINOLOGY, V155, P287, DOI 10.1210/en.2013-1304; Vodstrcil LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171856; Yellon SM, 2009, REPROD SCI, V16, P257, DOI 10.1177/1933719108325757; Yoshida K, 2016, ACTA BIOMATER, V36, P195, DOI 10.1016/j.actbio.2016.03.005; Yoshida K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112391	69	32	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191524	10.1371/journal.pone.0191524	http://dx.doi.org/10.1371/journal.pone.0191524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346438	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500059
J	Wong, YK; Wong, WW; Lui, KFH; Wong, ACN				Wong, Yetta Kwailing; Wong, Wing Wah; Lui, Kelvin F. H.; Wong, Alan C. -N.			Revisiting facial resemblance in couples	PLOS ONE			English	Article							MARITAL SATISFACTION; PERSONALITY; ATTRACTIVENESS; PERCEPTION; SYMMETRY; FACES	It is widely believed that couples look alike. Consistently, previous research reported higher facial similarity for couples than non-couples, and that facial similarity predicts marital satisfaction. However, it is unclear if facial similarity in couples shown in previous studies was solely driven by extrinsic features like hairstyle, glasses, etc. Also unclear is what attributes are perceived as similar from the faces of a couple. In three experiments, we showed that faces were considered more similar in couples than non-couples even without extrinsic features. Personality and age perceived from faces were also more similar in couples. Importantly, by matching pairs of faces according to their perceived personality, we found that a higher similarity in the perceived personality of a face pair led to higher facial similarity and couple likelihood ratings. These findings suggest that, instead of a result of pure physical analyses, facial similarity in couples is partly based on active social cognitive judgments on perceived personality, which may reveal the actual personality of the couples and thus inform relationship quality.	[Wong, Yetta Kwailing] Chinese Univ Hong Kong, Fac Educ, Dept Educ Psychol, Shatin, Hong Kong, Peoples R China; [Wong, Wing Wah] City Univ Hong Kong, Dept Appl Social Sci, Kowloon Tong, Hong Kong, Peoples R China; [Lui, Kelvin F. H.; Wong, Alan C. -N.] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; City University of Hong Kong; Chinese University of Hong Kong	Wong, YK (corresponding author), Chinese Univ Hong Kong, Fac Educ, Dept Educ Psychol, Shatin, Hong Kong, Peoples R China.; Wong, ACN (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.	yetta.wong@gmail.com; alanwong@cuhk.edu.hk	Wong, Alan C.-N./H-3414-2019; Lui, Kelvin Fai Hong/AAX-9734-2020	Wong, Alan C.-N./0000-0002-2129-3485; Lui, Kelvin Fai Hong/0000-0003-4818-3136	Department of Applied Social Sciences of City University of Hong Kong; Department of Psychology of the Chinese University of Hong Kong	Department of Applied Social Sciences of City University of Hong Kong; Department of Psychology of the Chinese University of Hong Kong	The study was funded by internal funding of the Department of Applied Social Sciences of City University of Hong Kong to YKW and WWW, and by internal funding of the Department of Psychology of the Chinese University of Hong Kong to AW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2004, EVOLUTIONARY PSYCHOL, V2, P177, DOI DOI 10.1177/1474704904002001223; Botwin MD, 1997, J PERS, V65, P107, DOI 10.1111/j.1467-6494.1997.tb00531.x; Burriss RP, 2011, PERS SOC PSYCHOL B, V37, P601, DOI 10.1177/0146167211399584; FEINGOLD A, 1988, PSYCHOL BULL, V104, P226, DOI 10.1037/0033-2909.104.2.226; Freeman JB, 2016, TRENDS COGN SCI, V20, P362, DOI 10.1016/j.tics.2016.03.003; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; GRIFFITHS RW, 1973, SOC BIOL, V20, P448, DOI 10.1080/19485565.1973.9988075; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; HINSZ VB, 1989, J SOC PERS RELAT, V6, P223, DOI 10.1177/026540758900600205; Honekopp J, 2004, HUM NATURE-INT BIOS, V15, P147, DOI 10.1007/s12110-004-1018-4; KELLY EL, 1987, J PERS SOC PSYCHOL, V52, P27, DOI 10.1037/0022-3514.52.1.27; Little AC, 2006, PERS INDIV DIFFER, V40, P973, DOI 10.1016/j.paid.2005.09.016; Little AC, 2007, BRIT J PSYCHOL, V98, P111, DOI 10.1348/000712606X109648; Little AC, 2006, PERS INDIV DIFFER, V41, P1107, DOI 10.1016/j.paid.2006.04.015; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; OToole AJ, 1997, PERCEPTION, V26, P719, DOI 10.1068/p260719; SPUHLER JN, 1968, EUGEN QUART, V15, P128, DOI 10.1080/19485565.1968.9987763; THIESSEN D, 1980, ETHOL SOCIOBIOL, V1, P111, DOI 10.1016/0162-3095(80)90003-5; ZAJONC RB, 1987, MOTIV EMOTION, V11, P335, DOI 10.1007/BF00992848	19	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191456	10.1371/journal.pone.0191456	http://dx.doi.org/10.1371/journal.pone.0191456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9PC	29346428	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500053
J	Chen, X; Zhang, HL; Wan, YJ; Chen, X; Li, YY				Chen, Xiao; Zhang, Hongling; Wan, Yanjian; Chen, Xi; Li, Yuanyuan			Determination of 2,4-Dichlorophenoxyacetic acid (2,4-D) in rat serum for pharmacokinetic studies with a simple HPLC method	PLOS ONE			English	Article							SPRAGUE-DAWLEY RATS; SYRIAN-HAMSTERS; B6C3F1 MICE; HERBICIDE; TOXICOLOGY; SAMPLES; UV	2,4-Dichlorophenoxyacetic acid (2,4-D) is a chlorophenoxy herbicide used worldwide. We describe a high-performance liquid chromatography (HPLC) method with UV detection for the determination of 2,4-D in female and male rat serum. This allows to observe the change of serum 2,4-D concentration in rats with time and its pharmacokinetics characteristics with a simple, rapid, optimized and validated method. The serum samples are pretreated and introduced into the HPLC system. The analytes are separated in a XDB-C-18 column with a mobile phase of acetonitrile (solvent A) and 0.02 M ammonium acetate (containing 0.1% formic acid) (solvent B) using a gradient elution at a flow rate of 1.0 mUmin. The wavelength for UV detection was set at 230 nm. Calibration curve for 2,4-D was constructed over a range of 0.1-400 mg/L. The method was successfully applied to study the pharmacokinetics of 2,4-D in rats in this study. After oral administration of 300 mg/kg and 60 mg/kg 2,4-D, the mean C-max values were 601.9 and 218.4 mg/L, the AUC(0 ->infinity) values were 23,722 and 4,127 mgxh/L and the clearance (CI) were 1.10 and 0.02 U(hxkg), respectively. The developed method was found to be specific, precise, reproducible and rapid.	[Chen, Xiao] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China; [Zhang, Hongling] Wuhan Polytech Univ, Coll Hlth Sci & Nursing, Wuhan, Hubei, Peoples R China; [Wan, Yanjian] Wuhan Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China; [Chen, Xi; Li, Yuanyuan] Minist Educ, Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China; [Chen, Xi; Li, Yuanyuan] Minist Environm Protect, Wuhan, Hubei, Peoples R China; [Chen, Xi; Li, Yuanyuan] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, State Key Lab Environm Hlth Incubating, Wuhan, Hubei, Peoples R China	Wuhan Polytechnic University; Wuhan Polytechnic University; Huazhong University of Science & Technology	Zhang, HL (corresponding author), Wuhan Polytech Univ, Coll Hlth Sci & Nursing, Wuhan, Hubei, Peoples R China.; Li, YY (corresponding author), Minist Educ, Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China.; Li, YY (corresponding author), Minist Environm Protect, Wuhan, Hubei, Peoples R China.; Li, YY (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, State Key Lab Environm Hlth Incubating, Wuhan, Hubei, Peoples R China.	zhl1965@whpu.edu.cn; liyuanyuan@hust.edu.cn			National Natural Science Foundation of China [81372959]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81372959) to Y.L. The funder had a role in the preparation of the manuscript.	Alfarra HY, 2016, IMPACT 2 4 DICHLOROP; Amani V, 2011, ANAL METHODS-UK, V3, P2261, DOI 10.1039/c1ay05150d; Aydin H., 2006, FRESENIUS ENV B, V2; Bus JS, 2007, CROP PROT, V26, P266, DOI 10.1016/j.cropro.2005.06.010; Charles JM, 2001, TOXICOL SCI, V60, P121, DOI 10.1093/toxsci/60.1.121; Dakhakhni TH, 2016, EUROPEAN BIOPHYSICS, V45, P1; de Menezes CC, 2011, PESTIC BIOCHEM PHYS, V100, P145, DOI 10.1016/j.pestbp.2011.03.002; Dickow LM, 2001, J ANAL TOXICOL, V25, P35, DOI 10.1093/jat/25.1.35; Freese C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091003; Goggin DE, 2016, J EXP BOT, V67, P3223, DOI 10.1093/jxb/erw120; Gokmen V, 1996, J LIQ CHROMATOGR R T, V19, P1917, DOI 10.1080/10826079608014015; Griffin RJ, 1997, J TOXICOL ENV HEALTH, V51, P401, DOI 10.1080/009841097160014; Griffin RJ, 1997, DRUG METAB DISPOS, V25, P1065; Hassanein KMA, 2012, VET WORLD, V5, P24, DOI 10.5455/vetworld.2012.24-30; Ibrahim MA, 1992, ENVIRON HEALTH PERSP, V96, P213; Kashyap SM, 2005, J CHROMATOGR SCI, V43, P81, DOI 10.1093/chromsci/43.2.81; Lu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065719; MUNRO IC, 1992, J AM COLL TOXICOL, V11, P559, DOI 10.3109/10915819209141893; Obidike I. R., 2012, Comparative Clinical Pathology, V21, P1457, DOI 10.1007/s00580-011-1314-4; Oghabian Z, 2014, INT J MED TOXICLOGY, V4, P104; OLIVEIRA GH, 1995, J ANAL TOXICOL, V19, P251, DOI 10.1093/jat/19.4.251; Paulino CA, 1996, VET HUM TOXICOL, V38, P348; Peller J, 2004, J PHYS CHEM A, V108, P10925, DOI 10.1021/jp046450l; Tayeb W, 2012, TOXICOL MECH METHOD, V22, P696, DOI 10.3109/15376516.2012.717650; Van Ravenzwaay B, 2003, XENOBIOTICA, V33, P805, DOI 10.1080/0049825031000135405	25	8	9	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191149	10.1371/journal.pone.0191149	http://dx.doi.org/10.1371/journal.pone.0191149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342170	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800049
J	Szabo, E; Turk, D; Telbisz, A; Kucsma, N; Horvath, T; Szakacs, G; Homolya, L; Sarkadi, B; Varady, G				Szabo, Edit; Tuerk, Dora; Telbisz, Agnes; Kucsma, Nora; Horvath, Tamas; Szakacs, Gergely; Homolya, Laszlo; Sarkadi, Balazs; Varady, Gyoergy			A new fluorescent dye accumulation assay for parallel measurements of the ABCG2, ABCB1 and ABCC1 multidrug transporter functions	PLOS ONE			English	Article							SIDE POPULATION; P-GLYCOPROTEIN; RESISTANCE; MODIFY; CELLS	ABC multidrug transporters are key players in cancer multidrug resistance and in general xenobiotic elimination, thus their functional assays provide important tools for research and diagnostic applications. In this study we have examined the potential interactions of three key human ABC multidrug transporters with PhenGreen diacetate (PGD), a cell permeable fluorescent metal ion indicator. The non-fluorescent, hydrophobic PGD rapidly enters the cells and, after cleavage by cellular esterases, in the absence of quenching metal ions, PhenGreen (PG) becomes highly fluorescent. We found that in cells expressing functional ABCG2, ABCB1, or ABCC1 transporters, cellular PG fluorescence is strongly reduced. This fluorescence signal in the presence of specific transporter inhibitors is increased to the fluorescence levels in the control cells. Thus the PG accumulation assay is a new, unique tool for the parallel determination of the function of the ABCG2, ABCB1, and ABCC1 multidrug transporters. Since PG has very low cellular toxicity, the PG accumulation assay also allows the selection, separation and culturing of selected cell populations expressing either of these transporters.	[Szabo, Edit; Telbisz, Agnes; Kucsma, Nora; Horvath, Tamas; Szakacs, Gergely; Homolya, Laszlo; Sarkadi, Balazs; Varady, Gyoergy] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Tuerk, Dora] Natl Inst Oncol, Dept Expt Pharmacol, Budapest, Hungary; [Szakacs, Gergely] Med Univ Vienna, Inst Canc Res, Vienna, Austria; [Sarkadi, Balazs] Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; National Institute of Oncology Hungary; Medical University of Vienna; Semmelweis University	Varady, G (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary.	varady.gyorgy@ttk.mta.hu	Homolya, Laszlo/N-1154-2016; György, Várady/J-8118-2017; Szakacs, Gergely/A-2580-2009	Homolya, Laszlo/0000-0003-1639-8140; Szakacs, Gergely/0000-0002-9311-7827; Turk, Dora/0000-0003-1215-3453; Gyorgy, Varady/0000-0003-2012-9680; Szabo, Edit Zsuzsanna/0000-0002-0150-0926	National Research, Development and Innovation Fund (Hungary) [TET_13_DST-1-2013-0012, OTKA_K 115375, FIEK_16-1-2016-0005]; Momentum Program of the Hungarian Academy of Sciences [LP2012-025]	National Research, Development and Innovation Fund (Hungary); Momentum Program of the Hungarian Academy of Sciences	This research has been supported by the National Research, Development and Innovation Fund (Hungary) (grant numbers: TET_13_DST-1-2013-0012, to G.Sz, OTKA_K 115375 to B.S., and FIEK_16-1-2016-0005 to L.H. and B.S.), as well as by the Momentum Program of the Hungarian Academy of Sciences (LP2012-025).	Boesch M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1652389; Boesch M, 2012, CYTOM PART A, V81A, P517, DOI 10.1002/cyto.a.22038; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Elkind NB, 2005, MULTIDRUG TRANSPORTE, P1770; Gorbunov NV, 2012, BIOMETALS, V25, P203, DOI 10.1007/s10534-011-9498-2; Hegedus C, 2009, ADV DRUG DELIVER REV, V61, P47, DOI 10.1016/j.addr.2008.09.007; Hollo Z, 1998, ANTICANCER RES, V18, P2981; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Homolya L, 1996, BRIT J CANCER, V73, P849, DOI 10.1038/bjc.1996.151; Homolya L, 2011, BBA-BIOMEMBRANES, V1808, P154, DOI 10.1016/j.bbamem.2010.07.031; Horsey AJ, 2016, BIOCHEM SOC T, V44, P824, DOI 10.1042/BST20160014; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Karaszi E, 2001, BRIT J HAEMATOL, V112, P308, DOI 10.1046/j.1365-2141.2001.02554.x; Kovacik J, 2014, PLANT PHYSIOL BIOCH, V80, P33, DOI 10.1016/j.plaphy.2014.03.015; Laszlo L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164426; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; Ma YM, 2015, METALLOMICS, V7, P212, DOI 10.1039/c4mt00214h; Mathew G, 2009, CELL CYCLE, V8, P1053, DOI 10.4161/cc.8.7.8043; Morisaki K, 2005, CANCER CHEMOTH PHARM, V56, P161, DOI 10.1007/s00280-004-0931-x; Nerada Z, 2016, CYTOM A; Ozvegy-Laczka C, 2005, J BIOL CHEM, V280, P4219, DOI 10.1074/jbc.M411338200; Robey RW, 2011, CURR PHARM BIOTECHNO, V12, P595; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; She JJ, 2008, CANCER BIOL THER, V7, P1663, DOI 10.4161/cbt.7.10.6637; Strouse JJ, 2013, ANAL BIOCHEM, V437, P77, DOI 10.1016/j.ab.2013.02.018; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Taylor NMI, 2017, NATURE, V546, P504, DOI 10.1038/nature22345; Telford WG, 2007, STEM CELLS, V25, P1029, DOI 10.1634/stemcells.2006-0567; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	31	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190629	10.1371/journal.pone.0190629	http://dx.doi.org/10.1371/journal.pone.0190629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342177	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000422653800027
J	Wedell-Neergaard, AS; Eriksen, L; Gronbaek, M; Pedersen, BK; Krogh-Madsen, R; Tolstrup, J				Wedell-Neergaard, Anne-Sophie; Eriksen, Louise; Gronbaek, Morten; Pedersen, Bente Klarlund; Krogh-Madsen, Rikke; Tolstrup, Janne			Low fitness is associated with abdominal adiposity and low-grade inflammation independent of BMI	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIORESPIRATORY FITNESS; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; BREAST-CANCER; NORMAL-WEIGHT; RISK; OBESITY; MORTALITY; FAT	Objective Up to 30% of obese individuals are metabolically healthy. Metabolically healthy obese (MHO) individuals are characterized by having low abdominal adiposity, low inflammation level and low risk of developing metabolic comorbidity. In this study, we hypothesize that cardiorespiratory fitness (fitness) is a determinant factor for the MHO individuals and aim to investigate the associations between fitness, abdominal adiposity and low-grade inflammation within different BMI categories. Method Data from 10,976 individuals from the general population, DANHES 2007-2008, on waist circumference, fitness and C-reactive protein (hsCRP) were analysed using multiple linear and median quantile regressions. Results In men, an inverse association between fitness (+5 mL min(-1) kg(-1)) and waist circumference (-1.45 cm; 95% CI: -1.55 to -1.35 cm; p<0.001), and an inverse association between fitness (+5 mL min(-1) kg(-1)) and hsCRP (-0.22 mg/L; 95% CI: -0.255 to -0.185 mg/L; p<0.001) was found, all independent of BMI. Similarly in women, an inverse association between fitness (+5 mL min(-1) kg(-1)) and waist circumference (-1.15 cm; 95% CI: -1.25 to -1.0 cm; p<0.001), and an inverse association between fitness (+5 mL min(-1) kg(-1)) and hsCRP (-0.26 mg/L; 95% CI: -0.3 to -0.22 mg/L; p<0.001) was found, all independent of BMI. Additionally, significant positive associations between waist circumference and hsCRP were found for both men and women, independently of BMI. Conclusion Fitness was found to be inversely associated with both abdominal adiposity and low-grade inflammation independent of BMI. These data suggest that, in spite of BMI, high fitness levels lead to a reduction in abdominal fat mass and low-grade inflammation.	[Wedell-Neergaard, Anne-Sophie; Pedersen, Bente Klarlund; Krogh-Madsen, Rikke] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark; [Wedell-Neergaard, Anne-Sophie; Pedersen, Bente Klarlund; Krogh-Madsen, Rikke] Univ Copenhagen, Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark; [Eriksen, Louise; Gronbaek, Morten; Tolstrup, Janne] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark	Krogh-Madsen, R (corresponding author), Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark.; Krogh-Madsen, R (corresponding author), Univ Copenhagen, Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark.	krogh-madsen@inflammation-metabolism.dk	Pedersen, Bente Klarlund/AGR-3217-2022; Stefanadis, Christodoulos/ABH-2232-2020	Pedersen, Bente Klarlund/0000-0001-6508-6288; Stefanadis, Christodoulos/0000-0001-5974-6454; Wedell-Neergaard, Anne-Sophie/0000-0001-9316-0748; Gronbaek, Morten Klocker/0000-0002-8473-6474; Krogh-Madsen, Rikke/0000-0003-4914-2715; Tolstrup, Janne/0000-0002-9796-3967	TrygFonden; Centre of Inflammation and Metabolism (CIM); Danish National Research Foundation [DNRF55]; Danish Council for Strategic Research [09-067009, 09-075724]	TrygFonden; Centre of Inflammation and Metabolism (CIM); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The Centre for Physical Activity Research (CFAS), supported by a grant from TrygFonden and The Centre of Inflammation and Metabolism (CIM), supported by a grant from the Danish National Research Foundation (DNRF55), executed this study. CIM is a member of DD2 - the Danish Centre for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The Danish Ministry of Health and Prevention together with Trygfonden, Denmark, founded the DANHES 2007-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen L. B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P318; Araujo JP, 2009, J CARD FAIL, V15, P256, DOI 10.1016/j.cardfail.2008.10.030; Aronson D, 2004, ATHEROSCLEROSIS, V176, P173, DOI 10.1016/j.atherosclerosis.2004.04.025; Belavy DL, 2014, INT J OBESITY, V38, P1478, DOI 10.1038/ijo.2014.26; Biolo G, 2005, J RENAL NUTR, V15, P49, DOI 10.1053/j.jrn.2004.09.009; Boonchaya-Anant P, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0441-1; Borg G, 1998, BORGS PERCEIVED EXER; Church TS, 2002, ARTERIOSCL THROM VAS, V22, P1869, DOI 10.1161/01.ATV.0000036611.77940.F8; Debette S, 2010, ANN NEUROL, V68, P136, DOI 10.1002/ana.22062; DeFina LF, 2013, ANN INTERN MED, V158, P162, DOI 10.7326/0003-4819-158-3-201302050-00005; Eriksen L, 2011, SCAND J PUBLIC HEALT, V39, P203, DOI 10.1177/1403494810393557; Farooq A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/497324; Forouhi NG, 2001, INT J OBESITY, V25, P1327, DOI 10.1038/sj.ijo.0801723; Fuentes E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/136584; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Goedecke JH, 2014, MED SPORT SCI, V60, P82, DOI 10.1159/000357338; Groenwold RHH, 2013, CAN MED ASSOC J, V185, P401, DOI 10.1503/cmaj.120592; Haffner SM, 2007, AM J MED, V120, P10, DOI 10.1016/j.amjmed.2007.06.006; Harder-Iauridsen XNM, 2017, EFFECT ALTERNATE DAY, P230; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Janssen I, 2004, OBES RES, V12, P525, DOI 10.1038/oby.2004.60; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; KOENKER R., 2005, ECONOMETRIC SOC MONO, V38, DOI [10.1017/CBO9780511754098, DOI 10.1017/CBO9780511754098]; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Laukkanen JA, 2010, EUR J CANCER, V46, P355, DOI 10.1016/j.ejca.2009.07.013; Lavie CJ, 2011, J CARDIOPULM REHABIL, V31, P137, DOI 10.1097/HCR.0b013e3182122827; MYERS J, 1990, CIRCULATION, V82, P1839, DOI 10.1161/01.CIR.82.5.1839; Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003; Olsen RH, 2008, JAMA-J AM MED ASSOC, V299, P1261, DOI 10.1001/jama.299.11.1259; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Peel JB, 2009, MED SCI SPORT EXER, V41, P742, DOI 10.1249/MSS.0b013e31818edac7; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; Ridker PM, 1998, CIRCULATION, V97, P425; Ross R, 2003, INT J OBESITY, V27, P204, DOI 10.1038/sj.ijo.802222; Sassen B, 2009, EUR J CARDIOV PREV R, V16, P677, DOI 10.1097/HJR.0b013e3283312e94; Shi H, 2009, PHYSIOL BEHAV, V97, P199, DOI 10.1016/j.physbeh.2009.02.017; SHINE B, 1981, CLIN CHIM ACTA, V117, P13, DOI 10.1016/0009-8981(81)90005-X; Shomaker LB, 2012, J ADOLESCENT HEALTH, V50, P87, DOI 10.1016/j.jadohealth.2011.05.015; Thompson PD, 2013, CURR SPORT MED REP, V12, P215, DOI 10.1249/JSR.0b013e31829a68cf; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Williams MJA, 2005, EUR J CARDIOV PREV R, V12, P216, DOI 10.1097/00149831-200506000-00005; Williams PT, 2001, MED SCI SPORT EXER, V33, P754, DOI 10.1097/00005768-200105000-00012; Wong SL, 2004, MED SCI SPORT EXER, V36, P286, DOI 10.1249/01.MSS.0000113665.40775.35; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Zaccardi F, 2015, ATHEROSCLEROSIS, V243, P131, DOI 10.1016/j.atherosclerosis.2015.09.016; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhao GC, 2005, FRONT BIOSCI-LANDMRK, V10, P2005, DOI 10.2741/1675	49	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190645	10.1371/journal.pone.0190645	http://dx.doi.org/10.1371/journal.pone.0190645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342196	Green Submitted, Green Published, gold			2022-12-27	WOS:000422653800029
J	Yamada, K; Mizukoshi, E; Seike, T; Horii, R; Kitahara, M; Sunagozaka, H; Arai, K; Yamashita, T; Honda, M; Kaneko, S				Yamada, Kazutoshi; Mizukoshi, Eishiro; Seike, Takuya; Horii, Rika; Kitahara, Masaaki; Sunagozaka, Hajime; Arai, Kuniaki; Yamashita, Tatsuya; Honda, Masao; Kaneko, Shuichi			Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease	PLOS ONE			English	Article							KILLER T-CELLS; DECREASED PREVALENCE; STEATOHEPATITIS; RISK; NAFLD; DIET; PROGRESSION; TOLERANCE; MECHANISM; CYTOKINES	Background & aims The modest consumption of alcohol has been reported to decrease the incidence of fatty liver or prevalence of steatohepatitis. In this study, we investigated the effect of light alcohol consumption on liver function and gene expression in patients with non-alcoholic fatty liver disease (NAFLD). Methods The study group was formed of 178 patients diagnosed with non-alcoholic fatty liver disease, subclassified into two groups for analysis based on the daily alcohol consumption: non-alcohol group and light alcohol consumer group (<20 g of ethanol/day). Clinical characteristics, liver histological features, gene expression, comprehensively analyzed using microarrays (BRB-Array tools), and molecular network were evaluated and compared between the two groups. Results No significant differences in steatosis or inflammation score were noted among the groups. However, the ballooning and fibrosis scores were significantly lower in the light alcohol consumer group than in the non-alcohol group. Gene expression analysis revealed a marked inhibition of the pathways involved in the immune response in the light alcohol group compared to that in the non-alcohol group. Conclusions Light alcohol consumption might suppress activity of non-alcoholic steatohepatitis by reducing gene expression levels involved in the immune response. This inhibition in gene expression was associated with a lowering of liver fibrosis and hepatocellular injury.	[Yamada, Kazutoshi; Mizukoshi, Eishiro; Seike, Takuya; Horii, Rika; Kitahara, Masaaki; Sunagozaka, Hajime; Arai, Kuniaki; Yamashita, Tatsuya; Honda, Masao; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan	Kanazawa University	Mizukoshi, E (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan.	eishirom@m-kanazawa.jp	Yamashita, Tatsuya/K-8648-2015	Yamashita, Tatsuya/0000-0002-3602-8086; Seike, Takuya/0000-0002-4787-6910	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [26253046] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. There was no additional external funding received for this study.	Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Dunn W, 2008, HEPATOLOGY, V47, P1947, DOI 10.1002/hep.22292; Dunn W, 2012, J HEPATOL, V57, P384, DOI 10.1016/j.jhep.2012.03.024; Gabele E, 2011, ALCOHOL CLIN EXP RES, V35, P1361, DOI 10.1111/j.1530-0277.2011.01472.x; Galli A, 2001, J BIOL CHEM, V276, P68, DOI 10.1074/jbc.M008791200; Hashimoto Y, 2015, J GASTROEN HEPATOL, V30, P546, DOI 10.1111/jgh.12786; Hellerbrand C, 2010, DIGEST DIS, V28, P783, DOI 10.1159/000324286; Honda M, 2006, HEPATOLOGY, V44, P1122, DOI 10.1002/hep.21383; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kwon HK, 2014, LIVER INT, V34, P129, DOI 10.1111/liv.12230; LIEBER CS, 1989, J CLIN INVEST, V83, P1682, DOI 10.1172/JCI114068; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Lu B, 2014, ARTHRITIS RHEUMATOL, V66, P1998, DOI 10.1002/art.38634; Miyake T, 2016, J GASTROENTEROL, V51, P1090, DOI 10.1007/s00535-016-1194-0; Muralidharan S, 2014, J IMMUNOL, V193, P1975, DOI 10.4049/jimmunol.1303468; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; ROTILY M, 1990, EUR J CLIN NUTR, V44, P595; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Saha B, 2015, J IMMUNOL, V194, P3079, DOI 10.4049/jimmunol.1402190; Seitz HK, 2015, HEPATOBIL SURG NUTR, V4, P147, DOI 10.3978/j.issn.2304-3881.2014.12.01; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Sookoian S, 2014, GUT, V63, P530, DOI 10.1136/gutjnl-2013-305718; Syn WK, 2010, HEPATOLOGY, V51, P1998, DOI 10.1002/hep.23599; Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042; Tajiri K, 2009, EUR J GASTROEN HEPAT, V21, P673, DOI 10.1097/MEG.0b013e32831bc3d6; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wakabayashi I, 2012, GERONTOLOGY, V58, P24, DOI 10.1159/000323080; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342	33	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191026	10.1371/journal.pone.0191026	http://dx.doi.org/10.1371/journal.pone.0191026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342182	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800041
J	Su, YK; Wang, JH; Hsieh, SY; Liu, XZ; Lam, CF; Huang, SC				Su, Yi-Kai; Wang, Jen-Hung; Hsieh, Shiu-Ying; Liu, Xiu-Zhu; Lam, Chen-Fuh; Huang, Shian-Che			Incidence and risk factors for postoperative lingual neuropraxia following airway instrumentation: A retrospective matched case-control study	PLOS ONE			English	Article							NERVE INJURY; INTUBATION; COMPLICATION; SELECTION	Background Lingual nerve injury or neuropraxia is a rare but potentially serious perioperative complication following airway instrumentation during general anesthesia. This study explored the the incidence and perioperative risk factors for lingual nerve injury in patients receiving laryngeal mask (LMA) or endotracheal (ETGA) general anesthesia in a single center experience. Methods and results All surgical patients in our hospital who received LMA or ETGA from 2009 to 2013 were included, and potential perioperative risk factors were compared. Matched controls were randomly selected (in 1:5 ratio) from the same database in non-case patients. A total of 36 patients in the records had reported experiencing tongue numbness after anesthesia in this study. Compared with the non-case surgical population (n = 54314), patients with tongue numbness were significantly younger (52.2 +/- 19.5 vs 42.0 +/- 14.5; P = 0.002) and reported lower ASA physical statuses (2.3 +/- 0.7 vs 1.6 +/- 0.6; P<0.001). Patient gender, anesthesia technique used, and airway device type (LMA or ETGA) did not differ significantly across the two groups. A significantly higher proportion of patients underwent operations of the head-and-neck region (38.9 vs 15.6%; P = 0.002) developed tongue numbness after anesthesia. Multivariate logistic regression analysis indicated that head-and-neck operations remained the most significant independent risk factor for postoperative lingual nerve injury (AOR 7.63; 95% Cl 2.03-28.70). Conclusion The overall incidence rate of postoperative lingual neuropraxy was 0.066% in patients receiving general anesthesia with airway device in place. Young and generally healthy patients receiving head-and-neck operation are at higher risk in developing postoperative lingual neuropraxy. Attention should be particularly exercised to reduce the pressure of endotracheal tube or laryngeal mask on the tongue during head-and-neck operation to avert the occurrence of postoperative lingual neuropraxy.	[Su, Yi-Kai; Hsieh, Shiu-Ying; Liu, Xiu-Zhu; Lam, Chen-Fuh; Huang, Shian-Che] Buddhist Tzu Chi Gen Hosp, Dept Anesthesiol, Hualien, Taiwan; [Su, Yi-Kai; Hsieh, Shiu-Ying; Liu, Xiu-Zhu; Lam, Chen-Fuh; Huang, Shian-Che] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Wang, Jen-Hung] Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan; [Lam, Chen-Fuh] I Shou Univ, E Da Canc Hosp, E Da Hosp, Dept Anesthesiol, Kaohsiung, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; E-Da Hospital; I Shou University	Lam, CF; Huang, SC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Anesthesiol, Hualien, Taiwan.; Lam, CF; Huang, SC (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Lam, CF (corresponding author), I Shou Univ, E Da Canc Hosp, E Da Hosp, Dept Anesthesiol, Kaohsiung, Taiwan.	ed110208@edah.org.tw; e1380@tzuchi.com.tw			Ministry of Science and Technology of Taiwan [MOST 105-2314-B-303-007-MY2]; Buddhist Tzu Chi General Hospital, Taiwan [TC RD105-06]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Buddhist Tzu Chi General Hospital, Taiwan	This study was funded, in part, by the Ministry of Science and Technology of Taiwan (grant number MOST 105-2314-B-303-007-MY2) and the Buddhist Tzu Chi General Hospital, Taiwan (grant number TCRD105-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Eid R, 2012, AGE, V34, P651, DOI 10.1007/s11357-011-9261-1; Biglioli F, 2010, Minerva Stomatol, V59, P561; BRIMACOMBE J, 1993, ANAESTH INTENS CARE, V21, P107, DOI 10.1177/0310057X9302100127; Cardoso Hugo Eckener Dantas de Pereira, 2007, Rev. Bras. Anestesiol., V57, P410, DOI 10.1590/S0034-70942007000400009; Farrow S, 2012, ANAESTHESIA, V67, P815, DOI 10.1111/j.1365-2044.2012.07250.x; Foley E, 2010, IRISH J MED SCI, V179, P297, DOI 10.1007/s11845-009-0347-z; HEGTVEDT AK, 1990, J ORAL MAXIL SURG, V48, P647, DOI 10.1016/S0278-2391(10)80485-9; JONES BC, 1971, BRIT J ANAESTH, V43, P730; Kadry MA, 2001, EUR J ANAESTH, V18, P264, DOI 10.1046/j.0265-0215.2000.00838.x; Kihara S, 2003, ANESTH ANALG, V97, P280, DOI 10.1213/01.ANE.0000068824.86773.B0; Koyama Tomohiro, 2006, Masui, V55, P445; Mckenna Gerald, 2010, Dent Update, V37, P519; Pippi R, 2017, J ORAL MAXIL SURG, V75, P890, DOI 10.1016/j.joms.2016.12.040; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; Thiruvenkatarajan V, 2015, ANAESTHESIA, V70, P344, DOI 10.1111/anae.12917; Thiruvenkatarajan V, 2014, J CLIN ANESTH, V26, P65, DOI 10.1016/j.jclinane.2013.10.003; Ulusoy H, 2014, REV BRAS ANESTESIOL, V64, P124, DOI [10.1016/j.bjan.2012.12.003, 10.1016/j.bjane.2012.12.003]; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190589	10.1371/journal.pone.0190589	http://dx.doi.org/10.1371/journal.pone.0190589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329350	gold, Green Submitted, Green Published			2022-12-27	WOS:000419954100017
J	Iscan, Z; Nikulin, VV				Iscan, Zafer; Nikulin, Vadim V.			Steady state visual evoked potential (SSVEP) based brain-computer interface (BCI) performance under different perturbations	PLOS ONE			English	Article							CANONICAL CORRELATION-ANALYSIS; MULTIVARIATE SYNCHRONIZATION INDEX; FREQUENCY RECOGNITION; ARTIFACTS; MUSIC	Brain-computer interface (BCI) paradigms are usually tested when environmental and biological artifacts are intentionally avoided. In this study, we deliberately introduced different perturbations in order to test the robustness of a steady state visual evoked potential (SSVEP) based BCI. Specifically we investigated to what extent a drop in performance is related to the degraded quality of EEG signals or rather due to increased cognitive load. In the online tasks, subjects focused on one of the four circles and gave feedback on the correctness of the classification under four conditions randomized across subjects: Control (no perturbation), Speaking (counting loudly and repeatedly from one to ten), Thinking (mentally counting repeatedly from one to ten), and Listening (listening to verbal counting from one to ten). Decision tree, Naive Bayes and K-Nearest Neighbor classifiers were used to evaluate the classification performance using features generated by canonical correlation analysis. During the online condition, Speaking and Thinking decreased moderately the mean classification accuracy compared to Control condition whereas there was no significant difference between Listening and Control conditions across subjects. The performances were sensitive to the classification method and to the perturbation conditions. We have not observed significant artifacts in EEG during perturbations in the frequency range of interest except in theta band. Therefore we concluded that the drop in the performance is likely to have a cognitive origin. During the Listening condition relative alpha power in a broad area including central and temporal regions primarily over the left hemisphere correlated negatively with the performance thus most likely indicating active suppression of the distracting presentation of the playback. This is the first study that systematically evaluates the effects of natural artifacts (i.e. mental, verbal and audio perturbations) on SSVEP-based BCIs. The results can be used to improve individual classification performance taking into account effects of perturbations.	[Iscan, Zafer; Nikulin, Vadim V.] Natl Res Univ, Higher Sch Econ, Ctr Cognit & Decis Making, Moscow, Russia; [Iscan, Zafer] Univ Paris Saclay, Univ Paris Sud, INSERM, Cognit Neuroimaging Unit,CEA DRF Joliot Inst,Neuro, Gif Sur Yvette, France; [Nikulin, Vadim V.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Nikulin, Vadim V.] Charite, Dept Neurol, Neurophys Grp, Campus Benjamin Franklin, Berlin, Germany	HSE University (National Research University Higher School of Economics); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Iscan, Z; Nikulin, VV (corresponding author), Natl Res Univ, Higher Sch Econ, Ctr Cognit & Decis Making, Moscow, Russia.; Iscan, Z (corresponding author), Univ Paris Saclay, Univ Paris Sud, INSERM, Cognit Neuroimaging Unit,CEA DRF Joliot Inst,Neuro, Gif Sur Yvette, France.; Nikulin, VV (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.; Nikulin, VV (corresponding author), Charite, Dept Neurol, Neurophys Grp, Campus Benjamin Franklin, Berlin, Germany.	zaferiscan@yahoo.com; nikulin@cbs.mpg.de	Iscan, Zafer/G-8771-2015; Nikulin, Vadim V/A-6050-2014	Iscan, Zafer/0000-0001-9832-6591; Nikulin, Vadim V/0000-0001-6082-3859	Russian Academic Excellence Project '5-100'	Russian Academic Excellence Project '5-100'(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation)	The study has been funded by the Russian Academic Excellence Project '5-100'. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bender T, 2013, IEEE ENG MED BIO, P4279, DOI 10.1109/EMBC.2013.6610491; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brandl S, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/5/056012; Carlson S, 1997, NEUROREPORT, V8, P2853, DOI 10.1097/00001756-199709080-00010; Dalton Brian H., 2007, Occupational Ergonomics, V7, P143; de Graaf TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060035; Ettwig JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118216; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fink A, 2006, INT J PSYCHOPHYSIOL, V62, P46, DOI 10.1016/j.ijpsycho.2006.01.001; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Herweg NA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01639; Iscan Z, 2014, BIOMED SIGNAL PROCES, V10, P145, DOI 10.1016/j.bspc.2013.11.009; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Kwak NS, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/5/056009; Lin YP, 2013, IEEE ENG MED BIO, P1350, DOI 10.1109/EMBC.2013.6609759; Lin YP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00182; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Mak Joseph N, 2009, IEEE Rev Biomed Eng, V2, P187, DOI 10.1109/RBME.2009.2035356; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MCFARLAND DJ, 1993, PSYCHOBIOLOGY, V21, P77; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Nakanishi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140703; Nan WY, 2011, I IEEE EMBS C NEUR E, P469, DOI 10.1109/NER.2011.5910588; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Perham N, 2011, APPL COGNITIVE PSYCH, V25, P625, DOI 10.1002/acp.1731; Schlogl A, 2007, CLIN NEUROPHYSIOL, V118, P98, DOI 10.1016/j.clinph.2006.09.003; Srinivasan R, 2006, BRAIN TOPOGR, V18, P167, DOI 10.1007/s10548-006-0267-4; Muller SMT, 2011, IEEE ENG MED BIO, P6352, DOI 10.1109/IEMBS.2011.6091568; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wu ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22801; Xie J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163426; Xie J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04953; Yuan H, 2014, IEEE T BIO-MED ENG, V61, P1425, DOI 10.1109/TBME.2014.2312397; Zhang YS, 2016, COGN NEURODYNAMICS, V10, P505, DOI 10.1007/s11571-016-9398-9; Zhang YS, 2014, J NEUROSCI METH, V221, P32, DOI 10.1016/j.jneumeth.2013.07.018	36	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191673	10.1371/journal.pone.0191673	http://dx.doi.org/10.1371/journal.pone.0191673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360843	Green Published, gold, Green Submitted			2022-12-27	WOS:000423161800050
J	Sahin, K; Orhan, C; Tuzcu, M; Hayirli, A; Komorowski, JR; Sahin, N				Sahin, Kazim; Orhan, Cemal; Tuzcu, Mehmet; Hayirli, Armagan; Komorowski, James R.; Sahin, Nurhan			Effects of dietary supplementation of arginine-silicate-inositol complex on absorption and metabolism of calcium of laying hens	PLOS ONE			English	Article							IMPROVE EGGSHELL QUALITY; VITAMIN-D; GENE-EXPRESSION; BONE LOSS; QUAIL; RATS; DEFICIENCY; EXCHANGER; MEMBRANE; PROTEIN	The effects of supplementation of arginine-silicate-inositol complex (ASI; 49.5-8.2-25 g/kg, respectively) to laying hens were investigated with respect to eggshell quality, calcium (Ca) balance, and expression of duodenal proteins related to Ca metabolism (calbindin and tight junction proteins). A total of 360 laying hens, 25 weeks old, were divided into 3 groups consisting of 6 replicate of cages, 20 birds per cage. The groups were fed a basal diet and the basal diet supplemented with 500 or 1000 mg ASI complex per kilogram for 90 days. Data were analyzed by ANCOVA using data during the first week of the adaptation period as covariates. As the ASI complex supplementation level increased, there were increases in feed intake (P < 0.0001), egg production (P < 0.001), egg weight (P < 0.0001) and eggshell weight (P < 0.001) weight, and shell thickness (P < 0.001) and decreases in feed conversion ratio and cracked egg percentage (P < 0.0001 for both). Concentrations of serum osteocalcin (P < 0.0001), vitamin D (P < 0.0001), calcium (P < 0.001), phosphorus (P < 0.001), and alkaline phosphatase (P < 0.008) as well as amounts of calcium retention (P < 0.0001) and eggshell calcium deposition (P < 0.001), and Ca balance (P < 0.0001) increased, whereas amount of calcium excretion (P<0.001) decreased linearly in a dose-dependent manner. The ASI complex supplementation increased expressions of calcium transporters (calbindin-D28k, N sodium-calcium exchanger, plasma membrane calcium ATPase, and vitamin D receptor) and tight junction proteins (zonula occludens-1 and occludin) in the duodenum in a linear fashion (P < 0.0001 for all). In conclusion, provision of dietary ASI complex to laying hens during the peak laying period improved eggshell quality through improving calcium utilization as reflected by upregulation of genes related to the calcium metabolism. Further studies are needed to elucidate the contribution of each of the ASI complex ingredients.	[Sahin, Kazim; Orhan, Cemal; Sahin, Nurhan] Firat Univ, Fac Vet Med, Dept Anim Nutr & Nutr Disorders, Elazig, Turkey; [Tuzcu, Mehmet] Firat Univ, Fac Sci, Div Biol, Elazig, Turkey; [Hayirli, Armagan] Ataturk Univ, Fac Vet Med, Dept Anim Nutr & Nutr Disorders, Erzurum, Turkey; [Komorowski, James R.] Nutr 21 Inc, Sci & Regulatory Affairs, New York, NY USA	Firat University; Firat University; Ataturk University	Sahin, K (corresponding author), Firat Univ, Fac Vet Med, Dept Anim Nutr & Nutr Disorders, Elazig, Turkey.	nsahinkm@yahoo.com	Sahin, Kazim/D-5625-2009; Sahin, Nurhan/D-5626-2009; sahin, nurhan/ABF-8007-2020; Orhan, Cemal/Q-2086-2015; Tuzcu, Mehmet/H-2953-2018	Sahin, Kazim/0000-0001-9542-5244; sahin, nurhan/0000-0001-9487-1154; Orhan, Cemal/0000-0003-4138-7689; Tuzcu, Mehmet/0000-0002-1329-3143	Turkish Academy of Sciences (Ankara, Turkey); Small and Medium Business Development and Support Administration of Turkey (KOSGEB)	Turkish Academy of Sciences (Ankara, Turkey)(Turkish Academy of Sciences); Small and Medium Business Development and Support Administration of Turkey (KOSGEB)	The study was funded by Small and Medium Business Development and Support Administration of Turkey (KOSGEB) and also in part by Turkish Academy of Sciences (Ankara, Turkey)". Moreover, tested product was donated by "Nutrition 21 Inc". "The funder provided support in the form of salaries for authors [J.R.K], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.& para;& para;The study was funded by Small and Medium Business Development and Support Administration of Turkey (KOSGEB) and also in part by Turkish Academy of Sciences (Ankara, Turkey).	AOAC, 2007, OFFICIAL METHODS ANA, V18th; Balda MS, 2009, BBA-BIOMEMBRANES, V1788, P761, DOI 10.1016/j.bbamem.2008.11.024; Bar A., 2009, COMP BIOCHEM PHYS A, V152, P447, DOI [DOI 10.1016/j.cbpa.2008.11.020, 10.1016/j.cbpa.2008.11.020]; CARLISLE EM, 1986, CIBA F SYMP, V121, P123; Centeno VA, 2004, COMP BIOCHEM PHYS A, V139, P133, DOI 10.1016/j.cbpb.2004.08.002; Centeno V, 2011, ARCH BIOCHEM BIOPHYS, V509, P191, DOI 10.1016/j.abb.2011.03.011; Chirayath MV, 1998, AM J PHYSIOL-GASTR L, V274, pG389, DOI 10.1152/ajpgi.1998.274.2.G389; Clementi G, 2001, PHARMACOL TOXICOL, V88, P16, DOI 10.1034/j.1600-0773.2001.088001016.x; Colao A, 1999, J CLIN ENDOCR METAB, V84, P1919, DOI 10.1210/jc.84.6.1919; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Ebeid TA, 2012, POULTRY SCI, V91, P2282, DOI 10.3382/ps.2011-01898; EISEN EJ, 1962, POULTRY SCI, V41, P1461, DOI 10.3382/ps.0411461; Enko D, 2015, BIOCHEM MEDICA, V25, P203, DOI 10.11613/BM.2015.020; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Fiore CE, 2000, EUR J PHARMACOL, V408, P323, DOI 10.1016/S0014-2999(00)00800-1; Gordon RW, 1998, POULTRY SCI, V77, P290, DOI 10.1093/ps/77.2.290; Harms R. H., 1996, Journal of Applied Poultry Research, V5, P1, DOI 10.1093/japr/5.1.1; Hwang I, 2013, INT J MOL SCI, V14, P22997, DOI 10.3390/ijms141122997; Jensen TP, 2004, DEV BRAIN RES, V152, P129, DOI 10.1016/j.devbrainres.2004.06.004; Jiang MJ, 2015, BRIT POULTRY SCI, V56, P740, DOI 10.1080/00071668.2015.1113499; Jurgens M. H., 1996, ANIMAL FEEDING NUTR; Lavelin I, 2000, POULTRY SCI, V79, P1014, DOI 10.1093/ps/79.7.1014; National Research Council, 1994, NUTR REQ POULTR; Neijat M, 2011, POULTRY SCI, V90, P2383, DOI 10.3382/ps.2011-01401; Onderci M, 2006, BRIT POULTRY SCI, V47, P209, DOI 10.1080/00071660600611052; Pavlovski Z., 2012, Biotechnology in Animal Husbandry, V28, P393; Pearson D A, 1976, CHEM ANAL FOOD, V7th; Proctor SD, 2005, DIABETOLOGIA, V48, P1925, DOI 10.1007/s00125-005-1862-8; Proctor SD, 2007, METABOLISM, V56, P1318, DOI 10.1016/j.metabol.2007.05.022; Rivoira MA, 2012, COMP BIOCHEM PHYS A, V162, P397, DOI 10.1016/j.cbpa.2012.04.016; Ruuskanen S, 2014, ENVIRON SCI POLLUT R, V21, P3304, DOI 10.1007/s11356-013-2299-0; Sahin K, 2006, POULTRY SCI, V85, P486, DOI 10.1093/ps/85.3.486; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; SAS, 2002, SAS US GUID STAT; Seaborn CD, 2002, BIOL TRACE ELEM RES, V89, P251, DOI 10.1385/BTER:89:3:251; Singh J., 2007, J APPL PACKAGING RES, V2, P45; STRIEM S, 1991, MOL CELL ENDOCRINOL, V75, P169, DOI 10.1016/0303-7207(91)90232-H; TRIPPEL SB, 1998, CLIN ORTHOP S, V355, P301; VISSER JJ, 1994, MED HYPOTHESES, V43, P339, DOI 10.1016/0306-9877(94)90113-9; Wasserman RH, 2004, J NUTR, V134, P3137, DOI 10.1093/jn/134.11.3137; Wasserman RH, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P411; Xiao JF, 2014, POULTRY SCI, V93, P380, DOI 10.3382/ps.2013-03354; Zhang LC, 2005, POULTRY SCI, V84, P1209, DOI 10.1093/ps/84.8.1209	43	5	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0189329	10.1371/journal.pone.0189329	http://dx.doi.org/10.1371/journal.pone.0189329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360830	Green Submitted, gold, Green Published			2022-12-27	WOS:000423161800004
J	Yuasa, N; Nagata, E; Fujii, N; Ito, M; Tsukamoto, H; Takizawa, S				Yuasa, Naoki; Nagata, Eiichiro; Fujii, Natsuko; Ito, Masatoshi; Tsukamoto, Hideo; Takizawa, Shunya			Serum apolipoprotein E may be a novel biomarker of migraine	PLOS ONE			English	Article							CORTICAL SPREADING DEPRESSION; ALZHEIMERS-DISEASE; GENE; POLYMORPHISM; ASSOCIATION; PROTEIN; ALLELE; RISK	Migraine attacks alter various molecules that might be related to the pathophysiology of migraine, such as serotonin, calcitonin gene-related peptide, and nitric oxide. The underlying pathophysiology of migraine is as yet unclear. We explored key proteins related to the pathogenesis of migraine here. Serum was collected from two patients with migraine with aura (MA) and seven patients with migraine without aura (MO) during attack-free periods and migraine attacks. Samples were analyzed using 2-dimensional gel electrophoresis. Nineteen protein spots were altered between the attack-free versus migraine attack periods. Mass spectrometric analysis was performed to identify the proteins within each of the 19 altered spots. Thirty-six proteins were significantly altered in samples collected during attack-free periods versus migraine attacks. The protein with the statistically most significant MASCOT/Mowse score (268 +/- 112) among lipoproteins was apolipoprotein (ApoE). In the MA and MO groups, ApoE protein levels were significantly higher during migraine attack than during the attack-free period (p<0.05). ApoE protein levels were also significantly increased in the MA group during the attack-free period compared to healthy controls and patients with tension type headaches (p<0.01). Migraine alters ApoE levels, especially in MA. ApoE might play an important role in the pathophysiology of migraine, and may act as a diagnostic biomarker of migraine.	[Yuasa, Naoki] Isehara Kyodo Hosp, Dept Internal Med, Div Neurol, Isehara, Kanagawa, Japan; [Nagata, Eiichiro; Fujii, Natsuko; Takizawa, Shunya] Tokai Univ, Dept Neurol, Sch Med, Isehara, Kanagawa, Japan; [Ito, Masatoshi; Tsukamoto, Hideo] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa, Japan	Tokai University; Tokai University	Nagata, E (corresponding author), Tokai Univ, Dept Neurol, Sch Med, Isehara, Kanagawa, Japan.	enagata@is.icc.u-tokai.ac.jp		Nagata, Eiichiro/0000-0001-6902-8309				Bellei E, 2017, SCI REP-UK, V7, DOI 10.1038/srep41723; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Charles AC, 2013, NAT REV NEUROL, V9, P637, DOI 10.1038/nrneurol.2013.192; Choudhuri R, 2002, ANN NEUROL, V51, P499, DOI 10.1002/ana.10158; Colton CA, 2002, ANN NY ACAD SCI, V962, P212, DOI 10.1111/j.1749-6632.2002.tb04070.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fusayasu E, 2007, PAIN, V128, P209, DOI 10.1016/j.pain.2006.09.017; Gupta R, 2009, J HEADACHE PAIN, V10, P115, DOI 10.1007/s10194-008-0094-y; Hashikawa-Hobara N, 2012, J PHARMACOL SCI, V119, P117, DOI 10.1254/jphs.12R02CP; Hashikawa-Hobara N, 2011, J PHARMACOL EXP THER, V338, P694, DOI 10.1124/jpet.111.181487; Imamura K, 2008, HEADACHE, V48, P135, DOI 10.1111/j.1526-4610.2007.00958.x; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kowa H, 2000, AM J MED GENET, V96, P762, DOI 10.1002/1096-8628(20001204)96:6<762::AID-AJMG12>3.0.CO;2-X; Landy SH, 2004, PRIMARY CARE, V31, P429, DOI 10.1016/j.pop.2004.02.013; Lee ST, 2008, NEUROLOGY, V70, P1510, DOI 10.1212/01.wnl.0000294329.93565.94; Loder E, 2006, HEADACHE, V46, P1046, DOI 10.1111/j.1526-4610.2006.00498.x; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Marziniak M, 2005, NEUROLOGY, V64, P157, DOI 10.1212/01.WNL.0000148597.52312.9E; Melemedjian OK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-14; Miao JY, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0385-2; MOSKOWITZ MA, 1992, TRENDS PHARMACOL SCI, V13, P307, DOI 10.1016/0165-6147(92)90097-P; Nagata E, 2009, NEUROSCI RES, V64, P104, DOI 10.1016/j.neures.2009.02.001; Oterino A, 2007, J HEADACHE PAIN, V8, P231, DOI 10.1007/s10194-007-0399-2; Paterna S, 2000, EUR NEUROL, V43, P133, DOI 10.1159/000008151; Rainero I, 2002, NEUROSCI LETT, V317, P111, DOI 10.1016/S0304-3940(01)02432-6; Ramon C, 2017, CURR OPIN NEUROL, V30, P281, DOI 10.1097/WCO.0000000000000440; Riesco N, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0618-8; Rothrock JF, 2006, HEADACHE, V46, P726, DOI 10.1111/j.1526-4610.2006.00428.x; Shibata M, 2017, J CEREBR BLOOD F MET, V37, P1182, DOI 10.1177/0271678X17690537; Starling AJ, 2015, MAYO CLIN PROC, V90, P408, DOI 10.1016/j.mayocp.2015.01.010; van Dongen RM, 2017, CEPHALALGIA, V37, P49, DOI 10.1177/0333102415625614	33	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0190620	10.1371/journal.pone.0190620	http://dx.doi.org/10.1371/journal.pone.0190620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357368	Green Submitted, Green Published, gold			2022-12-27	WOS:000422919500005
J	Brown, CA				Brown, Christopher A.			Corrective binaural processing for bilateral cochlear implant patients	PLOS ONE			English	Article							INTERAURAL LEVEL DIFFERENCES; SOUND SOURCE LOCALIZATION; SPEECH RECOGNITION; TIME DIFFERENCES; HORIZONTAL-PLANE; NORMAL-HEARING; FINE-STRUCTURE; SENSITIVITY; LISTENERS; NOISE	Although bilateral cochlear implant users receive input to both ears, they nonetheless have relatively poor localization abilities in the horizontal plane. This is likely because of the two binaural cues, they have good sensitivity to interaural differences of level (inter-aural level differences, or ILDs), but not those of time (inter-aural time differences; ITDs). Here, localization performance is assessed in six bilateral cochlear implant patients when instantaneous ITDs are measured and converted to ILDs, a strategy that results in larger-thantypical ILDs. The added ILDs are corrective, in that they are derived from individual listener performance across both frequency and azimuth, so that they are small where a listener performs well, and increase as performance deviates from ideal. Results show significantly improved localization performance as a result of this strategy, with two of the six listeners achieving levels of performance typically observed in NH listeners.	[Brown, Christopher A.] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA 15217 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brown, CA (corresponding author), Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA 15217 USA.	cbrown1@pitt.edu		Brown, Christopher/0000-0001-7550-3014	National Institutes of Health [R01DC008329]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grant number R01DC008329 from the National Institutes of Health, awarded to author CB.	[Anonymous], 2017, EARPLUG; Baumgartel RM, 2017, J ACOUST SOC AM, V141, P2338, DOI 10.1121/1.4979114; Brown CA, 2014, EAR HEARING, V35, P580, DOI 10.1097/AUD.0000000000000044; Brown CA, 2013, ADV EXP MED BIOL, V787, P247, DOI 10.1007/978-1-4614-1590-9_28; Brown CA, 2011, J ACOUST SOC AM, V130, pEL358, DOI 10.1121/1.3647263; Brown CA, 2010, HEARING RES, V266, P52, DOI 10.1016/j.heares.2009.08.011; Brughera A, 2013, J ACOUST SOC AM, V133, P2839, DOI 10.1121/1.4795778; Day ML, 2013, J NEUROSCI, V33, P15837, DOI 10.1523/JNEUROSCI.2034-13.2013; Dietz M, 2016, NETWORK-COMP NEURAL, V27, P186, DOI 10.1080/0954898X.2016.1219411; Dorman MF, 2016, AUDIOL NEURO-OTOL, V21, P127, DOI 10.1159/000444740; Dorman MF, 2014, EAR HEARING, V35, P633, DOI 10.1097/AUD.0000000000000057; Francart T, 2007, J ACOUST SOC AM, V122, P2826, DOI 10.1121/1.2783130; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P180, DOI 10.1007/s10162-005-5061-6; Goupell MJ, 2013, J ACOUST SOC AM, V133, pEL101, DOI 10.1121/1.4776772; Grantham DW, 2007, EAR HEARING, V28, P524, DOI 10.1097/AUD.0b013e31806dc21a; Grantham DW, 2008, LARYNGOSCOPE, V118, P145, DOI 10.1097/MLG.0b013e31815661f9; Hancock KE, 2012, J NEUROPHYSIOL, V108, P714, DOI 10.1152/jn.00269.2012; Hancock KE, 2010, J NEUROSCI, V30, P14068, DOI 10.1523/JNEUROSCI.3213-10.2010; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Imennov NS, 2013, HEARING RES, V298, P60, DOI 10.1016/j.heares.2013.01.004; JAVER AR, 1995, J OTOLARYNGOL, V24, P111; Jones H, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514554574; Jones HG, 2016, EAR HEARING, V37, pE341, DOI 10.1097/AUD.0000000000000297; Kan A, 2015, EAR HEARING, V36, pE62, DOI 10.1097/AUD.0000000000000135; Kelvasa D, 2015, TRENDS HEAR, V19, DOI 10.1177/2331216515616378; Laback B, 2004, EAR HEARING, V25, P488, DOI 10.1097/01.aud.0000145124.85517.e8; Loizou PC, 2009, J ACOUST SOC AM, V125, P372, DOI 10.1121/1.3036175; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Macaulay EJ, 2010, J ACOUST SOC AM, V127, P1440, DOI 10.1121/1.3294654; Moore BCJ, 2016, J ACOUST SOC AM, V140, P2817, DOI 10.1121/1.4965299; Noel VA, 2013, J ACOUST SOC AM, V133, P2314, DOI 10.1121/1.4794372; Perreau A, 2010, J AM ACAD AUDIOL, V21, P110, DOI 10.3766/jaaa.21.2.5; Savel S, 2014, HUM FACTORS, V56, P772, DOI 10.1177/0018720813503366; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Smith ZM, 2007, JARO-J ASSOC RES OTO, V8, P134, DOI 10.1007/s10162-006-0069-0; YOST WA, 1988, J ACOUST SOC AM, V83, P1846, DOI 10.1121/1.396520; Yost WA, 2013, J ACOUST SOC AM, V133, P2876, DOI 10.1121/1.4799803; Young PT, 1928, J EXP PSYCHOL, V11, P399, DOI 10.1037/h0073089; Zahorik P, 2006, J ACOUST SOC AM, V120, P343, DOI 10.1121/1.2208429	40	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0187965	10.1371/journal.pone.0187965	http://dx.doi.org/10.1371/journal.pone.0187965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351279	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300005
J	Wu, HX; Zhang, BJ; Li, J; Liu, QY; Zhao, TT				Wu, Hongxun; Zhang, Bingjie; Li, Jie; Liu, Qianyun; Zhao, Tingting			Echogenic foci with comet-tail artifact in resected thyroid nodules: Not an absolute predictor of benign disease	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; PSAMMOMA BODIES; ULTRASOUND; PITFALLS; SONOGRAPHY; MALIGNANCY; MANAGEMENT; FEATURES; PEARLS	The purpose of this study was to evaluate the frequency of echogenic foci with comet-tail artifact in histologically proven thyroid nodules, and to determine the types of echogenic foci with comet-tail artifact that are associated with malignancy. We retrospectively analyzed the sonographic findings of echogenic foci with comet-tail artifact, present in thyroid nodules in 63 patients who underwent surgery for thyroid nodules at our institution between January 2016 and September 2016. The sonographic findings (appearance and background of echogenic foci, shape of comet-tail artifact) in benign and malignant nodules were compared. Seventy-one (7.4%) nodules with ultrasound finding of echogenic foci with comet-tail artifact were encountered in 962 thyroid nodules of 556 patients; 25 of these were benign, and 46 were malignant. Among the echogenic foci with comet-tail artifact categories, those (11/11, 100%) freely distributed in cystic components were all in benign nodules, whereas those (48/67, 71.6%) any part of echogenic foci or comet-tail artifact associated with solid components, were more common in malignant nodules (P < 0.001). There was no statistically significant difference in the appearance of echogenic foci and the shape of comet-tail between the benign and malignant nodules (P = 0.139, P = 0.626, respectively). Echogenic foci with comet-tail artifact freely distributed in cystic component may predict a benign nodule; those associated with solid components cannot be considered a benign finding.	[Wu, Hongxun; Zhang, Bingjie; Li, Jie; Liu, Qianyun; Zhao, Tingting] Jiangyuan Hosp, Key Lab Nucl Med, Jiangsu Key Lab Mol Nucl Med, Dept Ultrasound,Jiangsu Inst Nucl Med,Minist Hlth, Wuxi, Jiangsu, Peoples R China		Wu, HX (corresponding author), Jiangyuan Hosp, Key Lab Nucl Med, Jiangsu Key Lab Mol Nucl Med, Dept Ultrasound,Jiangsu Inst Nucl Med,Minist Hlth, Wuxi, Jiangsu, Peoples R China.	whxmd@outlook.com	Wu, Hong xun/AAD-8875-2022	Wu, Hong xun/0000-0003-2837-2458	Wuxi Municipal Science and Technology Development Planning Funds [CSE31N1622]; Wuxi Health and Family Planning Commission Planning Funds [MS 201633]	Wuxi Municipal Science and Technology Development Planning Funds; Wuxi Health and Family Planning Commission Planning Funds	The work was supported by Wuxi Municipal Science and Technology Development Planning Funds [grant number CSE31N1622] to HW; and Wuxi Health and Family Planning Commission Planning Funds [grant number MS 201633] to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 1996, J CLIN ULTRASOUND, V24, P129, DOI 10.1002/(SICI)1097-0096(199603)24:3<129::AID-JCU4>3.0.CO;2-J; Bonavita JA, 2009, AM J ROENTGENOL, V193, P207, DOI 10.2214/AJR.08.1820; Chan BK, 2003, J ULTRAS MED, V22, P1083, DOI 10.7863/jum.2003.22.10.1083; Das DK, 2009, DIAGN CYTOPATHOL, V37, P534, DOI 10.1002/dc.21081; DUGAN JM, 1987, ACTA CYTOL, V31, P330; Feldman MK, 2009, RADIOGRAPHICS, V29, P1179, DOI 10.1148/rg.294085199; FIORELLA RM, 1993, DIAGN CYTOPATHOL, V9, P351, DOI 10.1002/dc.2840090321; Ginat DT, 2010, ULTRASOUND Q, V26, P171, DOI 10.1097/RUQ.0b013e3181efa710; Grant EG, 2015, J AM COLL RADIOL, V12, P1272, DOI 10.1016/j.jacr.2015.07.011; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hoang JK, 2007, RADIOGRAPHICS, V27, P847, DOI 10.1148/rg.273065038; JOHANNESSEN JV, 1980, LAB INVEST, V43, P287; Klang K, 2015, ULTRASOUND Q, V31, P69, DOI 10.1097/RUQ.0000000000000079; Li Volsi VA, 1990, SURG PATHOLOGY THYRO, P138; Malhi H, 2014, AM J ROENTGENOL, V203, P1310, DOI 10.2214/AJR.13.11934; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Moon WJ, 2011, KOREAN J RADIOL, V12, P1, DOI 10.3348/kjr.2011.12.1.1; Patel BN, 2013, SEMIN ULTRASOUND CT, V34, P226, DOI 10.1053/j.sult.2012.11.001; Reading Carl C, 2005, Ultrasound Q, V21, P157, DOI 10.1097/01.ruq.0000174750.27010.68; Tahvildari AM, 2016, J ULTRAS MED, V35, pe27; Teng W., 2012, CHIN J ENDOCRINOL ME, V28, P779, DOI [10.3760/cma.j.issn.1000-6699.2012.10.002, DOI 10.3760/CMA.J.ISSN.1000-6699.2012.10.002]; Triggiani V, 2008, THYROID, V18, P1017, DOI 10.1089/thy.2008.0082	22	5	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191505	10.1371/journal.pone.0191505	http://dx.doi.org/10.1371/journal.pone.0191505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352286	Green Submitted, gold, Green Published			2022-12-27	WOS:000422911300102
J	Aleza, K; Villamor, GB; Nyarko, BK; Wala, K; Akpagana, K				Aleza, Koutchoukalo; Villamor, Grace B.; Nyarko, Benjamin Kofi; Wala, Kperkouma; Akpagana, Koffi			Shea (Vitellaria paradoxa Gaertn C. F.) fruit yield assessment and management by farm households in the Atacora district of Benin	PLOS ONE			English	Article							WEST-AFRICA; BURKINA-FASO; CF GAERTN.; AGROFORESTRY; TREES; SELECTION; IMPACT; RATES; MALI	Vitellaria paradoxa (Gaertn C. F.), or shea tree, remains one of the most valuable trees for farmers in the Atacora district of northern Benin, where rural communities depend on shea products for both food and income. To optimize productivity and management of shea agro-forestry systems, or "parklands," accurate and up-to-date data are needed. For this purpose, we monitored120 fruiting shea trees for two years under three land-use scenarios and different soil groups in Atacora, coupled with a farm household survey to elicit information on decision making and management practices. To examine the local pattern of shea tree productivity and relationships between morphological factors and yields, we used a randomized branch sampling method and applied a regression analysis to build a shea yield model based on dendrometric, soil and land-use variables. We also compared potential shea yields based on farm household socio-economic characteristics and management practices derived from the survey data. Soil and land-use variables were the most important determinants of shea fruit yield. In terms of land use, shea trees growing on farmland plots exhibited the highest yields (i.e., fruit quantity and mass) while trees growing on Lixisols performed better than those of the other soil group. Contrary to our expectations, dendrometric parameters had weak relationships with fruit yield regardless of land-use and soil group. There is an inter-annual variability in fruit yield in both soil groups and land-use type. In addition to observed inter-annual yield variability, there was a high degree of variability in production among individual shea trees. Furthermore, household socioeconomic characteristics such as road accessibility, landholding size, and gross annual income influence shea fruit yield. The use of fallow areas is an important land management practice in the study area that influences both conservation and shea yield.	[Aleza, Koutchoukalo] Univ Cape Coast, Dept Soil Sci, Sch Agr,Grad Res Programme, West African Sci Serv Ctr Climate Change & Adapte, Cape Coast, Ghana; [Aleza, Koutchoukalo; Wala, Kperkouma; Akpagana, Koffi] Univ Lome, Lab Bot & Ecol Vegetale, Lome, Togo; [Villamor, Grace B.] Univ Bonn, Ctr Dev Res, Bonn, Germany; [Nyarko, Benjamin Kofi] Univ Cape Coast, Dept Geog & Reg Planning, Cape Coast, Ghana	University of Cape Coast; University of Bonn; University of Cape Coast	Aleza, K (corresponding author), Univ Cape Coast, Dept Soil Sci, Sch Agr,Grad Res Programme, West African Sci Serv Ctr Climate Change & Adapte, Cape Coast, Ghana.; Aleza, K (corresponding author), Univ Lome, Lab Bot & Ecol Vegetale, Lome, Togo.	alezafaustin@gmail.com	Nyarko, Benjamin Kofi/I-2155-2019	Nyarko, Benjamin Kofi/0000-0002-6560-9613	German Federal Ministry of Education and Research (BMBF) through the West African Science Service Center on Climate Change and Adaptive Land Use (WASCAL)	German Federal Ministry of Education and Research (BMBF) through the West African Science Service Center on Climate Change and Adaptive Land Use (WASCAL)	This research was funded by the German Federal Ministry of Education and Research (BMBF) through the West African Science Service Center on Climate Change and Adaptive Land Use (WASCAL).; We are grateful to all of our field assistants from Dassaricatchmentin Benin for their valuable efforts and contributions. We also appreciate Guido Luchster for his valuable statistical suggestions. This research was financed by the German Federal Ministry of Education and Research through the West African Science Service Center on Climate Change and Adaptive Land Use (WASCAL).	AGBAHUNGBA G, 1989, BOIS FOR TROP, V222, P41; Akais Okia C, 2005, AFR CROP SCI SOC, V7, P5; Akpo LE, 2002, REV ELEVAGE MED VET, V55; Akpona T, 2015, AGROFOREST SYST, V89, p1 ; Aleza K., 2015, International Journal of Biodiversity and Conservation, V7, P245; Aleza K, 2015, AGROFOREST SYST, V89, P511, DOI 10.1007/s10457-015-9787-9; [Anonymous], 2005, CONDITIONS AGR GROWT; Bayala J., 2002, TREE CROWN PRUNING M; Bayala J, 2008, AGROFOREST SYST, V72, P187, DOI 10.1007/s10457-007-9099-9; Bellefontaine R, 2002, TREES OUTSIDE FOREST; Boffa J., 1999, AGROFORESTRY PARKLAN; Boffa J. M., 2000, Unasylva (English ed.), V51, P11; Bonkoungou E, 1987, BUTYROSPERMUM PARADO; Bonkoungou EG, 2004, INT WORKSH PROC MARK, P51; Byakagaba P., 2011, Agricultural Journal, V6, P14, DOI 10.3923/aj.2011.14.22; Byakagaba P, 2012, RES J APPL SCI, V7, p92 ; Dah-Dovonon JZ, 2006, EVALUATION POTENTIAL; Delolme A, 1947, OLEAGINEUX, V4, p186 ; Desmarest J, 1958, OBSERVATIONS POPULAT; Dianda M, 2009, BIOTECHNOL AGRON SOC, V13, P93; Djossa Bruno A., 2008, Ecotropica (Bonn), V14, P37; Djossa BA, 2008, AGROFOREST SYST, V72, P205, DOI 10.1007/s10457-007-9097-y; Elias M, 2013, AGROFOREST SYST, V87, P203, DOI 10.1007/s10457-012-9536-2; FAO IIASA ISRIC ISSCAS, 2014, HARM WORLD SOIL DAT; Feller C., 1995, AGR DEV, V8, P35; HALL JB, 1996, VITELLARIA PARADOXA; Houehanou TD, 2013, FRUITS, V68, P109, DOI 10.1051/fruits/2013057; INSAE, 2013, NOU, P8; JESSEN RJ, 1955, BIOMETRICS, V11, P99, DOI 10.2307/3001484; Jones A, 2013, SOIL ATLAS AFRICA UN; Kelly BA, 2004, AGROFOREST SYST, V60, P3, DOI 10.1023/B:AGFO.0000009400.24606.e3; Ker A., 1995, FARMING SYSTEMS AFRI; KESSLER JJ, 1991, AGROFOREST SYST, V13, P41, DOI 10.1007/BF00129618; Lamien N., 2004, Fruits (Paris), V59, P423, DOI 10.1051/fruits:2005004; Lamien N, 2007, AGROFOREST SYST, V69, P1, DOI 10.1007/s10457-006-9013-x; Lovett PN, 2000, AGROFOREST SYST, V48, P273, DOI 10.1023/A:1006379217851; Lovett PNC, 2000, GENETIC DIVERSITY SH; Luedeling E, 2012, CLIMATIC CHANGE, V115, P443, DOI 10.1007/s10584-012-0438-0; Martini E, 2012, AGROFOREST SYST, V86, P401, DOI 10.1007/s10457-011-9441-0; Naughton CC, 2015, APPL GEOGR, V58, P217, DOI 10.1016/j.apgeog.2015.02.007; Norman DW, 1981, RES B, V4, P94; NRC, 2006, VEGETABLES, VII; Odebiyi J., 2009, WEST AFR J APPL ECOL, V5, DOI [10.4314/wajae.v5i1.45597, DOI 10.4314/WAJAE.V5I1.45597]; Okiror P, 2012, INT J FORESTRY RES, V2012, p1 ; Okullo JBL, 2004, AGROFOREST SYST, V60, P77, DOI 10.1023/B:AGFO.0000009407.63892.99; Ouedraogo S, 1996, JACHERE LIEU PRODUCT, p81 ; Platts PJ., 2010, REPORT INNOVKAR WORK; Romain Glele K, 2011, AFRICAN J ECOLOGY, V49, p440 , DOI DOI 10.1111/j.1365-2028.2011.01279.x; Roshetko J. M., 2013, Forests, Trees and Livelihoods, V22, P241, DOI 10.1080/14728028.2013.855150; Ruthenberg H., 1980, FARMING SYSTEMS TROP, V3rd; RUYSSEN B., 1957, Agron. trop., V12, P279; Sanogo K, 2016, DENDROCHRONOLOGIA, V40, P26, DOI 10.1016/j.dendro.2016.05.004; Sanou H, 2004, AGROFOREST SYST, V60, P93, DOI 10.1023/B:AGFO.0000009408.03728.46; Schreckenberg K., 1996, FORESTS FIELDS MARKE; Schreckenberg K., 2004, FOREST PRODUCTS LIVE, V2, P91; Some N Antoine, 2007, Biotechnologie Agronomie Societe et Environnement, V11, P245; Soro D., 2012, Journal of Applied Biosciences, V52, P3676; Traore KM, 2002, INT WORKSH PROC MARK, P185; Ugese FD, 2010, AGROFOREST SYST, V79, P201, DOI 10.1007/s10457-009-9261-7; USSCS, 1975, SOIL TAX BAS SYST SO; WRB, 2015, WORLD REF BAS SOIL R	61	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190234	10.1371/journal.pone.0190234	http://dx.doi.org/10.1371/journal.pone.0190234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346406	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500011
J	Lebenbaum, M; Espin-Garcia, O; Li, Y; Rosella, LC				Lebenbaum, Michael; Espin-Garcia, Osvaldo; Li, Yi; Rosella, Laura C.			Development and validation of a population based risk algorithm for obesity: The Obesity Population Risk Tool (OPoRT)	PLOS ONE			English	Article							MODELS; PERFORMANCE	Background Given the dramatic rise in the prevalence of obesity, greater focus on prevention is necessary. We sought to develop and validate a population risk tool for obesity to inform prevention efforts. Methods We developed the Obesity Population Risk Tool (OPoRT) using the longitudinal National Population Health Survey and sex-specific Generalized Estimating Equations to predict the 10-year risk of obesity among adults 18 and older. The model was validated using a boot-strap approach accounting for the survey design. Model performance was measured by the Brier statistic, discrimination was measured by the C-statistic, and calibration was assessed using the Hosmer-Lemeshow Goodness of Fit Chi Square (HL chi(2)). Results Predictive factors included baseline body mass index, age, time and their interactions, smoking status, living arrangements, education, alcohol consumption, physical activity, and ethnicity. OPoRT showed good performance for males and females (Brier 0.118 and 0.095, respectively), excellent discrimination (C statistic >= 0.89) and achieved calibration (HL chi(2) < 20). Conclusion OPoRT is a valid and reliable algorithm that can be applied to routinely collected survey data to estimate the risk of obesity and identify groups at increased risk of obesity. These results can guide prevention efforts aimed at reducing the population burden of obesity.	[Lebenbaum, Michael; Espin-Garcia, Osvaldo; Li, Yi; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Lebenbaum, Michael; Rosella, Laura C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Li, Yi; Rosella, Laura C.] Publ Hlth Ontario, Toronto, ON, Canada	University of Toronto; University of Toronto	Rosella, LC (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Rosella, LC (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Rosella, LC (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	laura.rosella@utoronto.ca			Canadian Institutes of Health Research (CIHR) [MOP137130]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This project was funded a Canadian Institutes of Health Research (CIHR) Operating Grant held by LR (MOP137130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Echouffo-Tcheugui JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067370; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Harrell Jr FE, 2012, R PACKAGE VERSION 3; Kennedy KF, 2009 MIDWEST SAS US; Kuhle S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-173; Levy DT, 2011, OBES REV, V12, P378, DOI 10.1111/j.1467-789X.2010.00804.x; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Manuel DG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002082; Manuel DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143342; Manuel DG, 2012, J EPIDEMIOL COMMUN H, V66, P859, DOI 10.1136/jech-2012-200971; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nichols MS, 2010, OBES REV, V11, P731, DOI 10.1111/j.1467-789X.2009.00705.x; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rosella L, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-35; Rosella LC, 2014, PREV MED, V58, P17, DOI 10.1016/j.ypmed.2013.10.007; Rosella LC, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-20; Rosella LC, 2011, J EPIDEMIOL COMMUN H, V65, P613, DOI 10.1136/jech.2009.102244; Shields Margot, 2011, Health Rep, V22, P35; Statistics Canada, 2012, HLTH SURV PDHS 2012; Steffen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067429; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Swain L, 1999, Health Rep, V10, P69; Tambay J L, 1995, Health Rep, V7, P29; Vergouwe Y, 2010, J CLIN EPIDEMIOL, V63, P205, DOI 10.1016/j.jclinepi.2009.03.017; von Ruesten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027455; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191169	10.1371/journal.pone.0191169	http://dx.doi.org/10.1371/journal.pone.0191169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346391	Green Submitted, Green Published, gold			2022-12-27	WOS:000422749500033
J	Rivillas, JC; Rodriguez, RD; Song, G; Martel, A				Rivillas, Juan Carlos; Rodriguez, Raul Devia; Song, Gloria; Martel, Andreanne			How do we reach the girls and women who are the hardest to reach? Inequitable opportunities in reproductive and maternal health care services in armed conflict and forced displacement settings in Colombia	PLOS ONE			English	Article								Objectives This paper assesses inequalities in access to reproductive and maternal health services among females affected by forced displacement and sexual and gender-based violence in conflict settings in Colombia. This was accomplished through the following approaches: first, we assessed the gaps and gradients in three selected reproductive and maternal health care services. Second, we analyzed the patterns of inequalities in reproductive and maternal health care services and changes over time. And finally, we identified challenges and strategies for reaching girls and women who are the hardest to reach in conflict settings, in order to accelerate progress towards universal health coverage and to contribute to meeting the Sustainable Development Goals of good health and well-being and gender equality by 2030. Methods Three types of data were required: data about health outcomes (relating to rates of females affected by conflict), information about reproductive and maternal health care services to provide a social dimension to unmask inequalities (unmet needs in family planning, antenatal care and skilled births attendance); and data on the female population. Data sources used include the National Information System for Social Protection, the National Registry of Victims, the National Administrative Department of Statistics, and Demographic Health Survey at three specific time points: 2005, 2010 and 2015. We estimated the slope index of inequality to express absolute inequality (gaps) and the concentration index to expresses relative inequality (gradients), and to understand whether inequality was eliminated over time. Results Our findings show that even though absolute health care service-related inequalities dropped over time, relative inequalities worsened or remain unchanged. All summary measures still indicated the existence of inequalities as well as common patterns. Our findings suggest that there is a pattern of marginal exclusion and incremental patterns of inequality in the reproductive and maternal health care service provided to female affected by armed conflict. Conclusions Overall, the effects of conflict continue to threaten reproductive and maternal health in Colombia, impeding progress towards the realization of universal health care (UHC) and reinforcing already-existing inequities. Key messages and steps forward include the need to understand the two distinct patterns of inequalities identified in this study in order to prompt improved general policy responses. Addressing unmet needs in reproductive and maternal health requires supporting gender equality and prioritizing the girls and women in regions with the highest rates of victims of armed conflict, with the objective of leaving no girl or woman behind. This analysis represents the first attempt to analyze coverage-related inequality in reproductive and maternal health care services for female affected by armed conflict in Colombia. As the World Health Organization and global health systems leaders call for more inclusive engagement, this approach may serve as the key to shaping people-centred health systems. In this particular case, health care facilities must be located in close proximity to girls and women in conflict and post-conflict settings in order to deliver essential reproductive and maternal health care services. Finally, reducing inequalities in opportunities would not only promote equity, but also drive sustainable development.	[Rivillas, Juan Carlos] Univ Valle, Sch Publ Hlth, Initiat Res Hlth Serv & Syst, Cali, Colombia; [Rodriguez, Raul Devia] Univ Valle, Fac Med, Cali, Colombia; [Rodriguez, Raul Devia] Harvard Med Sch, Ctr Adv Orthoped Studies BIDMC, Boston, MA USA; [Song, Gloria] Univ Ottawa, Fac Law, Ottawa, ON, Canada; [Martel, Andreanne] CCIC, Ottawa, ON, Canada	Universidad del Valle; Universidad del Valle; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Ottawa	Rivillas, JC (corresponding author), Univ Valle, Sch Publ Hlth, Initiat Res Hlth Serv & Syst, Cali, Colombia.	jcrivillas@gmail.com	Rodriguez, Raul Devia/AAA-8820-2020; Rivillas, Juan Carlos/I-2707-2012	Rodriguez, Raul Devia/0000-0001-8102-7739; Rivillas, Juan Carlos/0000-0002-0961-3079	Bill AMP; Melinda Gates Foundation [OPP1125608]	Bill AMP; Melinda Gates Foundation	This research received support from the Bill & Melinda Gates Foundation - Grant #OPP1125608 to the Maternal Health Task Force at the Women and Health Initiative at the Harvard T. H. Chan School of Public Health (to Juan Carlos Rivillas).	Akol AD, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2037; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Falb KL, 2014, MATERN CHILD HLTH J, V18, P29, DOI 10.1007/s10995-013-1230-0; Hosseinpoor AR, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0307-y; Hosseinpoor AR, 2015, B WORLD HEALTH ORGAN, V93, P591, DOI 10.2471/BLT.15.162081; Hosseinpoor AR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001727; Kruk M, ASSESSMENT QUALITY B; Langer A, 2015, LANCET, V386, P1165, DOI 10.1016/S0140-6736(15)60497-4; Lincetto Ornella, ANTENATAL CARE OPPOR; Ministerio de Salud y Proteccio A n Social, 2015, SAL SIT POBL GEN VIC; MInisterio de Salud y Proteccio A n Social MSPS, 2017, CUB POBL ESP REG VIC; Ministerio de Salud y Proteccion Social, 2015, OBS MED DES AN EQ SA; Ministerio de Salud y Proteccion Social, 2012, PLAN DEC SAL PUBL 20; Ministerio de Salud y Proteccion Social, 2017, DHS 2015; Ministerio de Salud y Proteccion Social, 2012, SIST INF PROT SOC SI; Percival V, 2014, CONFL HEALTH, V8, P19, DOI DOI 10.1186/1752-1505-8-19; Restrepo-Mendez MC, 2015, REV PANAM SALUD PUBL, V38, P9; Scott Jennifer, 2013, Confl Health, V7, P24, DOI 10.1186/1752-1505-7-24; Seednet, 2005, YITP; Spangaro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062600; UN Sustainable Development Goals, 2019, SUSTAINABLE DEV GOAL; WHO, 2017, SEX REPR HLTH; WHO, 2015, STAT IN REPR MAT NEW; Wirtz Andrea L, 2014, Confl Health, V8, P10, DOI 10.1186/1752-1505-8-10; World Health Organization, 2015, TRACK UN HLTH COV 1; 2013, HDB HLTH IN MON SPEC, P1	27	10	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0188654	10.1371/journal.pone.0188654	http://dx.doi.org/10.1371/journal.pone.0188654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346375	gold, Green Published, Green Submitted			2022-12-27	WOS:000422749500003
J	Smith, CM				Smith, C. Michael			RETRACTION: Virulent Diuraphis noxia Aphids Over-Express Calcium Signaling Proteins to Overcome Defenses of Aphid-Resistant Wheat Plants (Retraction of Vol 11, art no E0146809, 2016)	PLOS ONE			English	Retraction																		Sinha DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146809; SMITH CM, 2016, PLOS ONE, V11, DOI DOI 10.1371/J0URNAL.PONE.0146809	2	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191678	10.1371/journal.pone.0191678	http://dx.doi.org/10.1371/journal.pone.0191678			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346432	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500062
J	Taylor, TE; Muls, HL; Costello, RW; Reilly, RB				Taylor, Terence E.; Muls, Helena Lacalle; Costello, Richard W.; Reilly, Richard B.			Estimation of inhalation flow profile using audio-based methods to assess inhaler medication adherence	PLOS ONE			English	Article							DRY POWDER INHALER; ASTHMA; DISEASE; SOUNDS	Asthma and chronic obstructive pulmonary disease (COPD) patients are required to inhale forcefully and deeply to receive medication when using a dry powder inhaler (DPI). There is a clinical need to objectively monitor the inhalation flow profile of DPIs in order to remotely monitor patient inhalation technique. Audio-based methods have been previously employed to accurately estimate flow parameters such as the peak inspiratory flow rate of inhalations, however, these methods required multiple calibration inhalation audio recordings. In this study, an audio-based method is presented that accurately estimates inhalation flow profile using only one calibration inhalation audio recording. Twenty healthy participants were asked to perform 15 inhalations through a placebo Ellipta (TM) DPI at a range of inspiratory flow rates. Inhalation flow signals were recorded using a pneumotachograph spirometer while inhalation audio signals were recorded simultaneously using the Inhaler Compliance Assessment device attached to the inhaler. The acoustic (amplitude) envelope was estimated from each inhalation audio signal. Using only one recording, linear and power law regression models were employed to determine which model best described the relationship between the inhalation acoustic envelope and flow signal. Each model was then employed to estimate the flow signals of the remaining 14 inhalation audio recordings. This process repeated until each of the 15 recordings were employed to calibrate single models while testing on the remaining 14 recordings. It was observed that power law models generated the highest average flow estimation accuracy across all participants (90.89 +/- 0.9% for power law models and 76.63 +/- 2.38% for linear models). The method also generated sufficient accuracy in estimating inhalation parameters such as peak inspiratory flow rate and inspiratory capacity within the presence of noise. Estimating inhaler inhalation flow profiles using audio based methods may be clinically beneficial for inhaler technique training and the remote monitoring of patient adherence.	[Taylor, Terence E.; Muls, Helena Lacalle; Reilly, Richard B.] Univ Dublin, Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland; [Taylor, Terence E.; Reilly, Richard B.] Univ Dublin, Trinity Coll Dublin, Sch Engn, Dublin, Ireland; [Muls, Helena Lacalle] Univ Barcelona, Fac Med, Barcelona, Spain; [Costello, Richard W.] Royal Coll Surgeons Ireland, Dept Med, Dublin, Ireland; [Reilly, Richard B.] Univ Dublin, Trinity Coll Dublin, Sch Med, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; University of Barcelona; Royal College of Surgeons - Ireland; Trinity College Dublin	Taylor, TE (corresponding author), Univ Dublin, Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland.; Taylor, TE (corresponding author), Univ Dublin, Trinity Coll Dublin, Sch Engn, Dublin, Ireland.	taylorte@tcd.ie	Taylor, Terence/M-2158-2019; Reilly, Richard/N-1080-2019; Reilly, Richard B/F-7034-2011	Reilly, Richard/0000-0001-8578-1245; Reilly, Richard B/0000-0001-8578-1245; Costello, Richard/0000-0003-1179-6692	Irish Research Council (IRC) Enterprise Partnership Scheme (EPS) scholarship; Vitalograph Ireland (Ltd.); Health Research Board (HRB) Clinician Scientist Award (CSA) [CSA/59]; Enterprise Ireland Innovation Partnership award [2015/0412/6]	Irish Research Council (IRC) Enterprise Partnership Scheme (EPS) scholarship; Vitalograph Ireland (Ltd.); Health Research Board (HRB) Clinician Scientist Award (CSA); Enterprise Ireland Innovation Partnership award	This research was part funded by an Irish Research Council (IRC) (http://www.research.ie/) Enterprise Partnership Scheme (EPS) scholarship to TET which was also part funded by Vitalograph Ireland (Ltd.) (https:Vitalograph.le/), a Health Research Board (HRB) (http://www.hrb.ie/home/) Clinician Scientist Award (CSA) to RWC (CSA/59) and an Enterprise Ireland (https://www.enterprise ireland:corn/en/) Innovation Partnership award to RBR (2015/0412/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was part funded by an Irish Research Council (IRC) Enterprise Partnership Scheme (EPS) scholarship to TET which was also part funded by Vitalograph Ireland (Ltd.), a Health Research Board (HRB) Clinician Scientist Award (CSA/59) to RWC and an Enterprise Ireland Innovation Partnership award to RBR (2015/0412/B).	Azouz W, 2012, PRIM CARE RESP J, V21, P208, DOI 10.4104/pcrj.2012.00010; Broeders MEAC, 2004, RESP MED, V98, P1173, DOI 10.1016/j.rmed.2004.04.010; D'Arcy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098701; Gavriely N, 1996, J APPL PHYSIOL, V80, P5, DOI 10.1152/jappl.1996.80.1.5; Hamilton M, 2015, J AEROSOL MED PULM D, V28, P498, DOI 10.1089/jamp.2015.1225; Holmes MS, 2014, IEEE J TRANSL ENG HE, V2, DOI 10.1109/JTEHM.2014.2310480; Holmes MS, 2013, PHYSIOL MEAS, V34, P903, DOI 10.1088/0967-3334/34/8/903; Holmes MS, 2012, AUTOMATIC IDENTIFICA; Laube BL, 2011, EUR RESPIR J, V37, P1308, DOI 10.1183/09031936.00166410; Lyons R.G., 2010, UNDERSTANDING DIGITA, V3rd; Mahler DA, 2013, J AEROSOL MED PULM D, V26, P174, DOI 10.1089/jamp.2012.0987; McCartan TA, 2016, ENG MED BIOL SOC EMB; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Prime D, 2015, J AEROSOL MED PULM D, V28, P486, DOI 10.1089/jamp.2015.1224; Que CL, 2002, J APPL PHYSIOL, V93, P1515, DOI 10.1152/japplphysiol.00028.2002; Reyes BA, 2014, SENSORS-BASEL, V14, P13830, DOI 10.3390/s140813830; Seheult JN, 2014, PHARM RES-DORDR, V31, P2735, DOI 10.1007/s11095-014-1371-x; Sulaiman I, 2016, J ALLER CL IMM-PRACT, V4, P900, DOI 10.1016/j.jaip.2016.07.009; Taylor TE, 2016, BIOMED PHYS ENG EXPR, V2, DOI 10.1088/2057-1976/2/5/055021; Taylor TE, 2016, J AEROSOL MED PULM D, V29, P439, DOI 10.1089/jamp.2015.1276; Westerik JAM, 2016, J ASTHMA, V53, P321, DOI 10.3109/02770903.2015.1099160; Yadollahi A, 2008, ENG MED BIOL SOC EMB; Yadollahi A, 2013, ANN BIOMED ENG, V41, P537, DOI 10.1007/s10439-012-0692-3; Yadollahi A, 2011, IEEE T BIO-MED ENG, V58, P1663, DOI 10.1109/TBME.2011.2109717	24	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191330	10.1371/journal.pone.0191330	http://dx.doi.org/10.1371/journal.pone.0191330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346430	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500042
J	Mackin, D; Fave, X; Zhang, LF; Yang, JZ; Jones, AK; Ng, CS; Court, L				Mackin, Dennis; Fave, Xenia; Zhang, Lifei; Yang, Jinzhong; Jones, A. Kyle; Ng, Chaan S.; Court, Laurence			Harmonizing the pixel size in retrospective computed tomography radiomics studies (vol 12, e0178524, 2017)	PLOS ONE			English	Correction																		Mackin D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178524	1	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191597	10.1371/journal.pone.0191597	http://dx.doi.org/10.1371/journal.pone.0191597			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342209	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800076
J	Tutino, VM; Poppenberg, KE; Jiang, KY; Jarvis, JN; Sun, YJ; Sonig, A; Siddiqui, AH; Snyder, KV; Levy, EI; Kolega, J; Meng, H				Tutino, Vincent M.; Poppenberg, Kerry E.; Jiang, Kaiyu; Jarvis, James N.; Sun, Yijun; Sonig, Ashish; Siddiqui, Adnan H.; Snyder, Kenneth V.; Levy, Elad I.; Kolega, John; Meng, Hui			Circulating neutrophil transcriptome may reveal intracranial aneurysm signature	PLOS ONE			English	Article							HUMAN CEREBRAL ANEURYSMS; GENE-EXPRESSION; MYELOPEROXIDASE; INFLAMMATION; ASSOCIATION; LIPOPROTEIN; BIOMARKERS; MANAGEMENT; CUFFLINKS; TOPHAT	Background Unruptured intracranial aneurysms (lAs) are typically asymptomatic and undetected except for incidental discovery on imaging. Blood-based diagnostic biomarkers could lead to improvements in IA management. This exploratory study examined circulating neutrophils to determine whether they carry RNA expression signatures of lAs. Methods Blood samples were collected from patients receiving cerebral angiography. Eleven samples were collected from patients with lAs and 11 from patients without lAs as controls. Samples from the two groups were paired based on demographics and comorbidities. RNA was extracted from isolated neutrophils and subjected to next-generation RNA sequencing to obtain differential expressions for identification of an IA-associated signature. Bioinformatics analyses, including gene set enrichment analysis and Ingenuity Pathway Analysis, were used to investigate the biological function of all differentially expressed transcripts. Results Transcriptome profiling identified 258 differentially expressed transcripts in patients with and without lAs. Expression differences were consistent with peripheral neutrophil activation. An IA-associated RNA expression signature was identified in 82 transcripts (p<0.05, fold-change >= 2). This signature was able to separate patients with and without lAs on hierarchical clustering. Furthermore, in an independent, unpaired, replication cohort of patients with lAs (n = 5) and controls (n = 5), the 82 transcripts separated 9 of 10 patients into their respective groups. Conclusion Preliminary findings show that RNA expression from circulating neutrophils carries an IA associated signature. These findings highlight a potential to use predictive biomarkers from peripheral blood samples to identify patients with lAs.	[Tutino, Vincent M.; Poppenberg, Kerry E.; Sonig, Ashish; Siddiqui, Adnan H.; Snyder, Kenneth V.; Levy, Elad I.; Kolega, John; Meng, Hui] SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY 14260 USA; [Tutino, Vincent M.; Poppenberg, Kerry E.; Meng, Hui] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA; [Jiang, Kaiyu; Jarvis, James N.] SUNY Buffalo, Genet Genom & Bioinformat Program, Buffalo, NY 14260 USA; [Jarvis, James N.] SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA; [Sun, Yijun] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Sun, Yijun] SUNY Buffalo, Dept Comp Sci & Engn, Buffalo, NY 14260 USA; [Sonig, Ashish; Siddiqui, Adnan H.; Snyder, Kenneth V.; Levy, Elad I.; Meng, Hui] SUNY Buffalo, Dept Neurosurg, Buffalo, NY 14260 USA; [Siddiqui, Adnan H.; Snyder, Kenneth V.; Levy, Elad I.] SUNY Buffalo, Dept Radiol, Buffalo, NY 14260 USA; [Snyder, Kenneth V.] SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA; [Kolega, John] SUNY Buffalo, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA; [Meng, Hui] SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Meng, H (corresponding author), SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY 14260 USA.; Meng, H (corresponding author), SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA.; Meng, H (corresponding author), SUNY Buffalo, Dept Neurosurg, Buffalo, NY 14260 USA.; Meng, H (corresponding author), SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA.	huimeng@buffalo.edu	Meng, Hui/F-7929-2010; Siddiqui, Adnan H./AAG-9781-2019; Kolega, John/J-8386-2016	Kolega, John/0000-0001-6933-8681; Poppenberg, Kerry/0000-0002-1748-887X	Brain Aneurysm Foundation Carol Harvey Chair of Research Grant; Team Cindy-Alcatraz Chair of Research Grant; NIH [R01-AR-060604]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125982] Funding Source: NIH RePORTER	Brain Aneurysm Foundation Carol Harvey Chair of Research Grant; Team Cindy-Alcatraz Chair of Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Brain Aneurysm Foundation Carol Harvey Chair of Research Grant (HM) and Team Cindy-Alcatraz Chair of Research Grant (HM), and NIH grant R01-AR-060604 (JNJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alg VS, 2013, NEUROLOGY, V80, P2154, DOI 10.1212/WNL.0b013e318295d751; Andrews S., 2017, FASTQC QUALITY CONTR; BAKER CJ, 1995, NEUROSURGERY, V37, P56, DOI 10.1227/00006123-199507000-00008; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chalouhi N, 2015, DNA CELL BIOL, V34, P78, DOI 10.1089/dna.2014.2618; Chalouhi N, 2013, STROKE, V44, P2594, DOI 10.1161/STROKEAHA.113.002361; Chen Jiadi, 2015, INT J ANTENN PROPAG, V2015, P12, DOI DOI 10.1016/J.EJPHAR.2015.12.038; Chu Y, 2015, STROKE, V46, P1651, DOI 10.1161/STROKEAHA.114.008589; Eteleeb A, 2013, OA BIOINFORMATICS, V1; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3; Ghosh S, 2016, METHODS MOL BIOL, V1374, P339, DOI 10.1007/978-1-4939-3167-5_18; Goff L, 2016, ANAL EXPLORATION MAN, P73; Gounis MJ, 2014, STROKE, V45, P1474, DOI 10.1161/STROKEAHA.114.004956; Hart SN, 2013, J COMPUT BIOL, V20, P970, DOI 10.1089/cmb.2012.0283; Hussain I, 2013, STROKE, V44, P2670, DOI 10.1161/STROKEAHA.113.001753; Hussain S, 2015, WORLD NEUROSURG, V84, P1473, DOI 10.1016/j.wneu.2015.06.034; Jarvis JN, 2004, ARTHRITIS RES THER, V6, pR15, DOI 10.1186/ar1018; Jiang KY, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0128-7; Jin HW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-296; Kimura H, 2001, AM J RESP CRIT CARE, V164, P319, DOI 10.1164/ajrccm.164.2.2006154; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Langfelder P, 2012, J STAT SOFTW, V46, P1; Leopold JA, 2015, HYPERTENSION, V66, P20, DOI 10.1161/HYPERTENSIONAHA.115.05479; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; Meng H, 2014, AM J NEURORADIOL, V35, P1254, DOI 10.3174/ajnr.A3558; Pera J, 2010, STROKE, V41, P224, DOI 10.1161/STROKEAHA.109.562009; Phillips J, 1997, NEUROSURGERY, V40, P1112, DOI 10.1097/00006123-199705000-00067; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Raaymakers TWM, 1999, NEW ENGL J MED, V341, P1344; Ray L, 2013, AGING DIS, V4, P57; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabatino G, 2013, J BIOL REG HOMEOS AG, V27, P729; Sandalcioglu IE, 2006, NEUROSURG REV, V29, P26, DOI 10.1007/s10143-005-0411-8; Serra R., 2014, BRIT J NEUROSURGERY; Stapleton PP, 1998, ADV EXP MED BIOL, V442, P183; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tromp G, 2014, ANN MED, V46, P597, DOI 10.3109/07853890.2014.949299; Tulamo R, 2010, J NEUROINTERV SURG, V2, P120, DOI 10.1136/jnis.2009.002055; Vega C, 2002, AM FAM PHYSICIAN, V66, P601; Wang Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001050; Wardlaw JM, 2000, BRAIN, V123, P205, DOI 10.1093/brain/123.2.205; Yu LB, 2017, WORLD NEUROSURG, V105, P28, DOI 10.1016/j.wneu.2017.04.064; Zhang HF, 2013, INFLAMMATION, V36, P1195, DOI 10.1007/s10753-013-9655-6; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	47	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191407	10.1371/journal.pone.0191407	http://dx.doi.org/10.1371/journal.pone.0191407			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342213	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800069
J	Adams, NL; Rose, TC; Hawker, J; Violato, M; O'Brien, SJ; Barr, B; Howard, VJK; Whitehead, M; Harris, R; Taylor-Robinson, DC				Adams, Natalie L.; Rose, Tanith C.; Hawker, Jeremy; Violato, Mara; O'Brien, Sarah J.; Barr, Benjamin; Howard, Victoria J. K.; Whitehead, Margaret; Harris, Ross; Taylor-Robinson, David C.			Relationship between socioeconomic status and gastrointestinal infections in developed countries: A systematic review and meta-analysis	PLOS ONE			English	Review							GROUP-A ROTAVIRUS; RISK-FACTORS; CAMPYLOBACTER INFECTION; CHILDREN; ENGLAND; IMPACT; PREVALENCE; NOROVIRUS; LEVEL; BIAS	Background The association between socioeconomic status (SES) and health is well-documented; however limited evidence on the relationship between SES and gastrointestinal (GI) infections exists, with published studies producing conflicting results. This systematic review aimed to assess the association between SES and GI infection risk, and explore possible sources of heterogeneity in effect estimates reported in the literature. Methods MEDLINE, Scopus, Web of Science and grey literature were searched from 1980 to October 2015 for studies reporting an association between GI infections and SES in a representative population sample from a member-country of the Organisation for Economic Co-operation and Development. Harvest plots and meta-regression were used to investigate potential sources of heterogeneity such as age; level of SES variable; GI infection measurement; and predominant mode of transmission. The protocol was registered on PROSPERO: CRD42015027231. Results In total, 6021 studies were identified; 102 met the inclusion criteria. Age was identified as the only statistically significant potential effect modifier of the association between SES and GI infection risk. For children, GI infection risk was higher for those of lower SES versus high (RR 1.51, 95% CI; 1.26-1.83), but there was no association for adults (RR 0.79, 95% CI; 0.58-1.06). In univariate analysis, the increased risk comparing low and high SES groups was significantly higher for pathogens spread by person-to-person transmission, but lower for environmental pathogens, as compared to foodborne pathogens. Conclusions Disadvantaged children, but not adults, have greater risk of GI infection compared to their more advantaged counterparts. There was high heterogeneity and many studies were of low quality. More high quality studies are needed to investigate the association between SES and GI infection risk, and future research should stratify analyses by age and pathogen type. Gaining further insight into this relationship will help inform policies to reduce inequalities in GI illness in children.	[Adams, Natalie L.; Rose, Tanith C.; Hawker, Jeremy; Violato, Mara; O'Brien, Sarah J.; Barr, Benjamin; Whitehead, Margaret; Taylor-Robinson, David C.] NIHR Hlth Protect Res Unit Gastrointestinal Infec, Liverpool, Merseyside, England; [Adams, Natalie L.; Rose, Tanith C.; O'Brien, Sarah J.; Barr, Benjamin; Howard, Victoria J. K.; Whitehead, Margaret; Taylor-Robinson, David C.] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Adams, Natalie L.; Hawker, Jeremy; Harris, Ross] Publ Hlth England, Natl Infect Serv, London, England; [Violato, Mara] Univ Oxford, Hlth Econ Res Ctr, Oxford, England	University of Liverpool; Public Health England; University of Oxford	Adams, NL (corresponding author), NIHR Hlth Protect Res Unit Gastrointestinal Infec, Liverpool, Merseyside, England.; Adams, NL (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England.; Adams, NL (corresponding author), Publ Hlth England, Natl Infect Serv, London, England.	Natalie.Adams@phe.gov.uk	Barr, Ben R/W-9989-2018	Barr, Ben R/0000-0002-4208-9475; Violato, Mara/0000-0002-0484-7706; Taylor-Robinson, David/0000-0002-5828-7724	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Gastrointestinal Infections at University of Liverpool in partnership with Public Health England (PHE) [NIHR HPRU 2012-10038]; University of East Anglia; University of Oxford; Institute of Food Research; National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections; MRC [MR/P008577/1] Funding Source: UKRI	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Gastrointestinal Infections at University of Liverpool in partnership with Public Health England (PHE); University of East Anglia; University of Oxford; Institute of Food Research; National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Gastrointestinal Infections [grant number NIHR HPRU 2012-10038] at University of Liverpool in partnership with Public Health England (PHE), in collaboration with University of East Anglia, University of Oxford and the Institute of Food Research. Natalie Adams is a PhD student based at the University of Liverpool and Public Health England. Tanith Rose is a PhD student based at the University of Liverpool. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.; This work was funded by the National Institute for Health Research Health Protection Research Unit in Gastrointestinal Infections.	[Anonymous], METAFOR PACKAGE META; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Bessell PR, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-423; Biering-Sorensen S, 2012, PAEDIATR PERINAT EP, V26, P226, DOI 10.1111/j.1365-3016.2011.01255.x; Borgnolo G, 1996, ACTA PAEDIATR, V85, P804, DOI 10.1111/j.1651-2227.1996.tb14155.x; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Davis MA, 2013, J CLIN MICROBIOL, V51, P3921, DOI 10.1128/JCM.01433-13; de Wit MAS, 2003, EMERG INFECT DIS, V9, P1563, DOI 10.3201/eid0912.020076; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; Fernandez H, 2008, BRAZ J MICROBIOL, V39, P56, DOI [10.1590/S1517-83822008000100013, 10.1590/S1517-838220080001000013]; Food Standards Agency, 2 STUD INF INT DIS C; Food Standards Agency, 2011, FOODB DIS STRAT 2010; Fullerton KE, 2007, PEDIATR INFECT DIS J, V26, P19, DOI 10.1097/01.inf.0000247137.43495.34; Gillespie IA, 2010, EUROSURVEILLANCE, V15, P7; Gillespie IA, 2008, EPIDEMIOL INFECT, V136, P1717, DOI 10.1017/S0950268808000319; Hempel S, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-107; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Jackson R, 2015, PEDIATR INFECT DIS J, V34, P843, DOI 10.1097/INF.0000000000000746; KAKAI R, 1995, E AFR MED J, V72, P288; Lake IR, 2007, EUR J EPIDEMIOL, V22, P805, DOI 10.1007/s10654-007-9179-1; LLOYDEVANS N, 1983, T ROY SOC TROP MED H, V77, P245, DOI 10.1016/0035-9203(83)90082-2; Majowicz SE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-162; Met Office, CLIM ZON; Nematian J, 2004, ACTA TROP, V92, P179, DOI 10.1016/j.actatropica.2004.06.010; Newman KL, 2015, EPIDEMIOL INFECT, V143, P2473, DOI 10.1017/S0950268814003847; Nichols GL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001179; O'Ryan Miguel, 2005, Semin Pediatr Infect Dis, V16, P125, DOI 10.1053/j.spid.2005.12.008; Ogilvie D, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-8; Olowokure B, 1999, LANCET, V353, P807, DOI 10.1016/S0140-6736(99)00611-X; Pasturel BZ, 2013, AM J PUBLIC HEALTH, V103, P2267, DOI 10.2105/AJPH.2013.301338; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Phillips G, 2011, EPIDEMIOL INFECT, V139, P1676, DOI 10.1017/S0950268810002839; Pockett RD, 2011, CURR MED RES OPIN, V27, P777, DOI 10.1185/03007995.2011.555757; Pollard CM, 2014, PUBLIC HEALTH NUTR, V17, P2270, DOI 10.1017/S1368980013002371; Pope D., 2015, INTRO SYSTEMATIC REV; Puzzolo E, 2013, FACTORS INFLUENCING; Quetz JD, 2010, DIAGN MICR INFEC DIS, V67, P220, DOI 10.1016/j.diagmicrobio.2010.02.025; Rehfuess EA, 2014, ENVIRON HEALTH PERSP, V122, P120, DOI 10.1289/ehp.1306639; Rose TC, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0187-7; Sethi D, 2001, EPIDEMIOL INFECT, V126, P63, DOI 10.1017/S0950268801005088; Simonsen J, 2008, EPIDEMIOLOGY, V19, P282, DOI 10.1097/EDE.0b013e3181633c19; Tam CC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-739; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; United Nations Development Programme, HUM DEV IND HDI; Voss PH, 2013, J EPIDEMIOL COMMUN H, V67, P98, DOI 10.1136/jech-2011-200940; Wilking H, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-37	46	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191633	10.1371/journal.pone.0191633	http://dx.doi.org/10.1371/journal.pone.0191633			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360884	Green Published, gold			2022-12-27	WOS:000423161800045
J	Henriques, SF; Patissier, C; Bourg, N; Fecchio, C; Sandona, D; Marsolier, J; Richard, I				Henriques, Sara F.; Patissier, Cecile; Bourg, Nathalie; Fecchio, Chiara; Sandona, Doriana; Marsolier, Justine; Richard, Isabelle			Different outcome of sarcoglycan missense mutation between human and mouse	PLOS ONE			English	Article							DYSTROPHIN-GLYCOPROTEIN COMPLEX; DUCHENNE MUSCULAR-DYSTROPHY; ALPHA-SARCOGLYCAN; BETA-SARCOGLYCAN; GAMMA-SARCOGLYCAN; DEFICIENT MICE; ENDOPLASMIC-RETICULUM; SKELETAL-MUSCLE; QUALITY-CONTROL; SMOOTH-MUSCLE	Sarcoglycanopathies are rare autosomic limb girdle muscular dystrophies caused by mutations in one of the genes coding for sarcoglycan (alpha, beta, delta, and gamma-sarcoglycans). Sarcoglycans form a complex, which is an important part of the dystrophin-associated glycoprotein complex that protects sarcolemma against muscle contraction-induced damages. Absence of one of the sarcoglycan at the plasma membrane induces the disappearance of the whole complex and perturbs muscle fiber membrane integrity. We previously demonstrated that point mutations in the human sarcoglycan genes affects the folding of the corresponding protein, which is then retained in the endoplasmic reticulum by the protein quality control and prematurely degraded by the proteasome. Interestingly, modulation of the quality control using pharmacological compounds allowed the rescue of the membrane localization of the mutated sarcoglycan. Two previously generated mouse models, knock-in for the most common sarcoglycan mutant, R77C alpha-sarcoglycan, failed in reproducing the dystrophic phenotype observed in human patients. Based on these results and the need to test therapies for these fatal diseases, we decided to generate a new knock-in mouse model carrying the missense mutation T151R in the beta-sarcoglycan gene since this is the second sarcoglycan protein with the most frequently reported missense mutations. Muscle analysis, performed at the age of 4 and 9-months, showed the presence of the mutated beta-sarcoglycan protein and of the other components of the dystrophin-associated glycoprotein complex at the muscle membrane. In addition, these mice did not develop a dystrophic phenotype, even at a late stage or in condition of stress-inducing exercise. We can speculate that the absence of phenotype in mouse may be due to a higher tolerance of the endoplasmic reticulum quality control for amino-acid changes in mice compared to human.	[Henriques, Sara F.; Patissier, Cecile; Bourg, Nathalie; Marsolier, Justine; Richard, Isabelle] Univ Paris Saclay, Univ Evry, INSERM, INTEGRARE,Genethon, Evry, France; [Fecchio, Chiara; Sandona, Doriana] Univ Padua, Dept Biomed Sci, Via U Bassi, Padua, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Padua	Richard, I (corresponding author), Univ Paris Saclay, Univ Evry, INSERM, INTEGRARE,Genethon, Evry, France.	richard@genethon.fr	Richard, isabelle/J-8298-2013; sandona, dorianna/AAB-9480-2020	Marsolier, Justine/0000-0001-8464-9306	Fondation de France; AFM-Telethon [18620]	Fondation de France(Fondation de France); AFM-Telethon(Association Francaise contre les Myopathies)	This work was supported by Fondation de France, https://www.fondationdefrance.org/fr; and AFM-Telethon 18620, http://www.afm-telethon.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araishi K, 1999, HUM MOL GENET, V8, P1589, DOI 10.1093/hmg/8.9.1589; Bartoli M, 2008, HUM MOL GENET, V17, P1214, DOI 10.1093/hmg/ddn029; Davidson D J, 2001, Trends Genet, V17, pS29, DOI 10.1016/S0168-9525(01)02452-0; Draviam RA, 2006, TRAFFIC, V7, P793, DOI 10.1111/j.1600-0854.2006.00433.x; Duclos F, 1998, NEUROMUSCULAR DISORD, V8, P30, DOI 10.1016/S0960-8966(97)00135-1; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Elsea Sarah H, 2002, ILAR J, V43, P66; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Gastaldello S, 2008, AM J PATHOL, V173, P170, DOI 10.2353/ajpath.2008.071146; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Hack AA, 2000, J CELL SCI, V113, P2535; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Israeli D, 2016, SCI REP-UK, V6, DOI 10.1038/srep28097; Kobuke K, 2008, HUM MOL GENET, V17, P1201, DOI 10.1093/hmg/ddn009; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Lavelle GM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5258727; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; Marsolier J, 2017, NEUROMUSCULAR DISORD, V27, P683, DOI 10.1016/j.nmd.2017.02.011; McCaffrey K, 2016, ESSAYS BIOCHEM, V60, P227, DOI 10.1042/EBC20160003; Melacini P, 1999, MUSCLE NERVE, V22, P473, DOI 10.1002/(SICI)1097-4598(199904)22:4<473::AID-MUS8>3.0.CO;2-5; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Ozawa E, 1998, MUSCLE NERVE, V21, P421, DOI 10.1002/(SICI)1097-4598(199804)21:4<421::AID-MUS1>3.3.CO;2-W; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Politano L, 2001, NEUROMUSCULAR DISORD, V11, P178, DOI 10.1016/S0960-8966(00)00174-7; Sasaoka T, 2003, NEUROMUSCULAR DISORD, V13, P193, DOI 10.1016/S0960-8966(02)00220-1; Semplicini C, 2015, NEUROLOGY, V84, P1772, DOI 10.1212/WNL.0000000000001519; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soheili T, 2012, HUM MUTAT, V33, P429, DOI 10.1002/humu.21659; Straub V, 1999, J BIOL CHEM, V274, P27989, DOI 10.1074/jbc.274.39.27989; Sun Gui-Lian, 2006, Neurosci Bull, V22, P85; Wang RB, 2010, AM J PHYSIOL-REG I, V299, pR259, DOI 10.1152/ajpregu.00060.2010; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wheeler MT, 2002, COLD SPRING HARB SYM, V67, P389, DOI 10.1101/sqb.2002.67.389; Zanotti S, 2007, MATRIX BIOL, V26, P615, DOI 10.1016/j.matbio.2007.06.004	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191274	10.1371/journal.pone.0191274	http://dx.doi.org/10.1371/journal.pone.0191274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360879	Green Submitted, Green Published, gold			2022-12-27	WOS:000423161800021
J	Knytl, M; Kalous, L; Rylkova, K; Choleva, L; Merila, J; Rab, P				Knytl, Martin; Kalous, Lukas; Rylkova, Katerina; Choleva, Lukas; Merila, Juha; Rab, Petr			Morphologically indistinguishable hybrid Carassius female with 156 chromosomes: A threat for the threatened crucian carp, C. carassius, L	PLOS ONE			English	Article							CARASSIUS-AURATUS-GIBELIO; FRESH-WATER FISH; IN-SITU HYBRIDIZATION; RIBOSOMAL-RNA GENE; PRUSSIAN CARP; 5S RDNA; DETECT HYBRIDIZATION; TELEOSTEI CYPRINIDAE; MOLECULAR APPROACH; 28S RDNA	The crucian carp Carassius carassius (Linnaeus, 1758), is native to many European freshwaters. Despite its wide distribution, the crucian carp is declining in both the number and sizes of populations across much of its range. Here we studied 30 individuals of a putative pure population from Helsinki, Finland. Despite clear external morphological features of C. carassius, an individual was of a higher ploidy level than the others. We therefore applied a set of molecular genetic (S7 nuclear and cytochrome b mitochondrial genes) and cytogenetic tools (sequential fluorescent 4', 6-diamidino-2-phenylindole [DAPI], Chromomycin A(3) [CMA(3)], C-banding and in situ hybridization [FISH] with both 5S and 28S ribosomal DNA probes) to determine its origin. While all examined characteristics of a diploid representative male (CCAHe2Fi) clearly corresponded to those of C. carassius, a triploid individual (CCAHe1Fi) was more complex. Phylogenetic analysis revealed that the nuclear genome of CCAHe1Fi contained three haploid sets: two C. gibelio and one C. carassius. However the mitochondrial DNA was that of C. gibelio, demonstrating its hybrid origin. The FISH revealed three strong (more intensive) 5S rDNA loci, confirming the triploid status, and an additional 24 weak (less intensive) signals were observed in the chromosome complement of CCAHe1Fi. On the other hand, only two strong and 16 weak 5S rDNA signals were visible on the chromosomes of the CCAHe2Fi male. 28S rDNA FISH revealed four strong signals in both CCAHe1Fi and CCAHe2Fi individuals. CMA(3) staining revealed four to six CMA(3)-positive bands of CCAHe1Fi, while that of diploids contained only two to four. The fact that a polyploid hybrid Carassius female with a strong invasive potential may share morphological characters typical for endangered C. carassius highlights a need to combine genetic investigations of Carassius cryptic diversity with conservation measures of C. carassius in Europe.	[Knytl, Martin] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic; [Kalous, Lukas] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic; [Rylkova, Katerina] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Genet & Breeding, Prague, Czech Republic; [Choleva, Lukas; Rab, Petr] Czech Acad Sci, Inst Anim Physiol & Genet, Lab Fish Genet, Libechov, Czech Republic; [Choleva, Lukas] Univ Ostrava, Fac Sci, Dept Biol & Ecol, Ostrava, Czech Republic; [Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	Charles University Prague; Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; University of Ostrava; University of Helsinki	Knytl, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic.	martin.knytl@natur.cuni.cz	Rylková, Kateřina/ABA-2891-2021; Kalous, Lukáš/B-2952-2013; Merila, Juha/A-4061-2008; Knytl, Martin/V-7793-2017	Rylková, Kateřina/0000-0003-4838-9599; Kalous, Lukáš/0000-0001-5518-1505; Merila, Juha/0000-0001-9614-0072; Knytl, Martin/0000-0002-6325-6957	Charles University [SW: 244-260435, UNCE: 204013]; Academy of Finland [218343]; Czech Academy of Sciences (CAS) within the program for internal support of projects of international cooperation from The Czech Science Foundation [CAS: 15-19947Y, M200451271]; Internal Grant Agency of the Czech University of Life Sciences Prague "CIGA" [20152007, EXCELLENCE CZ.02.1.01/ 0.0/0.0/15_003/0000460 OP RDE]; Charles University [SW: 244-260435, UNCE: 204013]; Academy of Finland [218343]; Czech Academy of Sciences (CAS) within the program for internal support of projects of international cooperation from The Czech Science Foundation [CAS: 15-19947Y, M200451271]; Internal Grant Agency of the Czech University of Life Sciences Prague "CIGA" [20152007, EXCELLENCE CZ.02.1.01/ 0.0/0.0/15_003/0000460 OP RDE];  [RVO: 67985904]	Charles University; Academy of Finland(Academy of Finland); Czech Academy of Sciences (CAS) within the program for internal support of projects of international cooperation from The Czech Science Foundation; Internal Grant Agency of the Czech University of Life Sciences Prague "CIGA"; Charles University; Academy of Finland(Academy of Finland); Czech Academy of Sciences (CAS) within the program for internal support of projects of international cooperation from The Czech Science Foundation; Internal Grant Agency of the Czech University of Life Sciences Prague "CIGA"; 	The research was funded by Charles University grant SW: 244-260435 (MK), UNCE: 204013 (MK), Internal Grant Agency of the Czech University of Life Sciences Prague "CIGA": 20152007 (LK), project EXCELLENCE CZ.02.1.01/ 0.0/0.0/15_003/0000460 OP RDE and with the institutional support RVO: 67985904 (LC, PR). Further support was provided by the Czech Academy of Sciences (CAS; [http://www.cas.cz]:) M200451271 (LC) within the program for internal support of projects of international cooperation CAS: 15-19947Y from The Czech Science Foundation (LC), and Academy of Finland: 218343 (JM).	Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Alves-Costa FA, 2008, GENET MOL BIOL, V31, P303, DOI 10.1590/S1415-47572008000200025; Avise JC, 2015, P NATL ACAD SCI USA, V112, P8867, DOI 10.1073/pnas.1501820112; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Barus V., 1995, FAUNA CR SR MIHULOVC, P623; Bertollo LAC, 2015, FISH CYTOGENETIC TEC, P21, DOI DOI 10.1201/B18534-4; Boron A, 2011, ACTA ICHTHYOL PISCAT, V41, P19, DOI 10.3750/AIP2011.41.1.04; Cambray JA, 2003, HYDROBIOLOGIA, V500, P217, DOI 10.1023/A:1024648719995; Cherfas N.B., 1966, GENETIKA+, V5, P16; Choleva L, 2013, CYTOGENET GENOME RES, V140, P151, DOI 10.1159/000353464; Chow S, 1998, MOL ECOL, V7, P1255; Cremer Marion, 2008, V463, P205, DOI 10.1007/978-1-59745-406-3_15; ECONOMIDIS PS, 1995, BIOL CONSERV, V72, P201, DOI 10.1016/0006-3207(94)00083-3; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Gornung E, 2013, CYTOGENET GENOME RES, V141, P90, DOI 10.1159/000354832; Gromicho M, 2006, CHROMOSOME RES, V14, P297, DOI 10.1007/s10577-006-1047-4; Gromicho M, 2005, CYTOGENET GENOME RES, V109, P507, DOI 10.1159/000084211; GUERRA MD, 1986, REV BRAS GENET, V9, P741; Gui J, 1992, CHINESE SCI BULL, V37, P255; GUI JF, 1993, CHINESE SCI BULL, V38, P332; GUI JF, 1993, CHINESE SCI BULL, V38, P327; Gui JF, 2010, SCI CHINA LIFE SCI, V53, P409, DOI 10.1007/s11427-010-0092-6; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Hanfling B, 2005, FRESHWATER BIOL, V50, P403, DOI 10.1111/j.1365-2427.2004.01330.x; Haynes GD, 2012, ANIM CONSERV, V15, P83, DOI 10.1111/j.1469-1795.2011.00490.x; Helfman GS, 2007, FISH CONSERVATION GU; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inafuku J, 2000, CHROMOSOME RES, V8, P193, DOI 10.1023/A:1009292610618; Janko K, 2007, GENETICA, V131, P185, DOI 10.1007/s10709-006-9130-5; Jeffries DL, 2017, ECOL EVOL, V7, P2871, DOI 10.1002/ece3.2831; Jeffries DL, 2016, MOL ECOL, V25, P2997, DOI 10.1111/mec.13613; Jiang Y, 1983, ACTA HYDROBIOL SIN; JOTTERAN.M, 1974, EXPERIENTIA, V30, P1003, DOI 10.1007/BF01938973; Kalous L, 2007, J FISH BIOL, V70, P132, DOI 10.1111/j.1095-8649.2006.01290.x; Kalous L, 2013, J FISH BIOL, V82, P703, DOI 10.1111/j.1095-8649.2012.03492.x; Kalous L, 2012, ICHTHYOL EXPLOR FRES, V23, P11; Kalous L, 2011, FOLIA ZOOL, V60, P115; Knytl M, 2013, CYTOGENET GENOME RES, V139, P276, DOI 10.1159/000350689; Knytl M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177087; Knytl M, 2013, COMP CYTOGENET, V7, P205, DOI 10.3897/CompCytogen.v7i3.5411; KOMIYA H, 1979, J BIOCHEM-TOKYO, V86, P1067, DOI 10.1093/oxfordjournals.jbchem.a132601; Lamatsch DK, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P399, DOI 10.1007/978-90-481-2770-2_19; Lusk S, 2004, FOLIA ZOOL, V53, P215; Lusk S., 2017, RED LIST LAMPREYS FI, V34, P51; Luskova V., 2010, Russian Journal of Biological Invasions, V1, P176, DOI 10.1134/S2075111710030069; Mandrak NE, 2010, AQUAT ECOSYST HEALTH, V13, P255, DOI 10.1080/14634988.2010.507150; Mantovani M, 2005, GENETICA, V123, P211, DOI 10.1007/s10709-004-2281-3; Mezhzherin SV, 2012, CYTOL GENET+, V46, P28, DOI 10.3103/S0095452712010069; NAITO E, 1992, J FORENSIC SCI, V37, P396; OJIMA Y, 1979, P JPN ACAD B-PHYS, V55, P346, DOI 10.2183/pjab.55.346; Papousek I, 2008, J FISH BIOL, V72, P1230, DOI 10.1111/j.1095-8649.2007.01783.x; Payseur BA, 2016, MOL ECOL, V25, P2337, DOI 10.1111/mec.13557; Penaz M., 1979, Acta Scientiarum Naturalium Academiae Scientiarum Bohemoslovacae Brno, V13, P1; Rab P, 2007, FISH CYTOGENETICS, P229; Roberts DG, 2009, J EVOLUTION BIOL, V22, P27, DOI 10.1111/j.1420-9101.2008.01620.x; Rylkova K, 2013, AQUACULTURE, V380, P13, DOI 10.1016/j.aquaculture.2012.11.027; Rylkova K, 2010, AQUACULTURE, V302, P36, DOI 10.1016/j.aquaculture.2010.02.003; Savini D, 2010, J APPL ICHTHYOL, V26, P1, DOI 10.1111/j.1439-0426.2010.01503.x; Sayer CD, 2011, J FISH BIOL, V79, P1608, DOI 10.1111/j.1095-8649.2011.03059.x; Sember A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0532-9; Simkova A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0438-6; Slechtova V, 2006, MOL PHYLOGENET EVOL, V39, P529, DOI 10.1016/j.ympev.2005.09.018; Spoz A, 2014, COMP CYTOGENET, V8, P233, DOI 10.3897/CompCytogen.v8i3.7718; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Symonova R., 2015, FISH CYTOGENETIC TEC, P118; Symonova R, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-42; Takada M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-7; Toledo LFA., 2015, FISH CYTOGENETIC TEC, P92, DOI DOI 10.1201/618534-15; Toth B, 2005, J FISH BIOL, V66, P784, DOI 10.1111/j.0022-1112.2005.00644.x; TYMOWSKA J, 1982, CYTOGENET CELL GENET, V34, P149, DOI 10.1159/000131803; Volker M, 2007, CYTOGENET GENOME RES, V116, P116, DOI 10.1159/000097429; Wheeler A, 2000, FISHERIES MANAG ECOL, V7, P315, DOI 10.1046/j.1365-2400.2000.007004315.x; Wouters J, 2012, J FISH BIOL, V80, P2595, DOI 10.1111/j.1095-8649.2012.03312.x; Wyatt PMW, 2006, J FISH BIOL, V69, P52, DOI 10.1111/j.1095-8649.2006.01104.x; Xiao J, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-20; Yang L, 2015, MOL PHYLOGENET EVOL, V85, P97, DOI 10.1016/j.ympev.2015.01.014; Zhang C, 2011, J FISH CHINA, V35, P1370; Zhang Q, 2000, J FISH BIOL, V56, P388, DOI 10.1111/j.1095-8649.2000.tb02113.x; Zhao J, 2004, AQUACULTURE, V237, P117, DOI 10.1016/j.aquaculture.2004.05.001; Zhu HP, 2006, CHROMOSOME RES, V14, P767, DOI 10.1007/s10577-006-1083-0; Zhu HP, 2007, AQUACULTURE, V265, P109, DOI 10.1016/j.aquaculture.2006.10.026	81	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190924	10.1371/journal.pone.0190924	http://dx.doi.org/10.1371/journal.pone.0190924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360831	gold, Green Published, Green Submitted			2022-12-27	WOS:000423161800011
J	Noyce, RS; Lederman, S; Evans, DH				Noyce, Ryan S.; Lederman, Seth; Evans, David H.			Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments	PLOS ONE			English	Article							EVOLUTIONARY RELATIONSHIPS; NUCLEOTIDE-LEVEL; GENOMIC ANALYSIS; RECOMBINATION; REACTIVATION; REPLICATION; RESOLUTION; ORIGINS; BASE	Edward Jenner and his contemporaries believed that his variolae vaccinae originated in horses and molecular analyses show that modern vaccinia virus (VACV) strains share common ancestry with horsepox virus (HPXV). Given concerns relating to the toxicity of modern VACV vaccines, we asked whether an HPXV-based vaccine might provide a superior alternative. Since HPXV may be extinct and the only specimen of HPXV that has been identified is unavailable for investigation, we explored whether HPXV could be obtained by large-scale gene synthesis. Ten large (10 +/- 30 kb) fragments of DNA were synthesized based on the HPXV sequence along with two 157 nt VACV terminal sequences, and were recombined into a live synthetic chimeric HPXV (scHPXV) in cells infected with Shope fibroma virus (SFV). Sequencing of the 212 kbp scHPXV confirmed it encoded a faithful copy of the input DNA. We believe this is the first complete synthesis of a poxvirus using synthetic biology approaches. This scHPXV produced smaller plaques, produced less extracellular virus and exhibited less virulence in mice than VACV, but still provided vaccine protection against a lethal VACV challenge. Collectively, these findings support further development of scHPXV as a novel replication-proficient smallpox vaccine.	[Noyce, Ryan S.; Evans, David H.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Noyce, Ryan S.; Evans, David H.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada; [Lederman, Seth] Tonix Pharmaceut Inc, New York, NY USA	University of Alberta; University of Alberta	Evans, DH (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.; Evans, DH (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.	devans@ualberta.ca	; Evans, David/M-1912-2016	Lederman, Seth/0000-0003-2781-1455; Evans, David/0000-0001-5871-299X	Canadian Institutes for Health Research; Natural Sciences & Engineering Research Council of Canada; Alberta Innovates; Canada Foundation for Innovation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences & Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	We thank Ms. M. Desaulniers for her excellent technical assistance and members of our laboratory, and the poxvirus and synthetic biology research communities, for thoughtful discussions. The advice and guidance received from representatives of the Canadian federal agencies responsible for biosafety and biosecurity is also gratefully acknowledged. DE thanks the Canadian Institutes for Health Research, Natural Sciences & Engineering Research Council of Canada, Alberta Innovates, and the Canada Foundation for Innovation for long-term research support.	[Anonymous], 2015, WHOHSEPED20151; BAROUDY BM, 1982, COLD SPRING HARB SYM, V47, P723, DOI 10.1101/SQB.1983.047.01.083; BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; Baxby D., 1981, TRENDS IMMUNOL, V3, P26; Bell G., 1807, A TREATISE ON THE CO, pxii; Breitbach CJ, 2015, CURR OPIN VIROL, V13, P49, DOI 10.1016/j.coviro.2015.03.016; Brodie R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-96; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; DELANGE AM, 1987, J VIROL, V61, P1957, DOI 10.1128/JVI.61.6.1957-1963.1987; Esparza J, 2013, VET REC, V173, P272, DOI 10.1136/vr.f5587; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Jezek Z, 1988, HUMAN MONKEYPOX; JOKLIK WK, 1960, VIROLOGY, V11, P168, DOI 10.1016/0042-6822(60)90060-X; Loy JG., 1801, AN ACCOUNT OF SOME E; Medaglia MLG, 2015, J VIROL, V89, P11909, DOI 10.1128/JVI.01833-15; MERCHLINSKY M, 1990, J VIROL, V64, P5029, DOI 10.1128/JVI.64.10.5029-5035.1990; Murphy JG, 2003, LANCET, V362, P1378, DOI 10.1016/S0140-6736(03)14635-1; PARKINSON JE, 1994, VIROLOGY, V204, P376, DOI 10.1006/viro.1994.1542; Potts KG, 2017, EMBO MOL MED, V9, P638, DOI 10.15252/emmm.201607296; Qin L, 2015, J VIROL, V89, P1809, DOI 10.1128/JVI.02797-14; Qin L, 2014, J VIROL, V88, P5277, DOI 10.1128/JVI.00022-14; Qin L, 2011, J VIROL, V85, P13049, DOI 10.1128/JVI.05779-11; Rintoul JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024643; SAM CK, 1981, ANN INST PASTEUR VIR, V132, P135, DOI 10.1016/S0769-2617(81)80016-0; SCHEIFLINGER F, 1992, P NATL ACAD SCI USA, V89, P9977, DOI 10.1073/pnas.89.21.9977; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schrick L, 2017, NEW ENGL J MED, V377, P1491, DOI 10.1056/NEJMc1707600; Senkevicha TG, 2015, P NATL ACAD SCI USA, V112, P10908, DOI 10.1073/pnas.1514809112; SHCHELKUNOV SN, 1993, FEBS LETT, V327, P321, DOI 10.1016/0014-5793(93)81013-P; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Tcherepanov V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-150; Trindade GD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120328; Tulman ER, 2006, J VIROL, V80, P9244, DOI 10.1128/JVI.00945-06; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Yao XD, 2003, J VIROL, V77, P7281, DOI 10.1128/JVI.77.13.7281-7290.2003; Yao Xiao-Dan, 2004, Methods Mol Biol, V269, P51	38	111	117	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0188453	10.1371/journal.pone.0188453	http://dx.doi.org/10.1371/journal.pone.0188453			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351298	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300006
J	Pucelik, B; Paczynski, R; Dubin, G; Pereira, MM; Arnaut, LG; Dabrowski, JM				Pucelik, Barbara; Paczynski, Robert; Dubin, Grzegorz; Pereira, Mariette M.; Arnaut, Luis G.; Dabrowski, Janusz M.			Properties of halogenated and sulfonated porphyrins relevant for the selection of photosensitizers in anticancer and antimicrobial therapies (vol 12, e0185984, 2017)	PLOS ONE			English	Correction													Dabrowski, Janusz M./E-7250-2015; Pucelik, Barbara/HII-5213-2022	Dabrowski, Janusz M./0000-0002-8791-7035; Pucelik, Barbara/0000-0002-0235-6532				Pucelik B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185984	1	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191777	10.1371/journal.pone.0191777	http://dx.doi.org/10.1371/journal.pone.0191777			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352293	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300133
J	William, D; Walther, M; Schneider, B; Linnebacher, M; Classen, CF				William, Doreen; Walther, Madlin; Schneider, Bjoern; Linnebacher, Michael; Classen, Carl Friedrich			Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma	PLOS ONE			English	Article							CANCER STEM-CELLS; EXPRESSION; CONCOMITANT; GLIOMA	Glioblastoma multiforme (GBM) is a highly heterogeneous and aggressive brain tumor with a dismal prognosis. Development of resistance towards cytostatic drugs like the GBM standard drug temozolomide is a severe problem in GBM treatment. One potential source of GBM relapse could be so called cancer stem like cells (CSCs). These represent an undifferentiated subpopulation of cells with high potential for tumor initiation. Furthermore, it has been shown that differentiated GBM cells can regain CSC properties when exposed to continuous temozolomide treatment in vitro. In this study, treatment of several primary GBM cell lines with clinically relevant doses of temozolomide increased their tumorigenicity as determined by colony formation assays in soft agar. Increased tumorigenicity is a known property of CSCs. Hence, therapy options that specifically target CSCs are under investigation. CSCs appear to be particularly dependent on mitochondria biogenesis which may represent a useful target for CSC elimination. Toxicity towards mitochondria is a known side effect of several antibiotics. Thus, addition of antibiotics like doxycycline may represent a useful tool to inhibit CSCs in GBM. Here, we show that combining temozolomide treatment of primary GBM cells with doxycycline could counteract the increase of tumorigenicity induced by temozolomide treatment.	[William, Doreen; Walther, Madlin; Classen, Carl Friedrich] Univ Med Rostock, Univ Childrens & Adolescents Hosp, Rostock, Germany; [Schneider, Bjoern] Univ Med Rostock, Inst Pathol, Rostock, Germany; [Linnebacher, Michael] Univ Med Rostock, Dept Surg, Schillingallee Rostock, Germany	University of Rostock; University of Rostock	William, D (corresponding author), Univ Med Rostock, Univ Childrens & Adolescents Hosp, Rostock, Germany.	doreenwilliam@web.de	Linnebacher, Michael/AAT-3763-2021; William, Doreen/AHA-1288-2022	Linnebacher, Michael/0000-0001-8054-1402; 				Auffinger B, 2014, CELL DEATH DIFFER, V21, P1119, DOI 10.1038/cdd.2014.31; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Blough MD, 2010, NEURO-ONCOLOGY, V12, P756, DOI 10.1093/neuonc/noq032; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; BRADSHAW A, 2016, FRONT SURG, V3; Cheng L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.450; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; de Vries T, 2001, GLYCOBIOLOGY, V11, p119R, DOI 10.1093/glycob/11.10.119R; DOLECEK TA, 2005, NEUROONCOLOGY S5, V14, P1, DOI DOI 10.1093/NEUONC/N0S218; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kenney-Herbert E, 2015, STEM CELL TRANSL MED, V4, P822, DOI 10.5966/sctm.2014-0047; Lamb R, 2015, ONCOTARGET, V6, P4569, DOI 10.18632/oncotarget.3174; Lamb R, 2014, ONCOTARGET, V5, P11029, DOI 10.18632/oncotarget.2789; Lattova E, 2010, J PROTEOME RES, V9, P1533, DOI 10.1021/pr9010266; Lima FRS, 2012, BBA-REV CANCER, V1826, P338, DOI 10.1016/j.bbcan.2012.05.004; Mejias-Luque R, 2007, CANCER SCI, V98, P1000, DOI 10.1111/j.1349-7006.2007.00484.x; Moullan N., 2015, CELL REP; Mullins CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071070; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Persano L, 2013, BIOCHEM PHARMACOL, V85, P612, DOI 10.1016/j.bcp.2012.10.001; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shu H, 2011, ACTA BIOCH BIOPH SIN, V43, P528, DOI 10.1093/abbs/gmr038; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tivnan A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00218; Vasseur JA, 2012, GLYCOBIOLOGY, V22, P1684, DOI 10.1093/glycob/cws108; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang-Gillam A., 2007, J CANC MOL, V3, P147; Yamamuro S, 2015, INT J ONCOL, V47, P91, DOI 10.3892/ijo.2015.2992; Yang XS, 2010, J CELL PHYSIOL, V225, P612, DOI 10.1002/jcp.22250; Zhang Jihong, 2012, Curr Mol Pharmacol, V5, P102	35	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191511	10.1371/journal.pone.0191511	http://dx.doi.org/10.1371/journal.pone.0191511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352318	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300105
J	Akerman, L; Casas, R; Ludvigsson, J; Tavira, B; Skoglund, C				Akerman, Linda; Casas, Rosaura; Ludvigsson, Johnny; Tavira, Beatriz; Skoglund, Camilla			Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; MICRORNAS; EXPRESSION; DYSFUNCTION; BIOMARKERS; FAMILY; TARGET	Micro RNAs (miRNAs) are promising disease biomarkers due to their high stability. Their expression in serum is altered in type 1 diabetes, but whether deviations exist in individuals with high risk for type 1 diabetes remains unexplored. We therefore assessed serum miRNAs in high-risk individuals (n = 21) positive for multiple islet autoantibodies, age-matched healthy children (n = 17) and recent-onset type 1 diabetes patients (n = 8), using Serum/Plasma Focus microRNA PCR Panels from Exiqon. The miRNA levels in the high-risk group were similar to healthy controls, and no specific miRNA profile was identified for the high-risk group. However, serum miRNAs appeared to reflect glycemic status and ongoing islet auto-immunity in high-risk individuals, since several miRNAs were associated to glucose homeostasis and autoantibody titers. High-risk individuals progressing to clinical disease after the sampling could not be clearly distinguished from non-progressors, while miRNA expression in the type 1 diabetes group deviated significantly from high-risk individuals and healthy controls, perhaps explained by major metabolic disturbances around the time of diagnosis.	[Akerman, Linda; Casas, Rosaura; Ludvigsson, Johnny; Tavira, Beatriz] Linkoping Univ, Fac Med & Hlth Sci, Dept Clin & Expt Med, Div Pediat, Linkoping, Sweden; [Ludvigsson, Johnny] Univ Hosp, Crown Princess Victoria Childrens Hosp, Linkoping, Region Ostergot, Sweden; [Skoglund, Camilla] Linkoping Univ, Fac Med & Hlth Sci, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden	Linkoping University; Linkoping University	Skoglund, C (corresponding author), Linkoping Univ, Fac Med & Hlth Sci, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden.	camilla.skoglund@liu.se	TAVIRA, BEATRIZ/G-6744-2017; Ludvigsson, Johnny/AAI-2051-2020	TAVIRA, BEATRIZ/0000-0002-5986-6998; Ludvigsson, Johnny/0000-0003-1695-5234; Skoglund, Camilla/0000-0003-4770-8594; Tavira, Beatriz/0000-0001-5578-9756	Swedish Child Diabetes Foundation (Barndiabetesfonden); Swedish Research Council (Vetenskapsradet); Medical Research Council of Southeast Sweden (Forskningsradet i sydostra sverige, FORSS); Novo Nordisk Foundation; ALF/County Council of Ostergotland	Swedish Child Diabetes Foundation (Barndiabetesfonden); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Medical Research Council of Southeast Sweden (Forskningsradet i sydostra sverige, FORSS); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); ALF/County Council of Ostergotland	This research was supported by the Swedish Child Diabetes Foundation (Barndiabetesfonden, http://www.bamdiabetesfonden.se, CS, RC), the Swedish Research Council (Vetenskapsradet, https://www.vr.se, JL, RC), the Medical Research Council of Southeast Sweden (Forskningsradet i sydostra sverige, FORSS, http://www.fou.nu/ls/forss, JL, RC), the Novo Nordisk Foundation (http://novonordiskfonden.dk, JL) and ALF/County Council of Ostergotland (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhatzira L, 2015, FASEB J, V29, P4374, DOI 10.1096/fj.15-273649; Akerman L, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2900; BJORK E, 1992, J CLIN ENDOCR METAB, V75, P1574, DOI 10.1210/jc.75.6.1574; Brorsson C, 2011, AUTOIMMUNITY, V44, P107, DOI 10.3109/08916934.2010.509120; Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; Collares Cristhianna V A, 2013, BMC Res Notes, V6, P491, DOI 10.1186/1756-0500-6-491; Dooley J, 2016, DIABETES, V65, P53, DOI 10.2337/db15-0770; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hezova R, 2010, CELL IMMUNOL, V260, P70, DOI 10.1016/j.cellimm.2009.10.012; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Krist B, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/281756; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Ludvigsson J, 2001, Pediatr Diabetes, V2, P170, DOI 10.1034/j.1399-5448.2001.20405.x; Mandemakers W, 2013, DIABETOLOGIA, V56, P1547, DOI 10.1007/s00125-013-2901-5; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mo MH, 2012, J CANCER, V3, P432, DOI 10.7150/jca.4919; Nagy Zn, 2015, CIRCULATING MICRORNA; Nielsen Lotte B, 2012, Exp Diabetes Res, V2012, P896362, DOI 10.1155/2012/896362; Nielsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087308; Roggli E, 2012, DIABETES, V61, P1742, DOI 10.2337/db11-1086; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Salas-Perez F, 2013, IMMUNOBIOLOGY, V218, P733, DOI 10.1016/j.imbio.2012.08.276; Samandari N, 2017, DIABETOLOGIA, V60, P354, DOI 10.1007/s00125-016-4156-4; Sebastiani G, 2012, DIABETOLOGIA, V55, pS48; Sebastiani G, 2011, DIABETES-METAB RES, V27, P862, DOI 10.1002/dmrr.1262; Takahashi P, 2014, GENE, V539, P213, DOI 10.1016/j.gene.2014.01.075; Yang ML, 2015, J DIABETES, V7, P158, DOI 10.1111/1753-0407.12163; Zhang Y, 2013, MOL CELL ENDOCRINOL, V381, P230, DOI 10.1016/j.mce.2013.08.004; Zhang Y, 2016, J AUTOIMMUN, V68, P52, DOI 10.1016/j.jaut.2015.12.006; Zhou R, 2015, SCI REP-UK, V5, DOI 10.1038/srep17743	35	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191067	10.1371/journal.pone.0191067	http://dx.doi.org/10.1371/journal.pone.0191067			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346396	Green Submitted, gold, Green Published			2022-12-27	WOS:000422749500025
J	Higgins, R; Kabbaj, MH; Hatcher, A; Wang, YC				Higgins, Ryan; Kabbaj, Marie-Helene; Hatcher, Alexa; Wang, Yanchang			The absence of specific yeast heat-shock proteins leads to abnormal aggregation and compromised autophagic clearance of mutant Huntingtin proteins	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; UBIQUITIN-PROTEASOME SYSTEM; INCLUSION-BODY FORMATION; QUALITY-CONTROL; MOLECULAR CHAPERONES; MISFOLDED PROTEINS; FACTOR FES1; HSP70; DEGRADATION; HSP104	The functionality of a protein depends on its correct folding, but newly synthesized proteins are susceptible to aberrant folding and aggregation. Heat shock proteins (HSPs) function as molecular chaperones that aid in protein folding and the degradation of misfolded proteins. Trinucleotide (CAG) repeat expansion in the Huntingtin gene (HTT) results in the expression of misfolded Huntingtin protein (Htt), which contributes to the development of Huntington's disease. We previously found that the degradation of mutated Htt with polyQ expansion (Htt103QP) depends on both ubiquitin proteasome system and autophagy. However, the role of heat shock proteins in the clearance of mutated Htt remains poorly understood. Here, we report that cytosolic Hsp70 (Ssa family), its nucleotide exchange factors (Sse1 and Fes1), and a Hsp40 co-chaperone (Ydj1) are required for inclusion body formation of Htt103QP proteins and their clearance via autophagy. Extended induction of Htt103QPGFP leads to the formation of a single inclusion body in wild-type yeast cells, but mutant cells lacking these HSPs exhibit increased number of Htt103QP aggregates. Most notably, we detected more aggregated forms of Htt103QP in sse1 Delta. mutant cells using an agarose gel assay. Increased protein aggregates are also observed in these HSP mutants even in the absence Htt103QP overexpression. Importantly, these HSPs are required for autophagy- mediated Htt103QP clearance, but are less critical for proteasome-dependent degradation. These findings suggest a chaperone network that facilitates inclusion body formation of misfolded proteins and the subsequent autophagic clearance.	[Higgins, Ryan; Kabbaj, Marie-Helene; Wang, Yanchang] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Hatcher, Alexa] Florida State Univ, Coll Nursing, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Wang, YC (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	yanchang.wang@med.fsu.edu		Wang, Yanchang/0000-0001-6782-0570	National Institutes of Health [R01GM102115]; FSU CRC planning grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FSU CRC planning grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by R01GM102115, National Institutes of Health to YW, https://www.nih.gov/. This work is also supported by a FSU CRC planning grant to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich H, 2003, MOL BIOL CELL, V14, P477, DOI 10.1091/mbc.E02-07-0413; Abrams JL, 2014, J BIOL CHEM, V289, P13155, DOI 10.1074/jbc.M113.530014; Bauerlein FJB, 2017, CELL, V171, P179, DOI 10.1016/j.cell.2017.08.009; Bersuker K, 2013, J BIOL CHEM, V288, P23633, DOI 10.1074/jbc.C113.481945; Bhat KP, 2014, P NATL ACAD SCI USA, V111, P5706, DOI 10.1073/pnas.1402215111; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Chuang KH, 2016, MOL BIOL CELL, V27, P2025, DOI 10.1091/mbc.E16-01-0026; Ciechanover A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00185; Cyr Douglas M, 2015, Subcell Biochem, V78, P91, DOI 10.1007/978-3-319-11731-7_4; de Oliveira GAP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00097; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2011, PRION, V5, P285, DOI [10.4161/pri.5.4.18071, 10.4161/pri.18071]; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Gallagher PS, 2014, J CELL SCI, V127, P1980, DOI 10.1242/jcs.141838; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gong B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041450; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Gowda NKC, 2016, MOL BIOL CELL, V27, P1210, DOI 10.1091/mbc.E15-10-0697; Gowda NKC, 2013, P NATL ACAD SCI USA, V110, P5975, DOI 10.1073/pnas.1216778110; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hwang JS, 2007, J GERONTOL A-BIOL, V62, P490, DOI 10.1093/gerona/62.5.490; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaimal JM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00027-17; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kempf C, 2017, MICROBIOL RES, V200, P53, DOI 10.1016/j.micres.2017.03.009; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Li XJ, 2010, AUTOPHAGY, V6, P663, DOI 10.4161/auto.6.5.12336; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Mukherjee A, 2015, TRENDS MOL MED, V21, P439, DOI 10.1016/j.molmed.2015.04.005; Nagy M, 2016, P NATL ACAD SCI USA, V113, P5424, DOI 10.1073/pnas.1604885113; Nair U, 2011, AUTOPHAGY, V7, P1546, DOI 10.4161/auto.7.12.18424; Needham PG, 2015, J MOL BIOL, V427, P2948, DOI 10.1016/j.jmb.2015.04.010; Nillegoda NB, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00057; O'Driscoll J, 2015, J CELL BIOL, V211, P145, DOI 10.1083/jcb.201505104; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Peter L, 2011, GEN COMP ENDOCR, V172, P39, DOI 10.1016/j.ygcen.2011.02.005; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Qi L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046834, 10.1371/journal.pone.0029572]; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Shahmoradian SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00710; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shen K, 2016, ELIFE, V5, DOI 10.7554/eLife.18065; Shiber A, 2013, MOL BIOL CELL, V24, P2076, DOI 10.1091/mbc.E13-01-0010; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Tkach JM, 2008, TRAFFIC, V9, P39, DOI 10.1111/j.1600-0854.2007.00666.x; Torrente MP, 2013, PRION, V7, P457, DOI 10.4161/pri.27531; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Wolfe KJ, 2013, MOL BIOL CELL, V24, P3588, DOI 10.1091/mbc.E13-06-0315; Xu Z, 2013, J CELL SCI, V126, P4173, DOI 10.1242/jcs.126102; Yang J, 2016, ELIFE, V5; Zaffagnini G, 2016, J MOL BIOL, V428, P1714, DOI 10.1016/j.jmb.2016.02.004	73	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191490	10.1371/journal.pone.0191490	http://dx.doi.org/10.1371/journal.pone.0191490			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346421	gold, Green Published, Green Submitted			2022-12-27	WOS:000422749500056
J	Alvarado-Sizzo, H; Casas, A; Parra, F; Arreola-Nava, HJ; Terrazas, T; Sanchez, C				Alvarado-Sizzo, Hernan; Casas, Alejandro; Parra, Fabiola; Julieta Arreola-Nava, Hilda; Terrazas, Teresa; Sanchez, Cristian			Species delimitation in the Stenocereus griseus (Cactaceae) species complex reveals a new species, S-huastecorum	PLOS ONE			English	Article							POPULATION-STRUCTURE; POLASKIA-CHICHIPE; GENETIC-STRUCTURE; TEHUACAN VALLEY; EVOLUTION; CACTUS; DOMESTICATION; PHYLOGENY; SOFTWARE; PHYLOGEOGRAPHY	The Stenocereus griseus species complex (SGSC) has long been considered taxonomically challenging because the number of taxa belonging to the complex and their geographical boundaries remain poorly understood. Bayesian clustering and genetic distance-based methods were used based on nine microsatellite loci in 377 individuals of three main putative species of the complex. The resulting genetic clusters were assessed for ecological niche divergence and areolar morphology, particularly spination patterns. We based our species boundaries on concordance between genetic, ecological, and morphological data, and were able to resolve four species, three of them corresponding to S. pruinosus from central Mexico, S. laevigatus from southern Mexico, and S. griseus from northern South America. A fourth species, previously considered to be S. griseus and commonly misidentified as S. pruinosus in northern Mexico showed significant genetic, ecological, and morphological differentiation suggesting that it should be considered a new species, S. huastecorum, which we describe here. We show that population genetic analyses, ecological niche modeling, and morphological studies are complementary approaches for delimiting species in taxonomically challenging plant groups such as the SGSC.	[Alvarado-Sizzo, Hernan; Casas, Alejandro] Univ Nacl Autonoma Mexico, IIES, Morelia, Michoacan, Mexico; [Parra, Fabiola] Univ Nacl Agraria La Molina, CIZA, Lima, Peru; [Julieta Arreola-Nava, Hilda] Univ Guadalajara, CUCBA, Zapopan, Jalisco, Mexico; [Terrazas, Teresa] Univ Nacl Autonoma Mexico, Inst Biol IB, Mexico City, DF, Mexico; [Sanchez, Cristian] Herbario Univ La Guajira, Riohacha, La Guajira, Colombia; [Sanchez, Cristian] Nucl Univ Pedro Rincon Gutierrez, Univ Los Andes, Fac Ciencias, Posgrad Botan Taxonom Neotrop, Merida, Venezuela	Universidad Nacional Autonoma de Mexico; University Nacional Agraria La Molina; Universidad de Guadalajara; Universidad Nacional Autonoma de Mexico; University of Los Andes Venezuela	Casas, A (corresponding author), Univ Nacl Autonoma Mexico, IIES, Morelia, Michoacan, Mexico.	acasas@iies.unam.mx		Casas, Alejandro/0000-0002-8181-5118; Alvarado-Sizzo, Hernan/0000-0001-7291-0917; Parra, Fabiola/0000-0001-6612-5250	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CB-2013-01-221800, 298299]; Program of Support to Research and Technological Innovation (PAPIIT), UNAM, Mexico [IN209214, IN206217]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Program of Support to Research and Technological Innovation (PAPIIT), UNAM, Mexico	This study was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT), which funded the Research project CB-2013-01-221800 and provided a grant (298299) for Hernan Alvarado-Sizzo (URL: http://www.conacyt.gob.mx/) and the Program of Support to Research and Technological Innovation (PAPIIT), UNAM, Mexico (research projects IN209214 and IN206217). http://dgapa.unam.mx/index.php/impulso-a-la-investigacion/papiit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Garcia-Rubio LA, 2015, BOT SCI, V93, P921, DOI 10.17129/botsci.282; Arakaki M, 2011, P NATL ACAD SCI USA, V108, P8379, DOI 10.1073/pnas.1100628108; Arreola-Nava HJ., 2006, THESIS, P71; Bautista F, 2011, GEOMORPHOLOGY, V135, P308, DOI 10.1016/j.geomorph.2011.02.014; Bonatelli IAS, 2014, MOL ECOL, V23, P3044, DOI 10.1111/mec.12780; Bravo-Hollis H, 1978, CACTACEAS MEXICO, V1, P352; Britton N.L., 1920, CACTACEAE, V2; Brunet J., 1967, PREHISTORY TEHUACAN, P66; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Copetti D, 2017, P NATL ACAD SCI USA, V114, P12003, DOI 10.1073/pnas.1706367114; Cruse-Sanders JM, 2013, ECOL EVOL, V3, P1340, DOI 10.1002/ece3.524; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Duminil J, 2009, PLANT BIOSYST, V143, P528, DOI 10.1080/11263500902722964; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Espinosa D, 2016, BIODIVERSIDAD SIERRA, P21; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ornelas JF, 2015, J HERED, V106, P196, DOI 10.1093/jhered/esu113; Ornelas JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056283; Franck AR, 2013, SYST BOT, V38, P210, DOI 10.1600/036364413X662105; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Gibson A. C., 1991, Cactus and Succulent Journal, V63, P92; GIBSON AC, 1978, ANN MO BOT GARD, V65, P999, DOI 10.2307/2398781; Gibson AC, 1990, AREOLES SPINES CACTU, P94; Gomez-Tuena A, 2007, GEOL SOC AM SPEC PAP, V422, P129, DOI 10.1130/2007.2422(05); Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hernandez HM, 2011, SUCCULENT PLANT RES, V7, P1; Hernandez-Hernandez T, 2014, NEW PHYTOL, V202, P1382, DOI 10.1111/nph.12752; Hernandez-Hernandez T, 2011, AM J BOT, V98, P44, DOI 10.3732/ajb.1000129; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hippolyte JC, 2011, MAR PETROL GEOL, V28, P259, DOI 10.1016/j.marpetgeo.2009.06.010; Iturralde-Vinent MA, 2006, INT GEOL REV, V48, P791, DOI 10.2747/0020-6814.48.9.791; Moran-Zenteno DJ, 2007, GEOL SOC AM SPEC PAP, V422, P71, DOI 10.1130/2007.2422(03); Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Leinfellner W., 1961, ENTWICKLUNGSLINIEN T; Lozano G., 2015, OPEN J GEN, V5, P1, DOI DOI 10.4236/0JGEN.2015.51001; Luna-Morales C., 2007, Agrociencia (Montevideo), V11, P10; Manea VC, 2006, GEOL SOC AM SPEC PAP, V412, P27, DOI 10.1130/2006.2412(02); Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; MOLINAGARZA RS, 1994, TECTONOPHYSICS, V235, P339, DOI 10.1016/0040-1951(94)90193-7; Mutke J, 2015, SCHUMANNIA, V7, P30; Nassar JM, 2003, AM J BOT, V90, P1628, DOI 10.3732/ajb.90.11.1628; NEI M, 1974, GENETICS, V76, P379; Nyffeler R, 2002, AM J BOT, V89, P312, DOI 10.3732/ajb.89.2.312; Otero-Arnaiz A, 2005, MOL ECOL, V14, P1603, DOI 10.1111/j.1365-294X.2005.02494.x; Otero-Arnaiz A, 2004, MOL ECOL NOTES, V4, P265, DOI 10.1111/j.1471-8286.2004.00642.x; Parra F, 2015, GENET RESOUR CROP EV, V62, P893, DOI 10.1007/s10722-014-0199-x; Parra F, 2010, ANN BOT-LONDON, V106, P483, DOI 10.1093/aob/mcq143; Pennington RT, 2000, J BIOGEOGR, V27, P261, DOI 10.1046/j.1365-2699.2000.00397.x; Perez MF, 2016, MOL PHYLOGENET EVOL, V95, P11, DOI 10.1016/j.ympev.2015.11.005; Phillips SJ, 2011, MAXENT SOFTWARE SPEC; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez-Barahona S, 2013, ECOL EVOL, V3, P725, DOI 10.1002/ece3.483; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rowley GD, 1999, BRADLEYA, V17, P1, DOI DOI 10.25223/BRAD.N17.1999.A1; Ruiz A, 2002, COLUMNAR CACTI THEIR, P324; SAS Institute Inc, 2007, JMP VERS 7, P1989; Sneath PHA., 1973, NUMERICAL TAXONOMY, P230, DOI DOI 10.1111/J.1523-1739.2007.00775.X; Stafleu FA, 1985, REGNUM VEGETABILE; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapia HJ, 2016, REV MEX BIODIVERS, V87, P288, DOI 10.1016/j.rmb.2016.04.006; Terrazas T, 2002, BOT REV, V68, P444, DOI 10.1663/0006-8101(2002)068[0444:CSAITS]2.0.CO;2; Thiers B, 2017, INDEX HERBARIORUM GL; Valiente-Banuet A, 2000, BOT SCI, V67, P25, DOI 10.17129/botsci.1625; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vazquez-Sanchez M, 2013, SYST BIODIVERS, V11, P103, DOI 10.1080/14772000.2013.775191; Wallace R. S., 2002, CACTI BIOL USES, P1	69	19	19	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190385	10.1371/journal.pone.0190385	http://dx.doi.org/10.1371/journal.pone.0190385			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342184	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800020
J	De Samber, B; Meul, E; Laforce, B; De Paepe, B; Smet, J; De Bruyne, M; De Rycke, R; Bohic, S; Cloetens, P; Van Coster, R; Vandenabeele, P; Vanden Berghe, T				De Samber, Bjorn; Meul, Eline; Laforce, Brecht; De Paepe, Boel; Smet, Joel; De Bruyne, Michiel; De Rycke, Riet; Bohic, Sylvain; Cloetens, Peter; Van Coster, Rudy; Vandenabeele, Peter; Vanden Berghe, Tom			Nanoscopic X-ray fluorescence imaging and quantification of intracellular key-elements in cryofrozen Friedreich's ataxia fibroblasts	PLOS ONE			English	Article							YEAST FRATAXIN; OXIDATIVE STRESS; IRON; ZINC; CARDIOMYOPATHY; REDISTRIBUTION; DEFICIENCY; LIBRARY; PROTEIN; COPPER	Synchrotron radiation based nanoscopic X-ray fluorescence (SR nano-XRF) analysis can visualize trace level elemental distribution in a fully quantitative manner within single cells. However, in-air XRF analysis requires chemical fixation modifying the cell's chemical composition. Here, we describe first nanoscopic XRF analysis upon cryogenically frozen (-150 degrees C) fibroblasts at the ID16A-NI 'Nano-imaging' end-station located at the European Synchrotron Radiation Facility (ESRF) in Grenoble (France). Fibroblast cells were obtained from skin biopsies from control and Friedreich's ataxia (FRDA) patients. FRDA is an autosomal recessive disorder with dysregulation of iron metabolism as a key feature. By means of the X-ray Fundamental Parameter (FP) method, including absorption correction of the ice layer deposited onto the fibroblasts, background-corrected mass fraction elemental maps of P, S, Cl, K, Ca, Fe and Zn of entire cryofrozen human fibroblasts were obtained. Despite the presence of diffracting microcrystals in the vitreous ice matrix and minor sample radiation damage effects, clusters of iron-rich hot-spots with similar mass fractions were found in the cytoplasm of both control and FRDA fibroblasts. Interestingly, no significant difference in the mean iron concentration was found in the cytoplasm of FRDA fibroblasts, but a significant decrease in zinc concentration. This finding might underscore metal dysregulation, beyond iron, in cells derived from FRDA patients. In conclusion, although currently having slightly increased limits of detection (LODs) compared to non-cryogenic mode, SR based nanoscopic XRF under cryogenic sample conditions largely obliterates the debate on chemical sample preservation and provides a unique tool for trace level elemental imaging in single cells close to their native state with a superior spatial resolution of 20 nm.	[De Samber, Bjorn; Laforce, Brecht] Univ Ghent, Dept Analyt Chem, Ghent, Belgium; [Meul, Eline; De Bruyne, Michiel; De Rycke, Riet; Vandenabeele, Peter; Vanden Berghe, Tom] VIB Ctr Inflammat Res, Ghent, Belgium; [Meul, Eline; De Bruyne, Michiel; De Rycke, Riet; Vandenabeele, Peter; Vanden Berghe, Tom] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [De Paepe, Boel; Smet, Joel] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, Ghent, Belgium; [Bohic, Sylvain] INSERM, Grenoble, France; [Cloetens, Peter] European Synchrotron Radiat Facil, Grenoble, France	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; Ghent University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); European Synchrotron Radiation Facility (ESRF)	De Samber, B (corresponding author), Univ Ghent, Dept Analyt Chem, Ghent, Belgium.	bjorn.desamber@ugent.be	De Paepe, Boel/B-7548-2013; NanoImaging, ID16A/AAJ-7861-2020; Cloetens, Peter/AAJ-6131-2020; Vanden Berghe, Tom/C-4916-2009; BOHIC, Sylvain/F-6464-2013; Berghe, Tom Vanden/N-2902-2019; Laforce, Brecht/GPX-2175-2022; Vandenabeele, Peter/C-8597-2009; Laforce, Brecht/AAF-9215-2021; De Samber, Bjorn/K-9636-2015	De Paepe, Boel/0000-0001-9403-4401; Cloetens, Peter/0000-0002-4129-9091; Vanden Berghe, Tom/0000-0002-1633-0974; BOHIC, Sylvain/0000-0001-6355-7592; Berghe, Tom Vanden/0000-0002-1633-0974; Vandenabeele, Peter/0000-0002-6669-8822; De Samber, Bjorn/0000-0002-6759-4195	FWO Vlaanderen [12B3313N]; Flemish Institute for the Promotion of Scientific and Technological Research in Industry (IWT Flanders, Belgium); Vlaams Instituut voor Biotechnologie (VIB); Ghent University (MRP, GROUP-ID consortium); Foundation against Cancer [2012-188, FAF-F/2016/865]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) [FWO G.0875.11, FWO G.0A45.12N, FWO G.0787.13N, FWO G.0C37.14N, FWO G.0E04.16N]; Flemish Government [BOF09/01M00709, BOF16/MET_V/007]; Belgian science policy office (BELSPO) [IAP 7/32]	FWO Vlaanderen(FWO); Flemish Institute for the Promotion of Scientific and Technological Research in Industry (IWT Flanders, Belgium); Vlaams Instituut voor Biotechnologie (VIB); Ghent University (MRP, GROUP-ID consortium); Foundation against Cancer; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Flemish Government(European Commission); Belgian science policy office (BELSPO)(Belgian Federal Science Policy Office)	Bjorn De Samber acknowledges his postdoctoral research grant from FWO Vlaanderen (www.fwo.be, application no. 12B3313N) and Brecht Laforce was funded by a PhD grant from the Flemish Institute for the Promotion of Scientific and Technological Research in Industry (IWT Flanders, Belgium). Research in the Vandenabeele lab is supported by grants from the Vlaams Instituut voor Biotechnologie (VIB), from Ghent University (MRP, GROUP-ID consortium), grants from the 'Foundation against Cancer' (2012-188 and FAF-F/2016/865), grants from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) (FWO G.0875.11, FWO G.0A45.12N, FWO G.0787.13N, FWO G.0C37.14N, FWO G.0E04.16N), grants from the Flemish Government (Methusalem BOF09/01M00709 and BOF16/MET_V/007), a grant from the Belgian science policy office (BELSPO)(IAP 7/32). Tom Vanden Berghe has an assistant academic staff position at Ghent University.	Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Bencze KZ, 2007, CHEM COMMUN, P1798, DOI 10.1039/b703195e; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Brunetti A, 2004, SPECTROCHIM ACTA B, V59, P1725, DOI 10.1016/j.sab.2004.03.014; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Da Silva JC, 2017, OPTICA, V4, P492, DOI 10.1364/OPTICA.4.000492; De Samber B, 2013, ANAL BIOANAL CHEM, V405, P6061, DOI 10.1007/s00216-013-7019-6; De Samber B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165604; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Kempenaers L, 2000, SPECTROCHIM ACTA B, V55, P651, DOI 10.1016/S0584-8547(00)00207-X; Koeppen A, 2013, J NEUROPATH EXP NEUR, V72, P554; Koeppen AH, 2012, CEREBELLUM, V11, P845, DOI 10.1007/s12311-012-0383-5; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Kruger PC, 2016, AM J CARDIOL, V118, P127, DOI 10.1016/j.amjcard.2016.04.024; Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; Le Gros M. A., 2014, J SYNCHROTRON RADIAT, V21, P1; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Longo DL, 2005, NEW ENGL J MED, V372, P1832; Martelli A, 2015, CELL METAB, V21, P311, DOI 10.1016/j.cmet.2015.01.010; Martelli A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00130; Oteiza PI, 2000, FREE RADICAL BIO MED, V28, P1091, DOI 10.1016/S0891-5849(00)00200-8; Ramirez RL, 2012, AM J CARDIOL, V110, P1820, DOI 10.1016/j.amjcard.2012.08.018; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Schoonjans T, 2011, SPECTROCHIM ACTA B, V66, P776, DOI 10.1016/j.sab.2011.09.011; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; VEKEMANS B, 1994, X-RAY SPECTROM, V23, P278, DOI 10.1002/xrs.1300230609; Weidemann F, 2012, CIRCULATION, V125, P1626, DOI 10.1161/CIRCULATIONAHA.111.059477	32	12	12	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190495	10.1371/journal.pone.0190495	http://dx.doi.org/10.1371/journal.pone.0190495			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342155	Green Submitted, gold, Green Published			2022-12-27	WOS:000422653800024
J	Tanida-Miyake, E; Koike, M; Uchiyama, Y; Tanida, I				Tanida-Miyake, Emiko; Koike, Masato; Uchiyama, Yasuo; Tanida, Isei			Optimization of mNeonGreen for Homo sapiens increases its fluorescent intensity in mammalian cells	PLOS ONE			English	Article							IN-VIVO; PROTEINS; EXPRESSION; LOCALIZATION; GFPS	Green fluorescent protein (GFP) is tremendously useful for investigating many cellular and intracellular events. The monomeric GFP mNeonGreen is about 3-to 5-times brighter than GFP and monomeric enhanced GFP and shows high photostability. The maturation halftime of mNeonGreen is about 3-fold faster than that of monomeric enhanced GFP. However, the cDNA sequence encoding mNeonGreen contains some codons that are rarely used in Homo sapiens. For better expression of mNeonGreen in human cells, we synthesized a human-optimized cDNA encoding mNeonGreen and generated an expression plasmid for humanized mNeonGreen under the control of the cytomegalovirus promoter. The resultant plasmid was introduced into HEK293 cells. The fluorescent intensity of humanized mNeonGreen was about 1.4-fold higher than that of the original mNeonGreen. The humanized mNeonGreen with a mitochondria-targeting signal showed mitochondrial distribution of mNeonGreen. We further generated an expression vector of humanized mNeonGreen with 3xFLAG tags at its carboxyl terminus as these tags are useful for immunological analyses. The 3xFLAG-tagged mNeonGreen was recognized well with an anti-FLAG-M2 antibody. These plasmids for the expression of humanized mNeonGreen and mNeonGreen-3xFLAG are useful tools for biological studies in mammalian cells using mNeonGreen.	[Tanida-Miyake, Emiko; Koike, Masato; Tanida, Isei] Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo, Japan; [Tanida-Miyake, Emiko] Machida Municipal Hosp, Dept Gastroenterol, Tokyo, Japan; [Uchiyama, Yasuo] Juntendo Univ, Dept Cellular & Mol Neuropathol, Sch Med, Tokyo, Japan	Juntendo University; Juntendo University	Tanida, I (corresponding author), Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo, Japan.	tanida@juntendo.ac.jp	Koike, Masato/F-9584-2010	Koike, Masato/0000-0002-3174-5684; Tanida, Isei/0000-0001-8999-3990	Japan Society for the Promotion of Science (JSPS KAKENHI) [15K12749]; Institute for Environmental & Gender-Specific Medicine at Juntendo University; Research Institute for Diseases of Old Age at the Juntendo University School of Medicine	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute for Environmental & Gender-Specific Medicine at Juntendo University; Research Institute for Diseases of Old Age at the Juntendo University School of Medicine	This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS KAKENHI 15K12749)(https://www.jsps.go.jp/j-grantsinaid/) to Isei Tanida, a grant from the Institute for Environmental & Gender-Specific Medicine at Juntendo University (http://www.juntendo.ac.jp/english/department/gra/gender_specific_medicine/) to Isei Tanida, and the Research Institute for Diseases of Old Age at the Juntendo University School of Medicine (http://www.juntendo.ac.jp/english/department/gra/diseases_old_age/) to Isei Tanida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Michael Davidson and Brian Kuhlman for providing respective mCherry2-C1 and pLL7.0: Venus-iLID-Mito (From ActA). This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS KAKENHI 15K12749), a grant from the Institute for Environmental & Gender-Specific Medicine at Juntendo University (Tokyo, Japan), and the Research Institute for Diseases of Old Age at the Juntendo University School of Medicine to I.T.	Bach JN, 2017, METHODS MOL BIOL, V1563, P129, DOI 10.1007/978-1-4939-6810-7_9; Barykina NV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34447; Bonnefois T, 2016, J BIOTECHNOL, V236, P35, DOI 10.1016/j.jbiotec.2016.08.006; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cranfill PJ, 2016, NAT METHODS, V13, P557, DOI [10.1038/NMETH.3891, 10.1038/nmeth.3891]; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Heppert JK, 2016, MOL BIOL CELL, V27, P3385, DOI 10.1091/mbc.E16-01-0063; Hernan R, 2000, BIOTECHNIQUES, V28, P789, DOI 10.2144/00284pf01; Hostettler L, 2017, G3-GENES GENOM GENET, V7, P607, DOI 10.1534/g3.116.038133; Kaishima M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35932; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	12	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191108	10.1371/journal.pone.0191108	http://dx.doi.org/10.1371/journal.pone.0191108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342181	Green Submitted, gold, Green Published			2022-12-27	WOS:000422653800045
J	Ye, BH; Zhang, YB; Shu, JP; Wu, H; Wang, HJ				Ye, Bi-huan; Zhang, Ya-bo; Shu, Jin-ping; Wu, Hong; Wang, Hao-jie			RNA-sequencing analysis of fungi-induced transcripts from the bamboo wireworm Melanotus cribricollis (Coleoptera: Elateridae) larvae	PLOS ONE			English	Article							BETA-1,3-GLUCAN RECOGNITION PROTEIN; SHORT-CHAIN DEHYDROGENASE/REDUCTASE; IMMUNITY-RELATED GENES; METARHIZIUM-ANISOPLIAE; PATHOGEN RECOGNITION; INSECT; BEETLE; LYSOZYME; MOSQUITO; BACTERIA	Larvae of Melanotus cribricollis, feed on bamboo shoots and roots, causing serious damage to bamboo in Southern China. However, there is currently no effective control measure to limit the population of this underground pest. Previously, a new entomopathogenic fungal strain isolated from M. cribricollis larvae cadavers named Metarhizium pingshaense WP08 showed high pathogenic efficacy indoors, indicated that the fungus could be used as a bio-control measure. So far, the genetic backgrounds of both M. cribricollis and M. pingshaense WP08 were blank. Here, we analyzed the whole transcriptome of M. cribricollis larvae, infected with M. pingshaenseWP08 or not, using high-throughput next generation sequencing technology. In addition, the transcriptome sequencing of M. pingshaense WP08 was also performed for data separation of those two non-model species. The reliability of the RNA-Seq data was also validated through qRT-PCR experiment. The de novo assembly, functional annotation, sequence comparison of four insect species, and analysis of DEGs, enriched pathways, GO terms and immune related candidate genes were operated. The results indicated that, multiple defense mechanisms of M. cribricollis larvae are initiated to protect against the more serious negative effects caused by fungal infection. To our knowledge, this was the first report of transcriptome analysis of Melanotus spp. infected with a fungus, and it could provide insights to further explore insect-fungi interaction mechanisms.	[Ye, Bi-huan; Zhang, Ya-bo; Shu, Jin-ping; Wu, Hong; Wang, Hao-jie] Chinese Acad Forestry, Res Inst Subtrop Forestry, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Shu, JP; Wu, H (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Hangzhou, Zhejiang, Peoples R China.	shu_jinping001@163.com; wh931908@sohu.com		Shu, Jinping/0000-0002-3685-9349	Fundamental Research Funds for the Central Non profit Research Institution of CAF [CAFYBB2016SY012]; Special Fund for Forestry Scientific Research [201304403]	Fundamental Research Funds for the Central Non profit Research Institution of CAF; Special Fund for Forestry Scientific Research	This work was supported by "The Fundamental Research Funds for the Central Non profit Research Institution of CAF (CAFYBB2016SY012)" and "The Special Fund for Forestry Scientific Research in the Public Interest (201304403)."	Altincicek B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052004; Amiteye S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-500; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Bajwa R, 2015, ARCH PHARM, V348, P635; Berende A, 2010, EUR CYTOKINE NETW, V21, P7, DOI 10.1684/ecn.2009.0179; Cherry R., 2016, FLORIDA ENTOMOLOGIST, V90, P426; Dai HE, 2013, BIOCHEMISTRY-US, V52, P161, DOI 10.1021/bi301440p; Das Suchismita, 2009, P69; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Deng S, 2012, CHINESE BULL ENTOMOL, V47, P983; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Feyereisen R, 2005, COMPREHENSIVE MOL IN, V4, P1; Hou Cheng-Xiang, 2014, Acta Entomologica Sinica, V57, P13; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jantana W, 2015, BIOSCIENCE REP, V35; Javar S, 2015, INVERTEBR REPROD DEV, V59, P230, DOI 10.1080/07924259.2015.1108934; Jiang H, 2004, INSECT BIOCH MOL BIO; Kabaluk JT, 2007, AGRON J, V99, P1377, DOI 10.2134/agronj2007.0017N; Kabaluk T, 2014, BIOCONTROL, V59, P607, DOI 10.1007/s10526-014-9603-x; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lemaitre B, 2007, IMMUNOLOGY, V25; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lopera D, 2008, REV INST MED TROP SP, V50, P169, DOI 10.1590/S0036-46652008000300008; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; OCHIAI M, 1992, CELL TISSUE RES, V268, P431, DOI 10.1007/BF00319149; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Reddy GVP, 2014, J INVERTEBR PATHOL, V120, P43, DOI 10.1016/j.jip.2014.05.005; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; ROBERTSON LN, 1993, AUST J EXP AGR, V33, P953, DOI 10.1071/EA9930953; Saurabh S, 2008, AQUAC RES, V39, P223, DOI 10.1111/j.1365-2109.2007.01883.x; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shu Jin-ping, 2012, Forest Research, V25, P620; Sowa-Jasilek A, 2014, PEPTIDES, V53, P194, DOI 10.1016/j.peptides.2014.01.012; Stambergova H, 2014, CHEM-BIOL INTERACT, V207, P52, DOI 10.1016/j.cbi.2013.11.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vogel H, 2014, INSECT MOL BIOL, V23, P98, DOI 10.1111/imb.12067; Vogel H, 2011, INSECT MOL BIOL, V20, P787, DOI 10.1111/j.1365-2583.2011.01109.x; Wang HongMin, 2013, Mycosystema, V32, P269; Wang XG, 2005, MOL BIOCHEM PARASIT, V139, P65, DOI 10.1016/j.molbiopara.2004.09.009; Wang XG, 2006, CELL MICROBIOL, V8, P1581, DOI 10.1111/j.1462-5822.2006.00732.x; Werck-Reichhart D, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-6-REVIEWS3003; Xu TS, 2004, MAIN PESTS BAMBOO CH, P27; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Yabo, 2012, Scientia Silvae Sinicae, V48, P134; Zhang Y, 2009, ARCH INSECT BIOCHEM, V70, P18, DOI 10.1002/arch.20258; Zheng XL, 2012, DEV COMP IMMUNOL, V36, P602, DOI 10.1016/j.dci.2011.10.010; Zhong DB, 2013, EXP PARASITOL, V134, P61, DOI 10.1016/j.exppara.2013.01.014; [周云娥 ZHOU Yun'e], 2008, [浙江林业科技, Journal of Zhejiang Forestry Science and Technology], V28, P28; ZIMMERMANN G, 1993, PESTIC SCI, V37, P375, DOI 10.1002/ps.2780370410	56	5	6	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191187	10.1371/journal.pone.0191187	http://dx.doi.org/10.1371/journal.pone.0191187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338057	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700039
J	Oppenheim, SJ; Feindt, W; DeSalle, R; Goldstein, PZ				Oppenheim, Sara J.; Feindt, Wiebke; DeSalle, Rob; Goldstein, Paul Z.			De Novo characterization of transcriptomes from two North American Papaipema stem-borers (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; P-ELEMENTS; GENES; EVOLUTION; GENOME; DROSOPHILA; PLANT; DATABASE; RETROTRANSPOSONS; INSECTS	Stem-borers in the genus Papaipema (Lepidoptera: Noctuidae) range from highly polyphagous agricultural pests to specialists on more than 20 families of flowering plants, many of them highly toxic. Papaipema is the largest genus of noctuids endemic to North America and provides an excellent study system for the evolution of noctuid host plant use. To improve the availability of genomic resources for such investigations, we performed de novo transcriptome sequencing and assembly for two specialist Papaipema with unusual larval hosts: P. speciosissima, which is associated with ferns, and the undescribed P. "sp. 4," which is associated with bamboo. The resulting transcriptomes were similar in terms of completeness, gene count, and gene identity, but we identified some 8,000 genes (similar to 17% of each transcriptome) not shared between the two species. While some of these have identifiable orthologs in other Lepidoptera, similar to 5% of each transcriptome consists of species-specific genes. We examine the function of these genes and find that almost half have retrotransposon-related functional domains. The potential role of species-specific genes is discussed, and the expansion of certain retrotransposon families in Papaipema is examined.	[Oppenheim, Sara J.; DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Gen, New York, NY 10024 USA; [Feindt, Wiebke] Univ Vet Med Hannover, ITZ, Div Ecol & Evolut, Hannover, Germany; [Goldstein, Paul Z.] USDA, Natl Museum Nat Hist, Systemat Entomol Lab, Washington, DC 20250 USA	American Museum of Natural History (AMNH); University of Veterinary Medicine Hannover, Foundation; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA)	Oppenheim, SJ (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Gen, New York, NY 10024 USA.	soppenheim@amnh.org	Oppenheim, Sara/A-4641-2014	Oppenheim, Sara/0000-0003-1109-3639				Adrion JR, 2017, GENOME BIOL EVOL, V9, P1329, DOI 10.1093/gbe/evx050; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERENBAUM M, 1983, EVOLUTION, V37, P163, DOI 10.1111/j.1558-5646.1983.tb05524.x; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bomfleur B, 2014, SCIENCE, V343, P1376, DOI 10.1126/science.1249884; Burt A, 2008, GENES CONFLICT BIOL, P228; Buza TJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1167; Chen B, 2007, J EVOLUTION BIOL, V20, P2056, DOI 10.1111/j.1420-9101.2007.01348.x; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Donoghue MTA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-47; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Goke J, 2016, EMBO REP, V17, P1131, DOI 10.15252/embr.201642743; Goodier JL, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0070-z; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HENDRIX SD, 1980, AM NAT, V115, P171, DOI 10.1086/283554; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Janz N, 1997, P ROY SOC B-BIOL SCI, V264, P701, DOI 10.1098/rspb.1997.0100; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Koga A, 2006, MOL BIOL EVOL, V23, P1414, DOI 10.1093/molbev/msl003; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; Laissue PP, 2008, ADV EXP MED BIOL, V628, P102, DOI 10.1007/978-0-387-78261-4_7; Le Goff G, 2017, PEST MANAG SCI, V73, P493, DOI 10.1002/ps.4470; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Mahdavi A, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.8101; Mailafiya DM, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0115; Majorek KA, 2014, RNASE H LIKE SUPERFA; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; McBride AE, 2017, 2 PAPAIPEMA LIFE HIS, V59; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; McLysaght A, 2016, NAT REV GENET, V17, P567, DOI 10.1038/nrg.2016.78; Menken SBJ, 2010, EVOLUTION, V64, P1098, DOI 10.1111/j.1558-5646.2009.00889.x; Minneci F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063754; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Negi P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01448; Ono H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2247-0; Preisser EL, 2005, J PLANT INTERACT, V1, P197, DOI 10.1080/17429140601040570; Price MN, 2010, FASTTREE COMPUTING L; Pruitt KD, 2007, NUCL ACIDS RES; Rambaut A., 2016, FIGTREE V4 1 3; Reinhardt JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003860; Schlotterer C, 2015, TRENDS GENET, V31, P215, DOI 10.1016/j.tig.2015.02.007; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Seddigh S, 2016, TURK J BIOL, V40, P69, DOI 10.3906/biy-1412-88; Servant G, 2012, NUCLEIC ACIDS RES, V40, P5271, DOI 10.1093/nar/gks166; Simao FA, 2015, BIOINFORMATICS; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smith-Unna R, 2016, GENOME RES, V26, P1134, DOI 10.1101/gr.196469.115; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Tripp HJ, 2011, NUCLEIC ACIDS RES, V39, P8792, DOI 10.1093/nar/gkr576; US Department of Agriculture AaPHIS, 2017, PLANT PESTS DIS PROG; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; Wissler L, 2013, GENOME BIOL EVOL, V5, P439, DOI 10.1093/gbe/evt009; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46	70	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0191061	10.1371/journal.pone.0191061	http://dx.doi.org/10.1371/journal.pone.0191061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364900	Green Submitted, Green Published, gold			2022-12-27	WOS:000423412500034
J	Schwarz, KRL; de Castro, FC; Schefer, L; Botigelli, RC; Paschoal, DM; Fernandes, H; Leal, CLV				Schwarz, Katia R. L.; de Castro, Fernanda C.; Schefer, Leticia; Botigelli, Ramon C.; Paschoal, Daniela M.; Fernandes, Hugo; Leal, Claudia L. V.			The role of cGMP as a mediator of lipolysis in bovine oocytes and its effects on embryo development and cryopreservation	PLOS ONE			English	Article							DIFFERENT CULTURE-SYSTEMS; PHOSPHODIESTERASE TYPE 5; IN-VITRO PRODUCTION; ADIPOSE-TISSUE; BLASTOCYST DEVELOPMENT; NATRIURETIC PEPTIDES; LIPID DROPLETS; FATTY-ACID; CYCLIC-GMP; LINOLEIC-ACID	This study aimed to determine the influence of cyclic guanosine 3'5'-monophosphate (cGMP) and cGMP-dependent kinase (PKG) during in vitro maturation (IVM) on lipolysis-related parameters in bovine cumulus-oocyte complexes (COCs), and on embryo development and cryosurvival. COCs were matured with cGMP/PKG modulators and assessed for metaphase II rates (MII), cGMP levels, lipid content in oocytes (OO), transcript abundance for genes involved in lipolysis (ATGL) and lipid droplets (PLIN2) in cumulus cells (CC) and OO, and presence of phosphorylated (active) hormone sensitive lipase (HSLser563) in OO. Embryo development, lipid contents and survival to vitrification were also assessed. Phosphodiesterase 5 inhibition (PDE5; cGMP-hydrolyzing enzyme) with 10(-5)M sildenafil (SDF) during 24 h IVM increased cGMP in COCs (56.9 vs 9.5 fMol/COC in untreated controls, p<0.05) and did not affect on maturation rate (84.3 +/- 6.4% MII). Fetal calf serum (FCS) in IVM medium decreased cGMP in COCs compared to bovine serum albumin (BSA) + SDF (19.6 vs 66.5 fMol/COC, respectively, p<0.05). FCS increased lipid content in OO (40.1 FI, p<0.05) compared to BSA (34.6 FI), while SDF decreased (29.8 and 29.6 FI, with BSA or FCS, respectively p<0.05). PKG inhibitor (KT5823) reversed this effect (38.9 FI, p<0.05). ATGL and PLIN2 transcripts were detected in CC and OO, but were affected by cGMP and PKG only in CC. HSLser563 was detected in OO matured with or without modulators. Reduced lipid content in embryos were observed only when SDF was added during IVM and IVC (27.6 FI) compared to its use in either or none of the culture periods (34.2 FI, p<0.05). Survival to vitrification was unaffected by SDF. In conclusion, cGMP and PKG are involved in lipolysis in OO and possibly in CC and embryos; serum negatively affects this pathway, contributing to lipid accumulation, and cGMP modulation may reduce lipid contents in oocytes and embryos, but without improving embryo cryotolerance.	[Schwarz, Katia R. L.; de Castro, Fernanda C.; Schefer, Leticia; Paschoal, Daniela M.; Fernandes, Hugo; Leal, Claudia L. V.] Univ Sao Paulo, FZEA, Dept Med Vet, Pirassununga, SP, Brazil; [Botigelli, Ramon C.] Univ Estadual Paulista, IBB, Dept Farmacol, UNESP, Botucatu, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Schwarz, KRL; Leal, CLV (corresponding author), Univ Sao Paulo, FZEA, Dept Med Vet, Pirassununga, SP, Brazil.	ka.lancellotti@hotmail.com; clvleal@usp.br	Botigelli, Ramon/ABF-2847-2020; Leal, Cláudia/F-3518-2012	Botigelli, Ramon/0000-0002-2796-6062; Leal, Cláudia/0000-0002-9061-2574	 [2013/15374-3];  [2015/20379-0]	; 	This work was supported by Grant numbers 2013/15374-3 ; 2015/20379-0, www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, MOL REPROD DEV, V61, P57, DOI 10.1002/mrd.1131; Accorsi MF, 2016, ZYGOTE, V24, P485, DOI 10.1017/S0967199415000428; Al Darwich A, 2014, ANIM REPROD SCI, V145, P105, DOI 10.1016/j.anireprosci.2014.01.010; Al Darwich A, 2010, PROSTAG OTH LIPID M, V93, P30, DOI 10.1016/j.prostaglandins.2010.06.002; Armani A, 2011, TRENDS ENDOCRIN MET, V22, P404, DOI 10.1016/j.tem.2011.05.004; Auclair S, 2013, AM J PHYSIOL-ENDOC M, V304, pE599, DOI 10.1152/ajpendo.00469.2012; Barcelo-Fimbres M, 2007, MOL REPROD DEV, V74, P1406, DOI 10.1002/mrd.20700; Barcelo-Fimbres M, 2011, THERIOGENOLOGY, V75, P434, DOI 10.1016/j.theriogenology.2010.09.007; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Bezaire V, 2009, P NUTR SOC, V68, P350, DOI 10.1017/S0029665109990279; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bilodeaul-Goeseels S, 2007, THERIOGENOLOGY, V68, P693, DOI 10.1016/j.theriogenology.2007.05.063; Campos-Chillon LE, 2006, THERIOGENOLOGY, V65, P1200, DOI 10.1016/j.theriogenology.2005.07.015; Corbin JD, 2002, UROLOGY, V60, P4, DOI 10.1016/S0090-4295(02)01686-2; del Collado M, 2016, REPROD FERT DEVELOP, V28, P1721, DOI 10.1071/RD15067; DELOOS F, 1991, MOL REPROD DEV, V28, P255, DOI 10.1002/mrd.1080280307; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Fair T, 2001, MOL REPROD DEV, V58, P186, DOI 10.1002/1098-2795(200102)58:2&lt;186::AID-MRD8&gt;3.0.CO;2-N; Ferguson EM, 1999, J REPROD FERTIL, V116, P373, DOI 10.1530/jrf.0.1160373; De La Torre-Sanchez JF, 2006, REPROD FERT DEVELOP, V18, P597, DOI 10.1071/RD05064; Ferreira CR, 2010, J LIPID RES, V51, P1218, DOI 10.1194/jlr.D001768; Fu XW, 2011, THERIOGENOLOGY, V75, P268, DOI 10.1016/j.theriogenology.2010.08.013; Gupta MK, 2010, FERTIL STERIL, V93, P2602, DOI 10.1016/j.fertnstert.2010.01.043; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Kim JY, 2001, REPRODUCTION, V122, P131, DOI 10.1530/rep.0.1220131; Krisher RL, 2015, REPROD FERT DEVELOP, V27, P602, DOI 10.1071/RD14359; Krisher RL, 1999, BIOL REPROD, V60, P1345, DOI 10.1095/biolreprod60.6.1345; Kuhn M, 2003, CIRC RES, V93, P700, DOI 10.1161/01.RES.0000094745.28948.4D; Lafontan M, 2008, TRENDS ENDOCRIN MET, V19, P130, DOI 10.1016/j.tem.2007.11.006; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Schwarz KRL, 2014, THERIOGENOLOGY, V81, P556, DOI 10.1016/j.theriogenology.2013.11.008; Langin D, 2006, CR BIOL, V329, P598, DOI 10.1016/j.crvi.2005.10.008; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonergan P, 2003, Reprod Biomed Online, V7, P657; Marquez YC, 2005, REPROD DOMEST ANIM, V40, P553, DOI 10.1111/j.1439-0531.2005.00632.x; Maurice DH, 2003, P W PHARMACOL SOC, V46, P32; Men HS, 2006, THERIOGENOLOGY, V66, P2008, DOI 10.1016/j.theriogenology.2006.05.018; Morato R, 2010, REPROD FERT DEVELOP, V22, P1141, DOI 10.1071/RD10013; Moro C, 2007, AM J PHYSIOL-REG I, V293, pR612, DOI 10.1152/ajpregu.00162.2007; Mucci N, 2006, THERIOGENOLOGY, V65, P1551, DOI 10.1016/j.theriogenology.2005.08.020; Nicacio AC, 2012, ZYGOTE, V20, P117, DOI 10.1017/S0967199410000717; Nielsen TS, 2014, J MOL ENDOCRINOL, V52, pR199, DOI 10.1530/JME-13-0277; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Paschoal DM, 2017, THERIOGENOLOGY, V87, P108, DOI 10.1016/j.theriogenology.2016.08.011; Paschoal DM, 2014, ZYGOTE, V22, P146, DOI 10.1017/S0967199412000354; Pereira RM, 2007, ANIM REPROD SCI, V98, P293, DOI 10.1016/j.anireprosci.2006.03.015; Rizos D, 2008, REPROD DOMEST ANIM, V43, P44, DOI 10.1111/j.1439-0531.2008.01230.x; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; Rizos D, 2002, BIOL REPROD, V66, P589, DOI 10.1095/biolreprod66.3.589; Romek M, 2011, THERIOGENOLOGY, V75, P42, DOI 10.1016/j.theriogenology.2010.06.040; Sanchez-Lazo L, 2014, MOL ENDOCRINOL, V28, P1502, DOI 10.1210/me.2014-1049; Sasseville M, 2008, ENDOCRINOLOGY, V149, P5568, DOI 10.1210/en.2008-0547; Sastre D, 2014, THERIOGENOLOGY, V81, P326, DOI 10.1016/j.theriogenology.2013.10.002; Schwarz KRL, 2017, REPROD FERT DEVELOP, V29, P1593, DOI 10.1071/RD15512; Sengenes C, 2005, M S-MED SCI, V21, P29; Sengenes C, 2003, J BIOL CHEM, V278, P48617, DOI 10.1074/jbc.M303713200; Sengenes C, 2002, INT J OBESITY, V26, P24, DOI 10.1038/sj.ijo.0801845; Shuhaibar LC, 2015, P NATL ACAD SCI USA, V112, P5527, DOI 10.1073/pnas.1423598112; Spricigo JFW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130164; Sudano MJ, 2013, ANIM REPROD, V10, P160; Sudano MJ, 2014, ZYGOTE, V22, P124, DOI 10.1017/S0967199412000196; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; TORNELL J, 1990, ACTA PHYSIOL SCAND, V139, P511, DOI 10.1111/j.1748-1716.1990.tb08953.x; Wang S, 2008, FRONT BIOSCI, V13, P7087, DOI 10.2741/3212; Yamashita S, 1999, CYTOTECHNOLOGY, V31, P121, DOI 10.1023/A:1008044827145; Yang X, 2010, REPROD FERT DEVELOP, V22, P1262, DOI 10.1071/RD10091; Zhang RN, 2014, REPROD DOMEST ANIM, V49, P875, DOI 10.1111/rda.12386	72	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191023	10.1371/journal.pone.0191023	http://dx.doi.org/10.1371/journal.pone.0191023			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360833	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800014
J	Atkinson, TP; Centor, RM; Xiao, L; Wang, FCC; Cui, XQ; Van der Pol, W; Morrow, CD; Ratliff, AE; Crabb, DM; Totten, AH; Estrada, CA; Faircloth, MB; Waites, KB				Atkinson, T. Prescott; Centor, Robert M.; Xiao, Li; Wang, Fuchenchu; Cui, Xiangqin; Van der Pol, William; Morrow, Casey D.; Ratliff, Amy E.; Crabb, Donna M.; Totten, Arthur H.; Estrada, Carlos A.; Faircloth, Michael B.; Waites, Ken B.			Analysis of the tonsillar microbiome in young adults with sore throat reveals a high relative abundance of Fusobacterium necrophorum with low diversity	PLOS ONE			English	Article							PHARYNGITIS; INFECTIONS; PREVALENCE; SEQUENCES	Fusobacterium necrophorum (Fn), a gram-negative anaerobe, is increasingly implicated as an etiologic agent in older adolescents and young adults with sore throat. Inadequately treated Fn pharyngitis may result in suppurative complications such as peritonsillar abscess and Lemierre's syndrome. Data from the literature suggest that the incidence of life-threating complications in these age groups from Fn pharyngitis (Lemierre's syndrome) in the United States exceeds those associated with group A beta-hemolytic streptococcal (GAS) pharyngitis (acute rheumatic fever). Using real-time PCR, we previously reported about a 10% prevalence of Fn in asymptomatic medical students and about 20% in students complaining of sore throat at a university student health clinic (p = 0.009). In this study, a comprehensive microbiome analysis of the same study samples confirms that Fn pharyngitis was more common than GAS pharyngitis. Eighteen patients were found to have Fn OTU values exceeding an arbitrary cutoff value of 0.1, i.e. greater than 10% of total sequences, with five subjects reaching values above 0.7. By contrast only 9 patients had GAS OTU values greater than 0.1 and none exceeded 0.6. When the data were analyzed using five separate assessments of alpha diversity, in each case for Fn there were statistically significant differences between Fn positive_high (OTU abundance >0.1) vs control, Fn positive_high vs Fn negative (OTU abundance = 0), Fn positive_high vs Fn positive_low (OTU abundance >0 and <0.1). When the data were analyzed using three beta diversity indexes (Bray-Curtis, weighted unifrac, and unweighted unifrac), there were statistically significant differences between Fn positive_high (OTU abundance >= 0.1) vs control for all three. Statistically significant differences remained if we chose somewhat different OTU abundance cutoffs of 0.05 or 0.15. We conclude that Fn appears to play a dominant role in bacterial pharyngitis in the older adolescent and young adult age groups and that the development of a productive mucosal infection with Fn is linked to a significant decrease in the diversity of the associated tonsillar microbiome.	[Atkinson, T. Prescott] Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL 35487 USA; [Centor, Robert M.; Xiao, Li; Estrada, Carlos A.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL USA; [Wang, Fuchenchu; Cui, Xiangqin] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Van der Pol, William] Univ Alabama Birmingham, Sch Med, Ctr Clin & Translat Sci, Birmingham, AL USA; [Morrow, Casey D.] Univ Alabama Birmingham, Sch Med, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Ratliff, Amy E.; Crabb, Donna M.; Waites, Ken B.] Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL USA; [Totten, Arthur H.] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA; [Faircloth, Michael B.] Univ Alabama Birmingham, Sch Med, Dept Family & Community Med, Birmingham, AL USA; [Cui, Xiangqin] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University; Rollins School Public Health	Atkinson, TP (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL 35487 USA.	patkinson@peds.uab.edu	Totten, Arthur H/AAD-6643-2019	Totten, Arthur H/0000-0002-2979-7522; Atkinson, Thomas/0000-0003-2528-6976	UAB Depts of Pediatrics and Medicine	UAB Depts of Pediatrics and Medicine	This work was internally funded by the UAB Depts of Pediatrics and Medicine (to TPA).	Aliyu SH, 2004, J MED MICROBIOL, V53, P1029, DOI 10.1099/jmm.0.45648-0; Amess JA, 2007, BRIT J BIOMED SCI, V64, P63, DOI 10.1080/09674845.2007.11732757; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Batty A, 2005, J INFECTION, V51, P299, DOI 10.1016/j.jinf.2004.09.013; Batty A, 2005, BRIT J BIOMED SCI, V62, P66, DOI 10.1080/09674845.2005.11732687; Brazier JS, 2006, ANAEROBE, V12, P165, DOI 10.1016/j.anaerobe.2005.11.003; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Centor RM, 2015, ANN INTERN MED, V162, P241, DOI 10.7326/M14-1305; Centor RM, 2009, ANN INTERN MED, V151, P812, DOI 10.7326/0003-4819-151-11-200912010-00011; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FOY HM, 1993, CLIN INFECT DIS, V17, pS37, DOI 10.1093/clinids/17.Supplement_1.S37; Jensen A, 2007, CLIN MICROBIOL INFEC, V13, P695, DOI 10.1111/j.1469-0691.2007.01719.x; Jensen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056418; JOUSIMIESSOMER H, 1993, CLIN INFECT DIS, V16, pS292, DOI 10.1093/clinids/16.Supplement_4.S292; Klug TE, 2016, EUR J CLIN MICROBIOL, V27, P27; Klug TE, 2009, CLIN INFECT DIS, V49, P1467, DOI 10.1086/644616; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kumar R, 2014, CURR PROTOC HUM GENE, V82, P1, DOI [DOI 10.1002/0471142905.HG1808S82, 10.1002/0471142905.hg1808s82]; Kumar R, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-015-0622-2; Kuppalli K, 2012, LANCET INFECT DIS, V12, P808, DOI 10.1016/S1473-3099(12)70089-0; Linder JA, 2015, ANN INTERN MED, V162, P878, DOI 10.7326/L15-5100-2; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Ludlam H, 2009, J MED MICROBIOL, V58, P1264, DOI 10.1099/jmm.0.006718-0; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McKenney Erin A., 2017, Microbial Ecology in Health and Disease, V28, P1335165, DOI 10.1080/16512235.2017.1335165; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Riordan T, 2007, CLIN MICROBIOL REV, V20, P622, DOI 10.1128/CMR.00011-07; She R, 2017, CURR MICROBIOL, V26; Van TT, 2017, J CLIN MICROBIOL, V55, P1147, DOI 10.1128/JCM.02174-16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wood MR, 2017, AM J TROP MED HYG, V96, P1274, DOI 10.4269/ajtmh.16-0581	33	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0189423	10.1371/journal.pone.0189423	http://dx.doi.org/10.1371/journal.pone.0189423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351278	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300008
J	Pankratova, EV; Kalyakulina, AI; Krivonosov, MI; Denisov, SV; Taute, KM; Zaburdaev, VY				Pankratova, Evgeniya V.; Kalyakulina, Alena I.; Krivonosov, Mikhail I.; Denisov, Sergei V.; Taute, Katja M.; Zaburdaev, Vasily Yu.			Chemotactic drift speed for bacterial motility pattern with two alternating turning events	PLOS ONE			English	Article							MARINE-BACTERIA; PROKARYOTES; PERSISTENCE; DIRECTION; TRACKING; KINETICS	Bacterial chemotaxis is one of the most extensively studied adaptive responses in cells. Many bacteria are able to bias their apparently random motion to produce a drift in the direction of the increasing chemoattractant concentration. It has been recognized that the particular motility pattern employed by moving bacteria has a direct impact on the efficiency of chemotaxis. The linear theory of chemotaxis pioneered by de Gennes allows for calculation of the drift velocity in small gradients for bacteria with basic motility patterns. However, recent experimental data on several bacterial species highlighted the motility pattern where the almost straight runs of cells are interspersed with turning events leading to the reorientation of the cell swimming directions with two distinct angles following in strictly alternating order. In this manuscript we generalize the linear theory of chemotaxis to calculate the chemotactic drift speed for the motility pattern of bacteria with two turning angles. By using the experimental data on motility parameters of V. alginolyticus bacteria we can use our theory to relate the efficiency of chemotaxis and the size of bacterial cell body. The results of this work can have a straightforward extension to address most general motility patterns with alternating angles, speeds and durations of runs.	[Pankratova, Evgeniya V.; Kalyakulina, Alena I.; Krivonosov, Mikhail I.; Denisov, Sergei V.] Lobachevsky State Univ, Inst Informat Technol Math & Mech, Nizhnii Novgorod, Russia; [Denisov, Sergei V.] Univ Augsburg, Dept Theoret Phys, Augsburg, Germany; [Taute, Katja M.] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02138 USA; [Zaburdaev, Vasily Yu.] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Zaburdaev, Vasily Yu.] Lobachevsky State Univ, Inst Supercomp Technol, Nizhnii Novgorod, Russia	Lobachevsky State University of Nizhni Novgorod; University of Augsburg; Harvard University; Max Planck Society; Lobachevsky State University of Nizhni Novgorod	Pankratova, EV (corresponding author), Lobachevsky State Univ, Inst Informat Technol Math & Mech, Nizhnii Novgorod, Russia.	evgenia.pankratova@itmm.unn.ru	Kalyakulina, Alena I./O-7818-2017; Pankratova, Evgeniya V./M-2733-2016; Zaburdaev, Vasily/B-8194-2017; Taute, Katja/AAC-6942-2019; Krivonosov, Mikhail/AAJ-5810-2020; Denisov, Sergey V/B-8340-2008	Kalyakulina, Alena I./0000-0001-9277-502X; Pankratova, Evgeniya V./0000-0003-4214-7230; Zaburdaev, Vasily/0000-0001-8234-3442; Taute, Katja/0000-0003-2230-717X; Krivonosov, Mikhail/0000-0002-1169-5149; 	Russian Science Foundation (RSF) [16-12-10496]	Russian Science Foundation (RSF)(Russian Science Foundation (RSF))	The authors acknowledge financial support by the Russian Science Foundation (RSF project 16-12-10496, http://rscf.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altindal T, 2011, BIOPHYS J, V100, P32, DOI 10.1016/j.bpj.2010.11.029; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Berg HC, 2013, NAT PHYS, V9, P460, DOI 10.1038/nphys2678; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Bubendorfer S, 2014, P NATL ACAD SCI USA, V111, P11485, DOI 10.1073/pnas.1405820111; Celani A, 2010, P NATL ACAD SCI USA, V107, P1391, DOI 10.1073/pnas.0909673107; de Gennes PG, 2004, EUR BIOPHYS J BIOPHY, V33, P691, DOI 10.1007/s00249-004-0426-z; Eisenbach M, 2004, CHEMOTAXIS, DOI DOI 10.1142/P303; GRABERT H, 1977, Z PHYS B CON MAT, V26, P389, DOI 10.1007/BF01570749; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Johansen JE, 2002, AQUAT MICROB ECOL, V28, P229, DOI 10.3354/ame028229; Kafri Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.238101; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kupferman R, 2004, J STAT PHYS, V114, P291, DOI 10.1023/B:JOSS.0000003113.22621.f0; Liu B, 2014, P NATL ACAD SCI USA, V111, P11252, DOI 10.1073/pnas.1407636111; Locsei JT, 2007, J MATH BIOL, V55, P41, DOI 10.1007/s00285-007-0080-z; O'Toole G, 2010, ANNU REV MICROBIOL, V54, P49; Son K, 2016, P NATL ACAD SCI USA, V113, P8624, DOI 10.1073/pnas.1602307113; Son K, 2013, NAT PHYS, V9, P494, DOI 10.1038/NPHYS2676; Stocker R, 2011, P NATL ACAD SCI USA, V108, P2635, DOI 10.1073/pnas.1019199108; Taktikos J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081936; Taute KM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9776; Theves M, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/28007; Theves M, 2013, BIOPHYS J, V105, P1915, DOI 10.1016/j.bpj.2013.08.047; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xie L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141654; Xie L, 2015, BIOPHYS J, V108, P766, DOI 10.1016/j.bpj.2014.11.3479; Xie L, 2014, BIOPHYS J, V107, P1712, DOI 10.1016/j.bpj.2014.07.058; Xie L, 2011, P NATL ACAD SCI USA, V108, P2246, DOI 10.1073/pnas.1011953108	31	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190434	10.1371/journal.pone.0190434	http://dx.doi.org/10.1371/journal.pone.0190434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351336	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300018
J	Sun, L; Zou, T; Wang, BZ; Liu, F; Yuan, QH; Ma, YT; Ma, X				Sun, Ling; Zou, Ting; Wang, Bao-Zhu; Liu, Fen; Yuan, Qing-Hua; Ma, Yi-Tong; Ma, Xiang			Epidemiological investigation into the prevalence of abnormal inter-arm blood pressure differences among different ethnicities in Xinjiang, China	PLOS ONE			English	Article							DISEASE; HYPERTENSION	Objectives The prevalence of and risk factors for IAD among different ethnicity groups was unknown. Our aim was to investigate the prevalence of and risk factors for IAD among Han, Uygur and Kazakh ethnicities in Xinjiang. China. Methods In total, 14,618 adult participants (7,799 males and 6,819 females) were recruited from the Cardiovascular Risk Survey. A 4-stage stratified cluster random sampling method was used. The participants' personal information and medical history were assessed by questionnaire. IAD was diagnosed by a noninvasive arteriosclerosis analyzer. Results The prevalence of abnormal IAD among the general population was 14.3%, with 12.5% in the Han, 14.9% in the Uygur, and 16.4% in the Kazakh populations. The prevalence of abnormal IAD among the hypertensive population was 19.4%, with 17.0% in the Han, 18.1% in the Uygur, and 22.7% in the Kazakh populations. The prevalence of abnormal IAD increased with age (all P < 0.01) but was not significantly different between the genders (all P>0.05). Multivariate logistic regression analysis showed that age more than 45 years, obesity and hypertriglyceridemia were significantly associated with a higher prevalence of IAD. There were different risk factors for abnormal IAD in different ethnicities. Middle or old age, obesity, ABI and diabetes mellitus were risk factors for the Han population, smoking was a risk factor in the Uygur population, and obesity and PAD were risk factors in the Kazakh population. Conclusion The prevalence of abnormal IAD in the Kazakh participants was higher than that in the Han and Uygur populations among both the general population and the hypertensive population in Xinjiang, China. The main risk factors of IAD were age, obesity, and triglyceride levels. Different ethnicities had different kinds of risk factors for IAD.	[Sun, Ling; Wang, Bao-Zhu; Liu, Fen; Yuan, Qing-Hua; Ma, Yi-Tong; Ma, Xiang] Xingjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Zou, Ting] Xinjiang Med Univ, Affiliated Hosp 5, Dept Cardiol, Urumqi, Henan, Peoples R China; [Liu, Fen; Ma, Yi-Tong; Ma, Xiang] Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Xin Jiang Key Lab Cardiovasc Dis, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Ma, X (corresponding author), Xingjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.; Ma, X (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Xin Jiang Key Lab Cardiovasc Dis, Urumqi, Peoples R China.	maxiangxj@yeah.net						[Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Arnett DK, 2005, J HYPERTENS, V23, P1141, DOI 10.1097/01.hjh.0000170376.23461.f7; Arroyo D, 2017, NEPHROL DIAL TRANSPL, V32, P513, DOI 10.1093/ndt/gfw039; Clark CE, 2016, BRIT J GEN PRACT, V66, pE838, DOI 10.3399/bjgp16X687553; Clark CE, 2015, CURR PHARM DESIGN, V21, P737; Clark CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1327; Clark CE, 2012, LANCET, V379, P905, DOI 10.1016/S0140-6736(11)61710-8; FOTHERBY MD, 1993, POSTGRAD MED J, V69, P194, DOI 10.1136/pgmj.69.809.194; Gao Xia, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P857; Grossman A, 2014, J CLIN HYPERTENS, V16, P518, DOI 10.1111/jch.12345; Kim SA, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003888; Kimura A, 2004, J HYPERTENS, V22, P2277, DOI 10.1097/00004872-200412000-00009; Lane D, 2002, J HYPERTENS, V20, P1089, DOI 10.1097/00004872-200206000-00019; Liu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145325; Liu Fen, 2010, Zhonghua Yi Xue Za Zhi, V90, P3259; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; McManus RJ, 2012, BMJ-BRIT MED J, V344, pe181, DOI DOI 10.1136/BMJ.E181; Mumford SL, 2011, CLIN LIPIDOL, V6, P225, DOI 10.2217/CLP.11.9; National Institue for Health and Clinical Excellence, 2011, HYP CLIN MAN PRIM HY, V127, P905; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Orme S, 1999, AGE AGEING, V28, P537, DOI 10.1093/ageing/28.6.537; Pan SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053746; Singh S, 2015, BLOOD PRESS MONIT, V20, P178, DOI 10.1097/MBP.0000000000000115; Song BM, 2016, KOREAN CIRC J, V46, P374, DOI 10.4070/kcj.2016.46.3.374; Su HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041173; Weinberg I, 2014, AM J MED, V127, P209, DOI 10.1016/j.amjmed.2013.10.027; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Zhang RB, 2000, AM J HYPERTENS, V13, P1308, DOI 10.1016/S0895-7061(00)01254-1	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0188546	10.1371/journal.pone.0188546	http://dx.doi.org/10.1371/journal.pone.0188546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346374	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500002
J	Chamberlain, BP; Levy-Kramer, J; Humby, C; Deisenroth, MP				Chamberlain, Benjamin Paul; Levy-Kramer, Josh; Humby, Clive; Deisenroth, Marc Peter			Real-time community detection in full social networks on a laptop	PLOS ONE			English	Article								For a broad range of research and practical applications it is important to understand the allegiances, communities and structure of key players in society. One promising direction towards extracting this information is to exploit the rich relational data in digital social networks (the social graph). As global social networks (e.g., Facebook and Twitter) are very large, most approaches make use of distributed computing systems for this purpose. Distributing graph processing requires solving many difficult engineering problems, which has lead some researchers to look at single-machine solutions that are faster and easier to maintain. In this article, we present an approach for analyzing full social networks on a standard laptop, allowing for interactive exploration of the communities in the locality of a set of user specified query vertices. The key idea is that the aggregate actions of large numbers of users can be compressed into a data structure that encapsulates the edge weights between vertices in a derived graph. Local communities can be constructed by selecting vertices that are connected to the query vertices with high edge weights in the derived graph. This compression is robust to noise and allows for interactive queries of local communities in realtime, which we define to be less than the average human reaction time of 0.25s. We achieve single-machine real-time performance by compressing the neighborhood of each vertex using minhash signatures and facilitate rapid queries through Locality Sensitive Hashing. These techniques reduce query times from hours using industrial desktop machines operating on the full graph to milliseconds on standard laptops. Our method allows exploration of strongly associated regions (i.e., communities) of large graphs in real-time on a laptop. It has been deployed in software that is actively used by social network analysts and offers another channel for media owners to monetize their data, helping them to continue to provide free services that are valued by billions of people globally.	[Chamberlain, Benjamin Paul; Deisenroth, Marc Peter] Imperial Coll London, Dept Comp, London, England; [Levy-Kramer, Josh; Humby, Clive] Starcount Insights, London, England	Imperial College London	Chamberlain, BP (corresponding author), Imperial Coll London, Dept Comp, London, England.	b.chamberlain14@imperial.ac.uk	Deisenroth, Marc/G-8947-2013	Deisenroth, Marc/0000-0003-1503-680X	Royal Commission for the Exhibition of 1851; Google Faculty Research Award; Starcount Insights	Royal Commission for the Exhibition of 1851; Google Faculty Research Award(Google Incorporated); Starcount Insights	Ben Chamberlain is partially funded by an Industrial Fellowship from the Royal Commission for the Exhibition of 1851. The research has also received partial funding through a Google Faculty Research Award (Marc Deisenroth). The company's employees supported the project through data collection and curation, computing infrastructure and development of the general concept.; This work was partly funded by an Industrial Fellowship of the Royal Commission for the Exhibition of 1851 (BC) and a Google Faculty Research Award (MPD). We thank Starcount Insights for supporting this project with data.	Adler M, 2001, IEEE DATA COMPR CONF, P203, DOI 10.1109/DCC.2001.917151; Andoni A., 2014, P 25 ANN ACM SIAM S, P1018, DOI DOI 10.1137/1.9781611973402.76; [Anonymous], [No title captured]; [Anonymous], 2014, GRAPHLAB NEW FRAMEWO; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Bahmani B., 2011, SIGMOD, P973; Bastian M., 2009, ICWSM, V3, P361, DOI 10.13140/2.1.1341.1520; Becchetti L, 2010, ACM T KNOWL DISCOV D, V4, DOI 10.1145/1839490.1839494; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boldi P., 2004, WWW 04, P595, DOI DOI 10.1145/988672.988752; Broder AZ, 1998, COMPRESSION AND COMPLEXITY OF SEQUENCES 1997 - PROCEEDINGS, P21, DOI 10.1109/SEQUEN.1997.666900; Broder AZ, 2000, J COMPUT SYST SCI, V60, P630, DOI 10.1006/jcss.1999.1690; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Charikar M.S., 2002, P 34 ANN ACM S THEOR, V34, P380, DOI DOI 10.1145/509907.509965; Chen R., 2010, PROC ACM SIGMOD INT, P1123; Chierichetti F, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P219; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Flake G. W., 2000, Proceedings. KDD-2000. Sixth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P150, DOI 10.1145/347090.347121; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gibson D., 2005, P 31 INT C VER LARG, P721, DOI DOI 10.5555/1083592.1083676; Gleich D. F., 2012, P 18 ACM SIGKDD INT, P597, DOI DOI 10.1145/2339530.2339628; Gupta P., 2013, P 22 INT C WORLD WID, P505, DOI [DOI 10.1145/2488388.2488433, 10.1145/2488388.2488433]; Haveliwava T. H., 2002, P 11 INT C WORLD WID, P517, DOI [DOI 10.1145/511446.511513, 10.1145/511446.511513]; Hewett T., 1992, ACM SIGCHI CURRICULA, DOI 10.11452594128////; Indyk P., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P604, DOI 10.1145/276698.276876; Karonski M, 1999, COMB PROBAB COMPUT, V8, P131, DOI 10.1017/S0963548398003459; Kloumann IM, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1366, DOI 10.1145/2623330.2623621; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lee BC, 2010, COMMUN ACM, V53, P99, DOI 10.1145/1785414.1785441; Leskovec J., 2010, P 19 INT C WORLD WID, P631, DOI 10.1145/1772690.1772755; Leskovec J., 2008, P 17 INT C WORLD WID, P695, DOI DOI 10.1145/1367497.1367591; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Li YX, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P658, DOI 10.1145/2736277.2741676; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mitzenmacher M, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P109, DOI 10.1145/2566486.2568017; Motwani R, 2007, SIAM J DISCRETE MATH, V21, P930, DOI 10.1137/050646858; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pace MF, 2012, PROCEDIA COMPUT SCI, V9, P246, DOI 10.1016/j.procs.2012.04.026; PAGE L., 1998, 199966 STANF INFOLAB, P161; Perry M, 2011, SEMAT WEB BEYOND-COM, V12, P61, DOI 10.1007/978-1-4419-9446-2_3; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Shang YL, 2015, J PHYS A-MATH THEOR, V48, DOI 10.1088/1751-8113/48/39/395101; Shang YL, 2012, FRONT MATH CHINA, V7, P117, DOI 10.1007/s11464-011-0165-2; Shang YL, 2010, ELECTRON J COMB, V17; Yang J, 2015, KNOWL INF SYST, V42, P181, DOI 10.1007/s10115-013-0693-z; Yang Jaewon, 2013, P 6 ACM INT C WEB SE, P587, DOI [DOI 10.1145/2433396.2433471, 10.1145/2433396.2433471]; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	60	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0188702	10.1371/journal.pone.0188702	http://dx.doi.org/10.1371/journal.pone.0188702			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342158	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800005
J	Clarke, SB; Deighton, K; Newman, C; Nicholson, G; Gallagher, L; Boos, CJ; Mellor, A; Woods, DR; O'Hara, JP				Clarke, Sarah B.; Deighton, Kevin; Newman, Caroline; Nicholson, Gareth; Gallagher, Liam; Boos, Christopher J.; Mellor, Adrian; Woods, David R.; O'Hara, John P.			Changes in balance and joint position sense during a 12-day high altitude trek: The British Services Dhaulagiri medical research expedition	PLOS ONE			English	Article							ACUTE MOUNTAIN-SICKNESS; POSTURAL STABILITY; DYNAMIC POSTUROGRAPHY; VISUAL INFORMATION; NORMOBARIC HYPOXIA; HYPOBARIC HYPOXIA; PART I; ATAXIA; RELIANCE; PROGRAM	Postural control and joint position sense are essential for safely undertaking leisure and professional activities, particularly at high altitude. We tested whether exposure to a 12-day trek with a gradual ascent to high altitude impairs postural control and joint position sense. This was a repeated measures observational study of 12 military service personnel (28 4 years). Postural control (sway velocity measured by a portable force platform) during standing balance, a Sharpened Romberg Test and knee joint position sense were measured, in England (113m elevation) and at 3 research camps (3619m, 4600m and 5140m) on a 12-day high altitude trek in the Dhaulagiri region of Nepal. Pulse oximetry, and Lake Louise scores were also recorded on the morning and evening of each trek day. Data were compared between altitudes and relationships between pulse oximetry, Lake Louise score, and sway velocity were explored. Total sway velocity during standing balance with eyes open (p = 0.003, d = 1.9) and during Sharpened Romberg test with eyes open (p = 0.007, d = 1.6) was significantly greater at altitudes of 3619m and 5140m when compared with sea level. Anterior-posterior sway velocity during standing balance with eyes open was also significantly greater at altitudes of 3619m and 5140m when compared with sea level (p = 0.001, d = 1.9). Knee joint position sense was not altered at higher altitudes. There were no significant correlations between Lake Louise scores, pulse oximetry and postural sway. Despite a gradual ascent profile, exposure to 3619 m was associated with impairments in postural control without impairment in knee joint position sense. Importantly, these impairments did not worsen at higher altitudes of 4600 m or 5140 m. The present findings should be considered during future trekking expeditions when developing training strategies targeted to manage impairments in postural control that occur with increasing altitude.	[Clarke, Sarah B.; Deighton, Kevin; Nicholson, Gareth; Gallagher, Liam; Boos, Christopher J.; Mellor, Adrian; Woods, David R.; O'Hara, John P.] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England; [Clarke, Sarah B.] Northern Michigan Univ, Sch Hlth & Human Performance, Marquette, MI 49855 USA; [Newman, Caroline; Boos, Christopher J.; Mellor, Adrian; Woods, David R.] Def Med Serv, Lichfield, England; [Boos, Christopher J.] Poole Hosp NHS Trust, Dept Cardiol, Longfleet Rd, Poole, Dorset, England; [Boos, Christopher J.] Bournemouth Univ, Dept Postgrad Med Educ, Bournemouth, Dorset, England; [Mellor, Adrian] James Cook Univ Hosp, South Tees Hosp NHS Trust, Middlesbrough, Cleveland, England; [Woods, David R.] Wansbeck Gen & Royal Victoria Infirm, Northumbria & Newcastle NHS Trusts, Newcastle Upon Tyne, Tyne & Wear, England; [Woods, David R.] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England	Leeds Beckett University; Northern Michigan University; Bournemouth University; James Cook University Hospital; Newcastle University - UK	Clarke, SB (corresponding author), Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England.; Clarke, SB (corresponding author), Northern Michigan Univ, Sch Hlth & Human Performance, Marquette, MI 49855 USA.	sabreen@nmu.edu	Breen, Sarah/AAD-7910-2022; Nicholson, Gareth/X-1657-2019; Breen, Sarah/H-3682-2019	Breen, Sarah/0000-0002-6101-5359; Nicholson, Gareth/0000-0002-9559-0562; Breen, Sarah/0000-0002-6101-5359; Deighton, Kevin/0000-0001-7994-2137	Surgeon General (Defence Medical Services) Research Fund, UK; Leeds Beckett University	Surgeon General (Defence Medical Services) Research Fund, UK; Leeds Beckett University	Research reported in this study was supported by the Surgeon General (Defence Medical Services) Research Fund, UK and Leeds Beckett University.	Baumgartner RW, 2002, EUR J APPL PHYSIOL, V86, P322, DOI 10.1007/s00421-001-0534-8; Binks AP, 2008, J APPL PHYSIOL, V104, P212, DOI 10.1152/japplphysiol.00069.2007; Bird BA, 2011, WILD ENVIRON MED, V22, P172, DOI 10.1016/j.wem.2011.02.001; Bonan IV, 2004, ARCH PHYS MED REHAB, V85, P274, DOI 10.1016/j.apmr.2003.06.016; Bonan IV, 2004, ARCH PHYS MED REHAB, V85, P268, DOI 10.1016/j.apmr.2003.06.017; Cohen J, 1988, STAT POWER ANAL BEHA, DOI 10.1234/12345678; Costello JT, 2012, SCAND J MED SCI SPOR, V22, P190, DOI 10.1111/j.1600-0838.2011.01292.x; Cymerman A, 2001, HIGH ALT MED BIOL, V2, P509, DOI 10.1089/152702901753397072; Degache F, 2012, HIGH ALT MED BIOL, V13, P40, DOI 10.1089/ham.2011.1042; Dewhurst S, 2007, J ELECTROMYOGR KINES, V17, P292, DOI 10.1016/j.jelekin.2006.03.002; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FOWLER B, 1995, AVIAT SPACE ENVIR MD, V66, P645; FRASER WD, 1987, AVIAT SPACE ENVIR MD, V58, P768; His Majesty's Government of Nepal, 1986, NEP TOUR STAT 1986; His Majesty's Government of Nepal, 2015, NEP TOUR STAT 2015; Hopper DM, 2003, ARCH PHYS MED REHAB, V84, P868, DOI 10.1016/S0003-9993(03)00007-8; Hoshikawa M, 2010, EUR J APPL PHYSIOL, V110, P539, DOI 10.1007/s00421-010-1530-7; Johnson BG, 2005, WILD ENVIRON MED, V16, P62, DOI 10.1580/PR02-04.1; Mellor A, J R ARMY ME IN PRESS; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Nordahl SHG, 1998, AVIAT SPACE ENVIR MD, V69, P590; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; Relph N, 2015, J SPORT REHABIL; Relph N, 2014, J SPORT REHABIL; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Roach RC, 2000, J APPL PHYSIOL, V88, P581, DOI 10.1152/jappl.2000.88.2.581; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SEVERINGHAUS JW, 1995, J APPL PHYSIOL, V79, P375, DOI 10.1152/jappl.1995.79.2.375; Sparrer I, ACTA OTOLARYNGOL STO; Stadelmann K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116695; Tredici TJ, 2008, FUNDAMENTALS AEROSPA, P356; Wagner DR, 2016, HIGH ALT MED BIOL, V17, P222, DOI 10.1089/ham.2016.0040; Wagner LS, 2011, AVIAT SPACE ENVIR MD, V82, P518, DOI 10.3357/ASEM.2885.2011; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9	35	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190919	10.1371/journal.pone.0190919	http://dx.doi.org/10.1371/journal.pone.0190919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342191	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000422653800038
J	Diaz-Mazariegos, S; Cabrera, N; Perez-Montfort, R				Diaz-Mazariegos, Selma; Cabrera, Nallely; Perez-Montfort, Ruy			Three unrelated and unexpected amino acids determine the susceptibility of the interface cysteine to a sulfhydryl reagent in the triosephosphate isomerases of two trypanosomes	PLOS ONE			English	Article							SPECIES-SPECIFIC INHIBITION; DIMER-INTERFACE; CRUZI; BRUCEI; SEQUENCE; REACTIVITY; PROTEINS; RESIDUES; ENZYME	Proteins with great sequence similarity usually have similar structure, function and other physicochemical properties. But in many cases, one or more of the physicochemical or functional characteristics differ, sometimes very considerably, among these homologous proteins. To better understand how critical amino acids determine quantitative properties of function in proteins, the responsible residues must be located and identified. This can be difficult to achieve, particularly in cases where multiple amino acids are involved. In this work, two triosephosphate isomerases with very high similarity from two related human parasites were used to address one such problem. We demonstrate that a seventy-fold difference in the reactivity of an interface cysteine to the sulfhydryl reagent methylmethane sulfonate in these two enzymes depends on three amino acids located far away from this critical residue and which could not have been predicted using other current methods. Starting from previous observations with chimeric proteins involving these two triosephosphate isomerases, we developed a strategy involving additive mutant enzymes and selected site directed mutants to locate and identify the three amino acids. These three residues seem to induce changes in the interface cysteine in reactivity by increasing (or decreasing) its apparent pKa. Some enzymes with four to seven mutations also exhibited altered reactivity. This study completes a strategy for identifying key residues in the sequences of proteins that can have applications in future protein structure-function studies.	[Diaz-Mazariegos, Selma; Cabrera, Nallely; Perez-Montfort, Ruy] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioqum & Biol Estruct, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Perez-Montfort, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioqum & Biol Estruct, Mexico City, DF, Mexico.	ruy@ifc.unam.mx		Perez-Montfort, Ruy/0000-0003-0810-1159; Cabrera Gonzalez, Elizabeth Nallely/0000-0001-8766-6996	Consejo Nacional de Ciencia y Tecnologia [254694]; Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico [IN206816]; CONACyT [263707]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grant no. 254694 from the Consejo Nacional de Ciencia y Tecnologia and grant no. IN206816 from the Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (to RP-M). SD-M was the recipient of a fellowship from CONACyT (no. 263707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORCHERT TV, 1993, EUR J BIOCHEM, V211, P703, DOI 10.1111/j.1432-1033.1993.tb17599.x; Cabrera N, 2008, BIOCHEMISTRY-US, V47, P3499, DOI 10.1021/bi702439r; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Garcia-Torres I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018791; Garza-Ramos G, 1998, EUR J BIOCHEM, V253, P684, DOI 10.1046/j.1432-1327.1998.2530684.x; GarzaRamos G, 1996, EUR J BIOCHEM, V241, P114, DOI 10.1111/j.1432-1033.1996.0114t.x; GomezPuyou A, 1995, CHEM BIOL, V2, P847, DOI 10.1016/1074-5521(95)90091-8; Kaczanowski S, 2010, THEOR CHEM ACC, V125, P643, DOI 10.1007/s00214-009-0656-3; Kosloff M, 2008, PROTEINS, V71, P891, DOI 10.1002/prot.21770; Maldonado E, 1997, PROTEIN PEPTIDE LETT, V4, P139; Maldonado E, 1998, J MOL BIOL, V283, P193, DOI 10.1006/jmbi.1998.2094; Olivares-Illana V, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000001; OstoaSaloma P, 1997, EUR J BIOCHEM, V244, P700, DOI 10.1111/j.1432-1033.1997.00700.x; Pearson WR, 2013, CURR PROTOC BIOINFOR, V42, DOI 10.1002/0471250953.bi0301s42; Perez-Montfort R, 1999, BIOCHEMISTRY-US, V38, P4114, DOI 10.1021/bi982425s; Reyes-Vivas H, 2002, PROTEINS, V48, P580, DOI 10.1002/prot.10179; Reyes-Vivas H, 2001, BIOCHEMISTRY-US, V40, P3134, DOI 10.1021/bi002619j; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Rodriguez-Bolanos M, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160161; Tellez-Valencia A, 2002, BIOCHEM BIOPH RES CO, V295, P958, DOI 10.1016/S0006-291X(02)00796-9; Zomosa-Signoret V, 2003, BIOCHEMISTRY-US, V42, P3311, DOI 10.1021/bi0206560	21	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189525	10.1371/journal.pone.0189525	http://dx.doi.org/10.1371/journal.pone.0189525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342154	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800008
J	Schoening, JM; Corner, LAL; Messam, LLM; Cassidy, JP; Wolfe, A				Schoening, Janne M.; Corner, Leigh A. L.; Messam, Locksley L. McV.; Cassidy, Joseph P.; Wolfe, Alan			Environmental dust inhalation in the European badger (Meles meles): Systemic distribution of silica-laden macrophages, pathological changes, and association with Mycobacterium bovis infection status	PLOS ONE			English	Article							FRESHLY FRACTURED SILICA; AFRICAN GOLD MINERS; EXTRAPULMONARY SILICOSIS; ALVEOLAR MACROPHAGES; NITRIC-OXIDE; PULMONARY SILICOSIS; POTENTIAL ROLE; FREE-RADICALS; LUNG INJURY; TUBERCULOSIS	Chronic inhalation of crystalline silica and silicates may lead to severe lung disease in humans, termed silicosis. The disease is an occupational health concern in miners and related professions worldwide. Silicosis is also a strong risk factor for tuberculosis in humans. Due to its subterranean lifestyle, the European badger (Meles meles) is continuously exposed to environmental dust, while this species is also susceptible to tuberculosis, caused by Mycobacterium bovis. To date, a thorough investigation of mineral dust retention and its possible implication as a risk factor for mycobacterial infection in badgers has not been performed. The aims of this retrospective histological study were (1) to describe the systemic tissue distribution of silica-laden macrophages (SLMs) in badgers; (2) to compare the amount of SLMs in tissues of badgers of differing M. bovis infection status, pulmonary SLM burden and age; and (3) to assess whether inflammation was associated with SLMs. We assessed lung, lymph nodes, liver and spleen of 60 wild-caught badgers of known M. bovis infection status for the presence of SLMs using polarizing light microscopy. SLMs were consistently present within the lungs and were widely distributed throughout the lymphatic system. No inflammatory reaction to SLMs, as occurs in human silicosis, was observed in any tissue. Distribution and amount of SLMs were similar between M. bovis positive and negative badgers, and we were not able to show an association between the amount of SLMs and M. bovis infection status. The amount of SLMs within intra-and extra-thoracic lymph nodes was positively associated with the amount of pulmonary SLMs, and with age. This is the first report of substantial and systemic tissue retention of mineral dust particles in a mammalian species lacking associated chronic inflammation (i.e. silicosis). We further highlight different pathogenetic mechanisms underlying silicosis and benign SLM accumulations following siliceous dust inhalation.	[Schoening, Janne M.; Corner, Leigh A. L.; Messam, Locksley L. McV.; Cassidy, Joseph P.; Wolfe, Alan] Univ Coll Dublin, Sch Vet Med, Dublin, Ireland	University College Dublin	Schoening, JM (corresponding author), Univ Coll Dublin, Sch Vet Med, Dublin, Ireland.	janne.schoening@ucdconnect.ie		Messam, Locksley L. McV./0000-0001-5791-555X; Cassidy, Joseph/0000-0002-9229-1831	Department of Agriculture, Food; Marine	Department of Agriculture, Food; Marine	Tissue samples for this study were funded by the Department of Agriculture, Food and the Marine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboza Carlos Eduardo Galvão, 2008, J. bras. pneumol., V34, P959, DOI 10.1590/S1806-37132008001100012; BARZIV J, 1974, ARCH ENVIRON HEALTH, V29, P121, DOI 10.1080/00039896.1974.10666548; Bilham K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45470; BLACKFORD JA, 1994, AM J RESP CELL MOL, V11, P426, DOI 10.1165/ajrcmb.11.4.7522485; Borges VM, 2001, J EXP MED, V194, P155, DOI 10.1084/jem.194.2.155; BRAMBILLA C, 1979, AM J PATHOL, V96, P149; BROWN GM, 1989, TOXICOL APPL PHARM, V101, P95, DOI 10.1016/0041-008X(89)90215-9; Castranova V, 2000, ENVIRON HEALTH PERSP, V108, P675, DOI 10.2307/3454404; Castranova V, 2000, INHAL TOXICOL, V12, P7, DOI 10.1080/08958378.2000.11463226; Castranova V., 1996, APPL OCCUP ENVIRON H, V11, P937, DOI [10.1080/1047322X.1996.10389993, DOI 10.1080/1047322X.1996.10389993]; Charalambous S, 2001, INT J TUBERC LUNG D, V5, P1044; Corbett EL, 2000, AIDS, V14, P2759, DOI 10.1097/00002030-200012010-00016; Corner LAL, 2011, J COMP PATHOL, V144, P1, DOI 10.1016/j.jcpa.2010.10.003; Corner LAL, 2012, VET J, V194, P166, DOI 10.1016/j.tvjl.2012.03.013; COWIE RL, 1994, AM J RESP CRIT CARE, V150, P1460, DOI 10.1164/ajrccm.150.5.7952577; Cox-Ganser JM, 2009, J OCCUP ENVIRON MED, V51, P164, DOI 10.1097/JOM.0b013e31818f6a0f; Day MJ, 1996, VET PATHOL, V33, P29, DOI 10.1177/030098589603300104; Domingo-Neumann R, 2009, PORTL GSA ANN M PORT; Environmental Protection Agency, IR SOIL INF SYST 201; GALLAGHER J, 1976, VET REC, V98, P9, DOI 10.1136/vr.98.1.9; Gilberti RM, 2008, AM J RESP CELL MOL, V39, P619, DOI 10.1165/rcmb.2008-0046OC; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Greenberg MI, 2007, DM-DIS MON, V53, P394, DOI 10.1016/j.disamonth.2007.09.020; Hamilton RF, 2008, FREE RADICAL BIO MED, V44, P1246, DOI 10.1016/j.freeradbiomed.2007.12.027; Hammond RF, 2001, PREV VET MED, V51, P137, DOI 10.1016/S0167-5877(01)00230-6; HIGGINS DA, 1985, INFECT IMMUN, V48, P252, DOI 10.1128/IAI.48.1.252-256.1985; Hnizdo E, 1998, OCCUP ENVIRON MED, V55, P496, DOI 10.1136/oem.55.7.496; HUERGO DG, 1991, REV ESP ENFERM DIG, V80, P95; Joshi GN, 2013, APOPTOSIS, V18, P271, DOI 10.1007/s10495-012-0798-y; Kuehn BM, 2006, JAMA-J AM MED ASSOC, V295, P2463, DOI 10.1001/jama.295.21.2463; LANGLOIS SLP, 1977, AUSTRALAS RADIOL, V21, P143, DOI 10.1111/j.1440-1673.1977.tb03185.x; Liebich H.-G, 2014, VET ANATOMY DOMESTIC; Martin Larranaga N, 2004, An Med Interna, V21, P187; McCarthy G, 2009, VET CLIN PATH, V38, P381, DOI 10.1111/j.1939-165X.2009.00127.x; MCDONALD JW, 1995, ARCH PATHOL LAB MED, V119, P242; Messmer UK, 1996, BIOCHEM J, V319, P299, DOI 10.1042/bj3190299; Morman SA, 2013, AEOLIAN RES, V9, P203, DOI 10.1016/j.aeolia.2012.12.001; Porter DW, 2002, TOXICOLOGY, V175, P63, DOI 10.1016/S0300-483X(02)00061-6; Rimal B, 2005, CURR OPIN PULM MED, V11, P169, DOI 10.1097/01.mcp.0000152998.11335.24; ROPERTO F, 1995, J COMP PATHOL, V112, P97, DOI 10.1016/S0021-9975(05)80092-1; Schenker MB, 2009, ENVIRON HEALTH PERSP, V117, P988, DOI 10.1289/ehp.0800144; Schwartz L W, 1981, Chest, V80, P82; SLAVIN RE, 1985, HUM PATHOL, V16, P393, DOI 10.1016/S0046-8177(85)80233-1; Smal C, 1995, BADGER HABITAT SURVE; SMITH BL, 1973, VET PATHOL, V10, P94, DOI 10.1177/030098587301000202; Stafoggia M, 2016, ENVIRON HEALTH PERSP, V124, P413, DOI 10.1289/ehp.1409164; Suedmeyer WK, 1999, J ZOO WILDLIFE MED, V30, P564; teWaterNaude JM, 2006, OCCUP ENVIRON MED, V63, P187, DOI 10.1136/oem.2004.018614; Tripathi S., 2011, J APP PHARM SCI, V1, P1; VALLYATHAN V, 1995, AM J RESP CRIT CARE, V152, P1003, DOI 10.1164/ajrccm.152.3.7663775; VALLYATHAN V, 1988, AM REV RESPIR DIS, V138, P1213, DOI 10.1164/ajrccm/138.5.1213; Wong T W, 1998, Respirology, V3, P281	52	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190230	10.1371/journal.pone.0190230	http://dx.doi.org/10.1371/journal.pone.0190230			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342164	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800015
J	Hsia, HP; Yang, YH; Szeto, WC; Nilsson, BE; Lo, CY; Ng, AKL; Fodor, E; Shaw, PC				Hsia, Ho-Pan; Yang, Yin-Hua; Szeto, Wun-Chung; Nilsson, Benjamin E.; Lo, Chun-Yeung; Ng, Andy Ka-Leung; Fodor, Ervin; Shaw, Pang-Chui			Amino acid substitutions affecting aspartic acid 605 and valine 606 decrease the interaction strength between the influenza virus RNA polymerase PB2 '627' domain and the viral nucleoprotein	PLOS ONE			English	Article							STRUCTURAL INSIGHT; A VIRUSES; PROTEIN; REPLICATION; BINDING; IDENTIFICATION; MECHANISMS; ABSENCE	The influenza virus RNA genome is transcribed and replicated in the context of the viral ribonucleoprotein (vRNP) complex by the viral RNA polymerase. The nucleoprotein (NP) is the structural component of the vRNP providing a scaffold for the viral RNA. In the vRNP as well as during transcription and replication the viral polymerase interacts with NP but it is unclear which parts of the polymerase and NP mediate these interactions. Previously the C-terminal '627' domain (amino acids 538-693) of PB2 was shown to interact with NP. Here we report that a fragment encompassing amino acids 146-185 of NP is sufficient to mediate this interaction. Using NMR chemical shift perturbation assays we show that amino acid region 601 to 607 of the PB2 '627' domain interacts with this fragment of NP. Substitutions of these PB2 amino acids resulted in diminished RNP activity and surface plasmon resonance assays showed that amino acids D605 was essential for the interaction with NP and V606 may also play a partial role in the interaction. Collectively these results reveal a possible interaction surface between NP and the PB2 subunit of the RNA polymerase complex.	[Hsia, Ho-Pan; Yang, Yin-Hua; Szeto, Wun-Chung; Lo, Chun-Yeung; Ng, Andy Ka-Leung; Shaw, Pang-Chui] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Nilsson, Benjamin E.; Fodor, Ervin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England	Chinese University of Hong Kong; University of Oxford	Shaw, PC (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China.	pcshaw@cuhk.edu.hk	Nilsson-Payant, Benjamin/AAQ-5302-2020	Nilsson-Payant, Benjamin/0000-0003-2661-7837; Fodor, Ervin/0000-0003-3249-196X; Shaw, Pang-Chui/0000-0001-6848-5073	Research Grants Council of Hong Kong SAR [473111, T11-705/14N]; Area of Excellent Scheme of the University Grants Committee of HKSAR [AoE/M-12/06]; Medical Research Council (MRC) program grant [MR/K000241/1]; Wellcome Trust studentship [102053/Z/13/Z]; Medical Research Council [MR/K000241/1] Funding Source: researchfish; MRC [MR/K000241/1] Funding Source: UKRI	Research Grants Council of Hong Kong SAR(Hong Kong Research Grants Council); Area of Excellent Scheme of the University Grants Committee of HKSAR; Medical Research Council (MRC) program grant; Wellcome Trust studentship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant (Project number: 473111) from the Research Grants Council of Hong Kong SAR, in part from the Area of Excellent Scheme of the University Grants Committee of HKSAR (Grant AoE/M-12/06) on the Control of Pandemic and Inter-Pandemic Influenza and Theme-based Research from the Research Grants Council of Hong Kong SAR (T11-705/14N) to PC. S., Medical Research Council (MRC) program grant MR/K000241/1 to E.F. and Wellcome Trust studentship 102053/Z/13/Z to B.E. N. http://www.ugc.edu.hk/eng/rgc/; https://wellcome.ac.uk/; https://www.mrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; BEATON AR, 1986, P NATL ACAD SCI USA, V83, P6282, DOI 10.1073/pnas.83.17.6282; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Cauldwell AV, 2013, J VIROL, V87, P1278, DOI 10.1128/JVI.02597-12; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Goddard TD, 1993, SPARKY 3; Hengrung N, 2015, NATURE, V527, P114, DOI 10.1038/nature15525; Hutchinson EC, 2012, PLOS PATHOG, V8; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Li OTW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005658; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Ng AKL, 2012, PLOS ONE, V7; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Nilsson BE, 2017, J VIROL, V91, DOI [10.1128/JVI.02467-16, 10.1128/JVI.00523-17]; PALESE P, 1977, CELL, V10, P1, DOI 10.1016/0092-8674(77)90133-7; Paterson D, 2014, J VIROL, V88, P339, DOI 10.1128/JVI.02022-13; Pflug A., 2017, VIRUS RES; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; SHAPIRO GI, 1988, J VIROL, V62, P2285, DOI 10.1128/JVI.62.7.2285-2290.1988; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; te Velthuis AJW, 2016, NAT REV MICROBIOL, V14, P479, DOI 10.1038/nrmicro.2016.87; Turrell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2589; Vasin AV, 2014, VIRUS RES, V185, P53, DOI 10.1016/j.virusres.2014.03.015; Vidic J, 2016, BIOCHEMISTRY-US, V55, P4259, DOI 10.1021/acs.biochem.6b00514; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; York A, 2013, P NATL ACAD SCI USA, V110, pE4238, DOI 10.1073/pnas.1315068110	33	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191226	10.1371/journal.pone.0191226	http://dx.doi.org/10.1371/journal.pone.0191226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338047	Green Submitted, Green Published, gold			2022-12-27	WOS:000422652700041
J	Nakagawa, P; Romero, CA; Jiang, X; D'Ambrosio, M; Bordcoch, G; Peterson, EL; Harding, P; Yang, XP; Carretero, OA				Nakagawa, Pablo; Romero, Cesar A.; Jiang, Xu; D'Ambrosio, Martin; Bordcoch, Ginette; Peterson, Edward L.; Harding, Pamela; Yang, Xiao-Ping; Carretero, Oscar A.			Ac-SDKP decreases mortality and cardiac rupture after acute myocardial infarction	PLOS ONE			English	Article							ASPARTYL-LYSYL-PROLINE; HEART-FAILURE; HYPERTENSIVE-RATS; KNOCKOUT MICE; INFLAMMATION; MACROPHAGES; INHIBITION; ACTIVATION; FIBROSIS; REPAIR	The natural peptide N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) decreases inflammation in chronic diseases such as hypertension and heart failure. However, Ac-SDKP effects on acute inflammatory responses during myocardial infarction (MI) are unknown. During the first 72 hours post-MI, neutrophils, M1 macrophages (pro-inflammatory), and M2 macrophages (pro-resolution) and release of myeloperoxidase (MPO) and matrix metalloproteinases (MMP) are involved in cardiac rupture. We hypothesized that in the acute stage of MI, Ac-SDKP decreases the incidence of cardiac rupture and mortality by preventing immune cell infiltration as well as by decreasing MPO and MMP expression. MI was induced by ligating the left descending coronary artery in C57BL/6 mice. Vehicle or Ac-SDKP (1.6 mg/kg/d) was infused via osmotic minipump. Cardiac immune cell infiltration was assessed by flow cytometry, cardiac MPO and MMP levels were measured at 24-48 hrs post-MI. Cardiac rupture and mortality incidence were determined at 7 days post-MI. In infarcted mice, Ac-SDKP significantly decreased cardiac rupture incidence from 51.0% (26 of 51 animals) to 27.3% (12 of 44) and mortality from 56.9% (29 of 51) to 31.8% (14 of 44). Ac-SDKP reduced M1 macrophages in cardiac tissue after MI, without affecting M2 macrophages and neutrophils. Ac-SDKP decreased MMP-9 activation in infarcted hearts with no changes on MPO expression. Ac-SDKP prevents cardiac rupture and decreases mortality post-acute MI. These protective effects of Ac-SDKP are associated with decreased pro-inflammatory M1 macrophage infiltration and MMP-9 activation.	[Nakagawa, Pablo; Romero, Cesar A.; Jiang, Xu; D'Ambrosio, Martin; Bordcoch, Ginette; Harding, Pamela; Yang, Xiao-Ping; Carretero, Oscar A.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA; [Peterson, Edward L.] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Carretero, OA (corresponding author), Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA.	ocarret1@comcast.net			NIH [HL028982]; American Heart Association pre-doctoral fellowship [AHA 13PRE17100074]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association pre-doctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant HL028982 to Oscar A. Carretero, and American Heart Association pre-doctoral fellowship AHA 13PRE17100074 to Pablo Nakagawa.	Askari AT, 2003, J EXP MED, V197, P615, DOI 10.1084/jem.20021426; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Gonzalez GE, 2014, CLIN SCI, V126, P85, DOI 10.1042/CS20120619; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hinkel R, 2015, J MOL CELL CARDIOL, V87, P113, DOI 10.1016/j.yjmcc.2015.07.004; Hulsmans M, 2016, J MOL CELL CARDIOL, V93, P149, DOI 10.1016/j.yjmcc.2015.11.015; Liao TD, 2015, AM J PHYSIOL-RENAL, V308, pF1146, DOI 10.1152/ajprenal.00039.2015; Liao TD, 2010, HYPERTENSION, V55, P459, DOI 10.1161/HYPERTENSIONAHA.109.144568; Liu WX, 2015, CELL PHYSIOL BIOCHEM, V35, P2483, DOI 10.1159/000374048; Liu YH, 2002, HYPERTENSION, V39, P375, DOI 10.1161/hy02t2.102796; Ma XW, 2014, INT J CARDIOL, V175, P376, DOI 10.1016/j.ijcard.2014.05.016; Nakagawa P, 2012, AM J PHYSIOL-HEART C, V303, pH1114, DOI 10.1152/ajpheart.00300.2011; Omata M, 2006, J AM SOC NEPHROL, V17, P674, DOI 10.1681/ASN.2005040385; Peng HM, 2014, AM J PHYSIOL-HEART C, V307, pH741, DOI 10.1152/ajpheart.00129.2014; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Rhaleb NE, 2001, HYPERTENSION, V37, P827, DOI 10.1161/01.HYP.37.3.827; Sane DC, 2009, CARDIOL REV, V17, P293, DOI 10.1097/CRD.0b013e3181bf4ab4; Sharma U, 2008, AM J PHYSIOL-HEART C, V294, pH1226, DOI 10.1152/ajpheart.00305.2007; Shiraishi M, 2016, J CLIN INVEST, V126, P2151, DOI 10.1172/JCI85782; Wang DH, 2004, AM J PHYSIOL-HEART C, V287, pH2099, DOI 10.1152/ajpheart.00592.2004; Yan XX, 2013, J MOL CELL CARDIOL, V62, P24, DOI 10.1016/j.yjmcc.2013.04.023; Yang F, 2004, HYPERTENSION, V43, P229, DOI 10.1161/01.HYP.0000107777.91185.89; Yang XP, 1999, HYPERTENSION, V34, P24, DOI 10.1161/01.HYP.34.1.24; Zhu LP, 2016, AM J PHYSIOL-HEART C, V310, pH1176, DOI 10.1152/ajpheart.00252.2015	25	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0190300	10.1371/journal.pone.0190300	http://dx.doi.org/10.1371/journal.pone.0190300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364896	Green Published, Green Submitted, gold			2022-12-27	WOS:000423412500012
J	Li, YM; Zhou, CH; Li, J; Liu, JY; Lin, LM; Li, L; Cao, DL; Li, Q; Wang, Z				Li, Yumei; Zhou, Changhua; Li, Jing; Liu, Jiayu; Lin, Limin; Li, Li; Cao, Donglin; Li, Qing; Wang, Zhong			Single domain based bispecific antibody, Muc1-Bi-1, and its humanized form, Muc1-Bi-2, induce potent cancer cell killing in muc1 positive tumor cells	PLOS ONE			English	Article							T-CELLS; STRESS-RESPONSE; COLON-CANCER; PHASE-I; IMMUNOTHERAPY; CONSTRUCT; THERAPY; BLINATUMOMAB; EXPRESSION; PANKOMAB	Muc1 is one of the most studied tumor antigens. However, antibodies or antibody-toxin conjugates against Muc1 have not shown significant efficacy for tumors with Muc1 overexpression. In this study, we employed bispecific antibody approach to target Muc1 positive tumor cells. A novel bispecific antibody, Muc1-Bi-1, was constructed by linking single domain antibodies, anti-Muc1-VHH and anti-CD16-VHH. Muc1-Bi-2, the humanized form of Muc1-Bi-1, was also constructed by grafting. Both Muc1-Bi bispecific antibodies can be efficiently expressed and purified from bacteria. In vitro, the Muc1-Bi bispecific antibodies can recruit Natural Killer (NK) cells to drive potent and specific cell killing of Muc1-overexpressing tumor cells. In xenograft model, the Muc1-Bi bispecific antibodies can suppress tumor growth in the presence of human peripheral blood mononuclear cells (PBMC). These data suggested that the single domain based Muc1-Bi may provide a valid strategy for targeting tumors with Muc1 overexpression.	[Li, Yumei; Zhou, Changhua; Li, Jing; Liu, Jiayu; Lin, Limin; Li, Li; Li, Qing; Wang, Zhong] Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Li, Yumei; Zhou, Changhua; Li, Jing; Liu, Jiayu; Lin, Limin; Li, Li; Li, Qing; Wang, Zhong] Sun Yat Sen Univ, Ctr Cellular & Struct Biol, Guangzhou, Guangdong, Peoples R China; [Cao, Donglin] Guangdong Second Prov Gen Hosp, Dept Lab Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Li, Q; Wang, Z (corresponding author), Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.; Li, Q; Wang, Z (corresponding author), Sun Yat Sen Univ, Ctr Cellular & Struct Biol, Guangzhou, Guangdong, Peoples R China.	liqing66@mail.sysu.edu.cn; wangzh357@mail.sysu.edu.cn			Department of Science and Technology of Guangdong Province (P.R.China), China [20160503]	Department of Science and Technology of Guangdong Province (P.R.China), China	This work was supported by the Department of Science and Technology of Guangdong Province (P.R.China) (20160503), China.	[Anonymous], 1998, TUMOUR BIOL J INT S1, V19, P1; Azhdarzadeh M, 2016, COLLOID SURFACE B, V143, P224, DOI 10.1016/j.colsurfb.2016.02.058; Bachanova Veronika, 2014, Critical Reviews in Oncogenesis, V19, P133; Betge J, 2016, VIRCHOWS ARCH, V469, P255, DOI 10.1007/s00428-016-1970-5; Chen SQ, 2016, HUM VACC IMMUNOTHER, V12, P2491, DOI 10.1080/21645515.2016.1187802; Chiu ML, 2016, CURR OPIN STRUC BIOL, V38, P163, DOI 10.1016/j.sbi.2016.07.012; Danielczyk A, 2006, CANCER IMMUNOL IMMUN, V55, P1337, DOI 10.1007/s00262-006-0135-9; David JM, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1117738; Dong B, 2016, CANCER BIOL THER, V17, P364, DOI 10.1080/15384047.2016.1139266; Fiedler W, 2016, EUR J CANCER, V63, P55, DOI 10.1016/j.ejca.2016.05.003; Genitsch V, 2016, PROSTATE CANCER P D, V19, P242, DOI 10.1038/pcan.2016.11; Goebeler ME, 2016, J CLIN ONCOL, V34, P1104, DOI 10.1200/JCO.2014.59.1586; Goulart LR, 2004, REPROD BIOMED ONLINE, V8, P477, DOI 10.1016/S1472-6483(10)60933-9; Hiraki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26643; Ismaili A, 2007, BIOTECHNOL APPL BIOC, V47, P11, DOI 10.1042/BA20060071; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Kunert R, 2016, APPL MICROBIOL BIOT, V100, P3451, DOI 10.1007/s00253-016-7388-9; Lees Catherine J, 2016, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V37, P15, DOI 10.1515/prilozi-2016-0001; Li AF, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0201-4; Li L, 2015, J IMMUNOTHER, V38, P350, DOI 10.1097/CJI.0000000000000099; Lillehoj EP, 2004, AM J PHYSIOL-LUNG C, V287, pL809, DOI 10.1152/ajplung.00385.2003; Manoutcharian K, 2016, CURRENT NEUROPHARMAC; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Oak E, 2015, EXPERT OPIN INV DRUG, V24, P715, DOI 10.1517/13543784.2015.1021415; Oberst MD, 2014, MABS-AUSTIN, V6, P1571, DOI 10.4161/19420862.2014.975660; Posey AD, 2016, IMMUNITY, V44, P1444, DOI 10.1016/j.immuni.2016.05.014; Reis CA, 1998, INT J CANCER, V79, P402, DOI 10.1002/(SICI)1097-0215(19980821)79:4<402::AID-IJC16>3.0.CO;2-6; Reusch U, 2004, INT J CANCER, V112, P509, DOI 10.1002/ijc.20417; Rossi DL, 2014, MABS-AUSTIN, V6, P381, DOI 10.4161/mabs.27385; Rozan C, 2013, MOL CANCER THER, V12, P1481, DOI 10.1158/1535-7163.MCT-12-1012; Schlereth B, 2005, CANCER RES, V65, P2882, DOI 10.1158/0008-5472.CAN-04-2637; Singh R, 2007, CANCER BIOL THER, V6, P481, DOI 10.4161/cbt.6.4.4201; Souza-Fonseca-Guimaraes F, 2016, DISCOV MED, V21, P197; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Zhu M, 2016, CLIN PHARMACOKINET, V55, P1271, DOI 10.1007/s40262-016-0405-4	36	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191024	10.1371/journal.pone.0191024	http://dx.doi.org/10.1371/journal.pone.0191024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357376	Green Submitted, Green Published, gold			2022-12-27	WOS:000422919500009
J	Britch, SC; Linthicum, KJ; Aldridge, RL; Breidenbaugh, MS; Latham, MD; Connelly, PH; Rush, MJE; Remmers, JL; Kerce, JD; Silcox, CA				Britch, Seth C.; Linthicum, Kenneth J.; Aldridge, Robert L.; Breidenbaugh, Mark S.; Latham, Mark D.; Connelly, Peter H.; Rush, Mattie J. E.; Remmers, Jennifer L.; Kerce, Jerry D.; Silcox, Charles A.		US Navy Entomology Ctr Ex	Aerial ULV control of Aedes aegypti with naled (Dibrom) inside simulated rural village and urban cryptic habitats	PLOS ONE			English	Article							LOW-VOLUME APPLICATIONS; THERMAL FOG; ZIKA VIRUS; INSECTICIDE; DIPTERA; DENGUE; TRANSMISSION; PERFORMANCE; CULICIDAE; EFFICACY	We conducted aerial fixed wing ultra low volume (ULV) spray trials with naled to investigate penetration of exposed and simulated cryptic habitat within opened buildings, partially sealed buildings, and outdoor locations targeting sentinel adult Aedes aegypti mosquitoes in north central Florida. Mortality was observed in open and closed buildings and outdoors, even in mosquitoes placed in cryptic habitats. Observations on the impact of building type, mosquito exposure method such as placement in cryptic habitat, and spray nozzle size on mosquito mortality are described and analyzed.	[Britch, Seth C.; Linthicum, Kenneth J.; Aldridge, Robert L.; Rush, Mattie J. E.] ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Breidenbaugh, Mark S.; Remmers, Jennifer L.] Youngstown Air Reserve Stn, Aerial Spray Branch, 910 Airlift Wing,757 Airlift Squadron, Vienna, OH USA; [Latham, Mark D.] Manatee Cty Mosquito Control Dist, West Palmetto, FL USA; [Connelly, Peter H.; Silcox, Charles A.] AMVAC Environm Prod, Newport Beach, CA USA; [Kerce, Jerry D.] Camp Blanding Joint Training Ctr, Starke, FL USA; [US Navy Entomology Ctr Ex] US Navy, Entomol Ctr Excellence, Naval Air Stn, Jacksonville, FL USA	United States Department of Agriculture (USDA); United States Department of Defense; United States Navy; US Navy Naval Air Systems Command	Britch, SC (corresponding author), ARS, USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.	seth.britch@ars.usda.gov	Aldridge, Robert L./J-9828-2019	Aldridge, Robert L./0000-0001-7656-365X	US Department of Agriculture, Agricultural Research Service [NP-104, 6036-32000-050-00D]; Department of Defense Deployed Warfighter Protection Program Project [6036-32000-050-671]; US Department of Defense (DOD) Deployed War-Fighter Protection Program (DWFP)	US Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Department of Defense Deployed Warfighter Protection Program Project; US Department of Defense (DOD) Deployed War-Fighter Protection Program (DWFP)(United States Department of Defense)	Funding from the US Department of Agriculture, Agricultural Research Service NP-104, Project 6036-32000-050-00D and the Department of Defense Deployed Warfighter Protection Program Project 6036-32000-050-671. AMVAC Environmental Products provided support in the form of salaries for authors (PHC and CAS) and provided Dibrom. The specific roles of these authors are articulated in the "author contributions" section. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The membership of the US Navy Entomology Center of Excellence Team was (alphabetically) Hanayo Arimoto, Christopher Dooling, Carl Doud, Kevin Justice, Jennifer Knapp, Marcus McDonough, Peter Nunn, Dominick Spatola, Paulo Torresalvarado, Brent Turnwall, Matthew Yans. We thank Bryan Smith and Christopher Swain (USDA-ARS-CMAVE) for expert production of insectary specimens for this study. This research was supported by the US Department of Agriculture (USDA)-Agricultural Research Service and the US Department of Defense (DOD) Deployed War-Fighter Protection Program (DWFP). Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA, the DOD, the US Navy, the US Air Force, the Florida Army National Guard, or the DWFP. The USDA is an equal opportunity provider and employer.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; AFREHNUAMAH K, 1988, INSECT SCI APPL, V9, P629, DOI 10.1017/S1742758400005129; Aldridge RL, 2012, J AM MOSQUITO CONTR, V28, P65, DOI 10.2987/11-6195.1; Alto BW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005724; BILANIN AJ, 1989, T ASAE, V32, P327; Bonds JAS, 2009, J AM MOSQUITO CONTR, V25, P474, DOI 10.2987/09-5882.1; Breidenbaugh M, 2009, ARMY MED DEP J   JUL, P1; Britch SC, 2011, J MED ENTOMOL, V48, P1145, DOI 10.1603/ME11025; Britch SC, 2010, J AM MOSQUITO CONTR, V26, P183, DOI 10.2987/09-5948.1; Burkett DA, 1996, J AM MOSQUITO CONTR, V12, P380; Chaskopoulou A, 2011, J AM MOSQUITO CONTR, V27, P414, DOI 10.2987/11-6177.1; Chen Y. S., 1984, Journal of the Florida Anti-Mosquito Association, V55, P46; Clark G. G., 1989, Arbovirus research in Australia. Proceedings Fifth Symposium, August 28-September 1, 1989, Brisbane, Australia., P192; Conlon J. M., 1990, Journal of the Florida Anti-Mosquito Association, V61, P19; Cooper JF, 1996, CROP PROT, V15, P249, DOI 10.1016/0261-2194(95)00113-1; Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x; Farooq M, 2013, J AM MOSQUITO CONTR, V29, P389, DOI 10.2987/13-6333.1; Fritz B. K., 2008, AGR ENG, VX, P10; FUKUTO T. R., 1971, Pesticides in the environment. Volume 1, Part I., V1, P145; GRATZ NG, 1991, J AM MOSQUITO CONTR, V7, P353; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Hudson J E, 1986, Bull Pan Am Health Organ, V20, P294; Jokanovic M, 2001, TOXICOLOGY, V166, P139, DOI 10.1016/S0300-483X(01)00463-2; Koenraadt CJM, 2007, J MED ENTOMOL, V44, P65, DOI 10.1603/0022-2585(2007)44[65:SATPIT]2.0.CO;2; Kramer LD, 2017, INNOVATIVE APPROACH; Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1; LOFGREN CS, 1970, B WORLD HEALTH ORGAN, V42, P15; Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745; Matthews G. A., 1996, Pesticide Outlook, V7, P24; Merk W, 1971, WHOVBC71317; Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601; Newhart K., 2006, ENV FATE MALATHION; Phanthumachinda B, 1976, WHOVBC76651117; Ponlawat A, 2017, J AM MOSQUITO CONTR, V33, P116, DOI 10.2987/16-6594.1; Reiter I. P., 1989, Arbovirus research in Australia. Proceedings Fifth Symposium, August 28-September 1, 1989, Brisbane, Australia., P192; Reiter P., 1992, Journal of the American Mosquito Control Association, V8, P315; Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; SUNDARAM A, 1991, J ENVIRON SCI HEAL B, V26, P115, DOI 10.1080/03601239109372727; Teske ME, 1999, ASAE CSAE SCGR ANN I; Travis BV, 1968, P 55 ANN M NEW JERS, V55, P122; United States of America Department of Health and Human Services Centers for Disease Control and Prevention, 1987, EFF AER APPL DIBR 14; WHO Pesticide Evaluation Scheme (WHOPES) Communicable Disease Control Prevention and Eradication, 2003, SPAC SPRAY APPL INS; Wooster M. T., 1989, Journal of the Florida Anti-Mosquito Association, V60, P62	44	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191555	10.1371/journal.pone.0191555	http://dx.doi.org/10.1371/journal.pone.0191555			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352307	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300113
J	Gerli, MFM; Guyette, JP; Evangelista-Leite, D; Ghoshhajra, BB; Ott, HC				Gerli, Mattia Francesco Maria; Guyette, Jacques Paul; Evangelista-Leite, Daniele; Ghoshhajra, Brian Burns; Ott, Harald Christian			Perfusion decellularization of a human limb: A novel platform for composite tissue engineering and reconstructive surgery	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ORTHOTOPIC TRANSPLANTATION; BIOLOGIC SCAFFOLD; MATRIX; REGENERATION; FLAPS; GENERATION; DESIGN	Muscle and fasciocutaneous flaps taken from autologous donor sites are currently the most utilized approach for trauma repair, accounting annually for 4.5 million procedures in the US alone. However, the donor tissue size is limited and the complications related to these surgical techniques lead to morbidities, often involving the donor sites. Alternatively, recent reports indicated that extracellular matrix (ECM) scaffolds boost the regenerative potential of the injured site, as shown in a small cohort of volumetric muscle loss patients. Perfusion decellularization is a bioengineering technology that allows the generation of clinical-scale ECM scaffolds with preserved complex architecture and with an intact vascular template, from a variety of donor organs and tissues. We recently reported that this technology is amenable to generate full composite tissue scaffolds from rat and non-human primate limbs. Translating this platform to human extremities could substantially benefit soft tissue and volumetric muscle loss patients providing tissue-and species-specific grafts. In this proof-ofconcept study, we show the successful generation a large-scale, acellular composite tissue scaffold from a full cadaveric human upper extremity. This construct retained its morphological architecture and perfusable vascular conduits. Histological and biochemical validation confirmed the successful removal of nuclear and cellular components, and highlighted the preservation of the native extracellular matrix components. Our results indicate that perfusion decellularization can be applied to produce human composite tissue acellular scaffolds. With its preserved structure and vascular template, these biocompatible constructs, could have significant advantages over the currently implanted matrices by means of nutrient distribution, size-scalability and immunological response.	[Gerli, Mattia Francesco Maria; Guyette, Jacques Paul; Evangelista-Leite, Daniele; Ott, Harald Christian] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Gerli, Mattia Francesco Maria; Guyette, Jacques Paul; Ghoshhajra, Brian Burns; Ott, Harald Christian] Harvard Med Sch, Boston, MA 02115 USA; [Ghoshhajra, Brian Burns] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Ghoshhajra, Brian Burns] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Ott, Harald Christian] Massachusetts Gen Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02114 USA; [Ott, Harald Christian] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Gerli, Mattia Francesco Maria] UCL, Great Ormond St Inst Child Hlth, London, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of London; University College London	Ott, HC (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.; Ott, HC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Ott, HC (corresponding author), Massachusetts Gen Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02114 USA.; Ott, HC (corresponding author), Harvard Stem Cell Inst, Boston, MA 02115 USA.	hott@mgh.harvard.edu	Gerli, Mattia Francesco Maria/AAL-2430-2021; da Silva, Daniele Evangelista Leite/AAK-8662-2020; Ghoshhajra, Brian/J-2114-2016	Gerli, Mattia Francesco Maria/0000-0002-9331-7394; da Silva, Daniele Evangelista Leite/0000-0002-2755-0091; Ghoshhajra, Brian/0000-0002-3865-3432	National Institute of Health [NIH 2 U42 0 D011158, NIH P30 AR066261]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011158] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by departmental funds. The National Disease Research Interchange and the MGH Skeletal core facilities received support from the National Institute of Health with the grants NIH 2 U42 0 D011158 and NIH P30 AR066261, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Philipp T. Moser, Jonathan M. Charest, Sarah E. Gilpin, Antonio Citro, Xi Ren and Claire M. Crowley for the helpful discussions. We acknowledge the use of tissues procured by the National Disease Research Interchange (NDRI; NIH 2 U42 OD011158) and thank the MGH Skeletal Core Facility for the mu CT scan and analysis (NIH P30 AR066261).	Agostini T, 2013, J CRANIO MAXILL SURG, V41, P15, DOI 10.1016/j.jcms.2012.05.003; ASPS ASoPS, 2017, 2016 PLAST SURG STAT; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Brewer MB, 2015, AM SURGEON, V81, P1163; Charest JM, 2015, BIOMATERIALS, V52, P79, DOI 10.1016/j.biomaterials.2015.02.016; Chaturvedi V, 2016, J TISSUE ENG REGENER; Chiron S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036173; Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001; Corona BT, 2016, BIOMATERIALS, V104, P238, DOI 10.1016/j.biomaterials.2016.07.020; Corona BT, 2013, BIOMATERIALS, V34, P3324, DOI 10.1016/j.biomaterials.2013.01.061; Cossu G, 2015, EMBO MOL MED, V7, P1513, DOI 10.15252/emmm.201505636; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dimitrievska S, 2015, ACTA BIOMATER, V13, P177, DOI 10.1016/j.actbio.2014.11.015; Duisit J, 2017, ANN SURG, V266, P754, DOI 10.1097/SLA.0000000000002396; Dziki J, 2016, NPJ REGEN MED, V1, DOI 10.1038/npjregenmed.2016.8; Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006; Freedman BR, 2015, BBA-MOL CELL RES, V1853, P3153, DOI 10.1016/j.bbamcr.2015.04.015; Fuoco C, 2015, EMBO MOL MED, V7, P411, DOI 10.15252/emmm.201404062; Garg K, 2014, CELL TISSUE RES, V358, P857, DOI 10.1007/s00441-014-2006-6; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gilpin A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9831534; Gilpin SE, 2014, J HEART LUNG TRANSPL, V33, P298, DOI 10.1016/j.healun.2013.10.030; Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007; Guyette JP, 2016, CIRC RES, V118, P56, DOI 10.1161/CIRCRESAHA.115.306874; Guyette JP, 2014, NAT PROTOC, V9, P1451, DOI 10.1038/nprot.2014.097; Hajimiri M, 2015, J BIOMED MATER RES A, V103, P819, DOI 10.1002/jbm.a.35193; Hitchcock T, 2008, ANN NY ACAD SCI, V1131, P44, DOI 10.1196/annals.1413.004; Hwang JM, 2017, ACTA BIOMATER, V53, P268, DOI 10.1016/j.actbio.2017.01.079; Jank BJ, 2017, TISSUE ENG PT A, V23, P696, DOI [10.1089/ten.tea.2016.0487, 10.1089/ten.TEA.2016.0487]; Jank BJ, 2015, BIOMATERIALS, V61, P246, DOI 10.1016/j.biomaterials.2015.04.051; Juhas M, 2016, METHODS, V99, P81, DOI 10.1016/j.ymeth.2015.10.002; Kitano K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00779-y; Klebuc Michael, 2013, Methodist Debakey Cardiovasc J, V9, P95; Ko SH, 2015, J VASC SURG, V61, P1521, DOI 10.1016/j.jvs.2015.01.036; Lee SH, 2016, CLIN ORTHOP SURG, V8, P444, DOI 10.4055/cios.2016.8.4.444; Madden L, 2015, ELIFE, V4, DOI 10.7554/eLife.04885; Marino D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006894; Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24; Mast BA, 1996, ANN PLAS SURG, V36, P569, DOI 10.1097/00000637-199606000-00002; Mazza G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13079; McDiarmid SV, 2011, HAND CLIN, V27, P545, DOI 10.1016/j.hcl.2011.08.007; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Peloso A, 2016, ANN SURG, V264, P169, DOI 10.1097/SLA.0000000000001364; Perniconi B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00255; Piccoli M, 2016, BIOMATERIALS, V74, P245, DOI 10.1016/j.biomaterials.2015.10.005; Porzionato A, 2015, INT J MOL SCI, V16, P14808, DOI 10.3390/ijms160714808; Ren X, 2015, NAT BIOTECHNOL, V33, P1097, DOI 10.1038/nbt.3354; Richard PL, 2010, CELL TRANSPLANT, V19, P67, DOI [10.3727/096368909X578812, 10.3727/096368909X478812]; Schaverien MV, 2014, HAND CLIN, V30, P165, DOI 10.1016/j.hcl.2014.01.001; Shandalov Y, 2014, P NATL ACAD SCI USA, V111, P6010, DOI 10.1073/pnas.1402679111; Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085; Siemionow MZ, 2011, ANN PLAS SURG, V66, P410, DOI 10.1097/SAP.0b013e3182121db9; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Swiontkowski MF, 2002, J TRAUMA, V52, P641, DOI 10.1097/00005373-200204000-00005; Tedesco FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002342; Teodori L, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00218; Urbani L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179341; Werner NL, 2017, TRANSPLANTATION, V101, pe68, DOI 10.1097/TP.0000000000001500; Zhang J, 2016, BIOMATERIALS, V89, P114, DOI 10.1016/j.biomaterials.2016.02.040; Zhou H, 2017, ANN SURG	62	34	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191497	10.1371/journal.pone.0191497	http://dx.doi.org/10.1371/journal.pone.0191497			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352303	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300099
J	Greiner, S; Jud, A; Aurich, M; Geisenberger, C; Uhlmann, L; Hilbel, T; Kieser, M; Katus, HA; Mereles, D				Greiner, Sebastian; Jud, Andreas; Aurich, Matthias; Geisenberger, Christoph; Uhlmann, Lorenz; Hilbel, Thomas; Kieser, Meinhard; Katus, Hugo A.; Mereles, Derliz			Prognostic relevance of elevated pulmonary arterial pressure assessed non-invasively: Analysis in a large patient cohort with invasive measurements in near temporal proximity	PLOS ONE			English	Article							DOPPLER-ECHOCARDIOGRAPHY; HEART-FAILURE; EUROPEAN ASSOCIATION; SYSTOLIC PRESSURES; AMERICAN SOCIETY; HYPERTENSION; DIAGNOSIS; REGISTRY; CATHETERIZATION; GUIDELINES	Background The clinical relevance of non-invasively derived pulmonary arterial pressure (PAP) by Doppler echocardiography (DE) has been questioned in the past. However, transthoracic echocardiography is used as a cornerstone examination for patients with dyspnea and suspected pulmonary hypertension (PH). This study aimed to evaluate the prognostic value of non-invasive assessed PAP in a large population of patients with known or suspected cardiopulmonary disease. Methods The analyses are based on data of patients of a tertiary cardiology center that received right heart catheterization (RHC) as well as non-invasively assessed PAP by DE within five days, and includes serological and clinical parameters in a retrospective follow-up for up to eight years. Results Of 1,237 patients, clinical follow-up was possible in 1,038 patients who were included in the statistical analysis. The mean-follow up time was 1,002 days. The composite endpoint of heart transplantation (HTx) or death occurred in n = 308 patients. Elevated PAP measured non-invasively as well as invasively had significant prognostic impact (hazard ratio (HR) 2.32; 95% confidence interval (CI) 1.78-3.04; chi(2) = 37.9; p<0.001 versus HR 2.84; 95% CI 2.11-3.82; chi(2) = 51.9; p<0.001, respectively). By multivariate analysis, NYHA functional class, N-terminal pro-brain natriuretic peptide, cardiac troponin T, left ventricular ejection fraction, and right ventricular dysfunction remained independently predictive. Incremental prognostic information in a multimodal approach was highly relevant. Conclusions In this comprehensive study, elevated pulmonary arterial pressure measured by DE offers similar prognostic information on survival or need for HTx as right heart catheterization. Furthermore, the addition of functional capacity and serological biomarkers delivered incremental prognostic information.	[Greiner, Sebastian; Jud, Andreas; Aurich, Matthias; Hilbel, Thomas; Katus, Hugo A.; Mereles, Derliz] Heidelberg Univ, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany; [Geisenberger, Christoph] Heidelberg Univ, Div Expt Neurosurg, Heidelberg, Germany; [Uhlmann, Lorenz; Kieser, Meinhard] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Greiner, S (corresponding author), Heidelberg Univ, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany.	sebastian.greiner@med.uni-heidelberg.de	Uhlmann, Lorenz/AAL-9839-2020; Aurich, Matthias/ABF-6976-2021	Mereles, Derliz/0000-0001-9601-7103				Amsallem M, 2016, J AM SOC ECHOCARDIOG, V29, P93, DOI 10.1016/j.echo.2015.11.001; Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Batal O, 2012, AM J CARDIOL, V109, P1514, DOI 10.1016/j.amjcard.2012.01.366; Bossone E, 2013, J AM SOC ECHOCARDIOG, V26, P1, DOI 10.1016/j.echo.2012.10.009; Bursi F, 2012, J AM COLL CARDIOL, V59, P222, DOI 10.1016/j.jacc.2011.06.076; Carbone R, 2005, Eur Rev Med Pharmacol Sci, V9, P331; Coghlan JG, 2014, ANN RHEUM DIS, V73, P1340, DOI 10.1136/annrheumdis-2013-203301; D'Alto M, 2013, INT J CARDIOL, V168, P4058, DOI 10.1016/j.ijcard.2013.07.005; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Farber HJ, 2015, CHEST, V148, P573, DOI 10.1378/chest.15-0767; Galie N, 2015, EUR RESPIR J, V46, P903, DOI 10.1183/13993003.01032-2015; Galie N, 2013, J AM COLL CARDIOL, V62, pD1, DOI 10.1016/j.jacc.2013.10.030; Giannitsis E, 2009, HERZ, V34, P600, DOI 10.1007/s00059-009-3306-6; Greiner S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001103; Kalogeropoulos AP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000363; Kiatchoosakun S, 2011, CLIN CARDIOL, V34, P488, DOI 10.1002/clc.20920; KIRCHER BJ, 1990, AM J CARDIOL, V66, P493, DOI 10.1016/0002-9149(90)90711-9; Kusunose K, 2013, CIRC-CARDIOVASC IMAG, V6, P167, DOI 10.1161/CIRCIMAGING.112.000162; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lewis GD, 2009, J AM COLL CARDIOL, V53, P1127, DOI 10.1016/j.jacc.2009.01.006; Mahapatra S, 2006, J AM SOC ECHOCARDIOG, V19, P1045, DOI 10.1016/j.echo.2006.03.008; Matthan NR, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005066; Merlos P, 2013, EUR J INTERN MED, V24, P562, DOI 10.1016/j.ejim.2013.04.009; Opitz CF, 2016, J AM COLL CARDIOL, V68, P368, DOI 10.1016/j.jacc.2016.05.047; Rich JD, 2013, CHEST, V143, P1536, DOI 10.1378/chest.13-0297; Rich JD, 2011, CHEST, V139, P988, DOI 10.1378/chest.10-1269; Rudski LG, 2013, CHEST, V143, P1533, DOI 10.1378/chest.13-0296; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Shapiro S, 2012, CHEST, V141, P363, DOI 10.1378/chest.10-3114; Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992; Vachiery JL, 2013, J AM COLL CARDIOL, V62, pD100, DOI 10.1016/j.jacc.2013.10.033; Wood AM, 2008, STAT MED, V27, P3227, DOI 10.1002/sim.3177	33	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191206	10.1371/journal.pone.0191206	http://dx.doi.org/10.1371/journal.pone.0191206			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351312	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300057
J	Keenan, KG; Senefeld, JW; Hunter, SK				Keenan, Kevin G.; Senefeld, Jonathon W.; Hunter, Sandra K.			Girls in the boat: Sex differences in rowing performance and participation	PLOS ONE			English	Article							GENDER; MEN; RUNNERS; WOMEN; AGE; COMPETITIVENESS; EVOLUTION; DISTANCE; MASS	Men outperform women in many athletic endeavors due to physiological and anatomical differences (e.g. larger and faster muscle); however, the observed sex differences in elite athletic performance are typically larger than expected, and may reflect sex-related differences in opportunity or incentives. As collegiate rowing in the United States has been largely incentivized for women over the last 20 years, but not men, the purpose of this study was to examine sex differences in elite rowing performance over that timeframe. Finishing times from grand finale races for collegiate championship on-water performances (n = 480) and junior indoor performances (n = 1,280) were compared between men and women across 20 years (1997 +/- 2016), weight classes (heavy vs. lightweight) and finishing place. Participation of the numbers of men and women rowers were also quantified across years. Men were faster than women across all finishing places, weight classes and years of competition and performance declined across finishing place for both men and women (P<0.001). Interestingly, the reduction in performance time across finishing place was greater (P<0.001) for collegiate men compared to women in the heavyweight division. This result is opposite to other sports (e.g. running and swimming), and to lightweight rowing in this study, which provides women fewer incentives than in heavyweight rowing. Correspondingly, participation in collegiate rowing has increased by similar to 113 women per year (P<0.001), with no change (P = 0.899) for collegiate men. These results indicate that increased participation and incentives within collegiate rowing for women vs. men contribute to sex differences in athletic performance.	[Keenan, Kevin G.] Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA; [Keenan, Kevin G.] Univ Wisconsin, Ctr Aging & Translat Res, Milwaukee, WI 53201 USA; [Senefeld, Jonathon W.; Hunter, Sandra K.] Marquette Univ, Dept Phys Therapy, Milwaukee, WI 53233 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; Marquette University	Keenan, KG (corresponding author), Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA.; Keenan, KG (corresponding author), Univ Wisconsin, Ctr Aging & Translat Res, Milwaukee, WI 53201 USA.	keenan@uwm.edu	Senefeld, Jack/ABF-1286-2020	Senefeld, Jonathon/0000-0001-8116-3538				Anderson T, 1996, SPORTS MED, V22, P76, DOI 10.2165/00007256-199622020-00003; Deaner RO, 2006, EVOL HUM BEHAV, V27, P63, DOI 10.1016/j.evolhumbehav.2005.04.005; Deaner RO., 2016, EVOL BEHAV SCI, V10, P73, DOI [DOI 10.1037/EBS0000049, 10.1037/ebs0000049]; Deaner RO, 2015, MED SCI SPORT EXER, V47, P607, DOI 10.1249/MSS.0000000000000432; Deaner RO, 2014, EVOL PSYCHOL-US, V12, P848, DOI 10.1177/147470491401200501; Deaner RO, 2013, ARCH SEX BEHAV, V42, P413, DOI 10.1007/s10508-012-9965-z; Deaner RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049168; Deaner RO, 2011, EVOL PSYCHOL-US, V9, P600; Geary DC, 2003, DEV REV, V23, P444, DOI 10.1016/j.dr.2003.08.001; Hunter SK, 2016, MED SCI SPORT EXER, V48, P2247, DOI 10.1249/MSS.0000000000000928; Hunter SK, 2013, MED SCI SPORT EXER, V45, P148, DOI 10.1249/MSS.0b013e31826900f6; Hunter SK, 2011, MED SCI SPORT EXER, V43, P656, DOI 10.1249/MSS.0b013e3181fb4e00; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Joyner M J, 1993, Exerc Sport Sci Rev, V21, P103; Lepers R, 2011, MED SCI SPORT EXER, V43, P134, DOI 10.1249/MSS.0b013e3181e57997; MAYHEW JL, 1990, EUR J APPL PHYSIOL, V60, P133, DOI 10.1007/BF00846033; McDonald MM, 2012, PHILOS T R SOC B, V367, P670, DOI 10.1098/rstb.2011.0301; NCAA, 2015, STUD ATHL PART NCAA; Rust CA, 2013, PERCEPT MOTOR SKILL, V116, P690, DOI 10.2466/30.06.PMS.116.2.690-706; Seiler S, 2007, MED SCI SPORT EXER, V39, P534, DOI 10.1249/01.mss.0000247005.17342.2b; Senefeld J, 2016, SCAND J MED SCI SPOR, V26, P17, DOI 10.1111/sms.12412; Senefeld J, 2016, INT J SPORT PHYSIOL, V11, P635, DOI 10.1123/ijspp.2015-0418; SPARLING PB, 1980, RES Q EXERCISE SPORT, V51, P542, DOI 10.1080/02701367.1980.10608077; Stefani RT, 2006, J SPORT SCI, V24, P1329, DOI 10.1080/02640410500520559; Unterweger CM, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2209-2; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0; Zamparo P, 2006, EUR J APPL PHYSIOL, V97, P52, DOI 10.1007/s00421-006-0133-9	27	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191504	10.1371/journal.pone.0191504	http://dx.doi.org/10.1371/journal.pone.0191504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352279	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300101
J	Collaco, JM; Appel, LJ; McGready, J; Cutting, GR				Collaco, Joseph M.; Appel, Lawrence J.; McGready, John; Cutting, Garry R.			The relationship of lung function with ambient temperature	PLOS ONE			English	Article							AIR-POLLUTION; PULMONARY-FUNCTION; PHYSICAL-ACTIVITY; UNITED-STATES; EXPOSURE; HERITABILITY; POPULATION; PREVALENCE; MORTALITY; CHILDREN	Background Lung function is complex trait with both genetic and environmental factors contributing to variation. It is unknown how geographic factors such as climate affect population respiratory health. Objective To determine whether ambient air temperature is associated with lung function (FEV1) in the general population. Design/Setting Associations between spirometry data from two National Health and Nutrition Examination Survey (NHANES) periods representative of the U.S. non-institutionalized population and mean annual ambient temperature were assessed using survey-weighted multivariate regression. Participants/Measurements The NHANES III (1988-94) cohort included 14,088 individuals (55.6% female) and the NHANES 2007-12 cohort included 14,036 individuals (52.3% female), with mean ages of 37.4 +/- 23.4 and 34.4 +/- 21.8 years old and FEV1 percent predicted values of 99.8 +/- 15.8% and 99.2 +/- 14.5%, respectively. Results After adjustment for confounders, warmer ambient temperatures were associated with lower lung function in both cohorts (NHANES III p = 0.020; NHANES 2007-2012 p = 0.014). The effect was similar in both cohorts with a 0.71% and 0.59% predicted FEV1 decrease for every 10'F increase in mean temperature in the NHANES III and NHANES 2007-2012 cohorts, respectively. This corresponds to similar to 2 percent predicted difference in FEV1 between the warmest and coldest regions in the continental United States. Conclusions In the general U.S. population, residing in regions with warmer ambient air temperatures was associated with lower lung function with an effect size similar to that of traffic pollution. Rising temperatures associated with climate change could have effects on pulmonary function in the general population.	[Collaco, Joseph M.; Appel, Lawrence J.; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Appel, Lawrence J.; McGready, John] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Collaco, JM (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	mcollac1@jhmi.edu	Appel, Larry/GLT-2608-2022		National Institutes of Health [R01HL128475, R01DK044003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health (https://projectreporter.nih.gov/ reporter.cfm) (R01HL128475 [JMC] and R01DK044003 [GRC]), which did not have any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Adam M, 2015, EUR RESPIR J, V45, P38, DOI 10.1183/09031936.00130014; Adjemian J, 2014, AM J RESP CRIT CARE, V190, P581, DOI 10.1164/rccm.201405-0884OC; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; Barone-Adesi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142565; BERKEY CS, 1986, AM J EPIDEMIOL, V123, P250, DOI 10.1093/oxfordjournals.aje.a114233; Bernstein AS, 2013, CHEST, V143, P1455, DOI 10.1378/chest.12-2384; Bowatte G, 2016, J ALLERGY CLIN IMMUN; Carlsen HK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007624; Collaco JM, 2016, J CYST FIBROS; Collaco JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027784; Czogala J, 2014, NICOTINE TOB RES, V16, P655, DOI 10.1093/ntr/ntt203; D'Amato G, 2015, MULTIDISCIP RESP MED, V10, DOI 10.1186/s40248-015-0036-x; ESCHENBACHER WL, 1992, LUNG, V170, P51, DOI 10.1007/BF00164755; Fatima SS, 2013, J PAK MED ASSOC, V63, P310; Gauderman WJ, 2007, LANCET, V369, P571, DOI 10.1016/S0140-6736(07)60037-3; GHIO AJ, 1989, CHEST, V96, P743, DOI 10.1378/chest.96.4.743; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hansel NN, 2015, CMA EVOLUTION STRATE, P1; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Hukkinen M, 2011, TWIN RES HUM GENET, V14, P401, DOI 10.1375/twin.14.5.401; Kan HD, 2007, THORAX, V62, P873, DOI 10.1136/thx.2006.073015; Kosacz Nicole M., 2012, Morbidity and Mortality Weekly Report, V61, P938; Li SS, 2014, EUR RESPIR J, V43, P1059, DOI 10.1183/09031936.00079313; Li SS, 2014, ANN ALLERG ASTHMA IM, V112, P348, DOI 10.1016/j.anai.2014.01.007; Martin SL, 2005, J RURAL HEALTH, V21, P239, DOI 10.1111/j.1748-0361.2005.tb00089.x; MCCLEARN GE, 1994, J GERONTOL, V49, pM264, DOI 10.1093/geronj/49.6.M264; Miller MR, 2009, RESP MED, V103, P442, DOI 10.1016/j.rmed.2008.09.016; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mireku N, 2009, ANN ALLERG ASTHMA IM, V103, P220, DOI 10.1016/S1081-1206(10)60185-8; Moritsugu KP, 2007, AM J PREV MED, V32, P542, DOI 10.1016/j.amepre.2007.02.026; National Center for Health Statistics, SPEC WEIGHT PAR; Rice MB, 2015, AM J RESP CRIT CARE, V191, P656, DOI 10.1164/rccm.201410-1875OC; Rice MB, 2015, AM J RESP CRIT CARE; Schultzl ES, 2016, AM J RESP CRIT CARE, V193, P171, DOI 10.1164/rccm.201505-0928OC; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Shi LH, 2015, NAT CLIM CHANGE, V5, P988, DOI 10.1038/NCLIMATE2704; Singh GK, 2009, J PHYS ACT HEALTH, V6, P73, DOI 10.1123/jpah.6.1.73; Stocker T F, 2013, CLIM CHANG 2013 PHYS; von Glasow R, 2013, AMBIO, V42, P13, DOI 10.1007/s13280-012-0343-9; Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; WHO, 2014, WHO GUID IND AIR QUA; XU XP, 1991, ARCH ENVIRON HEALTH, V46, P198, DOI 10.1080/00039896.1991.9937448; Zhai GJ, 2007, CHEST, V132, P1772, DOI 10.1378/chest.07-1438	44	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191409	10.1371/journal.pone.0191409	http://dx.doi.org/10.1371/journal.pone.0191409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346418	Green Submitted, gold, Green Published			2022-12-27	WOS:000422749500047
J	Hollingsworth, LR; Brown, AM; Gandour, RD; Bevan, DR				Hollingsworth, Louis R.; Brown, Anne M.; Gandour, Richard D.; Bevan, David R.			Computational study of HIV gp120 as a target for polyanionic entry inhibitors: Exploiting the V3 loop region	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PARTICLE MESH EWALD; PROTEIN FORCE-FIELD; CRYO-EM STRUCTURE; MOLECULAR-DYNAMICS; ENVELOPE GLYCOPROTEINS; STRUCTURAL DYNAMICS; ENV TRIMER; ANTIBODY; RECEPTOR	Multiple approaches are being utilized to develop therapeutics to treat HIV infection. One approach is designed to inhibit entry of HIV into host cells, with a target being the viral envelope glycoprotein, gp120. Polyanionic compounds have been shown to be effective in inhibiting HIV entry, with a mechanism involving electrostatic interactions with the V3 loop of gp120 being proposed. In this study, we applied computational methods to elucidate molecular interactions between the repeat unit of the precisely alternating polyanion, Poly(4,4'-stil-benedicarboxylate-alt-maleic acid) (DCSti-alt-MA) and the V3 loop of gp120 from strains of HIV against which these polyanions were previously tested (IIIb, BaL, 92UG037, JR-CSF) as well as two strains for which gp120 crystal structures are available (YU2, 2B4C). Homology modeling was used to create models of the gp120 proteins. Using monomers of the gp120 protein, we applied extensive molecular dynamics simulations to obtain dominant morphologies that represent a variety of open-closed states of the V3 loop to examine the interaction of 112 ligands of the repeating units of DCSti-alt-MA docked to the V3 loop and surrounding residues. Using the distance between the V1/V2 and V3 loops of gp120 as a metric, we revealed through MD simulations that gp120 from the lab-adapted strains (BaL and IIIb), which are more susceptible to inhibition by DCSti-alt-MA, clearly transitioned to the closed state in one replicate of each simulation set, whereas none of the replicates from the Tier II strains (92UG037 and JR-CSF) did so. Docking repeat unit microspecies to the gp120 protein before and after MD simulation enabled identification of residues that were key for binding. Notably, only a few residues were found to be important for docking both before and after MD simulation as a result of the conformational heterogeneity provided by the simulations. Consideration of the residues that were consistently involved in interactions with the ligand revealed the importance of both hydrophilic and hydrophobic moieties of the ligand for effective binding. The results also suggest that polymers of DCSti-alt-MA with repeating units of different configurations may have advantages for therapeutic efficacy.	[Hollingsworth, Louis R.] Virginia Tech, Dept Chem Engn, Blacksburg, VA USA; [Hollingsworth, Louis R.; Brown, Anne M.; Bevan, David R.] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Hollingsworth, Louis R.; Gandour, Richard D.; Bevan, David R.] Virginia Tech, Dept Chem, Blacksburg, VA USA; [Brown, Anne M.] Virginia Tech, Res & Informat, Univ Lib, Blacksburg, VA USA; [Gandour, Richard D.; Bevan, David R.] Virginia Tech, Ctr Drug Discovery, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Bevan, DR (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.; Bevan, DR (corresponding author), Virginia Tech, Ctr Drug Discovery, Blacksburg, VA USA.	drbevan@vt.edu	Gandour, Richard D./AAN-8407-2020	Gandour, Richard D./0000-0001-5941-9517; Brown, Anne M./0000-0001-6951-8228; Hollingsworth, Louis/0000-0002-4130-3580	Virginia Tech University Libraries Open Access Subvention Fund	Virginia Tech University Libraries Open Access Subvention Fund	The authors thank the Virginia Tech University Libraries Open Access Subvention Fund for supporting us to publish open access. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Advanced Research Computing and the Department of Chemistry at Virginia Tech for computing time on the BlueRidge and Cerebro computing clusters, respectively. We also thank Robert L. Fuchs (B.S.) for his contribution of coordinate files for all 112 ligands of the repeating units of DCSti-alt-MA that were used in the docking protocol. The authors thank the Virginia Tech University Libraries Open Access Subvention Fund for supporting us to publish open access. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Andrianov AM, 2017, J MOL MODEL, V23, DOI 10.1007/s00894-016-3189-4; Andrianov AM, 2015, J BIOMOL STRUCT DYN, V33, P1051, DOI 10.1080/07391102.2014.926832; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BATINIC D, 1992, J BIOL CHEM, V267, P6664; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; CALLAHAN LN, 1991, J VIROL, V65, P1543, DOI 10.1128/JVI.65.3.1543-1550.1991; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chandramouli B, 2014, J STRUCT BIOL, V186, P132, DOI 10.1016/j.jsb.2014.02.014; Chandramouli B, 2013, J BIOMOL STRUCT DYN, V31, P403, DOI 10.1080/07391102.2012.703068; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Danial M, 2015, MACROMOL BIOSCI, V15, P9, DOI 10.1002/mabi.201400298; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deng Z, 2004, J MED CHEM, V47, P337, DOI 10.1021/jm030331x; DEVICTORIA AL, 2012, PLOS ONE, V0007; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Ellingson SR, 2015, J PHYS CHEM B, V119, P1026, DOI 10.1021/jp506511p; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Este JA, 1997, MOL PHARMACOL, V52, P98, DOI 10.1124/mol.52.1.98; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Gordts SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131219; Guttman M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7144; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Herschhorn A, 2016, MBIO, V7, DOI 10.1128/mBio.01598-16; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; Kong L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12040; Kong R, 2016, SCIENCE, V352, P828, DOI 10.1126/science.aae0474; LaLonde JM, 2013, ACS MED CHEM LETT, V4, P338, DOI 10.1021/ml300407y; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Li L, 2013, J MOL MODEL, V19, P905, DOI 10.1007/s00894-012-1619-5; Li Y, 2013, J POLYM SCI POL PHYS, V51, P1565, DOI 10.1002/polb.23370; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu QB, 2017, NAT STRUCT MOL BIOL, V24, P370, DOI 10.1038/nsmb.3382; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Meyerson JR, 2013, P NATL ACAD SCI USA, V110, P513, DOI 10.1073/pnas.1214810110; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; Molecular Operating Environment (MOE), 2016, 1010 SHERB W SUIT 91; Moraca F, 2016, J CHEM INF MODEL, V56, P2069, DOI 10.1021/acs.jcim.6b00393; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Munro JB, 2015, J VIROL, V89, P5752, DOI 10.1128/JVI.03187-14; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Neurath AR, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-17; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pall S., 2014, SOLVING SOFTWARE CHA, P3; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirrone V, 2011, ANTIVIR RES, V90, P168, DOI 10.1016/j.antiviral.2011.03.176; Prevost J, 2017, J VIROLOGY, V91; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Rasheed M, 2015, STRUCTURE, V23, P1138, DOI 10.1016/j.str.2015.03.026; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; Rohan LC, 2007, J INFECT DIS, V196, P1285, DOI 10.1086/522610; Sabbagh R, 2016, SEP PURIF TECHNOL, V163, P341, DOI 10.1016/j.seppur.2016.03.009; Sang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104714; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Savage AM, 2014, J MED CHEM, V57, P6354, DOI 10.1021/jm401913w; Schmidt JRP, 2013, W F WEBMO ENTERPRISE; Schrodinger, 2017, REL 2017 1; Schrodinger LLC, 2015, JYMOL MOL GRAPH DEV; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; Shrivastava IH, 2012, BIOCHEMISTRY-US, V51, P7783, DOI 10.1021/bi300878d; Singh J, 2006, CHEM BIOL DRUG DES, V67, P5, DOI 10.1111/j.1747-0285.2005.00323.x; Spyrakis F, 2015, J CHEM INF MODEL, V55, P2256, DOI 10.1021/acs.jcim.5b00169; STAMATATOS L, 1993, J VIROL, V67, P5635, DOI 10.1128/JVI.67.9.5635-5639.1993; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Veillette M, 2015, J VIROL, V89, P545, DOI 10.1128/JVI.02868-14; Wang HQ, 2016, P NATL ACAD SCI USA, V113, pE7151, DOI 10.1073/pnas.1615939113; Wood NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080301; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yokoyama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037530; Yuan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069789; Yuan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065115; Zhao Q, 2005, VIROLOGY, V339, P213, DOI 10.1016/j.virol.2005.06.008	99	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190658	10.1371/journal.pone.0190658	http://dx.doi.org/10.1371/journal.pone.0190658			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346393	Green Submitted, Green Published, gold			2022-12-27	WOS:000422749500017
J	Lee, C; Haneuse, S; Wang, HL; Rose, S; Spellman, SR; Verneris, M; Hsu, KC; Fleischhauer, K; Lee, SJ; Abdi, R				Lee, Catherine; Haneuse, Sebastien; Wang, Hai-Lin; Rose, Sherri; Spellman, Stephen R.; Verneris, Michael; Hsu, Katharine C.; Fleischhauer, Katharina; Lee, Stephanie J.; Abdi, Reza			Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation	PLOS ONE			English	Article							MORTALITY; REGRESSION; SURVIVAL; BLOOD; BIOMARKERS; SELECTION; THERAPY; GVHD; ST2	Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for a variety of hematologic malignancies and disorders. Unfortunately, acute graft-versus-host disease (GVHD) is a frequent complication of HCT. While substantial research has identified clinical, genetic and proteomic risk factors for acute GVHD, few studies have sought to develop risk prediction tools that quantify absolute risk. Such tools would be useful for: optimizing donor selection; guiding GVHD prophylaxis, post-transplant treatment and monitoring strategies; and, recruitment of patients into clinical trials. Using data on 9,651 patients who underwent first allogeneic HLA-identical sibling or unrelated donor HCT between 01/1999-12/2011 for treatment of a hematologic malignancy, we developed and evaluated a suite of risk prediction tools for: (i) acute GVHD within 100 days post-transplant and (ii) a composite endpoint of acute GVHD or death within 100 days post-transplant. We considered two sets of inputs: (i) clinical factors that are typically readily-available, included as main effects; and, (ii) main effects combined with a selection of a priori specified two-way interactions. To build the prediction tools we used the super learner, a recently developed ensemble learning statistical framework that combines results from multiple other algorithms/methods to construct a single, optimal prediction tool. Across the final super learner prediction tools, the area-under-the curve (AUC) ranged from 0.613-0.640. Improving the performance of risk prediction tools will likely require extension beyond clinical factors to include biological variables such as genetic and proteomic biomarkers, although the measurement of these factors may currently not be practical in standard clinical settings.	[Lee, Catherine] Kaiser Permanente, Div Res, Oakland, CA USA; [Haneuse, Sebastien] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wang, Hai-Lin] Ctr Int Blood & Bone Marrow Transplant Res, Milwaukee, WI USA; [Rose, Sherri] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Spellman, Stephen R.; Lee, Stephanie J.] Ctr Int Blood & Bone Marrow Transplant Res, Minneapolis, MN USA; [Verneris, Michael] Univ Colorado, Dept Med, Denver, CO USA; [Hsu, Katharine C.] Mem Sloan Kettering Canc Ctr, New York, NY USA; [Fleischhauer, Katharina] Univ Hosp, Inst Expt Cellular Therapy, Essen, Germany; [Lee, Stephanie J.] Fred Hutchinson Canc Res Ctr, Seattle, WA USA; [Abdi, Reza] Brigham & Womens Hosp, Renal Div, Transplantat Res Ctr, Boston, MA USA; [Abdi, Reza] Childrens Hosp, Boston, MA USA	Kaiser Permanente; Harvard University; Harvard T.H. Chan School of Public Health; Center for International Blood & Marrow Transplant Research; Harvard University; Harvard Medical School; Center for International Blood & Marrow Transplant Research; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Memorial Sloan Kettering Cancer Center; University of Duisburg Essen; Fred Hutchinson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Haneuse, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	shaneuse@hsph.harvard.edu		Lee, Catherine/0000-0003-0008-9052	National Institutes of Health [R01 CA181360-01, 5K24AI116925]; Center for International Blood and Marrow Research (CIBMTR); National Cancer Institute (NCI) [5U24-CA076518]; National Heart, Lung and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases (NIAID); NHLBI [5U10HL069294]; NCI; Health Resources and Services Administration (HRSA/DHHS) [HHSH250201200016C]; Office of Naval Research [N00014-15-1-0848, N00014-16-1-2020]; *Actinium Pharmaceuticals, Inc.; Alexion; *Amgen, Inc.; Astellas Pharma US; AstraZeneca; Atara Biotherapeutics, Inc.; Be the Match Foundation; Bluebird Bio, Inc.; Bristol Myers Squibb Oncology; Celgene Corporation; Cellular Dynamics International, Inc.; Cerus Corporation; Chimerix, Inc.; Fred Hutchinson Cancer Research Center; Gamida Cell Ltd.; Genentech, Inc.; Genzyme Corporation; Gilead Sciences, Inc.; Health Research, Inc.; Roswell Park Cancer Institute; HistoGenetics, Inc.; Incyte Corporation; Janssen Scientific Affairs, LLC; Jazz Pharmaceuticals, Inc.; Jeff Gordon Children's Foundation; The Leukemia & Lymphoma Society; Medac, GmbH; Medlmmune; Medical College of Wisconsin; Merck Co, Inc.; Mesoblast; MesoScale Diagnostics, Inc.; Miltenyi Biotec, Inc.; National Marrow Donor Program; Neovii Biotech NA, Inc.; Novartis Pharmaceuticals Corporation; Onyx Pharmaceuticals; Optum Healthcare Solutions, Inc.; Otsuka America Pharmaceutical, Inc.; Otsuka Pharmaceutical Co, Ltd. Japan; PCORI; Perkin Elmer, Inc.; Pfizer, Inc; Sanofi US; Seattle Genetics; Spectrum Pharmaceuticals, Inc.; St. Baldrick's Foundation; Sunesis Pharmaceuticals, Inc.; Swedish Orphan Biovitrum, Inc.; Takeda Oncology; Telomere Diagnostics, Inc.; University of Minnesota; Wellpoint, Inc.; NATIONAL CANCER INSTITUTE [U24CA076518, R01CA181360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for International Blood and Marrow Research (CIBMTR); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Health Resources and Services Administration (HRSA/DHHS)(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Office of Naval Research(Office of Naval Research); *Actinium Pharmaceuticals, Inc.(Takeda Pharmaceutical Company Ltd); Alexion; *Amgen, Inc.(Amgen); Astellas Pharma US(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Atara Biotherapeutics, Inc.; Be the Match Foundation; Bluebird Bio, Inc.; Bristol Myers Squibb Oncology(Bristol-Myers Squibb); Celgene Corporation(Bristol-Myers SquibbCelgene Corporation); Cellular Dynamics International, Inc.; Cerus Corporation; Chimerix, Inc.; Fred Hutchinson Cancer Research Center; Gamida Cell Ltd.; Genentech, Inc.(Roche HoldingGenentech); Genzyme Corporation(Sanofi-AventisGenzyme Corporation); Gilead Sciences, Inc.(Gilead Sciences); Health Research, Inc.; Roswell Park Cancer Institute; HistoGenetics, Inc.; Incyte Corporation; Janssen Scientific Affairs, LLC; Jazz Pharmaceuticals, Inc.(Jazz Pharmaceuticals); Jeff Gordon Children's Foundation; The Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Medac, GmbH; Medlmmune; Medical College of Wisconsin(General Electric); Merck Co, Inc.(Merck & Company); Mesoblast; MesoScale Diagnostics, Inc.; Miltenyi Biotec, Inc.; National Marrow Donor Program; Neovii Biotech NA, Inc.; Novartis Pharmaceuticals Corporation(Novartis); Onyx Pharmaceuticals; Optum Healthcare Solutions, Inc.; Otsuka America Pharmaceutical, Inc.(Otsuka Pharmaceutical); Otsuka Pharmaceutical Co, Ltd. Japan(Otsuka Pharmaceutical); PCORI(Patient-Centered Outcomes Research Institute - PCORI); Perkin Elmer, Inc.; Pfizer, Inc(Pfizer); Sanofi US; Seattle Genetics; Spectrum Pharmaceuticals, Inc.; St. Baldrick's Foundation; Sunesis Pharmaceuticals, Inc.; Swedish Orphan Biovitrum, Inc.; Takeda Oncology(Takeda Pharmaceutical Company Ltd); Telomere Diagnostics, Inc.; University of Minnesota(University of Minnesota System); Wellpoint, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was provided by National Institutes of Health grants R01 CA181360-01 and 5K24AI116925 and the Center for International Blood and Marrow Research (CIBMTR). CIBMTR is supported by several commercial entities, of which the full list can be found at https://wwwtest.cibmtr.org/Suppprt/Supporters/pages/index.aspx. The views expressed in this article do not reflect the official policy or position of the National Institutes of Health, the Department of the Navy, the Department of Defense, Health Resources and Services Administration (HRSA) or any other agency of the U.S. Government. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this work was provided by National Institutes of Health grants R01 CA181360-01 and 5K24AI116925. The CIBMTR is supported primarily by Public Health Service Grant/Cooperative Agreement 5U24-CA076518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID); a Grant/Cooperative Agreement 5U10HL069294 from NHLBI and NCI; a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/DHHS); two Grants N00014-15-1-0848 and N00014-16-1-2020 from the Office of Naval Research; and grants from *Actinium Pharmaceuticals, Inc.; Alexion; *Amgen, Inc.; Anonymous donation to the Medical College of Wisconsin; Astellas Pharma US; AstraZeneca; Atara Biotherapeutics, Inc.; Be the Match Foundation; *Bluebird Bio, Inc.; *Bristol Myers Squibb Oncology; *Celgene Corporation; Cellular Dynamics International, Inc.; Cerus Corporation; *Chimerix, Inc.; Fred Hutchinson Cancer Research Center; Gamida Cell Ltd.; Genentech, Inc.; Genzyme Corporation; Gilead Sciences, Inc.; Health Research, Inc. Roswell Park Cancer Institute; HistoGenetics, Inc.; Incyte Corporation; Janssen Scientific Affairs, LLC; *Jazz Pharmaceuticals, Inc.; Jeff Gordon Children's Foundation; The Leukemia & Lymphoma Society; Medac, GmbH; Medlmmune; The Medical College of Wisconsin; *Merck & Co, Inc.; *Mesoblast; MesoScale Diagnostics, Inc.; *Miltenyi Biotec, Inc.; National Marrow Donor Program; Neovii Biotech NA, Inc.; Novartis Pharmaceuticals Corporation; Onyx Pharmaceuticals; Optum Healthcare Solutions, Inc.; Otsuka America Pharmaceutical, Inc.; Otsuka Pharmaceutical Co, Ltd. Japan; PCORI; Perkin Elmer, Inc.; Pfizer, Inc; *Sanofi US; *Seattle Genetics; *Spectrum Pharmaceuticals, Inc.; St. Baldrick's Foundation; *Sunesis Pharmaceuticals, Inc.; Swedish Orphan Biovitrum, Inc.; Takeda Oncology; Telomere Diagnostics, Inc.; University of Minnesota; and *Wellpoint, Inc. The views expressed in this article do not reflect the official policy or position of the National Institute of Health, the Department of the Navy, the Department of Defense, Health Resources and Services Administration (HRSA) or any other agency of the U.S. Government.	Bembom O, 2007, STAT APPL GENET MOL, V6; Chen YB, 2013, BONE MARROW TRANSPL, V48, P755, DOI 10.1038/bmt.2012.143; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; Choi SW, 2010, IMMUNOL ALLERGY CLIN, V30, P75, DOI 10.1016/j.iac.2009.10.001; Cutler C, 2009, MANIFESTATIONS TREAT, P1287; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Griffith Linda M, 2008, Biol Blood Marrow Transplant, V14, P379, DOI 10.1016/j.bbmt.2008.01.005; Hahn T, 2013, J CLIN ONCOL, V31, P2437, DOI 10.1200/JCO.2012.46.6193; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harris AC, 2013, BRIT J HAEMATOL, V160, P288, DOI 10.1111/bjh.12142; Hastie T, 2009, ELEMENTS STAT LEARNI, Vxvi; Hastie TJ., 2017, GEN ADDITIVE MODELS; Holler E, 2004, BLOOD, V104, P889, DOI 10.1182/blood-2003-10-3543; Jagasia M, 2012, BLOOD, V119, P296, DOI 10.1182/blood-2011-06-364265; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Joseph Richard W, 2008, J Support Oncol, V6, P361; Kessler RC, 2014, WORLD PSYCHIATRY, V13, P265, DOI 10.1002/wps.20150; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Lee SJ, 2006, BONE MARROW TRANSPL, V38, P305, DOI 10.1038/sj.bmt.1705434; Levine JE, 2012, BLOOD, V119, P3854, DOI 10.1182/blood-2012-01-403063; Li W, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86660; Middleton PG, 2002, BONE MARROW TRANSPL, V30, P223, DOI 10.1038/sj.bmt.1703629; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Nelson RP, 2014, BIOL BLOOD MARROW TR, V20, P1861, DOI 10.1016/j.bbmt.2014.06.039; Nordlander A, 2002, BRIT J HAEMATOL, V119, P1133, DOI 10.1046/j.1365-2141.2002.03965.x; Paczesny S, 2009, BLOOD, V113, P273, DOI 10.1182/blood-2008-07-167098; Pasquini MC, 2015, CURRENT USES OUTCOME; Passweg JR, 2016, BONE MARROW TRANSPL, V51, P786, DOI 10.1038/bmt.2016.20; Pepe MS, 2003, STAT EVALUATION MED, Vxvi; Petersen ML, 2015, JAIDS-J ACQ IMM DEF, V69, P109, DOI 10.1097/QAI.0000000000000548; Pidala J, 2014, BLOOD, V124, P2596, DOI 10.1182/blood-2014-05-576041; Pirracchio R, 2015, LANCET RESP MED, V3, P42, DOI 10.1016/S2213-2600(14)70239-5; Ponce DM, 2015, BLOOD, V125, P199, DOI 10.1182/blood-2014-06-584789; R Core Team, R LANG ENV STAT COMP; Remberger M, 2002, BRIT J HAEMATOL, V119, P751, DOI 10.1046/j.1365-2141.2002.03924.x; Rose S, 2013, AM J EPIDEMIOL, V177, P443, DOI 10.1093/aje/kws241; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Sorror ML, 2014, BLOOD, V124, P287, DOI 10.1182/blood-2014-01-550566; STONE CJ, 1994, ANN STAT, V22, P118, DOI 10.1214/aos/1176325361; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Urbano-Ispizua A, 2002, BLOOD, V100, P724, DOI 10.1182/blood-2001-11-0057; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529, DOI 10.1056/NEJMoa1213299; Venables W., 2013, MODERN APPL STAT S, V53, P86; Weissinger EM, 2007, BLOOD, V109, P5511, DOI 10.1182/blood-2007-01-069757; Wermke M, 2010, BIOL BLOOD MARROW TR, V16, P1718, DOI 10.1016/j.bbmt.2010.06.001; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	49	14	14	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190610	10.1371/journal.pone.0190610	http://dx.doi.org/10.1371/journal.pone.0190610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346409	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500016
J	Radovich, E; el-Shitany, A; Sholkamy, H; Benova, L				Radovich, Emma; el-Shitany, Atef; Sholkamy, Hania; Benova, Lenka			Rising up: Fertility trends in Egypt before and after the revolution	PLOS ONE			English	Article							REPLACEMENT FERTILITY; TRANSITION; WORLD	In 2014, Egypt's Demographic and Health Survey (EDHS) documented an increase in the total fertility rate (TFR) to 3.5, up from a low of 3.0 recorded by the 2008 EDHS. The increase has been anecdotally attributed to the social upheaval following Egypt's January 2011 revolution, but little is known about when fertility first began to increase and among which sub-groups of women. Using birth histories from seven rounds of EDHS (1992-2014), this study reconstructed fertility rates for single years from 1990-2013 and examined patterns of childbearing in five-year birth cohorts of women. We found that the decline in fertility reversed in 2007, earlier than postulated, plateaued and then increased again in 2013. The increase in TFR coincided with a convergence of fertility rates across education levels, and there is evidence of a shift toward childbearing at younger ages among more educated women, which may be inflating period measures of fertility.	[Radovich, Emma; Benova, Lenka] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [el-Shitany, Atef] Minist Hlth & Populat, Populat & Family Planning Div, Cairo, Egypt; [Sholkamy, Hania] Amer Univ Cairo, Social Res Ctr, Cairo, Egypt	University of London; London School of Hygiene & Tropical Medicine; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); American University Cairo	Radovich, E (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.	emma.radovich@lshtm.ac.uk	sholkamy, hania/F-5423-2019	Radovich, Emma/0000-0002-8975-8015				[Anonymous], 2006, DEMOGRAPHIC REVOLUTI; [Anonymous], 2015, ECONOMIST; [Anonymous], 2017, WORLD POPULATION PRO; [Anonymous], 2014, GUARDIAN; Baschieri A, 2007, DEMOGR RES, V16, P59, DOI 10.4054/DemRes.2007.16.3; Bongaarts J, 2003, POP STUD-J DEMOG, V57, P321, DOI 10.1080/0032472032000137835; Bongaarts J, 1998, POPUL DEV REV, V24, P271, DOI 10.2307/2807974; Bongaarts J, 2002, POPUL DEV REV, V28, P419, DOI 10.1111/j.1728-4457.2002.00419.x; Cetorelli V, 2014, POPUL DEV REV, V40, P581, DOI 10.1111/j.1728-4457.2014.00001.x; Courbage Y., 2015, DIFI FAM RES P; El-Zanaty F, 1993, EGYPT DEMOGRAPHIC HL; El-Zanaty F., 2001, EGYPT DEMOGRAPHIC HL; El-Zanaty F. H., 2004, EGYPT INTERIM DEMOGR; El-Zeini LO, 2008, STUD FAMILY PLANN, V39, P161, DOI 10.1111/j.1728-4465.2008.164.x; Eltigani EE, 2001, STUD FAMILY PLANN, V32, P17, DOI 10.1111/j.1728-4465.2001.00017.x; Eltigani EE, 2009, STUD FAMILY PLANN, V40, P215, DOI 10.1111/j.1728-4465.2009.00204.x; Fahim Kareem, 2013, NY TIMES; Hendy R., 2015, WORKING PAPERS, V907; Krafft C., 2016, WHY IS FERTILITY RIS; Krafft C, 2015, BEWARE ECHO IMPENDIN; LaGraffe D., 2012, J STRATEGIC SECURITY, V5, P65, DOI [10.5038/1944-0472.5.2.4, DOI 10.5038/1944-0472.5.2.4]; Pullum T. W., 2006, ASSESSMENT AGE DATE; Ren R., NOTE DHS STANDARD WE; Riggs-Perla J, 2011, EGYPT HLTH POPULATIO, V1; Roudi-Fahimi Farzaneh, 2005, MARRIAGE ARAB WORLD; Rutstein SO, 2006, GUIDE DHS STAT; Salem R., 2015, CHANGES I MARRIAGE E; Schoumaker B., 2014, QUALITY CONSISTENCY, V12; Schoumaker B, 2013, DEMOGR RES, V28, P1093, DOI 10.4054/DemRes.2013.28.38; The World Bank, 2010, MIDDL E N AFR WOM WO; United Nations, 2013, WORLD POP AG 2013; Vignoli D., 2006, DEMOGR RES, P15; Youssef H, 2014, RESPONDING RAPID POP; Zaky, 2013, COMP ANAL FERTILITY	34	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190148	10.1371/journal.pone.0190148	http://dx.doi.org/10.1371/journal.pone.0190148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9PC	29346389	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500008
J	Deveza, L; Ortinau, L; Lei, K; Park, D				Deveza, Lorenzo; Ortinau, Laura; Lei, Kevin; Park, Dongsu			Comparative analysis of gene expression identifies distinct molecular signatures of bone marrow- and periosteal-skeletal stem/progenitor cells	PLOS ONE			English	Article							FRACTURE REPAIR; STEM-CELL; SPECIFICATION; MAINTENANCE; PROGENITORS; TARGET	Periosteum and bone marrow (BM) both contain skeletal stem/progenitor cells (SSCs) that participate in fracture repair. However, the functional difference and selective regulatory mechanisms of SSCs in different locations are unknown due to the lack of specific markers. Here, we report a comprehensive gene expression analysis of bone marrow SSCs (BMSSCs), periosteal SSCs (P-SSCs), and more differentiated osteoprogenitors by using reporter mice expressing Interferon-inducible Mxl and Nestin(GFP), previously known SSC markers. We first defined that the BM-SSCs can be enriched by the combination of Mx1 and NestinGFP expression, while endogenous P-SSCs can be isolated by positive selection of Mx1, CD105 and CD140a (known SSC markers) combined with the negative selection of CD45, CD31, and osteocalcin(GFP) (a mature osteoblast marker). Comparative gene expression analysis with FACS-sorted BM-SSCs, P-SSCs, Osterix(+) preosteoblasts, CD51(+) stroma cells and CD45(+) hematopoietic cells as controls revealed that BM-SSCs and P-SSCs have high similarity with few potential differences without statistical significance. We also found that CD51(+) cells are highly heterogeneous and have little overlap with SSCs. This was further supported by the microarray cluster analysis, where the two SSC populations clustered together but are separate from the CD51(+) cells. However, when comparing SSC population to controls, we found several genes that are uniquely upregulated in endogenous SSCs. Amongst these genes, we found KDR (aka Flk1 or VEGFR2) to be most interesting and discovered that it is highly and selectively expressed in P-SSCs. This finding suggests that endogenous P-SSCs are functionally very similar to BM-SSCs with undetectable significant differences in gene expression but there are distinct molecular signatures in P-SSCs, which can be useful to specify P-SSC subset in vivo.	[Deveza, Lorenzo] Baylor Coll Med, Dept Orthopaed Surg, Houston, TX 77030 USA; [Ortinau, Laura; Lei, Kevin; Park, Dongsu] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Park, Dongsu] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Park, D (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Park, D (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	Dongsu.park@bcm.edu		Park, Dongsu/0000-0002-2570-3250	National Institute of Arthritis and Muscloskeletal and Skin Diseases of the National Institutes of Health [1K01AR061434]; Bone Disease Program of Texas Award; Caroline Wiess Law Fund Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR072018, K01AR061434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060445] Funding Source: NIH RePORTER	National Institute of Arthritis and Muscloskeletal and Skin Diseases of the National Institutes of Health; Bone Disease Program of Texas Award; Caroline Wiess Law Fund Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by National Institute of Arthritis and Muscloskeletal and Skin Diseases of the National Institutes of Health under grant number 1K01AR061434 and by the Bone Disease Program of Texas Award to D.P and The Caroline Wiess Law Fund Award to DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research reported in this publication was supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under grant number 1K01AR061434 and by the Bone Disease Program of Texas Award to D.P and The Caroline Wiess Law Fund Award to D.P. We are grateful to B. Garrison and M. Kim for advice and technical assistance. We also thank J. Lee and former members of the Park laboratory and Lee laboratory for discussions. We thank M. E. Dickinson in the BCM Optical Imaging and Vital Microscopy Core, and J. Sederstrom in the BCM Cytometry and Cell Sorting Core.	Bianco P, 2015, DEVELOPMENT, V142, P1023, DOI 10.1242/dev.102210; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Colnot C, 2006, BIOCHEM BIOPH RES CO, V350, P557, DOI 10.1016/j.bbrc.2006.09.079; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hadjiargyrou M, 2014, J BONE MINER RES, V29, P2307, DOI 10.1002/jbmr.2373; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Murao H, 2013, J BONE MINER METAB, V31, P390, DOI 10.1007/s00774-013-0429-x; O'Keefe RJ, 2015, NEW ENGL J MED, V373, P1776, DOI 10.1056/NEJMcibr1510090; Ouyang ZF, 2014, BONE, V58, P136, DOI 10.1016/j.bone.2013.10.016; Ozaki A, 2000, J Orthop Sci, V5, P64, DOI 10.1007/s007760050010; Ozaki A, 2000, ROLE FRACTURE HEMATO, P64; Park D, 2014, JOVE-J VIS EXP, DOI 10.3791/51289; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Ransom RC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36524; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Visnjic D, 2001, J BONE MINER RES, V16, P2222, DOI 10.1359/jbmr.2001.16.12.2222; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Worthley Daniel L, CELL, V160, P269; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	30	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190909	10.1371/journal.pone.0190909	http://dx.doi.org/10.1371/journal.pone.0190909			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342188	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800037
J	Ward, JL; Harrison, K; Viner, RM; Costello, A; Heys, M				Ward, Joseph L.; Harrison, Katherine; Viner, Russell M.; Costello, Anthony; Heys, Michelle			Adolescent cohorts assessing growth, cardiovascular and cognitive outcomes in low and middle-income countries	PLOS ONE			English	Article							HONG-KONG CHILDREN; BLOOD-PRESSURE; BIRTH COHORT; SOCIAL-CLASS; PROFILE; HEALTH; AGE; CHINESE; OBESITY; RISK	Introduction Life-course studies are needed to explore how exposures during adolescence, particularly puberty, contribute to later cardiovascular risk and cognitive health in low and middle income countries (LMIC), where 90% of the world's young people live. The extent of any existing cohorts investigating these outcomes in LMIC has not previously been described. Methods We performed a systematic literature review to identify population cohort studies of adolescents in LMIC that assessed anthropometry and any of cardiovascular risk (blood pressure, physical activity, plasma glucose/lipid profile and substance misuse), puberty (age at menarche, Tanner staging, or other form of pubertal staging) or cognitive outcomes. Studies that recruited participants on the basis of a pre-existing condition or involved less than 500 young people were excluded. Findings 1829 studies were identified, and 24 cohorts fulfilled inclusion criteria based in Asia (10), Africa (6) and South / Central America (8). 14 (58%) of cohorts identified were based in one of four countries; India, Brazil, Vietnam or Ethiopia. Only 2 cohorts included a comprehensive cardiovascular assessment, tanner pubertal staging, andcognitive outcomes. Conclusion Improved utilisation of existing datasets and additional cohort studies of adolescents in LMIC that collect contemporaneous measures of growth, cognition, cardiovascular risk and pubertal development are needed to better understand how this period of the life course influences future non-communicable disease morbidity and cognitive outcomes.	[Ward, Joseph L.; Viner, Russell M.] UCL, UCL Inst Child Hlth, London, England; [Harrison, Katherine] Univ Coll London Hosp NHS Fdn Trust, London, England; [Costello, Anthony; Heys, Michelle] UCL, UCL Inst Global Hlth, London, England; [Costello, Anthony] WHO, Dept Maternal Newborn Child & Adolescent Hlth MCA, Geneva, Switzerland	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; World Health Organization	Ward, JL (corresponding author), UCL, UCL Inst Child Hlth, London, England.	joseph.ward.14@ucl.ac.uk	; Viner, Russell/A-1441-2009	Ward, Joseph/0000-0001-7263-8845; Viner, Russell/0000-0003-3047-2247	National Institute for Health Research [CL-2010-18-007] Funding Source: researchfish; Medical Research Council [MR/R00160X/1] Funding Source: Medline; World Health Organization [001] Funding Source: Medline; MRC [MR/R00160X/1] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); World Health Organization(World Health Organization); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adair LS, 2010, INT J EPIDEMIOL; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2014, QUAL ASS TOOL OBS CO; Anthony D, 2011, STAT WORLDS CHILDR 2; Antonisamy B, 2009, INT J EPIDEMIOL, V38, P663, DOI 10.1093/ije/dyn159; Barnett I, 2013, INT J EPIDEMIOL, V42, P701, DOI 10.1093/ije/dys082; Belachew T, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-125; Campbell Alasdair, 2011, J Glob Health, V1, P46; Cardoso VC, 2007, BRAZ J MED BIOL RES, V40, P1165, DOI 10.1590/S0100-879X2006005000148; De Weerdt J., 2012, ROCKWOOL FDN WORKING, V46; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Goddings AL, 2014, NEUROIMAGE, V88, P242, DOI 10.1016/j.neuroimage.2013.09.073; Goncalves H, 2014, INT J EPIDEMIOL; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Hadley C, 2009, ANN ANTHROPL PRACT, V32, P77, DOI 10.1111/j.1556-4797.2009.01029.x; Hardy R, 2006, J HYPERTENS, V24, P59, DOI 10.1097/01.hjh.0000198033.14848.93; Heys M, 2013, PEDIATRICS, V131, pE62, DOI 10.1542/peds.2012-0574; Heys M, 2010, ANN EPIDEMIOL, V20, P948, DOI 10.1016/j.annepidem.2010.06.011; Heys M, 2009, EPIDEMIOLOGY, V20, P91, DOI 10.1097/EDE.0b013e3181880396; Jimenez-Chillaron Josep C, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P23, DOI 10.1097/MED.0b013e328013da8e; [Jimma University Brown University], JIMM LONG FAM SURV Y; Jumbe NLn, 2016, N ENGL J MED; Kinra S, 2014, INT J EPIDEMIOL, V43, P1417, DOI 10.1093/ije/dyt128; Krishnaveni GV, 2014, INT J EPIDEMIOL; Kwok MK, 2010, INT J EPIDEMIOL, V39, P297, DOI 10.1093/ije/dyp274; Laitinen J, 2001, AM J CLIN NUTR, V74, P287; Lam D, 2011, CAPE AREA PANEL STUD; Leonard WR, 2015, ECON HUM BIOL, V19, P51, DOI 10.1016/j.ehb.2015.07.004; Li S, 2015, OBESITY; Longo DL, 2016, NEW ENGL J MED, V374, P276, DOI 10.1056/NEJMe1516564; MARMOT MG, 1978, BMJ-BRIT MED J, V2, P1109, DOI 10.1136/bmj.2.6145.1109; MARTORELL R, 1995, J NUTR, V125, pS1027, DOI 10.1093/jn/125.suppl_4.1027S; McCaw-Binns A., 1986, INT J EPIDEMIOL, V40, P1469, DOI DOI 10.1093/IJE/DY4149; McKinnon Rachel, 2011, J Glob Health, V1, P59; Patton GC, 2016, LANCET; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Prentice P, 2013, INT J OBESITY, V37, P1036, DOI 10.1038/ijo.2012.177; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; Richter LM, 2012, INT J EPIDEMIOL, V41, P621, DOI 10.1093/ije/dyq251; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Schooling CM, 2007, AM J PUBLIC HEALTH, V97, P1834, DOI 10.2105/AJPH.2006.088096; Sletner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073058; Trang Nguyen Hoang Hanh Doan, 2012, BMJ Open, V2, pe000362, DOI 10.1136/bmjopen-2011-000362; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; Victora CG, 1993, INT J EPIDEMIOL, V2008, P704, DOI DOI 10.1093/IJEIDYRN277; Victora CG, 2012, J ADOLESCENT HEALTH, V51, P53; Zhang ZX, 2009, NEUROLOGY, V73, P186, DOI 10.1212/WNL.0b013e3181ae7c90	50	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190443	10.1371/journal.pone.0190443	http://dx.doi.org/10.1371/journal.pone.0190443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338025	gold, Green Submitted, Green Published			2022-12-27	WOS:000422652700009
J	Nycz, BT; Dominguez, SR; Friedman, D; Hilden, JM; Ir, D; Robertson, CE; Frank, DN				Nycz, Bryan T.; Dominguez, Samuel R.; Friedman, Deborah; Hilden, Joanne M.; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.			Evaluation of bloodstream infections, Clostridium difficile infections, and gut microbiota in pediatric oncology patients	PLOS ONE			English	Article							RISK-FACTORS; BURDEN; EPIDEMIOLOGY; HOSPITALS; SOFTWARE; CHILDREN; HEALTH	Bloodstream infections (BSI) and Clostridium difficile infections (CDI) in pediatric oncology/hematology/bone marrow transplant (BMT) populations are associated with significant morbidity and mortality. The objective of this study was to explore possible associations between altered microbiome composition and the occurrence of BSI and CDI in a cohort of pediatric oncology patients. Stool samples were collected from all patients admitted to the pediatric oncology floor from Oct.-Dec. 2012. Bacterial profiles from patient stools were determined by bacterial 16S rRNA gene profiling. Differences in overall microbiome composition were assessed by a permutation-based multivariate analysis of variance test, while differences in the relative abundances of specific taxa were assessed by Kruskal-Wallis tests. At admission, 9 of 42 patients (21%) were colonized with C. difficile, while 6 of 42 (14%) subsequently developed a CDI. Furthermore, 3 patients (7%) previously had a BSI and 6 patients (14%) subsequently developed a BSI. Differences in overall microbiome composition were significantly associated with disease type (p = 0.0086), chemotherapy treatment (p = 0.018), BSI following admission from any cause (p < 0.0001) or suspected gastrointestinal organisms (p = 0.00043). No differences in baseline microbiota were observed between individuals who did or did not subsequently develop C. difficile infection. Additionally, multiple bacterial groups varied significantly between subjects with post-admission BSI compared with no BSI. Our results suggest that differences in gut microbiota not only are associated with type of cancer and chemotherapy, but may also be predictive of subsequent bloodstream infection.	[Nycz, Bryan T.; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Div Adult Infect Dis, Sch Med, Aurora, CO 80045 USA; [Dominguez, Samuel R.] Univ Colorado, Div Pediat Infect Dis, Sch Med, Aurora, CO 80045 USA; [Friedman, Deborah] Childrens Hosp Colorado, Dept Epidemiol, Aurora, CO USA; [Hilden, Joanne M.] Childrens Hosp Colorado, Ctr Blood & Canc Disorders, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Children's Hospital Colorado	Frank, DN (corresponding author), Univ Colorado, Div Adult Infect Dis, Sch Med, Aurora, CO 80045 USA.; Dominguez, SR (corresponding author), Univ Colorado, Div Pediat Infect Dis, Sch Med, Aurora, CO 80045 USA.	Samuel.Dominguez@childrenscolorado.org; daniel.frank@ucdenver.edu		ROBERTSON, CHARLES/0000-0002-4136-4121	American Medical Association (AMA) Foundation; Seed Grant Research Program; Infectious Disease Society of America (IDSA) Education and Research Foundation; Medical Scholar program; University of Colorado School of Medicine Medical Student Research Track; University of Colorado School of Medicine Department of Medicine Research and Equity in Academic Medicine (DREAM) Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	American Medical Association (AMA) Foundation; Seed Grant Research Program; Infectious Disease Society of America (IDSA) Education and Research Foundation; Medical Scholar program; University of Colorado School of Medicine Medical Student Research Track; University of Colorado School of Medicine Department of Medicine Research and Equity in Academic Medicine (DREAM) Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Bryan T. Nycz received funding from the following: 1. American Medical Association (AMA) Foundation. 2016 Seed Grant Research Program (no grant number). https://www.ama.-assn.org/2. Infectious Disease Society of America (IDSA) Education and Research Foundation. 2015 Medical Scholar program (no grant number). http://www.Idsociety.org/Medical_Scholors_Program/3. University of Colorado School of Medicine Medical Student Research Track (no grant number), http://www.ucdenver.edu/academics/colleges/medicalschool/education/degree_programs/MDProgram/longitudinal/tracks/researchtrack/Pages/default.aspx 4. University of Colorado School of Medicine Department of Medicine Research and Equity in Academic Medicine (DREAM) Program (no grant number). http://www.ucdenver.edu/academics/colleges/medicalschool/departments/medicine/pages/DREAM-Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano M, 2016, NAT REV UROL, V13, P77, DOI 10.1038/nrurol.2015.292; Brumbaugh DE, 2016, J PEDIATR GASTR NUTR, V63, P320, DOI 10.1097/MPG.0000000000001124; Bultman SJ, 2014, CARCINOGENESIS, V35, P249, DOI 10.1093/carcin/bgt392; Bultman SJ., 2016, SEMINARS ONCOLOGY; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Dantes R, 2016, AM J INFECT CONTROL, V44, P138, DOI 10.1016/j.ajic.2015.09.004; de Blank P, 2013, J PEDIATR-US, V163, P699, DOI 10.1016/j.jpeds.2013.01.062; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; Dominguez SR, 2014, CLIN INFECT DIS, V59, P401, DOI 10.1093/cid/ciu302; Dominguez SR, 2015, J PEDIAT INFECT DIS; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; El Feghaly RE, 2013, J PEDIATR GASTR NUTR, V57, P813, DOI 10.1097/MPG.0b013e3182a3202f; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Frank DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131944; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Galloway-Pena J, 2017, TRENDS MICROBIOL, V25, P992, DOI 10.1016/j.tim.2017.06.006; Gaur AH, 2015, INFECT CONT HOSP EP, V34, P315; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kelly DL, 2016, CANCER NURS, V39, pE56, DOI 10.1097/NCC.0000000000000286; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Kim J, 2012, PEDIATR INFECT DIS J, V31, P134, DOI 10.1097/INF.0b013e3182352e2c; Kim J, 2008, PEDIATRICS, V122, P1266, DOI 10.1542/peds.2008-0469; Kwa M, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw029; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Magurran AE, 2013, MEASURING BIOL DIVER; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; Montassier E, 2015, ALIMENT PHARM THER, V42, P515, DOI 10.1111/apt.13302; Needell JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183786; Needell JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173968; Ohtani N, 2015, MICROBIOME CANC SEMI; Price V, 2013, PEDIATR INFECT DIS J, V32, P610, DOI 10.1097/INF.0b013e31828690a4; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2014, R LANG ENV STAT COMP; Rajagopala SV, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2965-y; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Rogers AEJ, 2016, PEDIAT BLOOD CANC; Rogers AEJ, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26254; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Schloss PD, 2007, ANNU REV MICROBIOL, V61, P23, DOI 10.1146/annurev.micro.61.011507.151712; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Seekatz AM, 2014, J CLIN INVEST, V124, P4182, DOI 10.1172/JCI72336; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shah DN, 2016, J HOSP INFECT, V93, P286, DOI 10.1016/j.jhin.2016.04.004; Simon A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-70; Son JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127985; Tai E, 2011, PEDIATR INFECT DIS J, V30, P610, DOI 10.1097/INF.0b013e31820970d1; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Vogtmann E, 2016, BRIT J CANC; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102116; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yang L, 2015, ENCY METAGENOMICS EN, P379	62	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191232	10.1371/journal.pone.0191232	http://dx.doi.org/10.1371/journal.pone.0191232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329346	Green Published, Green Submitted, gold			2022-12-27	WOS:000419954100053
J	Kim, YG; Choi, JI; Kim, MN; Cho, DH; Oh, SK; Kook, H; Park, HS; Lee, KN; Baek, YS; Roh, SY; Shim, J; Park, SM; Shim, WJ; Kim, YH				Kim, Yun Gi; Choi, Jong-Il; Kim, Mi-Na; Cho, Dong-Hyuk; Oh, Suk-Kyu; Kook, Hyungdon; Park, Hee-Soon; Lee, Kwang No; Baek, Yong-Soo; Roh, Seung-Young; Shim, Jaemin; Park, Seong-Mi; Shim, Wan Joo; Kim, Young-Hoon			Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: A trans-esophageal echocardiography study	PLOS ONE			English	Article							RISK STRATIFICATION; STROKE; THROMBOEMBOLISM; RIVAROXABAN; APIXABAN; EDOXABAN; SMOKE; AF	Spontaneous echo-contrast (SEC) and thrombus observed in trans-esophageal echocardiography (TEE) is known as a strong surrogate marker for future risk of ischemic stroke in patients with atrial fibrillation (AF) or atrial flutter (AFL). The efficacy of non-vitamin K antagonist oral anticoagulants (NOAC) compared to warfarin to prevent SEC or thrombus in patients with AF or AFL is currently unknown. AF or AFL patients who underwent direct current cardioversion (DCCV) and pre-DCCV TEE evaluation from January 2014 to October 2016 in a single center were analyzed. The prevalence of SEC and thrombus were compared between patients who received NOAC and those who took warfarin. NOAC included direct thrombin inhibitor and factor Xa inhibitors. Among 1,050 patients who were considered for DCCV, 424 patients anticoagulated with warfarin or NOAC underwent TEE prior to DCCV. Eighty patients who were anticoagulated for less than 21 days were excluded. Finally, 344 patients were included for the analysis (180 warfarin users vs. 164 NOAC users). No significant difference in the prevalence of SEC (44.4% vs. 43.9%; p = 0.919), dense SEC (13.9% vs. 15.2%; p = 0.722), or thrombus (2.2% vs. 4.3%; p = 0.281) was observed between the warfarin group and the NOAC group. In multivariate analysis, there was no association between NOAC and risk of SEC (odds ratio [OR]: 1.4, 95% CI: 0.796-2.297, p = 0.265) or thrombus (OR: 3.4, 95% CI: 0.726-16.039, p = 0.120). In conclusion, effectiveness of NOAC is comparable to warfarin in preventing SEC and thrombus in patients with AF or AFL undergoing DCCV. However, numerical increase in the prevalence of thrombus in NOAC group warrants further evaluation.	[Choi, Jong-Il] Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea; Korea Univ, Med Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Choi, JI (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.	jongilchoi@korea.ac.kr	Baek, Yong-Soo/GXF-3223-2022; Kim, Young-Hoon/AAO-5792-2021	Baek, Yong-Soo/0000-0002-6086-0446; Kim, Mi-Na/0000-0001-6589-5122; Kim, Young-Hoon/0000-0002-4254-647X; Choi, Jong-Il/0000-0001-6617-508X	Korean Society of Cardiology [2015-05-01]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2015R1D1A1A02061859]; Ministry of Science, ICT & Future Planning [NRF-2012R1A1A1013260]; Korea University Anam Hospital; Korea University	Korean Society of Cardiology; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea University Anam Hospital; Korea University	This work was supported by a Korea University Grant (J-IC) and a grant of Korea University Anam Hospital (J-IC) and in part by a grant from the Korean Society of Cardiology (2015-05-01 to J-IC), and grants from Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2015R1D1A1A02061859 to J-IC) and the Ministry of Science, ICT & Future Planning (NRF-2012R1A1A1013260 to J-IC).	ARNOLD AZ, 1992, J AM COLL CARDIOL, V19, P851, DOI 10.1016/0735-1097(92)90530-Z; Asinger RW, 1999, J AM SOC ECHOCARDIOG, V12, P1088, DOI 10.1016/S0894-7317(99)70106-9; BLACK IW, 1993, J AM COLL CARDIOL, V21, P451, DOI 10.1016/0735-1097(93)90688-W; Black IW, 2000, ECHOCARDIOGR-J CARD, V17, P373, DOI 10.1111/j.1540-8175.2000.tb01153.x; Calenda BW, 2016, NAT REV CARDIOL, V13, P549, DOI 10.1038/nrcardio.2016.106; Camm AJ, 2012, EUR HEART J, V33; Cappato R, 2014, EUR HEART J, V35, P3346, DOI 10.1093/eurheartj/ehu367; Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026; Choi JI, 2016, KOREAN CIRC J, V46, P335, DOI 10.4070/kcj.2016.46.3.335; Choi JI, 2008, CIRC J, V72, P2051, DOI 10.1253/circj.CJ-08-0428; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Ezekowitz MD, 2016, AM HEART J, V179, P59, DOI 10.1016/j.ahj.2016.06.008; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Goette A, 2016, LANCET, V388, P1995, DOI 10.1016/S0140-6736(16)31474-X; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kim MN, 2015, INT HEART J, V56, P286, DOI 10.1536/ihj.14-380; Kim Y, 2016, IEEE C ELECTR PERFOR, P11, DOI 10.1109/EDAPS.2016.7893112; Klein AL, 2001, NEW ENGL J MED, V344, P1411, DOI 10.1056/NEJM200105103441901; Komatsu T, 2014, INT HEART J, V55, P119, DOI 10.1536/ihj.13-242; Lee JM, 2014, AM J CARDIOL, V113, P963, DOI 10.1016/j.amjcard.2013.11.058; Lip GYH, 2016, AM HEART J, V178, P126, DOI 10.1016/j.ahj.2016.05.007; Lowe GDO, 2003, PATHOPHYSIOL HAEMO T, V33, P455, DOI 10.1159/000083845; MERINO A, 1992, J AM COLL CARDIOL, V20, P1661, DOI 10.1016/0735-1097(92)90463-W; Oh S, 2016, INT J CARDIOL, V223, P543, DOI 10.1016/j.ijcard.2016.08.236; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Patel SV, 2008, CLIN CARDIOL, V31, P148, DOI 10.1002/clc.20172; Peverill RE, 1996, CIRCULATION, V94, P331, DOI 10.1161/01.CIR.94.3.331; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Soncini M, 1997, Minerva Med, V88, P501; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; Vazquez FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142222; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; WEINBERG DM, 1989, AM J CARDIOL, V63, P745, DOI 10.1016/0002-9149(89)90264-6; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Yamashita T, 2015, J CARDIOL, V65, P175, DOI 10.1016/j.jjcc.2014.07.013; YASAKA M, 1991, BRIT HEART J, V66, P22; Zabalgoitia M, 1998, ANN INTERN MED, V128, P639, DOI 10.7326/0003-4819-128-8-199804150-00005	39	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191648	10.1371/journal.pone.0191648	http://dx.doi.org/10.1371/journal.pone.0191648			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360845	Green Published, gold, Green Submitted			2022-12-27	WOS:000423161800048
J	Menigoz, K; Nathan, A; Heesch, KC; Turrell, G				Menigoz, Karen; Nathan, Andrea; Heesch, Kristiann C.; Turrell, Gavin			Neighbourhood disadvantage, geographic remoteness and body mass index among immigrants to Australia: A national cohort study 2006-2014	PLOS ONE			English	Article							ETHNIC RESIDENTIAL SEGREGATION; UNITED-STATES; BUILT ENVIRONMENT; SOCIOECONOMIC DISADVANTAGE; RACIAL/ETHNIC DIFFERENCES; HEALTH INEQUALITIES; STRUCTURAL RACISM; BMI TRAJECTORIES; WEIGHT STATUS; OBESITY	Obesity is socioeconomically, geographically and ethnically patterned. Understanding these elements of disadvantage is vital in understanding population obesity trends and the development of effective and equitable interventions. This study examined the relationship between neighbourhood socioeconomic disadvantage and geographic remoteness with prospective trends in mean body mass index (BMI) among immigrants to Australia. Longitudinal data (2006-2014) from a national panel survey of Australian adults was divided into an immigrant-only sample (n = 4,293, 52.6% women and 19,404 person-year observations). The data were analysed using multi-level random effects linear regression modelling that controlled for individual socioeconomic and demographic factors. Male immigrants living in the most disadvantaged neighbourhoods had significantly higher mean BMI compared with those living in the least disadvantaged. Over time, mean BMI increased for all groups except for men living in the least disadvantaged neighbourhoods, for whom mean BMI remained almost static (0.1 kg/m(2) increase from 2006 to 2014), effectively widening neighbourhood inequalities. Among women, mean BMI was also significantly higher in the most compared with the least, disadvantaged neighbourhoods (beta = 2.08 kg/m(2); 95%Cl: 1.48, 2.68). Neighbourhood inequalities were maintained over time as mean BMI increased for all groups at a similar rate. Male and female immigrants residing in outer regional areas had significantly higher mean BMI compared with those living in major cities; however, differences were attenuated and no longer significant following adjustment for ethnicity, individual socioeconomic position and neighbourhood disadvantage. Over time, mean BMI increased in all male and female groups with no differences based on geographic remoteness. Obesity prevention policy targeted at immigrant cohorts needs to include area-level interventions that address inequalities in BMI arising from neighbourhood disadvantage, and be inclusive of immigrants living outside Australia's major cities.	[Menigoz, Karen; Heesch, Kristiann C.; Turrell, Gavin] QUT, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia; [Menigoz, Karen; Heesch, Kristiann C.; Turrell, Gavin] QUT, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Nathan, Andrea; Turrell, Gavin] ACU, Inst Hlth & Ageing, Melbourne, Vic, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Australian Catholic University	Menigoz, K (corresponding author), QUT, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.; Menigoz, K (corresponding author), QUT, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.	karen.menigoz@hdr.qut.edu.au	Heesch, Kristiann C/J-1288-2012	Heesch, Kristiann C/0000-0003-1931-3683; Turrell, Gavin/0000-0002-3576-8744; Menigoz, Karen/0000-0002-5875-7941	Australian Government Department of Social Services (DSS)	Australian Government Department of Social Services (DSS)(Australian Government)	This paper uses unit record data from the Household, Income and Labour Dynamics in Australia (HILDA) Survey. The HILDA Project was initiated and is funded by the Australian Government Department of Social Services (DSS) and is managed by the Melbourne Institute of Applied Economic and Social Research (Melbourne Institute). The findings and views reported in this paper, however, are those of the author and should not be attributed to either DSS or the Melbourne Institute.	Albrecht SS, 2015, ANN EPIDEMIOL, V25, P767, DOI 10.1016/j.annepidem.2015.07.003; Anikeeva O, 2010, ASIA-PAC J PUBLIC HE, V22, P159, DOI 10.1177/1010539509358193; Astell-Burt T, 2013, SOC SCI MED, V93, P70, DOI 10.1016/j.socscimed.2013.06.006; Australian Bureau of Statistics, 2015, NATL HLTH SURV 1 RES; Australian Bureau of Statistics, 2011, TECHN PAP SOC EC IND; Australian Bureau of Statistics, 2016, MIGR AUSTR 2014 15; Australian Bureau of Statistics, 2011, REM STRUCT, V5; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Becares Laia, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2012.300832; Befort CA, 2012, J RURAL HEALTH, V28, P392, DOI 10.1111/j.1748-0361.2012.00411.x; Bonevski B, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-42; Burdette AM, 2012, J ADOLESCENT HEALTH, V50, P30, DOI 10.1016/j.jadohealth.2011.03.009; Chiu M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007232; Clarke P, 2009, INT J EPIDEMIOL, V38, P499, DOI 10.1093/ije/dyn214; Cleland V, 2010, MED J AUSTRALIA, V192, P137, DOI 10.5694/j.1326-5377.2010.tb03451.x; Cozier YvetteC, 2014, AM J EPIDEMIOL; Do DP, 2007, ECON HUM BIOL, V5, P179, DOI 10.1016/j.ehb.2007.03.006; Do DP, 2017, HEALTH PLACE, V46, P201, DOI 10.1016/j.healthplace.2017.05.010; El-Sayed AM, 2011, OBES REV, V12, pe516, DOI 10.1111/j.1467-789X.2010.00829.x; Feng XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141499; Feng XQ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007052; Feng XQ, 2014, PREV MED, V69, P172, DOI 10.1016/j.ypmed.2014.09.015; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gee GC, 2011, DU BOIS REV, V8, P115, DOI 10.1017/S1742058X11000130; Guo SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115627; Hauck K, 2011, HEALTH PLACE, V17, P78, DOI 10.1016/j.healthplace.2010.08.016; Hugo G., 2014, RURAL CHANGE AUSTR, P57; Johnston R, 2007, ANN ASSOC AM GEOGR, V97, P713, DOI 10.1111/j.1467-8306.2007.00579.x; Jokela M, 2009, SOC SCI MED, V68, P867, DOI 10.1016/j.socscimed.2008.12.022; Kershaw KN, 2013, AM J EPIDEMIOL, V177, P299, DOI 10.1093/aje/kws372; King T, 2006, INT J OBESITY, V30, P281, DOI 10.1038/sj.ijo.0803176; Kirby JB, 2012, AM J PUBLIC HEALTH, V102, P1572, DOI 10.2105/AJPH.2011.300452; Lau R, 2008, AUST J RURAL HEALTH, V16, P5, DOI 10.1111/j.1440-1584.2007.00933.x; Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005; McDonald JT, 2005, SOC SCI MED, V61, P2469, DOI 10.1016/j.socscimed.2005.05.004; Menigoz K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3608-6; Moloney KL, 2015, HEALTH PLACE, V31, P199, DOI 10.1016/j.healthplace.2014.12.006; Mujahid MS, 2008, AM J EPIDEMIOL, V167, P1349, DOI 10.1093/aje/kwn047; Mujahid MS, 2017, HEALTH PLACE, V44, P61, DOI 10.1016/j.healthplace.2017.01.005; Mujahid MS, 2005, OBES RES, V13, P1412, DOI 10.1038/oby.2005.171; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nicholson LM, 2012, J YOUTH ADOLESCENCE, V41, P53, DOI 10.1007/s10964-011-9685-z; Organization for Economic Co-operation and Development, 2017, OB UPD 2017; Osypuk TL, 2010, HEALTH PLACE, V16, P1113, DOI 10.1016/j.healthplace.2010.07.002; Patterson KAE, 2017, ANN EPIDEMIOL, V27, P169, DOI 10.1016/j.annepidem.2017.01.007; Patterson KAE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1278; Rachele JN, 2017, PREV MED, V105, P271, DOI 10.1016/j.ypmed.2017.09.017; Rasbash J, 2013, MLWIN VERSION 2 27; Renzaho A, 2016, AUST HEALTH REV, V40, P3, DOI 10.1071/AH14132; Richmond TK, 2015, INT J OBESITY, V39, P546, DOI 10.1038/ijo.2014.147; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Ruel E, 2010, HEALTH PLACE, V16, P191, DOI 10.1016/j.healthplace.2009.09.009; Smith NR, 2012, EUR J PUBLIC HEALTH, V22, P508, DOI 10.1093/eurpub/ckr070; Summerfield M, 2015, HILDA USER MANUAL PL; The University of Adelaide Hugo Centre for Migration and Population Research, 2015, ARIA ACC REM IND AUS; Turrell G, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0151-7; Turrell G, 2013, HEALTH PLACE, V19, P89, DOI 10.1016/j.healthplace.2012.10.008; Ullmann SH, 2013, SOC SCI MED, V90, P40, DOI 10.1016/j.socscimed.2013.04.024; UNDP, 2015, HUM DEV REP, P1; Viruell-Fuentes EA, 2012, SOC SCI MED, V75, P2099, DOI 10.1016/j.socscimed.2011.12.037; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Watson N, 2011, METHODOLOGY HILDA TO; Watson N, 2002, ASSESSING QUALITY HI; Watson N, 2015, FACTORS AFFECTING RE; Watson N, 2012, LONGITUDINAL CROSS S; Watson N, 2012, LONGITUD LIFE COURSE, V3, P369; Wen M, 2012, HEALTH PLACE, V18, P1314, DOI 10.1016/j.healthplace.2012.09.002	67	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191729	10.1371/journal.pone.0191729	http://dx.doi.org/10.1371/journal.pone.0191729			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360878	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800055
J	Rudi, G; Bailly, JS; Vinatier, F				Rudi, Gabrielle; Bailly, Jean-Stephane; Vinatier, Fabrice			Using geomorphological variables to predict the spatial distribution of plant species in agricultural drainage networks	PLOS ONE			English	Article							DISTRIBUTION MODELS; MANAGEMENT REGIMES; SORGHUM-HALEPENSE; ARABLE WEEDS; DITCH BANKS; VEGETATION; DISPERSAL; VARIABILITY; LANDSCAPES; EROSION	To optimize ecosystem services provided by agricultural drainage networks (ditches) in headwater catchments, we need to manage the spatial distribution of plant species living in these networks. Geomorphological variables have been shown to be important predictors of plant distribution in other ecosystems because they control the water regime, the sediment deposition rates and the sun exposure in the ditches. Whether such variables may be used to predict plant distribution in agricultural drainage networks is unknown. We collected presence and absence data for 10 herbaceous plant species in a subset of a network of drainage ditches (35 km long) within a Mediterranean agricultural catchment. We simulated their spatial distribution with GLM and Maxent model using geomorphological variables and distance to natural lands and roads. Models were validated using k-fold cross-validation. We then compared the mean Area Under the Curve (AUC) values obtained for each model and other metrics issued from the confusion matrices between observed and predicted variables. Based on the results of all metrics, the models were efficient at predicting the distribution of seven species out of ten, confirming the relevance of geomorphological variables and distance to natural lands and roads to explain the occurrence of plant species in this Mediterranean catchment. In particular, the importance of the landscape geomorphological variables, ie the importance of the geomorphological features encompassing a broad environment around the ditch, has been highlighted. This suggests that agro-ecological measures for managing ecosystem services provided by ditch plants should focus on the control of the hydrological and sedimentological connectivity at the catchment scale. For example, the density of the ditch network could be modified or the spatial distribution of vegetative filter strips used for sediment trapping could be optimized. In addition, the vegetative filter strips could constitute new seed bank sources for species that are affected by the distance to natural lands and roads.	[Rudi, Gabrielle; Bailly, Jean-Stephane; Vinatier, Fabrice] Univ Montpellier, INRA, IRD, Montpellier SupAgro,LISAH, Montpellier, France; [Rudi, Gabrielle] Univ Montpellier, AgroParisTech, CIRAD, IRD,IRSTEA,Montpellier SupAgro,G Eau, Montpellier, France; [Bailly, Jean-Stephane] AgroParisTech, Paris, France	INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; AgroParisTech; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; AgroParisTech	Rudi, G (corresponding author), Univ Montpellier, INRA, IRD, Montpellier SupAgro,LISAH, Montpellier, France.; Rudi, G (corresponding author), Univ Montpellier, AgroParisTech, CIRAD, IRD,IRSTEA,Montpellier SupAgro,G Eau, Montpellier, France.	gabrielle.rudi@supagro.fr	Vinatier, Fabrice/AAF-7014-2020	Vinatier, Fabrice/0000-0003-3693-4422; Bailly, Jean-Stephane/0000-0003-4163-5275	INRA institution via the EcoServ metaprogram; Agropolis Fondation through the "Investissements d'avenir" programme (LabexAgro) [1605-034, ANR-10-LABX-0001-01]; Montpellier Supagro via the EcoServ metaprogram; INRA institution	INRA institution via the EcoServ metaprogram; Agropolis Fondation through the "Investissements d'avenir" programme (LabexAgro)(French National Research Agency (ANR)); Montpellier Supagro via the EcoServ metaprogram; INRA institution	Authors are grateful to the INRA institution who partly funded the experimental work exposed in this paper within the 'Pari-Scientifique: Hydro-ecologie des fosses agricoles' project (INRA-EA) to FV. This project was also funded by Agropolis Fondation under the reference ID 1605-034 through the "Investissements d'avenir" programme (LabexAgro:ANR-10-LABX-0001-01) to FV. Lastly, the project was also supported by funds from a PhD grant provided by Montpellier Supagro and the INRA institution via the EcoServ metaprogram to GR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.& para;& para;The authors thank Marie-Noelle Moresmau, Jeanne Dollinger, Benoit Bellot, and Alexandre Bassini for their valuable field work. Marie-Noelle Moresmau created the GIS application for the survey using App Inventor. We also thank Laurent Prevot and Guillaume Coulouma for their expertise and advice regarding the study area. Authors are grateful to the INRA institution who partly funded the experimental work exposed in this paper within the 'Pari-Scientifique: Hydro-ecologie des fosses agricoles' project (INRA-EA). This project was also funded by Agropolis Fondation under the reference ID 1605-034 through the "Investissements d'avenir" programme (Labex Agro:ANR-10-LABX-0001-01). Lastly, the project was also supported by funds from a PhD grant provided by Montpellier Supagro and the INRA institution via the EcoServ metaprogram. Authors thank the three anonymous referees for helpful comments and suggestions on the manuscript, and Bruce Jaffee for the English revision.	Alignier A, 2013, ECOL COMPLEX, V15, P17, DOI 10.1016/j.ecocom.2013.01.007; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2016, DISMO SPECIES DISTRI; [Anonymous], 1998, INDEX BOT ECOLOGIQUE; Baddeley A, 2015, SPATIAL POINT PATTER; Bailly JS, 2008, INT J REMOTE SENS, V29, P3489, DOI 10.1080/01431160701469057; Balandier P, 2013, FORESTRY, V86, P39, DOI 10.1093/forestry/cps066; Bassa M, 2012, BIODIVERS CONSERV, V21, P1101, DOI 10.1007/s10531-012-0245-y; Arnold RLB, 1988, FUNCT ECOL, V2, P311, DOI 10.2307/2389403; Bennett ER, 2005, ENVIRON TOXICOL CHEM, V24, P2121, DOI 10.1897/04-357R.1; Bivand, 2016, RGEOS INTERFACE GEOM; Bivand R., 2016, RGDAL BINDINGS GEOSP; Bivand R., 2016, MAPTOOLS TOOLS READI; Blomqvist M. M., 2006, Journal for Nature Conservation (Jena), V14, P16, DOI 10.1016/j.jnc.2005.08.003; Blomqvist MM, 2009, BASIC APPL ECOL, V10, P368, DOI 10.1016/j.baae.2008.08.007; Blomqvist MM, 2003, BIOL CONSERV, V109, P391, DOI 10.1016/S0006-3207(02)00165-9; Brenning A., 2008, HAMBURGER BEITRAEGE, V19, P23; Castaldelli G, 2015, AGR ECOSYST ENVIRON, V212, P253, DOI 10.1016/j.agee.2015.07.009; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Clarke SJ, 2015, J NAT CONSERV, V24, P93, DOI 10.1016/j.jnc.2014.10.003; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cordeau S, 2012, AGR ECOSYST ENVIRON, V155, P35, DOI 10.1016/j.agee.2012.03.022; Coulouma G., 2008, CARTE SOLS BASSE VAL; Cousens R, 2004, OIKOS, V107, P251, DOI 10.1111/j.0030-1299.2004.13188.x; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; David M, 2014, GEOMORPHOLOGY, V214, P10, DOI 10.1016/j.geomorph.2014.03.016; DGFAR, 2008, CIRC 2008 MES AGR NE; Dollinger J, 2016, SCI TOTAL ENVIRON, V573, P716, DOI 10.1016/j.scitotenv.2016.08.168; Dollinger J, 2015, AGRON SUSTAIN DEV, V35, P999, DOI 10.1007/s13593-015-0301-6; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duan RY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112764; DUNAWAY D, 1994, GEOMORPHOLOGY, V9, P47, DOI 10.1016/0169-555X(94)90030-2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2017, REFERENCE MODULE LIF; Favre-Bac L, 2014, ACTA OECOL, V61, P57, DOI 10.1016/j.actao.2014.10.006; Firbank LG, 2008, PHILOS T R SOC B, V363, P777, DOI 10.1098/rstb.2007.2183; Gaba S, 2010, AGR ECOSYST ENVIRON, V138, P318, DOI 10.1016/j.agee.2010.06.005; Gabriel D, 2005, PERSPECT PLANT ECOL, V7, P85, DOI 10.1016/j.ppees.2005.04.001; Gallant JC, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001426; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gumiere SJ, 2011, HYDROL PROCESS, V25, P1717, DOI 10.1002/hyp.7931; Herzon I, 2008, BIOL CONSERV, V141, P1171, DOI 10.1016/j.biocon.2008.03.005; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; HOLT JS, 1995, WEED SCI, V43, P474, DOI 10.1017/S0043174500081509; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jarnevich CS, 2015, ECOL INFORM, V29, P6, DOI 10.1016/j.ecoinf.2015.06.007; Jayet H., 2001, ECONOMETRIE DONNEES, P58; Konsuer KM, 2016, GEOMORPHOLOGY, V252, P80, DOI 10.1016/j.geomorph.2015.08.002; Kroger R., 2010, ACTA ECOLOGICA SINIC, V30, P280; Lagacherie P, 2006, ECOL INDIC, V6, P265, DOI 10.1016/j.ecolind.2005.02.003; Lancaster LT, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0046; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Lelievre F, 2011, EVOLUTION CLIMAT SUD; Leng X, 2011, J NAT CONSERV, V19, P166, DOI 10.1016/j.jnc.2010.11.003; Leonard J, 1998, CATENA, V32, P209, DOI 10.1016/S0341-8162(98)00049-6; Levavasseur F, 2015, J LAND USE SCI, V10, P256, DOI 10.1080/1747423X.2014.884644; Levavasseur F, 2016, LAND USE POLICY, V50, P441, DOI 10.1016/j.landusepol.2015.08.033; Levavasseur F, 2014, AGR WATER MANAGE, V140, P14, DOI 10.1016/j.agwat.2014.03.012; Levavasseur F, 2012, HYDROL PROCESS, V26, P3393, DOI 10.1002/hyp.8422; Levavasseur F., 2012, THESIS; Li XH, 2013, INTEGR ZOOL, V8, P124, DOI 10.1111/1749-4877.12000; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x; Luzuriaga AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041270; Maheu-Giroux M, 2007, LANDSCAPE ECOL, V22, P285, DOI 10.1007/s10980-006-9024-z; Maidment D. R., 1996, 3 INT C GIS ENV MOD; Manhoudt AGE, 2007, AGR ECOSYST ENVIRON, V119, P353, DOI 10.1016/j.agee.2006.08.004; Manolaki P, 2016, RIVER RES APPL, V32, P639, DOI 10.1002/rra.2878; Margoum C, 2006, CHEMOSPHERE, V63, P1835, DOI 10.1016/j.chemosphere.2005.10.032; Meineri E, 2012, ECOL MODEL, V231, P1, DOI 10.1016/j.ecolmodel.2012.01.021; Merritt DM, 2010, FRESHWATER BIOL, V55, P206, DOI 10.1111/j.1365-2427.2009.02206.x; Merritt DM, 2006, RIVER RES APPL, V22, P1, DOI 10.1002/rra.890; MINSHALL GW, 1985, CAN J FISH AQUAT SCI, V42, P1045, DOI 10.1139/f85-130; Moore MT, 2010, ENVIRON POLLUT, V158, P175, DOI 10.1016/j.envpol.2009.07.024; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Moresmau M. N., 2013, THESIS; Needelman BA, 2007, J SOIL WATER CONSERV, V62, P207; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; OCALLAGHAN JF, 1984, COMPUT VISION GRAPH, V28, P323, DOI [10.1016/S0734-189X(84)80011-0, 10.1016/0734-189X(89)90053-4]; Pebesma E. J., 2005, R NEWS, V5, P9; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Petit S, 2011, AGRON SUSTAIN DEV, V31, P309, DOI 10.1051/agro/2010020; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; QGIS Development Team, 2016, QGIS GEOGR INF SYST; R Development Core Team, 2016, R LANG ENV STAT COMP; Rivaes R, 2013, ECOHYDROLOGY, V6, P413, DOI 10.1002/eco.1287; Saco PM, 2007, HYDROL EARTH SYST SC, V11, P1717, DOI 10.5194/hess-11-1717-2007; San Martin C, 2016, FOREST ECOL MANAG, V379, P37, DOI 10.1016/j.foreco.2016.08.001; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Solymos P, 2016, PBAPPLY ADDING PROGR; Soomers H, 2010, FRESHWATER BIOL, V55, P2032, DOI 10.1111/j.1365-2427.2010.02460.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thomas RE, 2014, J HYDRAUL RES, V52, P311, DOI 10.1080/00221686.2013.876453; Twisk W, 2003, AQUAT ECOL, V37, P191, DOI 10.1023/A:1023944028022; Valladares F, 2015, FRONT PLANT SCI, P6; van Dijk WFA, 2014, BIOL CONSERV, V171, P91, DOI 10.1016/j.biocon.2014.01.006; von der Lippe M, 2012, PERSPECT PLANT ECOL, V14, P123, DOI 10.1016/j.ppees.2011.09.006; West AM, 2016, ECOL INFORM, V36, P126, DOI 10.1016/j.ecoinf.2016.11.001; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	103	6	6	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191397	10.1371/journal.pone.0191397	http://dx.doi.org/10.1371/journal.pone.0191397			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360857	gold, Green Published, Green Submitted			2022-12-27	WOS:000423161800027
J	Yu, X; Stallone, JN; Heaps, CL; Han, GC				Yu, Xuan; Stallone, John N.; Heaps, Cristine L.; Han, Guichun			The activation of G protein-coupled estrogen receptor induces relaxation via cAMP as well as potentiates contraction via EGFR transactivation in porcine coronary arteries	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; KINASE CASCADES; HEART-DISEASE; AGONIST; REQUIRES; GPR30; TONE; VASOCONSTRICTION; STIMULATION; INVOLVEMENT	Estrogen exerts protective effects against cardiovascular diseases in premenopausal women, but is associated with an increased risk of both coronary heart disease and stroke in older postmenopausal women. Studies have shown that activation of the G-protein-coupled estrogen receptor 1 (GPER) can cause either relaxation or contraction of arteries. It is highly likely that these dual actions of GPER may contribute to the seemingly paradoxical effects of estrogen in regulating coronary artery function. The objective of this study was to test the hypothesis that activation of GPER enhances agonist-stimulated porcine coronary artery contraction via epidermal growth factor receptor (EGFR) transactivation and its downstream extracellular signal-regulated kinases (ERK1/2) pathway. Isometric tension studies and western blot were performed to determine the effect of GPER activation on coronary artery contraction. Our findings demonstrated that G-1 caused concentration-dependent relaxation of ET-1 -induced contraction, while pretreatment of arterial rings with G-1 significantly enhanced ET-1-induced contraction. GPER antagonist, G-36, significantly inhibited both the G-1-induced relaxation effect and G-1 -enhanced ET-1 contraction. Gallein, a G beta gamma inhibitor, significantly increased G-1-induced relaxation, yet inhibited G-1-enhanced ET-1-mediated contraction. Similarly, inhibition of EGFR with AG 1478 or inhibition of Src with phosphatase 2 further increased G-1-induced relaxation responses in coronary arteries, but decreased G-1-enhanced ET-1-induced contraction. Western blot experiments in porcine coronary artery smooth muscle cells (PCASMC) showed that G-1 increased tyrosine phosphorylation of EGFR, which was inhibited by AG-1478. Furthermore, enzyme-linked immunosorbent assays showed that the level of heparin-binding EGF (HB-EGF) released by ET-1 treatment increased two-fold; whereas pre-incubation with G-1 further increased ET-1-induced HB-EGF release to four-fold over control conditions. Lastly, the role of ERK1/2 was determined by applying the MEK inhibitor, PD98059, in isometric tension studies and detecting phospho-ERK1/2 in immunoblotting. PD98059 potentiated G-1-induced relaxation response, but blocked G-1-enhanced ET-1-induced contraction. By western blot, G-1 treatment decreased phospho-ERK1/2, however, in the presence of the adenylyl cyclase inhibitor, SQ22536, G-1 significantly increased ERK1/2 phosphorylation in PCASMC. These data demonstrate that activation of GPER induces relaxation via cAMP as well as contraction via a mechanism involving transactivation of EGFR and the phosphorylation of ERK1/2 in porcine coronary arteries.	[Yu, Xuan; Stallone, John N.; Heaps, Cristine L.; Han, Guichun] Texas A&M Univ, Coll Vet Med & Biomed Sci, Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Stallone, John N.; Heaps, Cristine L.; Han, Guichun] Texas A&M Univ, Michael E DeBakey Inst, Womens Hlth Div, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Han, GC (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Vet Physiol & Pharmacol, College Stn, TX 77843 USA.; Han, GC (corresponding author), Texas A&M Univ, Michael E DeBakey Inst, Womens Hlth Div, College Stn, TX 77843 USA.	ghan@cvm.tamu.edu		Han, Guichun/0000-0001-5269-0363; Yu, Xuan/0000-0003-3343-7105	American Heart Association [15BGIA25060013]	American Heart Association(American Heart Association)	Funded by grant number: 15BGIA25060013. URLs: http://www.heart.org/HEARTORG/ American Heart Association. GH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AH, 2011, MICROVASC RES, V81, P135, DOI 10.1016/j.mvr.2010.11.001; [Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a; Batenburg WW, 2012, CARDIOVASC RES; Belmadani S, 2008, DIABETES, V57, P1629, DOI 10.2337/db07-0739; Benter IF, 2005, BRIT J PHARMACOL, V145, P829, DOI 10.1038/sj.bjp.0706238; Bhattacharya I, 2011, EUR J PHARMACOL, V658, P22, DOI 10.1016/j.ejphar.2010.09.053; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Broughton BRS, 2010, AM J PHYSIOL-HEART C, V298, pH1055, DOI 10.1152/ajpheart.00878.2009; CHAMLEYCAMPBELL JH, 1981, J CELL BIOL, V89, P379, DOI 10.1083/jcb.89.2.379; Debortoli AR, 2017, J MOL ENDOCRINOL, V59, P171, DOI 10.1530/JME-16-0117; Dennis MK, 2011, J STEROID BIOCHEM, V127, P358, DOI 10.1016/j.jsbmb.2011.07.002; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Feng J, 2010, SURGERY, V147, P798, DOI 10.1016/j.surg.2009.11.016; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Griol-Charhbili V, 2011, HYPERTENSION, V57, P238, DOI 10.1161/HYPERTENSIONAHA.110.153619; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Han GC, 2013, PHARMACOL RES, V71, P53, DOI 10.1016/j.phrs.2013.02.008; Hao L, 2004, CIRC RES, V94, P68, DOI 10.1161/01.RES.0000109413.57726.91; Hodis HN, 2014, J STEROID BIOCHEM, V142, P68, DOI 10.1016/j.jsbmb.2013.06.011; Iwasaki H, 1999, ENDOCRINOLOGY, V140, P4659, DOI 10.1210/en.140.10.4659; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kopetz Scott, 2007, Gastrointest Cancer Res, V1, pS37; Kurt AH, 2013, EUR J PHARMACOL, V702, P71, DOI 10.1016/j.ejphar.2013.01.020; Lekontseva ON, 2010, MENOPAUSE, V17, P516, DOI 10.1097/gme.0b013e3181c91f04; Li F, 2013, ACTIVATION GPER INDU; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064771; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Low AK, 2002, AM J MED SCI, V324, P180, DOI 10.1097/00000441-200210000-00003; Lucchesi PA, 2004, CIRCULATION, V110, P3587, DOI 10.1161/01.CIR.0000148780.36121.47; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Makki N, 2013, INT J MOL SCI, V14, P20597, DOI 10.3390/ijms141020597; Meyer MR, 2010, PHARMACOLOGY, V86, P58, DOI 10.1159/000315497; Nagareddy PR, 2010, CARDIOVASC RES, V87, P177, DOI 10.1093/cvr/cvq030; Nagareddy PR, 2009, CARDIOVASC RES, V84, P368, DOI 10.1093/cvr/cvp230; Nakao F, 2002, CIRC RES, V91, P953, DOI 10.1161/01.RES.0000042702.04920.BF; Overland AC, 2015, J BIOL CHEM, V290, P9941, DOI 10.1074/jbc.C115.647073; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Quinn JA, 2009, MOL ENDOCRINOL, V23, P1052, DOI 10.1210/me.2008-0262; Syrovatkina V, 2016, J MOL BIOL, V428, P3850, DOI 10.1016/j.jmb.2016.08.002; Yu XY, 2011, CHEMOSPHERE, V85, P1284, DOI 10.1016/j.chemosphere.2011.07.031; Yu X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173085; Yu X, 2014, AM J PHYSIOL-ENDOC M, V307, pE398, DOI 10.1152/ajpendo.00534.2013; Yu X, 2011, AM J PHYSIOL-ENDOC M, V301, pE882, DOI 10.1152/ajpendo.00037.2011	47	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191418	10.1371/journal.pone.0191418	http://dx.doi.org/10.1371/journal.pone.0191418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360846	Green Published, gold, Green Submitted			2022-12-27	WOS:000423161800030
J	Coutinho, E; Schuller, B				Coutinho, Eduardo; Schuller, Bjorn			Shared acoustic codes underlie emotional communication in music and speech-Evidence from deep transfer learning (vol 12, e0179289, 2017)	PLOS ONE			English	Correction																		Coutinho E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179289	1	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191754	10.1371/journal.pone.0191754	http://dx.doi.org/10.1371/journal.pone.0191754			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352291	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300129
J	Ghandhi, SA; Turner, HC; Shuryak, I; Dugan, GO; Bourland, JD; Olson, JD; Tooze, JA; Morton, SR; Batinic-Haberle, I; Cline, JM; Amundson, SA				Ghandhi, Shanaz A.; Turner, Helen C.; Shuryak, Igor; Dugan, Gregory O.; Bourland, J. Daniel; Olson, John D.; Tooze, Janet A.; Morton, Shad R.; Batinic-Haberle, Ines; Cline, J. Mark; Amundson, Sally A.			Whole thorax irradiation of non-human primates induces persistent nuclear damage and gene expression changes in peripheral blood cells	PLOS ONE			English	Article							ACUTE-RADIATION-SYNDROME; RHESUS MACAQUES; ANIMAL-MODELS; IONIZING-RADIATION; MICRONUCLEUS ASSAY; TRANSGLUTAMINASE 2; DOSE IRRADIATION; PROTEIN; BIODOSIMETRY; EXPOSURE	We investigated the cytogenetic and gene expression responses of peripheral blood cells of non-human primates (NHP, Macaca mulatta) that were whole-thorax irradiated with a single dose of 10 Gy. In this model, partial irradiation of NHPs in the thoracic region (Whole Thorax Lung Irradiation, WTLI) allows the study of late radiation-induced lung injury, while avoiding acute radiation syndromes related to hematopoietic and gastrointestinal injury. A transient drop in circulating lymphocytes and platelets was seen by 9 days, followed by elevations in respiratory rate, circulating neutrophils, lymphocytes, and monocytes at 60 +/- 100 days, corresponding to computed tomography (CT) and histologic evidence of pneumonitis, and elective euthanasia of four animals. To evaluate long-term DNA damage in NHP peripheral blood lymphocytes after 10 Gy WTLI, we used the cytokinesis-block micronucleus (CBMN) assay to measure chromosomal aberrations as post-mitotic micronuclei in blood samples collected up to 8 months after irradiation. Regression analysis showed significant induction of micronuclei in NHP blood cells that persisted with a gradual decline over the 8-month study period, suggesting long-term DNA damage in blood lymphocytes after WTLI. We also report transcriptomic changes in blood up to 30 days after WTLI. We isolated total RNA from peripheral blood at 3 days before and then at 2, 5 and 30 days after irradiation. We identified 1187 transcripts that were significantly changed across the 30-day time course. From changes in gene expression, we identified biological processes related to immune responses, which persisted across the 30-day study. Response to oxygen-containing compounds and bacteria were implicated by gene-expression changes at the earliest day 2 and latest, day 30 time-points. Gene expression changes suggest a persistent altered state of the immune system, specifically response to infection, for at least a month after WTLI.	[Ghandhi, Shanaz A.; Turner, Helen C.; Shuryak, Igor; Morton, Shad R.; Amundson, Sally A.] Columbia Univ, Med Ctr, Ctr Radiol Res, New York, NY 10027 USA; [Dugan, Gregory O.; Bourland, J. Daniel; Olson, John D.; Tooze, Janet A.; Cline, J. Mark] Wake Forest Baptist Med Ctr, Med Ctr Blvd, Winston Salem, NC USA; [Batinic-Haberle, Ines] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Columbia University; Wake Forest University; Wake Forest Baptist Medical Center; Duke University	Ghandhi, SA (corresponding author), Columbia Univ, Med Ctr, Ctr Radiol Res, New York, NY 10027 USA.	sg2423@cumc.columbia.edu	Ghandhi, Shanaz/C-5930-2016		Center for High-Throughput Minimally-Invasive Radiation Biodosimetry; National Institute of Allergy and Infectious Diseases [U19 A1067773]; Radiation Countermeasures Center of Research Excellence, National Institute of Allergy and Infectious Diseases [U19 AI A167798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798, U19AI067773] Funding Source: NIH RePORTER	Center for High-Throughput Minimally-Invasive Radiation Biodosimetry; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Radiation Countermeasures Center of Research Excellence, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Center for High-Throughput Minimally-Invasive Radiation Biodosimetry, National Institute of Allergy and Infectious Diseases (https://www.niaid.nil.gov/) grant number U19 A1067773 and the Radiation Countermeasures Center of Research Excellence, National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/) grant number U19 AI A167798. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa6593; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; [Anonymous], 2011, GUIDE FOR THE CARE A; Batinic-Haberle I, 2014, ANTIOXID REDOX SIGN, V20, P2372, DOI 10.1089/ars.2012.5147; Boraschi D, 2013, SEMIN IMMUNOL, V25, P394, DOI 10.1016/j.smim.2013.10.023; Bosco MC, 2006, J IMMUNOL, V177, P1941, DOI 10.4049/jimmunol.177.3.1941; Broustas CG, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3436-1; Budworth H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048619; BUTTURINI A, 1988, LANCET, V2, P471; Choi SY, 2006, J BIOL CHEM, V281, P7049, DOI 10.1074/jbc.M512000200; Daadi MM, 2014, STEM CELLS DEV, V23, P83, DOI 10.1089/scd.2014.0374; Dillman JF, 2005, TOXICOL SCI, V87, P306, DOI 10.1093/toxsci/kfi243; DOCK DS, 1961, J CLIN INVEST, V40, P317, DOI 10.1172/JCI104259; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Falasca L, 2008, J IMMUNOL, V180, P2616, DOI 10.4049/jimmunol.180.4.2616; Farese AM, 2015, HEALTH PHYS, V109, P414, DOI 10.1097/HP.0000000000000348; Farese AM, 2012, HEALTH PHYS, V103, P367, DOI 10.1097/HP.0b013e31825f75a7; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P65, DOI 10.1016/S1383-5718(02)00249-8; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fenech M, 2010, HEALTH PHYS, V98, P234, DOI 10.1097/HP.0b013e3181b85044; Ganapathy S, 2014, J BIOL CHEM, V289, P5340, DOI 10.1074/jbc.M113.531020; Gao Y., 2017, IONICS, V7, P1, DOI DOI 10.1016/J.GENE.2017.03.021; Garofalo M, 2014, HEALTH PHYS, V106, P56, DOI 10.1097/HP.0b013e3182a32b3f; Ghandhi SA, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0097-x; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gregoire E, 2006, INT J RADIAT BIOL, V82, P493, DOI 10.1080/09553000600840930; Grow DA, 2016, STEM CELL RES, V17, P352, DOI 10.1016/j.scr.2016.08.013; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Haber S, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025092; Hematti P, 2005, EXP HEMATOL, V33, P980, DOI 10.1016/j.exphem.2005.06.008; Hong SG, 2016, MOL THER, V24, P1165, DOI 10.1038/mt.2016.131; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iskow RC, 2012, P NATL ACAD SCI USA, V109, P12656, DOI 10.1073/pnas.1205199109; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Leinonen HM, 2015, BIOCHEM SOC T, V43, P645, DOI 10.1042/BST20150048; Lu TX, 2013, J IMMUNOL, V190, P1576, DOI 10.4049/jimmunol.1202897; MacVittie TJ, 2015, HEALTH PHYS, V109, P342, DOI 10.1097/HP.0000000000000352; MacVittie TJ, 2012, HEALTH PHYS, V103, P411, DOI 10.1097/HP.0b013e31826525f0; MacVittie TJ, 2012, HEALTH PHYS, V103, P427, DOI 10.1097/HP.0b013e318266eb4c; MacVittie TJ, 2012, HEALTH PHYS, V103, P340, DOI 10.1097/HP.0b013e318261175a; Manning G, 2013, INT J RADIAT BIOL, V89, P512, DOI 10.3109/09553002.2013.769694; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Park JG, 2017, RADIAT RES, V187, P708, DOI 10.1667/RR14655.1; Paul S, 2015, RADIAT RES, V184, P24, DOI 10.1667/RR14044.1; Paul S, 2014, RADIAT RES, V182, P380, DOI 10.1667/RR13466.1; Petibone DM, 2008, MUTAT RES-GEN TOX EN, V653, P76, DOI 10.1016/j.mrgentox.2008.03.012; Port M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030541; Prado C, 2015, HEALTH PHYS, V109, P367, DOI 10.1097/HP.0000000000000336; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao RP, 2001, CANCER RES, V61, P7413; Simon R, 2007, CANCER INFORM, V3, P11; Singh VK, 2017, EXPERT OPIN DRUG DIS, V12, P695, DOI 10.1080/17460441.2017.1323863; Singh VK, 2014, EXPERT OPIN THER PAT, V24, P1229, DOI 10.1517/13543776.2014.964684; Song J, 2016, VIRUS RES, V214, P1, DOI 10.1016/j.virusres.2016.01.002; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Thierens H, 2005, RADIAT PROT DOSIM, V113, P408, DOI 10.1093/rpd/nch483; Thrall KD, 2015, HEALTH PHYS, V109, P502, DOI 10.1097/HP.0000000000000339; U. S Department of Health and Human Services FDA Center for Devices and Radiological Health, 2016, GUID IND FOOD DRUG A; VANDYK J, 1981, INT J RADIAT ONCOL, V7, P461, DOI 10.1016/0360-3016(81)90131-0; Vral A, 2011, MUTAGENESIS, V26, P11, DOI 10.1093/mutage/geq078; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1	66	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191402	10.1371/journal.pone.0191402	http://dx.doi.org/10.1371/journal.pone.0191402			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351567	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300084
J	Lungu, EA; Obse, AG; Darker, C; Biesma, R				Lungu, Edgar Arnold; Obse, Amarech Guda; Darker, Catherine; Biesma, Regien			What influences where they seek care? Caregivers' preferences for under-five child healthcare services in urban slums of Malawi: A discrete choice experiment	PLOS ONE			English	Article							MORTALITY; INSURANCE; ACCESS; SECTOR	Access to and utilisation of quality healthcare promotes positive child health outcomes. However, to be optimally utilised, the healthcare system needs to be responsive to the expectations of the population it serves. Health systems in many sub-Saharan African countries, including Malawi, have historically focused on promoting access to health services by the rural poor. However, in the context of increasing urbanisation and consequent proliferation of urban slums, promoting health of children under five years of age in these settings is a public health imperative. We conducted a discrete choice experiment to determine the relative importance of health facility factors in seeking healthcare for childhood illnesses in urban slums of Malawi. Caregivers of children under five years of age were presented with choice cards that depicted two hypothetical health facilities using six health facility attributes: availability of medicines and supplies, thoroughness of physical examination of the child, attitude of health workers, cost, distance, and waiting time. Caregivers were asked to indicate the health facility they would prefer to use. A mixed logit model was used to estimate the relative importance of and willingness to pay (WTP) for health facility attributes. Attributes with greatest influence on choice were: availability of medicines and supplies (beta = 0.842, p<0.001) and thorough examination of the child (beta = 0.479, p < 0.001) with WTP of MK3698.32 ($11) (95% CI: $8 +/- $13) and MK2049.13 ($6) (95% CI: $3 +/- $9) respectively. Respondents were willing to pay 1.8 and 2.4 times more for medicine availability over thorough examination and positive attitude of health workers respectively. Therefore, strengthening health service delivery system through investment in sustained availability of essential medicines and supplies, sufficient and competent health workforce with positive attitude and clinical discipline to undertake thorough examination, and reductions in waiting times have the potential to improve child healthcare utilization in the urban slums.	[Lungu, Edgar Arnold] UNICEF Malawi, HIV AIDS Sect, Lilongwe, Malawi; [Obse, Amarech Guda] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, Cape Town, South Africa; [Darker, Catherine] Trinity Coll Dublin, Dept Publ Hlth & Primary Care, Dublin, Ireland; [Biesma, Regien] Royal Coll Surgeons Ireland, Dept Epidemiol & Publ Hlth Med, Dublin, Ireland	University of Cape Town; Trinity College Dublin; Royal College of Surgeons - Ireland	Lungu, EA (corresponding author), UNICEF Malawi, HIV AIDS Sect, Lilongwe, Malawi.	edgar.lungu@gmail.com	Biesma, Regien/D-8803-2017	Biesma, Regien/0000-0002-5532-0242	Connecting Health Research in Africa and Ireland Consortium (CHRAIC); Health Research Capacity Strengthening Initiative	Connecting Health Research in Africa and Ireland Consortium (CHRAIC); Health Research Capacity Strengthening Initiative	We would like to acknowledge the support rendered by the Connecting Health Research in Africa and Ireland Consortium (CHRAIC) and the Health Research Capacity Strengthening Initiative for the financial support to undertake field work for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiiro GA, 2014, SOC SCI MED, V120, P160, DOI 10.1016/j.socscimed.2014.09.021; APHRC (African Population and Health Research Centre), 2002, POP HLTH DYN NAIR IN; Bassiahi A. S, 2014, J URBAN HEALTH, V92, P1; Biesma RG, 2007, ECON EDUC REV, V26, P375, DOI 10.1016/j.econedurev.2006.01.004; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Government of Malawi, 2011, MAL HLTH SECT STRAT; Government Of Malawi, 2013, CHILD HLTH STRAT SUR; Government Of Malawi, 2017, MAL HLTH SECT STRAT; Government of Malawi, 2008, NAT STRAT PLAN ACC C; Hanson K, 2005, HEALTH ECON, V14, P687, DOI 10.1002/hec.959; Harpham T, 2009, HEALTH PLACE, V15, P107, DOI 10.1016/j.healthplace.2008.03.004; Hole AR, 2007, STATA J, V7, P388, DOI 10.1177/1536867X0700700306; Honda A, 2015, HEALTH POLICY PLANN, V30, P600, DOI 10.1093/heapol/czu038; Kimani-Murage EW, 2014, HEALTH PLACE, V29, P95, DOI 10.1016/j.healthplace.2014.06.003; Kruk ME, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2009.087973; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Krukz ME, 2011, HEALTH SERV RES, V46, P2057, DOI 10.1111/j.1475-6773.2011.01266.x; Kuhfeld W.F., 2010, SAS; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Larson E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135621; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; Lungu EA, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1678-x; Lusk JL, 2003, AM J AGR ECON, V85, P840, DOI 10.1111/1467-8276.00492; Mandeville KL, 2016, SOC SCI MED, V169, P109, DOI 10.1016/j.socscimed.2016.09.034; Mangham LJ, 2009, HEALTH POLICY PLANN, V24, P151, DOI 10.1093/heapol/czn047; Mangham LJ, 2008, TROP MED INT HEALTH, V13, P1433, DOI 10.1111/j.1365-3156.2008.02167.x; MANSKI CF, 1977, THEOR DECIS, V8, P229, DOI 10.1007/BF00133443; McFadden D., 1974, CONDITIONAL LOGIT AN, P105, DOI DOI 10.1108/EB028592; Michaels-Igbokwe C, 2015, PLOS ONE, V2, P10; Michaels-Igbokwe C, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-015-0046-6; Michaels-Igbokwe C, 2014, SOC SCI MED, V105, P93, DOI 10.1016/j.socscimed.2014.01.016; Noor AM, 2003, TROP MED INT HEALTH, V8, P917, DOI 10.1046/j.1365-3156.2003.01112.x; Obse A, 2016, HEALTH POLICY PLANN, V31, P1423, DOI 10.1093/heapol/czw084; Pokhrel S, 2006, HLTH RES POLICY SYST, V4; Rutherford ME, 2010, TROP MED INT HEALTH, V15, P508, DOI 10.1111/j.1365-3156.2010.02497.x; Ryan M, 2008, USING DISCRETE EXPT; Ryan M, 2012, APPL DISCRETE CHOICE; Train K.E., 2002, DISCRETE CHOICE METH; UN-HABITAT, 2006, STAT WORLDS CIT REP; UN-HABITAT, 2010, MAL URB CHALL; Walker N, 2013, LANCET, V382, P1029, DOI 10.1016/S0140-6736(13)61748-1; WHO, 2007, EV BUS STRENGTH HLTH; WHO, 2008, KNOWL NETW URB SETT; World Health Organisation, 2007, CHALL IN HLTH SYST; World Health Organization, 2008, OUR CITIES OUR HLTH; Wynn JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119849	46	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0189940	10.1371/journal.pone.0189940	http://dx.doi.org/10.1371/journal.pone.0189940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351299	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300011
J	Peltier, E; Bernard, M; Trujillo, M; Prodhomme, D; Barbe, JC; Gibon, Y; Marullo, P				Peltier, Emilien; Bernard, Margaux; Trujillo, Marine; Prodhomme, Duyen; Barbe, Jean-Christophe; Gibon, Yves; Marullo, Philippe			Wine yeast phenomics: A standardized fermentation method for assessing quantitative traits of Saccharomyces cerevisiae strains in enological conditions	PLOS ONE			English	Article							SULFITE EFFLUX; OXYGEN; GLYCEROL; VOLATILE; NITROGEN; IDENTIFICATION; DOMESTICATION; VARIANTS; ESTERS; MET2	This work describes the set up of a small scale fermentation methodology for measuring quantitative traits of hundreds of samples in an enological context. By using standardized screw cap vessels, the alcoholic fermentation kinetics of Saccharomyces cerevisiae strains were measured by following their weight loss over the time. This dispositive was coupled with robotized enzymatic assays for measuring metabolites of enological interest in natural grape juices. Despite the small volume used, kinetic parameters and fermentation end products measured are similar with those observed in larger scale vats. The vessel used also offers the possibility to assay 32 volatiles compounds using a headspace solid-phase micro-extraction coupled to gas chromatography and mass spectrometry. The vessel shaking applied strongly impacted most of the phenotypes investigated due to oxygen transfer occuring in the first hours of the alcoholic fermentation. The impact of grape must and micro-oxygenation was investigated illustrating some relevant genetic x environmental interactions. By phenotyping a wide panel of commercial wine starters in five grape juices, broad phenotypic correlations between kinetics and metabolic end products were evidentiated. Moreover, a multivariate analysis illustrates that some grape musts are more able than others to discriminate commercial strains since some are less robust to environmental changes.	[Peltier, Emilien; Bernard, Margaux; Trujillo, Marine; Barbe, Jean-Christophe; Marullo, Philippe] Univ Bordeaux, ISVV, INRA, bordeaux INP,USC 1366 INRA,Unite Rech Enol,EA4577, Villenave Dornon, France; [Peltier, Emilien; Bernard, Margaux; Marullo, Philippe] Biolaffort, Bordeaux, France; [Trujillo, Marine] Pernod Ricard, Creteil, France; [Prodhomme, Duyen; Gibon, Yves] Univ Bordeaux, INRA, UMR 1332, Fruit Biol & Pathol, Villenave Dornon, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Peltier, E (corresponding author), Univ Bordeaux, ISVV, INRA, bordeaux INP,USC 1366 INRA,Unite Rech Enol,EA4577, Villenave Dornon, France.; Peltier, E (corresponding author), Biolaffort, Bordeaux, France.	emilien.peltier@u-bordeaux.fr		Nurmi, Petteri/0000-0001-8262-6434; Gibon, Yves/0000-0001-8161-1089; Marullo, Philippe/0000-0002-3594-5173; Peltier, Emilien/0000-0002-1773-5308	Region d'Aquitaine	Region d'Aquitaine	This work was funded by Region d'Aquitaine (https://www.nouvelle-aquitaine.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertin W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094246; Albertin W, 2011, APPL ENVIRON MICROB, V77, P2772, DOI 10.1128/AEM.02547-10; Alfenore S, 2004, APPL MICROBIOL BIOT, V63, P537, DOI 10.1007/s00253-003-1393-5; Almeida P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5044; Ambroset C, 2011, G3-GENES GENOM GENET, V1, P263, DOI 10.1534/g3.111.000422; ANDERSON RG, 1975, J I BREWING, V81, P111, DOI 10.1002/j.2050-0416.1975.tb03671.x; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Antalick G, 2010, FOOD CHEM, V121, P1236, DOI 10.1016/j.foodchem.2010.01.011; Bean GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085177; BELY M, 1990, AM J ENOL VITICULT, V41, P319; Bertrand A, 1984, SCI ALIMENTS; Blateyron L, 2001, J BIOSCI BIOENG, V91, P184, DOI 10.1263/jbb.91.184; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Borneman AR, 2016, G3-GENES GENOM GENET, V6, P957, DOI 10.1534/g3.115.025692; Borneman AR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004161; Camarasa C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025147; Campbell-Sills H, 2015, GENOME BIOL EVOL, V7, P1506, DOI 10.1093/gbe/evv084; Cubillos FA, 2017, G3-GENES GENOM GENET, V7, P1693, DOI 10.1534/g3.117.042127; da Silva T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123834; de Mendiburu F., 2019, AGRICOLAE STAT PROCE; Delfini C., 1991, VITIC ENOL SCI, V46, P142; du Toit W. J., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P76; Dufour M, 2013, APPL MICROBIOL BIOT, V97, P5893, DOI 10.1007/s00253-013-4739-7; Fornairon-Bonnefond C, 2003, J BIOSCI BIOENG, V95, P496, DOI 10.1016/S1389-1723(03)80051-8; Gallone B, 2016, CELL, V166, P1397, DOI 10.1016/j.cell.2016.08.020; Garcia-Rios E, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3572-2; GARDNER N, 1993, APPL ENVIRON MICROB, V59, P2022, DOI 10.1128/AEM.59.7.2022-2028.1993; Gibbons JG, 2015, CURR OPIN GENET DEV, V35, P1, DOI 10.1016/j.gde.2015.07.003; Huang C, 2014, APPL MICROBIOL BIOT, V98, P7125, DOI 10.1007/s00253-014-5789-1; Husnik JI, 2007, AM J ENOL VITICULT, V58, P42; Julien A, 2000, AM J ENOL VITICULT, V51, P215; Liti G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002912; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Malcorps P, 1991, J AM SOC BREWING CHE; Marsit S, 2015, MOL BIOL EVOL; Marsit S, 2017, NAT REV GENET; Marti-Raga M, 2016, FOOD MICROBIOL, V54, P106, DOI 10.1016/j.fm.2015.10.009; Marti-Raga M, 2017, G3-GENES GENOM GENET, V7, P399, DOI 10.1534/g3.116.037283; Marullo P, 2007, FEMS YEAST RES, V7, P1295, DOI 10.1111/j.1567-1364.2007.00281.x; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; Marullo P, 2009, FEMS YEAST RES, V9, P1148, DOI 10.1111/j.1567-1364.2009.00550.x; Nardi T, 2010, MICROBIOL-SGM, V156, P1686, DOI 10.1099/mic.0.036723-0; Noble J, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0245-1; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Park H, 2000, YEAST, V16, P881, DOI 10.1002/1097-0061(200007)16:10<881::AID-YEA576>3.0.CO;2-3; Perez-Ortin JE, 2002, GENOME RES, V12, P1533, DOI 10.1101/gr.436602; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; R Development Core Team, 2011, R FDN STAT COMP; Reddy LVA, 2011, FOOD BIOPROD PROCESS, V89, P487, DOI 10.1016/j.fbp.2010.11.007; Remize F, 2000, J APPL MICROBIOL, V88, P371, DOI 10.1046/j.1365-2672.2000.00964.x; Saayman M, 2006, BIOCH MALIC ACID MET; Salinas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049640; STITT M, 1989, METHOD ENZYMOL, V174, P518; Torrens J, 2008, INT J FOOD MICROBIOL, V124, P48, DOI 10.1016/j.ijfoodmicro.2008.02.023; Valero E, 2002, FOOD CHEM, V78, P57, DOI 10.1016/S0308-8146(01)00361-2; Varela C, 2012, FOOD CHEM, V135, P2863, DOI 10.1016/j.foodchem.2012.06.127; Volschenk H, 2003, CURR GENET, V43, P379, DOI 10.1007/s00294-003-0411-6; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Warringer J, 2014, YEAST PHENOMICS LARG; Wilkening S, 2014, GENETICS, V196, P853, DOI 10.1534/genetics.113.160291; Zimmer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086298	62	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190094	10.1371/journal.pone.0190094	http://dx.doi.org/10.1371/journal.pone.0190094			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351285	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300015
J	van der Ven, AT; Kobbe, B; Kohl, S; Shril, S; Pogoda, HM; Imhof, T; Ityel, H; Vivante, A; Chen, J; Hwang, DY; Connaughton, DM; Mann, N; Widmeier, E; Taglienti, M; Schmidt, JM; Nakayama, M; Senguttuvan, P; Kumar, S; Tasic, V; Kehinde, EO; Mane, SM; Lifton, RP; Soliman, N; Lu, WN; Bauer, SB; Hammerschmidt, M; Wagener, R; Hildebrandt, F				van der Ven, Amelie T.; Kobbe, Birgit; Kohl, Stefan; Shril, Shirlee; Pogoda, Hans-Martin; Imhof, Thomas; Ityel, Hadas; Vivante, Asaf; Chen, Jing; Hwang, Daw-Yang; Connaughton, Dervla M.; Mann, Nina; Widmeier, Eugen; Taglienti, Mary; Schmidt, Johanna Magdalena; Nakayama, Makiko; Senguttuvan, Prabha; Kumar, Selvin; Tasic, Velibor; Kehinde, Elijah O.; Mane, Shrikant M.; Lifton, Richard P.; Soliman, Neveen; Lu, Weining; Bauer, Stuart B.; Hammerschmidt, Matthias; Wagener, Raimund; Hildebrandt, Friedhelm			A homozygous missense variant in VWA2, encoding an interactor of the Fraser-complex, in a patient with vesicoureteral refluxy	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEIN; URINARY-TRACT MALFORMATIONS; MULTIPOINT LINKAGE ANALYSIS; CONGENITAL-ANOMALIES; RECESSIVE MUTATIONS; KIDNEY-DISEASES; IDENTIFICATION; DYSREGULATION; NEPHRONECTIN; EXPRESSION	Congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause (40-50%) of chronic kidney disease (CKD) in children. About 40 monogenic causes of CAKUT have so far been discovered. To date less than 20% of CAKUT cases can be explained by mutations in these 40 genes. To identify additional monogenic causes of CAKUT, we performed whole exome sequencing (WES) and homozygosity mapping (HM) in a patient with CAKUT from Indian origin and consanguineous descent. We identified a homozygous missense mutation (c.1336C>T, p.Arg446Cys) in the gene Von Willebrand factor A domain containing 2 (VWA2). With immunohistochemistry studies on kidneys of newborn (P1) mice, we show that Vwa2 and Fraser extracellular matrix complex subunit 1 (Fras1) co-localize in the nephrogenic zone of the renal cortex. We identified a pronounced expression of Vwa2 in the basement membrane of the ureteric bud (UB) and derivatives of the metanephric mesenchyme (MM). By applying in vitro assays, we demonstrate that the Arg446Cys mutation decreases translocation of monomeric VWA2 protein and increases translocation of aggregated VWA2 protein into the extracellular space. This is potentially due to the additional, unpaired cysteine residue in the mutated protein that is used for intermolecular disulfide bond formation. VWA2 is a known, direct interactor of FRAS1 of the Fraser-Complex (FC). FC-encoding genes and interacting proteins have previously been implicated in the pathogenesis of syndromic and/or isolated CAKUT phenotypes in humans. VWA2 therefore constitutes a very strong candidate in the search for novel CAKUT-causing genes. Our results from in vitro experiments indicate a dose-dependent neomorphic effect of the Arg446Cys homozygous mutation in VWA2.	[van der Ven, Amelie T.; Kohl, Stefan; Shril, Shirlee; Ityel, Hadas; Vivante, Asaf; Chen, Jing; Hwang, Daw-Yang; Connaughton, Dervla M.; Mann, Nina; Widmeier, Eugen; Taglienti, Mary; Schmidt, Johanna Magdalena; Nakayama, Makiko; Hildebrandt, Friedhelm] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Div Nephrol, Boston, MA USA; [Kobbe, Birgit; Wagener, Raimund] Univ Cologne, Ctr Mol Med Cologne, Ctr Biochem, Cologne, Germany; [Kohl, Stefan] Cologne Childrens Hosp, Dept Pediat, Cologne, Germany; [Pogoda, Hans-Martin; Hammerschmidt, Matthias] Univ Cologne, Ctr Mol Med Cologne, Bioctr Cologne, Inst Zool Dev Biol, Cologne, Germany; [Imhof, Thomas] Univ Cologne, Med Fac, Inst Dent Res & Oral Musculoskeletal Biol, Cologne, Germany; [Vivante, Asaf] Sheba Med Ctr, Talpiot Med Leadership Program, Tel Hashomer, Israel; [Chen, Jing] Fudan Univ, Childrens Hosp, Dept Nephrol, Shanghai, Peoples R China; [Hwang, Daw-Yang] Kaohsiung Med Univ, Dept Med, Div Nephrol, Kaohsiung, Taiwan; [Senguttuvan, Prabha] Dr Mehtas Multispecial Hosp, Dept Pediat Nephrol, Chennai, Tamil Nadu, India; [Kumar, Selvin] Tamil Nadu Dr MGR Med Univ, Inst Child Hlth, Dept Pediat Nephrol, Chennai, Tamil Nadu, India; [Kumar, Selvin] Tamil Nadu Dr MGR Med Univ, Hosp Children, Chennai, Tamil Nadu, India; [Tasic, Velibor] Univ Childrens Hosp, Med Fac Skopje, Skopje, Macedonia; [Kehinde, Elijah O.] Nazarbayev Univ, Dept Surg, Div Urol, Astana, Kazakhstan; [Mane, Shrikant M.; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT USA; [Lifton, Richard P.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Soliman, Neveen] Cairo Univ, Ctr Pediat Nephrol & Transplantat, Dept Pediat, Egyptian Grp Orphan Renal Dis, Cairo, Egypt; [Lu, Weining] Boston Univ, Med Ctr, Dept Med, Renal Sect, Boston, MA 02215 USA; [Bauer, Stuart B.] Boston Childrens Hosp, Dept Urol, Boston, MA USA; [Bauer, Stuart B.] Harvard Med Sch, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Chaim Sheba Medical Center; Fudan University; Kaohsiung Medical University; Nazarbayev University; Yale University; Howard Hughes Medical Institute; Egyptian Knowledge Bank (EKB); Cairo University; Boston University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Wagener, R (corresponding author), Univ Cologne, Ctr Mol Med Cologne, Ctr Biochem, Cologne, Germany.	Raimund.wagener@uni-koeln.de; Friedhelm.Hildebrandt@childrens.harvard.edu	Soliman, Neveen A/T-2687-2018; Widmeier, Eugen/AAQ-9854-2020; Wang, Guilin/G-8794-2018; Soliman, Neveen/Y-1583-2019; Shril, Shirlee/Q-5825-2016; Connaughton, Dervla M/AFA-8011-2022; Tasic, Velibor/H-8714-2019	Soliman, Neveen A/0000-0002-8942-1973; Widmeier, Eugen/0000-0002-7773-5190; Soliman, Neveen/0000-0002-8942-1973; Connaughton, Dervla M/0000-0003-3466-6305; Tasic, Velibor/0000-0002-3377-1245; Lu, Weining/0000-0002-6570-3044	National Institutes of Health [DK088767]; German Research Foundation (DFG) [SFB829/B2, SFB829/A9]; Begg family foundation; DFG [VE916/1-1]; Fulbright postdoctoral scholar award; Manton Center Fellowship Program; Boston Children's Hospital, Boston, Massachusetts, USA; Mallinckrodt Research Fellowship Award; Leopoldina Fellowship Program; German National Academy of Sciences Leopoldina [LPDS 2015-07]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078226, R01DK088767, T32DK007726, P30DK079310] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); Begg family foundation; DFG(German Research Foundation (DFG)); Fulbright postdoctoral scholar award; Manton Center Fellowship Program; Boston Children's Hospital, Boston, Massachusetts, USA; Mallinckrodt Research Fellowship Award; Leopoldina Fellowship Program; German National Academy of Sciences Leopoldina; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health [DK088767] to F.H. and from the German Research Foundation (DFG) [SFB829/B2] to R.W. and [SFB829/A9] to M.H. F. H. is supported by the Begg family foundation. A.v. d.V. is supported by a Postdoctoral Research Fellowship from the DFG [VE916/1-1]. A.V. is a recipient of the Fulbright postdoctoral scholar award for 2013 and is also supported by grants from the Manton Center Fellowship Program, Boston Children's Hospital, Boston, Massachusetts, USA, and the Mallinckrodt Research Fellowship Award. EW is supported by the Leopoldina Fellowship Program, German National Academy of Sciences Leopoldina [LPDS 2015-07]. F.H. is a co-founder of Goldfinch Bio with stock options and a consultancy contract, and he receives royalties from Claritas, to whom a diagnostic assay was licensed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Barratt TM, 1999, PEDIAT NEPHROLOGY; Bertoli-Avella AM, 2008, J AM SOC NEPHROL, V19, P825, DOI 10.1681/ASN.2007060692; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Devuyst O, 2014, LANCET, V383, P1844, DOI 10.1016/S0140-6736(14)60659-0; Gebauer JM, 2009, MATRIX BIOL, V28, P456, DOI 10.1016/j.matbio.2009.07.006; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Hildebrandt F, 2010, LANCET, V375, P1287, DOI 10.1016/S0140-6736(10)60236-X; Humbert C, 2014, AM J HUM GENET, V94, P288, DOI 10.1016/j.ajhg.2013.12.017; Hwang DY, 2015, HUM GENET, V134, P905, DOI 10.1007/s00439-015-1570-5; Hwang DY, 2014, KIDNEY INT, V85, P1429, DOI 10.1038/ki.2013.508; Ichikawa I, 2002, KIDNEY INT, V61, P889, DOI 10.1046/j.1523-1755.2002.00188.x; Jadeja S, 2005, NAT GENET, V37, P520, DOI 10.1038/ng1549; Jaworski A, 2015, SCIENCE, V350, P961, DOI 10.1126/science.aad2615; Ju LG, 2017, J IMMUNOL, V198, P1274, DOI 10.4049/jimmunol.1601194; Kereszturi E, 2009, HUM MUTAT; Kiyozumi D, 2006, P NATL ACAD SCI USA, V103, P11981, DOI 10.1073/pnas.0601011103; Kiyozumi D, 2012, J CELL BIOL, V197, P677, DOI 10.1083/jcb.201203065; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Kohl S, 2014, J AM SOC NEPHROL, V25, P1917, DOI 10.1681/ASN.2013101103; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Richardson RJ, 2014, J INVEST DERMATOL, V134, P1313, DOI 10.1038/jid.2013.492; Sanna-Cherchi S, 2007, PEDIATR NEPHROL, V22, P1675, DOI 10.1007/s00467-007-0479-1; Sanna-Cherchi S, 2012, AM J HUM GENET, V91, P987, DOI 10.1016/j.ajhg.2012.10.007; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sengle G, 2003, J BIOL CHEM, V278, P50240, DOI 10.1074/jbc.M307794200; Sigruener A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178368; Slavotinek AM, 2002, J MED GENET, V39, P623, DOI 10.1136/jmg.39.9.623; Soliman NA, 2015, NEPHROLOGY, V20, P413, DOI 10.1111/nep.12414; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Vivante A, 2016, J AM SOC NEPHROL; Vivante A, 2017, J AM SOC NEPHROL; Vivante A H F, 2016, CONGENIT ANOM, P310; Vivante A, 2017, J AM SOC NEPHROL, V28, P2364, DOI 10.1681/ASN.2016060694; Vivante A, 2016, NAT REV NEPHROL, V12, P133, DOI 10.1038/nrneph.2015.205; Vivante A, 2015, AM J HUM GENET, V97, P291, DOI 10.1016/j.ajhg.2015.07.001; Vivante A, 2014, PEDIATR NEPHROL, V29, P695, DOI 10.1007/s00467-013-2684-4; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22861; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	47	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191224	10.1371/journal.pone.0191224	http://dx.doi.org/10.1371/journal.pone.0191224			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351342	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300059
J	Rorvang, MV; Herskin, MS; Jensen, MB				Rorvang, Maria Vilain; Herskin, Mette S.; Jensen, Margit Bak			The motivation-based calving facility: Social and cognitive factors influence isolation seeking behaviour of Holstein dairy cows at calving	PLOS ONE			English	Article							SHORT-COMMUNICATION; MATERNAL-BEHAVIOR; BEEF-COWS; CATTLE; PARTURITION; CONSISTENCY; DEVICES; PREDICT; HEALTH; SOWS	In order to improve animal welfare it is recommended that dairy farmers move calving cows from the herd to individual pens when calving is imminent. However, the practicality of moving cows has proven a challenge and may lead to disturbance of the cows rather than easing the process of calving. One solution may be to allow the cow to seek isolation prior to calving. This study examined whether pre-parturient dairy cows will isolate in an individual calving pen placed in a group calving setting and whether a closing gate in this individual calving pen will cause more cows to isolate prior to calving. Danish Holstein cows (n = 66) were housed in groups of six in a group pen with access to six individual calving pens connected to the group area. Cows were trained to use one of two isolation opportunities i.e. individual calving pens with functional closing gates (n = 35) allowing only one cow access at a time, or individual calving pens with permanently open gates allowing free cow traffic between group area and individual pen (n = 31). The response variables were calving site, calving behaviour and social behaviour. Unexpectedly, a functional gate did not facilitate isolation seeking, perhaps because the cows were not able to combine a learnt response with the motivation to isolate. Dominant cows had the highest chance of calving in an individual calving pen. If an alien calf was present in the group pen or any of the individual pens, cows were less likely to calve in an individual calving pen. Future studies should allow cows easy access to an individual calving pen and explore what motivates pre-parturient cows to seek isolation in order to facilitate voluntary use of individual calving pens.	[Rorvang, Maria Vilain; Herskin, Mette S.; Jensen, Margit Bak] Aarhus Univ, Dept Anim Sci, Tjele, Denmark	Aarhus University	Jensen, MB (corresponding author), Aarhus Univ, Dept Anim Sci, Tjele, Denmark.	MargitBak.Jensen@anis.au.dk	Rørvang, Maria Vilain/J-4643-2019; Herskin, Mette S./J-3529-2019	Rørvang, Maria Vilain/0000-0002-3503-2059; Herskin, Mette S./0000-0002-3744-4524	Green Development & Demonstration Programme of the Danish Ministry of Food, Agriculture & Fisheries, Copenhagen, Denmark; Graduate School of Science & Technology, Aarhus University, Denmark	Green Development & Demonstration Programme of the Danish Ministry of Food, Agriculture & Fisheries, Copenhagen, Denmark; Graduate School of Science & Technology, Aarhus University, Denmark	The authors thank Green Development & Demonstration Programme of the Danish Ministry of Food, Agriculture & Fisheries, Copenhagen, Denmark, and Graduate School of Science & Technology, Aarhus University, Denmark, for funding to MVR. The funders had no role in the design of this study, data collection/analysis or preparation of the manuscript.	APPLEBY MC, 1980, BEHAVIOUR, V74, P294, DOI 10.1163/156853980X00519; AREY DS, 1992, APPL ANIM BEHAV SCI, V34, P49, DOI 10.1016/S0168-1591(05)80056-5; Barkema HW, 2015, J DAIRY SCI, V98, P7426, DOI 10.3168/jds.2015-9377; Bates D, 2015, R PACKAG VERSION 099; Bewick V, 2005, CRIT CARE, V9, P112, DOI 10.1186/cc3045; BUDDENBERG BJ, 1986, J ANIM SCI, V62, P42, DOI 10.2527/jas1986.62142x; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Dwyer CM, 2008, J NEUROENDOCRINOL, V20, P526, DOI 10.1111/j.1365-2826.2008.01657.x; Dwyer CM, 2014, ANIMAL, V8, P102, DOI 10.1017/S1751731113001614; EDWARDS SA, 1983, APPL ANIM ETHOL, V10, P191, DOI 10.1016/0304-3762(83)90140-2; Flury R, 2016, BEHAV PROCESS, V133, P56, DOI 10.1016/j.beproc.2016.11.004; Gibbons JM, 2010, APPL ANIM BEHAV SCI, V122, P84, DOI 10.1016/j.applanim.2009.11.011; Hirata M, 2016, APPL ANIM BEHAV SCI, V180, P18, DOI 10.1016/j.applanim.2016.04.004; Ingvartsen KL, 2006, ANIM FEED SCI TECH, V126, P175, DOI 10.1016/j.anifeedsci.2005.08.003; Jensen MB, 2012, APPL ANIM BEHAV SCI, V139, P195, DOI 10.1016/j.applanim.2012.04.002; Leblanc S, 2010, J REPROD DEVELOP, V56, pS29, DOI 10.1262/jrd.1056S29; Leuthold W., 1977, AFRICAN UNGULATES; LIDFORS LM, 1994, APPL ANIM BEHAV SCI, V42, P11, DOI 10.1016/0168-1591(94)90003-5; Machado LCP, 1997, APPL ANIM BEHAV SCI, V53, P183, DOI 10.1016/S0168-1591(96)01158-6; Mainau E, 2011, APPL ANIM BEHAV SCI, V135, P241, DOI 10.1016/j.applanim.2011.10.020; Mazurek M, 2011, APPL ANIM BEHAV SCI, V131, P21, DOI 10.1016/j.applanim.2011.01.004; Mee I, 2008, VET J, V176, P93, DOI 10.1016/j.tvjl.2007.12.032; Miedema HM, 2011, APPL ANIM BEHAV SCI, V132, P14, DOI 10.1016/j.applanim.2011.03.003; Miedema HM, 2011, APPL ANIM BEHAV SCI, V131, P8, DOI 10.1016/j.applanim.2011.01.012; MILLER K, 1991, ANIM PROD, V53, P271, DOI 10.1017/S0003356100020262; Muller R, 2006, APPL ANIM BEHAV SCI, V99, P193, DOI 10.1016/j.applanim.2005.05.012; National Farm Animal Care Council C, 2009, PRACTICE; Noakes D, 2001, ARTHURS VET REPROD O, P577; Ouellet V, 2016, J DAIRY SCI, V99, P1539, DOI 10.3168/jds.2015-10057; Proudfoot KL, 2014, J DAIRY SCI, V97, P2731, DOI 10.3168/jds.2013-7274; Proudfoot KL, 2014, J ANIM SCI, V92, P277, DOI 10.2527/jas.2013-6648; Proudfoot KL, 2013, J DAIRY SCI, V96, P1638, DOI 10.3168/jds.2012-6000; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rorvang MV, 2017, J DAIRY SCI, V100, P2967, DOI 10.3168/jds.2016-11989; Rorvang MV, 2017, J DAIRY SCI, V100, P1467, DOI 10.3168/jds.2016-11681; Rorvang MV, 2015, ANIM COGN, V18, P847, DOI 10.1007/s10071-015-0852-6; Saint-Dizier M, 2015, VET J, V205, P349, DOI 10.1016/j.tvjl.2015.05.006; Schirmann K, 2013, J DAIRY SCI, V96, P7088, DOI 10.3168/jds.2013-7023; Schrader L, 2002, APPL ANIM BEHAV SCI, V77, P255, DOI 10.1016/S0168-1591(02)00075-8; Siegel S., 1988, NONPARAMETRIC STAT B, P213, DOI DOI 10.1177/014662168901300212; Teetor Paul, 2011, R COOKBOOK PROVEN RE; Thomsen PT, 2008, J DAIRY SCI, V91, P119, DOI 10.3168/jds.2007-0496; Turner SP, 2007, LIVEST SCI, V106, P182, DOI 10.1016/j.livsci.2006.08.002; Uetake K, 1996, INT J PSYCHOL, V31, P15476; Val-Laillet D, 2008, J DAIRY SCI, V91, P3922, DOI 10.3168/jds.2008-1332; von Keyserlingk MAG, 2008, J DAIRY SCI, V91, P1011, DOI 10.3168/jds.2007-0532; Waiblinger S, 2003, APPL ANIM BEHAV SCI, V84, P23, DOI 10.1016/S0168-1591(03)00148-5	47	23	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191128	10.1371/journal.pone.0191128	http://dx.doi.org/10.1371/journal.pone.0191128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346399	gold, Green Published			2022-12-27	WOS:000422749500030
J	Deshpande, P; Dapkekar, A; Oak, M; Paknikar, K; Rajwade, J				Deshpande, Paresh; Dapkekar, Ashwin; Oak, Manoj; Paknikar, Kishore; Rajwade, Jyutika			Nanocarrier-mediated foliar zinc fertilization influences expression of metal homeostasis related genes in flag leaves and enhances gluten content in durum wheat	PLOS ONE			English	Article							GRAIN PROTEIN; ZIP FAMILY; ZN; IDENTIFICATION; DEFICIENCY; NICOTIANAMINE; TRANSPORT; RICE; BIOFORTIFICATION; TRANSLOCATION	Background Wheat is the staple food for most of the world's population; however, it is a poor source of zinc. Foliar fertilization of zinc via zinc loaded chitosan nanocarriers (Zn-CNP) post-anthesis has proved to be a promising approach for grain zinc enhancement in durum wheat as evidenced in our earlier study. However, the molecular mechanism of uptake of zinc via Zn-CNP remains unclear. Methods/Principle findings Foliar application of Zn-CNP was performed at post anthesis stages in two durum wheat cultivars (MACS 3125 and UC1114, containing the Gpc-B1 gene), and expression levels of several metal-related genes were analyzed during early senescence. Zn-CNP application indeed caused changes in gene expression as revealed by qPCR data on representative genes involved in metal homeostasis, phloem transporters, and leaf senescence. Furthermore, zinc-regulated transporters and iron (Fe)-regulated transporter-like protein (ZIP) family [ZIP1, ZIP7, ZIP15], CA (carbonic anhydrase), and DMAS (2'-deoxymugineic acid synthase) in flag leaves exhibited significant correlation with zinc content in the seeds. The analysis of grain endosperm proteins showed enhancement of gamma gliadins while other gluten subunits decreased. Gene expression within ZIP family members varied with the type of cultivar mostly attributed to the Gpc-B1, concentration of external zinc ions as well as the type of tissue analyzed. Correlation analysis revealed the involvement of the selected genes in zinc enhancement. Conclusion At the molecular level, uptake of zinc via Zn-CNP nanocarrier was comparable to the uptake of zinc via common zinc fertilizers i.e. ZnSO4.	[Deshpande, Paresh; Dapkekar, Ashwin; Paknikar, Kishore; Rajwade, Jyutika] Agharkar Res Inst, Nanobiosci Grp, Pune, Maharashtra, India; [Deshpande, Paresh; Dapkekar, Ashwin; Oak, Manoj; Paknikar, Kishore; Rajwade, Jyutika] Savitribai Phule Pune Univ, Pune, Maharashtra, India; [Oak, Manoj] Agharkar Res Inst, Genet & Plant Breeding, Pune, Maharashtra, India	Department of Science & Technology (India); Agharkar Research Institute (ARI); Savitribai Phule Pune University; Department of Science & Technology (India); Agharkar Research Institute (ARI)	Paknikar, K; Rajwade, J (corresponding author), Agharkar Res Inst, Nanobiosci Grp, Pune, Maharashtra, India.; Oak, M; Paknikar, K; Rajwade, J (corresponding author), Savitribai Phule Pune Univ, Pune, Maharashtra, India.; Oak, M (corresponding author), Agharkar Res Inst, Genet & Plant Breeding, Pune, Maharashtra, India.	mdoak@aripune.org; kmpaknikar@aripune.org; jrajwade@aripune.org	Rajwade, J/P-7813-2019; Paknikar, Kishore/A-4963-2010; Oak, Manoj/P-8612-2017	Paknikar, Kishore/0000-0001-5602-7518; Oak, Manoj/0000-0002-4073-5306; Rajwade, Jyutika/0000-0001-9465-3595	Indian Council for Agricultural Research (ICAR) Fund for Basic, Strategic and Frontier Application in Agriculture Research, New Delhi, India [Mn-3023]; Council of Scientific and Industrial Research (CSIR), New Delhi, India; University Grants Commission (UGC), New Delhi, India	Indian Council for Agricultural Research (ICAR) Fund for Basic, Strategic and Frontier Application in Agriculture Research, New Delhi, India; Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), New Delhi, India(University Grants Commission, India)	The funding for the study was received from Indian Council for Agricultural Research (ICAR) Fund for Basic, Strategic and Frontier Application in Agriculture Research, New Delhi, India (Grant no. Mn-3023). Paresh Deshpande received fellowship from Council of Scientific and Industrial Research (CSIR), New Delhi, India. Ashwin Dapkekar received fellowship from University Grants Commission (UGC), New Delhi, India. There was no additional external funding received for this study.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Bonneau J, 2016, PLANT BIOTECHNOL J, V14, P2228, DOI 10.1111/pbi.12577; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Cakmak I, 2002, PLANT SOIL, V247, P3, DOI 10.1023/A:1021194511492; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Cakmak I, 2010, CEREAL CHEM, V87, P10, DOI 10.1094/CCHEM-87-1-0010; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Corbo MD, 2013, J AM ACAD DERMATOL, V69, P616, DOI 10.1016/j.jaad.2013.04.028; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; Deshpande P, 2017, CARBOHYD POLYM, V165, P394, DOI 10.1016/j.carbpol.2017.02.061; Distelfeld A, 2007, PHYSIOL PLANTARUM, V129, P635, DOI 10.1111/j.1399-3054.2006.00841.x; DuPont FM, 2005, J AGR FOOD CHEM, V53, P1575, DOI 10.1021/jf048697l; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Erenoglu EB, 2011, NEW PHYTOL, V189, P438, DOI 10.1111/j.1469-8137.2010.03488.x; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Grotz N, 2006, BBA-MOL CELL RES, V1763, P595, DOI 10.1016/j.bbamcr.2006.05.014; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Hacisalihoglu G, 2003, NEW PHYTOL, V159, P341, DOI 10.1046/j.1469-8137.2003.00826.x; Hwalla N, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030229; Kade M, 2005, PLANT BREEDING, V124, P343, DOI 10.1111/j.1439-0523.2005.01110.x; Khalid N, 2014, CRIT REV FOOD SCI, V54, P1222, DOI 10.1080/10408398.2011.630541; Kutman UB, 2010, CEREAL CHEM, V87, P1, DOI 10.1094/CCHEM-87-1-0001; Liu DY, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050465; Liu HE, 2015, PLANT SOIL ENVIRON, V61, P195, DOI 10.17221/817/2014-PSE; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Millan AF, 2005, PLANT SCI, V168, P1015, DOI 10.1016/j.plantsci.2004.11.018; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mikkelsen MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049027; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Nishiyama R, 2012, PLANT CELL PHYSIOL, V53, P381, DOI 10.1093/pcp/pcr188; Noh YS, 1999, PLANT MOL BIOL, V41, P181, DOI 10.1023/A:1006342412688; Olsen LI, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.36, 10.1038/nplants.2016.36]; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Pearce S, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0368-2; Peck AW, 2008, J CEREAL SCI, V47, P266, DOI 10.1016/j.jcs.2007.04.006; Pedas P, 2009, PLANT SIGNAL BEHAV, V4, P842, DOI 10.4161/psb.4.9.9375; Persson DP, 2009, METALLOMICS, V1, P418, DOI 10.1039/b905688b; Prasad AS, 2013, ADV NUTR, V4, P176, DOI 10.3945/an.112.003210; Ram H, 2015, CURR SCI INDIA, V109, P1171, DOI 10.18520/v109/i6/1171-1176; Ramos I, 2016, SPECTROCHIM ACTA B, V120, P30, DOI 10.1016/j.sab.2016.03.014; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Sperotto RA, 2010, J PLANT PHYSIOL, V167, P1500, DOI 10.1016/j.jplph.2010.05.003; STARKS TL, 1985, J AGR FOOD CHEM, V33, P691, DOI 10.1021/jf00064a032; Subbaiah LV, 2016, J AGR FOOD CHEM, V64, P3778, DOI 10.1021/acs.jafc.6b00838; Suzuki M, 2008, PLANT MOL BIOL, V66, P609, DOI 10.1007/s11103-008-9292-x; Tiong JW, 2015, NEW PHYTOL, V207, P1097, DOI 10.1111/nph.13413; Tiong J, 2014, NEW PHYTOL, V201, P131, DOI 10.1111/nph.12468; Uauy C, 2006, J EXP BOT, V57, P2785, DOI 10.1093/jxb/erl047; Uddin MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108546; Weiser H., 2000, EUROPEAN J FOOD RES, V211, P262; Weiser H, 1994, RELATIONSHIP AMOUNT, P141; White PJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00080	54	18	18	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191035	10.1371/journal.pone.0191035	http://dx.doi.org/10.1371/journal.pone.0191035			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342185	Green Submitted, Green Published, gold			2022-12-27	WOS:000422653800042
J	Huang, ZF; Song, WH; Zhang, YS; Zhang, Q; Zhou, DS; Zhou, X; He, Y				Huang, Zhenfei; Song, Wenhao; Zhang, Yaoshen; Zhang, Qiang; Zhou, Dongsheng; Zhou, Xi; He, Yu			Three-dimensional printing model improves morphological understanding in acetabular fracture learning: A multicenter, randomized, controlled study	PLOS ONE			English	Article							COMPUTER-AIDED-INSTRUCTION; TEACHING ANATOMY; METAANALYSIS; CLASSIFICATION; TOMOGRAPHY; EDUCATION; SURGERY	Conventional education results in unsatisfactory morphological understanding of acetabular fractures due to lack of three-dimensional (3D) details and tactile feedback of real fractures. Virtual reality (VR) and 3D printing (3DP) techniques are widely applied in teaching. The purpose of this study was to identify the effect of physical model (PM), VR and 3DP models in education of morphological understanding of acetabular fractures. 141 students were invited to participate in this study. Participants were equally and randomly assigned to the PM, VR and 3DP learning groups. Three-level objective tests were conducted to evaluate learning, including identifying anatomical landmarks, describing fracture lines, identifying classification, and inferring fracture mechanism. Four subjective questions were asked to evaluate the usability and value of instructional materials. Generally, the 3DP group showed a clear advantage over the PM and VR groups in objective tests, while there was no significant difference between the PM and VR groups. 3DP was considered to be the most valuable learning tool for understanding acetabular fractures. The findings demonstrate that 3DP modelling of real fractures is an effective learning instrument that can be used to understand the morphology of acetabular fractures and promote subjective interest.	[Huang, Zhenfei; Zhou, Xi; He, Yu] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthopaed, Beijing, Peoples R China; [Huang, Zhenfei; Zhou, Xi; He, Yu] Peking Union Med Coll, Beijing, Peoples R China; [Song, Wenhao; Zhou, Dongsheng] Shandong Univ, Shandong Prov Hosp Affiliated, Dept Orthopaed, Jinan, Shandong, Peoples R China; [Zhang, Yaoshen] Capital Med Univ, Beijing Chaoyang Hosp, Dept Orthopaed, Beijing, Peoples R China; [Zhang, Yaoshen; Zhang, Qiang] Capital Med Univ, Beijing Ditan Hosp, Dept Orthopaed, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Capital Medical University; Capital Medical University	Zhou, X (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Orthopaed, Beijing, Peoples R China.; Zhou, X (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	xizhoupumch@sina.com; heyuworkmail@sina.com			Shandong Provincial Hospital Affiliated	Shandong Provincial Hospital Affiliated	An internal hospital grant ("The application of three-dimensional printing in orthopedics" grant from Shandong Provincial Hospital Affiliated to Shandong University) funded the purchase of the 3D reconstruction software and 3D printing system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton TB, 2014, CLIN ORTHOP RELAT R, V472, P35, DOI 10.1007/s11999-013-3375-y; Beermann J, 2010, MED EDUC, V44, P936, DOI 10.1111/j.1365-2923.2010.03742.x; Chan LK, 2011, ANAT SCI EDUC, V4, P256, DOI 10.1002/ase.239; Fadero PE, 2014, SURG-J R COLL SURG E, V12, P328, DOI 10.1016/j.surge.2014.03.008; Geijer M, 2007, EMERG RADIOL, V14, P271, DOI 10.1007/s10140-007-0638-5; Giannoudis PV, 2005, J BONE JOINT SURG BR, V87B, P2, DOI 10.1302/0301-620X.87B1.15605; Khot Z, 2013, ANAT SCI EDUC, V6, P211, DOI 10.1002/ase.1355; Li ZZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11570; Lynch TG, 2001, AM J SURG, V181, P368, DOI 10.1016/S0002-9610(01)00575-X; Malik HH, 2015, J SURG RES, V199, P512, DOI 10.1016/j.jss.2015.06.051; Marro A, 2016, CURR PROBL DIAGN RAD, V45, P2, DOI 10.1067/j.cpradiol.2015.07.009; Mashiko T, 2015, WORLD NEUROSURG, V83, P351, DOI 10.1016/j.wneu.2013.10.032; MASTERS MS, 1993, BEHAV GENET, V23, P337, DOI 10.1007/BF01067434; McNulty JA, 2009, ANAT SCI EDUC, V2, P2, DOI 10.1002/ase.66; Minogue J, 2006, REV EDUC RES, V76, P317, DOI 10.3102/00346543076003317; O'Toole RV, 2010, J ORTHOP TRAUMA, V24, P284, DOI 10.1097/BOT.0b013e3181c83bc0; Oh CS, 2009, ANAT SCI EDUC, V2, P156, DOI 10.1002/ase.92; Pahuta Markian A, 2012, J Bone Joint Surg Am, V94, pe182, DOI 10.2106/JBJS.K.00996; Preece D, 2013, ANAT SCI EDUC, V6, P216, DOI 10.1002/ase.1345; Scheinfeld MH, 2015, RADIOGRAPHICS, V35, P555, DOI 10.1148/rg.352140098; Seixas-Mikelus SA, 2010, J ENDOUROL, V24, P629, DOI 10.1089/end.2009.0556; Sugand K, 2010, ANAT SCI EDUC, V3, P83, DOI 10.1002/ase.139; Vaughan N, 2016, MED ENG PHYS, V38, P59, DOI 10.1016/j.medengphy.2015.11.021; Yammine K, 2016, ADV HEALTH SCI EDUC, V21, P883, DOI 10.1007/s10459-015-9644-7; Yammine K, 2015, ANAT SCI EDUC, V8, P525, DOI 10.1002/ase.1510	25	34	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191328	10.1371/journal.pone.0191328	http://dx.doi.org/10.1371/journal.pone.0191328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342198	Green Submitted, Green Published, gold			2022-12-27	WOS:000422653800063
J	Makondi, PT; Lee, CH; Huang, CY; Chu, CM; Chang, YJ; Wei, PL				Makondi, Precious Takondwa; Lee, Chia-Hwa; Huang, Chien-Yu; Chu, Chi-Ming; Chang, Yu-Jia; Wei, Po-Li			Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; RECEPTOR 4; CYTOSCAPE PLUGIN; PHASE-III; EXPRESSION; THERAPY; SURVIVAL; CHEMOTHERAPY; COLON; FLUOROURACIL	Bevacizumab combined with cytotoxic chemotherapy is the backbone of metastatic colorectal cancer (mCRC) therapy; however, its treatment efficacy is hampered by therapeutic resistance. Therefore, understanding the mechanisms underlying bevacizumab resistance is crucial to increasing the therapeutic efficacy of bevacizumab. The Gene Expression Omnibus (GEO) database (dataset, GSE86525) was used to identify the key genes and pathways involved in bevacizumab-resistant mCRC. The GEO2R web tool was used to identify differentially expressed genes (DEGs). Functional and pathway enrichment analyses of the DEGs were performed using the Database for Annotation, Visualization, and Integrated Discovery(DAVID). Protein protein interaction (PPI) networks were established using the Search Tool for the Retrieval of Interacting Genes/Proteins database(STRING) and visualized using Cytoscape software. A total of 124 DEGs were obtained, 57 of which upregulated and 67 were downregulated. PPI network analysis showed that seven upregulated genes and nine downregulated genes exhibited high PPI degrees. In the functional enrichment, the DEGs were mainly enriched in negative regulation of phosphate metabolic process and positive regulation of cell cycle process gene ontologies (GOs); the enriched pathways were the phosphoinositide 3-kinase-serine/threonine kinase signaling pathway, bladder cancer, and microRNAs in cancer. Cyclin-dependent kinase inhibitor 1 A(CDKN1A), toll-like receptor 4 (TLR4), CD19 molecule (CD19), breast cancer 1, early onset (BRCA1), platelet-derived growth factor subunit A (PDGFA), and matrix metallopeptidase 1 (MMP1) were the DEGs involved in the pathways and the PPIs. The clinical validation of the DEGs in mCRC (TNM clinical stages 3 and 4) revealed that high PDGFA expression levels were associated with poor overall survival, whereas high BRCA1 and MMP1 expression levels were associated with favorable progress free survival(PFS). The identified genes and pathways can be potential targets and predictors of therapeutic resistance and prognosis in bevacizumab-treated patients with mCRC.	[Makondi, Precious Takondwa; Chang, Yu-Jia] Taipei Med Univ, Coll Med, Int PhD Program Med, Taipei, Taiwan; [Makondi, Precious Takondwa; Chang, Yu-Jia] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lee, Chia-Hwa] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Huang, Chien-Yu; Wei, Po-Li] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Huang, Chien-Yu] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Chu, Chi-Ming] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chang, Yu-Jia; Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Canc Res Ctr & Translat Lab, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Wan Fang Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Int PhD Program Med, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan.; Chang, YJ; Wei, PL (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Canc Res Ctr & Translat Lab, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan.	r5424012@tmu.edu.tw; poliwei@tmu.edu.tw						Advani R, 2009, J CLIN ONCOLOGY OF S, V27, P11063; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Anders CK, 2010, CLIN CANCER RES, V16, P4702, DOI 10.1158/1078-0432.CCR-10-0939; Andre F, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds195; Andre T, 2015, J CLIN ONCOL, V33, P4176, DOI 10.1200/JCO.2015.63.4238; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Candeil L, 2004, INT J CANCER, V109, P848, DOI 10.1002/ijc.20032; Carser JE, 2011, GYNECOL ONCOL, V123, P492, DOI 10.1016/j.ygyno.2011.08.017; Davudian Sadaf, 2016, Biomed Pharmacother, V84, P191, DOI 10.1016/j.biopha.2016.09.021; de Groot JF, 2011, CLIN CANCER RES, V17, P4872, DOI 10.1158/1078-0432.CCR-11-0271; Des Guetz G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007046.pub2; Earl TM, 2009, ANN SURG ONCOL, V16, P1043, DOI 10.1245/s10434-009-0325-8; El Khoury F, 2016, INT J ONCOL, V49, P2558, DOI 10.3892/ijo.2016.3725; Eyking A, 2011, GASTROENTEROLOGY, V141, P2154, DOI 10.1053/j.gastro.2011.08.043; Gallagher DJ, 2010, ONCOLOGY-BASEL, V78, P237, DOI 10.1159/000315730; Ganji PN, 2013, ANGIOGENESIS, V16, P903, DOI 10.1007/s10456-013-9364-7; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Gomyo Y, 1997, CANCER, V79, P2067, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2067::AID-CNCR3>3.0.CO;2-M; Hay KA, 2017, DRUGS, V77, P237, DOI 10.1007/s40265-017-0690-8; Heinemann V, 2013, CANCER TREAT REV, V39, P592, DOI 10.1016/j.ctrv.2012.12.011; Huang CY, 2016, AM J TRANSL RES, V8, P384; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Ignatov T, 2014, J CANCER RES CLIN, V140, P1457, DOI 10.1007/s00432-014-1704-5; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kaplan JB, 2015, INVEST NEW DRUG, V33, P1271, DOI 10.1007/s10637-015-0289-4; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kramer I, 2007, J CLIN PHARM THER, V32, P1, DOI 10.1111/j.1365-2710.2007.00800.x; Le Cesne A, 2013, ONCOLOGIST, V18, P1192, DOI 10.1634/theoncologist.2012-0361; Lenz, 2016, ASCO ANN M P, V34, P493, DOI DOI 10.1200/jco.2016.34.4_suppl.493; Levy P, 2007, CLIN CANCER RES, V13, P398, DOI 10.1158/1078-0432.CCR-06-0182; Lips EH, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0642-8; Liu XC, 2016, ONCOTARGET, V7, P23227, DOI 10.18632/oncotarget.7594; Loupakis F, 2014, NEW ENGL J MED, V371, P1609, DOI 10.1056/NEJMoa1403108; Lu Zhen-hai, 2011, Zhonghua Yi Xue Za Zhi, V91, P2895; Lu-Emerson C, 2013, NEURO-ONCOLOGY, V15, P1079, DOI 10.1093/neuonc/not082; Luengo-Gil G, 2015, BREAST CANCER RES TR, V151, P577, DOI 10.1007/s10549-015-3421-4; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maru D, 2013, CLIN CANCER RES, V19, P2824, DOI 10.1158/1078-0432.CCR-12-3409; Maurel J, 2015, CURR CANCER DRUG TAR, V15, P703, DOI 10.2174/156800961508151001102822; Moench R, 2016, ONCOTARGET; Murad S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00313; Nordlinger B, 2009, ANN ONCOL, V20, P985, DOI 10.1093/annonc/mdn735; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okamoto S, 2016, BRAIN TUMOR PATHOL, V33, P129, DOI 10.1007/s10014-016-0248-6; Paulsson J, 2014, FUTURE ONCOL, V10, P1695, DOI [10.2217/FON.14.83, 10.2217/fon.14.83]; Pietruszewska Wioletta, 2016, Otolaryngol Pol, V70, P32, DOI 10.5604/00306657.1202546; Piha-Paul SA, 2014, ONCOTARGET, V5, P1846, DOI 10.18632/oncotarget.1834; Quinn JE, 2007, CLIN CANCER RES, V13, P7413, DOI 10.1158/1078-0432.CCR-07-1083; Ramos CA, 2016, J CLIN INVEST, V126, P2588, DOI 10.1172/JCI86000; Raufi Ali, 2013, Cancer Manag Res, V5, P225, DOI 10.2147/CMAR.S45957; Riddell JR, 2011, CANCER RES, V71, P1637, DOI 10.1158/0008-5472.CAN-10-3674; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ross JS, 2010, AM J CLIN PATHOL, V134, P478, DOI 10.1309/AJCP2Y8KTDPOAORH; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Said AH, 2017, BIOCHEM J, V474, P647, DOI 10.1042/BCJ20160704; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slattery ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116169; Slattery ML, 2012, INT J CANCER, V130, P2974, DOI 10.1002/ijc.26314; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Staub E, 2009, J MOL MED, V87, P633, DOI 10.1007/s00109-009-0467-y; Sun YL, 2016, EXP CELL RES, V347, P274, DOI 10.1016/j.yexcr.2016.07.009; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taghavi N, 2010, WORLD J GASTROENTERO, V16, P4958, DOI 10.3748/wjg.v16.i39.4958; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Tebbutt NC, 2002, EUR J CANCER, V38, P1000, DOI 10.1016/S0959-8049(02)00062-X; Turtle CJ, 2016, CLIN PHARMACOL THER, V100, P252, DOI 10.1002/cpt.392; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Venook Alan P, 2014, Am Soc Clin Oncol Educ Book, P83, DOI 10.14694/EdBook_AM.2014.34.83; Verstraete M, 2015, BRIT J CANCER, V112, P1314, DOI 10.1038/bjc.2015.93; Villaruz LC, 2011, SEMIN THORAC CARDIOV, V23, P281, DOI 10.1053/j.semtcvs.2012.01.001; Wadlow RC, 2010, CANCER-AM CANCER SOC, V116, P3537, DOI 10.1002/cncr.25155; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Wu JJ, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0195-4; Xiong YQ, 2011, J CANCER RES CLIN, V137, P505, DOI 10.1007/s00432-010-0914-8; Yamazaki K, 2016, ANN ONCOL, V27, P1539, DOI 10.1093/annonc/mdw206	89	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189582	10.1371/journal.pone.0189582	http://dx.doi.org/10.1371/journal.pone.0189582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342159	gold, Green Submitted, Green Published			2022-12-27	WOS:000422653800009
J	Mughini-Gras, L; Schaapveld, M; Kramers, J; Mooij, S; Neefjes-Borst, EA; van Pelt, W; Neefjes, J				Mughini-Gras, Lapo; Schaapveld, Michael; Kramers, Jolanda; Mooij, Sofie; Neefjes-Borst, E. Andra; van Pelt, Wilfrid; Neefjes, Jacques			Increased colon cancer risk after severe Salmonella infection	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; HELICOBACTER-PYLORI; GASTRIC-CANCER; BACTERIAL; NETHERLANDS; HOST; MECHANISMS; TUMORIGENESIS; ASSOCIATIONS	Background Colon cancer constitutes one of the most frequent malignancies. Previous studies showed that Salmonella manipulates host cell signaling pathways and that Salmonella Typhimurium infection facilitates colon cancer development in genetically predisposed mice. This epidemiological study examined whether severe Salmonella infection, usually acquired from contaminated food, is associated with increased colon cancer risk in humans. Methods and findings We performed a nationwide registry-based study to assess colon cancer risk after diagnosed Salmonella infection. National infectious disease surveillance records (1999-2015) for Dutch residents aged >= 20 years when diagnosed with salmonellosis (n = 14,264) were linked to the Netherlands Cancer Registry. Salmonella-infected patients were laboratory-confirmed under medical consultation after 1-2 weeks of illness. These datasets also contained information on Salmonella serovar and type of infection. Colon cancer risk (overall and per colon subsite) among patients with a diagnosed Salmonella infection was compared with expected colon cancer risk in the general population. Data from the nationwide registry of histo-and cytopathology (PALGA) and Statistics Netherlands (CBS) allowed assessing potential effects of age, gender, latency, socioeconomic status, genetic predisposition, inflammatory bowel disease (IBD), and tumor features. We found that compared to the general population, colon cancer risk was significantly increased (standardized incidence ratio [SIR] 1.54; 95% CI 1.09-2.10) among patients with Salmonella infection diagnosed <60 years of age. Such increased risk concerned specifically the ascending/transverse colon (SIR 2.12; 95% CI 1.38-3.09) after S. Enteritidis infection (SIR 2.97; 95% CI 1.73-4.76). Salmonellosis occurred more frequently among colon cancer patients with pre-infectious IBD, a known risk factor for colon cancer. Colon tumors of patients with a history of Salmonella infection were mostly of low grade. Conclusions Patients diagnosed with severe salmonellosis have an increased risk of developing cancer in the ascending/transverse parts of the colon. This risk concerns particularly S. Enteritidis infection, suggesting a contribution of this major foodborne pathogen to colon cancer development.	[Mughini-Gras, Lapo; Kramers, Jolanda; Mooij, Sofie; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm RIVM, Antonie van Leeuwenhoeklaan 9, Bilthoven, Netherlands; [Mughini-Gras, Lapo] Univ Utrecht, Dept Infect Dis & Immunol, Yalelaan 1, Utrecht, Netherlands; [Schaapveld, Michael] Netherlands Canc Inst NKI, Div Epidemiol, Plesmanlaan 121, Amsterdam, Netherlands; [Neefjes-Borst, E. Andra] Free Univ Med Ctr VUmc, Dept Pathol, Boelelaan 1117, Amsterdam, Netherlands; [Neefjes, Jacques] Leiden Univ, Med Ctr, Dept Chem Immunol, Einthovenweg 20, Leiden, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Neefjes, J (corresponding author), Leiden Univ, Med Ctr, Dept Chem Immunol, Einthovenweg 20, Leiden, Netherlands.	j.j.c.neefjes@lumc.nl	Neefjes, Jacques J.C./H-8780-2017; Schaapveld, Michael/ABC-9714-2020	Neefjes, Jacques J.C./0000-0001-6763-2211; Neefjes-Borst, Andra/0000-0001-7945-7916; Schaapveld, Michael/0000-0003-4390-7182	KWF grant 'Salmonella infections and gallbladder cancer' (NKI) [2013-5969]; ERC Advanced grant ERCOPE	KWF grant 'Salmonella infections and gallbladder cancer' (NKI); ERC Advanced grant ERCOPE	This work was supported by KWF grant 'Salmonella infections and gallbladder cancer' (NKI 2013-5969); ERC Advanced grant ERCOPE. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlam SB, 2011, EPIDEMIOL INFECT, V139, P302, DOI 10.1017/S0950268810000932; Berger H, 2016, HELICOBACTER, V21, P34, DOI 10.1111/hel.12338; Boccellato F, 2015, CELL HOST MICROBE, V17, P728, DOI 10.1016/j.chom.2015.05.016; Casparie M, 2007, CELL ONCOL, V29, P19; CAYGILL CPJ, 1994, LANCET, V343, P83, DOI 10.1016/S0140-6736(94)90816-8; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Chumduri C, 2016, NAT REV MOL CELL BIO, V17, P659, DOI 10.1038/nrm.2016.100; Coghill AE, 2014, AM J EPIDEMIOL, V180, P687, DOI 10.1093/aje/kwu176; Darwin KH, 1999, CLIN MICROBIOL REV, V12, P405, DOI 10.1128/CMR.12.3.405; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Doorduyn Y, 2006, EPIDEMIOL INFECT, V134, P617, DOI 10.1017/S0950268805005406; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Friesema IHM, 2009, VACCINE, V27, P6353, DOI 10.1016/j.vaccine.2009.05.042; Gagnaire A, 2017, NAT REV MICROBIOL, V15, P109, DOI 10.1038/nrmicro.2016.171; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Havelaar AH, 2013, EPIDEMIOL INFECT, V141, P293, DOI 10.1017/S0950268812000568; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Kato I, 2013, NUTR CANCER, V65, P169, DOI 10.1080/01635581.2013.748922; Kuo SH, 2013, HEMATOL-AM SOC HEMAT, P109, DOI 10.1182/asheducation-2013.1.109; La Vecchia C, 2013, INT J CANCER, V133, P1447, DOI 10.1002/ijc.28133; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; Liu XY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-326; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; Lu R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.20; Lu R, 2017, ONCOTARGET, V8, P55104, DOI 10.18632/oncotarget.19052; Lutgens MWMD, 2013, INFLAMM BOWEL DIS, V19, P789, DOI 10.1097/MIB.0b013e31828029c0; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Mughini-Gras L, 2014, INFECT GENET EVOL, V28, P251, DOI 10.1016/j.meegid.2014.10.003; Nath G, 2008, J INFECT DEV COUNTR, V2, P302; (NKR) NK, 2016, CIJF KANK INT KANK N; Samaras V, 2010, J INFECT DEV COUNTR, V4, P267, DOI 10.3855/jidc.819; Scanu T, 2015, CELL HOST MICROBE, V17, P763, DOI 10.1016/j.chom.2015.05.002; Scherer D, 2014, GENE CHROMOSOME CANC, V53, P568, DOI 10.1002/gcc.22167; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Stewart B, 2014, WORLD CANC REP 2014; Sun Jun, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P214; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; van Pelt W, 2003, EPIDEMIOL INFECT, V130, P431, DOI 10.1017/S0950268803008392; Vohlonen I, 2016, SCAND J GASTROENTERO, V51, P1159, DOI 10.1080/00365521.2016.1183225; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	48	49	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189721	10.1371/journal.pone.0189721	http://dx.doi.org/10.1371/journal.pone.0189721			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342165	Green Published, gold			2022-12-27	WOS:000422653800011
J	Geremew, A; Stiers, I; Sierens, T; Kefalew, A; Triest, L				Geremew, Addisie; Stiers, Iris; Sierens, Tim; Kefalew, Alemayehu; Triest, Ludwig			Clonal growth strategy, diversity and structure: A spatiotemporal response to sedimentation in tropical Cyperus papyrus swamps	PLOS ONE			English	Article							SPATIAL GENETIC-STRUCTURE; LAKE TANA BASIN; BURIAL DISTURBANCE; COMPUTER-PROGRAM; POPULATION; PLANT; SEAGRASS; DYNAMICS; RESILIENCE; WETLANDS	Land degradation and soil erosion in the upper catchments of tropical lakes fringed by papyrus vegetation can result in a sediment load gradient from land to lakeward. Understanding the dynamics of clonal modules (ramets and genets) and growth strategies of plants on such a gradient in both space and time is critical for exploring a species adaptation and processes regulating population structure and differentiation. We assessed the spatial and temporal dynamics in clonal growth, diversity, and structure of an emergent macrophyte, Cyperus papyrus (papyrus), in response to two contrasting sedimentation regimes by combining morphological traits and genotype data using 20 microsatellite markers. A total of 636 ramets from six permanent plots (18 x 30 m) in three Ethiopian papyrus swamps, each with discrete sedimentation regimes (high vs. low) were sampled for two years. We found that ramets under the high sedimentation regime (HSR) were significantly clumped and denser than the sparse and spreading ramets under the low sedimentation regime (LSR). The HSR resulted in significantly different ramets with short culm height and girth diameter as compared to the LSR. These results indicated that C. papyrus ameliorates the effect of sedimentation by shifting clonal growth strategy from guerrilla (in LSR) to phalanx (in HSR). Clonal richness, size, dominance, and clonal subrange differed significantly between sediment regimes and studied time periods. Each swamp under HSR revealed a significantly high clonal richness (R = 0.80) as compared to the LSR (R = 0.48). Such discrepancy in clonal richness reflected the occurrence of initial and repeated seedling recruitment strategies as a response to different sedimentation regimes. Overall, our spatial and short-term temporal observations highlighted that HSR enhances clonal richness and decreases clonal subrange owing to repeated seedling recruitment and genets turnover.	[Geremew, Addisie; Stiers, Iris; Sierens, Tim; Triest, Ludwig] Vrije Univ Brussel VUB, Dept Biol, Lab Plant Biol & Nat Management APNA, Brussels, Belgium; [Kefalew, Alemayehu] Addis Ababa Univ, Coll Nat Sci, Dept Plant Biol & Biodivers Management, Addis Ababa, Ethiopia	Vrije Universiteit Brussel; Addis Ababa University	Geremew, A (corresponding author), Vrije Univ Brussel VUB, Dept Biol, Lab Plant Biol & Nat Management APNA, Brussels, Belgium.	addisie2009@yahoo.com		Triest, Ludwig/0000-0002-4946-9614; Stiers, Iris/0000-0002-0367-1315; Geremew, Addisie/0000-0002-2895-5349	Development Cooperation; Vrije Universiteit Brussel, IRMO; VUB [BAS42]; Rufford Foundation [RUF-16029-1]	Development Cooperation; Vrije Universiteit Brussel, IRMO; VUB; Rufford Foundation	This work was supported by the Development Cooperation for funding field based research, PhD scholarship by the Vrije Universiteit Brussel, IRMO for Addisie Geremew and project funding from the VUB (BAS42). The Rufford Foundation is acknowledged for the grant provided with the goal of nature conservation (grant number RUF-16029-1).	Alberto F, 2005, MOL ECOL, V14, P2669, DOI 10.1111/j.1365-294X.2005.02640.x; Alberto F, 2008, J BIOGEOGR, V35, P1279, DOI 10.1111/j.1365-2699.2007.01876.x; Amare S., 2011, ETHIOPIAN J ENV STUD, V4, P56; Araki K, 2007, PLANT ECOL, V189, P175, DOI 10.1007/s11258-006-9173-9; Araki K, 2009, ANN BOT-LONDON, V104, P71, DOI 10.1093/aob/mcp092; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Arnaud-Haond S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030454; Arnaud-Haond S, 2010, ESTUAR COAST, V33, P878, DOI 10.1007/s12237-009-9238-9; Azzaa NGT, 2002, AQUAT BOT, V67, P169; Becheler R, 2014, HEREDITY, V112, P114, DOI 10.1038/hdy.2013.82; Binks RM, 2015, BIOL J LINN SOC, V114, P873, DOI 10.1111/bij.12465; Burgess SC, 2012, ECOLOGY, V93, P1378; Chebud YA, 2009, HYDROL PROCESS, V23, P3534, DOI 10.1002/hyp.7416; Chen XS, 2011, FLORA, V206, P347, DOI 10.1016/j.flora.2010.07.006; Chen XS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120846; Chen XS, 2014, AQUAT ECOL, V48, P409, DOI 10.1007/s10452-014-9493-0; Cornelissen JHC, 2014, ANN BOT-LONDON, V114, P369, DOI 10.1093/aob/mcu113; Dargahi B, 2011, J HYDROL, V398, P44, DOI 10.1016/j.jhydrol.2010.12.009; de Witte LC, 2010, ANN BOT-LONDON, V106, P859, DOI 10.1093/aob/mcq191; Dessie M, 2014, J HYDROL, V519, P699, DOI 10.1016/j.jhydrol.2014.08.007; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Eckert CG, 2001, EVOL ECOL, V15, P501, DOI 10.1023/A:1016005519651; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; ERIKSSON O, 1993, TRENDS ECOL EVOL, V8, P313, DOI 10.1016/0169-5347(93)90237-J; Friess DA, 2012, BIOL REV, V87, P346, DOI 10.1111/j.1469-185X.2011.00198.x; Friis I., 2010, ATLAS POTENTIAL VEGE; Frosini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047561; Gaudet J., 2014, PAPYRUS PLANT CHANGE; Gilbert M, 2008, OECOLOGIA, V156, P169, DOI 10.1007/s00442-008-0968-3; Gilbert ME, 2010, AUSTRAL ECOL, V35, P53, DOI 10.1111/j.1442-9993.2009.02011.x; Goude J., 2002, FSTAT SOFTWARE V 2 9; Graae BJ, 2011, OECOLOGIA, V166, P565, DOI 10.1007/s00442-010-1878-8; Grimsby JL, 2007, AM J BOT, V94, P957, DOI 10.3732/ajb.94.6.957; Harper David M., 2011, Freshwater Reviews, V4, P89, DOI 10.1608/FRJ-4.2.149; Hazelton Eric L G, 2014, AoB Plants, V6, DOI 10.1093/aobpla/plu001; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Hoyle M, 2005, CONSERV BIOL, V19, P1113, DOI 10.1111/j.1523-1739.2005.00166.x; Huang Y, 2015, PLANT BIOLOGY, V17, P1187, DOI 10.1111/plb.12368; Humphrey LD, 2001, CAN J BOT, V79, P1122, DOI 10.1139/cjb-79-9-1122; Jahnke M, 2015, MOL ECOL, V24, P2336, DOI 10.1111/mec.13174; Kansiime Frank, 2007, Wetlands Ecology and Management, V15, P443, DOI 10.1007/s11273-007-9043-9; Kartzinel TR, 2015, ANN BOT-LONDON, V116, P739, DOI 10.1093/aob/mcv117; Kebede S, 2006, J HYDROL, V316, P233, DOI 10.1016/j.jhydrol.2005.05.011; Kui L, 2013, WEED RES, V53, P370, DOI 10.1111/wre.12036; Kyambadde J, 2004, WATER RES, V38, P475, DOI 10.1016/j.watres.2003.10.008; Lamb HF, 2007, GEOPHYS RES, V8, P161; Lezberg AL, 2001, CAN J BOT, V79, P1028, DOI 10.1139/b01-083; Li F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121270; Li SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08935; Louapre P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038288; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Maclean IMD, 2011, ENVIRON MANAGE, V47, P218, DOI 10.1007/s00267-010-9592-1; Macreadie PI, 2014, ECOL EVOL, V4, P450, DOI 10.1002/ece3.933; Massa SI, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-39; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Mitsch WJ, 2010, WETL ECOL MANAG, V18, P573, DOI 10.1007/s11273-009-9164-4; Mnaya Bakari, 2002, Wetlands Ecology and Management, V10, P133; Mock KE, 2008, MOL ECOL, V17, P4827, DOI 10.1111/j.1365-294X.2008.03963.x; Morrison E. H. J., 2009, Ecohydrology and Hydrobiology, V9, P83, DOI 10.2478/v10104-009-0036-6; Mou XJ, 2011, J EXP MAR BIOL ECOL, V409, P99, DOI 10.1016/j.jembe.2011.08.006; Nanninga GB, 2014, MOL ECOL, V23, P591, DOI 10.1111/mec.12623; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Ohsako T, 2010, AM J BOT, V97, P458, DOI 10.3732/ajb.0900262; Owino Alfred O., 2007, Wetlands Ecology and Management, V15, P1, DOI 10.1007/s11273-006-9001-y; Pan Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05612; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perkol-Finkel S, 2012, J APPL ECOL, V49, P1457, DOI 10.1111/j.1365-2664.2012.02204.x; Poppe L, 2013, J MAPS, V9, P431, DOI 10.1080/17445647.2013.801000; Riginos C, 2013, GEOGR COMPASS, V7, P197, DOI 10.1111/gec3.12032; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryken N, 2015, SCI TOTAL ENVIRON, V511, P756, DOI 10.1016/j.scitotenv.2014.12.048; Setegn SG, 2010, HYDROL PROCESS, V24, P357, DOI 10.1002/hyp.7457; Setegne S. G., 2008, OPEN HYDROL J, V2, P24; Somme L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099295; Tamm A, 2001, EVOL ECOL, V15, P383, DOI 10.1023/A:1016093116926; Terer T, 2014, AQUAT BOT, V116, P93, DOI 10.1016/j.aquabot.2014.02.008; Thouvenot L, 2013, FLORA, V208, P430, DOI 10.1016/j.flora.2013.07.004; Tilahun SA., 2014, NILE RIVER BASIN, DOI DOI 10.1007/978-3-319-02720-3_9; Triest L, 2013, MOL ECOLOGY RESOURCE, V13, P546; Triest L, 2014, HYDROBIOLOGIA, V737, P131, DOI 10.1007/s10750-013-1584-8; Vallejo-Marin M, 2010, ANNU REV ECOL EVOL S, V41, P193, DOI 10.1146/annurev.ecolsys.110308.120258; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veeneklaas R, 2011, PRESLIA, V83, P455; Vijverberg J, 2009, MONOGR BIOL, V89, P163; Wondie Ayalew, 2010, Ecohydrology & Hydrobiology, V10, P123, DOI 10.2478/v10104-011-0017-4; Ye D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094009; Ye XH, 2006, ANN BOT-LONDON, V98, P187, DOI 10.1093/aob/mcl086; Yu FH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01467	90	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190810	10.1371/journal.pone.0190810	http://dx.doi.org/10.1371/journal.pone.0190810			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338034	Green Published, gold			2022-12-27	WOS:000422652700018
J	Raffington, L; Schmiedek, F; Heim, C; Shing, YL				Raffington, Laurel; Schmiedek, Florian; Heim, Christine; Shing, Yee Lee			Cognitive control moderates parenting stress effects on children's diurnal cortisol	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; SALIVARY CORTISOL; YOUNG-CHILDREN; ALLOSTATIC LOAD; HAIR CORTISOL; INDIVIDUAL-DIFFERENCES; ADAPTIVE CALIBRATION; EXECUTIVE FUNCTIONS; AWAKENING RESPONSE; EARLY EXPERIENCE	This study investigated associations between parenting stress in parents and self-reported stress in children with children's diurnal cortisol secretion and whether these associations are moderated by known stress-regulating capacities, namely child cognitive control. Salivary cortisol concentrations were assessed from awakening to evening on two weekend days from 53 6-to-7-year-old children. Children completed a cognitive control task and a self-report stress questionnaire with an experimenter, while parents completed a parenting stress inventory. Hierarchical, linear mixed effects models revealed that higher parenting stress was associated with overall reduced cortisol secretion in children, and this effect was moderated by cognitive control. Specifically, parenting stress was associated with reduced diurnal cortisol levels in children with lower cognitive control ability and not in children with higher cognitive control ability. There were no effects of self-reported stress in children on their cortisol secretion, presumably because 6-to-7-year-old children cannot yet self-report on stress experiences. Our results suggest that higher cognitive control skills may buffer the effects of parenting stress in parents on their children's stress regulation in middle childhood. This could indicate that training cognitive control skills in early life could be a target to prevent stress-related disorders.	[Raffington, Laurel; Heim, Christine] Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany; [Raffington, Laurel; Schmiedek, Florian; Shing, Yee Lee] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Raffington, Laurel; Heim, Christine] Charite, Inst Med Psychol, Berlin, Germany; [Schmiedek, Florian] German Inst Int Educ Res DIPF, Frankfurt, Germany; [Heim, Christine] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Shing, Yee Lee] Univ Stirling, Div Psychol, Stirling, Scotland; [Shing, Yee Lee] Goethe Univ Frankfurt, Dept Psychol, Frankfurt, Germany	Humboldt University of Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Institute for International Educational Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Stirling; Goethe University Frankfurt	Shing, YL (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany.; Shing, YL (corresponding author), Univ Stirling, Div Psychol, Stirling, Scotland.; Shing, YL (corresponding author), Goethe Univ Frankfurt, Dept Psychol, Frankfurt, Germany.	shing@psych.uni-frankfurt.de	Heim, Christine/J-4693-2014	Shing, Yee Lee/0000-0001-8922-7292; Raffington, Laurel/0000-0002-0144-5605; Heim, Christine/0000-0002-6580-6326	Minerva Research Group; Max Planck Society; Berlin School of Mind and Brain Graduate Fellowship	Minerva Research Group; Max Planck Society(Max Planck Society); Berlin School of Mind and Brain Graduate Fellowship	This study was funded by a Minerva Research Group to YLS by the Max Planck Society and Laurel Raffington was supported by the Berlin School of Mind and Brain Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin RR., 1990, PARENTING STRESS IND, DOI [10.4236/psych.2018.97104, DOI 10.4236/PSYCH.2018.97104]; Adam EK, 2017, PSYCHONEUROENDOCRINO, V83, P25, DOI 10.1016/j.psyneuen.2017.05.018; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Aiken L.S., 1991, MULTIPLE REGRESSION; [Anonymous], [No title captured]; Badanes LS, 2011, DEV PSYCHOPATHOL, V23, P881, DOI 10.1017/S095457941100037X; Baumler D, 2013, PSYCHONEUROENDOCRINO, V38, P2485, DOI 10.1016/j.psyneuen.2013.05.008; Baumler D, 2014, BIOL PSYCHOL, P59; Bernard K, 2010, ARCH PEDIAT ADOL MED, V164, P438, DOI 10.1001/archpediatrics.2010.54; Blair C, 2005, CHILD DEV, V76, P554, DOI 10.1111/j.1467-8624.2005.00863.x; Blair C, 2013, PSYCHONEUROENDOCRINO, V38, P2666, DOI 10.1016/j.psyneuen.2013.06.025; Blair C, 2012, AM PSYCHOL, V67, P309, DOI 10.1037/a0027493; Blair C, 2011, CHILD DEV, V82, P1970, DOI 10.1111/j.1467-8624.2011.01643.x; Blair C, 2011, DEV PSYCHOPATHOL, V23, P845, DOI 10.1017/S0954579411000344; Bogels SM, 2001, BEHAV RES THER, V39, P273, DOI 10.1016/S0005-7967(00)00005-X; Briley DA, 2017, J PERS, V85, P51, DOI 10.1111/jopy.12186; Broderick JE, 2004, PSYCHONEUROENDOCRINO, V29, P636, DOI 10.1016/S0306-4530(03)00093-3; Byrne DG, 2011, INT J STRESS MANAGE, V18, P88, DOI 10.1037/a0021577; CADET R, 1986, J DEV PHYSIOL, V8, P467; Carnegie R, 2014, BRIT J PSYCHIAT, V204, P137, DOI 10.1192/bjp.bp.113.126250; Caster JB, 1999, J ANXIETY DISORD, V13, P237, DOI 10.1016/S0887-6185(99)00002-X; Chen E, 2006, HEALTH PSYCHOL, V25, P704, DOI 10.1037/0278-6133.25.6.704; Chen E, 2010, PSYCHOL SCI, V21, P31, DOI 10.1177/0956797609355566; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Davis EP, 2002, DEV PSYCHOBIOL, V40, P43, DOI 10.1002/dev.10012; Deary I, 2008, NATURE, V456, P175, DOI 10.1038/456175a; Deary Ian J, 2010, Psychol Sci Public Interest, V11, P53, DOI 10.1177/1529100610387081; Dedovic K, 2009, NEUROIMAGE, V47, P864, DOI 10.1016/j.neuroimage.2009.05.074; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; Del Giudice M, 2011, NEUROSCI BIOBEHAV R, V35, P1562, DOI 10.1016/j.neubiorev.2010.11.007; Dettling AC, 1999, PSYCHONEUROENDOCRINO, V24, P519, DOI 10.1016/S0306-4530(99)00009-8; Dettling AC, 2000, PSYCHONEUROENDOCRINO, V25, P819, DOI 10.1016/S0306-4530(00)00028-7; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Finegood E.D., 2017, PARENTAL STRESS EARL, P181, DOI [10.1007/978-3-319-55376-4_8, DOI 10.1007/978-3-319-55376-4_8]; Fisher PA, 2008, DEV PSYCHOPATHOL, V20, P1003, DOI 10.1017/S0954579408000473; Flom M, 2017, DEV PSYCHOBIOL, V59, P26, DOI 10.1002/dev.21449; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; Gershoff ET, 2007, CHILD DEV, V78, P70, DOI 10.1111/j.1467-8624.2007.00986.x; Gross JJ, 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Guerry JD, 2011, CLIN CHILD FAM PSYCH, V14, P135, DOI 10.1007/s10567-011-0084-5; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Gunnar MR, 2006, DEV PSYCHOPATHOL, V18, P651, DOI 10.1017/S0954579406060330; Gunnar MR, 2009, PSYCHONEUROENDOCRINO, V34, P953, DOI 10.1016/j.psyneuen.2009.02.010; Gunnar MR, 1997, DEV PSYCHOBIOL, V31, P65, DOI 10.1002/(SICI)1098-2302(199707)31:1<65::AID-DEV6>3.0.CO;2-S; Halberstadt AG, 1999, FAMILY EXPRESSIVENES; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Hostinar CE, 2015, DEV PSYCHOL, V51, P1597, DOI 10.1037/dev0000029; Hostinar CE, 2015, DEVELOPMENTAL SCI, V18, P281, DOI 10.1111/desc.12195; Hostinar CE, 2014, PSYCHOL BULL, V140, P256, DOI 10.1037/a0032671; Johnson MH, 2012, TRENDS COGN SCI, V16, P454, DOI 10.1016/j.tics.2012.07.001; Kliewer W, 2009, J BLACK PSYCHOL, V35, P24, DOI 10.1177/0095798408323355; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Koss KJ, 2016, PSYCHONEUROENDOCRINO, V66, P31, DOI 10.1016/j.psyneuen.2015.12.018; Koss KJ, 2014, PSYCHONEUROENDOCRINO, V50, P1, DOI 10.1016/j.psyneuen.2014.07.028; LaPrairie JL, 2010, IMPACT EARLY LIFE TR, P247; Lehman BJ, 2015, SOC PERSONAL PSYCHOL, V9, P551, DOI 10.1111/spc3.12202; LeMoult J, 2015, J ABNORM PSYCHOL, V124, P850, DOI 10.1037/abn0000087; LEVINE S, 1994, ANN NY ACAD SCI, V746, P275, DOI 10.1111/j.1749-6632.1994.tb39245.x; Llabre MM, 2004, PSYCHOSOM MED, V66, P29, DOI 10.1097/01.PSY.0000107886.51781.9C; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; Lupien SJ, 2001, DEV PSYCHOPATHOL, V13, P653, DOI 10.1017/S0954579401003133; Lupien SJ, 2000, BIOL PSYCHIAT, V48, P976, DOI 10.1016/S0006-3223(00)00965-3; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maldonado EF, 2008, SPAN J PSYCHOL, V11, P3, DOI 10.1017/S1138741600004066; Martin CG, 2016, PSYCHONEUROENDOCRINO, V67, P18, DOI 10.1016/j.psyneuen.2016.01.025; Martin CG, 2014, PSYCHONEUROENDOCRINO, V40, P170, DOI 10.1016/j.psyneuen.2013.11.015; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; MCLOYD VC, 1990, CHILD DEV, V61, P311, DOI 10.1111/j.1467-8624.1990.tb02781.x; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Murgatroyd CA, 2013, PSYCHONEUROENDOCRINO, V38, P219, DOI 10.1016/j.psyneuen.2012.05.020; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Pagliaccio D, 2014, NEUROPSYCHOPHARMACOL, V39, P1245, DOI 10.1038/npp.2013.327; Peckins MK, 2015, DEV PSYCHOPATHOL, V27, P1461, DOI 10.1017/S0954579415000875; Quevedo K, 2012, INT J BEHAV DEV, V36, P19, DOI 10.1177/0165025411406860; Rippe RCA, 2016, PSYCHONEUROENDOCRINO, V66, P56, DOI 10.1016/j.psyneuen.2015.12.016; Ross KM, 2014, PSYCHONEUROENDOCRINO, V39, P184, DOI 10.1016/j.psyneuen.2013.09.016; Rotenberg S, 2012, PSYCHONEUROENDOCRINO, V37, P1981, DOI 10.1016/j.psyneuen.2012.04.014; Schmidt-Reinwald A, 1999, LIFE SCI, V64, P1653, DOI 10.1016/S0024-3205(99)00103-4; Smyth N, 2013, SOC PERSONAL PSYCHOL, V7, P605, DOI 10.1111/spc3.12057; Sroufe L.A., 1996, EMOTIONAL DEV ORG EM, DOI DOI 10.1017/CBO9780511527661; Stalder T, 2016, PSYCHONEUROENDOCRINO, V63, P414, DOI 10.1016/j.psyneuen.2015.10.010; Stalder T, 2009, PSYCHONEUROENDOCRINO, V34, P607, DOI 10.1016/j.psyneuen.2008.10.023; Suor JH, 2015, CHILD DEV, V86, P1142, DOI 10.1111/cdev.12376; TEIN JY, 1994, J MARRIAGE FAM, V56, P341, DOI 10.2307/353104; Tr/ster H., 2011, PARENTING STRESS INV; Tucker-Drob EM, 2017, PSYCHOL MED, V47, P1389, DOI 10.1017/S0033291716003068; Vaghri Z, 2013, PSYCHONEUROENDOCRINO, V38, P331, DOI 10.1016/j.psyneuen.2012.06.009; Wagner SL, 2016, CHILD NEUROPSYCHOL, V22, P853, DOI 10.1080/09297049.2015.1080232; Wang YN, 2016, HUM BRAIN MAPP, V37, P3757, DOI 10.1002/hbm.23273; Watamura SE, 2004, DEV PSYCHOBIOL, V45, P125, DOI 10.1002/dev.20026; WEISSMAN MM, 1980, J NERV MENT DIS, V168, P736, DOI 10.1097/00005053-198012000-00005; Williford AP, 2007, J ABNORM CHILD PSYCH, V35, P251, DOI 10.1007/s10802-006-9082-3; Wolf JM, 2008, BIOL PSYCHOL, V78, P20, DOI 10.1016/j.biopsycho.2007.12.004; Wright Andy, 2014, Front Psychol, V5, P213, DOI 10.3389/fpsyg.2014.00213; Wust S, 2000, PSYCHONEUROENDOCRINO, V25, P707, DOI 10.1016/s0306-4530(00)00021-4; Yim IS, 2015, PSYCHONEUROENDOCRINO, V57, P61, DOI 10.1016/j.psyneuen.2015.03.021; Zalewski M, 2012, INFANT CHILD DEV, V21, P537, DOI 10.1002/icd.1759	99	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191215	10.1371/journal.pone.0191215	http://dx.doi.org/10.1371/journal.pone.0191215			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BY	29329340	Green Published, Green Submitted, gold			2022-12-27	WOS:000419954100050
J	Wahn, B; Czeszumski, A; Konig, P				Wahn, Basil; Czeszumski, Artur; Koenig, Peter			Performance similarities predict collective benefits in dyadic and triadic joint visual search	PLOS ONE			English	Article							TO-NUMBERS PROBLEMS; DECISION-MAKING; SHARED GAZE; COORDINATION; INDIVIDUALS; COGNITION; MINDS; TASK	When humans perform tasks together, they may reach a higher performance in comparison to the best member of a group (i.e., a collective benefit). Earlier research showed that interindividual performance similarities predict collective benefits for several joint tasks. Yet, researchers did not test whether this is the case for joint visuospatial tasks. Also, researchers did not investigate whether dyads and triads reach a collective benefit when they are forbidden to exchange any information while performing a visuospatial task. In this study, participants performed a joint visual search task either alone, in dyads, or in triads, and were not allowed to exchange any information while doing the task. We found that dyads reached a collective benefit. Triads did outperform their best individual member and dyads-yet, they did not outperform the best dyad pairing within the triad. In addition, similarities in performance significantly predicted the collective benefit for dyads and triads. Furthermore, we find that the dyads' and triads' search performances closely match a simulated performance based on the individual search performances, which assumed that members of a group act independently. Overall, the present study supports the view that performance similarities predict collective benefits in joint tasks. Moreover, it provides a basis for future studies to investigate the benefits of exchanging information between co-actors in joint visual search tasks.	[Wahn, Basil; Czeszumski, Artur; Koenig, Peter] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany; [Koenig, Peter] Univ Med Ctr Hamburg Eppendorf, Ctr Expt Med, Dept Neurophysiol & Pathophysiol, Hamburg, Germany	University Osnabruck; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wahn, B (corresponding author), Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany.	bwahn@uos.de	König, Peter/ABB-2380-2020; Wahn, Basil/AAV-5770-2021; Czeszumski, Artur/AAI-1334-2020	König, Peter/0000-0003-3654-5267; Czeszumski, Artur/0000-0002-5317-7948; Wahn, Basil/0000-0002-0318-7160	H-FETPROACT [641321]; ERC-AdG [269716]; Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of Osnabruck University; Osnabruck Open Access Prize	H-FETPROACT; ERC-AdG; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of Osnabruck University; Osnabruck Open Access Prize	We acknowledge the support by H2020-H2020-FETPROACT-2014 641321-socSMCs (for BW), ERC-2010-AdG #269716-MULTISENSE (for PK), Deutsche Forschungsgemeinschaft (DFG), Open Access Publishing Fund of Osnabruck University, and the Osnabruck Open Access Prize (for BW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Bang D, 2017, OPEN SCI, V4, P170; Bang D, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0117; Bietti LM, 2015, INTERACT STUD, V16, P419, DOI 10.1075/is.16.3.04bie; Brennan AA, 2015, PSYCHON B REV, V22, P1076, DOI 10.3758/s13423-014-0765-4; Brennan SE, 2008, COGNITION, V106, P1465, DOI 10.1016/j.cognition.2007.05.012; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Fusaroli R, 2012, PSYCHOL SCI, V23, P931, DOI 10.1177/0956797612436816; Ganesh G, 2014, SCI REPORTS, V4; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Knoblich G, 2003, J EXP PSYCHOL LEARN, V29, P1006, DOI 10.1037/0278-7393.29.5.1006; Kurvers RHJM, 2016, P NATL ACAD SCI USA, V113, P8777, DOI 10.1073/pnas.1601827113; Laughlin PR, 2006, J PERS SOC PSYCHOL, V90, P644, DOI 10.1037/0022-3514.90.4.644; Laughlin PR, 2002, ORGAN BEHAV HUM DEC, V88, P605, DOI 10.1016/S0749-5978(02)00003-1; Mahmoodi A, 2015, P NATL ACAD SCI USA, V112, P3835, DOI 10.1073/pnas.1421692112; Masumoto J, 2015, J NEUROPHYSIOL, V113, P3736, DOI 10.1152/jn.00313.2015; Neider MB, 2010, PSYCHON B REV, V17, P718, DOI 10.3758/PBR.17.5.718; Newman-Norlund RD, 2008, NEUROIMAGE, V41, P169, DOI 10.1016/j.neuroimage.2008.02.026; Pescetelli N, 2016, J EXP PSYCHOL GEN, V145, DOI 10.1037/xge0000180; Rajaram S, 2010, PERSPECT PSYCHOL SCI, V5, P649, DOI 10.1177/1745691610388763; Reed K, 2006, PSYCHOL SCI, V17, P365, DOI 10.1111/j.1467-9280.2006.01712.x; Rigoli L, 2015, P 37 ANN C COGN SCI, P1997; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sorkin RD, 2001, PSYCHOL REV, V108, P183, DOI 10.1037//0033-295X.108.1.183; Szymanski C, 2017, NEUROIMAGE, V152, P425, DOI 10.1016/j.neuroimage.2017.03.013; Takagi A, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0054; Tsai CC, 2006, EXP BRAIN RES, V175, P353, DOI 10.1007/s00221-006-0557-9; Vesper C, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02039; Wahn B., 2016, COGSCI, P2747; Wahn B, 2017, FRONTIERS PSYCHOL; Wahn B, 2016, ERGONOMICS, V59, P781, DOI 10.1080/00140139.2015.1099742	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191179	10.1371/journal.pone.0191179	http://dx.doi.org/10.1371/journal.pone.0191179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BY	29329331	Green Submitted, gold, Green Published			2022-12-27	WOS:000419954100043
J	Brzoska, P				Brzoska, Patrick			Disparities in health care outcomes between immigrants and the majority population in Germany: A trend analysis, 2006-2014	PLOS ONE			English	Article							MEDICAL REHABILITATION; DIVERSITY; MIGRANTS; INTERVENTIONS; NETHERLANDS; ATTENDANCE; MIGRATION; TURKISH; WOMEN	Background & para;& para;Immigrants often encounter barriers in the health system that may affect their health care outcomes. In order to better cater to the needs of immigrants, many health care institutions have increased their efforts in recent years to provide services which are more sensitive to the needs of an increasingly diverse population. Little is known about whether these efforts are successful. This study examines difference in outcomes of tertiary prevention between immigrants and the autochthonous population in Germany over the period of 2006-2014.& para;& para;Methods & para;& para;The analysis is based on a 10% random sample of routine data on completed tertiary preventive treatments in Germany during 2006-2014. Four different indicators of treatment effectiveness were compared between patients with a nationality from Germany, Portugal/Spain/Italy/Greece, Turkey and Former Yugoslavia using logistic regression adjusted for demographic/socioeconomic factors. Interaction terms for year were modeled to examine group differences over time.& para;& para;Results & para;& para;Depending on the outcome, Turkish and Former Yugoslavian nationals had an 23%-69% higher chance of a poor treatment effectiveness than Germans (OR = 1.23 [95%-CI = 1.15,1.32] and OR = 1.69 [95%-CI = 1.55,1.83], respectively). Fewer differences were observed between nationals from Portugal/Spain/Italy/Greece and Germans. Disparities did not significantly differ between the years in which services were utilized.& para;& para;Conclusion & para;& para;Measures implemented by health care institutions did not reduce existing health care disparities between immigrants and the majority population in Germany. One potential reason is that existing approaches are unsystematic and often not properly evaluated. More targeted strategies and a thorough evaluation is needed in order to improve health care for immigrants sustainably.	[Brzoska, Patrick] Tech Univ Chemnitz, Fac Behav & Social Sci, Chemnitz, Germany	Technische Universitat Chemnitz	Brzoska, P (corresponding author), Tech Univ Chemnitz, Fac Behav & Social Sci, Chemnitz, Germany.	patrick.brzoska@soziologie.tu-chemnitz.de			German Research Foundation/DFG; Technische Universitat Chemnitz	German Research Foundation/DFG(German Research Foundation (DFG)); Technische Universitat Chemnitz	The publication costs of this article were funded by the German Research Foundation/DFG and the Technische Universitat Chemnitz in the funding program Open Access Publishing. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LM, 2003, AM J PREV MED, V24, P68, DOI 10.1016/S0749-3797(02)00657-8; Andreeva VA, 2013, PSYCHO-ONCOLOGY, V22, P2664, DOI 10.1002/pon.3344; [Anonymous], 2017, BEV ERW BEV MIGR ERG; Beauftragte der Bundesregierung fur Migration, 2015, KULT KRANK ANS INT O; Berens EM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3810-6; Brause M, 2012, REHABILITATION, V51, P282, DOI 10.1055/s-0031-1295448; Brzoska P, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1348-z; Brzoska P., 2015, PUBLIC HLTH FORUM, V23, P113, DOI [10.1515/pubhef-2015-0041, DOI 10.1515/PUBHEF-2015-0041]; Brzoska P, 2016, INT J PUBLIC HEALTH, P1; Brzoska P, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015520; Brzoska P, 2017, BUNDESGESUNDHEITSBLA, V60, P841, DOI 10.1007/s00103-017-2572-3; Brzoska P, 2015, BUNDESGESUNDHEITSBLA, V58, P553, DOI 10.1007/s00103-015-2144-3; Brzoska P, 2015, INT J PUBLIC HEALTH, V60, P13, DOI 10.1007/s00038-014-0617-z; Brzoska P, 2010, EUR J EPIDEMIOL, V25, P651, DOI 10.1007/s10654-010-9468-y; Cooper LA, 2002, J GEN INTERN MED, V17, P477, DOI 10.1046/j.1525-1497.2002.10633.x; Cote D, 2013, DISABIL REHABIL, V35, P153, DOI 10.3109/09638288.2012.687034; Deutsche Rentenversicherung Bund, 2007, ARZTL REH ENTL LEITF; Dorenburg U., 2000, GRUNDLAGEN REHABILIT, P197; European Commission Implementation Checklist for Diversity Management, 2012, SUPP VOL IN PROM DIV; Gerdes N, 2006, RES REHABILITATION R, P3; Gordin J, 2011, ORG BEHAV HLTH CARE, P15; Graham JE, 2007, J GERONTOL A-BIOL, V63, P860; Hasnain R, 2011, FOCUS TECH BR, V31, P1; Ihle P, 2008, GESUNDHEITSWESEN, V70, P54, DOI 10.1055/s-2007-1022529; Keller A, 2005, J PUBLIC HEALTH-HEID, V13, P22, DOI 10.1007/s10389-004-0082-x; Lagerlund M, 2002, CANCER CAUSE CONTROL, V13, P73, DOI 10.1023/A:1013978421073; Maier C, 2008, INTERKULTURELLE MED, P85; OMH HHS, 2013, NATL STAND CULT LING; Ottenbacher KJ, 2008, STROKE, V39, P1514, DOI 10.1161/STROKEAHA.107.501254; Razum O, 2014, INT J PUBLIC HEALTH, V59, P893, DOI 10.1007/s00038-014-0584-4; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Rosano A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2549-9; Seeleman C, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1159-7; Sloots M, 2010, J REHABIL MED, V42, P566, DOI 10.2340/16501977-0536; Sole-Auro A, 2008, INT MIGR REV, V42, P861, DOI 10.1111/j.1747-7379.2008.00150.x; StataCorp, 2013, STATA STAT SOFTW REL; TF MFCCH, 2012, PROJ DEV STAND EQ HL; Vermeer B, 2010, EUR J CANCER PREV, V19, P195, DOI 10.1097/CEJ.0b013e328337214c; Voigtlander S., 2013, MIGRATION MEDIZINISC, P92; Weech-Maldonado R, 2002, J HEALTHC MANAG, V47, P111, DOI 10.1097/00115514-200203000-00009; Yilmaz-Aslan Y, 2014, CHRONIC ILLN, V10, P107, DOI 10.1177/1742395313501207; Zeeb H, 2004, GESUNDHEITSWESEN, V66, P76, DOI 10.1055/s-2004-812825	42	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191732	10.1371/journal.pone.0191732	http://dx.doi.org/10.1371/journal.pone.0191732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360874	Green Published, gold, Green Submitted			2022-12-27	WOS:000423161800057
J	Sutanto, EN; Scaffidi, A; Garrett, LW; Looi, K; Foo, CJ; Tessari, MA; Janssen, RA; Fischer, DF; Stick, SM; Kicic, A				Sutanto, Erika N.; Scaffidi, Amelia; Garrett, Luke W.; Looi, Kevin; Foo, Clara J.; Tessari, Michela A.; Janssen, Richard A.; Fischer, David F.; Stick, Stephen M.; Kicic, Anthony		AREST CF	Assessment of p.Phe508del-CFTR functional restoration in pediatric primary cystic fibrosis airway epithelial cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SENSITIVE FLUORESCENT INDICATORS; SMALL-MOLECULE CORRECTORS; PLURIPOTENT STEM-CELLS; CFTR EXPRESSION; CHLORIDE; PROTEIN; LUNG; TRAFFICKING; GENERATION	Background & para;& para;Mutations in the cystic fibrosis transmembrane regulator (CFTR) gene can reduce function of the CFTR ion channel activity and impair cellular chloride secretion. The gold standard method to assess CFTR function of ion transport using the Using chamber requires a high number of airway epithelial cells grown at air-liquid interface, limiting the application of this method for high throughput screening of potential therapeutic compounds in primary airway epithelial cells (pAECs) featuring less common CFTR mutations. This study assessed an alternative approach, using a small scale halide assay that can be adapted for a personalized high throughput setting to analyze CFTR function of pAEC.& para;& para;Methods & para;& para;Pediatric pAECs derived from children with CF (pAEC(CF) ) were established and expanded as monolayer cultures, before seeding into 96 well plates for the halide assay. Cells were then transduced with an adenoviral construct containing yellow fluorescent protein (eYFP) reporter gene, alone or in combination with either wild-type CFTR (WT-CFTR) or p.Phe508-del CFTR. Four days post transduction, cells were stimulated with forskolin and genistein, and assessed for quenching of the eYFP signal following injection of iodide solution into the assay media.& para;& para;Results & para;& para;Data showed that pAEC(CF) can express eYFP at high efficiency following transduction with the eYFP construct. The halide assay was able to discriminate functional restoration of CFTR in pAEC(CF) treated with either WT-CFTR construct or the positive controls syntaxin 8 and B-cell receptor-associated protein 31 shRNAs.& para;& para;Significance & para;& para;The current study demonstrates that the halide assay can be adapted for pediatric pAEC(CF) to evaluate restoration of CFTR function. With the ongoing development of small molecules to modulate the folding and/or activity of various mutated CFTR proteins, this halide assay presents a small-scale personalized screening platform that could assess therapeutic potential of molecules across a broad range of CFTR mutations.	[Sutanto, Erika N.; Garrett, Luke W.; Looi, Kevin; Stick, Stephen M.; Kicic, Anthony] Univ Western Australia, Telethon Kids Inst, Nedlands, WA, Australia; [Sutanto, Erika N.; Stick, Stephen M.; Kicic, Anthony] Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia; [Scaffidi, Amelia] Univ Western Australia, Off Res Enterprise, Nedlands, WA, Australia; [Foo, Clara J.; Stick, Stephen M.; Kicic, Anthony] Univ Western Australia, Sch Paediat & Child Hlth, Nedlands, WA, Australia; [Tessari, Michela A.; Janssen, Richard A.] Galapagos BV, NL-2300 AC Leiden, Netherlands; [Fischer, David F.] Charles River Labs, Leiden, Netherlands; [Stick, Stephen M.; Kicic, Anthony] Univ Western Australia, Sch Med & Pharmacol, Ctr Cell Therapy & Regenerat Med, Nedlands, WA, Australia; Royal Childrens Hosp, Dept Resp Med, Melbourne, Vic, Australia; [AREST CF] Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Galapagos NV; University of Western Australia; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute	Kicic, A (corresponding author), Univ Western Australia, Telethon Kids Inst, Nedlands, WA, Australia.; Kicic, A (corresponding author), Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia.; Kicic, A (corresponding author), Univ Western Australia, Sch Paediat & Child Hlth, Nedlands, WA, Australia.; Kicic, A (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Ctr Cell Therapy & Regenerat Med, Nedlands, WA, Australia.	Anthony.Kicic@telethonkids.org.au	Stick, Stephen/AAA-5945-2021; Stick, Stephen/GZG-7584-2022; Kicic, Anthony/ABA-1252-2021; Garratt, Luke Wisely/N-2371-2013	Stick, Stephen/0000-0002-5386-8482; Kicic, Anthony/0000-0002-0008-9733; Garratt, Luke Wisely/0000-0001-9381-326X; Sutanto, Erika/0000-0002-4224-2839; Fischer, David/0000-0002-6690-0197	National Health and Medical Research Council of Australia [303145, 458513, 513730]; Charles River Laboratory; Cystic Fibrosis Foundation Therapeutics [SLY04A0, STICK09A0]; Australian Cystic Fibrosis Research Trust; Galapagos BV Laboratory	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Charles River Laboratory; Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Australian Cystic Fibrosis Research Trust; Galapagos BV Laboratory	This work was supported by a grant from the Australian Cystic Fibrosis Research Trust, National Health and Medical Research Council of Australia (303145; 458513, 513730) and Cystic Fibrosis Foundation Therapeutics (SLY04A0, STICK09A0). Michela A. Tessari and Richard A. Janssen are employees of Galapagos BV, and David F. Fischer is from Charles River Laboratories. Both Galapagos BV and Charles River Laboratories provided research materials and financial support to the relevant authors (MA Tessari, RA Janssen and DF Fischer) and did not play a role in the study design, data collection and analysis, decision to publish and the preparation of the manuscript. Those authors were involved in reviewing the manuscript prior to submission. Stephen M. Stick is a National Health and Medical Research Council of Australia Practitioner Fellow. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi S, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0015-6; Bilan F, 2004, J CELL SCI, V117, P1923, DOI 10.1242/jcs.01070; Butler CR, 2016, AM J RESP CRIT CARE, P1; Cholon DM, 2015, NIH PUBLIC ACCESS, V6; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Dekkers JF, 2016, EUR RESPIR J, V48, P451, DOI 10.1183/13993003.01192-2015; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Doull IJM, 2001, ARCH DIS CHILD, V85, P62, DOI 10.1136/adc.85.1.62; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Firth AL, 2014, P NATL ACAD SCI USA, V111, pE1723, DOI 10.1073/pnas.1403470111; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Granio O, 2007, AM J RESP CELL MOL, V37, P631, DOI 10.1165/rcmb.2007-0026TE; Hild M, 2016, CURR PROTOC STEM CEL, V37, DOI [10.1002/cpsc.1, DOI 10.1002/CPSC.1]; Ikpa PT, 2014, INT J BIOCHEM CELL B, V52, P192, DOI 10.1016/j.biocel.2014.02.008; Jayaraman S, 1999, AM J PHYSIOL-CELL PH, V277, pC1008, DOI 10.1152/ajpcell.1999.277.5.C1008; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Jiang CW, 2001, AM J PHYSIOL-LUNG C, V281, pL1164, DOI 10.1152/ajplung.2001.281.5.L1164; Kicic A, INTRINSIC BIOCH FUNC; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Lambert G, 2001, J BIOL CHEM, V276, P20340, DOI 10.1074/jbc.M011209200; Lane C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-53; Leavesley SJ, 2016, CYTOM PART A, V89A, P325, DOI 10.1002/cyto.a.22851; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Loi R, 2006, AM J RESP CRIT CARE, V173, P171, DOI 10.1164/rccm.200502-309OC; Maitra R, 2013, J BIOMOL SCREEN, V18, P1132, DOI 10.1177/1087057113488420; Mansoura MK, 1999, HUM GENE THER, V10, P861, DOI 10.1089/10430349950018274; McNamara PS, 2008, EUR RESPIR J, V32, P763, DOI 10.1183/09031936.00162507; Morales MM, 1999, BRAZ J MED BIOL RES, V32, P1021, DOI 10.1590/S0100-879X1999000800013; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Munkonge Felix, 2004, J Cyst Fibros, V3 Suppl 2, P171, DOI 10.1016/j.jcf.2004.05.036; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Phuan PW, 2015, MOL PHARMACOL, V88, P791, DOI 10.1124/mol.115.099689; Ramachandran S, 2016, J BIOL CHEM, V291, P25489, DOI 10.1074/jbc.M116.754283; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Sutanto EN, 2011, AM J RESP CELL MOL, V44, P761, DOI 10.1165/rcmb.2010-0368OC; Tan Q, 2017, BIOMATERIALS, V113, P118, DOI 10.1016/j.biomaterials.2016.10.046; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; VERKMAN AS, 1990, AM J PHYSIOL, V259, pC375, DOI 10.1152/ajpcell.1990.259.3.C375; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Zhang L.J., 2009, ETHYLENE IND, V25, P7, DOI DOI 10.1371/J0URNAL.PBI0.1000155	46	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191618	10.1371/journal.pone.0191618	http://dx.doi.org/10.1371/journal.pone.0191618			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360847	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800041
J	Cataldo, DM; Migliano, AB; Vinicius, L				Cataldo, Dana Michelle; Migliano, Andrea Bamberg; Vinicius, Lucio			Speech, stone tool-making and the evolution of language	PLOS ONE			English	Article							COMMUNICATION; GESTURE; ORIGIN; BRAIN	The 'technological hypothesis' proposes that gestural language evolved in early hominins to enable the cultural transmission of stone tool-making skills, with speech appearing later in response to the complex lithic industries of more recent hominins. However, no flintknapping study has assessed the efficiency of speech alone (unassisted by gesture) as a tool-making transmission aid. Here we show that subjects instructed by speech alone underperform in stone tool-making experiments in comparison to subjects instructed through either gesture alone or 'full language' (gesture plus speech), and also report lower satisfaction with their received instruction. The results provide evidence that gesture was likely to be selected over speech as a teaching aid in the earliest hominin tool-makers; that speech could not have replaced gesturing as a tool-making teaching aid in later hominins, possibly explaining the functional retention of gesturing in the full language of modern humans; and that speech may have evolved for reasons unrelated to tool-making. We conclude that speech is unlikely to have evolved as tool-making teaching aid superior to gesture, as claimed by the technological hypothesis, and therefore alternative views should be considered. For example, gestural language may have evolved to enable tool-making in earlier hominins, while speech may have later emerged as a response to increased trade and more complex inter-and intra-group interactions in Middle Pleistocene ancestors of Neanderthals and Homo sapiens; or gesture and speech may have evolved in parallel rather than in sequence.	[Cataldo, Dana Michelle; Migliano, Andrea Bamberg; Vinicius, Lucio] UCL, Dept Anthropol, London, England	University of London; University College London	Vinicius, L (corresponding author), UCL, Dept Anthropol, London, England.	l.vinicius@ucl.ac.uk		Migliano, Andrea/0000-0003-4364-2735				Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Blegen N, 2017, J HUM EVOL, V103, P1, DOI 10.1016/j.jhevol.2016.11.002; Bolhuis JJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001934; Callahan E., 1979, BASICS BIFACE KNAPPI; Coolidge FL, 2005, CAMB ARCHAEOL J, V15, P5, DOI 10.1017/S0959774305000016; Corballis MC, 2009, ANN NY ACAD SCI, V1156, P19, DOI 10.1111/j.1749-6632.2009.04423.x; Dunbar R., 1996, GROOMING GOSSIP EVOL; Dunbar RIM, 2003, LANGUAGE EVOLUTION, P219; Fitch WT, 2017, SCI ADV, V2; Gatewood J., 1985, DIRECTIONS COGNITIVE, P199; GREENFIELD PM, 1991, BEHAV BRAIN SCI, V14, P531, DOI 10.1017/S0140525X00071235; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Higuchi S, 2009, NEUROREPORT, V20, P1376, DOI 10.1097/WNR.0b013e3283315570; HOLLOWAY RL, 1969, CURR ANTHROPOL, V10, P395, DOI 10.1086/201036; Iverson JM, 1998, NATURE, V396, P228, DOI 10.1038/24300; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lieberman P, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002064; MCNEILL D, 1985, PSYCHOL REV, V92, P350, DOI 10.1037/0033-295X.92.3.350; McNeill D, 1992, HAND MIND WHAT GESTU; MONTAGU A, 1976, ANN NY ACAD SCI, V280, P266, DOI 10.1111/j.1749-6632.1976.tb25493.x; Morgan TJH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7029; Ohnuma K, 1997, ANTHROPOL SCI, V105, P159, DOI 10.1537/ase.105.159; Putt SS, 2014, LITHIC TECHNOL, V39, P96, DOI 10.1179/0197726114Z.00000000036; REYNOLDS PC, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P407; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; Steele J, 2012, PHILOS T R SOC B, V367, P4, DOI 10.1098/rstb.2011.0295; Stout D, 2012, PHILOS T R SOC B, V367, P75, DOI 10.1098/rstb.2011.0099; Tomasello M, 2008, JEAN NICOD LECT, P1; Wiessner PW, 2014, P NATL ACAD SCI USA, V111, P14027, DOI 10.1073/pnas.1404212111	30	24	26	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191071	10.1371/journal.pone.0191071	http://dx.doi.org/10.1371/journal.pone.0191071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351319	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300045
J	Fernandez-Navarro, P; Aragones, MT; Ley, V				Fernandez-Navarro, Pablo; Aragones, Maria Teresa; Ley, Victoria			Leisure-time physical activity and prevalence of non-communicable pathologies and prescription medication in Spain	PLOS ONE			English	Article							AEROBIC EXERCISE; MORTALITY; ADULTS; HEALTH; CHOLESTEROL; FITNESS; OBESITY; CANCER; WOMEN; RISK	Our aims were to describe physical activity (PA) behaviour in Spain and to examine its association with the prevalence of some of the major non-communicable diseases and with the use of prescription medication. Individualized secondary data retrieved from the 2014 European Health Interview Survey (EHIS) for Spain were used to conduct a cross-sectional epidemiological study (n = 18926). PA was assessed by two different measures: a specific designed variable for EHIS and a leisure time PA frequency-based query of the national survey. Diseases analyzed were hypertension, diabetes, hypercholesterolemia, depression and anxiety. The use of prescription medication was also included in the study. Weighted percentages were computed and contingency tables were calculated to describe PA by levels of the traits and sociodemographic characteristics. Chi-square test was used to compare percentages between groups and weighted logistic regression models were used to assess the relationship between PA and the prevalence of the disease. About 73% of the Spanish population performs no PA at all or only occasionally during their leisure time, and only one third meets minimum PA international guidelines (>= 150min/week). Men are considerably more active than women and less PA is observed as the education level decreases and as age increases. The risk of the diseases evaluated was up to three times higher among inactive individuals. This study provides national population-based estimations highlighting the impact of PA in Spain, not only in the prevalence of some of the major non-communicable diseases but also in reducing prescription medication, and the potential sex and socioeconomic influence.	[Fernandez-Navarro, Pablo] Carlos III Inst Hlth, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain; [Fernandez-Navarro, Pablo] Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain; [Aragones, Maria Teresa; Ley, Victoria] Spanish Agcy Hlth Protect Sports, Natl Sports Council, Dept Sports & Hlth, Madrid, Spain	Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Fernandez-Navarro, P (corresponding author), Carlos III Inst Hlth, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain.; Fernandez-Navarro, P (corresponding author), Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain.; Ley, V (corresponding author), Spanish Agcy Hlth Protect Sports, Natl Sports Council, Dept Sports & Hlth, Madrid, Spain.	pfernandezn@isciii.es; victoria.ley@aei.gob.es	Ley, Victoria/I-8862-2017; Navarro, Pablo Fernandez/E-8893-2018	Ley, Victoria/0000-0003-2740-1560; Navarro, Pablo Fernandez/0000-0001-9427-2581; Gonzalez Palacios, Javier/0000-0002-8099-8469; Gonzalez Sanchez, Mario/0000-0003-0229-3559	Spain's Health Research Fund, Institute de Salud Carlos III [EPY 1271/15]	Spain's Health Research Fund, Institute de Salud Carlos III	This work was supported by EPY 1271/15 from Spain's Health Research Fund, Institute de Salud Carlos III; https://portalfis.isciii.es/es/Paginas/inicio.aspx. PFN is the PI of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Becofsky KM, 2015, AM J EPIDEMIOL, V181, P311, DOI 10.1093/aje/kwu330; Booth FW, 2015, DIABETOLOGIA, V58, P1730, DOI 10.1007/s00125-015-3617-5; Bull F, 2015, BRIT J SPORT MED, V49, P749, DOI 10.1136/bjsports-2013-093200; Cornelissen VA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004473; Craft Lynette L., 2004, Prim Care Companion J Clin Psychiatry, V6, P104; Devaux M, 2013, EUR J PUBLIC HEALTH, V23, P464, DOI 10.1093/eurpub/ckr058; Ekelund U, 2015, AM J CLIN NUTR, V101, P613, DOI 10.3945/ajcn.114.100065; Eurostat, 2015, EUR HLTH INT SURV ME; Finger JD, 2015, ARCH PUBLIC HEALTH, V73, P1; Fishman EI, 2016, MED SCI SPORT EXER, V48, P1303, DOI 10.1249/MSS.0000000000000885; Fiuza-Luces C, 2013, PHYSIOLOGY, V28, P330, DOI 10.1152/physiol.00019.2013; Gordon B, 2014, CURR SPORT MED REP, V13, P253, DOI 10.1249/JSR.0000000000000073; Hupin D, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094306; ISCA (International Sport and Culture Association) & CEBR (Centre for Economics and Business Research), 2015, EC COST PHYS IN EUR; Katzmarzyk PT, 2016, ANN INTERN MED, V164, P620, DOI 10.7326/M16-0269; Kodama S, 2007, ARCH INTERN MED, V167, P999, DOI 10.1001/archinte.167.10.999; Ladabaum U, 2014, AM J MED, V127, P717, DOI 10.1016/j.amjmed.2014.02.026; Laske C, 2010, INT J NEUROPSYCHOPH, V13, P595, DOI 10.1017/S1461145709991234; Lee DC, 2015, J AM COLL CARDIOL, V65, P420, DOI 10.1016/j.jacc.2014.11.022; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Mann S, 2014, SPORTS MED, V44, P211, DOI 10.1007/s40279-013-0110-5; Marques A, 2015, PREV MED, V81, P333, DOI 10.1016/j.ypmed.2015.09.018; Moore SC, 2016, JAMA INTERN MED, V176, P816, DOI 10.1001/jamainternmed.2016.1548; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Prince SA, 2014, OBES REV, V15, P905, DOI 10.1111/obr.12215; Romero V, 2007, PSYCHOSOMATICS, V54, P525; Schnohr P, 2015, J AM COLL CARDIOL, V65, P411, DOI 10.1016/j.jacc.2014.11.023; Smith AD, 2016, DIABETOLOGIA, V59, P2527, DOI 10.1007/s00125-016-4079-0; Smith Mark A, 2011, Front Psychiatry, V2, P82, DOI 10.3389/fpsyt.2011.00082; Therneau TM, 2016, SURVIVAL SURVIVAL AN, P128; Tomiyama AJ, 2016, INT J OBESITY, V40, P883, DOI 10.1038/ijo.2016.17; Wahid A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002495; WHO, 2015, GLOB REC PHYS ACT HL; WHO, 2015, WHO GLOBAL HEALTH OB; World Health Organization, GLOB DAT BOD MASS IN	38	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191542	10.1371/journal.pone.0191542	http://dx.doi.org/10.1371/journal.pone.0191542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352280	gold, Green Published, Green Submitted			2022-12-27	WOS:000422911300110
J	Holten, V; MacNeilage, PR				Holten, Vivian; MacNeilage, Paul R.			Optic flow detection is not influenced by visual-vestibular congruency	PLOS ONE			English	Article							SUPERIOR TEMPORAL AREA; SELF-MOTION; MST NEURONS; DIRECTIONAL ANISOTROPY; RESPONSE SELECTIVITY; SQUIRREL-MONKEY; POSTURAL SWAY; FIELD STIMULI; SENSITIVITY; PERCEPTION	Optic flow patterns generated by self-motion relative to the stationary environment result in congruent visual-vestibular self-motion signals. Incongruent signals can arise due to object motion, vestibular dysfunction, or artificial stimulation, which are less common. Hence, we are predominantly exposed to congruent rather than incongruent visual-vestibular stimulation. If the brain takes advantage of this probabilistic association, we expect observers to be more sensitive to visual optic flow that is congruent with ongoing vestibular stimulation. We tested this expectation by measuring the motion coherence threshold, which is the percentage of signal versus noise dots, necessary to detect an optic flow pattern. Observers seated on a hexapod motion platform in front of a screen experienced two sequential intervals. One interval contained optic flow with a given motion coherence and the other contained noise dots only. Observers had to indicate which interval contained the optic flow pattern. The motion coherence threshold was measured for detection of laminar and radial optic flow during leftward/rightward and fore/aft linear self-motion, respectively. We observed no dependence of coherence thresholds on vestibular congruency for either radial or laminar optic flow. Prior studies using similar methods reported both decreases and increases in coherence thresholds in response to congruent vestibular stimulation; our results do not confirm either of these prior reports. While methodological differences may explain the diversity of results, another possibility is that motion coherence thresholds are mediated by neural populations that are either not modulated by vestibular stimulation or that are modulated in a manner that does not depend on congruency.	[Holten, Vivian] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; [MacNeilage, Paul R.] Univ Nevada, Dept Psychol, Cognit & Brain Sci Program, Reno, NV 89557 USA	University of Munich; Nevada System of Higher Education (NSHE); University of Nevada Reno	Holten, V (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany.	vivian.holten@lrz.uni-muenchen.de			German Research Foundation [MA 6233/1-1]; German Ministry of Education and Research [01 E0 1401]	German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Research Foundation (www.dfg.de) under grant code MA 6233/1-1 to Paul R. MacNeilage and the German Ministry of Education and Research (www.bmbf.de) under grant code 01 E0 1401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badcock DR, 2001, PSYCHOL RES-PSYCH FO, V65, P50, DOI 10.1007/s004260000020; Bremmer F, 1999, ANN NY ACAD SCI, V871, P272, DOI 10.1111/j.1749-6632.1999.tb09191.x; Churchland AK, 2003, NEURON, V37, P1001, DOI 10.1016/S0896-6273(03)00145-4; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Day BL, 2005, CURR BIOL, V15, pR583, DOI 10.1016/j.cub.2005.07.053; DEBRUYN B, 1990, PERCEPTION, V19, P21, DOI 10.1068/p190021; Duffy CJ, 1998, J NEUROPHYSIOL, V80, P1816, DOI 10.1152/jn.1998.80.4.1816; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Durgin FH, 2005, J EXP PSYCHOL HUMAN, V31, P339, DOI 10.1037/0096-1523.31.2.339; EDWARDS M, 1993, PERCEPTION, V22, P1013, DOI 10.1068/p221013; Edwards M, 2007, PERCEPTION, V36, P113, DOI 10.1068/p5626; Edwards M, 2010, PERCEPTION, V39, P1303, DOI 10.1068/p6653; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Garzorz IT, 2017, CURR BIOL, V27, P2856, DOI 10.1016/j.cub.2017.08.011; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gibson JJ, 1950, PERCEPTION VISUAL WO; Gros BL, 1998, J OPT SOC AM A, V15, P2003, DOI 10.1364/JOSAA.15.002003; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; HARRIS LR, 1981, NATURE, V293, P139, DOI 10.1038/293139a0; Holten V, 2015, PERCEPTION, V44, P477, DOI 10.1068/p7925; Holten V, 2013, EXP BRAIN RES, V228, P117, DOI 10.1007/s00221-013-3543-z; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; KOENDERINK JJ, 1986, VISION RES, V26, P161, DOI 10.1016/0042-6989(86)90078-7; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Paris R, 2017, ATTEN PERCEPT PSYCHO, V79, P1182, DOI 10.3758/s13414-017-1299-4; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; RAYMOND JE, 1994, VISION RES, V34, P1029, DOI 10.1016/0042-6989(94)90007-8; Redlick FP, 2001, VISION RES, V41, P213, DOI 10.1016/S0042-6989(00)00243-1; Scase MO, 1996, VISION RES, V36, P2579, DOI 10.1016/0042-6989(95)00325-8; Schlack A, 2002, EUR J NEUROSCI, V16, P1877, DOI 10.1046/j.1460-9568.2002.02251.x; Shirai N, 2012, VISION RES, V62, P201, DOI 10.1016/j.visres.2012.04.008; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; Talsma D, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00019; Turano KA, 1999, VISION RES, V39, P1177, DOI 10.1016/S0042-6989(98)00174-6; Uesaki M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00775; VANDEGRIND WA, 1983, J OPT SOC AM, V73, P1674, DOI 10.1364/JOSA.73.001674; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; Wei KL, 2010, J VISION, V10, DOI 10.1167/10.14.4	48	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191693	10.1371/journal.pone.0191693	http://dx.doi.org/10.1371/journal.pone.0191693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29352317	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300122
J	Kim, JY; Yang, S; Lee, JI; Chang, MJ				Kim, Je-Yon; Yang, Seungwon; Lee, Jangik I.; Chang, Min Jung			Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis (vol 11, e0153502, 2016)	PLOS ONE			English	Correction																		Kim JY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153502	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191744	10.1371/journal.pone.0191744	http://dx.doi.org/10.1371/journal.pone.0191744			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352297	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300127
J	Sheikhzadeh, F; Ward, RK; van Niekerk, D; Guillaud, M				Sheikhzadeh, Fahime; Ward, Rabab K.; van Niekerk, Dirk; Guillaud, Martial			Automatic labeling of molecular biomarkers of immunohistochemistry images using fully convolutional networks	PLOS ONE			English	Article							QUANTIFICATION	This paper addresses the problem of quantifying biomarkers in multi-stained tissues based on the color and spatial information of microscopy images of the tissue. A deep learning-based method that can automatically localize and quantify the regions expressing biomarker(s) in any selected area on a whole slide image is proposed. The deep learning network, which we refer to as Whole Image (WI)-Net, is a fully convolutional network whose input is the true RGB color image of a tissue and output is a map showing the locations of each biomarker. The WI-Net relies on a different network, Nuclei (N)-Net, which is a convolutional neural network that classifies each nucleus separately according to the biomarker(s) it expresses. In this study, images of immunohistochemistry (IHC)-stained slides were collected and used. Images of nuclei (4679 RGB images) were manually labeled based on the expressing biomarkers in each nucleus (as p16 positive, Ki-67 positive, p16 and Ki-67 positive, p16 and Ki-67 negative). The labeled nuclei images were used to train the N-Net (obtaining an accuracy of 92% in a test set). The trained N-Net was then extended to WI-Net that generated a map of all biomarkers in any selected sub-image of the whole slide image acquired by the scanner (instead of classifying every nucleus image). The results of our method compare well with the manual labeling by humans (average F-score of 0.96). In addition, we carried a layer-based immunohistochemical analysis of cervical epithelium, and showed that our method can be used by pathologists to differentiate between different grades of cervical intraepithelial neoplasia by quantitatively assessing the percentage of proliferating cells in the different layers of HPV positive lesions.	[Sheikhzadeh, Fahime; Ward, Rabab K.] Univ British Columbia, Dept Elect Engn, Vancouver, BC, Canada; [Sheikhzadeh, Fahime; Guillaud, Martial] British Columbia Canc Res Ctr, Dept Integrated Oncol, Imaging Unit, Vancouver, BC, Canada; [van Niekerk, Dirk] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC, Canada	University of British Columbia; British Columbia Cancer Agency; British Columbia Cancer Agency	Sheikhzadeh, F (corresponding author), Univ British Columbia, Dept Elect Engn, Vancouver, BC, Canada.; Sheikhzadeh, F (corresponding author), British Columbia Canc Res Ctr, Dept Integrated Oncol, Imaging Unit, Vancouver, BC, Canada.	fahime@ece.ubc.ca		guillaud, martial/0000-0001-8982-2489	Natural Sciences and Engineering Research Council of Canada [RGPIN 2014-04462]; National Institute of Health [P01-CA-82710]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded through a Natural Sciences and Engineering Research Council of Canada grant (RGPIN 2014-04462) to RKW and a National Institute of Health funded program project grant (P01-CA-82710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen T, 2014, LECT NOTES COMPUT SC, V8679, P17, DOI 10.1007/978-3-319-10581-9_3; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; Guillaud M, 2004, CYTOM PART A, V60A, P81, DOI 10.1002/cyto.a.20034; Guillaud M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107088; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Irshad Humayun, 2014, IEEE Rev Biomed Eng, V7, P97, DOI 10.1109/RBME.2013.2295804; Jain V, 2007, IEEE I CONF COMP VIS, P636; Janowczyk Andrew, 2016, J Pathol Inform, V7, P29, DOI 10.4103/2153-3539.186902; Jia Y., 2014, ARXIV14085093, P675; Kamalov R, 2005, COMPUT METH PROG BIO, V77, P99, DOI 10.1016/j.cmpb.2004.04.003; Keating JT, 2001, AM J SURG PATHOL, V25, P884, DOI 10.1097/00000478-200107000-00006; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Litjens G, 2016, SCI REP-UK, V6, DOI 10.1038/srep26286; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Miralpeix E, 2017, MODERN PATHOL, V30, P304, DOI 10.1038/modpathol.2016.168; Reuschenbach M, 2012, INT J CANCER, V130, P388, DOI 10.1002/ijc.26017; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sheikhzadeh F, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0093-6; Van Niekerk D, 2007, GYNECOL ONCOL, V107, pS233, DOI 10.1016/j.ygyno.2007.07.064; VANRIJSBERGEN C, 1979, INFORM RETRIEVAL; Wang D., 2016, ARXIV PREPRINT ARXIV; Xu J, 2016, NEUROCOMPUTING, V191, P214, DOI 10.1016/j.neucom.2016.01.034	25	29	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190783	10.1371/journal.pone.0190783	http://dx.doi.org/10.1371/journal.pone.0190783			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351281	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300024
J	Villain, H; Benkahoul, A; Birmes, P; Ferry, B; Roullet, P				Villain, Helene; Benkahoul, Aicha; Birmes, Philippe; Ferry, Barbara; Roullet, Pascal			Influence of early stress on memory reconsolidation: Implications for post-traumatic stress disorder treatment	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; CHILDHOOD SEXUAL-ABUSE; NORADRENERGIC ACTIVITY; MATERNAL SEPARATION; PRENATAL STRESS; FEAR MEMORY; PROTEIN-SYNTHESIS; TRAUMA REACTIVATION; OFFSPRING EVIDENCE; EMOTIONAL-STRESS	Post-traumatic stress disorder (PTSD) is a common consequence of exposure to a life-threatening event. Currently, pharmacological treatments are limited by high rates of relapse, and novel treatment approaches are needed. We have recently demonstrated that propranolol, a beta-adrenergic antagonist, inhibited aversive memory reconsolidation in animals. Following this, in an open-label study 70% of patients with PTSD treated with propranolol during reactivation of traumatic memory exhibited full remission. However, the reason why 30% of these patients did not respond positively to propranolol treatment is still unclear. One of the major candidates as factor of treatment resistance is the patient's early-life traumatic history. To test the role of this factor, mice with pre-or postnatal stress are being tested in fear conditioning and in a new behavioral task, the "city-like", specifically designed as a mouse model of PTSD. After reactivation of the traumatic event, mice received propranolol injection to block the noradrenergic system during memory reconsolidation. Results show that, in the "city-like" test, control mice strongly avoided the shock compartment but also the compartments containing cues associated with the electric shocks. Injection of propranolol after reactivation greatly reduced the memory of the traumatic event, but this effect was not present when mice had received pre-or postnatal stress. Moreover, propranolol produced only a very weak effect in the fear conditioning test, and never changed the corticosterone level whatever the behavioral experiment. Taken together our results suggest that our new behavioural paradigm is well adapted to PTSD study in mice, and that early stress exposure may have an impact on propranolol PTSD treatment outcome. These data are critical to understanding the effect of propranolol treatment, in order to improve the therapeutic protocol currently used in humans.	[Villain, Helene; Benkahoul, Aicha; Roullet, Pascal] Univ Toulouse, UPS, Ctr Rech Cognit Anim, Ctr Biol Integrat,CNRS, Toulouse, France; [Birmes, Philippe] Univ Toulouse, Toulouse NeuroImaging Ctr, INSERM, UPS, Toulouse, France; [Ferry, Barbara] Univ Claude Bernard Lyon 1, Ctr Res Neurosci Lyon, UMR CNRS 5292, INSERM,U1028, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	Roullet, P (corresponding author), Univ Toulouse, UPS, Ctr Rech Cognit Anim, Ctr Biol Integrat,CNRS, Toulouse, France.	pascal.roullet@univ-tlse3.fr	Ferry, Barbara/N-6685-2014	Ferry, Barbara/0000-0001-5191-3035	CNRS; University Paul Sabatier of Toulouse; LABEX Cortex of Universite de Lyon within the program "Investissements d'Avenir" [NR-11-LABX-0042, ANR-11-IDEX-0007]	CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier of Toulouse; LABEX Cortex of Universite de Lyon within the program "Investissements d'Avenir"(French National Research Agency (ANR))	This study was supported by CNRS and the University Paul Sabatier of Toulouse and by the LABEX Cortex (Grant NR-11-LABX-0042) of Universite de Lyon within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Solene Thomas and Tiphaine Bailly for technical assistance. We thank the ABC animal facility and ANEXPLO for housing mice. This study was supported by CNRS and the University Paul Sabatier of Toulouse and by the LABEX Cortex (Grant NR-11-LABX-0042) of Universite de Lyon within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency.	ADER R, 1973, DEV PSYCHOBIOL, V6, P547, DOI 10.1002/dev.420060611; Aisa B, 2007, PSYCHONEUROENDOCRINO, V32, P256, DOI 10.1016/j.psyneuen.2006.12.013; Aisa B, 2009, HIPPOCAMPUS, V19, P1222, DOI 10.1002/hipo.20586; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Anisman H, 2001, AM J PSYCHIAT, V158, P1509, DOI 10.1176/appi.ajp.158.9.1509; Artinian J, 2008, EUR J NEUROSCI, V27, P3009, DOI 10.1111/j.1460-9568.2008.06262.x; Artinian J, 2007, HIPPOCAMPUS, V17, P181, DOI 10.1002/hipo.20256; Benoit JD, 2015, BEHAV BRAIN RES, V281, P1, DOI 10.1016/j.bbr.2014.12.001; Bernardi RE, 2006, NEUROREPORT, V17, P1443, DOI 10.1097/01.wnr.0000233098.20655.26; Betts KS, 2015, J AFFECT DISORDERS, V175, P241, DOI 10.1016/j.jad.2015.01.011; Bisson JI, 2007, BRIT J PSYCHIAT, V190, P97, DOI 10.1192/bjp.bp.106.021402; Bogoch Y, 2007, J NEUROCHEM, V101, P1018, DOI 10.1111/j.1471-4159.2006.04402.x; Bos KJ, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.016.2009; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Bremner JD, 2003, BIOL PSYCHIAT, V53, P879, DOI 10.1016/S0006-3223(02)01891-7; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Brunet A, 2014, CAN J PSYCHIAT, V59, P228, DOI 10.1177/070674371405900408; Brunet A, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00074; Brunet A, 2011, J CLIN PSYCHOPHARM, V31, P547, DOI 10.1097/JCP.0b013e318222f360; Brunson KL, 2005, J NEUROSCI, V25, P9328, DOI 10.1523/JNEUROSCI.2281-05.2005; Cannizzaro E, 2005, BEHAV BRAIN RES, V161, P320, DOI 10.1016/j.bbr.2005.02.022; Conversi D, 2014, PHARMACOL BIOCHEM BE, V122, P158, DOI 10.1016/j.pbb.2014.04.001; Cusack K, 2016, CLIN PSYCHOL REV, V43, P128, DOI 10.1016/j.cpr.2015.10.003; Daumas S, 2004, EUR J NEUROSCI, V20, P597, DOI 10.1111/j.1460-9568.2004.03484.x; de Quervain DJF, 2007, AM J PSYCHIAT, V164, P967, DOI 10.1176/appi.ajp.164.6.967; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Debiec J, 2006, ANN NY ACAD SCI, V1071, P521, DOI 10.1196/annals.1364.056; Delahanty DL, 2000, BIOL PSYCHIAT, V48, P940, DOI 10.1016/S0006-3223(00)00896-9; Diergaarde L, 2006, BEHAV BRAIN RES, V170, P333, DOI 10.1016/j.bbr.2006.02.014; Fenoglio KA, 2005, ENDOCRINOLOGY, V146, P4090, DOI 10.1210/en.2004-1285; FUSTER JM, 1991, PROG BRAIN RES, V87, P201; Gazarini L, 2013, LEARN MEMORY, V20, P210, DOI 10.1101/lm.030007.112; Hannan SM, 2015, J INTERPERS VIOLENCE, P1; Hoskins M, 2015, BRIT J PSYCHIAT, V206, P93, DOI 10.1192/bjp.bp.114.148551; Ipser JC, 2012, INT J NEUROPSYCHOPH, V15, P825, DOI 10.1017/S1461145711001209; Karatzias A, 2007, EUR ARCH PSY CLIN N, V257, P40, DOI 10.1007/s00406-006-0682-2; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Koseki Hiroyo, 2007, JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, V27, P19; Kosten TA, 2007, NEUROBIOL LEARN MEM, V88, P167, DOI 10.1016/j.nlm.2007.03.011; Kosten TA, 2012, NEUROSCI BIOBEHAV R, V36, P1985, DOI 10.1016/j.neubiorev.2012.07.003; Lee EJ, 2011, J NEUROSCI, V31, P7131, DOI 10.1523/JNEUROSCI.4692-10.2011; Lehmann J, 1998, PHARMACOL BIOCHEM BE, V59, P873, DOI 10.1016/S0091-3057(97)00529-7; Lehmann J, 2000, REV NEUROSCIENCE, V11, P383; LEWIS DJ, 1979, PSYCHOL BULL, V86, P1054, DOI 10.1037/0033-2909.86.5.1054; Liu H, 2017, JAMA PSYCHIAT, V74, P270, DOI 10.1001/jamapsychiatry.2016.3783; Lonergan M, 2014, J AGGRESS MALTREAT T, V23, P494, DOI 10.1080/10926771.2014.904467; Markham JA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00173; Maroun M, 2008, NEUROPSYCHOPHARMACOL, V33, P394, DOI 10.1038/sj.npp.1301401; Marshall RD, 1998, J CLIN PSYCHOPHARM, V18, P10, DOI 10.1097/00004714-199802000-00003; Matsumoto M, 2005, HIPPOCAMPUS, V15, P775, DOI 10.1002/hipo.20100; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Meerlo P, 1999, J NEUROENDOCRINOL, V11, P925; Meewisse ML, 2007, BRIT J PSYCHIAT, V191, P387, DOI 10.1192/bjp.bp.106.024877; Muravieva EV, 2010, LEARN MEMORY, V17, P306, DOI 10.1101/lm.1794710; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Narahari T, 2015, DEV PSYCHOBIOL, P1; Nasehi M, 2017, BEHAV BRAIN RES, V331, P76, DOI 10.1016/j.bbr.2017.04.055; National Institute for Clinical Excellence (NICE), 2005, POSTTR STRESS DIS MA; Navalta CP, 2006, J NEUROPSYCH CLIN N, V18, P45, DOI 10.1176/appi.neuropsych.18.1.45; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Packard MG, 2009, BRAIN RES, V1293, P121, DOI 10.1016/j.brainres.2009.03.029; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Resick PA, 2003, CNS SPECTR, V8, P340, DOI 10.1017/S1092852900018605; RESNICK HS, 1995, AM J PSYCHIAT, V152, P1675; Robinson MJF, 2007, BEHAV BRAIN RES, V182, P129, DOI 10.1016/j.bbr.2007.05.023; Roozendaal B, 2004, NEUROBIOL LEARN MEM, V81, P150, DOI 10.1016/j.nlm.2003.10.001; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; Roozendaal B, 2004, J NEUROSCI, V24, P8161, DOI 10.1523/JNEUROSCI.2574-04.2004; Roozendaal B, 2006, NEUROSCIENCE, V138, P901, DOI 10.1016/j.neuroscience.2005.07.049; Roozendaal B, 2006, NEUROBIOL LEARN MEM, V86, P249, DOI 10.1016/j.nlm.2006.03.003; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rossato JI, 2006, LEARN MEMORY, V13, P431, DOI 10.1101/lm.315206; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schwabe L, 2012, NEUROSCI BIOBEHAV R, V36, P1740, DOI 10.1016/j.neubiorev.2011.07.002; Schwabe L, 2010, J NEUROSCI, V30, P8190, DOI 10.1523/JNEUROSCI.0734-10.2010; Schwabe L, 2009, PSYCHONEUROENDOCRINO, V34, P446, DOI 10.1016/j.psyneuen.2008.10.009; Shalev A, 2017, NEW ENGL J MED, V376, P2459, DOI 10.1056/NEJMra1612499; Szuran TF, 2000, PHYSIOL BEHAV, V71, P353, DOI 10.1016/S0031-9384(00)00351-6; Tang ZL, 2012, TOXICOL LETT, V208, P1, DOI 10.1016/j.toxlet.2011.10.001; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Vallee M, 1997, J NEUROSCI, V17, P2626; van Stegeren AH, 2008, ACTA PSYCHOL, V127, P532, DOI 10.1016/j.actpsy.2007.10.004; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; Villain H, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00049; Yehuda R, 2000, AM J PSYCHIAT, V157, P1252, DOI 10.1176/appi.ajp.157.8.1252; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Yehuda R, 2005, J CLIN ENDOCR METAB, V90, P4115, DOI 10.1210/jc.2005-0550; Yehuda R, 1998, AM J PSYCHIAT, V155, P841; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x	93	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191563	10.1371/journal.pone.0191563	http://dx.doi.org/10.1371/journal.pone.0191563			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29352277	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300115
J	Chrostek, E; Teixeira, L				Chrostek, Ewa; Teixeira, Luis			Within host selection for faster replicating bacterial symbionts	PLOS ONE			English	Article							GENE AMPLIFICATION; WOLBACHIA STRAIN; EVOLUTION; DROSOPHILA; VIRULENT	Wolbachia is a widespread, intracellular symbiont of arthropods, able to induce reproductive distortions and antiviral protection in insects. Wolbachia can also be pathogenic, as is the case with wMelPop, a virulent variant of the endosymbiont of Drosophila melanogaster. An extensive genomic amplification of the 20kb region encompassing eight Wolbachia genes, called Octomom, is responsible for wMelPop virulence. The Octomom copy number in wMelPop can be highly variable between individual D. melanogaster flies, even when comparing siblings arising from a single female. Moreover, Octomom copy number can change rapidly between generations. These data suggest an intra-host variability in Octomom copy number between Wolbachia cells. Since wMelPop Wolbachia with different Octomom copy numbers grow at different rates, we hypothesized that selection could act on this intra-host variability. Here we tested if total Octomom copy number changes during the lifespan of individual Drosophila hosts, revealing selection for different Wolbachia populations. We performed a time course analysis of Octomom amplification in flies whose mothers were controlled for Octomom copy number. We show that despite the Octomom copy number being relatively stable it increases slightly throughout D. melanogaster adult life. This indicates that there is selection acting on the intra-host variation in the Octomom copy number over the lifespan of individual hosts. This within host selection for faster replicating bacterial symbionts may be in conflict with between host selection against highly pathogenic Wolbachia.	[Chrostek, Ewa; Teixeira, Luis] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Teixeira, Luis] Univ Lisbon, Fac Med, Lisbon, Portugal; [Chrostek, Ewa] Max Planck Inst Infect Biol, Berlin, Germany	Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Max Planck Society	Teixeira, L (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.; Teixeira, L (corresponding author), Univ Lisbon, Fac Med, Lisbon, Portugal.	lteixeira@igc.gulbenkian.pt	Chrostek, Ewa/AAA-4218-2022; Teixeira, Luis/H-6106-2013	Teixeira, Luis/0000-0001-8326-6645; Chrostek, Ewa/0000-0003-1825-372X	Fundacao para a Ciencia e Tecnologia [PTDC/BEX-GMG/3128/2014]; EMBO Long Term Fellowship [EMBO ALTF 1497-2015]; Marie Curie Actions by the European Commission (LTFCOFUND) [GA-2013-609409]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Actions by the European Commission (LTFCOFUND)	LT's lab is funded by the Fundacao para a Ciencia e Tecnologia (www.fct.pt) grant PTDC/BEX-GMG/3128/2014. EC is supported by EMBO Long Term Fellowship EMBO ALTF 1497-2015 (http://www.embo.org), co-funded by Marie Curie Actions by the European Commission (LTFCOFUND2013, GA-2013-609409) (ec.europa.eu/research/mariecurieactions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2009, ANNU REV GENET, V43, P167, DOI 10.1146/annurev-genet-102108-134805; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Chrostek E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006540; Chrostek E, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002065; Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Ohno S., 1970, P1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; R Core Team, 2018, R LANG ENV STAT COMP; Reynolds KT, 2003, GENETICS, V164, P1027; Rohrscheib CE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005888; Romero D, 1997, ANNU REV GENET, V31, P91, DOI 10.1146/annurev.genet.31.1.91; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood SN., 2006, BIOMETRICS, V67, P391, DOI DOI 10.1111/J.1541-0420.2007.00905_3.X; Woolfit M, 2013, GENOME BIOL EVOL, V5, P2189, DOI 10.1093/gbe/evt169; Young BC, 2017, ELIFE, V6, DOI 10.7554/eLife.30637	21	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191530	10.1371/journal.pone.0191530	http://dx.doi.org/10.1371/journal.pone.0191530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346449	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500060
J	Lewis, LS; Smith, JE; Eynaud, Y				Lewis, Levi S.; Smith, Jennifer E.; Eynaud, Yoan			Comparative metabolic ecology of tropical herbivorous echinoids on a coral reef	PLOS ONE			English	Article							BROWN ALGAL PHLOROTANNINS; SEA-URCHINS; BODY-SIZE; TRIPNEUSTES-GRATILLA; MARINE INVERTEBRATE; OCEAN ACIDIFICATION; NUTRIENT ENRICHMENT; FEEDING PREFERENCES; OXYGEN-CONSUMPTION; COMMUNITY DYNAMICS	Background The metabolic rate of consumers is a key driver of ecosystem dynamics. On coral reefs, herbivorous echinoids consume fleshy algae, facilitating the growth of reef-building calcified organisms; however, little is known about differences among species in their metabolic and functional ecology. Here, we used log-linear (log-log) regression models to examine the allometric scaling of mass and routine metabolic rate for five common herbivorous echinoids on a Hawaiian coral reef: Echinothrix calamaris, E. diadema, Echinometra matthaei, Hetero-centrotus mammillatus, and Tripneustes gratilla. Scaling relationships were then contrasted with empirical observations of echinoid ecology and general metabolic theory to broaden our understanding of diversity in the metabolic and functional ecology of tropical herbivorous echinoids. Results Test diameter and species explained 98% of the variation in mass, and mass and species explained 92.4% and 87.5% of the variation in individual (I) and mass-specific (B) metabolic rates, respectively. Scaling exponents did not differ for mass or metabolism; however, normalizing constants differed significantly among species. Mass varied as the cube of test diameter (b = 2.9), with HM exhibiting a significantly higher normalizing constant than other species, likely due to its heavily-calcified spines and skeleton. Individual metabolic rate varied approximately as the 2/5 power of mass (gamma = 0.44); significantly smaller than the 3/4 universal scaling coefficient, but inclusive of 2/3 scaling. E. calamaris and H. mammillatus exhibited the lowest normalizing constants, corresponding with their slow-moving, cryptic, rock-boring life-history. In contrast, E. calamaris, E. diadema, and T. gratilla, exhibited higher metabolic rates, likely reflecting their higher levels of activity and ability to freely browse for preferred algae due to chemical anti-predator defenses. Thus, differences in metabolic scaling appeared to correspond with differences in phylogeny, behavior, and ecological function. Such comparative metabolic assessments are central to informing theory, ecological models, and the effective management of ecosystems.	[Lewis, Levi S.; Smith, Jennifer E.; Eynaud, Yoan] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, San Diego, CA 92103 USA; [Lewis, Levi S.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Davis	Lewis, LS (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, San Diego, CA 92103 USA.; Lewis, LS (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	lewis.sci@gmail.com		Lewis, Levi/0000-0002-9664-9386	National Science Foundation [0903551]; Ford Foundation; PADI Foundation; Edna Baily Sussman Foundation; SciFund Challenge; Scripps Family Foundation; Edna-Bailey Sussman Foundation; NRC Ford Foundation Fellowship	National Science Foundation(National Science Foundation (NSF)); Ford Foundation; PADI Foundation; Edna Baily Sussman Foundation; SciFund Challenge; Scripps Family Foundation; Edna-Bailey Sussman Foundation; NRC Ford Foundation Fellowship	This work was funded by graduate fellowships from the National Science Foundation (0903551), www.nsf.gov, and Ford Foundation, www.fordfoundation.org, and grants from the PADI Foundation, www.padifoundation.org, Edna Baily Sussman Foundation, www.esf.edu/sussman/, and SciFund Challenge, scifundchallenge.org, to LLewis; and a grant to JSmith from the Scripps Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; G. Butler and S. Kram assisted with metabolic assays in the field. The SIO Scientific Diving Program (C. McDonald and R. Walsh) and Maui Scuba Diving Snorkel Center (R. Carman) supported diving operations. Maui Ocean Center (J. Luecke) provided wet-lab facilities, and SIO Center for Marine Biodiversity and Conservation (P. Dockry) provided administrative support. Echinoid artwork was provided by A. Khen. R. Hechinger, L. Levin, A. Khen, J. Shurin, S. Sandin, J. Leichter, and several anonymous reviewers provided comments and contributions that greatly improved the manuscript. This study was conducted in consultation with the Maui Division of Aquatic Resources (R. Sparks and D. White) under DAR permit number SAP2014-42. Funding came from the PADI Foundation, Edna-Bailey Sussman Foundation, Scripps Family Foundation, SciFund Challenge, NRC Ford Foundation Fellowship, and the National Science Foundation Grant No. 0903551.	Alendar CB, 1964, THESIS; ARMITAGE KB, 1982, COMP BIOCHEM PHYS A, V73, P63, DOI 10.1016/0300-9629(82)90092-5; Breitburg DL, 2015, OCEANOGRAPHY, V28, P48, DOI 10.5670/oceanog.2015.31; Brockington S, 2001, J EXP MAR BIOL ECOL, V258, P87, DOI 10.1016/S0022-0981(00)00347-6; Brockington S, 2001, MAR ECOL PROG SER, V219, P159, DOI 10.3354/meps219159; Brown James H., 2012, P21; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; CADOTTE MW, 2017, ECOL MONOGR, V87, P535, DOI [DOI 10.1002/ECM.1267, DOI 10.1002/ecm.1267]; Carey N, 2016, J EXP BIOL, V219, P1178, DOI 10.1242/jeb.136101; Carey N, 2014, MAR BIOL, V161, P2131, DOI 10.1007/s00227-014-2493-8; Carpenter R., 1997, LIFE DEATH CORAL REE, P536; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; Carr LA, 2013, PEERJ, V1, DOI 10.7717/peerj.109; Clarke A, 2010, J ANIM ECOL, V79, P610, DOI 10.1111/j.1365-2656.2010.01672.x; Coppard SE, 2007, AQUAT BOT, V86, P204, DOI 10.1016/j.aquabot.2006.10.005; Costa Daniel P., 2012, P225; Dailer ML, 2012, HARMFUL ALGAE, V17, P111, DOI 10.1016/j.hal.2012.03.008; Dailer ML, 2010, MAR POLLUT BULL, V60, P655, DOI 10.1016/j.marpolbul.2009.12.021; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; EBERT TA, 1971, PAC SCI, V25, P112; Edwards CB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1835; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; FELDMAN HA, 1983, RESP PHYSIOL, V52, P149, DOI 10.1016/0034-5687(83)90002-6; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Graham NAJ, 2014, CURR BIOL, V24, pR359, DOI 10.1016/j.cub.2014.03.069; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Idjadi JA, 2010, INTEGR COMP BIOL, V50, pE80; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kelly ELA, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1899; KLUMPP DW, 1988, MAR ECOL PROG SER, V45, P95, DOI 10.3354/meps045095; KNOWLTON N, 1992, AM ZOOL, V32, P674; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; Lawrence J.M., 2013, BOIL ECOL, V38; McClanahan TR, 2016, ECOLOGY, V97, P1862, DOI 10.1890/15-1492.1; McClanahan TR, 2015, CONSERV BIOL, V29, P409, DOI 10.1111/cobi.12430; McClanahan TR, 2013, DEV AQUAC FISH SCI, V38, P337, DOI 10.1016/B978-0-12-396491-5.00023-X; MCCLANAHAN TR, 1988, OECOLOGIA, V77, P210, DOI 10.1007/BF00379188; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Moulin L, 2015, MAR ENVIRON RES, V103, P103, DOI 10.1016/j.marenvres.2014.11.009; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; O'Leary JK, 2010, ECOLOGY, V91, P3584, DOI 10.1890/09-2059.1; OGDEN NB, 1989, B MAR SCI, V45, P539; PAINE RT, 1980, J ANIM ECOL, V49, P667; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V61, P31, DOI 10.1016/0022-0981(82)90020-X; Sanford E, 2002, INTEGR COMP BIOL, V42, P881, DOI 10.1093/icb/42.4.881; Secor SM, 2009, J COMP PHYSIOL B, V179, P1, DOI 10.1007/s00360-008-0283-7; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Sheppard-Brennand H, 2017, AM NAT, V189, P700, DOI 10.1086/691437; Sibly R. M., 2012, METABOLIC ECOLOGY SC; Smith JE, 2005, MAR ECOL PROG SER, V302, P77, DOI 10.3354/meps302077; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; Smith JE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.1985; SMITH SV, 1981, PAC SCI, V35, P279; STEINBERG PD, 1992, ECOL MONOGR, V62, P189, DOI 10.2307/2937093; Stimson J, 2007, MAR BIOL, V151, P1761, DOI 10.1007/s00227-007-0628-x; Targett NM, 1998, J PHYCOL, V34, P195, DOI 10.1046/j.1529-8817.1998.340195.x; ULBRICHT RJ, 1972, BIOL BULL-US, V142, P178, DOI 10.2307/1540254; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Vaitilingon D, 2003, MAR BIOL, V143, P451, DOI 10.1007/s00227-003-1111-y; vanRooij JM, 1996, MAR ECOL PROG SER, V132, P31, DOI 10.3354/meps132031; Walsh WJ, 2013, NA06NOS426011397; WEBSTER SK, 1975, BIOL BULL, V148, P157, DOI 10.2307/1540656; Westbrook CE, 2015, PEERJ, V3, DOI 10.7717/peerj.1235; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2011, AM NAT, V178, P746, DOI 10.1086/662666; Whitfield E, 2012, MARY PICKFORD: QUEEN OF THE MOVIES, P7; Williams ID, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159100	76	6	6	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190470	10.1371/journal.pone.0190470	http://dx.doi.org/10.1371/journal.pone.0190470			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346442	gold, Green Published, Green Submitted			2022-12-27	WOS:000422749500014
J	Martin, B; Gabris-Weber, BA; Reddy, R; Romero, G; Chattopadhyay, A; Salama, G				Martin, Brian; Gabris-Weber, Beth Ann; Reddy, Rajiv; Romero, Guillermo; Chattopadhyay, Ansuman; Salama, Guy			Relaxin reverses inflammatory and immune signals in aged hearts	PLOS ONE			English	Article							DIFFERENTIATION FACTOR 15; ATRIAL-FIBRILLATION; FAILURE; EXPRESSION; FIBROSIS; SERELAXIN; ARTERIAL; INSIGHTS; DEATH; CELLS	Background 'Healthy' aging drives structural and functional changes in the heart including maladaptive electrical remodeling, fibrosis and inflammation, which lower the threshold for cardiovascular diseases such as heart failure (HF) and atrial fibrillation (AF). Despite mixed results in recent clinical trials, Relaxin-therapy for 2-days could reduce mortality by 37% at 180-days post-treatment, in patients with acute decompensated HF. Relaxin's short life-span (hours) but long-lasting protective actions led us to test the hypothesis that relaxin acts at a genomic level to reverse maladaptive remodeling in aging and HF. Methods and results Young (9-month) and aged (24-month), male and female F-344/Brown Norway rats were treated with relaxin (0.4 mg/kg/day) for 2-weeks delivered by subcutaneous osmotic mini-pumps or with sodium acetate (controls). The genomic effects of aging and relaxin were evaluated by extracting RNA from the left ventricles and analyzing genomic changes by RNA-sequencing, Ingenuity Pathway Analysis, MetaCore and tissue immunohistochemistry. We found that aging promotes a native inflammatory response with distinct sex-differences and relaxin suppresses transcription of multiple genes and signaling pathways associated with inflammation and HF in both genders. In addition, aging significantly increased: macrophage infiltration and atrial natriuretic peptide levels in female ventricles, and activation of the complement cascade, whereas relaxin reversed these age-related effects. Conclusion These data support the hypothesis that relaxin alters gene transcription and suppresses inflammatory pathways and genes associated with HF and aging. Relaxin's suppression of inflammation and fibrosis supports its potential as a therapy for cardiovascular and inflammation-related diseases, such as HF, AF and diabetes.	[Martin, Brian; Salama, Guy] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Martin, Brian; Gabris-Weber, Beth Ann; Reddy, Rajiv; Salama, Guy] Univ Pittsburgh, Sch Med, Heart & Vasc Inst, Pittsburgh, PA 15260 USA; [Romero, Guillermo] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Chattopadhyay, Ansuman] Univ Pittsburgh, Mol Biol Informat Serv, Hlth Sci Lib Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Salama, G (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Salama, G (corresponding author), Univ Pittsburgh, Sch Med, Heart & Vasc Inst, Pittsburgh, PA 15260 USA.	gsalama@pitt.edu	Salama, Guy/GWQ-9862-2022	Chattopadhyay, Ansuman/0000-0002-5412-3749; Salama, Guy/0000-0002-5306-8178	Samuel and Emma Winters Foundation; University of Pittsburgh School of Medicine Bridge Funds; Vascular Medicine Institute/Heart and Vascular Institute of the University of Pittsburgh	Samuel and Emma Winters Foundation; University of Pittsburgh School of Medicine Bridge Funds; Vascular Medicine Institute/Heart and Vascular Institute of the University of Pittsburgh	This work was supported by Samuel and Emma Winters Foundation (GS), the University of Pittsburgh School of Medicine Bridge Funds (GS), and the Innovator Award from the Vascular Medicine Institute/Heart and Vascular Institute of the University of Pittsburgh (GS).	Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bacchiega BC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005038; Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424; Boluyt MO, 2004, J APPL PHYSIOL, V96, P822, DOI 10.1152/japplphysiol.01026.2003; BRANDT RR, 1993, J AM COLL CARDIOL, V22, pA86, DOI 10.1016/0735-1097(93)90468-G; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Chan MMY, 2016, EUR J HEART FAIL, V18, P81, DOI 10.1002/ejhf.431; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Debrah DO, 2005, HYPERTENSION, V46, P745, DOI 10.1161/01.HYP.0000184230.52059.33; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; Duncan Bruce B, DIABETES, V52, P1799; Felker GM, 2014, J AM COLL CARDIOL, V64, P1591, DOI 10.1016/j.jacc.2014.05.071; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Freeley M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00227; Fric J, 2012, BLOOD, V120, P1380, DOI 10.1182/blood-2012-02-404475; Gaggin HK, 2013, BBA-MOL BASIS DIS, V1832, P2442, DOI 10.1016/j.bbadis.2012.12.014; Ghosh RK, 2016, CARDIOVASC THER; Hayashi H, 2002, J CARDIOVASC ELECTR, V13, P801, DOI 10.1046/j.1540-8167.2002.00801.x; Henry BL, 2016, HEART RHYTHM, V13, P983, DOI 10.1016/j.hrthm.2015.12.030; Himes BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099625; Hofmann U, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0356-y; Hohensinner PJ, 2011, CURR OPIN INFECT DIS, V24, P259, DOI 10.1097/QCO.0b013e328344f50f; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Huerta A, 2016, J HYPERTENS, V34, P130, DOI 10.1097/HJH.0000000000000757; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kraakman MJ, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.31; Lakatta EG, 2015, J MOL CELL CARDIOL, V83, P1, DOI 10.1016/j.yjmcc.2015.04.005; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lekgabe ED, 2005, HYPERTENSION, V46, P412, DOI 10.1161/01.HYP.0000171930.00697.2f; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Licastro Federico, 2005, Immun Ageing, V2, P8; Lin Q, 2011, J IMMUNOL, V186, P3710, DOI 10.4049/jimmunol.1003007; Lind L, 2016, HEART; Liu JQ, 2016, CLIN MED INSIGHTS-CA, V10, P79, DOI 10.4137/CMC.S33164; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Muehlschlegel JD, 2015, ANESTHESIOLOGY, V122, P537, DOI 10.1097/ALN.0000000000000582; Parikh A, 2013, CIRC RES, V113, P313, DOI 10.1161/CIRCRESAHA.113.301646; Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832; Platonov PG, 2011, J AM COLL CARDIOL, V58, P2225, DOI 10.1016/j.jacc.2011.05.061; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Sangaralingham SJ, 2011, HYPERTENSION, V57, P201, DOI 10.1161/HYPERTENSIONAHA.110.160796; Savio-Galimberti Eleonora, 2014, Card Electrophysiol Clin, V6, P741; Schmied M, 1993, AM J PATHOLOGY, V143; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Teichman Sam L, 2010, Curr Heart Fail Rep, V7, P75, DOI 10.1007/s11897-010-0010-z; Thaker Youg R, 2015, INFLAMMATION CELL SI, V2, pe613; Wallentin L, 2014, CIRCULATION, V130, P1847, DOI 10.1161/CIRCULATIONAHA.114.011204; Yang Jialiang, 2015, NATURE, V5; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201	58	19	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190935	10.1371/journal.pone.0190935	http://dx.doi.org/10.1371/journal.pone.0190935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346407	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500021
J	Palanisamy, A; Kannappan, R; Xu, ZQ; Martino, A; Friese, MB; Boyd, JD; Crosby, G; Culley, DJ				Palanisamy, Arvind; Kannappan, Ramaswamy; Xu, Zhiqiang; Martino, Audrey; Friese, Matthew B.; Boyd, Justin D.; Crosby, Gregory; Culley, Deborah J.			Oxytocin alters cell fate selection of rat neural progenitor cells in vitro	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; STEM-CELLS; BRAIN-DEVELOPMENT; PLASMA OXYTOCIN; FETAL-BRAIN; DIFFERENTIATION; PROLIFERATION; EXPRESSION; LABOR; MANIPULATIONS	Synthetic oxytocin (sOT) is widely used during labor, yet little is known about its effects on fetal brain development despite evidence that it reaches the fetal circulation. Here, we tested the hypothesis that sOT would affect early neurodevelopment by investigating its effects on neural progenitor cells (NPC) from embryonic day 14 rat pups. NPCs expressed the oxytocin receptor (OXTR), which was downregulated by 45% upon prolonged treatment with sOT. Next, we examined the effects of sOT on NPC death, apoptosis, proliferation, and differentiation using antibodies to NeuN (neurons), Olig2 (oligodendrocytes), and GFAP (astrocytes). Treated NPCs were analysed with unbiased high-throughput immunocytochemistry. Neither 6 nor 24 h exposure to 100 pM or 100 nM sOT had an effect on viability as assessed by PI or CC-3 immunocytochemistry. Similarly, sOT had negligible effect on NPC proliferation, except that the overall rate of NPC proliferation was higher in the 24 h compared to the 6 h group regardless of sOT exposure. The most significant finding was that sOT exposure caused NPCs to select a predominantly neuronal lineage, along with a concomitant decrease in glial cells. Collectively, our data suggest that perinatal exposure to sOT can have neurodevelopmental consequences for the fetus, and support the need for in vivo anatomical and behavioral studies in offspring exposed to sOT in utero.	[Palanisamy, Arvind; Kannappan, Ramaswamy; Martino, Audrey; Friese, Matthew B.; Crosby, Gregory; Culley, Deborah J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Palanisamy, Arvind; Xu, Zhiqiang] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Boyd, Justin D.] Beryllium Discovery, Biol, Bedford, MA USA; [Kannappan, Ramaswamy] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham	Palanisamy, A (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	arvind.palanisamy@wustl.edu	Crosby, Gregory/N-6578-2019	Friese, Matthew/0000-0001-7410-285X; Boyd, Justin/0000-0002-5197-4724; Palanisamy, Arvind/0000-0001-8460-1759	Foundation for Anesthesia Education and Research; NIH [R01GM088817]	Foundation for Anesthesia Education and Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Foundation for Anesthesia Education and Research, to AP, https://asahq.org/faer/researchaudeducation; and NIH R01GM088817, to GC.	Altemus M, 2004, BIOL PSYCHIAT, V56, P386, DOI 10.1016/j.biopsych.2004.06.002; [Anonymous], 2009, Obstet Gynecol, V114, P386, DOI 10.1097/AOG.0b013e3181b48ef5; ARNAUDEAU S, 1994, PFLUG ARCH EUR J PHY, V428, P51, DOI 10.1007/BF00374751; Bales KL, 2007, NEUROSCIENCE, V144, P38, DOI 10.1016/j.neuroscience.2006.09.009; Bales KL, 2004, PHYSIOL BEHAV, V81, P519, DOI 10.1016/j.physbeh.2004.02.016; Bales KL, 2004, DEV PSYCHOBIOL, V44, P123, DOI 10.1002/dev.10165; Billeci L, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-148; Butron A M, 1974, J Endocrinol, V60, P499; Cassoni P, 2006, MOL CANCER RES, V4, P351, DOI 10.1158/1541-7786.MCR-06-0024; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Culley DJ, 2011, ANESTHESIOLOGY, V115, P754, DOI 10.1097/ALN.0b013e318223b78b; Dahlen HG, 2013, MED HYPOTHESES, V80, P656, DOI 10.1016/j.mehy.2013.01.017; DAWOOD MY, 1979, ACTA ENDOCRINOL-COP, V91, P704, DOI 10.1530/acta.0.0910704; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Dilworth MR, 2013, PLACENTA, V34, pS34, DOI 10.1016/j.placenta.2012.10.011; DISCALAGUENOT D, 1992, BIOCHEM J, V284, P491, DOI 10.1042/bj2840491; Eckertova M, 2011, BRIT J PHARMACOL, V162, P452, DOI 10.1111/j.1476-5381.2010.01037.x; Elabd C, 2008, STEM CELLS, V26, P2399, DOI 10.1634/stemcells.2008-0127; Ernst C, 2016, TRENDS NEUROSCI, V39, P290, DOI 10.1016/j.tins.2016.03.001; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Fathi F, 2009, INT J CARDIOL, V134, P75, DOI 10.1016/j.ijcard.2008.01.046; Forostyak O, 2016, CELL CALCIUM, V59, P57, DOI 10.1016/j.ceca.2016.02.001; Friedlander E, 2017, EARLY HUM DEV, V106, P13, DOI 10.1016/j.earlhumdev.2017.01.008; FUCHS AR, 1991, AM J OBSTET GYNECOL, V165, P1515; Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI 10.1293/tox.2013-0060; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; GLATZ TH, 1980, ENDOCRINOLOGY, V106, P1006, DOI 10.1210/endo-106-3-1006; Gregory SG, 2013, JAMA PEDIATR, V167, P959, DOI 10.1001/jamapediatrics.2013.2904; Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031; Grinevich V, 2015, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00164; Grotegut CA, 2011, AM J PHYSIOL-ENDOC M, V300, pE468, DOI 10.1152/ajpendo.00390.2010; Guillemot F, 2007, PROG NEUROBIOL, V83, P37, DOI 10.1016/j.pneurobio.2007.02.009; Gutkowska J, 2012, J NEUROENDOCRINOL, V24, P599, DOI 10.1111/j.1365-2826.2011.02235.x; Hammock EAD, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00195; Harris VM, 2015, METHODS MOL BIOL, V1312, P465, DOI 10.1007/978-1-4939-2694-7_47; Jafarzadeh N, 2014, NEUROSCI LETT, V564, P105, DOI 10.1016/j.neulet.2014.02.012; Jankowski M, 2004, P NATL ACAD SCI USA, V101, P13074, DOI 10.1073/pnas.0405324101; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kenkel WM, 2014, J NEUROENDOCRINOL, V26, P739, DOI 10.1111/jne.12186; Khazipov R, 2008, PROG BRAIN RES, V170, P243, DOI 10.1016/S0079-6123(08)00421-4; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kurth L, 2011, J ATTEN DISORD, V15, P423, DOI 10.1177/1087054710397800; Lee M. R., 2017, MOL PSYCHIAT; Lestanova Z, 2016, J MOL NEUROSCI, V59, P184, DOI 10.1007/s12031-015-0664-9; Malek A, 1996, J Matern Fetal Med, V5, P245, DOI 10.1002/(SICI)1520-6661(199609/10)5:5<245::AID-MFM3>3.3.CO;2-L; MENS WBJ, 1983, BRAIN RES, V262, P143, DOI 10.1016/0006-8993(83)90478-X; Meziane H, 2015, BIOL PSYCHIAT, V78, P85, DOI 10.1016/j.biopsych.2014.11.010; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Miller TV, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00076; MITCHELL MD, 1982, EUR J OBSTET GYN R B, V14, P115, DOI 10.1016/0028-2243(82)90045-4; Mogi K, 2014, PHYSIOL BEHAV, V133, P68, DOI 10.1016/j.physbeh.2014.05.010; Neumann ID, 2013, PSYCHONEUROENDOCRINO, V38, P1985, DOI 10.1016/j.psyneuen.2013.03.003; Palanisamy A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158058; Paquin J, 2002, P NATL ACAD SCI USA, V99, P9550, DOI 10.1073/pnas.152302499; Paridaen JTML, 2014, EMBO REP, V15, P351, DOI 10.1002/embr.201438447; Patient C, 1999, BRIT J OBSTET GYNAEC, V106, P1311, DOI 10.1111/j.1471-0528.1999.tb08188.x; Phaneuf S, 2000, J REPROD FERTIL, V120, P91, DOI 10.1530/reprod/120.1.91; Prevost M, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00001; Robinson C, 2003, AM J OBSTET GYNECOL, V188, P497, DOI 10.1067/mob.2003.22; SAPINO A, 1993, ENDOCRINOLOGY, V133, P838, DOI 10.1210/en.133.2.838; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Smallwood M, 2016, ASN NEURO, V8, DOI 10.1177/1759091416659742; SMOAK IW, 1993, TERATOLOGY, V47, P203, DOI 10.1002/tera.1420470304; TAKAGI T, 1985, HORM METAB RES, V17, P308, DOI 10.1055/s-2007-1013526; TAKEDA S, 1985, ENDOCRINOL JAPON, V32, P875; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; TRIBOLLET E, 1989, J NEUROSCI, V9, P1764; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Veening JG, 2010, PHYSIOL BEHAV, V101, P193, DOI 10.1016/j.physbeh.2010.05.004; Weisman O, 2015, BEHAV BRAIN RES, V284, P207, DOI 10.1016/j.bbr.2015.02.028; Yoshimura R, 1996, NEUROSCI RES, V24, P291, DOI 10.1016/0168-0102(95)01003-3	72	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191160	10.1371/journal.pone.0191160	http://dx.doi.org/10.1371/journal.pone.0191160			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346405	gold, Green Published			2022-12-27	WOS:000422749500032
J	Ponert, JM; Schwarz, S; Haschemi, R; Muller, J; Potzsch, B; Bendas, G; Schlesinger, M				Ponert, Jan Moritz; Schwarz, Svenja; Haschemi, Reza; Mueller, Jens; Poetzsch, Bernd; Bendas, Gerd; Schlesinger, Martin			The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; BREAST-CANCER; FLOW CONDITIONS; CARCINOMA-CELLS; TISSUE FACTOR; P-SELECTIN; GPIIB-IIIA; ADHESION; ANGIOGENESIS; MACROPHAGES	Metastasis is responsible for the majority of cancer associated fatalities. Tumor cells leaving the primary tumor and entering the blood flow immediately interact with platelets. Activated platelets contribute in different ways to cancer cell survival and proliferation, e.g. in formation of the early metastatic niche by release of different growth factors and chemokines. Here we show that a direct interaction between platelets and MV3 melanoma or MCF7 breast cancer cells induces platelet activation and a VEGF release in citrated plasma that cannot be further elevated by the coagulation cascade and generated thrombin. In contrast, the release of platelet-derived chemokines CXCL5 and CXCL7 depends on both, a thrombin-mediated platelet activation and a direct interaction between tumor cells and platelets. Preincubation of platelets with therapeutic concentrations of unfractionated heparin reduces the tumor cell initiated VEGF release from platelets. In contrast, tumor cell induced CXCL5 and CXCL7 release from platelets was not impacted by heparin pretreatment in citrated plasma. In defibrinated, recalcified plasma, on the contrary, heparin is able to reduce CXCL5 and CXCL7 release from platelets by thrombin inhibition. Our data indicate that different chemokines and growth factors in diverse platelet granules are released in tightly regulated processes by various trigger mechanisms. We show for the first time that heparin is able to reduce the mediator release induced by different tumor cells both in a contact and coagulation dependent manner.	[Ponert, Jan Moritz; Schwarz, Svenja; Haschemi, Reza; Bendas, Gerd; Schlesinger, Martin] Rheinische Friedrich Wilhelms Univ Bonn, Dept Pharm, Bonn, Germany; [Mueller, Jens; Poetzsch, Bernd] Univ Bonn, Med Ctr, Inst Expt Hematol & Transfus Med, Bonn, Germany	University of Bonn; University of Bonn	Schlesinger, M (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Dept Pharm, Bonn, Germany.	martin.schlesinger@uni-bonn.de	Müller, Jens/A-8264-2012	Müller, Jens/0000-0001-7713-9631	Pharmaceutical Institute of University of Bonn; Kirstin Diehl Stiftung, Neuwied, Germany	Pharmaceutical Institute of University of Bonn; Kirstin Diehl Stiftung, Neuwied, Germany	Experiments were primarily financed by budget resources of the Pharmaceutical Institute of University of Bonn. Experiments were partially supported by the Kirstin Diehl Stiftung, Neuwied, Germany. The funders (Kirstin Diehl Stiftung) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study, except Kirstin Diehl Stiftung.	Agnelli G, 2012, NEW ENGL J MED, V366, P601, DOI 10.1056/NEJMoa1108898; Battinelli EM, 2014, BLOOD, V123, P101, DOI 10.1182/blood-2013-02-485011; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Borsig L, 2010, PROG MOL BIOL TRANSL, V93, P335, DOI 10.1016/S1877-1173(10)93014-7; Borsig L, 2010, THROMB RES, V125, pS66, DOI 10.1016/S0049-3848(10)70017-7; Chatterjee M, 2011, BLOOD, V117, P3907, DOI 10.1182/blood-2010-12-327007; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Dardik R, 1997, INT J CANCER, V70, P201, DOI 10.1002/(SICI)1097-0215(19970117)70:2<201::AID-IJC11>3.0.CO;2-L; Dardik R, 1998, BRIT J CANCER, V77, P2069, DOI 10.1038/bjc.1998.349; FeldingHabermann B, 1996, J BIOL CHEM, V271, P5892, DOI 10.1074/jbc.271.10.5892; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gay LJ, 2011, CANCER CELL, V20, P553, DOI 10.1016/j.ccr.2011.11.001; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jain S, 2009, J THROMB HAEMOST, V7, P1713, DOI 10.1111/j.1538-7836.2009.03559.x; Kakkar AK, 2004, J CLIN ONCOL, V22, P1944, DOI 10.1200/JCO.2004.10.002; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Klement GL, 2009, BLOOD, V113, P2835, DOI 10.1182/blood-2008-06-159541; Kuznetsov HS, 2012, CANCER DISCOV, V2, P1150, DOI 10.1158/2159-8290.CD-12-0216; Labelle M, 2014, P NATL ACAD SCI USA, V111, pE3053, DOI 10.1073/pnas.1411082111; Labelle M, 2012, CANCER DISCOV, V2, P1091, DOI 10.1158/2159-8290.CD-12-0329; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Laubli H, 2009, BLOOD, V114, P4583, DOI 10.1182/blood-2008-10-186585; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lee AYY, 2005, J CLIN ONCOL, V23, P2123, DOI 10.1200/JCO.2005.03.133; Lu HH, 2014, NAT CELL BIOL, V16, P1105, DOI 10.1038/ncb3041; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; MADSEN PS, 1986, ACTA PATH MICRO IM C, V94, P193; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; McCarty OJT, 2000, BLOOD, V96, P1789, DOI 10.1182/blood.V96.5.1789.h8001789_1789_1797; Menter DG, 2014, CANCER METAST REV, V33, P231, DOI 10.1007/s10555-014-9498-0; Mitrugno A., 2015, BLOOD REV; Nieswandt B, 1999, CANCER RES, V59, P1295; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Palumbo JS, 2007, BLOOD, V110, P133, DOI 10.1182/blood-2007-01-065995; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Placke T, 2011, J INNATE IMMUN, V3, P374, DOI 10.1159/000323936; POGGI A, 1993, BAILLIERE CLIN HAEM, V6, P731, DOI 10.1016/S0950-3536(05)80196-9; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; RUSSO J, 1976, J NATL CANCER I, V56, P279, DOI 10.1093/jnci/56.2.279; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Spiegel A, 2016, CANCER DISCOV, V6, P630, DOI 10.1158/2159-8290.CD-15-1157; Stevenson JL, 2007, THROMB RES, V120, pS107, DOI 10.1016/S0049-3848(07)70138-X; VANMUIJEN GNP, 1991, INT J CANCER, V48, P85; VANOOST BA, 1986, BIOCHEM CELL BIOL, V64, P699, DOI 10.1139/o86-096; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012	55	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191303	10.1371/journal.pone.0191303	http://dx.doi.org/10.1371/journal.pone.0191303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346400	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500040
J	van Puijvelde, GHM; Foks, AC; van Bochove, RE; Bot, I; Habets, KLL; de Jager, SC; ter Borg, MND; van Osch, P; Boon, L; Vos, M; de Waard, V; Kuiper, J				van Puijvelde, Gijs H. M.; Foks, Amanda C.; van Bochove, Rosemarie E.; Bot, Ilze; Habets, Kim L. L.; de Jager, Saskia C.; ter Borg, Mariette N. D.; van Osch, Puck; Boon, Louis; Vos, Mariska; de Waard, Vivian; Kuiper, Johan			CD1d deficiency inhibits the development of abdominal aortic aneurysms in LDL receptor deficient mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KILLER T-CELLS; ANGIOTENSIN-II; NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; ATHEROSCLEROTIC LESIONS; ALTERNATIVE ACTIVATION; IMMUNE-RESPONSES; DENDRITIC CELLS; MURINE MODEL	An abdominal aortic aneurysm (AAA) is a dilatation of the abdominal aorta leading to serious complications and mostly to death. AAA development is associated with an accumulation of inflammatory cells in the aorta including NKT cells. An important factor in promoting the recruitment of these inflammatory cells into tissues and thereby contributing to the development of AAA is angiotensin II (Ang II). We demonstrate that a deficiency in CD1d dependent NKT cells under hyperlipidemic conditions (LDLr-/- CD1d(-/-) mice) results in a strong decline in the severity of angiotensin II induced aneurysm formation when compared with LDLr-/- mice. In addition, we show that Ang II amplifies the activation of NKT cells both in vivo and in vitro. We also provide evidence that type I NKT cells contribute to AAA development by inducing the expression of matrix degrading enzymes in vSMCs and macrophages, and by cytokine dependently decreasing vSMC viability. Altogether, these data prove that CD1d dependent NKT cells contribute to AAA development in the Ang II-mediated aneurysm model by enhancing aortic degradation, establishing that therapeutic applications which target NKT cells can be a successful way to prevent AAA development.	[van Puijvelde, Gijs H. M.; Foks, Amanda C.; van Bochove, Rosemarie E.; Bot, Ilze; Habets, Kim L. L.; de Jager, Saskia C.; ter Borg, Mariette N. D.; van Osch, Puck; Kuiper, Johan] Leiden Univ, Leiden Acad, Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Vos, Mariska; de Waard, Vivian] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Bioceros B.V.; University of Amsterdam; Academic Medical Center Amsterdam	van Puijvelde, GHM (corresponding author), Leiden Univ, Leiden Acad, Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands.	puijvelde@lacdr.leidenuniv.nl	van Puijvelde, Gijs/AAM-9889-2020; de+Jager, Saskia/ABC-4264-2020; de+Jager, Saskia/AAE-1132-2022; Boon, Laurence/HCI-3629-2022	Foks, Amanda/0000-0002-9747-3458; Bot, Ilze/0000-0002-1242-1959; de Jager, Saskia/0000-0002-5233-0066; Boon, Louis/0000-0002-0937-9171	Hartstichting [2007T039, 2008B048, 2012T083]	Hartstichting	This study was funded by Hartstichting, with the following grants: 2007T039 (Dr. Gijs H.M. van Puijvelde); 2008B048 (Ph.D. Amanda C. Foks); 2012T083 (Ph.D. Ilze Bot). Louis Boon, employed by Bioceros BV, Utrecht, The Netherlands, supported this study in the form of providing us with neutralizing alpha-IFN gamma, alpha-IL4 and alpha-IL10 antibodies and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanian AM, 2005, ARTERIOSCL THROM VAS, V25, P628, DOI 10.1161/01.ATV.0000153046.59370.13; Balce DR, 2011, BLOOD, V118, P4199, DOI 10.1182/blood-2011-01-328906; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Bown MJ, 2007, J VASC SURG, V46, P687, DOI 10.1016/j.jvs.2007.06.025; Burdin N, 1998, J IMMUNOL, V161, P3271; Cao RY, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00009; Chan WL, 2005, CIRC RES, V96, P675, DOI 10.1161/01.RES.0000160543.84254.f1; Chan WL, 2005, CELL IMMUNOL, V233, P109, DOI 10.1016/j.cellimm.2005.04.020; Chiba A, 2004, ARTHRITIS RHEUM, V50, P305, DOI 10.1002/art.11489; Chizzolini C, 2000, J IMMUNOL, V164, P5952, DOI 10.4049/jimmunol.164.11.5952; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2011, J ZHEJIANG UNIV-SC B, V12, P624, DOI 10.1631/jzus.B1101002; de Waard V, 2010, ATHEROSCLEROSIS, V211, P84, DOI 10.1016/j.atherosclerosis.2010.01.042; Galle C, 2005, CLIN EXP IMMUNOL, V142, P519, DOI 10.1111/j.1365-2249.2005.02938.x; Geng YJ, 1996, ARTERIOSCL THROM VAS, V16, P19, DOI 10.1161/01.ATV.16.1.19; Golledge ALV, 2009, DIS MARKERS, V26, P181, DOI [10.1155/2009/352319, 10.3233/DMA-2009-0629]; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Golledge J, 2010, AM J PATHOL, V176, P2098, DOI 10.2353/ajpath.2010.090416; Golledge J, 2010, ARTERIOSCL THROM VAS, V30, P1075, DOI 10.1161/ATVBAHA.110.206573; Harrison SC, 2012, EUR HEART J; Hoch NE, 2009, AM J PHYSIOL-REG I, V296, pR208, DOI 10.1152/ajpregu.90521.2008; Johnsen SH, 2010, ARTERIOSCL THROM VAS, V30, P1263, DOI 10.1161/ATVBAHA.110.203588; Johnston WF, 2013, ARTERIOSCL THROM VAS, V33, P294, DOI 10.1161/ATVBAHA.112.300432; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Li Y, 2016, CARDIOVASC RES, V109, P305, DOI 10.1093/cvr/cvv259; Liu J, 2015, ARTERIOSCL THROM VAS, V35, P1826, DOI 10.1161/ATVBAHA.115.305482; Lombardi V, 2010, J IMMUNOL, V184, P2107, DOI 10.4049/jimmunol.0901208; Manning MW, 2002, VASC MED, V7, P45, DOI 10.1191/1358863x02vm413ra; Michon IN, 2002, BBA-MOL CELL RES, V1591, P87, DOI 10.1016/S0167-4889(02)00254-9; Middleton RK, 2007, J VASC SURG, V45, P574, DOI 10.1016/j.jvs.2006.11.020; Moehle CW, 2011, J THORAC CARDIOV SUR, V142, P1567, DOI 10.1016/j.jtcvs.2011.07.053; Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje; Nahmod K, 2010, J PHARMACOL EXP THER, V334, P854, DOI 10.1124/jpet.109.161760; Nakai Y, 2004, BLOOD, V104, P2051, DOI 10.1182/blood-2003-10-3485; Nambiar J, 2015, MABS-AUSTIN, V7, P638, DOI 10.1080/19420862.2015.1016693; Ocana E, 2008, ATHEROSCLEROSIS, V200, P264, DOI 10.1016/j.atherosclerosis.2007.12.043; Oki S, 2005, INT IMMUNOL, V17, P1619, DOI 10.1093/intimm/dxh342; Owens AP, 2011, ARTERIOSCL THROM VAS, V31, P2813, DOI 10.1161/ATVBAHA.111.238642; Sasaguri T, 1998, ATHEROSCLEROSIS, V138, P247, DOI 10.1016/S0021-9150(97)00296-7; Schonbeck U, 2002, AM J PATHOL, V161, P499, DOI 10.1016/S0002-9440(10)64206-X; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Silverstein Marc D, 2005, Proc (Bayl Univ Med Cent), V18, P345; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Tazawa H, 2013, BLOOD, V122, P2582, DOI 10.1182/blood-2012-02-407452; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; Upchurch GR, 2006, AM FAM PHYSICIAN, V73, P1198; van Puijvelde GHM, 2017, EUR J PHARMACOL, V816, P47, DOI 10.1016/j.ejphar.2017.03.052; Wang Y. X., 2006, HDB MOUSE MODELS CAR, V125; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Xiong WF, 2009, J IMMUNOL, V183, P2741, DOI 10.4049/jimmunol.0803164; Xiong WF, 2004, J IMMUNOL, V172, P2607, DOI 10.4049/jimmunol.172.4.2607; Xu J, 2012, J SURG RES, V178, P512, DOI 10.1016/j.jss.2011.12.016; Yodoi K, 2015, HYPERTENSION, V65, P889, DOI 10.1161/HYPERTENSIONAHA.114.04934; Zhang JD, 2012, CIRC RES, V110, P1604, DOI 10.1161/CIRCRESAHA.111.261768	56	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190962	10.1371/journal.pone.0190962	http://dx.doi.org/10.1371/journal.pone.0190962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346401	Green Published, gold, Green Submitted			2022-12-27	WOS:000422749500023
J	Talukder, SK; Azhaguvel, P; Chekhovskiy, K; Saha, MC				Talukder, Shyamal K.; Azhaguvel, Perumal; Chekhovskiy, Konstantin; Saha, Malay C.			Molecular discrimination of tall fescue morphotypes in association with Festuca relatives	PLOS ONE			English	Article							SUMMER DORMANCY; PHYLOGENETIC-RELATIONSHIPS; ARUNDINACEA SCHREB.; CHLOROPLAST GENOME; GENETIC DIVERSITY; UNIVERSAL PRIMERS; DNA VARIATION; GRASSES; POACEAE; EVOLUTION	Tall fescue (Festuca arundinacea Schreb.) is an important cool-season perennial grass species used as forage and turf, and in conservation plantings. There are three morphotypes in hexaploid tall fescue: Continental, Mediterranean and Rhizomatous. This study was conducted to develop morphotype-specific molecular markers to distinguish Continental and Mediterranean tall fescues, and establish their relationships with other species of the Festuca genus for genomic inference. Chloroplast sequence variation and simple sequence repeat (SSR) polymorphism were explored in 12 genotypes of three tall fescue morphotypes and four Festuca species. Hypervariable chloroplast regions were retrieved by using 33 specifically designed primers followed by sequencing the PCR products. SSR polymorphism was studied using 144 tall fescue SSR primers. Four chloroplast (NFTCHL17, NFTCHL43, NFTCHL45 and NFTCHL48) and three SSR (nffa090, nffa204 and nffa338) markers were identified which can distinctly differentiate Continental and Mediterranean morphotypes. A primer pair, NFTCHL45, amplified a 47 bp deletion between the two morphotypes is being routinely used in the Noble Research Institute's core facility for morphotype discrimination. Both chloroplast sequence variation and SSR diversity showed a close association between Rhizomatous and Continental morphotypes, while the Mediterranean morphotype was in a distant Glade. F. pratensis and F. arundinacea var. glaucescens, the P and G1G2 genome donors, respectively, were grouped with the Continental Glade, and F. mairei (M1 M2 genome) grouped with the Mediterranean Glade in chloroplast sequence variation, while both F. pratensis and F. maireiformed independent Glade in SSR analysis. Age estimation based on chloroplast sequence variation indicated that the Continental and Mediterranean clades might have been colonized independently during 0.65 +/- 0.06 and 0.96 +/- 0.1 million years ago (Mya) respectively. The findings of the study will enhance tall fescue breeding for persistence and productivity.	[Talukder, Shyamal K.; Azhaguvel, Perumal; Chekhovskiy, Konstantin; Saha, Malay C.] Noble Res Inst LLC, Ardmore, OK USA; [Azhaguvel, Perumal] Syngenta, Slater, IA USA	Noble Research Institute; Syngenta	Saha, MC (corresponding author), Noble Res Inst LLC, Ardmore, OK USA.	mcsaha@noble.org	Talukder, Shyamal/AAW-6614-2021	Chekhovskiy, Konstantin/0000-0002-6149-2366				BORRILL M, 1971, CYTOLOGIA, V36, P1, DOI 10.1508/cytologia.36.1; BORRILL M, 1977, NEW PHYTOL, V78, P661, DOI 10.1111/j.1469-8137.1977.tb02171.x; BORRILL M, 1972, NEW PHYTOL, V71, P523, DOI 10.1111/j.1469-8137.1972.tb01953.x; Cahoon AB, 2010, AM J BOT, V97, P49, DOI 10.3732/ajb.0900008; Cao M, 2003, CROP SCI, V43, P1659, DOI 10.2135/cropsci2003.1659; Cao M, 2001, THEOR APPL GENET, V103, P248, DOI 10.1007/s001220100564; CHANDRASEKHARAN P, 1971, Z PFLANZENZUCHTUNG, V65, P345; Charmet G, 1997, THEOR APPL GENET, V94, P1038, DOI 10.1007/s001220050512; Charrier S, 2006, 13 AUSTR PLANT BREED; Chen FC, 2001, J HERED, V92, P481, DOI 10.1093/jhered/92.6.481; Cheng YJ, 2005, TREE PHYSIOL, V25, P661, DOI 10.1093/treephys/25.6.661; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; Clement SL, 2001, CROP SCI, V41, P570, DOI 10.2135/cropsci2001.412570x; De Bruijn J, 2004, Barenbrug USA, Inc (Tanget, OR) United States, Patent No. [6677507, 20046677507]; Dierking R, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.07.0032; Drummond JB., 2006, THESIS; Duchene D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-65; EVANS GM, 1973, CROP SCI, V13, P376, DOI 10.2135/cropsci1973.0011183X001300030026x; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Gaut BS, 2000, PLANT SYST EVOL, V224, P33, DOI 10.1007/BF00985265; Graham SW, 2000, INT J PLANT SCI, V161, pS83, DOI 10.1086/317583; Greiner S, 2011, MOL ECOL, V20, P671, DOI 10.1111/j.1365-294X.2010.04984.x; Hand ML, 2012, THEOR APPL GENET, V124, P1127, DOI 10.1007/s00122-011-1774-6; Hand ML, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-303; HUMPHREYS MW, 1995, HEREDITY, V75, P171, DOI 10.1038/hdy.1995.120; HUNT KL, 1981, CROP SCI, V21, P400, DOI 10.2135/cropsci1981.0011183X002100030012x; Inda LA, 2008, MOL PHYLOGENET EVOL, V46, P932, DOI 10.1016/j.ympev.2007.11.022; Ingvarsson PK, 2003, MOL BIOL EVOL, V20, P1737, DOI 10.1093/molbev/msg163; JADASHECART J, 1973, M FODD CROPS SECT EU; JAUHAR PP, 1975, CHROMOSOMA, V52, P363, DOI 10.1007/BF00364020; JERNSTEDT JA, 1985, CROP SCI, V25, P539, DOI 10.2135/cropsci1985.0011183X002500030026x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kopecky D, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00066; Lewis E, 1963, RESP WELSH PL BREED, P26; MALIK CP, 1967, CARYOLOGIA, V20, P1; Mathews DJ, 2001, GENOME RES, V11, P1382; Mian MAR, 2005, GENOME, V48, P637, DOI [10.1139/g05-029, 10.1139/G05-029]; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Nie ZN, 2009, CROP SCI, V49, P2405, DOI 10.2135/cropsci2009.06.0320; Norton MR, 2006, AUST J AGR RES, V57, P1267, DOI 10.1071/AR06082; Pasakinskiene I, 1998, HEREDITY, V81, P659, DOI 10.1046/j.1365-2540.1998.00446.x; Provan J, 2004, MOL ECOL NOTES, V4, P262, DOI 10.1111/j.1471-8286.2004.00636.x; Reed KFM, 2004, AUST J EXP AGR, V44, P873, DOI 10.1071/EA03173; Schardl C, 2007, ENDOPHYTES TALL FESC; SEAL AG, 1983, HEREDITY, V50, P225, DOI 10.1038/hdy.1983.26; Sleper D. A., 1990, Biotechnology in tall fescue improvement., P167; STAMMERS M, 1995, HEREDITY, V74, P19, DOI 10.1038/hdy.1995.3; Stewart A, 1997, 8 INT TURFGR RES C S; STEWART AV, 1995, NZ TURF MANAGEMENT J, V9, P32; Subramanian S, 2003, GENOME RES, V13, P838, DOI 10.1101/gr.1152803; Tabbasam N, 2014, PLANT SYST EVOL, V300, P559, DOI 10.1007/s00606-013-0891-x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takach JE, 2012, APPL ENVIRON MICROB, V78, P5501, DOI 10.1128/AEM.01084-12; TZVELEV NN, 1989, BOT REV, V55, P141, DOI 10.1007/BF02858328; Volaire F, 2006, ANN BOT-LONDON, V98, P927, DOI 10.1093/aob/mcl195; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; XU WW, 1994, THEOR APPL GENET, V88, P685, DOI 10.1007/BF01253971; Zwick ME, 2000, ANNU REV GENOM HUM G, V1, P387, DOI 10.1146/annurev.genom.1.1.387	58	3	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191343	10.1371/journal.pone.0191343	http://dx.doi.org/10.1371/journal.pone.0191343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342197	gold, Green Submitted, Green Published			2022-12-27	WOS:000422653800065
J	Andley, UP; Tycksen, E; McGlasson-Naumann, BN; Hamilton, PD				Andley, Usha P.; Tycksen, Eric; McGlasson-Naumann, Brittney N.; Hamilton, Paul D.			Probing the changes in gene expression due to alpha-crystallin mutations in mouse models of hereditary human cataract	PLOS ONE			English	Article							LENS EPITHELIAL-CELLS; A-CRYSTALLIN; B-CRYSTALLIN; DIFFERENTIAL EXPRESSION; CHAPERONE; PROTEIN; CHROMATIN; MECHANISM; STRESS; GROWTH	The mammalian eye lens expresses a high concentration of crystallins (alpha, beta and gamma-crystallins) to maintain the refractive index essential for lens transparency. Crystallins are long-lived proteins that do not turnover throughout life. The structural destabilization of crystallins by UV exposure, glycation, oxidative stress and mutations in crystallin genes leads to protein aggregation and development of cataracts. Several destabilizing mutations in crystallin genes are linked with human autosomal dominant hereditary cataracts. To investigate the mechanism by which the alpha-crystallin mutations Cryaa-R49C and Cryab-R120G lead to cataract formation, we determined whether these mutations cause an altered expression of specific transcripts in the lens at an early postnatal age by RNA-seq analysis. Using knock-in mouse models previously generated in our laboratory, in the present work, we identified genes that exhibited altered abundance in the mutant lenses, including decreased transcripts for Clic5, an intracellular water channel in Cryaa-R49C heterozygous mutant lenses, and increased transcripts for Eno1b in Cryab-R120G heterozygous mutant lenses. In addition, RNA-seq analysis revealed increased histones H2B, H2A, and H4 gene expression in Cryaa-R49C mutant lenses, suggesting that the alpha A-crystallin mutation regulates histone expression via a transcriptional mechanism. Additionally, these studies confirmed the increased expression of histones H2B, H2A, and H4 by proteomic analysis of Cryaa-R49C knock-in and Cryaa; Cryab gene knockout lenses reported previously. Taken together, these findings offer additional insight into the early transcriptional changes caused by Cryaa and Cryab mutations associated with autosomal dominant human cataracts, and indicate that the transcript levels of certain genes are affected by the expression of mutant alpha-crystallin in vivo.	[Andley, Usha P.; McGlasson-Naumann, Brittney N.; Hamilton, Paul D.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA; [Tycksen, Eric] Washington Univ St Louis, Genome Technol Access Ctr, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Andley, UP (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA.	andley@vision.wustl.edu		Hamilton, Paul/0000-0001-7187-706X; Tycksen, Eric/0000-0001-6362-0141	NEI [EY05681, EY02687]; Research to Prevent Blindness Unrestricted Grant; National Cancer Institute (NCI) Cancer Center [P30 CA91842]; National Center for Research Resources (NCRR) [UL1TR000448]; component of NIH and NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002687, R01EY005681] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Unrestricted Grant(Research to Prevent Blindness (RPB)); National Cancer Institute (NCI) Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); component of NIH and NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI EY05681 (Dr. Usha P. Andley), NEI EY02687, and Research to Prevent Blindness Unrestricted Grant to The Department of Ophthalmology and Visual Sciences. We would like to thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with the genomic analyses. The Center is partially supported by a National Cancer Institute (NCI) Cancer Center Support Grant (#P30 CA91842) to the Siteman Cancer Center and by an Institute for Clinical and Translational Science (ICTS)/Clinical and Translational Science Awards (CTSA) Grant (#UL1TR000448) from the National Center for Research Resources (NCRR), a component of NIH and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH.	Alfano G, 2005, HUM MOL GENET, V14, P913, DOI 10.1093/hmg/ddi084; Andley UP, 1998, J BIOL CHEM, V273, P31252, DOI 10.1074/jbc.273.47.31252; Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Andley UP, 2008, BIOCHEMISTRY-US, V47, P9697, DOI 10.1021/bi800594t; Andley Usha P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000111; Andley UP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095507; Andley UP, 2013, BIOCHEMISTRY-US, V52, P2933, DOI 10.1021/bi400180d; Andley UP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017671; Audette DS, 2016, DEVELOPMENT, V143, P318, DOI 10.1242/dev.127860; Bai F, 2004, EXP EYE RES, V79, P795, DOI 10.1016/j.exer.2004.05.006; Bai F, 2004, MOL CELL BIOCHEM, V265, P115, DOI 10.1023/B:MCBI.0000044365.48900.82; Bai F, 2003, J BIOL CHEM, V278, P36876, DOI 10.1074/jbc.M304010200; Biswas A, 2006, BIOCHEMISTRY-US, V45, P4569, DOI 10.1021/bi052574s; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Cook AJL, 2011, MOL CELL, V44, P918, DOI 10.1016/j.molcel.2011.11.021; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DWORK AJ, 1990, INVEST OPHTH VIS SCI, V31, P489; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Gunesdogan U, 2014, ELIFE, V3, DOI 10.7554/eLife.02443; Hegde SM, 2014, INVEST OPHTH VIS SCI, V55, P6398, DOI 10.1167/iovs.14-14623; Hoang TV, 2014, MOL VIS, V20, P1491; Hubner MR, 2013, CURR OPIN GENET DEV, V23, P89, DOI 10.1016/j.gde.2012.11.006; Khan SY, 2015, INVEST OPHTH VIS SCI, V56, P4919, DOI 10.1167/iovs.14-16253; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li XY, 2013, J NEUROSCI, V33, P19423, DOI 10.1523/JNEUROSCI.2561-13.2013; Li ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep27105; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; Maki N, 2010, MOL VIS, V16, P1893; Makley LN, 2015, SCIENCE, V350, P674, DOI 10.1126/science.aac9145; Martino VB, 2016, DIS MODEL MECH, V9, P849, DOI 10.1242/dmm.025262; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Nishida H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-108; Oh-hashi K, 2013, MOL CELL BIOCHEM, V380, P97, DOI 10.1007/s11010-013-1663-1; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Pietrowski D, 1997, BIOL CHEM, V378, P1183; PIETROWSKI D, 1994, GENE, V144, P171, DOI 10.1016/0378-1119(94)90375-1; Pineau P, 2005, MOL BIOL EVOL, V22, P582, DOI 10.1093/molbev/msi053; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Rein DB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1754, DOI 10.1001/archopht.124.12.1754; Resnikoff S, 2012, INDIAN J OPHTHALMOL, V60, P387, DOI 10.4103/0301-4738.100532; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson ML, 1996, INVEST OPHTH VIS SCI, V37, P2276; Salles FT, 2014, CYTOSKELETON, V71, P61, DOI 10.1002/cm.21159; Schlessinger A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388157; Sidjanin D, 1996, PHOTOCHEM PHOTOBIOL, V63, P79, DOI 10.1111/j.1751-1097.1996.tb02995.x; Stanger SJ, 2016, FASEB J, V30, P2777, DOI 10.1096/fj.201500136R; Tumelty KE, 2014, J BIOL CHEM, V289, P2526, DOI 10.1074/jbc.M113.502617; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Watson GW, 2010, BIOCHEM BIOPH RES CO, V401, P192, DOI 10.1016/j.bbrc.2010.09.023; Wolf L, 2013, NUCLEIC ACIDS RES, V41, P10199, DOI 10.1093/nar/gkt824; Wride MA, 2003, MOL VIS, V9, P360; Xi JH, 2003, J CELL SCI, V116, P1073, DOI 10.1242/jcs.00325; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Yang Y, 2007, J MOL BIOL, V369, P917, DOI 10.1016/j.jmb.2007.04.004; Yoshida N, 2015, CANCER SCI, V106, P1455, DOI 10.1111/cas.12742; ZHAO SL, 2014, BIOMED RES INT, DOI DOI 10.1155/2014/986048; Zhou YF, 2016, BBA-MOL BASIS DIS, V1862, P1433, DOI 10.1016/j.bbadis.2016.05.003	69	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190817	10.1371/journal.pone.0190817	http://dx.doi.org/10.1371/journal.pone.0190817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338044	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700019
J	Grottoli, AG; Martins, PD; Wilkins, MJ; Johnston, MD; Warner, ME; Cai, WJ; Melman, TF; Hoadley, KD; Pettay, DT; Levas, S; Schoepf, V				Grottoli, Andrea G.; Martins, Paula Dalcin; Wilkins, Michael J.; Johnston, Michael D.; Warner, Mark E.; Cai, Wei-Jun; Melman, Todd F.; Hoadley, Kenneth D.; Pettay, D. Tye; Levas, Stephen; Schoepf, Verena			Coral physiology and microbiome dynamics under combined warming and ocean acidification	PLOS ONE			English	Article							NATURAL PH GRADIENT; BACTERIAL COMMUNITIES; CLIMATE-CHANGE; SCLERACTINIAN CORALS; PARTIAL-PRESSURE; HEAT-STRESS; CO2; HOST; TEMPERATURE; HYPOTHESIS	Rising seawater temperature and ocean acidification threaten the survival of coral reefs. The relationship between coral physiology and its microbiome may reveal why some corals are more resilient to these global change conditions. Here, we conducted the first experiment to simultaneously investigate changes in the coral microbiome and coral physiology in response to the dual stress of elevated seawater temperature and ocean acidification expected by the end of this century. Two species of corals, Acropora millepora containing the thermally sensitive endosymbiont C21a and Turbinaria reniformis containing the thermally tolerant endosymbiont Symbiodinium trenchi, were exposed to control (26.5 degrees C and pCO(2) of 364 mu atm) and treatment (29.0 degrees C and pCO(2) of 750 mu atm) conditions for 24 days, after which we measured the microbial community composition. These microbial findings were interpreted within the context of previously published physiological measurements from the exact same corals in this study (calcification, organic carbon flux, ratio of photosynthesis to respiration, photosystem II maximal efficiency, total lipids, soluble animal protein, soluble animal carbohydrates, soluble algal protein, soluble algal carbohydrate, biomass, endosymbiotic algal density, and chlorophyll a). Overall, dually stressed A. millepora had reduced microbial diversity, experienced large changes in microbial community composition, and experienced dramatic physiological declines in calcification, photosystem II maximal efficiency, and algal carbohydrates. In contrast, the dually stressed coral T. reniformis experienced a stable and more diverse microbiome community with minimal physiological decline, coupled with very high total energy reserves and particulate organic carbon release rates. Thus, the microbiome changed and microbial diversity decreased in the physiologically sensitive coral with the thermally sensitive endosymbiotic algae but not in the physiologically tolerant coral with the thermally tolerant endosymbiont. Our results confirm recent findings that temperature-stress tolerant corals have a more stable microbiome, and demonstrate for the first time that this is also the case under the dual stresses of ocean warming and acidification. We propose that coral with a stable microbiome are also more physiologically resilient and thus more likely to persist in the future, and shape the coral species diversity of future reef ecosystems.	[Grottoli, Andrea G.; Wilkins, Michael J.; Johnston, Michael D.; Levas, Stephen; Schoepf, Verena] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Martins, Paula Dalcin; Wilkins, Michael J.] Ohio State Univ, Dept Microbiol, Columbus, OH USA; [Warner, Mark E.; Cai, Wei-Jun; Hoadley, Kenneth D.; Pettay, D. Tye] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Melman, Todd F.] Reef Syst Coral Farm, New Albany, OH USA; [Levas, Stephen] Univ Wisconsin, Dept Geol & Geog, Whitewater, WI 53190 USA; [Schoepf, Verena] Univ Western Australia, ARC Ctr Excellence Coral Reef Studies, UWA Oceans Inst, Crawley, WA, Australia; [Schoepf, Verena] Univ Western Australia, Sch Earth Sci, Crawley, WA, Australia	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Delaware; University of Wisconsin System; University of Western Australia; University of Western Australia	Grottoli, AG (corresponding author), Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA.	grottoli.1@osu.edu	Schoepf, Verena/H-5786-2014; Martins, Paula Dalcin/AAZ-1698-2020; Cai, Wei-Jun/C-1361-2013; Levas, Stephen/AAA-6774-2020; Warner, Mark E/J-6241-2013	Schoepf, Verena/0000-0002-9467-1088; Martins, Paula Dalcin/0000-0003-1242-0267; Cai, Wei-Jun/0000-0003-3606-8325; Warner, Mark/0000-0003-1015-9413; Hoadley, Kenneth/0000-0002-9287-181X; Wilkins, Michael/0000-0002-3595-0853	U.S. National Science Foundation [NSF-EF-1041124, 1040940, 1041070]; Ohio State University; Division Of Ocean Sciences [1459536] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Ohio State University(Ohio State University); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding by the U.S. National Science Foundation (NSF-EF-1041124, 1040940, 1041070 to AGG, MEW, and WJC, respectively) and from The Ohio State University (start-up funds to MJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Reef Systems Coral Farm funder provided space for the experiment and contributed to the physical construction and maintenance of the experimental setup, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank the staff at Reef Systems Coral Farm, E. Zebrowski, M. Berzelis, M. Ringwald, S. Blackhurst, K. Dobson, C. Saup, and Y. Matsui for their assistance with the experiment. This work was supported by funding from the U.S. National Science Foundation (NSF-EF-1041124, 1040940, 1041070 to AGG, MEW, and WJC, respectively) and from The Ohio State University (start-up funds to MJW). Sequences have been deposited in NCBI's Sequence Read Archive under accession number PRJNA344759. The physiological data are archived at www.bco-dmo.org/project/528004.	Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Banin F, 2000, WATER AIR SOIL POLL, V123, P337, DOI 10.1023/A:1005274331988; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Ben-Haim Y, 2003, INT J SYST EVOL MICR, P309; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036920; Chen CP, 2011, ISME J, V5, P728, DOI 10.1038/ismej.2010.151; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Comeau S, 2013, MAR BIOL, V160, P1127, DOI 10.1007/s00227-012-2165-5; Dove SG, 2013, P NATL ACAD SCI USA, V110, P15342, DOI 10.1073/pnas.1302701110; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edmunds PJ, 2012, GLOBAL CHANGE BIOL, V18, P2173, DOI 10.1111/j.1365-2486.2012.02695.x; Gorley C.K., 2006, GETTING STARTED PRIM; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2014, GLOBAL CHANGE BIOL, V20, P3823, DOI 10.1111/gcb.12658; Hadaidi G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45362; Hernandez-Agreda A, TRENDS MICR IN PRESS, V16; Hoadley KD, 2015, SCI REP-UK, V5, DOI 10.1038/srep18371; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; IPCC, 2013, SUMM POL; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jokiel P.L., 1978, Monographs on Oceanographic Methodology, P529; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Kvennefors ECE, 2012, MICROB ECOL, V63, P605, DOI 10.1007/s00248-011-9946-0; Lane DJ, 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Levas S, 2015, MAR ECOL PROG SER, V519, P153, DOI 10.3354/meps11072; Levas SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063267; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; Littman RA, 2010, MOL ECOL, V19, P1978, DOI 10.1111/j.1365-294X.2010.04620.x; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; MARSH JA, 1970, ECOLOGY, V51, P254; Meron D, 2013, MICROB ECOL, V65, P269, DOI 10.1007/s00248-012-0127-6; Meron D, 2012, ISME J, V6, P1775, DOI 10.1038/ismej.2012.19; Meron D, 2011, ISME J, V5, P51, DOI 10.1038/ismej.2010.102; Miller J, 2003, REV BIOL TROP, V51, P47; Morrow KM, 2015, ISME J, V9, P894, DOI 10.1038/ismej.2014.188; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Noonan SHC, 2016, ICES J MAR SCI, V73, P715, DOI 10.1093/icesjms/fsv127; Pogoreutz C, 2017, GLOBAL CHANGE BIOL, V23, P3838, DOI 10.1111/gcb.13695; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Radecker N, 2014, MAR ECOL PROG SER, V511, P297, DOI 10.3354/meps10912; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2004, BACTERIAL DIS HYPOTH; Santos HF, 2014, ISME J, V8, P2272, DOI 10.1038/ismej.2014.70; SASIKALA K, 1990, FEMS MICROBIOL LETT, V72, P23, DOI 10.1016/0378-1097(90)90338-Q; Schoepf V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1887; Schoepf V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075049; Sharp KH, 2012, BIOL BULL-US, V223, P66, DOI 10.1086/BBLv223n1p66; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Thompson JR, 2015, FRONTIERS CELLULAR I, P4; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Tremblay P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38112; Veal CJ, 2010, CORAL REEFS, V29, P893, DOI 10.1007/s00338-010-0647-9; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Warner ME., 2010, CHLOROPHYLL FLUORESC; Webster NS, 2016, SCI REP-UK, V6, DOI 10.1038/srep19324; Webster NS, 2013, ENV MICROBIOL REP, V5, P243, DOI 10.1111/1758-2229.12006; Winer BJ., 1970, STAT PRINCIPLES EXPT, V2nd; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zhou GW, 2016, SCI REP-UK, V6, DOI 10.1038/srep35971; Ziegler M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14213; Ziegler M, 2016, MAR POLLUT BULL, V105, P629, DOI 10.1016/j.marpolbul.2015.12.045	83	82	82	4	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191156	10.1371/journal.pone.0191156	http://dx.doi.org/10.1371/journal.pone.0191156			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338021	gold, Green Published, Green Submitted			2022-12-27	WOS:000422652700033
J	Horak, M; Zlamal, F; Iliev, R; Kucera, J; Cacek, J; Svobodova, L; Hlavonova, Z; Kalina, T; Slaby, O; Bienertova-Vasku, J				Horak, Martin; Zlamal, Filip; Iliev, Robert; Kucera, Jan; Cacek, Jan; Svobodova, Lenka; Hlavonova, Zuzana; Kalina, Tomas; Slaby, Ondrej; Bienertova-Vasku, Julie			Exercise-induced circulating microRNA changes in athletes in various training scenarios	PLOS ONE			English	Article							GROWTH	Background The aim of the study was to compare selected extracellular miRNA levels (miR-16, miR-21, miR-93 and miR-222 with the response to 8-week-long explosive strength training (EXPL), hypertrophic strength training (HYP) and high-intensity interval training (HIIT). Methods 30 young male athletes of white European origin (mean age: 22.5 +/- 4.06 years) recruited at the Faculty of Sports Studies of Masaryk University were enrolled in this study. The study participants were randomly assigned to three possible training scenarios: EXPL, HYP or HITT and participated in 8-week-long program in given arm. Blood plasma samples were collected at the baseline and at week 5 and 8 and anthropometric and physical activity parameters were measured. Pre- and post-intervention characteristics were compared and participants were further evaluated as responders (RES) or non-responders (NRES). RES/NRES status was established for the following characteristics: 300 degrees/s right leg extension (t300), 60 degrees/s right leg extension (t60), isometric extension (IE), vertical jump, isometric extension of the right leg and body fat percentage (BFP). Results No differences in miRNA levels were apparent between the intervention groups at baseline. No statistically significant prediction role was observed using crude univariate stepwise regression model analysis where RES/NRES status for t300, t60, IE, vertical jump and pFM was used as a dependent variable and miR-21, miR-222, miR-16 and miR-93 levels at baseline were used as independent variables. The baseline levels of miR-93 expressed an independent prediction role for responder status based on isometric extension of the right leg (beta estimate 0.76, 95% CI: -0.01; 1.53, p = 0.052). Discussion The results of the study indicate that 8-week-long explosive strength training, hypertrophic strength training and high-intensity interval training regimens are associated with significant changes in miR-16, mir-21, miR-222 and miR-93 levels compared to a baseline in athletic young men.	[Horak, Martin; Zlamal, Filip; Bienertova-Vasku, Julie] Masaryk Univ, Fac Med, Dept Pathol Physiol, Kamenice 5, Brno, Czech Republic; [Horak, Martin; Zlamal, Filip; Bienertova-Vasku, Julie] Masaryk Univ, Res Ctr Tox Cpds Environm, Kamenice 5, Brno, Czech Republic; [Iliev, Robert; Slaby, Ondrej] Masaryk Univ, Fac Sports Studies, Dept Athlet Swimming & Outdoor Sports, Kamenice 5, Brno, Czech Republic; [Cacek, Jan; Svobodova, Lenka; Hlavonova, Zuzana; Kalina, Tomas] Masaryk Univ, Cent European Inst Technol, Kamenice 5, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; Masaryk University Brno	Bienertova-Vasku, J (corresponding author), Masaryk Univ, Fac Med, Dept Pathol Physiol, Kamenice 5, Brno, Czech Republic.; Bienertova-Vasku, J (corresponding author), Masaryk Univ, Res Ctr Tox Cpds Environm, Kamenice 5, Brno, Czech Republic.	vasku.julie@seznam.cz	Horak, Martin/V-8484-2018; Kalina, Tomáš/AAH-4261-2021; Vasku, Julie Bienertova/AAV-6821-2020; Cacek, Jan/AAQ-6694-2021; Svobodová, Lenka/AAL-4356-2021	Horak, Martin/0000-0003-3928-2685; Kalina, Tomáš/0000-0003-0414-2922; Vasku, Julie Bienertova/0000-0001-5327-808X; Cacek, Jan/0000-0003-4277-8438; Svobodová, Lenka/0000-0003-1624-2859; Hlavonova, Zuzana/0000-0001-6872-1275	CETOCOEN PLUS project [CZ.02.1.01/0.0/0.0/15_003/0000469]	CETOCOEN PLUS project	The presented paper was supported from the CETOCOEN PLUS project CZ.02.1.01/0.0/0.0/15_003/0000469.	Altana Valentina, 2015, Microrna, V4, P74; Badal SS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12076; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cui S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00351-0; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Febbraio MA, 2017, NAT REV ENDOCRINOL, V13, P72, DOI 10.1038/nrendo.2016.218; Fernandes T, 2012, HYPERTENSION, V59, P513, DOI 10.1161/HYPERTENSIONAHA.111.185801; Ihle MA, 2015, MOL ONCOL, V9, P1421, DOI 10.1016/j.molonc.2015.03.013; Kilian Y, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00092; Liu XJ, 2015, CELL METAB, V21, P584, DOI 10.1016/j.cmet.2015.02.014; Lombardi G, 2016, CLIN BIOCHEM; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Missiaglia E, 2016, CANC LETT; Polakovicova M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101553; Roncarati R, 2014, J AM COLL CARDIOL, V63, P920, DOI 10.1016/j.jacc.2013.09.041; Russell AP, 2015, PROG MOL BIOL TRANSL, V135, P471, DOI 10.1016/bs.pmbts.2015.07.018; Sapp RM, 2017, J APPL PHYSIOL, V122, P702, DOI 10.1152/japplphysiol.00982.2016; Sheedy FJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00019; Viereck J, 2017, CIRC RES, V120, P381, DOI 10.1161/CIRCRESAHA.116.308434; Wahl P, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00643; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wardle SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122107; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405	28	28	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191060	10.1371/journal.pone.0191060	http://dx.doi.org/10.1371/journal.pone.0191060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338015	gold, Green Published, Green Submitted			2022-12-27	WOS:000422652700028
J	Yamanouchi, M; Hoshino, J; Ubara, Y; Takaichi, K; Kinowaki, K; Fujii, T; Ohashi, K; Mise, K; Toyama, T; Hara, A; Kitagawa, K; Shimizu, M; Furuichi, K; Wada, T				Yamanouchi, Masayuki; Hoshino, Junichi; Ubara, Yoshifumi; Takaichi, Kenmei; Kinowaki, Keiichi; Fujii, Takeshi; Ohashi, Kenichi; Mise, Koki; Toyama, Tadashi; Hara, Akinori; Kitagawa, Kiyoki; Shimizu, Miho; Furuichi, Kengo; Wada, Takashi			Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; JAPANESE PATIENTS; DISEASE; BIOPSY; PROGNOSIS; MELLITUS; SYSTEM	Background There have been a limited number of biopsy-based studies on diabetic nephropathy, and therefore the clinical importance of renal biopsy in patients with diabetes in late-stage chronic kidney disease (CKD) is still debated. We aimed to clarify the renal prognostic value of pathological information to clinical information in patients with diabetes and advanced CKD. Methods We retrospectively assessed 493 type 2 diabetics with biopsy-proven diabetic nephropathy in four centers in Japan. 296 patients with stage 3-5 CKD at the time of biopsy were identified and assigned two risk prediction scores for end-stage renal disease (ESRD): the Kidney Failure Risk Equation (KFRE, a score composed of clinical parameters) and the Diabetic Nephropathy Score (D-score, a score integrated pathological parameters of the Diabetic Nephropathy Classification by the Renal Pathology Society (RPS DN Classification)). They were randomized 2:1 to development and validation cohort. Hazard Ratios (HR) of incident ESRD were reported with 95% confidence interval (CI) of the KFRE, D-score and KFRE+D-score in Cox regression model. Improvement of risk prediction with the addition of D-score to the KFRE was assessed using c-statistics, continuous net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Results During median follow-up of 1.9 years, 194 patients developed ESRD. The cox regression analysis showed that the KFRE,D-score and KFRE+D-score were significant predictors of ESRD both in the development cohort and in the validation cohort. The c-statistics of the D-score was 0.67. The c-statistics of the KFRE was good, but its predictive value was weaker than that in the miscellaneous CKD cohort originally reported (c-statistics, 0.78 vs. 0.90) and was not significantly improved by adding the D-score (0.78 vs. 0.79, p = 0.83). Only continuous NRI was positive after adding the D-score to the KFRE (0.4%; CI: 0.0-0.8%). Conclusions We found that the predict values of the KFRE and the D-score were not as good as reported, and combining the D-score with the KFRE did not significantly improve prediction of the risk of ESRD in advanced diabetic nephropathy. To improve prediction of renal prognosis for advanced diabetic nephropathy may require different approaches with combining clinical and pathological parameters that were not measured in the KFRE and the RPS DN Classification.	[Yamanouchi, Masayuki; Wada, Takashi] Kanazawa Univ, Grad Sch Med Sci, Fac Med, Inst Pharmaceut & Hlth Sci,Dept Nephrol & Lab Med, Kanazawa, Ishikawa, Japan; [Yamanouchi, Masayuki; Hoshino, Junichi; Ubara, Yoshifumi; Takaichi, Kenmei] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan; [Yamanouchi, Masayuki; Hoshino, Junichi; Ubara, Yoshifumi; Takaichi, Kenmei] Toranomon Hosp Kajigaya, Nephrol Ctr, Kawasaki, Kanagawa, Japan; [Yamanouchi, Masayuki; Hoshino, Junichi; Ubara, Yoshifumi; Takaichi, Kenmei] Okinaka Mem Inst Med Res, Tokyo, Japan; [Kinowaki, Keiichi; Fujii, Takeshi; Ohashi, Kenichi] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa, Japan; [Mise, Koki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Toyama, Tadashi; Hara, Akinori; Shimizu, Miho; Furuichi, Kengo; Wada, Takashi] Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan; [Kitagawa, Kiyoki] Natl Hosp Org, Kanazawa Med Ctr, Div Internal Med, Kanazawa, Ishikawa, Japan	Kanazawa University; Toranomon Hospital; Toranomon Hospital; Yokohama City University; Okayama University; Kanazawa University	Yamanouchi, M; Wada, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Fac Med, Inst Pharmaceut & Hlth Sci,Dept Nephrol & Lab Med, Kanazawa, Ishikawa, Japan.; Yamanouchi, M (corresponding author), Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan.; Yamanouchi, M (corresponding author), Toranomon Hosp Kajigaya, Nephrol Ctr, Kawasaki, Kanagawa, Japan.; Yamanouchi, M (corresponding author), Okinaka Mem Inst Med Res, Tokyo, Japan.; Wada, T (corresponding author), Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan.	m.yamanouchi@toranomon.gr.jp; twada@m-kanazawa.jp	FURUICHI, Kengo/AAA-5685-2019; Fujii, Takeshi/D-5877-2014; Hara, Akinori/W-8522-2019	Fujii, Takeshi/0000-0001-7237-1183; Mise, Koki/0000-0003-0296-7429; Yamanouchi, Masayuki/0000-0003-3264-9691	Japan Agency for Medical Research and Development [15ek0310003h0001]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was partly supported by a Grant-in-Aid for Practical Research Projects for Renal Diseases from the Japan Agency for Medical Research and Development (grant no: 15ek0310003h0001). The funding source had no role in study design or execution, data analysis, manuscript writing, or manuscript submission.	Chang TI, 2011, DIABETES RES CLIN PR, V92, P198, DOI 10.1016/j.diabres.2011.01.017; Chen PM, 2017, CLIN EXP NEPHROL, V21, P307, DOI 10.1007/s10157-016-1290-8; Drawz PE, 2013, J AM GERIATR SOC, V61, P762, DOI 10.1111/jgs.12223; Fiorentino M, 2017, NEPHROL DIAL TRANSPL, V32, P97, DOI 10.1093/ndt/gfw070; Furuichi K, 2018, NEPHROL DIAL TRANSPL, V33, P138, DOI 10.1093/ndt/gfw417; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273; Hoshino J, 2015, AM J NEPHROL, V41, P337, DOI 10.1159/000431333; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Kerr KF, 2014, CLIN J AM SOC NEPHRO, V9, P1488, DOI 10.2215/CJN.10351013; Klessens CQF, 2016, KIDNEY INT, V90, P149, DOI 10.1016/j.kint.2016.01.023; Lennartz CS, 2016, CLIN J AM SOC NEPHRO, V11, P609, DOI 10.2215/CJN.08110715; Mise K, 2014, NEPHROL DIAL TRANSPL, V29, P109, DOI 10.1093/ndt/gft349; Oh SW, 2012, DIABETES RES CLIN PR, V97, P418, DOI 10.1016/j.diabres.2012.03.016; Okada T, 2012, NEPHROLOGY, V17, P68, DOI 10.1111/j.1440-1797.2011.01525.x; Schroeder EB, 2017, CLIN J AM SOC NEPHRO, V12, P87, DOI 10.2215/CJN.01290216; Sharma SG, 2013, CLIN J AM SOC NEPHRO, V8, P1718, DOI 10.2215/CJN.02510213; Tangri N, 2016, JAMA-J AM MED ASSOC, V315, P164, DOI 10.1001/jama.2015.18202; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wada T, 2014, CLIN EXP NEPHROL, V18, P613, DOI 10.1007/s10157-013-0879-4; Wong TYH, 2002, DIABETES CARE, V25, P900, DOI 10.2337/diacare.25.5.900; Yamamoto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091067	25	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190930	10.1371/journal.pone.0190930	http://dx.doi.org/10.1371/journal.pone.0190930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338014	gold, Green Published, Green Submitted			2022-12-27	WOS:000422652700023
J	Calvet, J; Orellana, C; Galisteo, C; Garcia-Manrique, M; Navarro, N; Caixas, A; Larrosa, M; Gratacos, J				Calvet, Joan; Orellana, Cristobal; Galisteo, Carlos; Garcia-Manrique, Maria; Navarro, Noemi; Caixas, Assumpta; Larrosa, Marta; Gratacos, Jordi			Clinical and ultrasonographic features associated to response to intraarticular corticosteroid injection. A one year follow up prospective cohort study in knee osteoarthritis patient with joint effusion	PLOS ONE			English	Article							CONTROLLED-TRIAL; TRIAMCINOLONE HEXACETONIDE; MULTICENTER OSTEOARTHRITIS; CARDIOVASCULAR-DISEASE; PAIN SENSITIZATION; STEROID INJECTIONS; SEX-DIFFERENCES; DOUBLE-BLIND; INFLAMMATION; EFFICACY	Objectives Intraarticular injection is used for pain relief in knee osteoarthritis (OA), but there is not a well defined profile of patient who could get more benefit from it. The purpose of this study was to evaluate the frequency of pain relief at one year after corticosteroids intraarticular injection and to identify clinical factors associated to response in patients with knee osteoarthritis with joint effusion. Methods One-year prospective cohort study of patients with knee OA with joint effusion confirmed by ultrasound. An intraarticular injection was performed following a clinical protocol. Anthropometric measurements, laboratory parameters, clinical severity, ultrasound parameters and radiological severity were collected. Response regarding pain and presence of synovial fluid on ultrasound at one month and at one year were evaluated. Clinical responder were consider in subjects with enough improvement to carry out normal daily activities with pain VAS<40mm. Results One hundred and thirty-two patients were included. A significant number of patients (61.4%) improved pain at one year following the protocol established in this study. Pain and ultrasound synovial fluid at one month appeared to predict the response at one year. The Lequesne index and the percentage of body fat were independently associated to pain at one year while the Lequesne index and ultrasound synovial hypertrophy were independently related to the presence of synovial fluid at one year. Conclusions The status regarding pain or ultrasound synovial fluid at one month after an intraarticular joint injection appeared to predict the status at one year in patients with knee osteoarthritis and synovial effusion.	[Calvet, Joan; Orellana, Cristobal; Galisteo, Carlos; Garcia-Manrique, Maria; Navarro, Noemi; Larrosa, Marta; Gratacos, Jordi] Parc Tauli Sabadell Univ Hosp, UAB, I3PT Res Inst, Rheumatol Dept, Barcelona, Spain; [Caixas, Assumpta] Parc Tauli Sabadell Univ Hosp, UAB, I3PT Res Inst, Endocrinol & Nutr Dept, Barcelona, Spain	Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari	Calvet, J (corresponding author), Parc Tauli Sabadell Univ Hosp, UAB, I3PT Res Inst, Rheumatol Dept, Barcelona, Spain.	joan.calvet.fontova@gmail.com	gratacos, jordi/AHC-4573-2022; Calvet, Joan/AFO-1210-2022	Calvet, Joan/0000-0002-0888-5152; Caixas, Assumpta/0000-0001-8472-9189; Gratacos, Jordi/0000-0003-4007-4103				ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Arden NK, 2008, OSTEOARTHR CARTILAGE, V16, P733, DOI 10.1016/j.joca.2007.10.011; Bannuru RR, 2009, ARTHRIT RHEUM-ARTHR, V61, P1704, DOI 10.1002/art.24925; Bartley EJ, 2016, ARTHRIT CARE RES, V68, P472, DOI 10.1002/acr.22712; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005328; Berenbaum F, 2017, ARTHRITIS RHEUMATOL, V69, P9, DOI 10.1002/art.39842; Berenbaum F, 2013, CURR OPIN RHEUMATOL, V25, P114, DOI 10.1097/BOR.0b013e32835a9414; Bevers K, 2014, CLIN EXP RHEUMATOL, V32, P930; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Boon AJ, 2010, PM&R, V2, P268, DOI 10.1016/j.pmrj.2010.02.011; Calvet J, 2015, SCAND J RHEUMATOL, P1; Chao J, 2010, J RHEUMATOL, V37, P650, DOI 10.3899/jrheum.090575; D'Agostino MA, 2005, ANN RHEUM DIS, V64, P1703, DOI 10.1136/ard.2005.037994; de Campos GC, 2013, CLIN ORTHOP RELAT R, V471, P613, DOI 10.1007/s11999-012-2659-y; DIEPPE PA, 1980, RHEUMATOL REHABIL, V19, P212, DOI 10.1093/rheumatology/19.4.212; Fingleton C, 2015, OSTEOARTHR CARTILAGE, V23, P1043, DOI 10.1016/j.joca.2015.02.163; FRIEDMAN DM, 1980, J RHEUMATOL, V7, P850; GAFFNEY K, 1995, ANN RHEUM DIS, V54, P379, DOI 10.1136/ard.54.5.379; Glass N, 2014, OSTEOARTHR CARTILAGE, V22, P1100, DOI 10.1016/j.joca.2014.06.030; Gross JB, 2014, BIO-MED MATER ENG, V24, pS17, DOI 10.3233/BME-140970; Hall M, 2014, OSTEOARTHR CARTILAGE, V22, P1627, DOI 10.1016/j.joca.2014.05.025; Hirsch G, 2013, SEMIN ARTHRITIS RHEU, V42, P451, DOI 10.1016/j.semarthrit.2012.08.005; Hochberg M C, 1996, Arthritis Care Res, V9, P170, DOI 10.1002/1529-0131(199606)9:3<170::AID-ANR1790090304>3.0.CO;2-K; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Jones A, 1996, ANN RHEUM DIS, V55, P829, DOI 10.1136/ard.55.11.829; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Juni P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005328.pub3; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; LEQUESNE MG, 1987, SCAND J RHEUMATOL, P85; Maricar N, 2013, RHEUMATOLOGY, V52, P1022, DOI 10.1093/rheumatology/kes368; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Neogi T, 2016, ARTHRITIS RHEUMATOL, V68, P654, DOI 10.1002/art.39488; O'Neill TW, 2016, ANN RHEUM DIS, V75, P84, DOI 10.1136/annrheumdis-2014-206927; Pendleton A, 2008, SCAND J RHEUMATOL, V37, P395, DOI 10.1080/03009740802050738; Rahman MM, 2013, ARTHRIT CARE RES, V65, P1951, DOI 10.1002/acr.22092; Ravaud P, 1999, ARTHRITIS RHEUM-US, V42, P475, DOI 10.1002/1529-0131(199904)42:3<475::AID-ANR12>3.0.CO;2-S; Raynauld JP, 2003, ARTHRITIS RHEUM, V48, P370, DOI 10.1002/art.10777; Richette P, 2011, ANN RHEUM DIS, V70, P139, DOI 10.1136/ard.2010.134015; Richter M., 2016, INT ORTHOP; Schumacher HR, 2005, AM J MED, V118, P1208, DOI 10.1016/j.amjmed.2005.05.003; van Middelkoop M, 2016, OSTEOARTHR CARTILAGE, V24, P1143, DOI 10.1016/j.joca.2016.01.983; Lomonte ABV, 2015, J RHEUMATOL, V42, P1677, DOI 10.3899/jrheum.150297; Wakefield RJ, 2005, J RHEUMATOL, V32, P2485; Wallace G., 2016, ARTHRITIS CARE RES H; Wang HR, 2016, SCI REP-UK, V6, DOI 10.1038/srep39672; Yavuz U, 2012, RHEUMATOL INT, V32, P3391, DOI 10.1007/s00296-011-2188-0	46	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191342	10.1371/journal.pone.0191342	http://dx.doi.org/10.1371/journal.pone.0191342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351562	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300074
J	Carolan, K; Verran, J; Crossley, M; Redfern, J; Whitton, N; Amos, M				Carolan, Kate; Verran, Joanna; Crossley, Matthew; Redfern, James; Whitton, Nicola; Amos, Martyn			Impact of educational interventions on adolescent attitudes and knowledge regarding vaccination: A pilot study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEALTH BELIEF MODEL; MMR VACCINATION; MEASLES-MUMPS; PARENTS; REFUSAL; GAME; HPV; RESISTANCE; PROMOTION	Background Current immunisation levels in England currently fall slightly below the threshold recommended by the World Health Organization, and the three-year trend for vaccination uptake is downwards. Attitudes towards vaccination can affect future decisions on whether or not to vaccinate, and this can have significant public health implications. Interventions can impact future vaccination decisions, and these interventions can take several forms. Relatively little work has been reported on the use of vaccination interventions in young people, who form the next generation of individuals likely to make vaccination decisions. Method We investigated the impact of two different types of educational intervention on attitudes towards vaccination in young people in England. A cohort of young people (n = 63) was recruited via a local school. This group was divided into three sub-groups; one (n = 21) received a presentation-based intervention, one (n = 26) received an interactive simulation-based intervention, and the third (n = 16) received no intervention. Participants supplied information on (1) their attitudes towards vaccination, and (2) their information needs and views on personal choice concerning vaccination, at three time points: immediately before and after the intervention, and after six months. Results Neither intervention had a significant effect on participants' attitudes towards vaccination. However, the group receiving the presentation-based intervention saw a sustained uplift in confidence about information needs, which was not observed in the simulation-based intervention group. Discussion Our findings with young people are consistent with previous work on vaccination interventions aimed at adults, which have shown limited effectiveness, and which can actually reduce intention to vaccinate. Our findings on the most effective mode of delivery for the intervention should inform future discussion in the growing "games for health" domain, which proposes the use of interactive digital resources in healthcare education.	[Carolan, Kate; Crossley, Matthew; Amos, Martyn] Manchester Metropolitan Univ, Sch Comp Math & Digital Technol, Manchester, Lancs, England; [Verran, Joanna; Redfern, James] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester, Lancs, England; [Whitton, Nicola] Manchester Metropolitan Univ, Fac Educ, Manchester, Lancs, England	Manchester Metropolitan University; Manchester Metropolitan University; Manchester Metropolitan University	Amos, M (corresponding author), Manchester Metropolitan Univ, Sch Comp Math & Digital Technol, Manchester, Lancs, England.	M.Amos@mmu.ac.uk	Redfern, James/AGR-6857-2022; Redfern, James/K-4638-2019	Redfern, James/0000-0003-0958-683X; Redfern, James/0000-0003-0958-683X; Amos, Martyn/0000-0003-1680-5535; Crossley, Matthew/0000-0001-5965-8147	Faculty of Science and Engineering, Manchester Metropolitan University; Society for Applied Microbiology	Faculty of Science and Engineering, Manchester Metropolitan University; Society for Applied Microbiology	KC was supported by a Ph.D. studentship from the Faculty of Science and Engineering, Manchester Metropolitan University. The development of SimFection was supported by a grant to JV from the Society for Applied Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnab S, 2013, COMPUT EDUC, V69, P15, DOI 10.1016/j.compedu.2013.06.013; Baranowski T, 2016, GAMES HEALTH J, V5, P1, DOI 10.1089/g4h.2015.0026; Bolton-Maggs D, 2012, VACCINE, V30, P5081, DOI 10.1016/j.vaccine.2012.05.078; Bond L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-943; Brown KF, 2012, VACCINE, V30, P1855, DOI 10.1016/j.vaccine.2011.12.127; Brown W, 2011, CONTRACEPTION, V83, P453, DOI 10.1016/j.contraception.2010.09.010; Carolan K, 2017, SIMFECTION A DIGITAL; Coil DA, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001984; Dale J, 2014, J MENT HEALTH, V23, P4, DOI 10.3109/09638237.2013.815336; Dannetun E, 2005, SCAND J PRIM HEALTH, V23, P149, DOI 10.1080/02813430510031306; Dube E, 2015, VACCINE, V33, P4191, DOI 10.1016/j.vaccine.2015.04.041; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; Farnsworth V, 2016, BRIT J EDUC STUD, V64, P139, DOI 10.1080/00071005.2015.1133799; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Fu LY, 2014, VACCINE, V32, P1901, DOI 10.1016/j.vaccine.2014.01.091; Gardner B, 2010, PSYCHOL HEALTH MED, V15, P220, DOI 10.1080/13548501003623963; Gowda C, 2013, HUM VACC IMMUNOTHER, V9, P437, DOI 10.4161/hv.22821; Gowda C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-509; Gross MS, 2014, OBSTET GYNECOL, V123, p114S, DOI 10.1097/01.AOG.0000447062.94587.52; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hanson JA, 2002, J NUTR EDUC BEHAV, V34, pS25, DOI 10.1016/S1499-4046(06)60308-4; Hilton S, 2013, VACCINE, V31, P2543, DOI 10.1016/j.vaccine.2013.04.023; Hobson-West P, 2003, HEALTH RISK SOC, V5, P273, DOI 10.1080/13698570310001606978; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Kato PM, 2008, PEDIATRICS, V122, pE305, DOI 10.1542/peds.2007-3134; Kennedy AM, 2005, PUBLIC HEALTH REP, V120, P252, DOI 10.1177/003335490512000306; Marek E, 2012, VACCINE, V30, P6824, DOI 10.1016/j.vaccine.2012.09.012; McCallum Simon, 2012, Stud Health Technol Inform, V177, P85; NHSDigital, 2016, NHS IMMUNISATION STA; Nyhan B, 2015, VACCINE, V33, P459, DOI 10.1016/j.vaccine.2014.11.017; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; Peretti-Watel Patrick, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289; Plotkin S.L., 2004, VACCINES-BASEL, V5, P1; Porter-Jones G, 2009, PUBLIC HEALTH, V123, P78, DOI 10.1016/j.puhe.2008.10.011; Reiter PL, 2011, CANCER EPIDEM BIOMAR, V20, P2354, DOI 10.1158/1055-9965.EPI-11-0562; Reiter PL, 2009, SOC SCI MED, V69, P475, DOI 10.1016/j.socscimed.2009.05.024; Sadaf A, 2013, VACCINE, V31, P4293, DOI 10.1016/j.vaccine.2013.07.013; Salmon DA, 2015, AM J PREV MED, V49, pS391, DOI 10.1016/j.amepre.2015.06.009; Schwartz JL, 2011, PRIMARY CARE, V38, P717, DOI 10.1016/j.pop.2011.07.009; Shapiro GK, 2014, VACCINE, V32, P6342, DOI 10.1016/j.vaccine.2014.09.045; Shourie S, 2013, VACCINE, V31, P6003, DOI 10.1016/j.vaccine.2013.10.025; Smeddinck JD, 2016, LECT NOTES COMPUT SC, V9970, P212, DOI 10.1007/978-3-319-46152-6_10; Smith PJ, 2011, PUBLIC HEALTH REP, V126, P135, DOI 10.1177/00333549111260S215; Streefland PH, 2001, HEALTH POLICY, V55, P159, DOI 10.1016/S0168-8510(00)00132-9; Thompson D, 2010, SIMULAT GAMING, V41, P587, DOI 10.1177/1046878108328087; Van Scoy LJ, 2016, J PALLIAT MED, V19, P661, DOI 10.1089/jpm.2015.0390; Verran J, 2014, J BIOL EDUC, V48, P98, DOI 10.1080/00219266.2013.849283; Viggiano A, 2015, EUR J PEDIATR, V174, P217, DOI 10.1007/s00431-014-2381-8; Wilson K, 2017, HUMAN VACCINES IMMUN, P1; WorldHealthOrganization, 1999, HEALTH21 THE HEALTH	52	7	7	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190984	10.1371/journal.pone.0190984	http://dx.doi.org/10.1371/journal.pone.0190984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351325	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000422911300035
J	Osadchii, OE				Osadchii, Oleg E.			Arrhythmogenic drugs can amplify spatial heterogeneities in the electrical restitution in perfused guinea-pig heart: An evidence from assessments of monophasic action potential durations and JT intervals	PLOS ONE			English	Article							RECTIFIER K+-CURRENT; ELECTROCARDIOGRAPHIC T-WAVE; VENTRICULAR REPOLARIZATION; TRANSMURAL DISPERSION; ANTIARRHYTHMIC-DRUGS; CHANNEL BLOCKADE; RATE DEPENDENCE; QT INTERVAL; I-KS; FLECAINIDE	Non-uniform shortening of the action potential duration (APD(90)) in different myocardial regions upon heart rate acceleration can set abnormal repolarization gradients and promote arrhythmia. This study examined whether spatial heterogeneities in APD(90) restitution can be amplified by drugs with clinically proved proarrhythmic potential (dofetilide, quinidine, procainamide, and flecainide) and, if so, whether these effects can translate to the appropriate changes of the ECG metrics of ventricular repolarization, such as JT intervals. In isolated, perfused guinea-pig heart preparations, monophasic action potentials and volume-conducted ECG were recorded at progressively increased pacing rates. The APD(90) measured at distinct ventricular sites, as well as the JTpeak and JTend values were plotted as a function of preceding diastolic interval, and the maximum slopes of the restitution curves were determined at baseline and upon drug administration. Dofetilide, quinidine, and procainamide reverse rate-dependently prolonged APD(90) and steepened the restitution curve, with effects being greater at the endocardium than epicardium, and in the right ventricular (RV) vs. the left ventricular (LV) chamber. The restitution slope was increased to a greater extent for the JTend vs. the JTpeak interval. In contrast, flecainide reduced the APD(90) restitution slope at LV epicardium without producing effect at LV endocardium and RV epicardium, and reduced the JTpeak restitution slope without changing the JTend restitution. Nevertheless, with all agents, these effects translated to the amplified epicardial-to-endocardial and the LV-to-RV non-uniformities in APD(90) restitution, paralleled by the increased JTend vs. JTpeak difference in the restitution slope. In summary, these findings suggest that arrhythmic drug profiles are partly attributable to the accentuated regional heterogeneities in APD(90) restitution, which can be indirectly determined through ECG assessments of the JTend vs. JTpeak dynamics at variable pacing rates.	[Osadchii, Oleg E.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Osadchii, Oleg E.] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark	University of Copenhagen; Aalborg University	Osadchii, OE (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.; Osadchii, OE (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark.	osadchiy@hst.aau.dk		Osadchii, Oleg/0000-0003-0222-3227	Department of Health Science and Technology, University of Aalborg	Department of Health Science and Technology, University of Aalborg	This work was supported by the Department of Health Science and Technology, University of Aalborg. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author appreciates financial support from the Department of Health Science and Technology, University of Aalborg.	Abi-Gerges N, 2004, FUND CLIN PHARMACOL, V18, P139, DOI 10.1111/j.1472-8206.2004.00230.x; ANASTASIOUNANA MI, 1987, AM HEART J, V113, P1071, DOI 10.1016/0002-8703(87)90914-8; [Anonymous], 1989, NEW ENGL J MED, V321, P406; Banville I, 2002, J CARDIOVASC ELECTR, V13, P1141, DOI 10.1046/j.1540-8167.2002.01141.x; Benton RE, 2000, CLIN PHARMACOL THER, V67, P413, DOI 10.1067/mcp.2000.105761; Bryant SM, 1998, CARDIOVASC RES, V40, P322, DOI 10.1016/S0008-6363(98)00133-3; Chiamvimonvat N, 2017, J PHYSIOL-LONDON, V595, P2229, DOI 10.1113/JP272883; Clayton RH, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-54; CONARD GJ, 1984, AM J CARDIOL, V53, pB41, DOI 10.1016/0002-9149(84)90501-0; Crow RS, 2003, CIRCULATION, V108, P1985, DOI 10.1161/01.CIR.0000095027.28753.9D; Dorenkamp M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054768; Dorian P, 2000, EUROPACE, V2, P277, DOI 10.1053/eupc.2000.0114; Eisner DA, 2009, EXP PHYSIOL, V94, P520, DOI 10.1113/expphysiol.2008.044008; Frommeyer G, 2016, NAT REV CARDIOL, V13, P36, DOI 10.1038/nrcardio.2015.110; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Goldhaber JI, 2005, CIRC RES, V96, P459, DOI 10.1161/01.RES.0000156891.66893.83; Grom A, 2005, EUROPACE, V7, P113, DOI 10.1016/j.eupc.2005.01.001; Higgins AY, 2015, AM J CARDIOL, V116, P1845, DOI 10.1016/j.amjcard.2015.09.042; Hilliard FA, 2010, J MOL CELL CARDIOL, V48, P293, DOI 10.1016/j.yjmcc.2009.10.005; Izumi D, 2012, HEART RHYTHM, V9, P796, DOI 10.1016/j.hrthm.2011.11.046; Jost N, 2005, CIRCULATION, V112, P1392, DOI 10.1161/CIRCULATIONAHA.105.550111; JURKIEWICZ NK, 1993, CIRC RES, V72, P75, DOI 10.1161/01.RES.72.1.75; KARAGUEUZIAN HS, 1993, CIRCULATION, V87, P1661, DOI 10.1161/01.CIR.87.5.1661; KOCHWESER J, 1971, J AMER MED ASSOC, V215, P1454, DOI 10.1001/jama.215.9.1454; KURZ RW, 1994, EUR HEART J, V15, P547, DOI 10.1093/oxfordjournals.eurheartj.a060541; Laurita KR, 1998, CIRCULATION, V98, P2774, DOI 10.1161/01.CIR.98.24.2774; Laurita KR, 1996, CIRC RES, V79, P493, DOI 10.1161/01.RES.79.3.493; Matthews GDK, 2013, J PHYSIOL-LONDON, V591, P4167, DOI 10.1113/jphysiol.2013.254938; Meijborg VMF, 2014, CIRC-ARRHYTHMIA ELEC, V7, P524, DOI 10.1161/CIRCEP.113.001622; Melgari D, 2015, J MOL CELL CARDIOL, V86, P42, DOI 10.1016/j.yjmcc.2015.06.021; MILNER PG, 1985, AM J CARDIOL, V56, P588, DOI 10.1016/0002-9149(85)91016-1; Minchole A, 2011, IEEE T BIO-MED ENG, V58, P1172, DOI 10.1109/TBME.2010.2097597; Mounsey JP, 2000, CIRCULATION, V102, P2665; Narayan SM, 2007, J AM COLL CARDIOL, V50, P2385, DOI 10.1016/j.jacc.2007.10.011; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Ng GA, 2009, HEART RHYTHM, V6, P696, DOI 10.1016/j.hrthm.2009.01.035; Nicolson WB, 2014, HEART, V100, P1878, DOI 10.1136/heartjnl-2014-305672; Opthof T, 2007, HEART RHYTHM, V4, P341, DOI 10.1016/j.hrthm.2006.11.022; Osadchii O, 2007, PHARMACOL RES, V55, P287, DOI 10.1016/j.phrs.2006.12.005; Osadchii OE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172683; Osadchii OE, 2014, SCAND CARDIOVASC J, V48, P357, DOI 10.3109/14017431.2014.976256; Osadchii OE, 2014, FUND CLIN PHARMACOL, V28, P382, DOI 10.1111/fcp.12046; Osadchii OE, 2013, CAN J PHYSIOL PHARM, V91, P306, DOI 10.1139/cjpp-2012-0379; Osadchii OE, 2012, CARDIOVASC DRUG THER, V26, P489, DOI 10.1007/s10557-012-6405-1; Osaka T, 2011, J CARDIOVASC ELECTR, V22, P669, DOI 10.1111/j.1540-8167.2010.01990.x; Pak HN, 2004, J CARDIOVASC ELECTR, V15, P1357, DOI 10.1046/j.1540-8167.2004.03569.x; PANIDIS IP, 1983, J AM COLL CARDIOL, V2, P798, DOI 10.1016/S0735-1097(83)80225-3; Pedersen HS, 2007, AM J CARDIOL, V100, P876, DOI 10.1016/j.amjcard.2007.04.020; Ridley JM, 2003, BIOCHEM BIOPH RES CO, V306, P388, DOI 10.1016/S0006-291X(03)00980-X; RODEN DM, 1988, CIRC RES, V62, P1055, DOI 10.1161/01.RES.62.5.1055; Sabir IN, 2008, PFLUG ARCH EUR J PHY, V455, P637, DOI 10.1007/s00424-007-0326-z; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Shattock MJ, 2017, CARDIOVASC RES, V113, P817, DOI 10.1093/cvr/cvx063; Soltysinska E, 2011, PFLUG ARCH EUR J PHY, V462, P529, DOI 10.1007/s00424-011-1005-7; STRASBERG B, 1981, AM J CARDIOL, V47, P1309, DOI 10.1016/0002-9149(81)90264-2; Tsai SF, 2014, HEART RHYTHM, V11, P485, DOI 10.1016/j.hrthm.2013.11.017; VARRO A, 1993, BASIC RES CARDIOL, V88, P93; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; VONSAVIGNY L, 1981, BASIC RES CARDIOL, V76, P276; Wang DW, 1996, J MOL CELL CARDIOL, V28, P893, DOI 10.1006/jmcc.1996.0084; Warren M, 2003, J CARDIOVASC ELECTR, V14, P621, DOI 10.1046/j.1540-8167.2003.03006.x; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Weiss JN, 2005, CIRCULATION, V112, P1232, DOI 10.1161/CIRCULATIONAHA.104.529545; Weiss JN, 1999, CIRCULATION, V99, P2819, DOI 10.1161/01.CIR.99.21.2819; Wu S, 2005, J CARDIOVASC ELECTR, V16, P872, DOI 10.1111/j.1540-8167.2005.40811.x; Xia YL, 2005, HEART RHYTHM, V2, P162, DOI 10.1016/j.hrthm.2004.11.011; Yan GX, 1998, CIRCULATION, V98, P1928, DOI 10.1161/01.CIR.98.18.1928; Yue AM, 2005, J AM COLL CARDIOL, V46, P1067, DOI 10.1016/j.jacc.2005.05.074; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140; Zulqarnain MA, 2015, AM J CARDIOL, V116, P74, DOI 10.1016/j.amjcard.2015.03.038	70	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191514	10.1371/journal.pone.0191514	http://dx.doi.org/10.1371/journal.pone.0191514			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352276	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300106
J	Tran, BX; Nguyen, LH; Tran, TT; Latkin, CA				Bach Xuan Tran; Long Hoang Nguyen; Tung Thanh Tran; Latkin, Carl A.			Social and structural barriers for adherence to methadone maintenance treatment among Vietnamese opioid dependence patients	PLOS ONE			English	Article							ADMINISTERED ANTIRETROVIRAL THERAPY; INJECTION-DRUG USERS; QUALITY-OF-LIFE; MEDICATION ADHERENCE; COST-EFFECTIVENESS; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; SERVICE UTILIZATION; INTERNET ADDICTION; RISK BEHAVIORS	Introduction Methadone maintenance treatment (MMT) services may reduce the risk of HIV transmission if patients completely adhere to the treatment. Identifying adherence patterns and potential related factors is vital for the sustainability of MMT program in Vietnam. This study examined social and structural factors associated with adherence to MMT among patients in different service delivery models. Materials and methods A total of 510 patients at three MMT clinics in Hanoi were interviewed. Measures of self-reported adherence included the number of missed doses in the past 7 days and the level of adherence in the past 30 days using a visual analog scale (VAS) scoring from 0 (non-adherence) to 100 (perfect adherence). Multivariate regressions were employed to identify factors associated with non-adherence to MMT. Results A total of 17.7% of participants reported incomplete MMT adherence in the last 30 days and 8.3% reported missing a dose in the last seven days, respectively. Living with HIV/AIDS, poor self-care and usual activities, and disclosure of health issues to spouses or intimate partners were associated with non-adherence. Those patients with pain or depression were more likely to report better adherence. Disclosing health status to spouse/partner increased the risk of incomplete adherence, while disclosing to friends reduced the number of missed dose in the last seven days. Patients attending clinics with comprehensive services had a lower VAS score of adherence compared to those enrolling in clinics with only MMT and general health care. Conclusions Sustaining the compliance of patients to MMT is principal in the rapid expansion of this service in Vietnam. It is necessary to address the complexity of health care demands of drug users, their difficulties to be rehabilitated into workforce and society, and the stigmatization to maximize the outcomes of MMT program.	[Bach Xuan Tran] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Bach Xuan Tran; Latkin, Carl A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Long Hoang Nguyen] Vietnam Natl Univ, Sch Med & Pharm, Hanoi, Vietnam; [Tung Thanh Tran] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam	Hanoi Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Vietnam National University Hanoi; Duy Tan University	Tran, BX (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.; Tran, BX (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	bach.jhu@gmail.com						Tran BX, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2405-y; Tran BX, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3983-z; Tran BX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168687; Tran BX, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0485-8; Tran BX, 2016, HARM REDUCT J, V13, DOI 10.1186/s12954-016-0091-4; Tran BX, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-132; Tran BX, 2012, GLOB PUBLIC HEALTH, V7, P1080, DOI 10.1080/17441692.2012.736259; Tran BX, 2012, AIDS CARE, V24, P283, DOI 10.1080/09540121.2011.608420; Barclay TR, 2007, HEALTH PSYCHOL, V26, P40, DOI 10.1037/0278-6133.26.1.40; Boyd J, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0159-9; Control VAoHA, 2015, ANN REV HIV AIDS CON; Control VAoHA, 2016, ANN REV HIV AIDS CON; Dima AL, 2014, SOC SCI MED, V108, P166, DOI 10.1016/j.socscimed.2014.02.045; Fekete EM, 2009, BRAIN BEHAV IMMUN, V23, P693, DOI 10.1016/j.bbi.2009.01.007; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Greenwald MK, 2002, EXP CLIN PSYCHOPHARM, V10, P39, DOI 10.1037//1064-1297.10.1.39; Haskew M, 2008, J SUBST ABUSE TREAT, V35, P109, DOI 10.1016/j.jsat.2007.08.013; Havens JR, J SUBSTANCE ABUSE TR, V36, P306; Herget Greg, 2005, HIV AIDS Policy Law Rev, V10, P23; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kermode M, 2011, B WORLD HEALTH ORGAN, V89, P243, DOI 10.2471/BLT.11.086850; Khalsa JH, 2010, AM J ADDICTION, V19, P96, DOI 10.1111/j.1521-0391.2009.00010.x; Larance B, 2012, NONADHERENCE OPIOID; Latkin CA, 1999, AM J DRUG ALCOHOL AB, V25, P463, DOI 10.1081/ADA-100101873; Latkin CA, 2016, AIDS EDUC PREV, V28, P417, DOI 10.1521/aeap.2016.28.5.417; Lin CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132589; Nguyen LH, 2017, SUBST ABUSE TREAT PR, V12, DOI 10.1186/s13011-017-0115-4; Nguyen LH, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0633-9; Lucas GM, 2004, CLIN INFECT DIS, V38, pS409, DOI 10.1086/421405; Lucas GM, 2007, AIDS PATIENT CARE ST, V21, P564, DOI 10.1089/apc.2006.0192; McCance-Katz EF, 1998, J ACQ IMMUN DEF SYND, V18, P435, DOI 10.1097/00042560-199808150-00004; Milloy MJS, 2012, AIDS, V26, P1049, DOI 10.1097/QAD.0b013e32835221cc; Musa R, 2012, ASIA-PAC J PUBLIC HE, V24, P826, DOI 10.1177/1010539511404396; National Committee for AIDS DaPPaC, 2012, NAT STRAT HIV AIDS P; Nguyen LH, 2015, AIDS BEHAV; Nguyen LH, 2017, AIDS BEHAV; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Pharmacists OCo, 2014, METH MAINT TREATM MM; Raffa JD, DRUG ALCOHOL DEPENDE, V89, P306; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Rao R, 2013, B WORLD HEALTH ORGAN, V91, P150, DOI 10.2471/BLT.12.111815; Riegel B, 2009, EUR J CARDIOVASC NUR, V8, P337, DOI 10.1016/j.ejcnurse.2009.06.003; Rotzinger A, PATIENT ED COUNSELIN, V99, P1413; Roux P, 2014, CURR PHARM DESIGN, V20, P4097, DOI 10.2174/13816128113199990623; Serovich JM, 2008, AIDS BEHAV, V12, P227, DOI 10.1007/s10461-007-9295-7; Shen JC, 2016, J ADDICT MED, V10, P40, DOI 10.1097/ADM.0000000000000180; Tran BX, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2897-0; Tran Bach Xuan, 2013, Int J Drug Policy, V24, pe105, DOI 10.1016/j.drugpo.2013.07.007; Tran BX, 2012, DRUG ALCOHOL DEPEN, V125, P260, DOI 10.1016/j.drugalcdep.2012.02.021; Tran BX, 2016, PLOS ONE, V11; Tran BX, 2015, PLOS ONE, V10; Tran BX, 2012, PLOS ONE, V7; Hoang TV, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0075-9; Ushie BA, 2012, AIDS PATIENT CARE ST, V26, P674, DOI 10.1089/apc.2011.0304; Van Nguyen H, 2017, HARM REDUCT J, V14; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; WHO Office for Europe, 2012, PRACT GUID TOOLK IMP; Wolff K, 2002, THER DRUG MONIT, V24, P457, DOI 10.1097/00007691-200208000-00001; Wong KH, 2003, J SUBST ABUSE TREAT, V24, P233, DOI 10.1016/S0740-5472(03)00029-1; Yang F, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-3; Zhang MWB, 2017, ASIAN J PSYCHIATR, V28, P15, DOI 10.1016/j.ajp.2017.03.025; Zhang MWB, 2017, HEALTHC INFORM RES, V23, P109, DOI 10.4258/hir.2017.23.2.109; Zhao M, 2015, TXB ADDICTION TREATM, P531; Zhou KN, 2017, J ADDICT MED, V11, P28, DOI 10.1097/ADM.0000000000000263; Zhou KN, 2014, ADDICT BEHAV, V39, P22, DOI 10.1016/j.addbeh.2013.09.001	65	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190941	10.1371/journal.pone.0190941	http://dx.doi.org/10.1371/journal.pone.0190941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9PC	29346444	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500022
J	Gifford, SC; Strachan, BC; Xia, H; Voros, E; Torabian, K; Tomasino, TA; Griffin, GD; Lichtiger, B; Aung, FM; Shevkoplyas, SS				Gifford, Sean C.; Strachan, Briony C.; Xia, Hui; Voros, Eszter; Torabian, Kian; Tomasino, Taylor A.; Griffin, Gary D.; Lichtiger, Benjamin; Aung, Fleur M.; Shevkoplyas, Sergey S.			A portable system for processing donated whole blood into high quality components without centrifugation	PLOS ONE			English	Article							RED-CELL STORAGE; PLATELET-RICH PLASMA; TRANSFUSION; ACTIVATION; LESION; INFLAMMATION; FILTRATION; APHERESIS; COMPLEX; FRESH	Background The use of centrifugation-based approaches for processing donated blood into components is routine in the industrialized world, as disparate storage conditions require the rapid separation of 'whole blood' into distinct red blood cell (RBC), platelet, and plasma products. However, the logistical complications and potential cellular damage associated with centrifugation/apheresis manufacturing of blood products are well documented. The objective of this study was to evaluate a proof-of-concept system for whole blood processing, which does not employ electromechanical parts, is easily portable, and can be operated immediately after donation with minimal human labor. Methods and findings In a split-unit study (n = 6), full (similar to 500mL) units of freshly-donated whole blood were divided, with one half processed by conventional centrifugation techniques and the other with the new blood separation system. Each of these processes took 2-3 hours to complete and were performed in parallel. Blood products generated by the two approaches were compared using an extensive panel of cellular and plasma quality metrics. Comparison of nearly all RBC parameters showed no significant differences between the two approaches, although the portable system generated RBC units with a slight but statistically significant improvement in 2,3-diphosphoglyceric acid concentration (p < 0.05). More notably, several markers of platelet damage were significantly and meaningfully higher in products generated with conventional centrifugation: the increase in platelet activation (assessed via P-selectin expression in platelets before and after blood processing) was nearly 4-fold higher for platelet units produced via centrifugation, and the release of pro-inflammatory mediators (soluble CD40-ligand, thromboxane B2) was significantly higher for centrifuged platelets as well (p < 0.01). Conclusion This study demonstrated that a simple, passive system for separating donated blood into components may be a viable alternative to centrifugation-particularly for applications in remote or resource-limited settings, or for patients requiring highly functional platelet product.	[Gifford, Sean C.] Halcyon Biomed Inc, Friendswood, TX USA; [Strachan, Briony C.; Xia, Hui; Voros, Eszter; Torabian, Kian; Tomasino, Taylor A.; Shevkoplyas, Sergey S.] Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA; [Griffin, Gary D.; Lichtiger, Benjamin; Aung, Fleur M.] MD Anderson Canc Ctr, Dept Lab Med, Sect Transfus Med, Blood Donor Ctr, Houston, TX USA	University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center	Shevkoplyas, SS (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA.	sshevkoplyas@uh.edu	Xia, Hui/F-5052-2016	Xia, Hui/0000-0002-3547-4631; Shevkoplyas, Sergey/0000-0002-8203-8365	U.S. Army [W81XWH-11-C-0008]; National Institutes of Health Director's Transformative Research Award (National Heart, Lung, and Blood Institute) [R01HL117329]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117329] Funding Source: NIH RePORTER	U.S. Army(United States Department of DefenseUnited States Army); National Institutes of Health Director's Transformative Research Award (National Heart, Lung, and Blood Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a Small Business Technology Transfer award from the U.S. Army (W81XWH-11-C-0008; CORs: Dr. Jill Sondeen, Dr. Daniel Darlington; PI: S.C.G.), and a 2012 National Institutes of Health Director's Transformative Research Award (National Heart, Lung, and Blood Institute R01HL117329, PI: S.S. S.). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S.C.G. and S.S.S. are part-owners of Halcyon Biomedical Incorporated, a startup company which would benefit from commercialization of the technology described in this manuscript. This funder provided support in the form of salaries for authors S.C.G. and S.S.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Basu D, 2014, INDIAN J ANAESTH, V58, P529, DOI 10.4103/0019-5049.144647; Bennett-Guerrero E, 2014, TRANSFUSION, V54, P2544, DOI 10.1111/trf.12660; Bianchi M, 2016, BLOOD TRANSFUS-ITALY, V14, P214, DOI 10.2450/2015.0154-15; Brune T, 2009, ADV HEMATOL, V2009; Brune T, 2007, TRANSFUSION, V47, P2271, DOI 10.1111/j.1537-2995.2007.01456.x; Cauwenberghs S, 2007, TRANSFUS MED REV, V21, P287, DOI 10.1016/j.tmrv.2007.05.004; Cholette JM, 2012, PEDIATR CRIT CARE ME, V13, P290, DOI 10.1097/PCC.0b013e31822f173c; Doctor A, 2012, SEMIN PERINATOL, V36, P248, DOI 10.1053/j.semperi.2012.04.005; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; Duck FA, 2013, PHYS PROPERTIES TISS; Fung MK, 2014, TECHNICAL MANUAL, V18th; Garraud O, 2017, J THORAC DIS, V9, pE146, DOI 10.21037/jtd.2017.02.03; Garraud O, 2017, TRANSFUS APHER SCI, V56, P98, DOI 10.1016/j.transci.2016.12.030; Getz TM, 2016, TRANSFUSION, V10, P13511; Ghandforoush P, 2010, DECIS SUPPORT SYST, V50, P32, DOI 10.1016/j.dss.2010.06.005; Gifford SC, 2014, LAB CHIP, V14, P4496, DOI 10.1039/c4lc00785a; Hendrickson JE, 2009, ANESTH ANALG, V108, P759, DOI 10.1213/ane.0b013e3181930a6e; Hess JR, 2014, VOX SANG, V107, P1, DOI 10.1111/vox.12130; Hess JR, 2011, TRANSFUSION, V51, p1S, DOI 10.1111/j.1537-2995.2010.02956.x; Hess JR, 2003, TRANSFUSION, V43, P1622, DOI 10.1046/j.1537-2995.2003.00576.x; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Hornsey VS, 2005, VOX SANG, V89, P81, DOI 10.1111/j.1423-0410.2005.00660.x; Huang R, 2008, PRENATAL DIAG, V28, P892, DOI 10.1002/pd.2079; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kim-Shapiro DB, 2011, TRANSFUSION, V51, P844, DOI 10.1111/j.1537-2995.2011.03100.x; LaLonde A, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4936371; Levin E, 2008, TRANSFUSION, V48, P2331, DOI 10.1111/j.1537-2995.2008.01836.x; Leytin V, 2004, TRANSFUSION, V44, P1487, DOI 10.1111/j.1537-2995.2004.04042.x; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Medicines EDftQo, 2013, HEALTHCARE GUID PREP; Metcalfe P, 1997, BRIT J HAEMATOL, V98, P86, DOI 10.1046/j.1365-2141.1997.1572983.x; Nobili M, 2008, ASAIO J, V54, P64, DOI 10.1097/MAT.0b013e31815d6898; Ooley P, 2015, STANDARDS BLOOD BANK; Pagana K.D., 2013, MOSBYS MANUAL DIAGNO; Paniccia R, 2015, VASC HEALTH RISK MAN, V11, P133, DOI 10.2147/VHRM.S44469; Piacentini N, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3640045; Pierskalla WP, 2005, SUPPLY CHAIN MANAG, P103; Pribush A, 2010, COLLOID SURFACE B, V75, P224, DOI 10.1016/j.colsurfb.2009.08.037; Pribush A, 2010, COLLOID SURFACE B, V75, P214, DOI 10.1016/j.colsurfb.2009.08.036; Rapido F, 2017, J CLIN INVEST, V127, P375, DOI 10.1172/JCI90837; Reinhart WH, 2015, TRANSFUSION, V55, P1872, DOI 10.1111/trf.13052; Roback JD, 2016, VOX SANG, V111, P357, DOI 10.1111/vox.12441; Schrezenmeier H, 2010, VOX SANG, V99, P1, DOI 10.1111/j.1423-0410.2009.01295.x; Skripchenko A, 2008, TRANSFUSION, V48, P1469, DOI 10.1111/j.1537-2995.2008.01733.x; Smith SA, 2015, CRIT REV BIOCHEM MOL, V50, P326, DOI 10.3109/10409238.2015.1050550; Sohrabi S, 2017, ARTIFICIAL ORGANS; Tynngard N, 2009, TRANSFUS APHER SCI, V41, P97, DOI 10.1016/j.transci.2009.07.001; van der Meer PF, 2016, TRANSFUSION MED, V26, P339, DOI 10.1111/tme.12325; van der Meer PF, 2013, TRANSFUS APHER SCI, V48, P129, DOI 10.1016/j.transci.2013.02.004; Vo TD, 2001, TRANSFUSION MED, V11, P45, DOI 10.1046/j.1365-3148.2001.00280.x; Whitaker B. I., 2015, 2013 AABB BLOOD COLL; Wong AP, 2008, LAB CHIP, V8, P2032, DOI 10.1039/b809830c; Xia H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35943; Zaheer HA, 2016, TRANSFUS APHER SCI, V55, P186, DOI 10.1016/j.transci.2016.09.007; Zhang JN, 2002, THROMB HAEMOSTASIS, V88, P817, DOI 10.1055/s-0037-1613308; Zhang ZY, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3659016; Zimring JC, 2015, BLOOD, V125, P2185, DOI 10.1182/blood-2014-11-567750	57	9	9	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190827	10.1371/journal.pone.0190827	http://dx.doi.org/10.1371/journal.pone.0190827			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346441	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500018
J	Liu, MJ; Ma, LY; Chou, WJ; Chen, YM; Liu, TL; Hsiao, RC; Hu, HF; Yen, CF				Liu, Meng-Jung; Ma, Le-Yin; Chou, Wen-Jiun; Chen, Yu-Min; Liu, Tai-Ling; Hsiao, Ray C.; Hu, Huei-Fan; Yen, Cheng-Fang			Effects of theory of mind performance training on reducing bullying involvement in children and adolescents with high functioning autism spectrum disorder	PLOS ONE			English	Article							CHINESE VERSION; SCHOOL; PREVALENCE; YOUTH	Bullying involvement is prevalent among children and adolescents with autism spectrum disorder (ASD). This study examined the effects of theory of mind performance training (ToMPT) on reducing bullying involvement in children and adolescents with high-functioning ASD. Children and adolescents with high-functioning ASD completed ToMPT (n = 26) and social skills training (SST; n = 23) programs. Participants in both groups and their mothers rated the pretraining and posttraining bullying involvement of participants on the Chinese version of the School Bullying Experience Questionnaire. The paired t test was used to evaluate changes in bullying victimization and perpetration between the pretraining and post training assessments. Furthermore, the linear mixed-effect model was used to examine the difference in the training effect between the ToMPT and SST groups. The paired ttest indicated that in the ToMPT group, the severities of both self-reported (p = .039) and mother reported (p = .003) bullying victimization significantly decreased from the pretraining to post training assessments, whereas in the SST group, only self-reported bullying victimization significantly decreased (p = .027). The linear mixed-effect model indicated that compared with the SST program, the ToMPT program significantly reduced the severity of mother reported bullying victimization (p = .041). The present study supports the effects of ToMPT on reducing mother-reported bullying victimization in children and adolescents with high functioning ASD.	[Liu, Meng-Jung; Ma, Le-Yin] Natl Kaohsiung Normal Univ, Dept Special Educ, Kaohsiung, Taiwan; [Chou, Wen-Jiun] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Child & Adolescent Psychiat, Kaohsiung, Taiwan; [Chou, Wen-Jiun] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Yu-Min; Liu, Tai-Ling; Yen, Cheng-Fang] Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Liu, Tai-Ling; Yen, Cheng-Fang] Kaohsiung Med Univ, Sch Med, Dept Psychiat, Kaohsiung, Taiwan; [Liu, Tai-Ling; Yen, Cheng-Fang] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Hsiao, Ray C.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA USA; [Hsiao, Ray C.] Childrens Hosp, Dept Psychiat, Seattle, WA USA; [Hu, Huei-Fan] Tainan Municipal Hosp, Dept Psychiat, Tainan, Taiwan	National Kaohsiung Normal University; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Yen, CF (corresponding author), Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan.; Yen, CF (corresponding author), Kaohsiung Med Univ, Sch Med, Dept Psychiat, Kaohsiung, Taiwan.; Yen, CF (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.; Hu, HF (corresponding author), Tainan Municipal Hosp, Dept Psychiat, Tainan, Taiwan.	cych07205@gmail.com; chfaye@cc.kmu.edu.tw		Liu, Meng-Jung/0000-0002-5433-8029	National Science Council, Taiwan, R.O.C. [NSC 102-2628-B-037-007-MY3]	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This study was supported by the grant NSC 102-2628-B-037-007-MY3 awarded by the National Science Council, Taiwan, R.O.C. (http://statistics.most.gov.tw/was2/award/AsAwardMulitiQuery.aspx). The funder had no role in study design, data collection and analysis,	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P285, DOI 10.1111/j.1469-7610.1989.tb00241.x; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Capage L., 2001, EARLY EDUC DEV, V12, P613, DOI [DOI 10.1207/S15566935EED1204_7, 10.1207=s15566935eed1204_7]; Cappadocia MC, 2012, J AUTISM DEV DISORD, V42, P266, DOI 10.1007/s10803-011-1241-x; Caravita SCS, 2010, J EARLY ADOLESCENCE, V30, P138, DOI 10.1177/0272431609342983; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Frith U., 2004, AUTISM MIND BRAIN; Gau SSF, 2013, RES AUTISM SPECT DIS, V7, P349, DOI 10.1016/j.rasd.2012.10.004; Hadwin J, 1997, J AUTISM DEV DISORD, V27, P519, DOI 10.1023/A:1025826009731; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Haq I., 2004, MEDICINE, V32, P61, DOI [10.1383/medc.32.8.61.43165, DOI 10.1383/MEDC.32.8.61.43165]; Howlin P, 1998, TEACHING CHILDREN AU; Hughes C, 2004, SOC DEV, V13, P590, DOI 10.1111/j.1467-9507.2004.00285.x; LESLIE AM, 1988, BRIT J DEV PSYCHOL, V6, P315, DOI 10.1111/j.2044-835X.1988.tb01104.x; Liu M, 2010, UNWRITTEN SOCIAL RUL; Maiano C, 2016, AUTISM RES, V9, P601, DOI 10.1002/aur.1568; MARTLEW M, 1991, BRIT J EDUC PSYCHOL, V61, P355, DOI 10.1111/j.2044-8279.1991.tb00992.x; Matson JL, 2007, RES DEV DISABIL, V28, P567, DOI 10.1016/j.ridd.2006.08.001; Mayes SD, 2013, RES AUTISM SPECT DIS, V7, P109, DOI 10.1016/j.rasd.2012.07.009; Mikami K, 2009, GEN HOSP PSYCHIAT, V31, P163, DOI 10.1016/j.genhosppsych.2008.12.003; Montes G, 2007, AMBUL PEDIATR, V7, P253, DOI 10.1016/j.ambp.2007.02.003; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Sterzing P. R., 2012, ARCH PEDIAT ADOL MED, V3, P1; Sterzing PR, 2012, ARCH PEDIAT ADOL MED, V166, P1058, DOI 10.1001/archpediatrics.2012.790; Sutton J, 1999, BRIT J DEV PSYCHOL, V17, P435, DOI 10.1348/026151099165384; van Roekel E, 2010, J AUTISM DEV DISORD, V40, P63, DOI 10.1007/s10803-009-0832-2; Wechsler DW., 1999, INTELLIGENCE SCALE C; Whitney I., 1992, SUPPORT LEARNING, V7, P3, DOI DOI 10.1111/J.1467-9604.1992.TB00445.X; Yen CF, 2012, KAOHSIUNG J MED SCI, V28, P500, DOI 10.1016/j.kjms.2012.04.008; 김영신, 2001, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V40, P867	32	11	12	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191271	10.1371/journal.pone.0191271	http://dx.doi.org/10.1371/journal.pone.0191271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8II	29342210	gold, Green Submitted, Green Published			2022-12-27	WOS:000422653800058
J	Furukawa, K; Ishida, F; Tsuji, M; Miura, Y; Kishimoto, T; Shiba, M; Tanemura, H; Umeda, Y; Sano, T; Yasuda, R; Shimosaka, S; Suzuki, H				Furukawa, Kazuhiro; Ishida, Fujimaro; Tsuji, Masanori; Miura, Yoichi; Kishimoto, Tomoyuki; Shiba, Masato; Tanemura, Hiroshi; Umeda, Yasuyuki; Sano, Takanori; Yasuda, Ryuta; Shimosaka, Shinichi; Suzuki, Hidenori			Hemodynamic characteristics of hyperplastic remodeling lesions in cerebral aneurysms	PLOS ONE			English	Article							HUMAN CAROTID BIFURCATION; WALL SHEAR-STRESS; PULSATILE FLOW; TIME	Background & purpose Hyperplastic remodeling (HR) lesions are sometimes found on cerebral aneurysm walls. Atherosclerosis is the results of HR, which may cause an adverse effect on surgical treatment for cerebral aneurysms. Previous studies have demonstrated that atherosclerotic changes had a correlation with certain hemodynamic characteristics. Therefore, we investigated local hemodynamic characteristics of HR lesions of cerebral aneurysms using computational fluid dynamics (CFD). Methods Twenty-four cerebral aneurysms were investigated using CFD and intraoperative video recordings. HR lesions and red walls were confirmed on the intraoperative images, and the qualification points were determined on the center of the HR lesions and the red walls. The qualification points were set on the virtual operative images for evaluation of wall shear stress (WSS), normalized WSS (NWSS), oscillatory shear index (OSI), relative residence time (RRT), and aneurysm formation indicator (AFI). These hemodynamic parameters at the qualification points were compared between HR lesions and red walls. Results HR lesions had lower NWSS, lower AFI, higher OSI and prolonged RRT compared with red walls. From analysis of the receiver-operating characteristic curve for hemodynamic parameters, OSI was the most optimal hemodynamic parameter to predict HR lesions (area under the curve, 0.745; 95% confidence interval, 0.603-0.887; cutoff value, 0.00917; sensitivity, 0.643; specificity, 0.893; P<0.01). With multivariate logistic regression analyses using stepwise method, NWSS was significantly associated with the HR lesions. Conclusions Although low NWSS was independently associated with HR lesions, OSI is the most valuable hemodynamic parameter to distinguish HR lesions from red walls.	[Furukawa, Kazuhiro; Tsuji, Masanori; Shiba, Masato; Umeda, Yasuyuki; Yasuda, Ryuta; Suzuki, Hidenori] Mie Univ, Grad Sch Med, Dept Neurosurg, Tsu, Mie, Japan; [Ishida, Fujimaro; Kishimoto, Tomoyuki; Shimosaka, Shinichi] Natl Hosp Org, Mie Chuo Med Ctr, Dept Neurosurg, Tsu, Mie, Japan; [Miura, Yoichi] Suzuka Kaisei Hosp, Dept Neurosurg, Suzuka, Mie, Japan; [Tanemura, Hiroshi; Sano, Takanori] Ise Red Cross Hosp, Dept Neurosurg, Ise, Mie, Japan	Mie University	Furukawa, K (corresponding author), Mie Univ, Grad Sch Med, Dept Neurosurg, Tsu, Mie, Japan.	k.furukawa0328@me.com		Furukawa, Kazuhiro/0000-0001-5744-8306	Grants-in-Aid for Scientific Research [17K10825] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amaya R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166569; Arzani A, 2017, BIOMECH MODEL MECHAN, V16, P787, DOI 10.1007/s10237-016-0853-7; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Fukazawa K, 2015, WORLD NEUROSURG, V83, P80, DOI 10.1016/j.wneu.2013.02.012; Furukawa K, 2015, PROGR COMPUTED IMAGI, V36, P73; Himburg HA, 2004, AM J PHYSIOL-HEART C, V286, pH1916, DOI 10.1152/ajpheart.00897.2003; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Lu X, 2004, J PHYSIOL-LONDON, V561, P575, DOI 10.1113/jphysiol.2004.075218; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Mantha A, 2006, AM J NEURORADIOL, V27, P1113; Miura Y, 2013, STROKE, V44, P519, DOI 10.1161/STROKEAHA.112.675306; Papaharilaou Y, 2013, MED BIOL ENG COMPUT, V51, P207, DOI 10.1007/s11517-012-0985-6; Park Chang Kyu, 2014, J Cerebrovasc Endovasc Neurosurg, V16, P247, DOI 10.7461/jcen.2014.16.3.247; Sakarunchai I, 2015, J STROKE CEREBROVASC, V24, P2497, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.032; Soulis JV, 2016, CARDIOL RES, V7, P66, DOI 10.14740/cr467w; Sugiyama S, 2013, NEUROSURGERY, V73, P767, DOI 10.1227/NEU.0000000000000096; Szelenyi A, 2011, CLIN NEUROL NEUROSUR, V113, P129, DOI 10.1016/j.clineuro.2010.10.012; Taylor CA, 1998, ANN BIOMED ENG, V26, P975, DOI 10.1114/1.140; Tsuji M, 2016, J NEUROSURG, V3, P1	20	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191287	10.1371/journal.pone.0191287	http://dx.doi.org/10.1371/journal.pone.0191287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338059	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700047
J	Schreiber, PW; Bischoff-Ferrari, HA; Boggian, K; Bonani, M; van Delden, C; Enriquez, N; Fehr, T; Garzoni, C; Hirsch, HH; Hirzel, C; Manuel, O; Meylan, P; Saleh, L; Weisser, M; Mueller, NJ				Schreiber, Peter W.; Bischoff-Ferrari, Heike A.; Boggian, Katia; Bonani, Marco; van Delden, Christian; Enriquez, Natalia; Fehr, Thomas; Garzoni, Christian; Hirsch, Hans H.; Hirzel, Cedric; Manuel, Oriol; Meylan, Pascal; Saleh, Lanja; Weisser, Maja; Mueller, Nicolas J.		STCS	Bone metabolism dynamics in the early post transplant period following kidney and liver transplantation	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; FRACTURE RISK; BIOCHEMICAL MARKERS; TURNOVER MARKERS; MINERAL DENSITY; DISEASE; OSTEOPOROSIS; RECIPIENTS; CYCLOSPORINE; IMMUNOSUPPRESSION	Bone disease contributes to relevant morbidity after solid organ transplantation. Vitamin D has a crucial role for bone metabolism. Activation of vitamin D depends on the endocrine function of both, liver and kidney. Our study assessed key markers of bone metabolism at time of transplantation and 6 months after transplantation among 70 kidney and 70 liver recipients. In 70 kidney recipients 25-OH vitamin D levels did not differ significantly between peri-transplant (median 32.5nmol/l) and 6 months post-transplant (median 41.9nmol/l; P = 0.272). Six months post-transplant median 1, 25-(OH)(2) vitamin D levels increased by >300% (from 9.1 to 36.5ng/l; P<0.001) and median intact parathyroid hormone levels decreased by 68.4% (from 208.7 to 66.0 ng/l; P<0.001). Median 6-Crosslaps (CTx) and total procollagen type 1 amino-terminal propeptide (P1NP) decreased by 65.1% (from 1.32 to 0.46ng/ml; P<0.001) and 60.6% (from 158.2 to 62.3ng/ml; P<0.001), respectively. Kidney recipients with incident fractures had significantly lower levels of 1, 25-(OH)(2) vitamin D at time of transplantation and of intact parathyroid hormone 6 months post-transplant. Among 70 liver recipients, 25-OH vitamin D, 1, 25-(OH)(2) vitamin D and intact parathyroid hormone levels were not significantly altered between peri-transplant and 6 months post-transplant. Contrary to kidney recipients, median CTx increased by 60.0% (from 0.45 to 0.72 ng/ml; P = 0.002) and P1NP by 49.3% (from 84.0 to 125.4ng/ml; P = 0.001) in the longitudinal course. Assessed biomarkers didn't differ between liver recipients with and without fractures. To conclude, the assessed panel of biomarkers proved highly dynamic after liver as well as kidney transplantation in the early post-transplant period. After kidney transplantation a significant gain in 1, 25-(OH)(2) vitamin D combined with a decline in iPTH, CTx and P1 NP, whereas after liver transplantation an increase in CTx and P1 NP were characteristic.	[Schreiber, Peter W.; Bischoff-Ferrari, Heike A.; Mueller, Nicolas J.] Univ Hosp Zurich, Zurich, Switzerland; [Schreiber, Peter W.; Mueller, Nicolas J.] Univ Zurich, Div Infect Dis, Zurich, Switzerland; [Schreiber, Peter W.; Mueller, Nicolas J.] Hosp Epidemiol, Zurich, Switzerland; [Bischoff-Ferrari, Heike A.] Univ Zurich, Dept Geriatr & Aging Res, Zurich, Switzerland; [Boggian, Katia] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland; [Boggian, Katia] Hosp Hyg, St Gallen, Switzerland; [Bonani, Marco] Univ Zurich, Dept Nephrol, Zurich, Switzerland; [van Delden, Christian; Enriquez, Natalia] Univ Hosp Geneva, Geneva, Switzerland; [van Delden, Christian; Enriquez, Natalia] Univ Geneva, Dept Surg, Serv Transplantat, Geneva, Switzerland; [Fehr, Thomas] Cantonal Hosp Chur, Internal Med, Chur, Switzerland; [Garzoni, Christian; Hirzel, Cedric] Univ Bern, Bern Univ Hosp, Inselspital, Dept Infect Dis, Bern, Switzerland; [Hirsch, Hans H.; Weisser, Maja] Univ Hosp Basel, Div Infect Dis, Basel, Switzerland; [Hirsch, Hans H.; Weisser, Maja] Hosp Epidemiol, Basel, Switzerland; [Manuel, Oriol; Meylan, Pascal] Univ Hosp CHUV, Lausanne, Switzerland; [Manuel, Oriol; Meylan, Pascal] Univ Lausanne, Infect Dis Serv, Lausanne, Switzerland; [Saleh, Lanja] Univ Hosp Zurich, Inst Clin Chem, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Kantonsspital St. Gallen; University of Zurich; University of Geneva; University of Geneva; University of Bern; University Hospital of Bern; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Zurich; University Zurich Hospital	Mueller, NJ (corresponding author), Univ Hosp Zurich, Zurich, Switzerland.	nicolas.mueller@usz.ch	Fehr, Thomas/AFQ-9308-2022; Mueller, Nicolas J./B-6864-2013; Study, STCS Swiss Transplant Cohort/G-8344-2017; cavassini, matthias/F-8987-2017	Fehr, Thomas/0000-0003-1668-1800; Mueller, Nicolas J./0000-0002-1059-3191; Study, STCS Swiss Transplant Cohort/0000-0002-6369-819X; cavassini, matthias/0000-0003-0933-7833; Bischoff-Ferrari, Heike/0000-0002-4554-658X; Weisser, Maja/0000-0002-0134-1929	Swiss National Science Foundation; Swiss University Hospitals and transplant centers [33CS30_148512 / 2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss University Hospitals and transplant centers	This study has been conducted in the framework of the Swiss Transplant Cohort Study, supported by the Swiss National Science Foundation, the Swiss University Hospitals and transplant centers (funding received by NM, PS), http://www.snf.ch/en/Pages/default.aspx, Longitudinal studies: 33CS30_148512 / 2.	Aroldi A, 1997, TRANSPLANTATION, V63, P380, DOI 10.1097/00007890-199702150-00009; Bang UC, 2014, CLIN GASTROENTEROL H, V12, P320, DOI 10.1016/j.cgh.2013.04.031; Bia Margaret, 2008, Transplant Rev (Orlando), V22, P52, DOI 10.1016/j.trre.2007.09.001; Bringhurstea FR, 2011, HARRISONS PRINCIPL E, V18E; Brown JE, 2010, NEOPLASIA, V12, P685, DOI 10.1593/neo.10610; Cavalier E, 2013, CLIN CHIM ACTA, V425, P117, DOI 10.1016/j.cca.2013.07.016; Chavassieux P, 2015, J CLIN ENDOCR METAB, V100, P4662, DOI 10.1210/jc.2015-2957; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Cohen AJ, 2002, LIVER TRANSPLANT, V8, P916, DOI 10.1053/jlts.2002.35668; Cueto-Manzano AM, 2003, TRANSPLANTATION, V75, P2053, DOI 10.1097/01.TP.0000068869.21770.F6; Dizdar O, 2007, AM J HEMATOL, V82, P185, DOI 10.1002/ajh.20794; Drueke TB, 2016, KIDNEY INT, V89, P289, DOI 10.1016/j.kint.2015.12.004; El Haggan W, 2002, TRANSPLANT P, V34, P1817, DOI 10.1016/S0041-1345(02)03094-4; Floreani A, 2001, OSTEOPOROSIS INT, V12, P749, DOI 10.1007/s001980170051; Gal-Moscovici A, 2007, SEMIN DIALYSIS, V20, P423, DOI 10.1111/j.1525-139X.2007.00319.x; Gallego-Rojo FJ, 1998, HEPATOLOGY, V28, P695, DOI 10.1002/hep.510280315; Garnero P, 2008, MOL DIAGN THER, V12, P157, DOI 10.1007/BF03256280; Hardinger KL, 2003, LIVER TRANSPLANT, V9, P857, DOI 10.1053/jlts.2003.50135; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; HRUSKA KA, 1995, NEW ENGL J MED, V333, P166, DOI 10.1056/NEJM199507203330307; KATZ I, 1994, J BONE MINER RES, V9, P59; Koller MT, 2013, EUR J EPIDEMIOL, V28, P347, DOI 10.1007/s10654-012-9754-y; Krol CG, 2014, J BONE MINER RES, V29, P1763, DOI 10.1002/jbmr.2214; Kumar R, 2011, J AM SOC NEPHROL, V22, P216, DOI 10.1681/ASN.2010020186; Leidig-Bruckner G, 2001, LANCET, V357, P342, DOI 10.1016/S0140-6736(00)03641-2; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MCDONALD JA, 1991, HEPATOLOGY, V14, P613, DOI 10.1002/hep.1840140407; Monegal A, 2001, OSTEOPOROSIS INT, V12, P484, DOI 10.1007/s001980170094; Monegal A, 2013, CALCIFIED TISSUE INT, V93, P571, DOI 10.1007/s00223-013-9797-4; Morris HA, 2016, CLIN CHIMICA ACTA; Naylor K, 2012, NAT REV RHEUMATOL, V8, P379, DOI 10.1038/nrrheum.2012.86; Naylor KL, 2015, TRANSPLANTATION; Naylor KL, 2013, TRANSPLANTATION, V95, P1461, DOI 10.1097/TP.0b013e31828eead8; Nikkel LE, 2009, TRANSPLANTATION, V87, P1846, DOI 10.1097/TP.0b013e3181a6bbda; Ninkovic M, 2000, EUR J GASTROEN HEPAT, V12, P931, DOI 10.1097/00042737-200012080-00013; Ninkovic M, 2001, CALCIFIED TISSUE INT, V69, P321, DOI 10.1007/s00223-001-2028-4; Phipps AI, 2010, MATURITAS, V67, P60, DOI 10.1016/j.maturitas.2010.04.015; Premaor MO, 2011, QJM-INT J MED, V104, P599, DOI 10.1093/qjmed/hcr025; Rizzari MD, 2012, CLIN J AM SOC NEPHRO, V7, P494, DOI 10.2215/CJN.08630811; Ruiz-Gaspa S, 2011, HEPATOLOGY, V54, P2104, DOI 10.1002/hep.24605; Ueda M, 2002, AM J KIDNEY DIS, V40, P802, DOI 10.1053/ajkd.2002.35692; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Vasikaran S, 2011, CLIN CHEM LAB MED, V49, P1271, DOI 10.1515/CCLM.2011.602; Wheater G, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-201; Zitta S, 2015, TRANSPLANTATION, V99, P1250, DOI 10.1097/TP.0000000000000521	46	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191167	10.1371/journal.pone.0191167	http://dx.doi.org/10.1371/journal.pone.0191167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338022	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000422652700035
J	Tien, CF; Huang, LQ; Watanabe, SM; Speidel, JT; Carter, CA; Chen, CP				Tien, ChihFeng; Huang, Liangqun; Watanabe, Susan M.; Speidel, Jordan T.; Carter, Carol A.; Chen, Chaoping			Context-dependent autoprocessing of human immunodeficiency virus type 1 protease precursors	PLOS ONE			English	Article							MALTOSE-BINDING PROTEIN; HIV-1 PROTEASE; ESCHERICHIA-COLI; CLEAVAGE; MODULATION; VARIANTS; UPSTREAM; RESIDUE; MUTANT; SITES	HIV-1 protease autoprocessing is responsible for liberation of free mature protease (PR) from the Gag-Pol polyprotein precursor. A cell-based model system was previously developed to examine the autoprocessing mechanism of fusion precursors carrying the p6*-PR miniprecursor sandwiched between various proteins or epitopes. We here report that precursor autoprocessing is context-dependent as its activity and outcomes can be modulated by sequences upstream of p6*-PR. This was exemplified by the 26aa maltose binding protein (MBP) signal peptide (SigP) when placed at the N-terminus of a fusion precursor. The mature PRs released from SigP-carrying precursors are resistant to self-degradation whereas those released from SigP-lacking fusion precursors are prone to self-degradation. A H69D mutation in PR abolished autoprocessing of SigP-containing fusion precursors whereas it only partially suppressed autoprocessing of fusion precursors lacking SigP. An autoprocessing deficient GFP fusion precursor with SigP exhibited a subcellular distribution pattern distinct from the one without it in transfected HeLa cells. Furthermore, a SigP fusion precursor carrying a substitution at the P1 position released the mature PR and PR-containing fragments that were different from those released from the precursor carrying the same mutation but lacking SigP. We also examined autoprocessing outcomes in viral particles produced by a NL4-3 derived proviral construct and demonstrated the existence of several PR-containing fragments along with the mature PR. Some of these resembled the SigP precursor autoprocessing outcomes. This finding of context-dependent modulation reveals the complexity of precursor autoprocessing regulation that most likely accompanies sequence variation imposed by the evolution of the upstream Gag moiety.	[Tien, ChihFeng; Huang, Liangqun; Speidel, Jordan T.; Chen, Chaoping] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Watanabe, Susan M.; Carter, Carol A.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Speidel, Jordan T.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	Colorado State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Medical Branch Galveston	Chen, CP (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Chaoping.Chen@colostate.edu		Chen, Chaoping/0000-0001-9387-6252	NIH [R03A1108392, R01A1120365, R01GM111028]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by NIH R03A1108392 & R01A1120365 to CC, and R01GM111028 to CAC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cherry E, 1998, J MOL BIOL, V284, P43, DOI 10.1006/jmbi.1998.1968; Counts CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123561; FIKES JD, 1990, J BIOL CHEM, V265, P3417; FIKES JD, 1987, J BACTERIOL, V169, P2345, DOI 10.1128/jb.169.6.2345-2351.1987; Huang LQ, 2013, FUTURE MED CHEM, V5, P1215, DOI 10.4155/fmc.13.89; Huang LQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-79; Huang LQ, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-27; Huang LQ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-24; Huang LQ, 2009, J VIROL, V83, P7789, DOI 10.1128/JVI.00473-09; Kemal KS, 2007, J INFECT DIS, V195, P535, DOI 10.1086/510855; Louis J M, 2000, Adv Pharmacol, V49, P111; LOUIS JM, 1991, EUR J BIOCHEM, V199, P361, DOI 10.1111/j.1432-1033.1991.tb16132.x; Louis JM, 1999, NAT STRUCT BIOL, V6, P868; Louis JM, 2007, ADV PHARMACOL, V55, P261, DOI 10.1016/S1054-3589(07)55008-8; Louis JM, 2011, P NATL ACAD SCI USA, V108, P9072, DOI 10.1073/pnas.1102278108; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; MILDNER AM, 1994, BIOCHEMISTRY-US, V33, P9405, DOI 10.1021/bi00198a005; Park JH, 2016, BIOCHEMISTRY-US, V55, P2390, DOI 10.1021/acs.biochem.6b00012; PARTIN K, 1991, P NATL ACAD SCI USA, V88, P4776, DOI 10.1073/pnas.88.11.4776; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Raran-Kurussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049589; Reuten R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152386; ROSE JR, 1993, J BIOL CHEM, V268, P11939; Sun P, 2011, METHODS MOL BIOL, V705, P259, DOI 10.1007/978-1-61737-967-3_16; TOOHEY K, 1995, VIROLOGY, V213, P70, DOI 10.1006/viro.1995.1547; Watanabe SM, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0298-1; Watanabe SM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-143; Waugh DS, 2016, PROTEIN SCI, V25, P559, DOI 10.1002/pro.2863; Wehrly K, 1997, METHODS, V12, P288, DOI 10.1006/meth.1997.0481; Yu FH, 2017, J VIROL; ZYBARTH G, 1995, J VIROL, V69, P3878, DOI 10.1128/JVI.69.6.3878-3884.1995	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e019137	10.1371/journal.pone.0191372	http://dx.doi.org/10.1371/journal.pone.0191372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338056	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700052
J	Chen, WC; Su, VYF; Yu, WK; Chen, YW; Yang, KY				Chen, Wei-Chih; Su, Vincent Yi-Fong; Yu, Wen-Kuang; Chen, Yen-Wen; Yang, Kuang-Yao			Prognostic factors of noninvasive mechanical ventilation in lung cancer patients with acute respiratory failure	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; RISK; EXTUBATION	Introduction Few studies have reported outcomes of lung cancer patients with acute respiratory failure (RF) using noninvasive positive pressure ventilation (NIPPV). The aim of this study was to investigate the prognostic factors in these patients. Materials and methods This retrospective observational study included all hospitalized lung cancer patients who received NIPPV for acute RF. It was conducted at a tertiary medical center in Taiwan from 2005 to 2010. The primary outcome was all cause mortality at 28 days after the initiation of NIPPV. Secondary outcomes included all-cause in-hospital mortality, weaning from NIPPV, intubation rate, tracheostomy rate, duration of NIPPV, hospital stay and intensive care unit stay. Results The all-cause mortality rate at day 28 of the enrolled 58 patients was 39.66%.The 90-day and 1-year mortality rates were 63.79% and 86.21%, respectively. NIPPV as the first line therapy for RF had higher 28-day mortality rate than it used for post-extubation RF (57.6% versus 16.0%, p<0.05). Independent predictors of mortality at 28 days were progressive disease or newly diagnosed lung cancer (OR 14.02 95% Cl 1.03-191.59, p = 0.048), combined with other organ failure (OR 18.07 95% Cl 1.87-172.7, p = 0.012), and NIPPV as the first line therapy for RF (OR 35.37 95% Cl 3.30-378.68, p = 0.003). Conclusion Lung cancer patients using NIPPV with progressive or newly diagnosed cancer disease, combined with other organ failure, or NIPPV as the first line therapy for respiratory failure have a poor outcome.	[Chen, Wei-Chih; Su, Vincent Yi-Fong; Yu, Wen-Kuang; Chen, Yen-Wen; Yang, Kuang-Yao] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Chen, Wei-Chih; Yu, Wen-Kuang; Chen, Yen-Wen; Yang, Kuang-Yao] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Su, Vincent Yi-Fong] Taipei City Hosp, Dept Internal Med, Yangming Branch, Taipei, Taiwan; [Yang, Kuang-Yao] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University	Yang, KY (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.; Yang, KY (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Yang, KY (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei, Taiwan.	kyyang@vghtpe.gov.tw			Taiwan National Science Council Research Grant [MOST 103-2314-B-075-049-MY2]; Taipei Veterans General Hospital [V102C-025, V103C-078, V104C-038, V106C-072, V107C-077]	Taiwan National Science Council Research Grant; Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by a Taiwan National Science Council Research Grant MOST 103-2314-B-075-049-MY2 and Taipei Veterans General Hospital Grants V102C-025, V103C-078, V104C-038, V106C-072, and V107C-077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AK, 2008, EUR RESPIR J, V31, P47, DOI 10.1183/09031936.00031607; Adda M, 2008, CRIT CARE MED, V36, P2766, DOI 10.1097/CCM.0b013e31818699f6; Andrejak C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-159; [Anonymous], 2013, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD004127; Azoulay E, 2001, CRIT CARE MED, V29, P519, DOI 10.1097/00003246-200103000-00009; Conti G, 1998, INTENS CARE MED, V24, P1283, DOI 10.1007/s001340050763; El Solh AA, 2006, EUR RESPIR J, V28, P588, DOI 10.1183/09031936.06.00150705; EWER MS, 1986, JAMA-J AM MED ASSOC, V256, P3364, DOI 10.1001/jama.256.24.3364; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferreira JC, 2015, J CRIT CARE, V30, P1003, DOI 10.1016/j.jcrc.2015.04.121; Ferrer M, 2006, AM J RESP CRIT CARE, V173, P164, DOI 10.1164/rccm.200505-718OC; Ferrer M, 2009, LANCET, V374, P1082, DOI 10.1016/S0140-6736(09)61038-2; Gristina GR, 2011, CRIT CARE MED, V39, P2232, DOI 10.1097/CCM.0b013e3182227a27; Meert AP, 2003, SUPPORT CARE CANCER, V11, P56, DOI 10.1007/s00520-002-0373-0; Nava S, 2005, CRIT CARE MED, V33, P2465, DOI 10.1097/01.CCM.0000186416.44752.72; Neuschwander A, 2017, J CRIT CARE, V38, P295, DOI 10.1016/j.jcrc.2016.11.042; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Organized jointly by the American Thoracic Society the European Respiratory Society the European Society of Intensive Care Medicine and the Societe de Reanimation de Langue Francaise and approved by ATS Board of Directors December 2000, 2001, Am J Respir Crit Care Med, V163, P283; PINGLETON SK, 1988, AM REV RESPIR DIS, V137, P1463, DOI 10.1164/ajrccm/137.6.1463; Rabbat A, 2005, BRIT J HAEMATOL, V129, P350, DOI 10.1111/j.1365-2141.2005.05459.x; Rathi NK, 2017, J CRIT CARE, V39, P56, DOI 10.1016/j.jcrc.2017.01.007; Roques S, 2009, INTENS CARE MED, V35, P2044, DOI 10.1007/s00134-009-1625-y; Slatore CG, 2012, J CLIN ONCOL, V30, P1686, DOI 10.1200/JCO.2011.40.0846; Soares M, 2014, ANN ONCOL, V25, P1829, DOI 10.1093/annonc/mdu234; Soares M, 2007, CHEST, V131, P840, DOI 10.1378/chest.06-2244; Toffart AC, 2011, CHEST, V139, P101, DOI 10.1378/chest.09-2863; Torres VBL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164537; Vallieres E, 2009, J THORAC ONCOL, V4, P1049, DOI 10.1097/JTO.0b013e3181b27799	28	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191204	10.1371/journal.pone.0191204	http://dx.doi.org/10.1371/journal.pone.0191204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329356	Green Published, Green Submitted, gold			2022-12-27	WOS:000419954100049
J	Belqaid, K; Tishelman, C; Orrevall, Y; Mansson-Brahme, E; Bernhardson, BM				Belqaid, Kerstin; Tishelman, Carol; Orrevall, Ylva; Mansson-Brahme, Eva; Bernhardson, Britt-Marie			Dealing with taste and smell alterations-A qualitative interview study of people treated for lung cancer	PLOS ONE			English	Article							SELF-REPORTED TASTE; PATIENTS RECEIVING CHEMOTHERAPY; NECK-CANCER; OF-LIFE; IMPACT; COMPLEMENTARY; DYSFUNCTION; DYSGEUSIA; MEDICINE; HEAD	Taste and smell alterations have been recognized as common symptoms in relation to various cancers. However, previous research suggests that patients do not receive sufficient support in managing taste and smell alterations. Therefore, the objective of this study is to investigate how persons with experience from lung cancer-related taste and smell alterations reason about resources and strategies offered and used to manage these symptoms. Data from semi-structured individual interviews with 13 women and four men were analyzed with qualitative content analysis. We used Kleinman's now classic medical anthropological model of local health care systems, consisting of the personal, professional, and folk sector, to interpret and understand how people respond to sickness experiences in their daily lives. By presenting the findings using this model, we demonstrate that most strategies for dealing with taste and smell alterations were undertaken in the personal sector, i.e. in participants' daily lives, on an individual level and in interaction with family, social networks and communities. Taste and smell alterations implied two overarching challenges: 1) adjusting to no longer being able to trust information provided by one's own senses of taste and/or smell, and 2) coming to terms with taste and smell alterations as a part of having lung cancer. Health care professionals' involvement was described as limited, but appeared to fulfil most participants' expectations. However, through provision of normalizing information, practical advice, and to some extent, emotional support, health care professionals had potential to influence strategies and resources used for dealing with taste and smell alterations. With this study, we further the understanding of how people deal with lung cancer-related taste and smell alterations and discuss the role of health care professionals for this process.	[Belqaid, Kerstin; Tishelman, Carol; Orrevall, Ylva; Bernhardson, Britt-Marie] Karolinska Inst, Med Management Ctr, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Belqaid, Kerstin; Orrevall, Ylva] Karolinska Univ Hosp, Funct Area Clin Nutr, Stockholm, Sweden; [Tishelman, Carol; Bernhardson, Britt-Marie] Karolinska Univ Hosp, Ctr Innovat, Stockholm, Sweden; [Mansson-Brahme, Eva] Karolinska Univ Hosp, Canc Theme, Stockholm, Sweden; [Mansson-Brahme, Eva] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Belqaid, Kerstin; Tishelman, Carol; Orrevall, Ylva; Bernhardson, Britt-Marie] Karolinska Inst, Dept Learning Informat Management & Eth, Div Innovat Care, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Belqaid, K (corresponding author), Karolinska Inst, Med Management Ctr, Dept Learning Informat Management & Eth, Stockholm, Sweden.; Belqaid, K (corresponding author), Karolinska Univ Hosp, Funct Area Clin Nutr, Stockholm, Sweden.; Belqaid, K (corresponding author), Karolinska Inst, Dept Learning Informat Management & Eth, Div Innovat Care, Stockholm, Sweden.	kerstin.belqaid@ki.se	Tishelman, Carol/AAB-8936-2020	Tishelman, Carol/0000-0003-4161-0342; Orrevall, Ylva/0000-0001-7393-7257; Bernhardson, Britt-Marie/0000-0001-6907-3134	Health Care Science Postgraduate School, Karolinska Institutet [2286/2009-532]; Strategic Research Program in Health Care Sciences [1976/2010]; CancerRehabFonden [F-C-001211]; Swedish Research Council [2009-33868-68207-63]	Health Care Science Postgraduate School, Karolinska Institutet; Strategic Research Program in Health Care Sciences; CancerRehabFonden; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Economic support was provided by the Swedish Research Council 2009-33868-68207-63 (https://www.vr.se/), the Strategic Research Program in Health Care Sciences 1976/2010 (http://ki.se/en/research/strategic-research-area-health-care-science-sfo-v), CancerRehabFonden F-C-001211 (https://www.cancerrehabfonden.se/) and the Health Care Science Postgraduate School, Karolinska Institutet 2286/2009-532 (http://ki.se/en/nvs/doctoral-school-in-health-care-sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Camacho M, 2016, QUAL LIFE RES, V25, P1495, DOI 10.1007/s11136-015-1185-2; Arends J, 2017, CLIN NUTR, V36, P11, DOI 10.1016/j.clnu.2016.07.015; Belqaid K, 2016, EUR J ONCOL NURS, V21, P232, DOI 10.1016/j.ejon.2015.10.009; Belqaid K, 2014, ACTA ONCOL, V53, P1405, DOI 10.3109/0284186X.2014.895035; Bernhardson BM, 2008, SUPPORT CARE CANCER, V16, P275, DOI 10.1007/s00520-007-0319-7; Bernhardson BM, 2007, J PAIN SYMPTOM MANAG, V34, P403, DOI 10.1016/j.jpainsymman.2006.12.010; Bernhardson BM, 2009, CANCER NURS, V32, P45, DOI 10.1097/01.NCC.0000343368.06247.74; Boltong A, 2015, CHEM PERCEPT, P1; Boltong A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103512; Boltong A, 2011, CANCER FORUM, V35, P81; Boltong A, 2012, SUPPORT CARE CANCER, V20, P2765, DOI 10.1007/s00520-012-1398-7; Brisbois TD, 2011, J PAIN SYMPTOM MANAG, V41, P673, DOI 10.1016/j.jpainsymman.2010.06.022; Comeau TB, 2001, SUPPORT CARE CANCER, V9, P575, DOI 10.1007/s005200100279; de Vries YC, 2016, SUPPORT CARE CANCER, V24, P3119, DOI 10.1007/s00520-016-3128-z; Epstein JB, 2016, SUPPORT CARE CANCER, V24, P1917, DOI 10.1007/s00520-016-3083-8; Epstein JB, 2010, ORAL ONCOL, V46, P77, DOI 10.1016/j.oraloncology.2009.11.008; Gamper EM, 2012, J PAIN SYMPTOM MANAG, V44, P880, DOI 10.1016/j.jpainsymman.2011.11.011; Hok J, 2009, THESIS; Hopkinson JB, 2007, J ADV NURS, V59, P454, DOI 10.1111/j.1365-2648.2007.04283.x; Hovan AJ, 2010, SUPPORT CARE CANCER, V18, P1081, DOI 10.1007/s00520-010-0902-1; Hutton JL, 2007, J PAIN SYMPTOM MANAG, V33, P156, DOI 10.1016/j.jpainsymman.2006.07.017; Kleinman A., 1980, PATIENTS HEALERS CON; Koizumi T, 2015, LUNG CANCER, V88, P112, DOI 10.1016/j.lungcan.2015.01.018; Kubrak C, 2013, HEAD NECK-J SCI SPEC, V35, P695, DOI 10.1002/hed.23023; Lancely A, 2001, CANC NURSING CARE CO, P100; Lincoln Y, 1985, NATURALISTIC ENQUIRY; Lovgren M, 2011, EUR J ONCOL NURS, V15, P311, DOI 10.1016/j.ejon.2010.10.004; McGreevy J, 2014, SUPPORT CARE CANCER, V22, P2635, DOI 10.1007/s00520-014-2215-2; National Center for Complementary and Integrative Health, 2016, COMPL ALT INT HLTH W; Regional Cancer Center Uppsala Orebro, 2015, CLIN CAR PROGR LUNG; Robinson A, 2004, COMPLEMENT THER MED, V12, P90, DOI 10.1016/j.ctim.2004.09.006; Sanchez-Lara K, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-15; Sirois FM, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-16; Speck RM, 2013, SUPPORT CARE CANCER, V21, P549, DOI 10.1007/s00520-012-1551-3; Spotten L, 2016, SUPPORT CARE CANCER, V24, P3201, DOI 10.1007/s00520-016-3133-2; Thorne S, 2008, INTERPRETIVE DESCRIP, V1; Thorne T, 2015, SUPPORT CARE CANCER, V23, P2843, DOI 10.1007/s00520-015-2827-1; Tishelman C, 1993, THESIS; Vincent C, 1996, BRIT J CLIN PSYCHOL, V35, P37, DOI 10.1111/j.2044-8260.1996.tb01160.x; Zabernigg A, 2010, ONCOLOGIST, V15, P913, DOI 10.1634/theoncologist.2009-0333	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191117	10.1371/journal.pone.0191117	http://dx.doi.org/10.1371/journal.pone.0191117			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360871	Green Submitted, gold, Green Published			2022-12-27	WOS:000423161800017
J	Rodriguez-Flores, L; Morales-Sandoval, M; Cumplido, R; Feregrino-Uribe, C; Algredo-Badillo, I				Rodriguez-Flores, Luis; Morales-Sandoval, Miguel; Cumplido, Rene; Feregrino-Uribe, Claudia; Algredo-Badillo, Ignacio			Compact FPGA hardware architecture for public key encryption in embedded devices	PLOS ONE			English	Article							MODULAR EXPONENTIATION; MULTIPLICATION; RSA; IMPLEMENTATION; CRYPTOGRAPHY; PARALLEL	Security is a crucial requirement in the envisioned applications of the Internet of Things (IoT), where most of the underlying computing platforms are embedded systems with reduced computing capabilities and energy constraints. In this paper we present the design and evaluation of a scalable low-area FPGA hardware architecture that serves as a building block to accelerate the costly operations of exponentiation and multiplication in GIF(p), commonly required in security protocols relying on public key encryption, such as in key agreement, authentication and digital signature. The proposed design can process operands of different size using the same datapath, which exhibits a significant reduction in area without loss of efficiency if compared to representative state of the art designs. For example, our design uses 96% less standard logic than a similar design optimized for performance, and 46% less resources than other design optimized for area. Even using fewer area resources, our design still performs better than its embedded software counterparts (190x and 697x).	[Rodriguez-Flores, Luis; Cumplido, Rene; Feregrino-Uribe, Claudia] Inst Nacl Astrofis Opt & Electr, Dept Comp Sci, Puebla 72840, Mexico; [Morales-Sandoval, Miguel] Cinvestav Tamaulipas, Victoria City 87130, Mexico; [Algredo-Badillo, Ignacio] Polytech Univ Tlaxcala, Dept Informat Technol, Tlaxcala, Mexico	Instituto Nacional de Astrofisica, Optica y Electronica; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Rodriguez-Flores, L (corresponding author), Inst Nacl Astrofis Opt & Electr, Dept Comp Sci, Puebla 72840, Mexico.	lrodriguez@inaoep.mx	Feregrino, Claudia/AAW-2607-2021; Morales-Sandoval, Miguel/CAG-1219-2022; Morales-Sandoval, Miguel/E-8851-2019; Algredo-Badillo, Ignacio/HDN-8875-2022	Morales-Sandoval, Miguel/0000-0003-1702-8467; Morales-Sandoval, Miguel/0000-0003-1702-8467; Algredo Badillo, Ignacio/0000-0002-4748-3500	CONACyT, Mexico [402861]	CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The author Luis Rodriguez is a Ph.D. student who has been granted with a scholarship "No. 402861 from CONACyT, Mexico" for living expenses only. The author(s) received no specific funding for this work.	Alkalbani A.S., 2010, PROCEEDING 3 INT C I, pE84; Amiet D, 2016, 19TH EUROMICRO CONFERENCE ON DIGITAL SYSTEM DESIGN (DSD 2016), P107, DOI 10.1109/DSD.2016.70; Atmel, 2015, ATM CRYPT AUTH DEV; Batina L, 2003, INTEGRATION, V34, P1, DOI 10.1016/S0167-9260(02)00053-6; DIFFIE W, 1976, IEEE T INFORM THEORY, V22, P644, DOI 10.1109/TIT.1976.1055638; Eisenbarth T, 2007, IEEE DES TEST COMPUT, V24, P522, DOI 10.1109/MDT.2007.178; Guajardo J, 2006, ACTA APPL MATH, V93, P75, DOI 10.1007/s10440-006-9072-z; Guo J, 2011, LECT NOTES COMPUT SC, V6841, P222, DOI 10.1007/978-3-642-22792-9_13; Guo X, 2008, LECT NOTES COMPUT SC, V5114, P106, DOI 10.1007/978-3-540-70550-5_12; Gura N, 2004, LECT NOTES COMPUT SC, V3156, P119; Homma N, 2010, IEEE T COMPUT, V59, P795, DOI 10.1109/TC.2009.176; Infineon, 2016, MIPAQ PRO NEW DIM SM; Jain D, 2012, STUDY INTERNET THING; Joye M., 2003, LNCS, P291; Koblitz N., 1987, J MATH COMPUTATION, V48, P203, DOI DOI 10.1090/S0025-5718-1987-0866109-5; Kocher P., 1999, Advances in Cryptology - CRYPTO'99. 19th Annual International Cryptology Conference. Proceedings, P388; Kocher P, 2011, J CRYPTOGR ENG, V1, P5, DOI 10.1007/s13389-011-0006-y; Kundi DES, 2016, COMPUT ELECTR ENG, V55, P138, DOI 10.1016/j.compeleceng.2016.04.004; Liu YL, 2013, J COMPUT, V8, P2880, DOI 10.4304/jcp.8.11.2880-2887; Liu ZB, 2011, SECRYPT 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SECURITY AND CRYPTOGRAPHY, P105; Miorandi D, 2012, AD HOC NETW, V10, P1497, DOI 10.1016/j.adhoc.2012.02.016; MONTGOMERY PL, 1985, MATH COMPUT, V44, P519, DOI 10.1090/S0025-5718-1985-0777282-X; MONTGOMERY PL, 1987, MATH COMPUT, V48, P243, DOI 10.1090/S0025-5718-1987-0866113-7; Morales-Sandoval M, 2013, P 23 ACM INT C GREAT, P245; National Institute of Standards and Technology (NIST). The Digital Signature Standard (DSS), 1991, FED INF PROC STAND P, V186; Nedjah N, 2006, IEEE T CIRCUITS-I, V53, P627, DOI 10.1109/TCSI.2005.858767; Nedjah N, 2012, IET COMPUT DIGIT TEC, V6, P290, DOI 10.1049/iet-cdt.2011.0074; Oksuzoglu Ersin, 2008, 2008 International Conference on Reconfigurable Computing and FPGAs (ReConFig), P391, DOI 10.1109/ReConFig.2008.13; Qiu LR, 2017, PERS UBIQUIT COMPUT, V21, P807, DOI 10.1007/s00779-017-1044-y; Rao M., 2016, P 10 INT C SENS TECH, P1, DOI DOI 10.1109/ICCTAC.2016; Rezai A, 2015, IEEE T VLSI SYST, V23, P1710, DOI 10.1109/TVLSI.2014.2355854; RIVEST RL, 1978, COMMUN ACM, V21, P120, DOI [10.1145/359340.359342, 10.1145/357980.358017]; Roy D.B., 2015, SAC, P161; San I, 2014, J SYST ARCHITECT, V60, P440, DOI 10.1016/j.sysarc.2013.10.013; Shylashree N, 2015, 2015 INTERNATIONAL CONFERENCE ON EMERGING RESEARCH IN ELECTRONICS, COMPUTER SCIENCE AND TECHNOLOGY (ICERECT), P476; Stallings W, 2013, CRYPTOGRAPHY NETWORK; Sutter GD, 2011, IEEE T IND ELECTRON, V58, P3101, DOI 10.1109/TIE.2010.2080653; Tajeddine A, 2014, IEEE MEDITERR ELECT, P367, DOI 10.1109/MELCON.2014.6820562; Thorp EO, 1998, SECOND INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS - DIGEST OF PAPERS, P4, DOI 10.1109/ISWC.1998.729523; Tuan T, 2007, XCELL J, P12; Walter CD, 1999, LECT NOTES COMPUT SC, V1717, P80; Walter CD., 1999, MONTGOMERYS MULTIPLI, P80; WEISER M, 1991, SCI AM, V265, P94, DOI 10.1038/scientificamerican0991-94; Wu T, 2013, INTEGRATION, V46, P323, DOI 10.1016/j.vlsi.2012.09.002; Xinkai Yan, 2013, 2013 International Conference on Information Science and Cloud Computing (ISCC), P32, DOI 10.1109/ISCC.2013.19; Yalla P, 2009, 2009 INTERNATIONAL CONFERENCE ON RECONFIGURABLE COMPUTING AND FPGAS, P225, DOI 10.1109/ReConFig.2009.54; Zhang YY, 2007, MICROPROCESS MICROSY, V31, P456, DOI 10.1016/j.micpro.2006.12.003	47	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190939	10.1371/journal.pone.0190939	http://dx.doi.org/10.1371/journal.pone.0190939			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360824	gold, Green Published, Green Submitted			2022-12-27	WOS:000423161800012
J	Sala, A				Sala, Antonello			Influence of tow duration on catch performance of trawl survey in the Mediterranean Sea	PLOS ONE			English	Article							FISHERY; SIZE; SELECTIVITY; CODENDS; PLAICE; MESH; COD	The aim of this study was to assess the effect of tow duration on catch per unit of swept area (CPUE), trawl catch performance, and the proportion of the species caught in a trawl survey. Longer tows are expected to have a greater probability of catching species. An average of 26 species were caught in the first 30 minutes, whereas only about one additional species was caught in the next 30 minutes in longer tows. The shorter tows involved a decrement in catch weight for 11 of the 12 target species sampled, demonstrating that tow duration did affect catch per unit of swept area CPUE. The shorter tows were associated with a significant reduction of the overall CPUE in terms of weight of the main target species and of the total catch (circa 60%). The same strong reduction of around 70% was found in particular for European hake (Merluccius merluccius) and surmullet (Mullus spp) and 50% for Nephrops (Nephrops norvegicus). The shorter tows were less efficient in catching large-sized hake, surmullet, Nephrops, Atlantic horse mackerel (Trachurus trachurus), and poor cod (Trisopterus minutus), even though the difference was significant only for Nephrops. Regardless of the p-value statistic, these findings suggest that the continuity of survey time series would be severely impaired by changing tow duration. Further work is required to explore a way to reduce tow duration without reducing CPUE.	[Sala, Antonello] CNR, Italian Natl Res Council, Inst Marine Sci ISMAR, Ancona, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Sala, A (corresponding author), CNR, Italian Natl Res Council, Inst Marine Sci ISMAR, Ancona, Italy.	a.sala@ismar.cnr.it	Sala, Antonello/B-8517-2016	Sala, Antonello/0000-0001-7066-1152				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bertrand J., 1997, ICES ANN SCI C, P1; Brcic J, 2014, SCI MAR, V78, P135, DOI 10.3989/scimar.03819.24A; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Cotter AJR, 1997, 1997Y24 ICES CM, V24, P1; Dremiere PY, 1999, AQUAT LIVING RESOUR, V12, P207, DOI 10.1016/S0990-7440(00)88471-5; Efron B, 1982, JACKKNIFE BOOTSTRAP; Eigaard OR, 2012, AQUAT LIVING RESOUR, V25, P15, DOI 10.1051/alr/2011152; Ferno A, 1994, MARINE FISH BEHAV CA; Finney DJ, 1971, STAT METHOD BIOL ASS; Fiorentini L, 1999, AQUAT LIVING RESOUR, V12, P187, DOI 10.1016/S0990-7440(00)88470-3; Frandsen RP, 2011, FISH RES, V111, P116, DOI 10.1016/j.fishres.2011.07.003; Goddard PD, 1997, THESIS; GODO OR, 1990, FISH RES, V9, P165, DOI 10.1016/0165-7836(90)90062-Z; HE P, 1988, J FISH BIOL, V33, P255, DOI 10.1111/j.1095-8649.1988.tb05468.x; He P., 2010, BEHAV MARINE FISHES; Herrmann B, 2013, ICES J MAR SCI, V70, P850, DOI 10.1093/icesjms/fst032; Katsanevakis S, 2006, FISH RES, V81, P229, DOI 10.1016/j.fishres.2006.07.002; Krag LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088819; MCCONNAUGHEY RA, 1993, FISH B-NOAA, V91, P107; Notti E, 2016, MAR COAST FISH, V8, P81, DOI 10.1080/19425120.2015.1095827; PENNINGTON M, 1994, BIOMETRICS, V50, P725, DOI 10.2307/2532786; Sala A, 2016, CANADIAN J FISHERIES; Sala A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160354; Sala A, 2015, FISH RES, V161, P182, DOI 10.1016/j.fishres.2014.07.011; Somerton DA, 2002, FISH RES, V55, P63, DOI 10.1016/S0165-7836(01)00293-4; Tokac A, 2014, FISH RES, V150, P76, DOI 10.1016/j.fishres.2013.10.015; Walsh SJ, 1991, 84 SCR NW ATL FISH O; Wardle CS., 1993, BEHAV TELEOST FISHES, P463, DOI DOI 10.1007/978-1-4684-8261-4_18; Wienbeck H, 2014, FISH RES, V150, P28, DOI 10.1016/j.fishres.2013.10.007; Wileman D.A., 1996, ICES COOP RES REP, V132, P126	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191662	10.1371/journal.pone.0191662	http://dx.doi.org/10.1371/journal.pone.0191662			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357381	Green Submitted, Green Published, gold			2022-12-27	WOS:000422919500018
J	D'Avanzo, B; Shaw, R; Riva, S; Apostolo, J; Bobrowicz-Campos, E; Kurpas, D; Bujnowska-Fedak, M; Holland, C				D'Avanzo, Barbara; Shaw, Rachel; Riva, Silvia; Apostolo, Joao; Bobrowicz-Campos, Elzbieta; Kurpas, Donata; Bujnowska-Fedak, Maria; Holland, Carol			Stakeholders' views and experiences of care and interventions for addressing frailty and pre-frailty: A meta-synthesis of qualitative evidence (vol 12, e0180127, 2017)	PLOS ONE			English	Correction													Kurpas, Donata/I-7054-2013; D'Avanzo, Barbara/AAA-7654-2020; Apostolo, Joao L A/H-6281-2012; Bujnowska-Fedak, Maria Magdalena/ABD-2237-2021; Holland, Carol/AAA-9849-2021	Kurpas, Donata/0000-0002-6996-8920; D'Avanzo, Barbara/0000-0002-0361-7263; Apostolo, Joao L A/0000-0002-3050-4264; Bujnowska-Fedak, Maria Magdalena/0000-0002-4624-5025; Shaw, Rachel/0000-0002-0438-7666; Bobrowicz Campos, Elzbieta Malgorzata/0000-0001-5889-5642; Holland, Carol/0000-0001-7109-6554				D'Avanzo B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180127	1	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191763	10.1371/journal.pone.0191763	http://dx.doi.org/10.1371/journal.pone.0191763			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352295	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000422911300130
J	Geroldinger, A; Sauter, SK; Heinze, G; Endel, G; Dorda, W; Duftschmid, G				Geroldinger, Angelika; Sauter, Simone Katja; Heinze, Georg; Endel, Gottfried; Dorda, Wolfgang; Duftschmid, Georg			Mortality and continuity of care - Definitions matter! A cohort study in diabetics	PLOS ONE			English	Article							SYSTEM; HOSPITALIZATION; COSTS	Objective To demonstrate that when investigating the relevance of continuity of care for patient outcomes, different definitions can lead to contradicting results. Methods We used claims data from the regional public health insurer of Lower Austria covering the period from 2008 to 2011. The study sample included subjects with repeated dispensings of anti-diabetic drugs. The continuity of care index was calculated firstly based on a patient's contacts with general practitioners (primary COCl) and secondly based on contacts at all medical disciplines (total COCl). The association of the two continuity of care measures with mortality was assessed in separate univariable and multivariable Cox regression models. Results Our study sample consisted of 51,717 patients with a median observation time of 3.65 years. The data showed that a high total COCI was associated with increased mortality, while there was no association between primary COCI and mortality. Conclusions Measures of continuity of care are highly sensitive to the type of medical disciplines taken into account. The continuity of care index calculated from contacts at all medical disciplines might measure diversity rather than continuity of care.	[Geroldinger, Angelika; Sauter, Simone Katja; Heinze, Georg; Dorda, Wolfgang; Duftschmid, Georg] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Endel, Gottfried] Main Assoc Austrian Social Secur Org, Vienna, Austria	Medical University of Vienna	Geroldinger, A (corresponding author), Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria.	angelika.geroldinger@gmx.at	Endel, Gottfried/Y-5456-2019	Endel, Gottfried/0000-0003-2071-4572; Geroldinger, Angelika/0000-0002-4659-4911; Heinze, Georg/0000-0003-1147-8491	Main Association of Austrian Social Security Organizations	Main Association of Austrian Social Security Organizations	This work was supported by the Main Association of Austrian Social Security Organizations, which provided access to a research data base containing administrative data and supported the authors AG, SKS and WD financially.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; [Anonymous], 2012, WAHL SICH GES BER JE; Bayliss EA, 2015, ANN FAM MED, V13, P123, DOI 10.1370/afm.1739; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; BRESLAU N, 1975, J MED EDUC, V50, P965; Chen CC, 2011, AM J MANAG CARE, V17, P420; Cheng SH, 2011, HEALTH POLICY PLANN, V26, P157, DOI 10.1093/heapol/czq035; Chini F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-688; Duftschmid G, 2016, C HLTH EXPL COMPL IN; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Jee SH, 2006, MED CARE RES REV, V63, P158, DOI 10.1177/1077558705285294; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Leleu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071669; Lustman A, 2016, PRIM CARE DIABETES, V10, P165, DOI 10.1016/j.pcd.2015.10.001; Nyweide DJ, 2013, JAMA INTERN MED, V173, P1879, DOI 10.1001/jamainternmed.2013.10059; Reid R.J., 2002, DEFUSING CONFUSION C; Rinner C, 2016, INT J MED INFORM, V92, P44, DOI 10.1016/j.ijmedinf.2016.05.001; Shin DW, 2014, ANN FAM MED, V12, P534, DOI 10.1370/afm.1685; STEINWACHS DM, 1979, MED CARE, V17, P551, DOI 10.1097/00005650-197906000-00001; Team RC, 2015, R LANG ENV STAT COMP; van Walraven C, 2010, J EVAL CLIN PRACT, V16, P947, DOI 10.1111/j.1365-2753.2009.01235.x; WHO Collaborating Centre for Drug Statistics Methodology, 2015, GUID ATC CLASS DDD A; Worrall G, 2011, CAN FAM PHYSICIAN, V57, pE16	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191386	10.1371/journal.pone.0191386	http://dx.doi.org/10.1371/journal.pone.0191386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351547	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300078
J	L'Engle, K; Sefa, E; Adimazoya, EA; Yartey, E; Lenzi, R; Tarpo, C; Heward-Mills, NL; Lew, K; Ampeh, Y				L'Engle, Kelly; Sefa, Eunice; Adimazoya, Edward Akolgo; Yartey, Emmanuel; Lenzi, Rachel; Tarpo, Cindy; Heward-Mills, Nii Lante; Lew, Katherine; Ampeh, Yvonne			Survey research with a random digit dial national mobile phone sample in Ghana: Methods and sample quality	PLOS ONE			English	Article							HEALTH SURVEYS; YOUNG-ADULTS; CELL-PHONE; SURVEILLANCE; POPULATION	Introduction Generating a nationally representative sample in low and middle income countries typically requires resource-intensive household level sampling with door-to-door data collection. High mobile phone penetration rates in developing countries provide new opportunities for alternative sampling and data collection methods, but there is limited information about response rates and sample biases in coverage and nonresponse using these methods. We utilized data from an interactive voice response, random-digit dial, national mobile phone survey in Ghana to calculate standardized response rates and assess representativeness of the obtained sample. Materials and methods The survey methodology was piloted in two rounds of data collection. The final survey included 18 demographic, media exposure, and health behavior questions. Call outcomes and response rates were calculated according to the American Association of Public Opinion Research guidelines. Sample characteristics, productivity, and costs per interview were calculated. Representativeness was assessed by comparing data to the Ghana Demographic and Health Survey and the National Population and Housing Census. Results The survey was fielded during a 27-day period in February-March 2017. There were 9,469 completed interviews and 3,547 partial interviews. Response, cooperation, refusal, and contact rates were 31%, 81%, 7%, and 39% respectively. Twenty-three calls were dialed to produce an eligible contact: nonresponse was substantial due to the automated calling system and dialing of many unassigned or non-working numbers. Younger, urban, better educated, and male respondents were overrepresented in the sample. Conclusions The innovative mobile phone data collection methodology yielded a large sample in a relatively short period. Response rates were comparable to other surveys, although substantial coverage bias resulted from fewer women, rural, and older residents completing the mobile phone survey in comparison to household surveys. Random digit dialing of mobile phones offers promise for future data collection in Ghana and may be suitable for other developing countries.	[L'Engle, Kelly] Univ San Francisco, Sch Nursing & Hlth Profess, San Francisco, CA 94117 USA; [Sefa, Eunice; Adimazoya, Edward Akolgo; Yartey, Emmanuel] FHI 360, Communicate Hlth C4H Project, Accra, Ghana; [Lenzi, Rachel] FHI 360, Behav Epidemiol & Clin Sci Div, Durham, NC USA; [Tarpo, Cindy; Heward-Mills, Nii Lante] VOTO Mobile, Accra, Ghana; [Lew, Katherine] FHI 360, Strateg Informat & Monitoring & Evaluat Div, Washington, DC USA; [Ampeh, Yvonne] Minist Hlth, Hlth Promot Dept, Ghana Hlth Serv, Accra, Ghana	University of San Francisco; FHI 360; Ghana Health Service	L'Engle, K (corresponding author), Univ San Francisco, Sch Nursing & Hlth Profess, San Francisco, CA 94117 USA.	klengle@usfca.edu		Lenzi-Weisbecker, Rachel/0000-0002-4032-7177	United States Agency for International Development [AID-641-A-15-00003]; VOTO Mobile	United States Agency for International Development(United States Agency for International Development (USAID)); VOTO Mobile	The Communicate for Health program was made possible by the support of the American people through the United States Agency for International Development (Cooperative Agreement AID-641-A-15-00003) to FHI 360. The contents of this manuscript are the sole responsibility of the authors and do not necessarily reflect the views of USAID or the United States government. The funder provided full or partial salary support for ES, EM, EY, RL, and KLew, provided contractual support to KL'Engle, and provided contractual support to CT and NLH through VOTO Mobile. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Authors' contributions' section.	AAPOR, 2016, ENCY SURVEY RES METH; Aday LA, 2011, DESIGNING CONDUCTING, V3rd; American Association of Public Opinion Researchers, 2010, NEW CONS SURV RES PL; [Anonymous], 2012, 2010 POP HOUS CENS N; [Anonymous], 2017, WORLD TEL ICT DEV RE; Barr ML, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-177; Chandy L, STUFFING DATA GAPS D; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; Dal Grande E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150231; Fowler Jr FJ., 2013, SURVEY RES METHODS; Frey J., 1989, SURVEY RES TELEPHONB; Gallup, 2016, DISP CELL PHON OWN P; Ghana Statistical Service, 2015, GHAN DEM HLTH SURV; GSMA, 2015, CONN WOM BRIDG GEND; Gundersen DA, 2014, AM J EPIDEMIOL, V180, P1047, DOI 10.1093/aje/kwu271; Gundersen DA, 2014, AM J EPIDEMIOL, V179, P39, DOI 10.1093/aje/kwt226; Hancioglu A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001391; Hu SHS, 2010, B WORLD HEALTH ORGAN, V88, P799, DOI 10.2471/BLT.10.082669; Kempf AM, 2007, ANNU REV PUBL HEALTH, V28, P113, DOI 10.1146/annurev.publhealth.28.021406.144059; Lee S, 2010, HEALTH SERV RES, V45, P1121, DOI 10.1111/j.1475-6773.2010.01120.x; Leo B., 2015, 398 CTR GLOB DEV; Lietz H, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.28330; Liu B, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-159; Mahfoud Z, 2015, FIELD METHOD, V27, P39, DOI 10.1177/1525822X14540084; Martsolf GR, 2013, HEALTH SERV RES, V48, P665, DOI 10.1111/j.1475-6773.2012.01464.x; Pew Research Center, 2015, CELL PHON AFR COMM L; Sibai AM, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0160-0; Smith TW., 2009, REVISED REV METHODS; Vaessen M, 2005, HOUSEHOLD SAMPLE SUR, P495; World Bank, 2016, WORLD DEV REP 2016 D	30	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190902	10.1371/journal.pone.0190902	http://dx.doi.org/10.1371/journal.pone.0190902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351349	Green Submitted, Green Published, gold			2022-12-27	WOS:000422911300030
J	Peek, J; Harvey, C; Gray, D; Rosenberg, D; Kolla, L; Levy-Myers, R; Yin, R; McMurry, JL; Kerscher, O				Peek, Jennifer; Harvey, Catherine; Gray, Dreux; Rosenberg, Danny; Kolla, Likhitha; Levy-Myers, Reuben; Yin, Rui; McMurry, Jonathan L.; Kerscher, Oliver			SUMO targeting of a stress-tolerant Ulp1 SUMO protease	PLOS ONE			English	Article							YEAST KLUYVEROMYCES-MARXIANUS; UBIQUITIN; SUMOYLATION; LOCALIZATION; ISOPEPTIDASE; PROGRESSION; MECHANISM; PROTEINS; SEQUENCE; PATHWAY	SUMO proteases of the SENP/Ulp family are master regulators of both sumoylation and desumoylation and regulate SUMO homeostasis in eukaryotic cells. SUMO conjugates rapidly increase in response to cellular stress, including nutrient starvation, hypoxia, osmotic stress, DNA damage, heat shock, and other proteotoxic stressors. Nevertheless, little is known about the regulation and targeting of SUMO proteases during stress. To this end we have undertaken a detailed comparison of the SUMO-binding activity of the budding yeast protein Ulp1 (ScUlp1) and its ortholog in the thermotolerant yeast Kluyveromyces marxianus, KmUlp1. We find that the catalytic UD domains of both ScUlp1 and KmUlp1 show a high degree of sequence conservation, complement a ulp1 Delta mutant in vivo, and process a SUMO precursor in vitro. Next, to compare the SUMO-trapping features of both SUMO proteases we produced catalytically inactive recombinant fragments of the UD domains of ScUlp1 and KmUlp1, termed ScUTAG and KmUTAG respectively. Both ScUTAG and KmUTAG were able to efficiently bind a variety of purified SUMO isoforms and bound immobilized SUMO1 with nanomolar affinity. However, KmUTAG showed a greatly enhanced ability to bind SUMO and SUMO-modified proteins in the presence of oxidative, temperature and other stressors that induce protein misfolding. We also investigated whether a SUMO-interacting motif (SIM) in the UD domain of KmULP1 that is not conserved in ScUlp1 may contribute to the SUMO-binding properties of KmUTAG. In summary, our data reveal important details about how SUMO proteases target and bind their sumoylated substrates, especially under stress conditions. We also show that the robust pan-SUMO binding features of KmUTAG can be exploited to detect and study SUMO-modified proteins in cell culture systems.	[Peek, Jennifer; Harvey, Catherine; Gray, Dreux; Rosenberg, Danny; Kolla, Likhitha; Levy-Myers, Reuben; Yin, Rui; Kerscher, Oliver] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA; [McMurry, Jonathan L.] Kennesaw State Univ, Dept Mol & Cellular Biol, Kennesaw, GA USA	William & Mary; University System of Georgia; Kennesaw State University	Kerscher, O (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA.	opkers@wm.edu		Kolla, Likhitha/0000-0002-1169-906X; Peek, Jennifer/0000-0002-1239-8752; Harvey, Catherine/0000-0002-9466-1517; Levy-Myers, Reuben/0000-0003-4024-2947; Yin, Rui/0000-0001-5330-8306; Kerscher, Oliver/0000-0001-6603-9352	Commonwealth Research Commercialization Fund (CRCF) [MF16-034-LS]; National Institute of General Medical Sciences R15 grant [GM120691]; Broderick Family/Goldman Sachs TDAP award; Alcoa Foundation Summer Fellowship Award; HHMI Science and Research Program at William and Mary	Commonwealth Research Commercialization Fund (CRCF); National Institute of General Medical Sciences R15 grant; Broderick Family/Goldman Sachs TDAP award; Alcoa Foundation Summer Fellowship Award; HHMI Science and Research Program at William and Mary	This work was supported by the Commonwealth Research Commercialization Fund (CRCF) award (grant no. MF16-034-LS) to OK, National Institute of General Medical Sciences R15 grant GM120691 to JLM, a Broderick Family/Goldman Sachs TDAP award to OK, an Alcoa Foundation Summer Fellowship Award to DG, and support from the HHMI Science and Research Program at William and Mary to DG, JP, CH, RLM, LK, and DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre KO, 2011, J BIOL CHEM, V286, P36142, DOI 10.1074/jbc.M111.268847; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Boudreau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045918; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Da Silva-Ferrada E, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/875148; de Albuquerque CP, 2016, J BIOL CHEM, V291, P8825, DOI 10.1074/jbc.M116.716399; Eckhoff J, 2015, J BIOL CHEM, V290, P12268, DOI 10.1074/jbc.M114.622217; Elmore ZC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-74; Fu J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004579; Guo WH, 2011, J CANCER RES CLIN, V137, P533, DOI 10.1007/s00432-010-0920-x; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim YM, 2011, J NEUROL SCI, V307, P157, DOI 10.1016/j.jns.2011.04.015; Kroetz MB, 2009, MOL BIOL CELL, V20, P2196, DOI 10.1091/mbc.E08-10-1090; Lertwattanasakul N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0227-x; Lewicki MC, 2015, J PROTEOMICS, V118, P39, DOI 10.1016/j.jprot.2014.11.012; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Makhnevych T, 2007, J CELL BIOL, V177, P39, DOI 10.1083/jcb.200608066; McNally BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002277; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Nayak A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0422-2; Nie MH, 2015, J BIOL CHEM, V290, P22678, DOI 10.1074/jbc.M115.673038; Oliver Kerscher, 2016, ELS; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pinheiro R, 2002, APPL MICROBIOL BIOT, V58, P842, DOI 10.1007/s00253-001-0927-y; Pinto MP, 2012, BBA-MOL CELL RES, V1823, P1958, DOI 10.1016/j.bbamcr.2012.07.010; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Rojas-Fernandez A, 2014, MOL CELL, V53, P880, DOI 10.1016/j.molcel.2014.02.031; Schwartz DC, 2007, MOL CELL BIOL, V27, P6948, DOI 10.1128/MCB.00774-07; Seifert A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2213; Srikumar T, 2013, J CELL BIOL, V201, P145, DOI 10.1083/jcb.201210019; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Sydorskyy Y, 2010, MOL CELL BIOL, V30, P4452, DOI 10.1128/MCB.00335-10; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Vigodner M, 2013, HUM REPROD, V28, P210, DOI 10.1093/humrep/des317; Wang Q, 2013, ONCOGENE, V32, P2493, DOI 10.1038/onc.2012.250; Westerbeck JW, 2014, MOL BIOL CELL, V25, P1, DOI 10.1091/mbc.E13-05-0291; Willson V., 2009, SUMO REGULATION CELL; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; Yamamoto H, 2015, J BIOL CHEM, V290, P29506, DOI 10.1074/jbc.M115.684233; Zhang HJ, 2013, CELL BIOCHEM BIOPHYS, V67, P1081, DOI 10.1007/s12013-013-9612-x; Zhang QS, 2016, ONCOL LETT, V12, P217, DOI 10.3892/ol.2016.4558; Zhao Q, 2014, NUCLEIC ACIDS RES, V42, pW325, DOI 10.1093/nar/gku383	53	5	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191391	10.1371/journal.pone.0191391	http://dx.doi.org/10.1371/journal.pone.0191391			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351565	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300081
J	Rocca, CH; Puri, M; Shrestha, P; Blum, M; Maharjan, D; Grossman, D; Regmi, K; Darney, PD; Harper, CC				Rocca, Corinne H.; Puri, Mahesh; Shrestha, Prabhakar; Blum, Maya; Maharjan, Dev; Grossman, Daniel; Regmi, Kiran; Darney, Philip D.; Harper, Cynthia C.			Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: A non-inferiority study in Nepal	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; MISOPROSTOL; PROVISION; WOMEN; WORKERS; ACCESS; INDUCE; INDIA; CARE	Background Expanding access to medication abortion through pharmacies is a promising avenue to reach women with safe and convenient care, yet no pharmacy provision interventions have been evaluated. This observational non-inferiority study investigated the effectiveness and safety of mifepristone-misoprostol medication abortion provided at pharmacies, compared to government-certified public health facilities, by trained auxiliary nurse-midwives in Nepal. Methods Auxiliary nurse-midwives were trained to provide medication abortion through twelve pharmacies and public facilities as part of a demonstration project in two districts. Eligible women were <= 63 days pregnant, aged 16-45, and had no medical contraindications. Between 2014-2015, participants (n = 605) obtained 200 mg mifepristone orally and 800 mu g misoprostol sublingually or intravaginally 24 hours later, and followed-up 14-21 days later. The primary outcome was complete abortion without manual vacuum aspiration; the secondary outcome was complication requiring treatment. We assessed risk differences by facility type with multivariable logistic mixed-effects regression. Results Over 99% of enrolled women completed follow-up (n = 600). Complete abortions occurred in 588 (98.0%) cases, with ten incomplete abortions and two continuing pregnancies. 293/297 (98.7%) pharmacy participants and 295/303 (97.4%) public facility participants had complete abortions, with an adjusted risk difference falling within the pre-specified 5 percentage-point non-inferiority margin (1.5% [-0.8%, 3.8%]). No serious adverse events occurred. Five (1.7%) pharmacy and two (0.7%) public facility participants experienced a complication warranting treatment (aRD, 0.8% [-1.0%-2.7%]). Conclusions Early mifepristone-misoprostol abortion was as effective and safe when provided by trained auxiliary nurse-midwives at pharmacies as at government-certified health facilities. Findings support policy expanding provision through registered pharmacies by trained auxiliary nurse-midwives to improve access to safe care.	[Rocca, Corinne H.; Blum, Maya; Maharjan, Dev; Grossman, Daniel; Regmi, Kiran; Darney, Philip D.; Harper, Cynthia C.] Univ Calif San Francisco, Sch Med, Bixby Ctr Global Reprod Hlth, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Rocca, Corinne H.; Grossman, Daniel] Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, ANSIRH, San Francisco, CA 94143 USA; [Puri, Mahesh; Shrestha, Prabhakar] CREHPA, Kathmandu, Nepal; [Regmi, Kiran] Minist Hlth, Kathmandu, Nepal	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rocca, CH (corresponding author), Univ Calif San Francisco, Sch Med, Bixby Ctr Global Reprod Hlth, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.; Rocca, CH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Obstet Gynecol & Reprod Sci, ANSIRH, San Francisco, CA 94143 USA.	corinne.rocca@ucsf.edu		Rocca, Corinne/0000-0001-9892-249X	Society of Family Planning Research Fund [SFPRF7-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052163] Funding Source: NIH RePORTER	Society of Family Planning Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Society of Family Planning Research Fund supported this study (grant: SFPRF7-1, http://www.societyfp.org/Research-and-grants.aspx). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KL, 2016, J MIDWIFERY WOM HEAL, V61, P177, DOI 10.1111/jmwh.12419; Blumenthal P, 2009, PROVIDING MED ABORTI; CREHPA, 2013, ENG PRIV PHARM CHEM; Olavarrieta CD, 2015, B WORLD HEALTH ORGAN, V93, P249, DOI 10.2471/BLT.14.143990; Fetters T, 2015, REPROD HEALTH MATTER, V22, P116, DOI 10.1016/S0968-8080(14)43794-7; Goel P, 1996, SOC SCI MED, V42, P1155, DOI 10.1016/0277-9536(95)00388-6; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Hedley A, 2004, CONTRACEPTION, V69, P157, DOI 10.1016/j.contraception.2003.11.010; Henderson JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064775; Hendrickson C, 2016, INT J GYNECOL OBSTET, V132, P214, DOI 10.1016/j.ijgo.2015.07.008; Huda FA, 2014, INT J GYNECOL OBSTET, V124, P164, DOI 10.1016/j.ijgo.2013.07.037; Iyengar K, 2015, LANCET GLOB HEALTH, V3, pE537, DOI 10.1016/S2214-109X(15)00150-3; Jejeebhoy SJ, 2012, INT PERSPECT SEX R H, V38, P133, DOI 10.1363/3813312; Karki YB, 2010, EVALUATION USAID NEP; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Lara D, 2011, INT PERSPECT SEX R H, V37, P75, DOI 10.1363/3707511; Ministry of Health and Population, 2015, MED AB REF MAN; Ministry of Health and Population Department of Health Services, 2003, NAT SAF AB IN PRESS; Piaggio G, 2010, JAMA-J AM MED ASSOC, V2012, P2594, DOI DOI 10.1001/JAMA.2012.87802; Powell-Jackson T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120637; Pradhan A, 2010, NEPAL MATERNAL MORTA; Raymond EG, 2015, CONTRACEPTION, V92, P212, DOI 10.1016/j.contraception.2015.04.008; Reiss K, 2016, J FAM PLAN REPROD H, V42, P208, DOI 10.1136/jfprhc-2013-100821; Rocca CH, 2013, BJOG-INT J OBSTET GY, V120, P1075, DOI 10.1111/1471-0528.12242; Samandari G, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-7; Singh S, 2016, BJOG-INT J OBSTET GY, V123, P1489, DOI 10.1111/1471-0528.13552; Sneeringer RK, 2012, J PUBLIC HEALTH POL, V33, P218, DOI 10.1057/jphp.2012.11; Subha B, 2012, INT J GYNECOL OBSTET, V118, pS33, DOI 10.1016/j.ijgo.2012.05.008; Tamang A, 2015, REPROD HEALTH MATTER, V22, P104, DOI 10.1016/S0968-8080(14)43785-6; Warriner IK, 2006, LANCET, V368, P1965, DOI 10.1016/S0140-6736(06)69742-0; Warriner IK, 2011, LANCET, V377, P1155, DOI 10.1016/S0140-6736(10)62229-5; World Health Organization, 2015, WHO MOD LIST ESS MED; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; World Health Organization, 2015, HLTH WORK ROL PROV S; Wu WJ, 2017, HEALTH HUM RIGHTS, V19, P221; Yarnall J, 2009, REPROD HEALTH MATTER, V17, P61, DOI 10.1016/S0968-8080(09)33445-X	36	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191174	10.1371/journal.pone.0191174	http://dx.doi.org/10.1371/journal.pone.0191174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351313	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300053
J	Lindegaard, B; Hvid, T; Mygind, HW; Hartvig-Mortensen, O; Grondal, T; Abildgaard, J; Gerstoft, J; Pedersen, BK; Baranowski, M				Lindegaard, Birgitte; Hvid, Thine; Mygind, Helene Wolsk; Hartvig-Mortensen, Ole; Grondal, Thomas; Abildgaard, Julie; Gerstoft, Jan; Pedersen, Bente Klarlund; Baranowski, Marcin			Low expression of IL-18 and IL-18 receptor in human skeletal muscle is associated with systemic and intramuscular lipid metabolism-Role of HIV lipodystrophy	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; IFN-GAMMA PRODUCTION; INSULIN-RESISTANCE; INFECTED PATIENTS; TNF-ALPHA; GENE-EXPRESSION; ELEVATED LEVELS; INTERLEUKIN-18; PLASMA; FAT	Introduction Interleukin (IL)-18 is involved in regulation of lipid and glucose metabolism. Mice lacking whole-body IL-18 signalling are prone to develop weight gain and insulin resistance, a phenotype which is associated with impaired fat oxidation and ectopic skeletal muscle lipid deposition. IL-18 mRNA is expressed in human skeletal muscle but a role for IL-18 in muscle has not been identified. Patients with HIV-infection and lipodystrophy (LD) are characterized by lipid and glucose disturbances and increased levels of circulating IL-18. We hypothesized that skeletal muscle IL-18 and IL-18 receptor (R) expression would be altered in patients with HIV-lipodystrophy. Design and methods Twenty-three HIV-infected patients with LD and 15 age-matched healthy controls were included in a cross-sectional study. Biopsies from the vastus lateralis muscle were obtained and IL-18 and IL-18R mRNA expression were measured by real-time PCR and sphingolipids (ceramides, sphingosine, sphingosine-1-Phosphate, sphinganine) were measured by HPLC. Insulin resistance was assessed by HOMA and the insulin response during an OGTT. Results Patients with HIV-LD had a 60% and 54% lower level of muscular IL-18 and IL-18R mRNA expression, respectively, compared to age-matched healthy controls. Patients with HIV-LD had a trend towards increased levels of ceramide (18.3 +/- 4.7 versus 14.8 +/- 3.0,p = 0.06) and sphingosine (0.41 +/- 0.13 versus 0.32 +/- 0.07, and lower level of sphinganine (p = 0.06). Low levels of muscle IL-18 mRNA correlated to high levels of ceramides (r = -0.31, p = 0.038) and sphingosine-1P (r = -0.29, p = 0.046) in skeletal muscle, whereas such a correlation was not found in healthy controls. Low expression of IL-18 mRNA in skeletal muscle correlated to elevated concentration of circulating triglycerides (R-p = -0.73, p<0.0001). Neither muscle expression of IL-18 mRNA or ceramide correlated to parameters of insulin resistance. Conclusion IL-18 (mRNA) in skeletal muscle appears to be involved in the regulation of intramuscular lipid metabolism and hypertriglyceridemia.	[Lindegaard, Birgitte; Hvid, Thine; Mygind, Helene Wolsk; Grondal, Thomas; Abildgaard, Julie; Pedersen, Bente Klarlund] Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark; [Lindegaard, Birgitte; Hvid, Thine; Mygind, Helene Wolsk; Grondal, Thomas; Abildgaard, Julie; Pedersen, Bente Klarlund] Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark; [Lindegaard, Birgitte; Gerstoft, Jan] Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Lindegaard, Birgitte] Nordsjaellands Hosp, Dept Lung & Infect Dis, Hillerod, Denmark; [Hartvig-Mortensen, Ole] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Baranowski, Marcin] Med Univ Bialystok, Dept Physiol, Bialystok, Poland	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Medical University of Bialystok	Lindegaard, B (corresponding author), Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark.; Lindegaard, B (corresponding author), Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark.; Lindegaard, B (corresponding author), Rigshosp, Dept Infect Dis, Copenhagen, Denmark.; Lindegaard, B (corresponding author), Nordsjaellands Hosp, Dept Lung & Infect Dis, Hillerod, Denmark.	birgitte.lindegaard.madsen@regionh.dk	Pedersen, Bente Klarlund/AGR-3217-2022; Abildgaard, Julie/ABB-2325-2020; Baranowski, Marcin/F-6718-2011; Lindegaard, Birgitte/AGY-9629-2022	Pedersen, Bente Klarlund/0000-0001-6508-6288; Abildgaard, Julie/0000-0003-1317-7051; Baranowski, Marcin/0000-0002-3714-5815; Lindegaard, Birgitte/0000-0002-5236-8427; Mortensen, Ole Hartvig/0000-0003-1118-6317	Danish National Research Foundation [DNRF55]; TrygFonden; Lundbeck foundation; Danish AIDS Foundation; Novo Nordisk Foundation; Direktor Emil Hertz og Hustru Inger Hertz Fond; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Fonden for Laegevidenskabens Fremme; Danish Council for Strategic Research [09-067009, 09-075724]	Danish National Research Foundation(Danmarks Grundforskningsfond); TrygFonden; Lundbeck foundation(Lundbeckfonden); Danish AIDS Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Direktor Emil Hertz og Hustru Inger Hertz Fond; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Fonden for Laegevidenskabens Fremme; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Danish National Research Foundation (DNRF55). The Centre for Physical Activity Research (CFAS) is supported by a grant from TrygFonden. This study was further supported by grants from the Lundbeck foundation, the Danish AIDS Foundation, the Novo Nordisk Foundation, Direktor Emil Hertz og Hustru Inger Hertz Fond, Direktor Jacob Madsen og Hustru Olga Madsens Fond, Fonden for Laegevidenskabens Fremme. CIM/CFAS is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The funders had a no role in study design, data collection adn analysis, decision to publish, or prepation of the manuscript.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; Aso Y, 2003, DIABETES CARE, V26, P2622, DOI 10.2337/diacare.26.9.2622; Benetti E, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/678627; Bergman BC, 2016, DIABETOLOGIA, V59, P785, DOI 10.1007/s00125-015-3850-y; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Bruun JM, 2007, EUR J ENDOCRINOL, V157, P465, DOI 10.1530/EJE-07-0206; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Capeau J, 2007, CURR OPIN HIV AIDS, V2, P247, DOI 10.1097/COH.0b013e3281e66919; Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6; Chandrasekar B, 2005, J BIOL CHEM, V280, P26263, DOI 10.1074/jbc.M502586200; Coen PM, 2010, DIABETES, V59, P80, DOI 10.2337/db09-0988; de WR, 2013, PLOS ONE, V8; Ebbert JO, 2013, NUTRIENTS, V5, P498, DOI 10.3390/nu5020498; Esposito K, 2002, J CLIN ENDOCR METAB, V87, P3864, DOI 10.1210/jc.2002-????; Fain JN, 2006, METABOLISM, V55, P1113, DOI 10.1016/j.metabol.2006.04.008; Falasca K, 2007, INT J IMMUNOPATH PH, V20, P519, DOI 10.1177/039463200702000310; Fukami T, 2001, CLIN IMMUNOL, V101, P12, DOI 10.1006/clim.2001.5080; Gallego-Escuredo JM, 2013, JAIDS-J ACQ IMM DEF, V64, P142, DOI 10.1097/QAI.0b013e31829bdb67; Gan SK, 2002, DIABETES, V51, P3163, DOI 10.2337/diabetes.51.11.3163; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Hoshino K, 1999, J IMMUNOL, V162, P5041; Kalina U, 2000, J IMMUNOL, V165, P1307, DOI 10.4049/jimmunol.165.3.1307; Kitessa SM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080466; Knapp M, 2013, PROSTAG OTH LIPID M, V106, P53, DOI 10.1016/j.prostaglandins.2013.10.001; Koenen TB, 2011, ENDOCRINOLOGY, V152, P3769, DOI 10.1210/en.2010-1480; Krogh-Madsen R, 2006, AM J PHYSIOL-ENDOC M, V291, pE108, DOI 10.1152/ajpendo.00471.2005; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Lee MKS, 2016, SEMIN IMMUNOL, V28, P441, DOI 10.1016/j.smim.2016.10.001; Lindegaard B, 2008, J CLIN ENDOCR METAB, V93, P3860, DOI 10.1210/jc.2007-2733; Lindegaard B, 2004, JAIDS-J ACQ IMM DEF, V36, P588, DOI 10.1097/00126334-200405010-00006; Lindegaard B, 2004, AIDS, V18, P1956, DOI 10.1097/00002030-200409240-00013; Lindegaard B, 2013, DIABETES, V62, P3064, DOI 10.2337/db12-1095; Lindegaard B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055632; Luzi L, 2003, AM J PHYSIOL-ENDOC M, V284, pE274, DOI 10.1152/ajpendo.00391.2001; Maagaard A, 2006, ANTIVIR THER, V11, P601; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moriwaki Y, 2003, METABOLISM, V52, P605, DOI 10.1053/meta.2003.50096; Murphy AJ, 2016, CELL METAB, V23, P155, DOI 10.1016/j.cmet.2015.09.024; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ortmeyer HK, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12794; Park M, 2016, J BIOL CHEM, V291, P23978, DOI 10.1074/jbc.M116.737684; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Petersen AMW, 2007, LUNG, V185, P161, DOI 10.1007/s00408-007-9000-7; Plomgaard P, 2005, EXERC IMMUNOL REV, V11, P53; Scheele C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039657; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Sievers M, 2009, J INFECT DIS, V200, P252, DOI 10.1086/599986; Smart MC, 2011, NUTR METAB CARDIOVAS, V21, P476, DOI 10.1016/j.numecd.2009.12.004; Spoto B, 2014, NUTR METAB CARDIOVAS, V24, P1137, DOI 10.1016/j.numecd.2014.04.017; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Torriani M, 2003, J APPL PHYSIOL, V95, P1005, DOI 10.1152/japplphysiol.00366.2003; Tucci M, 2006, CLIN EXP IMMUNOL, V146, P21, DOI 10.1111/j.1365-2249.2006.03180.x; Vassimon HS, 2012, NUTRITION, V28, P912, DOI 10.1016/j.nut.2011.12.010; Villarroya F, 2007, CURR OPIN HIV AIDS, V2, P261, DOI 10.1097/COH.0b013e32810fd785; Villarroya F, 2010, BBA-MOL CELL BIOL L, V1801, P392, DOI 10.1016/j.bbalip.2009.09.018; Wicks SE, 2015, P NATL ACAD SCI USA, V112, pE3300, DOI 10.1073/pnas.1418560112; Wood IS, 2005, BIOCHEM BIOPH RES CO, V337, P422, DOI 10.1016/j.bbrc.2005.09.068; Yoo JK, 2005, J IMMUNOL, V175, P8280, DOI 10.4049/jimmunol.175.12.8280; Zilverschoon GR, 2008, INT J OBES LOND; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	66	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0186755	10.1371/journal.pone.0186755	http://dx.doi.org/10.1371/journal.pone.0186755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342149	Green Submitted, Green Published, gold			2022-12-27	WOS:000422653800001
J	Pai, CW; Lin, HY; Tsai, SH; Chen, PL				Pai, Chih-Wei; Lin, Hsiao-Yu; Tsai, Shin-Han; Chen, Ping-Ling			Comparison of traffic-injury related hospitalisation between bicyclists and motorcyclists in Taiwan	PLOS ONE			English	Article							HELMET LAW; SEVERITY; CRASHES; VEHICLE; RISK; HEAD; ENVIRONMENT; ACCIDENTS; PATTERNS; OUTCOMES	Objectives Bicyclists and motorcyclists contribute substantially to the morbidity and mortality rates of road crash casualties. The objective of the study was to investigate the crash characteristics of bicyclist and motorcyclist casualties presented to hospitals in Taiwan resulting from crashes. Methods By using linked data from The National Traffic Crash Dataset and the National Health Insurance Database between 2003 and 2012, logistic regression models were used to examine the determinants of hospitalisation among motorcyclist and bicyclist casualties. The examined variables include demographic characteristics, road and weather conditions, and vehicle characteristics. Results A total of 1,998,606 two-wheelers were enrolled in the study, of whom 216,600 were hospitalised: 203,623 were motorcyclists and 12,964 were bicyclists. Bicyclists were more likely to be hospitalised than motorcyclists were (14.0% vs. 10.7%). The pooled logistic regression model shows that bicyclists had higher odds of hospitalisation than motorcyclists (adjusted odds ratio [AOR] =1.11, 95% confident interval [CI] = 1.08-1.14). In the motorcyclist and bicyclist models, helmet non-use appears to be a determinant of hospitalisation for motorcyclists (AOR = 1.14, CI = 1.12-1.16), although insignificant for cyclists (AOR = 1.03, CI = 0.94-1.12). Other important determinants of hospitalisation for motorcyclists and cyclists include female riders, elderly riders, rural roadways, unlicensed riding (for motorcyclists only), curved roadways, defective roadways, alcohol consumption (only for motorcyclists), and single-vehicle crashes (for motorcyclists only). Conclusions The result that bicyclists had an increased probability of being hospitalised than motorcyclists is particularly noteworthy, because there have recently been much more users of bikesharing systems in metropolitan cities where cycle helmets are not provided. We further found that helmet non-use was also a risk factor for motorcyclists, but insignificant for cyclists, possibly due to lower helmet utilization rates among bicyclists. Our findings regarding the increased hospitalisation percentage emphasize the importance of helmet use.	[Pai, Chih-Wei; Tsai, Shin-Han; Chen, Ping-Ling] Taipei Med Univ, Grad Inst Injury Prevent & Control, Coll Publ Hlth, Taipei, Taiwan; [Lin, Hsiao-Yu] Taipei Med Univ Hosp, Dept Urol, Taipei, Taiwan; [Tsai, Shin-Han] Shuang Ho Hosp, Dept Emergency Med, New Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Shuang Ho Hospital	Tsai, SH; Chen, PL (corresponding author), Taipei Med Univ, Grad Inst Injury Prevent & Control, Coll Publ Hlth, Taipei, Taiwan.; Lin, HY (corresponding author), Taipei Med Univ Hosp, Dept Urol, Taipei, Taiwan.; Tsai, SH (corresponding author), Shuang Ho Hosp, Dept Emergency Med, New Taipei, Taiwan.	ablin@tmu.edu.tw; shtsai@tmu.edu.tw; plchen@tmu.edu.tw			Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan [E1030909-104]; Taipei Medical University - Shuang Ho Hospital [102TMU-SHH-12]	Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan; Taipei Medical University - Shuang Ho Hospital	This study was supported by a grant from the Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan (Grant number: E1030909-104) and a grant from Taipei Medical University - Shuang Ho Hospital (Grant number: 102TMU-SHH-12) to PLC.	Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Boufous S, 2012, ACCIDENT ANAL PREV, V49, P404, DOI 10.1016/j.aap.2012.03.011; Broughton J, 2005, TRL6292005; Chen P-L, 2015, STAT INJURY SURVEILL; Chen P, 2016, ACCIDENT ANAL PREV, V86, P239, DOI 10.1016/j.aap.2015.11.002; Chiu WT, 2011, JAMA-J AM MED ASSOC, V306, P267, DOI 10.1001/jama.2011.989; Chung CH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-744; Cunningham G, 2012, ANZ J SURG, V82, P551, DOI 10.1111/j.1445-2197.2012.06127.x; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Gavin AL, 2005, J AUSTRALAS COLL ROA, V16, P25; Haworth N, 1997, CR174 FED OFF ROAD S; Ichikawa M, 2003, ACCIDENT ANAL PREV, V35, P183, DOI 10.1016/S0001-4575(01)00102-6; Islam S, 2017, ACCIDENT ANAL PREV, V108, P163, DOI 10.1016/j.aap.2017.08.016; Jung S, 2013, ACCIDENT ANAL PREV, V59, P357, DOI 10.1016/j.aap.2013.06.030; Kasantikul V, 2005, ACCIDENT ANAL PREV, V37, P357, DOI 10.1016/j.aap.2004.07.006; Keng SH, 2005, ACCIDENT ANAL PREV, V37, P349, DOI 10.1016/j.aap.2004.09.006; Kim JK, 2007, ACCIDENT ANAL PREV, V39, P238, DOI 10.1016/j.aap.2006.07.002; Klop J. R, 1999, TRANSPORT RES REC, V1674, P78; Liu BC, 2008, HELMETS PREVENTING I; Liu CY, 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Mackay M, 1988, SPECIAL REPORT 218 T, V2, P158; Mayrose J, 2008, J SAFETY RES, V39, P429, DOI 10.1016/j.jsr.2008.07.001; Meuleners LB, 2007, ACCIDENT ANAL PREV, V39, P1222, DOI 10.1016/j.aap.2007.03.006; Moore DN, 2011, ACCIDENT ANAL PREV, V43, P621, DOI 10.1016/j.aap.2010.09.015; National Expressway Engineering Bureau Ministry of Transportation and Communications, 2004, 2 HIGHW CONSTR ALB T, P68; Noland RB, 2004, TRANSPORT RES REC, P28; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw360, 10.1093/ije/dyw153]; Ouellet James V, 2006, Traffic Inj Prev, V7, P49, DOI 10.1080/15389580500338652; Pai CW, 2008, ACCIDENT ANAL PREV, V40, P479, DOI 10.1016/j.aap.2007.08.003; Passmore J, 2010, TRAFFIC INJ PREV, V11, P202, DOI 10.1080/15389580903497121; Preusser D. F., 2003, EVALUATION REPEAL MO; Quddus MA, 2002, J SAFETY RES, V33, P445, DOI 10.1016/S0022-4375(02)00051-8; Rifaat SM, 2012, ACCIDENT ANAL PREV, V49, P44, DOI 10.1016/j.aap.2011.02.025; Robartes E, 2017, ACCIDENT ANAL PREV, V104, P165, DOI 10.1016/j.aap.2017.04.020; ROSMAN DL, 1994, ACCIDENT ANAL PREV, V26, P215, DOI 10.1016/0001-4575(94)90091-4; Segui-Gomez M, 2008, INJURY RELATED HOSPI; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Sun Y, 2012, DIABETES CARE, V35, P1047, DOI 10.2337/dc11-1511; SUPRAMANIAM V, 1984, ACCIDENT ANAL PREV, V16, P157, DOI 10.1016/0001-4575(84)90009-5; Wen CH, 2012, ACCIDENT ANAL PREV, V49, P193, DOI 10.1016/j.aap.2011.03.006; Wiznia DH, 2016, TRAFFIC INJ PREV, V17, P633, DOI 10.1080/15389588.2015.1136059; Xiong LL, 2015, AIMS PUBLIC HEALTH, V2, P74, DOI 10.3934/publichealth.2015.1.74; Yan XP, 2011, ACCIDENT ANAL PREV, V43, P1751, DOI 10.1016/j.aap.2011.04.006	44	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191221	10.1371/journal.pone.0191221	http://dx.doi.org/10.1371/journal.pone.0191221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8II	29342208	Green Submitted, Green Published, gold			2022-12-27	WOS:000422653800052
J	Papackova, Z; Heczkova, M; Dankova, H; Sticova, E; Lodererova, A; Bartonova, L; Poruba, M; Cahova, M				Papackova, Zuzana; Heczkova, Marie; Dankova, Helena; Sticova, Eva; Lodererova, Alena; Bartonova, Lenka; Poruba, Martin; Cahova, Monika			Silymarin prevents acetaminophen-induced hepatotoxicity in mice	PLOS ONE			English	Article							INDUCED LIVER-INJURY; NITRIC-OXIDE SYNTHASE; CELL-DEATH; HEPATOPROTECTIVE ACTIVITY; OXIDATIVE STRESS; APOPTOSIS; ANTIOXIDANT; NECROSIS; CYTOCHROME-P450; RIP3	Acetaminophen or paracetamol (APAP) overdose is a common cause of liver injury. Silymarin (SLM) is a hepatoprotective agent widely used for treating liver injury of different origin. In order to evaluate the possible beneficial effects of SLM, Balb/c mice were pretreated with SLM (100 mg/kg b.wt. per os) once daily for three days. Two hours after the last SLM dose, the mice were administered APAP (300 mg/kg b.wt. i.p.) and killed 6 (T-6), 12 (T-12) and 24 (T-24) hours later. SLM-treated mice exhibited a significant reduction in APAP-induced liver injury, assessed according to AST and ALT release and histological examination. SLM treatment significantly reduced superoxide production, as indicated by lower GSSG content, lower HO-1 induction, alleviated nitrosative stress, decreased p-JNK activation and direct measurement of mitochondrial superoxide production in vitro. SLM did not affect the APAPinduced decrease in CYP2E1 activity and expression during the first 12 hrs. Neutrophil infiltration and enhanced expression of inflammatory markers were first detected at T-12 in both groups. Inflammation progressed in the APAP group at T-24 but became attenuated in SLMtreated animals. Histological examination suggests that necrosis the dominant cell death pathway in APAP intoxication, which is partially preventable by SLM pretreatment. We demonstrate that SLM significantly protects against APAP-induced liver damage through the scavenger activity of SLM and the reduction of superoxide and peroxynitrite content. Neutrophil-induced damage is probably secondary to necrosis development.	[Papackova, Zuzana; Heczkova, Marie; Dankova, Helena; Cahova, Monika] Inst Clin & Expt Med, Dept Metab & Diabet, Prague, Czech Republic; [Papackova, Zuzana] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Vet Sci, Prague, Czech Republic; [Sticova, Eva; Lodererova, Alena; Bartonova, Lenka] Inst Clin & Expt Med, Clin & Transplant Pathol Dept, Prague, Czech Republic; [Poruba, Martin] Palacky Univ Olomouc, Fac Med & Dent, Dept Pharmacol, Olomouc, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Czech University of Life Sciences Prague; Institute for Clinical & Experimental Medicine (IKEM); Palacky University Olomouc	Papackova, Z (corresponding author), Inst Clin & Expt Med, Dept Metab & Diabet, Prague, Czech Republic.; Papackova, Z (corresponding author), Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Vet Sci, Prague, Czech Republic.	zuzana.papackova@ikem.cz	Cahova, Monika/Z-1568-2018	Cahova, Monika/0000-0003-2640-5084; Sticova, Eva/0000-0003-2486-6266; Poruba, Martin/0000-0003-1252-4971	Czech Science Foundation [17-08888S]; Czech Republic; MH CZ DRO "Institute for Clinical and Experimental Medicine IKEM" [IN 00023001]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Republic(Czech Republic Government); MH CZ DRO "Institute for Clinical and Experimental Medicine IKEM"	This study was supported by grant 17-08888S from the Czech Science Foundation (http://gacr.cz/), Czech Republic to MP and by MH CZ DRO "Institute for Clinical and Experimental Medicine IKEM, IN 00023001" to MC. (http://www.mzcr.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rasheed N, 2016, PHARMACOGN MAG, V12, pS337, DOI 10.4103/0973-1296.185765; Bajt ML, 2011, TOXICOL SCI, V122, P598, DOI 10.1093/toxsci/kfr116; Bajt ML, 2001, AM J PHYSIOL-GASTR L, V281, pG1188, DOI 10.1152/ajpgi.2001.281.5.G1188; Bunchorntavakul C, 2013, CLIN LIVER DIS, V17, P587, DOI 10.1016/j.cld.2013.07.005; BUSTAMANTE E, 1977, ANAL BIOCHEM, V80, P401, DOI 10.1016/0003-2697(77)90661-3; Cederbaum AI, 2006, J GASTROEN HEPATOL, V21, pS22, DOI 10.1111/j.1440-1746.2006.04595.x; Chen Xingmiao, 2014, Biomed J, V37, P120, DOI 10.4103/2319-4170.134084; Cheung C, 2005, DRUG METAB DISPOS, V33, P449, DOI 10.1124/dmd.104.002402; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Comelli MC, 2007, INTEGR CANCER THER, V6, P120, DOI 10.1177/1534735407302349; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; Dara L, 2015, HEPATOLOGY, V62, P1847, DOI 10.1002/hep.27939; Du K, 2016, REDOX BIOL, V10, P148, DOI 10.1016/j.redox.2016.10.001; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Gardner CR, 1998, HEPATOLOGY, V27, P748, DOI 10.1002/hep.510270316; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; Gujral JS, 2002, TOXICOL SCI, V67, P322, DOI 10.1093/toxsci/67.2.322; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hinson JA, 2002, NITRIC OXIDE-BIOL CH, V6, P160, DOI 10.1006/niox.2001.0404; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; JAESCHKE H, 1993, HEPATOLOGY, V17, P915, DOI 10.1016/0270-9139(93)90169-N; Jaeschke H, 2008, HEPATOLOGY, V48, P699, DOI 10.1002/hep.22556; Jaeschke H, 2014, J CLIN TRANSL HEPATO, V2, P153, DOI 10.14218/JCTH.2014.00014; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Jaeschke H, 2011, LIFE SCI, V88, P737, DOI 10.1016/j.lfs.2011.01.025; Jain NK, 2011, ASIAN PAC J TROP MED, V4, P470, DOI 10.1016/S1995-7645(11)60128-4; Knight T. R., 2004, COMP HEPATOL, V3, P1; Knight TR, 2002, J PHARMACOL EXP THER, V303, P468, DOI 10.1124/jpet.102.038968; Koksal E, 2009, J ENZYM INHIB MED CH, V24, P395, DOI [10.1080/14756360802188081, 10.1080/14756360802188081 ]; Kuriakose GC, 2010, INDIAN J EXP BIOL, V48, P1123; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Manov I, 2006, ACTA PHARMACOL SIN, V27, P259, DOI 10.1111/j.1745-7254.2006.00278.x; Masubuchi Y, 2005, J HEPATOL, V42, P110, DOI 10.1016/j.jhep.2004.09.015; McGill MR, 2013, PHARM RES-DORDR, V30, P2174, DOI 10.1007/s11095-013-1007-6; Michael SL, 2001, NITRIC OXIDE-BIOL CH, V5, P432, DOI 10.1006/niox.2001.0385; MIGUEZ MP, 1994, CHEM-BIOL INTERACT, V91, P51, DOI 10.1016/0009-2797(94)90006-X; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Nayak SS, 2011, PHARM BIOL, V49, P111, DOI 10.3109/13880209.2010.501084; Patel N, 2010, TOXICOL APPL PHARM, V245, P143, DOI 10.1016/j.taap.2010.02.002; PRESCOTT LF, 1980, BRIT J CLIN PHARMACO, V10, pS373, DOI 10.1111/j.1365-2125.1980.tb01825.x; Ramachandran A, 2013, HEPATOLOGY, V58, P2099, DOI 10.1002/hep.26547; Rumack BH, 2004, HEPATOLOGY, V40, P10, DOI 10.1002/hep.20300; Sabina Evan Prince, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P1264, DOI 10.3736/jcim20111116; Serviddio G, 2014, FREE RADICAL BIO MED, V73, P117, DOI 10.1016/j.freeradbiomed.2014.05.002; Serviddio G, 2010, J PHARMACOL EXP THER, V332, P922, DOI 10.1124/jpet.109.161612; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; WAGNER H, 1974, ARZNEIMITTEL-FORSCH, V24, P466; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wu MZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006430; Xie WY, 2016, LIFE SCI, V152, P180, DOI 10.1016/j.lfs.2016.04.002; Xie YC, 2013, TOXICOL SCI, V131, P325, DOI 10.1093/toxsci/kfs283; Yang X, 2016, HEPATOLOGY, V64, P311, DOI 10.1002/hep.28263; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	57	52	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191353	10.1371/journal.pone.0191353	http://dx.doi.org/10.1371/journal.pone.0191353			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342206	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800066
J	Petrick, JL; Falk, RT; Hyland, PL; Caron, P; Pfeiffer, RM; Wood, SN; Dawsey, SM; Abnet, CC; Taylor, PR; Guillemette, C; Murray, LJ; Anderson, LA; Cook, MB				Petrick, Jessica L.; Falk, Roni T.; Hyland, Paula L.; Caron, Patrick; Pfeiffer, Ruth M.; Wood, Shannon N.; Dawsey, Sanford M.; Abnet, Christian C.; Taylor, Philip R.; Guillemette, Chantal; Murray, Liam J.; Anderson, Lesley A.; Cook, Michael B.			Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study	PLOS ONE			English	Article							BREAST-CANCER RISK; LONG-TERM STORAGE; BARRETTS-ESOPHAGUS; REFLUX ESOPHAGITIS; PROSTATE-CANCER; SERUM; TESTOSTERONE; MEN; INFLAMMATION; ESTROGEN	Background Esophageal adenocarcinoma (EA) is characterized by a strong male predominance. Sex steroid hormones have been hypothesized to underlie this sex disparity, but no population-based study to date has examined this potential association. Methods Using mass spectrometry and ELISA, we quantitated sex steroid hormones and sex hormone binding globulin, respectively, in plasma from males- 172 EA cases and 185 controls-within the Factors Influencing the Barrett/Adenocarcinoma Relationship (FINBAR) Study, a case-control investigation conducted in Northern Ireland and Ireland. Multivariable adjusted logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for associations between circulating hormones and EA. Results Higher androgen: estrogen ratio metrics were associated with increased odds of EA (e.g., testosterone: estradiol ratio ORQ4v.Q1 = 2.58, 95% CI = 1.23-5.43; P-trend = 0.009). All estrogens and androgens were associated with significant decreased odds of EA. When restricted to individuals with minimal to no decrease in body mass index, the size of association for the androgen: estrogen ratio was not greatly altered. Conclusions This first study of sex steroid hormones and EA provides tentative evidence that androgen: estrogen balance may be a factor related to EA. Replication of these findings in prospective studies is needed to enhance confidence in the causality of this effect.	[Petrick, Jessica L.; Falk, Roni T.; Hyland, Paula L.; Pfeiffer, Ruth M.; Wood, Shannon N.; Dawsey, Sanford M.; Abnet, Christian C.; Taylor, Philip R.; Cook, Michael B.] NIH, Natl Canc Inst, DHHS, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Caron, Patrick; Guillemette, Chantal] Laval Univ, Ctr Hosp Univ Laval Quebec CHU Quebec, Res Ctr, Quebec City, PQ, Canada; [Caron, Patrick; Guillemette, Chantal] Laval Univ, Fac Pharm, Pharmacogen Lab, Quebec City, PQ, Canada; [Murray, Liam J.; Anderson, Lesley A.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Laval University; Laval University; Queens University Belfast	Petrick, JL (corresponding author), NIH, Natl Canc Inst, DHHS, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	jessica.petrick@nih.gov	Abnet, Christian C/C-4111-2015; Petrick, Jessica/P-1678-2017; Cook, Michael B/A-5641-2009; Guillemette, Chantal/AAT-6246-2020; Guillemette, Chantal/J-6463-2012; Petrick, Jessica/AAA-9079-2020	Abnet, Christian C/0000-0002-3008-7843; Petrick, Jessica/0000-0001-6580-450X; Cook, Michael B/0000-0002-0533-7302; Guillemette, Chantal/0000-0002-1113-1212; Anderson, Lesley/0000-0002-1000-3649; Wood, Shannon/0000-0003-4389-3526	NIH Intramural Research Program, National Cancer Institute; Cancer Focus Northern Ireland (formerly the Ulster Cancer Foundation); Northern Ireland RD office; Health Research Board, Ireland; NATIONAL CANCER INSTITUTE [ZIACP010220] Funding Source: NIH RePORTER	NIH Intramural Research Program, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Focus Northern Ireland (formerly the Ulster Cancer Foundation); Northern Ireland RD office; Health Research Board, Ireland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by NIH Intramural Research Program, National Cancer Institute; Cancer Focus Northern Ireland (formerly the Ulster Cancer Foundation); the Northern Ireland R&D office; and the Health Research Board, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2008, GUT, V57, P734, DOI 10.1136/gut.2007.132662; Anderson LA, 2007, WORLD J GASTROENTERO, V13, P1585, DOI 10.3748/wjg.v13.i10.1585; Anderson LA, 2006, CANCER RES, V66, P4975, DOI 10.1158/0008-5472.CAN-05-4253; Anderson LA, 2009, GASTROENTEROLOGY, V136, P799, DOI 10.1053/j.gastro.2008.12.005; Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Asanuma K, 2016, WORLD J GASTROENTERO, V22, P1800, DOI 10.3748/wjg.v22.i5.1800; Awan AK, 2007, EJSO-EUR J SURG ONC, V33, P561, DOI 10.1016/j.ejso.2006.12.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burney BO, 2012, J CACHEXIA SARCOPENI, V3, P149, DOI 10.1007/s13539-012-0065-7; Burney BO, 2012, J CLIN ENDOCR METAB, V97, pE700, DOI 10.1210/jc.2011-2387; Caron P, 2015, STEROIDS, V104, P16, DOI 10.1016/j.steroids.2015.07.009; Cook MB, 2017, ANDROLOGY-US, V5, P240, DOI 10.1111/andr.12314; Cook MB, 2017, ANDROLOGY IN PRESS; Cook MB, 2015, CLIN GASTROENTEROL H, V13, P673, DOI 10.1016/j.cgh.2014.08.027; Cooper SC, 2012, CANCER CAUSE CONTROL, V23, P819, DOI 10.1007/s10552-012-9950-9; Cooper SC, 2009, CANCER CAUSE CONTROL, V20, P1363, DOI 10.1007/s10552-009-9359-2; Dai Q, 2016, BRIT J NUTR, V115, P342, DOI 10.1017/S0007114515004444; Denver P, 2013, WORLD J GASTROENTERO, V19, P1770, DOI 10.3748/wjg.v19.i11.1770; Ferguson HR, 2008, CANCER EPIDEM BIOMAR, V17, P727, DOI 10.1158/1055-9965.EPI-07-2570; Ferguson HR, 2008, CANCER EPIDEM BIOMAR, V17, P736, DOI 10.1158/1055-9965.EPI-07-2832; Freedman ND, 2010, EUR J CANCER, V46, P2473, DOI 10.1016/j.ejca.2010.05.005; Garcia JM, 2006, CANCER-AM CANCER SOC, V106, P2583, DOI 10.1002/cncr.21889; Gislefoss RE, 2009, CLIN CHEM LAB MED, V47, P596, DOI 10.1515/CCLM.2009.121; Holl K, 2008, ACTA ONCOL, V47, P406, DOI 10.1080/02841860701592400; Kupelian V, 2010, CLIN ENDOCRINOL, V72, P527, DOI 10.1111/j.1365-2265.2009.03713.x; Ladanchuk TC, 2010, SCAND J GASTROENTERO, V45, P1397, DOI 10.3109/00365521.2010.503968; Lagergren J, 1998, CANCER EPIDEM BIOMAR, V7, P913; LEYMARIE P, 1974, J STEROID BIOCHEM, V5, P167, DOI 10.1016/0022-4731(74)90124-1; Liao CH, 2012, CLIN CHIM ACTA, V413, P803, DOI 10.1016/j.cca.2012.01.021; Maggio M, 2005, J Endocrinol Invest, V28, P116; Mathieu LN, 2014, DIS ESOPHAGUS, V27, P757, DOI 10.1111/dote.12147; McGlynn KA, 2005, CANCER EPIDEM BIOMAR, V14, P1732, DOI 10.1158/1055-9965.EPI-05-0128; Mulholland HG, 2011, BRIT J NUTR, V106, P732, DOI 10.1017/S0007114511000742; Mulholland HG, 2009, CANCER CAUSE CONTROL, V20, P279, DOI 10.1007/s10552-008-9242-6; Muller M, 2003, EUR J ENDOCRINOL, V149, P583, DOI 10.1530/eje.0.1490583; Murphy SJ, 2007, CARCINOGENESIS, V28, P1323, DOI 10.1093/carcin/bgm007; Murphy SJ, 2005, WORLD J GASTROENTERO, V11, P7290, DOI 10.3748/wjg.v11.i46.7290; Murphy SJ, 2010, J NUTR, V140, P1757, DOI 10.3945/jn.110.124362; O'Doherty MG, 2011, INT J CANCER, V129, P1493, DOI 10.1002/ijc.26108; O'Doherty MG, 2010, CANCER CAUSE CONTROL, V21, P2269, DOI 10.1007/s10552-010-9652-0; O'Rorke MA, 2012, INT J CANCER, V131, P1882, DOI 10.1002/ijc.27434; Rashid F, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-9; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rutegard M, 2010, BRIT J CANCER, V103, P735, DOI 10.1038/sj.bjc.6605804; Schmidt M, 2006, ANN NY ACAD SCI, V1069, P236, DOI 10.1196/annals.1351.021; Sharp L, 2013, J NUTR, V143, P1966, DOI 10.3945/jn.113.174664; Shivappa N, 2017, BRIT J NUTR, V117, P1323, DOI 10.1017/S0007114517001131; SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3; Starka L, 2009, J STEROID BIOCHEM, V116, P118, DOI 10.1016/j.jsbmb.2009.05.008; Stroud LR, 2007, PSYCHONEUROENDOCRINO, V32, P140, DOI 10.1016/j.psyneuen.2006.11.008; Sukocheva OA, 2013, DIS ESOPHAGUS, V26, P628, DOI 10.1111/dote.12000; Thomas HV, 1997, BRIT J CANCER, V75, P1075, DOI 10.1038/bjc.1997.183; Thomas HV, 1997, BRIT J CANCER, V76, P401, DOI 10.1038/bjc.1997.398; UEO H, 1990, CANCER RES, V50, P7212; Vatten LJ, 1997, CANCER EPIDEM BIOMAR, V6, P967; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Yang HQ, 2012, WORLD J GASTROENTERO, V18, P393, DOI 10.3748/wjg.v18.i5.393	57	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190325	10.1371/journal.pone.0190325	http://dx.doi.org/10.1371/journal.pone.0190325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342161	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800018
J	Chowdhury, AI; Haider, R; Abdullah, AM; Christou, A; Ali, NA; Rahman, AE; Iqbal, A; Bari, S; Hoque, DME; El Arifeen, S; Kissoon, N; Larson, CP				Chowdhury, Atique Iqbal; Haider, Rafiqul; Abdullah, Abu Yousuf Md; Christou, Aliki; Ali, Nabeel Ashraf; Rahman, Ahmed Ehsnaur; Iqbal, Afrin; Bari, Sanwarul; Hoque, D. M. Emdadul; El Arifeen, Shams; Kissoon, Niranjan; Larson, Charles P.			Using geospatial techniques to develop an emergency referral transport system for suspected sepsis patients in Bangladesh	PLOS ONE			English	Article							HEALTH-CARE; DEVELOPING-COUNTRIES; INFORMATION-SYSTEMS; SERVICES; ACCESS; ACCESSIBILITY; INTERVENTION; AFRICA; EQUITY; MALAWI	Background A geographic information system (GIS)-based transport network within an emergency referral system can be the key to reducing health system delays and increasing the chances of survival, especially during an emergency. We employed a GIS to design an emergency transport system for the rapid transfer of pregnant or early post-partum women, newborns, and children under 5 years of age with suspected sepsis under the Interrupting Pathways to Sepsis Initiative (IPSI) project. Methods A GIS database was developed by mapping the villages, roads, and relevant physical features of the study area. A travel-time algorithm was developed to incorporate the time taken by different modes of local transport to reach the health complexes. These were used in a network analysis to identify the shortest routes to the hospitals from the villages, which were categorized into green, yellow, and red zones based on their proximity to the nearest hospitals to provide transport facilities. An emergency call-in centre established for the project managed the transport system, and its data was used to assess the uptake of this transport system amongst distant communities. Results Fifteen pre-existing and two new routes were identified as the shortest routes to the health complexes. The call-in centre personnel used this route information to direct both patients and transport drivers to the nearest transport hubs or pick-up points. Adherence with referral advice was high in areas where the IPSI transport operated. Over the study period, the utilisation of the project's transport doubled and referral compliance from distant zones similarly increased. Conclusions The GIS system created for this study facilitated rapid referral of patients in emergency from distant zones, using locally available transport and resources. The methodology described in this study to develop and implement an emergency transport system can be applied in similar, rural, low-income country settings.	[Chowdhury, Atique Iqbal; Haider, Rafiqul; Abdullah, Abu Yousuf Md; Ali, Nabeel Ashraf; Rahman, Ahmed Ehsnaur; Iqbal, Afrin; Bari, Sanwarul; Hoque, D. M. Emdadul; El Arifeen, Shams] Int Ctr Diarrhoeal Dis Res Icddr B, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Christou, Aliki] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Kissoon, Niranjan; Larson, Charles P.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada	International Centre for Diarrhoeal Disease Research (ICDDR); University of Sydney; University of British Columbia	Chowdhury, AI (corresponding author), Int Ctr Diarrhoeal Dis Res Icddr B, Maternal & Child Hlth Div, Dhaka, Bangladesh.	atiquei@icddrb.org	Christou, Aliki/D-1249-2018; Hoque, Dewan/O-3606-2015; Kissoon, Niranjan/AAC-6140-2021; Hoque, Dewan Md. Emdadul/J-1999-2019; Chowdhury, Atique Iqbal/A-6046-2016; Abdullah, Abu Yousuf Md/AAX-7051-2021; Haider, Rafiqul/A-4236-2016	Christou, Aliki/0000-0001-9525-8255; Hoque, Dewan/0000-0001-8219-9196; Hoque, Dewan Md. Emdadul/0000-0001-8219-9196; Chowdhury, Atique Iqbal/0000-0001-9140-5983; Abdullah, Abu Yousuf Md/0000-0001-8641-990X; Arifeen, Shams/0000-0002-5372-5932; Haider, Rafiqul/0000-0002-7864-3319; Kissoon, Niranjan/0000-0001-8847-9973	Global Affairs Canada Trade and Developments MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH) [S065353001]	Global Affairs Canada Trade and Developments MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH)	This study was a component of the project titled "Interrupting Pathways to Maternal, Newborn and Early Childhood Sepsis Initiative" (IPSI) (project number S065353001) that was funded by Global Affairs Canada Trade and Developments MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH), received by Dr. Charles Larson, url http://www.internatonal.gc.ca/. The funders had no role in study design, data collection, analysis and writing the manuscript.	Abdullah AYM, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0054-9; Al-Taiar A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-38; [Anonymous], 2017, INDEPENDENT; [Anonymous], 2016, DAILY STAR; [Anonymous], 2012, GOOGL EARTH 6 2; Bailey P., 2009, MON EM OBST CAR HDB; Bailey PE, 2011, INT J GYNECOL OBSTET, V115, P300, DOI 10.1016/j.ijgo.2011.09.004; Banu M, 2014, PUBLIC HEALTH, V128, P332, DOI 10.1016/j.puhe.2014.01.009; Banu M, 2010, MANOSHI WORKING PAPE, P1; BBS (Bangladesh Bureau of Statistics), POP HOUS CENS 2011 C; Bishop ID, 2000, CITIES, V17, P85, DOI 10.1016/S0264-2751(00)00004-4; Bossyns P, 2005, TROP MED INT HEALTH, V10, P879, DOI 10.1111/j.1365-3156.2005.01459.x; Brammer H, 1993, GEOGRAPHICAL COMPLEX, P246; Children St, 2013, MAMONI INTEGRATED SA; Dewan A, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0069-2; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Global Health Hub @ UBC, INT PATHW SEPS IN IP; Hofman JJ, 2008, INT J GYNECOL OBSTET, V102, P191, DOI 10.1016/j.ijgo.2008.04.001; Kim D, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0045-1; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Machira K, 2017, AFR HEALTH SCI, V17, P400, DOI 10.4314/ahs.v17i2.14; Makanga PT, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-016-0074-4; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1035, DOI 10.1001/jama.289.8.1035; Murray SF, 2006, SOC SCI MED, V62, P2205, DOI 10.1016/j.socscimed.2005.10.025; Neutens T, 2015, J TRANSP GEOGR, V43, P14, DOI 10.1016/j.jtrangeo.2014.12.006; Noor AM, 2006, TROP MED INT HEALTH, V11, P188, DOI 10.1111/j.1365-3156.2005.01555.x; Noor AM, 2003, TROP MED INT HEALTH, V8, P917, DOI 10.1046/j.1365-3156.2003.01112.x; Paul BK, 2009, NAT HAZARDS, V50, P289, DOI 10.1007/s11069-008-9340-5; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Rahman AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170267; Sabde Y, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-57; Schuurman Nadine, 2006, Int J Health Geogr, V5, P43, DOI 10.1186/1476-072X-5-43; STORY M, 1986, PHOTOGRAMM ENG REM S, V52, P397; Sudhof L, 2013, TROP MED INT HEALTH, V18, P18, DOI 10.1111/tmi.12016; Tanser F, 2006, SOC SCI MED, V63, P691, DOI 10.1016/j.socscimed.2006.01.015; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P166, DOI 10.1111/tmi.12022; Terkelsen CJ, 2011, ANN INTERN MED, V155, P361, DOI 10.7326/0003-4819-155-6-201109200-00004; United Nations Children's Fund (UNICEF), 2010, OP PER REF TRANSP SE; Zinszer K, 2014, B WORLD HEALTH ORGAN, V92, P178, DOI 10.2471/BLT.13.125260	39	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191054	10.1371/journal.pone.0191054	http://dx.doi.org/10.1371/journal.pone.0191054			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338012	gold, Green Published, Green Submitted			2022-12-27	WOS:000422652700027
J	Kim, AR; Lee, DH; Lee, SH; Rubino, I; Choi, HJ; Quan, FS				Kim, Ah-Ra; Lee, Dong-Hun; Lee, Su-Hwa; Rubino, Ilaria; Choi, Hyo-Jick; Quan, Fu-Shi			Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein	PLOS ONE			English	Article							IMMUNE-RESPONSES; INFECTION; RSV; INFLUENZA; MICE; DISEASE; RISK; EOSINOPHILIA; INFANTS; CELLS	Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract illness in infants, young children and the elderly. However, there is no licensed vaccine available against RSV infection. In this study, we generated virus-like particle (VLP) vaccine and investigated the vaccine efficacy in a mouse model. For VLP vaccines, tandem gene (1-780 bp) for V1 VLPs and tandem repeat gene (repeated 450-780 bp) for V5 VLPs were constructed in pFastBacTM vectors, respectively. Influenza matrix protein 1 (M1) was used as a core protein in the VLPs. Notably, upon challenge infection, significantly lower virus loads were measured in the lung of mice immunized with V1 or V5 VLPs compared to those of naive mice and formalin-inactivated RSV immunized control mice. In particular, V5 VLPs immunization showed significantly lower virus titers than V1 VLPs immunization. Furthermore, V5 VLPs immunization elicited increased memory B cells responses in the spleen. These results indicated that V5 VLP vaccine containing tandem repeat gene protein provided better protection than V1 VLPs with significantly decreased inflammation in the lungs. Thus, V5 VLPs could be a potential vaccine candidate against RSV.	[Kim, Ah-Ra; Lee, Dong-Hun; Lee, Su-Hwa] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kim, Ah-Ra; Lee, Dong-Hun; Lee, Su-Hwa; Quan, Fu-Shi] Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea; [Rubino, Ilaria; Choi, Hyo-Jick] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 1H9, Canada	Kyung Hee University; Kyung Hee University; University of Alberta	Quan, FS (corresponding author), Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea.	fsquan@khu.ac.kr	Quan, Fu-Shi/V-1826-2019	Choi, Hyo-Jick/0000-0001-8233-5864; Lee, Darrall/0000-0002-6990-4441; Rubino, Ilaria/0000-0003-1589-1566	National Research Foundation of Korea (NRF) [NRF-2014R1A2A2A01004899]; Agri-Bio Industry Technology Development Program [315030-03-1-HD020]; Ministry of Health and Welfare, Republic of Korea [HI15C2928]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Agri-Bio Industry Technology Development Program; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the National Research Foundation of Korea (NRF) (NRF-2014R1A2A2A01004899), and a grant from the Agri-Bio Industry Technology Development Program (315030-03-1-HD020), and a grant from the Ministry of Health and Welfare, Republic of Korea (HI15C2928).	Acosta PL, 2016, CLIN VACCINE IMMUNOL, V23, P189, DOI 10.1128/CVI.00609-15; Airoldi I, 2004, CLIN CANCER RES, V10, P144, DOI 10.1158/1078-0432.CCR-1026-3; Castilow EM, 2008, J IMMUNOL, V180, P2376, DOI 10.4049/jimmunol.180.4.2376; Choi HJ, 2012, BIOMATERIALS, V33, P3756, DOI 10.1016/j.biomaterials.2012.01.054; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; HOLBERG CJ, 1991, AM J EPIDEMIOL, V133, P1135, DOI 10.1093/oxfordjournals.aje.a115826; Jorquera PA, 2015, VACCINES-BASEL, V3, P829, DOI 10.3390/vaccines3040829; Kafuye-Mlwilo MY, 2012, INFECT IMMUN, V80, P633, DOI 10.1128/IAI.05188-11; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Kato Masahiko, 2004, Allergology International, V53, P301, DOI 10.1111/j.1440-1592.2004.00352.x; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Lang ML, 2009, EXPERT REV VACCINES, V8, P1109, DOI [10.1586/erv.09.56, 10.1586/ERV.09.56]; Lee YS, 2015, J INSTRUM, V10, DOI 10.1088/1748-0221/10/07/P07001; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Openshaw PJM, 2001, VACCINE, V20, pS27, DOI 10.1016/S0264-410X(01)00301-2; Openshaw PJM, 2001, AM J RESP CRIT CARE, V163, pS10, DOI 10.1164/ajrccm.163.supplement_1.2011111; Peebles RS, 2000, J INFECT DIS, V182, P671; Qi FF, 2015, INT IMMUNOPHARMACOL, V29, P408, DOI 10.1016/j.intimp.2015.10.022; Quan FS, 2016, EXPERT REV VACCINES, V15, P1281, DOI 10.1080/14760584.2016.1175942; Quan FS, 2011, J INFECT DIS, V204, P987, DOI 10.1093/infdis/jir474; Sharma A, 2016, J VIROL, V90, P5068, DOI 10.1128/JVI.00259-16; Singh SR, 2007, VACCINE, V25, P6211, DOI 10.1016/j.vaccine.2007.05.068; Sparer TE, 1998, J EXP MED, V187, P1921, DOI 10.1084/jem.187.11.1921; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08	29	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191277	10.1371/journal.pone.0191277	http://dx.doi.org/10.1371/journal.pone.0191277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338045	Green Published, Green Submitted, gold			2022-12-27	WOS:000422652700043
J	Rachid, TL; Silva-Veiga, FM; Graus-Nunes, F; Bringhenti, I; Mandarim-de-Lacerda, CA; Souza-Mello, V				Rachid, Tamiris Lima; Silva-Veiga, Flavia Maria; Graus-Nunes, Francielle; Bringhenti, Isabele; Mandarim-de-Lacerda, Carlos Alberto; Souza-Mello, Vanessa			Differential actions of PPAR-alpha and PPAR-beta/delta on beige adipocyte formation: A study in the subcutaneous white adipose tissue of obese male mice	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; BROWN-FAT; PEROXISOME PROLIFERATORS; ENERGY-EXPENDITURE; CLASSICAL BROWN; ENDOCRINE ORGAN; DEFICIENT MICE; LIVER-DISEASE; ADULT HUMANS	Background and aims Obesity compromises adipocyte physiology. PPARs are essential to adipocyte plasticity, but its isolated role in the browning phenomenon is not clear. This study aimed to examine whether activation of PPAR-a or PPAR-beta/delta could induce beige cell depots in the subcutaneous white adipose tissue of diet-induced obese mice. Material and methods Sixty animals were randomly assigned to receive a control diet (C, 10% lipids) or a high-fat diet (HF, 50% lipids) for ten weeks. Then each group was re-divided to begin the treatments that lasted 4 weeks, totalizing six groups: C, C-alpha (C plus PPAR-alpha agonist, 2.5 mg/ kg BM), C-beta (C plus PPAR-beta/delta agonist, 1 mg/ kg BM), HF, HF-alpha (HF plus PPAR-alpha agonist), HF-beta (HF plus PPAR-beta/delta agonist). Results HF animals presented with overweight, glucose intolerance and subcutaneous white adipocyte hypertrophy. Both treatments significantly attenuated these parameters. Browning, verified by UCP1 positive beige cells and enhanced body temperature, was just observed in PPAR-alpha treated groups. PPAR-alpha agonism also elicited an enhanced gene expression of the thermogenesis effector UCP1, the beige-selective gene TMEM26 and the PRDM16, an essential gene for brown-like phenotype maintenance in the beige adipocytes when compared to their counterparts. The enhanced CIDEA and the reduced UCP1 gene levels might justify the white phenotype predominance after the treatment with the PPAR-alpha/delta agonist. Conclusions This work provides evidence that the PPAR-beta/delta agonist ameliorated metabolic disorders through enhanced beta-oxidation and better tolerance to glucose, whereas the PPAR-alpha agonism was confirmed as a promising therapeutic target for treating metabolic diseases via beige cell induction and enhanced thermogenesis.	[Rachid, Tamiris Lima; Silva-Veiga, Flavia Maria; Graus-Nunes, Francielle; Bringhenti, Isabele; Mandarim-de-Lacerda, Carlos Alberto; Souza-Mello, Vanessa] Univ Estado Rio De Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Souza-Mello, V (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil.	souzamello.uerj@gmail.com	Souza-Mello, Vanessa/D-5092-2013; Souza-Mello, Vanessa/E-3463-2014; Mandarim-de-Lacerda, Carlos A/F-7125-2012; Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019	Souza-Mello, Vanessa/0000-0002-2510-9569; Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978; Nunes, Francielle/0000-0002-6212-3116; Veiga, Flavia Maria S/0000-0002-3320-5825	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/202.888/2015, E-26/010.001576/2016]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (www.faperj.br), award numbers: E-26/202.888/2015 and E-26/010.001576/2016 for V.S-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Barbosa-da-Silva S, 2015, LIFE SCI, V127, P73, DOI 10.1016/j.lfs.2015.02.003; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Barneda D, 2013, BBA-MOL CELL BIOL L, V1831, P924, DOI 10.1016/j.bbalip.2013.01.015; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brenmoehl J, 2017, J COMP PHYSIOL B, V187, P361, DOI 10.1007/s00360-016-1036-7; Chung Nana, 2017, J Exerc Nutrition Biochem, V21, P39, DOI 10.20463/jenb.2017.0020; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Corton JC, 2000, MUTAT RES-FUND MOL M, V448, P139, DOI 10.1016/S0027-5107(99)00232-8; CRUZORIVE LM, 1990, AM J PHYSIOL, V258, pL148, DOI 10.1152/ajplung.1990.258.4.L148; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Fonseca-Alaniz MH, 2007, J PEDIAT-BRAZIL, V83, pS192, DOI [10.1590/S0021-75572007000700011, 10.2223/JPED.1709]; Fraulob JC, 2012, CLIN SCI, V123, P259, DOI 10.1042/CS20110373; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gray SL, 2010, ENDOCRINOLOGY, V151, P4178, DOI 10.1210/en.2010-0102; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; Harrington WW, 2007, PPAR RES, V2007, DOI 10.1155/2007/97125; He HB, 2010, HYPERTENSION, V55, P869, DOI 10.1161/HYPERTENSIONAHA.109.143958; Jeong S, 2009, EXP MOL MED, V41, P397, DOI 10.3858/emm.2009.41.6.045; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Jiang L, 2010, MOL CELL BIOCHEM, V343, P249, DOI 10.1007/s11010-010-0520-8; Jimenez M, 2003, EUR J BIOCHEM, V270, P699, DOI 10.1046/j.1432-1033.2003.03422.x; Kalinovich AV, 2017, BIOCHIMIE, V134, P127, DOI 10.1016/j.biochi.2017.01.007; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kieffer TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1, DOI 10.1152/ajpendo.2000.278.1.E1; Kim SH, 2016, DIABETES METAB J, V40, P12, DOI 10.4093/dmj.2016.40.1.12; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Luo X, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050795; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Magliano DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064258; Malandrino MI, 2015, AM J PHYSIOL-ENDOC M, V308, pE756, DOI 10.1152/ajpendo.00362.2014; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Rachid TL, 2015, CELL BIOCHEM FUNCT, V33, P249, DOI 10.1002/cbf.3111; Rachid TL, 2015, MOL CELL ENDOCRINOL, V402, P86, DOI 10.1016/j.mce.2014.12.027; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ricquier D, 2000, INT J OBESITY, V24, pS86, DOI 10.1038/sj.ijo.0801286; Ricquier D, 2017, BIOCHIMIE, V134, P3, DOI 10.1016/j.biochi.2016.10.018; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Rost TH, 2009, BBA-MOL CELL BIOL L, V1791, P1076, DOI 10.1016/j.bbalip.2009.06.005; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Souza-Mello V, 2010, CLIN SCI, V119, P239, DOI 10.1042/CS20100061; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Srivastava RAK, 2006, MOL CELL BIOCHEM, V285, P35, DOI 10.1007/s11010-005-9053-y; Stanford KI, 2015, DIABETES, V64, P2361, DOI 10.2337/db15-0227; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Varela-Rodriguez BM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29898; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wingfield HL, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0010-3; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu MV, 2014, J BIOL CHEM, V289, P34129, DOI 10.1074/jbc.M114.591008; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	59	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191365	10.1371/journal.pone.0191365	http://dx.doi.org/10.1371/journal.pone.0191365			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351550	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300076
J	Dislich, C; Hettig, E; Salecker, J; Heinonen, J; Lay, J; Meyer, KM; Wiegand, K; Tarigan, S				Dislich, Claudia; Hettig, Elisabeth; Salecker, Jan; Heinonen, Johannes; Lay, Jann; Meyer, Katrin M.; Wiegand, Kerstin; Tarigan, Suria			Land-use change in oil palm dominated tropical landscapes-An agent-based model to explore ecological and socio-economic trade-offs	PLOS ONE			English	Article							USE DYNAMICS; BIODIVERSITY; ECOSYSTEM; EXPANSION; PROTOCOL; SUMATRA; FOREST	Land-use changes have dramatically transformed tropical landscapes. We describe an ecological- economic land-use change model as an integrated, exploratory tool used to analyze how tropical land-use change affects ecological and socio-economic functions. The model analysis seeks to determine what kind of landscape mosaic can improve the ensemble of ecosystem functioning, biodiversity, and economic benefit based on the synergies and trade-offs that we have to account for. More specifically, (1) how do specific ecosystem functions, such as carbon storage, and economic functions, such as household consumption, relate to each other? (2) How do external factors, such as the output prices of crops, affect these relationships? (3) How do these relationships change when production inefficiency differs between smallholder farmers and learning is incorporated? We initialize the ecological-economic model with artificially generated land-use maps parameterized to our study region. The economic sub-model simulates smallholder land-use management decisions based on a profit maximization assumption. Each household determines factor inputs for all household fields and decides on land-use change based on available wealth. The ecological sub-model includes a simple account of carbon sequestration in above-ground and below-ground vegetation. We demonstrate model capabilities with results on household consumption and carbon sequestration from different output price and farming efficiency scenarios. The overall results reveal complex interactions between the economic and ecological spheres. For instance, model scenarios with heterogeneous crop-specific household productivity reveal a comparatively high inertia of land-use change. Our model analysis even shows such an increased temporal stability in landscape composition and carbon stocks of the agricultural area under dynamic price trends. These findings underline the utility of ecological- economic models, such as ours, to act as exploratory tools which can advance our understanding of the mechanisms underlying the trade-offs and synergies of ecological and economic functions in tropical landscapes.	[Dislich, Claudia; Salecker, Jan; Heinonen, Johannes; Meyer, Katrin M.; Wiegand, Kerstin] Univ Goettingen, Fac Forest Sci & Forest Ecol, Ecosyst Modelling, Gottingen, Germany; [Hettig, Elisabeth; Lay, Jann] Univ Goettingen, Fac Econ Sci, Gottingen, Germany; [Hettig, Elisabeth; Lay, Jann] GIGA German Inst Global & Area Studies, Hamburg, Germany; [Wiegand, Kerstin] Univ Goettingen, Ctr Biodivers & Sustainable Land Use CBL, Gottingen, Germany; [Tarigan, Suria] Bogor Agr Univ, Soil & Nat Resources Management, Bogor, Indonesia; [Dislich, Claudia] Grad Sch HIGRADE, Helmholtz Ctr Environm Res UFZ, Leipzig, Germany	University of Gottingen; University of Gottingen; German Institute of Global & Area Studies; University of Gottingen; Bogor Agricultural University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Salecker, J (corresponding author), Univ Goettingen, Fac Forest Sci & Forest Ecol, Ecosyst Modelling, Gottingen, Germany.	jsaleck@gwdg.de	Meyer, Katrin M/E-6839-2013; Lay, Jann/AAP-7896-2020; Tarigan, Suria/ACN-8691-2022	Meyer, Katrin M/0000-0002-9990-4047; Tarigan, Suria/0000-0003-0153-0399; Lay, Jann/0000-0002-0784-3807; Wiegand, Kerstin/0000-0003-4854-0607; Salecker, Jan/0000-0002-9000-4229	German Research Foundation (DFG) in the framework of the collaborative German Indonesian research project EFForTS, Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia)	German Research Foundation (DFG) in the framework of the collaborative German Indonesian research project EFForTS, Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia)(German Research Foundation (DFG))	This study was financed by the German Research Foundation (DFG, http://www.dfg.de/) in the framework of the collaborative German Indonesian research project EFForTS (https://www.uni-goettingen.de/efforts), Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia).	Adelman I., 2003, REV ECON HOUSEHOLD, V1, P33, DOI [10.1023/A:1021847430758, DOI 10.1023/A:1021847430758]; Barnes AD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6351; Berger T, 2001, AGR ECON-BLACKWELL, V25, P245, DOI 10.1111/j.1574-0862.2001.tb00205.x; Clough Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13137; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Dislich C, 2016, BIOL REV IN PRESS; Drescher J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0275; Euler M, 2017, WORLD DEV, V93, P219, DOI 10.1016/j.worlddev.2016.12.019; Euler M, 2016, AGR SYST, V146, P111, DOI 10.1016/j.agsy.2016.04.007; Evans MR, 2013, TRENDS ECOL EVOL, V28, P578, DOI 10.1016/j.tree.2013.05.022; Faust H, 2013, EFFORTS DISCUSSION P, V1; Feintrenie L, 2010, ECOL SOC, V15; Fischer R, 2016, ECOL MODEL, V326, P124, DOI 10.1016/j.ecolmodel.2015.11.018; Gatto M, 2015, LAND USE POLICY, V46, P292, DOI 10.1016/j.landusepol.2015.03.001; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hettig E, 2016, LAND-BASEL, V5, DOI 10.3390/land5040032; Holdo RM, 2010, ECOL APPL, V20, P381, DOI 10.1890/08-0780.1; Jeltsch F, 2013, BASIC APPL ECOL, V14, P93, DOI 10.1016/j.baae.2013.01.001; Kelley H, 2011, ECOL ECON, V70, P1075, DOI 10.1016/j.ecolecon.2010.12.009; Kelly RA, 2013, ENVIRON MODELL SOFTW, V47, P159, DOI 10.1016/j.envsoft.2013.05.005; Kiesling E, 2012, CENT EUR J OPER RES, V20, P183, DOI 10.1007/s10100-011-0210-y; Klasen S, 2013, AGR ECON-BLACKWELL, V44, P349, DOI 10.1111/agec.12015; Koh LP, 2009, TRENDS ECOL EVOL, V24, P431, DOI 10.1016/j.tree.2009.03.012; Krashevska V, 2015, BIOL FERT SOILS, V51, P697, DOI 10.1007/s00374-015-1021-4; Krishna V, 2017, AGR ECON-BLACKWELL, V48, P639, DOI 10.1111/agec.12363; Laniak GF, 2013, ENVIRON MODELL SOFTW, V39, P3, DOI 10.1016/j.envsoft.2012.09.006; Le QB, 2008, ECOL INFORM, V3, P135, DOI 10.1016/j.ecoinf.2008.04.003; Le QB, 2010, ECOL INFORM, V5, P203, DOI 10.1016/j.ecoinf.2010.02.001; Muller B, 2013, ENVIRON MODELL SOFTW, V48, P37, DOI 10.1016/j.envsoft.2013.06.003; Mumme S, 2015, BIOL CONSERV, V191, P750, DOI 10.1016/j.biocon.2015.08.033; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Powell LL, 2015, BIOL CONSERV, V188, P100, DOI 10.1016/j.biocon.2015.01.028; Prabowo WE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154876; Railsback S., 2012, AGENT BASED INDIVIDU; Sayer J, 2012, GLOB FOOD SECUR-AGR, V1, P114, DOI 10.1016/j.gfs.2012.10.003; Schouten M, 2014, ENVIRON MODELL SOFTW, V54, P196, DOI 10.1016/j.envsoft.2014.01.003; Singh Inderjit, 1986, AGR HOUSEHOLD MODELS; Valbuena D, 2010, LANDSCAPE ECOL, V25, P185, DOI 10.1007/s10980-009-9380-6; Villamor GB, 2014, ENVIRON MODELL SOFTW, V61, P151, DOI 10.1016/j.envsoft.2014.07.013; Zhang H, 2016, ARXIV160808517PHYSIC	42	16	17	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190506	10.1371/journal.pone.0190506	http://dx.doi.org/10.1371/journal.pone.0190506			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351290	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300019
J	Kropf, J; Rossler, W				Kropf, Jan; Roessler, Wolfgang			In-situ recording of ionic currents in projection neurons and Kenyon cells in the olfactory pathway of the honeybee	PLOS ONE			English	Article							ANTENNAL-LOBE NEURONS; APIS-MELLIFERA-L; MUSHROOM BODY; BEE BRAIN; K+-CURRENTS; SUBSYSTEMS; ANATOMY; BODIES; REPRESENTATION; ORGANIZATION	The honeybee olfactory pathway comprises an intriguing pattern of convergence and divergence: similar to 60.000 olfactory sensory neurons (OSN) convey olfactory information on similar to 900 projection neurons (PN) in the antennal lobe (AL). To transmit this information reliably, PNs employ relatively high spiking frequencies with complex patterns. PNs project via a dual olfactory pathway to the mushroom bodies (MB). This pathway comprises the medial (m-ALT) and the lateral antennal lobe tract (l-ALT). PNs from both tracts transmit information from a wide range of similar odors, but with distinct differences in coding properties. In the MBs, PNs form synapses with many Kenyon cells (KC) that encode odors in a spatially and temporally sparse way. The transformation from complex information coding to sparse coding is a well-known phenomenon in insect olfactory coding. Intrinsic neuronal properties as well as GABAergic inhibition are thought to contribute to this change in odor representation. In the present study, we identified intrinsic neuronal properties promoting coding differences between PNs and KCs using in-situ patch-clamp recordings in the intact brain. We found very prominent K+ currents in KCs clearly differing from the PN currents. This suggests that odor coding differences between PNs and KCs may be caused by differences in their specific ion channel properties. Comparison of ionic currents of m-and l-ALT PNs did not reveal any differences at a qualitative level.	[Kropf, Jan; Roessler, Wolfgang] Univ Wurzburg, Behav Physiol & Sociobiol Zool 2, Biozentrum, Wurzburg, Germany; [Kropf, Jan] Univ Oxford, Ctr Neural Circuits & Behav, Oxford, England	University of Wurzburg; University of Oxford	Kropf, J (corresponding author), Univ Wurzburg, Behav Physiol & Sociobiol Zool 2, Biozentrum, Wurzburg, Germany.; Kropf, J (corresponding author), Univ Oxford, Ctr Neural Circuits & Behav, Oxford, England.	jan.kropf@cncb.ox.ac.uk	Rössler, Wolfgang/E-9526-2019	Rössler, Wolfgang/0000-0002-5195-8214; Kropf, Jan/0000-0002-4179-0446	Deutsche Forschungsgemeinschaft (DFG); DFG Priority Program Integrative Analysis of Olfaction [SPP 1392, RO1177/5-2]; DFG; University of Wurzburg in the funding program Open Access Publishing	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Priority Program Integrative Analysis of Olfaction(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Wurzburg in the funding program Open Access Publishing	This work was supported by the Deutsche Forschungsgemeinschaft (DFG); DFG Priority Program SPP 1392 Integrative Analysis of Olfaction (RO1177/5-2) to Wolfgang Rossler. This publication was funded by the DFG and the University of Wurzburg in the funding program Open Access Publishing; http://www.dfg.de/en/research_funding/announcements_proposals/2011/info_wissenschaft_11_26/index.html, https://www.uni-konstanz.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel R, 2001, J COMP NEUROL, V437, P363, DOI 10.1002/cne.1289; Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Bradler C, 2016, J NEUROPHYSIOL, V115, P2330, DOI 10.1152/jn.00840.2015; Brill MF, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00208; Brill MF, 2013, J NEUROSCI, V33, P2443, DOI 10.1523/JNEUROSCI.4268-12.2013; Carcaud J, 2015, J NEUROSCI, V35, P4157, DOI 10.1523/JNEUROSCI.0734-14.2015; Carcaud J, 2012, J NEUROPHYSIOL, V108, P1106, DOI 10.1152/jn.01034.2011; Demmer H, 2009, J NEUROPHYSIOL, V102, P1538, DOI 10.1152/jn.00183.2009; Derst C, 2003, EUR J NEUROSCI, V17, P1197, DOI 10.1046/j.1460-9568.2003.02550.x; Dubnau J, 2012, SCIENCE, V335, P664, DOI 10.1126/science.1218171; ESSLEN J, 1976, ZOOMORPHOLOGIE, V83, P227, DOI 10.1007/BF00993511; Froese A, 2014, J COMP PHYSIOL A, V200, P183, DOI 10.1007/s00359-013-0877-8; Galizia CG, 2012, J INSECT PHYSIOL, V58, P743, DOI 10.1016/j.jinsphys.2012.02.010; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Grolleau F, 2000, J EXP BIOL, V203, P1633; GROLLEAU F, 1994, NEUROSCI LETT, V167, P46, DOI 10.1016/0304-3940(94)91024-3; Grunewald B, 1999, J COMP NEUROL, V404, P114; Grunewald B, 2003, J EXP BIOL, V206, P117, DOI 10.1242/jeb.00053; Gupta N, 2011, CURR OPIN NEUROBIOL, V21, P768, DOI 10.1016/j.conb.2011.05.005; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; HOMBERG U, 1988, CELL TISSUE RES, V254, P255; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Kirschner S, 2006, J COMP NEUROL, V499, P933, DOI 10.1002/cne.21158; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; Kropf J, 2014, CELL TISSUE RES, V357, P583, DOI 10.1007/s00441-014-1892-y; Lei H, 2016, FRONT PHYSIOL, V8, P1; Lei Hong, 2009, Journal of Biology (London), V8, P21, DOI 10.1186/jbiol120; Leinwand SG, 2011, CURR OPIN GENET DEV, V21, P806, DOI 10.1016/j.gde.2011.07.006; Lin AC, 2014, NAT NEUROSCI, V17, P559, DOI 10.1038/nn.3660; Meyer A, 2012, J COMP PHYSIOL A, V198, P159, DOI 10.1007/s00359-011-0696-8; Muller D, 2002, J COMP PHYSIOL A, V188, P359, DOI 10.1007/s00359-002-0310-1; Palmer MJ, 2014, J NEUROPHYSIOL, V112, P2026, DOI 10.1152/jn.00180.2014; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Pelz C, 1999, J NEUROPHYSIOL, V81, P1749, DOI 10.1152/jn.1999.81.4.1749; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perk CG, 2006, J NEUROPHYSIOL, V95, P1147, DOI 10.1152/jn.01220.2004; Rossler W, 2013, J COMP PHYSIOL A, V199, P981, DOI 10.1007/s00359-013-0821-y; Rossler W, 2011, ARTHROPOD STRUCT DEV, V40, P349, DOI 10.1016/j.asd.2010.12.001; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Rybak J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00030; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; SCHAFER S, 1994, J NEUROSCI, V14, P4600; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Szyszka P, 2005, J NEUROPHYSIOL, V94, P3303, DOI 10.1152/jn.00397.2005; Tanaka NK, 2012, J COMP NEUROL, V520, P4131, DOI 10.1002/cne.23149; Wicher D, 2006, J NEUROPHYSIOL, V95, P311, DOI 10.1152/jn.00904.2005; WITTHOFT W., 1967, Z MORPHOL TIERE, V61, P160, DOI 10.1007/BF00298776; Wustenberg DG, 2004, J NEUROPHYSIOL, V92, P2589, DOI 10.1152/jn.01259.2003	50	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191425	10.1371/journal.pone.0191425	http://dx.doi.org/10.1371/journal.pone.0191425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351552	Green Published, Green Submitted, gold			2022-12-27	WOS:000422911300089
J	Li, XH; Wang, BN; Yang, TW; Zhu, DW; Nie, ZN; Xu, JC				Li, Xinghua; Wang, Baona; Yang, Tewu; Zhu, Duanwei; Nie, Zhongnan; Xu, Junchi			Identification of soil P fractions that are associated with P loss from surface runoff under various cropping systems and fertilizer rates on sloped farmland (vol 12, e0179275, 2017)	PLOS ONE			English	Correction																		Li XH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179275	1	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191753	10.1371/journal.pone.0191753	http://dx.doi.org/10.1371/journal.pone.0191753			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29352302	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300128
J	Lucas-de la Cruz, L; Martin-Espinosa, N; Cavero-Redondo, I; Gonzalez-Garcia, A; Diez-Fernandez, A; Martinez-Vizcaino, V; Notario-Pacheco, B				Lucas-de la Cruz, Lidia; Martin-Espinosa, Noelia; Cavero-Redondo, Ivan; Gonzalez-Garcia, Alberto; Diez-Fernandez, Ana; Martinez-Vizcaino, Vicente; Notario-Pacheco, Blanca			Sleep patterns and cardiometabolic risk in schoolchildren from Cuenca, Spain	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; DURATION; CHILDREN; OVERWEIGHT; BEDTIME; IMPACT; LINK	Sleep seems to have a significant influence on the metabolic syndrome (MetS). However, results in this association are still inconsistent in children. The aim of this study was to examine the influence of sleep characteristics in the MetS (index and factors) in Spanish children. Cross-sectional study including a sample of 210 children aged 8-to-1l-years belonging to 20 schools from the province of Cuenca, Spain was conducted. Cardiometabolic risk and actigraphy sleep patterns were determined and analysed using correlation coefficients, ANCOVA models and a propensity score derivation model. Overall, children in the lower time in bed category and those who went to bed later (> 23:15h) showed worse values in the cardiometabolic profile and risk index. Differences were observed when the total time in bed was below 9h 15mins. Our study shows that short sleep duration could be a risk factor for cardiometabolic risk in children, and bedtime may independently influence this risk. In addition, our data suggests that children's sleep hygiene should be incorporated in parenting educational programs.	[Lucas-de la Cruz, Lidia; Cavero-Redondo, Ivan; Gonzalez-Garcia, Alberto; Diez-Fernandez, Ana; Notario-Pacheco, Blanca] Univ Castilla La Mancha, Fac Nursing, Cuenca, Spain; [Lucas-de la Cruz, Lidia; Cavero-Redondo, Ivan; Gonzalez-Garcia, Alberto; Diez-Fernandez, Ana; Martinez-Vizcaino, Vicente; Notario-Pacheco, Blanca] Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain; [Martin-Espinosa, Noelia] Univ Castilla La Mancha, Fac Nursing, Toledo, Spain; [Martinez-Vizcaino, Vicente] Univ Autonoma Chile, Fac Ciencias Salud, Talca, Chile	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad Autonoma de Chile	Cavero-Redondo, I (corresponding author), Univ Castilla La Mancha, Fac Nursing, Cuenca, Spain.; Cavero-Redondo, I (corresponding author), Univ Castilla La Mancha, Hlth & Social Res Ctr, Cuenca, Spain.	Ivan.Cavero@uclm.es	Cavero-Redondo, Ivan/R-4818-2019; Diez-Fernandez, Ana/Z-3348-2019; VIZCAINO, VICENTE MARTINEZ/R-4336-2017; Cavero Redondo, Iván/HII-7855-2022; Notario Pacheco, Blanca/G-2583-2016	Diez-Fernandez, Ana/0000-0002-7673-986X; VIZCAINO, VICENTE MARTINEZ/0000-0001-6121-7893; Cavero Redondo, Iván/0000-0003-2617-0430; Martin Espinosa, Noelia Maria/0000-0002-1298-6976; Gonzalez-Garcia, Alberto/0000-0001-7314-1435; Notario Pacheco, Blanca/0000-0001-8406-6952	Ministry of Health [FIS PI081297]; Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha [PII1I09-0259-9898, P0II10-0208-5325]; Research Network on Preventative Activities and Health Promotion [RD06/0018/0038]	Ministry of Health; Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha; Research Network on Preventative Activities and Health Promotion	This study was funded by the Ministry of Education and Science-Junta de Comunidades de Castilla-La Mancha (PII1I09-0259-9898 and P0II10-0208-5325), and Ministry of Health (FIS PI081297). Additional funding was obtained from the Research Network on Preventative Activities and Health Promotion (Ref.- RD06/0018/0038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2016, J PEDIAT; Asarnow LD, 2015, SLEEP, V38, P1523, DOI 10.5665/sleep.5038; Au CT, 2014, PEDIATRICS, V133, pE64, DOI 10.1542/peds.2013-1379; Bathory E, 2017, CURR PROB PEDIATR AD, V47, P29, DOI 10.1016/j.cppeds.2016.12.001; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Deb S, 2016, CAN J CARDIOL, V32, P259, DOI 10.1016/j.cjca.2015.05.015; Fatima Y, 2015, OBES REV, V16, P137, DOI 10.1111/obr.12245; Gangwisch JE, 2014, AM J HYPERTENS, V27, P1235, DOI 10.1093/ajh/hpu071; Golley RK, 2013, INT J OBESITY, V37, P546, DOI 10.1038/ijo.2012.212; Gurnani M, 2015, PEDIATR CLIN N AM, V62, P821, DOI 10.1016/j.pcl.2015.04.001; Gutin B, 2011, PEDIATR EXERC SCI, V23, P169, DOI 10.1123/pes.23.2.169; Hjorth MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104677; Hjorth MF, 2012, SLEEP BIOL RHYTHMS, V10, P328, DOI 10.1111/j.1479-8425.2012.00578.x; Hunsberger M, 2015, NUTRIENTS, V7, P10223, DOI 10.3390/nu7125529; Javaheri S, 2011, J PEDIATR-US, V158, P617, DOI 10.1016/j.jpeds.2010.09.080; Kong AP, 2011, SLEEP MED, V12, P659, DOI 10.1016/j.sleep.2010.12.015; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Magee CA, 2013, J DEV BEHAV PEDIATR, V34, P165, DOI [10.1097/DBP.0b013e318289aa51., 10.1097/DBP.0b013e318289aa51]; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; Martinez-Vizcaino V, 2012, REV ESP CARDIOL, V65, P427, DOI [10.1016/j.recesp.2011.12.008, 10.1016/j.rec.2011.12.009]; Martinez-Vizcaino V, 2010, DIABETES CARE, V33, P1370, DOI 10.2337/dc09-2049; McDonald L, 2014, SLEEP MED, V15, P536, DOI 10.1016/j.sleep.2014.01.005; McNeil J, 2013, CAN J DIABETES, V37, P103, DOI 10.1016/j.jcjd.2013.02.060; Morrison JA, 2012, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2012-6; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Quist JS, 2016, SLEEP MED REV, V29, P76, DOI 10.1016/j.smrv.2015.09.001; Ruger M, 2009, REV ENDOCR METAB DIS, V10, P245, DOI 10.1007/s11154-009-9122-8; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sayin FK, 2016, CHILD OBES, V12, P272, DOI 10.1089/chi.2015.0126; Snell EK, 2007, CHILD DEV, V78, P309, DOI 10.1111/j.1467-8624.2007.00999.x; Urban D, 2013, INTEGR BLOOD PRESS C, V6, P119, DOI 10.2147/IBPC.S33958; Xi B, 2014, SLEEP MED REV, V18, P293, DOI 10.1016/j.smrv.2013.06.001	38	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191637	10.1371/journal.pone.0191637	http://dx.doi.org/10.1371/journal.pone.0191637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360869	gold, Green Published, Green Submitted			2022-12-27	WOS:000423161800047
J	Dong, YL; Li, XD; Liu, YH				Dong, Yilin; Li, Xinde; Liu, Yihai			A fast combination method in DSmT and its application to recommender system	PLOS ONE			English	Article							BELIEF FUNCTIONS; APPROXIMATION; PREFERENCES	In many applications involving epistemic uncertainties usually modeled by belief functions, it is often necessary to approximate general (non-Bayesian) basic belief assignments (BBAs) to subjective probabilities (called Bayesian BBAs). This necessity occurs if one needs to embed the fusion result in a system based on the probabilistic framework and Bayesian inference (e. g. tracking systems), or if one needs to make a decision in the decision making problems. In this paper, we present a new fast combination method, called modified rigid coarsening (MRC), to obtain the final Bayesian BBAs based on hierarchical decomposition (coarsening) of the frame of discernment. Regarding this method, focal elements with probabilities are coarsened efficiently to reduce computational complexity in the process of combination by using disagreement vector and a simple dichotomous approach. In order to prove the practicality of our approach, this new approach is applied to combine users' soft preferences in recommender systems (RSs). Additionally, in order to make a comprehensive performance comparison, the proportional conflict redistribution rule #6 (PCR6) is regarded as a baseline in a range of experiments. According to the results of experiments, MRC is more effective in accuracy of recommendations compared to original Rigid Coarsening (RC) method and comparable in computational time.	[Dong, Yilin; Li, Xinde] Southeast Univ, Sch Automat, Key Lab Measurement & Control CSE, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Liu, Yihai] Jiangsu Automat Res Inst, Lianyungang, Jiangsu, Peoples R China	Southeast University - China	Li, XD (corresponding author), Southeast Univ, Sch Automat, Key Lab Measurement & Control CSE, Minist Educ, Nanjing, Jiangsu, Peoples R China.	xindeli@seu.edu.cn			National Natural Science Foundation of China [61573097, 91748106]; Key Laboratory of Integrated Automation of Process Industry [PAL-N201704]; Qing Lan Project; Six Major Top-talent Plan; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Integrated Automation of Process Industry; Qing Lan Project(Jiangsu Polytech Institute); Six Major Top-talent Plan; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported in part by the National Natural Science Foundation of China under Grant 61573097, 91748106, in part by Key Laboratory of Integrated Automation of Process Industry (PAL-N201704), in part by the Qing Lan Project and Six Major Top-talent Plan, and in part by the Priority Academic Program Development of Jiangsu Higher Education Institutions to XL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, ADV APPL DSMT INFORM; Bagher RC, 2017, EXPERT SYST APPL, V87, P209, DOI 10.1016/j.eswa.2017.06.020; Bobadilla J, 2013, KNOWL-BASED SYST, V46, P109, DOI 10.1016/j.knosys.2013.03.012; Chan H, 2005, INT J APPROX REASON, V38, P149, DOI 10.1016/j.ijar.2004.07.001; Chen T, 2017, INT J INTELL SYST, V32, DOI 10.1002/int.21863; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Denoeux T, 2001, INT J UNCERTAIN FUZZ, V9, P437, DOI 10.1016/S0218-4885(01)00088-0; Denoeux T, 2013, IEEE T KNOWL DATA EN, V25, P119, DOI 10.1109/TKDE.2011.201; Dezert J., 2008, P THE11TH INT C INFO, P1; Dezert J., 2002, INFORM SECURITY INT, V9, DOI [10.11610/isij.0901, DOI 10.11610/ISIJ.0901]; Dong YL, 2017, 20  INT C I IN PRESS; Han DG, 2016, INT CONF UBIQ FUTUR, P1, DOI 10.1109/ICUFN.2016.7536966; Han DQ, 2015, P FUS 2015 WASH DC U; Herlocker JL, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P230, DOI 10.1145/312624.312682; Jglesias J, HAIS, P242; Jiang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177828; Kanjanatarakul O, 2014, INT J APPROX REASON, V55, P1113, DOI 10.1016/j.ijar.2014.01.005; KENNES R, 1992, IEEE T SYST MAN CYB, V22, P201, DOI 10.1109/21.148425; Ladyzynski P, 2015, EXPERT SYST APPL, V42, P9402, DOI 10.1016/j.eswa.2015.08.006; Li MZ, 2016, INT J INTELL SYST, V31, P44, DOI 10.1002/int.21744; Li X. D., 2010, ACTA ELECT SINICA, V38, P2567; Li X. D., 2011, ACTA ELECT SINICA, V39, P32; Li X. D., 2011, J HUAZHONG U SCI TEC, V39, P151; Masson MH, 2011, INT J APPROX REASON, V52, P92, DOI 10.1016/j.ijar.2010.04.007; Nguyen VD, ECSQARU, P429; SHAFER G, 1987, ARTIF INTELL, V33, P271, DOI 10.1016/0004-3702(87)90040-3; Shafer G. A., 1978, MATH THEORY EVIDENCE, V20, P106; Smets P, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P612; Smets P, 2007, INFORM FUSION, V8, P387, DOI 10.1016/j.inffus.2006.04.003; Troiano L, 2015, FUZZY SET SYST, V278, P98, DOI 10.1016/j.fss.2015.06.004; Nguyen VD, 2017, INT J APPROX REASON, V80, P225, DOI 10.1016/j.ijar.2016.09.005; Wickramarathne TL, 2011, IEEE T KNOWL DATA EN, V23, P175, DOI 10.1109/TKDE.2010.88; Yang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147799; Yang Y, 2013, CHINESE J AERONAUT, V26, P993, DOI 10.1016/j.cja.2013.04.061	34	0	0	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0189703	10.1371/journal.pone.0189703	http://dx.doi.org/10.1371/journal.pone.0189703			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351297	Green Submitted, gold, Green Published			2022-12-27	WOS:000422911300010
J	Maley, MJ; Minett, GM; Bach, AJE; Zietek, SA; Stewart, KL; Stewart, IB				Maley, Matthew J.; Minett, Geoffrey M.; Bach, Aaron J. E.; Zietek, Stephanie A.; Stewart, Kelly L.; Stewart, Ian B.			Internal and external cooling methods and their effect on body temperature, thermal perception and dexterity	PLOS ONE			English	Article							ICE SLURRY INGESTION; RESPIRATORY HEAT-LOSS; PHYSIOLOGICAL-RESPONSES; CORE TEMPERATURE; COLD IMMERSION; PERFORMANCE; EXERCISE; INTENSITY; RADIATION; HAND	Objective The present study aimed to compare a range of cooling methods possibly utilised by occupational workers, focusing on their effect on body temperature, perception and manual dexterity. Methods Ten male participants completed eight trials involving 30 min of seated rest followed by 30 min of cooling or control of no cooling (CON) (34 degrees C, 58% relative humidity). The cooling methods utilised were: ice cooling vest (CV0), phase change cooling vest melting at 14 degrees C (CV14), evaporative cooling vest (CVEV), arm immersion in 10 degrees C water (AI), portable waterperfused suit (WPS), heliox inhalation (HE) and ice slushy ingestion (SL). Immediately before and after cooling, participants were assessed for fine (Purdue pegboard task) and gross (grip and pinch strength) manual dexterity. Rectal and skin temperature, as well as thermal sensation and comfort, were monitored throughout. Results Compared with CON, SL was the only method to reduce rectal temperature (P = 0.012). All externally applied cooling methods reduced skin temperature (P < 0.05), though CV0 resulted in the lowest skin temperature versus other cooling methods. Participants felt cooler with CV0, CV14, WPS, AI and SL (P < 0.05). AI significantly impaired Purdue pegboard performance (P = 0.001), but did not affect grip or pinch strength (P > 0.05). Conclusion The present study observed that ice ingestion or ice applied to the skin produced the greatest effect on rectal and skin temperature, respectively. AI should not be utilised if workers require subsequent fine manual dexterity. These results will help inform future studies investigating appropriate pre-cooling methods for the occupational worker.	[Maley, Matthew J.; Minett, Geoffrey M.; Bach, Aaron J. E.; Zietek, Stephanie A.; Stewart, Kelly L.; Stewart, Ian B.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Exercise & Nutr Sci, Brisbane, Qld, Australia	Queensland University of Technology (QUT)	Maley, MJ (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Exercise & Nutr Sci, Brisbane, Qld, Australia.	matthew.maley@qut.edu.au	Stewart, Ian B/I-9927-2012; Maley, Matthew J/AAC-7041-2020; Minett, Geoffrey/L-5757-2017; Bach, Aaron/AAQ-2258-2020	Maley, Matthew J/0000-0001-5200-7640; Minett, Geoffrey/0000-0003-4617-2820; Bach, Aaron/0000-0002-5581-5018; Stewart, Kelly/0000-0002-3386-7001; Stewart, Ian/0000-0003-1741-718X	US Government through the Technical Support Working Group within the Combating Terrorism Technical Support Office	US Government through the Technical Support Working Group within the Combating Terrorism Technical Support Office	This project is financially supported by the US Government through the Technical Support Working Group within the Combating Terrorism Technical Support Office. This support does not represent an endorsement of the contents or conclusions of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong LE, 2005, NUTR REV, V63, pS40, DOI 10.1111/j.1753-4887.2005.tb00153.x; Bogerd N, 2010, J SPORT SCI, V28, P771, DOI 10.1080/02640411003716942; Bongers Coen C W G, 2017, Temperature (Austin), V4, P60, DOI 10.1080/23328940.2016.1277003; CAIN JB, 1990, RESP PHYSIOL, V79, P145, DOI 10.1016/0034-5687(90)90014-P; Chan APC, 2015, J THERM BIOL, V49-50, P16, DOI 10.1016/j.jtherbio.2015.01.007; Cheung SS, 2003, AVIAT SPACE ENVIR MD, V74, P990; Chi CF, 2012, INT J IND ERGONOM, V42, P113, DOI 10.1016/j.ergon.2011.08.008; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Costello JT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/857536; Cramer MN, 2016, AUTON NEUROSCI-BASIC, V196, P3, DOI 10.1016/j.autneu.2016.03.001; David HN, 2009, J CEREBR BLOOD F MET, V29, P1159, DOI 10.1038/jcbfm.2009.40; DeGroot DW, 2013, J THERM BIOL, V38, P305, DOI 10.1016/j.jtherbio.2013.03.010; DILL D. B., 1931, ARBEITSPHYSIOLOGIE, V4, P508; Duffield R, 2010, MED SCI SPORT EXER, V42, P577, DOI 10.1249/MSS.0b013e3181b675da; Filingeri D, 2015, SCAND J MED SCI SPOR, V25, P200, DOI 10.1111/sms.12322; Gagge A.P., 2010, COMPREHENSIVE PHYSL, P69, DOI DOI 10.1002/CPHY.CP090105; GAGGE AP, 1967, ENVIRON RES, V1, P1, DOI 10.1016/0013-9351(67)90002-3; Gagge AP, 1996, HDB PHYSL 4, P45; Hardy JD, 1938, J NUTR, V15, P461, DOI 10.1093/jn/15.5.461; Hardy JD, 1938, J NUTR, V15, P477, DOI 10.1093/jn/15.5.477; HARRISON MR, 1977, J PEDIATR SURG, V12, P821, DOI 10.1016/0022-3468(77)90590-5; Havenith G, 1995, Arctic Med Res, V54 Suppl 2, P37; HEUS R, 1995, APPL ERGON, V26, P5, DOI 10.1016/0003-6870(94)00004-I; International Organisation for Standardisation, 2004, 9886 ISO, DOI [10.1016/B978-075067555-0/50157-2, DOI 10.1016/B978-075067555-0/50157-2]; International Organisation for Standardisation, 2001, 12894 ISO; James CA, 2015, SCAND J MED SCI SPOR, V25, P190, DOI 10.1111/sms.12376; Kay D, 1999, J SPORT SCI, V17, P937, DOI 10.1080/026404199365326; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; LOCKHART JM, 1975, J APPL PSYCHOL, V60, P106, DOI 10.1037/h0076269; Minett GM, 2012, EUR J APPL PHYSIOL, V112, P3655, DOI 10.1007/s00421-012-2348-2; Minett GM, 2012, J SPORT SCI, V30, P907, DOI 10.1080/02640414.2012.679677; Minett GM, 2011, MED SCI SPORT EXER, V43, P1760, DOI 10.1249/MSS.0b013e318211be3e; Naito T, 2016, J THERM BIOL, V59, P13, DOI 10.1016/j.jtherbio.2016.04.006; Nybo L, 2014, COMPR PHYSIOL, V4, P657, DOI 10.1002/cphy.c130012; PIANTADOSI CA, 1981, J APPL PHYSIOL, V50, P829, DOI 10.1152/jappl.1981.50.4.829; Price M, 2015, EXTREME PHYSL MED, V4, pA127; Price MJ, 2009, APPL PHYSIOL NUTR ME, V34, P942, DOI 10.1139/H09-078; Pryor RR, 2015, PREHOSP EMERG CARE, V19, P241, DOI 10.3109/10903127.2014.959221; Quod MJ, 2008, J SPORT SCI, V26, P1477, DOI 10.1080/02640410802298268; Ross M, 2013, SPORTS MED, V43, P207, DOI 10.1007/s40279-012-0014-9; Siegel R, 2012, J SPORT SCI, V30, P155, DOI 10.1080/02640414.2011.625968; Siegel R, 2010, MED SCI SPORT EXER, V42, P717, DOI 10.1249/MSS.0b013e3181bf257a; Stevens CJ, 2016, SCAND J MED SCI SPOR, V26, P1209, DOI 10.1111/sms.12555; Stewart IB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083740; Stocks JM, 2004, AVIAT SPACE ENVIR MD, V75, P444; TAPPER D, 1974, J PEDIATR SURG, V9, P597, DOI 10.1016/0022-3468(74)90094-3; Taylor L, 2014, J STRENGTH COND RES, V28, P3416, DOI 10.1519/JSC.0000000000000558; Tokizawa K, 2014, INT J BIOMETEOROL, V58, P1919, DOI 10.1007/s00484-014-0794-8; VINCENT MJ, 1988, AVIAT SPACE ENVIR MD, V59, P738; Xiang JJ, 2015, OCCUP ENVIRON MED, V72, P580, DOI 10.1136/oemed-2014-102706; Zimmermann M, 2017, INT J SPORT NUTR EXE, V27, P220, DOI [10.1123/ijsnem.2016-0028, 10.1123/ijsnem.2015-0215, 10.1123/ijsnem.2016-0215]	52	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191416	10.1371/journal.pone.0191416	http://dx.doi.org/10.1371/journal.pone.0191416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1TP	29357373	Green Published, gold, Green Submitted			2022-12-27	WOS:000422919500013
J	Schaefer, A; Dickow, J; Schoen, G; Westhofen, S; Kloss, L; Al-Saydali, T; Reichenspurner, H; Philipp, SA; Detter, C				Schaefer, Andreas; Dickow, Jannis; Schoen, Gerhard; Westhofen, Sumi; Kloss, Lisa; Al-Saydali, Tarik; Reichenspurner, Hermann; Philipp, Sebastian A.; Detter, Christian			Stentless vs. stented bioprosthesis for aortic valve replacement: A case matched comparison of long-term follow-up and subgroup analysis of patients with native valve endocarditis	PLOS ONE			English	Article							INFECTIVE ENDOCARDITIS; IMPLANTATION; EXPERIENCE; OUTCOMES	Background Current retrospective evidence suggests similar clinical and superior hemodynamic outcomes of the Sorin Freedom Solo stentless aortic valve (SFS) (Livallova PLC, London, UK) compared to the Carpentier Edwards Perimount stented aortic valve (CEP) (Edwards Life sciences Inc., Irvine, California, USA). To date, no reports exist describing case-matched long-term outcomes and analysis for treatment of native valve endocarditis (NVE). Methods From 2004 through 2014, 77 consecutive patients (study group, 59.7% male, 68.9 12.5 years, logEuroSCORE 11 7.6 +/- 12.3%) received surgical aortic valve replacement (SAVR) with the SFS. A control group of patients after SAVR with the CEP was retrieved from our database and matched to the study group regarding 15 parameters including preoperative endocarditis. Acute perioperative outcomes and follow-up data (mean follow-up time 48.7 +/- 29.8 months, 95% complete) were retrospectively analyzed. Results No differences in early mortality occurred during 30-day follow up (3/77; 3.9% vs. 4/77; 5.2%; p = 0.699). Echocardiographic findings revealed lower postprocedural transvalvular pressure gradients (max. 17.0 +/- 8.2 vs. 24.5 +/- 9.2 mmHg, p < 0.001/mean pressure of 8.4 +/- 4.1 vs. 13.1 +/- 5.9 mmHg, p< 0.001) in the SFS group. Structural valve degeneration (SVD) (5.2% vs. 0%; p = 0.04) and valve explantation due to SVD or prosthetic valve endocarditis (PVE) (9.1% vs. 1.3%; p = 0.04) was more frequent in the SFS group. All-cause mortality during follow-up was 20.8% vs. 14.3% (p = 0.397). When patients were divided into subgroups of NVE and respective utilized bioprosthesis, the SFS presented impaired outcomes regarding mortality in NVE cases (p = 0.031). Conclusions The hemodynamic superiority of the SFS was confirmed in this comparison. However, clinical outcomes in terms of SVD and PVE rates, as well as survival after NVE, were inferior in this study. Therefore, we are reluctant to recommend utilization of the SFS for treatment of NVE.	[Schaefer, Andreas; Dickow, Jannis; Westhofen, Sumi; Kloss, Lisa; Al-Saydali, Tarik; Reichenspurner, Hermann; Detter, Christian] Univ Heart Ctr Hamburg, Cardiovasc Surg, Hamburg, Germany; [Schoen, Gerhard] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Philipp, Sebastian A.] Elbe Clin Stade, Dept Cardiol & Intens Care Med, Stade, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schaefer, A (corresponding author), Univ Heart Ctr Hamburg, Cardiovasc Surg, Hamburg, Germany.	and.schaefer@uke.de	Schäfer, Andreas/GPJ-9458-2022					Cahill TJ, 2016, LANCET, V387, P882, DOI 10.1016/S0140-6736(15)00067-7; Carrel T, 2016, EUR J CARDIO-THORAC, V49, P1180, DOI 10.1093/ejcts/ezv284; Conradi L, 2015, CLIN RES CARDIOL, V104, P735, DOI 10.1007/s00392-015-0836-1; Ejiofor JI, 2016, ANN THORAC SURG, V102, P1452, DOI 10.1016/j.athoracsur.2016.05.086; Ferrate S, 2016, THORAC CARDIOVASC SU; Grubitzsch H, 2015, EUR J CARDIO-THORAC, V47, pE97, DOI 10.1093/ejcts/ezu471; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Heimansohn D, 2016, EUR J CARDIO-THORAC, V49, P493, DOI 10.1093/ejcts/ezv169; Ho Daniel E., 2011, J STAT SOFTW, V42, P1, DOI [DOI 10.18637/JSS.V042.I08, 10.18637/jss.v042.i08]; Klieverik LMA, 2009, ANN THORAC SURG, V88, P1814, DOI 10.1016/j.athoracsur.2009.08.019; Meszaros K, 2012, ANN THORAC SURG, V94, P1204, DOI 10.1016/j.athoracsur.2012.04.093; Miceli A, 2013, INTERACT CARDIOV TH, V16, P27, DOI 10.1093/icvts/ivs438; Musci M, 2010, J THORAC CARDIOV SUR, V139, P665, DOI 10.1016/j.jtcvs.2009.07.026; Pfeiffer S, 2015, J CARDIOVASC MED, V16, P318, DOI 10.2459/JCM.0b013e3283536ac7; R Development Core Team, 2009, R LANG ENV STAT COMP; Repossini A, 2016, ANN THORAC SURG, V102, P1956, DOI 10.1016/j.athoracsur.2016.05.080; Rouze S, 2016, ANN THORAC SURG, V102, P549, DOI 10.1016/j.athoracsur.2016.02.019; Schneider AW, 2016, EUR J CARDIO-THORAC, V49, P1699, DOI 10.1093/ejcts/ezv463; Silaschi M, 2017, INTERACT CARDIOV TH, V24, P63, DOI 10.1093/icvts/ivw300; Sponga S, 2017, INTERACT CARDIOVASC; Stanger O, 2015, EUR J CARDIO-THORAC, V48, P562, DOI 10.1093/ejcts/ezu473; Stanger O, 2015, J THORAC CARDIOV SUR, V150, P70, DOI 10.1016/j.jtcvs.2015.01.060; Thalmann M, 2014, ANN THORAC SURG, V98, P1301, DOI 10.1016/j.athoracsur.2014.05.089; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; van der Straaten EPJ, 2016, EUR J CARDIO-THORAC, V49, P1174, DOI 10.1093/ejcts/ezv255	25	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191171	10.1371/journal.pone.0191171	http://dx.doi.org/10.1371/journal.pone.0191171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338037	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700036
J	Dahdal, S; Devetzis, V; Chalikias, G; Tziakas, D; Chizzolini, C; Ribi, C; Trendelenburg, M; Eisenberger, U; Hauser, T; Pasch, A; Huynh-Do, U; Arampatzis, S				Dahdal, Suzan; Devetzis, Vasilios; Chalikias, George; Tziakas, Dimitrios; Chizzolini, Carlo; Ribi, Camillo; Trendelenburg, Marten; Eisenberger, Ute; Hauser, Thomas; Pasch, Andreas; Huynh-Do, Uyen; Arampatzis, Spyridon		Swiss Systemic Lupus Erythematosus	Serum calcification propensity is independently associated with disease activity in systemic lupus erythematosus	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; RISK-FACTORS; FETUIN-A; ACCELERATED ATHEROSCLEROSIS; CALCIPROTEIN PARTICLES; SURVIVAL; PROGRESSION; EVENTS; WOMEN	Background Systemic lupus erythematosus (SLE) is associated with severe cardiovascular complications. The T-50 score is a novel functional blood test quantifying calcification propensity in serum. High calcification propensity (or low T-50) is a strong and independent determinant of all-cause mortality in various patient populations. Methods A total of 168 patients with >= 4 American College of Rheumatology (ACR) diagnostic criteria from the Swiss Systemic lupus erythematosus Cohort Study (SSCS) were included in this analysis. Serum calcification propensity was assessed using time-resolved nephelometry. Results The cohort mainly consisted of female (85%), middle-aged (43 +/- 14 years) Caucasians (77%). The major determinants of T-50 levels included hemoglobin, serum creatinine and serum protein levels explaining 43% of the variation at baseline. Integrating disease activity (SELENA-SLEDAI) into this multivariate model revealed a significant association between disease activity and T-50 levels. In a subgroup analysis considering only patients with active disease (SELENA-SLEDAI score >= 4) we found a negative association between T-50 and SELENA-SLEDAI score at baseline (Spearman's rho -0.233, P = 0.02). Conclusions Disease activity and T-50 are closely associated. Moreover, T-50 levels identify a subgroup of SLE patients with ongoing systemic inflammation as mirrored by increased disease activity. T-50 could be a promising biomarker reflecting SLE disease activity and might offer an earlier detection tool for high-risk patients.	[Dahdal, Suzan; Devetzis, Vasilios; Huynh-Do, Uyen; Arampatzis, Spyridon] Univ Bern, Bern Univ Hosp, Inselspital, Dept Nephrol & Hypertens, Bern, Switzerland; [Chalikias, George; Tziakas, Dimitrios] Democritus Univ Thrace, Med Sch, Dept Cardiol, Alexandroupolis, Greece; [Chizzolini, Carlo] Univ Hosp, Dept Internal Med Specialties, Div Clin Immunol & Allergy, Geneva, Switzerland; [Chizzolini, Carlo] Sch Med, Geneva, Switzerland; [Ribi, Camillo] Univ Hosp Lausanne, Div Clin Immunol & Allergy, Lausanne, Switzerland; [Trendelenburg, Marten] Univ Hosp Basel, Dept Biomed, Div Internal Med, Basel, Switzerland; [Trendelenburg, Marten] Univ Hosp Basel, Dept Biomed, Clin Immunol Lab, Basel, Switzerland; [Eisenberger, Ute] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Duisburg, Germany; [Hauser, Thomas] Immunol Zentrum, Zurich, Switzerland; [Pasch, Andreas] Univ Bern, Dept Biomed Res, Bern, Switzerland; [Pasch, Andreas] Calciscon AG, Nidau, Switzerland	University of Bern; University Hospital of Bern; Democritus University of Thrace; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; University of Basel; University of Duisburg Essen; University of Bern	Arampatzis, S (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Nephrol & Hypertens, Bern, Switzerland.	Spyridon.arampatzis@insel.ch	Tziakas, Dimitrios/AAO-8230-2021; Trendelenburg, Marten/AAM-1626-2020; Chizzolini, Carlo/V-4847-2019; Chalikias, George/AAO-8148-2021	Tziakas, Dimitrios/0000-0002-4982-9181; Trendelenburg, Marten/0000-0001-7036-8386; Chalikias, George/0000-0003-4331-730X; Arampatzis, Spyridon/0000-0002-6959-0411	Calciscon AG	Calciscon AG	Calciscon AG provided support in the form of salaries for author AP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Aghagolzadeh P, 2016, ATHEROSCLEROSIS, V251, P404, DOI 10.1016/j.atherosclerosis.2016.05.044; Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; Bengtsson C, 2012, LUPUS, V21, P452, DOI 10.1177/0961203311425524; Bjornadal L, 2004, J RHEUMATOL, V31, P713; Cabbage S, 2014, PATHOG DIS, V72, P61, DOI 10.1111/2049-632X.12185; Chizzolini Carlo, 2009, Rev Med Suisse, V5, P808; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Gautier EL, 2007, ARTERIOSCL THROM VAS, V27, P1625, DOI 10.1161/ATVBAHA.107.142430; Hahn BH, 2003, NEW ENGL J MED, V349, P2379, DOI 10.1056/NEJMp038168; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Jung HJ, 2010, ARTHRITIS RHEUM-US, V62, P863, DOI 10.1002/art.27289; Kadoglou NPE, 2014, CLIN DRUG INVEST, V34, P165, DOI 10.1007/s40261-013-0157-y; Keyzer CA, 2016, J AM SOC NEPHROL, V27, P239, DOI 10.1681/ASN.2014070670; Kyaw T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029371; Lertratanakul A, 2014, ARTHRIT CARE RES, V66, P1177, DOI 10.1002/acr.22271; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Mikdashi J, 2007, STROKE, V38, P281, DOI 10.1161/01.STR.0000254476.05620.14; Nikpour M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3473; Pasch A, 2017, CLIN J AM SOC NEPHRO, V12, P315, DOI 10.2215/CJN.04720416; Pasch A, 2012, J AM SOC NEPHROL, V23, P1744, DOI 10.1681/ASN.2012030240; Ribi C, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13990; Roman MJ, 2007, ARTHRITIS RHEUM, V56, P3412, DOI 10.1002/art.22924; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Romero-Diaz J, 2012, RHEUMATOLOGY, V51, P110, DOI 10.1093/rheumatology/ker307; Ruiz-Irastorza G, 2006, LUPUS, V15, P577, DOI 10.1177/0961203306071872; Smith ER, 2014, J AM SOC NEPHROL, V25, P339, DOI 10.1681/ASN.2013060635; Smith ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060904; Smith ER, 2013, NEPHROLOGY, V18, P215, DOI 10.1111/nep.12021; Tam LS, 2000, J RHEUMATOL, V27, P2142; Thacker SG, 2012, ARTHRITIS RHEUM-US, V64, P2975, DOI 10.1002/art.34504; Yee CS, 2011, RHEUMATOLOGY, V50, P982, DOI 10.1093/rheumatology/keq376	31	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2018	13	1							e0188695	10.1371/journal.pone.0188695	http://dx.doi.org/10.1371/journal.pone.0188695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT8OQ	29364894	Green Published, gold, Green Submitted			2022-12-27	WOS:000423412500003
J	Santos, HP; Kossakowski, JJ; Schwartz, TA; Beeber, L; Fried, EI				Santos, Hudson P., Jr.; Kossakowski, Jolanda J.; Schwartz, Todd A.; Beeber, Linda; Fried, Eiko I.			Longitudinal network structure of depression symptoms and self-efficacy in low-income mothers	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; MATERNAL DEPRESSION; INFANTS; CENTRALITY; PREGNANCY; TODDLERS; ANXIETY; STRESS; IMPACT; STATES	Maternal depression was recently conceptualized as a network of interacting symptoms. Prior studies have shown that low self-efficacy, as an index of maternal functioning, is one important source of stress that worsens depression. We have limited information, however, on the specific relationships between depression symptoms and self-efficacy. In this study, we used regularized partial correlation networks to explore the multivariate relationships between maternal depression symptoms and self-efficacy over time. Depressed mothers (n = 306) completed the Center for Epidemiological Studies Depression (CES-D) scale at four time points, between four and eight weeks apart. We estimated (a) the network structure of the 20 CES-D depression symptoms and self-efficacy for each time point, (b) determined the centrality or structural importance of all variables, and (c) tested whether the network structure changed over time. In the resulting networks, self-efficacy was mostly negatively connected with depression symptoms. The strongest relationships among depression symptoms were lonely-sleep difficulties' and 'inability to get going-crying'. 'Feeling disliked' and 'concentration difficulty' were the two most central symptoms. In comparing the network structures, we found that the network structures were moderately stable over time. This is the first study to investigate the network structure and their temporal stability of maternal depression symptoms and self-efficacy in low-income depressed mothers. We discuss how these findings might help future research to identify clinically relevant symptom-to-symptom relationships that could drive maternal depression processes, and potentially inform tailored interventions. We share data and analytical code, making our results fully reproducible.	[Santos, Hudson P., Jr.; Schwartz, Todd A.; Beeber, Linda] Univ N Carolina, Sch Nursing, Chapel Hill, NC 27599 USA; [Kossakowski, Jolanda J.; Fried, Eiko I.] Univ Amsterdam, Dept Psychol Methods, Amsterdam, Netherlands; [Schwartz, Todd A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Amsterdam; University of North Carolina; University of North Carolina Chapel Hill	Santos, HP (corresponding author), Univ N Carolina, Sch Nursing, Chapel Hill, NC 27599 USA.	hsantos@unc.edu	Kossakowski, Jolanda/N-3587-2015; Schwartz, Todd/D-4995-2012; Fried, Eiko/H-3174-2019; Santos, Hudson/K-5650-2015	Kossakowski, Jolanda/0000-0002-6946-1732; Schwartz, Todd/0000-0002-0232-2543; Fried, Eiko/0000-0001-7469-594X; Santos, Hudson/0000-0002-4040-366X	European Research Council (ERC) [647209]; University of North Carolina at Chapel Hill School of Nursing, small pilot program; Research Priority Area Yield, part of the Research Institute of Child Development and Education, University of Amsterdam, the Netherlands; Department of Health and Human Services/ACF/ACYF [90YF0042]; National Institute of Mental Health [R01MH065524]	European Research Council (ERC)(European Research Council (ERC)); University of North Carolina at Chapel Hill School of Nursing, small pilot program; Research Priority Area Yield, part of the Research Institute of Child Development and Education, University of Amsterdam, the Netherlands; Department of Health and Human Services/ACF/ACYF; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Data used in this study were generated by grant # R01MH065524 (PI: Beeber) from the National Institute of Mental Health and grant # 90YF0042 from the Department of Health and Human Services/ACF/ACYF (PI: Beeber). H. Santos was supported by the University of North Carolina at Chapel Hill School of Nursing, small pilot program. J. Kossakowski is partly funded by the Research Priority Area Yield, part of the Research Institute of Child Development and Education, University of Amsterdam, the Netherlands. J. Kossakowski and E. Fried are supported by the European Research Council (ERC) Consolidator Grant # 647209. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or ERC.	American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Bandura A, 1999, J PERS SOC PSYCHOL, V76, P258, DOI 10.1037/0022-3514.76.2.258; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BANDURA A, 1989, DEV PSYCHOL, V25, P729, DOI 10.1037/0012-1649.25.5.729; Barkin JL, 2010, J WOMENS HEALTH, V19, P1493, DOI 10.1089/jwh.2009.1864; Barr JA, 2008, CAN FAM PHYSICIAN, V54, P1716; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Beck CT, 2002, QUAL HEALTH RES, V12, P453, DOI 10.1177/104973202129120016; Beeber LS, 2014, RES NURS HEALTH, V37, P276, DOI 10.1002/nur.21604; Beeber LS, 2013, NURS RES, V62, P82, DOI 10.1097/NNR.0b013e31828324c2; Beeber LS, 2010, RES NURS HEALTH, V33, P60, DOI 10.1002/nur.20363; Bernstein IH, 2008, DEPRESS ANXIETY, V25, P20, DOI 10.1002/da.20276; Borsboom D, 2017, J ABNORM PSYCHOL, V126, P989, DOI 10.1037/abn0000306; Borsboom D, 2017, WORLD PSYCHIATRY, V16, P5, DOI 10.1002/wps.20375; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Bringmann LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060188; Castro RTA, 2017, ARCH WOMEN MENT HLTH, V20, P123, DOI 10.1007/s00737-016-0685-6; Costantini G, 2015, J RES PERS, V54, P13, DOI 10.1016/j.jrp.2014.07.003; Cramer AOJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167490; Epskamp S., 2017, PSYCHOL MET IN PRESS; Epskamp S, 2016, NETWORK PSYCHOMETRIC; Epskamp S, 2018, BEHAV RES METHODS, V50, P195, DOI 10.3758/s13428-017-0862-1; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fathi F, WOMEN HLTH, V2017, P1; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; Fried EI, 2017, CLIN PSYCHO IN PRESS; Fried EI, 2017, PERSPECT PSYCHOL SCI, V12, P999, DOI 10.1177/1745691617705892; Fried EI, 2017, J AFFECT DISORDERS, V208, P191, DOI 10.1016/j.jad.2016.10.019; Fried EI, 2016, J AFFECT DISORDERS, V189, P314, DOI 10.1016/j.jad.2015.09.005; Fried EI, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0325-4; Fried EI, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00309; Fried EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090311; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Gaynes B. N., 2005, AGENCY HLTH RES QUAL, V119, P1, DOI DOI 10.1037/E439372005-001; GROSS D, 1994, RES NURS HEALTH, V17, P207, DOI 10.1002/nur.4770170308; Halbreich U, 2006, J AFFECT DISORDERS, V91, P97, DOI 10.1016/j.jad.2005.12.051; Hieronymus F, 2016, MOL PSYCHIATR, V21, P523, DOI 10.1038/mp.2015.53; Holland ML, 2011, MATERN CHILD HLTH J, V15, P1011, DOI 10.1007/s10995-010-0662-z; Homewood E., 2009, QUAL RES PSYCHOL, V6, P313, DOI [10.1080/14780880802473860, DOI 10.1080/14780880802473860]; Jokela M, 2016, JAMA PSYCHIAT, V73, P87, DOI 10.1001/jamapsychiatry.2015.1977; Judd LL, 2013, JAMA PSYCHIAT, V70, P1171, DOI 10.1001/jamapsychiatry.2013.1957; Kammerer M, 2009, ARCH WOMEN MENT HLTH, V12, P135, DOI 10.1007/s00737-009-0062-9; Kossakowski JJ, 2016, QUAL LIFE RES, V25, P781, DOI 10.1007/s11136-015-1127-z; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Martini J, 2015, J AFFECT DISORDERS, V175, P385, DOI 10.1016/j.jad.2015.01.012; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Orsolini L, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00138; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Razurel C, 2017, WOMEN HEALTH, V57, P154, DOI 10.1080/03630242.2016.1157125; Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999; Santor DA, 2006, MEAS-INTERDISCIP RES, V4, P135, DOI 10.1207/s15366359mea0403_1; Santos H, 2017, RES NURS HEALTH, V40, P218, DOI 10.1002/nur.21784; Schwarzer R., 1997, WORLD PSYCHOL, V3, P177; Seymour-Smith M, 2017, SOC PSYCH PSYCH EPID, V52, P201, DOI 10.1007/s00127-016-1315-3; Snippe E, 2017, SCI REP-UK, V7, DOI 10.1038/srep46523; van Borkulo C., 2016, NETWORK COMP TEST; Van Borkulo C. D., 2017, COMP NETWORK STRUCTU, P10; van Borkulo C, 2015, JAMA PSYCHIAT, V72, P1219, DOI 10.1001/jamapsychiatry.2015.2079; van de Leemput IA, 2014, P NATL ACAD SCI USA, V111, P87, DOI 10.1073/pnas.1312114110; Wisner KL, 2010, ARCH WOMEN MENT HLTH, V13, P37, DOI 10.1007/s00737-009-0119-9; Yim IS, 2015, ANNU REV CLIN PSYCHO, V11, P99, DOI 10.1146/annurev-clinpsy-101414-020426; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P327, DOI 10.1016/j.genhosppsych.2009.03.005	62	33	35	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191675	10.1371/journal.pone.0191675	http://dx.doi.org/10.1371/journal.pone.0191675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT4YS	29360876	Green Published, Green Submitted, gold			2022-12-27	WOS:000423161800051
J	Yang, YJ; Xu, HX; Lu, YH; Wang, CY; Lu, ZX				Yang, Yajun; Xu, Hongxing; Lu, Yanhui; Wang, Caiyun; Lu, Zhongxian			Midgut transcriptomal response of the rice leaffolder, &ITCnaphalocrocis medinalis&IT (Guenee) to Cry1C toxin	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; CNAPHALOCROCIS-MEDINALIS; DELTA-ENDOTOXIN; ALKALINE-PHOSPHATASE; MANDUCA-SEXTA; LEPIDOPTERA-PYRALIDAE; BT RICE; RESISTANCE; RECEPTOR; TRANSPORTER	Cnaphalocrocis medinalis (Guenee) is one of the important insect pests in rice field. Bt agents were recommended in the C. medinalis control and Bt rice is bred as a tactic to control this insect. However, the tolerance or resistance of insect to Bt protein is a main threat to the application of Bt protein. In order to investigate the response of C. medinalis transcriptome in defending a Cry1C toxin, high-through RNA-sequencing was carried in the C. medinalis larvae treated with and without Cry1C toxin. A total of 35,586 high-quality unigenes was annotated in the transcriptome of C. medinalis midgut. The comparative analysis identified 6,966 differently expressed unigenes (DEGs) between the two treatments. GO analysis showed that these genes involved in proteolysis and extracellular region. Among these DEGs, carboxylesterase, glutathione S-transferase and P450 were differently expressed in the treated C. medinalis midgut. Furthermore, trypsin, chymotrypsin, and carboxypeptidase were identified in DEGs, and most of them upregulated. In addition, thirteen ABC transporters were downregulated and three upregulated in Cry1C-treated C. medinalis mid-gut. Based on the pathway analysis, antigen processing and presentation pathway, and chronic myeloid leukemia pathway were significant in C. medinalis treated with Cry1C toxin. These results indicated that serine protease, detoxification enzymes and ABC transporter, antigen processing and presentation pathway, and chronic myeloid leukemia pathway may involved in the response of C. medinalis to Cry1C toxin. This study provides a transcriptomal foundation for the identification and functional characterization of genes involved in the toxicity of Bt Cry protein against C. medinalis, and provides potential clues to the studies on the tolerance or resistance of an agriculturally important insect pest C. medinalis to Cry1C toxin.	[Yang, Yajun; Xu, Hongxing; Lu, Yanhui; Wang, Caiyun; Lu, Zhongxian] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable P, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Lu, ZX (corresponding author), Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable P, Hangzhou, Zhejiang, Peoples R China.	luzxmh@163.com	Yang, Yajun/HGC-2463-2022		earmarked fund for China Agriculture Research System [CARS-01-36]; National Special Key Project of China [2016ZX08001-001]; National Natural Science Foundation of China [31501669]; Zhejiang Provincial Natural Science Foundation of China [LY15C140003]	earmarked fund for China Agriculture Research System; National Special Key Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was funded by National Natural Science Foundation of China (31501669), the earmarked fund for China Agriculture Research System (CARS-01-36), National Special Key Project of China (2016ZX08001-001), and Zhejiang Provincial Natural Science Foundation of China (LY15C140003).	Ali S, 2010, AFR J BIOTECHNOL, V9, P2022; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Aurade RM, 2010, BBA-BIOMEMBRANES, V1798, P1135, DOI 10.1016/j.bbamem.2010.02.019; Barrion A.T., 1991, Philippine Entomologist, V8, P987; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Brunet JF, 2010, J INVERTEBR PATHOL, V104, P203, DOI 10.1016/j.jip.2010.04.007; Chen JY, 2015, J COGN CULT, V15, P1, DOI 10.1163/15685373-12342137; Chen M, 2011, ANNU REV ENTOMOL, V56, P81, DOI 10.1146/annurev-ento-120709-144810; Chen WC, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/462929; Cheng J.A., 1996, RICE PESTS; Coates BS, 2015, INSECT BIOCHEM MOLEC, V63, P86, DOI 10.1016/j.ibmb.2015.06.003; Cohen Michael B., 2008, V5, P223, DOI 10.1007/978-1-4020-8373-0_8; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Correa S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-303; DEJONG PD, 1992, ENTOMOL EXP APPL, V63, P101, DOI 10.1007/BF00350352; Elleuch J, 2015, MICROBIOL RES, V176, P48, DOI 10.1016/j.micres.2015.04.007; ENGLISH LH, 1989, INSECT BIOCHEM, V19, P145, DOI 10.1016/0020-1790(89)90085-1; EWART GD, 1994, J BIOL CHEM, V269, P10370; Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517; Flores-Escobar B, 2013, APPL ENVIRON MICROB, V79, P4543, DOI 10.1128/AEM.01062-13; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo JY, 2011, SCI CHINA LIFE SCI, V54, P152, DOI 10.1007/s11427-010-4133-y; Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994; Holland I. B., 2003, ABC PROTEINS BACTERI; Keller M, 1996, INSECT BIOCHEM MOLEC, V26, P365, DOI 10.1016/0965-1748(95)00102-6; Lei YY, 2014, GENE, V533, P180, DOI 10.1016/j.gene.2013.09.091; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linser PJ, 2014, ADV INSECT PHYSIOL, V47, P1, DOI 10.1016/B978-0-12-800197-4.00001-4; Liu S, 2015, ARCH INSECT BIOCHEM, V90, P1, DOI 10.1002/arch.21240; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Z X, 2017, PICTORIAL HDB SUSTAI; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miranda R, 2001, INSECT BIOCHEM MOLEC, V31, P1155, DOI 10.1016/S0965-1748(01)00061-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Shanker M, 2010, LUNG CANCER-TARGETS, V1, P23; Shi GQ, 2012, ARCH INSECT BIOCHEM, V79, P87, DOI 10.1002/arch.21014; Sparks ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061190; Strauss AS, 2013, ELIFE, V2, DOI 10.7554/eLife.01096; Tabashnik BE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005646; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tassone EE, 2016, GIGASCIENCE, V5, DOI [10.1186/s13742-016-0109-6, 10.1186/s13742-016-0130-9]; Tetreau G, 2013, ARCH INSECT BIOCHEM, V82, P71, DOI 10.1002/arch.21076; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; Veegala RB, 2015, NEW HORIZONS INSECT, P95; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; WU Zhi-hong, 2015, Zhongguo Shuidao Kexue, V29, P417, DOI 10.3969/j.issn.1001-7216.2015.04.011; Xiao YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06184; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yamazaki T, 2011, PESTIC BIOCHEM PHYS, V101, P125, DOI 10.1016/j.pestbp.2011.09.001; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Yang YaJun, 2015, Acta Phytophylacica Sinica, V42, P691; Yang YJ, 2012, J ECON ENTOMOL, V105, P2122, DOI 10.1603/EC12236; Yang Z, 2011, PEST MANAG SCI, V67, P414, DOI 10.1002/ps.2079; Zhang X, 2005, CELL DEATH DIFFER, V12, P1407, DOI 10.1038/sj.cdd.4401675; Zhang X, 2008, COMP BIOCHEM PHYS B, V149, P581, DOI 10.1016/j.cbpb.2007.12.006; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhang ZG, 2011, BIOTECHNOL B, V51, P148; Zhou XG, 2010, PROTEIN CELL, V1, P520, DOI 10.1007/s13238-010-0065-3	66	10	10	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191686	10.1371/journal.pone.0191686	http://dx.doi.org/10.1371/journal.pone.0191686			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360856	Green Submitted, Green Published, gold			2022-12-27	WOS:000423161800052
J	Omosun, YO; Blackstock, AJ; Williamson, J; van Eijk, AM; Ayisi, J; Otieno, J; Lal, RB; ter Kuile, FO; Slutsker, L; Shi, YP				Omosun, Yusuf O.; Blackstock, Anna J.; Williamson, John; van Eijk, Anne Maria; Ayisi, John; Otieno, Juliana; Lal, Renu B.; ter Kuile, Feiko O.; Slutsker, Laurence; Shi, Ya Ping			Association of maternal KIR gene content polymorphisms with reduction in perinatal transmission of HIV-1	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNOGLOBULIN-LIKE RECEPTORS; ASYMPTOMATIC PREGNANT-WOMEN; NK CELL REPERTOIRE; WESTERN KENYA; RISK-FACTORS; CLASS-I; TYPE-1 TRANSMISSION; PLACENTAL MALARIA	The role of killer cell immunoglobulin-like receptors (KIRs) in the transmission of HIV-1 has not been extensively studied. Here, we investigated the association of KIR gene content polymorphisms with perinatal HIV-1 transmission. The KIR gene family comprising 16 genes was genotyped in 313 HIV-1 positive Kenyan mothers paired with their infants. Gene content polymorphisms were presented as presence of individual KIR genes, haplotypes, genotypes and KIR gene concordance. The genetic data were analyzed for associations with perinatal transmission of HIV. There was no association of infant KIR genes with perinatal HIV-1 transmission. After adjustment for gravidity, viral load, and CD4 cell count, there was evidence of an association between reduction in perinatal HIV-1 transmission and the maternal individual KIR genes KIR2DL2 (adjusted OR = 0.50; 95% CI: 0.24-1.02, P = 0.06), KIR2DL5 (adjusted OR = 0.47; 95% CI: 0.23-0.95, P = 0.04) and KIR2DS5 (adjusted OR = 0.39; 95% CI: 0.18-0.80, P = 0.01). Furthermore, these maternal KIR genes were only significantly associated with reduction in perinatal HIV transmission in women with CD4 cell count >= 350 cells/pl and viral load <10000 copies/ml. Concordance analysis showed that when both mother and child had KIR2DS2, there was less likelihood of perinatal HIV-1 transmission (adjusted OR = 0.44; 95% CI: 0.20-0.96, P = 0.039). In conclusion, the maternal KIR genes KIR2DL2, KIR2DL5, KIR2DS5, and KIR2DS2 were associated with reduction of HIV-1 transmission from mother to child. Furthermore, maternal immune status is an important factor in the association of KIR with perinatal HIV transmission.	[Omosun, Yusuf O.; Blackstock, Anna J.; Williamson, John; Slutsker, Laurence; Shi, Ya Ping] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA; [Omosun, Yusuf O.] Atlanta Res & Educ Fdn, Atlanta, GA USA; [van Eijk, Anne Maria; Ayisi, John] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [van Eijk, Anne Maria; ter Kuile, Feiko O.] Univ Liverpool Liverpool Sch Trop Med, Child & Reprod Hlth Grp, Liverpool, Merseyside, England; [Otieno, Juliana] Minist Hlth, New Nyanza Prov Gen Hosp, Kisumu, Kenya; [Lal, Renu B.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Liverpool School of Tropical Medicine; Centers for Disease Control & Prevention - USA	Shi, YP (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.	Yshi@cdc.gov	Omosun, Yusuf/P-9944-2019; van Eijk, Anna Maria/AAQ-9894-2021; Kuile, Feiko ter/ABD-6681-2020	Omosun, Yusuf/0000-0003-4759-6254; Kuile, Feiko ter/0000-0003-3663-5617; van Eijk, Anna Maria/0000-0003-1635-1289	National Office of Public Health Genomics, Centers for Disease Control and Prevention [92129RQ]; Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center	National Office of Public Health Genomics, Centers for Disease Control and Prevention; Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center	This study was supported by intramural funding from The National Office of Public Health Genomics, Centers for Disease Control and Prevention (Project ID# 92129RQ) and The Atlanta Research and Education Foundation, Atlanta Veterans Affairs Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayisi JG, 2000, INT J STD AIDS, V11, P393, DOI 10.1258/0956462001916119; Ayisi JG, 2004, EMERG INFECT DIS, V10, P643, DOI 10.3201/eid1004.030303; Ballan WM, 2007, J IMMUNOL, V179, P3362, DOI 10.4049/jimmunol.179.5.3362; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; Brahmbhatt H, 2003, AIDS, V17, P2539, DOI 10.1097/00002030-200311210-00020; Buchanan AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088679; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; Chaisavaneeyakorn S, 2002, J INFECT DIS, V186, P1371, DOI 10.1086/344322; Gouveia PAD, 2013, TROP MED INT HEALTH, V18, P276, DOI 10.1111/tmi.12042; David G, 2013, J IMMUNOL, V191, P4778, DOI 10.4049/jimmunol.1301580; Dutta A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001907; Faridi RM, 2009, HUM REPROD, V24, P1758, DOI 10.1093/humrep/dep047; Gallagher M, 2005, AIDS, V19, P1849, DOI 10.1097/01.aids.0000189846.90946.5d; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Gaudieri S, 2005, GENES IMMUN, V6, P683, DOI 10.1038/sj.gene.6364256; Gonzalez A, 2008, TISSUE ANTIGENS, V72, P11, DOI 10.1111/j.1399-0039.2008.01050.x; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hong HA, 2013, CLIN IMMUNOL, V149, P498, DOI 10.1016/j.clim.2013.09.005; Hou LH, 2010, IMMUNOGENETICS, V62, P491, DOI 10.1007/s00251-010-0458-8; Hou LH, 2009, HUM IMMUNOL, V70, P733, DOI 10.1016/j.humimm.2009.04.028; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Jennes W, 2013, BLOOD, V121, P1157, DOI 10.1182/blood-2012-09-455352; Jennes W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017043; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Khosa E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-7; Kouanda S, 2010, AIDS CARE, V22, P843, DOI 10.1080/09540120903499204; Kourtis AP, 2001, JAMA-J AM MED ASSOC, V285, P709, DOI 10.1001/jama.285.6.709; Long BR, 2008, J VIROL, V82, P4785, DOI 10.1128/JVI.02449-07; MacDonald KS, 1998, J INFECT DIS, V177, P551, DOI 10.1086/514243; MacDonald KS, 2001, J INFECT DIS, V183, P503, DOI 10.1086/318092; Marsh SGE, 2003, TISSUE ANTIGENS, V62, P79, DOI 10.1034/j.1399-0039.2003.00072.x; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Mmiro FA, 2009, JAIDS-J ACQ IMM DEF, V52, P32, DOI 10.1097/QAI.0b013e3181afd352; Moesta AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00336; Msamanga GI, 2009, AM J TROP MED HYG, V80, P508, DOI 10.4269/ajtmh.2009.80.508; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Nakimuli A, 2015, P NATL ACAD SCI USA, V112, P845, DOI 10.1073/pnas.1413453112; Norman PJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003938; Okawa S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0697-7; Omosun YO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038617; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2005, MOL IMMUNOL, V42, P459, DOI 10.1016/j.molimm.2004.07.027; Parham P, 2003, TISSUE ANTIGENS, V62, P194, DOI 10.1034/j.1399-0039.2003.00126.x; Paximadis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016541; Polycarpou A, 2002, AIDS RES HUM RETROV, V18, P741, DOI 10.1089/08892220260139477; Scarlatti G, 2004, AIDS REV, V6, P67; Shilling HG, 2002, J IMMUNOL, V169, P239, DOI 10.4049/jimmunol.169.1.239; Tiemessen CT, 2011, JAIDS-J ACQ IMM DEF, V57, P181, DOI 10.1097/QAI.0b013e3182174a76; Tiemessen CT, 2009, J IMMUNOL, V182, P5914, DOI 10.4049/jimmunol.0900419; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; van Eijk AM, 2002, T ROY SOC TROP MED H, V96, P586, DOI 10.1016/S0035-9203(02)90319-6; Van Eijk AM, 2001, AM J TROP MED HYG, V65, P623, DOI 10.4269/ajtmh.2001.65.623; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Williams AP, 2005, MOL INTERV, V5, P226, DOI 10.1124/mi.5.4.6; Winchester R, 2004, JAIDS-J ACQ IMM DEF, V36, P659, DOI 10.1097/00126334-200406010-00002; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884	56	7	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0191733	10.1371/journal.pone.0191733	http://dx.doi.org/10.1371/journal.pone.0191733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360870	Green Accepted, gold, Green Published			2022-12-27	WOS:000423161800058
J	Sabry, AH; Hasan, WZW; Ab Kadir, MZA; Radzi, MAM; Shafie, S				Sabry, A. H.; Hasan, W. Z. W.; Ab Kadir, M. Z. A.; Radzi, M. A. M.; Shafie, S.			Field data-based mathematical modeling by Bode equations and vector fitting algorithm for renewable energy applications	PLOS ONE			English	Article							RATIONAL APPROXIMATION; FREQUENCY-DOMAIN; POWER; PREDICTION; FILTERS; CURVES; DESIGN; SYSTEM; SOLAR	The power system always has several variations in its profile due to random load changes or environmental effects such as device switching effects when generating further transients. Thus, an accurate mathematical model is important because most system parameters vary with time. Curve modeling of power generation is a significant tool for evaluating system performance, monitoring and forecasting. Several numerical techniques compete to fit the curves of empirical data such as wind, solar, and demand power rates. This paper proposes a new modified methodology presented as a parametric technique to determine the system's modeling equations based on the Bode plot equations and the vector fitting (VF) algorithm by fitting the experimental data points. The modification is derived from the familiar VF algorithm as a robust numerical method. This development increases the application range of the VF algorithm for modeling not only in the frequency domain but also for all power curves. Four case studies are addressed and compared with several common methods. From the minimal RMSE, the results show clear improvements in data fitting over other methods. The most powerful features of this method is the ability to model irregular or randomly shaped data and to be applied to any algorithms that estimating models using frequency-domain data to provide state-space or transfer function for the model.	[Sabry, A. H.] Univ Putra Malaysia, Dept Control & Automat, Fac Engn, Serdang, Malaysia; [Hasan, W. Z. W.; Ab Kadir, M. Z. A.; Radzi, M. A. M.; Shafie, S.] Univ Putra Malaysia, Dept Elect & Elect Engn, Fac Engn, Serdang, Malaysia; [Sabry, A. H.] Minist Elect, Alqudus Power Plant, Baghdad, Iraq	Universiti Putra Malaysia; Universiti Putra Malaysia	Sabry, AH (corresponding author), Univ Putra Malaysia, Dept Control & Automat, Fac Engn, Serdang, Malaysia.; Hasan, WZW (corresponding author), Univ Putra Malaysia, Dept Elect & Elect Engn, Fac Engn, Serdang, Malaysia.; Sabry, AH (corresponding author), Minist Elect, Alqudus Power Plant, Baghdad, Iraq.	ahs4771384@gmail.com; wanzuha@upm.edu.my	Sabry, Ahmad H./ACN-4519-2022; Hassan, Wan Zuha Wan/AAD-8694-2020; Radzi, Mohd Amran Mohd/I-7637-2013; Kadir, Zainal/B-6629-2009	Sabry, Ahmad H./0000-0002-2736-5582; Hassan, Wan Zuha Wan/0000-0003-4691-066X; Radzi, Mohd Amran Mohd/0000-0003-3785-1573; Kadir, Zainal/0000-0001-7263-2953; Shafie, Suhaidi/0000-0002-8867-2754				Ai B, 2003, RENEW ENERG, V28, P1491, DOI 10.1016/S0960-1481(03)00011-9; Almeida MP, 2015, SOL ENERGY, V115, P354, DOI 10.1016/j.solener.2015.03.006; Andersson G, 2008, EEH POWER SYST L SEP, P183; [Anonymous], 2017, GRID DATA CONSUMPTIO; Chedid R, 1998, IEEE T ENERGY CONVER, V13, P76, DOI 10.1109/60.658207; Chiou-Jye Huang, 2013, International Journal of Smart Grid and Clean Energy, V2, P139; Cho HR, 2013, J AM STAT ASSOC, V108, P7, DOI 10.1080/01621459.2012.722900; De Tommasi L, 2010, AEU-INT J ELECTRON C, V64, P218, DOI 10.1016/j.aeue.2008.12.006; Deschrijver D, 2007, IEEE T ADV PACKAGING, V30, P216, DOI 10.1109/TADVP.2006.879429; Deschrijver D, 2007, IEEE T POWER DELIVER, V22, P1633, DOI 10.1109/TPWRD.2007.899584; Deschrijver D, 2007, IEEE T MICROW THEORY, V55, P736, DOI 10.1109/TMTT.2007.893651; Dhaene T, 2005, ELECTRON LETT, V41, P299, DOI 10.1049/el:20057913; Diaf S, 2007, ENERG POLICY, V35, P5708, DOI 10.1016/j.enpol.2007.06.020; Engineering C, COMP ARX AR MOD ASS; Gerald K B, 1991, Nurse Anesth, V2, P93; GIORSETTO P, 1983, IEEE T POWER AP SYST, V102, P134, DOI 10.1109/TPAS.1983.318006; Grivet-Talocia S, 2004, AEU-INT J ELECTRON C, V58, P293, DOI 10.1078/1434-8411-54100245; Grivet-Talocia S, 2003, IEEE MICROW WIREL CO, V13, P472, DOI 10.1109/LMWC.2003.819378; Gustavsen B, 1999, IEEE T POWER DELIVER, V14, P1052, DOI 10.1109/61.772353; Gustavsen B, 1998, IEEE T POWER DELIVER, V13, P605, DOI 10.1109/61.660941; Gustavsen B, 2006, IEEE T POWER DELIVER, V21, P1587, DOI 10.1109/TPWRD.2005.860281; Gustavsen B, 2008, IEEE T ADV PACKAGING, V31, P664, DOI 10.1109/TADVP.2008.927810; Hastie TJ., 2017, GEN ADDITIVE MODELS; Hu C, 2015, ENERGY COORDINATIVE, P1505; Jun T, 2010, PHOTOVOLTAIC ARRAY P, P10; Khalfallah MG, 2007, DESALINATION, V209, P221, DOI 10.1016/j.desal.2007.04.031; Kusiak A, 2009, RENEW ENERG, V34, P583, DOI 10.1016/j.renene.2008.05.032; Lawrence EO, 2010, ANAL WIND POWER LOAD; Lei CU, 2008, I CONF VLSI DESIGN, P469, DOI 10.1109/VLSI.2008.12; Lei CU, 2009, IEEE SIGNAL PROC LET, V16, P533, DOI 10.1109/LSP.2009.2017478; Lorenz E, 2011, PROG PHOTOVOLTAICS, V19, P757, DOI 10.1002/pip.1033; Lu N, 2004, MODELING POWER SYSTE; Lydia M, 2014, RENEW SUST ENERG REV, V30, P452, DOI 10.1016/j.rser.2013.10.030; Lydia M, 2013, IEEE T SUSTAIN ENERG, V4, P827, DOI 10.1109/TSTE.2013.2247641; Mechaqrane A, 2004, NEURAL COMPUT APPL, V13, P32, DOI 10.1007/s00521-004-0401-8; Nouri B, 2010, IEEE T ADV PACKAGING, V33, P293, DOI 10.1109/TADVP.2009.2019965; Olauson J, 2015, RENEW ENERG, V76, P717, DOI 10.1016/j.renene.2014.11.085; Paatero JV, 2006, INT J ENERG RES, V30, P273, DOI 10.1002/er.1136; Pelland S, 2011, SOLAR PHOTOVOLTAIC F; Pelland S, 2013, PROG PHOTOVOLTAICS, V21, P284, DOI 10.1002/pip.1180; Pollock DSG., 2008, SMOOTHING CUBIC SPLI; Price P., 2010, METHODS ANAL ELECT L; RTE, 2017, RTE CUST AR DAIL LOA; Sabry Ahmad H., 2015, Applied Mechanics and Materials, V785, P225, DOI 10.4028/www.scientific.net/AMM.785.225; Sabry A. H., 2015, J APPL MECH MAT, V785, P156; Seppala A., 1996, LOAD RES LOAD ESTIMA, P3; Shokrzadeh S, 2014, IEEE T SUSTAIN ENERG, V5, P1262, DOI 10.1109/TSTE.2014.2345059; Sihvola AH, 2006, SPECIAL PUBL ESA SP, V626, P310; Sohoni V, 2016, CRITICAL REV WIND TU, V2016, P1; Spataru S, 2013, IEEE PHOT SPEC C; Stevens N, 2007, 2007 IEEE WORKSHOP ON SIGNAL PROPAGATION ON INTERCONNECTS, P89, DOI 10.1109/SPI.2007.4512218; Ustuntas T, 2008, J WIND ENG IND AEROD, V96, P611, DOI 10.1016/j.jweia.2008.02.001; Weiliang Liu, 2013, Journal of Software, V8, P2569, DOI 10.4304/jsw.8.10.2569-2574; Wong N, 2007, IEEE INT SYMP CIRC S, P2343, DOI 10.1109/ISCAS.2007.378858; Zhang WP, 2009, IEEE T COMPUT AID D, V28, P1348, DOI 10.1109/TCAD.2009.2024711	55	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191478	10.1371/journal.pone.0191478	http://dx.doi.org/10.1371/journal.pone.0191478			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1QM	29351554	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000422911300095
J	Rezinciuc, S; Sandoval-Sierra, JV; Ruiz-Leon, Y; van West, P; Dieguez-Uribeondo, J				Rezinciuc, Svetlana; Vladimir Sandoval-Sierra, Jose; Ruiz-Leon, Yolanda; van West, Pieter; Dieguez-Uribeondo, Javier			Specialized attachment structure of the fish pathogenic oomycete Saprolegnia parasitica	PLOS ONE			English	Article							PHYTOPHTHORA-CINNAMOMI ZOOSPORES; APHANOMYCES-ASTACI; GENUS SAPROLEGNIA; IMAGE-ANALYSIS; BROWN TROUT; COMPLEX; FUNGUS; INFESTANS; ADHESION; DICLINA	The secondary cysts of the fish pathogen oomycete Saprolegnia parasitica possess bundles of long hooked hairs that are characteristic to this economically important pathogenic species. Few studies have been carried out on elucidating their specific role in the S. parasitica life cycle and the role they may have in the infection process. We show here their function by employing several strategies that focus on descriptive, developmental and predictive approaches. The strength of attachment of the secondary cysts of this pathogen was compared to other closely related species where bundles of long hooked hairs are absent. We found that the attachment of the S. parasitica cysts was around three times stronger than that of other species. The time sequence and influence of selected factors on morphology and the number of the bundles of long hooked hairs conducted by scanning electron microscopy study revealed that these are dynamic structures. They are deployed early after encystment, i.e., within 30 sec of zoospore encystment, and the length, but not the number, of the bundles steadily increased over the encystment period. We also observed that the number and length of the bundles was influenced by the type of substrate and encystment treatment applied, suggesting that these structures can adapt to different substrates (glass or fish scales) and can be modulated by different signals (i.e., protein media, 50 mM CaCl2 concentrations, carbon particles). Immunolocalization studies evidenced the presence of an adhesive extracellular matrix. The bioinformatic analyses of the S. parasitica secreted proteins showed that there is a high expression of genes encoding domains of putative proteins related to the attachment process and cell adhesion (fibronectin and thrombospondin) coinciding with the deployment stage of the bundles of long hooked hairs formation. This suggests that the bundles are structures that might contribute to the adhesion of the cysts to the host because they are composed of these adhesive proteins and/or by increasing the surface of attachment of this extracellular matrix.	[Rezinciuc, Svetlana; Vladimir Sandoval-Sierra, Jose; Dieguez-Uribeondo, Javier] CSIC, Real Jardin Bot, Dept Mycol, Madrid, Spain; [Ruiz-Leon, Yolanda] CSIC, UTAI, Real Jardin Bot, Madrid, Spain; [van West, Pieter] Univ Aberdeen, Int Ctr Aquaculture Res & Dev, Inst Med Sci, Aberdeen Oomycete Lab, Aberdeen, Scotland; [Rezinciuc, Svetlana] Royal Inst Technol KTH, AlbaNova Univ Ctr, Div Glycosci, Stockholm, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Aberdeen; Royal Institute of Technology	Dieguez-Uribeondo, J (corresponding author), CSIC, Real Jardin Bot, Dept Mycol, Madrid, Spain.	dieguez@rjb.csic.es	Sandoval, Vladimir/GYD-5018-2022; dieguez-uribeondo, javier/I-2178-2015; Diéguez-Uribeondo, Javier/ABF-1130-2021	Sandoval, Vladimir/0000-0003-2007-6582; dieguez-uribeondo, javier/0000-0002-4488-0658; Diéguez-Uribeondo, Javier/0000-0002-4488-0658; Ruiz-Leon, Yolanda/0000-0001-5872-742X; van West, Pieter/0000-0002-0767-6017	European Union [ITN-SAPRO-238550]; Ministerio de Economia y Competitividad, Spain [CGL2016-80526]; Biotechnology and Biological Sciences Research Council [BB/J018333/1, BB/P020224/1, BB/M026566/1] Funding Source: researchfish; BBSRC [BB/J018333/1, BB/P020224/1, BB/M026566/1] Funding Source: UKRI	European Union(European Commission); Ministerio de Economia y Competitividad, Spain; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The funding or sources of support were grants of: (1) European Union (ITN-SAPRO-238550), (2) Ministerio de Economia y Competitividad, Spain (CGL2016-80526), which supported lab-bench expenses and experiments. Moreover, Svetlana Rezinciuc and Jose V. Sandoval-Sierra were supported by fellowships from ITN-SAPRO-238550.	Andersson MG, 2002, EUKARYOT CELL, V1, P105, DOI 10.1128/EC.1.1.105-111.2002; Arnhold E., 2015, EASYNLS EASY NONLINE; BEAKES G, 1983, CAN J BOT, V61, P603, DOI 10.1139/b83-068; BEAKES G, 1983, J GEN MICROBIOL, V129, P2605; Beakes GW, 1994, SALMON SAPROLEGNIASI, P33; Bechinger C, 1999, SCIENCE, V285, P1896, DOI 10.1126/science.285.5435.1896; Brazee NJ, 2012, FUNGAL ECOL, V5, P600, DOI 10.1016/j.funeco.2012.03.002; BURR AW, 1994, PROTOPLASMA, V181, P142, DOI 10.1007/BF01666393; Carris L., 2012, PLANT HLTH INSTRUCTO, DOI [10.1094/PHI-I-2012-0426-01, DOI 10.1094/PHI-I-2012-0426-01]; CERENIUS L, 1985, EXP MYCOL, V9, P259, DOI 10.1016/0147-5975(85)90022-2; CERENIUS L, 1984, J INVERTEBR PATHOL, V43, P278, DOI 10.1016/0022-2011(84)90150-2; Deacon JW, 1998, MYCOL RES, V102, P33, DOI 10.1017/S0953756297004358; DEACON JW, 1993, MYCOL RES, V97, P1153, DOI 10.1016/S0953-7562(09)81278-1; Dieguez-Uribeondo J, 2004, FUNGAL GENET BIOL, V41, P293, DOI 10.1016/j.fgb.2003.10.012; Dieguez-Uribeondo J, 2007, FUNGAL GENET BIOL, V44, P585, DOI 10.1016/j.fgb.2007.02.010; DIEGUEZURIBEONDO J, 1994, AQUACULTURE, V120, P219, DOI 10.1016/0044-8486(94)90080-9; DIEGUEZURIBEONDO J, 1994, MYCOL RES, V98, P810, DOI 10.1016/S0953-7562(09)81060-5; DONALDSON SP, 1992, J GEN MICROBIOL, V138, P2051, DOI 10.1099/00221287-138-10-2051; Epstein L., 1997, PLANT RELATIONSHIPS, Vvol. 5, P11, DOI [10.1007/978-3-662-10370-8_2, DOI 10.1007/978-3-662-10370-8_2]; Epstein L, 2006, BIOLOGICAL ADHESIVES, P41, DOI 10.1007/978-3-540-31049-5_3; Fabritius AL, 2003, MOL PLANT MICROBE IN, V16, P926, DOI 10.1094/MPMI.2003.16.10.926; Fregeneda-Grandes JM, 2007, J FISH BIOL, V71, P510, DOI 10.1111/j.1095-8649.2007.01510.x; Grenville-Briggs LJ, 2008, PLANT CELL, V20, P720, DOI 10.1105/tpc.107.052043; GUBLER F, 1989, PROTOPLASMA, V149, P24, DOI 10.1007/BF01623979; GUBLER F, 1988, J CELL SCI, V90, P225; HARDHAM AR, 1990, CAN J MICROBIOL, V36, P183, DOI 10.1139/m90-032; Hardham AR, 2001, MYCOTA, V8, P91; Jiang RHY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003272; JONES MJ, 1990, APPL ENVIRON MICROB, V56, P3772, DOI 10.1128/AEM.56.12.3772-3778.1990; Kim KS, 2003, EUKARYOT CELL, V2, P1376, DOI 10.1128/EC.2.6.1376-1385.2003; Koya PR, 2013, OPEN J MODELLING SIM, V01, P12; KUNOH H, 1988, EXP MYCOL, V12, P325, DOI 10.1016/0147-5975(88)90024-2; Letourneau J, 2011, JOVE-J VIS EXP, V51, P1; MANTON I, 1951, J EXP BOT, V2, P321, DOI 10.1093/jxb/2.3.321; MEIER H, 1954, J EXP BOT, V5, P401, DOI 10.1093/jxb/5.3.401; Mendgen K, 1996, ANNU REV PHYTOPATHOL, V34, P367, DOI 10.1146/annurev.phyto.34.1.367; MERCURE EW, 1994, PHYSIOL MOL PLANT P, V45, P421, DOI 10.1016/S0885-5765(05)80040-2; MUELLER GJ, 1994, SALMON SAPROLEGNIASI, P163; PICKERING AD, 1979, T BRIT MYCOL SOC, V72, P427, DOI 10.1016/S0007-1536(79)80150-3; PRIETO AL, 1992, J CELL BIOL, V119, P663, DOI 10.1083/jcb.119.3.663; R Development Core Team, 2017, R LANG ENV STAT COMP; Raftoyannis Y, 2006, MICROBIOL RES, V161, P1, DOI 10.1016/j.micres.2005.04.003; Rand Thomas G., 1993, Journal of Aquatic Animal Health, V5, P240, DOI 10.1577/1548-8667(1993)005&lt;0240:COZOTF&gt;2.3.CO;2; REID B, 1995, EXP MYCOL, V19, P202, DOI 10.1006/emyc.1995.1025; Robold AV, 2005, CURR GENET, V47, P307, DOI 10.1007/s00294-004-0559-8; Saraiva M, 2014, FUNGAL BIOL-UK, V118, P621, DOI 10.1016/j.funbio.2014.01.011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw BD, BIOL FUNGAL CELL; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Smith A. M, 2006, BIOL ADHESIVES; SODERHALL K, 1991, AQUACULTURE, V92, P121, DOI 10.1016/0044-8486(91)90014-X; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stueland S, 2005, J FISH DIS, V28, P445, DOI 10.1111/j.1365-2761.2005.00635.x; Takano Y, 2000, MOL PLANT MICROBE IN, V13, P374, DOI 10.1094/MPMI.2000.13.4.374; UNESTAM T, 1965, PHYSIOL PLANTARUM, V18, P483, DOI 10.1111/j.1399-3054.1965.tb06911.x; van West P, 2010, FEMS MICROBIOL LETT, V310, P127, DOI 10.1111/j.1574-6968.2010.02055.x; Sandoval-Sierra JV, 2014, FUNGAL BIOL-UK, V118, P559, DOI 10.1016/j.funbio.2013.10.005; Walker Claire A., 2007, Fungal Biology Reviews, V21, P10, DOI 10.1016/j.fbr.2007.02.001; Wawra S, 2012, P NATL ACAD SCI USA, V109, P2096, DOI 10.1073/pnas.1113775109; WOOD SE, 1988, T BRIT MYCOL SOC, V90, P63, DOI 10.1016/S0007-1536(88)80181-5; Xiang QJ, 2009, FUNGAL GENET BIOL, V46, P400, DOI 10.1016/j.fgb.2009.02.006; Yamaoka N, 1999, PHYSIOL MOL PLANT P, V54, P145, DOI 10.1006/pmpp.1998.0194; Zhang WW, 2013, PEERJ, V1, DOI 10.7717/peerj.221	63	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190361	10.1371/journal.pone.0190361	http://dx.doi.org/10.1371/journal.pone.0190361			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342156	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800019
J	Nevers, MB; Byappanahalli, MN; Morris, CC; Shively, D; Przybyla-Kelly, K; Spoljaric, AM; Dickey, J; Roseman, EF				Nevers, Meredith B.; Byappanahalli, Murulee N.; Morris, Charles C.; Shively, Dawn; Przybyla-Kelly, Kasia; Spoljaric, Ashley M.; Dickey, Joshua; Roseman, Edward F.			Environmental DNA (eDNA): A tool for quantifying the abundant but elusive round goby (Neogobius melanostomus)	PLOS ONE			English	Article							MOTTLED SCULPIN; LAKE-MICHIGAN; WATER; BIODIVERSITY; DEGRADATION; BIOLOGY; GOBIES; QUANTIFICATION; SURVEILLANCE; TEMPERATURE	Environmental DNA (eDNA) is revolutionizing biodiversity monitoring, occupancy estimates, and real-time detections of invasive species. In the Great Lakes, the round goby (Neogobius melanostomus), an invasive benthic fish from the Black Sea, has spread to encompass all five lakes and many tributaries, outcompeting or consuming native species; however, estimates of round goby abundance are confounded by behavior and habitat preference, which impact reliable methods for estimating their population. By integrating eDNA into round goby monitoring, improved estimates of biomass may be obtainable. We conducted mesocosm experiments to estimate rates of goby DNA shedding and decay. Further, we compared eDNA with several methods of traditional field sampling to compare its use as an alternative/complementary monitoring method. Environmental DNA decay was comparable to other fish species, and first-order decay was lower at 12 degrees C (k = 0.043) than at 19 degrees C (k = 0.058). Round goby eDNA was routinely detected in known invaded sites of Lake Michigan and its tributaries (range log10 4.8 +/- 6.2 CN/L), but not upstream of an artificial fish barrier. Traditional techniques (mark-recapture, seining, trapping) in Lakes Michigan and Huron resulted in fewer, more variable detections than eDNA, but trapping and eDNA were correlated (Pearson R = 0.87). Additional field testing will help correlate round goby abundance with eDNA, providing insight on its role as a prey fish and its impact on food webs.	[Nevers, Meredith B.; Byappanahalli, Murulee N.; Shively, Dawn; Przybyla-Kelly, Kasia; Spoljaric, Ashley M.] US Geol Survey, Great Lakes Sci Ctr, Lake Michigan Ecol Res Stn, Chesterton, IN 46304 USA; [Morris, Charles C.; Dickey, Joshua] Indiana Dunes Natl Lakeshore, Natl Pk Serv, Porter, IN USA; [Roseman, Edward F.] US Geol Survey, Great Lakes Sci Ctr, Ann Arbor, MI USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Department of the Interior; United States Geological Survey	Nevers, MB (corresponding author), US Geol Survey, Great Lakes Sci Ctr, Lake Michigan Ecol Res Stn, Chesterton, IN 46304 USA.	mnevers@usgs.gov		Roseman, Edward/0000-0002-5315-9838; Byappanahalli, Muruleedhara/0000-0001-5376-597X; Shively, Dawn/0000-0002-6119-924X; Nevers, Meredith/0000-0001-6963-6734; Spoljaric, Ashley/0000-0001-6262-030X				Adrian-Kalchhauser I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147558; Amberg JJ, 2015, J GREAT LAKES RES, V41, P367, DOI 10.1016/j.jglr.2015.02.009; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bergstrom MA, 2009, T AM FISH SOC, V138, P1009, DOI 10.1577/T08-095.1; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Brozio S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170619; Bunnell DB, 2014, BIOSCIENCE, V64, P26, DOI 10.1093/biosci/bit001; Bylemans J, 2017, METHODS ECOL EVOL, V8, P646, DOI 10.1111/2041-210X.12709; Cai W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177724; Chotkowski MA, 1999, J GREAT LAKES RES, V25, P26, DOI 10.1016/S0380-1330(99)70714-8; Cooper MJ, 2009, J FRESHWATER ECOL, V24, P477, DOI 10.1080/02705060.2009.9664321; Corkum LD, 2004, BIOL INVASIONS, V6, P173, DOI 10.1023/B:BINV.0000022136.43502.db; Darling JA, 2015, BIOL INVASIONS, V17, P951, DOI 10.1007/s10530-014-0726-x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Egan SP, 2015, ENVIRON SCI TECHNOL, V49, P4113, DOI 10.1021/es5058659; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; French JRP, 2001, J GREAT LAKES RES, V27, P300, DOI 10.1016/S0380-1330(01)70645-4; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Hinlo R, 2017, MANAG BIOL INVASION, V8, P89, DOI 10.3391/mbi.2017.8.1.09; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Johnson TB, 2005, J GREAT LAKES RES, V31, P78, DOI 10.1016/S0380-1330(05)70239-2; JUDE DJ, 1992, CAN J FISH AQUAT SCI, V49, P416, DOI 10.1139/f92-047; Ki SJ, 2007, ENVIRON MANAGE, V39, P867, DOI 10.1007/s00267-006-0154-5; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Kornis MS, 2012, J FISH BIOL, V80, P235, DOI 10.1111/j.1095-8649.2011.03157.x; Lauer TE, 2004, T AM FISH SOC, V133, P185, DOI 10.1577/T02-123; Lee VA, 2005, J GREAT LAKES RES, V31, P125, DOI 10.1016/S0380-1330(05)70244-6; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Madenjian CP, 2011, BIOL INVASIONS, V13, P987, DOI 10.1007/s10530-010-9884-7; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; N'Guyen A, 2018, J APPL ECOL, V55, P342, DOI 10.1111/1365-2664.12934; Nathan LR, 2015, CONSERV BIOL, V29, P430, DOI 10.1111/cobi.12381; Nevers MB, 2011, FECAL BACTERIA, P165; O'Donnell JL, 2017, PEERJ, V5, DOI 10.7717/peerj.3044; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Primer-E Ltd, 2015, PLYM ROUT MULT EC RE, P7; R Development Core Team, 2009, R LANG ENV STAT COMP; Robson HLA, 2016, MOL ECOL RESOUR, V16, P922, DOI 10.1111/1755-0998.12505; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; SPSS, 2014, SPSS VERS 23; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Suss J, 2009, WATER RES, V43, P3705, DOI 10.1016/j.watres.2009.05.048; SYSTAT, 2009, SYST 13 0; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Tsuji S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176608; Tucker AJ, 2016, BIOL INVASIONS, V18, P3205, DOI 10.1007/s10530-016-1209-z; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Uchii K, 2016, MOL ECOL RESOUR, V16, P415, DOI 10.1111/1755-0998.12460; Whitman RL, 2004, APPL ENVIRON MICROB, V70, P4276, DOI 10.1128/AEM.70.7.4276-4285.2004	59	31	32	7	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191720	10.1371/journal.pone.0191720	http://dx.doi.org/10.1371/journal.pone.0191720			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT1TP	29357382	Green Published, Green Submitted, gold			2022-12-27	WOS:000422919500019
J	Cormier, N; McGlone, JJ; Leszyk, J; Hardy, DM				Cormier, Nathaly; McGlone, John J.; Leszyk, John; Hardy, Daniel M.			Immunocontraceptive target repertoire defined by systematic identification of sperm membrane alloantigens in a single species	PLOS ONE			English	Article							ZONA-PELLUCIDA; LIPID RAFTS; ANCHORED PROTEINS; BOAR SPERMATOZOA; BINDING-ACTIVITY; AUTO-ANTIGENS; FAMILY; FERTILIZATION; MOUSE; EXPRESSION	Sperm competence in animal fertilization requires the collective activities of numerous sperm-specific proteins that are typically alloimmunogenic in females. Consequently, sperm membrane alloantigens are potential targets for contraceptives that act by blocking the proteins' functions in gamete interactions. Here we used a targeted proteomics approach to identify the major alloantigens in swine sperm membranes and lipid rafts, and thereby systematically defined the repertoire of these sperm-specific proteins in a single species. Gilts with high alloantibody reactivity to proteins in sperm membranes or lipid rafts produced fewer offspring (73% decrease) than adjuvant-only or nonimmune control animals. Alloantisera recognized more than 20 potentially unique sperm membrane proteins and five sperm lipid raft proteins resolved on two-dimensional immunoblots with or without prior enrichment by anion exchange chromatography. Dominant sperm membrane alloantigens identified by mass spectrometry included the ADAMs fertilin a, fertilin 13, and cyritestin. Less abundant alloantigens included ATP synthase Fl p subunit, myo-inositol monophosphatase-1, and zymogen granule membrane glycoprotein-2. Immunodominant sperm lipid raft alloantigens included SAMP14, lymphocyte antigen 6K, and the epididymal sperm protein E12. Of the fifteen unique membrane alloantigens identified, eleven were known sperm-specific proteins with uncertain functions in fertilization, and four were not previously suspected to exist as sperm-specific isoforms. De novo sequences of tryptic peptides from sperm membrane alloantigen "M6" displayed no evident homology to known proteins, so is a newly discovered sperm-specific gene product in swine. We conclude that alloimmunizing gilts with sperm membranes or lipid rafts evokes formation of antibodies to a relatively small number of dominant alloantigens that include known and novel sperm-specific proteins with possible functions in fertilization and potential utility as targets for immunocontraception.	[Cormier, Nathaly; Hardy, Daniel M.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [McGlone, John J.] Texas Tech Univ, Dept Anim & Food Sci, Lubbock, TX 79409 USA; [Leszyk, John] Univ Massachusetts, Sch Med, Prote & Mass Spectrometry Facil, Shrewsbury, MA USA; [Leszyk, John] Univ Massachusetts, Sch Med, Dept Biochem & Pharmacol, Shrewsbury, MA USA; [Cormier, Nathaly] Univ Wisconsin, Dept Biol Sci, Whitewater, WI 53190 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; University of Massachusetts System; University of Massachusetts System; University of Wisconsin System	Hardy, DM (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	Daniel.Hardy@TTUHSC.edu	Hardy, Daniel/AAP-5823-2020; McGlone, John/AAJ-7362-2021	Hardy, Daniel/0000-0002-7297-3093; 	Texas Department of Agriculture; National Institutes of Health [HD35166]	Texas Department of Agriculture; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded in part by a grant from the Texas Department of Agriculture to JJM and DMH and by grant HD35166 from the National Institutes of Health to DMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2002, J REPROD IMMUNOL, V57, P273, DOI 10.1016/S0165-0378(02)00010-4; ALEXANDER NJ, 1989, CURR OPIN IMMUNOL, V1, P1125, DOI 10.1016/0952-7915(89)90003-4; Alonso MA, 2001, J CELL SCI, V114, P3957; BABA T, 1989, BIOCHEM BIOPH RES CO, V160, P1026, DOI 10.1016/S0006-291X(89)80105-6; BABA T, 1994, J BIOL CHEM, V269, P10133; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Bi M, 2003, BIOCHEM J, V375, P477, DOI 10.1042/BJ20030753; Bradley Mark P., 2002, P401, DOI 10.1016/B978-012311629-1/50016-4; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CALVETE JJ, 1993, FEBS LETT, V334, P37, DOI 10.1016/0014-5793(93)81675-P; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Cho C, 2012, NAT REV UROL, V9, P550, DOI 10.1038/nrurol.2012.167; Cross NL, 2004, BIOL REPROD, V71, P1367, DOI 10.1095/biolreprod.104.030502; DOSTALOVA Z, 1995, EUR J BIOCHEM, V230, P329, DOI 10.1111/j.1432-1033.1995.tb20567.x; Druce HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027952; Ekhlasi-Hundrieser M, 2007, GENE, V392, P253, DOI 10.1016/j.gene.2007.01.002; Ensslin M, 1998, BIOL REPROD, V58, P1057, DOI 10.1095/biolreprod58.4.1057; Flesch FM, 1998, BIOL REPROD, V59, P1530, DOI 10.1095/biolreprod59.6.1530; FREUND J, 1953, J EXP MED, V97, P711, DOI 10.1084/jem.97.5.711; Fujihara Y, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.112888; Fujinoki M, 2003, J BIOCHEM, V134, P559, DOI 10.1093/jb/mvg174; FUKUOKA SI, 1992, P NATL ACAD SCI USA, V89, P1189, DOI 10.1073/pnas.89.4.1189; Gibbs GM, 2010, ENDOCRINOLOGY, V151, P2331, DOI 10.1210/en.2009-1255; GOLDBERG E, 1973, SCIENCE, V181, P458, DOI 10.1126/science.181.4098.458; GUMLEY TP, 1995, IMMUNOL CELL BIOL, V73, P277, DOI 10.1038/icb.1995.45; Haden NP, 2000, BIOL REPROD, V63, P1839, DOI 10.1095/biolreprod63.6.1839; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; Hao ZL, 2002, BIOL REPROD, V66, P735, DOI 10.1095/biolreprod66.3.735; Hardy D. M., 2002, FERTILIZATION; HARDY DM, 1988, BIOL REPROD, V38, P423, DOI 10.1095/biolreprod38.2.423; Hickox JR, 2001, J BIOL CHEM, V276, P41502, DOI 10.1074/jbc.M106795200; Huang SY, 2005, PROTEOMICS, V5, P4205, DOI 10.1002/pmic.200401284; HUANG TTF, 1981, SCIENCE, V213, P1267, DOI 10.1126/science.7268435; Jonakova V, 1998, J REPROD FERTIL, V114, P25, DOI 10.1530/jrf.0.1140025; JONAKOVA V, 1991, FEBS LETT, V280, P183, DOI 10.1016/0014-5793(91)80233-S; Khalil MB, 2006, DEV BIOL, V290, P220, DOI 10.1016/j.ydbio.2005.11.030; Kim T, 2006, BIOL REPROD, V74, P744, DOI 10.1095/biolreprod.105.048892; Kirkpatrick JF, 2011, AM J REPROD IMMUNOL, V66, P40, DOI 10.1111/j.1600-0897.2011.01003.x; Lahm HW, 2000, ELECTROPHORESIS, V21, P2105, DOI 10.1002/1522-2683(20000601)21:11<2105::AID-ELPS2105>3.0.CO;2-M; Luo LL, 2016, ONCOTARGET, V7, P11165, DOI 10.18632/oncotarget.7163; Martinez-Heredia J, 2006, PROTEOMICS, V6, P4356, DOI 10.1002/pmic.200600094; Maruyama M, 2010, BIOCHEM BIOPH RES CO, V402, P75, DOI 10.1016/j.bbrc.2010.09.117; Naz RK, 2011, AM J REPROD IMMUNOL, V66, P5, DOI 10.1111/j.1600-0897.2011.01000.x; Nickels JD, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002214; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Nixon B, 2009, J CELL PHYSIOL, V218, P122, DOI 10.1002/jcp.21575; Ohta K, 1999, BIOCHEM BIOPH RES CO, V258, P616, DOI 10.1006/bbrc.1999.0686; ORAND MG, 1981, BIOL REPROD, V25, P621, DOI 10.1095/biolreprod25.3.621; ORAND MG, 1988, DEV BIOL, V129, P231, DOI 10.1016/0012-1606(88)90177-7; PARRY RV, 1992, MOL REPROD DEV, V33, P108, DOI 10.1002/mrd.1080330115; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; POLLACK SJ, 1994, P NATL ACAD SCI USA, V91, P5766, DOI 10.1073/pnas.91.13.5766; PRIMAKOFF P, 1983, DEV BIOL, V98, P417, DOI 10.1016/0012-1606(83)90371-8; PRIMAKOFF P, 1988, NATURE, V335, P543, DOI 10.1038/335543a0; Quill TA, 1996, J BIOL CHEM, V271, P33509, DOI 10.1074/jbc.271.52.33509; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; SALING PM, 1986, DEV BIOL, V117, P511, DOI 10.1016/0012-1606(86)90318-0; Schafer B, 2003, REPROD DOMEST ANIM, V38, P111, DOI 10.1046/j.1439-0531.2003.00403.x; Shadan S, 2004, BIOL REPROD, V71, P253, DOI 10.1095/biolreprod.103.026435; Shamsadin R, 1999, BIOL REPROD, V61, P1445, DOI 10.1095/biolreprod61.6.1445; Shetty J, 2003, J BIOL CHEM, V278, P30506, DOI 10.1074/jbc.M301713200; Sleight SB, 2005, BIOL REPROD, V73, P721, DOI 10.1095/biolreprod.105.041533; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tanphaichitr N, 1998, MOL REPROD DEV, V49, P203, DOI 10.1002/(SICI)1098-2795(199802)49:2&lt;203::AID-MRD11&gt;3.0.CO;2-Z; Travis AJ, 2001, DEV BIOL, V240, P599, DOI 10.1006/dbio.2001.0475; Tung KSK, 2017, J CLIN INVEST, V127, P1046, DOI 10.1172/JCI89927; TUNG KSK, 1980, BIOL REPROD, V23, P877, DOI 10.1095/biolreprod23.4.877; TUNG KSK, 1981, IMMUNOL REV, V55, P217, DOI 10.1111/j.1600-065X.1981.tb00344.x; van Gestel RA, 2005, MOL HUM REPROD, V11, P583, DOI 10.1093/molehr/gah200; Vazquez-Levin MH, 2014, AM J REPROD IMMUNOL, V72, P206, DOI 10.1111/aji.12272; Verdier Y, 2002, J ANDROL, V23, P529; Wang DX, 2004, RAPID COMMUN MASS SP, V18, P96, DOI 10.1002/rcm.1289; Wheeler K, 2011, P NATL ACAD SCI USA, V108, P7511, DOI 10.1073/pnas.1017615108; WOLFSBERG TG, 1995, DEV BIOL, V169, P378, DOI 10.1006/dbio.1995.1152; Wu A, 2007, J CELL PHYSIOL, V213, P201, DOI 10.1002/jcp.21113; Yanagimachi R., 1994, P189; YANAGIMACHI R, 1981, BIOL REPROD, V24, P512, DOI 10.1095/biolreprod24.3.512; Yoshitake H, 2008, BIOCHEM BIOPH RES CO, V372, P277, DOI 10.1016/j.bbrc.2008.05.088; Yoshitake Y, 2015, CLIN CANCER RES, V21, P312, DOI 10.1158/1078-0432.CCR-14-0202	81	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190891	10.1371/journal.pone.0190891	http://dx.doi.org/10.1371/journal.pone.0190891			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342175	Green Published, Green Submitted, gold			2022-12-27	WOS:000422653800035
J	Khalis, M; Charbotel, B; Chajes, V; Rinaldi, S; Moskal, A; Biessy, C; Dossus, L; Huybrechts, I; Fort, E; Mellas, N; Elfakir, S; Charaka, H; Nejjari, C; Romieu, I; El Rhazi, K				Khalis, Mohamed; Charbotel, Barbara; Chajes, Veronique; Rinaldi, Sabina; Moskal, Aurelie; Biessy, Carine; Dossus, Laure; Huybrechts, Inge; Fort, Emmanuel; Mellas, Nawfel; Elfakir, Samira; Charaka, Hafida; Nejjari, Chakib; Romieu, Isabelle; El Rhazi, Karima			Menstrual and reproductive factors and risk of breast cancer: A case-control study in the Fez region, Morocco	PLOS ONE			English	Article							COLLABORATIVE REANALYSIS; ORAL-CONTRACEPTIVES; WOMEN; AGE; ASSOCIATION; METAANALYSIS; MENOPAUSE; MENARCHE; ABORTION; PARITY	Background Breast cancer is the most common cancer in women worldwide. In the Moroccan context, the role of well-known reproductive factors in breast cancer remains poorly documented. The aim of this study was to explore the relationship between menstrual and reproductive factors and breast cancer risk in Moroccan women in the Fez region. Methods A case control study was conducted at the Hassan ll University Hospital of Fez between January 2014 and April 2015. A total of 237 cases of breast cancer and 237 age-matched controls were included. Information on sociodemographic characteristics, menstrual and reproductive history, family history of breast cancer, and lifestyle factors was obtained through a structured questionnaire. Conditional logistic regression models were used to estimate odds ratios and 95% confidence intervals for breast cancer by menstrual and reproductive factors adjusted for potential confounders. Results Early menarche (OR = 1.60, 95% CI: 1.08-2.38) and nulliparity (OR = 3.77, 95% CI: 1.987.30) were significantly related to an increased risk of breast cancer, whereas an early age at first full-term pregnancy was associated with a decreased risk of breast cancer (OR = 0.41, 95% CI: 0.25-0.65). Conclusion The results of this study confirm the role of established reproductive factors for breast cancer in Moroccan women. It identified some susceptible groups at high risk of breast cancer. Preventive interventions and screening should focus on these groups as a priority. These results should be confirmed in a larger, multicenter study.	[Khalis, Mohamed; Elfakir, Samira; Charaka, Hafida; Nejjari, Chakib; El Rhazi, Karima] Fac Med & Pharm, Dept Epidemiol, Fes, Morocco; [Khalis, Mohamed; Charbotel, Barbara; Fort, Emmanuel] Univ Claude Bernard Lyon1, Ifsttar, UMRESTTE, UMR T 9405, Lyon, France; [Khalis, Mohamed; Elfakir, Samira; Charaka, Hafida; El Rhazi, Karima] Sidi Mohamed Ben Abdellah Univ, Fes, Morocco; [Chajes, Veronique; Rinaldi, Sabina; Moskal, Aurelie; Biessy, Carine; Dossus, Laure; Huybrechts, Inge; Romieu, Isabelle] Int Agcy Res Canc, Sect Nutr & Metab, Lyon, France; [Mellas, Nawfel] Hassan II Univ Hosp Fez, Dept Oncol, Fes, Morocco; [Nejjari, Chakib] Mohammed VI Univ Hlth Sci, Casablanca, Morocco	Hassan II University Hospital Center of Fez; Mohammed First University of Oujda; Mohammed VI University Hospital Center of Oujda; Sidi Mohamed Ben Abdellah University of Fez; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Gustave-Eiffel; Sidi Mohamed Ben Abdellah University of Fez; World Health Organization; International Agency for Research on Cancer (IARC); Hassan II University Hospital Center of Fez; Mohammed VI University of Health Sciences (UM6SS)	Khalis, M (corresponding author), Fac Med & Pharm, Dept Epidemiol, Fes, Morocco.; Khalis, M (corresponding author), Univ Claude Bernard Lyon1, Ifsttar, UMRESTTE, UMR T 9405, Lyon, France.; Khalis, M (corresponding author), Sidi Mohamed Ben Abdellah Univ, Fes, Morocco.	khalis.mohamed79@gmail.com	Fort, Emmanuel/Q-4570-2019; Charbotel, Barbara/C-2936-2016; Dossus, Laure/AAW-9097-2021; Khalis, Mohamed/AAM-5446-2020	Fort, Emmanuel/0000-0003-1419-9914; Charbotel, Barbara/0000-0001-8805-6225; Dossus, Laure/0000-0003-2716-5748; moskal, aurelie/0000-0003-4127-4334; Chajes, Veronique/0000-0003-1297-3064				Awatef M, 2010, CANCER CAUSE CONTROL, V21, P393, DOI 10.1007/s10552-009-9471-3; Beral V, 2004, LANCET, V363, P1007, DOI 10.1016/S0140-6736(04)15835-2; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Bouchbika Z, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.31.2791; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Chie WC, 2000, AM J EPIDEMIOL, V151, P715, DOI 10.1093/oxfordjournals.aje.a010266; Clavel-Chapelon F, 2002, BREAST CANCER RES TR, V72, P107, DOI 10.1023/A:1014891216621; Clavel-Chapelon F, 2002, CANCER CAUSE CONTROL, V13, P831, DOI 10.1023/A:1020684821837; Corbex M, 2014, EUR J CANCER, V50, P1808, DOI 10.1016/j.ejca.2014.03.016; Coughlin SS, 2015, J ENV HLTH SCI, V1; DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535; EASTON DF, 1994, LANCET, V344, P761, DOI 10.1016/S0140-6736(94)92256-X; Ebrahimi M, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr454; Ewertz M, 1990, INT J CANCER, P46; Ferlay J, 2010, BREAST CANCER EPIDEMIOLOGY, P1, DOI 10.1007/978-1-4419-0685-4_1; Gao YT, 2000, INT J CANCER, V87, P295, DOI 10.1002/1097-0215(20000715)87:2<295::AID-IJC23>3.0.CO;2-7; Gray J, 2009, INT J OCCUP ENV HEAL, V15, P43; Guo J, 2015, CANCER CAUSE CONTROL, V26, P811, DOI 10.1007/s10552-015-0536-1; HSIEH CC, 1990, INT J CANCER, V46, P796, DOI 10.1002/ijc.2910460508; Huang YB, 2014, CANCER CAUSE CONTROL, V25, P227, DOI 10.1007/s10552-013-0325-7; Huo D, 2008, BRIT J CANCER, V98, P992, DOI 10.1038/sj.bjc.6604275; Kawai M, 2010, CANCER CAUSE CONTROL, V21, P135, DOI 10.1007/s10552-009-9443-7; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Khalis M, 2016, ASIAN PAC J CANCER P, V01, P17; Laamiri FZ, 2015, OPEN J OBSTET GYNECO, V5, P79, DOI [10.4236/ojog.2015.52011, DOI 10.4236/OJOG.2015.52011]; Lalla Salma Foundation Prevention Detection and Treatment of Cancers, 2017, REG GREAT CAS 2008 2; Lambe M, 1996, BREAST CANCER RES TR, V38, P305, DOI 10.1007/BF01806150; LAVECCHIA C, 1992, ANN ONCOL, V3, P625, DOI 10.1093/oxfordjournals.annonc.a058288; Lee E, 2008, CANCER EPIDEM BIOMAR, V17, P3170, DOI 10.1158/1055-9965.EPI-08-0396; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Loukid Mohamed, 2007, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V19, P65; MacMahon B, 2006, INT J CANCER, V118, P2373, DOI 10.1002/ijc.21404; Magnusson CM, 1999, INT J CANCER, V80, P231, DOI 10.1002/(SICI)1097-0215(19990118)80:2<231::AID-IJC11>3.3.CO;2-I; Martinez ME, 2013, CANCER EPIDEM BIOMAR, V22, P1853, DOI 10.1158/1055-9965.EPI-13-0560; Msolly A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0480-4; NAGATA C, 1995, JPN J CANCER RES, V86, P910, DOI 10.1111/j.1349-7006.1995.tb03000.x; Oran B, 2004, MED ONCOL, V21, P31, DOI 10.1385/MO:21:1:31; Palmer JR, 2011, CANCER EPIDEM BIOMAR, V20, P1883, DOI 10.1158/1055-9965.EPI-11-0465; Parsa P, 2009, ASIAN PAC J CANCER P, V10, P545; Redondo CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040543; Rosenberg L, 2009, AM J EPIDEMIOL, V169, P473, DOI 10.1093/aje/kwn360; Russo J, 2005, BREAST CANCER RES, V7, P131, DOI 10.1186/bcr1029; Tryggvadottir L, 2001, AM J EPIDEMIOL, V154, P37, DOI 10.1093/aje/154.1.37; Turkoz FP, 2013, BREAST, V22, P344, DOI 10.1016/j.breast.2012.08.005; World Health Organization, GLOB PHYS ACT QUEST; Xu YL, 2012, ARCH MED SCI, V8, P303, DOI 10.5114/aoms.2012.28558; Zhou Y, 2015, BREASTFEED MED, V10, P175, DOI 10.1089/bfm.2014.0141	50	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191333	10.1371/journal.pone.0191333	http://dx.doi.org/10.1371/journal.pone.0191333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338058	Green Published, gold, Green Submitted			2022-12-27	WOS:000422652700050
J	Yang, XZ; Li, H; Yang, YC; Wang, YQ; Mo, YL; Zhang, RM; Zhang, Y; Ma, JX; Wei, CH; Zhang, X				Yang, Xiaozhen; Li, Hao; Yang, Yongchao; Wang, Yongqi; Mo, Yanling; Zhang, Ruimin; Zhang, Yong; Ma, Jianxiang; Wei, Chunhua; Zhang, Xian			Identification and expression analyses of WRKY genes reveal their involvement in growth and abiotic stress response in watermelon (Citrullus lanatus)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; DIFFERENTIAL EXPRESSION; FUNCTIONAL-ANALYSIS; DISEASE RESISTANCE; SALICYLIC-ACID; ARABIDOPSIS; PLANT; TOLERANCE; SUPERFAMILY; GENOME	Despite identification of WRKY family genes in numerous plant species, a little is known about WRKY genes in watermelon, one of the most economically important fruit crops around the world. Here, we identified a total of 63 putative WRKY genes in watermelon and classified them into three major groups (I-III) and five subgroups (lla-lle) in group II. The structure analysis indicated that CIWRKYs with different WRKY domains or motifs may play different roles by regulating respective target genes. The expressions of CIWRKYs in different tissues indicate that they are involved in various tissue growth and development. Furthermore, the diverse responses of CIWRKYs to drought, salt, or cold stress suggest that they positively or negatively affect plant tolerance to various abiotic stresses. In addition, the altered expression patterns of CIWRKYs in response to phytohormones such as, ABA, SA, MeJA, and ETH, imply the occurrence of complex cross-talks between CIWRKYs and plant hormone signals in regulating plant physiological and biological processes. Taken together, our findings provide valuable clues to further explore the function and regulatory mechanisms of CIWRKY genes in watermelon growth, development, and adaption to environmental stresses.	[Yang, Xiaozhen; Li, Hao; Yang, Yongchao; Wang, Yongqi; Zhang, Ruimin; Zhang, Yong; Ma, Jianxiang; Wei, Chunhua; Zhang, Xian] Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Yang, Yongchao] Wenshan Acad Agr Sci, Wenshan, Peoples R China; [Wang, Yongqi] Hanzhong City Agrotechnol Extens Ctr, Hanzhong, Peoples R China; [Mo, Yanling] Yangtze Normal Univ, Fuling, Peoples R China	Northwest A&F University - China; Yangtze Normal University	Wei, CH; Zhang, X (corresponding author), Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China.	xjwend020405@163.com; zhangxian098@126.com			Earmarked Fund for Modern Agro-industry Technology Research System of China [CARS-25]; Science and Technological of Shaanxi Province [2015KTTSNY03-04]; Scientific Startup Foundation for Doctors of Northwest AF University [Z109021604]; Basal Research Foundation of Northwest AF University [Z109021612]; Key Project of Shaanxi Province [2017ZDXM-NY-025]	Earmarked Fund for Modern Agro-industry Technology Research System of China; Science and Technological of Shaanxi Province; Scientific Startup Foundation for Doctors of Northwest AF University; Basal Research Foundation of Northwest AF University; Key Project of Shaanxi Province	The present study was financially supported by grants from the Earmarked Fund for Modern Agro-industry Technology Research System of China (CARS-25), the Science and Technological of Shaanxi Province (2015KTTSNY03-04), the Scientific Startup Foundation for Doctors of Northwest A&F University (Z109021604), the Basal Research Foundation of Northwest A&F University (Z109021612) and the Key Project of Shaanxi Province (2017ZDXM-NY-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01979; Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen JN, 2017, PLANT CELL, V29, P1425, DOI 10.1105/tpc.17.00364; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Cheng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep39000; Cho SM, 2012, BIOL PLANTARUM, V56, P560, DOI 10.1007/s10535-012-0070-x; Ciolkowski I, 2008, PLANT MOL BIOL, V68, P81, DOI 10.1007/s11103-008-9353-1; Ding ZJ, 2015, PLANT J, V84, P56, DOI 10.1111/tpj.12958; Ding ZJ, 2014, PLANT J, V79, P13, DOI 10.1111/tpj.12538; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Gao QM, 2011, PLANT PHYSIOL, V155, P464, DOI 10.1104/pp.110.166876; Gu YZ, 2017, J EXP BOT, V68, P2717, DOI 10.1093/jxb/erx147; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; He HS, 2012, PLANT CELL REP, V31, P1199, DOI 10.1007/s00299-012-1241-0; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huang XS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2233-6; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Jaffar MA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050693; Jiang JJ, 2017, J INTEGR PLANT BIOL, V59, P86, DOI 10.1111/jipb.12513; Jiang YJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00145; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Jing-Hua Y, 2008, SCI HORTIC-AMSTERDAM, V118, P200, DOI 10.1016/j.scienta.2008.06.015; Karanja BK, 2017, PLANT CELL REP, V36, P1757, DOI 10.1007/s00299-017-2190-4; Kazan K, 2015, TRENDS PLANT SCI, V20, P219, DOI 10.1016/j.tplants.2015.02.001; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00462; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Kozik EU, 2014, HORTSCIENCE, V49, P240, DOI 10.21273/HORTSCI.49.3.240; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00295; Li J, 2013, NEW PHYTOL, V200, P455, DOI 10.1111/nph.12378; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Li W, 2016, MOL PLANT, V9, P1492, DOI 10.1016/j.molp.2016.08.003; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo DL, 2017, J AGR FOOD CHEM, V65, P3627, DOI 10.1021/acs.jafc.7b00915; Lv XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30574; Mo YL, 2016, PLANT GROWTH REGUL, V79, P229, DOI 10.1007/s10725-015-0128-9; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Singh AK, 2017, NEW PHYTOL, V215, P1115, DOI 10.1111/nph.14663; Song H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00534; Song QM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0681-4; van Verk MC, 2008, PLANT PHYSIOL, V146, P1983, DOI 10.1104/pp.107.112789; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Wang Z, 2014, MOL PLANT PATHOL, V15, P677, DOI 10.1111/mpp.12123; Wei KF, 2012, DNA RES, V19, P153, DOI 10.1093/dnares/dsr048; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yan HR, 2014, PLANT CELL PHYSIOL, V55, P2060, DOI 10.1093/pcp/pcu133; Yang BY, 2014, INDIAN J BIOCHEM BIO, V51, P302; Yang J, 2017, J PLANT GROWTH REGUL, V36, P590, DOI 10.1007/s00344-017-9670-1; Yang Y, 2016, J EXP BOT, V67, P4727, DOI 10.1093/jxb/erw252; Zhang H, 2017, 2017 4TH INTERNATIONAL CONFERENCE ON TRANSPORTATION INFORMATION AND SAFETY (ICTIS), P1, DOI 10.1109/ICTIS.2017.8047712; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhang M, 2016, ACTA HORTIC, V1110, P49, DOI 10.17660/ActaHortic.2016.1110.8; Zhang Y, 2016, PLANT PHYSIOL BIOCH, V108, P478, DOI 10.1016/j.plaphy.2016.08.013; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x	68	36	41	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191308	10.1371/journal.pone.0191308	http://dx.doi.org/10.1371/journal.pone.0191308			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338040	Green Submitted, gold, Green Published			2022-12-27	WOS:000422652700049
J	Debussche, X; Besancon, S; Balcou-Debussche, M; Ferdynus, C; Delisle, H; Huiart, L; Sidibe, AT				Debussche, Xavier; Besancon, Stephane; Balcou-Debussche, Maryvette; Ferdynus, Cyril; Delisle, Helene; Huiart, Laetitia; Sidibe, Assa T.			Structured peer-led diabetes self-management and support in a low-income country: The ST2EP randomised controlled trial in Mali	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; CARE; EDUCATION; OUTCOMES; AFRICA	Objectives Our objective was to evaluate the effectiveness of peer-led self-management education in improving glycaemic control in patients with type 2 diabetes in a low-income country (Mali). Methods We conducted an open-label randomised controlled trial. A total of 151 adults (76% women, mean age 52.5) with type 2 diabetes (HbA1c >= 8%), treated in the diabetes consultation units of two secondary health centres in Bamako, were allocated to peer-led structured patient education (n = 76) or conventional care alone (n = 75). The intervention group received 1 year of culturally tailored structured patient education (3 courses of 4 sessions) delivered in the community by five trained peer educators. Both groups underwent conventional diabetes monitoring and follow-up. Primary outcome was the mean absolute change in HbA1c from baseline to 12 months. Results 177 education sessions were delivered to the intervention group. Patient attrition was 8%. From baseline to 12 months, the decrease in HbA1c levels was 1.05% (SD = 2.0; CI95%: 1.54;-0.56) in the intervention group compared with 0.15% (SD = 1.7; CI95%: -0.56; 0.26) in the control group, p = 0.006. Mean BMI change was -1.65 kg/m(2) (SD = 2.5; CI95%: -2.25; -1.06) in the intervention group and + 0.05 kg/m(2) (SD = 3.2; CI95%: -0.71; 0.81) in the control group, p = 0.0005. Mean waist circumference decreased by 3.34 cm (SD = 9.3; CI95%: 5.56;- 1.13) in the intervention group and increased by 2.65 cm (SD = 10.3; CI95%: 0.20; 5.09) in the control group, p = 0.0003. Conclusions Peer-led structured patient education delivered over 1 year to patients with poorly controlled type 2 diabetes in Mali yielded substantial improvements in glycaemic control and anthropometric parameters. This is of importance for the scaling up of efficient interventions in low-resource settings in the future.	[Debussche, Xavier] Felix Guyon Univ Hosp, Dept Endocrinol Diabetol Nutr, St Denis, La Reunion, France; [Debussche, Xavier; Ferdynus, Cyril; Huiart, Laetitia] Reunion Univ Hosp, INSERM, Ctr Invest Clin 1410, St Pierre, La Reunion, France; [Besancon, Stephane] Nongovt Org Sante Diabet, Bamako, Mali; [Balcou-Debussche, Maryvette] Univ Reunion, EA7389, Inst Cooperatif Austral Rech Educ, St Denis, La Reunion, France; [Balcou-Debussche, Maryvette] Univ Reseau Educ Sante, Clermont Ferrand, France; [Ferdynus, Cyril; Huiart, Laetitia] CHU Reunion, Unite Soutien Methodol, St Denis, La Reunion, France; [Delisle, Helene] Univ Montreal, Med Fac, Dept Nutr, Montreal, PQ, Canada; [Huiart, Laetitia] IRD, INSERM, Unite Mixte Rech 912, Sci Econ & Sociales Sante & Traitement Informat M, Marseille, France; [Sidibe, Assa T.] Univ Hosp, Internal Med, Bamako, Mali	CHU Reunion; CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; CHU Reunion; Universite de Montreal; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Debussche, X (corresponding author), Felix Guyon Univ Hosp, Dept Endocrinol Diabetol Nutr, St Denis, La Reunion, France.; Debussche, X (corresponding author), Reunion Univ Hosp, INSERM, Ctr Invest Clin 1410, St Pierre, La Reunion, France.	xavier.debussche@chu-reunion.fr	ferdynus, cyril/AFV-1963-2022; Debussche, Xavier/S-8185-2016	ferdynus, cyril/0000-0003-1502-0672; Debussche, Xavier/0000-0003-3087-4297; Besancon, Stephane/0000-0002-3779-3441	Bridges programme of the International Diabetes Federation; Lilly Diabetes	Bridges programme of the International Diabetes Federation; Lilly Diabetes	This work was supported by the Bridges programme of the International Diabetes Federation. BRIDGES (Bringing Research in Diabetes to Global Environments and Systems) is a programme initiated by the International Diabetes Federation, and supported by an educational grant from Lilly Diabetes, https://www.idf.org/our-activities/epidemiology-research/bridges.html. The NGO Sante Diabete received the funding (https://santediabete.org/en/; Director: SB). The funders were not involved in the study design, in the collection, analysis and interpretation of the data, as well as in the writing of the report and in the decision to submit the paper or preparation of the manuscript for publication. The authors were independent from study funders.	Anderson JM, 1996, SOC SCI MED, V43, P697, DOI 10.1016/0277-9536(96)00153-0; Atlas D., 2021, IDF DIABETES ATLAS, V10th edn; Balcou-Debussche M., LIT SANTE INTERACTIO; Balcou-Debussche M, 2012, RECH SOINS INFIRM, P45, DOI 10.3917/rsi.110.0045; Balcou-Debussche M, 2009, QUAL HEALTH RES, V19, P1100, DOI 10.1177/1049732309341642; Batterham RW, 2016, PUBLIC HEALTH, V132, P3, DOI 10.1016/j.puhe.2016.01.001; Batterham Roy W, 2014, BMC Public Health, V14, P694, DOI 10.1186/1471-2458-14-694; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Besancon S, 2013, SOINS, V781, P7; Bril B., 2002, INTELLECTIA, V2, P251, DOI DOI 10.3406/INTEL.2002.1669; Brown JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106716; Brown SA, 2005, DIABETES CARE, V28, P527, DOI 10.2337/diacare.28.3.527; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Debussche X, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-91; Debussche Xavier, 2010, Glob Health Promot, V17, P68, DOI 10.1177/1757975910366515; Dube L, 2015, DIABETES EDUCATOR, V41, P69, DOI 10.1177/0145721714558305; Fisher EB, 2012, HEALTH AFFAIR, V31, P130, DOI 10.1377/hlthaff.2011.0914; Gagliardino JJ, 2012, DIABETES METAB, V38, P128, DOI 10.1016/j.diabet.2011.09.002; Glasgow RE, 2001, DIABETES CARE, V24, P124, DOI 10.2337/diacare.24.1.124; Gomersall T, 2011, QUAL HEALTH RES, V21, P853, DOI 10.1177/1049732311402096; Hawthorne K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006424.pub2; Hinder S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-83; MARR JW, 1973, P ROY SOC MED, V66, P639, DOI 10.1177/003591577306600718; Mash RJ, 2014, DIABETIC MED, V31, P987, DOI 10.1111/dme.12475; Norris SL, 2006, DIABETIC MED, V23, P544, DOI 10.1111/j.1464-5491.2006.01845.x; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Tuei Vivian C, 2010, Diabetes Metab Res Rev, V26, P433, DOI 10.1002/dmrr.1106; VYGOTSKI LS, 1986, THOUGHT LANGUAGE; WHO, 2015, NONC DIS; *WHO, 1998, THER PAT ED CONT ED; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026; Zhang XX, 2016, PATIENT EDUC COUNS, V99, P186, DOI 10.1016/j.pec.2015.09.006	32	51	52	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2018	13	1							e0191262	10.1371/journal.pone.0191262	http://dx.doi.org/10.1371/journal.pone.0191262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1TP	29357380	Green Published, Green Submitted, gold			2022-12-27	WOS:000422919500012
J	Richter, Y; Lind, PG; Maass, P				Richter, Yvonne; Lind, Pedro G.; Maass, Philipp			Modeling specific action potentials in the human atria based on a minimal single-cell model	PLOS ONE			English	Article							FIBRILLATION; CURRENTS; INSIGHTS	We present an effective method to model empirical action potentials of specific patients in the human atria based on the minimal model of Bueno-Orovio, Cherry and Fenton adapted to atrial electrophysiology. In this model, three ionic are currents introduced, where each of it is governed by a characteristic time scale. By applying a nonlinear optimization procedure, a best combination of the respective time scales is determined, which allows one to reproduce specific action potentials with a given amplitude, width and shape. Possible applications for supporting clinical diagnosis are pointed out.	[Richter, Yvonne; Lind, Pedro G.; Maass, Philipp] Univ Osnabruck, Fachbereich Phys, Barbarastr 7, D-49076 Osnabruck, Germany	University Osnabruck	Lind, PG (corresponding author), Univ Osnabruck, Fachbereich Phys, Barbarastr 7, D-49076 Osnabruck, Germany.	pelind@uos.de	lind, pedro/G-5124-2010; Maass, Philipp/H-1477-2011	lind, pedro/0000-0002-8176-666X; Maass, Philipp/0000-0002-1268-8688	Deutsche Forschungsgemeinschaft (DFG) [MA1636/8-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), http://www.dfg.de/foerderung/programme/, Project with reference number MA1636/8-1 to Yvonne Richter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.& para;& para; The authors thank C. Lenk and G. Seemann for helpful discussions and the Deutsche Forschungsgemeinschaft for financial support (Grant no. MA1636/8-1). They also thank U. Ravens and G. Seemann for providing AP data.	Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Cherry EM, 2008, PROG BIOPHYS MOL BIO, V98, P24, DOI 10.1016/j.pbiomolbio.2008.05.002; Courtemanche M, 1999, CARDIOVASC RES, V42, P477, DOI 10.1016/S0008-6363(99)00034-6; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Koivumaki JT, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001067; Lenk C, 2015, J THEOR BIOL, V366, P13, DOI 10.1016/j.jtbi.2014.10.030; Lindblad DS, 1996, AM J PHYSIOL-HEART C, V271, pH1666, DOI 10.1152/ajpheart.1996.271.4.H1666; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Maleckar MM, 2008, PROG BIOPHYS MOL BIO, V98, P161, DOI 10.1016/j.pbiomolbio.2009.01.010; Nygren A, 1998, CIRC RES, V82, P63; Press William H., 2007, NUMERICAL RECIPES, V3rd; Richter Y., 2017, CINC2017 IN PRESS, V2017; Richter Y, 2017, J THEOR BIOL, V419, P100, DOI 10.1016/j.jtbi.2017.02.008; Seemann G, 2010, COMPUT CARDIOL CONF, V37, P417; Tsujimae K, 2008, AM J PHYSIOL-HEART C, V294, pH793, DOI 10.1152/ajpheart.01229.2007; Weber FM, 2011, IEEE T BIO-MED ENG, V58, P2648, DOI 10.1109/TBME.2011.2160453; Wilhelms M, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00487; Zhang HG, 2005, CARDIOVASC RES, V66, P493, DOI 10.1016/j.cardiores.2005.01.020	18	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2018	13	1							e0190448	10.1371/journal.pone.0190448	http://dx.doi.org/10.1371/journal.pone.0190448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT4YS	29360837	gold, Green Published, Green Submitted			2022-12-27	WOS:000423161800008
J	O'Donoghue, G; Kennedy, A; Puggina, A; Aleksovska, K; Buck, C; Burns, C; Cardon, G; Carlin, A; Ciarapica, D; Colotto, M; Condello, G; Coppinger, T; Cortis, C; D'Haese, S; De Craemer, M; Di Blasio, A; Hansen, S; Iacoviello, L; Issartel, J; Izzicupo, P; Jaeschke, L; Kanning, M; Ling, F; Luzak, A; Napolitano, G; Nazare, JA; Perchoux, C; Pesce, C; Pischon, T; Polito, A; Sannella, A; Schulz, H; Simon, C; Sohun, R; Steinbrecher, A; Schlicht, W; MacDonncha, C; Capranica, L; Boccia, S				O'Donoghue, Grainne; Kennedy, Aileen; Puggina, Anna; Aleksovska, Katina; Buck, Christoph; Burns, Con; Cardon, Greet; Carlin, Angela; Ciarapica, Donatella; Colotto, Marco; Condello, Giancarlo; Coppinger, Tara; Cortis, Cristina; D'Haese, Sara; De Craemer, Marieke; Di Blasio, Andrea; Hansen, Sylvia; Iacoviello, Licia; Issartel, Johann; Izzicupo, Pascal; Jaeschke, Lina; Kanning, Martina; Ling, Fiona; Luzak, Agnes; Napolitano, Giorgio; Nazare, Julie-Anne; Perchoux, Camille; Pesce, Caterina; Pischon, Tobias; Polito, Angela; Sannella, Alessandra; Schulz, Holger; Simon, Chantal; Sohun, Rhoda; Steinbrecher, Astrid; Schlicht, Wolfgang; MacDonncha, Ciaran; Capranica, Laura; Boccia, Stefania			Socio-economic determinants of physical activity across the life course: A "DEterminants of DIet and Physical ACtivity" (DEDIPAC) umbrella literature review	PLOS ONE			English	Review							HEALTH BEHAVIORS; FOLLOW-UP; ADOLESCENTS; CHILDREN; ADULTS; MORTALITY; YOUTH; WOMEN	Background To date, the scientific literature on socioeconomic correlates and determinants of physical activity behaviours has been dispersed throughout a number of systematic reviews, often focusing on one factor (e.g. education or parental income) in one specific age group (e.g. pre-school children or adults). The aim of this umbrella review is to provide a comprehensive and systematic overview of the scientific literature from previously conducted research by summarising and synthesising the importance and strength of the evidence related to socioeconomic correlates and determinants of PA behaviours across the life course. Methods Medline, Embase, ISI Web of Science, Scopus and SPORTDiscus were searched for systematic literature reviews and meta-analyses of observational studies investigating the association between socioeconomic determinants of PA and PA itself (from January 2004 to September 2017). Data extraction evaluated the importance of determinants, strength of evidence, and methodological quality of the selected papers. The full protocol is available from PROSPERO (PROSPERO2014: CRD42015010616). Results Nineteen reviews were included. Moderate methodological quality emerged. For adults, convincing evidence supports a relationship between PA and socioeconomic status (SES), especially in relation to leisure time (positive relationship) and occupational PA (negative relationship). Conversely, no association between PA and SES or parental SES was found for pre-school, school-aged children and adolescents. Conclusions Available evidence on the socioeconomic determinants of PA behaviour across the life course is probable (shows fairly consistent associations) at best. While some evidence is available for adults, less was available for youth. This is mainly due to a limited quantity of primary studies, weak research designs and lack of accuracy in the PA and SES assessment methods employed. Further PA domain specific studies using longitudinal design and clear measures of SES and PA assessment are required.	[O'Donoghue, Grainne] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland; [O'Donoghue, Grainne; Kennedy, Aileen; Issartel, Johann] Dublin City Univ, Sch Hlth & Human Performance, Dublin, Ireland; [Puggina, Anna; Aleksovska, Katina; Colotto, Marco; Boccia, Stefania] Univ Cattol Sacro Cuore, Inst Publ Hlth, Sect Hyg, Rome, Italy; [Buck, Christoph] BIPS, Leibniz Inst Prevent Res & Epidemiol, Bremen, Germany; [Burns, Con; Coppinger, Tara] Cork Inst Technol, Dept Sport Leisure & Childhood Studies, Cork, Ireland; [Cardon, Greet; D'Haese, Sara; De Craemer, Marieke] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium; [Carlin, Angela; Ling, Fiona; Sohun, Rhoda; MacDonncha, Ciaran] Univ Limerick, Dept Phys Educ & Sports Sci, Limerick, Ireland; [Ciarapica, Donatella; Polito, Angela] Res Ctr Food & Nutr, Council Agr Res & Econ, Rome, Italy; [Condello, Giancarlo; Pesce, Caterina; Capranica, Laura] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, P Za Lauro Bosis, Rome, Italy; [Cortis, Cristina; Sannella, Alessandra] Univ Cassino & Lazio Meridionale, Dept Human Sci Soc & Hlth, Cassino, Italy; [Di Blasio, Andrea; Izzicupo, Pascal; Napolitano, Giorgio] G Annunzio Univ Chieti Pescara, Dept Med & Aging Sci, Chieti Pescara, Italy; [Hansen, Sylvia; Schlicht, Wolfgang] Univ Stuttgart, Dept Sport & Exercise Sci, Stuttgart, Germany; [Iacoviello, Licia] IRCCS Inst Neurol Mediterraneo NEUROMED, Dept Epidemiol & Prevent, Pozzilli, Italy; [Jaeschke, Lina; Pischon, Tobias; Steinbrecher, Astrid] Helmholtz Assoc MDC, Max Delbrueck Ctr Mol Med, Mol Epidemiol Grp, Berlin, Germany; [Kanning, Martina] Univ Konstanz, Dept Sports Sci, Constance, Germany; [Luzak, Agnes; Schulz, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Nazare, Julie-Anne; Perchoux, Camille; Simon, Chantal] Univ 1 Lyon, INSERM, CarMeN Lab, CRNH Rhone Alpes,CENS,U1060, Lyon, France	University College Dublin; Dublin City University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Leibniz Institute for Prevention Research & Epidemiology (BIPS); Cork Institute of Technology; Ghent University; University of Limerick; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Foro Italico University of Rome; University of Cassino; G d'Annunzio University of Chieti-Pescara; University of Stuttgart; IRCCS Neuromed; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Konstanz; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Institut National de la Sante et de la Recherche Medicale (Inserm)	O'Donoghue, G (corresponding author), Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland.; O'Donoghue, G (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, Dublin, Ireland.	grainne.odonoghue@ucd.ie	Sannella, Alessandra A.S./T-5636-2017; Siani, Alfonso/B-7925-2015; Carlin, Angela/AAC-4960-2019; Iacoviello, Licia/K-4676-2016; Boccia, Stefania/AAB-9533-2022; CORTIS, Cristina/AAB-9960-2020; Carmen, Team1/Y-7382-2019; Iacoviello, Licia/AGX-7071-2022; Donncha, Ciaran Mac/I-5861-2014; De Craemer, Marieke/Z-3050-2019; Sohun, Rhoda/F-4170-2012; Laura, Capranica/AFW-3460-2022; Ling, Fiona/AAV-9315-2020; Ciarapica, Donatella/AAL-5111-2021; Sannella, Alessandra/AAE-3932-2020; De Craemer, Marieke/P-6072-2016; Pischon, Tobias/HGE-8577-2022; Polito, Angela/AAO-1596-2020; Boccia, Stefania/AFN-1666-2022; IZZICUPO, PASCAL/K-9699-2018; Condello, Giancarlo/AAC-8365-2020	Sannella, Alessandra A.S./0000-0003-3347-1901; Iacoviello, Licia/0000-0003-0514-5885; Boccia, Stefania/0000-0002-1864-749X; CORTIS, Cristina/0000-0001-9643-5532; Carmen, Team1/0000-0003-4234-1746; Iacoviello, Licia/0000-0003-0514-5885; Donncha, Ciaran Mac/0000-0001-7999-4930; De Craemer, Marieke/0000-0002-5220-7850; Sohun, Rhoda/0000-0001-8711-9212; Ling, Fiona/0000-0003-2357-3779; Ciarapica, Donatella/0000-0003-2428-416X; Sannella, Alessandra/0000-0003-3347-1901; Pischon, Tobias/0000-0003-1568-767X; Polito, Angela/0000-0003-4898-796X; Boccia, Stefania/0000-0002-1864-749X; IZZICUPO, PASCAL/0000-0001-6944-8995; Condello, Giancarlo/0000-0001-5092-3258; Carlin, Angela/0000-0001-5404-017X; Buck, Christoph/0000-0003-0261-704X; Lab, Carmen/0000-0002-5935-3236; Perchoux, Camille/0000-0003-0654-3746; Jaeschke, Lina/0000-0002-5661-228X; ODonoghue, Grainne/0000-0002-9126-2094; Kennedy, Aileen/0000-0001-8921-9006; Aleksovska, Katina/0000-0002-2372-4453; Cardon, Greet/0000-0003-4983-6557	MIUR (Italian Ministry of Instruction, University and Research) [02.15.02 COD. B84G14000040008 -AP, CDR2.PRIN 2010/11 COD. 2010KL2Y73_003 - LI]; Research Foundation Flanders Belgium; Ministry of Agricultural, Food and Forestry Policies (Ministero delle Politiche Agricole Alimentari e Forestali) Italy [14474/7303/13]; Health Research Board Ireland [DEDIPAC/2013/1- GOD]; Federal Ministry of Education and Research (Bundesministerium fOr Bildung and Forschung, Fbrderkennzeichen Germany) [01EA1377, 01EA1374, 01EA1372C, 01EA1372E]; Institut National de la Recherche Agronomique (INRA); Institut National de Prevention et d'Education pour la Sante (INPES) France; MIUR (Italian Ministry of Instruction, University and Research) [02.15.02 COD. B84G14000040008 -AP, CDR2.PRIN 2010/11 COD. 2010KL2Y73_003 - LI]; Research Foundation Flanders Belgium; Ministry of Agricultural, Food and Forestry Policies (Ministero delle Politiche Agricole Alimentari e Forestali) Italy [14474/7303/13]; Health Research Board Ireland [DEDIPAC/2013/1- GOD]; Federal Ministry of Education and Research (Bundesministerium fOr Bildung and Forschung, Fbrderkennzeichen Germany) [01EA1377, 01EA1374, 01EA1372C, 01EA1372E]; Institut National de la Recherche Agronomique (INRA); Institut National de Prevention et d'Education pour la Sante (INPES) France	MIUR (Italian Ministry of Instruction, University and Research)(Ministry of Education, Universities and Research (MIUR)); Research Foundation Flanders Belgium(FWO); Ministry of Agricultural, Food and Forestry Policies (Ministero delle Politiche Agricole Alimentari e Forestali) Italy; Health Research Board Ireland; Federal Ministry of Education and Research (Bundesministerium fOr Bildung and Forschung, Fbrderkennzeichen Germany); Institut National de la Recherche Agronomique (INRA); Institut National de Prevention et d'Education pour la Sante (INPES) France; MIUR (Italian Ministry of Instruction, University and Research)(Ministry of Education, Universities and Research (MIUR)); Research Foundation Flanders Belgium(FWO); Ministry of Agricultural, Food and Forestry Policies (Ministero delle Politiche Agricole Alimentari e Forestali) Italy; Health Research Board Ireland; Federal Ministry of Education and Research (Bundesministerium fOr Bildung and Forschung, Fbrderkennzeichen Germany); Institut National de la Recherche Agronomique (INRA); Institut National de Prevention et d'Education pour la Sante (INPES) France	This work is supported by the following funding bodies: MIUR (Italian Ministry of Instruction, University and Research): DEDIPAC F. S.; 02.15.02 COD. B84G14000040008 -AP, KA, GC, CC, ADB, PI, GN, AS, SB, LC and CDR2.PRIN 2010/11 COD. 2010KL2Y73_003 - LI, GC; and Research Foundation Flanders Belgium - GC, MDC, SDH; and Ministry of Agricultural, Food and Forestry Policies (Ministero delle Politiche Agricole Alimentari e Forestali) Italy (DEDIPAC-IRILD, D.M., 14474/7303/13) AP, CD; and Health Research Board Ireland; DEDIPAC/2013/1- GOD, AK, CB, AC, TC, JI, FL, CMD, RS; and Federal Ministry of Education and Research (Bundesministerium fOr Bildung and Forschung, Fbrderkennzeichen Germany; 01EA1377, 01EA1374, 01EA1372C, 01EA1372E CB, SH, LJ, MK, AL, TP, HS, WS, AS; and Institut National de la Recherche Agronomique (INRA) and Institut National de Prevention et d'Education pour la Sante (INPES) France: CS, JAN, CP.	[Anonymous], 2013, GLOB HLTH OBS PREV I; Aromataris E, 2015, INT J EVID-BASED HEA, V13, P132, DOI 10.1097/XEB.0000000000000055; Barnett I, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-97; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116; Beets MW, 2010, HEALTH EDUC BEHAV, V37, P621, DOI 10.1177/1090198110363884; Bukman AJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1036; Capranica L, 2015, PROSPERO INT PROSPEC, P1; Chung AE, 2012, CLIN PEDIATR, V51, P122, DOI 10.1177/0009922811417291; Coble JD, 2006, AM J PREV MED, V31, P36, DOI 10.1016/j.amepre.2006.03.004; Craggs C, 2011, AM J PREV MED, V40, P645, DOI 10.1016/j.amepre.2011.02.025; De Craemer M, 2012, OBES REV, V13, P13, DOI 10.1111/j.1467-789X.2011.00941.x; Edwardson CL, 2010, PSYCHOL SPORT EXERC, V11, P522, DOI 10.1016/j.psychsport.2010.05.001; European Commission, 2014, SPORT PHYS ACT REP S; European Commission Expert Group on Health-enhancing Physical Activity, 2015, EXP GROUP HLTH ENH P; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; Gidlow C., 2006, HEALTH EDUC J, V65, P338, DOI DOI 10.1177/0017896906069378; Gustafson SL, 2006, SPORTS MED, V36, P79, DOI 10.2165/00007256-200636010-00006; Hartling L, 2012, PLOS ONE, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0034697; Hayes A. F, 2013, INTRO MEDIATION MODE, P3, DOI DOI 10.1111/JEDM.12050; Hinkley T, 2008, AM J PREV MED, V34, P435, DOI 10.1016/j.amepre.2008.02.001; Huurre T, 2003, SOC PSYCH PSYCH EPID, V38, P249, DOI 10.1007/s00127-003-0630-7; Laaksonen M, 2008, EUR J PUBLIC HEALTH, V18, P38, DOI 10.1093/eurpub/ckm051; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lu Congchao, 2017, Int J Behav Nutr Phys Act, V14, P36, DOI 10.1186/s12966-017-0486-y; Macintyre S, 2004, J R SOC PROMO HEALTH, V124, P66, DOI 10.1177/146642400412400209; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Olsen JM, 2013, PUBLIC HEALTH NURS, V30, P288, DOI 10.1111/phn.12023; Pavey T, 2012, J EPIDEMIOL COMMUN H, V66, P737, DOI 10.1136/jech-2011-200354; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Siddiqi Z, 2011, HEALTH EDUC RES, V26, P1010, DOI 10.1093/her/cyr068; Sleddens EFC, 2015, NUTR REV, V73, P477, DOI 10.1093/nutrit/nuv007; Sleddens EFC, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0164-x; Stanley RM, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-50; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wendel-Vos W, 2007, OBES REV, V8, P425, DOI 10.1111/j.1467-789X.2007.00370.x; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	42	131	134	7	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0190737	10.1371/journal.pone.0190737	http://dx.doi.org/10.1371/journal.pone.0190737			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351286	Green Published, Green Accepted, gold			2022-12-27	WOS:000422911300022
J	Everaert, T; Spruyt, A; De Houwer, J				Everaert, Tom; Spruyt, Adriaan; De Houwer, Jan			To IMPRES or to EXPRES? Exploiting comparative judgments to measure and visualize implicit and explicit preferences	PLOS ONE			English	Article							AFFECT MISATTRIBUTION PROCEDURE; ASSOCIATION TEST; ATTITUDES; METAANALYSIS; COGNITION; VALIDITY	We introduce an adaptation of the affect misattribution procedure (AMP), called the implicit preference scale (IMPRES). Participants who complete the IMPRES indicate their preference for one of two, simultaneously presented Chinese ideographs. Each ideograph is preceded by a briefly presented prime stimulus that is irrelevant to the task. Participants are hypothesized to prefer the ideograph that is preceded by the prime they prefer. In the present research, the IMPRES was designed to capture racial attitudes (preferences for white versus black faces) and age-related attitudes (preferences for young versus old faces). Results suggest that (a) the reliability of the IMPRES is similar (or even better) than the reliability of the AMP and (b) that the IMPRES and the AMP correlate significantly. However, neither the AMP nor the IMPRES were found to predict attitude-related outcome behavior (i. e., the preparedness to donate money to a charity benefiting ethnic minorities vs. the elderly). Further research is thus necessary to establish the validity of the IMPRES. Finally, we demonstrated that, unlike the AMP, the IMPRES allows for an in-depth assessment of unanticipated response patterns and/ or extreme observations using multidimensional scaling algorithms.	[Everaert, Tom; Spruyt, Adriaan; De Houwer, Jan] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium	Ghent University	Spruyt, A (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium.	Adriaan.Spruyt@UGent.be	De Houwer, Jan/ABF-6866-2021; Spruyt, Adriaan/H-8554-2019	De Houwer, Jan/0000-0003-0488-5224; 	Methusalem Grant of Ghent University [BOF16/MET_V/002]	Methusalem Grant of Ghent University	Preparation of this paper was supported by Methusalem Grant BOF16/MET_V/002 of Ghent University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G.W., 1935, HDB SOCIAL PSYCHOL, P798; Borg I, 2010, MODERN MULTIDIMENSIO; Cameron CD, 2012, PERS SOC PSYCHOL REV, V16, P330, DOI 10.1177/1088868312440047; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; De Leeuw J., 2005, ENCY STAT BEHAV SCI, V3, P1289; De Schryver M, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.07039; DELEEUW J, 2009, J STAT SOFTW, V31, P1, DOI DOI 10.18637/JSS.V031.I03; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; Gawronski B, 2015, SOC PSYCHOL PERS SCI, V6, P101, DOI 10.1177/1948550614543029; Gawronski B, 2010, COGNITION EMOTION, V24, P1008, DOI 10.1080/02699930903112712; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Martin I, 1978, ADV BEHAV RES THER, V1, P57, DOI [10.1016/0146-6402(78)90013-9, DOI 10.1016/0146-6402(78)90013-9]; McConahay JB., 1986, PREJUDICE DISCRIMINA, P91; Nosek BA, 2011, TRENDS COGN SCI, V15, P152, DOI 10.1016/j.tics.2011.01.005; Payne BK, 2008, J PERS SOC PSYCHOL, V94, P16, DOI 10.1037/0022-3514.94.1.16; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Payne K, 2014, SOC PERSONAL PSYCHOL, V8, P672, DOI 10.1111/spc3.12148; Spruyt A, 2010, EXP PSYCHOL, V57, P36, DOI 10.1027/1618-3169/a000005; Vanaelst J, COGNITION E IN PRESS; Vanaelst J, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00717	22	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2018	13	1							e0191302	10.1371/journal.pone.0191302	http://dx.doi.org/10.1371/journal.pone.0191302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT1QM	29351345	Green Published, gold, Green Submitted			2022-12-27	WOS:000422911300070
J	Ferrigno, A; Di Pasqua, LG; Berardo, C; Siciliano, V; Rizzo, V; Adorini, L; Richelmi, P; Vairetti, M				Ferrigno, Andrea; Di Pasqua, Laura Giuseppina; Berardo, Clarissa; Siciliano, Veronica; Rizzo, Vittoria; Adorini, Luciano; Richelmi, Plinio; Vairetti, Mariapia			The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTERS; VASCULAR ENDOTHELIAL-CELLS; PLACEBO-CONTROLLED TRIAL; PORTAL-HYPERTENSION; NUCLEAR RECEPTORS; BILE-ACIDS; FXR; LIVER; RATS; EXPRESSION	Background We previously showed that increased asymmetric dimethylarginine (ADMA) biliary excretion occurs during hepatic ischemia/reperfusion (I/R), prompting us to study the effects of the farnesoid X receptor (FXR) agonist obeticholic acid (OCA) on bile, serum and tissue levels of ADMA after I/R. Material and methods Male Wistar rats were orally administered 10mg/kg/day of OCA or vehicle for 5 days and were subjected to 60 min partial hepatic ischemia or sham-operated. After a 60 min reperfusion, serum, tissue and bile ADMA levels, liver mRNA and protein expression of ADMA transporters (CAT-1, CAT-2A, CAT-2B, OCT-1, MATE-1), and enzymes involved in ADMA synthesis (protein-arginine-N-methyltransferase-1, PRMT-1) and metabolism (dimethylarginine-dimethylaminohydrolase-1, DDAH-1) were measured. Results OCA administration induced a further increase in biliary ADMA levels both in sham and I/R groups, with no significant changes in hepatic ADMA content. A reduction in CAT-1, CAT2A or CAT-2B transcripts was found in OCA-treated sham-operated rats compared with vehicle. Conversely, OCA administration did not change CAT-1, CAT-2A or CAT-2B expression, already reduced by I/R. However, a marked decrease in OCT-1 and increase in MATE-1 expression was observed. A similar trend occurred with protein expression. Conclusion The reduced mRNA expression of hepatic CAT transporters suggests that the increase in serum ADMA levels is probably due to decreased liver uptake of ADMA from the systemic circulation. Conversely, the mechanism involved in further increasing biliary ADMA levels in sham and I/R groups treated with OCA appears to be MATE-1-dependent.	[Ferrigno, Andrea; Di Pasqua, Laura Giuseppina; Berardo, Clarissa; Siciliano, Veronica; Richelmi, Plinio; Vairetti, Mariapia] Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy; [Rizzo, Vittoria] Univ Pavia, IRCCS San Matteo, Dept Mol Med, Pavia, Italy; [Adorini, Luciano] Intercept Pharmaceut, San Diego, CA USA	University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; Intercept Pharmaceuticals	Vairetti, M (corresponding author), Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy.	mariapia.vairetti@unipv.it	Ferrigno, Andrea/J-2087-2019; Vairetti, Mariapia/AAM-1757-2020; Di Pasqua, Laura Giuseppina/Y-3987-2019; Berardo, Clarissa/U-7316-2019; Adorini, Luciano/AAE-5149-2020	Ferrigno, Andrea/0000-0003-2337-2897; Vairetti, Mariapia/0000-0002-2464-6127; Di Pasqua, Laura Giuseppina/0000-0003-0103-1493; Berardo, Clarissa/0000-0002-1257-5843; Siciliano, Veronica/0000-0002-5831-0226	University of Pavia	University of Pavia	The Department of Internal Medicine and Therapeutics had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Funds from University of Pavia were used. Intercept Pharmaceutical provided support in the form of research material, precisely by supplying obeticholic acid, but did not have any additional role in the study design, data collection and analysis, decision to publish manuscript. The specific roles of this author are articulated in the 'author contributions' section'.	Abdel-Gaber SA, 2015, LIFE SCI, V134, P42, DOI 10.1016/j.lfs.2015.04.025; Abel U, 2010, BIOORG MED CHEM LETT, V20, P4911, DOI 10.1016/j.bmcl.2010.06.084; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Ceulemans LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169331; Chen N, 2011, CELL PHYSIOL BIOCHEM, V27, P341, DOI 10.1159/000327960; Chen TH, 2014, TRANSPL P, V46, P1112, DOI [10.1016/j.transproceed.2014.01.002, 10.1016/j.transproceed.2013.12.018]; CHOMCZYNSKI P, 1995, ANAL BIOCHEM, V225, P163, DOI 10.1006/abio.1995.1126; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Closs EI, 1997, BIOCHEMISTRY-US, V36, P6462, DOI 10.1021/bi962829p; Cui JY, 2012, AM J PHYSIOL-GASTR L, V302, pG979, DOI 10.1152/ajpgi.00370.2011; Ferrigno A, 2016, BASIC CLIN PHARMACOL, V119, P101, DOI 10.1111/bcpt.12540; Ferrigno A, 2015, WORLD J GASTROENTERO, V21, P1108, DOI 10.3748/wjg.v21.i4.1108; Ferrigno A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/627434; Ferrigno A, 2011, CRYOBIOLOGY, V62, P152, DOI 10.1016/j.cryobiol.2011.02.004; Ghebremariam YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060653; Hattori Y, 1999, AM J PHYSIOL-HEART C, V276, pH2020, DOI 10.1152/ajpheart.1999.276.6.H2020; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Hu XL, 2009, CIRCULATION, V120, P2222, DOI 10.1161/CIRCULATIONAHA.108.819912; Huber RM, 2002, GENE, V290, P35, DOI 10.1016/S0378-1119(02)00557-7; Hyrsova L, 2016, DRUG METAB REV, V48, P139, DOI 10.1080/03602532.2016.1188936; Jonker JW, 2004, J PHARMACOL EXP THER, V308, P2, DOI 10.1124/jpet.103.053298; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kock K, 2012, CLIN PHARMACOL THER, V92, P599, DOI 10.1038/clpt.2012.79; Laleman W, 2005, HEPATOLOGY, V42, P1382, DOI 10.1002/hep.20968; Lee H, 2006, J LIPID RES, V47, P201, DOI 10.1194/jlr.M500417-JLR200; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li CY, 2015, J AM SOC HYPERTENS, V9, P507, DOI 10.1016/j.jash.2015.04.006; Li J, 2008, CARDIOVASC RES, V77, P169, DOI 10.1093/cvr/cvm016; Li J, 2009, J PHARMACOL EXP THER, V331, P234, DOI 10.1124/jpet.109.153510; Liu YP, 2003, J CLIN INVEST, V112, P1678, DOI 10.1172/JCI200318945; Maeda T, 2004, MOL PHARMACEUT, V1, P281, DOI 10.1021/mp0499656; Mazuy C, 2015, CELL MOL LIFE SCI, V72, P1631, DOI 10.1007/s00018-014-1805-y; Mookerjee RP, 2007, HEPATOLOGY, V45, P62, DOI 10.1002/hep.21491; Mookerjee RP, 2015, J HEPATOL, V62, P325, DOI 10.1016/j.jhep.2014.08.024; Motohashi H, 2013, AAPS J, V15, P581, DOI 10.1208/s12248-013-9465-7; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Palladini G, 2012, TOXICOL PATHOL, V40, P722, DOI 10.1177/0192623312441403; Pelis RM, 2014, CURR TOP MEMBR, V73, P233, DOI 10.1016/B978-0-12-800223-0.00006-2; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Porcelli V, 2016, AMINO ACIDS, V48, P427, DOI 10.1007/s00726-015-2096-9; Roda A, 2014, J PHARMACOL EXP THER, V350, P56, DOI 10.1124/jpet.114.214650; Sepe V, 2015, EXPERT OPIN THER PAT, V25, P885, DOI 10.1517/13543776.2015.1045413; Strobel J, 2013, AMINO ACIDS, V45, P989, DOI 10.1007/s00726-013-1556-3; Tain YL, 2007, KIDNEY INT, V72, P886, DOI 10.1038/sj.ki.5002446; Teerlink T, 2009, PHARMACOL RES, V60, P448, DOI 10.1016/j.phrs.2009.08.002; Vaquero J, 2013, BIOCHEM PHARMACOL, V86, P926, DOI 10.1016/j.bcp.2013.07.022; Vaquero J, 2013, BBA-MOL CELL RES, V1833, P2212, DOI 10.1016/j.bbamcr.2013.05.006; Verbeke L, 2016, SCI REP-UK, V6, DOI 10.1038/srep33453; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wagner M, 2011, HEPATOLOGY, V53, P1023, DOI 10.1002/hep.24148; Xu JY, 2014, WORLD J GASTROENTERO, V20, P13493, DOI 10.3748/wjg.v20.i37.13493; Yokoo S, 2007, BIOCHEM PHARMACOL, V74, P477, DOI 10.1016/j.bcp.2007.03.004; Zhang R, 2012, J PHYSIOL PHARMACOL, V63, P367; Zhang R, 2016, CLIN EXP PHARMACOL P, V43, P327, DOI 10.1111/1440-1681.12535	58	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191430	10.1371/journal.pone.0191430	http://dx.doi.org/10.1371/journal.pone.0191430			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346429	gold, Green Published, Green Submitted			2022-12-27	WOS:000422749500049
J	Hassan, MK; Kumar, D; Naik, M; Dixit, M				Hassan, Md. Khurshidul; Kumar, Dinesh; Naik, Monali; Dixit, Manjusha			The expression profile and prognostic significance of eukaryotic translation elongation factors in different cancers	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; GAMMA-RELATED SEQUENCE; FACTOR 1 ALPHA-2; FACTOR EEF1A2; FACTOR-I; PROTEIN-SYNTHESIS; DOWN-REGULATION; UP-REGULATION; FACTOR EEF2; OVEREXPRESSION	Eukaryotic translation factors, especially initiation factors have garnered much attention with regards to their role in the onset and progression of different cancers. However, the expression levels and prognostic significance of translation elongation factors remain poorly explored in different cancers. In this study, we have investigated the mRNA transcript levels of seven translation elongation factors in different cancer types using Oncomine and TCGA databases. Furthermore, we have identified the prognostic significance of these factors using Kaplan-Meier Plotter and SurvExpress databases. We observed altered expression levels of all the elongation factors in different cancers. Higher expression of EEF1A2, EEF1 B2, EEF1G, EEF1 D, EEF1 El and EEF2 was observed in most of the cancer types, whereas reverse trend was observed for EEF1A1. Overexpression of many factors predicted poor prognosis in breast (EEF1 D, EEF1 El, EEF2) and lung cancer (EEF1A2, EEF1 B2, EEF1G, EEF1 El). However, we didn't see any common correlation of expression levels of elongation factors with survival outcomes across cancer types. Cancer subtype stratification showed association of survival outcomes and expression levels of elongation factors in specific sub-types of breast, lung and gastric cancer. Most interestingly, we observed a reciprocal relationship between the expression levels of the two EEF1A isoforms viz. EEF1A1 and EEF1A2, in most of the cancer types. Our results suggest that translation elongation factors can have a role in tumorigenesis and affect survival in cancer specific manner. Elongation factors have potential to serve as biomarkers and therapeutic drug targets, yet further study is required. Reciprocal relationship of differential expression between EEF1A isoforms observed in multiple cancer types indicates opposing roles in cancer and needs further investigation.	[Hassan, Md. Khurshidul; Kumar, Dinesh; Naik, Monali; Dixit, Manjusha] HBNI, Sch Biol Sci, Natl Inst Sci Educ & Res, Khurja, Odisha, India	Homi Bhabha National Institute; National Institute of Science Education & Research (NISER)	Dixit, M (corresponding author), HBNI, Sch Biol Sci, Natl Inst Sci Educ & Res, Khurja, Odisha, India.	manjusha@niser.ac.in	Kalra, D/H-6661-2019; Dixit, Manjusha/Y-9892-2019	Kalra, D/0000-0001-5254-4067; Dixit, Manjusha/0000-0002-6997-1054; Hassan, Mohammed Khurshidul/0000-0002-4526-4849; Kumar, Dinesh/0000-0002-3890-326X				Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Byun HO, 2009, CANCER RES, V69, P4638, DOI 10.1158/0008-5472.CAN-08-4042; Chang YWE, 1997, J BIOL CHEM, V272, P28252, DOI 10.1074/jbc.272.45.28252; Chen E, 2000, EXP CELL RES, V259, P140, DOI 10.1006/excr.2000.4952; CHI KF, 1992, GASTROENTEROLOGY, V103, P98, DOI 10.1016/0016-5085(92)91101-9; De Bortoli M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-223; Dreos R, NUCL ACIDS RES, V41, pD157; Duanmin H, HEPATOGASTROENTEROLO, V60, P870; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; Flores IL, 2016, CLIN SCI, V130, P785, DOI 10.1042/CS20150646; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; HASSELL JA, 1976, BIOCHEMISTRY-US, V15, P1375, DOI 10.1021/bi00652a004; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Iadevaia V, 2008, RNA, V14, P1730, DOI 10.1261/rna.1037108; Johnsson A, 2000, BRIT J CANCER, V83, P1047, DOI 10.1054/bjoc.2000.1420; Joseph P, 2004, MOL CARCINOGEN, V40, P171, DOI 10.1002/mc.20033; Kawamura M, 2014, ANTICANCER RES, V34, P651; Kim SS, 2011, TUMORI, V97, P380, DOI 10.1700/912.10038; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Kulkarni G, 2007, BREAST CANCER RES TR, V102, P31, DOI 10.1007/s10549-006-9315-8; Lamberti A, 2007, CELL DEATH DIFFER, V14, P952, DOI 10.1038/sj.cdd.4402102; Lee Jonathan M, 2003, Reprod Biol Endocrinol, V1, P69, DOI 10.1186/1477-7827-1-69; LEW Y, 1992, PANCREAS, V7, P144, DOI 10.1097/00006676-199203000-00003; LI ZB, 2010, PLOS ONE, P1, DOI DOI 10.1371/J0URNAL.P0NE.0010755; Madhavan S, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0150-9; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MIMORI K, 1995, CANCER, V75, P1446, DOI 10.1002/1097-0142(19950315)75:6+<1446::AID-CNCR2820751509>3.0.CO;2-P; Nakamura J, 2009, INT J ONCOL, V34, P1181, DOI 10.3892/ijo_00000246; Newbery HJ, 2007, J BIOL CHEM, V282, P28951, DOI 10.1074/jbc.M703962200; Newbery HJ, 2011, BIOCHEM BIOPH RES CO, V411, P19, DOI 10.1016/j.bbrc.2011.06.062; Oji Y, 2014, INT J ONCOL, V44, P1461, DOI 10.3892/ijo.2014.2318; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; Pan J, 2004, DEV BRAIN RES, V149, P1, DOI 10.1016/j.devbrainres.2003.10.011; Pinke DE, 2008, GYNECOL ONCOL, V108, P561, DOI 10.1016/j.ygyno.2007.11.019; Pott LL, 2017, ONCOTARGET, V8, P11950, DOI 10.18632/oncotarget.14447; Qiu FN, 2016, WORLD J GASTROENTERO, V22, P4226, DOI 10.3748/wjg.v22.i16.4226; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ruest LB, 2002, J BIOL CHEM, V277, P5418, DOI 10.1074/jbc.M110685200; Scaggiante B, 2012, BRIT J CANCER, V106, P166, DOI 10.1038/bjc.2011.500; Spilka R, 2013, CANCER LETT, V340, P9, DOI 10.1016/j.canlet.2013.06.019; Sun HG, 2013, ASIAN PAC J CANCER P, V14, P6533, DOI 10.7314/APJCP.2013.14.11.6533; Sun Y, 2014, BIOCHEM BIOPH RES CO, V450, P1, DOI 10.1016/j.bbrc.2014.05.045; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; Talukder AH, 2001, J BIOL CHEM, V276, P5636, DOI 10.1074/jbc.M006824200; Thornton S, 2003, J MOL MED, V81, P536, DOI 10.1007/s00109-003-0461-8; VENEMA RC, 1991, J BIOL CHEM, V266, P11993; Xu C, 2013, CLIN EXP METASTAS, V30, P933, DOI 10.1007/s10585-013-9593-6; Yang S, 2015, J CANCER RES CLIN, V141, P1265, DOI 10.1007/s00432-014-1897-7; Zang WQ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0315-3	52	53	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191377	10.1371/journal.pone.0191377	http://dx.doi.org/10.1371/journal.pone.0191377			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342219	Green Published, gold, Green Submitted			2022-12-27	WOS:000422653800068
J	Rimkus, SA; Wassarman, DA				Rimkus, Stacey A.; Wassarman, David A.			A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA; DNA-DAMAGE; IN-VIVO; PARKINSONS-DISEASE; NEURODEGENERATION; CELLS; ACTIVATION; MITOPHAGY; DEFENSE; REPAIR	Ataxia-telangiectasia (A-T) is a neurodegenerative disease caused by mutation of the A-T mutated (ATM) gene. ATM encodes a protein kinase that is activated by DNA damage and phosphorylates many proteins, including those involved in DNA repair, cell cycle control, and apoptosis. Characteristic biological and molecular functions of ATM observed in mammals are conserved in Drosophila melanogaster. As an example, conditional loss-of-function ATM alleles in flies cause progressive neurodegeneration through activation of the innate immune response. However, unlike in mammals, null alleles of ATM in flies cause lethality during development. With the goals of understanding biological and molecular roles of ATM in a whole animal and identifying candidate therapeutics for A-T, we performed a screen of 2400 compounds, including FDA-approved drugs, natural products, and bioactive compounds, for modifiers of the developmental lethality caused by a temperature-sensitive ATM allele (ATM(8)) that has reduced kinase activity at non-permissive temperatures. Ten compounds reproducibly suppressed the developmental lethality of ATM(8) flies, including Ronnel, which is an organophosphate. Ronnel and other suppressor compounds are known to cause mitochondrial dysfunction or to inhibit the enzyme acetylcholinesterase, which controls the levels of the neurotransmitter acetylcholine, suggesting that detrimental consequences of reduced ATM kinase activity can be rescued by inhibiting the function of mitochondria or increasing acetylcholine levels. We carried out further studies of Ronnel because, unlike the other compounds that suppressed the developmental lethality of homozygous ATM(8) flies, Ronnel was toxic to the development of heterozygous ATM(8) flies. Ronnel did not affect the innate immune response of ATM(8) flies, and it further increased the already high levels of DNA damage in brains of ATM(8) flies, but its effects were not harmful to the lifespan of rescued ATM(8) flies. These results provide new leads for understanding the biological and molecular roles of ATM and for the treatment of A-T.	[Rimkus, Stacey A.; Wassarman, David A.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Med Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Wassarman, DA (corresponding author), Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Med Genet, Madison, WI 53706 USA.	dawassarman@wisc.edu		Wassarman, David/0000-0002-7042-9561	National Institutes of Health (NIH) [R21 NS085302, R01 NS083596]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083596, R21NS085302] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NIH) (R21 NS085302 and R01 NS083596 to D.A.W.).	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bessadottir M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051296; Biasibetti-Brendler H., 2017, MOL NEUROBIOL; Chang S, 2008, NAT CHEM BIOL, V4, P256, DOI 10.1038/nchembio.78; Chen JM, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0127-y; Choy KR, 2018, DEV DYNAM, V247, P33, DOI 10.1002/dvdy.24522; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Du LT, 2009, J EXP MED, V206, P2285, DOI 10.1084/jem.20081940; Fakhoury M, 2016, J NEUROL, V263, P1683, DOI 10.1007/s00415-016-8052-0; Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004; Farag MA, 2016, Z NATURFORSCH C, V71, P393, DOI 10.1515/znc-2016-0030; Fivenson E. M., 2017, NEUROCHEM INT; Gade S, 2017, BBA-GEN SUBJECTS, V1861, P541, DOI 10.1016/j.bbagen.2016.11.044; Galimberti D, 2016, CURR ALZHEIMER RES, V13, P1100; Gluck MR, 2004, J NEUROCHEM, V91, P788, DOI 10.1111/j.1471-4159.2004.02747.x; Guleria A, 2016, DNA REPAIR, V39, P1, DOI 10.1016/j.dnarep.2015.12.009; Gurley KE, 2001, CURR BIOL, V11, P191, DOI 10.1016/S0960-9822(01)00048-3; Jung MR, 2012, ADV EXP MED BIOL, V720, P181, DOI 10.1007/978-1-4614-0254-1_15; Karami-Mohajeri S, 2013, TOXICOL APPL PHARM, V270, P39, DOI 10.1016/j.taap.2013.04.001; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Lee EA, 2015, CANCER RES, V75, P2478, DOI 10.1158/0008-5472.CAN-14-2676; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine BD, 2016, CELL REP, V14, P1477, DOI 10.1016/j.celrep.2015.12.105; Liao WJ, 2009, METHODS, V48, P46, DOI 10.1016/j.ymeth.2009.02.016; Maciejczyk M, 2017, REDOX BIOL, V11, P375, DOI 10.1016/j.redox.2016.12.030; Mansouri A, 2008, NUTRITION, V24, P360, DOI 10.1016/j.nut.2007.12.008; McGrath-Morrow SA, 2016, J PEDIATR-US, V171, P256, DOI 10.1016/j.jpeds.2016.01.002; McGrath-Morrow SA, 2010, J PEDIATR-US, V156, P682, DOI 10.1016/j.jpeds.2009.12.007; Ojha A, 2013, ENVIRON TOXICOL, V28, P543, DOI 10.1002/tox.20748; Pagano G, 2015, J NEUROL NEUROSUR PS, V86, P767, DOI 10.1136/jnnp-2014-308764; Pedersen M, 2010, GENOME, V53, P778, DOI [10.1139/g10-067, 10.1139/G10-067]; Petersen AJ, 2013, GENETICS, V194, P133, DOI 10.1534/genetics.113.150854; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Rimkus SA, 2008, GENE DEV, V22, P1205, DOI 10.1101/gad.1639608; Rosati A, 2004, CELL DEATH DIFFER, V11, pS216, DOI 10.1038/sj.cdd.4401534; Rothblum-Oviatt C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0543-7; Silva E, 2004, CURR BIOL, V14, P1341, DOI 10.1016/j.cub.2004.06.056; Song YH, 2004, CURR BIOL, V14, P1354, DOI 10.1016/j.cub.2004.06.064; Sunkaria A, 2013, J NEUROSCI RES, V91, P444, DOI 10.1002/jnr.23173; Wang LQ, 2016, J NEUROSCI, V36, P1445, DOI 10.1523/JNEUROSCI.0256-15.2016; Whitworth AJ, 2017, CURR OPIN GENET DEV, V44, P47, DOI 10.1016/j.gde.2017.01.016; Willoughby LF, 2013, DIS MODEL MECH, V6, P521, DOI 10.1242/dmm.009985	42	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190821	10.1371/journal.pone.0190821	http://dx.doi.org/10.1371/journal.pone.0190821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338042	gold, Green Submitted, Green Published			2022-12-27	WOS:000422652700020
J	Egashira, K; Sumita, Y; Zhong, WJ; Takashi, I; Ohba, S; Nagai, K; Asahina, I				Egashira, Kazuhiro; Sumita, Yoshinori; Zhong, Weijian; Takashi, I; Ohba, Seigo; Nagai, Kazuhiro; Asahina, Izumi			Bone marrow concentrate promotes bone regeneration with a suboptimal-dose of rhBMP-2	PLOS ONE			English	Article							PLATELET-RICH PLASMA; PROGENITOR CELLS; POOR PLASMA; RECONSTRUCTION; SUBSTITUTES; COMBINATION; MORBIDITY; PROTEINS; EFFICACY; FIBRIN	Bone marrow concentrate (BMC), which is enriched in mononuclear cells (MNCs) and platelets, has recently attracted the attention of clinicians as a new optional means for bone engineering. We previously reported that the osteoinductive effect of bone morphogenetic protein-2 (BMP-2) could be enhanced synergistically by co-transplantation of peripheral blood (PB)-derived platelet-rich plasma (PRP). This study aims to investigate whether BMC can effectively promote bone formation induced by low-dose BMP-2, thereby reducing the undesirable side-effects of BMP-2, compared to PRP. Human BMC was obtained from bone marrow aspirates using an automated blood separator. The BMC was then seeded onto beta-TCP granules pre-adsorbed with a suboptimal-dose (minimum concentration to induce bone formation at 2 weeks in mice) of recombinant human (rh) BMP-2. These specimens were transplanted subcutaneously to the dorsal skin of immunodeficient-mice and the induction of ectopic bone formation was assessed 2 and 4 weeks post-transplantation. Transplantations of five other groups [PB, PRP, platelet-poor plasma (PPP), bone marrow aspirate (BM), and BM-PPP] were employed as experimental controls. Then, to clarify the effects on vertical bone augmentation, specimens from the six groups were transplanted for on-lay placement on the craniums of mice. The results indicated that BMC, which contained an approximately 2.5-fold increase in the number of MNCs compared to PRP, could accelerate ectopic bone formation until 2 weeks post-transplantation. On the cranium, the BMC group promoted bone augmentation with a suboptimal-dose of rhBMP-2 compared to other groups. Particularly in the BMC specimens harvested at 4 weeks, we observed newly formed bone surrounding the TCP granules at sites far from the calvarial bone. In conclusion, the addition of BMC could reduce the amount of rhBMP-2 by one-half via its synergistic effect on early-phase osteoinduction. We propose here that BMC transplantation facilitates the clinical use of rhBMP-2 as an alternative strategy for bone engineering.	[Egashira, Kazuhiro; Sumita, Yoshinori; Takashi, I; Ohba, Seigo; Asahina, Izumi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Unit Translat Med, Nagasaki, Japan; [Sumita, Yoshinori] Nagasaki Univ, Grad Sch Biomed Sci, Basic & Translat Res Ctr Hard Tissue Dis, Unit Translat Med, Nagasaki, Japan; [Zhong, Weijian] Dalian Med Univ, Coll Stomatol, Dept Oral & Maxillofacial Surg, Dalian, Liaoning, Peoples R China; [Nagai, Kazuhiro] Nagasaki Univ Hosp, Transfus & Cell Therapy Unit, Nagasaki, Japan	Nagasaki University; Nagasaki University; Dalian Medical University; Nagasaki University	Sumita, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Unit Translat Med, Nagasaki, Japan.; Sumita, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Basic & Translat Res Ctr Hard Tissue Dis, Unit Translat Med, Nagasaki, Japan.	y-sumita@nagasaki-u.ac.jp	Ohba, Seigo/ABE-3239-2020		Japan Society for Promotion of Science [24890163, 25670863]; Grants-in-Aid for Scientific Research [15H05044] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Research Activity Start-up Scientific Research (24890163; funded to KE) and for Challenging Exploratory Research (25670863; funded to IS and YS) from Japan Society for Promotion of Science.; The authors wish to thank Ms. Naoko Sakashita (Nagasaki University) for providing technical assistance with the experiments. This work was supported by Grants-in-Aid for Research Activity Start-up Scientific Research (24890163) and for Challenging Exploratory Research (25670863) from the Japan Society for Promotion of Science. All authors declare that there are no conflicts of interest.	Anavi Y, 2011, J ORAL IMPLANTOL, V37, P379, DOI 10.1563/AAID-JOI-D-09-00128.1; Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Atesok K, 2010, J ORTHOP RES, V28, P1007, DOI 10.1002/jor.21083; Bateman J, 2005, J PERIODONTOL, V76, P1833, DOI 10.1902/jop.2005.76.11.1833; Boyne PJ, 2005, J ORAL MAXIL SURG, V63, P1693, DOI 10.1016/j.joms.2005.08.018; Boyne PJ, 1998, BRIT J ORAL MAX SURG, V36, P84, DOI 10.1016/S0266-4356(98)90173-5; Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005; Diefenderfer DL, 2003, CONNECT TISSUE RES, V44, P305, DOI 10.1080/03008200390181825; El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302; Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd; Galliera E, 2012, J BIOL REGUL HOMEOST, V26, P35; Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009; Hamdan AAS, 2009, CLIN ORAL IMPLAN RES, V20, P616, DOI 10.1111/j.1600-0501.2008.01687.x; Hatakeyama I, 2014, TISSUE ENG PT A, V20, P874, DOI [10.1089/ten.tea.2013.0058, 10.1089/ten.TEA.2013.0058]; Herberg S, 2014, TISSUE ENG PT A, V20, P1444, DOI [10.1089/ten.TEA.2013.0442, 10.1089/ten.tea.2013.0442]; Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455; Hokugo A, 2014, BIOMATERIALS, V35, P5565, DOI 10.1016/j.biomaterials.2014.03.018; Imam MA, 2017, SICOT-J, V3, DOI 10.1051/sicotj/2017007; James AW, 2016, TISSUE ENG PART B-RE, V22, P284, DOI [10.1089/ten.teb.2015.0357, 10.1089/ten.TEB.2015.0357]; Kelly MP, 2016, J ORAL MAXIL SURG, V74, P928, DOI 10.1016/j.joms.2015.11.027; Kretlow JD, 2010, TISSUE ENG PT A, V16, P3555, DOI 10.1089/ten.TEA.2010.0471; Mankani MH, 2006, STEM CELLS, V24, P2140, DOI 10.1634/stemcells.2005-0567; Masuda T, 2015, J HARD TISSUE BIOL, V24, P7, DOI 10.2485/jhtb.24.7; Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922; Nakatani Y, 2017, ARCH ORAL BIOL, V73, P172, DOI 10.1016/j.archoralbio.2016.10.006; Nandi SK, 2010, INDIAN J MED RES, V132, P15; Nishimoto S, 2012, INDIAN J PLAST SURG, V45, P109, DOI 10.4103/0970-0358.96599; Nkenke E, 2001, CLIN ORAL IMPLAN RES, V12, P495, DOI 10.1034/j.1600-0501.2001.120510.x; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Pettine KA, 2015, STEM CELLS, V33, P146, DOI 10.1002/stem.1845; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Plachokova AS, 2007, CLIN ORAL IMPLAN RES, V18, P244, DOI 10.1111/j.1600-0501.2006.01327.x; Reddi AH, 1998, CLIN ORTHOP RELAT R, pS66; Sauerbier S, 2011, TISSUE ENG PT A, V17, P2187, DOI [10.1089/ten.tea.2010.0516, 10.1089/ten.TEA.2010.0516]; Schaaf H, 2010, ORAL SURG ORAL MED O, V109, P52, DOI 10.1016/j.tripleo.2009.08.023; Schmelzeisen R, 2010, BR J ORAL MAXILLOFAC, V49, P4980; Schorn L, 2017, HEAD FACE MED, V13, DOI 10.1186/s13005-017-0146-0; Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609; Skowronskim PP, 2003, MUSC ORTHOP J, V6, P58; Sununliganon L, 2014, J CRANIO MAXILL SURG, V42, P1753, DOI 10.1016/j.jcms.2014.06.011; Usami K, 2009, J BIOMED MATER RES A, V90A, P730, DOI 10.1002/jbm.a.32142; Wiltfang J, 2004, CLIN ORAL IMPLAN RES, V15, P187, DOI 10.1111/j.1600-0501.2004.00980.x; Wojtowicz Andrzej, 2007, N Y State Dent J, V73, P41; Yaremchuk KL, 2010, LARYNGOSCOPE, V120, P1954, DOI 10.1002/lary.21096; Yoshida K, 2013, BIO-MED MATER ENG, V23, P163, DOI 10.3233/BME-130741; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031722	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191099	10.1371/journal.pone.0191099	http://dx.doi.org/10.1371/journal.pone.0191099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346436	Green Published, Green Submitted, gold			2022-12-27	WOS:000422749500026
J	Dantas, KC; de Freitas, RS; da Silva, MV; Criado, PR; Luiz, OD; Vicentini, AP				Dantas, Katia Cristina; de Freitas, Roseli Santos; da Silva, Marcos Vinicius; Criado, Paulo Ricardo; Luiz, Olinda do Carmo; Vicentini, Adriana Pardini			Comparison of diagnostic methods to detect Histoplasma capsulatum in serum and blood samples from AIDS patients	PLOS ONE			English	Article							REAL-TIME PCR; VAR. CAPSULATUM; NESTED PCR; MOLECULAR DIAGNOSIS; INVASIVE MYCOSES; CLINICAL-SAMPLES; MULTIPLEX PCR; WHOLE-BLOOD; IDENTIFICATION; ASSAYS	Background Although early and rapid detection of histoplasmosis is essential to prevent morbidity and mortality, few diagnostic tools are available in resource-limited areas, especially where it is endemic and HIV/AIDS is also epidemic. Thus, we compared conventional and molecular methods to detect Histoplasma capsulatum in sera and blood from HIV/AIDS patients. Methodology We collected a total of 40 samples from control volunteers and patients suspected of histoplasmosis, some of whom were also infected with other pathogens. Samples were then analyzed by mycological, serological, and molecular methods, and stratified as histoplasmostic with (group I) or without AIDS (group II), uninfected (group III), and infected with HIV and other pathogens only (group IV). All patients were receiving treatment for histoplasmosis and other infections at the time of sample collection. Results Comparison of conventional methods with nested PCR using primers against H. capsulatum 18S rRNA (HC18S), 5.8S rRNA ITS (HC5.8S-ITS), and a 100 kDa protein (HC100) revealed that sensitivity against sera was highest for PCR with HC5.8S-ITS, followed by immunoblotting, double immunodiffusion, PCR with HC18S, and PCR with HC100. Specificity was equally high for double immunodiffusion, immunoblotting and PCR with HC100, followed for PCR with HC18S and HC5.8-ITS. Against blood, sensitivity was highest for PCR with HC5.8S-ITS, followed by PCR with HC18S, Giemsa staining, and PCR with HC100.Specificity was highest for Giemsa staining and PCR with HC100, followed by PCR with HC18S and HC5.8S-ITS. PCR was less efficient in patients with immunodeficiency due to HIV/AIDS and/or related diseases. Conclusion Molecular techniques may detect histoplasmosis even in cases with negative serology and mycology, potentially enabling early diagnosis.	[Dantas, Katia Cristina] Univ Sao Paulo, Med Sch, Dept Pathol, Sao Paulo, Brazil; [de Freitas, Roseli Santos; Criado, Paulo Ricardo] Univ Sao Paulo, Med Mycol Lab LIM 53, HCFMUSP, Sao Paulo, Brazil; [de Freitas, Roseli Santos; Criado, Paulo Ricardo] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil; [da Silva, Marcos Vinicius] Catholic Univ Sao Paulo, Dept Med, Minist Hlth, Emilio Ribas Inst Infect Dis, Sao Paulo, Brazil; [da Silva, Marcos Vinicius] Dept State Hlth, Program Postgrad Sci & Coordinat Dis Control, Sao Paulo, Brazil; [Criado, Paulo Ricardo] ABC Med Sch, Sao Paulo, Brazil; [Luiz, Olinda do Carmo] Univ Sao Paulo, Med Sch, Prevent Med Dept, Sao Paulo, Brazil; [Vicentini, Adriana Pardini] Adolfo Lutz Inst, Immunol Ctr, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Pontificia Universidade Catolica de Sao Paulo; Faculdade de Medicina do ABC; Universidade de Sao Paulo; Instituto Adolfo Lutz	Dantas, KC (corresponding author), Univ Sao Paulo, Med Sch, Dept Pathol, Sao Paulo, Brazil.	katia.dantas@fm.usp.br	DANTAS, KÁTIA/AAA-3630-2022; Silva, Marcos Vinicius Gualberto Barbosa/AAS-1837-2020; Criado, Paulo/D-5369-2009; Dantas, Katia Cristina/AAN-6543-2021; Luiz, Olinda do Carmo/C-6075-2012; Vicentini, Adriana P/B-4443-2018	Silva, Marcos Vinicius Gualberto Barbosa/0000-0001-5449-1413; Criado, Paulo/0000-0001-9785-6099; Dantas, Katia Cristina/0000-0003-1346-9003; Luiz, Olinda do Carmo/0000-0002-2596-3626; 	State of Sao Paulo Research Foundation (FAPESP) [2009/50362-0]	State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the State of Sao Paulo Research Foundation (FAPESP) under grant n. 2009/50362-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elias NA, 2012, MYCOPATHOLOGIA, V174, P451, DOI 10.1007/s11046-012-9567-2; Almeida MD, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1427-0; Bahr Nathan C, 2015, Curr Trop Med Rep, V2, P70; Bialek R, 2002, AM J CLIN PATHOL, V117, P597; Bialek R, 2002, J CLIN MICROBIOL, V40, P1644, DOI 10.1128/JCM.40.5.1644-1647.2002; Bracca A, 2003, J CLIN MICROBIOL, V41, P1753, DOI 10.1128/JCM.41.4.1753-1755.2003; Buitrago MJ, 2006, EUR J CLIN MICROBIOL, V25, P665, DOI 10.1007/s10096-006-0207-y; Caceres DH, 2015, AM J TROP MED HYG, V93, P662, DOI 10.4269/ajtmh.15-0108; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dantas KC, 2013, AN BRAS DERMATOL, V88, P141, DOI 10.1590/S0365-05962013000100025; De Hoog G. S., 2000, ATLAS CLIN FUNGI; DISALVO AF, 1980, J CLIN MICROBIOL, V11, P238, DOI 10.1128/JCM.11.3.238-241.1980; ERCOLANI L, 1988, J BIOL CHEM, V263, P15335; Falci DR, 2017, BRAZ J INFECT DIS, V21, P7, DOI 10.1016/j.bjid.2016.09.012; FLETCHER RH, 1996, EPIDEMIOLOGIA CLIN E, P52; Freitas RS, 2009, J VENOM ANIM TOXINS, V15, P278, DOI 10.1590/S1678-91992009000200010; Fujita SI, 2001, J CLIN MICROBIOL, V39, P3617, DOI 10.1128/JCM.39.10.3617-3622.2001; Garbee DD, 2017, CRIT CARE NURS CLIN, V29, P67, DOI 10.1016/j.cnc.2016.09.011; Frias-De-Leon M, 2017, FOLIA MICROBIOL, V62, P111, DOI 10.1007/s12223-016-0477-4; Guimaraes AJ, 2006, BRAZ J MICROBIOL, V37, P1, DOI 10.1590/S1517-83822006000100001; Kauffman CA, 2008, CURR OPIN INFECT DIS, V21, P421, DOI 10.1097/QCO.0b013e328306eb8d; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Martagon-Villamil J, 2003, J CLIN MICROBIOL, V41, P1295, DOI 10.1128/JCM.41.3.1295-1298.2003; Nacher M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002319; Negroni R, 2010, REV ARGENT MICROBIOL, V42, P254, DOI 10.1590/S0325-75412010000400003; Brilhante RSN, 2010, ANTIMICROB AGENTS CH, V54, P3978, DOI 10.1128/AAC.00793-10; Ohno H, 2013, J INFECT CHEMOTHER, V19, P999, DOI 10.1007/s10156-013-0548-2; Ostrosky-Zeichner L, 2012, AM J MED, V125, pS14, DOI 10.1016/j.amjmed.2011.10.008; Passos AN, 2014, BRAZ J MICROBIOL, V45, P1357, DOI 10.1590/S1517-83822014000400028; Powers-Fletcher MV, 2016, INFECT DIS CLIN N AM, V30, P37, DOI 10.1016/j.idc.2015.10.005; Prado M, 2009, MEM I OSWALDO CRUZ, V104, P513, DOI 10.1590/S0074-02762009000300019; Prattes J, 2016, CURR FUNGAL INFECT R, V10, P43, DOI 10.1007/s12281-016-0254-5; Rivasi F, 2001, APMIS, V109, P721, DOI 10.1034/j.1600-0463.2001.d01-138.x; Sampaio ID, 2012, REV IBEROAM MICOL, V29, P34, DOI 10.1016/j.riam.2011.03.008; Scheel CM, 2014, J CLIN MICROBIOL, V52, P483, DOI 10.1128/JCM.02739-13; Toranzo AI, 2009, REV ARGENT MICROBIOL, V41, P20; Wheat LJ, 2006, TRANSPL INFECT DIS, V8, P128, DOI 10.1111/j.1399-3062.2006.00165.x; Wheat LJ, 2016, INFECT DIS CLIN N AM, V30, P207, DOI 10.1016/j.idc.2015.10.009; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Zancope-Oliveira RM, 1994, CLIN DIAGN LAB IMMUN, V1, P197	40	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190408	10.1371/journal.pone.0190408	http://dx.doi.org/10.1371/journal.pone.0190408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342162	gold, Green Submitted, Green Published			2022-12-27	WOS:000422653800021
